PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cheung, CMG; Wong, TY				Cheung, Chui Ming Gemmy; Wong, Tien Y.			Treatment of age-related macular degeneration	LANCET			English	Editorial Material							RANIBIZUMAB; RISK		[Wong, Tien Y.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore 168751, Singapore; Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; Duke Natl Univ Singapore Grad Med Sch, Eye Acad Clin Program, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore	Wong, TY (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore 168751, Singapore.	ophwty@nus.edu.sg	Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264; Cheung, Chui Ming Gemmy/0000-0003-3358-3516				Boyer D, 2013, ASS RES VIS OPHTH AN; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chakravarthy U, 2013, LANCET; Chakravarthy U, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.04.015; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Cheung N, 2012, AM J OPHTHALMOL, V153, P193, DOI 10.1016/j.ajo.2011.11.022; Cohen SY, 2009, AM J OPHTHALMOL, V148, P409, DOI 10.1016/j.ajo.2009.04.001; Curtis LH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI 10.1001/archophthalmol.2010.223; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Holz FG, 2012, ACTA OPHTHALMOL, DOI 10.1111/j.1755-3768.2012.02493.x; Levinson DR, 2011, REV MEDICARE B; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lim LS, 2011, AM J OPHTHALMOL, V152, P329, DOI 10.1016/j.ajo.2011.05.040; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Wong TY, 2007, LANCET, V370, P204, DOI 10.1016/S0140-6736(07)61104-0; Wong TY, 2006, ANN INTERN MED, V145, P98, DOI 10.7326/0003-4819-145-2-200607180-00007	18	19	21	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2013	382	9900					1230	1232		10.1016/S0140-6736(13)61580-9	http://dx.doi.org/10.1016/S0140-6736(13)61580-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235XP	23870812	hybrid			2022-12-28	WOS:000325756400008
J	Beachler, DC; D'Souza, G				Beachler, Daniel C.; D'Souza, Gypsyamber			Natural history of oral papillomavirus infection in men	LANCET			English	Editorial Material							HPV INFECTION; PREVALENCE		[Beachler, Daniel C.; D'Souza, Gypsyamber] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	D'Souza, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	gdsouza@jhsph.edu		Beachler, Daniel/0000-0003-2788-3061				Beachler DC, 2013, J INFECT DIS, V208, P330, DOI 10.1093/infdis/jit170; Beachler DC, 2012, CANCER EPIDEM BIOMAR, V21, P122, DOI 10.1158/1055-9965.EPI-11-0734; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Edelstein ZR, 2012, SEX TRANSM DIS, V39, P860, DOI 10.1097/OLQ.0b013e318269d098; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Giuliano AR, 2002, J INFECT DIS, V186, P462, DOI 10.1086/341782; Pickard RKL, 2012, SEX TRANSM DIS, V39, P559, DOI 10.1097/OLQ.0b013e31824f1c65; Pierce Campbell CM, 2013, LANCET	10	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2013	382	9895					839	841		10.1016/S0140-6736(13)61123-X	http://dx.doi.org/10.1016/S0140-6736(13)61123-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215WE	23827091				2022-12-28	WOS:000324240700008
J	Chen, C; Ke, JY; Zhou, XE; Yi, W; Brunzelle, JS; Li, J; Yong, EL; Xu, HE; Melcher, K				Chen, Chen; Ke, Jiyuan; Zhou, X. Edward; Yi, Wei; Brunzelle, Joseph S.; Li, Jun; Yong, Eu-Leong; Xu, H. Eric; Melcher, Karsten			Structural basis for molecular recognition of folic acid by folate receptors	NATURE			English	Article							DIFFRACTION	Folate receptors (FR alpha, FR beta and FR gamma) are cysteine-rich cell-surface glycoproteins that bind folate with high affinity to mediate cellular uptake of folate. Although expressed at very low levels in most tissues, folate receptors, especially FR alpha, are expressed at high levels in numerous cancers to meet the folate demand of rapidly dividing cells under low folate conditions(1-3). The folate dependency of many tumours has been therapeutically and diagnostically exploited by administration of anti-FR alpha antibodies, high-affinity antifolates(4,5), folate-based imaging agents and folate-conjugated drugs and toxins(6-8). To understand how folate binds its receptors, we determined the crystal structure of human FR alpha in complex with folic acid at 2.8 angstrom resolution. FR alpha has a globular structure stabilized by eight disulphide bonds and contains a deep open folate-binding pocket comprised of residues that are conserved in all receptor subtypes. The folate pteroate moiety is buried inside the receptor, whereas its glutamate moiety is solvent-exposed and sticks out of the pocket entrance, allowing it to be conjugated to drugs without adversely affecting FR alpha binding. The extensive interactions between the receptor and ligand readily explain the high folate-binding affinity of folate receptors and provide a template for designing more specific drugs targeting the folate receptor system.	[Chen, Chen; Ke, Jiyuan; Zhou, X. Edward; Xu, H. Eric; Melcher, Karsten] Van Andel Res Inst, Program Struct Biol & Drug Discovery, Grand Rapids, MI 49503 USA; [Chen, Chen] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Yi, Wei; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, VARI SIMM Ctr,Ctr Struct & Funct Drug Targets, Shanghai 201203, Peoples R China; [Brunzelle, Joseph S.] Northwestern Univ, Synchrotron Res Ctr, Life Sci Collaborat Access Team, Argonne, IL 60439 USA; [Li, Jun; Yong, Eu-Leong] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hosp, Dept Obstet & Gynecol, Singapore 119074, Singapore	Van Andel Institute; National University of Singapore; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Northwestern University; National University of Singapore	Yong, EL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hosp, Dept Obstet & Gynecol, Singapore 119074, Singapore.	eu_leong_yong@nuhs.edu.sg; eric.xu@vai.org; Karsten.Melcher@vai.org	Xu, H. Eric/ABD-7487-2021; Melcher, Karsten/AAZ-3861-2020	Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; Yong, Eu-Leong/0000-0001-6511-770X	Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; Office of Science of the US Department of Energy [DE-AC02-06CH11357]; Jay and Betty Van Andel Foundation; American Asthma Foundation; Ministry of Science and Technology (China) [2012ZX09301001-005, 2012CB910403]; Amway (China); National Institutes of Health [R01 DK071662, R01 GM102545]; National Research Foundation Singapore [NMRC/CSA/026/2011]; NUS Graduate School for Integrative Sciences and Engineering Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104212, R01GM102545] Funding Source: NIH RePORTER	Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Jay and Betty Van Andel Foundation; American Asthma Foundation; Ministry of Science and Technology (China)(Ministry of Science and Technology, China); Amway (China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation Singapore(National Research Foundation, Singapore); NUS Graduate School for Integrative Sciences and Engineering Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Jones for the pHL-Fc plasmid and H. L. Monaco for providing the chicken riboflavin-binding protein coordinates. The atomic coordinates have been deposited in the Protein Data Bank with accession codes listed in Supplementary Table 1. We thank staff members of the Life Science Collaborative Access Team of the Advanced Photon Source (APS) for assistance in data collection at the beam lines of sector 21, which is in part funded by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). Use of APS was supported by the Office of Science of the US Department of Energy, under contract no. DE-AC02-06CH11357. This work was supported by the Jay and Betty Van Andel Foundation, and work by the Yong, Xu and Melcher laboratories is supported by the American Asthma Foundation, Ministry of Science and Technology (China) grants 2012ZX09301001-005 and 2012CB910403, Amway (China), by National Institutes of Health grants R01 DK071662 (H.E.X.) and R01 GM102545 (K.M.), and by the National Research Foundation Singapore under its Clinician Scientist Award NMRC/CSA/026/2011 (E.-L.Y.). C.C. is recipient of the NUS Graduate School for Integrative Sciences and Engineering Scholarship.	ANTONY AC, 1992, BLOOD, V79, P2807; Bailey LB, 1999, J NUTR, V129, P779, DOI 10.1093/jn/129.4.779; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Deng YJ, 2009, J MED CHEM, V52, P2940, DOI 10.1021/jm8011323; Elnakat H, 2004, ADV DRUG DELIVER REV, V56, P1067, DOI 10.1016/j.addr.2004.01.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KANE MA, 1988, J CLIN INVEST, V81, P1398, DOI 10.1172/JCI113469; Kelemen LE, 2006, INT J CANCER, V119, P243, DOI 10.1002/ijc.21712; Leamon CP, 2007, MOL PHARMACEUT, V4, P659, DOI 10.1021/mp070049c; Leamon CP, 2004, ADV DRUG DELIVER REV, V56, P1127, DOI 10.1016/j.addr.2004.01.008; Leamon CP, 1999, J DRUG TARGET, V7, P157, DOI 10.3109/10611869909085499; Liu Q, 2012, SCIENCE, V336, P1033, DOI 10.1126/science.1218753; MATSUE H, 1992, P NATL ACAD SCI USA, V89, P6006, DOI 10.1073/pnas.89.13.6006; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Monaco HL, 1997, EMBO J, V16, P1475, DOI 10.1093/emboj/16.7.1475; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Ratnam M., 1990, FOLIC ACID METABOLIS, P91; Reddy JA, 2007, CANCER RES, V67, P4434, DOI 10.1158/0008-5472.CAN-07-0033; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969; Zhao RB, 2009, J BIOL CHEM, V284, P4267, DOI 10.1074/jbc.M807665200	28	443	460	12	364	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					486	+		10.1038/nature12327	http://dx.doi.org/10.1038/nature12327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23851396	Green Accepted			2022-12-28	WOS:000323316100041
J	Gillick, MR				Gillick, Muriel R.			The Critical Role of Caregivers in Achieving Patient-Centered Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE		Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA 02215 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School	Gillick, MR (corresponding author), Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	mgillick@gmail.com						Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; Feinberg L., 2011, AARP PUBLIC POLICY I; Fried TR, 2011, ARCH INTERN MED, V171, P1854, DOI 10.1001/archinternmed.2011.424; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Hickman SE, 2005, HASTINGS CENT REP, V35, pS26, DOI 10.1353/hcr.2005.0093; Leff B, 2009, AM J MANAG CARE, V15, P555; Reinhard SC, 2012, PUBLIC POLICY INSTIT; Sabatino CP, 2010, MILBANK Q, V88, P211, DOI 10.1111/j.1468-0009.2010.00596.x; Smith M, 2012, BEST CARE AT LOWER C	9	96	97	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2013	310	6					575	576		10.1001/jama.2013.7310	http://dx.doi.org/10.1001/jama.2013.7310			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	200HI	23867885				2022-12-28	WOS:000323058400007
J	Koehler, KR; Mikosz, AM; Molosh, AI; Patel, D; Hashino, E				Koehler, Karl R.; Mikosz, Andrew M.; Molosh, Andrei I.; Patel, Dharmeshkumar; Hashino, Eri			Generation of inner ear sensory epithelia from pluripotent stem cells in 3D culture	NATURE			English	Article							IN-VITRO; NEURONAL DIFFERENTIATION; 3-DIMENSIONAL CULTURE; CORTICAL TISSUES; SELF-FORMATION; HAIR-CELLS; HUMAN ES; MOUSE; INDUCTION; EXPRESSION	The inner ear contains sensory epithelia that detect head movements, gravity and sound. It is unclear how to develop these sensory epithelia from pluripotent stem cells, a process that will be critical for modelling inner ear disorders or developing cell-based therapies for profound hearing loss and balance disorders(1,2). So far, attempts to derive inner ear mechanosensitive hair cells and sensory neurons have resulted in inefficient or incomplete phenotypic conversion of stem cells into inner-ear-like cells(3-7). A key insight lacking from these previous studies is the importance of the nonneural and preplacodal ectoderm, two critical precursors during inner ear development(8-11). Here we report the stepwise differentiation of inner ear sensory epithelia from mouse embryonic stem cells (ESCs) in three-dimensional culture(12,13). We show that by recapitulating in vivo development with precise temporal control of signalling pathways, ESC aggregates transform sequentially into non-neural, preplacodal and otic-placode-like epithelia. Notably, in a self-organized process that mimics normal development, vesicles containing prosensory cells emerge from the presumptive otic placodes and give rise to hair cells bearing stereocilia bundles and a kinocilium. Moreover, these stem-cell-derived hair cells exhibit functional properties of native mechanosensitive hair cells and form specialized synapses with sensory neurons that have also arisen from ESCs in the culture. Finally, we demonstrate how these vesicles are structurally and biochemically comparable to developing vestibular end organs. Our data thus establish a new in vitro model of inner ear differentiation that can be used to gain deeper insight into inner ear development and disorder.	[Koehler, Karl R.; Hashino, Eri] Indiana Univ Sch Med, Med Neurosci Grad Program, Indianapolis, IN 46202 USA; [Koehler, Karl R.; Mikosz, Andrew M.; Molosh, Andrei I.; Patel, Dharmeshkumar; Hashino, Eri] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Koehler, Karl R.; Mikosz, Andrew M.; Patel, Dharmeshkumar; Hashino, Eri] Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA; [Molosh, Andrei I.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Hashino, E (corresponding author), Indiana Univ Sch Med, Med Neurosci Grad Program, Indianapolis, IN 46202 USA.	krkoehle@iupui.edu; ehashino@iupui.edu		Koehler, Karl/0000-0002-0685-538X; Mikosz, Andrew/0000-0002-1235-9948; Molosh, Andrei/0000-0001-6451-7912	National Institutes of Health (NIH) [RC1DC010706, R21DC012617, R01GM086544]; Paul and Carole Stark Neurosciences Fellowship; Indiana Clinical and Translational Science Institute Predoctoral Fellowship [NIH TL1RR025759]; NIH [R01MH52619]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC012617, RC1DC010706] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul and Carole Stark Neurosciences Fellowship; Indiana Clinical and Translational Science Institute Predoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors would like to thank G. Oxford for contributing unpublished data and discussion; E. Beans, G. Kamocka, K. Dunn and C. Miller for technical assistance; P. Dolle, R. Romand, J. Williams, J. Meyer, X. Zhang and T. Cummins for comments and discussion; E. Tobin, R. Meadows, J. Hamilton, S. Majumdar and G. Wagner for editorial assistance. This work was supported by National Institutes of Health (NIH) grants RC1DC010706, R21DC012617 and R01GM086544. K. R. K. was supported by a Paul and Carole Stark Neurosciences Fellowship and an Indiana Clinical and Translational Science Institute Predoctoral Fellowship (NIH TL1RR025759). A.I.M. was supported by NIH R01MH52619 (awarded to A. Shekhar).	Bermingham-McDonogh O, 2011, NEURON, V71, P389, DOI 10.1016/j.neuron.2011.07.015; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Brigande JV, 2009, NAT NEUROSCI, V12, P679, DOI 10.1038/nn.2311; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Coate TM, 2012, NEURON, V73, P49, DOI 10.1016/j.neuron.2011.10.029; Desai SS, 2005, J NEUROPHYSIOL, V93, P251, DOI 10.1152/jn.00746.2003; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, NAT PROTOC, V7, P69, DOI 10.1038/nprot.2011.429; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Geleoc GSG, 2004, J NEUROSCI, V24, P11148, DOI 10.1523/JNEUROSCI.2662-04.2004; Grocott T, 2012, DEV BIOL, V370, P3, DOI 10.1016/j.ydbio.2012.06.028; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hu ZQ, 2007, P NATL ACAD SCI USA, V104, P16675, DOI 10.1073/pnas.0704576104; JEGALIAN BG, 1992, CELL, V71, P901, DOI 10.1016/0092-8674(92)90387-R; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Koehler KR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-82; Kondo T, 2008, P NATL ACAD SCI USA, V105, P5780, DOI 10.1073/pnas.0708704105; Kwon HJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001133; Kwon HJ, 2009, DEV DYNAM, V238, P1582, DOI 10.1002/dvdy.21955; Ladher RK, 2010, DEVELOPMENT, V137, P1777, DOI 10.1242/dev.040055; Laine H, 2010, DEV BIOL, V337, P134, DOI 10.1016/j.ydbio.2009.10.027; Li A, 2008, J NEUROPHYSIOL, V99, P718, DOI 10.1152/jn.00831.2007; Lysakowski A, 2011, J NEUROSCI, V31, P10101, DOI 10.1523/JNEUROSCI.0521-11.2011; Meyers JR, 2003, J NEUROSCI, V23, P4054; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Oesterle EC, 2008, JARO-J ASSOC RES OTO, V9, P65, DOI 10.1007/s10162-007-0106-7; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Ouji Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.56; Pieper M, 2012, DEVELOPMENT, V139, P1175, DOI 10.1242/dev.074468; Reyes JH, 2008, J NEUROSCI, V28, P12622, DOI 10.1523/JNEUROSCI.0563-08.2008; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Warchol ME, 2009, DEV NEUROBIOL, V69, P191, DOI 10.1002/dneu.20684; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	38	245	262	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2013	500	7461					217	+		10.1038/nature12298	http://dx.doi.org/10.1038/nature12298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23842490	Green Accepted			2022-12-28	WOS:000322825500037
J	Smith, PM; Howitt, MR; Panikov, N; Michaud, M; Gallini, CA; Bohlooly-Y, M; Glickman, JN; Garrett, WS				Smith, Patrick M.; Howitt, Michael R.; Panikov, Nicolai; Michaud, Monia; Gallini, Carey Ann; Bohlooly-Y, Mohammad; Glickman, Jonathan N.; Garrett, Wendy S.			The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T-reg Cell Homeostasis	SCIENCE			English	Article							LARGE-INTESTINE; GUT MICROBIOTA; DIVERSITY; INFLAMMATION; INHIBITION; RECEPTOR; PROTECT; MICE	Regulatory T cells (T-regs) that express the transcription factor Foxp3 are critical for regulating intestinal inflammation. Candidate microbe approaches have identified bacterial species and strain-specific molecules that can affect intestinal immune responses, including species that modulate T-reg responses. Because neither all humans nor mice harbor the same bacterial strains, we posited that more prevalent factors exist that regulate the number and function of colonic T-regs. We determined that short-chain fatty acids, gut microbiota-derived bacterial fermentation products, regulate the size and function of the colonic T-reg pool and protect against colitis in a Ffar2-dependent manner in mice. Our study reveals that a class of abundant microbial metabolites underlies adaptive immune microbiota coadaptation and promotes colonic homeostasis and health.	[Smith, Patrick M.; Howitt, Michael R.; Panikov, Nicolai; Michaud, Monia; Gallini, Carey Ann; Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Smith, Patrick M.; Howitt, Michael R.; Panikov, Nicolai; Michaud, Monia; Gallini, Carey Ann; Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Garrett, Wendy S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Garrett, Wendy S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Garrett, Wendy S.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Bohlooly-Y, Mohammad] AstraZeneca, RAD Transgen, Molndal, Sweden; [Glickman, Jonathan N.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Glickman, Jonathan N.] Miraca Life Sci, Newton, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; AstraZeneca; Harvard University; Harvard Medical School	Garrett, WS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	wgarrett@hsph.harvard.edu		Garrett, Wendy/0000-0002-5092-0150	National Research Service Award (NRSA) [F32DK095506]; NRSA [F32DK098826]; Burroughs Wellcome Career in Medical Sciences Award; Searle Scholars Award; Cancer Research Institute; Harvard University;  [R01CA154426];  [K08AI078942]; NATIONAL CANCER INSTITUTE [R01CA154426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI078942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095506, P30DK034854, F32DK098826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099537] Funding Source: NIH RePORTER	National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career in Medical Sciences Award; Searle Scholars Award; Cancer Research Institute; Harvard University; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Garrett Lab for discussion, K. Sigrist for embryo rederivation, C. Gallini for genotyping, J. Ramirez for animal husbandry, and A. Rudensky (Memorial Sloan-Kettering Cancer Center) for Foxp3<SUP>YFP-Cre</SUP> mice. A material transfer agreement was required for obtaining Ffar2<SUP>+/-</SUP> embryos from AstraZeneca. The data presented in this study are tabulated in the main paper and the supplementary materials. This study was supported by National Research Service Award (NRSA) F32DK095506 to P. M. S.; NRSA F32DK098826 to M. R. H.; and grants R01CA154426 and K08AI078942, a Burroughs Wellcome Career in Medical Sciences Award, a Searle Scholars Award, and a Cancer Research Institute Investigator Award to W. S. G. A patent (U.S. 61/800,299) was filed with the U.S. Patent and Trademark Office on 15 March 2013 on short chain fatty acids and their regulation of colonic regulatory T cell populations and function by Harvard University, with W. S. G. and P. M. S. as co-inventors. P. M. S., M. R. H., and W. S. G. designed and carried out the experiments and wrote the manuscript; M. M., C. A. G., and N.P. carried out experiments; J.N.G. performed all histological assessment; and M.B.-Y provided Ffar2<SUP>+/-</SUP> embryos.	Atarashi K, 2011, SEMIN IMMUNOL, V23, P146, DOI 10.1016/j.smim.2011.01.010; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Beier UH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002873; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; HOVERSTAD T, 1986, J NUTR, V116, P1772, DOI 10.1093/jn/116.9.1772; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002	25	2846	3007	43	625	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					569	573		10.1126/science.1241165	http://dx.doi.org/10.1126/science.1241165			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23828891	Green Accepted, Green Submitted			2022-12-28	WOS:000322586700059
J	Umesono, Y; Tasaki, J; Nishimura, Y; Hrouda, M; Kawaguchi, E; Yazawa, S; Nishimura, O; Hosoda, K; Inoue, T; Agata, K				Umesono, Yoshihiko; Tasaki, Junichi; Nishimura, Yui; Hrouda, Martina; Kawaguchi, Eri; Yazawa, Shigenobu; Nishimura, Osamu; Hosoda, Kazutaka; Inoue, Takeshi; Agata, Kiyokazu			The molecular logic for planarian regeneration along the anterior-posterior axis	NATURE			English	Article							DOUBLE-STRANDED-RNA; STEM-CELLS; EXPRESSION; POLARITY; BRAIN; GENE; HEAD; HOMOLOG; SYSTEM; REGION	The planarian Dugesia japonica can regenerate a complete individual from a head, trunk or tail fragment via activation of somatic pluripotent stem cells(1,2). About a century ago, Thomas Hunt Morgan attempted to explain the extraordinary regenerative ability of planarians by positing two opposing morphogenetic gradients of formative "head stuff" and "tail stuff" along the anterior-posterior axis(3,4). However, Morgan's hypothesis remains open to debate. Here we show that extracellular signal-related kinase (ERK) and Wnt/beta-catenin signalling pathways establish a solid framework for planarian regeneration. Our data suggest that ERK signalling forms a spatial gradient in the anterior region during regeneration. The fibroblast growth factor receptor-like gene nou-darake(5) (which serves as an output of ERK signalling in the differentiating head) and posteriorly biased beta-catenin activity(6-8) negatively regulate ERK signalling along the anterior-posterior axis in distinct manners, and thereby posteriorize regenerating tissues outside the head region to reconstruct a complete head-to-tail axis. On the basis of this knowledge about D. japonica, we proposed that beta-catenin signalling is responsible for the lack of head-regenerative ability of tail fragments in the planarian Phagocata kawakatsui, and our confirmation thereof supports the notion that posterior beta-catenin signalling negatively modulates the ERK signalling involved in anteriorization across planarian species. These findings suggest that ERK signalling has a pivotal role in triggering globally dynamic differentiation of stem cells in a head-to-tail sequence through a default program that promotes head tissue specification in the absence of posteriorizing signals. Thus, we have confirmed the broad outline of Morgan's hypothesis, and refined it on the basis of our proposed default property of planarian stem cells.	[Umesono, Yoshihiko] RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Umesono, Yoshihiko; Tasaki, Junichi; Nishimura, Yui; Hrouda, Martina; Kawaguchi, Eri; Yazawa, Shigenobu; Nishimura, Osamu; Hosoda, Kazutaka; Inoue, Takeshi; Agata, Kiyokazu] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan	RIKEN; Kyoto University	Umesono, Y (corresponding author), Univ Tokushima, Inst Technol & Sci, Dept Life Syst, 2-1 Minami Jyosanjima Cho, Tokushima 7708506, Japan.	umesono.yoshihiko@tokushima-u.ac.jp	Yazawa, Shigenobu/E-6395-2014; Nishimura, Osamu/AAC-1236-2020; Inoue, Takeshi/S-5623-2019	Yazawa, Shigenobu/0000-0003-4539-3875; Nishimura, Osamu/0000-0003-1969-2580; Inoue, Takeshi/0000-0003-3289-4478; Tasaki, Junichi/0000-0003-1798-5160; Agata, Kiyokazu/0000-0002-5195-2576	Naito Foundation; Sasakawa Scientific Research Grant; JSPS; Kyoto University;  [22124004];  [22124001];  [17GS0318]; Grants-in-Aid for Scientific Research [22124004] Funding Source: KAKEN	Naito Foundation(Naito Memorial Foundation); Sasakawa Scientific Research Grant; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyoto University; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank C. Hashimoto for discussions and comments. We also thank E. Nakajima and A. Alie for critical reading of the manuscript, Y. Saito for illustrations, and all of our other laboratory members for their help and encouragement. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas to Y.U. (22124004), a Grant-in-Aid for Scientific Research on Innovative Areas to K.A. (22124001), a Grant-in-Aid for Creative Scientific Research to K.A. (17GS0318), Global COE Program A06 of Kyoto University, the Naito Foundation, a Sasakawa Scientific Research Grant, and a JSPS Research Fellowship to J.T.	Agata K, 2003, DEV DYNAM, V226, P308, DOI 10.1002/dvdy.10249; Agata K, 2008, PHILOS T R SOC B, V363, P2071, DOI 10.1098/rstb.2008.2260; Agata K, 2007, DEV GROWTH DIFFER, V49, P73, DOI 10.1111/j.1440-169x.2007.00919.x; Agata K, 2012, DEV GROWTH DIFFER, V54, P143, DOI 10.1111/j.1440-169X.2011.01323.x; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; Kobayashi C, 1999, MECH DEVELOP, V89, P25, DOI 10.1016/S0925-4773(99)00192-6; Koinuma S, 2000, GENE, V259, P171, DOI 10.1016/S0378-1119(00)00426-1; LAWRENCE PA, 1988, CELL, V54, P1, DOI 10.1016/0092-8674(88)90172-9; Morgan TH, 1904, ARCH ENTWICKLUNG ORG, V17, P683, DOI 10.1007/BF02161815; Morgan TM, 1905, J EXP ZOOL, V2, P495, DOI 10.1002/jez.1400020404; Nishimura K, 2007, DEV NEUROBIOL, V67, P1059, DOI 10.1002/dneu.20377; Nogi T, 2001, DEV GROWTH DIFFER, V43, P177; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; Rouhana L, 2013, DEV DYNAM, V242, P718, DOI 10.1002/dvdy.23950; Shibata N, 2010, DEV GROWTH DIFFER, V52, P27, DOI 10.1111/j.1440-169X.2009.01155.x; Takano T, 2007, DEV GROWTH DIFFER, V49, P383, DOI 10.1111/j.1440-169x.2007.00936.x; Tasaki J, 2011, DEVELOPMENT, V138, P2417, DOI 10.1242/dev.060764; Umesono Y, 1997, DEV GROWTH DIFFER, V39, P723; Umesono Y, 2009, DEV GROWTH DIFFER, V51, P185, DOI 10.1111/j.1440-169X.2009.01099.x; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Yazawa S, 2009, P NATL ACAD SCI USA, V106, P22329, DOI 10.1073/pnas.0907464106	25	120	122	0	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					73	U93		10.1038/nature12359	http://dx.doi.org/10.1038/nature12359			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23883928				2022-12-28	WOS:000322514800030
J	Lupski, JR				Lupski, James R.			Genome Mosaicism-One Human, Multiple Genomes	SCIENCE			English	Editorial Material							L1 RETROTRANSPOSITION; HUMAN BRAIN; STEM-CELLS; ARRAY CGH; RECOMBINATION; EMBRYOS		[Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room 604B, Houston, TX 77030 USA.	jlupski@bcm.edu						Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Balliff BC, 2006, AM J MED GENET A, V140A, P2757, DOI 10.1002/ajmg.a.31539; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Cheung SW, 2007, AM J MED GENET A, V143A, P1679, DOI 10.1002/ajmg.a.31740; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Flores M, 2007, P NATL ACAD SCI USA, V104, P6099, DOI 10.1073/pnas.0701631104; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; Macosko EZ, 2012, NAT GENET, V44, P614, DOI 10.1038/ng.2311; Mertzanidou A, 2013, HUM REPROD, V28, P256, DOI 10.1093/humrep/des362; Mizuno K, 2013, NATURE, V493, P246, DOI 10.1038/nature11676; O'Huallachain M, 2012, P NATL ACAD SCI USA, V109, P18018, DOI 10.1073/pnas.1213736109; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Robberecht C, 2013, GENOME RES, V23, P411, DOI 10.1101/gr.145631.112; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924	17	116	120	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					358	359		10.1126/science.1239503	http://dx.doi.org/10.1126/science.1239503			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888031				2022-12-28	WOS:000322259200037
J	Ackerman, M; Alter, G				Ackerman, Margaret; Alter, Galit			Mapping the Journey to an HIV Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BROAD		[Ackerman, Margaret] Dartmouth Coll, Sch Engn, Hanover, NH 03755 USA; [Alter, Galit] MIT, Ragon Inst, Massachusetts Gen Hosp, Cambridge, MA 02139 USA; [Alter, Galit] Harvard Univ, Cambridge, MA 02138 USA	Dartmouth College; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Ackerman, M (corresponding author), Dartmouth Coll, Sch Engn, Hanover, NH 03755 USA.							Jardine J, 2013, SCIENCE; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930	5	14	14	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					389	391		10.1056/NEJMcibr1304437	http://dx.doi.org/10.1056/NEJMcibr1304437			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188VJ	23883384				2022-12-28	WOS:000322223900016
J	Prado-Martinez, J; Sudmant, PH; Kidd, JM; Li, H; Kelley, JL; Lorente-Galdos, B; Veeramah, KR; Woerner, AE; O'Connor, TD; Santpere, G; Cagan, A; Theunert, C; Casals, F; Laayouni, H; Munch, K; Hobolth, A; Halager, AE; Malig, M; Hernandez-Rodriguez, J; Hernando-Herraez, I; Prufer, K; Pybus, M; Johnstone, L; Lachmann, M; Alkan, C; Twigg, D; Petit, N; Baker, C; Hormozdiari, F; Fernandez-Callejo, M; Dabad, M; Wilson, ML; Stevison, L; Camprubi, C; Carvalho, T; Ruiz-Herrera, A; Vives, L; Mele, M; Abello, T; Kondova, I; Bontrop, RE; Pusey, A; Lankester, F; Kiyang, JA; Bergl, RA; Lonsdorf, E; Myers, S; Ventura, M; Gagneux, P; Comas, D; Siegismund, H; Blanc, J; Agueda-Calpena, L; Gut, M; Fulton, L; Tishkoff, SA; Mullikin, JC; Wilson, RK; Gut, IG; Gonder, MK; Ryder, OA; Hahn, BH; Navarro, A; Akey, JM; Bertranpetit, J; Reich, D; Mailund, T; Schierup, MH; Hvilsom, C; Andres, AM; Wall, JD; Bustamante, CD; Hammer, MF; Eichler, EE; Marques-Bonet, T				Prado-Martinez, Javier; Sudmant, Peter H.; Kidd, Jeffrey M.; Li, Heng; Kelley, Joanna L.; Lorente-Galdos, Belen; Veeramah, Krishna R.; Woerner, August E.; O'Connor, Timothy D.; Santpere, Gabriel; Cagan, Alexander; Theunert, Christoph; Casals, Ferran; Laayouni, Hafid; Munch, Kasper; Hobolth, Asger; Halager, Anders E.; Malig, Maika; Hernandez-Rodriguez, Jessica; Hernando-Herraez, Irene; Pruefer, Kay; Pybus, Marc; Johnstone, Laurel; Lachmann, Michael; Alkan, Can; Twigg, Dorina; Petit, Natalia; Baker, Carl; Hormozdiari, Fereydoun; Fernandez-Callejo, Marcos; Dabad, Marc; Wilson, Michael L.; Stevison, Laurie; Camprubi, Cristina; Carvalho, Tiago; Ruiz-Herrera, Aurora; Vives, Laura; Mele, Marta; Abello, Teresa; Kondova, Ivanela; Bontrop, Ronald E.; Pusey, Anne; Lankester, Felix; Kiyang, John A.; Bergl, Richard A.; Lonsdorf, Elizabeth; Myers, Simon; Ventura, Mario; Gagneux, Pascal; Comas, David; Siegismund, Hans; Blanc, Julie; Agueda-Calpena, Lidia; Gut, Marta; Fulton, Lucinda; Tishkoff, Sarah A.; Mullikin, James C.; Wilson, Richard K.; Gut, Ivo G.; Gonder, Mary Katherine; Ryder, Oliver A.; Hahn, Beatrice H.; Navarro, Arcadi; Akey, Joshua M.; Bertranpetit, Jaume; Reich, David; Mailund, Thomas; Schierup, Mikkel H.; Hvilsom, Christina; Andres, Aida M.; Wall, Jeffrey D.; Bustamante, Carlos D.; Hammer, Michael F.; Eichler, Evan E.; Marques-Bonet, Tomas			Great ape genetic diversity and population history	NATURE			English	Article							HUMAN GENOME; CHIMPANZEE GENOME; SEQUENCE; EVOLUTION; SELECTION; PATTERNS; DECLINE	Most great ape genetic variation remains uncharacterized(1,2); however, its study is critical for understanding population history(3-6), recombination(7), selection(8) and susceptibility to disease(9,10). Here we sequence to high coverage a total of 79 wild-and captive-born individuals representing all six great ape species and seven subspecies and report 88.8 million single nucleotide polymorphisms. Our analysis provides support for genetically distinct populations within each species, signals of gene flow, and the split of common chimpanzees into two distinct groups: Nigeria-Cameroon/western and central/eastern populations. We find extensive inbreeding in almost all wild populations, with eastern gorillas being the most extreme. Inferred effective population sizes have varied radically over time in different lineages and this appears to have a profound effect on the genetic diversity at, or close to, genes in almost all species. We discover and assign 1,982 loss-of-function variants throughout the human and great ape lineages, determining that the rate of gene loss has not been different in the human branch compared to other internal branches in the great ape phylogeny. This comprehensive catalogue of great ape genome diversity provides a framework for understanding evolution and a resource for more effective management of wild and captive great ape populations.	[Prado-Martinez, Javier; Lorente-Galdos, Belen; Santpere, Gabriel; Casals, Ferran; Laayouni, Hafid; Hernandez-Rodriguez, Jessica; Hernando-Herraez, Irene; Pybus, Marc; Petit, Natalia; Fernandez-Callejo, Marcos; Dabad, Marc; Carvalho, Tiago; Mele, Marta; Comas, David; Navarro, Arcadi; Bertranpetit, Jaume; Marques-Bonet, Tomas] Univ Pompeu Fabra, Inst Biol Evolut, CSIC, PRBB, Barcelona 08003, Catalonia, Spain; [Sudmant, Peter H.; O'Connor, Timothy D.; Malig, Maika; Baker, Carl; Hormozdiari, Fereydoun; Vives, Laura; Akey, Joshua M.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kidd, Jeffrey M.; Twigg, Dorina] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Kidd, Jeffrey M.; Kelley, Joanna L.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Li, Heng; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Veeramah, Krishna R.; Woerner, August E.; Johnstone, Laurel; Hammer, Michael F.] Univ Arizona, Div Biotechnol, Arizona Res Labs, Tucson, AZ 85721 USA; [Cagan, Alexander; Theunert, Christoph; Pruefer, Kay; Lachmann, Michael; Andres, Aida M.] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Munch, Kasper; Hobolth, Asger; Halager, Anders E.; Mailund, Thomas; Schierup, Mikkel H.] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus C, Denmark; [Alkan, Can] Bilkent Univ, Fac Engn, TR-06800 Ankara, Turkey; [Wilson, Michael L.] Univ Minnesota, Dept Anthropol, Minneapolis, MN 55455 USA; [Stevison, Laurie; Wall, Jeffrey D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Camprubi, Cristina; Ruiz-Herrera, Aurora] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Cerdanyola Del Valles 08193, Catalonia, Spain; [Ruiz-Herrera, Aurora] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Cerdanyola Del Valles 08193, Catalonia, Spain; [Abello, Teresa] Parc Zool Barcelona, Barcelona 08003, Catalonia, Spain; [Kondova, Ivanela; Bontrop, Ronald E.] Biomed Primate Res Ctr, NL-2280 GH Rijswijk, Netherlands; [Pusey, Anne] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Lankester, Felix; Kiyang, John A.] Limbe Wildlife Ctr, Limbe, Cameroon; [Lankester, Felix] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Bergl, Richard A.] North Carolina Zool Pk, Asheboro, NC 27205 USA; [Lonsdorf, Elizabeth] Franklin & Marshall Coll, Dept Psychol, Lancaster, PA 17604 USA; [Myers, Simon] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Ventura, Mario] Univ Bari, Dept Genet & Microbiol, I-70126 Bari, Italy; [Gagneux, Pascal] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Siegismund, Hans; Hvilsom, Christina] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Blanc, Julie; Agueda-Calpena, Lidia; Gut, Marta; Gut, Ivo G.] PCB, Ctr Nacl Anal Genom CNAG, Barcelona 08028, Catalonia, Spain; [Fulton, Lucinda; Wilson, Richard K.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; [Tishkoff, Sarah A.] Univ Penn, Dept Biol & Genet, Philadelphia, PA 19104 USA; [Mullikin, James C.] NIH, Intramural Sequencing Ctr NISC, Bethesda, MD 20892 USA; [Gonder, Mary Katherine] SUNY Albany, Albany, NY 12222 USA; [Ryder, Oliver A.] San Diego Zoo, Genet Div, Inst Conservat Res, Escondido, CA 92027 USA; [Hahn, Beatrice H.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hahn, Beatrice H.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Navarro, Arcadi] UPF, Inst Nacl Bioinformat, Barcelona 08003, Catalonia, Spain; [Navarro, Arcadi; Marques-Bonet, Tomas] ICREA, Barcelona 08010, Catalonia, Spain; [Schierup, Mikkel H.] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark; [Hvilsom, Christina] Copenhagen Zoo, DK-2000 Frederiksberg, Denmark; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Stanford University; Harvard University; Harvard Medical School; University of Arizona; Max Planck Society; Aarhus University; Ihsan Dogramaci Bilkent University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; Autonomous University of Barcelona; Autonomous University of Barcelona; Duke University; Washington State University; Franklin & Marshall College; University of Oxford; Universita degli Studi di Bari Aldo Moro; University of California System; University of California San Diego; University of Copenhagen; University of Barcelona; Washington University (WUSTL); University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); State University of New York (SUNY) System; State University of New York (SUNY) Albany; Zoological Society of San Diego; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pompeu Fabra University; ICREA; Aarhus University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Marques-Bonet, T (corresponding author), Univ Pompeu Fabra, Inst Biol Evolut, CSIC, PRBB, Doctor Aiguader 88, Barcelona 08003, Catalonia, Spain.	eee@gs.washington.edu; tomas.marques@upf.edu	Wilson, Richard K./AAF-4139-2019; Schierup, Mikkel H/F-1675-2010; Bertranpetit, Jaume/F-8550-2012; Myers, Simon R/A-6792-2015; Laayouni, Hafid/AAA-9254-2019; Dabad, Marc/M-9522-2015; Wilson, Michael Lawrence/AAC-9154-2020; Marques-Bonet, Tomas/ABF-3734-2020; hernando-herraez, irene/AAO-5832-2020; Bontrop, Ronald E/J-3628-2012; Hernando-Herraez, Irene/ABH-8676-2020; Navarro, Arcadi/F-1592-2011; Gut, Ivo/ABF-3188-2020; Marques-Bonet, Tomas/I-4618-2014; Prado-Martinez, Javier/AAA-6341-2020; Ruiz-Herrera, Aurora/K-3728-2012; Santpere, Gabriel/I-9437-2014; Schierup, Mikkel Heide/AAM-4997-2020; Marty, Natalia Petit/AAI-7449-2021; Munch, Kasper/A-1434-2010; Dabad, Marc/Q-9601-2019; Casals, Ferran/H-4347-2015; Andres, Aida/B-4088-2014; Alkan, Can/D-2982-2009; Comas, David/D-5382-2014; Stevison, Laurie/F-2881-2010; Kelley, Joanna L/H-1693-2012; Siegismund, Hans R./K-4332-2014; Ventura, Mario/E-6420-2011	Wilson, Richard K./0000-0002-1992-1358; Schierup, Mikkel H/0000-0002-5028-1790; Bertranpetit, Jaume/0000-0003-0100-0590; Myers, Simon R/0000-0002-2585-9626; Laayouni, Hafid/0000-0003-1297-5078; Dabad, Marc/0000-0002-6094-747X; Wilson, Michael Lawrence/0000-0003-3073-4518; Marques-Bonet, Tomas/0000-0002-5597-3075; Bontrop, Ronald E/0000-0003-0874-6467; Hernando-Herraez, Irene/0000-0003-1193-8419; Navarro, Arcadi/0000-0003-2162-8246; Gut, Ivo/0000-0001-7219-632X; Marques-Bonet, Tomas/0000-0002-5597-3075; Prado-Martinez, Javier/0000-0001-5402-2721; Ruiz-Herrera, Aurora/0000-0003-3868-6151; Santpere, Gabriel/0000-0001-5909-8637; Schierup, Mikkel Heide/0000-0002-5028-1790; Marty, Natalia Petit/0000-0002-3810-1152; Munch, Kasper/0000-0003-2880-6252; Dabad, Marc/0000-0002-6094-747X; Casals, Ferran/0000-0002-8941-0369; Andres, Aida/0000-0002-8590-9672; Alkan, Can/0000-0002-5443-0706; Comas, David/0000-0002-5075-0956; Stevison, Laurie/0000-0001-7900-5266; Kelley, Joanna L/0000-0002-7731-605X; Siegismund, Hans R./0000-0001-5757-3131; Hahn, Beatrice/0000-0002-9400-9887; Pybus, Marc/0000-0002-6195-5738; Hormozdiari, Fereydoun/0000-0003-2703-9274; Cagan, Alex/0000-0002-7857-4771; Hvilsom, Christina/0000-0001-7870-6888; Johnstone, Laurel/0000-0001-7335-3972; Sudmant, Peter/0000-0002-9573-8248; O'Connor, Timothy/0000-0002-0276-1896; Hernandez-Rodriguez, Jessica/0000-0002-0402-286X; Hobolth, Asger/0000-0003-4056-1286; Carvalho, Tiago/0000-0002-8943-8732; Kidd, Jeffrey/0000-0002-9631-1465; mele, marta/0000-0001-8874-6453; Lankester, Felix/0000-0002-0802-0693; Lorente-Galdos, Belen/0000-0001-5390-2452; Mailund, Thomas/0000-0001-6206-9239; Akey, Joshua/0000-0002-4411-1330; Pusey, Anne/0000-0002-2280-8954; Bustamante, Carlos D./0000-0002-4187-7920; Ventura, Mario/0000-0001-7762-8777	ERC [260372]; NIH [HG002385, R01_HG005226, GM100233]; NSF HOMINID [1032255]; MICINN(Spain) [BFU2011-28549, BFU2010-19443]; Spanish Government; FEDER [BFU2009-13409-C02-02, BFU2012-38236]; Direccio General de Recerca, Generalitat de Catalunya [2009 SGR 1101]; ERC Advanced Grant [233297]; Max Planck Society; Danish Council for Independent Research Natural Sciences; Zoo de Barcelona (Beca PRIC); EUPRIM-Net; NSF [0755823]; G. Harold and Leila Y. Mathers Foundation; HHMI;  [CGL-2010-20170];  [DP1ES022577-04 NIH]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, R01HG002385, R01HG005226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES022577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095882, R01GM100233] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	ERC(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF HOMINID; MICINN(Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Government(Spanish GovernmentEuropean Commission); FEDER(European Commission); Direccio General de Recerca, Generalitat de Catalunya(Generalitat de Catalunya); ERC Advanced Grant(European Research Council (ERC)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Danish Council for Independent Research Natural Sciences(Det Frie Forskningsrad (DFF)); Zoo de Barcelona (Beca PRIC); EUPRIM-Net; NSF(National Science Foundation (NSF)); G. Harold and Leila Y. Mathers Foundation; HHMI(Howard Hughes Medical Institute); ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	We thank the following funding agencies: ERC Starting Grant (260372) to T.M.-B.; NIH grants HG002385 to E. E. E., R01_HG005226 to K. R. V., A. E. W., M. F. H., L. S. and J.D.W., GM100233 and NSF HOMINID grant 1032255 to D. R. and He.Li.; MICINN(Spain) BFU2011-28549to T.M.-B., BFU2010-19443to Ja.Be., Spanish Government and FEDER for grants BFU2009-13409-C02-02 and BFU2012-38236 to A.N. and J.P.-M., Direccio General de Recerca, Generalitat de Catalunya (Grup de Recerca Consolidat 2009 SGR 1101) to Ja.Be., D. C., A.N. and T.M.-B.; ERC Advanced Grant (233297) and Max Planck Society to S. Paabo; Danish Council for Independent Research Natural Sciences to H. S.; Spanish Grant (CGL-2010-20170) and Zoo de Barcelona (Beca PRIC) to A. R.-H.; EUPRIM-Net to BPRC; DP1ES022577-04 NIH grant to S. A. T.; NSF Grant 0755823 to M. K. G.; P. G. is supported by the G. Harold and Leila Y. Mathers Foundation. A. N. and T. M.-B. are ICREA Research Investigators (Institut Catala d'Estudis i RecercaAvancats delaGeneralitat de Catalunya). J. P.-M. is supported by the Zoo de Barcelona and l'Ajuntament de Barcelona. P. H. S. is supported by an HHMI International Student Fellowship. E. E. E. is an investigator with the Howard Hughes Medical Institute. We are especially grateful to all those who generously provided the samples for the project: O. Thalmann and H. Siedel from Limbe Sanctuary; R. Garriga from Tacugama Sanctuary; W. Schempp (University of Freiburg), Burgers' Zoo; Zoo of Antwerp; Wilhelma Zoo; Givskud Zoo; Ngamba Island Chimpanzee Sanctuary and Centre de Primatologie; Centre International de Recherches Medicales de Franceville; North Carolina Zoological Park; Zoo Atlanta; the Lincoln Park Zoo (Chicago); the Antwerp Zoo and the Limbe Wildlife Centre (Cameroon); D. Travis from University of Minnesota and M. Kinsel from University of Illinois Urbana-Champaign and S. Paabo and L. Vigilant, Max Planck Institute for Evolutionary Anthropology. We thank T. Brown for revising the manuscript, L. Capilla and E. Eyras for technical support, and M. Dierssen for comments on genes expressed in the brain.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Beaumont MA, 2002, GENETICS, V162, P2025; Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Bjork A, 2011, MOL BIOL EVOL, V28, P615, DOI 10.1093/molbev/msq227; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Campbell G, 2008, CURR BIOL, V18, pR903, DOI 10.1016/j.cub.2008.08.015; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gonder MK, 2011, P NATL ACAD SCI USA, V108, P4766, DOI 10.1073/pnas.1015422108; Gonder MK, 1997, NATURE, V388, P337, DOI 10.1038/41005; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hammer MF, 2010, NAT GENET, V42, P830, DOI 10.1038/ng.651; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Junker J, 2012, DIVERS DISTRIB, V18, P1077, DOI 10.1111/ddi.12005; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mailund T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003125; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Nsubuga AM, 2010, CONSERV GENET, V11, P161, DOI 10.1007/s10592-009-0015-x; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Pool JE, 2007, EVOLUTION, V61, P3001, DOI 10.1111/j.1558-5646.2007.00238.x; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052	30	514	523	3	331	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2013	499	7459					471	475		10.1038/nature12228	http://dx.doi.org/10.1038/nature12228			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23823723	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-28	WOS:000322157900039
J	Marsden, G; Perry, M; Kelley, K; Davies, AH				Marsden, Grace; Perry, Mark; Kelley, Kate; Davies, Alun H.		Guideline Dev Grp	GUIDELINES Diagnosis and management of varicose veins in the legs: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POPULATION; PREVALENCE		[Marsden, Grace; Perry, Mark; Kelley, Kate] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Davies, Alun H.] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Vasc Surg Sect, London W6 8RF, England	Royal College of Physicians; Imperial College London	Marsden, G (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	grace.marsden@rcplondon.ac.uk	Hampson, Grace/M-4470-2014	Hampson, Grace/0000-0002-2019-1268; Wonderling, David/0000-0003-0315-6273				Bergan JJ, 2006, NEW ENGL J MED, V355, P488, DOI 10.1056/NEJMra055289; Carpentier PH, 2004, J VASC SURG, V40, P650, DOI 10.1016/j.jvs.2004.07.025; Evans CJ, 1999, J EPIDEMIOL COMMUN H, V53, P149, DOI 10.1136/jech.53.3.149; Lim CS, 2010, PHLEBOLOGY, V25, P184, DOI 10.1258/phleb.2009.009035; National Institute for Health and Care Excellence, 2013, CLIN GUID, V168; National Institute for Health and Clinical Excellence, 2003, INT PROC GUID, V8; National Institute for Health and Clinical Excellence, 2004, INT PROC GUID, V52; National Institute for Health and Clinical Excellence, 2008, CLIN GUID, V62; National Institute for Health and Clinical Excellence, 2006, CLIN GUID, V43; National Institute for Health and Clinical Excellence, 2013, INT PROC GUID, V440; Shepherd AC, 2011, J VASC SURG, V53, P374, DOI 10.1016/j.jvs.2010.09.022; Smith JJ, 1999, J VASC SURG, V30, P710, DOI 10.1016/S0741-5214(99)70110-2	12	104	106	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2013	347								f4279	10.1136/bmj.f4279	http://dx.doi.org/10.1136/bmj.f4279			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BM	23884969				2022-12-28	WOS:000322531800001
J	Keenan, TF; Hollinger, DY; Bohrer, G; Dragoni, D; Munger, JW; Schmid, HP; Richardson, AD				Keenan, Trevor F.; Hollinger, David Y.; Bohrer, Gil; Dragoni, Danilo; Munger, J. William; Schmid, Hans Peter; Richardson, Andrew D.			Increase in forest water-use efficiency as atmospheric carbon dioxide concentrations rise	NATURE			English	Article							NET ECOSYSTEM EXCHANGE; STOMATAL CONDUCTANCE; CO2; RESPONSES; PHOTOSYNTHESIS; PRODUCTIVITY; LESSONS; PLANT; LAND; FLUX	Terrestrial plants remove CO2 from the atmosphere through photosynthesis, a process that is accompanied by the loss of water vapour from leaves(1). The ratio of water loss to carbon gain, or water-use efficiency, is a key characteristic of ecosystem function that is central to the global cycles of water, energy and carbon(2). Here we analyse direct, long-term measurements of whole-ecosystem carbon and water exchange(3). We find a substantial increase in water-use efficiency in temperate and boreal forests of the Northern Hemisphere over the past two decades. We systematically assess various competing hypotheses to explain this trend, and find that the observed increase is most consistent with a strong CO2 fertilization effect. The results suggest a partial closure of stomata(1)-small pores on the leaf surface that regulate gas exchange-to maintain a near-constant concentration of CO2 inside the leaf even under continually increasing atmospheric CO2 levels. The observed increase in forest water-use efficiency is larger than that predicted by existing theory and 13 terrestrial biosphere models. The increase is associated with trends of increasing ecosystem-level photosynthesis and net carbon uptake, and decreasing evapotranspiration. Our findings suggest a shift in the carbon-and water-based economics of terrestrial vegetation, which may require a reassessment of the role of stomatal control in regulating interactions between forests and climate change, and a re-evaluation of coupled vegetation-climate models.	[Keenan, Trevor F.; Richardson, Andrew D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Hollinger, David Y.] US Forest Serv, No Res Stn, Durham, NH 03824 USA; [Bohrer, Gil] Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA; [Dragoni, Danilo] Indiana Univ, Dept Geog, Bloomington, IN 47405 USA; [Munger, J. William] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Munger, J. William] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Schmid, Hans Peter] Karlsruhe Inst Technol, Inst Meteorol & Climate Res, IMK IFU, D-82467 Garmisch Partenkirchen, Germany	Harvard University; United States Department of Agriculture (USDA); United States Forest Service; University System of Ohio; Ohio State University; Indiana University System; Indiana University Bloomington; Harvard University; Harvard University; Helmholtz Association; Karlsruhe Institute of Technology	Keenan, TF (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	tkeenan@oeb.harvard.edu; arichardson@oeb.harvard.edu	Bohrer, Gil/A-9731-2008; Keenan, Trevor F./B-2744-2010; Richardson, Andrew/F-5691-2011; Schmid, Hans Peter E/I-1224-2012; Schmid, Hans Peter/AAP-4450-2021; Keenan, Trevor/AAY-7786-2020; Munger, J William/H-4502-2013; Hollinger, David Y/G-7185-2012	Bohrer, Gil/0000-0002-9209-9540; Keenan, Trevor F./0000-0002-3347-0258; Richardson, Andrew/0000-0002-0148-6714; Schmid, Hans Peter E/0000-0001-9076-4466; Schmid, Hans Peter/0000-0001-9076-4466; Keenan, Trevor/0000-0002-3347-0258; Munger, J William/0000-0002-1042-8452; 	NOAA Climate Program Office, Global Carbon Cycle Program [NA11OAR4310054]; Office of Science (Biological and Environmental Research), US Department of Energy; National Science Foundation [DEB-0911461, DEB-1114804]; US Department of Energy, Biological and Environmental Research, Terrestrial Carbon Program [DE-FG02-04ER63917, DE-FG02-04ER63911, DE-SC0006708]; CFCAS; NSERC; BIOCAP; Environment Canada; NRCan; CarboEuropeIP; FAO-GTOS-TCO; iLEAPS; Max-Planck Institute for Biogeochemistry; University of Tuscia; Universite Laval and Environment Canada; US Department of Energy; USDA Forest Service's Northern Research Station; Office of Science (BER), US Department of Energy; Direct For Biological Sciences [1114804] Funding Source: National Science Foundation; Division Of Environmental Biology [0911461, 1237491] Funding Source: National Science Foundation	NOAA Climate Program Office, Global Carbon Cycle Program; Office of Science (Biological and Environmental Research), US Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Biological and Environmental Research, Terrestrial Carbon Program(United States Department of Energy (DOE)); CFCAS; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); BIOCAP; Environment Canada(CGIAR); NRCan(Natural Resources Canada); CarboEuropeIP(European Commission); FAO-GTOS-TCO; iLEAPS; Max-Planck Institute for Biogeochemistry; University of Tuscia; Universite Laval and Environment Canada; US Department of Energy(United States Department of Energy (DOE)); USDA Forest Service's Northern Research Station; Office of Science (BER), US Department of Energy(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the NOAA Climate Program Office, Global Carbon Cycle Program (award NA11OAR4310054) and the Office of Science (Biological and Environmental Research), US Department of Energy. G. B. acknowledges a grant from the National Science Foundation (grant number DEB-0911461). This work used eddy covariance data acquired by the FLUXNET community and in particular by the AmeriFlux, CarboEuropeIP and Fluxnet-Canada networks. AmeriFlux was supported by the US Department of Energy, Biological and Environmental Research, Terrestrial Carbon Program (grant numbers DE-FG02-04ER63917 and DE-FG02-04ER63911, DE-SC0006708) and Fluxnet-Canada was supported by CFCAS, NSERC, BIOCAP, Environment Canada and NRCan. We acknowledge financial support of the eddy covariance data harmonization provided by CarboEuropeIP, FAO-GTOS-TCO, iLEAPS, the Max-Planck Institute for Biogeochemistry, National Science Foundation, University of Tuscia, Universite Laval and Environment Canada and US Department of Energy and of the database development and technical support from Berkeley Water Center, Lawrence Berkeley National Laboratory, Microsoft Research eScience, Oak Ridge National Laboratory, University of California-Berkeley, University of Virginia. We thank all those involved in the NACP Site Synthesis, inparticular the modelling teams who provided model output. Research at the Bartlett Experimental Forest tower is supported by the National Science Foundation (grant DEB-1114804), and the USDA Forest Service's Northern Research Station. Research at Howland Forest is supported by the Office of Science (BER), US Department of Energy. Carbon flux and biometric measurements at Harvard Forest have been supported by the Office of Science (BER), US Department of Energy and the National Science Foundation Long-Term Ecological Research programmes. We thank S. Ollinger and S. Frey for maintaining the long-term leaf nitrogen measurements at Harvard Forest, and B. Yang for providing gap-filled meteorological data for the regional focus sites.	Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Ballantyne AP, 2012, NATURE, V488, P70, DOI 10.1038/nature11299; Battipaglia G, 2013, NEW PHYTOL, V197, P544, DOI 10.1111/nph.12044; Beer C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003233; Bernacchi CJ, 2007, PLANT PHYSIOL, V143, P134, DOI 10.1104/pp.106.089557; Berry JA, 2010, CURR OPIN PLANT BIOL, V13, P232, DOI 10.1016/j.pbi.2010.04.013; Betts RA, 2007, NATURE, V448, P1037, DOI 10.1038/nature06045; Buckley TN, 2008, J EXP BOT, V59, P1951, DOI 10.1093/jxb/erm234; Desai AR, 2008, AGR FOREST METEOROL, V148, P821, DOI 10.1016/j.agrformet.2007.11.012; Dragoni D, 2011, GLOBAL CHANGE BIOL, V17, P886, DOI 10.1111/j.1365-2486.2010.02281.x; Drake JE, 2011, ECOL LETT, V14, P349, DOI 10.1111/j.1461-0248.2011.01593.x; FIELD CB, 1995, PLANT CELL ENVIRON, V18, P1214, DOI 10.1111/j.1365-3040.1995.tb00630.x; Grelle A, 1997, J HYDROL, V197, P70, DOI 10.1016/S0022-1694(96)03267-2; Jones JA, 2012, BIOSCIENCE, V62, P390, DOI 10.1525/bio.2012.62.4.10; Katul GG, 2009, PLANT CELL ENVIRON, V32, P968, DOI 10.1111/j.1365-3040.2009.01977.x; Keys PW, 2012, BIOGEOSCIENCES, V9, P733, DOI 10.5194/bg-9-733-2012; KHAIRI MMA, 1976, PHYSIOL PLANTARUM, V36, P35, DOI 10.1111/j.1399-3054.1976.tb05024.x; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; McMahon SM, 2010, P NATL ACAD SCI USA, V107, P3611, DOI 10.1073/pnas.0912376107; Medlyn BE, 2011, GLOBAL CHANGE BIOL, V17, P2134, DOI 10.1111/j.1365-2486.2010.02375.x; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Niinemets U, 2011, TRENDS ECOL EVOL, V26, P136, DOI 10.1016/j.tree.2010.12.012; Norby RJ, 2011, ANNU REV ECOL EVOL S, V42, P181, DOI 10.1146/annurev-ecolsys-102209-144647; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Salzer MW, 2009, P NATL ACAD SCI USA, V106, P20348, DOI 10.1073/pnas.0903029106; Saurer M, 2004, GLOBAL CHANGE BIOL, V10, P2109, DOI 10.1111/j.1365-2486.2004.00869.x; Schmidt A, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002100; Schubert BA, 2012, GEOCHIM COSMOCHIM AC, V96, P29, DOI 10.1016/j.gca.2012.08.003; Seibt U, 2008, OECOLOGIA, V155, P441, DOI 10.1007/s00442-007-0932-7	33	743	777	42	970	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2013	499	7458					324	+		10.1038/nature12291	http://dx.doi.org/10.1038/nature12291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23842499				2022-12-28	WOS:000321910700033
J	Dyer, C				Dyer, Clare			LAW Has the Data Protection Act been misused as a fig leaf for medical secrecy?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Dyer, C (corresponding author), BMJ, London WC1H 9JR, England.	claredyer4@gmail.com						Dyer C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f4052; NHS Choices, 2013, CONS TREATM OUTC; Thornton Grant, CAR QUAL COMM RE PRO; Winnett R., 2013, DAILY TELEGRAPH	4	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 16	2013	347								f4515	10.1136/bmj.f4515	http://dx.doi.org/10.1136/bmj.f4515			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	189DE	23861430				2022-12-28	WOS:000322246500025
J	Narayanan, D; Luvai, A; Barski, R; Sharma, R				Narayanan, Deepa; Luvai, Ahai; Barski, Robert; Sharma, Reena			Stroke in a young man	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HOMOCYSTINURIA; HOMOCYSTEINE		[Narayanan, Deepa; Luvai, Ahai; Barski, Robert; Sharma, Reena] Leeds Teaching Hosp NHS Trust, Dept Chem Pathol & Metab Med, Leeds LS1 3EX, W Yorkshire, England	University of Leeds	Narayanan, D (corresponding author), Leeds Teaching Hosp NHS Trust, Dept Chem Pathol & Metab Med, Leeds LS1 3EX, W Yorkshire, England.	deepan@doctors.org.uk						Beard RS, 2011, AM J PHYSIOL-HEART C, V300, pH13, DOI 10.1152/ajpheart.00598.2010; Marini C, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/535672; Moat SJ, 1999, ANN CLIN BIOCHEM, V36, P372, DOI 10.1177/000456329903600311; MUDD SH, 1985, AM J HUM GENET, V37, P1; National Institute for Health Research, EXP NEWB SCREEN; Refsum H, 2004, CLIN CHEM, V50, P3, DOI 10.1373/clinchem.2003.021634; Testai FD, 2010, ARCH NEUROL-CHICAGO, V67, P148, DOI 10.1001/archneurol.2009.333; Wiebers DO, 1997, HDB STROKE, P237	8	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2013	347								f4484	10.1136/bmj.f4484	http://dx.doi.org/10.1136/bmj.f4484			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	189CP	23857996				2022-12-28	WOS:000322245000004
J	Holmes, D				Holmes, David			Rifat Atun: looking at the bigger picture	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 6	2013	382	9886					19	19		10.1016/S0140-6736(13)61515-9	http://dx.doi.org/10.1016/S0140-6736(13)61515-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177AD	23830330	Bronze			2022-12-28	WOS:000321347000012
J	Willcox, G				Willcox, George			The Roots of Cultivation in Southwestern Asia	SCIENCE			English	Editorial Material							DOMESTICATION; CYPRUS; JORDAN; EAST		Univ Lyon 2, CNRS, Archeorient, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); Universite Lyon 2	Willcox, G (corresponding author), Univ Lyon 2, CNRS, Archeorient, 1 Rue Raulin, F-69365 Lyon, France.	willcox.george@neuf.fr						Colledge S., 2010, ENV ARCHAEOL, V15, P13; Edwards PC, 2013, CULT HIST ANC, V59, P95; Kuijt I, 2009, P NATL ACAD SCI USA, V106, P10966, DOI 10.1073/pnas.0812764106; Manning SW, 2010, ANTIQUITY, V84, P693, DOI 10.1017/S0003598X00100171; Matthews R., 2013, CENTRAL ZAGROS ARCHA; Mithen SJ, 2011, ANTIQUITY, V85, P350, DOI 10.1017/S0003598X00067806; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Riehl S, 2013, SCIENCE, V341, P65, DOI 10.1126/science.1236743; Vigne JD, 2012, P NATL ACAD SCI USA, V109, P8445, DOI 10.1073/pnas.1201693109; Watkins T, 2010, ANTIQUITY, V84, P621, DOI 10.1017/S0003598X00100122; Willcox G, 2012, ANTIQUITY, V86, P99, DOI 10.1017/S0003598X00062487; Willcox G, 2012, VEG HIST ARCHAEOBOT, V21, P163, DOI 10.1007/s00334-011-0307-1; Zeder MA, 2011, CURR ANTHROPOL, V52, pS221, DOI 10.1086/659307	13	58	59	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					39	40		10.1126/science.1240496	http://dx.doi.org/10.1126/science.1240496			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	176GL	23828931				2022-12-28	WOS:000321291700037
J	Vize, R				Vize, Richard			BMJ briefing: meet the new masters of public health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												richard.vize@gmail.com							0	8	8	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2013	347								f4242	10.1136/bmj.f4242	http://dx.doi.org/10.1136/bmj.f4242			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180DG	23828895				2022-12-28	WOS:000321572600003
J	Freudenthal, BD; Beard, WA; Shock, DD; Wilson, SH				Freudenthal, Bret D.; Beard, William A.; Shock, David D.; Wilson, Samuel H.			Observing a DNA Polymerase Choose Right from Wrong	CELL			English	Article							INDUCED-FIT; MECHANISM; BETA; INTERMEDIATE	DNA polymerase (pol) beta is a model polymerase involved in gap-filling DNA synthesis utilizing two metals to facilitate nucleotidyl transfer. Previous structural studies have trapped catalytic intermediates by utilizing substrate analogs (dideoxy-terminated primer or nonhydrolysable incoming nucleotide). To identify additional intermediates during catalysis, we now employ natural substrates (correct and incorrect nucleotides) and follow product formation in real time with 15 different crystal structures. We are able to observe molecular adjustments at the active site that hasten correct nucleotide insertion and deter incorrect insertion not appreciated previously. A third metal binding site is transiently formed during correct, but not incorrect, nucleotide insertion. Additionally, long incubations indicate that pyrophosphate more easily dissociates after incorrect, compared to correct, nucleotide insertion. This appears to be coupled to subdomain repositioning that is required for catalytic activation/deactivation. The structures provide insights into a fundamental chemical reaction that impacts polymerase fidelity and genome stability.	[Freudenthal, Bret D.; Beard, William A.; Shock, David D.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Intramural Research Program of the NIH; National Institute of Environmental Health Sciences [ZO1-ES050158, Z01-ES050161]; National Institutes of Health [1U19CA105010]; NATIONAL CANCER INSTITUTE [U19CA177547, U19CA105010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158, Z01ES050158, Z01ES050161] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Lars Pedersen, Juno Krahn, and the Collaborative Crystallography group at the NIEHS for help with data collection and analysis. Use of the advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract W-31-109-Eng-38. This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (project numbers ZO1-ES050158 and Z01-ES050161) and in association with the National Institutes of Health grant 1U19CA105010.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BLASCO MA, 1991, J BIOL CHEM, V266, P7904; Chou KM, 2002, NATURE, V415, P655, DOI 10.1038/415655a; Crespan E, 2012, EMBO REP, V13, P68, DOI 10.1038/embor.2011.226; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freudenthal BD, 2012, STRUCTURE, V20, P1829, DOI 10.1016/j.str.2012.08.008; Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Krahn JM, 2004, STRUCTURE, V12, P1823, DOI 10.1016/j.str.2004.08.001; Lin P, 2006, P NATL ACAD SCI USA, V103, P13294, DOI 10.1073/pnas.0606006103; MCAULEYHECHT KE, 1994, BIOCHEMISTRY-US, V33, P10266, DOI 10.1021/bi00200a006; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812	23	156	158	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					157	168		10.1016/j.cell.2013.05.048	http://dx.doi.org/10.1016/j.cell.2013.05.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827680	Green Accepted, Bronze			2022-12-28	WOS:000321327900017
J	Hatch, EM; Fischer, AH; Deerinck, TJ; Hetzer, MW				Hatch, Emily M.; Fischer, Andrew H.; Deerinck, Thomas J.; Hetzer, Martin W.			Catastrophic Nuclear Envelope Collapse in Cancer Cell Micronuclei	CELL			English	Article							ENDOPLASMIC-RETICULUM; DNA-DAMAGE; REPLICATION; GENOME; TRANSCRIPTION; ANEUPLOIDY; RESOLUTION; INTEGRITY; CHROMATIN; MITOSIS	During mitotic exit, missegregated chromosomes can recruit their own nuclear envelope (NE) to form micronuclei (MN). MN have reduced functioning compared to primary nuclei in the same cell, although the two compartments appear to be structurally comparable. Here we show that over 60% of MN undergo an irreversible loss of compartmentalization during interphase due to NE collapse. This disruption of the MN, which is induced by defects in nuclear lamina assembly, drastically reduces nuclear functions and can trigger massive DNA damage. MN disruption is associated with chromatin compaction and invasion of endoplasmic reticulum (ER) tubules into the chromatin. We identified disrupted MN in both major subtypes of human non-small-cell lung cancer, suggesting that disrupted MN could be a useful objective biomarker for genomic instability in solid tumors. Our study shows that NE collapse is a key event underlying MN dysfunction and establishes a link between aberrant NE organization and aneuploidy.	[Hatch, Emily M.; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Fischer, Andrew H.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; [Deerinck, Thomas J.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Dept Neurosci, La Jolla, CA 92093 USA; [Deerinck, Thomas J.] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA	Salk Institute; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Diego; University of California System; University of California San Diego	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		Hatch, Emily/0000-0002-3393-4075; Fischer, Andrew/0000-0002-5944-4621	National Institutes of Health [RO1GM098749, NIH/NIGMS GM103412]; American Cancer Society; American Cancer Society [PF-12-137-01-CSM]; National Cancer Institute [P30CA014118195]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103412, R01GM098749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Jamie Kasuboski in the Waitt Advanced Biophotonics Core at the Salk Institute for performing structured illumination microscopy. M.W.H. is supported by the National Institutes of Health grant RO1GM098749 and a scholar award from the American Cancer Society. E.M.H. is supported by a postdoctoral fellowship, PF-12-137-01-CSM, from the American Cancer Society. T.J.D. is supported by the National Institutes of Health grant NIH/NIGMS GM103412. The project described was supported by Award Number P30CA014118195 from the National Cancer Institute.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Anderson DJ, 2008, J CELL SCI, V121, P137, DOI 10.1242/jcs.005777; Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Coffinier C, 2010, P NATL ACAD SCI USA, V107, P5076, DOI 10.1073/pnas.0908790107; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fischer A.H., 2008, CSH PROTOC, DOI DOI 10.1101/PDB.PR0T4989; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Gant TM, 1997, ANNU REV CELL DEV BI, V13, P669, DOI 10.1146/annurev.cellbio.13.1.669; Hetzer M.W., 2010, PERSPECT BIOL, V2; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Holland N, 2008, MUTAT RES-REV MUTAT, V659, P93, DOI 10.1016/j.mrrev.2008.03.007; Lemaitre JM, 1998, J CELL BIOL, V142, P1159, DOI 10.1083/jcb.142.5.1159; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; Mackay DR, 2009, MOL BIOL CELL, V20, P1652, DOI 10.1091/mbc.E08-08-0883; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Nakamura H, 2003, CLIN CANCER RES, V9, P2294; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; PaulinLevasseur M, 1996, CHROMOSOMA, V104, P367, DOI 10.1007/s004120050128; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Schumacher J, 2006, FEBS LETT, V580, P6211, DOI 10.1016/j.febslet.2006.10.023; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Terradas M, 2012, MUTAT RES-FUND MOL M, V729, P35, DOI 10.1016/j.mrfmmm.2011.09.003; Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004; Thompson SL, 2011, P NATL ACAD SCI USA, V108, P17974, DOI 10.1073/pnas.1109720108; Vargas JD, 2012, NUCLEUS-PHILA, V3, P88, DOI 10.4161/nucl.18954; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018618	41	389	398	3	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					47	60		10.1016/j.cell.2013.06.007	http://dx.doi.org/10.1016/j.cell.2013.06.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827674	Green Accepted, Bronze			2022-12-28	WOS:000321327900009
J	Xue, ZG; Huang, K; Cai, CC; Cai, LB; Jiang, CY; Feng, Y; Liu, ZS; Zeng, Q; Cheng, LM; Sun, YE; Liu, JY; Horvath, S; Fan, GP				Xue, Zhigang; Huang, Kevin; Cai, Chaochao; Cai, Lingbo; Jiang, Chun-yan; Feng, Yun; Liu, Zhenshan; Zeng, Qiao; Cheng, Liming; Sun, Yi E.; Liu, Jia-yin; Horvath, Steve; Fan, Guoping			Genetic programs in human and mouse early embryos revealed by single-cell RNA sequencing	NATURE			English	Article							ZYGOTIC TRANSITION; PREIMPLANTATION; TRANSCRIPTOME; SEQ; LANDSCAPE; NETWORKS	Mammalian pre-implantation development is a complex process involving dramatic changes in the transcriptional architecture(1-4). We report here a comprehensive analysis of transcriptome dynamics from oocyte to morula in both human and mouse embryos, using single-cell RNA sequencing. Based on single-nucleotide variants in human blastomere messenger RNAs and paternal-specific single-nucleotide polymorphisms, we identify novel stage-specific monoallelic expression patterns for a significant portion of polymorphic gene transcripts (25 to 53%). By weighted gene co-expression network analysis(5,6), we find that each developmental stage can be delineated concisely by a small number of functional modules of co-expressed genes. This result indicates a sequential order of transcriptional changes in pathways of cell cycle, gene regulation, translation and metabolism, acting in a step-wise fashion from cleavage to morula. Cross-species comparisons with mouse pre-implantation embryos reveal that the majority of human stage-specific modules (7 out of 9) are notably preserved, but developmental specificity and timing differ between human and mouse. Furthermore, we identify conserved key members (or hub genes) of the human and mouse networks. These genes represent novel candidates that are likely to be key in driving mammalian pre-implantation development. Together, the results provide a valuable resource to dissect gene regulatory mechanisms underlying progressive development of early mammalian embryos.	[Xue, Zhigang; Feng, Yun; Liu, Zhenshan; Zeng, Qiao; Cheng, Liming; Sun, Yi E.] Tongji Univ, Sch Med, Dept Regenerat Med, Translat Ctr Stem Cell Res,Tongji Hosp, Shanghai 200065, Peoples R China; [Huang, Kevin; Cai, Chaochao; Horvath, Steve; Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Cai, Lingbo; Jiang, Chun-yan; Liu, Jia-yin] Nanjing Med Univ, Affiliated Hosp 1, Ctr Clin Reprod Med, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China	Tongji University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Nanjing Medical University	Fan, GP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	xuezhigang75@gmail.com; jyliu_nj@126.com; gfan@mednet.ucla.edu	Xiao, Hu/GMX-0258-2022; Albertini, David/AAD-3856-2021; cheng, liming/GMX-4116-2022	Albertini, David/0000-0001-6536-2828; cai, lingbo/0000-0001-5094-0082; Fan, Guoping/0000-0001-5235-6410	Ministry of Science and Technology in China [2012CB966300, 2011CB966204, 2011CB965102]; International Science and Technology Cooperation Program of China [2011DFB30010]; National Natural Science Foundation of China [81271258]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004612] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD006576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	Ministry of Science and Technology in China(Ministry of Science and Technology, China); International Science and Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank many of our colleagues for invaluable discussions and comments on our study, in particular, P. Pajukanta at UCLA for very helpful suggestions on SNP analyses and D. Geschwind for critically reading the manuscript. This work was supported by 973 Grant Programs 2012CB966300, 2011CB966204 and 2011CB965102 from the Ministry of Science and Technology in China; the International Science and Technology Cooperation Program of China (no. 2011DFB30010); and the National Natural Science Foundation of China (81271258).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hu JJ, 2010, J BIOL CHEM, V285, P33113, DOI 10.1074/jbc.M110.117044; Hu ZJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-17; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Walser CB, 2011, CURR OPIN GENET DEV, V21, P431, DOI 10.1016/j.gde.2011.03.003; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Xie D, 2010, GENOME RES, V20, P804, DOI 10.1101/gr.100594.109; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007844	37	614	640	10	281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2013	500	7464					593	+		10.1038/nature12364	http://dx.doi.org/10.1038/nature12364			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23892778	Green Accepted, Green Published			2022-12-28	WOS:000323625900038
J	Breban, R; Riou, J; Fontanet, A				Breban, Romulus; Riou, Julien; Fontanet, Arnaud			Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk	LANCET			English	Article							SARS; EVOLUTION	Background The new Middle East respiratory syndrome coronavirus (MERS-CoV) infection shares many clinical, epidemiological, and virological similarities with that of severe acute respiratory syndrome (SARS)-CoV. We aimed to estimate virus transmissibility and the epidemic potential of MERS-CoV, and to compare the results with similar findings obtained for prepandemic SARS. Methods We retrieved data for MERS-CoV clusters from the WHO summary and subsequent reports, and published descriptions of cases, and took into account 55 of the 64 laboratory-confirmed cases of MERS-CoV reported as of June 21, 2013, excluding cases notified in the previous 2 weeks. To assess the interhuman transmissibility of MERS-CoV, we used Bayesian analysis to estimate the basic reproduction number (R-0) and compared it to that of prepandemic SARS. We considered two scenarios, depending on the interpretation of the MERS-CoV cluster-size data. Results With our most pessimistic scenario (scenario 2), we estimated MERS-CoV R-0 to be 0.69 (95% CI 0.50-0.92); by contrast, the R-0 for prepandemic SARS-CoV was 0.80 (0.54-1.13). Our optimistic scenario (scenario 1) yielded a MERS-CoV R-0 of 0.60 (0.42-0.80). Because of recent implementation of effective contact tracing and isolation procedures, further MERS-CoV transmission data might no longer describe an entire cluster, but only secondary infections directly caused by the index patient. Hence, we calculated that, under scenario 2, eight or more secondary infections caused by the next index patient would translate into a 5% or higher chance that the revised MERS-CoV R-0 would exceed 1-ie, that MERS-CoV might have pandemic potential. Interpretation Our analysis suggests that MERS-CoV does not yet have pandemic potential. We recommend enhanced surveillance, active contact tracing, and vigorous searches for the MERS-CoV animal hosts and transmission routes to human beings.	[Breban, Romulus; Riou, Julien; Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, F-75015 Paris, France; [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; heSam Universite; Conservatoire National Arts & Metiers (CNAM)	Fontanet, A (corresponding author), Inst Pasteur, Emerging Dis Epidemiol Unit, F-75015 Paris, France.	fontanet@pasteur.fr		Breban, Romulus/0000-0002-5821-8139; Riou, Julien/0000-0002-3808-2852; , arnaud/0000-0002-5239-6110	Agence Nationale de la Recherche (Labex Integrative Biology of Emerging Infectious Diseases); European Community's Seventh Framework Programme project PREDEMICS	Agence Nationale de la Recherche (Labex Integrative Biology of Emerging Infectious Diseases)(French National Research Agency (ANR)); European Community's Seventh Framework Programme project PREDEMICS	Agence Nationale de la Recherche (Labex Integrative Biology of Emerging Infectious Diseases), and the European Community's Seventh Framework Programme project PREDEMICS.	Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Blumberg S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002993; Buchholz U, 2013, EUROSURVEILLANCE, V18, P6; Cauchemez S, 2013, Euro Surveill, V18; Danielsson N, 2012, EUROSURVEILLANCE, V17, P9; Drosten C, 2013, LANCET INFECT DIS; European Center for Disease Prevention and Control, 2013, UPD RAP RISK ASS SEV; Guery B, 2013, LANCET; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; Hijawi B, 2013, E MEDITERR HEALTH J, V19, pS12; Holmes KV, 2005, SCIENCE, V309, P1822, DOI 10.1126/science.1118817; Leung GM, 2004, EMERG INFECT DIS, V10, P1653, DOI 10.3201/eid1009.040155; Memish ZA, 2013, NEW ENGL J MED, DOI [10.1056/NEJMoa1303729, DOI 10.1056/NEJM3A1303729]; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Tahir M, 2013, EUROSURVEILLANCE, V18, P4; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; WHO, MERS COV SUMM LIT UP; World Health Organization, 2006, SARS GLOB EP WAS STO; Xu RH, 2004, EMERG INFECT DIS, V10, P1030, DOI 10.3201/eid1006.030852; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2	25	243	261	2	74	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2013	382	9893					694	699		10.1016/S0140-6736(13)61492-0	http://dx.doi.org/10.1016/S0140-6736(13)61492-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206SI	23831141	Green Published, Bronze			2022-12-28	WOS:000323542400027
J	Singh, R; Low, ETL; Ooi, LCL; Ong-Abdullah, M; Ting, NC; Nagappan, J; Nookiah, R; Amiruddin, MD; Rosli, R; Manaf, MAA; Chan, KL; Halim, MA; Azizi, N; Lakey, N; Smith, SW; Budiman, MA; Hogan, M; Bacher, B; Van Brunt, A; Wang, CY; Ordway, JM; Sambanthamurthi, R; Martienssen, RA				Singh, Rajinder; Low, Eng-Ti Leslie; Ooi, Leslie Cheng-Li; Ong-Abdullah, Meilina; Ting, Ngoot-Chin; Nagappan, Jayanthi; Nookiah, Rajanaidu; Amiruddin, Mohd Din; Rosli, Rozana; Manaf, Mohamad Arif Abdul; Chan, Kuang-Lim; Halim, Mohd Amin; Azizi, Norazah; Lakey, Nathan; Smith, Steven W.; Budiman, Muhammad A.; Hogan, Michael; Bacher, Blaire; Van Brunt, Andrew; Wang, Chunyan; Ordway, Jared M.; Sambanthamurthi, Ravigadevi; Martienssen, Robert A.			The oil palm SHELL gene controls oil yield and encodes a homologue of SEEDSTICK	NATURE			English	Article							MADS-BOX GENES; ELAEIS-GUINEENSIS; AGAMOUS SUBFAMILY; LINKAGE MAP; DIVERSIFICATION; CONSERVATION; ARABIDOPSIS; CARPEL; FRUIT; LOCUS	A key event in the domestication and breeding of the oil palm Elaeis guineensis was loss of the thick coconut-like shell surrounding the kernel. Modern E. guineensis has three fruit forms, dura (thick-shelled), pisifera (shell-less) and tenera (thin-shelled), a hybrid between dura and pisifera(1-4). The pisifera palm is usually female-sterile. The tenera palm yields far more oil than dura, and is the basis for commercial palm oil production in all of southeast Asia(5). Here we describe the mapping and identification of the SHELL gene responsible for the different fruit forms. Using homozygosity mapping by sequencing, we found two independent mutations in the DNA-binding domain of a homologue of the MADS-box gene SEEDSTICK (STK, also known as AGAMOUS-LIKE 11), which controls ovule identity and seed development in Arabidopsis. The SHELL gene is responsible for the tenera phenotype in both cultivated and wild palms from sub-Saharan Africa, and our findings provide a genetic explanation for the single gene hybrid vigour (or heterosis) attributed to SHELL, via heterodimerization. This gene mutation explains the single most important economic trait in oil palm, and has implications for the competing interests of global edible oil production, biofuels and rainforest conservation(6).	[Singh, Rajinder; Low, Eng-Ti Leslie; Ooi, Leslie Cheng-Li; Ong-Abdullah, Meilina; Ting, Ngoot-Chin; Nagappan, Jayanthi; Nookiah, Rajanaidu; Amiruddin, Mohd Din; Rosli, Rozana; Manaf, Mohamad Arif Abdul; Chan, Kuang-Lim; Halim, Mohd Amin; Azizi, Norazah; Sambanthamurthi, Ravigadevi] Persiaran Inst, Malaysian Palm Oil Board, Kajang 43000, Selangor, Malaysia; [Lakey, Nathan; Smith, Steven W.; Budiman, Muhammad A.; Hogan, Michael; Bacher, Blaire; Van Brunt, Andrew; Wang, Chunyan; Ordway, Jared M.] Orion Genom, St Louis, MO 63108 USA; [Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Cold Spring Harbor, NY 11724 USA	Malaysian Palm Oil Board; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Sambanthamurthi, R (corresponding author), Persiaran Inst, Malaysian Palm Oil Board, Kajang 43000, Selangor, Malaysia.	raviga@mpob.gov.my; martiens@cshl.edu	Low, Eng Ti Leslie/AHD-7011-2022; Singh, Rajinder/P-9179-2015	Low, Eng Ti Leslie/0000-0003-3414-8401; Singh, Rajinder/0000-0001-9933-4884; Sambanthamurthi, Ravi/0000-0003-3023-9306; Chan, Kuang-Lim/0000-0002-8419-0432; Ong-Abdullah, Meilina/0000-0003-4825-5021; Ooi, Leslie/0000-0002-6996-2801; Azizi, Norazah/0000-0001-5023-9763	Malaysian Palm Oil Board; National Science Foundation [0421604]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER	Malaysian Palm Oil Board; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Jansen for assistance with JoinMap, and Beijing Genome Institute, The Genome Institute at Washington University, Tufts University Core Facility and the Arizona Genome Institute for mapping and genome sequencing. We thank Kulim, Sime Darby, FELDA Agricultural Services, United Plantations and Applied Agricultural Resources for providing materials and phenotype information of individual palms. Phylogeny, Inc. performed in situ hybridization services. Creative Biolabs performed yeast two-hybrid co-transformations and interaction assays. We thank J. Birchler and Z. Lippman for discussions on hybrid vigour. We appreciate the constant support of Y. M. Choo, and the Ministry of Plantation Industries and Commodities, Malaysia. The project was endorsed by the Cabinet Committee on the Competitiveness of the Palm Oil Industry (CCPO) and funded by the Malaysian Palm Oil Board. R. A. M. is supported by a grant from National Science Foundation 0421604 'Genomics of Comparative Seed Plant Evolution'.	Beirnaert A., 1941, PUBL I NAT ETUDE AGR, V27, P1; Bhasker Salini, 2001, Indian Journal of Experimental Biology, V39, P160; Billotte N, 2005, THEOR APPL GENET, V110, P754, DOI 10.1007/s00122-004-1901-8; Corley R. H. V., 2003, OIL PALM, V4th, P1; Cui RF, 2010, PLANT J, V61, P767, DOI 10.1111/j.1365-313X.2009.04101.x; Danielsen F, 2009, CONSERV BIOL, V23, P348, DOI 10.1111/j.1523-1739.2008.01096.x; DEVUYST A, 1953, NATURE, V172, P685, DOI 10.1038/172685a0; Dinneny JR, 2005, BIOESSAYS, V27, P42, DOI 10.1002/bies.20165; Dreni L, 2007, PLANT J, V52, P690, DOI 10.1111/j.1365-313X.2007.03272.x; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; GODDING R., 1930, BULL AGRIC CONGO BELGE, V21, P1263; Gschwend M, 1996, AM J HUM GENET, V59, P377; HARTLEY C, 1988, OIL PALM, P47; Huang H, 1996, PLANT CELL, V8, P81, DOI 10.1105/tpc.8.1.81; Immink RGH, 2010, SEMIN CELL DEV BIOL, V21, P87, DOI 10.1016/j.semcdb.2009.10.004; Janssens P, 1927, B AGR CONGO BELGE, V18, P29; Kramer EM, 2004, GENETICS, V166, P1011, DOI 10.1534/genetics.166.2.1011; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Mayes S, 1997, GENOME, V40, P116, DOI 10.1139/g97-016; Moretzsohn MC, 2000, THEOR APPL GENET, V100, P63, DOI 10.1007/s001220050009; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Rajanaidu N., 1989, Elaeis, V1, P1; Rajanaidu N., 2000, ADV OIL PALM RES, P171; Singh R, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-114; Tani E, 2007, TREE PHYSIOL, V27, P649, DOI 10.1093/treephys/27.5.649; Tani E, 2009, PLANT PHYSIOL BIOCH, V47, P690, DOI 10.1016/j.plaphy.2009.03.013; Veitia RA, 2011, FASEB J, V25, P476, DOI 10.1096/fj.10-170639; Vrebalov J, 2009, PLANT CELL, V21, P3041, DOI 10.1105/tpc.109.066936; Zahn LM, 2006, EVOL DEV, V8, P30, DOI 10.1111/j.1525-142X.2006.05073.x	30	124	139	5	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					340	+		10.1038/nature12356	http://dx.doi.org/10.1038/nature12356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23883930	Green Accepted			2022-12-28	WOS:000323112400034
J	Chao, DY; Dilkes, B; Luo, HB; Douglas, A; Yakubova, E; Lahner, B; Salt, DE				Chao, Dai-Yin; Dilkes, Brian; Luo, Hongbing; Douglas, Alex; Yakubova, Elena; Lahner, Brett; Salt, David E.			Polyploids Exhibit Higher Potassium Uptake and Salinity Tolerance in Arabidopsis	SCIENCE			English	Article							THALIANA	Genome duplication (or polyploidization) has occurred throughout plant evolutionary history and is thought to have driven the adaptive radiation of plants. We found that the cytotype of the root, and not the genotype, determined the majority of heritable natural variation in leaf potassium (K) concentration in Arabidopsis thaliana. Autopolyploidy also provided resistance to salinity and may represent an adaptive outcome of the enhanced K accumulation of plants with higher ploidy.	[Chao, Dai-Yin; Douglas, Alex; Salt, David E.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 3UU, Scotland; [Dilkes, Brian; Luo, Hongbing; Yakubova, Elena; Lahner, Brett] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	University of Aberdeen; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Salt, DE (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Cruickshank Bldg,St Machar Dr, Aberdeen AB24 3UU, Scotland.	david.salt@abdn.ac.uk	Chao, Dai-Yin/GYV-5944-2022; Dilkes, Brian/C-9293-2012	Dilkes, Brian/0000-0003-2799-954X; Douglas, Alex/0000-0001-6606-1058; ?, ??/0000-0003-2832-4800	NIH [R01GM078536]; European Commission [PCIG9-GA-2011-291798]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078536] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Chan for diploid Wa-1 and the haploid inducer, C. P. Huang for help with microscopy, and T. Graham and E. Svedin for flow cytometry results. We acknowledge support from the NIH (grant R01GM078536) and the European Commission (grant PCIG9-GA-2011-291798). ICP-MS data for Fig. 1, A to F, and fig. S1 are stored at www.ionomicshub.org. All other data are available as supplementary materials on Science Online. D.-Y.C., B. D., and D. E. S. conceived and designed the experiments; D.-Y.C., H. L., B. L., and E.Y. performed the experiments; D.-Y.C., B. D., B. L., A. D., and D. E. S. analyzed the data; and D.-Y.C., B. D., and D. E. S. wrote the manuscript.	Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Henry IM, 2005, GENETICS, V170, P1979, DOI 10.1534/genetics.104.037788; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Schiff CL, 2001, PLANT PATHOL, V50, P690, DOI 10.1046/j.1365-3059.2001.00611.x	7	215	234	9	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					658	659		10.1126/science.1240561	http://dx.doi.org/10.1126/science.1240561			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23887874	Green Accepted			2022-12-28	WOS:000322884800039
J	Qi, CH; Oberg, KI; Wilner, DJ; D'Alessio, P; Bergin, E; Andrews, SM; Blake, GA; Hogerheijde, MR; van Dishoeck, EF				Qi, Chunhua; Oeberg, Karin I.; Wilner, David J.; D'Alessio, Paola; Bergin, Edwin; Andrews, Sean M.; Blake, Geoffrey A.; Hogerheijde, Michiel R.; van Dishoeck, Ewine F.			Imaging of the CO Snow Line in a Solar Nebula Analog	SCIENCE			English	Article							PROTOPLANETARY DISKS; STAR-FORMATION; X-RAY; ICE; CHEMISTRY; MOLECULES; WATER; PLANETESIMALS; EVOLUTION; EMISSION	Planets form in the disks around young stars. Their formation efficiency and composition are intimately linked to the protoplanetary disk locations of "snow lines" of abundant volatiles. We present chemical imaging of the carbon monoxide (CO) snow line in the disk around TW Hya, an analog of the solar nebula, using high spatial and spectral resolution Atacama Large Millimeter/Submillimeter Array observations of diazenylium (N2H+), a reactive ion present in large abundance only where CO is frozen out. The N2H+ emission is distributed in a large ring, with an inner radius that matches CO snow line model predictions. The extracted CO snow line radius of similar to 30 astronomical units helps to assess models of the formation dynamics of the solar system, when combined with measurements of the bulk composition of planets and comets.	[Qi, Chunhua; Wilner, David J.; Andrews, Sean M.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Oeberg, Karin I.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Oeberg, Karin I.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [D'Alessio, Paola] Univ Nacl Autonoma Mexico, Ctr Radioastron & Astrofis, Mexico City 58089, DF, Mexico; [Bergin, Edwin] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Blake, Geoffrey A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Hogerheijde, Michiel R.; van Dishoeck, Ewine F.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [van Dishoeck, Ewine F.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Virginia; University of Virginia; Universidad Nacional Autonoma de Mexico; University of Michigan System; University of Michigan; California Institute of Technology; Leiden University; Leiden University - Excl LUMC; Max Planck Society	Qi, CH (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	cqi@cfa.harvard.edu		Andrews, Sean/0000-0003-2253-2270; Wilner, David/0000-0003-1526-7587	NASA Origins of Solar Systems [NNX11AK63]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica-UNAM; NSF [1008800]; Smithsonian Institution; Academia Sinica;  [2004-214]; Direct For Mathematical & Physical Scien [1008800, 1109857] Funding Source: National Science Foundation	NASA Origins of Solar Systems(National Aeronautics & Space Administration (NASA)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); NSF(National Science Foundation (NSF)); Smithsonian Institution(Smithsonian Institution); Academia Sinica(Academia Sinica - Taiwan); ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We are grateful to S. Schnee for data calibration and reduction assistance. C. Q. thanks the Smithsonian Astrophysical Observatory (SAO) Radio Telescope Data Center (RTDC) staff for their generous computational support. C. Q., K.I.O., and D.J.W. acknowledge grant NNX11AK63 from NASA Origins of Solar Systems. P. D. acknowledges a grant from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica-UNAM. E. B. acknowledges support from NSF grant 1008800. This Report makes use of the following ALMA data: ADS JAO. ALMA#2011.0.00340.S. ALMA is a partnership of the European Southern Observatory (ESO) (representing its member states), NSF (USA), and the National Institute of Natural Sciences (Japan), together with the National Research Council (Canada) and the National Science Council and Academia Sinica's Institute of Astronomy and Astrophysics (ASIAA) (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, Associated Universities, Inc. (AUI)/National Radio Astronomy Observatory, and the National Astronomical Observatory of Japan. We also make use of the Submillimeter Array (SMA) data: project #2004-214 (principal investigator, C. Q.). The SMA is a joint project between SAO and ASIAA and is funded by the Smithsonian Institution and the Academia Sinica.	Aikawa Y, 1999, ASTRON ASTROPHYS, V351, P233; Andrews SM, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/162; Bergin EA, 2002, ASTROPHYS J, V570, pL101, DOI 10.1086/340950; Bergin EA, 2013, NATURE, V493, P644, DOI 10.1038/nature11805; Bisschop SE, 2006, ASTRON ASTROPHYS, V449, P1297, DOI 10.1051/0004-6361:20054051; Chiang E, 2010, ANNU REV EARTH PL SC, V38, P493, DOI 10.1146/annurev-earth-040809-152513; Dodson-Robinson SE, 2009, ICARUS, V200, P672, DOI 10.1016/j.icarus.2008.11.023; Gundlach B, 2011, ICARUS, V214, P717, DOI 10.1016/j.icarus.2011.05.005; Hayashi C., 1981, Progress of Theoretical Physics Supplement, P35, DOI 10.1143/PTPS.70.35; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; Hogerheijde MR, 2000, ASTRON ASTROPHYS, V362, P697; Hollenbach D, 2009, ASTROPHYS J, V690, P1497, DOI 10.1088/0004-637X/690/2/1497; Johansen A, 2007, NATURE, V448, P1022, DOI 10.1038/nature06086; Jorgensen JK, 2004, ASTRON ASTROPHYS, V424, P589, DOI 10.1051/0004-6361:20040247; Kastner JH, 1997, SCIENCE, V277, P67, DOI 10.1126/science.277.5322.67; Lecar M, 2006, ASTROPHYS J, V640, P1115, DOI 10.1086/500287; LEWIS JS, 1974, SCIENCE, V186, P440, DOI 10.1126/science.186.4162.440; Mumma MJ, 2011, ANNU REV ASTRON ASTR, V49, P471, DOI 10.1146/annurev-astro-081309-130811; Oberg KI, 2011, ASTROPHYS J LETT, V743, DOI 10.1088/2041-8205/743/1/L16; Oberg KI, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/98; OWEN TC, 1993, SCIENCE, V261, P745, DOI 10.1126/science.261.5122.745; Qi CH, 2008, ASTROPHYS J, V681, P1396, DOI 10.1086/588516; Qi CH, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/34; Qi CH, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/84; Ros K, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220536; Rosenfeld KA, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/129; STEVENSON DJ, 1988, ICARUS, V75, P146, DOI 10.1016/0019-1035(88)90133-9; Tegler SC, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/76; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Walsh C, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/114; Willacy K, 2007, ASTROPHYS J, V660, P441, DOI 10.1086/512796; Wilner DJ, 2005, ASTROPHYS J, V626, pL109, DOI 10.1086/431757	33	184	184	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					630	632		10.1126/science.1239560	http://dx.doi.org/10.1126/science.1239560			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23868917	Green Submitted			2022-12-28	WOS:000322884800031
J	Moum, JN; Perlin, A; Nash, JD; McPhaden, MJ				Moum, James N.; Perlin, Alexander; Nash, Jonathan D.; McPhaden, Michael J.			Seasonal sea surface cooling in the equatorial Pacific cold tongue controlled by ocean mixing	NATURE			English	Article							TROPICAL PACIFIC; ANNUAL CYCLE; SHEAR-FLOW; TEMPERATURE; TURBULENCE; INSTABILITY; BALANCE; MODELS; BUDGET	Sea surface temperature (SST) is a critical control on the atmosphere(1), and numerical models of atmosphere-ocean circulation emphasize its accurate prediction. Yet many models demonstrate large, systematic biases in simulated SST in the equatorial 'cold tongues' (expansive regions of net heat uptake from the atmosphere) of the Atlantic(2) and Pacific(3) oceans, particularly with regard to a central but little-understood feature of tropical oceans: a strong seasonal cycle. The biases may be related to the inability of models to constrain turbulent mixing realistically(4), given that turbulent mixing, combined with seasonal variations in atmospheric heating, determines SST. In temperate oceans, the seasonal SST cycle is clearly related to varying solar heating(5); in the tropics, however, SSTs vary seasonally in the absence of similar variations in solar inputs(6). Turbulent mixing has long been a likely explanation, but firm, long-term observational evidence has been absent. Here we show the existence of a distinctive seasonal cycle of subsurface cooling via mixing in the equatorial Pacific cold tongue, using multi-year measurements of turbulence in the ocean. In boreal spring, SST rises by 2 kelvin when heating of the upper ocean by the atmosphere exceeds cooling by mixing from below. In boreal summer, SST decreases because cooling from below exceeds heating from above. When the effects of lateral advection are considered, the magnitude of summer cooling via mixing (4 kelvin per month) is equivalent to that required to counter the heating terms. These results provide quantitative assessment of how mixing varies on timescales longer than a few weeks, clearly showing its controlling influence on seasonal cooling of SST in a critical oceanic regime.	[Moum, James N.; Perlin, Alexander; Nash, Jonathan D.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [McPhaden, Michael J.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA	Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA	Moum, JN (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	moum@coas.oregonstate.edu	Moum, James N/A-1880-2012; Nash, Jonathan/K-8101-2019; McPhaden, Michael J/D-9799-2016; Moum, James N/N-1187-2019	McPhaden, Michael J/0000-0002-8423-5805; Nash, Jonathan/0000-0003-4005-9368	National Science Foundation [0424133, 0728375, 1256620]; Directorate For Geosciences [1256620] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by the National Science Foundation (grants 0424133, 0728375 and 1256620). We thank M. Neeley-Brown and R. Kreth, who were primarily responsible for construction, testing and maintenance of chi-pods, and P. Freitag and NOAA's PMEL mooring group, who helped us to get started with these measurements. We also thank NOAA's NDBC group, who have continued to deploy our chi-pods on TAO moorings. E. Shroyer, S. de Szoeke, K. Benoit-Bird and D. Chelton provided comments on the paper. This is PMEL contribution no. 3970. We dedicate this paper to the memory of our colleague and co-author A. Perlin, who passed away during final revisions, and to the memory of lab engineer R. Kreth.	GREGG MC, 1985, NATURE, V318, P140, DOI 10.1038/318140a0; Hummels R, 2013, PROG OCEANOGR, V111, P52, DOI 10.1016/j.pocean.2012.11.001; Inoue R, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007767; Jouanno J, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006912; Kumar BP, 2012, CLIM DYNAM, V38, P1521, DOI 10.1007/s00382-011-1115-0; LIEN RC, 1995, J GEOPHYS RES-OCEANS, V100, P6881, DOI 10.1029/94JC03312; Mcphaden MJ, 2008, J CLIMATE, V21, P3240, DOI 10.1175/2007JCLI2115.1; McPhaden MJ, 1998, J GEOPHYS RES-OCEANS, V103, P14169, DOI 10.1029/97JC02906; MITCHELL TP, 1992, J CLIMATE, V5, P1140, DOI 10.1175/1520-0442(1992)005<1140:TACIEC>2.0.CO;2; Moum JN, 2011, J PHYS OCEANOGR, V41, P397, DOI 10.1175/2010JPO4450.1; Moum JN, 2009, NAT GEOSCI, V2, P761, DOI 10.1038/NGEO657; Moum JN, 2009, J ATMOS OCEAN TECH, V26, P317, DOI 10.1175/2008JTECHO617.1; MOUM JN, 1985, SCIENCE, V230, P315, DOI 10.1126/science.230.4723.315; Ohlmann JC, 1996, J CLIMATE, V9, P2265, DOI 10.1175/1520-0442(1996)009<2265:OMLRHA>2.0.CO;2; Osborn T. R., 1972, Geophysical Fluid Dynamics, V3, P321, DOI 10.1080/03091927208236085; Perlin A, 2012, J ATMOS OCEAN TECH, V29, P1347, DOI 10.1175/JTECH-D-12-00019.1; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Richter I, 2008, CLIM DYNAM, V31, P587, DOI 10.1007/s00382-008-0364-z; Smyth W. D., J PHYS OCEANOG UNPUB; Sun CJ, 1998, J GEOPHYS RES-OCEANS, V103, P10323, DOI 10.1029/98JC00191; Swenson MS, 1999, J PHYS OCEANOGR, V29, P69, DOI 10.1175/1520-0485(1999)029<0069:TPOMLH>2.0.CO;2; Trenberth KE, 2001, CLIM DYNAM, V17, P259, DOI 10.1007/PL00007927; Wang B, 2001, J CLIMATE, V14, P2250, DOI 10.1175/1520-0442(2001)014<0001:PDTRRO>2.0.CO;2; Wang WM, 1999, J PHYS OCEANOGR, V29, P1812, DOI 10.1175/1520-0485(1999)029<1812:TSLHBI>2.0.CO;2; Wittenberg AT, 2006, J CLIMATE, V19, P698, DOI 10.1175/JCLI3631.1; Xie SP, 2004, B AM METEOROL SOC, V85, P195, DOI 10.1175/BAMS-85-2-195; XIE SP, 1994, J CLIMATE, V7, P2008, DOI 10.1175/1520-0442(1994)007<2008:OTGOTE>2.0.CO;2; Zaron ED, 2009, J PHYS OCEANOGR, V39, P2652, DOI 10.1175/2009JPO4133.1	28	85	87	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					64	67		10.1038/nature12363	http://dx.doi.org/10.1038/nature12363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23883934				2022-12-28	WOS:000322514800028
J	Holt, BG; Lessard, JP; Borregaard, MK; Fritz, SA; Araujo, MB; Dimitrov, D; Fabre, PH; Graham, CH; Graves, GR; Jonsson, KA; Nogues-Bravo, D; Wang, ZH; Whittaker, RJ; Fjeldsa, J; Rahbek, C				Holt, Ben G.; Lessard, Jean-Philippe; Borregaard, Michael K.; Fritz, Susanne A.; Araujo, Miguel B.; Dimitrov, Dimitar; Fabre, Pierre-Henri; Graham, Catherine H.; Graves, Gary R.; Jonsson, Knud A.; Nogues-Bravo, David; Wang, Zhiheng; Whittaker, Robert J.; Fjeldsa, Jon; Rahbek, Carsten			Response to Comment on "An Update of Wallace's Zoogeographic Regions of the World"	SCIENCE			English	Editorial Material							BIRDS; DIVERSITY; PATTERNS		[Holt, Ben G.; Lessard, Jean-Philippe; Borregaard, Michael K.; Fritz, Susanne A.; Araujo, Miguel B.; Graves, Gary R.; Nogues-Bravo, David; Wang, Zhiheng; Whittaker, Robert J.; Rahbek, Carsten] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen O, Denmark; [Holt, Ben G.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Lessard, Jean-Philippe] McGill Univ, Dept Biol, Quebec Ctr Biodivers Sci, Montreal, PQ H3A 1B1, Canada; [Fritz, Susanne A.] Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Fritz, Susanne A.] Senckenberg Gesell Nat Forsch, D-60325 Frankfurt, Germany; [Araujo, Miguel B.] CSIC, Natl Museum Nat Sci, Dept Biogeog & Global Change, E-28006 Madrid, Spain; [Araujo, Miguel B.] Univ Evora, Ctr Invest Biodiversidade & Recursos Genet, P-7000 Evora, Portugal; [Araujo, Miguel B.; Dimitrov, Dimitar; Fabre, Pierre-Henri; Graves, Gary R.; Jonsson, Knud A.; Nogues-Bravo, David; Wang, Zhiheng; Fjeldsa, Jon; Rahbek, Carsten] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen O, Denmark; [Dimitrov, Dimitar] Univ Oslo, Nat Hist Museum, NO-0318 Oslo, Norway; [Graham, Catherine H.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Graves, Gary R.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20013 USA; [Whittaker, Robert J.] Univ Oxford, Sch Geog & Environm, Biodivers Res Grp, Ctr Environm, Oxford OX1 3QY, England	University of Copenhagen; University of East Anglia; McGill University; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN); Consejo Superior de Investigaciones Cientificas (CSIC); University of Evora; University of Copenhagen; University of Oslo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Oxford	Lessard, JP (corresponding author), Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen O, Denmark.	jplessard@bio.ku.dk	Rahbek, Carsten/L-1129-2013; Graham, Catherine/A-9560-2011; Graves, Gary R/P-1003-2017; Wang, Zhiheng/G-1750-2010; Jonsson, Knud A/F-6902-2012; Dimitrov, Dimitar/A-9563-2009; Araújo, Miguel B/B-6117-2008; Fritz, Susanne/M-9872-2014; Jønsson, Knud/GMW-5310-2022; Borregaard, Michael/B-8442-2008; Fjeldså, Jon/A-9699-2013; Whittaker, Robert J/H-1548-2015; Graham, Catherine/AAN-1237-2020	Rahbek, Carsten/0000-0003-4585-0300; Graham, Catherine/0000-0001-9267-7948; Graves, Gary R/0000-0003-1406-5246; Wang, Zhiheng/0000-0003-0808-7780; Dimitrov, Dimitar/0000-0001-5830-5702; Araújo, Miguel B/0000-0002-5107-7265; Fritz, Susanne/0000-0002-4085-636X; Jønsson, Knud/0000-0002-1875-9504; Borregaard, Michael/0000-0002-8146-8435; Fjeldså, Jon/0000-0003-0790-3600; Whittaker, Robert J/0000-0001-7775-3383; Graham, Catherine/0000-0001-9267-7948; Pierre-Henri, Fabre/0000-0002-3414-5625; Holt, Ben G./0000-0003-0831-9684; Nogues-Bravo, David/0000-0002-4060-0153				Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Fritz SA, 2012, J BIOGEOGR, V39, P1373, DOI 10.1111/j.1365-2699.2012.02757.x; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kreft H, 2013, SCIENCE, V341, DOI 10.1126/science.1237471; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; Mayr G, 2013, SYST BIODIVERS, V11, P7, DOI 10.1080/14772000.2013.765521; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Muller P., 1986, BIOGEOGRAPHY, V16, P7; Proches S, 2012, BIOSCIENCE, V62, P260, DOI 10.1525/bio.2012.62.3.7; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Wallace, 1876, GEOGRAPHICAL DISTRIB; Williams PH, 1999, J BIOGEOGR, V26, P459, DOI 10.1046/j.1365-2699.1999.00294.x	14	8	9	4	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144								10.1126/science.1237541	http://dx.doi.org/10.1126/science.1237541			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888024				2022-12-28	WOS:000322259200023
J	Adhisivam, B; Chandrasekaran, V				Adhisivam, Bethou; Chandrasekaran, Venkatesh			A Half-Red Baby	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Adhisivam, Bethou; Chandrasekaran, Venkatesh] Jawaharlal Inst Postgrad Med Educ & Res, Pondicherry, India	Jawaharlal Institute of Postgraduate Medical Education & Research	Adhisivam, B (corresponding author), Jawaharlal Inst Postgrad Med Educ & Res, Pondicherry, India.		Chandrasekaran, Venkatesh/AAU-4872-2020; Bethou, Adhisivam/AAY-6948-2020	Chandrasekaran, Venkatesh/0000-0003-4409-6860; 					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					373	373		10.1056/NEJMicm1204130	http://dx.doi.org/10.1056/NEJMicm1204130			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188VJ	23883382				2022-12-28	WOS:000322223900012
J	Bolatto, AD; Warren, SR; Leroy, AK; Walter, F; Veilleux, S; Ostriker, EC; Ott, J; Zwaan, M; Fisher, DB; Weiss, A; Rosolowsky, E; Hodge, J				Bolatto, Alberto D.; Warren, Steven R.; Leroy, Adam K.; Walter, Fabian; Veilleux, Sylvain; Ostriker, Eve C.; Ott, Juergen; Zwaan, Martin; Fisher, David B.; Weiss, Axel; Rosolowsky, Erik; Hodge, Jacqueline			Suppression of star formation in the galaxy NGC 253 by a starburst-driven molecular wind	NATURE			English	Article							CHANDRA OBSERVATIONS; MASS FUNCTION; NGC-253; OUTFLOWS; FEEDBACK; GAS; M82; SUPERWINDS; EMISSION; ORIGIN	The under-abundance of very massive galaxies(1,2) in the Universe is frequently attributed to the effect of galactic winds(3-6). Although ionized galactic winds are readily observable, most of the expelled mass (that is, the total mass flowing out from the nuclear region) is likely to be in atomic(7,8) and molecular phases(9-11) that are cooler than the ionized phases. Expanding molecular shells observed in starburst systems such as NGC 253 (ref. 12) and M 82 (refs 13, 14) may facilitate the entrainment of molecular gas in the wind. Although shell properties are well constrained(12), determining the amount of outflowing gas emerging from such shells and the connection between this gas and the ionized wind requires spatial resolution better than 100 parsecs coupled with sensitivity to a wide range of spatial scales, a combination hitherto not available. Here we report observations of NGC 253, a nearby(15) starburst galaxy (distance similar to 3.4 megaparsecs) known to possess a wind(16-20), that trace the cool molecular wind at 50-parsec resolution. At this resolution, the extraplanar molecular gas closely tracks the Ha filaments, and it appears to be connected to expanding molecular shells located in the starburst region. These observations allow us to determine that the molecular outflow rate is greater than 3 solar masses per year and probably about 9 solar masses per year. This implies a ratio of mass-outflow rate to star-formation rate of at least 1, and probably similar to 3, indicating that the starburst-driven wind limits the star-formation activity and the final stellar content.	[Bolatto, Alberto D.; Warren, Steven R.; Veilleux, Sylvain; Fisher, David B.] Univ Maryland, Dept Astron, Lab Millimeter Wave Astron, College Pk, MD 20742 USA; [Bolatto, Alberto D.; Warren, Steven R.; Veilleux, Sylvain; Fisher, David B.] Univ Maryland, Joint Space Inst, College Pk, MD 20742 USA; [Leroy, Adam K.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Walter, Fabian; Hodge, Jacqueline] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Ostriker, Eve C.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Ott, Juergen] Natl Radio Astron Observ, Socorro, NM 87801 USA; [Zwaan, Martin] European So Observ, D-85748 Garching, Germany; [Weiss, Axel] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Rosolowsky, Erik] Univ British Columbia, Dept Phys & Astron, Kelowna, BC V1V 1V7, Canada	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Radio Astronomy Observatory (NRAO); Max Planck Society; Princeton University; National Radio Astronomy Observatory (NRAO); European Southern Observatory; Max Planck Society; University of British Columbia	Bolatto, AD (corresponding author), Univ Maryland, Dept Astron, Lab Millimeter Wave Astron, College Pk, MD 20742 USA.	bolatto@astro.umd.edu	Rosolowsky, Erik/ABI-3078-2020	Weiss, Axel/0000-0003-4678-3939; Ostriker, Eve/0000-0002-0509-9113; Ott, Juergen/0000-0001-8224-1956; Hodge, Jacqueline/0000-0001-6586-8845; Zwaan, Martin/0000-0003-0101-1804; Walter, Fabian/0000-0003-4793-7880; Leroy, Adam/0000-0002-2545-1700; Bolatto, Alberto/0000-0002-5480-5686; Fisher, Deanne/0000-0003-0645-5260	CAREER [NSF-AST0955836, NSF-AST1139998]; Research Corporation for Science Advancement Cottrell Scholar award; NSF [AST-0908185];  [NSF-AST100958]; Division Of Astronomical Sciences [1009583, 1318309] Funding Source: National Science Foundation	CAREER(National Science Foundation (NSF)); Research Corporation for Science Advancement Cottrell Scholar award; NSF(National Science Foundation (NSF)); ; Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	A.D.B. acknowledges partial support from a CAREER grant NSF-AST0955836, NSF-AST1139998 and from a Research Corporation for Science Advancement Cottrell Scholar award. S. V. acknowledges partial support through grant NSF-AST100958. E.C.O. is supported by the NSF through grant AST-0908185. ALMA is a partnership of ESO (representing its member states), NSF (USA) and NINS (Japan), together with NRC (Canada) and NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO and NAOJ. The National Radio Astronomy Observatory is a facility of the NSF operated under cooperative agreement by Associated Universities, Inc. We thank M. Lehnert for providing the Ha image, processed by himself and M. Dahlem.	Alatalo K, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/88; Alonso-Herrero A, 2003, ASTRON J, V125, P1210, DOI 10.1086/367790; Baldry IK, 2008, MON NOT R ASTRON SOC, V388, P945, DOI 10.1111/j.1365-2966.2008.13348.x; Dalcanton JJ, 2009, ASTROPHYS J SUPPL S, V183, P67, DOI 10.1088/0067-0049/183/1/67; Dave R, 2011, MON NOT R ASTRON SOC, V415, P11, DOI 10.1111/j.1365-2966.2011.18680.x; Feruglio C, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201015164; Forbes DA, 2000, MON NOT R ASTRON SOC, V312, P689, DOI 10.1046/j.1365-8711.2000.03120.x; Heckman TM, 2000, ASTROPHYS J SUPPL S, V129, P493, DOI 10.1086/313421; Hopkins PF, 2012, MON NOT R ASTRON SOC, V421, P3522, DOI 10.1111/j.1365-2966.2012.20593.x; Matsushita S, 2005, ASTROPHYS J, V618, P712, DOI 10.1086/425408; MCCRAY R, 1987, ASTROPHYS J, V317, P190, DOI 10.1086/165267; Oppenheimer BD, 2010, MON NOT R ASTRON SOC, V406, P2325, DOI 10.1111/j.1365-2966.2010.16872.x; Ott J, 2005, ASTROPHYS J, V629, P767, DOI 10.1086/431661; Rupke D. S. N., 2013, ASTROPHYS J IN PRESS; Rupke DS, 2005, ASTROPHYS J, V632, P751, DOI 10.1086/444451; Sakamoto K, 2006, ASTROPHYS J, V636, P685, DOI 10.1086/498075; Sakamoto K, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/19; Somerville RS, 2008, MON NOT R ASTRON SOC, V391, P481, DOI 10.1111/j.1365-2966.2008.13805.x; Strickland DK, 2002, ASTROPHYS J, V568, P689, DOI 10.1086/338889; Strickland DK, 2000, ASTRON J, V120, P2965, DOI 10.1086/316846; Sturm E, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/1/L16; Sugai H, 2003, ASTROPHYS J, V584, pL9, DOI 10.1086/368271; Tumlinson J, 2011, SCIENCE, V334, P948, DOI 10.1126/science.1209840; Ulvestad JS, 1997, ASTROPHYS J, V488, P621, DOI 10.1086/304739; Veilleux S, 2005, ANNU REV ASTRON ASTR, V43, P769, DOI 10.1146/annurev.astro.43.072103.150610; Weaver KA, 2002, ASTROPHYS J, V576, pL19, DOI 10.1086/342977; Weiss A, 1999, FORTUNE, V139, P23; YOUNG JS, 1995, ASTROPHYS J SUPPL S, V98, P219, DOI 10.1086/192159	30	187	187	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2013	499	7459					450	453		10.1038/nature12351	http://dx.doi.org/10.1038/nature12351			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23887428	Green Submitted			2022-12-28	WOS:000322157900034
J	Cryer, PE				Cryer, Philip E.			Mechanisms of Hypoglycemia-Associated Autonomic Failure in Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BRAIN GLUCOSE-CONCENTRATIONS; INSULIN-INDUCED HYPOGLYCEMIA; COUNTERREGULATORY RESPONSES; RECURRENT HYPOGLYCEMIA; GLUCAGON-RESPONSE; NORMAL HUMANS; ANTECEDENT HYPOGLYCEMIA; SUBSEQUENT HYPOGLYCEMIA; INTRAISLET INSULIN; IMPROVES GLUCAGON		[Cryer, Philip E.] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA	Washington University (WUSTL)	Cryer, PE (corresponding author), Washington Univ, Sch Med, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	pcryer@wustl.edu						[Anonymous], 2004, N ENGL J MED, V350, P2272; Arbelaez AM, 2008, DIABETES, V57, P470, DOI 10.2337/db07-1329; Arbelaez AM, 2012, DIABETES, V61, pA320; Arbelaez AM, 2012, DIABETES CARE, V35, P2570, DOI 10.2337/dc12-0297; Banarer S, 2003, DIABETES, V52, P1195, DOI 10.2337/diabetes.52.5.1195; Banarer S, 2002, DIABETES, V51, P958, DOI 10.2337/diabetes.51.4.958; Beall C, 2012, AM J PHYSIOL-REG I, V302, pR215, DOI 10.1152/ajpregu.00531.2011; Bhatnagar S, 2002, J NEUROENDOCRINOL, V14, P403, DOI 10.1046/j.0007-1331.2002.00792.x; Bingham EM, 2005, DIABETOLOGIA, V48, P2080, DOI 10.1007/s00125-005-1900-6; BOLLI G, 1983, DIABETES, V32, P134, DOI 10.2337/diabetes.32.2.134; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; BOYLE PJ, 1994, P NATL ACAD SCI USA, V91, P9352, DOI 10.1073/pnas.91.20.9352; Boyle PJ, 1995, NEW ENGL J MED, V333, P1726, DOI 10.1056/NEJM199512283332602; Briscoe VJ, 2008, DIABETES, V57, P3315, DOI 10.2337/db08-1000; Cooperberg BA, 2010, DIABETES, V59, P2936, DOI 10.2337/db10-0728; Cooperberg BA, 2009, DIABETES CARE, V32, P2275, DOI 10.2337/dc09-0798; Criego AB, 2005, J NEUROSCI RES, V82, P525, DOI 10.1002/jnr.20654; Criego AB, 2005, J NEUROSCI RES, V79, P42, DOI 10.1002/jnr.20296; Cryer P., 2012, HYPOGLYEMIA DIABETES; CRYER PE, 1985, NEW ENGL J MED, V313, P232; Cryer PE, 2012, ENDOCRINOLOGY, V153, P1039, DOI 10.1210/en.2011-1499; Cryer PE, 2011, AM J MED, V124, P993, DOI 10.1016/j.amjmed.2011.08.008; Cryer PE, 2011, DIABETES, V60, P24, DOI 10.2337/db10-1359; Cryer PE, 2006, J CLIN INVEST, V116, P1470, DOI 10.1172/JCI28735; DAGOGOJACK S, 1994, DIABETES, V43, P1426, DOI 10.2337/diabetes.43.12.1426; DAGOGOJACK SE, 1993, J CLIN INVEST, V91, P819, DOI 10.1172/JCI116302; Davis SN, 1996, J CLIN INVEST, V98, P680, DOI 10.1172/JCI118839; Davis SN, 1997, J CLIN INVEST, V100, P429, DOI 10.1172/JCI119550; De Feyter HM, 2013, DIABETES; DIEM P, 1990, J CLIN INVEST, V86, P2008, DOI 10.1172/JCI114936; Diggs-Andrews KA, 2010, DIABETES, V59, P2271, DOI 10.2337/db10-0401; Dunn JT, 2007, DIABETES, V56, P2766, DOI 10.2337/db07-0666; Ertl AC, 2004, DIABETES-METAB RES, V20, P124, DOI 10.1002/dmrr.450; Fan XN, 2008, DIABETES, V57, P3327, DOI 10.2337/db08-0793; Fanelli CG, 1998, DIABETES, V47, P1444, DOI 10.2337/diabetes.47.9.1444; FUKUDA M, 1988, DIABETES, V37, P81, DOI 10.2337/diabetes.37.1.81; Gabriely I, 2002, DIABETES, V51, P893, DOI 10.2337/diabetes.51.4.893; GERICH JE, 1973, SCIENCE, V182, P171, DOI 10.1126/science.182.4108.171; Goldberg PA, 2006, DIABETES, V55, P1121, DOI 10.2337/diabetes.55.04.06.db05-1169; Gosmanov NR, 2005, DIABETES CARE, V28, P1124, DOI 10.2337/diacare.28.5.1124; Grissom N, 2009, NEUROBIOL LEARN MEM, V92, P215, DOI 10.1016/j.nlm.2008.07.001; Gruetter R, 2003, J NEUROSCI RES, V74, P179, DOI 10.1002/jnr.10785; HELLER SR, 1991, DIABETES, V40, P223, DOI 10.2337/diabetes.40.2.223; Henry PG, 2010, METABOLISM, V59, P100, DOI 10.1016/j.metabol.2009.07.012; Herzog RI, 2008, ENDOCRINOLOGY, V149, P1499, DOI 10.1210/en.2007-1252; Herzog RI, 2013, J CLIN INVEST, V123, P1988, DOI 10.1172/JCI65105; Israelian Z, 2005, DIABETES CARE, V28, P2691, DOI 10.2337/diacare.28.11.2691; Itoh Y, 2003, P NATL ACAD SCI USA, V100, P4879, DOI 10.1073/pnas.0831078100; Jones TW, 1998, NEW ENGL J MED, V338, P1657, DOI 10.1056/NEJM199806043382303; KONARSKA M, 1990, BEHAV NEURAL BIOL, V53, P231, DOI 10.1016/0163-1047(90)90458-I; Levin BE, 2008, DIABETES, V57, P1371, DOI 10.2337/db07-1755; Lubow JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE149, DOI 10.1152/ajpendo.00049.2005; MARAN A, 1994, LANCET, V343, P16, DOI 10.1016/S0140-6736(94)90876-1; Maran A, 2000, DIABETOLOGIA, V43, P733, DOI 10.1007/s001250051371; MCCALL AL, 1986, AM J PHYSIOL, V251, pE442, DOI 10.1152/ajpendo.1986.251.4.E442; McCrimmon RJ, 2010, DIABETES, V59, P2333, DOI 10.2337/db10-0103; Menge BA, 2011, DIABETES, V60, P2160, DOI 10.2337/db11-0251; Oz G, 2012, J CEREBR BLOOD F MET, V32, P256, DOI 10.1038/jcbfm.2011.138; PALMER JP, 1976, J CLIN INVEST, V57, P522, DOI 10.1172/JCI108305; Puente EC, 2009, DIABETES, V58, pA13; Raju B, 2005, DIABETES, V54, P757, DOI 10.2337/diabetes.54.3.757; Raju B, 2003, DIABETES, V52, P2083, DOI 10.2337/diabetes.52.8.2083; Ramanathan R, 2011, DIABETES, V60, P602, DOI 10.2337/db10-1374; Sanders NM, 2008, AM J PHYSIOL-ENDOC M, V294, pE853, DOI 10.1152/ajpendo.00772.2007; Seaquist ER, 2012, DIABETES, V61, P1918, DOI 10.2337/db12-0571; Segel SA, 2001, DIABETES, V50, P1911, DOI 10.2337/diabetes.50.8.1911; Segel SA, 2002, DIABETES, V51, P724, DOI 10.2337/diabetes.51.3.724; Sherck SM, 2001, DIABETES, V50, P2487, DOI 10.2337/diabetes.50.11.2487; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; Teh MM, 2010, NEUROIMAGE, V53, P584, DOI 10.1016/j.neuroimage.2010.06.033; Teves D, 2004, P NATL ACAD SCI USA, V101, P6217, DOI 10.1073/pnas.0307048101; van de Ven KCC, 2012, DIABETES, V61, P1974, DOI 10.2337/db11-1778; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; Vele S, 2011, J CLIN ENDOCR METAB, V96, P3424, DOI 10.1210/jc.2011-1723; VENEMAN T, 1994, DIABETES, V43, P1311, DOI 10.2337/diabetes.43.11.1311; Wahren J, 1999, DIABETOLOGIA, V42, P812, DOI 10.1007/s001250051231; Weinberg MS, 2010, NEUROSCIENCE, V168, P744, DOI 10.1016/j.neuroscience.2010.04.006; WHITE NH, 1983, NEW ENGL J MED, V308, P485, DOI 10.1056/NEJM198303033080903; WIETHOP BV, 1993, DIABETES CARE, V16, P1124, DOI 10.2337/diacare.16.8.1124; Yue JTY, 2012, DIABETES, V61, P197, DOI 10.2337/db11-0690	80	255	257	3	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					362	372		10.1056/NEJMra1215228	http://dx.doi.org/10.1056/NEJMra1215228			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188VJ	23883381	Green Published			2022-12-28	WOS:000322223900011
J	Zhou, JF; Wang, DY; Gao, RB; Zhao, BH; Song, JD; Qi, X; Zhang, YJ; Shi, YL; Yang, L; Zhu, WF; Bai, T; Qin, K; Lan, Y; Zou, SM; Guo, JF; Dong, J; Dong, LB; Zhang, Y; Wei, HJ; Li, XD; Lu, J; Liu, LQ; Zhao, X; Li, XY; Huang, WJ; Wen, LY; Bo, H; Xin, L; Chen, YK; Xu, CL; Pei, YQ; Yang, Y; Zhang, XD; Wang, SW; Feng, ZJ; Han, J; Yang, WZ; Gao, GF; Wu, GZ; Li, DX; Wang, Y; Shu, YL				Zhou, Jianfang; Wang, Dayan; Gao, Rongbao; Zhao, Baihui; Song, Jingdong; Qi, Xian; Zhang, Yanjun; Shi, Yonglin; Yang, Lei; Zhu, Wenfei; Bai, Tian; Qin, Kun; Lan, Yu; Zou, Shumei; Guo, Junfeng; Dong, Jie; Dong, Libo; Zhang, Ye; Wei, Hejiang; Li, Xiaodan; Lu, Jian; Liu, Liqi; Zhao, Xiang; Li, Xiyan; Huang, Weijuan; Wen, Leying; Bo, Hong; Xin, Li; Chen, Yongkun; Xu, Cuilin; Pei, Yuquan; Yang, Yue; Zhang, Xiaodong; Wang, Shiwen; Feng, Zijian; Han, Jun; Yang, Weizhong; Gao, George F.; Wu, Guizhen; Li, Dexin; Wang, Yu; Shu, Yuelong			Biological features of novel avian influenza A (H7N9) virus	NATURE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INCREASED EXPRESSION; INFECTION; BINDING; CELLS; HEMAGGLUTININ; TRANSMISSION; SPECIFICITY; ADAPTATION; FERRETS	Human infection associated with a novel reassortant avian influenza H7N9 virus has recently been identified in China(1). A total of 132 confirmed cases and 39 deaths have been reported(2). Most patients presented with severe pneumonia and acute respiratory distress syndrome(3,4). Although the first epidemic has subsided, the presence of a natural reservoir and the disease severity highlight the need to evaluate its risk on human public health and to understand the possible pathogenesis mechanism. Here we show that the emerging H7N9 avian influenza virus poses a potentially high risk to humans. We discover that the H7N9 virus can bind to both avian-type (alpha 2,3-linked sialic acid) and human-type (alpha 2,6-linked sialic acid) receptors. It can invade epithelial cells in the human lower respiratory tract and type II pneumonocytes in alveoli, and replicated efficiently in ex vivo lung and trachea explant culture and several mammalian cell lines. In acute serum samples of H7N9-infected patients, increased levels of the chemokines and cytokines IP-10, MIG, MIP-1 beta, MCP-1, IL-6, IL-8 and IFN-alpha were detected. We note that the human population is naive to the H7N9 virus, and current seasonal vaccination could not provide protection.	[Zhou, Jianfang; Wang, Dayan; Gao, Rongbao; Song, Jingdong; Yang, Lei; Zhu, Wenfei; Bai, Tian; Qin, Kun; Lan, Yu; Zou, Shumei; Guo, Junfeng; Dong, Jie; Dong, Libo; Zhang, Ye; Wei, Hejiang; Li, Xiaodan; Lu, Jian; Liu, Liqi; Zhao, Xiang; Li, Xiyan; Huang, Weijuan; Wen, Leying; Bo, Hong; Xin, Li; Chen, Yongkun; Xu, Cuilin; Wang, Shiwen; Wu, Guizhen; Li, Dexin; Shu, Yuelong] Natl Hlth & Family Planning Commiss, Key Lab Med Virol, China CDC, Nat Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China; [Zhao, Baihui] Shanghai Municipal Dis Control & Prevent, Shanghai 200336, Peoples R China; [Qi, Xian] Jiangsu Prov Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China; [Zhang, Yanjun] Zhejiang Prov Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China; [Shi, Yonglin] Anhui Prov Dis Control & Prevent, Hefei 230601, Peoples R China; [Pei, Yuquan; Yang, Yue; Zhang, Xiaodong] Peking Univ, Canc Hosp, Key Lab Carcinogenesis & Translat Res, Beijing 100142, Peoples R China; [Feng, Zijian; Han, Jun; Yang, Weizhong; Gao, George F.; Wang, Yu] Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China	Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Peking University; Chinese Center for Disease Control & Prevention	Shu, YL (corresponding author), Natl Hlth & Family Planning Commiss, Key Lab Med Virol, China CDC, Nat Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.	yshu@cnic.org.cn	Gao, George Fu/ABD-5229-2021; Yang, Lei/GSD-3834-2022		National Basic Research Program (973) of China [2011CB504704]; National Ministry of Science and Technology [KJYJ-2013-01-01]; National Mega-projects for Infectious Diseases [2013ZX10004611]	National Basic Research Program (973) of China(National Basic Research Program of China); National Ministry of Science and Technology; National Mega-projects for Infectious Diseases	This study was supported by the National Basic Research Program (973) of China (2011CB504704, to Y.S.), Emergency Research Project on human infection with avian influenza H7N9 virus from the National Ministry of Science and Technology (no. KJYJ-2013-01-01 to Y.S.), and National Mega-projects for Infectious Diseases (2013ZX10004611 to J.Z.). We would like to acknowledge the Consortium for Functional Glycomics for providing the glycans for the receptor-binding test. We thank the US Centre for Disease Control and Prevention (CDC) for providing the strains A/Washington/1/2007(H3N2, WT), A/Texas/12/2007(H3N2, E119V), A/California/7/2009 (2009pdmH1N1, WT) and A/North Carolina/39/2009 (2009pdmH1N1, H275Y), and for the antiviral drug susceptibility test. We thank C. Li for critical comments of the manuscript and proofreading. We thank L. Huang, X. Xing, X. Zeng, Y. Zhu, L. Liu, S. Yang, Z. Li and T. Liu for technical support. We thank the provincial CDCs including Fujian, Sichuan, Guangdong, Hunan, Hubei and Jiangxi for providing sera specimens of patients with H5N1. The contents of this article are solely the responsibility of the authors and do not necessarily represent the views of the China CDC or other organizations.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Bateman AC, 2010, J BIOL CHEM, V285, P34016, DOI 10.1074/jbc.M110.115998; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Freeman CM, 2007, AM J PATHOL, V171, P767, DOI 10.2353/ajpath.2007.061177; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Goldsmith CS, 2003, VIRUS RES, V92, P89, DOI 10.1016/S0168-1702(02)00323-4; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hu Y., 2013, LANCET; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Nidom CA, 2010, EMERG INFECT DIS, V16, P1515, DOI 10.3201/eid1610.100508; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saetta M, 2002, AM J RESP CRIT CARE, V165, P1404, DOI 10.1164/rccm.2107139; Shalekoff S, 2004, CLIN DIAGN LAB IMMUN, V11, P229, DOI 10.1128/CDLI.11.1.229-234.2004; Srinivasan K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059550, 10.1371/journal.pone.0049597]; Tarazona R, 2000, MECH AGEING DEV, V121, P77; Walther T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003223; WHO, AV INFL A H7N9 VIR; *WHO COLL CTR REF, 1982, CONC PROC LAB BAS IN; WHO Global Influenza Surveillance Network, MAN LAB DIAGN VIR SU; Wu H, 2013, N ENGL J MED; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001081	30	286	331	6	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2013	499	7459					500	+		10.1038/nature12379	http://dx.doi.org/10.1038/nature12379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23823727	Bronze			2022-12-28	WOS:000322157900045
J	Sive, H; Sarma, S				Sive, Hazel; Sarma, Sanjay			Online on-ramps	NATURE			English	Editorial Material									[Sive, Hazel; Sarma, Sanjay] MIT, Cambridge, MA 02139 USA; [Sive, Hazel] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Sive, H (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sive@wi.mit.edu; sesarma@mit.edu		Sive, Hazel/0000-0002-4890-424X					0	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					277	278		10.1038/499277a	http://dx.doi.org/10.1038/499277a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23868246	Bronze			2022-12-28	WOS:000321910700014
J	Vaishnava, P; Eagle, KA				Vaishnava, Prashant; Eagle, Kim A.			Review: New oral anticoagulants added to antiplatelets reduce CV events but increase bleeding after ACS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Vaishnava, Prashant; Eagle, Kim A.] Univ Michigan, Ctr Cardiovasc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Vaishnava, P (corresponding author), Univ Michigan, Ctr Cardiovasc, Ann Arbor, MI 48109 USA.							Witzenbichler B, 2012, J AM COLL CARDIOL, V60, P1349, DOI 10.1016/j.jacc.2012.08.003	1	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2							JC7	10.7326/0003-4819-159-2-201307160-02007	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23856705				2022-12-28	WOS:000322112000006
J	Wallinga, D; Burch, DGS				Wallinga, David; Burch, David G. S.			Does adding routine antibiotics to animal feed pose a serious risk to human health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wallinga, David] Keep Antibiot Working Campaign End Antibiot Overu, St Paul, MN 55105 USA; [Burch, David G. S.] Octagon Serv, Old Windsor SL4 2NR, Berks, England		Wallinga, D (corresponding author), Keep Antibiot Working Campaign End Antibiot Overu, 305 Brimhall St, St Paul, MN 55105 USA.	dwallinga@gmail.com; d.burch@octagon-services.co.uk						Aarestrup F, 2012, NATURE, V486, P465, DOI 10.1038/486465a; Allen HK, 2011, MBIO, V2, DOI 10.1128/mBio.00260-11; Andreoletti O, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2106; Animal Health and Veterinary Laboratories Agency (AHVLA), 2012, OV SALM LIV POULTR S; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Commensal indicator organisms, 2011, MARAN 2009 MONITORIN, P49; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Herigon JC, 2010, PEDIATRICS, V125, pE1294, DOI 10.1542/peds.2009-2867; Institute for Agriculture and Trade Policy, 2012, NO TIM LOS 147 STUD; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; McDonald L. Clifford, 2012, Morbidity and Mortality Weekly Report, V61, P157; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Statums Serum Institut National Veterinary Institute National Food Institute, 2012, DANM 2011 US ANT AG, P111; US Food and Drug Administration, 2013, ANT AN DRUG DISTR RE; Veterinary Medicines Directorate, 2012, SECT SAL ROUT ADM SA, P20; WHO, 2011, CRIT IMP ANT HUM MED	17	19	19	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2013	347								f4214	10.1136/bmj.f4214	http://dx.doi.org/10.1136/bmj.f4214			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184MC	23843500				2022-12-28	WOS:000321893000006
J	Banerjee, S				Banerjee, Sube			Good news on dementia prevalence-we can make a difference	LANCET			English	Editorial Material									Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 9RY, E Sussex, England	University of Brighton; University of Sussex	Banerjee, S (corresponding author), Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 9RY, E Sussex, England.	s.banerjee@bsms.ac.uk		Banerjee, Sube/0000-0002-8083-7649				Alzheimer's Disease International, WORLD ALZH REP 2009; Banerjee S, 2012, ARCH MED RES, V43, P705, DOI 10.1016/j.arcmed.2012.10.006; Banerjee S, 2010, INT J GERIATR PSYCH, V25, P917, DOI 10.1002/gps.2598; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Department of Health, 2009, LIVING WELL DEMENTIA; Matthews FE, 2013, LANCET, P1405; World Health Organization and Alzheimers Disease International, 2012, DEM PUBL HLTH PRIOR	7	21	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2013	382	9902					1384	1386		10.1016/S0140-6736(13)61579-2	http://dx.doi.org/10.1016/S0140-6736(13)61579-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242JW	23871491	hybrid			2022-12-28	WOS:000326237500005
J	Watanabe, T; Kiso, M; Fukuyama, S; Nakajima, N; Imai, M; Yamada, S; Murakami, S; Yamayoshi, S; Iwatsuki-Horimoto, K; Sakoda, Y; Takashita, E; McBride, R; Noda, T; Hatta, M; Imai, H; Zhao, DM; Kishida, N; Shirakura, M; de Vries, RP; Shichinohe, S; Okamatsu, M; Tamura, T; Tomita, Y; Fujimoto, N; Goto, K; Katsura, H; Kawakami, E; Ishikawa, I; Watanabe, S; Ito, M; Sakai-Tagawa, Y; Sugita, Y; Uraki, R; Yamaji, R; Eisfeld, AJ; Zhong, GX; Fan, SF; Ping, JH; Maher, EA; Hanson, A; Uchida, Y; Saito, T; Ozawa, M; Neumann, G; Kida, H; Odagiri, T; Paulson, JC; Hasegawa, H; Tashiro, M; Kawaoka, Y				Watanabe, Tokiko; Kiso, Maki; Fukuyama, Satoshi; Nakajima, Noriko; Imai, Masaki; Yamada, Shinya; Murakami, Shin; Yamayoshi, Seiya; Iwatsuki-Horimoto, Kiyoko; Sakoda, Yoshihiro; Takashita, Emi; McBride, Ryan; Noda, Takeshi; Hatta, Masato; Imai, Hirotaka; Zhao, Dongming; Kishida, Noriko; Shirakura, Masayuki; de Vries, Robert P.; Shichinohe, Shintaro; Okamatsu, Masatoshi; Tamura, Tomokazu; Tomita, Yuriko; Fujimoto, Naomi; Goto, Kazue; Katsura, Hiroaki; Kawakami, Eiryo; Ishikawa, Izumi; Watanabe, Shinji; Ito, Mutsumi; Sakai-Tagawa, Yuko; Sugita, Yukihiko; Uraki, Ryuta; Yamaji, Reina; Eisfeld, Amie J.; Zhong, Gongxun; Fan, Shufang; Ping, Jihui; Maher, Eileen A.; Hanson, Anthony; Uchida, Yuko; Saito, Takehiko; Ozawa, Makoto; Neumann, Gabriele; Kida, Hiroshi; Odagiri, Takato; Paulson, James C.; Hasegawa, Hideki; Tashiro, Masato; Kawaoka, Yoshihiro			Characterization of H7N9 influenza A viruses isolated from humans	NATURE			English	Article							MOLECULAR-BASIS; AVIAN H5N1; IN-VITRO; TRANSMISSION; REPLICATION; INFECTION; BINDING; FERRETS; SITE; PATHOGENESIS	Avian influenza A viruses rarely infect humans; however, when human infection and subsequent human-to-human transmission occurs, worldwide outbreaks (pandemics) can result. The recent sporadic infections of humans in China with a previously unrecognized avian influenza A virus of the H7N9 subtype (A(H7N9)) have caused concern owing to the appreciable case fatality rate associated with these infections (more than 25%), potential instances of human-to-human transmission(1), and the lack of pre-existing immunity among humans to viruses of this subtype. Here we characterize two early human A(H7N9) isolates, A/Anhui/1/2013 (H7N9) and A/Shanghai/1/2013 (H7N9); hereafter referred to as Anhui/1 and Shanghai/1, respectively. In mice, Anhui/1 and Shanghai/1 were more pathogenic than a control avian H7N9 virus (A/duck/Gunma/466/2011 (H7N9); Dk/GM466) and a representative pandemic 2009 H1N1 virus (A/California/4/2009 (H1N1pdm09); CA04). Anhui/1, Shanghai/1 and Dk/GM466 replicated well in the nasal turbinates of ferrets. In nonhuman primates, Anhui/1 and Dk/GM466 replicated efficiently in the upper and lower respiratory tracts, whereas the replicative ability of conventional human influenza viruses is typically restricted to the upper respiratory tract of infected primates. By contrast, Anhui/1 did not replicate well in miniature pigs after intranasal inoculation. Critically, Anhui/1 transmitted through respiratory droplets in one of three pairs of ferrets. Glycan arrays showed that Anhui/1, Shanghai/1 and A/Hangzhou/1/2013 (H7N9) (a third human A(H7N9) virus tested in this assay) bind to human virus-type receptors, a property that may be critical for virus transmissibility in ferrets. Anhui/1 was found to be less sensitive in mice to neuraminidase inhibitors than a pandemic H1N1 2009 virus, although both viruses were equally susceptible to an experimental antiviral polymerase inhibitor. The robust replicative ability in mice, ferrets and nonhuman primates and the limited transmissibility in ferrets of Anhui/1 suggest that A(H7N9) viruses have pandemic potential.	[Watanabe, Tokiko; Fukuyama, Satoshi; Zhao, Dongming; Tomita, Yuriko; Fujimoto, Naomi; Goto, Kazue; Kawakami, Eiryo; Ishikawa, Izumi; Watanabe, Shinji; Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan; [Kiso, Maki; Yamada, Shinya; Yamayoshi, Seiya; Iwatsuki-Horimoto, Kiyoko; Noda, Takeshi; Katsura, Hiroaki; Ito, Mutsumi; Sakai-Tagawa, Yuko; Sugita, Yukihiko; Uraki, Ryuta; Yamaji, Reina; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; [Nakajima, Noriko; Hasegawa, Hideki] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Imai, Masaki; Takashita, Emi; Kishida, Noriko; Shirakura, Masayuki; Odagiri, Takato; Tashiro, Masato] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo 2080011, Japan; [Murakami, Shin; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens,Minato Ku, Tokyo 1088639, Japan; [Sakoda, Yoshihiro; Shichinohe, Shintaro; Okamatsu, Masatoshi; Tamura, Tomokazu; Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Microbiol Lab, Sapporo, Hokkaido 0600818, Japan; [McBride, Ryan; de Vries, Robert P.; Paulson, James C.] Scripps Res Inst, La Jolla, CA 92037 USA; [Hatta, Masato; Imai, Hirotaka; Eisfeld, Amie J.; Zhong, Gongxun; Fan, Shufang; Ping, Jihui; Maher, Eileen A.; Hanson, Anthony; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53711 USA; [Watanabe, Shinji] Miyazaki Univ, Dept Vet Sci, Lab Vet Microbiol, Miyazaki 8892192, Japan; [Uchida, Yuko; Saito, Takehiko] Natl Inst Anim Hlth, Influenza & Pr Dis Res Ctr, Tsukuba, Ibaraki 3050856, Japan; [Ozawa, Makoto] Kagoshima Univ, Joint Fac Vet Med, Lab Anim Hyg, Kagoshima 8900065, Japan; [Ozawa, Makoto] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima 8900065, Japan; [Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido 0010020, Japan; [Kawaoka, Yoshihiro] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Bioresponses Regulat, Kyoto 6068507, Japan	Japan Science & Technology Agency (JST); University of Tokyo; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); University of Tokyo; Hokkaido University; Scripps Research Institute; University of Wisconsin System; University of Wisconsin Madison; University of Miyazaki; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Kagoshima University; Kagoshima University; Hokkaido University; Kyoto University	Kawaoka, Y (corresponding author), Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan.	kawaokay@svm.vetmed.wisc.edu	de Vries, Robert/K-7212-2013; Yamayoshi, Seiya/C-1982-2013; McBride, Ryan/E-6812-2011; Paulson, James/AAG-3565-2019; Yamayoshi, Seiya/Y-7430-2019; Tamura, Tomokazu/AAP-6081-2021; Hasegawa, Hideki/C-7978-2014; Saito, Takehiko/AFM-3038-2022; Ozawa, Makoto/AFM-4137-2022; Shichinohe, Shintaro/C-7937-2017; Yukihiko, Sugita/K-9319-2013	Yamayoshi, Seiya/0000-0001-7768-5157; Yamayoshi, Seiya/0000-0001-7768-5157; Tamura, Tomokazu/0000-0003-1395-6610; Ozawa, Makoto/0000-0002-7731-5321; Shichinohe, Shintaro/0000-0002-8783-2103; Sugita, Yukihiko/0000-0001-6861-4840; Eisfeld, Amie/0000-0003-2231-3107; de Vries, Robert/0000-0002-1586-4464; Zhong, Gongxun/0000-0002-0748-9641	Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labour and Welfare, Japan; ERATO (Japan Science and Technology Agency); NIAID Public Health Service [AI099274, AI058113]; NIAID [HHSN266200700010C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113, T32AI078985] Funding Source: NIH RePORTER	Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); ERATO (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); NIAID Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Shufor A/Anhui/1/2013 (H7N9) and A/Shanghai/1/2013 (H7N9) viruses. We thank the IMSUT serum bank for providing human sera. We thank R. Webster for providing monoclonal antibody to A/seal/Massachusetts/1/80 (H7N7). Polyclonal anti-influenza virus H7 HA, A/Netherlands/219/2003 (H7N7) (anti-serum, goat) NR-9226, was obtained through the National Institutes of Health (NIH) Biodefense and Emerging Infections Research Resources Repository, National Institute of Allergy and Infectious Diseases (NIAID), NIH. We thank S. Watson for editing the manuscript, T. Suzuki, K. Takahashi, S. Fujisaki and H. Xu for discussions, and Y. Sato, H. Sugawara, A. Sato, M. Ejima and T. Miura for technical assistance. We thank Toyama Chemical Co. for providing favipiravir, Daiichi Sankyo Co. for providing laninamivir, F. Hoffmann-La Roche for providing oseltamivir carboxylate, GlaxoSmithKline for providing zanamivir and Shionogi & Co. for providing peramivir. This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, Japan; by grants-in-aid from the Ministry of Health, Labour and Welfare, Japan; by ERATO (Japan Science and Technology Agency); by NIAID Public Health Service research grants AI099274 and AI058113 to J.C.P., and by an NIAID-funded Center for Research on Influenza Pathogenesis (CRIP, HHSN266200700010C) to Y.K.	Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Jernigan D, 2013, MMWR-MORBID MORTAL W, V62, P366; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; LIU Q, 2013, MICROBES INFECT; Liu XH, 2013, EMERG MICROBES INFEC, V2, DOI [10.1038/emi2013.30, 10.1038/emi.2013.30]; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Makarova NV, 2003, VIROLOGY, V310, P8, DOI 10.1016/S0042-6822(03)00094-1; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; Min JY, 2010, VIROLOGY, V408, P128, DOI 10.1016/j.virol.2010.09.009; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Srinivasan K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059550, 10.1371/journal.pone.0049597]; SUBBARAO EK, 1993, J VIROL, V67, P7223, DOI 10.1128/JVI.67.12.7223-7228.1993; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Wetherall NT, 2003, J CLIN MICROBIOL, V41, P742, DOI 10.1128/JCM.41.2.742-750.2003; World Health Organization, 2013, CHINA WHO JOINT MISS; World Health Organization, 2013, REPORT 8 DATA IN WHO; Xu R, 2013, NAT STRUCT MOL BIOL, V20, P363, DOI 10.1038/nsmb.2500; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; ZHU H, 2013, SCIENCE	36	314	336	4	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					551	+		10.1038/nature12392	http://dx.doi.org/10.1038/nature12392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	23842494	Green Accepted			2022-12-28	WOS:000324826300059
J	Flot, JF; Hespeels, B; Li, X; Noel, B; Arkhipova, I; Danchin, EGJ; Hejnol, A; Henrissat, B; Koszul, R; Aury, JM; Barbe, V; Barthelemy, RM; Bast, J; Bazykin, GA; Chabrol, O; Couloux, A; Da Rocha, M; Da Silva, C; Gladyshev, E; Gouret, P; Hallatschek, O; Hecox-Lea, B; Labadie, K; Lejeune, B; Piskurek, O; Poulain, J; Rodriguez, F; Ryan, JF; Vakhrusheva, OA; Wajnberg, E; Wirth, B; Yushenova, I; Kellis, M; Kondrashov, AS; Welch, DBM; Pontarotti, P; Weissenbach, J; Wincker, P; Jaillon, O; Van Doninck, K				Flot, Jean-Francois; Hespeels, Boris; Li, Xiang; Noel, Benjamin; Arkhipova, Irina; Danchin, Etienne G. J.; Hejnol, Andreas; Henrissat, Bernard; Koszul, Romain; Aury, Jean-Marc; Barbe, Valerie; Barthelemy, Roxane-Marie; Bast, Jens; Bazykin, Georgii A.; Chabrol, Olivier; Couloux, Arnaud; Da Rocha, Martine; Da Silva, Corinne; Gladyshev, Eugene; Gouret, Philippe; Hallatschek, Oskar; Hecox-Lea, Bette; Labadie, Karine; Lejeune, Benjamin; Piskurek, Oliver; Poulain, Julie; Rodriguez, Fernando; Ryan, Joseph F.; Vakhrusheva, Olga A.; Wajnberg, Eric; Wirth, Benedicte; Yushenova, Irina; Kellis, Manolis; Kondrashov, Alexey S.; Welch, David B. Mark; Pontarotti, Pierre; Weissenbach, Jean; Wincker, Patrick; Jaillon, Olivier; Van Doninck, Karine			Genomic evidence for ameiotic evolution in the bdelloid rotifer Adineta vaga	NATURE			English	Article							GENE CONVERSION	Loss of sexual reproduction is considered an evolutionary dead end for metazoans, but bdelloid rotifers challenge this view as they appear to have persisted asexually for millions of years(1). Neither male sex organs nor meiosis have ever been observed in these microscopic animals: oocytes are formed through mitotic divisions, with no reduction of chromosome number and no indication of chromosome pairing(2). However, current evidence does not exclude that they may engage in sex on rare, cryptic occasions. Here we report the genome of a bdelloid rotifer, Adineta vaga (Davis, 1873)(3), and show that its structure is incompatible with conventional meiosis. At gene scale, the genome of A. vaga is tetraploid and comprises both anciently duplicated segments and less divergent allelic regions. However, in contrast to sexual species, the allelic regions are rearranged and sometimes even found on the same chromosome. Such structure does not allow meiotic pairing; instead, we find abundant evidence of gene conversion, which may limit the accumulation of deleterious mutations in the absence of meiosis. Gene families involved in resistance to oxidation, carbohydrate metabolism and defence against transposons are significantly expanded, which may explain why transposable elements cover only 3% of the assembled sequence. Furthermore, 8% of the genes are likely to be of non-metazoan origin and were probably acquired horizontally. This apparent convergence between bdelloids and prokaryotes sheds new light on the evolutionary significance of sex.	[Flot, Jean-Francois; Hespeels, Boris; Li, Xiang; Lejeune, Benjamin; Van Doninck, Karine] Univ Namur, Dept Biol, URBE, Lab Evolutionary Genet & Ecol, B-5000 Namur, Belgium; [Flot, Jean-Francois; Hespeels, Boris; Li, Xiang; Lejeune, Benjamin; Van Doninck, Karine] Namur Res Inst Life Sci NARILIS, B-5000 Namur, Belgium; [Flot, Jean-Francois; Noel, Benjamin; Aury, Jean-Marc; Barbe, Valerie; Couloux, Arnaud; Da Silva, Corinne; Labadie, Karine; Poulain, Julie; Weissenbach, Jean; Wincker, Patrick; Jaillon, Olivier] Ctr Natl Sequencage, GENOSCOPE, CEA Inst Genom, F-91057 Evry, France; [Flot, Jean-Francois; Weissenbach, Jean; Wincker, Patrick; Jaillon, Olivier] Univ Evry, UMR8030, F-91057 Evry, France; [Flot, Jean-Francois; Weissenbach, Jean; Wincker, Patrick; Jaillon, Olivier] CNRS, UMR 8030, F-91057 Evry, France; [Flot, Jean-Francois; Hallatschek, Oskar] Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany; [Arkhipova, Irina; Gladyshev, Eugene; Hecox-Lea, Bette; Rodriguez, Fernando; Yushenova, Irina; Welch, David B. Mark] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Danchin, Etienne G. J.; Da Rocha, Martine; Wajnberg, Eric] INRA, UMR ISA 1355, Inst Sophia Agrobiotech, F-06903 Sophia Antipolis, France; [Danchin, Etienne G. J.; Da Rocha, Martine; Wajnberg, Eric] CNRS, UMR ISA 7254, Inst Sophia Agrobiotech, F-06903 Sophia Antipolis, France; [Danchin, Etienne G. J.; Da Rocha, Martine; Wajnberg, Eric] Univ Nice Sophia Antipolis, UMR ISA, Inst Sophia Agrobiotech, F-06903 Sophia Antipolis, France; [Hejnol, Andreas; Ryan, Joseph F.] Univ Bergen, Sars Int Ctr Marine Mol Biol, N-5008 Bergen, Norway; [Henrissat, Bernard] Aix Marseille Univ, CNRS, UMR Architecture & Fonct Macromol Biol 7257, F-13288 Marseille, France; [Koszul, Romain] Inst Pasteur, CNRS, UMR 3525, Grp Spatial Regulat Genomes,Dept Genomes & Genet, F-75724 Paris, France; [Barthelemy, Roxane-Marie; Chabrol, Olivier; Gouret, Philippe; Wirth, Benedicte; Pontarotti, Pierre] Aix Marseille Univ, LATP UMR CNRS 7353, F-13331 Marseille 3, France; [Bast, Jens] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Bazykin, Georgii A.; Vakhrusheva, Olga A.; Kondrashov, Alexey S.] Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, Moscow 119991, Russia; [Bazykin, Georgii A.; Vakhrusheva, Olga A.] Russian Acad Sci, Kharkevich Inst, Inst Informat Transmiss Problems, Moscow 127994, Russia; [Hallatschek, Oskar] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Hecox-Lea, Bette] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Piskurek, Oliver] Univ Gottingen, Courant Res Ctr Geobiol, D-37077 Gottingen, Germany; [Kellis, Manolis; Jaillon, Olivier] Broad Inst MIT & Harvard, MIT Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Kondrashov, Alexey S.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Kondrashov, Alexey S.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Namur; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Max Planck Society; Marine Biological Laboratory - Woods Hole; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; University of Bergen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Aix-Marseille Universite; University of Gottingen; Lomonosov Moscow State University; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; University of California System; University of California Berkeley; Northeastern University; University of Gottingen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jaillon, O (corresponding author), Ctr Natl Sequencage, GENOSCOPE, CEA Inst Genom, 2 Rue Gaston Cremieux,CP5706, F-91057 Evry, France.	jean-francois.flot@ds.mpg.de; ojaillon@genoscope.cns.fr; karine.vandoninck@fundp.ac.be	Hejnol, Andreas/C-5577-2012; Aury, Jean-Marc/N-1621-2019; Vakhrusheva, Olga/AAP-3270-2021; Bazykin, Georgii/E-4601-2012; Henrissat, Bernard/J-2475-2012; Kellis, Manolis/ABE-7385-2020; Jaillon, Olivier/GRY-6287-2022; Labadie, Karine/AAG-7355-2022; Yushenova, Irina/J-8175-2019; Labadie, Karine/AFL-7408-2022; Wajnberg, Eric/A-4862-2009; Rodriguez, Fernando/E-9392-2013; , pontarotti/ABB-1753-2021; Danchin, Etienne GJ/X-6969-2019; Danchin, Etienne G.J./A-6648-2008; Hallatschek, Oskar/E-5541-2015; Van Doninck, Karine/B-3218-2016	Hejnol, Andreas/0000-0003-2196-8507; Aury, Jean-Marc/0000-0003-1718-3010; Bazykin, Georgii/0000-0003-2334-2751; Henrissat, Bernard/0000-0002-3434-8588; Kellis, Manolis/0000-0001-7113-9630; Labadie, Karine/0000-0001-7467-8509; Yushenova, Irina/0000-0001-6291-6215; Labadie, Karine/0000-0001-7467-8509; Wajnberg, Eric/0000-0002-6700-7114; Rodriguez, Fernando/0000-0003-4044-8734; Danchin, Etienne GJ/0000-0003-4146-5608; Danchin, Etienne G.J./0000-0003-4146-5608; Jaillon, Olivier/0000-0002-7237-9596; Pierre, Pontarotti/0000-0001-7202-3648; Vakhrusheva, Olga/0000-0002-9617-2303; Lejeune, Benjamin/0000-0001-6881-8931; Couloux, Arnaud/0000-0003-2356-0062; Noel, Benjamin/0000-0002-5830-3253; Mark Welch, David/0000-0001-9774-4580; Koszul, Romain/0000-0002-3086-1173; DA ROCHA, MARTINE/0000-0003-0959-2295; Poulain, Julie/0000-0002-8744-3116; Bast, Jens/0000-0003-0017-3860; Arkhipova, Irina/0000-0002-4805-1339; Gladyshev, Eugene/0000-0002-4074-4966; DA SILVA, Corinne/0000-0002-7618-7831; Flot, Jean-Francois/0000-0003-4091-7916; Van Doninck, Karine/0000-0002-4790-8951; Ryan, Joseph/0000-0001-5478-0522	Genoscope-CES; US National Science Foundation [MCB-0821956, MCB-1121334, MCB-0923676]; German Research Foundation [HA 5163/2-1]; Ministry of Education and Science of the Russian Federation [11.G34.31.0008]; NSF CAREER [0644282]; FRFC from the Belgian Fonds National de la Recherche Scientifique (FNRS) [2.4.655.09.F]; University of Namur; Direct For Biological Sciences [0821956, 1039946, 1121334] Funding Source: National Science Foundation; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation	Genoscope-CES; US National Science Foundation(National Science Foundation (NSF)); German Research Foundation(German Research Foundation (DFG)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); FRFC from the Belgian Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); University of Namur; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors would like to thank M. Meselson for his support during the initiation phase of this project and for inspiring us with his seminal works on bdelloid genetics. The authors are also grateful to M. Radman for useful discussions, M. Knapen and N. Debortoli for participating in laboratory work, M. Lliros for helping with Fig. 1, S. Henrissat for participating in CAZyme analyses, and S. Oztas, B. Vacherie, P. Lenoble and S. Mangenot for performing PCR validations of the assembly. This work was supported by Genoscope-CES (where most of the sequencing was performed), by US National Science Foundation grants MCB-0821956 and MCB-1121334 to I.A., by German Research Foundation grant HA 5163/2-1 to O.H., by grant 11.G34.31.0008 from the Ministry of Education and Science of the Russian Federation to A.S.K., by grant NSF CAREER number 0644282 to M.K., by US National Science Foundation grant MCB-0923676 to D.B.M.W., by FRFC grant 2.4.655.09.F from the Belgian Fonds National de la Recherche Scientifique (FNRS) and a start-up grant from the University of Namur to K.V.D.; J.F.F. and K.V.D. thank also J.-P. Descy (University of Namur) for funding support.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Arkhipova I, 2005, BIOESSAYS, V27, P76, DOI 10.1002/bies.20159; Birky CW, 1996, GENETICS, V144, P427; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Chevreux B, 1999, COMP SCI BIOL P GER, V99, P45, DOI DOI 10.1.1.23/7465; Danchin EGJ, 2011, EVOLUTIONARY BIOLOGY: CONCEPTS, BIODIVERSITY, MACROEVOLUTION AND GENOME EVOLUTION, P223, DOI 10.1007/978-3-642-20763-1_13; Davis H, 1873, MON MICR J, V9, P201, DOI DOI 10.1111/J.1365-2818.1873.TB02268.X; Forche A, 2008, PLOS BIOL, V6, P1084, DOI 10.1371/journal.pbio.0060110; Geisler-Lee J, 2006, PLANT PHYSIOL, V140, P946, DOI 10.1104/pp.105.072652; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Gladyshev EA, 2007, GENE, V390, P136, DOI 10.1016/j.gene.2006.09.025; HICKEY DA, 1982, GENETICS, V101, P519; Hsu WS, 1956, CELLULE, V57, P283; Hur JH, 2009, MOL BIOL EVOL, V26, P375, DOI 10.1093/molbev/msn260; Krisko A, 2012, P NATL ACAD SCI USA, V109, P2354, DOI 10.1073/pnas.1119762109; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Ricci C, 1998, HYDROBIOLOGIA, V387, P321, DOI 10.1023/A:1017086425934; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Segers Hendrik, 2007, Zootaxa, V1564, P1; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; SMITH JM, 1986, NATURE, V324, P300; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Teshima KM, 2004, GENETICS, V166, P1553, DOI 10.1534/genetics.166.3.1553; Vijg J, 2002, MECH AGEING DEV, V123, P907, DOI 10.1016/S0047-6374(02)00028-3; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Welch DBM, 2001, P NATL ACAD SCI USA, V98, P6720, DOI 10.1073/pnas.111144598	30	246	255	2	171	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					453	457		10.1038/nature12326	http://dx.doi.org/10.1038/nature12326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23873043	Green Published, hybrid			2022-12-28	WOS:000323316100034
J	Nakajima, Y; Meyer, EJ; Kroesen, A; McKinney, SA; Gibson, MC				Nakajima, Yu-ichiro; Meyer, Emily J.; Kroesen, Amanda; McKinney, Sean A.; Gibson, Matthew C.			Epithelial junctions maintain tissue architecture by directing planar spindle orientation	NATURE			English	Article							ASYMMETRIC CELL-DIVISION; TRANSGENIC RNAI; DROSOPHILA; POLARITY; CENTROSOME; PROTEINS; CANCER; MISORIENTATION; MORPHOGENESIS; ZEBRAFISH	During epithelial cell proliferation, planar alignment of the mitotic spindle coordinates the local process of symmetric cell cleavage with the global maintenance of polarized tissue architecture(1,2). Although the disruption of planar spindle alignment is proposed to cause epithelial to mesenchymal transition and cancer(3-6), the in vivo mechanisms regulating mitotic spindle orientation remain elusive. Here we demonstrate that the actomyosin cortex and the junction-localized neoplastic tumour suppressors Scribbled and Discs large 1 have essential roles in planar spindle alignment and thus the control of epithelial integrity in the Drosophila imaginal disc. We show that defective alignment of the mitotic spindle correlates with cell delamination and apoptotic death, and that blocking the death of misaligned cells is sufficient to drive the formation of basally localized tumour-like masses. These findings indicate a key role for junction-mediated spindle alignment in the maintenance of epithelial integrity, and also reveal a previously unknown cell-death-mediated tumour-suppressor function inherent in the polarized architecture of epithelia.	[Nakajima, Yu-ichiro; Meyer, Emily J.; Kroesen, Amanda; McKinney, Sean A.; Gibson, Matthew C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Gibson, Matthew C.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Gibson, MC (corresponding author), Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA.	MG2@stowers.org	Nakajima, Yu-ichiro/AAA-5016-2021	Nakajima, Yuichiro/0000-0002-1823-5989; McKinney, Sean/0000-0002-9740-6247; Gibson, Matthew/0000-0001-5588-8842	Stowers Institute for Medical Research; Burroughs Wellcome Fund for Biomedical Research	Stowers Institute for Medical Research; Burroughs Wellcome Fund for Biomedical Research(Burroughs Wellcome Fund)	We thank D. Bilder, M. Miura, Y. Yamashita, the Bloomington Stock Center, Vienna Drosophila RNAi Center, TRiP, and FlyTrap project for fly stocks and C. Doe, F. Matsuzaki and the Developmental Studies Hybridoma Bank for antibodies. We thank R. Fehon for suggestions. We thank T. Akiyama, A. Fritz, A. Ikmi and M. Szuperak for comments on the manuscript and L. Liang for technical advice. We also thank M. Gogol for graphical assistance, F. Guo for TEM support and L. Gutchewsky for administrative support. This work was supported by the Stowers Institute for Medical Research and the Burroughs Wellcome Fund for Biomedical Research.	Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bloor JW, 2001, DEV BIOL, V239, P215, DOI 10.1006/dbio.2001.0452; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fleming ES, 2007, J HISTOCHEM CYTOCHEM, V55, P1173, DOI 10.1369/jhc.7A7234.2007; Fleming ES, 2009, MOL CARCINOGEN, V48, P592, DOI 10.1002/mc.20506; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035; Gillies TE, 2011, CURR BIOL, V21, pR599, DOI 10.1016/j.cub.2011.06.055; Guilgur LG, 2012, DEVELOPMENT, V139, P503, DOI 10.1242/dev.071027; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; Megraw TL, 2002, J CELL SCI, V115, P4707, DOI 10.1242/jcs.00134; Meyer EJ, 2011, CURR BIOL, V21, P485, DOI 10.1016/j.cub.2011.02.002; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Noatynska A, 2012, J CELL BIOL, V199, P1025, DOI 10.1083/jcb.201209015; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pease JC, 2011, J CELL SCI, V124, P1007, DOI 10.1242/jcs.081406; Quintin S, 2008, TRENDS GENET, V24, P221, DOI 10.1016/j.tig.2008.02.005; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Sandquist JC, 2011, DEV CELL, V21, P410, DOI 10.1016/j.devcel.2011.07.018; Segalen M, 2010, DEV CELL, V19, P740, DOI 10.1016/j.devcel.2010.10.004; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Spear PC, 2012, DEV BIOL, V370, P33, DOI 10.1016/j.ydbio.2012.06.031; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Varmark H, 2007, CURR BIOL, V17, P1735, DOI 10.1016/j.cub.2007.09.031; Vasiliev JM, 2004, P NATL ACAD SCI USA, V101, P12526, DOI 10.1073/pnas.0404723101	41	136	137	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2013	500	7462					359	+		10.1038/nature12335	http://dx.doi.org/10.1038/nature12335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23873041				2022-12-28	WOS:000323112400038
J	Liu, SY; Selck, C; Friedrich, B; Lutz, R; Vila-Farre, M; Dahl, A; Brandl, H; Lakshmanaperumal, N; Henry, I; Rink, JC				Liu, S. -Y.; Selck, C.; Friedrich, B.; Lutz, R.; Vila-Farre, M.; Dahl, A.; Brandl, H.; Lakshmanaperumal, N.; Henry, I.; Rink, J. C.			Reactivating head regrowth in a regeneration-deficient planarian species	NATURE			English	Article							DENDROCOELUM-LACTEUM; POLARITY; NEOBLASTS; ALIGNMENT; REGION; CELLS	Species capable of regenerating lost body parts occur throughout the animal kingdom, yet close relatives are often regeneration incompetent(1,2). Why in the face of 'survival of the fittest' some animals regenerate but others do not remains a fascinating question(3). Planarian flatworms are well known and studied for their ability to regenerate from minute tissue pieces, yet species with limited regeneration abilities have been described even amongst planarians(4). Here we report the characterization of the regeneration defect in the planarian Dendrocoelum lacteum and its successful rescue. Tissue fragments cut from the posterior half of the body of this species are unable to regenerate a head and ultimately die(5). We find that this defect originates during the early stages of head specification, which require inhibition of canonical Wnt signalling in other planarian species(6-8). Notably, RNA interference (RNAi)-mediated knockdown of Dlac-beta-catenin-1, the Wnt signal transducer, restored the regeneration of fully functional heads on tail pieces, rescuing D. lacteum's regeneration defect. Our results demonstrate the utility of comparative studies towards the reactivation of regenerative abilities in regeneration-deficient animals. Furthermore, the availability of D. lacteum as a regeneration-impaired planarian model species provides a first step towards elucidating the evolutionary mechanisms that ultimately determine why some animals regenerate and others do not.	[Liu, S. -Y.; Vila-Farre, M.; Brandl, H.; Lakshmanaperumal, N.; Henry, I.; Rink, J. C.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Selck, C.; Friedrich, B.; Lutz, R.; Rink, J. C.] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden CRTD, D-01307 Dresden, Germany; [Dahl, A.] Tech Univ Dresden, Biotechnol Ctr Biotec, DFG Ctr Regenerat Therapies Dresden CRTD, Deep Sequencing Grp SFB655, D-01307 Dresden, Germany	Max Planck Society; Technische Universitat Dresden; Technische Universitat Dresden	Rink, JC (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	rink@mpi-cbg.de	Henry, Ian/J-7328-2019; Dahl, Andreas/E-3783-2017	Henry, Ian/0000-0002-7134-3110; Dahl, Andreas/0000-0002-2668-8371; Vila Farre, Miquel/0000-0002-2553-2842; Brandl, Holger/0000-0003-1911-8570; Selck, Claudia/0000-0002-1831-752X				Agata K, 1999, SEMIN CELL DEV BIOL, V10, P377, DOI 10.1006/scdb.1999.0324; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Beane WS, 2011, CHEM BIOL, V18, P77, DOI 10.1016/j.chembiol.2010.11.012; Bely AE, 2010, TRENDS ECOL EVOL, V25, P161, DOI 10.1016/j.tree.2009.08.005; Blassberg RA, 2013, DEVELOPMENT, V140, P730, DOI 10.1242/dev.082982; Brondsted H. V., 1969, PLANARIAN REGENERATI; Buchholz F, 2006, NAT METHODS, V3, P696, DOI 10.1038/NMETH912; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Chen CCG, 2013, DEVELOPMENT, V140, P719, DOI 10.1242/dev.083741; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Felix DA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000915; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Gurley KA, 2010, DEV BIOL, V347, P24, DOI 10.1016/j.ydbio.2010.08.007; Iglesias M, 2008, DEVELOPMENT, V135, P1215, DOI 10.1242/dev.020289; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Morgan TH, 1904, BIOL BULL-US, V6, P159, DOI 10.2307/1535722; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2011, SCIENCE, V332, P852, DOI 10.1126/science.1202143; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; Reddien PW, 2007, DEVELOPMENT, V134, P4043, DOI 10.1242/dev.007138; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rink JC, 2013, DEV GENES EVOL, V223, P67, DOI 10.1007/s00427-012-0426-4; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; SAUZINMONNOT MJ, 1973, J ULTRA MOL STRUCT R, V45, P206, DOI 10.1016/S0022-5320(73)80048-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schockaert ER, 2008, HYDROBIOLOGIA, V595, P41, DOI 10.1007/s10750-007-9002-8; STEPH.F, 1961, J EMBRYOL EXP MORPH, V9, P642; STEPHANDUBOIS F, 1975, ARCH ANAT MICROSC MO, V64, P75; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Tanaka EM, 2003, CELL, V113, P559, DOI 10.1016/S0092-8674(03)00395-7; Wenemoser D, 2012, GENE DEV, V26, P988, DOI 10.1101/gad.187377.112	39	116	120	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					81	U103		10.1038/nature12414	http://dx.doi.org/10.1038/nature12414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23883932	Green Submitted			2022-12-28	WOS:000322514800032
J	Siontis, KC; Hernandez-Boussard, T; Ioannidis, JPA				Siontis, Konstantinos C.; Hernandez-Boussard, Tina; Ioannidis, John P. A.			Overlapping meta-analyses on the same topic: survey of published studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SYSTEMATIC REVIEWS; QUALITY	Objective To assess how common it is to have multiple overlapping meta-analyses of randomized trials published on the same topic. Design Survey of published meta-analyses. Data sources PubMed. Study selection and methods Meta-analyses published in 2010 were identified, and 5% of them were randomly selected. We further selected those that included randomized trials and examined effectiveness of any medical intervention. For eligible meta-analyses, we searched for other meta-analyses on the same topic (covering the same comparisons, indications/settings, and outcomes or overlapping subsets of them) published until February 2013. Results Of 73 eligible meta-analyses published in 2010, 49 (67%) had at least one other overlapping meta-analysis (median two meta-analyses per topic, interquartile range 1-4, maximum 13). In 17 topics at least one author was involved in at least two of the overlapping meta-analyses. No characteristics of the index meta-analyses were associated with the potential for overlapping meta-analyses. Among pairs of overlapping meta-analyses in 20 randomly selected topics, 13 of the more recent meta-analyses did not include any additional outcomes. In three of the four topics with eight or more published meta-analyses, many meta-analyses examined only a subset of the eligible interventions or indications/settings covered by the index meta-analysis. Conversely, for statins in the prevention of atrial fibrillation after cardiac surgery, 11 meta-analyses were published with similar eligibility criteria for interventions and setting: there was still variability on which studies were included, but the results were always similar or even identical across meta-analyses. Conclusions While some independent replication of meta-analyses by different teams is possibly useful, the overall picture suggests that there is a waste of efforts with many topics covered by multiple overlapping meta-analyses.	[Siontis, Konstantinos C.] Mayo Clin, Coll Med, Dept Med, Rochester, MN USA; [Siontis, Konstantinos C.] Mayo Clin, Coll Med, Mayo Sch Grad Med Educ, Rochester, MN USA; [Hernandez-Boussard, Tina] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA	Mayo Clinic; Mayo Clinic; Stanford University; Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011					Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Booth A, 2011, LANCET, V377, P108, DOI 10.1016/S0140-6736(10)60903-8; Campbell J, 2007, OSTEOARTHR CARTILAGE, V15, P1424, DOI 10.1016/j.joca.2007.01.022; CHALMERS I, 1994, BMJ-BRIT MED J, V309, P862, DOI 10.1136/bmj.309.6958.862; Chou R, 2009, SPINE J, V9, P679, DOI 10.1016/j.spinee.2009.05.003; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P308, DOI 10.1001/jama.275.4.308; DAVIDOFF F, 1995, BRIT MED J, V310, P1085, DOI 10.1136/bmj.310.6987.1085; Garritty C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009914; Greenhalgh T, 1997, BMJ-BRIT MED J, V315, P243, DOI 10.1136/bmj.315.7102.243; Haidich AB, 2013, J CLIN EPIDEMIOL, V66, P371, DOI 10.1016/j.jclinepi.2012.10.014; Hernandez AV, 2008, AM HEART J, V156, P23, DOI 10.1016/j.ahj.2008.03.002; Ioannidis JPA, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4875; Ioannidis JPA, 2009, CAN MED ASSOC J, V181, P488, DOI 10.1503/cmaj.081086; Ioannidis JPA, 1996, LANCET, V348, P756, DOI 10.1016/S0140-6736(05)65647-4; Jadad AR, 1997, CAN MED ASSOC J, V156, P1411; Kirkham JJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-21; Linde K, 2003, J ROY SOC MED, V96, P17, DOI 10.1258/jrsm.96.1.17; Mallett Susan, 2003, ACP J Club, V139, pA11; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Minozzi S, 2010, DRUG ALCOHOL REV, V29, P304, DOI 10.1111/j.1465-3362.2009.00132.x; Moher D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000023.pub3; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Panagiotou OA, 2012, J CLIN EPIDEMIOL, V65, P740, DOI 10.1016/j.jclinepi.2012.01.008; Peinemann F, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-41; Poolman RW, 2007, J BONE JOINT SURG AM, V89A, P1542, DOI 10.2106/JBJS.F.01292; Shrier I, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-19; Starr M, 2009, INT J TECHNOL ASSESS, V25, P182, DOI 10.1017/S026646230909062X; Sutton AJ, 2009, J CLIN EPIDEMIOL, V62, P241, DOI 10.1016/j.jclinepi.2008.04.005; Thompson RL, 2008, PUBLIC HEALTH NUTR, V11, P1006, DOI 10.1017/S1368980007001334; Thorlund K, 2012, ANN RHEUM DIS; Tsertsvadze A, 2011, J CLIN EPIDEMIOL, V64, P1208, DOI 10.1016/j.jclinepi.2011.03.011; Tugwell P, 2011, J CLIN EPIDEMIOL, V64, P933, DOI 10.1016/j.jclinepi.2011.06.008; van Nieuwenhoven CA, 2001, JAMA-J AM MED ASSOC, V286, P335, DOI 10.1001/jama.286.3.335; Williamson P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000041	35	135	137	35	98	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2013	347								f4501	10.1136/bmj.f4501	http://dx.doi.org/10.1136/bmj.f4501			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	189DN	23873947	Green Published, hybrid			2022-12-28	WOS:000322247400002
J	Magnon, C; Hall, SJ; Lin, J; Xue, XN; Gerber, L; Freedland, SJ; Frenette, PS				Magnon, Claire; Hall, Simon J.; Lin, Juan; Xue, Xiaonan; Gerber, Leah; Freedland, Stephen J.; Frenette, Paul S.			Autonomic Nerve Development Contributes to Prostate Cancer Progression	SCIENCE			English	Article							BEAM RADIATION-THERAPY; PERINEURAL INVASION; RADICAL PROSTATECTOMY; BETA-BLOCKERS; CHOLINERGIC INNERVATION; MUSCARINIC RECEPTORS; BREAST-CANCER; TUMOR-GROWTH; SURVIVAL; CELLS	Nerves are a common feature of the microenvironment, but their role in tumor growth and progression remains unclear. We found that the formation of autonomic nerve fibers in the prostate gland regulates prostate cancer development and dissemination in mouse models. The early phases of tumor development were prevented by chemical or surgical sympathectomy and by genetic deletion of stromal beta(2)- and beta(3)-adrenergic receptors. Tumors were also infiltrated by parasympathetic cholinergic fibers that promoted cancer dissemination. Cholinergic-induced tumor invasion and metastasis were inhibited by pharmacological blockade or genetic disruption of the stromal type 1 muscarinic receptor, leading to improved survival of the mice. A retrospective blinded analysis of prostate adenocarcinoma specimens from 43 patients revealed that the densities of sympathetic and parasympathetic nerve fibers in tumor and surrounding normal tissue, respectively, were associated with poor clinical outcomes. These findings may lead to novel therapeutic approaches for prostate cancer.	[Magnon, Claire; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Magnon, Claire; Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Magnon, Claire; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Hall, Simon J.] Mt Sinai Sch Med, Dept Urol, New York, NY 10029 USA; [Lin, Juan; Xue, Xiaonan] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Gerber, Leah; Freedland, Stephen J.] Durham VA Med Ctr, Dept Surg, Durham, NC 27705 USA; [Gerber, Leah; Freedland, Stephen J.] Duke Univ, Dept Surg, Div Urol, Durham, NC 27705 USA; [Freedland, Stephen J.] Duke Univ, Dept Pathol, Durham, NC 27705 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University	Magnon, C (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA.	clairemagnon@free.fr; paul.frenette@einstein.yu.edu	Magnon, Claire/N-7073-2019; MAGNON, Claire/A-4343-2016; Frenette, Paul S/J-8272-2012	Magnon, Claire/0000-0003-2946-5269; Frenette, Paul S/0000-0003-0862-9922	U.S. Department of Defense Idea Development award [W81XWH-07-1-0165]; NIH [DK056638, HL069438, HL097819]; Fondation pour la Recherche Medicale, France; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438, R01HL097819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER	U.S. Department of Defense Idea Development award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale, France(Fondation pour la Recherche Medicale); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Mall, J. Harding, and R. Basu for tissue sectioning and H&E staining; Y. Zhou for assistance with bioluminescence scanning; E. Fine, L. Jelicks, and W. Koba for help with microPET scanning at the Gruss Magnetic Resonance Research Center at Einstein; W. Guo for comments on the manuscript; and H. Ostrer for advice on human samples. Supported by U.S. Department of Defense Idea Development award W81XWH-07-1-0165 and NIH grants DK056638, HL069438, and HL097819. C. M. was the recipient of a fellowship from the Fondation pour la Recherche Medicale, France. Albert Einstein College of Medicine and the authors (C. M., P. S. F.) have filed a patent application (WO 2012071573 A2) relating to the use of adrenergic and muscarinic receptor antagonists for cancer therapy.	Anderson PR, 1998, INT J RADIAT ONCOL, V41, P1087, DOI 10.1016/S0360-3016(98)00167-9; Anisuzzaman ASM, 2008, J PHARMACOL SCI, V106, P271, DOI 10.1254/jphs.FP0071435; Ayala GE, 2006, CANCER RES, V66, P5159, DOI 10.1158/0008-5472.CAN-05-1847; Ayala GE, 2001, PROSTATE, V49, P213, DOI 10.1002/pros.1137; Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; CARDEN MJ, 1987, J NEUROSCI, V7, P3489; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Farnsworth WE, 1999, PROSTATE, V38, P60; Grytli HH, 2014, EUR UROL, V65, P635, DOI 10.1016/j.eururo.2013.01.007; Grytli HH, 2013, PROSTATE, V73, P250, DOI 10.1002/pros.22564; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P745, DOI 10.1023/B:CLIN.0000006817.25962.87; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Lemeshow S, 2011, CANCER EPIDEM BIOMAR, V20, P2273, DOI 10.1158/1055-9965.EPI-11-0249; Liebig C, 2009, CANCER-AM CANCER SOC, V115, P3379, DOI 10.1002/cncr.24396; Magnon C, 2005, CANCER RES, V65, P4353, DOI 10.1158/0008-5472.CAN-04-3536; MALICK JB, 1975, J PHARM SCI, V64, P1066, DOI 10.1002/jps.2600640650; Maru N, 2001, HUM PATHOL, V32, P828, DOI 10.1053/hupa.2001.26456; MCVARY KT, 1994, BIOL REPROD, V51, P99, DOI 10.1095/biolreprod51.1.99; Melhem-Bertrandt A, 2011, J CLIN ONCOL, V29, P2645, DOI 10.1200/JCO.2010.33.4441; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; Schuller HM, 2012, CARCINOGENESIS, V33, P191, DOI 10.1093/carcin/bgr251; SIMON RH, 1980, SCIENCE, V209, P1132, DOI 10.1126/science.6250220; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Ventura S, 2002, PHARMACOL THERAPEUT, V94, P93, DOI 10.1016/S0163-7258(02)00174-2; VILLERS A, 1989, J UROLOGY, V142, P763, DOI 10.1016/S0022-5347(17)38881-X; VISINTAINER MA, 1982, SCIENCE, V216, P437, DOI 10.1126/science.7200261; Wecker L, 2010, BRODYS HUMAN PHARM; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; WITKIN JM, 1988, LIFE SCI, V42, P2467, DOI 10.1016/0024-3205(88)90345-1; Witte LPW, 2008, EUR UROL, V54, P326, DOI 10.1016/j.eururo.2007.12.007	36	628	663	18	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2013	341	6142					143	+	1236361	10.1126/science.1236361	http://dx.doi.org/10.1126/science.1236361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23846904				2022-12-28	WOS:000321965300033
J	Saquib, N; Saquib, J; Ioannidis, JPA				Saquib, Nazmus; Saquib, Juliann; Ioannidis, John P. A.			Practices and impact of primary outcome adjustment in randomized controlled trials: meta-epidemiologic study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REPRODUCIBLE RESEARCH; ARTEMETHER-LUMEFANTRINE; COVARIATE ADJUSTMENT; CONSORT STATEMENT; UGANDAN CHILDREN; CLINICAL-TRIALS; DOUBLE-BLIND; CANCER; INTERVENTION; CHEMOTHERAPY	Objective To assess adjustment practices for primary outcomes of randomized controlled trials and their impact on the results. Design Meta-epidemiologic study. Data sources 25 biomedical journals with the highest impact factor according to Journal Citation Reports 2009. Study selection Randomized controlled trials published in print in 2009 that reported primary outcomes. The search yielded 684 eligible papers of randomized controlled trials, of which 200 were randomly selected. Data extraction Two researchers independently extracted data on study population, intervention, primary outcome, and the adjustment plan for primary outcomes. They also recorded the magnitude and statistical significance of the intervention effect with and without adjustments, and estimated whether adjustment made a difference in the level of nominal significance. They also compared the analysis plan for model adjustment in the published trial versus the trial protocol with information on the protocol collected from registries, design papers, and communication with all corresponding authors. Results 54% of the trials used stratified randomization, 96% presented baseline characteristics in the compared arms, and 46% also evaluated differences in baseline factors with statistical testing. Half of the trials performed adjusted analyses for the main outcome, as the sole analysis (29%) or along with unadjusted analyses (21%). Adjustment for stratification variables and for baseline variables was performed in 39% (42/108) and 42% (84/199) of the trials, respectively. Among 40 comparisons with both adjusted and unadjusted analyses, 43% had statistically significant effects, 40% had non-significant effects, and 18% had significant effects with only one of the two analyses, but not with the other. Information on analysis plan regarding model adjustment was available in 6% (9/162) of trial registry entries, 78% (21/27) of design papers, and 74% (40/54) of protocols obtained from authors. The analysis plan disagreed between the published trial and the registry, protocol, or design paper in 47% (28/60) of the studies. Conclusions There is large diversity on whether and how analyses of primary outcomes are adjusted in randomized controlled trials and these choices can sometimes change the nominal significance of the results. Registered protocols should explicitly specify adjustments plans for main outcomes and analysis should follow these plans.	[Saquib, Nazmus; Saquib, Juliann; Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011					Achan Jane, 2009, BMJ, V339, pb2763, DOI 10.1136/bmj.b2763; Adamsen L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3410; Ades PA, 2009, CIRCULATION, V119, P2671, DOI 10.1161/CIRCULATIONAHA.108.834184; Adler A, 2009, GASTROENTEROLOGY, V136, P410, DOI 10.1053/j.gastro.2008.10.022; Ahmad F, 2009, ANN INTERN MED, V151, P93, DOI 10.7326/0003-4819-151-2-200907210-00124; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Bensimon G, 2009, BRAIN, V132, P156, DOI 10.1093/brain/awn291; Bhardwaj P, 2009, GASTROENTEROLOGY, V136, P149, DOI 10.1053/j.gastro.2008.09.028; Bonjer HJ, 2009, LANCET ONCOL, V10, P44, DOI 10.1016/S1470-2045(08)70310-3; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; Dennis CL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3064; Dennis M, 2009, LANCET, V373, P1958, DOI 10.1016/S0140-6736(09)60941-7; Diggle PJ, 2010, BIOSTATISTICS, V11, P375, DOI 10.1093/biostatistics/kxq029; Disertori M, 2009, NEW ENGL J MED, V360, P1606, DOI 10.1056/NEJMoa0805710; Dumville JC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b773; Eddleston M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000104; Ekeberg OM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3112; Hassiotis A, 2009, AM J PSYCHIAT, V166, P1278, DOI 10.1176/appi.ajp.2009.08111747; Hauck WW, 1998, CONTROL CLIN TRIALS, V19, P249, DOI 10.1016/S0197-2456(97)00147-5; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2011, SCIENCE, V334, P1230, DOI 10.1126/science.1211811; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Keiding N, 2010, BIOSTATISTICS, V11, P376, DOI 10.1093/biostatistics/kxq033; Kesecioglu J, 2009, AM J RESP CRIT CARE, V180, P989, DOI 10.1164/rccm.200812-1955OC; Kim GP, 2009, J CLIN ONCOL, V27, P2848, DOI 10.1200/JCO.2008.20.4552; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Lainchbury JG, 2009, J AM COLL CARDIOL, V55, P53, DOI 10.1016/j.jacc.2009.02.095; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Lee SM, 2009, J NATL CANCER I, V101, P1049, DOI 10.1093/jnci/djp200; Lewis JA, 1999, STAT MED, V18, P1903, DOI 10.1002/(SICI)1097-0258(19990815)18:15<1903::AID-SIM188>3.3.CO;2-6; Lo GH, 2009, GUT, V58, P1275, DOI 10.1136/gut.2008.165910; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; MATTS JP, 1978, J CHRON DIS, V31, P725, DOI 10.1016/0021-9681(78)90057-7; Muss HB, 2009, NEW ENGL J MED, V360, P2055, DOI 10.1056/NEJMoa0810266; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; PIANTADOSI S, 1997, CLIN TRIALS METHODOL; Piepers S, 2009, ANN NEUROL, V66, P227, DOI 10.1002/ana.21620; Piper ME, 2009, ARCH GEN PSYCHIAT, V66, P1253, DOI 10.1001/archgenpsychiatry.2009.142; Plint AC, 2009, NEW ENGL J MED, V360, P2079, DOI 10.1056/NEJMoa0900544; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Schnipper JL, 2009, ARCH INTERN MED, V169, P771, DOI 10.1001/archinternmed.2009.51; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Sezer M, 2009, J AM COLL CARDIOL, V54, P1065, DOI 10.1016/j.jacc.2009.04.083; Siebers AG, 2009, JAMA-J AM MED ASSOC, V302, P1757, DOI 10.1001/jama.2009.1569; Sorensen PS, 2009, LANCET NEUROL, V8, P519, DOI 10.1016/S1474-4422(09)70085-7; Spencer A, 2009, J CLIN ONCOL, V27, P1788, DOI 10.1200/JCO.2008.18.8573; Staedke SG, 2009, LANCET, V373, P1623, DOI 10.1016/S0140-6736(09)60328-7; Steinberg MB, 2009, ANN INTERN MED, V150, P447, DOI 10.7326/0003-4819-150-7-200904070-00004; Vandemheen KL, 2009, AM J RESP CRIT CARE, V180, P761, DOI 10.1164/rccm.200903-0421OC; von Minckwitz G, 2009, J CLIN ONCOL, V27, P1999, DOI 10.1200/JCO.2008.19.6618; Wake M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3308; Wiegel T, 2009, J CLIN ONCOL, V27, P2924, DOI 10.1200/JCO.2008.18.9563; Yu LM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-59; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112	65	40	40	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 12	2013	347								f4313	10.1136/bmj.f4313	http://dx.doi.org/10.1136/bmj.f4313			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184MT	23851720	hybrid, Green Published			2022-12-28	WOS:000321895300001
J	O'Connor, J; Zheng, XT; Zhou, ZH				O'Connor, Jingmai; Zheng, Xiaoting; Zhou, Zhonghe			Can ovarian follicles fossilize? reply	NATURE			English	Letter							DINOSAUR		[O'Connor, Jingmai; Zhou, Zhonghe] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing 100044, Peoples R China; [Zheng, Xiaoting] Linyi Univ, Inst Geol & Paleontol, Linyi 276000, Shandong, Peoples R China; [Zheng, Xiaoting] Tianyu Nat Hist Museum Shandong, Pingyi 273300, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Linyi University	O'Connor, J (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing 100044, Peoples R China.	jingmai.oconnor@gmail.com						Briggs DEG, 1997, J GEOL SOC LONDON, V154, P587, DOI 10.1144/gsjgs.154.4.0587; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Chinsamy A, 1995, PALEOBIOLOGY, V21, P561, DOI 10.1017/S0094837300013543; Dyke GJ, 2010, REC AUST MUS, V62, P207, DOI 10.3853/j.0067-1975.62.2010.1547; GILL FB, 2007, ORNITHOLOGY; Griffiths PJ, 1999, 1 C INT OUS CRIES DI, P77; Mayr G, 2013, NATURE, V499, pE1, DOI 10.1038/nature12367; Minnaar P, 1994, EMU FARMERS HDB; Thorbjarnarson JB, 1996, HERPETOLOGICA, V52, P8; WEINER S, 1976, P NATL ACAD SCI USA, V73, P2541, DOI 10.1073/pnas.73.8.2541; Zheng XT, 2013, NATURE, V495, P507, DOI 10.1038/nature11985; Zheng XT, 2011, P NATL ACAD SCI USA, V108, P15904, DOI 10.1073/pnas.1112694108; Zhou ZH, 2010, SCI CHINA EARTH SCI, V53, P1894, DOI 10.1007/s11430-010-4094-9	13	7	8	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					E1	E2		10.1038/nature12368	http://dx.doi.org/10.1038/nature12368			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23846662				2022-12-28	WOS:000321557600002
J	Posor, Y; Eichhorn-Gruenig, M; Puchkov, D; Schoneberg, J; Ullrich, A; Lampe, A; Muller, R; Zarbakhsh, S; Gulluni, F; Hirsch, E; Krauss, M; Schultz, C; Schmoranzer, J; Noe, F; Haucke, V				Posor, York; Eichhorn-Gruenig, Marielle; Puchkov, Dmytro; Schoeneberg, Johannes; Ullrich, Alexander; Lampe, Andre; Mueller, Rainer; Zarbakhsh, Sirus; Gulluni, Federico; Hirsch, Emilio; Krauss, Michael; Schultz, Carsten; Schmoranzer, Jan; Noe, Frank; Haucke, Volker			Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate	NATURE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PHOSPHOINOSITIDE 3-KINASE; COATED VESICLES; HOMOLOGY-DOMAIN; PROTEINS; KINASE; CELLS; PHOSPHOINOSITIDE-3-KINASE-C2-ALPHA; 4,5-BISPHOSPHATE; IDENTIFICATION	Phosphoinositides serve crucial roles in cell physiology, ranging from cell signalling to membrane traffic(1,2). Among the seven eukaryotic phosphoinositides the best studied species is phosphatidylinositol-4,5-bisphosphate (PI(4,5)P-2), which is concentrated at the plasma membrane where, among other functions, it is required for the nucleation of endocytic clathrin-coated pits(3-6). No phosphatidylinositol other than PI(4,5)P-2 has been implicated in clathrin-mediated endocytosis, whereas the subsequent endosomal stages of the endocytic pathway are dominated by phosphatidylinositol-3-phosphates(PI(3)P)(7). How phosphatidylinositol conversion from PI(4,5)P-2-positive endocytic intermediates to PI(3)P-containing endosomes is achieved is unclear. Here we show that formation of phosphatidylinositol-3,4-bisphosphate (PI(3,4)P-2) by class II phosphatidylinositol-3-kinase C2 alpha (PI(3) K C2 alpha) spatiotemporally controls clathrin-mediated endocytosis. Depletion of PI(3,4)P-2 or PI(3)K C2 alpha impairs the maturation of late-stage clathrin-coated pits before fission. Timed formation of PI(3,4)P-2 by PI(3)K C2 alpha is required for selective enrichment of the BAR domain protein SNX9 at late-stage endocytic intermediates. These findings provide a mechanistic framework for the role of PI(3,4)P-2 in endocytosis and unravel a novel discrete function of PI(3,4)P-2 in a central cell physiological process.	[Posor, York; Eichhorn-Gruenig, Marielle; Puchkov, Dmytro; Lampe, Andre; Krauss, Michael; Schmoranzer, Jan; Haucke, Volker] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Posor, York; Eichhorn-Gruenig, Marielle; Puchkov, Dmytro; Lampe, Andre; Krauss, Michael; Schmoranzer, Jan; Haucke, Volker] Free Univ Berlin, D-13125 Berlin, Germany; [Schoeneberg, Johannes; Ullrich, Alexander; Noe, Frank] Free Univ Berlin, DFG Res Ctr MATHEON, D-14195 Berlin, Germany; [Mueller, Rainer; Zarbakhsh, Sirus; Schultz, Carsten] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Gulluni, Federico; Hirsch, Emilio] Univ Turin, Ctr Mol Biotechnol, Dept Genet, I-10126 Turin, Italy; [Gulluni, Federico; Hirsch, Emilio] Univ Turin, Ctr Mol Biotechnol, Dept Biol, I-10126 Turin, Italy; [Gulluni, Federico; Hirsch, Emilio] Univ Turin, Ctr Mol Biotechnol, Dept Biochem, I-10126 Turin, Italy; [Haucke, Volker] Charite, NeuroCure Cluster Excellence, D-10117 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Free University of Berlin; German Research Foundation (DFG); European Molecular Biology Laboratory (EMBL); University of Turin; University of Turin; University of Turin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Haucke, V (corresponding author), Leibniz Inst Mol Pharmakol FMP, Robert Roessle Str 10, D-13125 Berlin, Germany.	haucke@fmp-berlin.de	Noe, Frank/Y-2766-2019; GULLUNI, Federico/AAZ-8223-2021; Hirsch, Emilio/F-4848-2013	GULLUNI, Federico/0000-0001-7706-1635; Schultz, Carsten/0000-0002-5824-2171; Ullrich, Alexander/0000-0002-4894-6124; Krauss, Michael/0000-0003-1010-9723; Lampe, Andre/0000-0003-0750-4757; Hirsch, Emilio/0000-0002-9073-6024; Schmoranzer, Jan/0000-0002-4482-7080; Mueller, Rainer/0000-0003-3464-494X; Schoneberg, Johannes/0000-0001-7083-1828; Haucke, Volker/0000-0003-3119-6993; Puchkov, Dmytro/0000-0001-8341-4847	Deutsche Forschungsgemeinschaft [SFB 740/C8, SFB 740/D7, SFB 958/A04, SFB 958/A07, SFB 958/Z02]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank E. Ungewickell, P. Di Fiore, P. De Camilli, H. McMahon, E. Wancker, T. Sudhof and S. Carlsson for antibodies, L. Cantley, T. Takenawa, M. Wymann, T. Ross, O. Daumke and W. Yang for plasmids, and O. Daumke, B. Eickolt and F. Wieland for critical comments. Supported by grants from the Deutsche Forschungsgemeinschaft (SFB 740/C8; SFB 740/D7; SFB 958/A04; SFB 958/A07; SFB 958/Z02).	Antonescu CN, 2011, MOL BIOL CELL, V22, P2588, DOI 10.1091/mbc.E11-04-0362; Bae YH, 2010, P NATL ACAD SCI USA, V107, P21547, DOI 10.1073/pnas.1002309107; Borner GHH, 2012, J CELL BIOL, V197, P141, DOI 10.1083/jcb.201111049; CAMPBELL C, 1984, BIOCHEMISTRY-US, V23, P4420, DOI 10.1021/bi00314a028; Chang-Ileto B, 2011, DEV CELL, V20, P206, DOI 10.1016/j.devcel.2010.12.008; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Fili N, 2006, P NATL ACAD SCI USA, V103, P15473, DOI 10.1073/pnas.0607040103; Gaidarov I, 2005, J BIOL CHEM, V280, P40766, DOI 10.1074/jbc.M507731200; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Gruenberg J, 2003, CURR OPIN CELL BIOL, V15, P382, DOI 10.1016/S0955-0674(03)00078-4; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Laketa V, 2009, CHEM BIOL, V16, P1190, DOI 10.1016/j.chembiol.2009.10.005; Leibiger B, 2010, FASEB J, V24, P1824, DOI 10.1096/fj.09-148072; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Malecz N, 2000, CURR BIOL, V10, P1383, DOI 10.1016/S0960-9822(00)00778-8; Maritzen T, 2012, P NATL ACAD SCI USA, V109, P10382, DOI 10.1073/pnas.1206468109; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Park J, 2010, J CELL SCI, V123, P1742, DOI 10.1242/jcs.064170; Pirola L, 2001, J BIOL CHEM, V276, P21544, DOI 10.1074/jbc.M011330200; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Stahelin RV, 2006, J BIOL CHEM, V281, P39396, DOI 10.1074/jbc.M607079200; Subramanian D, 2010, NAT CHEM BIOL, V6, P324, DOI 10.1038/nchembio.348; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wieffer M, 2012, METHOD CELL BIOL, V108, P209, DOI 10.1016/B978-0-12-386487-1.00011-0; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yarar D, 2008, TRAFFIC, V9, P133, DOI 10.1111/j.1600-0854.2007.00675.x; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	36	274	281	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2013	499	7457					233	+		10.1038/nature12360	http://dx.doi.org/10.1038/nature12360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23823722				2022-12-28	WOS:000321557600067
J	Robinson-Cohen, C; Hoofnagle, AN; Ix, JH; Sachs, MC; Tracy, RP; Siscovick, DS; Kestenbaum, BR; de Boer, IH				Robinson-Cohen, Cassianne; Hoofnagle, Andrew N.; Ix, Joachim H.; Sachs, Michael C.; Tracy, Russell P.; Siscovick, David S.; Kestenbaum, Bryan R.; de Boer, Ian H.			Racial Differences in the Association of Serum 25-Hydroxyvitamin D Concentration With Coronary Heart Disease Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; VITAMIN-D-RECEPTOR; 3RD NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; PARATHYROID-HORMONE; D DEFICIENCY; ALL-CAUSE; AFRICAN-AMERICANS; OLDER-ADULTS; RISK	IMPORTANCE Low circulating concentrations of 25-hydroxyvitamin D (25[OH]D) have been consistently associated with an increased risk of coronary heart disease (CHD) in white populations. This association has not been rigorously evaluated in other races or ethnicities, in which the distributions of 25(OH)D concentration and possibly other aspects of 25(OH)D metabolism differ. OBJECTIVE To examine the association of serum 25(OH)D concentration with risk of CHD in a multiethnic population. DESIGN, SETTING, AND PARTICIPANTS We studied 6436 participants in the Multi-Ethnic Study of Atherosclerosis (MESA), recruited from July 2000 through September 2002, who were free of known cardiovascular disease at baseline. We measured baseline serum 25(OH)D concentrations using a mass spectrometry assay calibrated to established standards. We tested associations of 25(OH)D with adjudicated CHD events assessed through May 2012. MAIN OUTCOME AND MEASURES Primary outcome measure was time to first adjudicated CHD event, defined as myocardial infarction, angina, cardiac arrest, or CHD death. RESULTS During a median follow-up of 8.5 years, 361 participants had an incident CHD event (7.38 events per 1000 person-years). Associations of 25(OH)D with CHD differed by race/ethnicity (P for interaction < .05). After adjustment, lower 25(OH)D concentration was associated with a greater risk of incident CHD among participants who were white (n = 167 events; hazard ratio [HR], 1.26 [95% CI, 1.06-1.49] for each 10-ng/mL decrement in 25(OH)D) or Chinese (HR, 1.67 [95% CI, 1.07-2.61]; n = 27). In contrast, 25(OH)D was not associated with risk of CHD in participants who were black (HR, 0.93 [95% CI, 0.73-1.20]; n = 94) or Hispanic (HR, 1.01 [95% CI, 0.77-1.33]; n = 73). CONCLUSIONS AND RELEVANCE Lower serum 25(OH)D concentration was associated with an increased risk of incident CHD events among participants who were white or Chinese but not black or Hispanic. Results evaluating 25(OH)D in ethnically homogeneous populations may not be broadly generalizable to other racial or ethnic groups.	[Robinson-Cohen, Cassianne; Sachs, Michael C.; Kestenbaum, Bryan R.; de Boer, Ian H.] Univ Washington, Dept Med, Kidney Res Inst, Seattle, WA 98104 USA; [Hoofnagle, Andrew N.] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA; [Ix, Joachim H.] Univ Calif San Diego, Div Nephrol & Hypertens, Dept Med, La Jolla, CA 92093 USA; [Ix, Joachim H.] San Diego VA Healthcare Syst, San Diego, CA USA; [Tracy, Russell P.] Univ Vermont, Dept Pathobiol, Colchester, Essex, England; [Tracy, Russell P.] Univ Vermont, Dept Biochem, Colchester, Essex, England; [Siscovick, David S.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98104 USA; [Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Kestenbaum, Bryan R.; de Boer, Ian H.] Univ Washington, Div Nephrol, Dept Med, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	de Boer, IH (corresponding author), Univ Washington, Div Nephrol, Dept Med, Kidney Res Inst, POB 359606, Seattle, WA 98104 USA.	deboer@u.washington.edu	de Boer, Ian/GYJ-3282-2022; Robinson-Cohen, Cassianne/ABB-4985-2021	Robinson-Cohen, Cassianne/0000-0003-4783-7046; Sachs, Michael/0000-0002-1279-8676	National Heart, Lung, and Blood Institute [R01DK088762, N01-HC-95159, N01-HC-95169]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095160, N01HC095168, N01HC095165, N01HC095166, N01HC095159, N01HC095161, N01HC095164, N01HC095167, N01HC095163, N01HC095169, N01HC095162] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL095169, R01HL096875, R43HL095169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088762] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants R01DK088762 and by N01-HC-95159 through N01-HC-95169 from the National Heart, Lung, and Blood Institute.	Agborsangaya C, 2010, NUTR CANCER, V62, P51, DOI 10.1080/01635580903191460; BELL NH, 1985, J CLIN INVEST, V76, P470, DOI 10.1172/JCI111995; Berger C, 2012, J BONE MINER RES, V27, P1381, DOI 10.1002/jbmr.1587; Bid Hemant K, 2005, Asian Pac J Cancer Prev, V6, P147; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bosworth C, 2013, CLIN ENDOCRINOL, V79, P429, DOI 10.1111/cen.12163; Bosworth CR, 2012, KIDNEY INT, V82, P693, DOI 10.1038/ki.2012.193; Budoff MJ, 2011, ATHEROSCLEROSIS, V215, P196, DOI 10.1016/j.atherosclerosis.2010.11.017; Budoff MJ, 2009, AM HEART J, V158, P554, DOI 10.1016/j.ahj.2009.08.007; Budoff MJ, 2009, J AM COLL CARDIOL, V53, P345, DOI 10.1016/j.jacc.2008.07.072; Cauley JA, 2011, J BONE MINER RES, V26, P2378, DOI 10.1002/jbmr.449; de Boer IH, 2012, ANN INTERN MED, V156, P627, DOI 10.7326/0003-4819-156-9-201205010-00004; de Boer IH, 2009, J AM SOC NEPHROL, V20, P1805, DOI 10.1681/ASN.2008111157; Deo R, 2011, HYPERTENSION, V58, P1021, DOI 10.1161/HYPERTENSIONAHA.111.179135; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Gutierrez OM, 2011, OSTEOPOROSIS INT, V22, P1745, DOI 10.1007/s00198-010-1383-2; Hannan MT, 2008, J CLIN ENDOCR METAB, V93, P40, DOI 10.1210/jc.2007-1217; Harris SS, 1997, J BONE MINER RES, V12, P1043, DOI 10.1359/jbmr.1997.12.7.1043; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Huang X, 2011, BIOSCI TRENDS, V5, P99, DOI 10.5582/bst.2011.v5.3.99; Hutchinson MS, 2010, EUR J ENDOCRINOL, V162, P935, DOI 10.1530/EJE-09-1041; Kendrick J, 2009, ATHEROSCLEROSIS, V205, P255, DOI 10.1016/j.atherosclerosis.2008.10.033; Kestenbaum B, 2011, J AM COLL CARDIOL, V58, P1433, DOI 10.1016/j.jacc.2011.03.069; Kilkkinen A, 2009, AM J EPIDEMIOL, V170, P1032, DOI 10.1093/aje/kwp227; Kritchevsky SB, 2012, J CLIN ENDOCR METAB, V97, P4156, DOI 10.1210/jc.2012-1551; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Levin GP, 2012, JAMA-J AM MED ASSOC, V308, P1898, DOI 10.1001/jama.2012.17304; Liu LJ, 2012, AM J CARDIOL, V110, P834, DOI 10.1016/j.amjcard.2012.05.013; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Michos ED, 2012, NUTRITION, V28, P367, DOI 10.1016/j.nut.2011.10.015; OConnell TD, 1997, AM J PHYSIOL-HEART C, V272, pH1751; Panichi V, 1998, KIDNEY INT, V54, P1463, DOI 10.1046/j.1523-1755.1998.00152.x; Phinney KW, 2008, AM J CLIN NUTR, V88, p511S, DOI 10.1093/ajcn/88.2.511S; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Rejnmark L, 2006, SCAND J CLIN LAB INV, V66, P227, DOI 10.1080/00365510600570623; RESNICK LM, 1986, ANN INTERN MED, V105, P649, DOI 10.7326/0003-4819-105-5-649; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Rubin DB, 1987, MULTIPLE IMPUTATION; Sachs MC, 2013, AM J CLIN NUTR, V97, P1243, DOI 10.3945/ajcn.112.054502; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Semba RD, 2010, EUR J CLIN NUTR, V64, P203, DOI 10.1038/ejcn.2009.140; Signorello LB, 2013, AM J EPIDEMIOL, V177, P171, DOI 10.1093/aje/kws348; Sonderman JS, 2012, AM J EPIDEMIOL, V176, P615, DOI 10.1093/aje/kws141; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wassel CL, 2009, CIRC-CARDIOVASC GENE, V2, P629, DOI 10.1161/CIRCGENETICS.109.876243	53	139	146	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					179	188		10.1001/jama.2013.7228	http://dx.doi.org/10.1001/jama.2013.7228			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23839752	Green Accepted, Bronze			2022-12-28	WOS:000321511500017
J	Hartland, GV; Lo, SS				Hartland, Gregory V.; Lo, Shun Shang			Spectroscopy Beyond the Single-Particle Limit	SCIENCE			English	Editorial Material							GOLD NANOPARTICLES; ACOUSTIC VIBRATIONS		[Hartland, Gregory V.; Lo, Shun Shang] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46557 USA	University of Notre Dame	Hartland, GV (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46557 USA.	ghartlan@nd.edu; shunshang.lo.2@nd.edu	Hartland, Gregory/K-2694-2012	Hartland, Gregory/0000-0002-8650-6891				Bogan MJ, 2008, NANO LETT, V8, P310, DOI 10.1021/nl072728k; Clark JN, 2013, SCIENCE, V341, P56, DOI 10.1126/science.1236034; Crut A, 2009, PHYS CHEM CHEM PHYS, V11, P5882, DOI 10.1039/b902107h; Hildner R, 2011, NAT PHYS, V7, P172, DOI [10.1038/nphys1858, 10.1038/NPHYS1858]; Major TA, 2013, PHYS CHEM CHEM PHYS, V15, P4169, DOI 10.1039/c2cp43330c; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Pelton M, 2009, NAT NANOTECHNOL, V4, P492, DOI [10.1038/NNANO.2009.192, 10.1038/nnano.2009.192]; Ruijgrok PV, 2012, NANO LETT, V12, P1063, DOI 10.1021/nl204311q; Tchebotareva AL, 2009, CHEMPHYSCHEM, V10, P111, DOI 10.1002/cphc.200800289; van Dijk MA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.267406; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654	11	2	2	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					36	37		10.1126/science.1240500	http://dx.doi.org/10.1126/science.1240500			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828929				2022-12-28	WOS:000321291700035
J	McCouch, S; Baute, GJ; Bradeen, J; Bramel, P; Bretting, PK; Buckler, E; Burke, JM; Charest, D; Cloutier, S; Cole, G; Dempewolf, H; Dingkuhn, M; Feuillet, C; Gepts, P; Grattapaglia, D; Guarino, L; Jackson, S; Knapp, S; Langridge, P; Lawton-Rauh, A; Lijua, Q; Lusty, C; Michael, T; Myles, S; Naito, K; Nelson, RL; Pontarollo, R; Richards, CM; Rieseberg, L; Ross-Ibarra, J; Rounsley, S; Hamilton, RS; Schurr, U; Stein, N; Tomooka, N; van der Knaap, E; van Tassel, D; Toll, J; Valls, J; Varshney, RK; Ward, J; Waugh, R; Wenzl, P; Zamir, D				McCouch, Susan; Baute, Gregory J.; Bradeen, James; Bramel, Paula; Bretting, Peter K.; Buckler, Edward; Burke, John M.; Charest, David; Cloutier, Sylvie; Cole, Glenn; Dempewolf, Hannes; Dingkuhn, Michael; Feuillet, Catherine; Gepts, Paul; Grattapaglia, Dario; Guarino, Luigi; Jackson, Scott; Knapp, Sandra; Langridge, Peter; Lawton-Rauh, Amy; Lijua, Qui; Lusty, Charlotte; Michael, Todd; Myles, Sean; Naito, Ken; Nelson, Randall L.; Pontarollo, Reno; Richards, Christopher M.; Rieseberg, Loren; Ross-Ibarra, Jeffrey; Rounsley, Steve; Hamilton, Ruaraidh Sackville; Schurr, Ulrich; Stein, Nils; Tomooka, Norihiko; van der Knaap, Esther; van Tassel, David; Toll, Jane; Valls, Jose; Varshney, Rajeev K.; Ward, Judson; Waugh, Robbie; Wenzl, Peter; Zamir, Daniel		Crop Wild Relative Genomics	Feeding the future	NATURE			English	Editorial Material							WILD		[McCouch, Susan; Buckler, Edward] Cornell Univ, Ithaca, NY 14850 USA; [Baute, Gregory J.; Rieseberg, Loren] Univ British Columbia, Vancouver, BC, Canada; [Bradeen, James] Univ Minnesota, St Paul, MN USA; [Bramel, Paula; Dempewolf, Hannes; Guarino, Luigi; Lusty, Charlotte; Toll, Jane] Global Crop Div Trust, Bonn, Germany; [Bretting, Peter K.; Buckler, Edward] USDA, Beltsville, MD USA; [Burke, John M.; Jackson, Scott] Univ Georgia, Athens, GA USA; [Charest, David] Genome BC, Vancouver, BC, Canada; [Cloutier, Sylvie] Agr & Agri Food Canada, Winnipeg, MB, Canada; [Cole, Glenn] Pioneer, Woodland, CA USA; [Dingkuhn, Michael] CIRAD, Montpellier, France; [Dingkuhn, Michael] Int Rice Res Inst IRRI, Banos, Philippines; [Feuillet, Catherine] Inst Natl Rech Agron INRA, Clermont Ferrand, France; [Gepts, Paul; Ross-Ibarra, Jeffrey] Univ Calif Davis, Davis, CA USA; [Grattapaglia, Dario; Valls, Jose] EMBRAPA, Campinas, SP, Brazil; [Knapp, Sandra] Nat Hist Museum, London, England; [Langridge, Peter] Australian Ctr Plant Funct Genom ACPFG, Adelaide, SA, Australia; [Lawton-Rauh, Amy] Clemson Univ, Clemson, SC USA; [Lijua, Qui] Chinese Acad Agr Sci, Beijing, Peoples R China; [Michael, Todd] Monsanto Co, Creve Coeur, MO USA; [Myles, Sean] Dalhousie Univ, Halifax, NS, Canada; [Naito, Ken; Tomooka, Norihiko] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Nelson, Randall L.] USDA, Urbana, IL USA; [Nelson, Randall L.] Univ Illinois, Urbana, IL USA; [Pontarollo, Reno] Genome Prairie, Saskatoon, SK, Canada; [Richards, Christopher M.] Colorado State Univ, Ft Collins, CO USA; [Richards, Christopher M.] USDA, Ft Collins, CO USA; [Rounsley, Steve] DowAgro, Indianapolis, IN USA; [Hamilton, Ruaraidh Sackville] Int Rice Res Inst IRRI, Banos, Philippines; [Schurr, Ulrich] Forschungszentrum Julich, Julich, Germany; [Stein, Nils] Leibniz Inst Pflanzengenet & Kulturpflanzenforsch, IPK, Gatersleben, Germany; [van der Knaap, Esther] Ohio State Univ, Wooster, OH USA; [van Tassel, David] Land Inst, Salina, KS USA; [Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Patancheru, Andhra Pradesh, India; [Ward, Judson] Driscolls, Watsonville, CA USA; [Waugh, Robbie] James Hutton Inst, Dundee, Scotland; [Wenzl, Peter] Int Maize & Wheat Improvement Ctr CIMMYT, El Batan, Mexico; [Zamir, Daniel] Hebrew Univ Jerusalem, Rehovot, Israel	Cornell University; University of British Columbia; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); University System of Georgia; University of Georgia; Agriculture & Agri Food Canada; CIRAD; INRAE; University of California System; University of California Davis; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Natural History Museum London; Clemson University; Chinese Academy of Agricultural Sciences; Monsanto; Dalhousie University; National Institute of Agrobiological Sciences - Japan; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; Colorado State University; United States Department of Agriculture (USDA); Helmholtz Association; Research Center Julich; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University System of Ohio; Ohio State University; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); James Hutton Institute; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Hebrew University of Jerusalem	McCouch, S (corresponding author), Cornell Univ, Ithaca, NY 14850 USA.	mccouch@cornell.edu	Rieseberg, Loren H/B-3591-2013; Grattapaglia, Dario/B-5864-2014; Schurr, Ulrich/AAA-3158-2022; Langridge, Peter/G-5864-2010; Valls, José Francisco Montenegro/ABD-8596-2021; Buckler, Edward/GPS-4932-2022; Grattapaglia, Dario/AAB-6805-2020; Stein, Nils/F-7507-2017; Buckler, Edward/L-7651-2019; Gepts, Paul/O-8229-2019; Ross-Ibarra, Jeffrey/D-7782-2011; Richards, Christopher/A-8328-2013; Varshney, Rajeev K/C-5295-2014; Burke, John/A-3502-2013	Rieseberg, Loren H/0000-0002-2712-2417; Grattapaglia, Dario/0000-0002-0050-970X; Langridge, Peter/0000-0001-9494-400X; Valls, José Francisco Montenegro/0000-0002-4586-5142; Grattapaglia, Dario/0000-0002-0050-970X; Stein, Nils/0000-0003-3011-8731; Buckler, Edward/0000-0002-3100-371X; Gepts, Paul/0000-0002-1056-4665; Ross-Ibarra, Jeffrey/0000-0003-1656-4954; Richards, Christopher/0000-0002-9978-6079; Varshney, Rajeev K/0000-0002-4562-9131; jackson, scott/0000-0002-3172-1607; van der Knaap, Esther/0000-0003-4963-7427; Naito, Ken/0000-0002-0273-7837; Burke, John/0000-0002-1412-5539; Michael, Todd/0000-0001-6272-2875	Direct For Biological Sciences [1026555] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		[Anonymous], RICE GENET NEWSLETT; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gur A, 2004, PLOS BIOL, V2, P1610, DOI 10.1371/journal.pbio.0020245; Imai I, 2013, MOL BREEDING, V32, P101, DOI 10.1007/s11032-013-9855-7; ITPGRFA, 2009, INT TREAT PLANT GEN; Pimentel D, 1997, BIOSCIENCE, V47, P747, DOI 10.2307/1313097; Plucknett D.L., 1987, GENE BANKS WORLDS FO; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Zamir D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001595	9	326	332	5	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					23	+		10.1038/499023a	http://dx.doi.org/10.1038/499023a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176ED	23823779	Bronze, Green Accepted			2022-12-28	WOS:000321285600013
J	Brandes, M; Klauschen, F; Kuchen, S; Germain, RN				Brandes, Marlene; Klauschen, Frederick; Kuchen, Stefan; Germain, Ronald N.			A Systems Analysis Identifies a Feedforward Inflammatory Circuit Leading to Lethal Influenza Infection	CELL			English	Article							KAPPA-B-ALPHA; IMMUNE-RESPONSE; DENDRITIC CELLS; PROTECTS MICE; HOST IMMUNE; VIRUS; NEUTROPHILS; RECEPTOR; MACROPHAGES; EXPRESSION	For acutely lethal influenza infections, the relative pathogenic contributions of direct viral damage to lung epithelium versus dysregulated immunity remain unresolved. Here, we take a top-down systems approach to this question. Multigene transcriptional signatures from infected lungs suggested that elevated activation of inflammatory signaling networks distinguished lethal from sublethal infections. Flow cytometry and gene expression analysis involving isolated cell subpopulations from infected lungs showed that neutrophil influx largely accounted for the predictive transcriptional signature. Automated imaging analysis, together with these gene expression and flow data, identified a chemokine-driven feedforward circuit involving proinflammatory neutrophils potently driven by poorly contained lethal viruses. Consistent with these data, attenuation, but not ablation, of the neutrophil-driven response increased survival without changing viral spread. These findings establish the primacy of damaging innate inflammation in at least some forms of influenza-induced lethality and provide a roadmap for the systematic dissection of infection-associated pathology.	[Brandes, Marlene; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Kuchen, Stefan] NIAMSD, Immunogenet Mol Lab, NIH, Bethesda, MD 20892 USA; [Klauschen, Frederick] Univ Med Berlin, Inst Pathol, D-10117 Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Brandes, M (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	marlene.brandes@insel.ch; rgermain@nih.gov	Germain, Ronald N./Z-1945-2019; Klauschen, Frederick/C-5637-2015; Germain, Ronald/ABE-7090-2020	Klauschen, Frederick/0000-0002-9131-2389; Kuchen, Stefan/0000-0003-4899-8132	Intramural Research Program of NIAID, NIH; Swiss Science Foundation [PA00A-1114666]; Human Frontier Science Program Young Investigator Award [RGY0077/2011]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000974, ZIAAI001034] Funding Source: NIH RePORTER	Intramural Research Program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Human Frontier Science Program Young Investigator Award(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J.R. Bennink and S.E. Hensley for virus seeds and initial advice; T.A. Torrey, C.L. Thomas, and the animal facility team for support and animal health observations; K.L. Holmes and C.L. Eigsti for FACS Aria operation; T.G. Myers, G. Owens, and A. Godinez for microarray hybridization and QC analysis; R. Kastenmayer, M.S. Orandle, O.M. Schwartz, and L. Koo for slide scanner access and advice; Y. Belkaid for bones from germ-free mice; and B. Dutta, J.R. Bennink, W. Resch, and I. Fraser for critical reading of the manuscript and valuable comments. This work was supported by the Intramural Research Program of NIAID, NIH, a fellowship from the Swiss Science Foundation PA00A-1114666 (M.B.), and a Human Frontier Science Program Young Investigator Award RGY0077/2011 (F.K.).	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Boon ACM, 2011, MBIO, V2, DOI 10.1128/mBio.00171-11; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brincks EL, 2008, J IMMUNOL, V181, P4918, DOI 10.4049/jimmunol.181.7.4918; Chakrabarti AK, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-219; Chang ST, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-202; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; de Bruin AM, 2012, BLOOD, V119, P1543, DOI 10.1182/blood-2011-07-367706; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Garigliany MM, 2010, EMERG INFECT DIS, V16, P595, DOI 10.3201/eid1604.091061; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Goldbach-Mansky R, 2009, J ALLERGY CLIN IMMUN, V124, P1141, DOI 10.1016/j.jaci.2009.11.016; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Jacobs JP, 2010, ARTHRITIS RHEUM-US, V62, P1921, DOI 10.1002/art.27470; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Otte A, 2011, AM J PATHOL, V179, P230, DOI 10.1016/j.ajpath.2011.03.041; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Qi L, 2011, VIROLOGY, V412, P426, DOI 10.1016/j.virol.2011.01.029; Qiu LQ, 2012, J IMMUNOL, V188, P5150, DOI 10.4049/jimmunol.1103700; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shinya K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-97; Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tate MD, 2012, IMMUNOL CELL BIOL, V90, P197, DOI 10.1038/icb.2011.26; Tate MD, 2011, J IMMUNOL, V187, P1884, DOI 10.4049/jimmunol.1100295; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Wang JP, 2008, BLOOD, V112, P2028, DOI 10.1182/blood-2008-01-132860; Watanabe T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001218; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603	54	257	261	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					197	212		10.1016/j.cell.2013.06.013	http://dx.doi.org/10.1016/j.cell.2013.06.013			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827683	Green Accepted, Bronze			2022-12-28	WOS:000321327900020
J	Mevissen, TET; Hospenthal, MK; Geurink, PP; Elliott, PR; Akutsu, M; Arnaudo, N; Ekkebus, R; Kulathu, Y; Wauer, T; El Oualid, F; Freund, SMV; Ovaa, H; Komander, D				Mevissen, Tycho E. T.; Hospenthal, Manuela K.; Geurink, Paul P.; Elliott, Paul R.; Akutsu, Masato; Arnaudo, Nadia; Ekkebus, Reggy; Kulathu, Yogesh; Wauer, Tobias; El Oualid, Farid; Freund, Stefan M. V.; Ovaa, Huib; Komander, David			OTU Deubiquitinases Reveal Mechanisms of Linkage Specificity and Enable Ubiquitin Chain Restriction Analysis	CELL			English	Article							KAPPA-B ACTIVATION; CROSS-REACTIVITY; LINKED UBIQUITIN; STRUCTURAL BASIS; POLYUBIQUITIN; ENZYME; RECOGNITION; PROTEIN; UBIQUITYLATION; INFLAMMATION	Sixteen ovarian tumor (OTU) family deubiquitinases (DUBs) exist in humans, and most members regulate cell-signaling cascades. Several OTU DUBs were reported to be ubiquitin (Ub) chain linkage specific, but comprehensive analyses are missing, and the underlying mechanisms of linkage specificity are unclear. Using Ub chains of all eight linkage types, we reveal that most human OTU enzymes are linkage specific, preferring one, two, or a defined subset of linkage types, including unstudied atypical Ub chains. Biochemical analysis and five crystal structures of OTU DUBs with or without Ub substrates reveal four mechanisms of linkage specificity. Additional Ub-binding domains, the ubiquitinated sequence in the substrate, and defined S1' and S2 Ub-binding sites on the OTU domain enable OTU DUBs to distinguish linkage types. We introduce Ub chain restriction analysis, in which OTU DUBs are used as restriction enzymes to reveal linkage type and the relative abundance of Ub chains on substrates.	[Mevissen, Tycho E. T.; Hospenthal, Manuela K.; Elliott, Paul R.; Akutsu, Masato; Arnaudo, Nadia; Kulathu, Yogesh; Wauer, Tobias; Freund, Stefan M. V.; Komander, David] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Mevissen, Tycho E. T.] Free Univ Berlin, Fachbereich Biol, D-14195 Berlin, Germany; [Geurink, Paul P.; Ekkebus, Reggy; El Oualid, Farid; Ovaa, Huib] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	MRC Laboratory Molecular Biology; Free University of Berlin; Netherlands Cancer Institute	Komander, D (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	dk@mrc-lmb.cam.ac.uk	Hospenthal, Manuela/AAU-3210-2020; Mevissen, Tycho E.T./AAX-4366-2020; akutsu, masato/L-4095-2016; ovaa, huib/M-2334-2016	Hospenthal, Manuela/0000-0003-1175-6826; Mevissen, Tycho E.T./0000-0002-2324-5292; akutsu, masato/0000-0002-9839-3345; ovaa, huib/0000-0002-0068-054X; Kulathu, Yogesh/0000-0002-3274-1642; Elliott, Paul/0000-0002-7641-2103; Geurink, Paul/0000-0003-1849-1111	MRC [U105192732]; European Research Council [309756]; European Molecular Biology Organization Young Investigator program; Lister Institute for Preventive Medicine; Netherlands Organization for Scientific Research [700.58.011]; Marie Curie Initial Training Network UPStream; Medical Research Council [MC_U105192732] Funding Source: researchfish; MRC [MC_U105192732] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization Young Investigator program(European Molecular Biology Organization (EMBO)); Lister Institute for Preventive Medicine; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Marie Curie Initial Training Network UPStream; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank E. Bennett (University of California, San Diego) for sharing unpublished mass spectrometry data, K. Bianchi and P. Meier (the Institute of Cancer Research, London) for the RIP1 purification protocol, T. Mund (Medical Research Council [MRC] Laboratory of Molecular Biology) for providing GST-tagged NEDD4 and E6AP, and members of the D.K. lab for reagents and helpful discussions. This work was supported by the MRC (U105192732 to D.K.), the European Research Council (309756 to D.K.), the European Molecular Biology Organization Young Investigator program (to D.K.), the Lister Institute for Preventive Medicine (to D.K.), the Netherlands Organization for Scientific Research (700.58.011 to H.O.), and the Marie Curie Initial Training Network UPStream (to T.E.T.M.). Crystallographic data were collected at the European Synchrotron Radiation Facility at beam lines ID23-1 and ID29 and at the Diamond Light Source beam lines I-03 and I-04. H.O. and F.E. are cofounders of UbiQ Bio BV.	Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Drag M, 2008, BIOCHEM J, V415, P367, DOI 10.1042/BJ20080779; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Ekkebus R, 2013, J AM CHEM SOC, V135, P2867, DOI 10.1021/ja309802n; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Geurink PP, 2012, CHEMBIOCHEM, V13, P293, DOI 10.1002/cbic.201100706; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hospenthal MK, 2013, NAT STRUCT MOL BIOL, V20, P555, DOI 10.1038/nsmb.2547; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Huang OW, 2012, NAT STRUCT MOL BIOL, V19, P171, DOI 10.1038/nsmb.2206; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Iwai K, 2011, CELL CYCLE, V10, P3095, DOI 10.4161/cc.10.18.17437; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nakasone MA, 2013, STRUCTURE, V21, P727, DOI 10.1016/j.str.2013.02.019; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Schaefer JB, 2011, J BIOL CHEM, V286, P45186, DOI 10.1074/jbc.M111.310094; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tsai YC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001038; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Williamson A, 2013, MOL CELL, V49, P591, DOI 10.1016/j.molcel.2013.01.028; Williamson A, 2011, MOL CELL, V42, P744, DOI 10.1016/j.molcel.2011.04.022; Ye Y, 2012, NATURE, V492, P266, DOI 10.1038/nature11722; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17	45	359	385	0	79	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					169	184		10.1016/j.cell.2013.05.046	http://dx.doi.org/10.1016/j.cell.2013.05.046			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827681	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000321327900018
J	Walker, K; Neuburger, J; Groene, O; Cromwell, DA; van der Meulen, J				Walker, Kate; Neuburger, Jenny; Groene, Oliver; Cromwell, David A.; van der Meulen, Jan			Public reporting of surgeon outcomes: low numbers of procedures lead to false complacency	LANCET			English	Article							CARDIAC-SURGERY; SURGICAL MORTALITY; PERFORMANCE; LESSONS; CARE	The English National Health Service published outcome information for individual surgeons for ten specialties in June, 2013. We looked at whether individual surgeons do sufficient numbers of procedures to be able to reliably identify those with poor performance. For some specialties, the number of procedures that a surgeon does each year is low and, as a result, the chance of identifying a surgeon with increased mortality rates is also low. Therefore, public reporting of individual surgeons' outcomes could lead to false complacency. We recommend use of outcomes that are fairly frequent, considering the hospital as the unit of reporting when numbers are low, and avoiding interpretation of no evidence of poor performance as evidence of acceptable performance.	[Walker, Kate; Neuburger, Jenny; Groene, Oliver; Cromwell, David A.; van der Meulen, Jan] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Neuburger, J (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England.	jenny.neuburger@lshtm.ac.uk	Cromwell, David/AAD-6519-2019	Walker, Kate/0000-0001-5392-6323; Groene, Oliver/0000-0002-1099-2950; van der Meulen, Jan/0000-0002-9451-2335	Royal College of Surgeons of England	Royal College of Surgeons of England	We thank Rob Wakeman for providing information on surgeon volume for hip fracture surgery. No specific funding was received for this report. The salaries of KW, JN, and OG were funded by a grant from the Royal College of Surgeons of England.	ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Bridgewater B, 2005, BMJ-BRIT MED J, V330, P506, DOI 10.1136/bmj.330.7490.506; Bridgewater B, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1139; Dimick JB, 2004, JAMA-J AM MED ASSOC, V292, P847, DOI 10.1001/jama.292.7.847; Dimick JB, 2010, HEALTH SERV RES, V45, P1614, DOI 10.1111/j.1475-6773.2010.01158.x; Ghaferi AA, 2011, MED CARE, V49, P1076, DOI 10.1097/MLR.0b013e3182329b97; Girling AJ, 2012, BMJ QUAL SAF, V21, P1052, DOI 10.1136/bmjqs-2012-001202; Hannan EL, 2012, J AM COLL CARDIOL, V59, P2309, DOI 10.1016/j.jacc.2011.12.051; Health and Social Care Information Centre, NATIONAL BOWEL CANCE; Health and Social Care Information Centre, NATIONAL OESOPHAGO G; Health and Social Care Information Centre, HOSPITAL EPISODE; Johal A, 2013, HOSPITAL EPISODE STA; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; National Hip Fracture Database, 2012, NATIONAL REPORT 2012; National Institute for Cardiovascular Outcomes Research, 2013, ADULT CARDIAC SURGER; NHS Commissioning Board, 2012, EVERYONE COUNTS PLAN; Shahian DM, 2012, J AM COLL CARDIOL, V59, P2383, DOI 10.1016/j.jacc.2011.12.050; Shahian DM, 2011, ANN THORAC SURG, V92, pS2, DOI 10.1016/j.athoracsur.2011.06.100; Society for Cardiothoracic Surgery in Great Britain and Ireland, UK SURGEONS RESULTS; Spiegelhalter DJ, 2005, QUAL SAF HEALTH CARE, V14, P347, DOI 10.1136/qshc.2005.013755	21	81	81	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1674	1677		10.1016/S0140-6736(13)61491-9	http://dx.doi.org/10.1016/S0140-6736(13)61491-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254CN	23831144				2022-12-28	WOS:000327140700027
J	Baguley, D; McFerran, D; Hall, D				Baguley, David; McFerran, Don; Hall, Deborah			Tinnitus	LANCET			English	Article							DEEP BRAIN-STIMULATION; DOUBLE-BLIND; CLINICAL-TRIALS; INTRAVENOUS LIDOCAINE; HEARING-AIDS; EAR; SUPPRESSION; GABAPENTIN; PREVALENCE; MECHANISMS	Tinnitus is a common medical symptom that can be debilitating. Risk factors include hearing loss, ototoxic medication, head injury, and depression. At presentation, the possibilities of otological disease, anxiety, and depression should be considered. No effective drug treatments are available, although much research is underway into mechanisms and possible treatments. Surgical intervention for any otological pathology associated with tinnitus might be effective for that condition, but the tinnitus can persist. Available treatments include hearing aids when hearing loss is identified (even mild or unilateral), wide-band sound therapy, and counselling. Cognitive behavioural therapy (CBT) is indicated for some patients, but availability of tinnitus-specific CBT in the UK is poor. The evidence base is strongest for a combination of sound therapy and CBT-based counselling, although clinical trials are constrained by the heterogeneity of patients with tinnitus.	[Baguley, David] Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England; [Baguley, David] Anglia Ruskin Univ, Cambridge, England; [McFerran, Don] Colchester Hosp Univ NHS Fdn Trust, Colchester, Essex, England; [Hall, Deborah] Natl Inst Hlth Res, Nottingham Hearing Biomed Res Unit, Nottingham, England	University of Cambridge; Anglia Ruskin University; University of Nottingham	Baguley, D (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England.	dmb29@cam.ac.uk		Hall, Deborah/0000-0002-3804-1452; McFerran, Don/0000-0002-4395-3405	National Institute for Health Research	National Institute for Health Research(National Institute for Health Research (NIHR))	DH is funded by the National Institute for Health Research. The views expressed are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health.	Aazh H, 2011, AM J AUDIOL, V20, P151, DOI 10.1044/1059-0889(2011/10-0041); Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; Alpiner JG, 2000, REHABILITATIVE AUDIO, P3; Anari M, 1999, SCAND AUDIOL, V28, P219, DOI 10.1080/010503999424653; Baguley DM, 2007, PROG BRAIN RES, V166, P347, DOI 10.1016/S0079-6123(07)66033-6; Baguley DM, 2005, OTOL NEUROTOL, V26, P169, DOI 10.1097/00129492-200503000-00007; Baguley DM, 1999, INT J PEDIATR OTORHI, V49, P99, DOI 10.1016/S0165-5876(99)00111-1; Baldo P, 2006, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003853.PUB2; Barany R, 1935, ACTA OTO-LARYNGOL, V23, P201; BARTON GR, 2003, AUDIOL MED, V1, P107; Bauer CA, 2006, LARYNGOSCOPE, V116, P675, DOI 10.1097/01.MLG.0000216812.65206.CD; Bhimrao SK, 2012, OTOLARYNG HEAD NECK, V146, P698, DOI 10.1177/0194599811434504; BLAYNEY AW, 1985, CLIN OTOLARYNGOL, V10, P97, DOI 10.1111/j.1365-2273.1985.tb01175.x; Campbell K, 2011, HEARING RES, V282, P138, DOI 10.1016/j.heares.2011.08.003; Cheung SW, 2010, NEUROSCIENCE, V169, P1768, DOI 10.1016/j.neuroscience.2010.06.007; Cianfrone G, 2011, EUR REV MED PHARMACO, V15, P601; Cima RFF, 2012, LANCET, V379, P1951, DOI 10.1016/S0140-6736(12)60469-3; COLES RRA, 1992, CLIN OTOLARYNGOL, V17, P240, DOI 10.1111/j.1365-2273.1992.tb01835.x; Coles RRA, 1984, J LARYNGOLOGY OTO S9, V98, P195; Cotanche DA, 2008, J COMMUN DISORD, V41, P421, DOI 10.1016/j.jcomdis.2008.03.004; DAVIES E, 1994, BRIT J AUDIOL, V28, P125, DOI 10.3109/03005369409086559; Davis A., 2000, TINNITUS HDB, P1; Davis PB, 2008, ENT-EAR NOSE THROAT, V87, P330, DOI 10.1177/014556130808700611; De Ridder D, 2011, TEXTBOOK OF TINNITUS, P327, DOI 10.1007/978-1-60761-145-5_40; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Department of Health, 2009, PROVISION OF SERVICE; Saldanha ADD, 2012, CRANIO, V30, P166, DOI 10.1179/crn.2012.026; Dobie RA, 1999, LARYNGOSCOPE, V109, P1202, DOI 10.1097/00005537-199908000-00004; DONALDSON I, 1981, J LARYNGOL OTOL, V95, P947, DOI 10.1017/S0022215100091659; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2000, HEARING RES, V142, P89, DOI 10.1016/S0378-5955(00)00024-1; Eggermont JJ, 2013, HEARING RES, V295, P140, DOI 10.1016/j.heares.2012.01.005; ENGLESSON S, 1976, ACTA OTO-LARYNGOL, V82, P297, DOI 10.3109/00016487609120910; Figueiredo RR, 2008, OTOLARYNG HEAD NECK, V138, P492, DOI 10.1016/j.otohns.2007.11.027; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Fowler E. P., 1942, LARYNGOSCOPE, V52, P275; Gander PE, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-162; Gatehouse Stuart, 2003, Int J Audiol, V42 Suppl 1, pS77, DOI 10.3109/14992020309074648; Gold S L, 2000, Am J Audiol, V9, P69, DOI 10.1044/1059-0889(2000/014); Hall D. A., 2013, Clinical Investigation, V3, P21, DOI 10.4155/cli.12.129; Hall DA, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-302; Henry JA, 2010, AUST NZ J AUDIOL, V32, P41; Henry JA, 2006, J AM ACAD AUDIOL, V17, P104, DOI 10.3766/jaaa.17.2.4; Hesser H, 2011, CLIN PSYCHOL REV, V31, P545, DOI 10.1016/j.cpr.2010.12.006; Hoare DJ, 2012, JARO-J ASSOC RES OTO, V13, P543, DOI 10.1007/s10162-012-0323-6; Hoare DJ, 2011, EVAL HEALTH PROF, V34, P413, DOI 10.1177/0163278710390355; Hoare DJ, 2011, LARYNGOSCOPE, V121, P1555, DOI 10.1002/lary.21825; Hoare DJ, 2012, J EVAL CLIN PRACT, V18, P326, DOI 10.1111/j.1365-2753.2010.01566.x; Hobson J, 2012, COCHRANE DB SYST REV, V14; House J W, 1981, Ciba Found Symp, V85, P204; Jalali MM, 2009, MED SCI MONITOR, V15, pPI55; James AL, 2001, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001873; JASTREBOFF PJ, 1993, BRIT J AUDIOL, V27, P7, DOI 10.3109/03005369309077884; Jayarajan V, 1993, J AUDIOL MED, V2, P114; JOHNSON RM, 1993, ARCH OTOLARYNGOL, V119, P842; Kay N J, 1981, Br J Audiol, V15, P123, DOI 10.3109/03005368109081425; Khalfa S, 2002, ORL-J OTO-RHIN-LARYN, V64, P436, DOI 10.1159/000067570; Khedr EM, 2010, NEUROEPIDEMIOLOGY, V35, P45, DOI 10.1159/000306630; Kleinjung T, 2011, TEXTBOOK OF TINNITUS, P749, DOI 10.1007/978-1-60761-145-5_93; Kvestad E, 2010, ARCH OTOLARYNGOL, V136, P178, DOI 10.1001/archoto.2009.220; Landgrebe M, 2012, J PSYCHOSOM RES, V73, P112, DOI 10.1016/j.jpsychores.2012.05.002; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; Lasisi AO, 2010, OTOLARYNG HEAD NECK, V143, P510, DOI 10.1016/j.otohns.2010.06.817; Le Prell CG, 2011, NOISE HEALTH, V13, P432, DOI 10.4103/1463-1741.90317; Lenarz T, 1995, AM J AUDIOL, V4, P9; Martinez Devesa P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005233.pub2; McFerran DJ, 2009, CLIN OTOLARYNGOL, V34, P99, DOI 10.1111/j.1749-4486.2009.01910.x; MCKENNA L, 1991, CLIN OTOLARYNGOL, V16, P452, DOI 10.1111/j.1365-2273.1991.tb01038.x; Meikle MB, 2012, EAR HEARING, V33, P153, DOI 10.1097/AUD.0b013e31822f67c0; MEIKLE MB, 1992, TINNITUS, V91, P231; Meng Z, 2011, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD007946.PUB2; Michikawa T, 2010, J EPIDEMIOL, V20, P271, DOI 10.2188/jea.JE20090121; Mora Renzo, 2003, Int Tinnitus J, V9, P109; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Noble William, 2008, Trends Amplif, V12, P236, DOI 10.1177/1084713808320552; Nondahl David M, 2002, J Am Acad Audiol, V13, P323; Nondahl DM, 2011, INT J AUDIOL, V50, P313, DOI 10.3109/14992027.2010.551220; Nondahl DM, 2010, INT J AUDIOL, V49, P580, DOI 10.3109/14992021003753508; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; Phillips JS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007330.pub2; Pulec J L, 1995, Ear Nose Throat J, V74, P470; Punte AK, 2011, TEXTBOOK OF TINNITUS, P619, DOI 10.1007/978-1-60761-145-5_77; Reavis KM, 2012, JARO-J ASSOC RES OTO, V13, P561, DOI 10.1007/s10162-012-0331-6; REED HT, 1985, ARCH OTOLARYNGOL, V111, P803; Rosenberg SI, 1998, LARYNGOSCOPE, V108, P305, DOI 10.1097/00005537-199803000-00001; Salembier L, 2006, ACTA OTO-LARYNGOL, V126, P93, DOI 10.1080/03655230600895242; Seely DR, 1996, LARYNGOSCOPE, V106, P1226, DOI 10.1097/00005537-199610000-00010; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; Sereda M, 2011, INT J AUDIOL, V50, P303, DOI 10.3109/14992027.2010.551221; Shi YB, 2009, OTOLARYNG HEAD NECK, V141, P285, DOI 10.1016/j.otohns.2009.05.020; Simpson JJ, 1999, AM J OTOL, V20, P627; Stouffer JL, 1990, J SPEECH LANG HEAR R, V55, P493; Suckfull M, 2011, BMC EAR NOSE THROAT, V11, DOI 10.1186/1472-6815-11-1; Sweetow RW, 2010, J AM ACAD AUDIOL, V21, P461, DOI 10.3766/jaaa.21.7.5; Tyler RS, 2006, ACTA OTO-LARYNGOL, V126, P44, DOI 10.1080/03655230600895424; Wazen JJ, 1997, ANN OTO RHINOL LARYN, V106, P568; Weinmeister KP, 2000, REGION ANESTH PAIN M, V25, P67, DOI 10.1016/S1098-7339(00)80013-9; Weise C, 2008, J CONSULT CLIN PSYCH, V76, P1046, DOI 10.1037/a0013811; Westerberg BD, 1996, AM J OTOL, V17, P896; Westin VZ, 2011, BEHAV RES THER, V49, P737, DOI 10.1016/j.brat.2011.08.001; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	103	572	600	8	141	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	2013	382	9904					1600	1607		10.1016/S0140-6736(13)60142-7	http://dx.doi.org/10.1016/S0140-6736(13)60142-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247NE	23827090	Green Published			2022-12-28	WOS:000326623900031
J	Bittles, AH				Bittles, Alan H.			Consanguineous marriages and congenital anomalies	LANCET			English	Editorial Material							MUTATIONS; DISEASES		[Bittles, Alan H.] Murdoch Univ, Ctr Comparat Genom, Perth, WA 6150, Australia; [Bittles, Alan H.] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia	Murdoch University; Edith Cowan University	Bittles, AH (corresponding author), Murdoch Univ, Ctr Comparat Genom, Perth, WA 6150, Australia.	abittles@ccg.murdoch.edu.au		Bittles, Alan/0000-0002-8176-2730				Bittles AH, 2010, P NATL ACAD SCI USA, V107, P1779, DOI 10.1073/pnas.0906079106; Bittles A. H., 2012, CONSANGUINITY CONTEX; BUNDEY S, 1990, J EPIDEMIOL COMMUN H, V44, P130, DOI 10.1136/jech.44.2.130; DARR A, 1988, J MED GENET, V25, P186, DOI 10.1136/jmg.25.3.186; Grjibovski AM, 2009, SCAND J PUBLIC HEALT, V37, P232, DOI 10.1177/1403494808100939; Hamamy H, 2011, GENET MED, V13, P841, DOI 10.1097/GIM.0b013e318217477f; Overall ADJ, 2009, POPULATION GENETICS, P85; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Romdhane L, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-52; Shaw Alison, 2009, NEGOTIATING RISK BRI; Sheridan E, 2013, LANCET; Szpiech ZA, 2013, AM J HUM GENET, DOI [10.1016/j/ajhg.2013.05.003, DOI 10.1016/J/AJHG.2013.05.003]; Zlotogora J, 2007, ANN HUM GENET, V71, P202, DOI 10.1111/j.1469-1809.2006.00308.x; Zlotogora J, 2007, EUR J HUM GENET, V15, P272, DOI 10.1038/sj.ejhg.5201760	14	14	14	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1316	1317		10.1016/S0140-6736(13)61503-2	http://dx.doi.org/10.1016/S0140-6736(13)61503-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	23830356				2022-12-28	WOS:000325975700007
J	Peng, T; Tian, Y; Boogerd, CJ; Lu, MM; Kadzik, RS; Stewart, KM; Evans, SM; Morrisey, EE				Peng, Tien; Tian, Ying; Boogerd, Cornelis J.; Lu, Min Min; Kadzik, Rachel S.; Stewart, Kathleen M.; Evans, Sylvia M.; Morrisey, Edward E.			Coordination of heart and lung co-development by a multipotent cardiopulmonary progenitor	NATURE			English	Article							SONIC HEDGEHOG; CELLS; EXPRESSION; DIFFERENTIATION; PROLIFERATION; SUFFICIENT; ENDODERM; LINEAGES; FOREGUT; ISL1	Co-development of the cardiovascular and pulmonary systems is a recent evolutionary adaption to terrestrial life that couples cardiac output with the gas exchange function of the lung(1). Here we show that the murine pulmonary vasculature develops even in the absence of lung development. We have identified a population of multipotent cardiopulmonary mesoderm progenitors (CPPs) within the posterior pole of the heart that are marked by the expression of Wnt2, Gli1 and Isl1. We show that CPPs arise from cardiac progenitors before lung development. Lineage tracing and clonal analysis demonstrates that CPPs generate the mesoderm lineages within the cardiac inflow tract and lung including cardiomyocytes, pulmonary vascular and airway smooth muscle, proximal vascular endothelium, and pericyte-like cells. CPPs are regulated by hedgehog expression from the foregut endoderm, which is required for connection of the pulmonary vasculature to the heart. Together, these studies identify a novel population of multipotent cardiopulmonary progenitors that coordinates heart and lung co-development that is required for adaptation to terrestrial existence.	[Peng, Tien; Tian, Ying; Stewart, Kathleen M.; Morrisey, Edward E.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Peng, Tien] Univ Penn, Div Pulm & Crit Care, Philadelphia, PA 19104 USA; [Tian, Ying; Lu, Min Min; Stewart, Kathleen M.; Morrisey, Edward E.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Boogerd, Cornelis J.; Evans, Sylvia M.] Univ Calif San Diego, Dept Med, Skaggs Sch Pharm, San Diego, CA 92093 USA; [Kadzik, Rachel S.; Morrisey, Edward E.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of California System; University of California San Diego; University of Pennsylvania; Pennsylvania Medicine	Morrisey, EE (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu	Boogerd, Cornelis/A-7470-2016; Evans, Sylvia/G-1980-2015; Boogerd, Cornelis J/D-3244-2009	Boogerd, Cornelis J/0000-0002-7119-5381	National Institutes of Health [HL110942, HL100405, HL087825, HL117649]; American Heart Association Jon DeHaan Myogenesis Center;  [T32 HL07586-23];  [P30 NS047101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP1HL117649, T32HL007843, U01HL100405, U01HL107442, T32HL007586, U01HL110942, R01HL087825, R01HL074066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Jon DeHaan Myogenesis Center(American Heart Association); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors appreciate the input of M. Kahn and J. Epstein in these studies. The authors are grateful to A. Stout for help in imaging. L. Guo provided assistance with figure illustrations. These studies were supported by funds from the National Institutes of Health (HL110942, HL100405, HL087825 to E. E. M. and HL117649 to S. M. E.) and the American Heart Association Jon DeHaan Myogenesis Center. T. P. is supported by T32 HL07586-23. C. J. B. is supported by P30 NS047101.	Bai LY, 2008, LEUKEMIA, V22, P226, DOI 10.1038/sj.leu.2404978; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Goss AM, 2011, DEV BIOL, V356, P541, DOI 10.1016/j.ydbio.2011.06.011; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harris-Johnson KS, 2009, P NATL ACAD SCI USA, V106, P16287, DOI 10.1073/pnas.0902274106; Hoffmann AD, 2009, DEVELOPMENT, V136, P1761, DOI 10.1242/dev.034157; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Lavine KJ, 2008, DEVELOPMENT, V135, P3161, DOI 10.1242/dev.019919; Lepore JJ, 2005, GENESIS, V41, P179, DOI 10.1002/gene.20112; Lin LZ, 2006, DEV BIOL, V295, P756, DOI 10.1016/j.ydbio.2006.03.053; Long FX, 2001, DEVELOPMENT, V128, P5099; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Peng T, 2013, PULM CIRC, V3, P176, DOI 10.4103/2045-8932.109954; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Shu WG, 2002, DEVELOPMENT, V129, P4831; Snippert HJ, 2011, NAT PROTOC, V6, P1221, DOI 10.1038/nprot.2011.365; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Tian Y, 2010, DEV CELL, V18, P275, DOI 10.1016/j.devcel.2010.01.008; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; White AC, 2007, DEVELOPMENT, V134, P3743, DOI 10.1242/dev.004879; Yokomizo T, 2012, NAT PROTOC, V7, P421, DOI 10.1038/nprot.2011.441	25	129	132	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					589	+		10.1038/nature12358	http://dx.doi.org/10.1038/nature12358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23873040	Green Accepted, Green Submitted			2022-12-28	WOS:000323625900037
J	Chen, W; Beck, KM; Bucker, R; Gullans, M; Lukin, MD; Tanji-Suzuki, H; Vuletic, V				Chen, Wenlan; Beck, Kristin M.; Buecker, Robert; Gullans, Michael; Lukin, Mikhail D.; Tanji-Suzuki, Haruka; Vuletic, Vladan			All-Optical Switch and Transistor Gated by One Stored Photon	SCIENCE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; PHASE-SHIFTS; QUANTUM-DOT; CAVITY; ATOM; LIGHT; STORAGE	The realization of an all-optical transistor, in which one "gate" photon controls a "source" light beam, is a long-standing goal in optics. By stopping a light pulse in an atomic ensemble contained inside an optical resonator, we realized a device in which one stored gate photon controls the resonator transmission of subsequently applied source photons. A weak gate pulse induces bimodal transmission distribution, corresponding to zero and one gate photons. One stored gate photon produces fivefold source attenuation and can be retrieved from the atomic ensemble after switching more than one source photon. Without retrieval, one stored gate photon can switch several hundred source photons. With improved storage and retrieval efficiency, our work may enable various new applications, including photonic quantum gates and deterministic multiphoton entanglement.	[Chen, Wenlan; Beck, Kristin M.; Buecker, Robert; Tanji-Suzuki, Haruka; Vuletic, Vladan] MIT, Dept Phys, Cambridge, MA 02139 USA; [Chen, Wenlan; Beck, Kristin M.; Buecker, Robert; Tanji-Suzuki, Haruka; Vuletic, Vladan] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Buecker, Robert] Vienna Univ Technol, Atominst, Vienna Ctr Quantum Sci & Technol, A-1020 Vienna, Austria; [Gullans, Michael; Lukin, Mikhail D.; Tanji-Suzuki, Haruka] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Tanji-Suzuki, Haruka] Univ Tokyo, Sch Engn, Photon Sci Ctr, Bunkyo Ku, Tokyo 1138656, Japan	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Technische Universitat Wien; Harvard University; University of Tokyo	Vuletic, V (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	vuletic@mit.edu	Tanji-Suzuki, Haruka/AAC-7555-2019; Bücker, Robert/A-8174-2013; Vuletic, Vladan/M-8736-2019	Bücker, Robert/0000-0001-7654-4707; Gullans, Michael/0000-0003-3974-2987; Chen, Wenlan/0000-0003-1521-5365; Beck, Kristin/0000-0003-2486-4164	NSF; Air Force Office of Scientific Research; NSF through the Graduate Research Fellowship [0645960]; Fonds zur Forderung der wissenschaftlichen Forschung through the doctoral program CoQuS [W1210]; Division Of Physics [1205554] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [24840016] Funding Source: KAKEN	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF through the Graduate Research Fellowship; Fonds zur Forderung der wissenschaftlichen Forschung through the doctoral program CoQuS; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by NSF and the Air Force Office of Scientific Research. K. M. B. gratefully acknowledges support from NSF through the Graduate Research Fellowship (0645960). R. B. gratefully acknowledges support from the Fonds zur Forderung der wissenschaftlichen Forschung through the doctoral program CoQuS (W1210).	Bajcsy M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.203902; Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; Bose R, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.227402; Brennecke F, 2007, NATURE, V450, P268, DOI 10.1038/nature06120; Brooks DWC, 2012, NATURE, V488, P476, DOI 10.1038/nature11325; Chang DE, 2007, NAT PHYS, V3, P807, DOI 10.1038/nphys708; Colombe Y, 2007, NATURE, V450, P272, DOI 10.1038/nature06331; Dayan B, 2008, SCIENCE, V319, P1062, DOI 10.1126/science.1152261; Dudin YO, 2012, SCIENCE, V336, P887, DOI 10.1126/science.1217901; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; Fushman I, 2008, SCIENCE, V320, P769, DOI 10.1126/science.1154643; Gorshkov AV, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.123601; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Harris SE, 1998, PHYS REV LETT, V81, P3611, DOI 10.1103/PhysRevLett.81.3611; Hwang J, 2009, NATURE, V460, P76, DOI 10.1038/nature08134; Imamoglu A, 1997, PHYS REV LETT, V79, P1467, DOI 10.1103/PhysRevLett.79.1467; Kubanek A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.203602; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; Lo HY, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.041804; Michler P, 2000, SCIENCE, V290, P2282, DOI 10.1126/science.290.5500.2282; Peyronel T, 2012, NATURE, V488, P57, DOI 10.1038/nature11361; Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; Press D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.117402; Schmidt H, 1996, OPT LETT, V21, P1936, DOI 10.1364/OL.21.001936; Tanji-Suzuki H, 2011, ADV ATOM MOL OPT PHY, V60, P201, DOI 10.1016/B978-0-12-385508-4.00004-8; Tanji-Suzuki H, 2011, SCIENCE, V333, P1266, DOI 10.1126/science.1208066; THOMPSON RJ, 1992, PHYS REV LETT, V68, P1132, DOI 10.1103/PhysRevLett.68.1132; TURCHETTE QA, 1995, PHYS REV LETT, V75, P4710, DOI 10.1103/PhysRevLett.75.4710; Volz T, 2012, NAT PHOTONICS, V6, P605, DOI [10.1038/nphoton.2012.181, 10.1038/NPHOTON.2012.181]	30	234	235	4	244	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2013	341	6147					768	770		10.1126/science.1238169	http://dx.doi.org/10.1126/science.1238169			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23828886	Green Submitted			2022-12-28	WOS:000323122200042
J	Kueh, HY; Champhekhar, A; Nutt, SL; Elowitz, MB; Rothenberg, EV				Kueh, Hao Yuan; Champhekhar, Ameya; Nutt, Stephen L.; Elowitz, Michael B.; Rothenberg, Ellen V.			Positive Feedback Between PU.1 and the Cell Cycle Controls Myeloid Differentiation	SCIENCE			English	Article							TRANSCRIPTION FACTOR PU.1; HEMATOPOIETIC STEM-CELLS; GENE-EXPRESSION; LEUKEMIA; PROGENITORS; FATES; MICE; PROLIFERATION; ACTIVATION; MACROPHAGE	Regulatory gene circuits with positive-feedback loops control stem cell differentiation, but several mechanisms can contribute to positive feedback. Here, we dissect feedback mechanisms through which the transcription factor PU.1 controls lymphoid and myeloid differentiation. Quantitative live-cell imaging revealed that developing B cells decrease PU.1 levels by reducing PU.1 transcription, whereas developing macrophages increase PU.1 levels by lengthening their cell cycles, which causes stable PU.1 accumulation. Exogenous PU.1 expression in progenitors increases endogenous PU.1 levels by inducing cell cycle lengthening, implying positive feedback between a regulatory factor and the cell cycle. Mathematical modeling showed that this cell cycle-coupled feedback architecture effectively stabilizes a slow-dividing differentiated state. These results show that cell cycle duration functions as an integral part of a positive autoregulatory circuit to control cell fate.	[Kueh, Hao Yuan; Champhekhar, Ameya; Elowitz, Michael B.; Rothenberg, Ellen V.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Nutt, Stephen L.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA	California Institute of Technology; Royal Melbourne Hospital; Walter & Eliza Hall Institute; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Kueh, HY (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	kueh@caltech.edu; evroth@its.caltech.edu	Nutt, Stephen L/C-9256-2013	Nutt, Stephen L/0000-0002-0020-6637; Rothenberg, Ellen/0000-0002-3901-347X	Cancer Research Institute/Irvington Postdoctoral Fellowship; Australian Research Council Future Fellowship; Victorian State Government Operational Infrastructure Support; National Health and Medical Research Council of Australia Independent Research Institute Infrastructure Scheme; NIH [RC2 CA148278, R33 HL089123, R01 AI083514, R01 CA90233]; Albert Billings Ruddock Professorship; Al Sherman Foundation; Louis A. Garfinkle Memorial Laboratory Fund; NATIONAL CANCER INSTITUTE [R01CA090233, RC2CA148278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083514] Funding Source: NIH RePORTER	Cancer Research Institute/Irvington Postdoctoral Fellowship; Australian Research Council Future Fellowship(Australian Research Council); Victorian State Government Operational Infrastructure Support; National Health and Medical Research Council of Australia Independent Research Institute Infrastructure Scheme(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Billings Ruddock Professorship; Al Sherman Foundation; Louis A. Garfinkle Memorial Laboratory Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Butler and S. Washburn for mouse care and J. Verceles, J. Grimm, and D. Perez of the Caltech Flow Cytometry Facility for cell sorting. We also thank members of the Rothenberg and Elowitz labs and L. Goentoro for insightful discussions. The data presented in this manuscript are tabulated in the main paper and the supplementary materials. This work was supported by a Cancer Research Institute/Irvington Postdoctoral Fellowship to H.Y.K.; an Australian Research Council Future Fellowship and the Victorian State Government Operational Infrastructure Support, National Health and Medical Research Council of Australia Independent Research Institute Infrastructure Scheme to S.L.N.; NIH grants to E. V. R. (RC2 CA148278, R33 HL089123, R01 AI083514, and R01 CA90233); the Albert Billings Ruddock Professorship; the Al Sherman Foundation; and the Louis A. Garfinkle Memorial Laboratory Fund.	Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Back J, 2005, EXP HEMATOL, V33, P395, DOI 10.1016/j.exphem.2004.12.010; Bellon T, 1997, BLOOD, V90, P1828, DOI 10.1182/blood.V90.5.1828; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Choe KS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.077727; Cook WD, 2004, BLOOD, V104, P3437, DOI 10.1182/blood-2004-06-2234; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Delgado MD, 1998, BIOCHEM BIOPH RES CO, V252, P383, DOI 10.1006/bbrc.1998.9587; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; Kihara-Negishi F, 1998, INT J CANCER, V76, P523, DOI 10.1002/(SICI)1097-0215(19980518)76:4<523::AID-IJC14>3.0.CO;2-8; Leddin M, 2011, BLOOD, V117, P2827, DOI 10.1182/blood-2010-08-302976; Metcalf D, 2006, P NATL ACAD SCI USA, V103, P1486, DOI 10.1073/pnas.0510616103; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Singh H, 1999, COLD SPRING HARB SYM, V64, P13, DOI 10.1101/sqb.1999.64.13; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Staber PB, 2013, MOL CELL, V49, P934, DOI 10.1016/j.molcel.2013.01.007; Steinman RA, 2002, ONCOGENE, V21, P3403, DOI 10.1038/sj.onc.1205325; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Trivedi AK, 2007, ONCOGENE, V26, P1789, DOI 10.1038/sj.onc.1209964; Walter MJ, 2005, P NATL ACAD SCI USA, V102, P12513, DOI 10.1073/pnas.0504247102; Zarnegar MA, 2010, MOL CELL BIOL, V30, P4922, DOI 10.1128/MCB.00354-10	33	180	181	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					670	673		10.1126/science.1240831	http://dx.doi.org/10.1126/science.1240831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23868921	Green Accepted			2022-12-28	WOS:000322884800043
J	Banerjee, A; Chandrasekhar, AG; Duflo, E; Jackson, MO				Banerjee, Abhijit; Chandrasekhar, Arun G.; Duflo, Esther; Jackson, Matthew O.			The Diffusion of Microfinance	SCIENCE			English	Article							NETWORKS; TECHNOLOGY	To study the impact of the choice of injection points in the diffusion of a new product in a society, we developed a model of word-of-mouth diffusion and then applied it to data on social networks and participation in a newly available microfinance loan program in 43 Indian villages. Our model allows us to distinguish information passing among neighbors from direct influence of neighbors' participation decisions, as well as information passing by participants versus nonparticipants. The model estimates suggest that participants are seven times as likely to pass information compared to informed nonparticipants, but information passed by nonparticipants still accounts for roughly one-third of eventual participation. An informed household is not more likely to participate if its informed friends participate. We then propose two new measures of how effective a given household would be as an injection point. We show that the centrality of the injection points according to these measures constitutes a strong and significant predictor of eventual village-level participation.	[Banerjee, Abhijit; Duflo, Esther] MIT, Dept Econ, Cambridge, MA 02142 USA; [Chandrasekhar, Arun G.] Microsoft Res New England, Cambridge, MA 02142 USA; [Chandrasekhar, Arun G.; Jackson, Matthew O.] Stanford Univ, Dept Econ, Stanford, CA 94305 USA; [Jackson, Matthew O.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Jackson, Matthew O.] CIFAR, Toronto, ON M5G 1Z8, Canada	Massachusetts Institute of Technology (MIT); Microsoft; Stanford University; The Santa Fe Institute; Canadian Institute for Advanced Research (CIFAR)	Banerjee, A (corresponding author), MIT, Dept Econ, Cambridge, MA 02142 USA.	banerjee@mit.edu; arungc@stanford.edu; eduflo@mit.edu; jacksonm@stanford.edu		Jackson, Matthew O./0000-0001-9846-4249	NSF Graduate Research Fellowship Program; NSF [SES-0647867, SES-0752735, SES-0961481, SES-1156182]; AFOSR; DARPA [FA9550-12-1-0411]; ARO MURI [W911NF-12-1-0509]; Divn Of Social and Economic Sciences [1155302] Funding Source: National Science Foundation	NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); ARO MURI(MURI); Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Supported by the NSF Graduate Research Fellowship Program (A. G. C.), NSF grants SES-0647867, SES-0752735, SES-0961481, and SES-1156182, AFOSR and DARPA grant FA9550-12-1-0411, and ARO MURI award W911NF-12-1-0509. D. Acemoglu and various seminar participants provided helpful comments and suggestions. We also thank B. Feigenberg, R. Lewis, B. Plummer, G. Nagaraj, M. Shaukat, J. Guo, T. Rodriguez-Barraquer, A. Sacarny, and X. Tan. The Centre for Microfinance at the Institute for Financial Management and Research and BSS provided valuable assistance. The data and code used in this paper are archived at the Abdul Latif Jameel Poverty Action Lab Dataverse at the Harvard Institute for Quantitative Social Science, http://hdl.handle.net/1902.1/21538.	Aral S, 2012, NATURE, V489, P212, DOI 10.1038/489212a; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Bailey NTJ, 1975, MATH THEORY INFECT D; Ballester C, 2006, ECONOMETRICA, V74, P1403, DOI 10.1111/j.1468-0262.2006.00709.x; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Coleman J. S., 1966, MED INNOVATION DIFFU; Conley TG, 2010, AM ECON REV, V100, P35, DOI 10.1257/aer.100.1.35; FOSTER AD, 1995, J POLIT ECON, V103, P1176, DOI 10.1086/601447; Jackson M, 2010, HDB SOCIAL EC; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Jovanovic B, 1996, ECONOMETRICA, V64, P1299, DOI 10.2307/2171832; Katz E., 1955, PERSONAL INFLUENCE P; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/NPHYS1746, 10.1038/nphys1746]; Kremer M, 2007, Q J ECON, V122, P1007, DOI 10.1162/qjec.122.3.1007; Lazarsfeld P. F., 1948, PEOPLES CHOICE VOTER, V2nd; MCFADDEN D, 1989, ECONOMETRICA, V57, P995, DOI 10.2307/1913621; Ryan B, 1943, RURAL SOCIOL, V8, P15; Topa G, 2001, REV ECON STUD, V68, P261, DOI 10.1111/1467-937X.00169	21	492	492	15	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144					363	+	1236498	10.1126/science.1236498	http://dx.doi.org/10.1126/science.1236498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	189HX	23888042	Green Submitted			2022-12-28	WOS:000322259200039
J	Kreft, H; Jetz, W				Kreft, Holger; Jetz, Walter			Comment on "An Update of Wallace's Zoogeographic Regions of the World"	SCIENCE			English	Editorial Material									[Kreft, Holger] Univ Gottingen, Biodivers Macroecol & Conservat Biogeog Grp, Fac Forestry & Forest Ecol, D-37077 Gottingen, Germany; [Jetz, Walter] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	University of Gottingen; Yale University	Kreft, H (corresponding author), Univ Gottingen, Biodivers Macroecol & Conservat Biogeog Grp, Fac Forestry & Forest Ecol, Busgenweg 1, D-37077 Gottingen, Germany.	hkreft@uni-goettingen.de	Jetz, Walter/ABF-1517-2020; Kreft, Holger/A-4736-2008; Kreft, Holger/AAY-7573-2020	Kreft, Holger/0000-0003-4471-8236; Kreft, Holger/0000-0003-4471-8236; Jetz, Walter/0000-0002-1971-7277				Cox CB, 2001, J BIOGEOGR, V28, P511; DELANY MJ, 1989, MAMMAL REV, V19, P133, DOI 10.1111/j.1365-2907.1989.tb00408.x; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Muller P., 1986, BIOGEOGRAPHY, V16, P18; Olivero J, 2011, SYST BIOL, V60, P645, DOI 10.1093/sysbio/syr026; Proches S, 2012, BIOSCIENCE, V62, P260, DOI 10.1525/bio.2012.62.3.7; SIMPSON GEORGE GAYLORD, 1950, AMER SCIENTIST, V38, P361; VERMEIJ GJ, 1991, SCIENCE, V253, P1099, DOI 10.1126/science.253.5024.1099; Wallace, 1876, GEOGRAPHICAL DISTRIB	13	53	54	4	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144								10.1126/science.1237471	http://dx.doi.org/10.1126/science.1237471			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888023				2022-12-28	WOS:000322259200022
J	Ward, BB				Ward, Bess B.			How Nitrogen Is Lost	SCIENCE			English	Editorial Material							OXYGEN-MINIMUM-ZONE; ANAEROBIC AMMONIUM OXIDATION; EASTERN SOUTH-PACIFIC; ARABIAN SEA; DENITRIFICATION; CYCLE; ANAMMOX; WATERS; CARBON		Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Princeton University	Ward, BB (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	bbw@princeton.edu						Babbin A. R., 2013, AM SOC LIMN OC AQ SC; Babbin AR, 2013, ENVIRON SCI TECHNOL, V47, P4189, DOI 10.1021/es304842r; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Dalsgaard T, 2012, LIMNOL OCEANOGR, V57, P1331, DOI 10.4319/lo.2012.57.5.1331; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/ngeo1739, 10.1038/NGEO1739]; Koeve W, 2010, BIOGEOSCIENCES, V7, P2327, DOI 10.5194/bg-7-2327-2010; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Nicholls JC, 2007, LIMNOL OCEANOGR, V52, P156, DOI 10.4319/lo.2007.52.1.0156; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; Thamdrup B, 2012, DEEP-SEA RES PT I, V65, P36, DOI 10.1016/j.dsr.2012.03.001; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Ward BB, 2008, DEEP-SEA RES PT I, V55, P1672, DOI 10.1016/j.dsr.2008.07.005	15	78	84	4	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					352	353		10.1126/science.1240314	http://dx.doi.org/10.1126/science.1240314			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888027				2022-12-28	WOS:000322259200033
J	Schwabe, T; Neuert, H; Clandinin, TR				Schwabe, Tina; Neuert, Helen; Clandinin, Thomas R.			A Network of Cadherin-Mediated Interactions Polarizes Growth Cones to Determine Targeting Specificity	CELL			English	Article							DROSOPHILA VISUAL-SYSTEM; STRUCTURED-ILLUMINATION MICROSCOPY; PLANAR CELL POLARITY; N-CADHERIN; CYTOSKELETAL DYNAMICS; FOCAL ADHESION; NERVE GROWTH; LIPRIN-ALPHA; AXON-AXON; FLAMINGO	Neuronal growth cones select synaptic partners through interactions with multiple cell surfaces in their environment. Many of these interactions are adhesive, yet it is unclear how growth cones integrate adhesive cues to direct their movements. Here, we examine the mechanisms that enable photoreceptors in the Drosophila visual system to choose synaptic partners. We demonstrate that the classical cadherin, N-cadherin, and an atypical cadherin, Flamingo, act redundantly to instruct the targeting choices made by every photoreceptor axon. These molecules gradually bias the spatial distribution of growth cone filopodia, polarizing each growth cone toward its future synaptic target before direct contact with the target occurs. We demonstrate that these molecules are localized to distinct subcellular domains and create a network of adhesive interactions distributed across many growth cones. Because this network comprises multiple redundant interactions, a complex wiring diagram can be constructed with extraordinary fidelity, suggesting a general principle.	[Schwabe, Tina; Clandinin, Thomas R.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Neuert, Helen] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	Stanford University; University of Munster	Clandinin, TR (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	trc@stanford.edu	Schwabe, Tina/AAA-3822-2021		postdoctoral fellowship from Walter V. and Idun Berry; Heinrich Hertz-Stiftung; National Eye Institute [R01 EY015231]; NATIONAL EYE INSTITUTE [R01EY015231] Funding Source: NIH RePORTER	postdoctoral fellowship from Walter V. and Idun Berry; Heinrich Hertz-Stiftung; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank P. Garrity, L. Luo, G. Rubin, I. Salecker, G. Struhl, L. Zipursky, the Bloomington and San Diego Stock Centers, as well as the Developmental Studies Hybridoma Bank, BacPac Resources, and the Vienna Drosophila RNAi Center for fly strains, antibodies, and plasmids. We are grateful to D. Clark for help with quantification and statistics, M. Silies for help with fly husbandry, and K. Shen, A. Huberman, and members of the Clandinin lab for helpful comments on the manuscript. This work was supported by a postdoctoral fellowship from Walter V. and Idun Berry (to T.S.), a travel fellowship of the Heinrich Hertz-Stiftung (to H.N.), and funding from the National Eye Institute, R01 EY015231 (to T.R.C.).	Bard L, 2008, J NEUROSCI, V28, P5879, DOI 10.1523/JNEUROSCI.5331-07.2008; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Chen PL, 2008, NEURON, V58, P26, DOI 10.1016/j.neuron.2008.01.007; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Choe KM, 2006, P NATL ACAD SCI USA, V103, P11601, DOI 10.1073/pnas.0601185103; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Hadjieconomou D, 2011, CURR OPIN NEUROBIOL, V21, P76, DOI 10.1016/j.conb.2010.07.012; Hakeda-Suzuki S, 2011, NAT NEUROSCI, V14, P314, DOI 10.1038/nn.2756; Hiesinger PR, 2006, CURR BIOL, V16, P1835, DOI 10.1016/j.cub.2006.07.047; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; HORRIDGE GA, 1970, PROC R SOC SER B-BIO, V175, P69, DOI 10.1098/rspb.1970.0012; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Mason CA, 1997, J NEUROSCI, V17, P1086; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Meinertzhagen Ian A., 1993, P1363; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; Millard SS, 2010, NEURON, V67, P761, DOI 10.1016/j.neuron.2010.08.030; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Myers JP, 2011, J NEUROSCI, V31, P13585, DOI 10.1523/JNEUROSCI.2381-11.2011; Nern A, 2008, NEURON, V58, P34, DOI 10.1016/j.neuron.2008.03.022; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Prakash S, 2009, DEV BIOL, V336, P10, DOI 10.1016/j.ydbio.2009.09.016; RAPER JA, 1983, COLD SPRING HARB SYM, V48, P587, DOI 10.1101/SQB.1983.048.01.063; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Thoumine O, 2006, MOL BIOL CELL, V17, P862, DOI 10.1091/mbc.E05-04-0335; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; Woo S, 2009, J NEUROSCI, V29, P13981, DOI 10.1523/JNEUROSCI.4028-09.2009; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	45	47	47	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 18	2013	154	2					351	364		10.1016/j.cell.2013.06.011	http://dx.doi.org/10.1016/j.cell.2013.06.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870124	Green Accepted, Bronze			2022-12-28	WOS:000321950700012
J	Wang, XM; Abraham, S; McKenzie, JAG; Jeffs, N; Swire, M; Tripathi, VB; Luhmann, UFO; Lange, CAK; Zhai, ZH; Arthur, HM; Bainbridge, JWB; Moss, SE; Greenwood, J				Wang, Xiaomeng; Abraham, Sabu; McKenzie, Jenny A. G.; Jeffs, Natasha; Swire, Matthew; Tripathi, Vineeta B.; Luhmann, Ulrich F. O.; Lange, Clemens A. K.; Zhai, Zhenhua; Arthur, Helen M.; Bainbridge, James W. B.; Moss, Stephen E.; Greenwood, John			LRG1 promotes angiogenesis by modulating endothelial TGF-beta signalling	NATURE			English	Article							OXYGEN-INDUCED RETINOPATHY; RETINAL VEIN OCCLUSION; GROWTH-FACTOR-BETA; CHOROIDAL NEOVASCULARIZATION; PATHOLOGICAL ANGIOGENESIS; VASCULAR DEVELOPMENT; BASEMENT-MEMBRANE; GENE-EXPRESSION; MOUSE; ENDOGLIN	Aberrant neovascularization contributes to diseases such as cancer, blindness and atherosclerosis, and is the consequence of inappropriate angiogenic signalling. Although many regulators of pathogenic angiogenesis have been identified, our understanding of this process is incomplete. Here we explore the transcriptome of retinal microvessels isolated from mouse models of retinal disease that exhibit vascular pathology, and uncover an upregulated gene, leucine-rich alpha-2-glycoprotein 1 (Lrg1), of previously unknown function. We show that in the presence of transforming growth factor-beta 1 (TGF-beta 1), LRG1 is mitogenic to endothelial cells and promotes angiogenesis. Mice lacking Lrg1 develop a mild retinal vascular phenotype but exhibit a significant reduction in pathological ocular angiogenesis. LRG1 binds directly to the TGF-beta accessory receptor endoglin, which, in the presence of TGF-beta 1, results in promotion of the pro-angiogenic Smad1/5/8 signalling pathway. LRG1 antibody blockade inhibits this switch and attenuates angiogenesis. These studies reveal a new regulator of angiogenesis that mediates its effect by modulating TGF-beta signalling.	[Wang, Xiaomeng; Abraham, Sabu; McKenzie, Jenny A. G.; Jeffs, Natasha; Swire, Matthew; Tripathi, Vineeta B.; Moss, Stephen E.; Greenwood, John] UCL Inst Ophthalmol, Dept Cell Biol, London EC1V 9EL, England; [Luhmann, Ulrich F. O.; Lange, Clemens A. K.; Bainbridge, James W. B.] UCL Inst Ophthalmol, Dept Genet, London EC1V 9EL, England; [Lange, Clemens A. K.; Bainbridge, James W. B.] Moorfields Eye Hosp, NIHR Biomed Res Ctr Ophthalmol, London EC1V 2PD, England; [Lange, Clemens A. K.] Univ Eye Hosp Freiburg, D-79106 Freiburg, Germany; [Zhai, Zhenhua; Arthur, Helen M.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Freiburg; Newcastle University - UK	Greenwood, J (corresponding author), UCL Inst Ophthalmol, Dept Cell Biol, London EC1V 9EL, England.	s.moss@ucl.ac.uk; j.greenwood@ucl.ac.uk	Abraham, Sabu/E-1144-2019; Arthur, Helen/C-7808-2009; Zhai, Zhen/GYA-1598-2022; Wang, Xiaomeng/F-9504-2015	Abraham, Sabu/0000-0002-0916-5827; Swire, Matthew/0000-0003-4294-4926; Arthur, Helen/0000-0001-6522-1363; Bainbridge, James/0000-0003-1318-8201; Luhmann, Ulrich F.O./0000-0002-1993-1951; Greenwood, John/0000-0003-4496-2984	Lowy Medical Research Foundation; Medical Research Council; Wellcome Trust; UCL Business (Proof of Concept Grant); Rosetrees Trust; NIHR Research Professorship; British Heart Foundation Senior Fellowship; MRC [G0902206, G1000466] Funding Source: UKRI; British Heart Foundation [RG/12/2/29416] Funding Source: researchfish; Medical Research Council [G0902206, G1000466] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-003] Funding Source: researchfish	Lowy Medical Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); UCL Business (Proof of Concept Grant); Rosetrees Trust(Rosetrees Trust); NIHR Research Professorship; British Heart Foundation Senior Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was supported by grants from the Lowy Medical Research Foundation, the Medical Research Council, The Wellcome Trust, UCL Business (Proof of Concept Grant) and the Rosetrees Trust. J.W.B.B. is supported by a NIHR Research Professorship. H. M. A. is supported by a British Heart Foundation Senior Fellowship. We would also like to thank M. Gillies for his role in initiating the original project, P. Luthert and C. Thaung for human tissue samples and advice on human pathology specimens, S. Perkins and R. Nan for assistance with the surface plasmon resonance analysis, and P. ten Dijke for discussions and advice.	ABBOTT NJ, 1992, J CELL SCI, V103, P23; Anderberg C, 2013, J EXP MED, V210, P563, DOI 10.1084/jem.20120662; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Balaggan KS, 2006, GENE THER, V13, P1153, DOI 10.1038/sj.gt.3302769; BLANKS JC, 1986, J COMP NEUROL, V254, P543, DOI 10.1002/cne.902540407; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; Deckers M, 2001, LAB INVEST, V81, P5, DOI 10.1038/labinvest.3780207; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Gregory AD, 2010, J LEUKOCYTE BIOL, V88, P123, DOI 10.1189/jlb.0709499; Hackett SF, 2002, J CELL PHYSIOL, V192, P182, DOI 10.1002/jcp.10128; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Kumar B, 1998, OPHTHALMOLOGY, V105, P424, DOI 10.1016/S0161-6420(98)93022-6; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Li XF, 2007, NEUROSCI LETT, V413, P141, DOI 10.1016/j.neulet.2006.11.039; Lynch J, 2012, CARCINOGENESIS, V33, P976, DOI 10.1093/carcin/bgs114; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; McKenzie JAG, 2012, AM J PATHOL, V180, P399, DOI 10.1016/j.ajpath.2011.09.035; NICOSIA RF, 1990, LAB INVEST, V63, P115; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Ray BN, 2010, CARCINOGENESIS, V31, P435, DOI 10.1093/carcin/bgp327; Romero IA, 2003, NEUROSCI LETT, V344, P112, DOI 10.1016/S0304-3940(03)00348-3; Saito K, 2002, J IMMUNOL, V168, P1050, DOI 10.4049/jimmunol.168.3.1050; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Spirin KS, 1999, CURR EYE RES, V18, P490, DOI 10.1076/ceyr.18.6.490.5267; SUN DT, 1995, CANCER LETT, V89, P73, DOI 10.1016/0304-3835(95)90160-4; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Toma HS, 2010, MICROVASC RES, V80, P295, DOI 10.1016/j.mvr.2010.05.011; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; ZHAO JL, 1993, OPHTHALMOLOGY, V100, P423	46	287	310	4	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					306	+		10.1038/nature12345	http://dx.doi.org/10.1038/nature12345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23868260	Green Accepted			2022-12-28	WOS:000321910700029
J	Baxter, R; Bartlett, J; Rowhani-Rahbar, A; Fireman, B; Klein, NP				Baxter, Roger; Bartlett, Joan; Rowhani-Rahbar, Ali; Fireman, Bruce; Klein, Nicola P.			Effectiveness of pertussis vaccines for adolescents and adults: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BORDETELLA-PERTUSSIS; IMMUNIZATION; EPIDEMIOLOGY; DIPHTHERIA; IMMUNITY; TETANUS; RECORDS	Objective To assess the effectiveness of reduced acellular pertussis (Tdap) vaccines in adolescents and adults. Setting Kaiser Permanente Northern California. Design Case-control study. Participants All polymerase chain reaction (PCR) confirmed cases of pertussis in members aged 11 years and older from January 2006 to December 2011. We compared the Tdap vaccination status of PCR positive cases with two control groups: people testing negative for pertussis by PCR and closely matched people from the general Kaiser Permanente Northern California population. Main outcome measure PCR confirmed pertussis. The association of Tdap vaccination with the odds of pertussis infection was estimated by conditional logistic regression, with adjustment for calendar time, pertussis vaccine type received in early childhood, age, sex, race or ethnic group, and medical clinic. We calculated Tdap vaccine effectiveness as 1 minus the adjusted odds ratio. Results The study population included 668 PCR positive cases, 10 098 PCR negative controls, and 21 599 Kaiser Permanente Northern California matched controls. Tdap vaccination rates were 24.0% in PCR positive cases and 31.9% in PCR negative controls (P < 0.001). The adjusted estimate of effectiveness of Tdap vaccination against pertussis was 53.0% (95% confidence interval 41.9% to 62.0%) in the comparison with PCR controls, and 64.0% (55.5% to 70.9%) in the comparison with Kaiser Permanente Northern California controls. Conclusion Tdap vaccination was moderately effective at preventing PCR confirmed pertussis among adolescents and adults.	[Baxter, Roger; Bartlett, Joan; Rowhani-Rahbar, Ali; Fireman, Bruce; Klein, Nicola P.] Kaiser Permanente Vaccine Study Ctr, Oakland, CA 94612 USA	Kaiser Permanente	Baxter, R (corresponding author), Kaiser Permanente Vaccine Study Ctr, 1 Kaiser Plaza, Oakland, CA 94612 USA.	roger.baxter@kp.org		Rowhani-Rahbar, Ali/0000-0002-2705-4485	Kaiser Permanente	Kaiser Permanente	This study was funded by Kaiser Permanente. There was no support from any other organizations for this work.	Administration. FFaD, 2005, PROP NAM TET TOX RED; Administration. FFaD, 2005, TET TOX RED DIPHTH T; Anonymous, 2012, Morbidity and Mortality Weekly Report, V61, P468; [Anonymous], 2010, HUM VACCINES, V6, P684; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Centers for Disease Control and Prevention (CDC) HIPAA Privacy Rule and Public Health, 2003, MMWR-MORBID MORTAL W, V52, P1; Cherry JD, 2006, PEDIATR INFECT DIS J, V25, P361, DOI 10.1097/01.inf.0000210478.60841.69; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Elliott MN, 2008, HEALTH SERV RES, V43, P1722, DOI 10.1111/j.1475-6773.2008.00854.x; Gordon NP, 2012, SIMILARITY ADULT KAI; Klein NP, 2013, PEDIATRICS, V131, pE1716, DOI 10.1542/peds.2012-3836; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; Kretsinger Katrina, 2006, Morbidity and Mortality Weekly Report, V55, P1; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Lavine J, 2010, VACCINE, V29, P11, DOI 10.1016/j.vaccine.2010.10.029; Misegades LK, 2012, JAMA-J AM MED ASSOC, V308, P2126, DOI 10.1001/jama.2012.14939; Nennig ME, 1996, JAMA-J AM MED ASSOC, V275, P1672, DOI 10.1001/jama.275.21.1672; Olin P, 2001, CLIN INFECT DIS, V33, pS288, DOI 10.1086/322564; Olin P, 1997, LANCET, V350, P1569, DOI 10.1016/S0140-6736(97)06508-2; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Plotkin SA, 2013, VACCINES; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Rank C, 2009, PEDIATR INFECT DIS J, V28, P152, DOI 10.1097/INF.0b013e318185608e; Roehr B, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4627; Selby JVSD, 2005, KAISER PERMANENTE ME; Sheridan SL, 2012, CLIN INFECT DIS, V55, P1434, DOI 10.1093/cid/cis672; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Wei SC, 2010, CLIN INFECT DIS, V51, P315, DOI 10.1086/653938; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287	32	62	63	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2013	347								f4249	10.1136/bmj.f4249	http://dx.doi.org/10.1136/bmj.f4249			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	189DG	23873919	hybrid			2022-12-28	WOS:000322246700007
J	Bach, RG				Bach, Richard G.			PCI was not as effective as CABG for severe coronary artery disease at 5 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BYPASS SURGERY		Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Bach, RG (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.		Bach, Richard G/G-9764-2011; Bach, Richard/AAI-2515-2021					Alderman EL, 1996, NEW ENGL J MED, V335, P217; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Kappetein AP, 2011, EUR HEART J, V32, P2125, DOI 10.1093/eurheartj/ehr213; Nam CW, 2011, J AM COLL CARDIOL, V58, P1211, DOI 10.1016/j.jacc.2011.06.020; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611	5	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2							JC4	10.7326/0003-4819-159-2-201307160-02004	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-02004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23856702				2022-12-28	WOS:000322112000003
J	Ejima, H; Richardson, JJ; Liang, K; Best, JP; van Koeverden, MP; Such, GK; Cui, JW; Caruso, F				Ejima, Hirotaka; Richardson, Joseph J.; Liang, Kang; Best, James P.; van Koeverden, Martin P.; Such, Georgina K.; Cui, Jiwei; Caruso, Frank			One-Step Assembly of Coordination Complexes for Versatile Film and Particle Engineering	SCIENCE			English	Article							METAL-ORGANIC FRAMEWORK; TANNIC-ACID; MICROCAPSULES; MULTILAYERS; COATINGS; NETWORKS; GOLD	The development of facile and versatile strategies for thin-film and particle engineering is of immense scientific interest. However, few methods can conformally coat substrates of different composition, size, shape, and structure. We report the one-step coating of various interfaces using coordination complexes of natural polyphenols and Fe(III) ions. Film formation is initiated by the adsorption of the polyphenol and directed by pH-dependent, multivalent coordination bonding. Aqueous deposition is performed on a range of planar as well as inorganic, organic, and biological particle templates, demonstrating an extremely rapid technique for producing structurally diverse, thin films and capsules that can disassemble. The ease, low cost, and scalability of the assembly process, combined with pH responsiveness and negligible cytotoxicity, makes these films potential candidates for biomedical and environmental applications.	[Ejima, Hirotaka; Richardson, Joseph J.; Liang, Kang; Best, James P.; van Koeverden, Martin P.; Such, Georgina K.; Cui, Jiwei; Caruso, Frank] Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3010, Australia	University of Melbourne	Caruso, F (corresponding author), Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3010, Australia.	fcaruso@unimelb.edu.au	Liang, Kang/D-5684-2013; Ejima, Hirotaka/E-8730-2012; Cui, Jiwei/E-9876-2012; Caruso, Frank/A-9587-2011; Such, Georgina K/B-1157-2011; Liang, Kang/AAC-4533-2019	Ejima, Hirotaka/0000-0002-4965-9493; Cui, Jiwei/0000-0003-1018-4336; Caruso, Frank/0000-0002-0197-497X; Such, Georgina K/0000-0002-2868-5799; Liang, Kang/0000-0003-3985-7688; Best, James/0000-0003-4728-2052; van Koeverden, Martin/0000-0002-7339-5168	Australian Research Council [FF0776078, FL120100030, DP0877360, FT120100564, FS110200025]; Japan Society for the Promotion of Science (JSPS)	Australian Research Council(Australian Research Council); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Supported by the Australian Research Council under Federation Fellowship FF0776078 (F. C.), Australian Laureate Fellowship FL120100030 (F. C.), Discovery Project DP0877360 (F. C.), Future Fellowship FT120100564 (G. K. S.), and Super Science Fellowship FS110200025 (J.C. and F. C.) schemes. H. E. thanks the Japan Society for the Promotion of Science (JSPS) for a postdoctoral fellowship for research abroad. The data presented in this paper are given in the main text and in the supplementary materials. We thank X. Duan (Surface and Chemical Analysis Network, the University of Melbourne) for assistance with XPS analysis. The University of Melbourne has filed a provisional patent on the assembly process.	Betard A, 2012, CHEM REV, V112, P1055, DOI 10.1021/cr200167v; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Hanke M, 2012, LANGMUIR, V28, P6877, DOI 10.1021/la300457z; Hatzor A, 1998, J AM CHEM SOC, V120, P13469, DOI 10.1021/ja9828307; Holten-Andersen N, 2011, P NATL ACAD SCI USA, V108, P2651, DOI 10.1073/pnas.1015862108; Kaminker R, 2010, J AM CHEM SOC, V132, P14554, DOI 10.1021/ja105518n; Kozlovskaya V, 2010, SOFT MATTER, V6, P3596, DOI 10.1039/b927369g; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Makiura R, 2010, NAT MATER, V9, P565, DOI [10.1038/NMAT2769, 10.1038/nmat2769]; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Motiei L, 2011, LANGMUIR, V27, P1319, DOI 10.1021/la103936t; ROSS TK, 1978, CORROS SCI, V18, P351, DOI 10.1016/S0010-938X(78)80049-3; Rouchon V, 2011, ANAL CHEM, V83, P2589, DOI 10.1021/ac1029242; Ryu DY, 2005, SCIENCE, V308, P236, DOI 10.1126/science.1106604; Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020; Shutava T, 2005, MACROMOLECULES, V38, P2850, DOI 10.1021/ma047629x; Sungur S, 2008, SPECTROCHIM ACTA A, V69, P225, DOI 10.1016/j.saa.2007.03.038; TANIZAWA Y, 1990, J CHEM SOC FARADAY T, V86, P1071, DOI 10.1039/ft9908601071; Tong WJ, 2012, CHEM SOC REV, V41, P6103, DOI 10.1039/c2cs35088b; Vinogradova OI, 2006, ANNU REV MATER RES, V36, P143, DOI 10.1146/annurev.matsci.36.011205.123733; Wanunu M, 2005, J AM CHEM SOC, V127, P17877, DOI 10.1021/ja0556676; Xu H, 2012, ACS MACRO LETT, V1, P457, DOI 10.1021/mz200217d; Yan Y, 2010, COORDIN CHEM REV, V254, P1072, DOI 10.1016/j.ccr.2009.12.024; Ye Q, 2011, CHEM SOC REV, V40, P4244, DOI 10.1039/c1cs15026j	25	1282	1323	169	2338	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					154	157		10.1126/science.1237265	http://dx.doi.org/10.1126/science.1237265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23846899	Green Submitted			2022-12-28	WOS:000321965300037
J	Wolfe, SM				Wolfe, Sidney M.			US study criticized for experimentation with premature infants	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Swolfe@citizen.org						[Anonymous], COMMUNICATION; Carlo WA, N ENGL J MED; DRAZEN J, N ENGL J MED; MODI N, 1993, BRIT MED J, V307, P1495, DOI 10.1136/bmj.307.6917.1495-b; Modi N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3786; NICHD Neonatal Research Network, 2004, SURF POS AIRW PRESS	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2013	347								f4198	10.1136/bmj.f4198	http://dx.doi.org/10.1136/bmj.f4198			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184LT	23838555				2022-12-28	WOS:000321892000004
J	Molina, DM; Jafari, R; Ignatushchenko, M; Seki, T; Larsson, EA; Dan, C; Sreekumar, L; Cao, YH; Nordlund, P				Molina, Daniel Martinez; Jafari, Rozbeh; Ignatushchenko, Marina; Seki, Takahiro; Larsson, E. Andreas; Dan, Chen; Sreekumar, Lekshmy; Cao, Yihai; Nordlund, Par			Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay	SCIENCE			English	Article							KINASE INHIBITORS; PROTEIN STABILITY; PHASE-I; CANCER; RESISTANCE; PARP; PHARMACOKINETICS; SUPPRESSION; MECHANISMS; DISCOVERY	The efficacy of therapeutics is dependent on a drug binding to its cognate target. Optimization of target engagement by drugs in cells is often challenging, because drug binding cannot be monitored inside cells. We have developed a method for evaluating drug binding to target proteins in cells and tissue samples. This cellular thermal shift assay (CETSA) is based on the biophysical principle of ligand-induced thermal stabilization of target proteins. Using this assay, we validated drug binding for a set of important clinical targets and monitored processes of drug transport and activation, off-target effects and drug resistance in cancer cell lines, as well as drug distribution in tissues. CETSA is likely to become a valuable tool for the validation and optimization of drug target engagement.	[Molina, Daniel Martinez; Jafari, Rozbeh; Ignatushchenko, Marina; Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Seki, Takahiro; Cao, Yihai] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Larsson, E. Andreas; Dan, Chen; Sreekumar, Lekshmy; Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Cao, Yihai] Linkoping Univ, Dept Med & Hlth Sci, S-58183 Linkoping, Sweden	Karolinska Institutet; Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Linkoping University	Nordlund, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Scheeles Vag 2, SE-17177 Stockholm, Sweden.	par.nordlund@ki.se		Larsson, Andreas/0000-0002-8706-3789; Seki, Takahiro/0000-0001-8910-4612; Jafari, Rozbeh/0000-0002-3396-4709; Chen, Dan/0000-0002-2790-5606	KI (Distinguished Professor Award); Swedish Research Council (Vetenskapsradet); Swedish Cancer Society (Cancerfonden); Strategic Centre grant from Nanyang Technological University (Singapore); Karolinska Institute Foundation; Torsten Soderbergs Foundation; European Research Council [250021]	KI (Distinguished Professor Award); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Strategic Centre grant from Nanyang Technological University (Singapore)(Nanyang Technological University); Karolinska Institute Foundation(Karolinska Institutet); Torsten Soderbergs Foundation; European Research Council(European Research Council (ERC)European Commission)	We thank K. Johansson [Karolinska Institute (KI), Department of Medical Biochemistry and Biophysics (MBB)] for assistance with cell culturing, H. Schuler KI/MBB for PARP-1 constructs, and T. Lundback KI/Chemical Biology Consortium Sweden for valuable discussions. This work was supported by grants from the KI (Distinguished Professor Award), the Swedish Research Council (Vetenskapsradet), and the Swedish Cancer Society (Cancerfonden) to P.N. and Y.C., as well as a Strategic Centre grant from Nanyang Technological University (Singapore) to P. N. and grants from the Karolinska Institute Foundation, the Torsten Soderbergs Foundation, and the European Research Council advanced grant ANGIOFAT (project no. 250021) to Y.H. P. N. is the inventor on a pending patent application covering aspects of the CETSA method, to be assigned to Pelago Bioscience AB. P. N. and D. M. M. are cofounders of Pelago Bioscience AB, which will develop CETSA for commercial applications.	Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Barouch-Bentov R, 2011, EXPERT OPIN INV DRUG, V20, P153, DOI 10.1517/13543784.2011.546344; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Cicenas J, 2011, J CANCER RES CLIN, V137, P1409, DOI 10.1007/s00432-011-1039-4; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dean E, 2012, BRIT J CANCER, V106, P468, DOI 10.1038/bjc.2011.555; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gillet JP, 2010, METHODS MOL BIOL, V596, P47, DOI 10.1007/978-1-60761-416-6_4; Guha M, 2011, NAT BIOTECHNOL, V29, P373, DOI 10.1038/nbt0511-373; Hagner Nicole, 2010, Cancer Manag Res, V2, P293, DOI 10.2147/CMR.S10043; Huang M, 2003, J PHARMACOL EXP THER, V304, P753, DOI 10.1124/jpet.102.044214; Hussmann GP, 2012, J PHARMACOL EXP THER, V343, P434, DOI 10.1124/jpet.112.198069; Kaitin KI, 2010, CLIN PHARMACOL THER, V87, P356, DOI 10.1038/clpt.2009.293; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P409, DOI 10.1023/A:1015277805345; Lee JT, 2010, PIGM CELL MELANOMA R, V23, P820, DOI 10.1111/j.1755-148X.2010.00763.x; Liu XS, 2012, CLIN CANCER RES, V18, P510, DOI 10.1158/1078-0432.CCR-11-1973; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marsh S, 2005, INVEST NEW DRUG, V23, P533, DOI 10.1007/s10637-005-4021-7; Matthews PM, 2012, BRIT J CLIN PHARMACO, V73, P175, DOI 10.1111/j.1365-2125.2011.04085.x; Moore JD, 2000, CANCER CHEMOTH PHARM, V46, P173, DOI 10.1007/s002800000149; Orloff J, 2009, NAT REV DRUG DISCOV, V8, P949, DOI 10.1038/nrd3025; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Ruiz-Garcia A, 2008, J PHARM SCI-US, V97, P654, DOI 10.1002/jps.21009; Schmidt C, 2010, NAT BIOTECHNOL, V28, P185, DOI 10.1038/nbt0310-185; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Visentin M, 2012, HEMATOL ONCOL CLIN N, V26, P629, DOI 10.1016/j.hoc.2012.02.002; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; West GM, 2008, ANAL CHEM, V80, P4175, DOI 10.1021/ac702610a; Yap TA, 2010, NAT REV CANCER, V10, P514, DOI 10.1038/nrc2870; Yin SQ, 2012, CURR MED CHEM, V19, P1021, DOI 10.2174/092986712799320709	36	991	1016	43	393	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					84	87		10.1126/science.1233606	http://dx.doi.org/10.1126/science.1233606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828940				2022-12-28	WOS:000321291700054
J	Suthanthiran, M; Schwartz, JE; Ding, RC; Abecassis, M; Dadhania, D; Samstein, B; Knechtle, SJ; Friedewald, J; Becker, YT; Sharma, VK; Williams, NM; Chang, CS; Hoang, C; Muthukumar, T; August, P; Keslar, KS; Fairchild, RL; Hricik, DE; Heeger, PS; Han, LY; Liu, J; Riggs, M; Ikle, DN; Bridges, ND; Shaked, A				Suthanthiran, Manikkam; Schwartz, Joseph E.; Ding, Ruchuang; Abecassis, Michael; Dadhania, Darshana; Samstein, Benjamin; Knechtle, Stuart J.; Friedewald, John; Becker, Yolanda T.; Sharma, Vijay K.; Williams, Nikki M.; Chang, Christina S.; Hoang, Christine; Muthukumar, Thangamani; August, Phyllis; Keslar, Karen S.; Fairchild, Robert L.; Hricik, Donald E.; Heeger, Peter S.; Han, Leiya; Liu, Jun; Riggs, Michael; Ikle, David N.; Bridges, Nancy D.; Shaked, Abraham		CTOT-04 Study Investigators	Urinary-Cell mRNA Profile and Acute Cellular Rejection in Kidney Allografts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-ALLOGRAFT; PREDICTION; MODELS; TRANSPLANTATION; CLASSIFICATION; CURVE	BACKGROUND The standard test for the diagnosis of acute rejection in kidney transplants is the renal biopsy. Noninvasive tests would be preferable. METHODS We prospectively collected 4300 urine specimens from 485 kidney-graft recipients from day 3 through month 12 after transplantation. Messenger RNA (mRNA) levels were measured in urinary cells and correlated with allograft-rejection status with the use of logistic regression. RESULTS A three-gene signature of 18S ribosomal (rRNA)-normalized measures of CD3 epsilon mRNA and interferon-inducible protein 10 (IP-10) mRNA, and 18S rRNA discriminated between biopsy specimens showing acute cellular rejection and those not showing rejection (area under the curve [AUC], 0.85; 95% confidence interval [CI], 0.78 to 0.91; P<0.001 by receiver-operating-characteristic curve analysis). The cross-validation estimate of the AUC was 0.83 by bootstrap resampling, and the Hosmer-Lemeshow test indicated good fit (P = 0.77). In an external-validation data set, the AUC was 0.74 (95% CI, 0.61 to 0.86; P<0.001) and did not differ significantly from the AUC in our primary data set (P = 0.13). The signature distinguished acute cellular rejection from acute antibody-mediated rejection and borderline rejection (AUC, 0.78; 95% CI, 0.68 to 0.89; P<0.001). It also distinguished patients who received anti-interleukin-2 receptor antibodies from those who received T-cell-depleting antibodies (P<0.001) and was diagnostic of acute cellular rejection in both groups. Urinary tract infection did not affect the signature (P = 0.69). The average trajectory of the signature in repeated urine samples remained below the diagnostic threshold for acute cellular rejection in the group of patients with no rejection, but in the group with rejection, there was a sharp rise during the weeks before the biopsy showing rejection (P<0.001). CONCLUSIONS A molecular signature of CD3 epsilon mRNA, IP-10 mRNA, and 18S rRNA levels in urinary cells appears to be diagnostic and prognostic of acute cellular rejection in kidney allografts.	[Suthanthiran, Manikkam; Ding, Ruchuang; Dadhania, Darshana; Sharma, Vijay K.; Chang, Christina S.; Hoang, Christine; Muthukumar, Thangamani; August, Phyllis] Weill Cornell Med Coll, New York, NY USA; [Samstein, Benjamin] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Heeger, Peter S.] Mt Sinai Sch Med, New York, NY USA; [Schwartz, Joseph E.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Abecassis, Michael; Friedewald, John] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Becker, Yolanda T.] Univ Chicago, Chicago, IL 60637 USA; [Knechtle, Stuart J.] Emory Univ, Atlanta, GA 30322 USA; [Williams, Nikki M.; Bridges, Nancy D.] NIAID, Bethesda, MD 20892 USA; [Keslar, Karen S.; Fairchild, Robert L.] Cleveland Clin, Cleveland, OH USA; [Hricik, Donald E.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Han, Leiya; Liu, Jun] Pharmaceut Prod Dev, Wilmington, NC USA; [Riggs, Michael; Ikle, David N.] Rho Fed Syst, Chapel Hill, NC USA; [Shaked, Abraham] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Cornell University; Columbia University; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Northwestern University; Feinberg School of Medicine; University of Chicago; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University Hospital; University of Pennsylvania	Suthanthiran, M (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Med & Transplantat Med, Div Nephrol & Hypertens, Hamad bin Khalifa Med Res Bldg,525 E 68th St,Box, New York, NY 10065 USA.	msuthan@med.cornell.edu	Ikle, David/AAK-7541-2020; Dadhania, Darshana/L-4651-2019; Samstein, Benjamin/AAJ-5846-2020; Suthanthiran, Manikkam/AAL-9104-2020	Ikle, David/0000-0003-0091-5246; Samstein, Benjamin/0000-0002-3934-2564; Schwartz, Joseph/0000-0002-8944-3566; Friedewald, John/0000-0002-9344-9928; Knechtle, Stuart/0000-0002-1625-385X	National Institutes of Health [UO1AI63589, R37AI051652]; Qatar National Research Foundation [NPRP 08-503-3-111]; Clinical and Translational Science Center Award [UL1TR000457]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051652, U01AI063589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatar National Research Foundation(National Research Foundation of Korea); Clinical and Translational Science Center Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health and others.; Supported in part by grants from the National Institutes of Health (UO1AI63589 and R37AI051652) and the Qatar National Research Foundation (NPRP 08-503-3-111) and by a Clinical and Translational Science Center Award (UL1TR000457, to Weill Cornell Medical College).	ALMOND PS, 1993, TRANSPLANTATION, V55, P752, DOI 10.1097/00007890-199304000-00013; Anglicheau D, 2008, TRANSPLANTATION, V86, P192, DOI 10.1097/TP.0b013e31817eef7b; Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Furness PN, 2001, KIDNEY INT, V60, P1998, DOI 10.1046/j.1523-1755.2001.00030.x; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Langone AJ, 2005, SEMIN DIALYSIS, V18, P185, DOI 10.1111/j.1525-139X.2005.18305.x; Le CT, 2006, STAT METHODS MED RES, V15, P571, DOI 10.1177/0962280206070637; LODISH HF, 1976, ANNU REV BIOCHEM, V45, P39, DOI 10.1146/annurev.bi.45.070176.000351; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Schenk AD, 2008, CLIN LAB MED, V28, P441, DOI 10.1016/j.cll.2008.07.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; STROM TB, 1975, NEW ENGL J MED, V292, P1257, DOI 10.1056/NEJM197506122922402; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; Tripepi G, 2010, NEPHROL DIAL TRANSPL, V25, P1402, DOI 10.1093/ndt/gfq046; Williams WW, 2012, NAT REV NEPHROL, V8, P110, DOI 10.1038/nrneph.2011.213	18	233	244	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					20	31		10.1056/NEJMoa1215555	http://dx.doi.org/10.1056/NEJMoa1215555			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175WE	23822777	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000321263500007
J	Smith, JM				Smith, Jeanette M.			Untitled	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					16	17		10.1001/jama.2013.5185	http://dx.doi.org/10.1001/jama.2013.5185			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175SK	23821069				2022-12-28	WOS:000321253000001
J	Chakravarthy, U; Harding, SP; Rogers, CA; Downes, SM; Lotery, AJ; Culliford, LA; Reeves, BC				Chakravarthy, Usha; Harding, Simon P.; Rogers, Chris A.; Downes, Susan M.; Lotery, Andrew J.; Culliford, Lucy A.; Reeves, Barnaby C.		IVAN Study Investigators	Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial	LANCET			English	Article							INTRAVITREAL BEVACIZUMAB AVASTIN; GROWTH-FACTOR INHIBITORS; MACULAR DEGENERATION; MYOCARDIAL-INFARCTION; ADVERSE EVENTS; RANIBIZUMAB; SAFETY; THERAPIES; EFFICACY; DESIGN	Background Bevacizumab has been suggested to have similar effectiveness to ranibizumab for treatment of neovascular age-related macular degeneration. The Inhibition of VEGF in Age-related choroidal Neovascularisation (IVAN) trial was designed to compare these drugs and different regimens. Here, we report the findings at the prespecified 2-year timepoint. Methods In a multicentre, 2x2 factorial, non-inferiority randomised trial, we enrolled adults aged at least 50 years with active, previously untreated neovascular age-related macular degeneration and a best corrected distance visual acuity (BCVA) of at least 25 letters from 23 hospitals in the UK. Participants were randomly assigned (1: 1: 1: 1) to intravitreal injections of ranibizumab (0.5 mg) or bevacizumab (1.25 mg) in continuous (every month) or discontinuous (as needed) regimens, with monthly review. Study participants and clinical assessors were masked to drug allocation. Allocation to continuous or discontinuous treatment was masked up to 3 months, at which point investigators and participants were unmasked. The primary outcome was BCVA at 2 years, with a prespecified noninferiority limit of 3.5 letters. The primary safety outcome was arterial thrombotic event or hospital admission for heart failure. Analyses were by modified intention to treat. This trial is registered, number ISRCTN92166560. Findings Between March 27, 2008, and Oct 15, 2010, 628 patients underwent randomisation. 18 were withdrawn; 610 received study drugs (314 ranibizumab; 296 bevacizumab) and were included in analyses. 525 participants reached the visit at 2 years: 134 ranibizumab in continuous regimen, 137 ranibizumab in discontinuous regimen, 127 bevacizumab in continuous regimen, and 127 bevacizumab in discontinuous regimen. For BCVA, bevacizumab was neither non-inferior nor inferior to ranibizumab (mean difference -1.37 letters, 95% CI -3.75 to 1.01; p=0.26). Discontinuous treatment was neither non-inferior nor inferior to continuous treatment (-1.63 letters, -4.01 to 0.75; p=0.18). Frequency of arterial thrombotic events or hospital admission for heart failure did not diff er between groups given ranibizumab (20 [6%] of 314 participants) and bevacizumab (12 [4%] of 296; odds ratio [OR] 1.69, 95% CI 0.80-3.57; p=0.16), or those given continuous (12 [4%] of 308) and discontinuous treatment (20 [7%] of 302; 0.56, 0.27-1.19; p=0.13). Mortality was lower with continuous than discontinuous treatment (OR 0.47, 95% CI 0.22-1.03; p=0.05), but did not diff er by drug group (0.96, 0.46-2.02; p=0.91). Interpretation Ranibizumab and bevacizumab have similar efficacy. Reduction in the frequency of retreatment resulted in a small loss of efficacy irrespective of drug. Safety was worse when treatment was administered discontinuously. These findings highlight that the choice of anti-VEGF treatment strategy is less straightforward than previously thought.	[Chakravarthy, Usha] Queens Univ Belfast, Inst Clin Sci, Belfast BT12 6BA, Antrim, North Ireland; [Harding, Simon P.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, Liverpool L69 3BX, Merseyside, England; [Rogers, Chris A.; Culliford, Lucy A.; Reeves, Barnaby C.] Univ Bristol, Sch Clin Sci, Clin Trials & Evaluat Unit, Bristol, Avon, England; [Downes, Susan M.] Oxford Univ Hosp NHS Trust, Oxford, England; [Lotery, Andrew J.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England	Queens University Belfast; University of Liverpool; University of Bristol; Oxford University Hospitals NHS Foundation Trust; University of Southampton	Chakravarthy, U (corresponding author), Queens Univ Belfast, Inst Clin Sci, RVH Site, Belfast BT12 6BA, Antrim, North Ireland.	u.chakravarthy@qub.ac.uk	; Aslam, Tariq/A-8532-2016	Lotery, Andrew/0000-0001-5541-4305; Harding, Simon/0000-0003-4676-1158; Maishman, Rachel/0000-0002-5052-5951; Aslam, Tariq/0000-0002-9739-7280; Chakravarthy, Usha/0000-0002-2606-3734; Foss, Alexander/0000-0001-9649-0072; Wordsworth, Sarah/0000-0002-2361-3040; Dakin, Helen/0000-0003-3255-748X; Reeves, Barnaby/0000-0002-5101-9487	UK National Institute for Health Research Health Technology Assessment programme; National Institute for Health Research [NF-SI-0507-10094, 07/36/01] Funding Source: researchfish	UK National Institute for Health Research Health Technology Assessment programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	UK National Institute for Health Research Health Technology Assessment programme.	Alsheikh-Ali AA, 2008, AM J CARDIOL, V101, p9B, DOI 10.1016/j.amjcard.2008.02.027; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Arevalo JF, 2008, RETINA-J RET VIT DIS, V28, P1387, DOI 10.1097/IAE.0b013e3181884ff4; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Biswas P, 2011, INDIAN J OPHTHALMOL, V59, P191, DOI 10.4103/0301-4738.81023; Brown, 2006, APPL MIXED MODELS ME; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Campbell RJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4203; Chakravarthy U, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.04.015; Curtis LH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI 10.1001/archophthalmol.2010.223; Dugel PU, 2013, OPHTHALMOLOGY, V120, P317, DOI 10.1016/j.ophtha.2012.07.068; European Medicines Agency, 2012, EYL AFL; Fadda V, 2011, BRIT J OPHTHALMOL, V95, P1476, DOI 10.1136/bjophthalmol-2011-300316; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Green S, 2011, COCHRANE HDB SYSTEMA, P914; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Kemp A, 2013, RETINA-J RET VIT DIS, V33, P920, DOI 10.1097/IAE.0b013e318276e07b; Krebs I, 2013, BRIT J OPHTHALMOL, V97, P266, DOI 10.1136/bjophthalmol-2012-302391; Lynch SS, 2007, ANN PHARMACOTHER, V41, P614, DOI 10.1345/aph.1H316; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; McClure ME, 2000, BRIT J OPHTHALMOL, V84, P244, DOI 10.1136/bjo.84.3.244; Mitchell J, 2008, AM J OPHTHALMOL, V146, P447, DOI 10.1016/j.ajo.2008.04.031; Mitchell P, 2011, CURR MED RES OPIN, V27, P1465, DOI 10.1185/03007995.2011.585394; PELLI DG, 1988, CLIN VISION SCI, V2, P187; Rich RM, 2006, RETINA-J RET VIT DIS, V26, P495, DOI 10.1097/01.iae.0000225766.75009.3a; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P275, DOI 10.1097/00006982-200603000-00004; Subramanian ML, 2009, AM J OPHTHALMOL, V148, P875, DOI 10.1016/j.ajo.2009.07.009; Tufail A, 2010, BMJ-BRIT MED J, V340, pc2459; US Food and Drug Administration, VACC BLOOD BIOL BIOL; Watson RR, 2009, HDB DIS BURDENS QUAL, P2633; WHO Expert Committee on Specifications for Pharmaceutical Preparations, 2011, 45 WHO EXP COMM SPEC; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams T, 2012, ARCH OPHTHALMOL-CHIC, V130, P124, DOI 10.1001/archopht.130.1.124	35	539	555	2	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2013	382	9900					1258	1267		10.1016/S0140-6736(13)61501-9	http://dx.doi.org/10.1016/S0140-6736(13)61501-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235XP	23870813	Green Published, hybrid			2022-12-28	WOS:000325756400029
J	Kapp, MB				Kapp, Marshall B.			Geriatric Patients, Firearms, and Physicians	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							GUN; DEMENTIA		Florida State Univ, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Kapp, MB (corresponding author), Florida State Univ, 1115 West Call St, Tallahassee, FL 32306 USA.	marshall.kapp@med.fsu.edu						Frattaroli S, 2013, ANN INTERN MED, V158, P697, DOI 10.7326/0003-4819-158-9-201305070-00597; Green RC, 1996, J AM GERIATR SOC, V44, P467, DOI 10.1111/j.1532-5415.1996.tb06421.x; Greene E, 2007, BEHAV SCI LAW, V25, P405, DOI 10.1002/bsl.766; LoConte NK, 2008, AM J ALZHEIMERS DIS, V23, P313, DOI 10.1177/1533317508317061; Lynch CA, 2008, INT J GERIATR PSYCH, V23, P1, DOI 10.1002/gps.1922; Palfrey JS, 2013, NEW ENGL J MED, V368, P401, DOI 10.1056/NEJMp1215606; The White House, 2013, NOW IS TIM PRES PLAN	7	12	13	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6					421	+		10.7326/0003-4819-159-5-201309030-00682	http://dx.doi.org/10.7326/0003-4819-159-5-201309030-00682			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	234EY	23836076				2022-12-28	WOS:000325625900018
J	Lang, GI; Rice, DP; Hickman, MJ; Sodergren, E; Weinstock, GM; Botstein, D; Desai, MM				Lang, Gregory I.; Rice, Daniel P.; Hickman, Mark J.; Sodergren, Erica; Weinstock, George M.; Botstein, David; Desai, Michael M.			Pervasive genetic hitchhiking and clonal interference in forty evolving yeast populations	NATURE			English	Article							INTEGRATIVE GENOMICS VIEWER; LONG-TERM EXPERIMENT; ASEXUAL POPULATIONS; BENEFICIAL MUTATIONS; SACCHAROMYCES-CEREVISIAE; ADAPTIVE MUTATIONS; ESCHERICHIA-COLI; VIRAL ADAPTATION; EVOLUTION; ALIGNMENT	The dynamics of adaptation determine which mutations fix in a population, and hence how reproducible evolution will be. This is central to understanding the spectra of mutations recovered in the evolution of antibiotic resistance(1), the response of pathogens to immune selection(2,3), and the dynamics of cancer progression(4,5). In laboratory evolution experiments, demonstrably beneficial mutations are found repeatedly(6-8), but are often accompanied by other mutations with no obvious benefit. Here we use whole-genome whole-population sequencing to examine the dynamics of genome sequence evolution at high temporal resolution in 40 replicate Saccharomyces cerevisiae populations growing in rich medium for 1,000 generations. We find pervasive genetic hitchhiking: multiple mutations arise and move synchronously through the population as mutational 'cohorts'. Multiple clonal cohorts are often present simultaneously, competing with each other in the same population. Our results show that patterns of sequence evolution are driven by a balance between these chance effects of hitchhiking and interference, which increase stochastic variation in evolutionary outcomes, and the deterministic action of selection on individual mutations, which favours parallel evolutionary solutions in replicate populations.	[Lang, Gregory I.; Botstein, David] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Lang, Gregory I.; Botstein, David] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Rice, Daniel P.; Desai, Michael M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Rice, Daniel P.; Desai, Michael M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Rice, Daniel P.; Desai, Michael M.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Hickman, Mark J.] Rowan Univ, Dept Biol Sci, Glassboro, NJ 08028 USA; [Hickman, Mark J.] Rowan Univ, Dept Chem & Biochem, Glassboro, NJ 08028 USA; [Sodergren, Erica; Weinstock, George M.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA	Princeton University; Princeton University; Harvard University; Harvard University; Harvard University; Rowan University; Rowan University; Washington University (WUSTL)	Lang, GI (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	glang@lehigh.edu; mmdesai@fas.harvard.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Desai, Michael/0000-0002-9581-1150; Hickman, Mark/0000-0003-3643-8023	NSF; NIGMS Centers of Excellence [GM071508]; NIH [GM046406]; James S. McDonnell Foundation; Alfred P. Sloan Foundation; Harvard Milton Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046406, P50GM071508, R37GM046406] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIGMS Centers of Excellence; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Harvard Milton Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the production team led by L. Fulton and R. Fulton at the Genome Institute at Washington University for sample management and data production, and E. Lobos for coordinating the project. We thank L. Parsons and J. Wiggins for assistance with data management, P. Gibney for assistance with sample preparation, and T. DeCoste for assistance with flow cytometry. We thank K. Kosheleva for discussions, and A. Murray, C. Marx, M. McDonald, G. Sherlock and D. Kvitek for comments on the manuscript. D. P. R. acknowledges support from an NSF Graduate Research Fellowship. D. B. acknowledges support from NIGMS Centers of Excellence grant GM071508 and NIH grant GM046406. M. M. D. acknowledges support from the James S. McDonnell Foundation, the Alfred P. Sloan Foundation, and the Harvard Milton Fund.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ATWOOD KC, 1951, P NATL ACAD SCI USA, V37, P146, DOI 10.1073/pnas.37.3.146; Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Betancourt AJ, 2009, GENETICS, V181, P1535, DOI 10.1534/genetics.107.085837; Bollback JP, 2007, MOL BIOL EVOL, V24, P1397, DOI 10.1093/molbev/msm056; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; Dettman JR, 2012, MOL ECOL, V21, P2058, DOI 10.1111/j.1365-294X.2012.05484.x; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Good BH, 2012, P NATL ACAD SCI USA, V109, P4950, DOI 10.1073/pnas.1119910109; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Hartl :D. L, 2000, PRIMER POPULATION GE; Joseph SB, 2004, GENETICS, V168, P1817, DOI 10.1534/genetics.104.033761; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; Lang GI, 2011, GENETICS, V188, P647, DOI 10.1534/genetics.111.128942; Levin Bruce R., 1994, Trends in Microbiology, V2, P76, DOI 10.1016/0966-842X(94)90538-X; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Miller CR, 2011, GENETICS, V187, P185, DOI 10.1534/genetics.110.121400; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; PAQUIN C, 1983, NATURE, V302, P495, DOI 10.1038/302495a0; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rouzine IM, 2003, P NATL ACAD SCI USA, V100, P587, DOI 10.1073/pnas.242719299; Saxer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014184; Schiffels S, 2011, GENETICS, V189, P1361, DOI 10.1534/genetics.111.132027; Sprouffske K, 2012, CURR BIOL, V22, pR762, DOI 10.1016/j.cub.2012.06.065; Strelkowa N, 2012, GENETICS, V192, P671, DOI 10.1534/genetics.112.143396; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103	36	346	350	0	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					571	+		10.1038/nature12344	http://dx.doi.org/10.1038/nature12344			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23873039	Green Accepted, Green Submitted			2022-12-28	WOS:000323625900033
J	Berthoud, HR				Berthoud, Hans-Rudolf			Why Does Gastric Bypass Surgery Work?	SCIENCE			English	Editorial Material							WEIGHT-LOSS; OBESITY		Louisiana State Univ Syst, Pennington Biomed Res Ctr, Neurobiol Nutr Lab, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Berthoud, HR (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Neurobiol Nutr Lab, Baton Rouge, LA 70808 USA.	berthohr@pbrc.edu	Berthoud, Hans-Rudolf/N-1950-2017					Cummings David E., 2004, Journal of Clinical Endocrinology & Metabolism, V89, P2608, DOI 10.1210/jc.2004-0433; Hansen CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065696; Holes-Lewis KA, 2013, AM J MED SCI, V345, P284, DOI 10.1097/MAJ.0b013e31828abcfd; le Roux CW, 2011, AM J PHYSIOL-REG I, V301, pR1057, DOI 10.1152/ajpregu.00139.2011; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Ling H, 2013, PHARMACOTHERAPY, V33, P1308, DOI 10.1002/phar.1277; Lingvay I, 2013, DIABETES CARE, V36, P2741, DOI 10.2337/dc12-2316; Lips MA, 2014, CLIN ENDOCRINOL, V80, P834, DOI 10.1111/cen.12254; Mumphrey MB, 2013, NEUROGASTROENT MOTIL, V25, pE70, DOI 10.1111/nmo.12034; Peterli R, 2012, OBES SURG, V22, P740, DOI 10.1007/s11695-012-0622-3; Saeidi N, 2013, SCIENCE, V341, P406, DOI 10.1126/science.1235103; Sigalet DL, 2006, DIGEST DIS SCI, V51, P1557, DOI 10.1007/s10620-006-9077-5; Stefater MA, 2012, ENDOCR REV, V33, P595, DOI 10.1210/er.2011-1044; Zheng HY, 2009, AM J PHYSIOL-REG I, V297, pR1273, DOI 10.1152/ajpregu.00343.2009	14	9	9	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144					351	352		10.1126/science.1242673	http://dx.doi.org/10.1126/science.1242673			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888026				2022-12-28	WOS:000322259200032
J	Shimizu, GKH; Taylor, JM; Kim, S				Shimizu, George K. H.; Taylor, Jared M.; Kim, SiRim			Proton Conduction with Metal-Organic Frameworks	SCIENCE			English	Editorial Material									[Shimizu, George K. H.; Taylor, Jared M.; Kim, SiRim] Univ Calgary, Dept Chem, Calgary, AB T2N 1N4, Canada	University of Calgary	Shimizu, GKH (corresponding author), Univ Calgary, Dept Chem, Calgary, AB T2N 1N4, Canada.	gshimizu@ucalgary.ca; jjaredddd@gmail.com; srkim@ucalgary.ca						ALBERTI G, 1992, SOLID STATE IONICS, V58, P339, DOI 10.1016/0167-2738(92)90138-F; Bureekaew S, 2009, NAT MATER, V8, P831, DOI [10.1038/NMAT2526, 10.1038/nmat2526]; Colodrero RMP, 2012, DALTON T, V41, P4045, DOI 10.1039/c2dt11992g; Goesten MG, 2011, J CATAL, V281, P177, DOI 10.1016/j.jcat.2011.04.015; Horike S, 2012, J AM CHEM SOC, V134, P7612, DOI 10.1021/ja301875x; Horike S, 2009, NAT CHEM, V1, P695, DOI [10.1038/NCHEM.444, 10.1038/nchem.444]; Hurd JA, 2009, NAT CHEM, V1, P705, DOI [10.1038/nchem.402, 10.1038/NCHEM.402]; Li SL, 2013, ENERG ENVIRON SCI, V6, P1656, DOI 10.1039/c3ee40507a; Liang XQ, 2013, CHEM SCI, V4, P983, DOI 10.1039/c2sc21927a; Morozan A, 2012, ENERG ENVIRON SCI, V5, P9269, DOI 10.1039/c2ee22989g; Pardo E, 2011, J AM CHEM SOC, V133, P15328, DOI 10.1021/ja206917z; Ponomareva VG, 2012, J AM CHEM SOC, V134, P15640, DOI 10.1021/ja305587n; Sadakiyo M, 2009, J AM CHEM SOC, V131, P9906, DOI 10.1021/ja9040016; Sahoo SC, 2011, J AM CHEM SOC, V133, P17950, DOI 10.1021/ja2078637; Taylor JM, 2013, J AM CHEM SOC, V135, P1193, DOI 10.1021/ja310435e; Wu B, 2013, CHEM COMMUN, V49, P143, DOI 10.1039/c2cc37045j; Yamada T, 2009, J AM CHEM SOC, V131, P3144, DOI 10.1021/ja808681m; Yoon M, 2013, ANGEW CHEM INT EDIT, V52, P2688, DOI 10.1002/anie.201206410	18	309	312	13	389	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					354	355		10.1126/science.1239872	http://dx.doi.org/10.1126/science.1239872			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888028				2022-12-28	WOS:000322259200034
J	Gulev, SK; Latif, M; Keenlyside, N; Park, W; Koltermann, KP				Gulev, Sergey K.; Latif, Mojib; Keenlyside, Noel; Park, Wonsun; Koltermann, Klaus Peter			North Atlantic Ocean control on surface heat flux on multidecadal timescales	NATURE			English	Article							THERMOHALINE CIRCULATION; INTERDECADAL VARIATIONS; DECADAL VARIABILITY; CLIMATE; IMPACT; OSCILLATION; ANOMALIES; TRENDS	Nearly 50 years ago Bjerknes(1) suggested that the character of large-scale air-sea interaction over the mid-latitude North Atlantic Ocean differs with timescales: the atmosphere was thought to drive directly most short-term-interannual-sea surface temperature (SST) variability, and the ocean to contribute significantly to long-term-multidecadal-SST and potentially atmospheric variability. Although the conjecture for short timescales is well accepted, understanding Atlantic multidecadal variability (AMV) of SST2,3 remains a challenge as a result of limited ocean observations. AMV is nonetheless of major socio-economic importance because it is linked to important climate phenomena such as Atlantic hurricane activity and Sahel rainfall, and it hinders the detection of anthropogenic signals in the North Atlantic sector(4-6). Direct evidence of the oceanic influence of AMV can only be provided by surface heat fluxes, the language of ocean-atmosphere communication. Here we provide observational evidence that in the mid-latitude North Atlantic and on timescales longer than 10 years, surface turbulent heat fluxes are indeed driven by the ocean and may force the atmosphere, whereas on shorter timescales the converse is true, thereby confirming the Bjerknes conjecture. This result, although strongest in boreal winter, is found in all seasons. Our findings suggest that the predictability of mid-latitude North Atlantic air-sea interaction could extend beyond the ocean to the climate of surrounding continents.	[Gulev, Sergey K.] PP Shirshov Inst Oceanol, Moscow 117997, Russia; [Gulev, Sergey K.; Latif, Mojib; Park, Wonsun] GEOMAR Helmholtz Zentrum Ozeanforsch Kiel, D-24105 Kiel, Germany; [Gulev, Sergey K.; Koltermann, Klaus Peter] Moscow MV Lomonosov State Univ, Fac Geog, Moscow 119991, Russia; [Latif, Mojib] Univ Kiel, Cluster Excellence Future Ocean, D-24118 Kiel, Germany; [Keenlyside, Noel] Univ Bergen, Inst Geophys, N-5007 Bergen, Norway; [Keenlyside, Noel] Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway	Russian Academy of Sciences; Shirshov Institute of Oceanology; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Lomonosov Moscow State University; University of Kiel; University of Bergen; Bjerknes Centre for Climate Research; University of Bergen	Gulev, SK (corresponding author), PP Shirshov Inst Oceanol, 36 Nakhimovsky Prospect, Moscow 117997, Russia.	gul@sail.msk.ru	Koltermann, Klaus Peter/D-4817-2014; Keenlyside, Noel S/E-8303-2013; Latif, Mojib/C-2428-2016; Gulev, Sergey/A-4994-2014; Park, Wonsun/J-8097-2012	Keenlyside, Noel S/0000-0002-8708-6868; Latif, Mojib/0000-0003-1079-5604; Park, Wonsun/0000-0002-6345-8428; Koltermann, Klaus Peter/0000-0002-6038-7599	Deutsche Forschungsgemeinschaft [KE 1471/2-1]; Russian Ministry of Education and Science through the Special Grant for establishing excellence at Russian Universities [11.G34.31.0007]; Russian Ministry of Education and Science; RACE project of the German Federal Ministry of Education and Research;  [2011-16-420-1-001];  [11.519.11.6034]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Russian Ministry of Education and Science through the Special Grant for establishing excellence at Russian Universities; Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); RACE project of the German Federal Ministry of Education and Research; ; 	This study was supported by the Deutsche Forschungsgemeinschaft under grant KE 1471/2-1 and by the Russian Ministry of Education and Science through the Special Grant for establishing excellence at Russian Universities, no. 11.G34.31.0007. We also benefited from contracts 2011-16-420-1-001 and 11.519.11.6034 with the Russian Ministry of Education and Science and the RACE project of the German Federal Ministry of Education and Research.	Bjerknes J., 1964, ADV GEOPHYS, V10, P1, DOI [10.1016/S0065-2687(08)60005-9, DOI 10.1016/S0065-2687(08)60005-9]; Booth BBB, 2012, NATURE, V484, P228, DOI 10.1038/nature10946; CAYAN DR, 1992, J PHYS OCEANOGR, V22, P859, DOI 10.1175/1520-0485(1992)022<0859:LASHFA>2.0.CO;2; Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776; DELWORTH T, 1993, J CLIMATE, V6, P1993, DOI 10.1175/1520-0442(1993)006<1993:IVOTTC>2.0.CO;2; DUCHON CE, 1979, J APPL METEOROL, V18, P1016, DOI 10.1175/1520-0450(1979)018<1016:LFIOAT>2.0.CO;2; Ebisuzaki W, 1997, J CLIMATE, V10, P2147, DOI 10.1175/1520-0442(1997)010<2147:AMTETS>2.0.CO;2; Eden C, 2001, J CLIMATE, V14, P2266, DOI 10.1175/1520-0442(2001)014<2266:MOITDV>2.0.CO;2; Fairall C. W., 2003, J CLIMATOL, V16, P591; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Gulev S, 2007, J CLIMATE, V20, P279, DOI 10.1175/JCLI4010.1; Gulev SK, 2012, J CLIMATE, V25, P184, DOI 10.1175/2011JCLI4211.1; Hayashi Y., 1981, J METEOROL SOC JPN, V59, P621; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Josey SA, 1999, J CLIMATE, V12, P2856, DOI 10.1175/1520-0442(1999)012<2856:NIITOH>2.0.CO;2; Kent EC, 2007, J ATMOS OCEAN TECH, V24, P214, DOI 10.1175/JTECH1949.1; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Kushnir Y, 2002, J CLIMATE, V15, P2233, DOI 10.1175/1520-0442(2002)015<2233:AGRTES>2.0.CO;2; KUSHNIR Y, 1994, J CLIMATE, V7, P141, DOI 10.1175/1520-0442(1994)007<0141:IVINAS>2.0.CO;2; Latif M, 2004, J CLIMATE, V17, P1605, DOI 10.1175/1520-0442(2004)017<1605:RMAPMC>2.0.CO;2; LIVEZEY RE, 1983, MON WEATHER REV, V111, P46, DOI 10.1175/1520-0493(1983)111<0046:SFSAID>2.0.CO;2; Ottera OH, 2010, NAT GEOSCI, V3, P688, DOI 10.1038/NGEO955; Pohlmann H, 2006, J CLIMATE, V19, P6062, DOI 10.1175/JCLI3941.1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Rodwell MJ, 1999, NATURE, V398, P320, DOI 10.1038/18648; Semenov VA, 2010, J CLIMATE, V23, P5668, DOI 10.1175/2010JCLI3347.1; Shaffrey L, 2006, J CLIMATE, V19, P1167, DOI 10.1175/JCLI3652.1; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Ting MF, 2009, J CLIMATE, V22, P1469, DOI 10.1175/2008JCLI2561.1; Woodruff SD, 2011, INT J CLIMATOL, V31, P951, DOI 10.1002/joc.2103; Yu B, 2011, CLIM DYNAM, V36, P589, DOI 10.1007/s00382-009-0669-6; Yu LS, 2007, B AM METEOROL SOC, V88, P527, DOI 10.1175/BAMS-88-4-527; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267	33	213	228	0	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					464	+		10.1038/nature12268	http://dx.doi.org/10.1038/nature12268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23887431				2022-12-28	WOS:000322157900037
J	Simonette, M				Simonette, Matt			Outcomes incentives: can they catch on in the US?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												matt.simonette@gmail.com						Centers for Medicare and Medicaid Services, BUNDL PAYM CAR IMPR; HARTOCOLLIS A, 2013, NY TIMES; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Medical Group Management Association, PHYS COMP PROD SURV	4	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2013	347								f4591	10.1136/bmj.f4591	http://dx.doi.org/10.1136/bmj.f4591			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	189DN	23873948				2022-12-28	WOS:000322247400003
J	Gilbert, LA; Larson, MH; Morsut, L; Liu, ZR; Brar, GA; Torres, SE; Stern-Ginossar, N; Brandman, O; Whitehead, EH; Doudna, JA; Lim, WA; Weissman, JS; Qi, LS				Gilbert, Luke A.; Larson, Matthew H.; Morsut, Leonardo; Liu, Zairan; Brar, Gloria A.; Torres, Sandra E.; Stern-Ginossar, Noam; Brandman, Onn; Whitehead, Evan H.; Doudna, Jennifer A.; Lim, Wendell A.; Weissman, Jonathan S.; Qi, Lei S.			CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes	CELL			English	Article							GENE-EXPRESSION; REPRESSION; BACTERIA; ACTIVATION; CHROMATIN; REVEALS; GENOMES; SYSTEMS; CELLS	The genetic interrogation and reprogramming of cells requires methods for robust and precise targeting of genes for expression or repression. The CRISPR-associated catalytically inactive dCas9 protein offers a general platform for RNA-guided DNA targeting. Here, we show that fusion of dCas9 to effector domains with distinct regulatory functions enables stable and efficient transcriptional repression or activation in human and yeast cells, with the site of delivery determined solely by a coexpressed short guide (sg)RNA. Coupling of dCas9 to a transcriptional repressor domain can robustly silence expression of multiple endogenous genes. RNA-seq analysis indicates that CRISPR interference (CRISPRi)-mediated transcriptional repression is highly specific. Our results establish that the CRISPR system can be used as a modular and flexible DNA-binding platform for the recruitment of proteins to a target DNA sequence, revealing the potential of CRISPRi as a general tool for the precise regulation of gene expression in eukaryotic cells.	[Gilbert, Luke A.; Larson, Matthew H.; Morsut, Leonardo; Brar, Gloria A.; Torres, Sandra E.; Stern-Ginossar, Noam; Brandman, Onn; Whitehead, Evan H.; Lim, Wendell A.; Weissman, Jonathan S.; Qi, Lei S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Larson, Matthew H.; Morsut, Leonardo; Brar, Gloria A.; Torres, Sandra E.; Stern-Ginossar, Noam; Brandman, Onn; Doudna, Jennifer A.; Lim, Wendell A.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Whitehead, Evan H.; Lim, Wendell A.; Weissman, Jonathan S.; Qi, Lei S.] Univ Calif San Francisco, UCSF Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Larson, Matthew H.; Brar, Gloria A.; Torres, Sandra E.; Stern-Ginossar, Noam; Brandman, Onn; Whitehead, Evan H.; Doudna, Jennifer A.; Lim, Wendell A.; Weissman, Jonathan S.; Qi, Lei S.] Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Larson, Matthew H.; Brar, Gloria A.; Torres, Sandra E.; Stern-Ginossar, Noam; Brandman, Onn; Doudna, Jennifer A.; Weissman, Jonathan S.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Liu, Zairan] Peking Univ, Beijing 100871, Peoples R China	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Peking University	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu	Qi, Lei S/AAC-5088-2019; Gilbert, Luke/AAC-5300-2019; Larson, Matthew/C-8289-2014	Larson, Matthew/0000-0002-6778-2604; Whitehead, Evan/0000-0002-4132-2140; Qi, Lei S/0000-0002-3965-3223; , Noam/0000-0003-3583-5932; Gilbert, Luke/0000-0001-5854-0825; Weissman, Jonathan/0000-0003-2445-670X	UCSF Center for Systems and Synthetic Biology; NIH [P50 GM102706, P50 GM081879, U01 CA168370]; Howard Hughes Medical Institute; NSF SynBERC [EEC-0540879]; NIGMS IMSD; Human Frontiers Scientific Program; Ruth L. Kirschstein National Research Service Award; NATIONAL CANCER INSTITUTE [U01CA168370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM102706, F32GM100611, P50GM081879] Funding Source: NIH RePORTER	UCSF Center for Systems and Synthetic Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF SynBERC(National Science Foundation (NSF)); NIGMS IMSD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Human Frontiers Scientific Program; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Martin Jinek for discussion and distribution of the dCas9 gene. The authors also thank Jason Park, Martin Kampmann, Mike Bassik, and Xin Xiong for lentiviral vectors, technical advice, and helpful discussion. L.S.Q. acknowledges support from the UCSF Center for Systems and Synthetic Biology. This work was supported by NIH P50 GM102706 (J.S.W. and J.A.D.), NIH P50 GM081879 (L.S.Q., W.A.L., Z.L., and E.H.W.), NIH U01 CA168370 (J.S.W.), Howard Hughes Medical Institute (L.A.G., G.A.B., O.B., J.A.D., J.S.W., and W.A.L.), NSF SynBERC EEC-0540879 (W.A.L.), NIGMS IMSD (S.E.T.), the Human Frontiers Scientific Program (N.S. and L.M.), and a Ruth L. Kirschstein National Research Service Award (M.H.L.).	Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; BATY D, 1984, NUCLEIC ACIDS RES, V12, P915, DOI 10.1093/nar/12.2.915; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Conaway JW, 2012, ANNU REV BIOCHEM, V81, P61, DOI 10.1146/annurev-biochem-090711-093103; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Fu Y., 2013, NAT BIOTECHNOL; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gratz SJ, 2013, GENETICS; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Harper SE, 1996, P NATL ACAD SCI USA, V93, P8536, DOI 10.1073/pnas.93.16.8536; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kasten MM, 1996, MOL CELL BIOL, V16, P4215; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/nmeth.2366, 10.1038/NMETH.2366]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Millau JF, 2011, BIOCHEM CELL BIOL, V89, P505, DOI [10.1139/o11-052, 10.1139/O11-052]; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zhang L, 2000, J BIOL CHEM, V275, P33850, DOI 10.1074/jbc.M005341200; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	46	2101	2405	47	807	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 18	2013	154	2					442	451		10.1016/j.cell.2013.06.044	http://dx.doi.org/10.1016/j.cell.2013.06.044			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23849981	Green Accepted, Bronze			2022-12-28	WOS:000321950700019
J	Cress, CD; Datta, S				Cress, Cory D.; Datta, Suman			Nanoscale Transistors-Just Around the Gate?	SCIENCE			English	Editorial Material							WALLED CARBON NANOTUBES		[Cress, Cory D.] US Naval Res Lab, Elect Sci & Technol Div, Washington, DC 20375 USA; [Datta, Suman] Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cress, CD (corresponding author), US Naval Res Lab, Elect Sci & Technol Div, Washington, DC 20375 USA.	cory.cress@nrl.navy.mil; sdatta@engr.psu.edu	Cress, Cory/AAM-3458-2020	Cress, Cory/0000-0001-7563-6693				Arnold MS, 2006, NAT NANOTECHNOL, V1, P60, DOI 10.1038/nnano.2006.52; Franklin A. D., 2011, IEEE INT EL DEV M, V2011, P23; Franklin A. D., 2010, DEV RES C, V2010, P275; Franklin AD, 2013, NANO LETT, V13, P2490, DOI 10.1021/nl400544q; Gu J. J., 2012, DEV RES C, V2012, P1; Han S, 2005, J AM CHEM SOC, V127, P5294, DOI 10.1021/ja042544x; Ismach A, 2004, ANGEW CHEM INT EDIT, V43, P6140, DOI 10.1002/anie.200460356; Kocabas C, 2004, NANO LETT, V4, P2421, DOI 10.1021/nl048487n; Larrieu G, 2013, NANOSCALE, V5, P2437, DOI 10.1039/c3nr33738c; Liu HP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1313; Liu J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2205; Lundstrom M, 2003, SCIENCE, V299, P210, DOI 10.1126/science.1079567; Radosavljevic M., 2011, IEEE INT EL DEV M, V2011, P33; Tomioka K, 2012, NATURE, V488, P189, DOI 10.1038/nature11293; Zhang ZY, 2009, ACS NANO, V3, P3781, DOI 10.1021/nn901079p	15	31	33	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					140	141		10.1126/science.1240452	http://dx.doi.org/10.1126/science.1240452			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23846898				2022-12-28	WOS:000321965300031
J	Rawlins, MD				Rawlins, Michael D.			NICE: Moving Onward	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rawlins, Michael D.] Royal Soc Med, London, England; [Rawlins, Michael D.] London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine	Rawlins, MD (corresponding author), Royal Soc Med, London, England.							[Anonymous], VTE RISK ASS DAT COL; Francis R., 2013, REPORT MID STAFFORDS; Rawlins Michael, 2009, PATIENTS PUBLIC PRIO; Rawlins MD, 2013, CLIN MED, V13, P13, DOI 10.7861/clinmedicine.13-1-13; Thornhill MH, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2392	5	17	17	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					3	5		10.1056/NEJMp1303907	http://dx.doi.org/10.1056/NEJMp1303907			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175WE	23822774	Green Published			2022-12-28	WOS:000321263500003
J	Kreimer, AR; Campbell, CMP; Lin, HY; Fulp, W; Papenfuss, MR; Abrahamsen, M; Hildesheim, A; Villa, LL; Salmeron, JJ; Lazcano-Ponce, E; Giuliano, AR				Kreimer, Aimee R.; Campbell, Christine M. Pierce; Lin, Hui-Yi; Fulp, William; Papenfuss, Mary R.; Abrahamsen, Martha; Hildesheim, Allan; Villa, Luisa L.; Salmeron, Jorge J.; Lazcano-Ponce, Eduardo; Giuliano, Anna R.			Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study	LANCET			English	Article							SQUAMOUS-CELL CARCINOMA; UNITED-STATES; HPV INFECTION; RISK-FACTOR; OROPHARYNGEAL CANCER; TOBACCO-SMOKE; YOUNG MEN; PREVALENCE; PERSISTENCE; HEAD	Background Oral human papillomavirus (HPV) infection causes a subset of oropharyngeal cancers. These cancers disproportionately affect men, are increasing in incidence, and have no proven prevention methods. We aimed to establish the natural history of oral HPV infection in men. Methods To estimate incidence and clearance of HPV infections, men residing in Brazil, Mexico, and the USA who were HIV negative and reported no history of anogenital cancer were recruited into the HPV Infection in Men (HIM) cohort study. A subset of the cohort who provided two or more oral rinse-and-gargle samples with valid HPV results and who completed a minimum of 2 weeks of follow-up were included in this analysis. Oral rinse-and-gargle samples and questionnaire data were obtained every 6 months for up to 4 years. Samples were analysed for the presence of oncogenic and non-oncogenic HPV infections by the linear array method. Findings 1626 men aged 18-73 years and with a median follow-up of 12.7 months (IQR 12.1-14.7) were included in the analysis. During the first 12 months of follow-up, 4.4% (95% CI 3.5-5.6; n=115 incident infections) of men acquired an incident oral HPV infection, 1.7% (1.2-2.5; n=53 incident infections) an oral oncogenic HPV infection, and 0.6% (0.3-1.1; n=18 incident infections) an oral HPV 16 infection. Acquisition of oral oncogenic HPV was significantly associated with smoking and not being married or cohabiting, but was similar across countries, age groups, and reported sexual behaviours. Median duration of infection was 6.9 months (95 % CI 6.2-9.3; n=45 cleared infections) for any HPV, 6.3 months (6.0-9.9; n=18 cleared infections) for oncogenic HPV, and 7.3 months (6.0-not estimable; n=5 cleared infections) for HPV 16. Eight of the 18 incident oral HPV 16 infections persisted for two or more study visits. Interpretation Newly acquired oral oncogenic HPV infections in healthy men were rare and most were cleared within 1 year. Additional studies into the natural history of HPV are needed to inform development of infection-related prevention efforts.	[Kreimer, Aimee R.; Hildesheim, Allan] NCI, NIH, Bethesda, MD 20892 USA; [Campbell, Christine M. Pierce; Lin, Hui-Yi; Fulp, William; Papenfuss, Mary R.; Abrahamsen, Martha; Giuliano, Anna R.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Villa, Luisa L.] Univ Sao Paulo, Sch Med, Dept Radiol & Basic Oncol, Sao Paulo, Brazil; [Villa, Luisa L.] Univ Sao Paulo, Sch Med, HPV Inst, Sao Paulo, Brazil; [Salmeron, Jorge J.] Inst Mexicano Seguro Social, Cuernavaca, Morelos, Mexico; [Lazcano-Ponce, Eduardo] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Mexicano del Seguro Social; Instituto Nacional de Salud Publica	Kreimer, AR (corresponding author), NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr,RM 6-E104, Bethesda, MD 20892 USA.	kreimera@mail.nih.gov	Hildesheim, Allan/B-9760-2015; VILLA, LUISA/AAH-4761-2019; Papilomavirus, Inct/I-2406-2013; Kreimer, Aimee ARK/H-1687-2015; Fulp, William/AAD-2369-2022; USP, Oncologia/F-9053-2014	Hildesheim, Allan/0000-0003-0257-2363; VILLA, LUISA/0000-0003-4074-2335; Lin, Hui-Yi/0000-0002-3307-5549; Fulp, William/0000-0001-6888-0794; Pierce, Christine/0000-0002-0233-4894; Salmeron, Jorge/0000-0002-5113-299X	US National Cancer Institute; Merck Sharp Dohme; NATIONAL CANCER INSTITUTE [R25CA147832, ZIACP010217, P30CA076292, ZIACP010209, R01CA098803] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Merck Sharp Dohme(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	US National Cancer Institute, Merck Sharp & Dohme.	[Anonymous], 2007, IARC MON EV CARC RIS; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Castle PE, 2008, J VIROL, V82, P6084, DOI 10.1128/JVI.00103-08; Rodriguez AC, 2010, JNCI-J NATL CANCER I, V102, P315, DOI 10.1093/jnci/djq001; Chaturvedi AK, 2010, 26 INT PAP C MONTR C, P575; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Edelstein ZR, 2012, SEX TRANSM DIS, V39, P860, DOI 10.1097/OLQ.0b013e318269d098; Fakhry C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011918; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Hong AM, 2010, VACCINE, V28, P3269, DOI 10.1016/j.vaccine.2010.02.098; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Kreimer AR, 2011, CANCER EPIDEM BIOMAR, V20, P172, DOI 10.1158/1055-9965.EPI-10-0682; Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Nyitray AG, 2011, J INFECT DIS, V204, P1711, DOI 10.1093/infdis/jir637; Pickard RKL, 2012, SEX TRANSM DIS, V39, P559, DOI 10.1097/OLQ.0b013e31824f1c65; Sanders AE, 2012, ORAL DIS, V18, P430, DOI 10.1111/j.1601-0825.2011.01892.x; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; YING Z, 1994, J MULTIVARIATE ANAL, V50, P17, DOI 10.1006/jmva.1994.1031	31	182	183	1	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 7	2013	382	9895					877	887		10.1016/S0140-6736(13)60809-0	http://dx.doi.org/10.1016/S0140-6736(13)60809-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215WE	23827089	Green Accepted			2022-12-28	WOS:000324240700029
J	Liu, B; Baskin, RJ; Kowalczykowski, SC				Liu, Bian; Baskin, Ronald J.; Kowalczykowski, Stephen C.			DNA unwinding heterogeneity by RecBCD results from static molecules able to equilibrate	NATURE			English	Article							RECOMBINATION HOTSPOT CHI; SINGLE-MOLECULE; ENZYME; RECOGNITION; TRANSLOCATION; HELICASE; PROTEIN; ENERGY; DYNAMICS; MOTOR	Single-molecule studies can overcome the complications of asynchrony and ensemble-averaging in bulk-phase measurements, provide mechanistic insights into molecular activities, and reveal interesting variations between individual molecules(1-3). The application of these techniques to the RecBCD helicase of Escherichia coli has resolved some long-standing discrepancies, and has provided otherwise unattainable mechanistic insights into its enzymatic behaviour(4-6). Enigmatically, the DNA unwinding rates of individual enzyme molecules are seen to vary considerably(6-8), but the origin of this heterogeneity remains unknown. Here we investigate the physical basis for this behaviour. Although any individual RecBCD molecule unwound DNA at a constant rate for an average of approximately 30,000 steps, we discover that transiently halting a single enzyme-DNA complex by depleting Mg2+-ATP could change the subsequent rates of DNA unwinding by that enzyme after reintroduction to ligand. The proportion of molecules that changed rate increased exponentially with the duration of the interruption, with a half-life of approximately 1 second, suggesting that a conformational change occurred during the time that the molecule was arrested. The velocity after pausing an individual molecule was any velocity found in the starting distribution of the ensemble. We suggest that substrate binding stabilizes the enzyme in one of many equilibrium conformational sub-states that determine the rate-limiting translocation behaviour of each RecBCD molecule. Each stabilized sub-state can persist for the duration (approximately 1 minute) of processive unwinding of a DNA molecule, comprising tens of thousands of catalytic steps, each of which is much faster than the time needed for the conformational change required to alter kinetic behaviour. This ligand-dependent stabilization of rate-defining conformational sub-states results in seemingly static molecule-to-molecule variation in RecBCD helicase activity, but in fact reflects one microstate from the equilibrium ensemble that a single molecule manifests during an individual processive translocation event.	[Liu, Bian; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Liu, Bian; Baskin, Ronald J.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Liu, Bian; Kowalczykowski, Stephen C.] Univ Calif Davis, Biophys Grad Grp, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu	Liu, Bian/C-4865-2011	Liu, Bian/0000-0001-8806-820X	National Institutes of Health [GM-62653, GM-64745]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064745, R01GM062653, R01GM041347, R37GM062653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the laboratory for their comments on this work. S.C.K. was supported by the National Institutes of Health (GM-62653 and GM-64745).	Amitani I, 2010, METHOD ENZYMOL, V472, P261, DOI 10.1016/S0076-6879(10)72007-3; Bianco PR, 1997, P NATL ACAD SCI USA, V94, P6706, DOI 10.1073/pnas.94.13.6706; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Craig DB, 1996, J AM CHEM SOC, V118, P5245, DOI 10.1021/ja9540839; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dillingham MS, 2005, J BIOL CHEM, V280, P37069, DOI 10.1074/jbc.M505520200; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Frauenfelder H, 2001, P NATL ACAD SCI USA, V98, P2370, DOI 10.1073/pnas.041614298; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; Handa N, 2005, MOL CELL, V17, P745, DOI 10.1016/j.molcel.2005.02.011; Handa N, 2012, P NATL ACAD SCI USA, V109, P8901, DOI 10.1073/pnas.1206076109; IKAI A, 1971, NATURE, V230, P100, DOI 10.1038/230100a0; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; LAM ST, 1974, GENETICS, V77, P425; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Nguyen HD, 2002, BIOTECHNOL BIOENG, V80, P823, DOI 10.1002/bit.10448; ONUCHIC JN, 1995, P NATL ACAD SCI USA, V92, P3626, DOI 10.1073/pnas.92.8.3626; Perkins TT, 2004, BIOPHYS J, V86, P1640, DOI 10.1016/S0006-3495(04)74232-0; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2863, DOI 10.1021/bi00433a018; SELA M, 1957, SCIENCE, V125, P691, DOI 10.1126/science.125.3250.691; Shi J, 2004, J AM CHEM SOC, V126, P6914, DOI 10.1021/ja038902y; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Spies M, 2005, J BIOL CHEM, V280, P37078, DOI 10.1074/jbc.M505521200; Spies M, 2007, CELL, V131, P694, DOI 10.1016/j.cell.2007.09.023; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Xie XS, 1999, J BIOL CHEM, V274, P15967, DOI 10.1074/jbc.274.23.15967; XUE QF, 1995, NATURE, V373, P681, DOI 10.1038/373681a0	35	60	65	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2013	500	7463					482	+		10.1038/nature12333	http://dx.doi.org/10.1038/nature12333			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23851395	Green Submitted, Green Accepted			2022-12-28	WOS:000323316100040
J	Black, JC; Manning, AL; Van Rechem, C; Kim, J; Ladd, B; Cho, J; Pineda, CM; Murphy, N; Daniels, DL; Montagna, C; Lewis, PW; Glass, K; Allis, CD; Dyson, NJ; Getz, G; Whetstine, JR				Black, Joshua C.; Manning, Amity L.; Van Rechem, Capucine; Kim, Jaegil; Ladd, Brendon; Cho, Juok; Pineda, Cristiana M.; Murphy, Nancy; Daniels, Danette L.; Montagna, Cristina; Lewis, Peter W.; Glass, Kimberly; Allis, C. David; Dyson, Nicholas J.; Getz, Gad; Whetstine, Johnathan R.			KDM4A Lysine Demethylase Induces Site-Specific Copy Gain and Rereplication of Regions Amplified in Tumors	CELL			English	Article							REPLICATION ORIGINS; NUMBER ALTERATION; DRUG-RESISTANCE; CANCER; MECHANISMS; AMPLIFICATION; INHIBITION; FEATURES; PR-SET7; DOMAIN	Acquired chromosomal instability and copy number alterations are hallmarks of cancer. Enzymes capable of promoting site-specific copy number changes have yet to be identified. Here, we demonstrate that H3K9/36me3 lysine demethylase KDM4A/JMJD2A overexpression leads to localized copy gain of 1q12, 1q21, and Xq13.1 without global chromosome instability. KDM4A-amplified tumors have increased copy gains for these same regions. 1q12h copy gain occurs within a single cell cycle, requires S phase, and is not stable but is regenerated each cell division. Sites with increased copy number are rereplicated and have increased KDM4A, MCM, and DNA polymerase occupancy. Suv39h1/KMT1A or HP1 gamma overexpression suppresses the copy gain, whereas H3K9/K36 methylation interference promotes gain. Our results demonstrate that overexpression of a chromatin modifier results in site-specific copy gains. This begins to establish how copy number changes could originate during tumorigenesis and demonstrates that transient overexpression of specific chromatin modulators could promote these events.	[Black, Joshua C.; Manning, Amity L.; Van Rechem, Capucine; Ladd, Brendon; Pineda, Cristiana M.; Dyson, Nicholas J.; Getz, Gad; Whetstine, Johnathan R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA; [Black, Joshua C.; Manning, Amity L.; Van Rechem, Capucine; Ladd, Brendon; Pineda, Cristiana M.; Dyson, Nicholas J.; Whetstine, Johnathan R.] Harvard Univ, Dept Med, Sch Med, Charlestown, MA 02129 USA; [Getz, Gad] Harvard Univ, Dept Pathol, Sch Med, Charlestown, MA 02129 USA; [Kim, Jaegil; Cho, Juok; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Murphy, Nancy; Daniels, Danette L.] Promega Corp, Madison, WI 53711 USA; [Montagna, Cristina] Yeshiva Univ Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Lewis, Peter W.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Glass, Kimberly] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Glass, Kimberly] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Promega Corporation; Yeshiva University; Albert Einstein College of Medicine; Rockefeller University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Getz, G (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, 13th St, Charlestown, MA 02129 USA.	gadgetz@broadinstitute.org; jwhetstine@hms.harvard.edu	Black, Joshua/Q-2484-2015; Manning, Amity/AAC-8205-2019	Manning, Amity/0000-0003-1332-9086; Glass, Kimberly/0000-0003-4394-5779; Van Rechem, Capucine/0000-0002-5408-6124; Black, Joshua/0000-0002-2491-8815; Lewis, Peter/0000-0002-9816-7823	Ellison Medical Foundation [CA059267, R01GM097360]; NIH [U24CA143845]; Jane Coffin Childs Memorial Fund for Medical Research; MGH ECOR Tosteson Postdoctoral Fellowship; CCSG [P30CA013330];  [R01CA155202]; NATIONAL CANCER INSTITUTE [C06CA059267, P30CA013330, U24CA143845, R01CA155202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097360] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; MGH ECOR Tosteson Postdoctoral Fellowship; CCSG; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Ravi Mylvaganam and the MGH Flow Cytometry core for assistance with the cell sorting. We thank Mo Motamedi for helpful comments on the manuscript. This work was supported by funding to J.R.W. from the Ellison Medical Foundation, CA059267 and R01GM097360. G.G. and J.K. are supported by NIH U24CA143845. J.C.B. was a Fellow of The Jane Coffin Childs Memorial Fund for Medical Research. This investigation has been aided by a grant from The Jane Coffin Childs Memorial Fund for Medical Research. N.J.D. is supported by R01CA155202. A.L.M. is supported by MGH ECOR Tosteson Postdoctoral Fellowship. C.M. is supported by CCSG P30CA013330.	Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Beck DB, 2012, GENE DEV, V26, P2580, DOI 10.1101/gad.195636.112; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Berry WL, 2012, INT J ONCOL, V41, P1701, DOI 10.3892/ijo.2012.1618; Black JC, 2010, MOL CELL, V40, P736, DOI 10.1016/j.molcel.2010.11.008; Brunet A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-144; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Ding QY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001112; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hook SS, 2007, CURR OPIN CELL BIOL, V19, P663, DOI 10.1016/j.ceb.2007.10.007; Inoue J, 2004, AM J PATHOL, V165, P71, DOI 10.1016/S0002-9440(10)63276-2; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Kiang L, 2010, J CELL SCI, V123, P3047, DOI 10.1242/jcs.067470; Kim TD, 2012, J CELL BIOCHEM, V113, P1368, DOI 10.1002/jcb.24009; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Kudoh K, 1999, CLIN CANCER RES, V5, P2526; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mallette FA, 2012, CELL REP, V2, P1233, DOI 10.1016/j.celrep.2012.09.033; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Manning AL, 2010, GENE DEV, V24, P1364, DOI 10.1101/gad.1917310; Maslov AY, 2009, BBA-GEN SUBJECTS, V1790, P963, DOI 10.1016/j.bbagen.2009.03.020; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Papamichos-Chronakis M, 2013, NAT REV GENET, V14, P62, DOI 10.1038/nrg3345; SCHIMKE RT, 1984, CANCER RES, V44, P1735; Snaith HA, 1999, GENETICS, V152, P839; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Takano M, 2001, Hum Cell, V14, P267; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Van Rechem C, 2011, J BIOL CHEM, V286, P30462, DOI 10.1074/jbc.M111.273508; Vassilev LT, 2006, CELL CYCLE, V5, P2555, DOI 10.4161/cc.5.22.3463; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wong N, 2001, AM J PATHOL, V159, P465, DOI 10.1016/S0002-9440(10)61718-X; Yakut T, 2006, LUNG CANCER, V54, P293, DOI 10.1016/j.lungcan.2006.08.011	39	156	162	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					541	555		10.1016/j.cell.2013.06.051	http://dx.doi.org/10.1016/j.cell.2013.06.051			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23871696	Bronze, Green Accepted			2022-12-28	WOS:000322629900009
J	Hirata, A; Kang, LJ; Fujita, T; Klumov, B; Matsue, K; Kotani, M; Yavari, AR; Chen, MW				Hirata, A.; Kang, L. J.; Fujita, T.; Klumov, B.; Matsue, K.; Kotani, M.; Yavari, A. R.; Chen, M. W.			Geometric Frustration of Icosahedron in Metallic Glasses	SCIENCE			English	Article							BOND-ORIENTATIONAL ORDER; MEDIUM-RANGE ORDER; EUTECTIC COMPOSITIONS; LIQUIDS; TRANSITION; PACKING	Icosahedral order has been suggested as the prevalent atomic motif of supercooled liquids and metallic glasses for more than half a century, because the icosahedron is highly close-packed but is difficult to grow, owing to structure frustration and the lack of translational periodicity. By means of angstrom-beam electron diffraction of single icosahedra, we report experimental observation of local icosahedral order in metallic glasses. All the detected icosahedra were found to be distorted with partially face-centered cubic symmetry, presenting compelling evidence on geometric frustration of local icosahedral order in metallic glasses.	[Hirata, A.; Kang, L. J.; Fujita, T.; Kotani, M.; Yavari, A. R.; Chen, M. W.] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Klumov, B.] Russian Acad Sci, Joint Inst High Temp, Moscow 125412, Russia; [Matsue, K.; Kotani, M.] Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan; [Yavari, A. R.] Inst Natl Polytech Grenoble, SIMAP CNRS, Euronano, F-38031 Grenoble, France; [Chen, M. W.] Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China	Tohoku University; Russian Academy of Sciences; Joint Institute for High Temperatures of the Russian Academy of Sciences; Tohoku University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Shanghai Jiao Tong University	Chen, MW (corresponding author), Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan.	mwchen@wpi-aimr.tohoku.ac.jp	Chen, Ming/GVU-8412-2022; Hirata, Akihiko/A-4850-2010; yavari, alain R/E-8192-2010; CHEN, Mingwei/A-4855-2010; Fujita, Takeshi/B-1867-2009; Chen, Mingwei/A-4855-2010	CHEN, Mingwei/0000-0002-8274-3099; Fujita, Takeshi/0000-0002-2318-0433; Hirata, Akihiko/0000-0002-1770-8780; Chen, Mingwei/0000-0002-2850-8872	"WPI Research Center Initiative for Atoms, Molecules and Materials," Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [24360260, 24656400]; "A mathematical challenge to a new phase of materials science," Japan Science and Technology Agency-Core Research for Evolutional Science and Technology; National Natural Science Foundation of China [51271113]; Grants-in-Aid for Scientific Research [24656400, 23654020] Funding Source: KAKEN	"WPI Research Center Initiative for Atoms, Molecules and Materials," Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); "A mathematical challenge to a new phase of materials science," Japan Science and Technology Agency-Core Research for Evolutional Science and Technology(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Hirotsu and T. Egami for constructive discussion and H. Sheng for providing Zr-Pt embedded atom model potentials and J. Saida for Zr<INF>80</INF>Pt<INF>20</INF> ribbons. This work was sponsored by "WPI Research Center Initiative for Atoms, Molecules and Materials," Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research (24360260 and 24656400), Japan Society for the Promotion of Science; "A mathematical challenge to a new phase of materials science," Japan Science and Technology Agency-Core Research for Evolutional Science and Technology; and the National Natural Science Foundation of China (grant 51271113).	BERNAL JD, 1960, NATURE, V185, P68, DOI 10.1038/185068a0; Berthier L, 2011, REV MOD PHYS, V83, P587, DOI 10.1103/RevModPhys.83.587; Chen MW, 1999, APPL PHYS LETT, V75, P1697, DOI 10.1063/1.124793; Cheng YQ, 2011, PROG MATER SCI, V56, P379, DOI 10.1016/j.pmatsci.2010.12.002; Di Cicco A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.135505; Ediger MD, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4747326; EGAMI T, 1987, J NON-CRYST SOLIDS, V89, P60, DOI 10.1016/S0022-3093(87)80321-6; FINNEY JL, 1977, NATURE, V266, P309, DOI 10.1038/266309a0; FRANK FC, 1952, PROC R SOC LON SER-A, V215, P43, DOI 10.1098/rspa.1952.0194; Guan PF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.175501; HUMEROTHERY W, 1960, PHILOS MAG, V5, P383, DOI 10.1080/14786436008235856; Kaczynski T., 2003, COMPUTATIONAL HOMOLO; Kelton KF, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.195504; Langer J, 2007, PHYS TODAY, V60, P8, DOI 10.1063/1.2711621; Ma D, 2009, NAT MATER, V8, P30, DOI [10.1038/nmat2340, 10.1038/NMAT2340]; Mauro NA, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.184109; Miracle DB, 2004, NAT MATER, V3, P697, DOI 10.1038/nmat1219; Nelson D. R., 2002, DEFECTS GEOMETRY CON; NELSON DR, 1983, PHYS REV B, V28, P5515, DOI 10.1103/PhysRevB.28.5515; NELSON DR, 1983, PHYS REV LETT, V50, P982, DOI 10.1103/PhysRevLett.50.982; Sadoc J.-F., 1999, GEOMETRICAL FRUSTRAT; Saksl K, 2003, APPL PHYS LETT, V83, P3924, DOI 10.1063/1.1626266; Schenk T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.075507; SCOTT GD, 1962, NATURE, V194, P956, DOI 10.1038/194956a0; Sheng HW, 2006, NATURE, V439, P419, DOI 10.1038/nature04421; Shintani H, 2006, NAT PHYS, V2, P200, DOI 10.1038/nphys235; STEINHARDT PJ, 1981, PHYS REV LETT, V47, P1297, DOI 10.1103/PhysRevLett.47.1297; STEINHARDT PJ, 1983, PHYS REV B, V28, P784, DOI 10.1103/PhysRevB.28.784; Takagi T, 2001, APPL PHYS LETT, V79, P485, DOI 10.1063/1.1383055; Tarjus G, 2005, J PHYS-CONDENS MAT, V17, pR1143, DOI 10.1088/0953-8984/17/50/R01; TOMIDA T, 1995, PHYS REV B, V52, P3290, DOI 10.1103/PhysRevB.52.3290; Yavari AR, 2005, NAT MATER, V4, P2, DOI 10.1038/nmat1289	32	305	315	25	448	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144					376	379		10.1126/science.1232450	http://dx.doi.org/10.1126/science.1232450			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23845945				2022-12-28	WOS:000322259200044
J	Voskoboynik, A; Newman, AM; Corey, DM; Sahoo, D; Pushkarev, D; Neff, NF; Passarelli, B; Koh, W; Ishizuka, KJ; Palmeri, KJ; Dimov, IK; Keasar, C; Fan, HC; Mantalas, GL; Sinha, R; Penland, L; Quake, SR; Weissman, IL				Voskoboynik, Ayelet; Newman, Aaron M.; Corey, Daniel M.; Sahoo, Debashis; Pushkarev, Dmitry; Neff, Norma F.; Passarelli, Benedetto; Koh, Winston; Ishizuka, Katherine J.; Palmeri, Karla J.; Dimov, Ivan K.; Keasar, Chen; Fan, H. Christina; Mantalas, Gary L.; Sinha, Rahul; Penland, Lolita; Quake, Stephen R.; Weissman, Irving L.			Identification of a Colonial Chordate Histocompatibility Gene	SCIENCE			English	Article							IMMUNE-SYSTEM; PROTOCHORDATE; ALLORECOGNITION; CELLS; MODEL; GERM	Histocompatibility is the basis by which multicellular organisms of the same species distinguish self from nonself. Relatively little is known about the mechanisms underlying histocompatibility reactions in lower organisms. Botryllus schlosseri is a colonial urochordate, a sister group of vertebrates, that exhibits a genetically determined natural transplantation reaction, whereby self-recognition between colonies leads to formation of parabionts with a common vasculature, whereas rejection occurs between incompatible colonies. Using genetically defined lines, whole-transcriptome sequencing, and genomics, we identified a single gene that encodes self-nonself and determines "graft" outcomes in this organism. This gene is significantly up-regulated in colonies poised to undergo fusion and/or rejection, is highly expressed in the vasculature, and is functionally linked to histocompatibility outcomes. These findings establish a platform for advancing the science of allorecognition.	[Voskoboynik, Ayelet; Newman, Aaron M.; Corey, Daniel M.; Sahoo, Debashis; Ishizuka, Katherine J.; Palmeri, Karla J.; Dimov, Ivan K.; Sinha, Rahul; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Voskoboynik, Ayelet; Ishizuka, Katherine J.; Palmeri, Karla J.; Weissman, Irving L.] Stanford Univ, Hopkins Marine Stn, Dept Dev Biol, Pacific Grove, CA 93950 USA; [Pushkarev, Dmitry; Neff, Norma F.; Passarelli, Benedetto; Koh, Winston; Fan, H. Christina; Mantalas, Gary L.; Penland, Lolita; Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Pushkarev, Dmitry; Neff, Norma F.; Passarelli, Benedetto; Koh, Winston; Fan, H. Christina; Mantalas, Gary L.; Penland, Lolita; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Pushkarev, Dmitry; Neff, Norma F.; Passarelli, Benedetto; Koh, Winston; Fan, H. Christina; Mantalas, Gary L.; Penland, Lolita; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Keasar, Chen] Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel; [Weissman, Irving L.] Stanford Univ, Sch Med, Ludwig Ctr Canc Stem Cell Res & Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Ben Gurion University; Stanford University	Voskoboynik, A (corresponding author), Illumina Inc, Hayward, CA 94545 USA.	ayeletv@stanford.edu; amnewman@stanford.edu; quake@stanford.edu; irv@stanford.edu	Koh, Lian Chye Winston/GYD-5873-2022; Newman, Aaron M/ABE-1620-2021; KEASAR, CHEN/HGB-9794-2022; Keasar, Chen/J-8413-2012	Koh, Lian Chye Winston/0000-0003-4611-6490; Newman, Aaron M/0000-0002-1857-8172; Keasar, Chen/0000-0003-0994-1520	NIH [1R56AI089968, R01GM100315, 1R01AG037968, K99CA151673-01A1]; Virginia and D. K. Ludwig Fund for Cancer Research; Department of Defense [W81XWH-10-1-0500]; Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; NATIONAL CANCER INSTITUTE [K99CA151673, T32CA009302, R00CA151673] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL087746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI089968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037968] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and D. K. Ludwig Fund for Cancer Research; Department of Defense(United States Department of Defense); Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank B. Rinkevich for pointing out the difficulty with the original cFuHC assignments and T. Snyder, J. Okamoto, L. Me, L. Ooi, A. Dominguez, C. Lowe, K. Uhlinger, L. Crowder, S. Karten, C. Patton, L. Jerabek, and T. Storm for invaluable technical advice and help. A. De Tomaso provided the fosmid sequence used to characterize cFuHC (12) (table S5). D. P., A. V., and S. R. Q. have filed U.S. and international patent applications (61/532,882 and 13/608,778, respectively) entitled "Methods for obtaining a sequence." This invention allows for the sequencing of long continuous (kilobase scale) nucleic acid fragments using conventional short read-sequencing technologies, useful for consensus sequencing and haplotype determination. This study was supported by NIH grants 1R56AI089968, R01GM100315, and 1R01AG037968 awarded to I. L. W., A. V., and S. R. Q., respectively, and the Virginia and D. K. Ludwig Fund for Cancer Research awarded to I. L. W. D. S. was supported by NIH grant K99CA151673-01A1 and Department of Defense Grant W81XWH-10-1-0500, and A.M.N., D. M. C., D. S., and I. K. D. were supported by a grant from the Siebel Stem Cell Institute and the Thomas and Stacey Siebel Foundation. The data in this paper are tabulated in the main manuscript and in the supplementary materials. BHF, sFuHC, and mFuHC sequences are available in GenBank under accession numbers KF017887-KF017889, and the RNA-Seq data are available on the Sequence Read Archive (SRA) database: BioProject SRP022042.	Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Colonna M, 2010, NAT IMMUNOL, V11, P1079, DOI [10.1038/ni1210-1079, 10.1038/ni0211-107]; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; De Tomaso AW, 1998, GENETICS, V149, P277; De Tomaso AW, 2003, IMMUNOGENETICS, V55, P480, DOI 10.1007/s00251-003-0612-7; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dishaw LJ, 2009, CURR BIOL, V19, pR286, DOI 10.1016/j.cub.2009.02.035; Girardi G, 2011, MOL IMMUNOL, V48, P1621, DOI 10.1016/j.molimm.2011.04.011; Hirano M, 2011, ADV IMMUNOL, V109, P125, DOI 10.1016/B978-0-12-387664-5.00004-2; Laird DJ, 2005, CELL, V123, P1351, DOI 10.1016/j.cell.2005.10.026; LaRosa DF, 2007, J IMMUNOL, V178, P7503, DOI 10.4049/jimmunol.178.12.7503; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Nakashima A, 2012, AM J REPROD IMMUNOL, V67, P304, DOI 10.1111/j.1600-0897.2012.01115.x; Oka H., 1957, Proceedings of the Japan Academy, V33, P657; OKA HIDEMITI, 1960, BULL MAR BIOL STA ASAMUSHI TOHOKU UNIV, V10, P153; Oren M, 2007, DEV COMP IMMUNOL, V31, P889, DOI 10.1016/j.dci.2006.12.009; Rinkevich B, 2012, DEV COMP IMMUNOL, V36, P718, DOI 10.1016/j.dci.2011.10.015; SABBADIN A, 1962, REND ACCAD NAZ LINCE, V32, P1031; Sachs DH, 2011, SEMIN IMMUNOL, V23, P165, DOI 10.1016/j.smim.2011.07.001; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Stoner DS, 1996, P NATL ACAD SCI USA, V93, P15254, DOI 10.1073/pnas.93.26.15254; Voskoboynik A, 2008, CELL STEM CELL, V3, P456, DOI 10.1016/j.stem.2008.07.023; Voskoboynik A, 2013, ELIFE, V2, DOI 10.7554/eLife.00569	24	56	56	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144					384	387		10.1126/science.1238036	http://dx.doi.org/10.1126/science.1238036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888037	Green Accepted			2022-12-28	WOS:000322259200046
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: motherhood	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], SURV 1 DAY WORLDS MO; Bates C, 2012, MAILONLINE      0201; Bellingham M., 2013, 37 ROYAL COLL OBST G; Centers for Disease Control and Prevention, 2010, PREGN WOM TOX; Collins Nick, 2013, TELEGRAPH; de Jonge A, 2013, BRIT MED J, V346, pf3263; Einarsdottir K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002789; Fewtrell M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c5955; Jonsdottir G, 2009, ACTA OBSTET GYN SCAN, V88, P621, DOI 10.1080/00016340902818196; NHS Choices, 2013, FOODS AV; Tuffnell D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5560	11	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2013	347								f4559	10.1136/bmj.f4559	http://dx.doi.org/10.1136/bmj.f4559			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BM	23884970				2022-12-28	WOS:000322531800008
J	Wright, MP; Michelson, JD				Wright, Michael P.; Michelson, James D.			EASILY MISSED? Lisfranc injuries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FRACTURE-DISLOCATION; MIDFOOT SPRAINS; MANAGEMENT; ATHLETE		[Wright, Michael P.; Michelson, James D.] Univ Vermont, Sch Med, Dept Orthopaed & Rehabil, Burlington, VT 05401 USA	University of Vermont	Michelson, JD (corresponding author), Univ Vermont, Sch Med, Dept Orthopaed & Rehabil, Stafford 418A,95 Carrigan Dr, Burlington, VT 05401 USA.	james.michelson@uvm.edu	Michelson, James/C-6653-2013	Michelson, James/0000-0001-6997-2666				Ebraheim NA, 1996, FOOT ANKLE INT, V17, P685, DOI 10.1177/107110079601701107; ENGLANOFF G, 1995, ANN EMERG MED, V26, P229, DOI 10.1016/S0196-0644(95)70156-7; HATCH RL, 1994, J FAM PRACTICE, V38, P238; KAPLAN JD, 1991, J AM PODIAT MED ASSN, V81, P531, DOI 10.7547/87507315-81-10-531; MEYER SA, 1994, AM J SPORT MED, V22, P392, DOI 10.1177/036354659402200316; Myerson MS, 2008, J BONE JOINT SURG AM, V90A, P2522; MYERSON MS, 1986, FOOT ANKLE, V6, P225, DOI 10.1177/107110078600600504; Nunley JA, 2002, AM J SPORT MED, V30, P871, DOI 10.1177/03635465020300061901; Potter HG, 1998, FOOT ANKLE INT, V19, P438, DOI 10.1177/107110079801900704; Sands AK, 2004, INJURY S2, V35, P71; Sherief TI, 2007, INJURY, V38, P856, DOI 10.1016/j.injury.2006.10.002; Van Rijn J, 2011, J FOOT ANKLE SURG; VUORI JP, 1993, J TRAUMA, V35, P40, DOI 10.1097/00005373-199307000-00007	13	8	11	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2013	347								f4561	10.1136/bmj.f4561	http://dx.doi.org/10.1136/bmj.f4561			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192YR	23881945				2022-12-28	WOS:000322524400005
J	Crow, MM				Crow, Michael M.			Look, then leap	NATURE			English	Editorial Material									[Crow, Michael M.] Arizona State Univ, Tempe, AZ 85287 USA; [Crow, Michael M.] Columbia Univ, New York, NY USA	Arizona State University; Arizona State University-Tempe; Columbia University	Crow, MM (corresponding author), Arizona State Univ, Tempe, AZ 85287 USA.	michael.crow@asu.edu							0	3	3	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					275	277		10.1038/499275a	http://dx.doi.org/10.1038/499275a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23868245	Bronze			2022-12-28	WOS:000321910700013
J	Iacobucci, G				Iacobucci, Gareth			A sixth of hospitals in England have expanded private patient options this year, the BMJ finds	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NHS											Care UK, SELF PAY; Care UK, INTR SELF PAY CAR UK; Iacobucci G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4432; Kmietowicz Z, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4507; Kmietowicz Z, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4823; O'Dowd A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5128; Warrington and Halton Hospitals, MY CHOIC VAR VEIN CA	7	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2013	347								f4524	10.1136/bmj.f4524	http://dx.doi.org/10.1136/bmj.f4524			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	189DG	23873920				2022-12-28	WOS:000322246700008
J	Cook, NR; Lee, IM; Zhang, SMM; Moorthy, MV; Buring, JE				Cook, Nancy R.; Lee, I-Min; Zhang, Shumin M.; Moorthy, M. Vinayaga; Buring, Julie E.			Alternate-Day, Low-Dose Aspirin and Cancer Risk: Long-Term Observational Follow-up of a Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							COLORECTAL-CANCER; PRIMARY PREVENTION; CHEMOPREVENTION; MORTALITY; MODELS; DRUGS	Background: Recent evidence suggests that daily aspirin use decreases cancer risk, particularly for colorectal cancer, but evidence for alternate-day use is scant. Objective: To examine the association between long-term, alternate-day, low-dose aspirin and cancer in healthy women. Design: Observational follow-up of a randomized trial. Setting: Female health professionals. Participants: 39 876 women aged 45 years or older in the Women's Health Study (ClinicalTrials.gov: NCT00000479), 33 682 of whom continued observational follow-up. Intervention: 100 mg of alternate-day aspirin or placebo through March 2004, with a median 10-year follow-up. Posttrial follow-up continued through March 2012. Measurements: Cancer incidence. Results: A total of 5071 cancer cases (including 2070 breast, 451 colorectal, and 431 lung cancer cases) and 1391 cancer deaths were confirmed. Over the entire follow-up, aspirin had no association with total (hazard ratio [HR], 0.97 [95% CI, 0.92 to 1.03]; P = 0.31), breast (HR, 0.98 [CI, 0.90 to 1.07]; P = 0.65), or lung (HR, 1.04 [CI, 0.86 to 1.26]; P = 0.67) cancer. Colorectal cancer was reduced in the aspirin group (HR, 0.80 [CI, 0.67 to 0.97]; P = 0.021), primarily for proximal colon cancer (HR, 0.73 [CI, 0.55 to 0.95]; P = 0.022). The difference emerged after 10 years, with a posttrial reduction of 42% (HR, 0.58 [CI, 0.42 to 0.80]; P < 0.001). There was no extended effect on cancer deaths or colorectal polyps. More gastrointestinal bleeding (HR, 1.14 [CI, 1.06 to 1.22]; P < 0.001) and peptic ulcers (HR, 1.17 [CI, 1.09 to 1.27]; P < 0.001) occurred in the aspirin group. Limitations: Not all women received extended follow-up, and posttrial ascertainment bias cannot be ruled out. Gastrointestinal bleeding, peptic ulcers, and polyps were self-reported during extended follow-up. Conclusion: Long-term use of alternate-day, low-dose aspirin may reduce risk for colorectal cancer in healthy women.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Cook, NR (corresponding author), Brigham & Womens Hosp, 900 Commonwealth Ave East, Boston, MA 02215 USA.	ncook@rics.bwh.harvard.edu	Lee, I-Min/ABD-5409-2021		National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851, R01HL080467, RC1HL099355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Primary Funding Source: National Institutes of Health.	Austin PC, 2012, STAT MED; Bosetti C, 2012, ANN ONCOL, V23, P1403, DOI 10.1093/annonc/mds113; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P27; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Calonge N, 2009, ANN INTERN MED, V150, P396; Chan AT, 2012, LANCET, V379, P1569, DOI 10.1016/S0140-6736(11)61654-1; Chan AT, 2012, CANCER PREV RES, V5, P164, DOI 10.1158/1940-6207.CAPR-11-0391; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; COX DR, 1972, J R STAT SOC B, V34, P187; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Dorresteijn JAN, 2011, EUR HEART J, V32, P2962, DOI 10.1093/eurheartj/ehr423; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Langley RE, 2011, BRIT J CANCER, V105, P1107, DOI 10.1038/bjc.2011.289; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Patrono C, 2001, CHEST, V119, p39S, DOI 10.1378/chest.119.1_suppl.39S; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; Therneau TM, 2000, MODELING SURVIVAL DA; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; Thun MJ, 2000, EPIDEMIOLOGY, V11, P371, DOI 10.1097/00001648-200007000-00001	28	226	230	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2					77	W32		10.7326/0003-4819-159-2-201307160-00002	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-00002			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23856681	Green Accepted			2022-12-28	WOS:000322112000013
J	Wayangankar, SA; Aronow, HD				Wayangankar, Siddharth A.; Aronow, Herbert D.			Nonemergency PCI without onsite cardiac surgery was noninferior to PCI with onsite services for MACE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Wayangankar, Siddharth A.] Univ Oklahoma, Oklahoma City, OK USA; [Aronow, Herbert D.] St Joseph Mercy Hosp, Ann Arbor, MI 48104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Saint Joseph Mercy Health System (SJMHS)	Wayangankar, SA (corresponding author), Univ Oklahoma, Oklahoma City, OK USA.							Aversano T, 2012, NEW ENGL J MED, V366, P1792, DOI 10.1056/NEJMoa1114540; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007	2	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2							JC6	10.7326/0003-4819-159-2-201307160-02006	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23856704				2022-12-28	WOS:000322112000005
J	Lyra, W; Kuchner, M				Lyra, W.; Kuchner, M.			Formation of sharp eccentric rings in debris disks with gas but without planets	NATURE			English	Article							BETA-PICTORIS; FOMALHAUT B; DUST; TURBULENCE; ORIGIN; SYSTEM	'Debris disks' around young stars (analogues of the Kuiper Belt in our Solar System) show a variety of non-trivial structures attributed to planetary perturbations and used to constrain the properties of those planets(1-3). However, these analyses have largely ignored the fact that some debris disks are found to contain small quantities of gas(4-9), a component that all such disks should contain at some level(10,11). Several debris disks have been measured with a dust-to-gas ratio of about unity(4-9), at which the effect of hydrodynamics on the structure of the disk cannot be ignored(12,13). Here we report linear and nonlinear modelling that shows that dust-gas interactions can produce some of the key patterns attributed to planets. We find a robust clumping instability that organizes the dust into narrow, eccentric rings, similar to the Fomalhaut debris disk(14). The conclusion that such disks might contain planets is not necessarily required to explain these systems.	[Lyra, W.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Lyra, W.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Lyra, W.] Amer Museum Nat Hist, Dept Astrophys, New York, NY 10024 USA; [Kuchner, M.] NASA, Goddard Space Flight Ctr, Exoplanets & Stellar Astrophys Lab, Greenbelt, MD 21230 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; American Museum of Natural History (AMNH); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Lyra, W (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	wlyra@caltech.edu; marc.j.kuchner@nasa.gov			National Science Foundation [AST10-09802]; National Aeronautics and Space Administration; National Science Foundation; NASA Astrobiology Institute through the Goddard Center for Astrobiology; Direct For Mathematical & Physical Scien [1009802] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); NASA Astrobiology Institute through the Goddard Center for Astrobiology; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank H. Latter and G. Stewart for discussions. The writing of this paper started at the American Museum of Natural History, with financial support by the National Science Foundation under grant no. AST10-09802, and was completed at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration. This research was supported by an allocation of advanced computing resources supported by the National Science Foundation. The computations were performed on the Kraken system at the National Institute for Computational Sciences. W. L. is a Carl Sagan fellow. M. K. is supported in part by the NASA Astrobiology Institute through the Goddard Center for Astrobiology.	Besla G, 2007, ASTROPHYS J, V655, P528, DOI 10.1086/509495; Boley AC, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/1/L21; Brandeker A, 2004, ASTRON ASTROPHYS, V413, P681, DOI 10.1051/0004-6361:20034326; Brandenburg A, 2002, COMPUT PHYS COMMUN, V147, P471, DOI 10.1016/S0010-4655(02)00334-X; Buenzli E, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201015799; Chiang E, 2009, ASTROPHYS J, V693, P734, DOI 10.1088/0004-637X/693/1/734; Currie T, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/2/L32; Czechowski A, 2007, ASTROPHYS J, V660, P1541, DOI 10.1086/512965; Grigorieva A, 2007, ASTRON ASTROPHYS, V475, P755, DOI 10.1051/0004-6361:20077686; Janson M, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/116; Kalas P, 2005, NATURE, V435, P1067, DOI 10.1038/nature03601; Klahr H, 2005, ASTROPHYS J, V632, P1113, DOI 10.1086/432965; Kuchner MJ, 2003, ASTROPHYS J, V588, P1110, DOI 10.1086/374213; Lagrange AM, 1998, ASTRON ASTROPHYS, V330, P1091; Lesur G, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200913594; Liseau R, 1999, ASTRON ASTROPHYS, V348, P133; Lyra W, 2008, ASTRON ASTROPHYS, V479, P883, DOI 10.1051/0004-6361:20077948; Lyra W, 2009, ASTRON ASTROPHYS, V497, P869, DOI 10.1051/0004-6361/200811265; Maness HL, 2008, ASTROPHYS J LETT, V686, pL25, DOI 10.1086/592783; Moor A, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/1/L7; Olofsson G, 2001, ASTROPHYS J, V563, pL77, DOI 10.1086/338354; Redfield S, 2007, ASTROPHYS J, V656, pL97, DOI 10.1086/512237; Roberge A, 2006, NATURE, V441, P724, DOI 10.1038/nature04832; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; STUART JT, 1971, ANNU REV FLUID MECH, V3, P347, DOI 10.1146/annurev.fl.03.010171.002023; Takeuchi T, 2001, ASTROPHYS J, V557, P990, DOI 10.1086/322252; Troutman MR, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/12; ZUCKERMAN B, 1995, NATURE, V373, P494, DOI 10.1038/373494a0	30	79	79	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					184	187		10.1038/nature12281	http://dx.doi.org/10.1038/nature12281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23846656	Green Published, Green Submitted			2022-12-28	WOS:000321557600056
J	Faith, JJ; Guruge, JL; Charbonneau, M; Subramanian, S; Seedorf, H; Goodman, AL; Clemente, JC; Knight, R; Heath, AC; Leibel, RL; Rosenbaum, M; Gordon, JI				Faith, Jeremiah J.; Guruge, Janaki L.; Charbonneau, Mark; Subramanian, Sathish; Seedorf, Henning; Goodman, Andrew L.; Clemente, Jose C.; Knight, Rob; Heath, Andrew C.; Leibel, Rudolph L.; Rosenbaum, Michael; Gordon, Jeffrey I.			The Long-Term Stability of the Human Gut Microbiota	SCIENCE			English	Article							ENERGY-EXPENDITURE; RIBOSOMAL-RNA; TWINS; WEIGHT; DIVERSITY; BACTERIA; GENOME; OBESE; FLORA	A low-error 16S ribosomal RNA amplicon sequencing method, in combination with whole-genome sequencing of >500 cultured isolates, was used to characterize bacterial strain composition in the fecal microbiota of 37 U.S. adults sampled for up to 5 years. Microbiota stability followed a power-law function, which when extrapolated suggests that most strains in an individual are residents for decades. Shared strains were recovered from family members but not from unrelated individuals. Sampling of individuals who consumed a monotonous liquid diet for up to 32 weeks indicated that changes in strain composition were better predicted by changes in weight than by differences in sampling interval. This combination of stability and responsiveness to physiologic change confirms the potential of the gut microbiota as a diagnostic tool and therapeutic target.	[Faith, Jeremiah J.; Guruge, Janaki L.; Charbonneau, Mark; Subramanian, Sathish; Seedorf, Henning; Goodman, Andrew L.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Clemente, Jose C.; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Biofrontiers Inst, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Leibel, Rudolph L.; Rosenbaum, Michael] Columbia Univ Coll Phys & Surg, Div Mol Genet, Dept Pediat, New York, NY 10032 USA; [Leibel, Rudolph L.; Rosenbaum, Michael] Columbia Univ Coll Phys & Surg, Div Mol Genet, Dept Med, New York, NY 10032 USA	Washington University (WUSTL); Washington University (WUSTL); University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Columbia University; Columbia University	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu	Seedorf, Henning/AAW-6023-2020; Knight, Rob/D-1299-2010	Seedorf, Henning/0000-0002-5763-0236; Knight, Rob/0000-0002-0975-9019	NIH [DK30292, DK078669, DK70977, DK64774, UL1TR000040]; Crohn's and Colitis Foundation of America; Groupe Danone; Howard Hughes Medical Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK064773, R01DK070977, R01DK030292, R37DK030292, P01DK078669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Groupe Danone(Danone Nutricia); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank D. Hopper and S. Marion for their contributions to the recruitment of twins from the MOAFTS cohort and for obtaining fecal samples for the present study; J. Hoisington-Lopez, M. Meier, and S. Deng for technical assistance; and members of the Gordon lab for their many helpful suggestions during the course of this study. Supported by NIH grants DK30292, DK078669, DK70977, DK64774, and UL1TR000040; the Crohn's and Colitis Foundation of America; Groupe Danone (through partial support of the postdoctoral stipend of J. J. F.); and the Howard Hughes Medical Institute. Draft genome assemblies are available from the European Bioinformatics Institute (EBI) under accession numbers PRJEB3419 to PRJEB3951. Raw and processed LEA-Seq data, as well as experimental protocols for LEA-Seq and phased 16S rRNA amplicon sequencing, can be found at http://gordonlab.wustl.edu/microbiota_stability/. The authors do not declare any conflicts of interest. Author contributions: J. J. F. and J. I. G. designed the experiments; A. C. H., R. L. L., and M. R. oversaw human studies; J. J. F., J. L. G., M. C., S. S., H. S., and A. L. G. generated the data; J. J. F., R. K., J. C. C., S. S., and J. I. G. analyzed data; J. J. F. and J. I. G. wrote the paper.	Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Halfvarson J, 2011, INFLAMM BOWEL DIS, V17, P6, DOI 10.1002/ibd.21295; Hansen EE, 2011, P NATL ACAD SCI USA, V108, P4599, DOI 10.1073/pnas.1000071108; Henz Stefan R, 2005, Bioinformatics, V21, P2329, DOI 10.1093/bioinformatics/bth324; Hiatt JB, 2010, NAT METHODS, V7, P119, DOI [10.1038/NMETH.1416, 10.1038/nmeth.1416]; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Kissileff HR, 2012, AM J CLIN NUTR, V95, P309, DOI 10.3945/ajcn.111.012385; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; MITSUOKA T, 1992, NUTR REV, V50, P438, DOI 10.1111/j.1753-4887.1992.tb02499.x; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2013, ENVIRON MICROBIOL, V15, P1146, DOI 10.1111/1462-2920.12023; Rosenbaum M, 1997, J CLIN ENDOCR METAB, V82, P3647, DOI 10.1210/jc.82.11.3647; Rosenbaum M, 1996, AM J PHYSIOL-REG I, V270, pR496, DOI 10.1152/ajpregu.1996.270.3.R496; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Slutske WS, 2004, J ABNORM PSYCHOL, V113, P530, DOI 10.1037/0021-843X.113.4.530; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Waldron M, 2013, J STUD ALCOHOL DRUGS, V74, P337, DOI 10.15288/jsad.2013.74.337; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	28	1147	1213	17	382	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2013	341	6141					44	+	1237439	10.1126/science.1237439	http://dx.doi.org/10.1126/science.1237439			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828941	Green Accepted			2022-12-28	WOS:000321291700041
J	Ghafur, A				Ghafur, Abdul			India must overhaul medical training to act on antimicrobial resistance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Apollo Hosp, Madras, Tamil Nadu, India		Ghafur, A (corresponding author), Apollo Hosp, Madras, Tamil Nadu, India.	drghafur@hotmail.com						Ghafur A, 2013, INDIAN J CANCER, V50, P71, DOI 10.4103/0019-509X.104065; Hopkins S., 2013, BRIT MED J, V346, pf591	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2013	347								f4230	10.1136/bmj.f4230	http://dx.doi.org/10.1136/bmj.f4230			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180CZ	23823999				2022-12-28	WOS:000321571800004
J	Sanna-Cherchi, S; Sampogna, RV; Papeta, N; Burgess, KE; Nees, SN; Perry, BJ; Choi, M; Bodria, M; Liu, Y; Weng, PL; Lozanovski, VJ; Verbitsky, M; Lugani, F; Sterken, R; Paragas, N; Caridi, G; Carrea, A; Dagnino, M; Materna-Kiryluk, A; Santamaria, G; Murtas, C; Ristoska-Bojkovska, N; Izzi, C; Kacak, N; Bianco, B; Giberti, S; Gigante, M; Piaggio, G; Gesualdo, L; Vukic, DK; Vukojevic, K; Saraga-Babic, M; Saraga, M; Gucev, Z; Allegri, L; Latos-Bielenska, A; Casu, D; State, M; Scolari, F; Ravazzolo, R; Kiryluk, K; Al-Awqati, Q; D'Agati, VD; Drummond, IA; Tasic, V; Lifton, RP; Ghiggeri, GM; Gharavi, AG				Sanna-Cherchi, S.; Sampogna, R. V.; Papeta, N.; Burgess, K. E.; Nees, S. N.; Perry, B. J.; Choi, M.; Bodria, M.; Liu, Y.; Weng, P. L.; Lozanovski, V. J.; Verbitsky, M.; Lugani, F.; Sterken, R.; Paragas, N.; Caridi, G.; Carrea, A.; Dagnino, M.; Materna-Kiryluk, A.; Santamaria, G.; Murtas, C.; Ristoska-Bojkovska, N.; Izzi, C.; Kacak, N.; Bianco, B.; Giberti, S.; Gigante, M.; Piaggio, G.; Gesualdo, L.; Vukic, D. Kosuljandic; Vukojevic, K.; Saraga-Babic, M.; Saraga, M.; Gucev, Z.; Allegri, L.; Latos-Bielenska, A.; Casu, D.; State, M.; Scolari, F.; Ravazzolo, R.; Kiryluk, K.; Al-Awqati, Q.; D'Agati, V. D.; Drummond, I. A.; Tasic, V.; Lifton, R. P.; Ghiggeri, G. M.; Gharavi, A. G.			Mutations in DSTYK and Dominant Urinary Tract Malformations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGENITAL-ANOMALIES; RENAL HYPODYSPLASIA; KIDNEY; FGF; CHILDREN; GENES	BackgroundCongenital abnormalities of the kidney and the urinary tract are the most common cause of pediatric kidney failure. These disorders are highly heterogeneous, and the etiologic factors are poorly understood. MethodsWe performed genomewide linkage analysis and whole-exome sequencing in a family with an autosomal dominant form of congenital abnormalities of the kidney or urinary tract (seven affected family members). We also performed a sequence analysis in 311 unrelated patients, as well as histologic and functional studies. ResultsLinkage analysis identified five regions of the genome that were shared among all affected family members. Exome sequencing identified a single, rare, deleterious variant within these linkage intervals, a heterozygous splice-site mutation in the dual serine-threonine and tyrosine protein kinase gene (DSTYK). This variant, which resulted in aberrant splicing of messenger RNA, was present in all affected family members. Additional, independent DSTYK mutations, including nonsense and splice-site mutations, were detected in 7 of 311 unrelated patients. DSTYK is highly expressed in the maturing epithelia of all major organs, localizing to cell membranes. Knockdown in zebrafish resulted in developmental defects in multiple organs, which suggested loss of fibroblast growth factor (FGF) signaling. Consistent with this finding is the observation that DSTYK colocalizes with FGF receptors in the ureteric bud and metanephric mesenchyme. DSTYK knockdown in human embryonic kidney cells inhibited FGF-stimulated phosphorylation of extracellular-signal-regulated kinase (ERK), the principal signal downstream of receptor tyrosine kinases. ConclusionsWe detected independent DSTYK mutations in 2.3% of patients with congenital abnormalities of the kidney or urinary tract, a finding that suggests that DSTYK is a major determinant of human urinary tract development, downstream of FGF signaling. (Funded by the National Institutes of Health and others.) Exome sequencing in a family with autosomal dominant congenital urinary tract malformations showed a mutation in dual serine-threonine and tyrosine protein kinase (DSTYK), confirmed in other, unrelated patients, identifying a major determinant of human urinary tract development. Congenital malformations of the kidney and urinary tract contribute to 23% of birth defects(1),(2) and account for 40 to 50% of pediatric cases and 7% of adult cases of end-stage renal disease (ESRD) worldwide.(3),(4) These disorders are genetically heterogeneous and encompass a wide range of anatomical defects, such as renal agenesis, renal hypodysplasia, ureteropelvic junction obstruction, or vesicoureteral reflux.(5) Mutations in genes that cause syndromic disorders, such as HNF1B and PAX2 mutations, are detected in only 5 to 10% of cases.(6),(7) Familial forms of nonsyndromic disease have been reported, further supporting genetic determination(8),(9); however, owing ...	[Sanna-Cherchi, S.; Sampogna, R. V.; Papeta, N.; Burgess, K. E.; Nees, S. N.; Perry, B. J.; Weng, P. L.; Verbitsky, M.; Lugani, F.; Sterken, R.; Paragas, N.; Kacak, N.; Kiryluk, K.; Al-Awqati, Q.; Gharavi, A. G.] Columbia Univ, Div Nephrol, New York, NY USA; [Weng, P. L.] Columbia Univ, Div Pediat Nephrol, New York, NY USA; [D'Agati, V. D.] Columbia Univ, Dept Pathol, New York, NY USA; [Sanna-Cherchi, S.] St Lukes Roosevelt Hosp, Dept Med, New York, NY USA; [Choi, M.; Saraga, M.; Lifton, R. P.] Yale Univ, Dept Genet, Howard & Hughes Med Inst, New Haven, CT USA; [Choi, M.; Saraga, M.; Lifton, R. P.] Yale Univ, Yale Ctr Mendelian Genom, New Haven, CT USA; [Choi, M.] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Bodria, M.; Lugani, F.; Caridi, G.; Carrea, A.; Dagnino, M.; Murtas, C.; Piaggio, G.; Ghiggeri, G. M.] Univ Genoa, Div Nephrol Dialysis & Transplantat, Ist Giannina Gaslini, I-16126 Genoa, Italy; [Santamaria, G.; Ravazzolo, R.] Univ Genoa, Mol Genet Lab, Ist Giannina Gaslini, I-16126 Genoa, Italy; [Bodria, M.] Univ Genoa, Div Nephrol, Dept Internal Med, I-16126 Genoa, Italy; [Ravazzolo, R.] Univ Genoa, Dipartimento Neurosci Riabilitaz Oftalmol Genet &, I-16126 Genoa, Italy; [Bodria, M.] IRCCS San Martino IST, Genoa, Italy; [Izzi, C.; Scolari, F.] Univ Brescia, Cattedra Nefrol, Div Nefrol 2, Azienda Osped Spedali Civili Brescia Presidio Mon, Brescia, Italy; [Bianco, B.; Giberti, S.; Allegri, L.] Univ Parma, Dept Clin Med Nephrol & Hlth Sci, Nephrol Unit, I-43100 Parma, Italy; [Gigante, M.] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy; [Gesualdo, L.] Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy; [Casu, D.] Hosp Alghero, Div Nephrol & Dialysis, Alghero, Italy; [Liu, Y.; Drummond, I. A.] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA USA; [Drummond, I. A.] Harvard Univ, Sch Med, Dept Genet, Charlestown, MA USA; [Lozanovski, V. J.; Ristoska-Bojkovska, N.; Gucev, Z.; Tasic, V.] Univ Childrens Hosp, Med Sch Skopje, Skopje, Macedonia; [Materna-Kiryluk, A.; Latos-Bielenska, A.] Poznan Univ Med Sci, Dept Med Genet, Poznan, Poland; [Vukic, D. Kosuljandic; Saraga, M.] Univ Split, Univ Hosp Split, Dept Pediat, Split, Croatia; [Vukojevic, K.; Saraga-Babic, M.] Univ Split, Dept Anat Histol & Embryol, Split, Croatia; [State, M.] Univ Split, Sch Med, Split, Croatia	Columbia University; Columbia University; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Howard Hughes Medical Institute; Yale University; Yale University; Seoul National University (SNU); University of Genoa; IRCCS Istituto Giannina Gaslini; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Brescia; University of Parma; University of Foggia; Universita degli Studi di Bari Aldo Moro; Harvard University; Massachusetts General Hospital; Harvard University; Poznan University of Medical Sciences; University of Split; University of Split; University of Split	Gharavi, AG (corresponding author), Columbia Univ Coll Phys & Surg, Div Nephrol, 1150 St Nicholas Ave,Russ Berrie Pavil 413, New York, NY 10032 USA.	ag2239@columbia.edu	Piaggio, Giorgio/AAA-7344-2020; Gesualdo, Loreto/K-7751-2016; Caridi, Gianluca/F-7052-2010; State, Matthew/W-2256-2019; Gigante, Maddalena/R-4369-2016; Tasic, Velibor/H-8714-2019; Wang, Guilin/G-8794-2018; Izzi, Claudia/GZG-8769-2022; Ghiggeri, Gian Marco/N-4712-2015; Vukojevic, Katarina/AAU-1906-2020; Choi, Murim/AAP-9120-2021; bodria, monica/K-2115-2016; Vukojevic, Katarina/D-5246-2017; scolari, francesco/AAC-5957-2022; Saraga-Babic, Mirna/D-6362-2017; Saraga, Marijan/E-7647-2017; Murtas, Corrado/N-4981-2019; Izzi, Claudia/AAB-7004-2022; Santamaria, Giuseppe/AAB-4185-2021; Lozanovski, Vladimir J/AAP-9781-2020; Lugani, Francesca/J-7183-2016	Piaggio, Giorgio/0000-0003-3814-9997; Gesualdo, Loreto/0000-0002-4861-0911; Caridi, Gianluca/0000-0001-6700-3001; Gigante, Maddalena/0000-0001-8228-7639; Tasic, Velibor/0000-0002-3377-1245; Ghiggeri, Gian Marco/0000-0003-3659-9062; Vukojevic, Katarina/0000-0003-2182-2890; bodria, monica/0000-0001-9690-9945; Vukojevic, Katarina/0000-0003-2182-2890; Saraga-Babic, Mirna/0000-0002-9776-2532; Murtas, Corrado/0000-0001-7801-6596; Santamaria, Giuseppe/0000-0002-7686-6703; Lozanovski, Vladimir J/0000-0002-7332-3973; Paragas, Neal/0000-0001-6084-8220; Scolari, Francesco/0000-0003-0233-9705; Lugani, Francesca/0000-0002-4189-8561; Al-Awqati, Qais/0000-0001-7141-1040; Nees, Shannon/0000-0003-4046-3942; Izzi, Claudia/0000-0001-6253-3185; State, Matthew/0000-0003-1624-8302	National Institutes of Health [1R01DK080099, DK071041]; Italian Telethon Foundation [GGP08050]; National Human Genome Research Institute Centers for Mendelian Genomics [HG006504]; National Institute of Diabetes and Digestive and Kidney Diseases [K23-DK090207]; American Heart Association Scientist Development Grant [0930151N]; American Heart Association Grant-in-Aid [13GRNT14680075]; American Society of Nephrology Carl W. Gottschalk Research Scholar Grant; Fondazione Malattie Renali nel Bambino; American Society of Nephrology; Doris Duke Charitable Foundation; Polish Ministry of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504, UM1HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080099, R01DK053093, P30DK079310, K23DK090207, R01DK071041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Telethon Foundation(Fondazione Telethon); National Human Genome Research Institute Centers for Mendelian Genomics; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association Scientist Development Grant(American Heart Association); American Heart Association Grant-in-Aid(American Heart Association); American Society of Nephrology Carl W. Gottschalk Research Scholar Grant; Fondazione Malattie Renali nel Bambino; American Society of Nephrology; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Polish Ministry of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health (1R01DK080099, to Dr. Gharavi; DK071041, to Dr. Drummond), the Italian Telethon Foundation (GGP08050, to Dr. Ghiggeri), the National Human Genome Research Institute Centers for Mendelian Genomics (HG006504, to Dr. Lifton), and the National Institute of Diabetes and Digestive and Kidney Diseases (K23-DK090207, to Dr. Kiryluk); an American Heart Association Scientist Development Grant (0930151N), an American Heart Association Grant-in-Aid (13GRNT14680075), and an American Society of Nephrology Carl W. Gottschalk Research Scholar Grant (all to Dr. Sanna-Cherchi); and funding from the Fondazione Malattie Renali nel Bambino (to Dr. Ghiggeri), the American Society of Nephrology and the Doris Duke Charitable Foundation (to Dr. Nees), and the Polish Ministry of Health (to Drs. Materna-Kiryluk and Latos-Bielenska).	Abe G, 2007, DEV BIOL, V304, P355, DOI 10.1016/j.ydbio.2006.12.040; [Anonymous], 1993, TERATOLOGY, V48, P658; Ardissino G, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e382; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Bates CM, 2011, AM J PHYSIOL-RENAL, V301, pF245, DOI 10.1152/ajprenal.00186.2011; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Griffin KJP, 2003, DEV BIOL, V264, P456, DOI 10.1016/j.ydbio.2003.09.008; Guillemot F, 2011, NEURON, V71, P574, DOI 10.1016/j.neuron.2011.08.002; Langenau DM, 2005, P NATL ACAD SCI USA, V102, P6068, DOI 10.1073/pnas.0408708102; Loane M, 2011, BIRTH DEFECTS RES A, V91, pS31, DOI 10.1002/bdra.20778; Nissen RM, 2003, DEVELOPMENT, V130, P2543, DOI 10.1242/dev.00455; Poladia DP, 2006, DEV BIOL, V291, P325, DOI 10.1016/j.ydbio.2005.12.034; Sanna-Cherchi S, 2007, PEDIATR NEPHROL, V22, P1675, DOI 10.1007/s00467-007-0479-1; Sanna-Cherchi S, 2007, AM J HUM GENET, V80, P539, DOI 10.1086/512248; Sanna-Cherchi S, 2012, AM J HUM GENET, V91, P987, DOI 10.1016/j.ajhg.2012.10.007; Sanna-Cherchi S, 2011, KIDNEY INT, V80, P389, DOI 10.1038/ki.2011.148; Sanna-Cherchi S, 2009, KIDNEY INT, V76, P528, DOI 10.1038/ki.2009.220; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Thomas R, 2011, PEDIATR NEPHROL, V26, P897, DOI 10.1007/s00467-011-1826-9; Weber S, 2006, J AM SOC NEPHROL, V17, P2864, DOI 10.1681/ASN.2006030277; Weng PL, 2009, J AM SOC NEPHROL, V20, P1633, DOI 10.1681/ASN.2008111199; Woolf AS, 2002, PEDIATR DEVEL PATHOL, V5, P108, DOI 10.1007/s10024-001-0141-z; Zha J, 2004, BIOCHEM BIOPH RES CO, V319, P98; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	25	77	83	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2013	369	7					621	629		10.1056/NEJMoa1214479	http://dx.doi.org/10.1056/NEJMoa1214479			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YO	23862974	Green Accepted, Green Published			2022-12-28	WOS:000326354500008
J	Claveria, C; Giovinazzo, G; Sierra, R; Torres, M				Claveria, Cristina; Giovinazzo, Giovanna; Sierra, Rocio; Torres, Miguel			Myc-driven endogenous cell competition in the early mammalian embryo	NATURE			English	Article							COMPARTMENTS; GROWTH; STEM; APOPTOSIS; PATTERNS; DEATH; LEADS; SIZE	The epiblast is the mammalian embryonic tissue that contains the pluripotent stem cells that generate the whole embryo. We have established a method for inducing functional genetic mosaics in the mouse. Using this system, here we show that induction of a mosaic imbalance of Myc expression in the epiblast provokes the expansion of cells with higher Myc levels through the apoptotic elimination of cells with lower levels, without disrupting development. In contrast, homogeneous shifts in Myc levels did not affect epiblast cell viability, indicating that the observed competition results from comparison of relative Myc levels between epiblast cells. During normal development we found that Myc levels are intrinsically heterogeneous among epiblast cells, and that endogenous cell competition refines the epiblast cell population through the elimination of cells with low relative Myc levels. These results show that natural cell competition in the early mammalian embryo contributes to the selection of the epiblast cell pool.	[Claveria, Cristina; Giovinazzo, Giovanna; Sierra, Rocio; Torres, Miguel] CNIC, Dept Desarrollo & Reparac Cardiovasc, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Torres, M (corresponding author), CNIC, Dept Desarrollo & Reparac Cardiovasc, E-28029 Madrid, Spain.	mtorres@cnic.es	Giovinazzo, Giovanna/I-1283-2015; Torres, Miguel/CAG-0003-2022; Torres, Miguel/A-7388-2013	Giovinazzo, Giovanna/0000-0002-5391-0441; Torres, Miguel/0000-0003-0906-4767; Torres, Miguel/0000-0003-0906-4767	Ministerio de Economia y Competitividad (MINECO); Pro-CNIC Foundation; MINECO/ISCIII TerCel [RD06/0010/0008]; Human Frontiers Science Program [RGP0008/2004]; Madrid Regional Government [S-SAL-0190-2006, P2010/BMD-2315]	Ministerio de Economia y Competitividad (MINECO); Pro-CNIC Foundation; MINECO/ISCIII TerCel; Human Frontiers Science Program(Human Frontier Science Program); Madrid Regional Government	We thank S. Srinivas for pBigT and pROSA26PA vectors; I. Moreno de Alboran for Myc<SUP>flox/flox</SUP> mice; C. G. Arques for suggestions and patience; M. Manzanares for comments on the manuscript; L. M. Criado and S. Ortega for mouse generation; T. Cordoba, V. Garcia, E. Escudero and S. Vela for mouse work; J. L. Ligos, M. Viton and R. Nieto for help with flow cytometry; E. Arza and A. M. Santos for help with microscopy and three-dimensional reconstruction; F. Sanchez-Cabo and P. Lopez-Romero for statistics; and S. Bartlett for text editing. The CNIC is supported by the Ministerio de Economia y Competitividad (MINECO) and the Pro-CNIC Foundation. This work was supported by a MINECO/ISCIII TerCel grant (RD06/0010/0008) and the Human Frontiers Science Program(RGP0008/2004). C. C. is supported by grants from the Madrid Regional Government (S-SAL-0190-2006 and P2010/BMD-2315).	Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Diaz B, 2005, EXP CELL RES, V306, P317, DOI 10.1016/j.yexcr.2005.03.017; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Heyer BS, 2000, GENE DEV, V14, P2072; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Luscher B, 1986, Princess Takamatsu Symp, V17, P291; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; POELMANN RE, 1980, J EMBRYOL EXP MORPH, V55, P33; SIMPSON P, 1979, DEV BIOL, V69, P182, DOI 10.1016/0012-1606(79)90284-7; SIMPSON P, 1976, DEV BIOL, V54, P100, DOI 10.1016/0012-1606(76)90289-X; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tamori Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000422; Torres M, 1998, CURR TOP DEV BIOL, V36, P99; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147	31	229	232	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					39	U53		10.1038/nature12389	http://dx.doi.org/10.1038/nature12389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23842495				2022-12-28	WOS:000322514800023
J	Kang, SA; Pacold, ME; Cervantes, CL; Lim, D; Lou, HJ; Ottina, K; Gray, NS; Turk, BE; Yaffe, MB; Sabatini, DM				Kang, Seong A.; Pacold, Michael E.; Cervantes, Christopher L.; Lim, Daniel; Lou, Hua Jane; Ottina, Kathleen; Gray, Nathanael S.; Turk, Benjamin E.; Yaffe, Michael B.; Sabatini, David M.			mTORC1 Phosphorylation Sites Encode Their Sensitivity to Starvation and Rapamycin	SCIENCE			English	Article							EXTENDS LIFE-SPAN; MAMMALIAN TARGET; S6 KINASE; FKBP12-RAPAMYCIN COMPLEX; PROTEIN; AUTOPHAGY; INHIBITION; RAPTOR; TOR; GENERATION	The mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) protein kinase promotes growth and is the target of rapamycin, a clinically useful drug that also prolongs life span in model organisms. A persistent mystery is why the phosphorylation of many bona fide mTORC1 substrates is resistant to rapamycin. We find that the in vitro kinase activity of mTORC1 toward peptides encompassing established phosphorylation sites varies widely and correlates strongly with the resistance of the sites to rapamycin, as well as to nutrient and growth factor starvation within cells. Slight modifications of the sites were sufficient to alter mTORC1 activity toward them in vitro and to cause concomitant changes within cells in their sensitivity to rapamycin and starvation. Thus, the intrinsic capacity of a phosphorylation site to serve as an mTORC1 substrate, a property we call substrate quality, is a major determinant of its sensitivity to modulators of the pathway. Our results reveal a mechanism through which mTORC1 effectors can respond differentially to the same signals.	[Kang, Seong A.; Pacold, Michael E.; Cervantes, Christopher L.; Ottina, Kathleen; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kang, Seong A.; Pacold, Michael E.; Cervantes, Christopher L.; Ottina, Kathleen; Yaffe, Michael B.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Pacold, Michael E.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Pacold, Michael E.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Lim, Daniel; Yaffe, Michael B.; Sabatini, David M.] MIT, David H Koch Ctr Integrat Canc Res, Cambridge, MA 02139 USA; [Lou, Hua Jane; Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Yaffe, Michael B.] Harvard Univ, Sch Med, Beth Israel Deaconess Hosp, Dept Surg, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Yale University; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		Cervantes, Christopher/0000-0001-7351-6954; /0000-0002-1446-7256	NIH [CA103866, AI047389, ES015339, GM59281, CA112967]; Department of Defense [W81XWH-07-0448]; W.M. Keck Foundation; LAM (lymphangioleiomyomatosis) Foundation; American Cancer Society; LAM Foundation; Damon Runyon Cancer Research Foundation; Department of Defense Breast Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA103866, P30CA014051, U54CA112967, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059281] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); W.M. Keck Foundation(W.M. Keck Foundation); LAM (lymphangioleiomyomatosis) Foundation; American Cancer Society(American Cancer Society); LAM Foundation; Damon Runyon Cancer Research Foundation; Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Sabatini laboratory for helpful discussions, especially S. Wang, D. Kim, C. Thoreen, T. Wang, and J. Cantor and E. Spooner for the mass spectrometric analysis of samples. We also thank M. Pende for the S6K1/2 null cells and R. Shaw and C. Thompson for the ULK1/2 null cells. This work was supported by grants from the NIH (CA103866 and AI047389 to D. M. S.; ES015339, GM59281, and CA112967 to M.B.Y.) and Department of Defense (W81XWH-07-0448 to D. M. S.); awards from the W.M. Keck Foundation and the LAM (lymphangioleiomyomatosis) Foundation to D. M. S.; fellowships from the American Cancer Society and the LAM Foundation to S. A. K. and the Damon Runyon Cancer Research Foundation and the Department of Defense Breast Cancer Research Program to M. E. P. D. M. S. is an investigator of the Howard Hughes Medical Institute. Torin1, the inhibitor used here, is part of a Whitehead-Dana-Farber Cancer Institute patent application on which S. A. K., N.S.G., and D. M. S. are inventors. Shared reagents are subject to a materials transfer agreement.	Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Boulbes D, 2010, MOL CANCER RES, V8, P896, DOI 10.1158/1541-7786.MCR-09-0409; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BROWN EJ, 1995, NATURE, V378, P644, DOI 10.1038/378644c0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; PRICE DJ, 1989, J BIOL CHEM, V264, P13825; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Tao ZH, 2010, BIOCHEMISTRY-US, V49, P8488, DOI 10.1021/bi100673c; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	49	319	330	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144					364	+	1236566	10.1126/science.1236566	http://dx.doi.org/10.1126/science.1236566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888043	Green Accepted, Green Submitted			2022-12-28	WOS:000322259200040
J	Munn, MM; Oura, H; Gallivan, M; Van Horne, K; Shouse, AW				Munn, Maureen M.; Oura, Hiroki; Gallivan, Mark; Van Horne, Katie; Shouse, Andrew W.			Engaging High School Students in Research on Smoking Behavior	SCIENCE			English	Editorial Material									[Munn, Maureen M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Oura, Hiroki; Van Horne, Katie; Shouse, Andrew W.] Univ Washington, Seattle, WA 98195 USA; [Oura, Hiroki; Van Horne, Katie; Shouse, Andrew W.] Univ Washington, Inst Sci & Math Educ, Seattle, WA 98195 USA; [Gallivan, Mark] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Munn, MM (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	mmunn@uw.edu			NIDA NIH HHS [R25 DA013180] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA013180] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		American Society of Addiction Medicine, 2010, PUBL POL STAT NIC DE; Bell P, 2000, INT J SCI EDUC, V22, P797, DOI 10.1080/095006900412284; Bell P., 2004, INTERNET ENV SCI ED, P115; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; King Brian, 2011, Morbidity and Mortality Weekly Report, V60, P1207; Linn M.C, 2004, INTERNET ENV SCI ED; Munn M, 2010, INVESTIGATING EFFECT; National Research Council, 2012, FRAM K 12 SCI ED PRA; National Research Council, 2009, LEARNING INFORMAL LO; Oura H., 2012, FUTURE LEARNING, V2, P41	10	0	0	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					360	361		10.1126/science.1229999	http://dx.doi.org/10.1126/science.1229999			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	189HX	23888032				2022-12-28	WOS:000322259200038
J	Patel, K				Patel, Kinesh			STARTING OUT Bureaucracy holds the NHS back	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2013	347								f4624	10.1136/bmj.f4624	http://dx.doi.org/10.1136/bmj.f4624			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BS	23894180				2022-12-28	WOS:000322532500004
J	Rinke, C; Schwientek, P; Sczyrba, A; Ivanova, NN; Anderson, IJ; Cheng, JF; Darling, A; Malfatti, S; Swan, BK; Gies, EA; Dodsworth, JA; Hedlund, BP; Tsiamis, G; Sievert, SM; Liu, WT; Eisen, JA; Hallam, SJ; Kyrpides, NC; Stepanauskas, R; Rubin, EM; Hugenholtz, P; Woyke, T				Rinke, Christian; Schwientek, Patrick; Sczyrba, Alexander; Ivanova, Natalia N.; Anderson, Iain J.; Cheng, Jan-Fang; Darling, Aaron; Malfatti, Stephanie; Swan, Brandon K.; Gies, Esther A.; Dodsworth, Jeremy A.; Hedlund, Brian P.; Tsiamis, George; Sievert, Stefan M.; Liu, Wen-Tso; Eisen, Jonathan A.; Hallam, Steven J.; Kyrpides, Nikos C.; Stepanauskas, Ramunas; Rubin, Edward M.; Hugenholtz, Philip; Woyke, Tanja			Insights into the phylogeny and coding potential of microbial dark matter	NATURE			English	Article							LATERAL GENE-TRANSFER; HYDROTHERMAL VENT; SP-NOV.; DIVERSITY; BACTERIA; DIVISION; VERRUCOMICROBIA; METAGENOMICS; SUPERPHYLUM; CHLAMYDIAE	Genome sequencing enhances our understanding of the biological world by providing blueprints for the evolutionary and functional diversity that shapes the biosphere. However, microbial genomes that are currently available are of limited phylogenetic breadth, owing to our historical inability to cultivate most microorganisms in the laboratory. We apply single-cell genomics to target and sequence 201 uncultivated archaeal and bacterial cells from nine diverse habitats belonging to 29 major mostly uncharted branches of the tree of life, so-called 'microbial dark matter'. With this additional genomic information, we are able to resolve many intra-and inter-phylum-level relationships and to propose two new superphyla. We uncover unexpected metabolic features that extend our understanding of biology and challenge established boundaries between the three domains of life. These include a novel amino acid use for the opal stop codon, an archaeal-type purine synthesis in Bacteria and complete sigma factors in Archaea similar to those in Bacteria. The single-cell genomes also served to phylogenetically anchor up to 20% of metagenomic reads in some habitats, facilitating organism-level interpretation of ecosystem function. This study greatly expands the genomic representation of the tree of life and provides a systematic step towards a better understanding of biological evolution on our planet.	[Rinke, Christian; Schwientek, Patrick; Sczyrba, Alexander; Ivanova, Natalia N.; Anderson, Iain J.; Cheng, Jan-Fang; Malfatti, Stephanie; Kyrpides, Nikos C.; Rubin, Edward M.; Woyke, Tanja] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Sczyrba, Alexander] Univ Bielefeld, Ctr Biotechnol, D-33602 Bielefeld, Germany; [Darling, Aaron; Eisen, Jonathan A.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [Darling, Aaron] Univ Technol Sydney, Inst I3, Ultimo, NSW 2007, Australia; [Swan, Brandon K.; Stepanauskas, Ramunas] Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA; [Gies, Esther A.; Hallam, Steven J.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Gies, Esther A.; Hallam, Steven J.] Univ British Columbia, Grad Program Bioinformat, Vancouver, BC V6T 1Z3, Canada; [Dodsworth, Jeremy A.; Hedlund, Brian P.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Tsiamis, George] Univ Patras, Dept Environm & Nat Resources Management, Agrinion 30100, TK, Greece; [Sievert, Stefan M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Liu, Wen-Tso] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61802 USA; [Hugenholtz, Philip] Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogenom, St Lucia, Qld 4072, Australia; [Hugenholtz, Philip] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	United States Department of Energy (DOE); University of Bielefeld; University of California System; University of California Davis; University of Technology Sydney; Bigelow Laboratory for Ocean Sciences; University of British Columbia; University of British Columbia; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Patras; Woods Hole Oceanographic Institution; University of Illinois System; University of Illinois Urbana-Champaign; University of Queensland; University of Queensland	Hugenholtz, P (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogenom, St Lucia, Qld 4072, Australia.	p.hugenholtz@uq.edu.au; twoyke@lbl.gov	Liu, Wen-Tso/C-8788-2011; Darling, Aaron/G-8119-2017; Rinke, Christian/ABA-3139-2021; Eisen, Jonathan A./H-2706-2019; Hugenholtz, Philip/AAD-9138-2019; Swan, Brandon K/O-9824-2018; Kyrpides, Nikos C./A-6305-2014; Rinke, Christian/AAE-8100-2019	Liu, Wen-Tso/0000-0002-8700-9803; Eisen, Jonathan A./0000-0002-0159-2197; Hugenholtz, Philip/0000-0001-5386-7925; Swan, Brandon K/0000-0003-0465-1444; Kyrpides, Nikos C./0000-0002-6131-0462; Rinke, Christian/0000-0003-4632-1187; Malfatti, Stephanie/0000-0003-4225-9857; Ivanova, Natalia/0000-0002-5802-9485; Sievert, Stefan/0000-0002-9541-2707; Stepanauskas, Ramunas/0000-0003-4458-3108; Dodsworth, Jeremy/0000-0003-2014-5488; Sczyrba, Alexander/0000-0002-4405-3847; Cheng, Jan-Fang/0000-0001-7315-7613; Darling, Aaron/0000-0003-2397-7925; Hedlund, Brian/0000-0001-8530-0448	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; BMBF [031A190]; NASA [EXO-NNX11AR78G]; NSF [OISE 096842, OCE-0452333, OCE-1136727, DEB-841933, EF-826924, OCE-1232982, OCE-821374, OCE-1136488]; WHOI's Andrew W. Mellon Fund for Innovative Research; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund; National Sciences and Engineering Research Council (NSERC) of Canada; TULA foundation; Alfred P. Sloan Foundation; Australian Research Council [DP120103498]; Directorate For Geosciences [1232982, 1136727] Funding Source: National Science Foundation; Division Of Ocean Sciences [1136488] Funding Source: National Science Foundation	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); BMBF(Federal Ministry of Education & Research (BMBF)); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); WHOI's Andrew W. Mellon Fund for Innovative Research; Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); TULA foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Australian Research Council(Australian Research Council); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the DOE JGI production sequencing, IMG and GOLD teams for their support; J. Lee and E. Ng for experimental assistance; H.-P. Klenk and D. Gleim for providing a DSMZ inventory database dump and I. Letunic ' for his knowledge and support to make iTOL work for this project. We are very grateful to B. Schink for invaluable etymological advice. The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. We also thank the CeBiTec Bioinformatics Resource Facility, which is supported by BMBF grant 031A190. B. P. H. and J. A. D. were supported by the NASA Exobiology grant EXO-NNX11AR78G and NSF OISE 096842 and B. P. H. by a generous contribution from G. Fullmer through the UNLV Foundation. S. M. S was supported by NSF grants OCE-0452333 and OCE-1136727, and the WHOI's Andrew W. Mellon Fund for Innovative Research; and S. J. H. by the Canadian Foundation for Innovation, the British Columbia Knowledge Development Fund, the National Sciences and Engineering Research Council (NSERC) of Canada and the TULA foundation funded Centre for Microbial Diversity and Evolution (CMDE), and the Canadian Institute for Advanced Research (CIFAR). R. S. was supported by NSF grants DEB-841933, EF-826924, OCE-1232982, OCE-821374 and OCE-1136488, and the Deep Life I grant by the Alfred P. Sloan Foundation. P. H. was supported by a Discovery Outstanding Researcher Award (DORA) from the Australian Research Council, grant DP120103498.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Atkinson GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023479; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; Battistuzzi FU, 2009, MOL BIOL EVOL, V26, P335, DOI 10.1093/molbev/msn247; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Campbell JH, 2013, P NATL ACAD SCI USA, V110, P5540, DOI 10.1073/pnas.1303090110; Chouari R, 2005, APPL ENVIRON MICROB, V71, P2145, DOI 10.1128/AEM.71.4.2145-2153.2005; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dalevi D, 2001, INT J SYST EVOL MICR, V51, P385, DOI 10.1099/00207713-51-2-385; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; Droge J, 2012, BRIEF BIOINFORM, V13, P646, DOI 10.1093/bib/bbs031; Gilbert JA, 2011, ANNU REV MAR SCI, V3, P347, DOI 10.1146/annurev-marine-120709-142811; Gordon DA, 1996, APPL ENVIRON MICROB, V62, P1171, DOI 10.1128/AEM.62.4.1171-1177.1996; Gupta RS, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00327; Gupta RS, 2004, CRIT REV MICROBIOL, V30, P123, DOI 10.1080/10408410490435133; Guy L, 2011, TRENDS MICROBIOL, V19, P580, DOI 10.1016/j.tim.2011.09.002; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Harris JK, 2004, APPL ENVIRON MICROB, V70, P845, DOI 10.1128/AEM.70.2.845-849.2004; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Hugenholtz P, 2009, ENVIRON MICROBIOL, V11, P551, DOI 10.1111/j.1462-2920.2009.01888.x; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Kyrpides NC, 1997, J MOL EVOL, V45, P706; LAKE JA, 1984, P NATL ACAD SCI-BIOL, V81, P3786, DOI 10.1073/pnas.81.12.3786; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; McCutcheon JP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000565; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miroshnichenko ML, 2003, INT J SYST EVOL MICR, V53, P323, DOI 10.1099/ijs.0.02390-0; Narasingarao P, 2012, ISME J, V6, P81, DOI 10.1038/ismej.2011.78; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Rajendhran J, 2011, MICROBIOL RES, V166, P99, DOI 10.1016/j.micres.2010.02.003; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Stepanauskas R, 2012, CURR OPIN MICROBIOL, V15, P613, DOI 10.1016/j.mib.2012.09.001; Sutcliffe IC, 2011, ENVIRON MICROBIOL, V13, P279, DOI 10.1111/j.1462-2920.2010.02339.x; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Szollosi GJ, 2012, P NATL ACAD SCI USA, V109, P17513, DOI 10.1073/pnas.1202997109; Takai K, 1999, GENETICS, V152, P1285; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Tamaki H, 2011, INT J SYST EVOL MICR, V61, P1442, DOI 10.1099/ijs.0.025643-0; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; Williams TA, 2012, P ROY SOC B-BIOL SCI, V279, P4870, DOI 10.1098/rspb.2012.1795; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; YAMAO F, 1985, P NATL ACAD SCI USA, V82, P2306, DOI 10.1073/pnas.82.8.2306; Zaneveld JR, 2010, NUCLEIC ACIDS RES, V38, P3869, DOI 10.1093/nar/gkq066; Zhang H, 2003, INT J SYST EVOL MICR, V53, P1155, DOI 10.1099/ijs.0.02520-0; Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8	50	1334	1413	21	670	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					431	437		10.1038/nature12352	http://dx.doi.org/10.1038/nature12352			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23851394	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000322157900031
J	Takebe, T; Sekine, K; Enomura, M; Koike, H; Kimura, M; Ogaeri, T; Zhang, RR; Ueno, Y; Zheng, YW; Koike, N; Aoyama, S; Adachi, Y; Taniguchi, H				Takebe, Takanori; Sekine, Keisuke; Enomura, Masahiro; Koike, Hiroyuki; Kimura, Masaki; Ogaeri, Takunori; Zhang, Ran-Ran; Ueno, Yasuharu; Zheng, Yun-Wen; Koike, Naoto; Aoyama, Shinsuke; Adachi, Yasuhisa; Taniguchi, Hideki			Vascularized and functional human liver from an iPSC-derived organ bud transplant	NATURE			English	Article							CHIMERIC MICE; STEM-CELL; ORGANOGENESIS; GENERATION; ENDODERM; GROWTH; MOUSE; MODEL	A critical shortage of donor organs for treating end-stage organ failure highlights the urgent need for generating organs from human induced pluripotent stem cells (iPSCs)(1). Despite many reports describing functional cell differentiation(2-4), no studies have succeeded in generating a three-dimensional vascularized organ such as liver. Here we show the generation of vascularized and functional human liver from human iPSCs by transplantation of liver buds created in vitro (iPSC-LBs). Specified hepatic cells (immature endodermal cells destined to track the hepatic cell fate) self-organized into three-dimensional iPSC-LBs by recapitulating organogenetic interactions between endothelial and mesenchymal cells(5). Immunostaining and gene-expression analyses revealed a resemblance between in vitro grown iPSC-LBs and in vivo liver buds. Human vasculatures in iPSC-LB transplants became functional by connecting to the host vessels within 48 hours. The formation of functional vasculatures stimulated the maturation of iPSC-LBs into tissue resembling the adult liver. Highly metabolic iPSC-derived tissue performed liver-specific functions such as protein production and human-specific drug metabolism without recipient liver replacement(6). Furthermore, mesenteric transplantation of iPSC-LBs rescued the drug-induced lethal liver failure model. To our knowledge, this is the first report demonstrating the generation of a functional human organ from pluripotent stem cells. Although efforts must ensue to translate these techniques to treatments for patients, this proof-of-concept demonstration of organ-bud transplantation provides a promising new approach to study regenerative medicine.	[Takebe, Takanori; Sekine, Keisuke; Enomura, Masahiro; Koike, Hiroyuki; Kimura, Masaki; Ogaeri, Takunori; Zhang, Ran-Ran; Ueno, Yasuharu; Zheng, Yun-Wen; Koike, Naoto; Taniguchi, Hideki] Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Takebe, Takanori; Taniguchi, Hideki] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa 2360004, Japan; [Koike, Naoto] Seirei Sakura Citizen Hosp, Dept Surg, Sakura, Chiba 2858765, Japan; [Aoyama, Shinsuke; Adachi, Yasuhisa] Sekisui Med Co Ltd, ADME & Tox Res Inst, Tokai, Ibaraki 3191182, Japan	Yokohama City University; Yokohama City University; Sekisui Chemical Co Ltd	Takebe, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	ttakebe@yokohama-cu.ac.jp; rtanigu@yokohama-cu.ac.jp	Koike, Hiroyuki/AAT-6065-2020; Koike, Hiroyuki/AAZ-9941-2020; Zheng, Yun-Wen/R-2874-2019; Koike, Hiroyuki/R-5103-2018; ZHANG, RANRAN/W-1020-2018	Koike, Hiroyuki/0000-0001-9934-6930; Koike, Hiroyuki/0000-0001-9934-6930; Zheng, Yun-Wen/0000-0001-9002-3190; Koike, Hiroyuki/0000-0001-9934-6930; ZHANG, RANRAN/0000-0001-5698-1950; Sekine, Keisuke/0000-0001-5133-0876; Adachi, Yasuhisa/0000-0003-4197-092X; Takebe, Takanori/0000-0002-6989-3041	Strategic Promotion of Innovative Research and Development (S-innovation) of the Japan Science and Technology Agency (JST) [62890004]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24106510, 24689052, 22390260, 21249071, 25253079]; Takeda Science Foundation; Japan IDDM network; Yokohama Foundation for Advanced Medical Science; Grants-in-Aid for Scientific Research [25253079, 24659785] Funding Source: KAKEN	Strategic Promotion of Innovative Research and Development (S-innovation) of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan IDDM network; Yokohama Foundation for Advanced Medical Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank F. Kawamata, E. Yoshizawa, Y. Suzuki, S. Nakai, Y. Takahashi, N. Tsuchida and N. Sasaki for kindly providing technical support; J. Nakabayashi, K. Yasumura, R. Fujiwara, T. Amiya, A. Nakano, Y. Mitsuhashi and all of the members of our laboratory for help with several experiments and comments. We are also grateful to D. Fukumura, Y. Goshima, T. Hirose, M. Ichino, U. Yokoyama, T. Ogawa and R. K. Jain for critical evaluation of the manuscript. This work was supported by grants to H. Taniguchi from the Strategic Promotion of Innovative Research and Development (S-innovation, 62890004) of the Japan Science and Technology Agency (JST). This work was also supported by the Grants-in-Aid of the Ministry of Education, Culture, Sports, Science, and Technology of Japan to T. Takebe (no. 24106510, 24689052), N. Koike (no. 22390260) and H. Taniguchi (no. 21249071, 25253079); by the Specified Research Grant of the Takeda Science Foundation and a grant from the Japan IDDM network to H. Taniguchi; and by a grant of the Yokohama Foundation for Advanced Medical Science to T. Takebe.	Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Dudley SC, 2005, CIRC RES, V97, P99, DOI 10.1161/01.RES.00000175827.99824.7f; Espejel S, 2010, J CLIN INVEST, V120, P3120, DOI 10.1172/JCI43267; Gouysse G, 2002, J HEPATOL, V37, P730, DOI 10.1016/S0168-8278(02)00282-9; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; ISHIZAKI T, 1980, EUR J CLIN PHARMACOL, V18, P407, DOI 10.1007/BF00636794; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kamimura H, 2010, DRUG METAB PHARMACOK, V25, P223, DOI 10.2133/dmpk.25.223; Katoh M, 2007, J PHARM SCI-US, V96, P428, DOI 10.1002/jps.20783; Klein AS, 2010, AM J TRANSPLANT, V10, P973, DOI 10.1111/j.1600-6143.2009.03008.x; Kobayashi S, 2011, P NATL ACAD SCI USA, V108, P14479, DOI 10.1073/pnas.1109767108; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; MARTINEZHERNANDEZ A, 1984, LAB INVEST, V51, P57; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Takebe T, 2012, TRANSPL P, V44, P1130, DOI 10.1016/j.transproceed.2012.03.039; Yu AM, 2004, DRUG METAB REV, V36, P243, DOI 10.1081/DMR-120034000; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691	23	1219	1301	36	534	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					481	+		10.1038/nature12271	http://dx.doi.org/10.1038/nature12271			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23823721				2022-12-28	WOS:000322157900041
J	Asai, M; Ramachandrappa, S; Joachim, M; Shen, Y; Zhang, R; Nuthalapati, N; Ramanathan, V; Strochlic, DE; Ferket, P; Linhart, K; Ho, C; Novoselova, TV; Garg, S; Ridderstrale, M; Marcus, C; Hirschhorn, JN; Keogh, JM; O'Rahilly, S; Chan, LF; Clark, AJ; Farooqi, IS; Majzoub, JA				Asai, Masato; Ramachandrappa, Shwetha; Joachim, Maria; Shen, Yuan; Zhang, Rong; Nuthalapati, Nikhil; Ramanathan, Visali; Strochlic, David E.; Ferket, Peter; Linhart, Kirsten; Ho, Caroline; Novoselova, Tatiana V.; Garg, Sumedha; Ridderstrale, Martin; Marcus, Claude; Hirschhorn, Joel N.; Keogh, Julia M.; O'Rahilly, Stephen; Chan, Li F.; Clark, Adrian J.; Farooqi, I. Sadaf; Majzoub, Joseph A.			Loss of Function of the Melanocortin 2 Receptor Accessory Protein 2 Is Associated with Mammalian Obesity	SCIENCE			English	Article							MRAP2	Melanocortin receptor accessory proteins (MRAPs) modulate signaling of melanocortin receptors in vitro. To investigate the physiological role of brain-expressed melanocortin 2 receptor accessory protein 2 (MRAP2), we characterized mice with whole-body and brain-specific targeted deletion of Mrap2, both of which develop severe obesity at a young age. Mrap2 interacts directly with melanocortin 4 receptor (Mc4r), a protein previously implicated in mammalian obesity, and it enhances Mc4r-mediated generation of the second messenger cyclic adenosine monophosphate, suggesting that alterations in Mc4r signaling may be one mechanism underlying the association between Mrap2 disruption and obesity. In a study of humans with severe, early-onset obesity, we found four rare, potentially pathogenic genetic variants in MRAP2, suggesting that the gene may also contribute to body weight regulation in humans.	[Asai, Masato; Joachim, Maria; Shen, Yuan; Zhang, Rong; Nuthalapati, Nikhil; Ramanathan, Visali; Strochlic, David E.; Linhart, Kirsten; Ho, Caroline; Hirschhorn, Joel N.; Majzoub, Joseph A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Endocrinol,Dept Med, Boston, MA 02115 USA; [Asai, Masato] Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Asai, Masato] Nagoya Univ, Grad Sch Med, Dept Endocrinol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Asai, Masato] Nagoya Univ, Grad Sch Med, Dept Diabet, Showa Ku, Nagoya, Aichi 4668550, Japan; [Ramachandrappa, Shwetha; Garg, Sumedha; Keogh, Julia M.; O'Rahilly, Stephen; Farooqi, I. Sadaf] Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England; [Ramachandrappa, Shwetha; Garg, Sumedha; Keogh, Julia M.; O'Rahilly, Stephen; Farooqi, I. Sadaf] Addenbrookes Hosp, Inst Metab Sci, Natl Inst Hlth Res, Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England; [Ferket, Peter] N Carolina State Univ, Prestage Dept Poultry Sci, Raleigh, NC 27695 USA; [Novoselova, Tatiana V.; Chan, Li F.; Clark, Adrian J.] Univ London, Barts & London Sch Med & Dent, Ctr Endocrinol, William Harvey Res Inst, London EC1M 6BQ, England; [Ridderstrale, Martin] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Ridderstrale, Martin] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Marcus, Claude] Karolinska Inst, Natl Childhood Obes Ctr, Dept Clin Sci Intervent & Technol, Div Pediat, S-14186 Huddinge, Sweden; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Cambridge, MA 02142 USA; [Hirschhorn, Joel N.] Broad Inst, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Nagoya University; Nagoya University; Nagoya University; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of North Carolina; North Carolina State University; University of London; Queen Mary University London; Lund University; Steno Diabetes Center; Karolinska Institutet; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Farooqi, IS (corresponding author), Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England.	isf20@cam.ac.uk; joseph.majzoub@childrens.harvard.edu	O'Rahilly, Stephen/ABF-6509-2020; asai, masato/I-7294-2014; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Marcus, Claude/ABE-1177-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Marcus, Claude/0000-0003-0890-2650; Farooqi, Sadaf/0000-0001-7609-3504; Chan, Li/0000-0001-5146-8242; Ferket, Peter/0000-0002-2897-4312	National Institutes of Health [NIHP30-HD18655]; Timothy Murphy Fund; National Alliance for Research on Schizophrenia and Depression; Wellcome Trust; Medical Research Council [G0802796]; NIHR Cambridge Biomedical Research Centre; Pfizer; Correlagen Diagnostics;  [R01DK075787]; MRC [G0600717, MC_UU_12012/1, G0900554, G0802796, G9824984, G0600408] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075787, T32DK007699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; Medical Research Council [G0600717B, MC_UU_12012/5/B, G9824984, MC_UU_12012/1, G0900554, G0600717] Funding Source: researchfish; Novo Nordisk Fonden [NNF11OC1014660] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Timothy Murphy Fund; National Alliance for Research on Schizophrenia and Depression(NARSAD); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Pfizer(Pfizer); Correlagen Diagnostics; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank T. Nguyen for DNA analysis; H. Feldman and A. Fleisch for statistical advice; M. Mulcahey for thyroid assays; H. Turkova for catecholamine assays; S. Cabi for creating the software program used to analyze calorimetry data; M. Geibel for bioinformatics analyses; and D. Margulies, B. Lowell, J. Flier, and Boston Children's Hospital Endocrinology Division scientists for helpful discussions. We are indebted to the patients and their families for their participation and to the physicians involved in GOOS and the Swedish obese children's cohort study. This work was supported by grants from the National Institutes of Health, including NIHP30-HD18655 (J. A. M.), the Timothy Murphy Fund (J. A. M.), the National Alliance for Research on Schizophrenia and Depression (M. A.), the Wellcome Trust (I. S. F. and S.O'R.), the Medical Research Council [I. S. F. and L. F. C. (grant no. G0802796)], the NIHR Cambridge Biomedical Research Centre (I. S. F. and S.O'R.), and R01DK075787 (J.N.H.). S.O'R. is a paid Scientific Adviser for Pfizer in the area of cardiometabolic disease. Until 2010, J. A. M. was on the Board of, and was a paid Scientific Advisor for, Correlagen Diagnostics, a company whose projects included molecular diagnostic tests related to obesity. The authors (M. A., J. A. M., Boston Children's Hospital) have filed a patent application related to modulating Mrap2 to alter growth.	Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Chan LF, 2011, EUR J PHARMACOL, V660, P171, DOI 10.1016/j.ejphar.2010.11.041; Chan LF, 2009, P NATL ACAD SCI USA, V106, P6146, DOI 10.1073/pnas.0809918106; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Cooray SN, 2011, MOL CELL ENDOCRINOL, V331, P215, DOI 10.1016/j.mce.2010.07.015; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Hay DL, 2006, PHARMACOL THERAPEUT, V109, P173, DOI 10.1016/j.pharmthera.2005.06.015; Hinkle PM, 2009, MOL CELL ENDOCRINOL, V300, P25, DOI 10.1016/j.mce.2008.10.041; Johansson LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005327; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Sebag JA, 2013, SCIENCE, V341, P278, DOI 10.1126/science.1232995; Sebag JA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000593; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]	13	169	175	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143					275	278		10.1126/science.1233000	http://dx.doi.org/10.1126/science.1233000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869016	Green Accepted			2022-12-28	WOS:000321959300043
J	Fry, DP; Soderberg, P				Fry, Douglas P.; Soderberg, Patrik			Lethal Aggression in Mobile Forager Bands and Implications for the Origins of War	SCIENCE			English	Article							EVOLUTION	It has been argued that warfare evolved as a component of early human behavior within foraging band societies. We investigated lethal aggression in a sample of 21 mobile forager band societies (MFBS) derived systematically from the standard cross-cultural sample. We hypothesized, on the basis of mobile forager ethnography, that most lethal events would stem from personal disputes rather than coalitionary aggression against other groups (war). More than half of the lethal aggression events were perpetrated by lone individuals, and almost two-thirds resulted from accidents, interfamilial disputes, within-group executions, or interpersonal motives such as competition over a particular woman. Overall, the findings suggest that most incidents of lethal aggression among MFBS may be classified as homicides, a few others as feuds, and a minority as war.	[Fry, Douglas P.; Soderberg, Patrik] Abo Akad Univ, FIN-65101 Vaasa, Finland; [Fry, Douglas P.] Sch Anthropol, Bur Appl Res Anthropol, Tucson, AZ 85721 USA	Abo Akademi University	Fry, DP (corresponding author), Abo Akad Univ, POB 311, FIN-65101 Vaasa, Finland.	dfry@abo.fi			NSF [03-13670]	NSF(National Science Foundation (NSF))	Some of the data reported here were collected during research funded by the NSF (grant 03-13670). We are grateful to the Svenska Kulturfonden for assisting with the costs of publication. The data reported in this study are located in the supplementary materials.	Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Fry DP, 2013, WAR PEACE HUMAN NATU, P1; Fry DP., 2006, HUMAN POTENTIAL PEAC; LEACOCK E, 1978, CURR ANTHROPOL, V19, P247, DOI 10.1086/202074; Lee R.B., 1999, CAMBRIDGE ENCY HUNTE, P1, DOI [10.1017/cbo9780511752964.002, DOI 10.1017/CBO9780511752964.002]; MURDOCK GP, 1967, ETHNOLOGY, V6, P109, DOI 10.2307/3772751; Pinker S., 2011, BETTER ANGELS OUR NA; Service E. R., 1966, HUNTERS; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Steward J. H., 1968, MAN HUNTER, P321; Tonkinson R., 2013, WAR PEACE HUMAN NATU, P262; Tonkinson Robert, 2004, KEEPING PEACE CONFLI, P89; White D.R., 1989, BEHAV SCI RES, V23, P1, DOI [DOI 10.1177/106939718902300102, 10.1177/106939718902300102]; Wrangham RW, 2012, HUM NATURE-INT BIOS, V23, P5, DOI 10.1007/s12110-012-9132-1	14	105	108	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					270	273		10.1126/science.1235675	http://dx.doi.org/10.1126/science.1235675			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869015				2022-12-28	WOS:000321959300041
J	Tang, ZY; Chen, WY; Shimada, M; Nguyen, UTT; Kim, J; Sun, XJ; Sengoku, T; McGinty, RK; Fernandez, JP; Muir, TW; Roeder, RG				Tang, Zhanyun; Chen, Wei-Yi; Shimada, Miho; Nguyen, Uyen T. T.; Kim, Jaehoon; Sun, Xiao-Jian; Sengoku, Toru; McGinty, Robert K.; Fernandez, Joseph P.; Muir, Tom W.; Roeder, Robert G.			SET1 and p300 Act Synergistically, through Coupled Histone Modifications, in Transcriptional Activation by p53	CELL			English	Article							TRITHORAX GROUP PROTEINS; H3K4 METHYLATION; H2B UBIQUITYLATION; METHYLTRANSFERASE ACTIVITY; CHROMATIN TRANSCRIPTION; LYSINE 4; COMPLEX; CELLS; DIFFERENTIATION; TRIMETHYLATION	The H3K4me3 mark in chromatin is closely correlated with actively transcribed genes, although the mechanisms involved in its generation and function are not fully understood. In vitro studies with recombinant chromatin and purified human factors demonstrate a robust SET1 complex (SET1C)-mediated H3K4 trimethylation that is dependent upon p53- and p300-mediated H3 acetylation, a corresponding SET1C-mediated enhancement of p53- and p300-dependent transcription that reflects a primary effect of SET1C through H3K4 trimethylation, and direct SET1C-p53 and SET1C-p300 interactions indicative of a targeted recruitment mechanism. Complementary cell-based assays demonstrate a DNA-damage-induced p53- SET1C interaction, a corresponding enrichment of SET1C and H3K4me3 on a p53 target gene (p21/WAF1), and a corresponding codependency of H3K4 trimethylation and transcription upon p300 and SET1C. These results establish a mechanism in which SET1C and p300 act cooperatively, through direct interactions and coupled histone modifications, to facilitate the function of p53.	[Tang, Zhanyun; Chen, Wei-Yi; Shimada, Miho; Kim, Jaehoon; Sun, Xiao-Jian; Sengoku, Toru; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA; [McGinty, Robert K.; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10065 USA; [Fernandez, Joseph P.] Rockefeller Univ, Prote Resource Ctr, New York, NY 10065 USA; [Nguyen, Uyen T. T.; Muir, Tom W.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Rockefeller University; Rockefeller University; Rockefeller University; Princeton University	Roeder, RG (corresponding author), Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA.	roeder@rockefeller.edu	Muir, Tom/AHD-0860-2022; Kim, Jaehoon/G-2711-2011; Sengoku, Toru/E-4304-2013; Sun, Xiao-Jian/D-1560-2011	Muir, Tom/0000-0001-9635-0344; Kim, Jaehoon/0000-0003-4035-0438; Sengoku, Toru/0000-0001-9461-8714; Sun, Xiao-Jian/0000-0001-8826-4614; Chen, Wei-Yi/0000-0002-0661-6899	NIH [CA129325]; Leukemia and Lymphoma Society; Ellison Medical Foundation; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [R01CA129325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, R01GM107047] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Ellison Medical Foundation(Lawrence Ellison Foundation); Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ming Yu for advice on ChIP assays; laboratory members for discussions; Sohail Malik for critical reading of the manuscript; Wei Gu (Columbia University) for p53 7KR/8KR mutant plasmids; W. Lee Kraus (UT Southwestern) and James T. Kadonaga (UCSD) for the mutant p300 plasmids; Peter B. Becker (Adolf-Butenandt-Institute, Germany) for the ACF1 Delta bromodomain plasmid; Christina Hughes (The Rockefeller University), Winship Herr (University of Lausanne), and David G. Skalnik (Indiana University) for antibodies; and Carlos Caldas (University of Cambridge) for p300 WT and null HCT116 cell lines. This work was supported by grants from the NIH (CA129325), the Leukemia and Lymphoma Society, the Ellison Medical Foundation, and the Starr Cancer Consortium to R.G.R.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; An WJ, 2004, METHOD ENZYMOL, V377, P460; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Filippakopoulos P, 2012, FEBS LETT, V586, P2692, DOI 10.1016/j.febslet.2012.04.045; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Guo CC, 2012, P NATL ACAD SCI USA, V109, P17603, DOI 10.1073/pnas.1208807109; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kim J, 2013, MOL CELL, V49, P1121, DOI 10.1016/j.molcel.2013.01.034; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lee JS, 2012, GENE DEV, V26, P914, DOI 10.1101/gad.186841.112; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lin JJ, 2011, GENE DEV, V25, P2198, DOI 10.1101/gad.17554711; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Santoso BY, 2006, NAT STRUCT MOL BIOL, V13, P131, DOI 10.1038/nsmb1048; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Vermeulen M, 2010, EPIGENOMICS-UK, V2, P395, DOI 10.2217/EPI.10.11; Vethantham V, 2012, MOL CELL BIOL, V32, P1044, DOI 10.1128/MCB.06026-11; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Z, 2009, J BIOL CHEM, V284, P34870, DOI 10.1074/jbc.M109.046250; Wu LP, 2013, MOL CELL, V49, P1108, DOI 10.1016/j.molcel.2013.01.033; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	44	122	124	0	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					297	310		10.1016/j.cell.2013.06.027	http://dx.doi.org/10.1016/j.cell.2013.06.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870121	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000321950700008
J	Goldfarb, DS				Goldfarb, David S.			Review: Thiazide, citrate, or allopurinol reduces recurrence after >= 2 kidney stone episodes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Goldfarb, David S.] New York Harbor VA Healthcare Syst, New York, NY USA; [Goldfarb, David S.] NYU, Langone Med Ctr, New York, NY USA	New York University; NYU Langone Medical Center	Goldfarb, DS (corresponding author), New York Harbor VA Healthcare Syst, New York, NY USA.			Goldfarb, David/0000-0002-9215-1273				CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203	1	1	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2							JC12	10.7326/0003-4819-159-2-201307160-02012	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23856698				2022-12-28	WOS:000322112000011
J	Ikegami, H; Tsutsumi, Y; Kono, K				Ikegami, H.; Tsutsumi, Y.; Kono, K.			Chiral Symmetry Breaking in Superfluid He-3-A	SCIENCE			English	Article							ANISOTROPIC SUPERFLUID	Spontaneous symmetry breaking is an important concept in many branches of physics. In helium-3 (He-3), the breaking of symmetry leads to the orbital chirality in the superfluid phase known as He-3-A. Chirality is a fundamental property of He-3-A, but its direct detection has been challenging. We report direct detection of chirality by transport measurements of electrons trapped below a free surface of He-3-A. In particular, we observed the so-called intrinsic Magnus force experienced by a moving electron; the direction of the force directly reflected the chirality. We further showed that, at the superfluid transition, the system selected either right-or left-handed chirality. The observation of such selection directly demonstrates chiral symmetry breaking.	[Ikegami, H.; Kono, K.] RIKEN, Low Temp Phys Lab, Wako, Saitama 3510198, Japan; [Ikegami, H.; Kono, K.] RIKEN, RIKEN Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Tsutsumi, Y.] RIKEN, Condensed Matter Theory Lab, Wako, Saitama 3510198, Japan	RIKEN; RIKEN; RIKEN	Ikegami, H (corresponding author), RIKEN, Low Temp Phys Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hikegami@riken.jp	Tsutsumi, Yasumasa/L-1808-2015; Ikegami, Hiroki/F-9513-2012; Kono, Kimitoshi/H-3329-2012; Tsutsumi, Yasumasa/AAH-2364-2019	Ikegami, Hiroki/0000-0002-3171-858X; Kono, Kimitoshi/0000-0002-4446-4419; 	Japan Society for the Promotion of Science [23684030, 23103517, 24840048, 24000007]; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank M. Tsubota, A. I. Golov, T. Mizushima, H. Takeuchi, H. Akimoto, J. A. Sauls, M. Krusius, Y. Okuda, A. Furusaki, G. E. Volovik, and A. J. Leggett for fruitful discussions. This work was partly supported by Grants-in-Aid for Scientific Research (grants 23684030, 23103517, 24840048, and 24000007) from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	AHONEN AI, 1978, J LOW TEMP PHYS, V30, P205, DOI 10.1007/BF00115525; AMBEGAOKAR V, 1974, PHYS REV A, V9, P2676, DOI 10.1103/PhysRevA.9.2676; Bevan TDC, 1997, J LOW TEMP PHYS, V109, P423, DOI 10.1007/s10909-005-0095-z; Dobbs E. R., 2000, HELIUM 3; Fetter A. L., 1976, Physics of liquid and solid helium, pt.1, P207; Kallin C, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/4/042501; KYYNARAINEN JM, 1990, PHYS REV LETT, V64, P1027, DOI 10.1103/PhysRevLett.64.1027; LEGGETT AJ, 1977, NATURE, V270, P585, DOI 10.1038/270585a0; Mermin N.D., 1977, QUANTUM FLUIDS SOLID, P3; SALMELIN RH, 1989, PHYS REV LETT, V63, P868, DOI 10.1103/PhysRevLett.63.868; SALMELIN RH, 1990, PHYS REV B, V41, P4142, DOI 10.1103/PhysRevB.41.4142; Vollhardt D., 1990, SUPERFLUID PHASES HE, V3; Walmsley PM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.215301; Walmsley PM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.195301; ZUREK WH, 1985, NATURE, V317, P505, DOI 10.1038/317505a0	15	42	43	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					59	62		10.1126/science.1236509	http://dx.doi.org/10.1126/science.1236509			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828937				2022-12-28	WOS:000321291700046
J	Schroll, J				Schroll, Jeppe			Deaths in trials should always be reported	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED-TRIALS; REPAGLINIDE; BIAS; GLYBURIDE		Rigshosp, Nord Cochrane Ctr, Dept 7811, DK-2100 Copenhagen O, Denmark	Rigshospitalet	Schroll, J (corresponding author), Rigshosp, Nord Cochrane Ctr, Dept 7811, DK-2100 Copenhagen O, Denmark.	js@cochrane.dk						Center for Drug Evaluation and Research, 2000, 20741S009 CTR DRUG E; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Curfman GD, 2006, NEW ENGL J MED, V354, P1193, DOI 10.1056/NEJMe068054; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Hemmingsen B, COCHRANE DA IN PRESS; Madsbad S, 2001, DIABETIC MED, V18, P395, DOI 10.1046/j.1464-5491.2001.00490.x; Marbury T, 1999, DIABETES RES CLIN PR, V43, P155, DOI 10.1016/S0168-8227(99)00002-9; MEINERT CL, 1970, DIABETES, V19, P789; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Owens DR, 1998, DIABETIC MED, V15, pS28, DOI 10.1002/(SICI)1096-9136(1998120)15:4+<S28::AID-DIA748>3.3.CO;2-K; Owens DR, 2001, LANCET, V358, P739, DOI 10.1016/S0140-6736(01)05842-1; Psaty BM, 2010, JAMA-J AM MED ASSOC, V304, P793, DOI 10.1001/jama.2010.1161; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Williamson PR, 2005, STAT MED, V24, P1547, DOI 10.1002/sim.2025; Wolffenbuttel BHR, 1999, DIABETES CARE, V22, P463, DOI 10.2337/diacare.22.3.463	15	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2013	347								f4219	10.1136/bmj.f4219	http://dx.doi.org/10.1136/bmj.f4219			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180DG	23828897				2022-12-28	WOS:000321572600002
J	Zschiedrich, S; Huber, TB; Hildebrandt, F; Mihatsch, MJ; Wiech, T				Zschiedrich, Stefan; Huber, Tobias B.; Hildebrandt, Friedhelm; Mihatsch, Michael J.; Wiech, Thorsten			Karyomegalic interstitial nephritis	LANCET			English	Editorial Material									[Zschiedrich, Stefan; Huber, Tobias B.] Univ Hosp Freiburg, Dept Med, Renal Devis, D-79106 Freiburg, Germany; [Hildebrandt, Friedhelm] Boston Childrens Hosp, Div Nephrol, Boston, MA USA; [Mihatsch, Michael J.] Univ Basel, Inst Pathol, CH-4003 Basel, Switzerland; [Wiech, Thorsten] Univ Hosp Eppendorf, Dept Pathol, Hamburg, Germany	University of Freiburg; Harvard University; Boston Children's Hospital; University of Basel; University of Hamburg; University Medical Center Hamburg-Eppendorf	Zschiedrich, S (corresponding author), Univ Hosp Freiburg, Dept Med, Renal Devis, Hugstetler Str 55, D-79106 Freiburg, Germany.	stefan.zschiedrich@uniklinik-freiburg.de	Zschiedrich, Stefan/ABE-9871-2020; Wiech, Thorsten/ABA-3632-2020	Wiech, Thorsten/0000-0003-4053-1474; Huber, Tobias B./0000-0001-7175-5062	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK068306] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))			0	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2093	2093		10.1016/S0140-6736(13)60224-X	http://dx.doi.org/10.1016/S0140-6736(13)60224-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275OX	23831142	Green Accepted			2022-12-28	WOS:000328687800030
J	Arrow, K; Cropper, M; Gollier, C; Groom, B; Heal, G; Newell, R; Nordhaus, W; Pindyck, R; Pizer, W; Portney, P; Sterner, T; Tol, RSJ; Weitzman, M				Arrow, K.; Cropper, M.; Gollier, C.; Groom, B.; Heal, G.; Newell, R.; Nordhaus, W.; Pindyck, R.; Pizer, W.; Portney, P.; Sterner, T.; Tol, R. S. J.; Weitzman, M.			Determining Benefits and Costs for Future Generations	SCIENCE			English	Editorial Material							DISTANT FUTURE		[Arrow, K.] Stanford Univ, Stanford, CA 94305 USA; [Cropper, M.] Univ Maryland, College Pk, MD 20742 USA; [Cropper, M.; Newell, R.; Pizer, W.; Portney, P.; Sterner, T.] Resources Future Inc, Washington, DC 20036 USA; [Gollier, C.] Toulouse Sch Econ, F-31000 Toulouse, France; [Groom, B.] London Sch Econ, London WC2A 2AE, England; [Heal, G.] Columbia Business Sch, New York, NY 10027 USA; [Newell, R.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Newell, R.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Nordhaus, W.] Yale Univ, Cowles Fdn, New Haven, CT 06511 USA; [Pindyck, R.] MIT, Sloan Sch Management, Newton, MA 02159 USA; [Pizer, W.] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Portney, P.] Univ Arizona, Tucson, AZ 85721 USA; [Sterner, T.] Univ Gothenburg, SE-40530 Gothenburg, Sweden; [Tol, R. S. J.] Univ Sussex, Brighton BN1 9SL, E Sussex, England; [Tol, R. S. J.] Vrije Univ Amsterdam, Inst Environm Studies, NL-1081 HV Amsterdam, Netherlands; [Tol, R. S. J.] Vrije Univ Amsterdam, Dept Econ, NL-1081 HV Amsterdam, Netherlands; [Weitzman, M.] Harvard Univ, Cambridge, MA 02138 USA	Stanford University; University System of Maryland; University of Maryland College Park; Resources for the Future; Universite de Toulouse; Universite Toulouse 1 Capitole; Toulouse School of Economics; University of London; London School Economics & Political Science; Columbia University; Duke University; National Bureau of Economic Research; Yale University; Massachusetts Institute of Technology (MIT); Duke University; University of Arizona; University of Gothenburg; University of Sussex; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Harvard University	Cropper, M (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	cropper@rff.org	Groom, Ben/AAP-9305-2021; Newell, Richard G/I-3838-2015; Tol, Richard S. J./D-5245-2011	Groom, Ben/0000-0003-0729-143X; Newell, Richard G/0000-0002-3205-5562; Tol, Richard S. J./0000-0002-8012-3988				Cecchetti SG, 2000, AM ECON REV, V90, P787, DOI 10.1257/aer.90.4.787; COCHRANE JH, 1988, J POLIT ECON, V96, P893, DOI 10.1086/261569; EPA NHTSA, 2010, RUL EST LIGHT DUT VE; Gollier C, 2012, PRICING PLANETS FUTU, DOI DOI 10.1515/9781400845408; Gollier C, 2008, ECON POLICY, P759, DOI 10.1002/9781444307238.ch4; Groom B., 2013, 129 CTR CLIM CHANG E; Groom B, 2007, J APPL ECONOMET, V22, P641, DOI 10.1002/jae.937; Hepburn C, 2009, J ENVIRON ECON MANAG, V57, P140, DOI 10.1016/j.jeem.2008.04.004; HM Treasury, 2003, GREEN BOOK APPR EV C; Kocherlakota NR, 1996, J ECON LIT, V34, P42; LEBEGUE D, 2005, PRIX TEMPS DECISION; Newell RG, 2003, J ENVIRON ECON MANAG, V46, P52, DOI 10.1016/S0095-0696(02)00031-1; Nordhaus WD, 2010, P NATL ACAD SCI USA, V107, P11721, DOI 10.1073/pnas.1005985107; U. S. Office of Management and Budget, 2003, A4 OMB US OFF MAN BU; Weitzman, 2012, 1253 RES FUT; Weitzman ML, 1998, J ENVIRON ECON MANAG, V36, P201, DOI 10.1006/jeem.1998.1052; Weitzman ML, 2001, AM ECON REV, V91, P260, DOI 10.1257/aer.91.1.260	17	189	192	4	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144					349	350		10.1126/science.1235665	http://dx.doi.org/10.1126/science.1235665			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	189HX	23888025				2022-12-28	WOS:000322259200031
J	Parker, C; Nilsson, S; Heinrich, D; Helle, SI; O'Sullivan, JM; Fossa, SD; Chodacki, A; Wiechno, P; Logue, J; Seke, M; Widmark, A; Johannessen, DC; Hoskin, P; Bottomley, D; James, ND; Solberg, A; Syndikus, I; Kliment, J; Wedel, S; Boehmer, S; Dall'Oglio, M; Franzen, L; Coleman, R; Vogelzang, NJ; O'Bryan-Tear, CG; Staudacher, K; Garcia-Vargas, J; Shan, M; Bruland, OS; Sartor, O				Parker, C.; Nilsson, S.; Heinrich, D.; Helle, S. I.; O'Sullivan, J. M.; Fossa, S. D.; Chodacki, A.; Wiechno, P.; Logue, J.; Seke, M.; Widmark, A.; Johannessen, D. C.; Hoskin, P.; Bottomley, D.; James, N. D.; Solberg, A.; Syndikus, I.; Kliment, J.; Wedel, S.; Boehmer, S.; Dall'Oglio, M.; Franzen, L.; Coleman, R.; Vogelzang, N. J.; O'Bryan-Tear, C. G.; Staudacher, K.; Garcia-Vargas, J.; Shan, M.; Bruland, O. S.; Sartor, O.		ALSYMPCA Investigators	Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE METASTASES; SKELETAL METASTASES; PHASE-II; TARGETED THERAPY; CLINICAL-TRIALS; RA-223; MULTICENTER; BISPHOSPHONATES; CHEMOTHERAPY; MITOXANTRONE	Background Radium-223 dichloride (radium-223), an alpha emitter, selectively targets bone metastases with alpha particles. We assessed the efficacy and safety of radium-223 as compared with placebo, in addition to the best standard of care, in men with castration-resistant prostate cancer and bone metastases. Methods In our phase 3, randomized, double-blind, placebo-controlled study, we randomly assigned 921 patients who had received, were not eligible to receive, or declined docetaxel, in a 2:1 ratio, to receive six injections of radium-223 (at a dose of 50 kBq per kilogram of body weight intravenously) or matching placebo; one injection was administered every 4 weeks. In addition, all patients received the best standard of care. The primary end point was overall survival. The main secondary efficacy end points included time to the first symptomatic skeletal event and various biochemical end points. A prespecified interim analysis, conducted when 314 deaths had occurred, assessed the effect of radium-223 versus placebo on survival. An updated analysis, when 528 deaths had occurred, was performed before crossover from placebo to radium-223. Results At the interim analysis, which involved 809 patients, radium-223, as compared with placebo, significantly improved overall survival (median, 14.0 months vs. 11.2 months; hazard ratio, 0.70; 95% confidence interval [CI], 0.55 to 0.88; two-sided P=0.002). The updated analysis involving 921 patients confirmed the radium-223 survival benefit (median, 14.9 months vs. 11.3 months; hazard ratio, 0.70; 95% CI, 0.58 to 0.83; P<0.001). Assessments of all main secondary efficacy end points also showed a benefit of radium-233 as compared with placebo. Radium-223 was associated with low myelosuppression rates and fewer adverse events. Conclusions In this study, which was terminated for efficacy at the prespecified interim analysis, radium-223 improved overall survival. (Funded by Algeta and Bayer HealthCare Pharmaceuticals; ALSYMPCA ClinicalTrials.gov number, NCT00699751.)	[Parker, C.] Royal Marsden Natl Hlth Serv Fdn Trust, Sutton, Surrey, England; [Parker, C.] Inst Canc Res, Sutton, Surrey, England; [O'Sullivan, J. M.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Logue, J.] Christie Hosp, Manchester, Lancs, England; [Hoskin, P.] Mt Vernon Hosp, Ctr Canc, Northwood HA6 2RN, Middx, England; [Bottomley, D.] St James Univ Hosp, Leeds, W Yorkshire, England; [James, N. D.] Canc Res UK Clin Trials Unit, Sch Canc Sci, Birmingham, W Midlands, England; [Syndikus, I.] Clatterbridge Ctr Oncol, Wirral, Merseyside, England; [Coleman, R.] Weston Pk Hosp, Sheffield, S Yorkshire, England; [Nilsson, S.] Karolinska Univ Hosp, Stockholm, Sweden; [Seke, M.] Cent Lasarettet Vaxjo, Vaxjo, Sweden; [Widmark, A.] Umea Univ, Umea, Sweden; [Franzen, L.] Umea Univ Hosp, S-90185 Umea, Sweden; [Franzen, L.] Lanssjukhuset Sundsvall Harnosand Cty Hosp, Sundsvall, Sweden; [Heinrich, D.] Akershus Univ Hosp, Lorenskog, Norway; [Helle, S. I.] Haukeland Hosp, N-5021 Bergen, Norway; [Fossa, S. D.] Radiumhospitalet, Oslo, Norway; [Johannessen, D. C.] Ullevaal Univ Hosp, Oslo, Norway; [O'Bryan-Tear, C. G.; Staudacher, K.] Algeta, Oslo, Norway; [Bruland, O. S.] Univ Oslo, Norwegian Radium Hosp, Oslo, Norway; [Bruland, O. S.] Univ Oslo, Fac Med, Oslo, Norway; [Solberg, A.] St Olavs Hosp, Trondheim, Norway; [Chodacki, A.] Hosp Kochova, Chomutov, Czech Republic; [Wiechno, P.] Maria Sklodowska Curie Inst Oncol, Warsaw, Poland; [Kliment, J.] Univ Hosp, Jessenius Sch Med, Martin, Slovakia; [Wedel, S.] Ortenau Klinikum Offenburg Gengenbach, Klin Urol & Kinderurol, Offenburg, Germany; [Dall'Oglio, M.] Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo, Hosp Clin, Sao Paulo, Brazil; [Vogelzang, N. J.] Comprehens Canc Ctr Nevada, Las Vegas, NV USA; [Garcia-Vargas, J.; Shan, M.] Bayer HealthCare Pharmaceut, Montville, NJ USA; [Sartor, O.] Tulane Canc Ctr, New Orleans, LA USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Queens University Belfast; Christie NHS Foundation Trust; Christie Hospital; Saint James's University Hospital; Cancer Research UK; University of Birmingham; Clatterbridge Cancer Centre; Weston Park Hospital; Karolinska Institutet; Karolinska University Hospital; Umea University; Umea University; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); Maria Sklodowska-Curie National Research Institute of Oncology; Comenius University Bratislava; Universidade de Sao Paulo; Comprehensive Cancer Centers of Nevada; Bayer AG; Bayer Healthcare Pharmaceuticals; Tulane University	Parker, C (corresponding author), Royal Marsden Hosp, Acad Urol Unit, Downs Rd, Sutton SM2 5PT, Surrey, England.	chris.parker@rmh.nhs.uk	Sapienza, MT/A-4438-2013; James, Nick/AAL-6802-2020; Arbizu, Javier/H-9255-2017; Perez-Gracia, Jose Luis/I-8372-2017; Dall'Oglio, Marcos Francisco/K-5515-2016; Jarzab, Barbara/AAI-7942-2020	Sapienza, MT/0000-0001-9766-6332; Arbizu, Javier/0000-0002-8370-5510; Perez-Gracia, Jose Luis/0000-0003-4941-9075; Jarzemski, Piotr/0000-0002-9451-7320; O'Sullivan, Joe/0000-0001-6999-2739; Reynes, Gaspar/0000-0001-8636-6094; Wiechno, Pawel/0000-0002-4894-3273; Dall'Oglio, Marcos Francisco/0000-0002-9611-6846; Hoskin, Peter/0000-0001-8323-9567; Carles, Joan/0000-0002-9983-5934; James, Nicholas/0000-0002-7314-8204; Mitjavila Casanovas, Mercedes/0000-0001-6030-4266; Jarzab, Barbara/0000-0001-9811-9584; Bruland, Oyvind Sverre/0000-0003-1631-3733	Amgen; Astellas; Bayer; Janssen; Bristol-Myers Squibb; BN ImmunoTherapeutics; Takeda; Sanofi-Aventis; Pfizer; Novartis; Sanofi; Janssen-Cilag; Medivation; Pierre Fabre; Roche; Debiopharm; Novartis Biociencias; AstraZeneca; Dendreon; Johnson Johnson; Aragon; Bavarian Nordic; Bellicum; OncoGeneX; Algeta; Bayer HealthCare Pharmaceuticals	Amgen(Amgen); Astellas(Astellas Pharmaceuticals); Bayer(Bayer AG); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bristol-Myers Squibb(Bristol-Myers Squibb); BN ImmunoTherapeutics; Takeda(Takeda Pharmaceutical Company Ltd); Sanofi-Aventis(Sanofi-Aventis); Pfizer(Pfizer); Novartis(Novartis); Sanofi; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Medivation; Pierre Fabre; Roche(Roche Holding); Debiopharm; Novartis Biociencias; AstraZeneca(AstraZeneca); Dendreon; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Aragon; Bavarian Nordic; Bellicum; OncoGeneX; Algeta; Bayer HealthCare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals)	Supported by Algeta and Bayer HealthCare Pharmaceuticals.; Dr. Parker reports receiving consulting and lecture fees from Amgen, Astellas, Bayer, and Janssen, consulting fees from Bristol-Myers Squibb, BN ImmunoTherapeutics, and Takeda, and lecture fees from Sanofi-Aventis; Dr. Nilsson reports serving as an advisory board member for Algeta; Dr. Heinrich reports receiving lecture fees from Bayer, Sanofi-Aventis, Pfizer, and Novartis, payment for the development of educational presentations from Bayer and travel support from Bayer, Sanofi-Aventis, Pfizer, Novartis, and GlaxoSmithKline; Dr. Fossa reports serving as a board member for Bristol-Myers Squibb and receiving consulting and lecture fees from Amgen, Sanofi, and Janssen-Cilag; Dr. Widmark reports serving as a board member and receiving lecture fees from Astellas, and being employed by Sanofi; Dr. James reports receiving consulting fees from Janssen, Sanofi, Medivation, Bayer, and Pierre Fabre, receiving grant support through his institution from Pfizer, Sanofi, Novartis, Amgen, Bayer, Astellas, Janssen, and GlaxoSmithKline, receiving lecture fees from Sanofi, Pierre Fabre, Amgen, and Janssen, and travel support from Sanofi and Ferring; Dr. Wedel reports receiving consulting fees from Roche and Sanofi-Aventis, payment for the development of educational presentations from Roche, Amgen, and Sanofi-Aventis, and travel support from Sanofi-Aventis, Janssen, Roche, and Pfizer; Dr. Dall'Oglio reports serving as a board member and receiving consulting fees from Debiopharm, serving as an unpaid consultant to Ferring Pharmaceuticals, receiving grant support through his institution from GlaxoSmithKline and Novartis Biociencias, and receiving lecture fees from AstraZeneca; Dr. Coleman reports receiving consulting and lecture fees from Amgen and providing expert testimony for Novartis in cases regarding the development of osteonecrosis of the jaw associated with use of zoledronic acid, a Novartis product; Dr. Vogelzang reports receiving consulting fees from Dendreon, Sanofi-Aventis, Amgen, and Novartis, consulting and lecture fees from Johnson & Johnson, and lecture fees and payment for the development of educational presentations from Astellas; Dr. O'Bryan-Tear and Ms. Staudacher report being employees of and holding stock in Algeta; Dr. Garcia-Vargas reports being an employee of Bayer; Dr. Shan reports being an employee of and holding stock in Bayer; Dr. Bruland reports serving as a board member for and holding stock in Algeta, being a co-inventor on U. S. patent number 6,635,234 B1 regarding Alpharadin, which is owned by Algeta, and receiving lecture fees from Novartis and Amgen; and Dr. Sartor reports receiving consulting fees from Aragon, Astellas, Bavarian Nordic, Bellicum, Dendreon, Medivation, OncoGeneX, and Pfizer, consulting fees and grant support through his institution from Johnson & Johnson and Sanofi-Aventis, and grant support through his institution from Algeta, Bayer, and Takeda. No other potential conflict of interest relevant to this article was reported.	Adami S, 1997, CANCER, V80, P1674, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1674::AID-CNCR18>3.3.CO;2-D; Bruland OS, 2006, CLIN CANCER RES, V12, p6250S, DOI 10.1158/1078-0432.CCR-06-0841; Cella D, 2009, VALUE HEALTH, V12, P124, DOI 10.1111/j.1524-4733.2008.00409.x; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Finlay OG, 2005, LANCET ONCOL, V6, P392, DOI 10.1016/S1470-2045(05)70206-0; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Fizazi K, 2009, J CLIN ONCOL, V27, P1564, DOI 10.1200/JCO.2008.19.2146; Harris V, 2011, CLIN ONCOL-UK, V23, P706, DOI 10.1016/j.clon.2011.04.014; Henriksen G, 2003, J NUCL MED, V44, P252; Henriksen G, 2002, CANCER RES, V62, P3120; Kerr C, 2002, LANCET ONCOL, V3, P453, DOI 10.1016/S1470-2045(02)00835-5; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lange PH, 1998, CANCER METAST REV, V17, P331, DOI 10.1023/A:1006106209527; Lewington VJ, 2005, J NUCL MED, V46, p38S; Li Yong, 2004, Expert Rev Anticancer Ther, V4, P459, DOI 10.1586/14737140.4.3.459; Liepe K, 2009, CURR OPIN INVEST DR, V10, P1346; Lipton A, 2010, SEMIN ONCOL, V37, pS15, DOI 10.1053/j.seminoncol.2010.10.002; McDevitt MR, 1998, EUR J NUCL MED, V25, P1341, DOI 10.1007/s002590050306; Nilsson S, 2005, CLIN CANCER RES, V11, P4451, DOI 10.1158/1078-0432.CCR-04-2244; Nilsson S, 2012, EUR J CANCER, V48, P678, DOI 10.1016/j.ejca.2011.12.023; Nilsson S, 2007, LANCET ONCOL, V8, P587, DOI 10.1016/S1470-2045(07)70147-X; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Parker CC, 2013, EUR UROL, V63, P189, DOI 10.1016/j.eururo.2012.09.008; Perlroth DJ, 2012, AM SOC CLIN ONC GEN; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Sartor O, 2011, ASIAN J ANDROL, V13, P783, DOI 10.1038/aja.2011.120; Sartor O, 2011, CLIN GENITOURIN CANC, V9, P1, DOI 10.1016/j.clgc.2011.08.001; Sartor O, 2011, ASIAN J ANDROL, V13, P366, DOI 10.1038/aja.2011.23; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Silberstein EB, 2000, SEMIN RADIAT ONCOL, V10, P240, DOI 10.1053/srao.2000.6592; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720	33	2071	2138	7	177	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 18	2013	369	3					213	223		10.1056/NEJMoa1213755	http://dx.doi.org/10.1056/NEJMoa1213755			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DQ	23863050	Bronze			2022-12-28	WOS:000321945800007
J	Wong, SD; Srnec, M; Matthews, ML; Liu, LV; Kwak, Y; Park, K; Bell, CB; Alp, EE; Zhao, JY; Yoda, Y; Kitao, S; Seto, M; Krebs, C; Bollinger, JM; Solomon, EI				Wong, Shaun D.; Srnec, Martin; Matthews, Megan L.; Liu, Lei V.; Kwak, Yeonju; Park, Kiyoung; Bell, Caleb B., III; Alp, E. Ercan; Zhao, Jiyong; Yoda, Yoshitaka; Kitao, Shinji; Seto, Makoto; Krebs, Carsten; Bollinger, J. Martin, Jr.; Solomon, Edward I.			Elucidation of the Fe(IV)=O intermediate in the catalytic cycle of the halogenase SyrB2	NATURE			English	Article							RESONANCE VIBRATIONAL SPECTROSCOPY; AUXILIARY BASIS-SETS; GAUSSIAN-BASIS SETS; CORRELATION-ENERGY; MOLECULAR CALCULATIONS; ALIPHATIC HALOGENASE; ELECTRONIC-STRUCTURE; SCATTERING BEAMLINE; ROW ATOMS; IRON	Mononuclear non-haem iron (NHFe) enzymes catalyse a broad range of oxidative reactions, including halogenation, hydroxylation, ring closure, desaturation and aromatic ring cleavage reactions. They are involved in a number of biological processes, including phenylalanine metabolism, the production of neuro-transmitters, the hypoxic response and the biosynthesis of secondary metabolites(1-3). The reactive intermediate in the catalytic cycles of these enzymes is a high-spin S = 2 Fe(IV)=O species, which has been trapped for a number of NHFe enzymes(4-8), including the halogenase SyrB2 (syringomycin biosynthesis enzyme 2). Computational studies aimed at understanding the reactivity of this Fe(IV)=O intermediate(9-13) are limited in applicability owing to the paucity of experimental knowledge about its geometric and electronic structure. Synchrotron-based nuclear resonance vibrational spectroscopy (NRVS) is a sensitive and effective method that defines the dependence of the vibrational modes involving Fe on the nature of the Fe(IV)=O active site(14-16). Here we present NRVS structural characterization of the reactive Fe(IV)=O intermediate of a NHFe enzyme, namely the halogenase SyrB2 from the bacterium Pseudomonas syringae pv. syringae. This intermediate reacts via an initial hydrogen-atom abstraction step, performing subsequent halogenation of the native substrate or hydroxylation of non-native substrates(17). Acorrelation of the experimental NRVS data to electronic structure calculations indicates that the substrate directs the orientation of the Fe(IV)=O intermediate, presenting specific frontier molecular orbitals that can activate either selective halogenation or hydroxylation.	[Wong, Shaun D.; Srnec, Martin; Liu, Lei V.; Kwak, Yeonju; Park, Kiyoung; Bell, Caleb B., III; Solomon, Edward I.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Matthews, Megan L.; Krebs, Carsten; Bollinger, J. Martin, Jr.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Alp, E. Ercan; Zhao, Jiyong] Argonne Natl Lab, APS XFD, Argonne, IL 60439 USA; [Yoda, Yoshitaka] JASRI, SPring 8, Hyogo 6795198, Japan; [Kitao, Shinji; Seto, Makoto] Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan; [Krebs, Carsten; Bollinger, J. Martin, Jr.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Solomon, Edward I.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Energy (DOE); Argonne National Laboratory; Kyoto University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Krebs, C (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	ckrebs@psu.edu; jmb21@psu.edu; edward.solomon@stanford.edu	Matthews, Megan/W-2217-2017; Srnec, Martin/F-5625-2014; Krebs, Carsten/D-4773-2009; Park, Kiyoung/J-3204-2014; Bollinger, Joseph/C-1425-2016	Matthews, Megan/0000-0003-1178-4616; Krebs, Carsten/0000-0002-3302-7053; Solomon, Edward/0000-0003-0291-3199; Yoda, Yoshitaka/0000-0003-3062-8651	National Institutes of Health [GM-40392, GM-69657]; National Science Foundation [MCB-0919027, MCB-642058, CHE-724084]; Department of Energy, Office of Science [DE-AC-02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040392, R01GM069657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Energy, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided by the National Institutes of Health (GM-40392 to E. I. S. and GM-69657 to J.M.B. and C. K.) and the National Science Foundation (MCB-0919027 to E. I. S., and MCB-642058 and CHE-724084 to J.M.B. and C. K.). Work at the Advanced Photon Source was supported by the Department of Energy, Office of Science, under contract DE-AC-02-06CH11357. Synchrotron experiments at SPring-8 were performed with the approval of the Japan Synchrotron Radiation Research Institute (JASRI; proposal no. 2010B1569). M. S. thanks the Rulisek group at the IOCB, Prague, for use of their computational resources.	AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; ALP EE, 1994, HYPERFINE INTERACT, V90, P323, DOI 10.1007/BF02069136; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bell CB, 2008, ANGEW CHEM INT EDIT, V47, P9071, DOI 10.1002/anie.200803740; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Borowski T, 2010, J AM CHEM SOC, V132, P12887, DOI 10.1021/ja101877a; Cammi R, 1999, J PHYS CHEM A, V103, P9100, DOI 10.1021/jp991564w; Cammi R, 2000, J PHYS CHEM A, V104, P5631, DOI 10.1021/jp000156l; Chumakov AI, 1999, HYPERFINE INTERACT, V123, P781, DOI 10.1023/A:1017052730094; Comba P, 2010, CHEM-EUR J, V16, P7293, DOI 10.1002/chem.201000092; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; de Visser SP, 2009, J PHYS CHEM B, V113, P12, DOI 10.1021/jp8097632; Diebold AR, 2011, J AM CHEM SOC, V133, P18148, DOI 10.1021/ja202549q; Eichkorn K, 1997, THEOR CHEM ACC, V97, P119, DOI 10.1007/s002140050244; EICHKORN K, 1995, CHEM PHYS LETT, V240, P283, DOI 10.1016/0009-2614(95)00621-A; Eser BE, 2007, J AM CHEM SOC, V129, P11334, DOI 10.1021/ja074446s; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fujimori DG, 2007, J AM CHEM SOC, V129, P13408, DOI 10.1021/ja076454e; Grimme S, 2004, J COMPUT CHEM, V25, P1463, DOI 10.1002/jcc.20078; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; HAY PJ, 1977, J CHEM PHYS, V66, P4377, DOI 10.1063/1.433731; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Krebs C, 2013, COORDIN CHEM REV, V257, P234, DOI 10.1016/j.ccr.2012.06.020; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; Kulik HJ, 2009, J AM CHEM SOC, V131, P14426, DOI 10.1021/ja905206k; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Leu BM, 2004, J AM CHEM SOC, V126, P4211, DOI 10.1021/ja038526h; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; Matthews ML, 2009, BIOCHEMISTRY-US, V48, P4331, DOI 10.1021/bi900109z; MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980; Mennucci B, 1997, J PHYS CHEM B, V101, P10506, DOI 10.1021/jp971959k; Mennucci B, 1997, J CHEM PHYS, V106, P5151, DOI 10.1063/1.473558; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Neidig ML, 2006, P NATL ACAD SCI USA, V103, P12966, DOI 10.1073/pnas.0605067103; Panay AJ, 2011, BIOCHEMISTRY-US, V50, P1928, DOI 10.1021/bi1019868; Pandian S, 2009, DALTON T, P6201, DOI 10.1039/b906866j; Park K, 2013, P NATL ACAD SCI USA, V110, P6275, DOI 10.1073/pnas.1304238110; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Sage JT, 2001, J PHYS-CONDENS MAT, V13, P7707, DOI 10.1088/0953-8984/13/34/315; Schafer A, 2000, PHYS CHEM CHEM PHYS, V2, P2187, DOI 10.1039/b000184h; SETO M, 1995, PHYS REV LETT, V74, P3828, DOI 10.1103/PhysRevLett.74.3828; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Srnec M, 2012, P NATL ACAD SCI USA, V109, P14326, DOI 10.1073/pnas.1212693109; Srnec M, 2012, INORG CHEM, V51, P2806, DOI 10.1021/ic2018067; Tenderholt A., 2009, GENNRVS; Usharani D, 2011, J AM CHEM SOC, V133, P176, DOI 10.1021/ja107339h; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; WACHTERS AJ, 1970, J CHEM PHYS, V52, P1033, DOI 10.1063/1.1673095; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Wong SD, 2011, ANGEW CHEM INT EDIT, V50, P3215, DOI 10.1002/anie.201007692; Yoda Y, 2001, NUCL INSTRUM METH A, V467, P715, DOI 10.1016/S0168-9002(01)00474-0	55	144	147	6	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2013	499	7458					320	+		10.1038/nature12304	http://dx.doi.org/10.1038/nature12304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23868262	Green Accepted			2022-12-28	WOS:000321910700032
J	Woo, SB; Stone, JH; Kraft, S				Woo, Sook-Bin; Stone, John H.; Kraft, Stefan			Case 22-2013: A 51-Year-Old Woman with Epistaxis and Oral Mucosal Ulcers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ERYTHEMA MULTIFORME; WEGENERS-GRANULOMATOSIS; PEMPHIGUS-VULGARIS; LONG-TERM; RITUXIMAB; MANIFESTATIONS; CRITERIA; DISEASE; PATHOGENESIS; DIAGNOSIS		[Woo, Sook-Bin] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Woo, Sook-Bin] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Stone, John H.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Kraft, Stefan] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Woo, Sook-Bin] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Stone, John H.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kraft, Stefan] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Woo, SB (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.				Genentech and Roche	Genentech and Roche	Dr. Stone reports receiving consulting fees from Genentech and Roche, grant support through his institution from Genentech and Roche, and travel support through his institution from Genentech, Biogen Idec, and Genzyme. No other potential conflict of interest relevant to this article was reported.	Alexandre M, 2006, MEDICINE, V85, P239, DOI 10.1097/01.md.0000231954.08350.52; Ayangco L, 2003, DERMATOL CLIN, V21, P195, DOI 10.1016/S0733-8635(02)00062-1; BEAN SF, 1983, JAMA-J AM MED ASSOC, V249, P2810, DOI 10.1001/jama.249.20.2810; Bruch-Gerharz D, 2007, EUR J DERMATOL, V17, P191; Bystryn JC, 2005, LANCET, V366, P61, DOI 10.1016/S0140-6736(05)66829-8; Chan LS, 2012, CLIN DERMATOL, V30, P34, DOI 10.1016/j.clindermatol.2011.03.007; Chan LS, 2002, ARCH DERMATOL, V138, P370, DOI 10.1001/archderm.138.3.370; Egan CA, 2003, MEDICINE, V82, P177, DOI 10.1097/00005792-200305000-00004; Falk RJ, 2011, ARTHRITIS RHEUM-US, V63, P863, DOI 10.1002/art.30286; Joly P, 2007, NEW ENGL J MED, V357, P545, DOI 10.1056/NEJMoa067752; Jurge S, 2006, ORAL DIS, V12, P1, DOI 10.1111/j.1601-0825.2005.01143.x; Kasperkiewicz M, 2012, AUTOIMMUNITY, V45, P55, DOI 10.3109/08916934.2011.606447; Kasperkiewicz M, 2011, J AM ACAD DERMATOL, V65, P552, DOI 10.1016/j.jaad.2010.07.032; Khosroshahi A, 2012, MEDICINE, V91, P57, DOI 10.1097/MD.0b013e3182431ef6; Khosroshahi A, 2010, ARTHRITIS RHEUM-US, V62, P1755, DOI 10.1002/art.27435; lcully C, 2008, BR J ORAL MAXILLOFAC, V46, P15; LEAVITT RY, 1990, ARTHRITIS RHEUM, V33, P1101, DOI 10.1002/art.1780330807; Leshem YA, 2013, J AM ACAD DERMATOL, V68, P404, DOI 10.1016/j.jaad.2012.08.010; LEWIS MAO, 1989, BRIT DENT J, V166, P371, DOI 10.1038/sj.bdj.4806846; Mendes D, 2009, J AUTOIMMUN, V32, P178, DOI 10.1016/j.jaut.2009.02.011; Mignogna MD, 2010, AM J CLIN DERMATOL, V11, P137, DOI 10.2165/11530050-000000000-00000; Scully C, 1999, BRIT J DERMATOL, V140, P84; SILMAN AJ, 1990, LANCET, V335, P1078; Stewart C, 2007, J AM DENT ASSOC, V138, P338, DOI 10.14219/jada.archive.2007.0166; Woo SB, 1997, ORAL SURG ORAL MED O, V83, P239, DOI 10.1016/S1079-2104(97)90011-1; Zakka LR, 2011, AUTOIMMUN REV, V11, P40, DOI 10.1016/j.autrev.2011.07.002	26	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	2013	369	3					265	274		10.1056/NEJMcpc1209275	http://dx.doi.org/10.1056/NEJMcpc1209275			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DQ	23863054				2022-12-28	WOS:000321945800013
J	Mangurian, C; Cowan, MJ				Mangurian, Christina; Cowan, Morton J.			The missing vital sign	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mangurian, Christina] Univ Calif San Francisco, Dept Psychiat, San Francisco Gen Hosp, UCSF Publ Psychiat Fellowship, San Francisco, CA 94110 USA; [Cowan, Morton J.] Univ Calif San Francisco, Allergy Immunol & Blood & Marrow Transplant Div, UCSF Benioff Childrens Hosp, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mangurian, C (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco Gen Hosp, UCSF Publ Psychiat Fellowship, San Francisco, CA 94110 USA.	Christina.Mangurian@ucsf.edu			NIMH NIH HHS [K23MH093689, K23 MH093689] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH093689] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))			0	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2013	347								f4163	10.1136/bmj.f4163	http://dx.doi.org/10.1136/bmj.f4163			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180DN	23833077	Green Published, Bronze			2022-12-28	WOS:000321573400003
J	Ortiz, A; Sanchez-Nino, MD				Ortiz, Alberto; Dolores Sanchez-Nino, Maria			The demise of calcium-based phosphate binders	LANCET			English	Editorial Material							CHRONIC-RENAL-FAILURE; DIALYSIS; TRIAL		[Ortiz, Alberto] Fdn Jimenez Diaz, Inst Invest Sanitaria, Dept Hypertens & Nephrol, E-28040 Madrid, Spain; [Ortiz, Alberto] Univ Autonoma Madrid, Inst Reina Sofia Invest Nefrol, Madrid 28040, Spain; [Dolores Sanchez-Nino, Maria] Hosp Univ La Paz, Inst Invest, Dept Nephrol, Red Invest Renal, Madrid 28040, Spain	Fundacion Jimenez Diaz; Autonomous University of Madrid; Hospital Universitario La Paz	Ortiz, A (corresponding author), Fdn Jimenez Diaz, Inst Invest Sanitaria, Dept Hypertens & Nephrol, E-28040 Madrid, Spain.	aortiz@fjd.es	ortiz, alberto/Y-7582-2018; Sanchez-Niño, Maria Dolores/B-7350-2019	ortiz, alberto/0000-0002-9805-9523; Sanchez-Niño, Maria Dolores/0000-0001-7110-6409				ALFREY AC, 1976, NEW ENGL J MED, V294, P184, DOI 10.1056/NEJM197601222940402; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Block GA, 2012, J AM SOC NEPHROL, V23, P1407, DOI 10.1681/ASN.2012030223; Bolland MJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2040; Chertow GM, 1997, AM J KIDNEY DIS, V29, P66, DOI 10.1016/S0272-6386(97)90009-3; Gonzalez-Parra E, 2012, CARDIOVASC PATHOL, V21, P372, DOI 10.1016/j.carpath.2012.02.008; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Jamal SA, 2013, LANCET; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; SLATOPOLSKY E, 1986, NEW ENGL J MED, V315, P157, DOI 10.1056/NEJM198607173150304; Tonelli M, 2010, NEW ENGL J MED, V362, P1312, DOI 10.1056/NEJMra0912522; Wuthrich RP, 2013, CLIN J AM SOC NEPHRO, V8, P280, DOI 10.2215/CJN.08230811	14	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2013	382	9900					1232	1234		10.1016/S0140-6736(13)61165-4	http://dx.doi.org/10.1016/S0140-6736(13)61165-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235XP	23870814				2022-12-28	WOS:000325756400009
J	Atarashi, K; Tanoue, T; Oshima, K; Suda, W; Nagano, Y; Nishikawa, H; Fukuda, S; Saito, T; Narushima, S; Hase, K; Kim, S; Fritz, JV; Wilmes, P; Ueha, S; Matsushima, K; Ohno, H; Olle, B; Sakaguchi, S; Taniguchi, T; Morita, H; Hattori, M; Honda, K				Atarashi, Koji; Tanoue, Takeshi; Oshima, Kenshiro; Suda, Wataru; Nagano, Yuji; Nishikawa, Hiroyoshi; Fukuda, Shinji; Saito, Takuro; Narushima, Seiko; Hase, Koji; Kim, Sangwan; Fritz, Joelle V.; Wilmes, Paul; Ueha, Satoshi; Matsushima, Kouji; Ohno, Hiroshi; Olle, Bernat; Sakaguchi, Shimon; Taniguchi, Tadatsugu; Morita, Hidetoshi; Hattori, Masahira; Honda, Kenya			T-reg induction by a rationally selected mixture of Clostridia strains from the human microbiota	NATURE			English	Article							GUT MICROBIOTA; CELLS; COLONIZATION; DISEASE	Manipulation of the gut microbiota holds great promise for the treatment of inflammatory and allergic diseases(1,2). Although numerous probiotic microorganisms have been identified(3), there remains a compelling need to discover organisms that elicit more robust therapeutic responses, are compatible with the host, and can affect a specific arm of the host immune system in a well-controlled, physiological manner. Here we use a rational approach to isolate CD4(+)FOXP3(+) regulatory T (T-reg)-cell-inducing bacterial strains from the human indigenous microbiota. Starting with a healthy human faecal sample, a sequence of selection steps was applied to obtain mice colonized with human microbiota enriched in T-reg-cell-inducing species. From these mice, we isolated and selected 17 strains of bacteria on the basis of their high potency in enhancing T-reg cell abundance and inducing important anti-inflammatory molecules-including interleukin-10 (IL-10) and inducible T-cell co-stimulator (ICOS)-in T-reg cells upon inoculation into germ-free mice. Genome sequencing revealed that the 17 strains fall within clusters IV, XIVa and XVIII of Clostridia, which lack prominent toxins and virulence factors. The 17 strains act as a community to provide bacterial antigens and a TGF-beta-rich environment to help expansion and differentiation of T-reg cells. Oral administration of the combination of 17 strains to adult mice attenuated disease in models of colitis and allergic diarrhoea. Use of the isolated strains may allow for tailored therapeutic manipulation of human immune disorders.	[Atarashi, Koji; Tanoue, Takeshi; Nagano, Yuji; Fukuda, Shinji; Narushima, Seiko; Hase, Koji; Ohno, Hiroshi; Honda, Kenya] RIKEN Ctr Integrat Med Sci IMS RCAI, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Atarashi, Koji; Tanoue, Takeshi; Nagano, Yuji; Taniguchi, Tadatsugu; Honda, Kenya] Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; [Atarashi, Koji; Hase, Koji] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Oshima, Kenshiro; Morita, Hidetoshi; Honda, Kenya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Oshima, Kenshiro; Suda, Wataru; Kim, Sangwan; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Nishikawa, Hiroyoshi; Saito, Takuro; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan; [Fritz, Joelle V.; Wilmes, Paul] Univ Luxembourg, Luxembourg Ctr Syst Biomed, L-4362 Esch Sur Alzette, Luxembourg; [Ueha, Satoshi; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 1130033, Japan; [Olle, Bernat] PureTech Ventures, Boston, MA 02116 USA; [Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa 2525201, Japan	RIKEN; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Tokyo; Osaka University; Keio University; University of Luxembourg; University of Tokyo; Azabu University	Hattori, M (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan.	hattori@k.u-tokyo.ac.jp; kenya@rcai.riken.jp	Atarashi, Koji/I-5363-2014; Suda, Wataru/AAF-4469-2019; Ohno, Hiroshi/L-7899-2014; Hattori, Masahira/AAD-3785-2019; Saito, Takuro/AAN-9682-2021; Nishikawa, Hiroyoshi/AAI-7044-2020; Sakaguchi, Shimon/C-9535-2009; Honda, Kenya/N-5297-2015; Wilmes, Paul/B-1707-2017; Hattori, Masahira/C-6958-2016	Atarashi, Koji/0000-0001-5422-0736; Ohno, Hiroshi/0000-0001-8776-9661; Wilmes, Paul/0000-0002-6478-2924; Hattori, Masahira/0000-0001-9467-0344; Ueha, Satoshi/0000-0002-3871-9921; Fukuda, Shinji/0000-0001-5161-9880; Hase, Koji/0000-0001-9550-2334; Fritz, Joelle/0000-0002-4694-3923	JSPS NEXT program; Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002]; global COE project of 'Genome Information Big Bang'; Waksman Foundation of Japan Inc.; Grants-in-Aid for Scientific Research [24117723, 23300354] Funding Source: KAKEN	JSPS NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); global COE project of 'Genome Information Big Bang'; Waksman Foundation of Japan Inc.(Waksman Foundation of Japan Inc.); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS NEXT program, Grant in Aid for Scientific Research on Innovative Areas 'Genome Science' from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No.221S0002), the global COE project of 'Genome Information Big Bang' and the Waksman Foundation of Japan Inc. We thank M. Suyama, K. Furuya, C. Yoshino, H. Inaba, E. Iioka, Y. Takayama, M. Kiuchi, Y. Hattori, N. Fukuda and A. Nakano for technical assistance, and P. D. Burrows for review of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Candela M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-95; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Jolley KA, 2012, MICROBIOL-SGM, V158, P1005, DOI 10.1099/mic.0.055459-0; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Kweon MN, 2000, J CLIN INVEST, V106, P199, DOI 10.1172/JCI8490; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Morita H, 2007, MICROBES ENVIRON, V22, P214, DOI 10.1264/jsme2.22.214; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; O'Toole Paul W, 2008, Interdiscip Perspect Infect Dis, V2008, P175285, DOI 10.1155/2008/175285; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	28	1735	1878	16	359	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					232	+		10.1038/nature12331	http://dx.doi.org/10.1038/nature12331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23842501				2022-12-28	WOS:000322825500040
J	Rhinn, H; Fujita, R; Qiang, L; Cheng, R; Lee, JH; Abeliovich, A				Rhinn, Herve; Fujita, Ryousuke; Qiang, Liang; Cheng, Rong; Lee, Joseph H.; Abeliovich, Asa			RETRACTED: Integrative genomics identifies APOE epsilon 4 effectors in Alzheimer's disease (Retracted article. See vol. 523, 2015)	NATURE			English	Article; Retracted Publication							AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN-E; WIDE ASSOCIATION; COMMON VARIANTS; BETA-SECRETASE; EXPRESSION; ONSET; RISK; RECEPTOR-2; METABOLISM	Late-onset Alzheimer's disease (LOAD) risk is strongly influenced by genetic factors such as the presence of the apolipoprotein E epsilon 4 allele (referred to here as APOE4), as well as non-genetic determinants including ageing. To pursue mechanisms by which these affect human brain physiology and modify LOAD risk, we initially analysed whole-transcriptome cerebral cortex gene expression data in unaffected APOE4 carriers and LOAD patients. APOE4 carrier status was associated with a consistent transcriptomic shift that broadly resembled the LOAD profile. Differential co-expression correlation network analysis of the APOE4 and LOAD transcriptomic changes identified a set of candidate core regulatory mediators. Several of these-including APBA2, FYN, RNF219 and SV2A-encode known or novel modulators of LOAD associated amyloid beta A4 precursor protein (APP) endocytosis and metabolism. Furthermore, a genetic variant within RNF219 was found to affect amyloid deposition in human brain and LOAD age-of-onset. These data implicate an APOE4 associated molecular pathway that promotes LOAD.	[Rhinn, Herve; Fujita, Ryousuke; Qiang, Liang; Abeliovich, Asa] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Rhinn, Herve; Fujita, Ryousuke; Qiang, Liang; Abeliovich, Asa] Columbia Univ, Dept Cell Biol, New York, NY 10032 USA; [Rhinn, Herve; Fujita, Ryousuke; Qiang, Liang; Abeliovich, Asa] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Rhinn, Herve; Fujita, Ryousuke; Qiang, Liang; Cheng, Rong; Lee, Joseph H.; Abeliovich, Asa] Columbia Univ, Taub Inst Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Lee, Joseph H.] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; [Lee, Joseph H.] Columbia Univ, Dept Epidemiol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Abeliovich, A (corresponding author), Columbia Univ, Dept Pathol, 650 W 168th St, New York, NY 10032 USA.	aa900@columbia.edu	Lee, Joseph H/D-2441-2012	Lee, Joseph H/0000-0002-2000-4821	National Institutes of Health (NIH) [R01AG042317, R01NS064433]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (NIH) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514];  [R37 AG015473];  [R01 MH084995]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG024904, K01AG030514, R37AG015473, R01AG042317, P30AG010129] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Disease Neuroimaging Initiative (ADNI) (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Mayeux, G. Di Paulo, S. Small and A. Rosenthal for comments on the manuscript; D. Holtzman and J. Cirrito for antibody reagents; and S. Bajjalieh and J. Yao for SV2A expression vectors. We are especially grateful to the many laboratories who contributed data sets included in this study. The work was supported by grants from the National Institutes of Health (NIH) (R01AG042317 and R01NS064433). J. H. L. and R. C. were partially funded by R37 AG015473 and R01 MH084995. Additionally, data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (NIH grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica; Biogen Idec; Bristol-Myers Squibb; Eisai; Elan Pharmaceuticals; Eli Lilly; F. Hoffmann-La Roche and its affiliated company Genentech; GE Healthcare; Innogenetics, NV; IXICO; Janssen Alzheimer Immunotherapy Research and Development; Johnson and Johnson Pharmaceutical Research and Development; Medpace; Merck; Meso Scale Diagnostics; NeuroRx Research; Novartis; Pfizer; Piramal Imaging; Servier; Synarc; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (http://fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514.	Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Bossers K, 2010, BRAIN, V133, P3699, DOI 10.1093/brain/awq258; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Cirulli ET, 2010, EUR J HUM GENET, V18, P815, DOI 10.1038/ejhg.2010.2; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; Dik MG, 2001, NEUROLOGY, V57, P2217, DOI 10.1212/WNL.57.12.2217; Fotinopoulou A, 2005, J BIOL CHEM, V280, P30768, DOI 10.1074/jbc.C500231200; Furney SJ, 2011, MOL PSYCHIATR, V16, P1130, DOI 10.1038/mp.2010.123; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Hoe HS, 2008, J BIOL CHEM, V283, P6288, DOI 10.1074/jbc.M704140200; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang YD, 2006, NEUROLOGY, V66, pS79, DOI 10.1212/01.wnl.0000192102.41141.9e; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Liang DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040498; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Pasinetti GM, 2001, J NEUROSCI RES, V65, P471, DOI 10.1002/jnr.1176; Presson AP, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-95; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Ramanan VK, 2014, MOL PSYCHIATR, V19, P351, DOI 10.1038/mp.2013.19; Ray M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-136; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Rhinn H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2032; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Sano Y, 2006, J BIOL CHEM, V281, P37853, DOI 10.1074/jbc.M609312200; Selkoe Dennis J, 2003, Harvey Lect, V99, P23; Soler-Lopez M, 2011, GENOME RES, V21, P364, DOI 10.1101/gr.114280.110; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ullrich S, 2010, J BIOL CHEM, V285, P20664, DOI 10.1074/jbc.M109.055608; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	57	113	117	0	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					45	U62		10.1038/nature12415	http://dx.doi.org/10.1038/nature12415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23883936				2022-12-28	WOS:000322514800024
J	Varghese, RT				Varghese, Ron Thomas			NON-COMMUNICABLE DISEASE The advent of bariatric surgery for diabetes in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICAL THERAPY; OBESITY; BMI		Christian Med Coll & Hosp, Dept Endocrinol Diabet & Metab, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore	Varghese, RT (corresponding author), Christian Med Coll & Hosp, Dept Endocrinol Diabet & Metab, Vellore, Tamil Nadu, India.	ronthomasv@gmail.com		VARGHESE, RON/0000-0002-6198-4352				Batsis JA, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.05.024; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Centre for Obesity and Digestive Surgery, AS CONS M MET SURG; Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; Dixon JB, 2011, DIABETIC MED, V28, P628, DOI 10.1111/j.1464-5491.2011.03306.x; Ikramuddin S, 2011, BRIT J SURG, V98, P1339, DOI 10.1002/bjs.7652; Klein S, 2011, OBESITY, V19, P581, DOI 10.1038/oby.2010.199; Lee W-J., CONSENSUS ASIAN DIAB; Leff DR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3402; Livingston EH, 2012, JAMA-J AM MED ASSOC, V307, P88, DOI 10.1001/jama.2011.1950; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Misra A, 2001, INT J OBESITY, V25, P1722, DOI 10.1038/sj.ijo.0801748; NHLBI Obesity Education Initiative, 2000, PRACT GUID ID EV TRE; Pandya H., 2011, INT J BIOL MED RES, V2, P556; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Shelar J., 2012, TIMES INDIA; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Varghese RT, 2008, CALICUT MED J, V6, pe3; Vijayakumar K, 2010, HDB DIS BURDENS QU 3, P2071; Wallace AE, 2010, OBES SURG, V20, P1354, DOI 10.1007/s11695-009-0054-x	20	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2013	347								f3391	10.1136/bmj.f3391	http://dx.doi.org/10.1136/bmj.f3391			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BS	23894187				2022-12-28	WOS:000322532500001
J	Yuan, CX; Liang, Y; Hernandez, T; Berriochoa, A; Houk, KN; Siegel, D				Yuan, Changxia; Liang, Yong; Hernandez, Taylor; Berriochoa, Adrian; Houk, Kendall N.; Siegel, Dionicio			Metal-free oxidation of aromatic carbon-hydrogen bonds through a reverse-rebound mechanism	NATURE			English	Article							CYCLIC DIACYL PEROXIDES; C-H OXYGENATION; PHTHALOYL PEROXIDE; ATOM TRANSFER; SELECTIVITY; PHOTODECOMPOSITION; DECOMPOSITION; REACTIVITY; PRODUCTS; RADICALS	Methods for carbon-hydrogen (C-H) bond oxidation have a fundamental role in synthetic organic chemistry, providing functionality that is required in the final target molecule or facilitating subsequent chemical transformations. Several approaches to oxidizing aliphatic C-H bonds have been described, drastically simplifying the synthesis of complex molecules(1-6). However, the selective oxidation of aromatic C-H bonds under mild conditions, especially in the context of substituted arenes with diverse functional groups, remains a challenge. The direct hydroxylation of arenes was initially achieved through the use of strong Bronsted or Lewis acids to mediate electrophilic aromatic substitution reactions with super-stoichiometric equivalents of oxidants, significantly limiting the scope of the reaction(7). Because the products of these reactions are more reactive than the starting materials, over-oxidation is frequently a competitive process. Transition-metal-catalysed C-H oxidation of arenes with or without directing groups has been developed, improving on the acid-mediated process; however, precious metals are required(8-13). Here we demonstrate that phthaloyl peroxide functions as a selective oxidant for the transformation of arenes to phenols under mild conditions. Although the reaction proceeds through a radical mechanism, aromatic C-H bonds are selectively oxidized in preference to activated Csp3-H bonds. Notably, a wide array of functional groups are compatible with this reaction, and this method is therefore well suited for late-stage transformations of advanced synthetic intermediates. Quantum mechanical calculations indicate that this transformation proceeds through a novel addition-abstraction mechanism, a kind of 'reverse-rebound' mechanism as distinct from the common oxygen-rebound mechanism observed for metal-oxo oxidants. These calculations also identify the origins of the experimentally observed aryl selectivity.	[Yuan, Changxia; Hernandez, Taylor; Berriochoa, Adrian; Siegel, Dionicio] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Liang, Yong; Houk, Kendall N.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of Texas System; University of Texas Austin; University of California System; University of California Los Angeles	Siegel, D (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	dsiegel@cm.utexas.edu	Yuan, Changxia/K-9293-2013; Liang, Yong/J-4541-2017	Liang, Yong/0000-0001-5026-6710	University of Texas at Austin; Welch Foundation [F-1694]; US National Science Foundation [CHE-1059084, OCI-1053575]; Direct For Mathematical & Physical Scien [1361104] Funding Source: National Science Foundation	University of Texas at Austin; Welch Foundation(The Welch Foundation); US National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Financial support from the University of Texas at Austin, the Welch Foundation (F-1694 to D. S.), and the US National Science Foundation (CHE-1059084 to K.N.H.) are gratefully acknowledged. Calculations were performed on the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by the US National Science Foundation (OCI-1053575).	Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Chen MS, 2010, SCIENCE, V327, P566, DOI 10.1126/science.1183602; Cheng X, 2010, ORG LETT, V12, P1304, DOI 10.1021/ol100214x; Curci R, 2006, ACCOUNTS CHEM RES, V39, P1, DOI 10.1021/ar050163y; Emmert MH, 2011, ANGEW CHEM INT EDIT, V50, P9409, DOI 10.1002/anie.201103327; Ensing B, 2004, J AM CHEM SOC, V126, P4355, DOI 10.1021/ja038865a; Frisch M.J., 2011, GAUSSIAN 09 VERSION, DOI 10.1021/ja5111392; Fujimori K, 1996, J CHEM SOC PERK T 2, P413, DOI 10.1039/p29960000413; GREENE FD, 1958, J AM CHEM SOC, V80, P3432, DOI 10.1021/ja01546a058; GREENE FD, 1956, J AM CHEM SOC, V78, P2250, DOI 10.1021/ja01591a061; Gulevich AV, 2012, J AM CHEM SOC, V134, P5528, DOI 10.1021/ja3010545; Gutekunst WR, 2011, CHEM SOC REV, V40, P1976, DOI 10.1039/c0cs00182a; Huang CH, 2011, J AM CHEM SOC, V133, P17630, DOI 10.1021/ja208572v; Jursic BS, 1996, INT J QUANTUM CHEM, V59, P495, DOI 10.1002/(SICI)1097-461X(1996)59:6<495::AID-QUA7>3.0.CO;2-T; Malkowsky IM, 2007, SYNTHESIS-STUTTGART, P773, DOI 10.1055/s-2007-965895; Neufeldt SR, 2012, ACCOUNTS CHEM RES, V45, P936, DOI 10.1021/ar300014f; Powers DC, 2010, J AM CHEM SOC, V132, P14530, DOI 10.1021/ja1054274; Rappoport Z., 2003, CHEM PHENOLS, V1, P395; Rappoport Z., 2003, CHEM PHENOLS, V2, P395; Roizen JL, 2012, ACCOUNTS CHEM RES, V45, P911, DOI 10.1021/ar200318q; RUSSELL KE, 1955, J AM CHEM SOC, V77, P4814, DOI 10.1021/ja01623a037; Shuklov IA, 2007, SYNTHESIS-STUTTGART, P2925, DOI 10.1055/s-2007-983902; Simmons EM, 2012, NATURE, V483, P70, DOI 10.1038/nature10785; TAKAHARA S, 1985, B CHEM SOC JPN, V58, P688, DOI 10.1246/bcsj.58.688; Virtamo J., 2011, JAMA-J AM MED ASSOC, V3, P962; WANG J, 1995, B CHEM SOC JPN, V68, P1213, DOI 10.1246/bcsj.68.1213; Wender PA, 2008, ACCOUNTS CHEM RES, V41, P40, DOI 10.1021/ar700155p; WILKERSON WW, 1993, BIOORG MED CHEM LETT, V3, P2087, DOI 10.1016/S0960-894X(01)81022-2; Yuan CX, 2011, TETRAHEDRON LETT, V52, P2540, DOI 10.1016/j.tetlet.2011.03.005; Zhang YH, 2009, J AM CHEM SOC, V131, P14654, DOI 10.1021/ja907198n	31	127	130	11	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					192	196		10.1038/nature12284	http://dx.doi.org/10.1038/nature12284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23846658				2022-12-28	WOS:000321557600058
J	Richardson, R				Richardson, Ruth			A dismal prospect: workhouse health care	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Richardson, R (corresponding author), The Lancet, London NW1 7BY, England.								0	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 6	2013	382	9886					20	21		10.1016/S0140-6736(13)61516-0	http://dx.doi.org/10.1016/S0140-6736(13)61516-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177AD	23841152	Bronze			2022-12-28	WOS:000321347000013
J	Kershaw, MH; Smyth, MJ				Kershaw, Michael H.; Smyth, Mark J.			Making Macrophages Eat Cancer	SCIENCE			English	Editorial Material							ANTIBODIES; THERAPY; PLUS		[Kershaw, Michael H.] Univ Melbourne, Canc Immunol Program, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia; [Smyth, Mark J.] Queensland Inst Med Res, Immunol Canc & Infect Lab, Herston, Qld 4006, Australia; [Smyth, Mark J.] Univ Queensland, Sch Med, Herston, Qld 4006, Australia	Peter Maccallum Cancer Center; University of Melbourne; QIMR Berghofer Medical Research Institute; University of Queensland	Kershaw, MH (corresponding author), Univ Melbourne, Canc Immunol Program, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia.	mark.smyth@qimr.edu.au	Smyth, Mark J/H-8709-2014	Smyth, Mark J/0000-0001-7098-7240; Kershaw, Michael/0000-0002-2697-487X				CO MS, 1991, NATURE, V351, P501, DOI 10.1038/351501a0; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Mathew M, 2009, CANCER SCI, V100, P1359, DOI 10.1111/j.1349-7006.2009.01192.x; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Salles G, 2011, LANCET, V377, P42, DOI 10.1016/S0140-6736(10)62175-7; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wolchok J. D., 2013, NEW ENGL J MED, DOI [10.1056/NEJ-Moa1302369, DOI 10.1056/NEJ-MOA1302369]	13	24	29	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					41	42		10.1126/science.1241716	http://dx.doi.org/10.1126/science.1241716			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828933				2022-12-28	WOS:000321291700039
J	Riehl, S; Zeidi, M; Conard, NJ				Riehl, Simone; Zeidi, Mohsen; Conard, Nicholas J.			Emergence of Agriculture in the Foothills of the Zagros Mountains of Iran	SCIENCE			English	Article							FERTILE CRESCENT; NORTHERN SYRIA; NEAR-EAST; DOMESTICATION; WILD; CULTIVATION; ORIGINS	The role of Iran as a center of origin for domesticated cereals has long been debated. High stratigraphic resolution and rich archaeological remains at the aceramic Neolithic site of Chogha Golan (Ilam Province, present-day Iran) reveal a sequence ranging over 2200 years of cultivation of wild plants and the first appearance of domesticated-type species. The botanical record from Chogha Golan documents how the inhabitants of the site cultivated wild barley (Hordeum spontaneum) and other wild progenitor species of modern crops, such as wild lentil and pea. Wild wheat species (Triticum spp.) are initially present at less than 10% of total plant species but increase to more than 20% during the last 300 years of the sequence. Around 9800 calendar years before the present, domesticated-type emmer appears. The archaeobotanical remains from Chogha Golan represent the earliest record of long-term plant management in Iran.	[Riehl, Simone] Univ Tubingen, Inst Archaeol Sci, D-72070 Tubingen, Germany; [Riehl, Simone; Zeidi, Mohsen; Conard, Nicholas J.] Tubingen Senckenberg Ctr Human Evolut & Palaeoeco, D-72070 Tubingen, Germany; [Zeidi, Mohsen; Conard, Nicholas J.] Univ Tubingen, Inst Ur & Fruhgeschichte & Archaol Mittelalters, Abt Altere Urgeschichte & Quartarokol, D-72070 Tubingen, Germany	Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Eberhard Karls University of Tubingen	Riehl, S (corresponding author), Univ Tubingen, Inst Archaeol Sci, Rumelinstr 23, D-72070 Tubingen, Germany.	simone.riehl@uni-tuebingen.de	Riehl, Simone/AAI-5815-2020	Riehl, Simone/0000-0002-1744-0032; Conard, Nicholas/0000-0002-4633-0385; Zeidi, Mohsen/0000-0002-4718-9555	Eberhard-Karls-Universitat Tubingen; Heidelberg Academy of Sciences; Tubingen Senckenberg Center for Human Evolution and Palaeoecology; German Research Foundation (DFG)	Eberhard-Karls-Universitat Tubingen; Heidelberg Academy of Sciences; Tubingen Senckenberg Center for Human Evolution and Palaeoecology; German Research Foundation (DFG)(German Research Foundation (DFG))	We thank the Tubingen-Iranian Stone Age Research Project team and S. Hamzavi, representative of the Iranian students, for their support during fieldwork. A. Khoshnevis, the former director of the Research Center of the Iran Cultural Heritage and Tourism Organization, provided permission for the fieldwork. We are grateful to M. Mortezayi and A. Lashkari, directors of the Iranian Center for Archaeological Research and L. Niyakan for granting our permits. Additional support was bestowed by M. Skandari, Director of the Cultural Heritage Office of Ilam Province, and by D. Chamanara, prefect of Salehabad. We thank A. Orendi and D. Karakaya for their contributions to the archaeobotanical study and K. Pustovoytov for technical support with geographic information systems. The Eberhard-Karls-Universitat Tubingen, the Heidelberg Academy of Sciences, the Tubingen Senckenberg Center for Human Evolution and Palaeoecology, and the German Research Foundation (DFG) funded this research. The University of Hohenheim provided scanning electron microscopy facilities. The archaeobotanical samples are currently archived at the University of Tubingen. The raw data are presented in the supplementary materials.	Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; BRAIDWOOD RJ, 1960, SCI AM, V203, P130, DOI 10.1038/scientificamerican0960-130; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Fuller DQ, 2011, WORLD ARCHAEOL, V43, P628, DOI 10.1080/00438243.2011.624747; Gebel H.G.K., 2004, NEOLITHICS, V1, P28; Hillman G, 2001, HOLOCENE, V11, P383, DOI 10.1191/095968301678302823; Hole FA., 1998, TNE ORIGINS SPREAD A, P263; KISLEV ME, 1989, BAR INT SERIES, V508, P147; Matthews R., 2010, ANTIQUITY PROJECT GA; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Morrell PL, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P309, DOI 10.1007/978-3-642-14228-4_6; Naderi S, 2008, P NATL ACAD SCI USA, V105, P17659, DOI 10.1073/pnas.0804782105; Nesbitt M, 1998, SCIENCE, V279, P1433; Nesbitt M., 2002, DAWN FARMING NEAR E, P113; Riehl S, 2012, VEG HIST ARCHAEOBOT, V21, P95, DOI 10.1007/s00334-011-0318-y; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Tanno K, 2012, VEG HIST ARCHAEOBOT, V21, P107, DOI 10.1007/s00334-011-0316-0; Willcox G, 1999, VEG HIST ARCHAEOBOT, V8, P21, DOI 10.1007/BF02042838; Willcox G, 2008, VEG HIST ARCHAEOBOT, V17, P313, DOI 10.1007/s00334-007-0121-y; Willcox G, 2012, VEG HIST ARCHAEOBOT, V21, P163, DOI 10.1007/s00334-011-0307-1; Zeidi M., 2012, P 7 INT C ARCH ANC N, P259	22	128	136	7	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2013	341	6141					65	67		10.1126/science.1236743	http://dx.doi.org/10.1126/science.1236743			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828939				2022-12-28	WOS:000321291700048
J	Scholz, F; Himmel, D; Heinemann, FW; Schleyer, PV; Meyer, K; Krossing, I				Scholz, F.; Himmel, D.; Heinemann, F. W.; Schleyer, P. v R.; Meyer, K.; Krossing, I.			Crystal Structure Determination of the Nonclassical 2-Norbornyl Cation	SCIENCE			English	Article							STABLE CARBONIUM-IONS; C-13 NMR-SPECTRA; NORBORNYL CATION; SOLID-STATE; CARBOCATION; CHEMISTRY; ATOM; STABILIZATION; ANIONS	After decades of vituperative debate over the classical or nonclassical structure of the 2-norbornyl cation, the long-sought x-ray crystallographic proof of the bridged, nonclassical geometry of this prototype carbonium ion in the solvated [C7H11](+)[(AlBr7)-Br-2](-)center dot CH2Br2 salt has finally been realized. This achievement required exceptional treatment. Crystals obtained by reacting norbornyl bromide with aluminum tribromide in CH2Br2 undergo a reversible order-disorder phase transition at 86 kelvin due to internal 6,1,2-hydride shifts of the 2-norbornyl cation moiety. Cooling with careful annealing gave a suitably ordered phase. Data collection at 40 kelvin and refinement revealed similar molecular structures of three independent 2-norbornyl cations in the unit cell. All three structures agree very well with quantum chemical calculations at the MP2(FC)/def2-QZVPP level of theory.	[Scholz, F.; Himmel, D.; Krossing, I.] Univ Freiburg, Inst Anorgan & Analyt Chem, D-79104 Freiburg, Germany; [Heinemann, F. W.; Meyer, K.] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91058 Erlangen, Germany; [Schleyer, P. v R.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Schleyer, P. v R.] Univ Erlangen Nurnberg, Dept Organ Chem, D-91054 Erlangen, Germany	University of Freiburg; University of Erlangen Nuremberg; University System of Georgia; University of Georgia; University of Erlangen Nuremberg	Meyer, K (corresponding author), Univ Erlangen Nurnberg, Dept Chem & Pharm, Egerlandstr 1, D-91058 Erlangen, Germany.	karsten.meyer@chemie.uni-erlangen.de; krossing@uni-freiburg.de	Meyer, Karsten/G-2570-2012; Krossing, Ingo/L-7693-2015; Heinemann, Frank Wilhelm/AAC-3062-2022	Meyer, Karsten/0000-0002-7844-2998; Krossing, Ingo/0000-0002-7182-4387; Heinemann, Frank Wilhelm/0000-0002-9007-8404	University of Freiburg; Friedrich-Alexander-University of Erlangen-Nuremberg; Freiburg Institute for Advanced Studies; Deutsche Forschungs Gemeinschaft [SFB 583]; European Research Council in the UniChem project [291383]; Fonds der Chemischen Industrie; U.S. NSF [CHE 105-7466]	University of Freiburg; Friedrich-Alexander-University of Erlangen-Nuremberg; Freiburg Institute for Advanced Studies; Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG)); European Research Council in the UniChem project; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); U.S. NSF(National Science Foundation (NSF))	This paper is dedicated to the memory of Saul Winstein and Daniel S. Trifan, who first studied the 2-norbornyl cation. This work was supported by the University of Freiburg, the Friedrich-Alexander-University of Erlangen-Nuremberg, the Freiburg Institute for Advanced Studies, the Deutsche Forschungs Gemeinschaft (Normalverfahren and SFB 583), and the European Research Council in the UniChem project 291383. We also thank the Fonds der Chemischen Industrie and the U.S. NSF (grant CHE 105-7466) for support. All crystal structures have been deposited with the Cambridge crystallographic database and may be accessed by quoting the deposition numbers: CCDC 931449 (for 1 at 120 K, crystal 1), CCDC 931450 (for 1 at 40 K, crystal 1), CCDC 931451 (for 1 at 40 K, crystal 2), CCDC 895701 (for 1 at 120 K, crystal 4), and CCDC 901047 (for 1 at 50 K, crystal 5).	Brown H.C., 1977, NONCLASSICAL ION PRO; Brown H. C., 1962, CHEM SOC SPEC PUBL, V16, P140; BROWN HC, 1986, ACCOUNTS CHEM RES, V19, P34, DOI 10.1021/ar00122a001; DEWAR MJS, 1986, J AM CHEM SOC, V108, P5634, DOI 10.1021/ja00278a050; Hong YJ, 2007, J ORG CHEM, V72, P8877, DOI 10.1021/jo701526x; KOCH W, 1990, ANGEW CHEM INT EDIT, V29, P183, DOI 10.1002/anie.199001831; KOCH W, 1989, J AM CHEM SOC, V111, P1527, DOI 10.1021/ja00186a073; Krossing I, 2004, ANGEW CHEM INT EDIT, V43, P2066, DOI 10.1002/anie.200300620; Krossing I, 2003, ANGEW CHEM INT EDIT, V42, P1531, DOI 10.1002/anie.200250172; Krossing I, 2006, COORDIN CHEM REV, V250, P2721, DOI 10.1016/j.ccr.2005.10.023; LAUBE T, 1986, ANGEW CHEM INT EDIT, V25, P349, DOI 10.1002/anie.198603491; LAUBE T, 1987, ANGEW CHEM INT EDIT, V26, P560, DOI 10.1002/anie.198705601; LAUBE T, 1989, J AM CHEM SOC, V111, P9224, DOI 10.1021/ja00208a017; Lehner AJ, 2011, DALTON T, V40, P1448, DOI 10.1039/c0dt01076f; MONTGOMERY LK, 1987, J AM CHEM SOC, V109, P4749, DOI 10.1021/ja00249a064; Olah G.A., 2009, SUPERACID CHEM, V2; OLAH GA, 1985, ACCOUNTS CHEM RES, V18, P292, DOI 10.1021/ar00118a002; OLAH GA, 1973, ANGEW CHEM INT EDIT, V12, P173, DOI 10.1002/anie.197301731; OLAH GA, 1969, J AM CHEM SOC, V91, P3956, DOI 10.1021/ja01042a054; OLAH GA, 1970, J AM CHEM SOC, V92, P4627, DOI 10.1021/ja00718a027; OLAH GA, 1968, J AM CHEM SOC, V90, P3882, DOI 10.1021/ja01016a062; OLAH GA, 1976, ACCOUNTS CHEM RES, V9, P41, DOI 10.1021/ar50098a001; OLAH GA, 1982, J AM CHEM SOC, V104, P7105, DOI 10.1021/ja00389a037; Perera SA, 1996, J AM CHEM SOC, V118, P7849, DOI 10.1021/ja960995e; Raabe I, 2008, DALTON T, P946, DOI 10.1039/b714271d; RAGHAVACHARI K, 1983, J AM CHEM SOC, V105, P5915, DOI 10.1021/ja00356a034; SAUNDERS M, 1964, J AM CHEM SOC, V86, P5680, DOI 10.1021/ja01078a057; SAUNDERS M, 1983, J AM CHEM SOC, V105, P3571, DOI 10.1021/ja00349a034; SCHLEYER PV, 1964, J AM CHEM SOC, V86, P5679, DOI 10.1021/ja01078a056; Scholz F, 2013, CHEM-EUR J, V19, P109, DOI 10.1002/chem.201203260; VANCIK H, 1989, J AM CHEM SOC, V111, P3742, DOI 10.1021/ja00192a038; Werstiuk NH, 2000, J PHYS CHEM A, V104, P11601, DOI 10.1021/jp001978l; Whitmore FC, 1932, J AM CHEM SOC, V54, P3274, DOI 10.1021/ja01347a037; WINSTEIN S, 1952, J AM CHEM SOC, V74, P1154, DOI 10.1021/ja01125a007; WINSTEIN S, 1952, J AM CHEM SOC, V74, P1147, DOI 10.1021/ja01125a006; WINSTEIN S, 1965, J AM CHEM SOC, V87, P376, DOI 10.1021/ja01080a040; WINSTEIN S, 1949, J AM CHEM SOC, V71, P2953, DOI 10.1021/ja01176a536; YANNONI CS, 1982, J AM CHEM SOC, V104, P7380, DOI 10.1021/ja00389a108; YANNONI CS, 1982, J AM CHEM SOC, V104, P907, DOI 10.1021/ja00367a068; Zuo TM, 2004, J THEOR COMPUT CHEM, V3, P269, DOI 10.1142/S021963360400101X	40	81	81	3	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					62	64		10.1126/science.1238849	http://dx.doi.org/10.1126/science.1238849			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828938				2022-12-28	WOS:000321291700047
J	Koh, TW; Carlson, JR				Koh, Tong-Wey; Carlson, John R.			Interspecies Sex and Taste	CELL			English	Editorial Material							DROSOPHILA; COURTSHIP		[Koh, Tong-Wey; Carlson, John R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu	Koh, Tong-Wey/M-3774-2013	Koh, Tong-Wey/0000-0001-9136-3189	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011697, R01DC002174, R01DC004729] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC011697, R01 DC004729, R01 DC002174] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Fan P, 2013, CELL, V154, P89, DOI 10.1016/j.cell.2013.06.008; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168	10	0	0	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					20	21		10.1016/j.cell.2013.06.015	http://dx.doi.org/10.1016/j.cell.2013.06.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827670	Bronze, Green Accepted			2022-12-28	WOS:000321327900005
J	Macilwain, C				Macilwain, Colin			Biology Boom Goes Bust	CELL			English	Editorial Material																			0	3	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					16	19		10.1016/j.cell.2013.05.051	http://dx.doi.org/10.1016/j.cell.2013.05.051			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827669	Bronze			2022-12-28	WOS:000321327900004
J	Matthews, FE; Arthur, A; Barnes, LE; Bond, J; Jagger, C; Robinson, L; Brayne, C				Matthews, Fiona E.; Arthur, Antony; Barnes, Linda E.; Bond, John; Jagger, Carol; Robinson, Louise; Brayne, Carol		Med Res Council Cognitive Function	A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II	LANCET			English	Article							ALZHEIMERS-DISEASE; GLOBAL PREVALENCE; TRENDS; POPULATION; IMPAIRMENT; MORTALITY; RATES	Background The prevalence of dementia is of interest worldwide. Contemporary estimates are needed to plan for future care provision, but much evidence is decades old. We aimed to investigate whether the prevalence of dementia had changed in the past two decades by repeating the same approach and diagnostic methods as used in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) in three of the original study areas in England. Methods Between 1989 and 1994, MRC CFAS investigators did baseline interviews in populations aged 65 years and older in six geographically defined areas in England and Wales. A two stage process, with screening followed by diagnostic assessment, was used to obtain data for algorithmic diagnoses (geriatric mental state-automated geriatric examination for computer assisted taxonomy), which were then used to estimate dementia prevalence. Data from three of these areas-Cambridgeshire, Newcastle, and Nottingham-were selected for CFAS I. Between 2008 and 2011, new fieldwork was done in the same three areas for the CFAS II study. For both CFAS I and II, each area needed to include 2500 individuals aged 65 years and older to provide power for geographical and generational comparison. Sampling was stratified according to age group (65-74 years vs = 75 years). CFAS II used identical sampling, approach, and diagnostic methods to CFAS I, except that screening and assessement were combined into one stage. Prevalence estimates were calculated using inverse probability weighting methods to adjust for sampling design and non-response. Full likelihood Bayesian models were used to investigate informative non-response. Findings 7635 people aged 65 years or older were interviewed in CFAS I (9602 approached, 80% response) in Cambridgeshire, Newcastle, and Nottingham, with 1457 being diagnostically assessed. In the same geographical areas, the CFAS II investigators interviewed 7796 individuals (14 242 approached, 242 with limited frailty information, 56% response). Using CFAS I age and sex specific estimates of prevalence in individuals aged 65 years or older, standardised to the 2011 population, 8.3% (884 000) of this population would be expected to have dementia in 2011. However, CFAS II shows that the prevalence is lower (6.5%; 670 000), a decrease of 1.8% (odds ratio for CFAS II vs CFAS I 0.7, 95% CI 0.6-0.9, p=0.003). Sensitivity analyses suggest that these estimates are robust to the change in response. Interpretation This study provides further evidence that a cohort effect exists in dementia prevalence. Later-born populations have a lower risk of prevalent dementia than those born earlier in the past century.	[Matthews, Fiona E.] Univ Cambridge, Cambridge Inst Publ Hlth, MRC Biostat Unit, Cambridge, England; [Arthur, Antony] Univ E Anglia, Sch Nursing Sci, Norwich NR4 7TJ, Norfolk, England; [Barnes, Linda E.; Brayne, Carol] Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England; [Bond, John; Jagger, Carol; Robinson, Louise] Newcastle Univ, Fac Med, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	MRC Biostatistics Unit; University of Cambridge; University of East Anglia; University of Cambridge; Newcastle University - UK	Brayne, C (corresponding author), Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England.	carol.brayne@medschl.cam.ac.uk	Dening, Tom/E-1335-2013; Brayne, Carol/AAA-4285-2020; Matthews, Fiona/O-6932-2015	Dening, Tom/0000-0003-3387-4241; Brayne, Carol/0000-0001-5307-663X; Matthews, Fiona/0000-0002-1728-2388; Robinson, Louise/0000-0003-0209-2503; Arthur, Antony/0000-0001-8617-5714; Jagger, Carol/0000-0002-6377-9926	UK Medical Research Council; MRC [G9901400, MC_U105292687, G0601022] Funding Source: UKRI; Medical Research Council [G9901400, MC_U105292687, G0601022] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-043, NF-SI-0611-10084] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	UK Medical Research Council.	Banks L, CHANGES COMMUNAL PRO; Brayne C, 1998, PSYCHOL MED, V28, P319; Brayne C, 2011, ALZHEIMERS DEMENT, V7, P3, DOI 10.1016/j.jalz.2010.12.003; Capewell S, 2011, LANCET, V378, P752, DOI 10.1016/S0140-6736(10)62302-1; Chatfield MD, 2005, J CLIN EPIDEMIOL, V58, P13, DOI 10.1016/j.jclinepi.2004.05.006; Christensen K, 2013, LANCET, V382, P1507, DOI 10.1016/S0140-6736(13)60777-1; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; Dunn G, 1999, BRIT J PSYCHIAT, V174, P95, DOI 10.1192/bjp.174.2.95; Erkinjuntti T, 1997, NEW ENGL J MED, V337, P1667, DOI 10.1056/NEJM199712043372306; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; George DR, 2011, CULT MED PSYCHIAT, V35, P417, DOI 10.1007/s11013-011-9219-x; Jagger C, 2009, AGE AGEING, V38, P319, DOI 10.1093/ageing/afp016; Jones DS, 2012, HEALTH AFFAIR, V31, P2250, DOI 10.1377/hlthaff.2011.0639; Kay DWK, 1998, INT J GERIATR PSYCH, V13, P852, DOI 10.1002/(SICI)1099-1166(1998120)13:12<852::AID-GPS882>3.0.CO;2-Y; Knapp M, DEMENTIA UK 2007; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lobo A, 2007, ACTA PSYCHIAT SCAND, V116, P299, DOI 10.1111/j.1600-0447.2007.01006.x; Manton K C, 2005, Adv Gerontol, V16, P30; Marmot M., FAIR SOC HLTH LIVES; Matthews F, 2005, PLOS MED, V2, P753, DOI 10.1371/journal.pmed.0020193; Meng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038268; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; National End of Life Care Intelligence Network, 2010, DEATHS ALZH DIS DEM; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Rocca WA, 2011, ALZHEIMERS DEMENT, V7, P80, DOI 10.1016/j.jalz.2010.11.002; SAUNDERS PA, 1993, INT J EPIDEMIOL, V22, P838, DOI 10.1093/ije/22.5.838; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Sekita A, 2010, ACTA PSYCHIAT SCAND, V122, P319, DOI 10.1111/j.1600-0447.2010.01587.x; Townsend PP., 1988, HLTH DEPRIVATION INE; Weir DR, 2011, ALZHEIMERS DEMENT, V7, P94, DOI 10.1016/j.jalz.2010.11.004; Wimo A, WORLD ALZHEIMER REPO; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066252	35	589	597	2	82	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2013	382	9902					1405	1412		10.1016/S0140-6736(13)61570-6	http://dx.doi.org/10.1016/S0140-6736(13)61570-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242JW	23871492	Green Published, hybrid			2022-12-28	WOS:000326237500025
J	Kayagaki, N; Wong, MT; Stowe, IB; Ramani, SR; Gonzalez, LC; Akashi-Takamura, S; Miyake, K; Zhang, J; Lee, WP; Muszynski, A; Forsberg, LS; Carlson, RW; Dixit, VM				Kayagaki, Nobuhiko; Wong, Michael T.; Stowe, Irma B.; Ramani, Sree Ranjani; Gonzalez, Lino C.; Akashi-Takamura, Sachiko; Miyake, Kensuke; Zhang, Juan; Lee, Wyne P.; Muszynski, Artur; Forsberg, Lennart S.; Carlson, Russell W.; Dixit, Vishva M.			Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4	SCIENCE			English	Article							BACTERIAL LIPOPOLYSACCHARIDE; PATTERN-RECOGNITION; IMMUNE RECOGNITION; INTERLEUKIN-1-BETA; CASPASE-11; FLAGELLIN; PROTEASE; TOLL; RECEPTORS; IPAF	Gram-negative bacteria including Escherichia coli, Citrobacter rodentium, Salmonella typhimurium, and Shigella flexneri are sensed in an ill-defined manner by an intracellular inflammasome complex that activates caspase-11. We show that macrophages loaded with synthetic lipid A, E. coli lipopolysaccharide (LPS), or S. typhimurium LPS activate caspase-11 independently of the LPS receptor Toll-like receptor 4 (TLR4). Consistent with lipid A triggering the noncanonical inflammasome, LPS containing a divergent lipid A structure antagonized caspase-11 activation in response to E. coli LPS or Gram-negative bacteria. Moreover, LPS-mutant E. coli failed to activate caspase-11. Tlr4(-/-) mice primed with TLR3 agonist polyinosinic:polycytidylic acid [poly(I:C)] to induce pro-caspase-11 expression were as susceptible as wild-type mice were to sepsis induced by E. coli LPS. These data unveil a TLR4-independent mechanism for innate immune recognition of LPS.	[Kayagaki, Nobuhiko; Wong, Michael T.; Stowe, Irma B.; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Ramani, Sree Ranjani; Gonzalez, Lino C.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Akashi-Takamura, Sachiko; Miyake, Kensuke] Univ Tokyo, Dept Microbiol & Immunol, Ctr Expt Med & Syst Biol, Div Innate Immun,Lab Innate Immun,Inst Med Sci, Tokyo 1088639, Japan; [Zhang, Juan; Lee, Wyne P.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Muszynski, Artur; Forsberg, Lennart S.; Carlson, Russell W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Roche Holding; Genentech; Roche Holding; Genentech; University of Tokyo; Roche Holding; Genentech; University System of Georgia; University of Georgia	Kayagaki, N (corresponding author), Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA.	kayagaki@gene.com; dixit@gene.com	Gonzalez, Lino/E-4102-2012; dixit, vishva m/A-4496-2012	Gonzalez, Lino/0000-0003-3817-6450; dixit, vishva m/0000-0001-6983-0326; Muszynski, Artur/0000-0003-3497-9977	U.S. Department of Energy [DE-FG02-09ER20097]; Japan Society for the Promotion of Science [KAKENHI 23590564]; Ministry of Education, Culture, Sports, Science and Technology [KAKENHI 21117002]	U.S. Department of Energy(United States Department of Energy (DOE)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank S. Louie, J. Dong, J. Starks, K. O'Rourke, E. Suto, B. L. Lee, and P. Martinez for technical support; M. van Lookeren Campagne, G.-J. Boons, M. Roose-Girma, E. Naik, and K. Newton for discussions and manuscript editing; S. Akira, O. Takeuchi, and W. W. Leitner for mice; and T. M. Stephen for CMR300. Structural work on LPS was supported, in part, by U.S. Department of Energy grant DE-FG02-09ER20097 to the Complex Carbohydrate Research Center. Generation of Md1<SUP>-/-</SUP>Md2<SUP>-/-</SUP> and Rp105<SUP>-/-</SUP> mice was supported by grants from the Japan Society for the Promotion of Science (KAKENHI 23590564) and Ministry of Education, Culture, Sports, Science and Technology (KAKENHI 21117002).	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Chung HS, 2010, BIOCHEMISTRY-US, V49, P4126, DOI 10.1021/bi100343e; FAUCHEU C, 1995, EMBO J, V14, P1914, DOI 10.1002/j.1460-2075.1995.tb07183.x; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kenyon JJ, 2011, GLYCOBIOLOGY, V21, P1131, DOI 10.1093/glycob/cwr006; Kitchens RL, 1998, J IMMUNOL, V160, P1920; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2007, MICROBES INFECT, V9, P664, DOI 10.1016/j.micinf.2007.01.017; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Moran AP, 1997, J BACTERIOL, V179, P6453, DOI 10.1128/jb.179.20.6453-6463.1997; Ogawa T, 2003, FEMS IMMUNOL MED MIC, V36, P1, DOI 10.1016/S0928-8244(03)00093-2; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thieblemont N, 1998, IMMUNITY, V8, P771, DOI 10.1016/S1074-7613(00)80582-8; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5	35	933	979	19	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1246	1249		10.1126/science.1240248	http://dx.doi.org/10.1126/science.1240248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	23887873				2022-12-28	WOS:000324248800045
J	Hirose, T; Horvitz, HR				Hirose, Takashi; Horvitz, H. Robert			An Sp1 transcription factor coordinates caspase-dependent and -independent apoptotic pathways	NATURE			English	Article							PROGRAMMED CELL-DEATH; C-ELEGANS; PROTEIN; GENETICS; ENCODES; EGL-1	During animal development, the proper regulation of apoptosis requires the precise spatial and temporal execution of cell-death programs, which can include both caspase-dependent and caspase-independent pathways(1,2). Although the mechanisms of caspase-dependent and -independent cell killing have been examined extensively, how these pathways are coordinated within a single cell that is fated to die is unknown. Here we show that the Caenorhabditis elegans Sp1 transcription factor SPTF-3 specifies the programmed cell deaths of at least two cells-the sisters of the pharyngeal M4 motor neuron and the AQR sensory neuron-by transcriptionally activating both caspase-dependent and -independent apoptotic pathways. SPTF-3 directly drives the transcription of the geneegl-1, which encodes a BH3-only protein that promotes apoptosis through the activation of the CED-3 caspase(3). In addition, SPTF-3 directly drives the transcription of the AMP-activated protein kinase-related gene pig-1, which encodes a protein kinase and functions in apoptosis of the M4 sister and AQR sister independently of the pathway that activates-CED-3 (refs 4, 5). Thus, a single transcription factor controls two distinct cell-killing programs that act in parallel to drive apoptosis. Our findings reveal a bivalent regulatory node for caspase-dependent and -independent pathways in the regulation of cell-type-specific apoptosis. We propose that such nodes might act as features of a general mechanism for regulating cell-type-specific apoptosis and could be therapeutic targets for diseases involving the dysregulation of apoptosis through multiple cell-killing mechanisms.	[Hirose, Takashi; Horvitz, H. Robert] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Horvitz, HR (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	horvitz@mit.edu			NIH Office of Research Infrastructure Programs [P40 OD010440]; National BioResource project for strains; Howard Hughes Medical Institute; Ministry of Education, Science, Technology, Sports and Culture of Japan; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs; National BioResource project for strains; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ministry of Education, Science, Technology, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Fire, J. Gaudet, C. Barbara and Y. Iino for reporter constructs used to observe cell-type-specific apoptosis; G. Garriga for pig-1 strains; the Caenorhabditis Genetic Center, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440) and the National BioResource project for strains; D. Denning, K. Boulias, A. Corrionero and H. Johnsen for comments about the manuscript; and members of the Horvitz laboratory for technical support and discussions. This work was supported by the Howard Hughes Medical Institute. T. H. was supported in part by the Ministry of Education, Science, Technology, Sports and Culture of Japan. H. R. H. is the David H. Koch Professor of Biology at the Massachusetts Institute of Technology and an Investigator of the Howard Hughes Medical Institute.	Andersen EC, 2008, GENETICS, V179, P2001, DOI 10.1534/genetics.108.092197; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BRENNER S, 1974, GENETICS, V77, P71; CLARK SG, 1994, GENETICS, V137, P987; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Cordes S, 2006, DEVELOPMENT, V133, P2747, DOI 10.1242/dev.02447; Denning DP, 2012, NATURE, V488, P226, DOI 10.1038/nature11240; Ercan S, 2007, NAT GENET, V39, P403, DOI 10.1038/ng1983; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Hirose T, 2010, P NATL ACAD SCI USA, V107, P15479, DOI 10.1073/pnas.1010023107; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; MADURO M, 1995, GENETICS, V141, P977; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Rosenbaum DM, 2010, J NEUROSCI RES, V88, P1569, DOI 10.1002/jnr.22314; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Ulm EA, 2011, MECH DEVELOP, V128, P428, DOI 10.1016/j.mod.2011.08.003; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yochem J, 1998, GENETICS, V149, P1323; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410	28	46	59	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					354	+		10.1038/nature12329	http://dx.doi.org/10.1038/nature12329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23851392	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000323112400037
J	Venkatraman, A; He, XC; Thorvaldsen, JL; Sugimura, R; Perry, JM; Tao, F; Zhao, M; Christenson, MK; Sanchez, R; Yu, JY; Peng, L; Haug, JS; Paulson, A; Li, H; Zhong, XB; Clemens, TL; Bartolomei, MS; Li, LH				Venkatraman, Aparna; He, Xi C.; Thorvaldsen, Joanne L.; Sugimura, Ryohichi; Perry, John M.; Tao, Fang; Zhao, Meng; Christenson, Matthew K.; Sanchez, Rebeca; Yu, Jaclyn Y.; Peng, Lai; Haug, Jeffrey S.; Paulson, Ariel; Li, Hua; Zhong, Xiao-bo; Clemens, Thomas L.; Bartolomei, Marisa S.; Li, Linheng			Maternal imprinting at the H19-Igf2 locus maintains adult haematopoietic stem cell quiescence	NATURE			English	Article							PROBE LEVEL DATA; SELF-RENEWAL; RNA-SEQ; GROWTH; NICHE; EXPRESSION; GENES; DIFFERENTIATION; IDENTIFICATION; NORMALIZATION	The epigenetic regulation of imprinted genes by monoallelic DNA methylation of either maternal or paternal alleles is critical for embryonic growth and development(1). Imprinted genes were recently shown to be expressed in mammalian adult stem cells to support self-renewal of neural and lung stem cells(2-4); however, a role for imprinting per se in adult stem cells remains elusive. Here we show upregulation of growth-restricting imprinted genes, including in the H19-Igf2 locus(5), in long-term haematopoietic stem cells and their downregulation upon haematopoietic stem cell activation and proliferation. A differentially methylated region upstream of H19 (H19-DMR), serving as the imprinting control region, determines the reciprocal expression of H19 from the maternal allele and Igf2 from the paternal allele(1). In addition, H19 serves as a source of miR-675, which restricts Igf1r expression(6). We demonstrate that conditional deletion of the maternal but not the paternal H19-DMR reduces adult haematopoietic stem cell quiescence, a state required for long-term maintenance of haematopoietic stem cells, and compromises haematopoietic stem cell function. Maternal-specific H19-DMR deletion results in activation of the Igf2-Igfr1 pathway, as shown by the translocation of phosphorylated FoxO3 (an inactive form) from nucleus to cytoplasm and the release of FoxO3-mediated cell cycle arrest, thus leading to increased activation, proliferation and eventual exhaustion of haematopoietic stem cells. Mechanistically, maternal-specific H19-DMR deletion leads to Igf2 upregulation and increased translation of Igf1r, which is normally suppressed by H19-derived miR-675. Similarly, genetic inactivation of Igf1r partly rescues the H19-DMR deletion phenotype. Our work establishes a new role for this unique form of epigenetic control at the H19-Igf2 locus in maintaining adult stem cells.	[Venkatraman, Aparna; He, Xi C.; Sugimura, Ryohichi; Perry, John M.; Tao, Fang; Zhao, Meng; Christenson, Matthew K.; Sanchez, Rebeca; Yu, Jaclyn Y.; Haug, Jeffrey S.; Paulson, Ariel; Li, Hua; Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Venkatraman, Aparna] Christian Med Coll & Hosp, Ctr Stem Cell Res, Vellore 632002, Tamil Nadu, India; [Thorvaldsen, Joanne L.; Bartolomei, Marisa S.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Sanchez, Rebeca] Inst Recerca Vall Dhebron, Cell Therapy & Genet Lab, Barcelona 08035, Spain; [Peng, Lai; Zhong, Xiao-bo] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Clemens, Thomas L.] Johns Hopkins Med, Ctr Musculoskeletal Res, Baltimore, MD 21287 USA; [Li, Linheng] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Christian Medical College & Hospital (CMCH) Vellore; University of Pennsylvania; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Kansas; University of Kansas Medical Center; Johns Hopkins University; Johns Hopkins Medicine; University of Kansas; University of Kansas Medical Center	Li, LH (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	lil@stowers.org	Sanchez, Rebeca/GXH-6596-2022; Sugimura, Rio/AAR-7280-2020; Sanchez, Rebeca/L-7138-2014	Sanchez, Rebeca/0000-0002-2073-2810; Sugimura, Rio/0000-0001-5701-3628; Sanchez, Rebeca/0000-0002-2073-2810; Bartolomei, Marisa/0000-0001-9410-5222; Li, Linheng/0000-0001-9963-430X	Stowers Institute for Medical Research; Department of Biotechnology, Ministry of Science and Technology, Government of India; National Institutes of Health [GM51279]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087376, R37GM051279, R01GM051279] Funding Source: NIH RePORTER	Stowers Institute for Medical Research; Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Hembree, T. Johnson, H. Marshall, B. Lewis, D. Dukes, C. Semerad, J. Park and A. Box for technical support, and members of the Li laboratory for scientific discussion. We thank J. Lu and Y. Huang for communications about miR-675 and Let-7. We thank K. Tannen for editing. This work was supported by the Stowers Institute for Medical Research and by the Department of Biotechnology, Ministry of Science and Technology, Government of India, as an overseas associateship to A. Venkatraman. M. Bartolomei is supported by the National Institutes of Health (GM51279).	Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Berg JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026410; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Dijke P., 2006, SMAD SIGNAL TRANSDUC; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Hudson QJ, 2010, HEREDITY, V105, P45, DOI 10.1038/hdy.2010.23; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kang HM, 2011, CELL PROLIFERAT, V44, P254, DOI 10.1111/j.1365-2184.2011.00755.x; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; Kubota Y, 2009, BLOOD, V114, P4383, DOI 10.1182/blood-2009-07-230292; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LERNER C, 1990, EXP HEMATOL, V18, P114; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Smith FM, 2006, CYTOGENET GENOME RES, V113, P279, DOI 10.1159/000090843; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Thorvaldsen JL, 2006, MOL CELL BIOL, V26, P1245, DOI 10.1128/MCB.26.4.1245-1258.2006; Toledano H, 2012, NATURE, V485, P605, DOI 10.1038/nature11061; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Yu W, 2007, ONCOGENE, V26, P1178, DOI 10.1038/sj.onc.1209899; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	42	184	191	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					345	+		10.1038/nature12303	http://dx.doi.org/10.1038/nature12303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23863936	Green Accepted			2022-12-28	WOS:000323112400035
J	Lu, GW; Hu, YW; Wang, QH; Qi, JX; Gao, F; Li, Y; Zhang, YF; Zhang, W; Yuan, Y; Bao, JK; Zhang, BC; Shi, Y; Yan, JH; Gao, GF				Lu, Guangwen; Hu, Yawei; Wang, Qihui; Qi, Jianxun; Gao, Feng; Li, Yan; Zhang, Yanfang; Zhang, Wei; Yuan, Yuan; Bao, Jinku; Zhang, Buchang; Shi, Yi; Yan, Jinghua; Gao, George F.			Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26	NATURE			English	Article							CRYSTAL-STRUCTURE; SPIKE PROTEIN; FUNCTIONAL RECEPTOR; AMINOPEPTIDASE-N; MIDDLE-EAST; REVEALS; MEMBRANE; COMPLEX; ORIGIN; VIRUS	The newly emergent Middle East respiratory syndrome coronavirus (MERS-CoV) can cause severe pulmonary disease in humans(1,2), representing the second example of a highly pathogenic coronavirus, the first being SARS-CoV3. CD26 (also known as dipeptidyl peptidase 4, DPP4) was recently identified as the cellular receptor for MERS-CoV4. The engagement of the MERS-CoV spike protein with CD26 mediates viral attachment to host cells and virus-cell fusion, thereby initiating infection. Here we delineate the molecular basis of this specific interaction by presenting the first crystal structures of both the free receptor binding domain (RBD) of the MERS-CoV spike protein and its complex with CD26. Furthermore, binding between the RBD and CD26 is measured using real-time surface plasmon resonance with a dissociation constant of 16.7 nM. The viral RBD is composed of a core subdomain homologous to that of the SARS-CoV spike protein, and a unique strand-dominated external receptor binding motif that recognizes blades IV and V of the CD26 beta-propeller. The atomic details at the interface between the two binding entities reveal a surprising protein-protein contact mediated mainly by hydrophilic residues. Sequence alignment indicates, among beta-coronaviruses, a possible structural conservation for the region homologous to the MERS-CoV RBD core, but a high variation in the external receptor binding motif region for virus-specific pathogenesis such as receptor recognition.	[Lu, Guangwen; Wang, Qihui; Qi, Jianxun; Li, Yan; Zhang, Yanfang; Zhang, Wei; Yuan, Yuan; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Hu, Yawei; Zhang, Buchang] Anhui Univ, Sch Life Sci, Hefei 230039, Peoples R China; [Gao, Feng] Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100101, Peoples R China; [Gao, Feng; Bao, Jinku] Sichuan Univ, Sch Life Sci, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Yanfang; Gao, George F.] Tianjin Inst Ind Biotechnol, Lab Prot Engn & Vaccines, Tianjin 300308, Peoples R China; [Yuan, Yuan; Gao, George F.] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Shi, Yi; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China; [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Anhui University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Sichuan University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Chinese Center for Disease Control & Prevention	Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	gaof@im.ac.cn	Qi, Jianxun/ABF-1646-2021; Qihui, Wang/GLR-4206-2022; Lu, Guangwen/HCH-9193-2022; Gao, George Fu/ABD-5229-2021	Qihui, Wang/0000-0003-3768-0401; 	Ministry of Science and Technology of China (MOST) [2011CB504703]; National Natural Science Foundation of China (NSFC) [81290342]; NSFC Innovative Research Group [81021003]	Ministry of Science and Technology of China (MOST)(Ministry of Science and Technology, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC Innovative Research Group	This work was supported by the Ministry of Science and Technology of China (MOST) 973 Project (Grant no. 2011CB504703) and the National Natural Science Foundation of China (NSFC, Grant no. 81290342). Assistance by the staff at the Shanghai Synchrotron Radiation Facility (SSRF) of China and the High Energy Accelerator Research Organization (KEK) of Japan is acknowledged. We thank Z. Fan and T. Zhao for their technical assistance. G. F. G. is a leading principal investigator of the NSFC Innovative Research Group (Grant no. 81021003). We thank M. Yang from Tsinghua University for his help with data collection.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; Gao GF, 2007, COMBATING THE THREAT OF PANDEMIC INFLUENZA: DRUG DISCOVERY APPROACHES, P226, DOI 10.1002/9780470179727.ch10; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Lai M.M.C., 2007, FIELDS VIROLOGY, P1305; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li F, 2012, J VIROL, V86, P2856, DOI 10.1128/JVI.06882-11; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lu GW, 2012, PROTEIN CELL, V3, P803, DOI 10.1007/s13238-012-2811-1; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reguera J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002859; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; Weihofen WA, 2004, J BIOL CHEM, V279, P43330, DOI 10.1074/jbc.M405001200; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; World Health Organization, 2013, NOV COR INF UPD; World Health Organization, CUM NUMB REP PROB CA; Wu KL, 2009, P NATL ACAD SCI USA, V106, P19970, DOI 10.1073/pnas.0908837106; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang W, 2010, PROTEIN CELL, V1, P459, DOI 10.1007/s13238-010-0059-1; Zhu JQ, 2004, BIOCHEM BIOPH RES CO, V319, P283, DOI 10.1016/j.bbrc.2004.04.141	38	472	521	4	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					227	+		10.1038/nature12328	http://dx.doi.org/10.1038/nature12328			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23831647	Bronze, Green Published			2022-12-28	WOS:000322825500039
J	Feder, J				Feder, Judith			Bundle with Care Rethinking Medicare Incentives for Post-Acute Care Services	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Feder, Judith] Georgetown Univ, Urban Inst, Ctr Hlth Policy, Washington, DC USA; [Feder, Judith] Georgetown Univ, Georgetown Publ Policy Inst, Washington, DC USA	Georgetown University; Urban Institute; Georgetown University	Feder, J (corresponding author), Georgetown Univ, Urban Inst, Ctr Hlth Policy, Washington, DC USA.							Christman E, 2009, MED PAYM ASS COMM NO; Korea Health Promotion Institute, 2020, 04202000301; Newhouse JP, 2012, HEALTH AFFAIR, V31, P2618, DOI 10.1377/hlthaff.2012.0345; Newhouse JP, 1997, HLTH AFF MILLWOOD, V16, P16	4	13	13	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					400	401		10.1056/NEJMp1302730	http://dx.doi.org/10.1056/NEJMp1302730			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193GQ	23841702				2022-12-28	WOS:000322547400003
J	Timonen, JVI; Latikka, M; Leibler, L; Ras, RHA; Ikkala, O				Timonen, Jaakko V. I.; Latikka, Mika; Leibler, Ludwik; Ras, Robin H. A.; Ikkala, Olli			Switchable Static and Dynamic Self-Assembly of Magnetic Droplets on Superhydrophobic Surfaces	SCIENCE			English	Article							BLOCK-COPOLYMERS; FLUIDS	Self-assembly is a process in which interacting bodies are autonomously driven into ordered structures. Static structures such as crystals often form through simple energy minimization, whereas dynamic ones require continuous energy input to grow and sustain. Dynamic systems are ubiquitous in nature and biology but have proven challenging to understand and engineer. Here, we bridge the gap from static to dynamic self-assembly by introducing a model system based on ferrofluid droplets on superhydrophobic surfaces. The droplets self-assemble under a static external magnetic field into simple patterns that can be switched to complicated dynamic dissipative structures by applying a time-varying magnetic field. The transition between the static and dynamic patterns involves kinetic trapping and shows complexity that can be directly visualized.	[Timonen, Jaakko V. I.; Latikka, Mika; Ras, Robin H. A.; Ikkala, Olli] Aalto Univ, Dept Appl Phys, FI-02150 Espoo, Finland; [Leibler, Ludwik] Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7167, F-75005 Paris, France	Aalto University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Timonen, JVI (corresponding author), Northwestern Univ, Nonequilibrium Energy Res Ctr, 2145 Sheridan Rd, Evanston, IL 60208 USA.	jaakko.timonen@aalto.fi; robin.ras@aalto.fi; olli.ikkala@aalto.fi	Latikka, Mika T/H-8749-2013; Ikkala, Olli T./K-7447-2012; Timonen, Jaakko V I/K-5754-2015; Ras, Robin/F-7680-2010	Latikka, Mika T/0000-0002-5060-158X; Ikkala, Olli T./0000-0002-0470-1889; Timonen, Jaakko V I/0000-0002-5499-1482; Ras, Robin/0000-0002-2076-242X	National Doctoral Programme in Materials Physics; Nokia Research Center; Academy of Finland; European Research Council; Finnish Agency of Technology and Innovation (TEKES)	National Doctoral Programme in Materials Physics; Nokia Research Center(Nokia Corporation); Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission); Finnish Agency of Technology and Innovation (TEKES)	We acknowledge financial support from the National Doctoral Programme in Materials Physics, Nokia Research Center, the Academy of Finland, a European Research Council Advanced Grant, and the Finnish Agency of Technology and Innovation (TEKES). Electron microscopy was performed using the devices of the Nanomicroscopy Center of Aalto University. We thank A. Walther (RWTH Aachen University), A. Kuzyk, and M. Kostiainen for comments on the manuscript and T. Huhtamaki and J. Korhonen for preparing the silicone nanofilament surfaces.	Bacri J.-C., 2011, MORPHOGENESIS ORIGIN, P15; Ball P., 2011, NATURES PATTERNS TAP; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bates FS, 2012, SCIENCE, V336, P434, DOI 10.1126/science.1215368; BERKOVSKY B, 1980, IEEE T MAGN, V16, P288, DOI 10.1109/TMAG.1980.1060613; Castelvecchi, 2005, PHYSICS, V15, P18; Gao XF, 2007, ADV MATER, V19, P2213, DOI 10.1002/adma.200601946; Grzybowski BA, 2000, NATURE, V405, P1033, DOI 10.1038/35016528; Grzybowski BA, 2004, CHEM ENG SCI, V59, P1667, DOI 10.1016/j.ces.2004.01.023; Grzybowski BA, 2009, SOFT MATTER, V5, P1110, DOI 10.1039/b819321p; Ikkala O, 2002, SCIENCE, V295, P2407, DOI 10.1126/science.1067794; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Kato T, 2006, ANGEW CHEM INT EDIT, V45, P38, DOI 10.1002/anie.200501384; Kauffman S., 1995, HOME UNIVERSE SEARCH; Larmour IA, 2007, ANGEW CHEM INT EDIT, V46, P1710, DOI 10.1002/anie.200604596; Liu K, 2011, CHEM SOC REV, V40, P656, DOI 10.1039/c0cs00133c; MASSART R, 1981, IEEE T MAGN, V17, P1247, DOI 10.1109/TMAG.1981.1061188; MASSART R, 1995, J MAGN MAGN MATER, V149, P1, DOI 10.1016/0304-8853(95)00316-9; Mateus AM, 2009, SEMIN CELL DEV BIOL, V20, P877, DOI 10.1016/j.semcdb.2009.07.009; Mertaniemi H, 2012, ADV MATER, V24, P5738, DOI 10.1002/adma.201202980; Mertaniemi H, 2011, ADV MATER, V23, P2911, DOI 10.1002/adma.201100461; Park S, 2009, SCIENCE, V323, P1030, DOI 10.1126/science.1168108; Rosensweig RE, 1997, FERROHYDRODYNAMICS; Ruzette AV, 2005, NAT MATER, V4, P19, DOI 10.1038/nmat1295; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Tretiakov KV, 2009, SOFT MATTER, V5, P1279, DOI 10.1039/b811254a; Verho T, 2012, P NATL ACAD SCI USA, V109, P10210, DOI 10.1073/pnas.1204328109; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Yoon J, 2005, MRS BULL, V30, P721, DOI 10.1557/mrs2005.270	29	320	325	43	648	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					253	257		10.1126/science.1233775	http://dx.doi.org/10.1126/science.1233775			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869012				2022-12-28	WOS:000321959300036
J	Chen, TW; Wardill, TJ; Sun, Y; Pulver, SR; Renninger, SL; Baohan, A; Schreiter, ER; Kerr, RA; Orger, MB; Jayaraman, V; Looger, LL; Svoboda, K; Kim, DS				Chen, Tsai-Wen; Wardill, Trevor J.; Sun, Yi; Pulver, Stefan R.; Renninger, Sabine L.; Baohan, Amy; Schreiter, Eric R.; Kerr, Rex A.; Orger, Michael B.; Jayaraman, Vivek; Looger, Loren L.; Svoboda, Karel; Kim, Douglas S.			Ultrasensitive fluorescent proteins for imaging neuronal activity	NATURE			English	Article							PRIMARY VISUAL-CORTEX; ENCODED CA2+ INDICATORS; IN-VIVO; NEURAL ACTIVITY; ORIENTATION SELECTIVITY; CORTICAL-NEURONS; CALCIUM TRANSIENTS; TARGET RECOGNITION; DENDRITIC SPINES; STRUCTURAL BASIS	Fluorescent calcium sensors are widely used to image neural activity. Using structure-based mutagenesis and neuron-based screening, we developed a family of ultrasensitive protein calcium sensors (GCaMP6) that outperformed other sensors in cultured neurons and in zebrafish, flies and mice in vivo. In layer 2/3 pyramidal neurons of the mouse visual cortex, GCaMP6 reliably detected single action potentials in neuronal somata and orientation-tuned synaptic calcium transients in individual dendritic spines. The orientation tuning of structurally persistent spines was largely stable over timescales of weeks. Orientation tuning averaged across spine populations predicted the tuning of their parent cell. Although the somata of GABAergic neurons showed little orientation tuning, their dendrites included highly tuned dendritic segments (5-40-mm long). GCaMP6 sensors thus provide new windows into the organization and dynamics of neural circuits over multiple spatial and temporal scales.	[Chen, Tsai-Wen; Wardill, Trevor J.; Sun, Yi; Pulver, Stefan R.; Baohan, Amy; Schreiter, Eric R.; Kerr, Rex A.; Jayaraman, Vivek; Looger, Loren L.; Svoboda, Karel; Kim, Douglas S.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Renninger, Sabine L.; Orger, Michael B.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal; [Baohan, Amy] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; Fundacao Champalimaud; University of California System; University of California Los Angeles	Orger, MB (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Ave Brasilia, P-1400038 Lisbon, Portugal.	michael.orger@neuro.fchampalimaud.org; jayaramanv@janelia.hhmi.org; loogerl@janelia.hhmi.org; svobodak@janelia.hhmi.org; kimd@janelia.hhmi.org	Sun, Yi/I-1450-2012	Kim, Douglas/0000-0001-9029-314X; Renninger, Sabine/0000-0003-3228-3204; Wardill, Trevor/0000-0002-2049-113X; Pulver, Stefan/0000-0001-5170-7522; Sun, Yi/0000-0002-1746-0404; Orger, Michael/0000-0002-9763-8902; Schreiter, Eric/0000-0002-2864-7469; Chen, Tsai-Wen/0000-0001-6782-3819	Swiss National Science Foundation; Marie Curie Career Integration Grant [PCIG09-GA-2011-294049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie Career Integration Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Akerboom and L. Tian for constructs and advice; J. Hasseman, M. Ramirez, G. Tsegaye for molecular cloning; B. Shields for neuronal culture; A. Hu for histology; B. Fosque, R. Behnam, K. Ritola for virus production; J. Macklin and R. Patel for spectroscopy; B. Coop and L. Ramasamy for multiwell electrode manufacturing; K. Smith for mouse viral transduction; K. Hibbard for fly husbandry; and J. Yu, C. Niell, M. Stryker, J. Trachtenberg and A. Kerlin for advice on visual cortex experiments. S. L. R. is supported by a Fellowship from the Swiss National Science Foundation. M.B.O. is supported by a Marie Curie Career Integration Grant PCIG09-GA-2011-294049.	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BAKER PF, 1971, J PHYSIOL-LONDON, V218, P709, DOI 10.1113/jphysiol.1971.sp009641; Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P49, DOI 10.1113/jphysiol.2003.042580; Guerrero G, 2005, NAT NEUROSCI, V8, P1188, DOI 10.1038/nn1526; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; Hansel D, 2012, J NEUROSCI, V32, P4049, DOI 10.1523/JNEUROSCI.6284-11.2012; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Katona G, 2011, P NATL ACAD SCI USA, V108, P2148, DOI 10.1073/pnas.1009270108; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kobat D, 2009, OPT EXPRESS, V17, P13354, DOI 10.1364/OE.17.013354; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Suter BA, 2010, FRONT NEURAL CIRCUIT, V4, P100, DOI DOI 10.3389/FNCIR.2010.00100; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	64	3387	3438	47	730	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					295	+		10.1038/nature12354	http://dx.doi.org/10.1038/nature12354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23868258	Green Accepted			2022-12-28	WOS:000321910700027
J	Selkoe, DJ				Selkoe, Dennis J.			SnapShot: Pathobiology of Alzheimer's Disease	CELL			English	Editorial Material									Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.				NATIONAL INSTITUTE ON AGING [R01AG006173] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG006173] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Castellano J.M., 2011, COLD SPRING HARB PER, V3; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Selkoe DJ, 2012, BIOL ALZHEIMER DIS; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346	7	40	41	0	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					468	+	468.e1	10.1016/j.cell.2013.07.003	http://dx.doi.org/10.1016/j.cell.2013.07.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870132	Bronze			2022-12-28	WOS:000321950700022
J	Teno, JM; Gozalo, P; Mitchell, SL; Tyler, D; Mor, V				Teno, Joan M.; Gozalo, Pedro; Mitchell, Susan L.; Tyler, Denise; Mor, Vincent			Survival After Multiple Hospitalizations for Infections and Dehydration in Nursing Home Residents With Advanced Cognitive Impairment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MINIMUM DATA SET		[Teno, Joan M.; Gozalo, Pedro; Tyler, Denise; Mor, Vincent] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA; [Mitchell, Susan L.] Hebrew SeniorLife, Inst Aging Res, Boston, MA USA	Brown University; Harvard University; Hebrew SeniorLife	Teno, JM (corresponding author), Brown Univ, Ctr Gerontol & Hlth Care Res, 121 S Main St,Room 612, Providence, RI 02912 USA.	joan_teno@brown.edu		Tyler, Denise/0000-0001-8555-9011	NIA NIH HHS [P01AG027296, P01 AG027296, K24 AG033640] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K24AG033640, P01AG027296] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Loeb M, 2006, JAMA-J AM MED ASSOC, V295, P2503, DOI 10.1001/jama.295.21.2503; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Mor V, 2004, MED CARE, V42, P50, DOI 10.1097/01.mlr.0000120104.01232.5e; Mor V, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-78; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174	5	21	21	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					319	320		10.1001/jama.2013.8392	http://dx.doi.org/10.1001/jama.2013.8392			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23860991	Green Accepted, Bronze			2022-12-28	WOS:000321835700020
J	Kuratani, S				Kuratani, Shigeru			A Muscular Perspective on Vertebrate Evolution	SCIENCE			English	Editorial Material							ORIGINS; NECK; GNATHOSTOMES; MUSCLES		RIKEN Ctr Dev Biol, Lab Evolutionary Morphol, Chuo Ku, Kobe, Hyogo 6500047, Japan	RIKEN	Kuratani, S (corresponding author), RIKEN Ctr Dev Biol, Lab Evolutionary Morphol, Chuo Ku, 2-2-3 Minatojima Minami, Kobe, Hyogo 6500047, Japan.	saizo@cdb.riken.jp	Kuratani, Shigeru/J-4146-2014	Kuratani, Shigeru/0000-0001-9717-7221				Birchmeier C, 2000, CURR OPIN CELL BIOL, V12, P725, DOI 10.1016/S0955-0674(00)00159-9; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burke AC, 2003, DEV CELL, V4, P159, DOI 10.1016/S1534-5807(03)00033-9; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Ericsson R, 2013, J ANAT, V222, P67, DOI 10.1111/j.1469-7580.2012.01530.x; Janvier P., 1996, EARLY VERTEBRATES; Johanson Z, 2003, J VERTEBR PALEONTOL, V23, P735, DOI 10.1671/2; Kuratani S, 2008, DEV GROWTH DIFFER, V50, pS189, DOI 10.1111/j.1440-169X.2008.00985.x; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Sanchez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056992; Trinajstic K, 2013, SCIENCE, V341, P160, DOI 10.1126/science.1237275; Young GC, 2008, BIOL LETTERS, V4, P110, DOI 10.1098/rsbl.2007.0545	12	3	3	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					139	140		10.1126/science.1241451	http://dx.doi.org/10.1126/science.1241451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23846897				2022-12-28	WOS:000321965300030
J	Amin, M				Amin, Massoud			The smart-grid solution	NATURE			English	Editorial Material									[Amin, Massoud] Univ Minnesota, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Amin, M (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.	amin@umn.edu						[Anonymous], GLOB COMP REP 2011 2; Electric Power Research Institute, 2002, COST POW DIST IND DI; Pacific Northwest National Laboratory, 2010, SMART GRID EST EN CO; U. S. Department of Energy Electricity Delivery and Energy Reliability, 2013, EC IMP REC ACT INV S	4	31	31	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2013	499	7457					145	147		10.1038/499145a	http://dx.doi.org/10.1038/499145a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23846644				2022-12-28	WOS:000321557600015
J	Goldacre, B				Goldacre, Ben			Are clinical trial data shared sufficiently today? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PUBLICATION; POLICY		Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Goldacre, B (corresponding author), Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.	ben@badscience.net		Goldacre, Ben/0000-0002-5127-4728	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], YAL U OP DAT ACC YOD; Doshi P, 2013, JAMA INTERN MED, V173, P380, DOI 10.1001/jamainternmed.2013.3838; Doshi P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7898; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; European Medicines Agency, 2012, REL DAT CLIN TRIALS; Godlee F, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7888; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Vedula SS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001378	11	22	23	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2013	347								f1880	10.1136/bmj.f1880	http://dx.doi.org/10.1136/bmj.f1880			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184LT	23838460	Bronze, Green Submitted			2022-12-28	WOS:000321892000001
J	Ostmeyer, J; Chakrapani, S; Pan, AC; Perozo, E; Roux, B				Ostmeyer, Jared; Chakrapani, Sudha; Pan, Albert C.; Perozo, Eduardo; Roux, Benoit			Recovery from slow inactivation in K+ channels is controlled by water molecules	NATURE			English	Article							C-TYPE INACTIVATION; STRUCTURAL BASIS; QUANTITATIVE DESCRIPTION; DYNAMICS; KCSA; ACTIVATION	Application of a specific stimulus opens the intracellular gate of a K+ channel (activation), yielding a transient period of ion conduction until the selectivity filter spontaneously undergoes a conformational change towards a non-conductive state (inactivation). Removal of the stimulus closes the gate and allows the selectivity filter to interconvert back to its conductive conformation (recovery). Given that the structural differences between the conductive and inactivated filter are very small, it is unclear why the recovery process can take up to several seconds. The bacterial K+ channel KcsA from Streptomyces lividans can be used to help elucidate questions about channel inactivation and recovery at the atomic level. Although KcsA contains only a pore domain, without voltage-sensing machinery, it has the structural elements necessary for ion conduction, activation and inactivation(1-7). Here we reveal, by means of a series of long molecular dynamics simulations, how the selectivity filter is sterically locked in the inactive conformation by buried water molecules bound behind the selectivity filter. Potential of mean force calculations show how the recovery process is affected by the buried water molecules and the rebinding of an external K+ ion. A kinetic model deduced from the simulations shows how releasing the buried water molecules can stretch the timescale of recovery to seconds. This leads to the prediction that reducing the occupancy of the buried water molecules by imposing a high osmotic stress should accelerate the rate of recovery, which was verified experimentally by measuring the recovery rate in the presence of a 2-molar sucrose concentration.	[Ostmeyer, Jared; Pan, Albert C.; Perozo, Eduardo; Roux, Benoit] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Chakrapani, Sudha] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	University of Chicago; Case Western Reserve University	Roux, B (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E57th St, Chicago, IL 60637 USA.	roux@uchicago.edu		Pan, Albert/0000-0001-5050-5603; chakrapani, sudha/0000-0003-0722-2338	National Institute of Health [R01-GM062342, R01-GM57846]; Office of Science of the Department of Energy [DE-AC05-00OR22725]; Pittsburgh Supercomputing Center (PSC) through National Institutes of Health [RC2GM093307]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093307, R01GM062342, R01GM057846] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science of the Department of Energy(United States Department of Energy (DOE)); Pittsburgh Supercomputing Center (PSC) through National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health through grant R01-GM062342 (J.O. and B. R) and R01-GM57846 (S. C. and E. P.). R. Hulse and C. Palka provided purified KcsA. J.O. is a student in the Graduate Program in Computational Neuroscience at the University of Chicago. This research used resources of the Oak Ridge Leadership Computing Facility located in the Oak Ridge National Laboratory, which is supported by the Office of Science of the Department of Energy under Contract DE-AC05-00OR22725. Anton computer time was provided by the National Resource for Biomedical Supercomputing and the Pittsburgh Supercomputing Center (PSC) through Grant RC2GM093307 from the National Institutes of Health and from a generous loan from D. E. Shaw. We are most grateful for the opportunity to use Anton<SUP>20</SUP> and for the support from R. Roskies and M. Dittrich at the PSC.	Bhate MP, 2010, J MOL BIOL, V401, P155, DOI 10.1016/j.jmb.2010.06.031; Chakrapani S, 2007, J GEN PHYSIOL, V130, P479, DOI 10.1085/jgp.200709844; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; Chakrapani S, 2011, NAT STRUCT MOL BIOL, V18, P67, DOI 10.1038/nsmb.1968; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cordero-Morales JF, 2011, BIOPHYS J, V100, P2387, DOI 10.1016/j.bpj.2011.01.073; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; Dror RO, 2010, J GEN PHYSIOL, V135, P555, DOI 10.1085/jgp.200910373; Imai S, 2010, P NATL ACAD SCI USA, V107, P6216, DOI 10.1073/pnas.0911270107; Jiang W, 2012, J CHEM THEORY COMPUT, V8, P4672, DOI 10.1021/ct300468g; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Levy DI, 1996, BIOPHYS J, V70, P798, DOI 10.1016/S0006-3495(96)79619-4; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Meyer R, 1997, EUR BIOPHYS J BIOPHY, V26, P433, DOI 10.1007/s002490050098; Pan AC, 2011, J GEN PHYSIOL, V138, P571, DOI 10.1085/jgp.201110670; PARSEGIAN VA, 1986, METHOD ENZYMOL, V127, P400; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rector KD, 2001, J PHYS CHEM B, V105, P1081, DOI 10.1021/jp0023563; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; ROUX B, 1991, J PHYS CHEM-US, V95, P4856, DOI 10.1021/j100165a049; Shaw D. E., 2009, MILLISECOND SCALE SC, VSC09; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	26	133	135	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465								10.1038/nature12395	http://dx.doi.org/10.1038/nature12395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8YC	23892782	Green Accepted			2022-12-28	WOS:000339424700003
J	Price, MJ				Price, Matthew J.			Platelet reactivity after coronary stenting	LANCET			English	Editorial Material							ANTIPLATELET THERAPY; CLOPIDOGREL; INTERVENTION; PRASUGREL; OUTCOMES; IMPACT; TRIAL; TIME		[Price, Matthew J.] Scripps Clin, La Jolla, CA 92037 USA; [Price, Matthew J.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Price, MJ (corresponding author), Scripps Clin, La Jolla, CA 92037 USA.	price.matthew@scrippshealth.org	Price, Matthew/AAJ-7679-2020	Price, Matthew/0000-0002-7892-2430				Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Brar SS, 2011, J AM COLL CARDIOL, V58, P1945, DOI 10.1016/j.jacc.2011.06.059; Campo G, 2011, J AM COLL CARDIOL, V57, P2474, DOI 10.1016/j.jacc.2010.12.047; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Dahlen JR, 2013, THROMB HAEMOSTASIS, V109, P808, DOI 10.1160/TH12-08-0608; Price MJ, 2011, CIRCULATION, V124, P1132, DOI 10.1161/CIRCULATIONAHA.111.029165; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Price MJ, 2009, CIRCULATION, V119, P2625, DOI 10.1161/CIRCULATIONAHA.107.696732; Stone GW, 2013, LANCET; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2001, NEW ENGL J MED, V345, P494	14	0	1	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 17	2013	382	9892					583	584		10.1016/S0140-6736(13)61542-1	http://dx.doi.org/10.1016/S0140-6736(13)61542-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DV	23890996				2022-12-28	WOS:000323422800008
J	Stone, GW; Witzenbichler, B; Weisz, G; Rinaldi, MJ; Neumann, FJ; Metzger, DC; Henry, TD; Cox, DA; Duffy, PL; Mazzaferri, E; Gurbel, PA; Xu, K; Parise, H; Kirtane, AJ; Brodie, BR; Mehran, R; Stuckey, TD				Stone, Gregg W.; Witzenbichler, Bernhard; Weisz, Giora; Rinaldi, Michael J.; Neumann, Franz-Josef; Metzger, D. Christopher; Henry, Timothy D.; Cox, David A.; Duffy, Peter L.; Mazzaferri, Ernest; Gurbel, Paul A.; Xu, Ke; Parise, Helen; Kirtane, Ajay J.; Brodie, Bruce R.; Mehran, Roxana; Stuckey, Thomas D.		ADAPT-DES Investigators	Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; ASPIRIN RESISTANCE; CARDIOVASCULAR EVENTS; ANTIPLATELET THERAPY; CLOPIDOGREL; INTERVENTION; THROMBOSIS; TRIAL; REVASCULARIZATION; RESPONSIVENESS	Background The relation between platelet reactivity and stent thrombosis, major bleeding, and other adverse events after coronary artery implantation of drug-eluting stents has been incompletely characterised. We aimed to determine the relation between platelet reactivity during dual therapy with aspirin and clopidogrel and clinical outcomes after successful coronary drug-eluting stent implantation. Methods ADAPT-DES was a prospective, multicentre registry of patients successfully treated with one or more drug-eluting stents and given aspirin and clopidogrel at 10-15 US and European hospitals. We assessed platelet reactivity in those patients after successful percutaneous coronary intervention using VerifyNow point-of-care assays, and assigned different cutoffs to define high platelet reactivity. The primary endpoint was definite or probable stent thrombosis; other endpoints were all-cause mortality, myocardial infarction, and clinically relevant bleeding. We did a propensity-adjusted multivariable analysis to determine the relation between platelet reactivity and subsequent adverse events. This study is registered with ClinicalTrials.gov, number NCT00638794. Findings Between Jan 7, 2008, and Sept 16, 2010, 8665 patients were prospectively enrolled at 11 sites, of which 8583 were eligible. At 1-year follow-up, stent thrombosis had occurred in 70 (0.8%) patients, myocardial infarction in 269 (3.1%), clinically relevant bleeding in 531 (6.2%), and death in 161 (1.9%) patients. High platelet reactivity on clopidogrel was strongly related to stent thrombosis (adjusted HR 2.49 [95% CI 1.43-4.31], p=0.001) and myocardial infarction (adjusted HR 1.42 [1.09-1.86], p=0.01), was inversely related to bleeding (adjusted HR 0.73 [0.61-0.89], p=0.002), but was not related to mortality (adjusted HR 1.20 [0.85-1.70], p=0.30). High platelet reactivity on aspirin was not significantly associated with stent thrombosis (adjusted HR 1.46 [0.58-3.64], p=0.42), myocardial infarction, or death, but was inversely related to bleeding (adjusted HR 0.65 [0.43-0.99], p=0.04). Interpretation The findings from this study emphasise the counter-balancing effects of haemorrhagic and ischaemic complications after stent implantation, and suggest that safer drugs or tailored strategies for the use of more potent agents must be developed if the benefits of greater platelet inhibition in patients with cardiovascular disease are to be realised.	[Stone, Gregg W.; Weisz, Giora; Xu, Ke; Parise, Helen; Kirtane, Ajay J.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY 10022 USA; [Stone, Gregg W.; Weisz, Giora; Xu, Ke; Parise, Helen; Kirtane, Ajay J.] Columbia Univ, Cardiovasc Res Fdn, New York, NY 10022 USA; [Witzenbichler, Bernhard] Charite Campus Benjamin Franklin, Berlin, Germany; [Rinaldi, Michael J.] Sanger Heart & Vasc Inst, Charlotte, NC USA; [Neumann, Franz-Josef] Univ Herzzentrum Freibrug Bad Krozingen, Bad Krozingen, Germany; [Metzger, D. Christopher] Wellmont CVA Heart Inst, Kingsport, TN USA; [Henry, Timothy D.] Minneapolis Heart Inst, Minneapolis, MN USA; [Cox, David A.] Lehigh Valley Hlth Network, Allentown, PA USA; [Duffy, Peter L.] FirstHlth Moore Reg Hosp, Pinehurst, NC USA; [Mazzaferri, Ernest] Ohio State Univ, Columbus, OH 43210 USA; [Gurbel, Paul A.] Sinai Hosp, Baltimore, MD 21215 USA; [Brodie, Bruce R.; Stuckey, Thomas D.] Moses Cone Heart & Vasc Ctr, Greensboro, NC USA; [Mehran, Roxana] Mt Sinai Med Ctr, New York, NY 10029 USA; [Mehran, Roxana] Cardiovasc Res Fdn, New York, NY USA	Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF); Columbia University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universitats Herzzentrum Freiburg; Minneapolis Heart Institute Foundation; Lehigh Valley Health Network; University System of Ohio; Ohio State University; Sinai Hospital of Baltimore; Icahn School of Medicine at Mount Sinai; Cardiovascular Research Foundation (CRF)	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, 111 E 59th St, New York, NY 10022 USA.	gs2184@columbia.edu	Witzenbichler, Bernhard/ABC-2525-2021; Mehran, Roxana/ABF-4160-2021	Witzenbichler, Bernhard/0000-0001-9322-1926; Parise, Helen/0000-0001-7761-4973	Boston Scientific; Abbott Vascular; Medtronic; Cordis; Biosensors; Medicines Company; Daiichi-Sankyo; Eli Lilly; Volcano; Accumetrics	Boston Scientific(Boston Scientific); Abbott Vascular(Abbott Laboratories); Medtronic(Medtronic); Cordis; Biosensors; Medicines Company; Daiichi-Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Volcano; Accumetrics	Funding Boston Scientific, Abbott Vascular, Medtronic, Cordis, Biosensors, The Medicines Company, Daiichi-Sankyo, Eli Lilly, Volcano, and Accumetrics	Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Campo G, 2010, J AM COLL CARDIOL, V56, P1447, DOI 10.1016/j.jacc.2010.03.103; Chen WH, 2004, J AM COLL CARDIOL, V43, P1122, DOI 10.1016/j.jacc.2003.12.034; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Geisler T, 2010, EUR HEART J, V31, P59, DOI 10.1093/eurheartj/ehp402; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1820, DOI 10.1016/j.jacc.2005.07.041; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V308, P1785, DOI 10.1001/jama.2012.17312; Herbert Jean-Marc, 2003, Semin Vasc Med, V3, P113; Holmes DR, 2010, J AM COLL CARDIOL, V56, P1357, DOI 10.1016/j.jacc.2010.07.016; Jaitner J, 2011, THROMB HAEMOSTASIS, V105, P107, DOI 10.1160/TH10-07-0440; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Mangiacapra F, 2012, JACC-CARDIOVASC INTE, V5, P281, DOI 10.1016/j.jcin.2012.01.009; Marcucci R, 2006, AM J CARDIOL, V98, P1156, DOI 10.1016/j.amjcard.2006.05.041; Mehran R, 2008, AM HEART J, V156, P44, DOI 10.1016/j.ahj.2008.02.008; Park DW, 2011, J AM COLL CARDIOL, V58, P2630, DOI 10.1016/j.jacc.2011.08.057; Parodi G, 2011, JAMA-J AM MED ASSOC, V306, P1215, DOI 10.1001/jama.2011.1332; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Price MJ, 2011, CIRCULATION, V124, P1132, DOI 10.1161/CIRCULATIONAHA.111.029165; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Sibbing D, 2010, J AM COLL CARDIOL, V56, P317, DOI 10.1016/j.jacc.2010.03.048; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Tantry US, 2005, J AM COLL CARDIOL, V46, P1705, DOI 10.1016/j.jacc.2005.05.090; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Varenhorst C, 2009, AM HEART J, V157, DOI 10.1016/j.ahj.2008.11.021	31	617	649	3	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2013	382	9892					614	623		10.1016/S0140-6736(13)61170-8	http://dx.doi.org/10.1016/S0140-6736(13)61170-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DV	23890998				2022-12-28	WOS:000323422800025
J	Engreitz, JM; Pandya-Jones, A; McDonel, P; Shishkin, A; Sirokman, K; Surka, C; Kadri, S; Xing, J; Goren, A; Lander, ES; Plath, K; Guttman, M				Engreitz, Jesse M.; Pandya-Jones, Amy; McDonel, Patrick; Shishkin, Alexander; Sirokman, Klara; Surka, Christine; Kadri, Sabah; Xing, Jeffrey; Goren, Alon; Lander, Eric S.; Plath, Kathrin; Guttman, Mitchell			The Xist lncRNA Exploits Three-Dimensional Genome Architecture to Spread Across the X Chromosome	SCIENCE			English	Article							LONG NONCODING RNAS; HISTONE H3; CHROMATIN INTERACTIONS; INACTIVATION; REVEALS; DOMAINS; METHYLATION; LOCALIZATION; ORGANIZATION; EXPRESSION	Many large noncoding RNAs (lncRNAs) regulate chromatin, but the mechanisms by which they localize to genomic targets remain unexplored. We investigated the localization mechanisms of the Xist lncRNA during X-chromosome inactivation (XCI), a paradigm of lncRNA-mediated chromatin regulation. During the maintenance of XCI, Xist binds broadly across the X chromosome. During initiation of XCI, Xist initially transfers to distal regions across the X chromosome that are not defined by specific sequences. Instead, Xist identifies these regions by exploiting the three-dimensional conformation of the X chromosome. Xist requires its silencing domain to spread across actively transcribed regions and thereby access the entire chromosome. These findings suggest a model in which Xist coats the X chromosome by searching in three dimensions, modifying chromosome structure, and spreading to newly accessible locations.	[Engreitz, Jesse M.; McDonel, Patrick; Shishkin, Alexander; Sirokman, Klara; Surka, Christine; Kadri, Sabah; Xing, Jeffrey; Goren, Alon; Lander, Eric S.; Guttman, Mitchell] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Engreitz, Jesse M.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Pandya-Jones, Amy; Plath, Kathrin] Univ Calif Los Angeles, Dept Biol Chem, Jonsson Comprehens Canc Ctr, Inst Mol Biol, Los Angeles, CA 90095 USA; [Pandya-Jones, Amy; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Lander, ES (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	lander@broadinstitute.org; kplath@mednet.ucla.edu; mguttman@caltech.edu		Kadri, Sabah/0000-0003-0365-6550; Pandya-Jones, Amy/0000-0001-5519-4613; Xing, Jeffrey/0000-0003-0696-1390; Plath, Kathrin/0000-0001-7796-3372; Goren, Alon/0000-0001-5669-9357	Fannie and John Hertz Foundation; National Defense Science and Engineering Graduate Fellowship; NIH [1F32GM103139-01, DP5OD012190]; National Human Genome Research Institute Center for Excellence for Genomic Sciences [P50HG006193]; National Institute of General Medical Sciences [P01GM099134]; California Institute for Regenerative Medicine [RN1-00564, RB3-05080, RB4-06133]; Broad Institute of MIT and Harvard; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134, F32GM103139] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012190] Funding Source: NIH RePORTER	Fannie and John Hertz Foundation; National Defense Science and Engineering Graduate Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute Center for Excellence for Genomic Sciences; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Broad Institute of MIT and Harvard; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Gnirke for initial discussions about the RAP method; T. Mikkelsen for assistance with oligonucleotide synthesis; M. Garber and J. Rinn for helpful discussions and ideas; A. Wutz for generously providing Xist transgenic cell lines; S. Rao, N. Cherniavsky, and E. Lieberman-Aiden for analytical help and discussions; P. Russell, M. Cabili, E. Hacisuleyman, and L. Goff for critical reading of the manuscript; L. Gaffney for assistance with figures; and S. Knemeyer for illustrations. Supported by the Fannie and John Hertz Foundation and National Defense Science and Engineering Graduate Fellowship (J.M.E.); an NIH postdoctoral fellowship (1F32GM103139-01) (A.P.-J.); NIH Director's Early Independence Award DP5OD012190 (M. G.), National Human Genome Research Institute Center for Excellence for Genomic Sciences grant P50HG006193 (M. G.); National Institute of General Medical Sciences grant P01GM099134 (K. P.); California Institute for Regenerative Medicine grants RN1-00564, RB3-05080, and RB4-06133 (K. P.); the Broad Institute of MIT and Harvard (M. G. and E. S. L.); and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA (K. P.). Sequencing data are available online from the NCBI Gene Expression Omnibus (accession no. GSE46918, www.ncbi.nlm.nih.gov/geo/) and additional data and information is available at www.lncRNA.caltech.edu/RAP/. J.M.E., E. S. L., and M. G. are inventors on a patent application from the Broad Institute that covers the selective purification of RNA-bound molecular complexes in cells.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Arthold S, 2011, HUM GENET, V130, P295, DOI 10.1007/s00439-011-1002-0; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Beletskii A, 2001, P NATL ACAD SCI USA, V98, P9215, DOI 10.1073/pnas.161173098; Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Chureau C, 2011, HUM MOL GENET, V20, P705, DOI 10.1093/hmg/ddq516; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dietzel S, 1999, EXP CELL RES, V252, P363, DOI 10.1006/excr.1999.4635; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Gontan C, 2011, PROG MOL SUBCELL BIO, V51, P43, DOI 10.1007/978-3-642-16502-3_3; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kanhere Aditi, 2012, Silence, V3, P2, DOI 10.1186/1758-907X-3-2; Kim DH, 2011, SEMIN CELL DEV BIOL, V22, P336, DOI 10.1016/j.semcdb.2011.02.025; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Maass PG, 2012, J CLIN INVEST, V122, P3990, DOI 10.1172/JCI65508; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Naughton C, 2010, MOL CELL, V40, P397, DOI 10.1016/j.molcel.2010.10.013; Nozawa RS, 2013, NAT STRUCT MOL BIOL, V20, P566, DOI 10.1038/nsmb.2532; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pinter SF, 2012, GENOME RES, V22, P1864, DOI 10.1101/gr.133751.111; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pullirsch D, 2010, DEVELOPMENT, V137, P935, DOI 10.1242/dev.035956; Rego A, 2008, J CELL SCI, V121, P1119, DOI 10.1242/jcs.026104; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Senner CE, 2011, DEVELOPMENT, V138, P1541, DOI 10.1242/dev.056812; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Tattermusch A, 2011, HUM GENET, V130, P247, DOI 10.1007/s00439-011-1027-4; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Umlauf D, 2008, BIOL CHEM, V389, P323, DOI 10.1515/BC.2008.047; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	62	652	687	4	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					767	+	1237973	10.1126/science.1237973	http://dx.doi.org/10.1126/science.1237973			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23828888	Green Submitted, Green Accepted			2022-12-28	WOS:000323122200041
J	Mayer, K; Beyrer, C				Mayer, Kenneth; Beyrer, Chris			WHO's new HIV guidelines: opportunities and challenges	LANCET			English	Editorial Material							AFRICA; ART		[Mayer, Kenneth] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Fenway Hlth, Boston, MA 02215 USA; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Dept Epidemiol, Baltimore, MD USA	Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mayer, K (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Fenway Hlth, Boston, MA 02215 USA.	khmayer@gmail.com						[Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2013, HUMAN RIGHTS WATCH; [Anonymous], 2012, GLOB REP UNAIDS REP; Audelin AM, 2013, JAIDS-J ACQ IMM DEF, V62, P102, DOI 10.1097/QAI.0b013e318276becc; Birrell PJ, 2013, LANCET INFECT DIS, V13, P313, DOI 10.1016/S1473-3099(12)70341-9; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; De Cock KM, 2013, NEW ENGL J MED, V368, P886, DOI 10.1056/NEJMp1300458; Deeks S, 2013, 7 IAS C PATH TREATM; Lundgren JD, 2013, CLIN INFECT DIS, V57, P888, DOI 10.1093/cid/cit381; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; WHO, 2010, ANT THER HIV INF AD	11	8	8	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 27	2013	382	9889					287	288		10.1016/S0140-6736(13)61578-0	http://dx.doi.org/10.1016/S0140-6736(13)61578-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193FT	23890033				2022-12-28	WOS:000322544900004
J	Whiteman, G; Hope, C; Wadhams, P				Whiteman, Gail; Hope, Chris; Wadhams, Peter			Vast costs of Arctic change	NATURE			English	Editorial Material							ICE		[Whiteman, Gail] Erasmus Univ, NL-3000 DR Rotterdam, Netherlands; [Hope, Chris] Univ Cambridge, Judge Business Sch, Cambridge CB2 1TN, England; [Wadhams, Peter] Univ Cambridge, Cambridge CB2 1TN, England	Erasmus University Rotterdam; University of Cambridge; University of Cambridge	Whiteman, G (corresponding author), Erasmus Univ, NL-3000 DR Rotterdam, Netherlands.	gwhiteman@rsm.nl		Whiteman, Gail/0000-0002-4152-5538				Emmerson C., 2012, ARCTIC OPENING OPPOR; Francis JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051000; Gautier DL, 2009, SCIENCE, V324, P1175, DOI 10.1126/science.1169467; Hope C, 2013, CLIMATIC CHANGE, V117, P531, DOI 10.1007/s10584-012-0633-z; International Monetary Fund (IMF), 2013, DOG DIDNT BARK HAS I; Maslowski W, 2012, ANNU REV EARTH PL SC, V40, P625, DOI 10.1146/annurev-earth-042711-105345; Shakhova NE, 2010, DOKL EARTH SCI, V430, P190, DOI 10.1134/S1028334X10020091; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Smith LC, 2013, P NATL ACAD SCI USA, V110, pE1191, DOI 10.1073/pnas.1214212110; Wadhams P, 2012, AMBIO, V41, P23, DOI 10.1007/s13280-011-0222-9	10	95	99	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2013	499	7459					401	403		10.1038/499401a	http://dx.doi.org/10.1038/499401a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23887416	Bronze			2022-12-28	WOS:000322157900015
J	Mora, C; Rollo, A; Tittensor, DP				Mora, Camilo; Rollo, Audrey; Tittensor, Derek P.			Comment on "Can We Name Earth's Species Before They Go Extinct?"	SCIENCE			English	Editorial Material							RATES; STATE		[Mora, Camilo] Univ Hawaii, Dept Geog, Honolulu, HI 96822 USA; [Rollo, Audrey] Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Tittensor, Derek P.] World Conservat Monitoring Ctr, United Nations Environm Programme, Cambridge, England; [Tittensor, Derek P.] Microsoft Res Computat Sci Lab, Cambridge, England; [Tittensor, Derek P.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	University of Hawaii System; Microsoft; Dalhousie University	Mora, C (corresponding author), Univ Hawaii, Dept Geog, Honolulu, HI 96822 USA.	cmora@hawaii.edu	Tittensor, Derek P./AAV-1117-2021	Tittensor, Derek P./0000-0002-9550-3123				Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Bacher S, 2012, TRENDS ECOL EVOL, V27, P65, DOI 10.1016/j.tree.2011.11.003; Balmford A, 2003, TRENDS ECOL EVOL, V18, P326, DOI 10.1016/S0169-5347(03)00067-3; Bouchet Philippe, 2006, P31; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Costello MJ, 2012, SYST BIOL, V61, P871, DOI 10.1093/sysbio/syr080; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; ERWIN TL, 1991, CONSERV BIOL, V5, P330, DOI 10.1111/j.1523-1739.1991.tb00145.x; He FL, 2012, NATURE, V482, pE5, DOI 10.1038/nature10859; Mora C., 2013, BALANCE NATURE HUMAN; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Pimm S, 2006, P NATL ACAD SCI USA, V103, P10941, DOI 10.1073/pnas.0604181103; Rybicki J, 2013, ECOL LETT, V16, P27, DOI 10.1111/ele.12065; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Stork NE, 2010, BIODIVERS CONSERV, V19, P357, DOI 10.1007/s10531-009-9761-9; Wheeler Q. D., 2011, STATE OBSERVED SPECI	16	25	27	2	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143								10.1126/science.1237254	http://dx.doi.org/10.1126/science.1237254			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	185HV	23869005				2022-12-28	WOS:000321959300023
J	Cole, TB				Cole, Thomas B.			Juan de Pareja Diego Rodriguez de Silva y Velazquez	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					236	237		10.1001/jama.2013.5211	http://dx.doi.org/10.1001/jama.2013.5211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23860969				2022-12-28	WOS:000321835700001
J	Mentzelopoulos, SD; Malachias, S; Chamos, C; Konstantopoulos, D; Ntaidou, T; Papastylianou, A; Kolliantzaki, I; Theodoridi, M; Ischaki, H; Makris, D; Zakynthinos, E; Zintzaras, E; Sourlas, S; Aloizos, S; Zakynthinos, SG				Mentzelopoulos, Spyros D.; Malachias, Sotirios; Chamos, Christos; Konstantopoulos, Demetrios; Ntaidou, Theodora; Papastylianou, Androula; Kolliantzaki, Iosifinia; Theodoridi, Maria; Ischaki, Helen; Makris, Dimosthemis; Zakynthinos, Epaminondas; Zintzaras, Elias; Sourlas, Sotirios; Aloizos, Stavros; Zakynthinos, Spyros G.			Vasopressin, Steroids, and Epinephrine and Neurologically Favorable Survival After In-Hospital Cardiac Arrest A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTRESUSCITATION MYOCARDIAL DYSFUNCTION; EUROPEAN-RESUSCITATION-COUNCIL; AMERICAN-HEART-ASSOCIATION; CARDIOPULMONARY-RESUSCITATION; COMATOSE SURVIVORS; SEPTIC SHOCK; GUIDELINES; HYPOTHERMIA; MANAGEMENT; OUTCOMES	IMPORTANCE Among patients with cardiac arrest, preliminary data have shown improved return of spontaneous circulation and survival to hospital discharge with the vasopressin-steroids-epinephrine (VSE) combination. OBJECTIVE To determine whether combined vasopressin-epinephrine during cardiopulmonary resuscitation (CPR) and corticosteroid supplementation during and after CPR improve survival to hospital discharge with a Cerebral Performance Category (CPC) score of 1 or 2 in vasopressor-requiring, in-hospital cardiac arrest. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind, placebo-controlled, parallel-group trial performed from September 1, 2008, to October 1, 2010, in 3 Greek tertiary care centers (2400 beds) with 268 consecutive patients with cardiac arrest requiring epinephrine according to resuscitation guidelines (from 364 patients assessed for eligibility). INTERVENTIONS Patients received either vasopressin (20 IU/CPR cycle) plus epinephrine (1 mg/CPR cycle; cycle duration approximately 3 minutes) (VSE group, n = 130) or saline placebo plus epinephrine (1 mg/CPR cycle; cycle duration approximately 3 minutes) (control group, n = 138) for the first 5 CPR cycles after randomization, followed by additional epinephrine if needed. During the first CPR cycle after randomization, patients in the VSE group received methylprednisolone (40 mg) and patients in the control group received saline placebo. Shock after resuscitation was treated with stress-dose hydrocortisone (300 mg daily for 7 days maximum and gradual taper) (VSE group, n = 76) or saline placebo (control group, n = 73). MAIN OUTCOMES AND MEASURES Return of spontaneous circulation (ROSC) for 20 minutes or longer and survival to hospital discharge with a CPC score of 1 or 2. RESULTS Follow-up was completed in all resuscitated patients. Patients in the VSE group vs patients in the control group had higher probability for ROSC of 20 minutes or longer (109/130 [83.9%] vs 91/138 [65.9%]; odds ratio [OR], 2.98; 95% CI, 1.39-6.40; P = .005) and survival to hospital discharge with CPC score of 1 or 2 (18/130 [13.9%] vs 7/138 [5.1%]; OR, 3.28; 95% CI, 1.17-9.20; P = .02). Patients in the VSE group with postresuscitation shock vs corresponding patients in the control group had higher probability for survival to hospital discharge with CPC scores of 1 or 2 (16/76 [21.1%] vs 6/73 [8.2%]; OR, 3.74; 95% CI, 1.20-11.62; P = .02), improved hemodynamics and central venous oxygen saturation, and less organ dysfunction. Adverse event rates were similar in the 2 groups. CONCLUSION AND RELEVANCE Among patients with cardiac arrest requiring vasopressors, combined vasopressin-epinephrine and methylprednisolone during CPR and stress-dose hydrocortisone in postresuscitation shock, compared with epinephrine/saline placebo, resulted in improved survival to hospital discharge with favorable neurological status.	[Mentzelopoulos, Spyros D.; Malachias, Sotirios; Papastylianou, Androula; Kolliantzaki, Iosifinia; Ischaki, Helen; Zakynthinos, Epaminondas] Univ Athens, Sch Med, Dept Intens Care Med 1, GR-11527 Athens, Greece; [Chamos, Christos; Konstantopoulos, Demetrios; Ntaidou, Theodora; Theodoridi, Maria] Evaggelismos Gen Hosp, Dept Anesthesiol, Athens 10675, Greece; [Makris, Dimosthemis; Zakynthinos, Epaminondas] Univ Thessaly, Sch Med, Dept Intens Care Med, Larisa, Greece; [Zintzaras, Elias] Univ Thessaly, Sch Med, Dept Biomath, Larisa, Greece; [Zintzaras, Elias] Tufts Univ, Sch Med, Inst Clin Res & Hlth Policy Studies, Ctr Clin Evidence Synth,Tufts Med Ctr, Boston, MA 02111 USA; [Sourlas, Sotirios; Aloizos, Stavros] 401 Greek Army Hosp, Dept Intens Care Med, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; University of Thessaly; University of Thessaly; Tufts Medical Center; Tufts University	Mentzelopoulos, SD (corresponding author), Evaggelismos Gen Hosp, Dept Intens Care Med, 45-47 Ipsilandou St, Athens 10675, Greece.	sdmentzelopoulos@yahoo.com	Zakynthinos, Epameinondas/N-9024-2019; MAKRIS, DEMOSTHENES/J-5953-2015	MAKRIS, DEMOSTHENES/0000-0003-1951-6421; ALOIZOS, STAVROS/0000-0001-5868-7413; Chamos, Christos/0000-0001-6208-130X	Greek Society of Intensive Care Medicine; Greek Ministry of Education [09SigmaYN-12-1075]	Greek Society of Intensive Care Medicine; Greek Ministry of Education(Greek Ministry of Development-GSRT)	This work has been funded in part by the Greek Society of Intensive Care Medicine and the Project "Synergasia" (ie, Cooperation) of the Greek Ministry of Education (09 Sigma YN-12-1075). All funding was used for purchasing necessary materials for the study (eg, study drugs, study drug boxes, syringes) and for partial coverage of expenses related to a scientific congress presentation.	Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Annane D, 1998, BRIT J CLIN PHARMACO, V46, P589; Aufderheide TP, 2011, NEW ENGL J MED, V365, P798, DOI 10.1056/NEJMoa1010821; Aufderheide TP, 2011, LANCET, V377, P301, DOI 10.1016/S0140-6736(10)62103-4; BAUMANN G, 1976, J CLIN INVEST, V57, P1109, DOI 10.1172/JCI108377; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Cely CM, 2004, CHEST, V126, P879, DOI 10.1378/chest.126.3.879; Chang WT, 2007, INTENS CARE MED, V33, P88, DOI 10.1007/s00134-006-0442-9; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Ertmer C, 2007, SHOCK, V27, P281, DOI 10.1097/01.shk.0000235140.97903.90; Gueugniaud PY, 2008, NEW ENGL J MED, V359, P21, DOI 10.1056/NEJMoa0706873; Hagihara A, 2012, JAMA-J AM MED ASSOC, V307, P1161, DOI 10.1001/jama.2012.294; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jacobs IG, 2011, RESUSCITATION, V82, P1138, DOI 10.1016/j.resuscitation.2011.06.029; KELSEY SF, 1991, CONTROL CLIN TRIALS, V12, P525; Meaney PA, 2010, CRIT CARE MED, V38, P101, DOI 10.1097/CCM.0b013e3181b43282; Mentzelopoulos SD, 2012, RESUSCITATION, V83, P32, DOI 10.1016/j.resuscitation.2011.07.015; Mentzelopoulos SD, 2009, ARCH INTERN MED, V169, P15, DOI 10.1001/archinternmed.2008.509; NILSSON F, 1985, JPEN-PARENTER ENTER, V9, P159, DOI 10.1177/0148607185009002159; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; O'Connor E, 2012, ANAESTH INTENS CARE, V40, P598, DOI 10.1177/0310057X1204000404; Olasveengen TM, 2009, JAMA-J AM MED ASSOC, V302, P2222, DOI 10.1001/jama.2009.1729; Ong MEH, 2007, ANN EMERG MED, V50, P635, DOI 10.1016/j.annemergmed.2007.03.028; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Ristagno G, 2008, RESUSCITATION, V77, P229, DOI 10.1016/j.resuscitation.2007.12.013; Ristagno G, 2007, CRIT CARE MED, V35, P2145, DOI 10.1097/01.CCM.0000280427.76175.D2; Ristagno G, 2009, CRIT CARE MED, V37, P1408, DOI 10.1097/CCM.0b013e31819cedc9; Sandroni C, 2007, INTENS CARE MED, V33, P237, DOI 10.1007/s00134-006-0326-z; SHIZUKUDA Y, 1991, CAN J CARDIOL, V7, P447; Skyschally A, 2004, CIRCULATION, V109, P2337, DOI 10.1161/01.CIR.0000127961.66744.F4; TANG WC, 1995, CIRCULATION, V92, P3089, DOI 10.1161/01.CIR.92.10.3089; Tsai MS, 2007, AM J EMERG MED, V25, P318, DOI 10.1016/j.ajem.2006.12.007; Tsuneyoshi I, 1996, BRIT J ANAESTH, V76, P251, DOI 10.1093/bja/76.2.251; Voelckel WG, 2002, CRIT CARE MED, V30, P957, DOI 10.1097/00003246-200205000-00001; von Lewinski D, 2005, CIRCULATION, V111, P2588, DOI 10.1161/CIRCULATIONAHA.104.497461; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431	37	174	186	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					270	279		10.1001/jama.2013.7832	http://dx.doi.org/10.1001/jama.2013.7832			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23860985	Bronze			2022-12-28	WOS:000321835700014
J	Adler-Milstein, J; Salzberg, C; Franz, C; Orav, EJ; Newhouse, JP; Bates, DW				Adler-Milstein, Julia; Salzberg, Claudia; Franz, Calvin; Orav, E. John; Newhouse, Joseph P.; Bates, David W.			Effect of Electronic Health Records on Health Care Costs: Longitudinal Comparative Evidence From Community Practices	ANNALS OF INTERNAL MEDICINE			English	Article							INFORMATION-TECHNOLOGY; AMBULATORY-CARE; MEDICAL-RECORDS; PHYSICIANS; IMPLEMENTATION; TRANSFORM; IMPACT; TESTS	Background: The United States is aiming to achieve nationwide adoption of electronic health records (EHRs) but lacks robust empirical evidence to anticipate the effect on health care costs. Objective: To assess short-term cost savings from community-wide adoption of ambulatory EHRs. Design: Longitudinal trial with parallel control group. Setting: Natural experiment in which 806 ambulatory clinicians across 3 Massachusetts communities adopted subsidized EHRs. Six matched control communities applied but were not selected to participate. Patients: 47 979 intervention patients and 130 603 control patients. Measurements: Monthly standardized health care costs from commercial claims data from January 2005 to June 2009, including total cost, inpatient cost, and ambulatory cost and its subtypes (pharmacy, laboratory, and radiology). Projected savings per member per month (PMPM), excluding EHR adoption costs. Results: Ambulatory EHR adoption did not impact total cost (pre- to postimplementation difference in monthly trend change, -0.30 percentage point; P = 0.135), but the results favored savings (95% CI, $21.95 PMPM in savings to $1.53 PMPM in higher costs). It slowed ambulatory cost growth (difference in monthly trend change, -0.35 percentage point; P = 0.012); projected ambulatory savings were $4.69 PMPM (CI, $8.45 to $1.09 PMPM) (3.10% of total PMPM cost). Ambulatory radiology costs decreased (difference in monthly trend change, -1.61 percentage points; P < 0.001), with projected savings of $1.61 PMPM (1.07% of total PMPM cost). Limitations: Intervention communities were not randomly selected and received implementation support, suggesting that results may represent a best-case scenario. Confounding is possible. Conclusion: Using commercially available EHRs in community practices seems to modestly slow ambulatory cost growth. Broader changes in the organization and payment of care may prompt clinicians to use EHRs in ways that result in more substantial savings.	Univ Michigan, Ann Arbor, MI 48109 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Eastern Res Grp, Lexington, MA USA; Harvard Univ, Kennedy Sch, Cambridge, MA 02138 USA	University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Adler-Milstein, J (corresponding author), Univ Michigan, Sch Informat, 4376 North Quad,105 South State St, Ann Arbor, MI 48109 USA.	juliaam@umich.edu	Newhouse, Joseph/AGJ-5632-2022; Newhouse, Joseph/AAD-9763-2019; Bates, David/AAE-7283-2019		Massachusetts eHealth Collaborative	Massachusetts eHealth Collaborative	Primary Funding Source: Massachusetts eHealth Collaborative.	Adler-Milstein J, 2013, HEALTH AFFAIR, V32, P562, DOI 10.1377/hlthaff.2012.0306; Blumenthal D, 2007, NEW ENGL J MED, V356, P2527, DOI 10.1056/NEJMhpr066212; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Blumenthal D, 2009, NEW ENGL J MED, V360, P1477, DOI 10.1056/NEJMp0901592; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Evidence on the costs and benefits of health information technology, 2008, EV COSTS BEN HLTH IN; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Fleurant M, 2012, J AM MED INFORM ASSN, V19, P541, DOI 10.1136/amiajnl-2011-000689; Fleurant M, 2011, HEALTH AFFAIR, V30, P1256, DOI 10.1377/hlthaff.2010.1020; Garrido T, 2005, BMJ-BRIT MED J, V330, P581, DOI 10.1136/bmj.330.7491.581; Goroll AH, 2009, J AM MED INFORM ASSN, V16, P132, DOI 10.1197/jamia.M2899; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Himmelstein DU, 2005, HEALTH AFFAIR, V24, P1121, DOI 10.1377/hlthaff.24.5.1121; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; McCormick D, 2012, HEALTH AFFAIR, V31, P488, DOI 10.1377/hlthaff.2011.0876; Medicare Payment Advisory Commission, 2011, REP C REG VAR MED SE; Medicare Payment Advisory Committee, 2009, REP C MEAS REG VAR S; Mostashari F, 2009, HEALTH AFFAIR, V28, P345, DOI 10.1377/hlthaff.28.2.345; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; RUBIN DB, 1979, J AM STAT ASSOC, V74, P318, DOI 10.2307/2286330; Sidorov J, 2006, HEALTH AFFAIR, V25, P1079, DOI 10.1377/hlthaff.25.4.1079; Simon SR, 2007, ARCH INTERN MED, V167, P507, DOI 10.1001/archinte.167.5.507; Simon Steven R, 2008, Inform Prim Care, V16, P129; Steinwachs D M, 1998, Am J Med Qual, V13, P63, DOI 10.1177/106286069801300203; TIERNEY WM, 1987, ANN INTERN MED, V107, P569, DOI 10.7326/0003-4819-107-4-569; TIERNEY WM, 1990, NEW ENGL J MED, V322, P1499, DOI 10.1056/NEJM199005243222105; Tripathi M, 2009, MEASURING MEANINGFUL; Tripathi M, 2009, HEALTH AFFAIR, V28, P435, DOI 10.1377/hlthaff.28.2.435; Walker Jan, 2005, Health Aff (Millwood), VSuppl Web Exclusives, pW5; Wang SJ, 2003, AM J MED, V114, P397, DOI 10.1016/S0002-9343(03)00057-3	31	27	27	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2					97	W37		10.7326/0003-4819-159-2-201307160-00004	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	187IX	23856682				2022-12-28	WOS:000322112000015
J	Watts, G				Watts, Geoff			Mary-Claire King: taking genes beyond the lab	LANCET			English	Biographical-Item																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 13	2013	382	9887					119	119		10.1016/S0140-6736(13)61551-2	http://dx.doi.org/10.1016/S0140-6736(13)61551-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187JY	23849913				2022-12-28	WOS:000322115300012
J	van der Elst, NJ; Savage, HM; Keranen, KM; Abers, GA				van der Elst, Nicholas J.; Savage, Heather M.; Keranen, Katie M.; Abers, Geoffrey A.			Enhanced Remote Earthquake Triggering at Fluid-Injection Sites in the Midwestern United States	SCIENCE			English	Article							FAULT; SEISMICITY; PARKFIELD; TEXAS	A recent dramatic increase in seismicity in the midwestern United States may be related to increases in deep wastewater injection. Here, we demonstrate that areas with suspected anthropogenic earthquakes are also more susceptible to earthquake-triggering from natural transient stresses generated by the seismic waves of large remote earthquakes. Enhanced triggering susceptibility suggests the presence of critically loaded faults and potentially high fluid pressures. Sensitivity to remote triggering is most clearly seen in sites with a long delay between the start of injection and the onset of seismicity and in regions that went on to host moderate magnitude earthquakes within 6 to 20 months. Triggering in induced seismic zones could therefore be an indicator that fluid injection has brought the fault system to a critical state.	[van der Elst, Nicholas J.; Savage, Heather M.; Abers, Geoffrey A.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Keranen, Katie M.] Univ Oklahoma, ConocoPhillips Sch Geol & Geophys, Norman, OK 73069 USA	Columbia University; ConocoPhillips; University of Oklahoma System; University of Oklahoma - Norman	van der Elst, NJ (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, POB 1000,61 Route 9W, Palisades, NY 10964 USA.	nicholas@ldeo.columbia.edu			U.S. National Science Foundation (NSF) [EAR-1144503]; U.S. Geological Survey (USGS) National Earthquake Hazards Reduction Program (NEHRP) [G13AP00024]; USGS NEHRP [G13AP00025]; NSF	U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); U.S. Geological Survey (USGS) National Earthquake Hazards Reduction Program (NEHRP); USGS NEHRP(United States Geological Survey); NSF(National Science Foundation (NSF))	This paper benefitted from discussions with E. Brodsky and W.-Y. Kim. Injection data for Cogdell Oilfield was provided by C. Frohlich. The Oklahoma Corporation Commission, the Texas Railroad Commission, and the Colorado Oil and Gas Conservation Commission supplied well databases. Earthquake locations were provided by ANSS. Seismic waveforms are from the Incorporated Research Institutions for Seismology Data Management Center. N.J.v.d.E. was supported by U.S. National Science Foundation (NSF) grant EAR-1144503. H. M. S. and G. A. A. were partially supported by U.S. Geological Survey (USGS) National Earthquake Hazards Reduction Program (NEHRP) grant G13AP00024. K. M. K. received support from USGS NEHRP grant G13AP00025. This project made use of EarthScope's Transportable Array, a facility funded by NSF. The enhanced seismicity catalogs are available as supplementary materials on Science Online.	Brodsky EE, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003211; Brodsky EE, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002321; DAVIS SD, 1989, B SEISMOL SOC AM, V79, P1477; Elkhoury JE, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007759; Frohlich C, 2012, B SEISMOL SOC AM, V102, P457, DOI 10.1785/0120110179; Frohlich C, 2011, B SEISMOL SOC AM, V101, P327, DOI 10.1785/0120100131; Hill D. P., 2007, DYNAMIC TRIGGERING T, V4, p[257, 292]; HILL DP, 1993, SCIENCE, V260, P1617, DOI 10.1126/science.260.5114.1617; Horner R. B., 1994, CAN J EXPLOR GEOPHYS, V30, P39; Horton S, 2012, SEISMOL RES LETT, V83, P250, DOI 10.1785/gssrl.83.2.250; Husen S, 2004, GEOLOGY, V32, P537, DOI 10.1130/G20381.1; Keranen KM, 2013, GEOLOGY, V41, P699, DOI 10.1130/G34045.1; Kim W, 2012, J THORAC ONCOL, V7, pS43; Micklethwaite S, 2006, EARTH PLANET SC LETT, V250, P318, DOI 10.1016/j.epsl.2006.07.050; Mitchell TM, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005588; National Research Council, 2012, IND SEISM POT EN TEC; Parsons T, 2011, NAT GEOSCI, V4, P312, DOI [10.1038/ngeo1110, 10.1038/NGEO1110]; Peng ZG, 2009, NAT GEOSCI, V2, P877, DOI 10.1038/ngeo697; RALEIGH CB, 1976, SCIENCE, V191, P1230, DOI 10.1126/science.191.4233.1230; Rubinstein J. L., 2013, BSSA 2013 ANN M; Savage HM, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005277; Taira T, 2009, NATURE, V461, P636, DOI 10.1038/nature08395; van der Elst NJ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006681; Vidale JE, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004034	24	163	165	1	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					164	167		10.1126/science.1238948	http://dx.doi.org/10.1126/science.1238948			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23846900				2022-12-28	WOS:000321965300040
J	Hergott, LJ				Hergott, Lawrence J.			The View From Fiesole	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Colorado, Dept Med, Denver, CO 80202 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Hergott, LJ (corresponding author), Univ Colorado, Dept Med, Denver, CO 80202 USA.	lawrence.hergott@ucdenver.edu						Rumi Jalal al-Din, 1995, ESSENTIAL RUMI; Schiff S, 2002, NY TIMES	2	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					147	148		10.1001/jama.2013.6006	http://dx.doi.org/10.1001/jama.2013.6006			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23839746				2022-12-28	WOS:000321511500010
J	Coombes, R				Coombes, Rebecca			The long march from fountain pens to wireless tablets: how data are changing medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Coombes, R (corresponding author), BMJ, London WC1H 9JR, England.	rcoombes@bmj.com						Cartwright M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f653	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2013	347								f4381	10.1136/bmj.f4381	http://dx.doi.org/10.1136/bmj.f4381			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184LT	23838462				2022-12-28	WOS:000321892000005
J	Christensen, K; Thinggaard, M; Oksuzyan, A; Steenstrup, T; Andersen-Ranberg, K; Jeune, B; McGue, M; Vaupel, JW				Christensen, Kaare; Thinggaard, Mikael; Oksuzyan, Anna; Steenstrup, Troels; Andersen-Ranberg, Karen; Jeune, Bernard; McGue, Matt; Vaupel, James W.			Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart	LANCET			English	Article							AGE TRAJECTORIES; UNITED-STATES; HEALTH; TRENDS; POPULATION; IMPAIRMENT; PREVALENCE; MORTALITY; AMERICANS; NONAGENARIANS	Background A rapidly increasing proportion of people in high-income countries are surviving into their tenth decade. Concern is widespread that the basis for this development is the survival of frail and disabled elderly people into very old age. To investigate this issue, we compared the cognitive and physical functioning of two cohorts of Danish nonagenarians, born 10 years apart. Methods People in the first cohort were born in 1905 and assessed at age 93 years (n=2262); those in the second cohort were born in 1915 and assessed at age 95 years (n=1584). All cohort members were eligible irrespective of type of residence. Both cohorts were assessed by surveys that used the same design and assessment instrument, and had almost identical response rates (63%). Cognitive functioning was assessed by mini-mental state examination and a composite of five cognitive tests that are sensitive to age-related changes. Physical functioning was assessed by an activities of daily living score and by physical performance tests (grip strength, chair stand, and gait speed). Findings The chance of surviving from birth to age 93 years was 28% higher in the 1915 cohort than in the 1905 cohort (6.50% vs 5.06%), and the chance of reaching 95 years was 32% higher in 1915 cohort (3.93% vs 2.98%). The 1915 cohort scored significantly better on the mini-mental state examination than did the 1905 cohort (22.8 [SD 5.6] vs 21.4 [6.0]; p<0.0001), with a substantially higher proportion of participants obtaining maximum scores (28-30 points; 277 [23%] vs 235 [13%]; p<0.0001). Similarly, the cognitive composite score was significantly better in the 1915 than in the 1905 cohort (0.49 [SD 3.6] vs 0.01 [SD 3.6]; p=0.0003). The cohorts did not differ consistently in the physical performance tests, but the 1915 cohort had significantly better activities of daily living scores than did the 1905 cohort (2.0 [SD 0.8] vs 1.8 [0.7]; p<0.0001). Interpretation Despite being 2 years older at assessment, the 1915 cohort scored significantly better than the 1905 cohort on both the cognitive tests and the activities of daily living score, which suggests that more people are living to older ages with better overall functioning.	[Christensen, Kaare; Thinggaard, Mikael; Oksuzyan, Anna; Andersen-Ranberg, Karen; Jeune, Bernard; Vaupel, James W.] Univ Southern Denmark, Inst Publ Hlth, Danish Aging Res Ctr, DK-5000 Odense C, Denmark; [Steenstrup, Troels] Univ Southern Denmark, Dept Biostat, DK-5000 Odense C, Denmark; [Christensen, Kaare; Vaupel, James W.] Univ Southern Denmark, Max Planck Odense Ctr, DK-5000 Odense C, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Andersen-Ranberg, Karen] Odense Univ Hosp, Dept Geriatr, DK-5000 Odense, Denmark; [McGue, Matt] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Vaupel, James W.] Max Planck Inst Demog Res, Rostock, Germany	University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Minnesota System; University of Minnesota Twin Cities; Max Planck Society	Christensen, K (corresponding author), Univ Southern Denmark, Inst Publ Hlth, Danish Aging Res Ctr, JB Winslows Vej 9B, DK-5000 Odense C, Denmark.	kchristensen@health.sdu.dk	Andersen, Mette Adalheidur/D-5608-2017; Jeune, Bernard/P-6866-2015; Andersen-Ranberg, Karen/P-7053-2015; Christensen, Kaare/C-2360-2009	Andersen-Ranberg, Karen/0000-0003-1970-7076; Christensen, Kaare/0000-0002-5429-5292; Vaupel, James/0000-0003-0783-3905; Thinggaard, Mikael/0000-0002-7029-453X; Oksuzyan, Anna/0000-0003-4138-5886	Danish National Research Foundation; US National Institutes of Health-National Institute on Aging; Danish Agency for Science, Technology and Innovation; VELUX Foundation; NATIONAL INSTITUTE ON AGING [P30AG034424, P01AG031719, P01AG008761] Funding Source: NIH RePORTER	Danish National Research Foundation(Danmarks Grundforskningsfond); US National Institutes of Health-National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Danish Agency for Science, Technology and Innovation; VELUX Foundation(Velux Fonden); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding Danish National Research Foundation; US National Institutes of Health-National Institute on Aging; Danish Agency for Science, Technology and Innovation; VELUX Foundation.	Baltes PB, 2003, GERONTOLOGY, V49, P123, DOI 10.1159/000067946; Bramell-Risberg E, 2012, CLIN INTERV AGING, V7, P195, DOI 10.2147/CIA.S31777; Christensen K, 1999, J AGING HEALTH, V11, P49, DOI 10.1177/089826439901100103; Christensen K, 2003, BEHAV GENET, V33, P125, DOI 10.1023/A:1022501817781; Christensen K, 2002, AM J EPIDEMIOL, V155, P132, DOI 10.1093/aje/155.2.132; Christensen K., 2010, INT DIFFERENCES MORT, P385; Christensen K, 2008, P NATL ACAD SCI USA, V105, P13274, DOI 10.1073/pnas.0804931105; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P75, DOI 10.1093/geronb/gbq088; Engberg H, 2008, DEMENT GERIATR COGN, V26, P153, DOI 10.1159/000149819; Engberg H, 2008, J GERONTOL A-BIOL, V63, P1186, DOI 10.1093/gerona/63.11.1186; Flynn JR, 1999, AM PSYCHOL, V54, P5, DOI 10.1037/0003-066X.54.1.5; Frederiksen H, 2006, ANN EPIDEMIOL, V16, P554, DOI 10.1016/j.annepidem.2005.10.006; Freedman VA, 2001, J GERONTOL B-PSYCHOL, V56, pS100, DOI 10.1093/geronb/56.2.S100; Gerstorf D, 2011, DEV PSYCHOL, V47, P1026, DOI 10.1037/a0023426; King DE, 2013, JAMA INTERN MED, V173, P385, DOI 10.1001/jamainternmed.2013.2006; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Manton KG, 2008, J GERONTOL B-PSYCHOL, V63, pS269, DOI 10.1093/geronb/63.5.S269; Nybo H, 2001, J AM GERIATR SOC, V49, P601, DOI 10.1046/j.1532-5415.2001.49121.x; Nybo H, 2003, J AM GERIATR SOC, V51, P1365, DOI 10.1046/j.1532-5415.2003.51453.x; Parker MG, 2005, J GERONTOL A-BIOL, V60, P1351, DOI 10.1093/gerona/60.10.1351; Rodgers WL, 2003, J GERONTOL B-PSYCHOL, V58, pS338, DOI 10.1093/geronb/58.6.S338; Sarkeala T, 2011, EUR J AGEING, V8, P87, DOI 10.1007/s10433-011-0188-2; Schaie K Warner, 2005, Res Hum Dev, V2, P43, DOI 10.1207/s15427617rhd0201&2_3; Seeman TE, 2010, AM J PUBLIC HEALTH, V100, P100, DOI 10.2105/AJPH.2008.157388; Sheffield KM, 2011, AM J EPIDEMIOL, V174, P274, DOI 10.1093/aje/kwr074; WAIDMANN T, 1995, MILBANK Q, V73, P253, DOI 10.2307/3350259; WEISSMAN MM, 1992, JAMA-J AM MED ASSOC, V268, P3098, DOI 10.1001/jama.1992.03490210080039	29	228	232	3	53	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1507	1513		10.1016/S0140-6736(13)60777-1	http://dx.doi.org/10.1016/S0140-6736(13)60777-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247MR	23849796	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000326622500028
J	Fisher, CE; Lieberman, JA				Fisher, Carl E.; Lieberman, Jeffrey A.			Getting the Facts Straight About Gun Violence and Mental Illness: Putting Compassion Before Fear	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Fisher, Carl E.; Lieberman, Jeffrey A.] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Lieberman, JA (corresponding author), Columbia Univ, New York State Psychiat Inst, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	jlieberman@nyspi.columbia.edu	Lieberman, Jeffrey/AAY-8239-2020					[Anonymous], 2012, WASHINGTON POST; Appelbaum PS, 2010, PSYCHIAT SERV, V61, P652, DOI 10.1176/ps.2010.61.7.652; Barry CL, 2013, NEW ENGL J MED, V368, P1077, DOI 10.1056/NEJMp1300512; Centers for Disease Control and Prevention, 2013, FASTSTATS A Z; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Swanson J. W., 1994, VIOLENCE MENTAL DISO, P101, DOI DOI 10.1371/JOURNAL.PMED.1000120; Swanson JW, 2011, PSYCHIAT SERV, V62, P1369, DOI 10.1176/ps.62.11.pss6211_1369; Wintemute GJ, 1999, NEW ENGL J MED, V341, P1583, DOI 10.1056/NEJM199911183412106	8	11	12	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6					423	+		10.7326/0003-4819-159-5-201309030-00679	http://dx.doi.org/10.7326/0003-4819-159-5-201309030-00679			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	234EY	23836046				2022-12-28	WOS:000325625900019
J	Aiuti, A; Biasco, L; Scaramuzza, S; Ferrua, F; Cicalese, MP; Baricordi, C; Dionisio, F; Calabria, A; Giannelli, S; Castiello, MC; Bosticardo, M; Evangelio, C; Assanelli, A; Casiraghi, M; Di Nunzio, S; Callegaro, L; Benati, C; Rizzardi, P; Pellin, D; Di Serio, C; Schmidt, M; Von Kalle, C; Gardner, J; Mehta, N; Neduva, V; Dow, DJ; Galy, A; Miniero, R; Finocchi, A; Metin, A; Banerjee, PP; Orange, JS; Galimberti, S; Valsecchi, MG; Biffi, A; Montini, E; Villa, A; Ciceri, F; Roncarolo, MG; Naldini, L				Aiuti, Alessandro; Biasco, Luca; Scaramuzza, Samantha; Ferrua, Francesca; Cicalese, Maria Pia; Baricordi, Cristina; Dionisio, Francesca; Calabria, Andrea; Giannelli, Stefania; Castiello, Maria Carmina; Bosticardo, Marita; Evangelio, Costanza; Assanelli, Andrea; Casiraghi, Miriam; Di Nunzio, Sara; Callegaro, Luciano; Benati, Claudia; Rizzardi, Paolo; Pellin, Danilo; Di Serio, Clelia; Schmidt, Manfred; Von Kalle, Christof; Gardner, Jason; Mehta, Nalini; Neduva, Victor; Dow, David J.; Galy, Anne; Miniero, Roberto; Finocchi, Andrea; Metin, Ayse; Banerjee, Pinaki P.; Orange, Jordan S.; Galimberti, Stefania; Valsecchi, Maria Grazia; Biffi, Alessandra; Montini, Eugenio; Villa, Anna; Ciceri, Fabio; Roncarolo, Maria Grazia; Naldini, Luigi			Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome	SCIENCE			English	Article							RETROVIRAL INTEGRATION SITES; SYNDROME PROTEIN; MOUSE MODEL; T-CELLS; VECTOR; TRANSPLANTATION; WASP; IMMUNODEFICIENCIES; EXPRESSION; EFFICACY	Wiskott-Aldrich syndrome (WAS) is an inherited immunodeficiency caused by mutations in the gene encoding WASP, a protein regulating the cytoskeleton. Hematopoietic stem/progenitor cell (HSPC) transplants can be curative, but, when matched donors are unavailable, infusion of autologous HSPCs modified ex vivo by gene therapy is an alternative approach. We used a lentiviral vector encoding functional WASP to genetically correct HSPCs from three WAS patients and reinfused the cells after a reduced-intensity conditioning regimen. All three patients showed stable engraftment of WASP-expressing cells and improvements in platelet counts, immune functions, and clinical scores. Vector integration analyses revealed highly polyclonal and multilineage haematopoiesis resulting from the gene-corrected HSPCs. Lentiviral gene therapy did not induce selection of integrations near oncogenes, and no aberrant clonal expansion was observed after 20 to 32 months. Although extended clinical observation is required to establish long-term safety, lentiviral gene therapy represents a promising treatment for WAS.	[Aiuti, Alessandro; Biasco, Luca; Scaramuzza, Samantha; Baricordi, Cristina; Dionisio, Francesca; Calabria, Andrea; Giannelli, Stefania; Castiello, Maria Carmina; Bosticardo, Marita; Biffi, Alessandra; Montini, Eugenio; Villa, Anna; Roncarolo, Maria Grazia; Naldini, Luigi] Ist Sci San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, San Raffaele Telethon Inst Gene Therapy HSR TIGET, I-20132 Milan, Italy; [Aiuti, Alessandro; Ferrua, Francesca; Cicalese, Maria Pia; Evangelio, Costanza; Casiraghi, Miriam; Di Nunzio, Sara; Callegaro, Luciano; Biffi, Alessandra; Roncarolo, Maria Grazia] Ist Sci San Raffaele, HSR TIGET Pediat Clin Res Unit, I-20132 Milan, Italy; [Aiuti, Alessandro; Ferrua, Francesca; Cicalese, Maria Pia; Evangelio, Costanza; Assanelli, Andrea; Valsecchi, Maria Grazia; Biffi, Alessandra] Ist Sci San Raffaele, Pediat Immunohematol & Bone Marrow Transplant Uni, I-20132 Milan, Italy; [Aiuti, Alessandro] Bambino Gesu Pediat Hosp, Univ Dept Pediat DPUO, I-00165 Rome, Italy; [Aiuti, Alessandro; Finocchi, Andrea] Tor Vergata Univ, Sch Med, I-20132 Rome, Italy; [Ferrua, Francesca; Castiello, Maria Carmina; Roncarolo, Maria Grazia] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Assanelli, Andrea] Ist Sci San Raffaele, Hematol & Bone Marrow Transplant Unit, I-20132 Milan, Italy; [Benati, Claudia; Rizzardi, Paolo] MolMed SpA, Milan, Italy; [Pellin, Danilo; Di Serio, Clelia] Univ Vita Salute San Raffaele, Univ Ctr Stat Biomed Sci CUSSB, I-20132 Milan, Italy; [Schmidt, Manfred] Deutsch Krebsforschungszentrum, Nat Zentrum Tumorerkrankungen, D-69120 Heidelberg, Germany; [Gardner, Jason] GlaxoSmithKline Res & Dev Ltd, Regenerat Med Discovery Performance Unit, King Of Prussia, PA 19406 USA; [Mehta, Nalini; Neduva, Victor; Dow, David J.] GlaxoSmithKline, Stevenage SG1 2NY, Herts, England; [Galy, Anne] UMR 951, F-91002 Evry, France; [Miniero, Roberto] Magna Graecia Univ Catanzaro, Dipartimento Sci Med Chirurg, I-88100 Catanzaro, Italy; [Metin, Ayse] Ankara Childrens Hosp, TR-06050 Ankara, Turkey; [Orange, Jordan S.] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; [Galimberti, Stefania; Valsecchi, Maria Grazia] Univ Milano Bicocca, Dipartimento Med Clin & Prevenzione, I-20126 Monza, Italy; [Villa, Anna] CNR, IRGB, I-20138 Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Bambino Gesu; University of Rome Tor Vergata; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Helmholtz Association; German Cancer Research Center (DKFZ); GlaxoSmithKline; GlaxoSmithKline; Magna Graecia University of Catanzaro; Ankara Children's Hematology Oncology Training & Research Hospital; Baylor College of Medicine; University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR)	Aiuti, A (corresponding author), Ist Sci San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, San Raffaele Telethon Inst Gene Therapy HSR TIGET, I-20132 Milan, Italy.	aiuti.alessandro@hsr.it	Bosticardo, Marita/ABA-2688-2021; Calabria, Andrea/AAA-3349-2019; Valsecchi, Maria Grazia/K-8891-2016; Castiello, Maria Carmina/K-9767-2016; Giannelli, Stefania/AAR-2316-2020; galimberti, stefania/H-2594-2012; Biffi, Alessandra/AAA-8890-2019; Montini, Eugenio/L-1152-2016; Finocchi, Andrea/K-5926-2016; Metin, Ayşe/AAS-2382-2020; Scaramuzza, Samantha/AAN-2204-2020; Ferrua, Francesca/K-4340-2016; Galy, Anne HM/J-4439-2013; Di Serio, Clelia/AAO-5494-2020; AIUTI, ALESSANDRO/K-3918-2016	Bosticardo, Marita/0000-0002-1771-4523; Calabria, Andrea/0000-0003-3515-3384; Valsecchi, Maria Grazia/0000-0001-5574-3504; Castiello, Maria Carmina/0000-0003-2581-9648; Montini, Eugenio/0000-0003-1771-6067; Finocchi, Andrea/0000-0003-0958-8536; Metin, Ayşe/0000-0002-0731-5799; Scaramuzza, Samantha/0000-0003-2903-3650; Ferrua, Francesca/0000-0002-5695-4490; Galy, Anne HM/0000-0002-0153-4392; AIUTI, ALESSANDRO/0000-0002-5398-1717; orange, jordan/0000-0001-7117-7725; Villa, Anna/0000-0003-4428-9013; GALIMBERTI, STEFANIA/0000-0003-1504-7242; DI SERIO, Mariaclelia Stefania/0000-0001-6385-6058; NALDINI, Luigi/0000-0002-7835-527X; RONCAROLO, Maria Grazia/0000-0002-2193-9186; , sara/0000-0001-7899-5966	Fondazione Telethon (TIGET); European Commission [CLINIGENE LSHB-CT2006-018933, CELL-PID HEALTH-F5-2010-261387, GA 222878 PERSIST, 249845]; Ministero della Salute (Ricerca Finalizzata) [005/RF-2009-1485896]; Ministero della Salute (Progetto Giovani Ricercatori) [GR-2007-684057]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067946] Funding Source: NIH RePORTER	Fondazione Telethon (TIGET)(Fondazione Telethon); European Commission(European CommissionEuropean Commission Joint Research Centre); Ministero della Salute (Ricerca Finalizzata)(Ministry of Health, Italy); Ministero della Salute (Progetto Giovani Ricercatori); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Fondazione Telethon (TIGET core grant to A.A., M.G.R., L.N., E.M., and A.V.); the European Commission (CLINIGENE LSHB-CT2006-018933 to M.G.R. and A.A.; CELL-PID HEALTH-F5-2010-261387 to A.A.; GA 222878 PERSIST and ERC, Advanced Grant 249845 Targeting Gene Therapy to L.N.) and Ministero della Salute (Ricerca Finalizzata, 005/RF-2009-1485896 to A.A. and A.V.; and Progetto Giovani Ricercatori GR-2007-684057 to E.M.). We thank all medical staff of the HSR-TIGET Pediatric Clinical Research Unit, Pediatric Immunohematology, and Bone Marrow Transplant Unit; R. Fiori, P. Silvani, E. Zoia, A. Mandelli, and A. Moscatelli for patient care; L. Dupre for initiating the project and conducting preclinical studies; R. Chiesa and B. Cappelli for initial contributions to the clinical trial; M. Gabaldo for support with project management; M. Bonopane and G. Tomaselli for clinical trial management; P. Massariello and other MolMed staff for patient cell manipulation; H. Ochs and L. Notarangelo for the antibody to WASP; G. Royal, L. King, and F. Govani for technical help on 454-pyrosequencing and sequence data management; J. Appleby and A. Chuang for advice and support; and F. Pasinelli for continuous support to this project. We are indebted to the patients and their families for their commitment and endurance. L.N. is an inventor of several patents on lentiviral vector technology that are owned by the Salk Institute and Cell Genesis and are licensed to Lentigen. L.N. is entitled to receive royalties from one of these patents (U.S. Patent no. 6,013,516 with Salk Institute).	Abel U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024247; Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2012, CURR OPIN IMMUNOL, V24, P585, DOI 10.1016/j.coi.2012.07.012; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Astrakhan A, 2012, BLOOD, V119, P4395, DOI 10.1182/blood-2011-03-340711; Bartholomae C., 2012, HUM GENE THER, V23, pA3; Biasco L, 2012, MOL THER, V20, P709, DOI 10.1038/mt.2011.289; Biasco L, 2011, EMBO MOL MED, V3, P89, DOI 10.1002/emmm.201000108; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Biffi A, 2011, BLOOD, V117, P5332, DOI 10.1182/blood-2010-09-306761; Bosticardo M, 2011, J ALLERGY CLIN IMMUN, V127, P1376, DOI 10.1016/j.jaci.2011.03.030; Bosticardo M, 2009, BLOOD, V113, P6288, DOI 10.1182/blood-2008-12-115253; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Bystrykh LV, 2012, NAT METHODS, V9, P567, DOI [10.1038/NMETH.2043, 10.1038/nmeth.2043]; Candotti F, 2012, BLOOD, V120, P3635, DOI 10.1182/blood-2012-02-400937; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Cattoglio C, 2010, BLOOD, V116, P5507, DOI 10.1182/blood-2010-05-283523; Catucci M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00209; Cavazzana-Calvo M, 2012, CURR OPIN IMMUNOL, V24, P580, DOI 10.1016/j.coi.2012.08.008; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chao A, 2001, J AGR BIOL ENVIR ST, V6, P158, DOI 10.1198/108571101750524670; Charrier S, 2007, GENE THER, V14, P415, DOI 10.1038/sj.gt.3302863; Corrigan-Curay J, 2012, MOL THER, V20, P1084, DOI 10.1038/mt.2012.93; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Deichmann A, 2011, MOL THER, V19, P2031, DOI 10.1038/mt.2011.178; Dupre L, 2006, HUM GENE THER, V17, P303, DOI 10.1089/hum.2006.17.303; Dupre L, 2004, MOL THER, V10, P903, DOI 10.1016/j.ymthe.2004.08.008; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002715; Gaspar HB, 2009, BLOOD, V114, P3524, DOI 10.1182/blood-2009-06-189209; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; HEO DS, 1990, CANCER RES, V50, P3681; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Maillard MH, 2007, J EXP MED, V204, P381, DOI 10.1084/jem.20061338; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; Marangoni F, 2009, MOL THER, V17, P1073, DOI 10.1038/mt.2009.31; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Moratto D, 2011, BLOOD, V118, P1675, DOI 10.1182/blood-2010-11-319376; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Notarangelo LD, 2008, CURR OPIN HEMATOL, V15, P30, DOI 10.1097/MOH.0b013e3282f30448; Ochs HD, 2009, BIOL BLOOD MARROW TR, V15, P84, DOI 10.1016/j.bbmt.2008.10.007; Orange JS, 2011, J CLIN INVEST, V121, P1535, DOI 10.1172/JCI44862; Orange JS, 2002, P NATL ACAD SCI USA, V99, P11351, DOI 10.1073/pnas.162376099; Ozsahin H, 2008, BLOOD, V111, P439, DOI 10.1182/blood-2007-03-076679; Paruzynski A, 2010, NAT PROTOC, V5, P1379, DOI 10.1038/nprot.2010.87; Sauer AV, 2012, BLOOD, V119, P1428, DOI 10.1182/blood-2011-07-366781; Scaramuzza S, 2013, MOL THER, V21, P175, DOI 10.1038/mt.2012.23; Seymour LW, 2012, NAT BIOTECHNOL, V30, P588, DOI 10.1038/nbt.2290; Shin CR, 2012, BONE MARROW TRANSPL, V47, P1428, DOI 10.1038/bmt.2012.31; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; Wada T, 2003, J CLIN INVEST, V111, P1389, DOI 10.1172/JCI200315485; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wang GP, 2010, BLOOD, V115, P4356, DOI 10.1182/blood-2009-12-257352; Westerberg LS, 2012, BLOOD, V119, P3966, DOI 10.1182/blood-2010-09-308197; Yamaguchi K, 2002, BLOOD, V100, P1208, DOI 10.1182/blood-2002-01-0211; Zhu QL, 1997, BLOOD, V90, P2680, DOI 10.1182/blood.V90.7.2680.2680_2680_2689	62	746	795	3	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					865	U71		10.1126/science.1233151	http://dx.doi.org/10.1126/science.1233151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23845947	Green Accepted, Green Published			2022-12-28	WOS:000323370600035
J	Simanshu, DK; Kamlekar, RK; Wijesinghe, DS; Zou, XQ; Zhai, XH; Mishra, SK; Molotkovsky, JG; Malinina, L; Hinchcliffe, EH; Chalfant, CE; Brown, RE; Patel, DJ				Simanshu, Dhirendra K.; Kamlekar, Ravi Kanth; Wijesinghe, Dayanjan S.; Zou, Xianqiong; Zhai, Xiuhong; Mishra, Shrawan K.; Molotkovsky, Julian G.; Malinina, Lucy; Hinchcliffe, Edward H.; Chalfant, Charles E.; Brown, Rhoderick E.; Patel, Dinshaw J.			Non-vesicular trafficking by a ceramide-1-phosphate transfer protein regulates eicosanoids	NATURE			English	Article							GLYCOLIPID TRANSFER PROTEIN; CERAMIDE KINASE; STRUCTURAL BASIS; EVOLUTION; COMPLEX; LOCALIZATION; ORGANIZATION; 1-PHOSPHATE; RECOGNITION; TRANSPORT	Phosphorylated sphingolipids ceramide-1-phosphate (C1P) and sphingosine-1-phosphate (S1P) have emerged as key regulators of cell growth, survival, migration and inflammation(1-5). C1P produced by ceramide kinase is an activator of group IVA cytosolic phospholipase A(2)alpha (cPLA(2)alpha), the rate-limiting releaser of arachidonic acid used for pro-inflammatory eicosanoid production(3,6-9), which contributes to disease pathogenesis in asthma or airway hyper-responsiveness, cancer, atherosclerosis and thrombosis. To modulate eicosanoid action and avoid the damaging effects of chronic inflammation, cells require efficient targeting, trafficking and presentation of C1P to specific cellular sites. Vesicular trafficking is likely(10) but non-vesicular mechanisms for C1P sensing, transfer and presentation remain unexplored(11,12). Moreover, the molecular basis for selective recognition and binding among signalling lipids with phosphate headgroups, namely C1P, phosphatidic acid or their lyso-derivatives, remains unclear. Here, a ubiquitously expressed lipid transfer protein, human GLTPD1, named here CPTP, is shown to specifically transfer C1P between membranes. Crystal structures establish C1P binding through a novel surface-localized, phosphate headgroup recognition centre connected to an interior hydrophobic pocket that adaptively expands to ensheath differing-length lipid chains using a cleft-like gating mechanism. The two-layer, alpha-helically-dominated 'sandwich' topology identifies CPTP as the prototype for a new glycolipid transfer protein fold(13) subfamily. CPTP resides in the cell cytosol but associates with the trans-Golgi network, nucleus and plasma membrane. RNA interference-induced CPTP depletion elevates C1P steady-state levels and alters Golgi cisternae stack morphology. The resulting C1P decrease in plasma membranes and increase in the Golgi complex stimulates cPLA(2)alpha release of arachidonic acid, triggering pro-inflammatory eicosanoid generation.	[Simanshu, Dhirendra K.; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Kamlekar, Ravi Kanth; Zou, Xianqiong; Zhai, Xiuhong; Mishra, Shrawan K.; Hinchcliffe, Edward H.; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Wijesinghe, Dayanjan S.; Chalfant, Charles E.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Molotkovsky, Julian G.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Malinina, Lucy] CIC BioGUNE, Struct Biol Unit, Derio Bilbao 48160, Spain; [Chalfant, Charles E.] Hunter Holmes McGuire Vet Adm Med Ctr, Richmond, VA 23249 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA	Memorial Sloan Kettering Cancer Center; University of Minnesota System; Virginia Commonwealth University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; CIC bioGUNE; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University	Brown, RE (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	ehinchcliffe@hi.umn.edu; cechalfant@vcu.edu; reb@umn.edu; pateld@mskcc.org	Mishra, Shrawan/N-1592-2019; Kamlekar, Ravikanth/B-9447-2009; Mishra, Shrawan K/J-7972-2013; Malinina, Lucy/B-8161-2013	Mishra, Shrawan/0000-0001-5513-9876; Kamlekar, Ravikanth/0000-0003-1627-122X; Malinina, Lucy/0000-0001-7973-1831; Simanshu, Dhirendra/0000-0002-9717-4618; Brown, Rhoderick/0000-0002-7337-3604	NIH/NCI [CA121493]; NIH/NIGMS [GM45928, GM072754]; VA Merit Award; VA Research Career Scientist Award; VA Career Devel. Award; Spanish Ministerio de Ciencia e Innovacion [BFU2010-17711]; Russian Foundation for Basic Research [12-04-00168]; Hormel Foundation; Abby Rockefeller Mauze Trust; Maloris Foundation;  [NIH/CA154314];  [NRS-T32/NIGMS 008695]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA154314, R01CA121493] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072754, R01GM045928] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010641] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001792] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); VA Merit Award(US Department of Veterans Affairs); VA Research Career Scientist Award; VA Career Devel. Award; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Hormel Foundation; Abby Rockefeller Mauze Trust; Maloris Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This research was supported by NIH/NCI CA121493 (D.J.P. & R.E.B.), NIH/NIGMS GM45928 (R.E.B.), NIH/NIGMS GM072754 (E.H.H.), NIH/CA154314 (C.E.C.), VA Merit Award (C.E.C.), VA Research Career Scientist Award (C.E.C.), VA Career Devel. Award (D.S.W.), NRS-T32/NIGMS 008695 (D.S.W.), Spanish Ministerio de Ciencia e Innovacion BFU2010-17711 (L.M.), Russian Foundation for Basic Research #12-04-00168 (J.G.M.), Hormel Foundation. (R.E.B.), Abby Rockefeller Mauze Trust (D.J.P.) and Maloris Foundation (D.J.P.). We thank H. Pike for expressing and purifying protein used for transfer activity analyses, K. Karanjeet for preparing cells for confocal and epifluorescence microscopy, and the staff of X-29 beamline at the National Synchrotron Light Source and ID-24-C/E beamlines at the Advanced Photon Source for help.	Bechler ME, 2012, TRENDS CELL BIOL, V22, P116, DOI 10.1016/j.tcb.2011.10.003; Berna A, 2009, CELL MOL LIFE SCI, V66, P2205, DOI 10.1007/s00018-009-0006-6; Blaho VA, 2009, J BIOL CHEM, V284, P21599, DOI 10.1074/jbc.M109.003822; Boath A, 2008, J BIOL CHEM, V283, P8517, DOI 10.1074/jbc.M707107200; Bornancin F, 2011, CELL SIGNAL, V23, P999, DOI 10.1016/j.cellsig.2010.11.012; Bourquin F, 2010, STRUCTURE, V18, P1054, DOI 10.1016/j.str.2010.05.011; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Durcan TM, 2008, J CELL BIOL, V181, P595, DOI 10.1083/jcb.200711160; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Galperin MY, 2012, J BIOL CHEM, V287, P21, DOI 10.1074/jbc.R111.241976; Gangoiti P, 2010, PROG LIPID RES, V49, P316, DOI 10.1016/j.plipres.2010.02.004; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Hirsch AKH, 2007, ANGEW CHEM INT EDIT, V46, P338, DOI 10.1002/anie.200603420; Hornick JE, 2011, CURR BIOL, V21, P598, DOI 10.1016/j.cub.2011.02.049; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Lamour NF, 2008, CURR DRUG TARGETS, V9, P674, DOI 10.2174/138945008785132349; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Lamour NF, 2009, J BIOL CHEM, V284, P26897, DOI 10.1074/jbc.M109.001677; Leslie CC, 2010, BIOCHIMIE, V92, P620, DOI 10.1016/j.biochi.2010.03.001; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Liberles DA, 2012, PROTEIN SCI, V21, P769, DOI 10.1002/pro.2071; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; MANDERS EMM, 1992, J CELL SCI, V103, P857; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Prinz WA, 2010, CELL, V143, P870, DOI 10.1016/j.cell.2010.11.031; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Samygina VR, 2011, STRUCTURE, V19, P1644, DOI 10.1016/j.str.2011.09.011; Wijesinghe DS, 2010, J LIPID RES, V51, P641, DOI 10.1194/jlr.D000430; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Zou XQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-72	34	130	136	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2013	500	7463					463	+		10.1038/nature12332	http://dx.doi.org/10.1038/nature12332			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23863933	Green Published, Green Accepted			2022-12-28	WOS:000323316100036
J	Geim, AK; Grigorieva, IV				Geim, A. K.; Grigorieva, I. V.			Van der Waals heterostructures	NATURE			English	Article							HEXAGONAL BORON-NITRIDE; GRAPHENE FILMS; VALLEY POLARIZATION; MONOLAYER MOS2; DIRAC FERMIONS; HIGH-QUALITY; LARGE-AREA; H-BN; GROWTH; LAYERS	Research on graphene and other two-dimensional atomic crystals is intense and is likely to remain one of the leading topics in condensed matter physics and materials science for many years. Looking beyond this field, isolated atomic planes can also be reassembled into designer heterostructures made layer by layer in a precisely chosen sequence. The first, already remarkably complex, such heterostructures (often referred to as 'van der Waals') have recently been fabricated and investigated, revealing unusual properties and new phenomena. Here we review this emerging research area and identify possible future directions. With steady improvement in fabrication techniques and using graphene's springboard, van der Waals heterostructures should develop into a large field of their own.	[Geim, A. K.; Grigorieva, I. V.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Geim, A. K.] Univ Manchester, Ctr Mesosci & Nanotechnol, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Grigorieva, IV (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England.	irina.grigorieva@man.ac.uk	Geim, Andre K/J-7888-2012	Geim, Andre K/0000-0003-2861-8331	Royal Society; European Research Council; Korber Foundation; Office of Naval Research; Air Force Office of Scientific Research; Engineering and Physical Sciences Research Council [EP/K005014/1, EP/G035954/1, EP/G02491X/1] Funding Source: researchfish; EPSRC [EP/G02491X/1, EP/K005014/1, EP/G035954/1] Funding Source: UKRI	Royal Society(Royal Society of London); European Research Council(European Research Council (ERC)European Commission); Korber Foundation; Office of Naval Research(Office of Naval Research); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank all participants of the Friday Graphene Seminar in Manchester for discussions, and R. Gorbachev and J. Chapman for help with the figures. This work was supported by the Royal Society, the European Research Council, the Korber Foundation, the Office of Naval Research and the Air Force Office of Scientific Research.	Addou R, 2013, NAT NANOTECHNOL, V8, P41, DOI [10.1038/nnano.2012.217, 10.1038/NNANO.2012.217]; Ariga K, 2012, NPG ASIA MATER, V4, DOI 10.1038/am.2012.30; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Bertolazzi S, 2013, ACS NANO, V7, P3246, DOI 10.1021/nn3059136; Bianco E, 2013, ACS NANO, V7, P4414, DOI 10.1021/nn4009406; Bjorkman T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.235502; Bresnehan MS, 2012, ACS NANO, V6, P5234, DOI 10.1021/nn300996t; Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Britnell L, 2012, NANO LETT, V12, P1707, DOI 10.1021/nl3002205; Butler SZ, 2013, ACS NANO, V7, P2898, DOI 10.1021/nn400280c; Ci L, 2010, NAT MATER, V9, P430, DOI [10.1038/nmat2711, 10.1038/NMAT2711]; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Das Sarma S, 2011, REV MOD PHYS, V83, P407, DOI 10.1103/RevModPhys.83.407; Dean C, 2012, SOLID STATE COMMUN, V152, P1275, DOI 10.1016/j.ssc.2012.04.021; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Decker R, 2011, NANO LETT, V11, P2291, DOI 10.1021/nl2005115; Eisenstein JP, 2004, NATURE, V432, P691, DOI 10.1038/nature03081; Elias DC, 2009, SCIENCE, V323, P610, DOI 10.1126/science.1167130; Fang H, 2012, NANO LETT, V12, P3788, DOI [10.1021/nl3040674, 10.1021/nl301702r]; Fleurence A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.245501; Fuhrer MS, 2013, NAT NANOTECHNOL, V8, P146, DOI 10.1038/nnano.2013.30; GAMBLE FR, 1971, SCIENCE, V174, P493, DOI 10.1126/science.174.4008.493; Garcia JM, 2012, SOLID STATE COMMUN, V152, P975, DOI 10.1016/j.ssc.2012.04.005; Geim AK, 2011, REV MOD PHYS, V83, P851, DOI 10.1103/RevModPhys.83.851; Georgiou T, 2013, NAT NANOTECHNOL, V8, P100, DOI [10.1038/NNANO.2012.224, 10.1038/nnano.2012.224]; Gorbachev RV, 2012, NAT PHYS, V8, P896, DOI [10.1038/NPHYS2441, 10.1038/nphys2441]; Gordon RA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.125407; Guinea F, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.134521; Haigh SJ, 2012, NAT MATER, V11, P764, DOI [10.1038/nmat3386, 10.1038/NMAT3386]; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Jin Z, 2011, ACS NANO, V5, P4112, DOI 10.1021/nn200766e; Kastner MA, 1998, REV MOD PHYS, V70, P897, DOI 10.1103/RevModPhys.70.897; Kim KK, 2012, NANO LETT, V12, P161, DOI 10.1021/nl203249a; Kim K, 2011, NATURE, V479, P338, DOI 10.1038/nature10680; Kim S, 2012, SOLID STATE COMMUN, V152, P1283, DOI 10.1016/j.ssc.2012.04.032; KOMA A, 1992, THIN SOLID FILMS, V216, P72, DOI 10.1016/0040-6090(92)90872-9; Kosmider K, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.075451; Kotov VN, 2012, REV MOD PHYS, V84, P1067, DOI 10.1103/RevModPhys.84.1067; Lee GH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662043; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Liu L, 2008, NANO LETT, V8, P1965, DOI 10.1021/nl0808684; Liu Z, 2011, NANO LETT, V11, P2032, DOI 10.1021/nl200464j; Lui CH, 2009, NATURE, V462, P339, DOI 10.1038/nature08569; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; Mas-Balleste R, 2011, NANOSCALE, V3, P20, DOI 10.1039/c0nr00323a; Mayorov AS, 2012, NANO LETT, V12, P4629, DOI 10.1021/nl301922d; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; McChesney JL, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.136803; Meric I, 2010, INT EL DEVICES MEET; Min HK, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.121401; Nair RR, 2012, SCIENCE, V335, P442, DOI 10.1126/science.1211694; Nair RR, 2010, SMALL, V6, P2877, DOI 10.1002/smll.201001555; Nandi D, 2012, NATURE, V488, P481, DOI 10.1038/nature11302; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Orenstein J, 2000, SCIENCE, V288, P468, DOI 10.1126/science.288.5465.468; Osada M, 2012, ADV MATER, V24, P210, DOI 10.1002/adma.201103241; Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/NNANO.2009.58, 10.1038/nnano.2009.58]; Perali A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.146803; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Ponomarenko LA, 2011, NAT PHYS, V7, P958, DOI [10.1038/nphys2114, 10.1038/NPHYS2114]; Ponomarenko LA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.206603; Profeta G, 2012, NAT PHYS, V8, P131, DOI [10.1038/NPHYS2181, 10.1038/nphys2181]; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; ROSS S, 1955, J PHYS CHEM-US, V59, P889, DOI 10.1021/j150531a020; Savini G, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.037002; Shi YM, 2012, NANO LETT, V12, P2784, DOI [10.1021/nl204562J, 10.1021/nl204562j]; Song L, 2010, NANO LETT, V10, P3209, DOI 10.1021/nl1022139; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Tanaka T, 2003, SURF REV LETT, V10, P721, DOI 10.1142/S0218625X03005529; Tonndorf P, 2013, OPT EXPRESS, V21, P4908, DOI 10.1364/OE.21.004908; Tusche C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.026102; Vogt P, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.155501; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Watanabe K, 2004, NAT MATER, V3, P404, DOI 10.1038/nmat1134; Weller TE, 2005, NAT PHYS, V1, P39, DOI 10.1038/nphys0010; Xu MS, 2013, CHEM REV, V113, P3766, DOI 10.1021/cr300263a; Yan Z, 2011, ACS NANO, V5, P8187, DOI 10.1021/nn202829y; Yang H, 2012, SCIENCE, V336, P1140, DOI 10.1126/science.1220527; Young RJ, 2012, COMPOS SCI TECHNOL, V72, P1459, DOI 10.1016/j.compscitech.2012.05.005; Yu GL, 2013, P NATL ACAD SCI USA, V110, P3282, DOI 10.1073/pnas.1300599110; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Zhao WJ, 2013, ACS NANO, V7, P791, DOI 10.1021/nn305275h; Zomer PJ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3665405	92	6865	6955	202	5184	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					419	425		10.1038/nature12385	http://dx.doi.org/10.1038/nature12385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23887427	Green Submitted			2022-12-28	WOS:000322157900029
J	Kang, JW; Kim, JH				Kang, Ju Wan; Kim, Jeong Hong			Symmetric Lipomatosis of the Tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 76-year-old woman presented with a several-year history of slow-growing masses on both lateral aspects of her tongue. She reported having no pain, dysphagia, or dysarthria. She also reported no intake of alcohol, and she was not obese (body-mass index [the weight in kilograms divided by the square of the height in meters], 23.4). The physical examination showed diffusely yellow globular masses on both lateral borders of the tongue (Panels A and B). There were no abnormal findings on the neck and superior portion of the trunk. Excisional biopsy was performed, and histologic analysis revealed mature fat tissue consistent with lipoma. Symmetric lipomatosis of the tongue (related to Madelung's disease) occurs in the Mediterranean region in adults between the ages of 30 and 60 years of age and is strongly associated with alcohol abuse. Solitary symmetric lipomatosis that develops on the tongue in Asian populations tends to occur predominantly in patients who are older than 60 years of age and who have no history of alcohol abuse or adiposity elsewhere in the body.	[Kang, Ju Wan] Yonsei Univ, Coll Med, Seoul, South Korea; [Kim, Jeong Hong] Jeju Natl Univ, Sch Med, Cheju, South Korea	Yonsei University; Yonsei University Health System; Jeju National University	Kang, JW (corresponding author), Yonsei Univ, Coll Med, Seoul, South Korea.	jeonghongkimmd@gmail.com		Kang, Ju Wan/0000-0002-6260-0680					0	6	6	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					E5	E5		10.1056/NEJMicm1303413	http://dx.doi.org/10.1056/NEJMicm1303413			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188VJ	23883389				2022-12-28	WOS:000322223900001
J	O'Regan, DP; Harden, SP; Cook, SA				O'Regan, Declan P.; Harden, Stephen P.; Cook, Stuart A.			RATIONAL IMAGING Investigating stable chest pain of suspected cardiac origin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY-ARTERY-DISEASE; COMPUTED-TOMOGRAPHY ANGIOGRAPHY; CARDIOVASCULAR MAGNETIC-RESONANCE; DIAGNOSTIC PERFORMANCE; HEART-DISEASE; CALCIFICATION; ECHOCARDIOGRAPHY; COMPLICATIONS; SEVERITY; ACCURACY		[O'Regan, Declan P.; Cook, Stuart A.] MRC Clin Sci Ctr, Robert Steiner MRI Unit, London W12 0NN, England; [Harden, Stephen P.] Univ Hosp Southampton NHS Fdn Trust, Dept Cardiothorac Radiol, Southampton, Hants, England; [Cook, Stuart A.] Natl Heart Ctr Singapore, Dept Cardiol, Singapore, Singapore	University of Southampton; University Hospital Southampton NHS Foundation Trust; National Heart Centre Singapore	O'Regan, DP (corresponding author), MRC Clin Sci Ctr, Robert Steiner MRI Unit, London W12 0NN, England.	declan.oregan@imperial.ac.uk		O'Regan, Declan/0000-0002-0691-0270; Cook, Stuart/0000-0001-6628-194X				Achenbach S, 2010, EUR HEART J, V31, P340, DOI 10.1093/eurheartj/ehp470; [Anonymous], 2010, CG95; Arbab-Zadeh A, 2012, J AM COLL CARDIOL, V59, P379, DOI 10.1016/j.jacc.2011.06.079; d'Othee BJ, 2008, EUR J RADIOL, V65, P449, DOI 10.1016/j.ejrad.2007.05.003; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Geleijnse ML, 2010, CIRCULATION, V121, P1756, DOI 10.1161/CIRCULATIONAHA.109.859264; GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87; Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4; Hamon M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-29; Jaarsma C, 2012, J AM COLL CARDIOL, V59, P1719, DOI 10.1016/j.jacc.2011.12.040; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Mulvagh SL, 2000, J AM SOC ECHOCARDIOG, V13, P331, DOI 10.1067/mje.2000.105462; Nandalur KR, 2007, J AM COLL CARDIOL, V50, P1343, DOI 10.1016/j.jacc.2007.06.030; National Institute for Health and Care Excellence, 2011, CG126; National Institute for Health and Clinical Excellence, 2010, CHEST PAIN OF RECENT; National Institute for Health and Clinical Excellence, 2012, CT750; Nilsson S, 2003, BRIT J GEN PRACT, V53, P378; Office for National Statistics, 2011, DEATHS REGISTERED IN; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Sarwar A, 2009, JACC-CARDIOVASC IMAG, V2, P675, DOI 10.1016/j.jcmg.2008.12.031; Sicari R, 2009, EUR HEART J, V30, P278, DOI 10.1093/eurheartj/ehn492; Villines TC, 2011, J AM COLL CARDIOL, V58, P2533, DOI 10.1016/j.jacc.2011.10.851; West R, 2006, HEART, V92, P810, DOI 10.1136/hrt.2005.073890; Westwood M, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17090	25	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2013	347								f3940	10.1136/bmj.f3940	http://dx.doi.org/10.1136/bmj.f3940			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192XV	23878151	Green Submitted			2022-12-28	WOS:000322522200001
J	Petersen, LR; Brault, AC; Nasci, RS				Petersen, Lyle R.; Brault, Aaron C.; Nasci, Roger S.			West Nile Virus: Review of the Literature	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							UNITED-STATES; RISK-FACTORS; NEW-YORK; ARBOVIRUS TRANSMISSION; FUNCTIONAL OUTCOMES; INFECTION; DISEASE; ENCEPHALITIS; FEVER; RNA	IMPORTANCE Since its introduction in North America in 1999, West Nile virus has produced the 3 largest arboviral neuroinvasive disease outbreaks ever recorded in the United States. OBJECTIVE To review the ecology, virology, epidemiology, clinical characteristics, diagnosis, prevention, and control of West Nile virus, with an emphasis on North America. EVIDENCE REVIEW PubMed electronic database was searched through February 5, 2013. United States national surveillance data were gathered from the Centers for Disease Control and Prevention. FINDINGS West Nile virus is now endemic throughout the contiguous United States, with 16 196 human neuroinvasive disease cases and 1549 deaths reported since 1999. More than 780 000 illnesses have likely occurred. To date, incidence is highest in the Midwest from mid-July to early September. West Nile fever develops in approximately 25% of those infected, varies greatly in clinical severity, and symptoms may be prolonged. Neuroinvasive disease (meningitis, encephalitis, acute flaccid paralysis) develops in less than 1% but carries a fatality rate of approximately 10%. Encephalitis has a highly variable clinical course but often is associated with considerable long-term morbidity. Approximately two-thirds of those with paralysis remain with significant weakness in affected limbs. Diagnosis usually rests on detection of IgM antibody in serum or cerebrospinal fluid. Treatment is supportive; no licensed human vaccine exists. Prevention uses an integrated pest management approach, which focuses on surveillance, elimination of mosquito breeding sites, and larval and adult mosquito management using pesticides to keep mosquito populations low. During outbreaks or impending outbreaks, emphasis shifts to aggressive adult mosquito control to reduce the abundance of infected, biting mosquitoes. Pesticide exposure and adverse human health events following adult mosquito control operations for West Nile virus appear negligible. CONCLUSIONS AND RELEVANCE In North America, West Nile virus has and will remain a formidable clinical and public health problem for years to come.	[Petersen, Lyle R.; Brault, Aaron C.; Nasci, Roger S.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, US Publ Hlth Serv,Dept Hlth & Human Serv, Ft Collins, CO USA	Centers for Disease Control & Prevention - USA; United States Public Health Service	Petersen, LR (corresponding author), Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.	lxp2@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Baty SA, 2012, J INFECT DIS, V205, P1476, DOI 10.1093/infdis/jis221; Beasley DWC, 2011, IMMUNOTHERAPY-UK, V3, P269, DOI 10.2217/IMT.10.93; Berg Patti J, 2010, S D Med, V63, P127; Berg PJ, 2010, S D MED, V63, P131; Bode AV, 2006, CLIN INFECT DIS, V42, P1234, DOI 10.1086/503038; Bondre VP, 2007, J GEN VIROL, V88, P875, DOI 10.1099/vir.0.82403-0; Bowden SE, 2011, AM J TROP MED HYG, V84, P234, DOI 10.4269/ajtmh.2011.10-0134; Brown JA, 2007, VECTOR-BORNE ZOONOT, V7, P479, DOI 10.1089/vbz.2006.0611; Burton JM, 2004, CAN J NEUROL SCI, V31, P185, DOI 10.1017/S0317167100053828; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; Carson PJ, 2006, CLIN INFECT DIS, V43, P723, DOI 10.1086/506939; Carson PJ, 2012, EMERG INFECT DIS, V18, P684, DOI 10.3201/eid1804.111313; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P529; Cho H, 2012, VIRUSES-BASEL, V4, P3812, DOI 10.3390/v4123812; Cook RL, 2010, AM J TROP MED HYG, V83, P1133, DOI 10.4269/ajtmh.2010.09-0717; Davis CT, 2005, VIROLOGY, V342, P252, DOI 10.1016/j.virol.2005.07.022; DeGroote JP, 2012, VECTOR-BORNE ZOONOT, V12, P657, DOI 10.1089/vbz.2011.0786; Diamond MS, 2009, ANTIVIR RES, V83, P214, DOI 10.1016/j.antiviral.2009.05.006; Duprey Z, 2008, J AM MOSQUITO CONTR, V24, P42, DOI 10.2987/5559.1; Emig M, 2004, CLIN INFECT DIS, V38, P289, DOI 10.1086/380458; Ferguson DD, 2005, CLIN INFECT DIS, V41, P1204, DOI 10.1086/444506; Freifeld AG, 2010, TRANSPL INFECT DIS, V12, P120, DOI 10.1111/j.1399-3062.2009.00464.x; Gibney KB, 2011, J INFECT DIS, V203, P344, DOI 10.1093/infdis/jiq057; Gyure KA, 2009, J NEUROPATH EXP NEUR, V68, P1053, DOI 10.1097/NEN.0b013e3181b88114; Haaland KY, 2006, EMERG INFECT DIS, V12, P1260, DOI 10.3201/eid1708.060097; Hartley DM, 2012, AM J TROP MED HYG, V86, P884, DOI 10.4269/ajtmh.2012.11-0342; Jeha LE, 2003, NEUROLOGY, V61, P55, DOI 10.1212/01.WNL.0000073617.08185.0A; Kanagarajan K, 2003, SOUTH MED J, V96, P600, DOI 10.1097/01.SMJ.0000054912.04257.DC; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Klee AL, 2004, EMERG INFECT DIS, V10, P1405, DOI 10.3201/eid1008.030879; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Kumar D, 2004, AM J TRANSPLANT, V4, P1883, DOI 10.1111/j.1600-6143.2004.00592.x; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Landesman WJ, 2007, VECTOR-BORNE ZOONOT, V7, P337, DOI 10.1089/vbz.2006.0590; Lim JK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000321; Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10; Lindsey NP, 2012, AM J TROP MED HYG, V87, P179, DOI 10.4269/ajtmh.2012.12-0113; Lindsey NP, 2012, VECTOR-BORNE ZOONOT, V12, P230, DOI 10.1089/vbz.2011.0721; Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1; Loeb M, 2008, ANN INTERN MED, V149, P232, DOI 10.7326/0003-4819-149-4-200808190-00004; Lothrop HD, 2008, VECTOR-BORNE ZOONOT, V8, P475, DOI 10.1089/vbz.2007.0238; Macedo PA, 2010, J AM MOSQUITO CONTR, V26, P57, DOI 10.2987/09-5961.1; May FJ, 2011, J VIROL, V85, P2964, DOI 10.1128/JVI.01963-10; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Murray K, 2006, EPIDEMIOL INFECT, V134, P1325, DOI 10.1017/S0950268806006339; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Nett RJ, 2012, TRANSPL INFECT DIS, V14, P268, DOI 10.1111/j.1399-3062.2012.00743.x; O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024; Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969; Pepperell C, 2003, CAN MED ASSOC J, V168, P1399; Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070; Petersen LR, 2008, MED CLIN N AM, V92, P1307, DOI 10.1016/j.mcna.2008.07.004; Reisen WK, 2008, EMERG INFECT DIS, V14, P1747, DOI 10.3201/eid1411.080719; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; Rhee C, 2011, TRANSPL INFECT DIS, V13, P312, DOI 10.1111/j.1399-3062.2010.00595.x; Robinson RL, 2003, AM J MED, V115, P252, DOI 10.1016/S0002-9343(03)00291-2; Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10; Sadek JR, 2010, J CLIN EXP NEUROPSYC, V32, P81, DOI 10.1080/13803390902881918; Sambri V, 2013, CLIN MICROBIOL INFEC; Sayao AL, 2004, CAN J NEUROL SCI, V31, P194, DOI 10.1017/S031716710005383X; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Sejvar JJ, 2011, VECTOR-BORNE ZOONOT, V11, P161, DOI 10.1089/vbz.2009.0086; Sejvar JJ, 2008, J NEUROPSYCHOL, V2, P477, DOI 10.1348/174866407X218312; Sejvar JJ, 2006, EMERG INFECT DIS, V12, P514, DOI 10.3201/eid1203.050643; Sejvar JJ, 2005, EMERG INFECT DIS, V11, P1021, DOI 10.3201/eid1107.040991; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; Soverow JE, 2009, ENVIRON HEALTH PERSP, V117, P1049, DOI 10.1289/ehp.0800487; Stokic DS, 2012, FRONT NEUROL, V3, P1; Tilley PAG, 2006, J INFECT DIS, V193, P1361, DOI 10.1086/503577; Tyler KL, 2006, NEUROLOGY, V66, P361, DOI 10.1212/01.wnl.0000195890.70898.1f; Watson JT, 2004, ANN INTERN MED, V141, P360, DOI 10.7326/0003-4819-141-5-200409070-00010; Weber IB, 2012, EPIDEMIOL INFECT, V140, P1632, DOI 10.1017/S0950268811002494; Zohrabian A, 2006, EMERG INFECT DIS, V12, P375, DOI 10.3201/eid1203.050782; Zou SMA, 2010, J INFECT DIS, V202, P1354, DOI 10.1086/656602	76	381	397	10	190	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					308	315		10.1001/jama.2013.8042	http://dx.doi.org/10.1001/jama.2013.8042			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23860989	Green Accepted			2022-12-28	WOS:000321835700018
J	Reis, JP; Loria, CM; Lewis, CE; Powell-Wiley, TM; Wei, GS; Carr, JJ; Terry, JG; Liu, K				Reis, Jared P.; Loria, Catherine M.; Lewis, Cora E.; Powell-Wiley, Tiffany M.; Wei, Gina S.; Carr, J. Jeffrey; Terry, James G.; Liu, Kiang			Association Between Duration of Overall and Abdominal Obesity Beginning in Young Adulthood and Coronary Artery Calcification in Middle Age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEPENDENT DIABETES-MELLITUS; BODY-MASS INDEX; RISK DEVELOPMENT; ADIPOSE-TISSUE; WEIGHT CHANGE; ATHEROSCLEROSIS; TRENDS; OVERWEIGHT; CALCIUM; HYPERTENSION	IMPORTANCE Younger individuals are experiencing a greater cumulative exposure to excess adiposity over their lifetime. However, few studies have determined the consequences of long-term obesity. OBJECTIVE To examine whether the duration of overall and abdominal obesity was associated with the presence and 10-year progression of coronary artery calcification (CAC), a subclinical predictor of coronary heart disease. DESIGN, SETTING, AND PARTICIPANTS Prospective study of 3275 white and black adults aged 18 to 30 years at baseline in 1985-1986 who did not initially have overall obesity (body mass index [BMI] >= 30) or abdominal obesity (men: waist circumference [WC] >102 cm; women: >88 cm) in the multicenter, community-based Coronary Artery Risk Development in Young Adults (CARDIA) study. Participants completed computed tomography scanning for the presence of CAC during the 15-, 20-, or 25-year follow-up examinations. Duration of overall and abdominal obesity was calculated using repeat measurements of BMI and WC, respectively, performed 2, 5, 7, 10, 15, 20, and 25 years after baseline. MAIN OUTCOMES AND MEASURES Presence of CAC was measured by computed tomography at the year 15 (2000-2001), year 20 (2005-2006), or year 25 (2010-2011) follow-up examinations. Ten-year progression of CAC (2000-2001 to 2010-2011) was defined as incident CAC in 2010-2011 or an increase in CAC score of 20 Agatston units or greater. RESULTS During follow-up, 40.4% and 41.0% developed overall and abdominal obesity, respectively. Rates of CAC per 1000 person-years were higher for those who experienced more than 20 years vs 0 years of overall obesity (16.0 vs 11.0, respectively) and abdominal obesity (16.7 vs 11.0). Approximately 25.2% and 27.7% of those with more than 20 years of overall and abdominal obesity, respectively, experienced progression of CAC vs 20.2% and 19.5% of those with 0 years. After adjustment for BMI or WC and potential confounders, the hazard ratios for CAC for each additional year of overall or abdominal obesity were 1.02 (95% CI, 1.01-1.03) and 1.03 (95% CI, 1.02-1.05), respectively. The adjusted odds ratios for CAC progression were 1.04 (95% CI, 1.01-1.06) and 1.04 (95% CI, 1.01-1.07), respectively. Associations were attenuated but largely persisted following additional adjustment for potential intermediate metabolic factors during follow-up. CONCLUSIONS AND RELEVANCE Longer duration of overall and abdominal obesity was associated with subclinical coronary heart disease and its progression through midlife independent of the degree of adiposity. Preventing or at least delaying the onset of obesity in young adulthood may lower the risk of developing atherosclerosis through middle age.	[Reis, Jared P.; Loria, Catherine M.; Wei, Gina S.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Lewis, Cora E.] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL USA; [Powell-Wiley, Tiffany M.] NHLBI, Cardiovasc & Pulm Branch, Bethesda, MD 20892 USA; [Powell-Wiley, Tiffany M.] NCI, Appl Res Program, Div Canc Control & Populat Studies, Bethesda, MD 20892 USA; [Carr, J. Jeffrey; Terry, James G.] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA; [Liu, Kiang] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Wake Forest University; Northwestern University; Feinberg School of Medicine	Reis, JP (corresponding author), NHLBI, Div Cardiovasc Sci, 6701 Rockledge Dr,Ste 10197, Bethesda, MD 20892 USA.	reisjp@mail.nih.gov	Carr, John Jeffrey/A-1938-2012; Carr, John/AAN-7531-2021	Carr, John Jeffrey/0000-0002-4398-8237; Carr, John/0000-0002-4398-8237; Terry, James/0000-0001-6659-3441	National Heart, Lung, and Blood Institute [N01-HC95095, N01-HC48047, N01-HC48050, N01-HC48049, N01-HC48048, R01-HL098445]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048050, N01HC048048, N01HC048047, N01HC095095, N01HC048049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098445, R01HL048048, ZIAHL006148, R29HL048048, R01HL048049, R01HL048050] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Coronary Risk Development in Young Adults Study (CARDIA) was conducted and supported by grants from the National Heart, Lung, and Blood Institute (N01-HC95095 and N01-HC48047 awarded to the University of Alabama at Birmingham; grant N01-HC48050 awarded to the Kaiser Foundation Research Institute; grant N01-HC48049 awarded to Northwestern University; N01-HC48048 awarded to the University of Minnesota; and grant R01-HL098445 awarded to Wake Forest School of Medicine). Dr Powell-Wiley is supported by the intramural research program of the National Heart, Lung, and Blood Institute.	Abdullah A, 2011, INT J EPIDEMIOL, V40, P985, DOI 10.1093/ije/dyr018; Abdullah A, 2011, PUBLIC HEALTH NUTR, V14, P119, DOI 10.1017/S1368980010001813; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Arad Y, 1996, CIRCULATION, V93, P1951, DOI 10.1161/01.CIR.93.11.1951; Avogaro A, 2005, CLIN CHIM ACTA, V360, P9, DOI 10.1016/j.cccn.2005.04.020; Carlsson S, 1998, AM J EPIDEMIOL, V148, P539, DOI 10.1093/oxfordjournals.aje.a009679; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Cassidy AE, 2005, CIRCULATION, V111, P1877, DOI 10.1161/01.CIR.0000161820.40494.5D; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Ford ES, 2011, INT J OBESITY, V35, P736, DOI 10.1038/ijo.2010.186; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hekimsoy Z, 2003, DIABETES OBES METAB, V5, P432, DOI 10.1046/j.1463-1326.2003.00298.x; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Janowitz WR, 2001, J THORAC IMAG, V16, P2, DOI 10.1097/00005382-200101000-00002; Janssen I, 2004, ANN EPIDEMIOL, V14, P585, DOI 10.1016/j.annepidem.2004.01.007; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; Lee CD, 2007, AM J CLIN NUTR, V86, P48, DOI 10.1093/ajcn/86.1.48; Little R.J.A., 2002, STAT ANAL MISSING DA; McClelland RL, 2006, CIRCULATION, V113, P30, DOI 10.1161/CIRCULATIONAHA.105.580696; MCDONALD A, 1991, J AM DIET ASSOC, V91, P1104; Mertens I, 2002, Obes Rev, V3, P85, DOI 10.1046/j.1467-789X.2002.00056.x; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pontiroli AE, 1998, ACTA DIABETOL, V35, P130, DOI 10.1007/s005920050117; Raghunathan T.E., 2001, SURV METHODOL, V27, P85; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; Reis JP, 2010, ARTERIOSCL THROM VAS, V30, P2059, DOI 10.1161/ATVBAHA.110.208280; Sakurai Y, 1999, AM J EPIDEMIOL, V149, P256; Sheehan TJ, 2003, INT J OBESITY, V27, P498, DOI 10.1038/sj.ijo.0802263; Silver AE, 2007, CIRCULATION, V115, P627, DOI 10.1161/CIRCULATIONAHA.106.657486; Solerte SB, 1997, INT J OBESITY, V21, P417, DOI 10.1038/sj.ijo.0800421; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Walls HL, 2011, OBESITY, V19, P216, DOI 10.1038/oby.2010.149; Wannamethee SG, 1999, DIABETES CARE, V22, P1266, DOI 10.2337/diacare.22.8.1266	36	121	131	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					280	288		10.1001/jama.2013.7833	http://dx.doi.org/10.1001/jama.2013.7833			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23860986	Green Accepted, Bronze			2022-12-28	WOS:000321835700015
J	Sethi, SS; Farkouh, ME				Sethi, Sanjum S.; Farkouh, Michael E.			Meta-analysis: Atorvastatin reduces CV events and increases new-onset diabetes in patients with coronary disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sethi, Sanjum S.] Icahn Sch Med Mt Sinai, New York, NY USA; [Farkouh, Michael E.] Univ Toronto, Toronto, ON, Canada	Icahn School of Medicine at Mount Sinai; University of Toronto	Sethi, SS (corresponding author), Icahn Sch Med Mt Sinai, New York, NY USA.		Sethi, Sanjum S./AAO-2601-2020	Sethi, Sanjum S./0000-0002-3438-7034				Mallinson JE, 2009, J PHYSIOL-LONDON, V587, P219, DOI 10.1113/jphysiol.2008.164699; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068	3	0	0	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2							JC3	10.7326/0003-4819-159-2-201307160-02003	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23856701				2022-12-28	WOS:000322112000002
J	Kerr, EA; Hayward, RA				Kerr, Eve A.; Hayward, Rodney A.			Patient-Centered Performance Management Enhancing Value for Patients and Health Care Systems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS; SERVICES		[Kerr, Eve A.; Hayward, Rodney A.] VA Ann Arbor Healthcare Syst, Dept Vet Affairs, Hlth Serv Res & Dev Ctr Clin Management Res, Ann Arbor, MI 48113 USA; [Kerr, Eve A.; Hayward, Rodney A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.] Univ Michigan, Robert Wood Johnson Clin Scholars Program, Ann Arbor, MI 48109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kerr, EA (corresponding author), VA Ann Arbor Healthcare Syst, VA Ctr Clin Management Res, POB 130170, Ann Arbor, MI 48113 USA.	ekerr@umich.edu	Kerr, Eve/I-3330-2013		NIDDK NIH HHS [P30 DK092926, P30DK092926] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brook RH, 2011, JAMA-J AM MED ASSOC, V306, P650, DOI 10.1001/jama.2011.1136; Fraenkel L, 2010, ARCH INTERN MED, V170, P566, DOI 10.1001/archinternmed.2010.8; Hayward RA, 2007, NEW ENGL J MED, V356, P951, DOI 10.1056/NEJMe068285; Kale MS, 2013, JAMA INTERN MED, V173, P142, DOI 10.1001/2013.jamainternmed.1022; Kent DM, 2012, JAMA-J AM MED ASSOC, V307, P1585, DOI 10.1001/jama.2012.469; Kerr EA, 2012, ARCH INTERN MED, V172, P938, DOI 10.1001/archinternmed.2012.2253; Pogach L, 2012, ARCH INTERN MED, V172, P1510, DOI 10.1001/archinternmed.2012.4392; Volpp KG, 2012, JAMA-J AM MED ASSOC, V308, P1635, DOI 10.1001/jama.2012.13616	8	49	49	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					137	138		10.1001/jama.2013.6828	http://dx.doi.org/10.1001/jama.2013.6828			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23839743	Green Accepted			2022-12-28	WOS:000321511500006
J	Bouche, N; Murphy, MT; Kacprzak, GG; Peroux, C; Contini, T; Martin, CL; Dessauges-Zavadsky, M				Bouche, N.; Murphy, M. T.; Kacprzak, G. G.; Peroux, C.; Contini, T.; Martin, C. L.; Dessauges-Zavadsky, M.			Signatures of Cool Gas Fueling a Star-Forming Galaxy at Redshift 2.3	SCIENCE			English	Article							MASS ACCRETION RATES; COLD STREAMS; HALOES; ABSORPTION; OUTFLOWS	Galaxies are thought to be fed by the continuous accretion of intergalactic gas, but direct observational evidence has been elusive. The accreted gas is expected to orbit about the galaxy's halo, delivering not just fuel for star formation but also angular momentum to the galaxy, leading to distinct kinematic signatures. We report observations showing these distinct signatures near a typical distant star-forming galaxy, where the gas is detected using a background quasar passing 26 kiloparsecs from the host. Our observations indicate that gas accretion plays a major role in galaxy growth because the estimated accretion rate is comparable to the star-formation rate.	[Bouche, N.; Contini, T.] CNRS, IRAP, F-31400 Toulouse, France; [Bouche, N.; Contini, T.] Univ Toulouse, UPS OMP, IRAP, F-31400 Toulouse, France; [Murphy, M. T.; Kacprzak, G. G.] Swinburne Univ Technol, Hawthorn, Vic 3122, Australia; [Peroux, C.] Aix Marseille Univ, CNRS, LAM, UMR 7326, F-13388 Marseille, France; [Martin, C. L.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Dessauges-Zavadsky, M.] Observ Geneva, CH-1290 Versoix, Switzerland	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Swinburne University of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; University of California System; University of California Santa Barbara; University of Geneva	Bouche, N (corresponding author), CNRS, IRAP, 14 Ave E Belin, F-31400 Toulouse, France.	nicolas.bouche@irap.omp.eu	Murphy, Michael/B-8832-2008; Contini, Thierry/AAQ-1509-2021	Murphy, Michael/0000-0002-7040-5498; Kacprzak, Glenn/0000-0003-1362-9302; Contini, Thierry/0000-0003-0275-938X; Peroux, Celine/0000-0002-4288-599X; Dessauges-Zavadsky, Miroslava/0000-0003-0348-2917	NSF [1066293, AST-1109288]; Marie Curie International Outgoing Fellowship [PIOF-GA-2009-236012]; Marie Curie International Career Integration Grant within European Community [PCIG11-GA-2012-321702]; Australian Research Council for a QEII Fellowship [DP0877998]; Discovery Project grant [DP130100568]; Direct For Mathematical & Physical Scien [1109288] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Marie Curie International Outgoing Fellowship(European Commission); Marie Curie International Career Integration Grant within European Community; Australian Research Council for a QEII Fellowship(Australian Research Council); Discovery Project grant(Australian Research Council); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the ESO Paranal staff for their continuous support and the SINFONI instrument team for their hard work, which made SINFONI a very reliable instrument. N. B. thanks S. Lilly and R. Bordoloi for stimulating discussions and S. Genel for a careful read of the manuscript. We thank I. Schroetter for his assistance in making Fig. 2. We thank the reviewers for their thorough review, comments, and suggestions. This research was based on work supported in part by NSF grant 1066293 and the hospitality of the Aspen Center for Physics. It was partly supported by a Marie Curie International Outgoing Fellowship (PIOF-GA-2009-236012) and by a Marie Curie International Career Integration Grant (PCIG11-GA-2012-321702) within the 7th European Community Framework Program. M. T. M. thanks the Australian Research Council for a QEII Fellowship (DP0877998) and Discovery Project grant DP130100568. C. L. M. is supported by NSF grant AST-1109288. The data used in this paper are tabulated in the supplementary materials and archived at http://archive.eso.org under program ID 383.A-0750 and 088.B-0715. G. G. K. is an Australian Research Council Super Science Fellow.	Birnboim Y, 2003, MON NOT R ASTRON SOC, V345, P349, DOI 10.1046/j.1365-8711.2003.06955.x; Bordoloi R, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/10; Bouche N, 2012, MON NOT R ASTRON SOC, V426, P801, DOI 10.1111/j.1365-2966.2012.21114.x; Bouche N, 2012, MON NOT R ASTRON SOC, V419, P2, DOI 10.1111/j.1365-2966.2011.19500.x; Bouche N, 2010, ASTROPHYS J, V718, P1001, DOI 10.1088/0004-637X/718/2/1001; Daddi E, 2010, ASTROPHYS J, V713, P686, DOI 10.1088/0004-637X/713/1/686; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Dutton AA, 2010, MON NOT R ASTRON SOC, V405, P1690, DOI 10.1111/j.1365-2966.2010.16620.x; Faucher-Giguere CA, 2011, MON NOT R ASTRON SOC, V417, P2982, DOI 10.1111/j.1365-2966.2011.19457.x; Fumagalli M, 2011, MON NOT R ASTRON SOC, V418, P1796, DOI 10.1111/j.1365-2966.2011.19599.x; Genel S, 2008, ASTROPHYS J, V688, P789, DOI 10.1086/592241; Genzel R, 2010, MON NOT R ASTRON SOC, V407, P2091, DOI 10.1111/j.1365-2966.2010.16969.x; Giavalisco M, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/95; Goerdt T, 2012, MON NOT R ASTRON SOC, V424, P2292, DOI 10.1111/j.1365-2966.2012.21397.x; Kacprzak GG, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/1/L7; Keres D, 2005, MON NOT R ASTRON SOC, V363, P2, DOI 10.1111/j.1365-2966.2005.09451.x; Lopez S, 2002, ASTRON ASTROPHYS, V385, P778, DOI 10.1051/0004-6361:20020181; McBride J, 2009, MON NOT R ASTRON SOC, V398, P1858, DOI 10.1111/j.1365-2966.2009.15329.x; Ribaudo J, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/207; Rubin KHR, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/2/L26; Schreiber NMF, 2009, ASTROPHYS J, V706, P1364, DOI 10.1088/0004-637X/706/2/1364; Shen SJ, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/89; Stewart KR, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/39; Stewart KR, 2011, ASTROPHYS J LETT, V735, DOI 10.1088/2041-8205/735/1/L1; Tripp TM, 2011, SCIENCE, V334, P952, DOI 10.1126/science.1209850; van de Voort F, 2011, MON NOT R ASTRON SOC, V414, P2458, DOI 10.1111/j.1365-2966.2011.18565.x; Vladilo G, 2006, ASTRON ASTROPHYS, V454, P151, DOI 10.1051/0004-6361:20054742	28	169	169	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					50	53		10.1126/science.1234209	http://dx.doi.org/10.1126/science.1234209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828935	Green Submitted			2022-12-28	WOS:000321291700043
J	Reeves, GD; Spence, HE; Henderson, MG; Morley, SK; Friedel, RHW; Funsten, HO; Baker, DN; Kanekal, SG; Blake, JB; Fennell, JF; Claudepierre, SG; Thorne, RM; Turner, DL; Kletzing, CA; Kurth, WS; Larsen, BA; Niehof, JT				Reeves, G. D.; Spence, H. E.; Henderson, M. G.; Morley, S. K.; Friedel, R. H. W.; Funsten, H. O.; Baker, D. N.; Kanekal, S. G.; Blake, J. B.; Fennell, J. F.; Claudepierre, S. G.; Thorne, R. M.; Turner, D. L.; Kletzing, C. A.; Kurth, W. S.; Larsen, B. A.; Niehof, J. T.			Electron Acceleration in the Heart of the Van Allen Radiation Belts	SCIENCE			English	Article							RELATIVISTIC ELECTRONS; ULF; ENERGIZATION; STORM; CHORUS; POWER	The Van Allen radiation belts contain ultrarelativistic electrons trapped in Earth's magnetic field. Since their discovery in 1958, a fundamental unanswered question has been how electrons can be accelerated to such high energies. Two classes of processes have been proposed: transport and acceleration of electrons from a source population located outside the radiation belts (radial acceleration) or acceleration of lower-energy electrons to relativistic energies in situ in the heart of the radiation belts (local acceleration). We report measurements from NASA's Van Allen Radiation Belt Storm Probes that clearly distinguish between the two types of acceleration. The observed radial profiles of phase space density are characteristic of local acceleration in the heart of the radiation belts and are inconsistent with a predominantly radial acceleration process.	[Reeves, G. D.; Henderson, M. G.; Morley, S. K.; Friedel, R. H. W.; Funsten, H. O.; Larsen, B. A.; Niehof, J. T.] Los Alamos Natl Lab, Space Sci & Applicat Grp, Los Alamos, NM 87545 USA; [Spence, H. E.] Univ New Hampshire, Each Inst Study Earth Oceans & Space, Durham, NH 03824 USA; [Baker, D. N.] Univ Colorado, Lab Atmospher & Space Res, Boulder, CO 80309 USA; [Kanekal, S. G.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Blake, J. B.; Fennell, J. F.; Claudepierre, S. G.] Aerosp Corp, El Segundo, CA 90245 USA; [Thorne, R. M.] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Turner, D. L.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Kletzing, C. A.; Kurth, W. S.] Univ Iowa, Dept Phys, Iowa City, IA 52242 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University System Of New Hampshire; University of New Hampshire; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Aerospace Corporation - USA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Iowa	Reeves, GD (corresponding author), Los Alamos Natl Lab, Space Sci & Applicat Grp, POB 1663, Los Alamos, NM 87545 USA.	reeves@lanl.gov	Larsen, Brian A/A-7822-2011; Turner, Drew L/G-3224-2012; Morley, Steven K/A-8321-2008; Morley, Steven/AAP-5637-2021; Kurth, William/AAA-7334-2019; Reeves, Geoffrey D/E-8101-2011; Claudepierre, Seth G/A-6109-2012; Spence, Harlan E/A-1942-2011; Funsten, Herbert O/A-5702-2015; Henderson, Michael G/A-3948-2011; Friedel, Reiner HW/D-1410-2012	Larsen, Brian A/0000-0003-4515-0208; Turner, Drew L/0000-0002-2425-7818; Morley, Steven K/0000-0001-8520-0199; Kurth, William/0000-0002-5471-6202; Reeves, Geoffrey D/0000-0002-7985-8098; Claudepierre, Seth G/0000-0001-5513-5947; Spence, Harlan E/0000-0002-2526-2205; Funsten, Herbert O/0000-0002-6817-1039; Henderson, Michael G/0000-0003-4975-9029; Friedel, Reiner HW/0000-0002-5228-0281; Kletzing, Craig/0000-0002-4136-3348	RBSP-Energetic Particle, Composition, and Thermal Plasma under NASA [NAS5-01072]	RBSP-Energetic Particle, Composition, and Thermal Plasma under NASA	This work was supported by RBSP-Energetic Particle, Composition, and Thermal Plasma funding under NASA's Prime contract no. NAS5-01072. All Van Allen Probes (RBSP) observations used in this study, along with display and analysis software, are publicly available at the Web site www.rbsp-ect.lanl.gov.	Baker DN, 2013, SCIENCE, V340, P186, DOI [10.1126/science.1233518, 10.1126/science.1231518]; Blake JB, 2013, SPACE SCI REV, V179, P383, DOI 10.1007/s11214-013-9991-8; Chen Y, 2007, NAT PHYS, V3, P614, DOI 10.1038/nphys655; Elkington SR, 2006, GEOPHYS MONOGR SER, V169, P177; FALTHAMM.CG, 1965, J GEOPHYS RES, V70, P2503, DOI 10.1029/JZ070i011p02503; Fennell JF, 2008, J ATMOS SOL-TERR PHY, V70, P1760, DOI 10.1016/j.jastp.2008.03.014; Green JC, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010153; Horne RB, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010811; Horne RB, 1998, GEOPHYS RES LETT, V25, P3011, DOI 10.1029/98GL01002; Hudson MK, 2001, GEOPH MONOG SERIES, V125, P289; Iles RHA, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011206; Kintner P. M., 2002, NASATM2002211613; Lanzerotti L. J., 1974, PARTICLE DIFFUSION R, DOI DOI 10.1007/978-3-642-65675-0; Liu WW, 1999, J GEOPHYS RES-SPACE, V104, P17391, DOI 10.1029/1999JA900168; Mathie RA, 2000, GEOPHYS RES LETT, V27, P3261, DOI 10.1029/2000GL003822; Mauk BH, 2013, SPACE SCI REV, V179, P3, DOI 10.1007/s11214-012-9908-y; Meredith NP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017698; Millan RM, 2012, SPACE SCI REV, V173, P103, DOI 10.1007/s11214-012-9941-x; O'Brien TP, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009784; Reeves GD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016513; Reeves GD, 1998, GEOPHYS RES LETT, V25, P3265, DOI 10.1029/98GL02509; Rostoker G, 1998, GEOPHYS RES LETT, V25, P3701, DOI 10.1029/98GL02801; Roth I, 1999, ANN GEOPHYS-ATM HYDR, V17, P631, DOI 10.1007/s00585-999-0631-2; Selesnick RS, 2000, J GEOPHYS RES-SPACE, V105, P2607, DOI 10.1029/1999JA900445; Selesnick RS, 1998, GEOPHYS RES LETT, V25, P2553, DOI 10.1029/98GL00665; Shprits YY, 2008, J ATMOS SOL-TERR PHY, V70, P1694, DOI 10.1016/j.jastp.2008.06.014; Summers D, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016039; Summers D, 1998, J GEOPHYS RES-SPACE, V103, P20487, DOI 10.1029/98JA01740; Tsyganenko NA, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010798; Ukhorskiy AY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024380; Walker A.D.M., 1993, PLASMA WAVES MAGNETO	31	403	406	6	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					991	994		10.1126/science.1237743	http://dx.doi.org/10.1126/science.1237743			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23887876				2022-12-28	WOS:000323652300039
J	Jiang, J; Jing, YC; Cost, GJ; Chiang, JC; Kolpa, HJ; Cotton, AM; Carone, DM; Carone, BR; Shivak, DA; Guschin, DY; Pearl, JR; Rebar, EJ; Byron, M; Gregory, PD; Brown, CJ; Urnov, FD; Hall, LL; Lawrence, JB				Jiang, Jun; Jing, Yuanchun; Cost, Gregory J.; Chiang, Jen-Chieh; Kolpa, Heather J.; Cotton, Allison M.; Carone, Dawn M.; Carone, Benjamin R.; Shivak, David A.; Guschin, Dmitry Y.; Pearl, Jocelynn R.; Rebar, Edward J.; Byron, Meg; Gregory, Philip D.; Brown, Carolyn J.; Urnov, Fyodor D.; Hall, Lisa L.; Lawrence, Jeanne B.			Translating dosage compensation to trisomy 21	NATURE			English	Article							EMBRYONIC STEM-CELLS; HUMAN XIST GENE; DNA METHYLATION; X-CHROMOSOME; INACTIVATION; RNA; EXPRESSION	Down's syndrome is a common disorder with enormous medical and social costs, caused by trisomy for chromosome 21. We tested the concept that gene imbalance across an extra chromosome can be de facto corrected by manipulating a single gene, XIST (the X-inactivation gene). Using genome editing with zinc finger nucleases, we inserted a large, inducible XIST transgene into the DYRK1A locus on chromosome 21, in Down's syndrome pluripotent stem cells. The XIST non-coding RNA coats chromosome 21 and triggers stable heterochromatin modifications, chromosome-wide transcriptional silencing and DNA methylation to form a 'chromosome 21 Barr body'. This provides a model to study human chromosome inactivation and creates a system to investigate genomic expression changes and cellular pathologies of trisomy 21, free from genetic and epigenetic noise. Notably, deficits in proliferation and neural rosette formation are rapidly reversed upon silencing one chromosome 21. Successful trisomy silencing in vitro also surmounts the major first step towards potential development of 'chromosome therapy'.	[Jiang, Jun; Jing, Yuanchun; Chiang, Jen-Chieh; Kolpa, Heather J.; Carone, Dawn M.; Carone, Benjamin R.; Byron, Meg; Hall, Lisa L.; Lawrence, Jeanne B.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA; [Cost, Gregory J.; Shivak, David A.; Guschin, Dmitry Y.; Pearl, Jocelynn R.; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci, Richmond, CA 94804 USA; [Cotton, Allison M.; Brown, Carolyn J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada	University of Massachusetts System; University of Massachusetts Worcester; Sangamo Therapeutics, Inc.; University of British Columbia	Lawrence, JB (corresponding author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, 55 Lake Ave North, Worcester, MA 01655 USA.	furnov@sangamo.com; Jeanne.Lawrence@umassmed.edu	Brown, Carolyn J/A-5159-2014; Guschin, Dmitry/U-3731-2019; Guschin, Dmitry/O-7594-2018	Brown, Carolyn J/0000-0002-8959-0101; Guschin, Dmitry/0000-0002-4184-0001; Guschin, Dmitry/0000-0002-4184-0001; Carone, Benjamin/0000-0002-9822-4218; Carone, Dawn/0000-0002-4362-6690; Cost, Gregory/0000-0002-8509-4653; Gregory, Philip/0000-0001-9249-2468; Matthews, Allison/0000-0001-8394-0337; Lawrence, Jeanne/0000-0001-6572-3128	CIHR [MOP-13680]; NIH [1F32CA154086, 2T32HD007439];  [GM053234];  [GM085548];  [GM096400 RC4]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007439] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [F32CA154086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC4GM096400, R01GM085548, R01GM053234] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We appreciate recent initiatives by administrators of NIGMS and NIH to support more high-risk, high-impact research. Research began with support from GM053234 to J.B.L. for basic X chromosome research, and was made fully possible by GM085548 and GM096400 RC4 to J.B.L. C.J.B. and A.M.C. were supported by CIHR (MOP-13680) to C.J.B. We thank T. Flotte for encouragement and advice regarding genome editing strategies, and similarly appreciate the support of S. Jones and P. Newburger. We thank T. Collingwood for initial discussions regarding this project, and the George Daley laboratory (Harvard) for the Down's syndrome iPS cell line. L. Lizotte, Z. Matijasevic, K. Smith and E. Swanson provided various assistance. M. S. Kobor and L. Lam (Kobor laboratory) assisted with methylation analysis. D.M.C. is supported by an NIH fellowship 1F32CA154086 and B.R.C. (O. Rando laboratory) is supported by NIH training grant 2T32HD007439 (G. Witman, PI).	Biancotti JC, 2010, STEM CELLS, V28, P1530, DOI 10.1002/stem.483; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Byron Meg, 2013, Curr Protoc Hum Genet, VChapter 4, DOI 10.1002/0471142905.hg0415s76; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Cotton AM, 2011, HUM GENET, V130, P187, DOI 10.1007/s00439-011-1007-8; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Gardiner KJ, 2010, TRENDS PHARMACOL SCI, V31, P66, DOI 10.1016/j.tips.2009.10.010; Guidi S, 2011, BRAIN PATHOL, V21, P361, DOI 10.1111/j.1750-3639.2010.00459.x; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hall LL, 2010, COLD SH Q B, V75, P345, DOI 10.1101/sqb.2010.75.030; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Hall LL, 2002, HUM MOL GENET, V11, P3157, DOI 10.1093/hmg/11.25.3157; Haydar TF, 2012, TRENDS NEUROSCI, V35, P81, DOI 10.1016/j.tins.2011.11.001; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Lavon N, 2008, STEM CELLS, V26, P1874, DOI 10.1634/stemcells.2008-0156; Lee B, 2011, HUM MOL GENET, V20, pR1, DOI 10.1093/hmg/ddr188; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Megarbane A, 2009, GENET MED, V11, P611, DOI 10.1097/GIM.0b013e3181b2e34c; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yahya-Graison EA, 2007, AM J HUM GENET, V81, P475, DOI 10.1086/520000	35	213	224	1	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					296	+		10.1038/nature12394	http://dx.doi.org/10.1038/nature12394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23863942	Green Submitted, Green Accepted			2022-12-28	WOS:000323112400024
J	Layton, S; Ripley, DP; Bellenger, NG				Layton, Susie; Ripley, David P.; Bellenger, Nick G.			A PATIENT'S JOURNEY Left atrial myxoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ripley, David P.; Bellenger, Nick G.] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England	University of Exeter	Ripley, DP (corresponding author), Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England.	david.ripley@nhs.net		Ripley, David/0000-0001-8460-9873					0	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2013	347								f4430	10.1136/bmj.f4430	http://dx.doi.org/10.1136/bmj.f4430			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BS	23894179	Bronze			2022-12-28	WOS:000322532500003
J	Saeidi, N; Meoli, L; Nestoridi, E; Gupta, NK; Kvas, S; Kucharczyk, J; Bonab, AA; Fischman, AJ; Yarmush, ML; Stylopoulos, N				Saeidi, Nima; Meoli, Luca; Nestoridi, Eirini; Gupta, Nitin K.; Kvas, Stephanie; Kucharczyk, John; Bonab, Ali A.; Fischman, Alan J.; Yarmush, Martin L.; Stylopoulos, Nicholas			Reprogramming of Intestinal Glucose Metabolism and Glycemic Control in Rats After Gastric Bypass	SCIENCE			English	Article							BARIATRIC SURGERY; INSULIN SENSITIVITY; MEDICAL THERAPY; TRANSPORT	The resolution of type 2 diabetes after Roux-en-Y gastric bypass (RYGB) attests to the important role of the gastrointestinal tract in glucose homeostasis. Previous studies in RYGB-treated rats have shown that the Roux limb displays hyperplasia and hypertrophy. Here, we report that the Roux limb of RYGB-treated rats exhibits reprogramming of intestinal glucose metabolism to meet its increased bioenergetic demands; glucose transporter-1 is up-regulated, basolateral glucose uptake is enhanced, aerobic glycolysis is augmented, and glucose is directed toward metabolic pathways that support tissue growth. We show that reprogramming of intestinal glucose metabolism is triggered by the exposure of the Roux limb to undigested nutrients. We demonstrate by positron emission tomography-computed tomography scanning and biodistribution analysis using 2-deoxy-2-[18F]fluoro-D-glucose that reprogramming of intestinal glucose metabolism renders the intestine a major tissue for glucose disposal, contributing to the improvement in glycemic control after RYGB.	[Saeidi, Nima; Meoli, Luca; Nestoridi, Eirini; Gupta, Nitin K.; Kvas, Stephanie; Kucharczyk, John; Stylopoulos, Nicholas] Harvard Univ, Sch Med, Ctr Basic & Translat Obes Res, Div Endocrinol,Boston Childrens Hosp, Boston, MA 02115 USA; [Saeidi, Nima; Bonab, Ali A.; Fischman, Alan J.; Yarmush, Martin L.] Shriners Hosp Children, Boston, MA 02114 USA; [Saeidi, Nima; Yarmush, Martin L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Stylopoulos, N (corresponding author), Harvard Univ, Sch Med, Ctr Basic & Translat Obes Res, Div Endocrinol,Boston Childrens Hosp, Boston, MA 02115 USA.	Nicholas.Stylopoulos@childrens.harvard.edu	Stylopoulos, Nicholas/V-1377-2019; Gupta, Nitin/A-1076-2016	Stylopoulos, Nicholas/0000-0002-5025-7854; Gupta, Nitin/0000-0002-4471-2363; Yarmush, Martin/0000-0003-4986-8444	Department of Medicine; Clinical and Translational Executive Committee at Boston Children's Hospital; National Institutes of Health (NIH) [T32DK007191, F32DK095558]; NIH [DK089503]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, T32DK007191, F32DK095558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021700] Funding Source: NIH RePORTER	Department of Medicine; Clinical and Translational Executive Committee at Boston Children's Hospital; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Li for help with tissue sectioning, G. Gorski for help with electron microscopy, M. Markle and M. Luitje for help with biodistribution analysis, and A. Moses for help with lipid analysis. This research was supported by funds from the Department of Medicine and the Clinical and Translational Executive Committee at Boston Children's Hospital (N. Stylopoulos) and grants T32DK007191 (N. K. G.) and F32DK095558 (N. Saeidi) from the National Institutes of Health (NIH). We used the core services of the Lipidomics Lab at the Nutrition Obesity Research Center of the University of Michigan (Ann Arbor, MI), which is supported by grant DK089503 from NIH.	Bradley D, 2012, J CLIN INVEST, V122, P4667, DOI 10.1172/JCI64895; Buchwald H., 2004, JAMA (Journal of the American Medical Association), V292, P1724, DOI 10.1001/jama.292.14.1724; Bueter M, 2010, GASTROENTEROLOGY, V138, P1845, DOI 10.1053/j.gastro.2009.11.012; Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082; Cummings DE, 2012, NAT MED, V18, P656, DOI 10.1038/nm.2773; Falken Y, 2011, J CLIN ENDOCR METAB, V96, P2227, DOI 10.1210/jc.2010-2876; Hayes MT, 2011, OBES SURG, V21, P759, DOI 10.1007/s11695-011-0380-7; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Isbell JM, 2010, DIABETES CARE, V33, P1438, DOI 10.2337/dc09-2107; Kucharczyk J, 2013, J SURG RES, V179, pE91, DOI 10.1016/j.jss.2012.02.036; Laferrere B, 2011, ENDOCRINE, V40, P162, DOI 10.1007/s12020-011-9514-x; le Roux CW, 2010, ANN SURG, V252, P50, DOI 10.1097/SLA.0b013e3181d3d21f; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Mumphrey MB, 2013, NEUROGASTROENT MOTIL, V25, pE70, DOI 10.1111/nmo.12034; Nestoridi E, 2012, ENDOCRINOLOGY, V153, P2234, DOI 10.1210/en.2011-2041; Pacha J, 2000, PHYSIOL REV, V80, P1633, DOI 10.1152/physrev.2000.80.4.1633; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Rodieux F, 2008, OBESITY, V16, P298, DOI 10.1038/oby.2007.83; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Spak E, 2010, HISTOPATHOLOGY, V57, P680, DOI 10.1111/j.1365-2559.2010.03677.x; Stearns AT, 2009, AM J PHYSIOL-GASTR L, V297, pG950, DOI 10.1152/ajpgi.00253.2009; Stefater MA, 2012, ENDOCR REV, V33, P595, DOI 10.1210/er.2011-1044; Taqia E, 2010, J PEDIATR SURG, V45, P987, DOI 10.1016/j.jpedsurg.2010.02.036; Thorens B, 1996, AM J PHYSIOL-GASTR L, V270, pG541, DOI 10.1152/ajpgi.1996.270.4.G541; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Wang G, 2012, OBES SURG, V22, P1263, DOI 10.1007/s11695-012-0656-6; Wilson-Perez HE, 2013, DIABETES, V62, P2380, DOI 10.2337/db12-1498; Wolff BS, 2009, AM J PHYSIOL-GASTR L, V297, pG594, DOI 10.1152/ajpgi.00104.2009	31	251	262	4	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144					406	410		10.1126/science.1235103	http://dx.doi.org/10.1126/science.1235103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888041	Green Accepted			2022-12-28	WOS:000322259200052
J	Mahato, RN; Lulf, H; Siekman, MH; Kersten, SP; Bobbert, PA; de Jong, MP; De Cola, L; van der Wiel, WG				Mahato, R. N.; Luelf, H.; Siekman, M. H.; Kersten, S. P.; Bobbert, P. A.; de Jong, M. P.; De Cola, L.; van der Wiel, W. G.			Ultrahigh Magnetoresistance at Room Temperature in Molecular Wires	SCIENCE			English	Article							CONDUCTIVITY; FILMS; ZEOLITES; CATIONS	Systems featuring large magnetoresistance (MR) at room temperature and in small magnetic fields are attractive owing to their potential for applications in magnetic field sensing and data storage. Usually, the magnetic properties of materials are exploited to achieve large MR effects. Here, we report on an exceptionally large (>2000%), room-temperature, small-field (a few millitesla) MR effect in one-dimensional, nonmagnetic systems formed by molecular wires embedded in a zeolite host crystal. This ultrahigh MR effect is ascribed to spin blockade in one-dimensional electron transport. Its generic nature offers very good perspectives to exploit the effect in a wide range of low-dimensional systems.	[Mahato, R. N.; Siekman, M. H.; de Jong, M. P.; van der Wiel, W. G.] Univ Twente, MESA Inst Nanotechnol, NanoElect Grp, NL-7500 AE Enschede, Netherlands; [Luelf, H.; De Cola, L.] Univ Strasbourg, ISIS, F-67000 Strasbourg, France; [Siekman, M. H.] Univ Twente, MESA Inst Nanotechnol, Transducers Sci & Technol Grp, NL-7500 AE Enschede, Netherlands; [Kersten, S. P.; Bobbert, P. A.] Eindhoven Univ Technol, Dept Appl Phys, NL-5600 MB Eindhoven, Netherlands; [De Cola, L.] Karlsruhe Inst Technol, Inst Nanotechnol, D-76344 Eggenstein Leopoldshafen, Germany	University of Twente; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Twente; Eindhoven University of Technology; Helmholtz Association; Karlsruhe Institute of Technology	van der Wiel, WG (corresponding author), Univ Twente, MESA Inst Nanotechnol, NanoElect Grp, POB 217, NL-7500 AE Enschede, Netherlands.	w.g.vanderwiel@utwente.nl	van der Wiel, Wilfred/F-8812-2014; De Cola, Luisa/AAO-1015-2021; Bobbert, Peter A/L-4959-2013	van der Wiel, Wilfred/0000-0002-3479-8853; De Cola, Luisa/0000-0002-2152-6517; Bobbert, Peter A/0000-0001-7780-7062	Netherlands Technology Foundation STW; European Research Council; ERC [240433, 280020, 247365]; NanoScience Europe program (NanoSci-ERA) [11003]; Foundation for Fundamental Research on Matter (FOM), Netherlands Organisation for Scientific Research (NWO)	Netherlands Technology Foundation STW(Technologiestichting STW); European Research Council(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission); NanoScience Europe program (NanoSci-ERA); Foundation for Fundamental Research on Matter (FOM), Netherlands Organisation for Scientific Research (NWO)(FOM (The Netherlands)Netherlands Organization for Scientific Research (NWO))	We thank B. Koopmans, L. Abelmann, L. P. Kouwenhoven, Y. Tokura, and S. Tarucha for fruitful discussions. We acknowledge financial support from the Netherlands Technology Foundation STW, the European Research Council, ERC Starting Grant nos. 240433 and 280020, ERC Advanced Grant no. 247365, NanoScience Europe program (NanoSci-ERA), grant no. 11003, and the Foundation for Fundamental Research on Matter (FOM), part of the Netherlands Organisation for Scientific Research (NWO). A link to the data reported here is included in the supplementary materials. R.N.M. and M. H. S. carried out the magnetoresistance experiments and performed the data analysis. H. L. performed the zeolite L crystal synthesis and molecular loading. W.G.v.d.W. conceived the experiments and planned and supervised the project. L. D. C. conceived the project together with W.G.v.d.W. and supervised the zeolite synthesis and loading. S. P. K. and P. A. B. performed the theoretical analysis and numerical simulations. M.P.d.J. contributed to planning and supervision. All authors discussed the results, provided important insights, and helped write the manuscript.	Alvaro M, 2006, CHEM MATER, V18, P26, DOI 10.1021/cm050467e; Anderson PA, 2004, DALTON T, P3122, DOI 10.1039/b402668c; Bai JW, 2010, NAT NANOTECHNOL, V5, P655, DOI [10.1038/nnano.2010.154, 10.1038/NNANO.2010.154]; BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472; Bein T, 1996, STUD SURF SCI CATAL, V102, P295; Bentmann H, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.205302; BINASCH G, 1989, PHYS REV B, V39, P4828, DOI 10.1103/PhysRevB.39.4828; Bornhauser P, 1996, J PHYS CHEM-US, V100, P2035, DOI 10.1021/jp952198t; Calzaferri G, 2003, ANGEW CHEM INT EDIT, V42, P3732, DOI 10.1002/anie.200300570; Cardin DJ, 2002, ADV MATER, V14, P553, DOI 10.1002/1521-4095(20020418)14:8<553::AID-ADMA553>3.0.CO;2-F; Desai P, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.235202; Francis TL, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/185; GONG GQ, 1995, APPL PHYS LETT, V67, P1783, DOI 10.1063/1.114382; Hanson R, 2007, REV MOD PHYS, V79, P1455, DOI 10.1103/RevModPhys.79.1455; Ikeda S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2976435; JANSEN FJ, 1973, J CHEM SOC FARAD T 1, V69, P1338, DOI 10.1039/f19736901338; JULLIERE M, 1975, PHYS LETT A, V54, P225, DOI 10.1016/0375-9601(75)90174-7; KELLY MJ, 1995, J PHYS-CONDENS MAT, V7, P5507, DOI 10.1088/0953-8984/7/28/008; Kersten SP, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.045210; Lee SK, 1999, J AM CHEM SOC, V121, P3513, DOI 10.1021/ja984188m; MOODERA JS, 1995, PHYS REV LETT, V74, P3273, DOI 10.1103/PhysRevLett.74.3273; Nardes AM, 2008, ORG ELECTRON, V9, P727, DOI 10.1016/j.orgel.2008.05.006; Ono K, 2002, SCIENCE, V297, P1313, DOI 10.1126/science.1070958; Prigodin VN, 2006, SYNTHETIC MET, V156, P757, DOI 10.1016/j.synthmet.2006.04.010; Simon U., 2003, HOST GUEST SYSTEMS B, P364; Siwach PK, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/27/273201; Tang ZK, 2001, SCIENCE, V292, P2462, DOI 10.1126/science.1060470; Wagemans W, 2011, SPIN-SINGAPORE, V1, P93, DOI 10.1142/S2010324711000082; Yue FJ, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/2/025001; Zhang YT, 2009, J MAGN MAGN MATER, V321, P1199, DOI 10.1016/j.jmmm.2008.10.030	30	78	80	1	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					257	260		10.1126/science.1237242	http://dx.doi.org/10.1126/science.1237242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23828887				2022-12-28	WOS:000321959300037
J	Karpac, J; Jasper, H				Karpac, Jason; Jasper, Heinrich			Aging: Seeking Mitonuclear Balance	CELL			English	Editorial Material							ELEGANS LIFE-SPAN; RESPIRATION; LONGEVITY		[Karpac, Jason; Jasper, Heinrich] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Jasper, H (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	hjasper@buckinstitute.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028127] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG028127] Funding Source: Medline; NIGMS NIH HHS [R01 GM100196] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011	10	10	10	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					271	273		10.1016/j.cell.2013.06.046	http://dx.doi.org/10.1016/j.cell.2013.06.046			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870118	Bronze			2022-12-28	WOS:000321950700005
J	Marshall, WF				Marshall, Wallace F.			Differential Geometry Meets the Cell	CELL			English	Editorial Material							SCALES		Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Marshall, WF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St, San Francisco, CA 94158 USA.	wallace.marshall@ucsf.edu						Almsherqi ZA, 2006, J CELL BIOL, V173, P839, DOI 10.1083/jcb.200603055; [Anonymous], 1996, ARXIVCONDMAT9605129; Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; GHIRADELLA H, 1989, J MORPHOL, V202, P69, DOI 10.1002/jmor.1052020106; Goldsmith CS, 2004, EMERG INFECT DIS, V10, P320, DOI 10.3201/eid1002.030913; Helfrich W., 1973, Z NATURFORSCH C; Michielsen K, 2008, J R SOC INTERFACE, V5, P85, DOI 10.1098/rsif.2007.1065; Mim C, 2012, TRENDS BIOCHEM SCI, V37, P526, DOI 10.1016/j.tibs.2012.09.001; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Terasaki M, 2013, CELL, V154, P285, DOI 10.1016/j.cell.2013.06.031	10	9	9	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 18	2013	154	2					265	266		10.1016/j.cell.2013.06.032	http://dx.doi.org/10.1016/j.cell.2013.06.032			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870115	Bronze			2022-12-28	WOS:000321950700002
J	Sedrakyan, A; Marinac-Dabic, D; Holmes, DR				Sedrakyan, Art; Marinac-Dabic, Danica; Holmes, David R., Jr.			The International Registry Infrastructure for Cardiovascular Device Evaluation and Surveillance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sedrakyan, Art] Cornell Univ, Weill Cornell Med Coll, Dept Publ Hlth & Cardiac Surg, New York, NY 10021 USA; [Marinac-Dabic, Danica] US FDA, Div Epidemiol, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA; [Holmes, David R., Jr.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	Cornell University; US Food & Drug Administration (FDA); Mayo Clinic	Marinac-Dabic, D (corresponding author), US FDA, Div Epidemiol, Ctr Devices & Radiol Hlth, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	danica.marinac-dabic@fda.hhs.gov		Marinac-Dabic, Danica/0000-0002-1824-0104	PHS HHS [HHSF22321110172C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 2013, FED REG; Kappetein AP, 2013, J THORAC CARDIOV SUR, V145, P6, DOI 10.1016/j.jtcvs.2012.09.002; Mack MJ, 2011, JAMA-J AM MED ASSOC, V306, P2149, DOI 10.1001/jama.2011.1675; Sedrakyan Art, 2011, J Bone Joint Surg Am, V93 Suppl 3, P76, DOI 10.2106/JBJS.K.01141; Sedrakyan Art, 2011, J Bone Joint Surg Am, V93 Suppl 3, P1, DOI 10.2106/JBJS.K.01125; US Food and Drug Administration (FDA), 2012, 2012 MEETING MATERIA; US Food and Drug Administration (FDA), MEDICAL DEVICE EPIDE; US Food and Drug Administration (FDA), NATIONAL MEDICAL DEV	8	17	17	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					257	258		10.1001/jama.2013.7133	http://dx.doi.org/10.1001/jama.2013.7133			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23860981				2022-12-28	WOS:000321835700007
J	Elley, CR				Elley, C. Raina			Review: Statins reduce mortality and major vascular events in patients with no history of CV disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							REHABILITATION; TRIALS		Univ Auckland, Auckland 1, New Zealand	University of Auckland	Elley, CR (corresponding author), Univ Auckland, Auckland 1, New Zealand.							Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Briffa TG, 2005, MED J AUSTRALIA, V183, P450, DOI 10.5694/j.1326-5377.2005.tb07121.x; Lawler PR, 2011, AM HEART J, V162, P571, DOI 10.1016/j.ahj.2011.07.017; Ward S, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11140	4	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2							JC2	10.7326/0003-4819-159-2-201307160-02002	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23856700				2022-12-28	WOS:000322112000001
J	Masoodi, NA				Masoodi, Nasseer A.			Screening for abdominal aortic aneurysm (AAA) in older men reduced AAA mortality at 13 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Florida State Univ, Coll Med, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Masoodi, NA (corresponding author), Florida State Univ, Coll Med, Tallahassee, FL 32306 USA.							Cosford PA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002945.pub2; Thompson SG, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2307	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2							JC11	10.7326/0003-4819-159-2-201307160-02011	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23856697				2022-12-28	WOS:000322112000010
J	Ray, D; Kazan, H; Cook, KB; Weirauch, MT; Najafabadi, HS; Li, X; Gueroussov, S; Albu, M; Zheng, H; Yang, A; Na, H; Irimia, M; Matzat, LH; Dale, RK; Smith, SA; Yarosh, CA; Kelly, SM; Nabet, B; Mecenas, D; Li, WM; Laishram, RS; Qiao, M; Lipshitz, HD; Piano, F; Corbett, AH; Carstens, RP; Frey, BJ; Anderson, RA; Lynch, KW; Penalva, LOF; Lei, EP; Fraser, AG; Blencowe, BJ; Morris, QD; Hughes, TR				Ray, Debashish; Kazan, Hilal; Cook, Kate B.; Weirauch, Matthew T.; Najafabadi, Hamed S.; Li, Xiao; Gueroussov, Serge; Albu, Mihai; Zheng, Hong; Yang, Ally; Na, Hong; Irimia, Manuel; Matzat, Leah H.; Dale, Ryan K.; Smith, Sarah A.; Yarosh, Christopher A.; Kelly, Seth M.; Nabet, Behnam; Mecenas, Desirea; Li, Weimin; Laishram, Rakesh S.; Qiao, Mei; Lipshitz, Howard D.; Piano, Fabio; Corbett, Anita H.; Carstens, Russ P.; Frey, Brendan J.; Anderson, Richard A.; Lynch, Kristen W.; Penalva, Luiz O. F.; Lei, Elissa P.; Fraser, Andrew G.; Blencowe, Benjamin J.; Morris, Quaid D.; Hughes, Timothy R.			A compendium of RNA-binding motifs for decoding gene regulation	NATURE			English	Article							PRE-MESSENGER-RNA; GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTORS; SPLICING REGULATOR; PROTEINS; SPECIFICITIES; RECOGNITION; REVEALS; FAMILY; CODE	RNA-binding proteins are key regulators of gene expression, yet only a small fraction have been functionally characterized. Here we report a systematic analysis of the RNA motifs recognized by RNA-binding proteins, encompassing 205 distinct genes from 24 diverse eukaryotes. The sequence specificities of RNA-binding proteins display deep evolutionary conservation, and the recognition preferences for a large fraction of metazoan RNA-binding proteins can thus be inferred from their RNA-binding domain sequence. The motifs that we identify in vitro correlate well with in vivo RNA-binding data. Moreover, we can associate them with distinct functional roles in diverse types of post-transcriptional regulation, enabling new insights into the functions of RNA-binding proteins both in normal physiology and in human disease. These data provide an unprecedented overview of RNA-binding proteins and their targets, and constitute an invaluable resource for determining post-transcriptional regulatory mechanisms in eukaryotes.	[Ray, Debashish; Weirauch, Matthew T.; Najafabadi, Hamed S.; Albu, Mihai; Zheng, Hong; Yang, Ally; Na, Hong; Irimia, Manuel; Fraser, Andrew G.; Blencowe, Benjamin J.; Morris, Quaid D.; Hughes, Timothy R.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Kazan, Hilal; Morris, Quaid D.] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 2E4, Canada; [Cook, Kate B.; Li, Xiao; Gueroussov, Serge; Lipshitz, Howard D.; Fraser, Andrew G.; Blencowe, Benjamin J.; Morris, Quaid D.; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Najafabadi, Hamed S.; Frey, Brendan J.; Morris, Quaid D.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [Matzat, Leah H.; Dale, Ryan K.; Lei, Elissa P.] NIDDK, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA; [Smith, Sarah A.; Yarosh, Christopher A.; Nabet, Behnam; Carstens, Russ P.; Lynch, Kristen W.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Kelly, Seth M.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Mecenas, Desirea; Piano, Fabio] NYU, Dept Biol, New York, NY 10003 USA; [Mecenas, Desirea; Piano, Fabio] NYU, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Li, Weimin; Laishram, Rakesh S.; Anderson, Richard A.] Univ Wisconsin, Sch Med & Publ Hlth, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA; [Qiao, Mei; Penalva, Luiz O. F.] UTHSCSA, Childrens Canc Res Inst, San Antonio, TX 78229 USA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Pennsylvania; Pennsylvania Medicine; Emory University; New York University; New York University; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Health San Antonio	Hughes, TR (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada.	quaid.morris@utoronto.ca; t.hughes@utoronto.ca	Kazan, Hilal/B-2247-2014; Irimia, Manuel/E-3040-2010; Morris, Quaid/ABE-8343-2020; Weirauch, Matthew/M-5459-2019; Corbett, Anita/AAH-6106-2021; Nabet, Behnam/AAZ-4987-2020	Irimia, Manuel/0000-0002-2179-2567; Corbett, Anita/0000-0002-0461-6895; Nabet, Behnam/0000-0002-6738-4200; Najafabadi, Hamed/0000-0003-2735-4231; Cook, Kate/0000-0002-0174-1113; Fraser, Andrew/0000-0001-9939-6014; Morris, Quaid/0000-0002-2760-6999; Dale, Ryan/0000-0003-2664-3744; Penalva, Luiz/0000-0003-4491-6769; Lipshitz, Howard/0000-0002-7372-4419; Li, Weimin/0000-0002-2170-7094; Laishram, Rakesh/0000-0003-4124-0468; Anderson, Richard/0000-0001-6265-8359	NIH [1R01HG00570, R01GM084034]; CIHR [MOP-49451, MOP-93671, MOP-125894, MOP-67011, MOP-14409]; Intramural Program of the NIDDK [DK015602-05]; NSERC Alexander Graham Bell Canada Graduate Scholarships; CIHR; CIFAR; Charles H. Best Fellowship; HFSP LT Fellowship; NATIONAL CANCER INSTITUTE [P30CA014520, R01CA104708] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061, R01GM058728, R01GM051968, R01GM084034, R01GM114386] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Intramural Program of the NIDDK; NSERC Alexander Graham Bell Canada Graduate Scholarships; CIHR(Canadian Institutes of Health Research (CIHR)); CIFAR(Canadian Institute for Advanced Research (CIFAR)); Charles H. Best Fellowship; HFSP LT Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. van Bakel for computational support, A. Ramani and J. Calarco for discussions, Y. Wu, G. Rasanathan, M. Krishnamoorthy, O. Boright, A. Janska, J. Li, S. Talukder, A. Cote and S. Votruba for technical assistance, L. Sutherland for purchasing RBM5 protein and for feedback on the manuscript, S. Jain for software modified to create Fig. 2, and N. Barbosa-Morais for generating cRPKM values from autism RNA-seq data. We thank M. Kiledjian (PCBP1 and PCBP2), J. Stevenin (SRSF2 and SFRS7), S. Richard (QKI), M. Gorospe (TIA1), B. Chabot (SRSF9), A. Berglund (MBNL1), F. Pagani (DAZAP1), A. Bindereif (HNRNPL), M. Freeman (HNRNPK), E. Miska (LIN28A), K. Kohno (YBX1), M. Garcia-Blanco (PTBP1), R. Wharton (PUM-HD), C. Smibert (Vts1p) and M. Blanchette (Hrb27C, Hrb87F and Hrb98DE) for sending published constructs. This work was supported by funding from NIH (1R01HG00570 to T. R. H. and Q. D. M., R01GM084034 to K. W. L.), CIHR (MOP-49451 to T. R. H., MOP-93671 to Q. D. M., MOP-125894 to Q. D. M. and T. R. H., MOP-67011 to B. J. B., and MOP-14409 to H. D. L.), and the Intramural Program of the NIDDK (DK015602-05 to E. P. L.). K. B. C. and S. G. hold NSERC Alexander Graham Bell Canada Graduate Scholarships. M. T. W. was funded by fellowships from CIHR and CIFAR. H. S. N. holds a Charles H. Best Fellowship and was funded partially by awards from CIFAR to T. R. H. and B. J. F. M. I. is the recipient of an HFSP LT Fellowship.	Anyanful A, 2004, J CELL BIOL, V167, P639, DOI 10.1083/jcb.200407085; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Biedermann B, 2010, CELL CYCLE, V9, P1929, DOI 10.4161/cc.9.10.11533; Blanchette M, 2009, MOL CELL, V33, P438, DOI 10.1016/j.molcel.2009.01.022; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Christensen RG, 2012, BIOINFORMATICS, V28, pI84, DOI 10.1093/bioinformatics/bts202; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; De Gaudenzi JG, 2011, ESSAYS BIOCHEM, V51, P31, DOI [10.1042/bse0510031, 10.1042/BSE0510031]; Fogel BL, 2012, HUM MOL GENET, V21, P4171, DOI 10.1093/hmg/dds240; Gabut M, 2008, CELL, V133, P192, DOI 10.1016/j.cell.2008.03.010; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Izquierdo JM, 2008, J BIOL CHEM, V283, P19077, DOI 10.1074/jbc.M800017200; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Li X, 2010, RNA, V16, P1096, DOI 10.1261/rna.2017210; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Liu JJ, 2008, BIOINFORMATICS, V24, P1850, DOI 10.1093/bioinformatics/btn331; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Markus MA, 2009, INT J BIOCHEM CELL B, V41, P740, DOI 10.1016/j.biocel.2008.05.027; Miyamoto S, 2009, GENES CELLS, V14, P1241, DOI 10.1111/j.1365-2443.2009.01347.x; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Qin XL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r63; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; Van Etten J, 2012, J BIOL CHEM, V287, P36370, DOI 10.1074/jbc.M112.373522; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	47	891	922	7	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2013	499	7457					172	177		10.1038/nature12311	http://dx.doi.org/10.1038/nature12311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23846655	Green Accepted			2022-12-28	WOS:000321557600054
J	Spence, D				Spence, Des			The power of doing nothing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2013	347								f4409	10.1136/bmj.f4409	http://dx.doi.org/10.1136/bmj.f4409			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184LT	23838464				2022-12-28	WOS:000321892000007
J	Cordes, JM				Cordes, James M.			Radio Bursts, Origin Unknown	SCIENCE			English	Editorial Material									Cornell Univ, Dept Astron, Ithaca, NY 14853 USA	Cornell University	Cordes, JM (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	jmc33@cornell.edu						Hankins TH, 2007, ASTROPHYS J, V670, P693, DOI 10.1086/522362; REES MJ, 1977, NATURE, V266, P333, DOI 10.1038/266333a0; Thornton D, 2013, SCIENCE, V341, P53, DOI 10.1126/science.1236789	3	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					40	41		10.1126/science.1240618	http://dx.doi.org/10.1126/science.1240618			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828932				2022-12-28	WOS:000321291700038
J	Jack, A				Jack, Andrew			Bring me sunshine: EU drug companies make payments to doctors public	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				Danish Health and Medicines Authority, DOCT DENT PROP PHARM; Ethical Standards in Health and Life Sciences Group, 2013, EST REG PAYM REC UK; Jack A., 2012, FINANCIAL TIMES; Jack A, 2013, FINANCIAL TIMES; Jack A, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6459; Jack Andrew, 2011, FINANC TIMES; Rosenthal MB, 2013, NEW ENGL J MED, V368, P2052, DOI 10.1056/NEJMp1305090	7	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2013	347								f4342	10.1136/bmj.f4342	http://dx.doi.org/10.1136/bmj.f4342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180DN	23833114				2022-12-28	WOS:000321573400008
J	Marchi, S; Chapman, CR; Fassett, CI; Head, JW; Bottke, WF; Strom, RG				Marchi, Simone; Chapman, Clark R.; Fassett, Caleb I.; Head, James W.; Bottke, W. F.; Strom, Robert G.			Global resurfacing of Mercury 4.0-4.1 billion years ago by heavy bombardment and volcanism	NATURE			English	Article							CRATER CHRONOLOGY; LUNAR; STRATIGRAPHY; IMPACTS; ORIGIN; MOON; AGES	The most heavily cratered terrains on Mercury have been estimated to be about 4 billion years (Gyr) old(1-4), but this was based on images of only about 45 per cent of the surface; even older regions could have existed in the unobserved portion. These terrains have a lower density of craters less than 100 km in diameter than does the Moon(1,3,5), an observation attributed to preferential resurfacing on Mercury. Here we report global crater statistics of Mercury's most heavily cratered terrains on the entire surface. Applying a recent model for early lunar crater chronology(6) and an updated dynamical extrapolation to Mercury(7), we find that the oldest surfaces were emplaced just after the start of the Late Heavy Bombardment (LHB) about 4.0-4.1 Gyr ago. Mercury's global record of large impact basins(8), which has hitherto not been dated, yields a similar surface age. This agreement implies that resurfacing was global and was due to volcanism, as previously suggested(1,5). This activity ended during the tail of the LHB, within about 300-400 million years after the emplacement of the oldest terrains on Mercury. These findings suggest that persistent volcanism could have been aided by the surge of basin-scale impacts during this bombardment.	[Marchi, Simone] NASA, Lunar Sci Inst, SW Res Inst, Boulder, CO 80302 USA; [Chapman, Clark R.; Bottke, W. F.] SW Res Inst, Boulder, CO 80302 USA; [Fassett, Caleb I.] Mt Holyoke Coll, Dept Astron, S Hadley, MA 01075 USA; [Head, James W.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Strom, Robert G.] Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA	National Aeronautics & Space Administration (NASA); Mount Holyoke College; Brown University; University of Arizona	Marchi, S (corresponding author), NASA, Lunar Sci Inst, SW Res Inst, Boulder, CO 80302 USA.	marchi@boulder.swri.edu		Fassett, Caleb/0000-0001-9155-3804	NASA Lunar Science Institute (Center for Lunar Origin and Evolution at the Southwest Research Institute in Boulder, Colorado-NASA) [NNA09DB32A]; NASA [NASW-00002, NAS5-97271]; NASA Lunar Science Institute (Center for Lunar Science and Exploration at the Lunar and Planetary Institute in Houston, Texas)	NASA Lunar Science Institute (Center for Lunar Origin and Evolution at the Southwest Research Institute in Boulder, Colorado-NASA); NASA(National Aeronautics & Space Administration (NASA)); NASA Lunar Science Institute (Center for Lunar Science and Exploration at the Lunar and Planetary Institute in Houston, Texas)	The contributions of S. M. and W. F. B. were supported by the NASA Lunar Science Institute (Center for Lunar Origin and Evolution at the Southwest Research Institute in Boulder, Colorado-NASA Grant NNA09DB32A; Center for Lunar Science and Exploration at the Lunar and Planetary Institute in Houston, Texas). S. M. is grateful for being welcomed as a collaborator with the Geology Discipline Group of MESSENGER. C.R.C.'s contribution was supported by the MESSENGER Project. The MESSENGER Project is supported by the NASA Discovery Program under contracts NASW-00002 to the Carnegie Institution of Washington and NAS5-97271 to the Johns Hopkins University Applied Physics Laboratory.	[Anonymous], 1979, ICARUS, V37, P467, DOI 10.1016/0019-1035(79)90009-5; Bottke WF, 2002, ICARUS, V156, P399, DOI 10.1006/icar.2001.6788; Bottke WF, 2012, NATURE, V485, P78, DOI 10.1038/nature10967; Elkins-Tanton LT, 2005, EARTH PLANET SC LETT, V239, P219, DOI 10.1016/j.epsl.2005.07.029; Fassett CI, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003951; Fassett CI, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047294; Fassett CI, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004154; Hartmann W.K., 1981, BASALTIC VOLCANISM T, P1049; HARTMANN WK, 1984, ICARUS, V60, P56, DOI 10.1016/0019-1035(84)90138-6; Head JW, 2011, SCIENCE, V333, P1853, DOI 10.1126/science.1211997; Hiesinger H, 2011, GEOL SOC AM SPEC PAP, V477, P1, DOI 10.1130/2011.2477(01); Ivanov BA, 2003, GEOLOGY, V31, P869, DOI 10.1130/G19669.1; Le Feuvre M, 2011, ICARUS, V214, P1, DOI 10.1016/j.icarus.2011.03.010; Leake M. A., 1982, THESIS U ARIZONA; Mainzer A, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/156; Marchi S, 2011, PLANET SPACE SCI, V59, P1968, DOI 10.1016/j.pss.2011.06.007; Marchi S, 2012, EARTH PLANET SC LETT, V325, P27, DOI 10.1016/j.epsl.2012.01.021; Marchi S, 2009, ASTRON J, V137, P4936, DOI 10.1088/0004-6256/137/6/4936; Morbidelli A, 2012, EARTH PLANET SC LETT, V355, P144, DOI 10.1016/j.epsl.2012.07.037; Neukum G, 2001, PLANET SPACE SCI, V49, P1507, DOI 10.1016/S0032-0633(01)00089-7; Neukum G., 1994, HAZARDS DUE COMETS A, P359; Shoemaker E. M., 1963, ADV ASTRONAUTICAL SC, V8, P70; Smith DE, 2010, ICARUS, V209, P88, DOI 10.1016/j.icarus.2010.04.007; Stoffler D, 2001, SPACE SCI REV, V96, P9, DOI 10.1023/A:1011937020193; Strom R. G., 1988, MERCURY, P336; Strom RG, 2005, SCIENCE, V309, P1847, DOI 10.1126/science.1113544; STROM RG, 1977, PHYS EARTH PLANET IN, V15, P156, DOI 10.1016/0031-9201(77)90028-0; Strom RG, 2008, SCIENCE, V321, P79, DOI 10.1126/science.1159317; Strom RG, 2011, PLANET SPACE SCI, V59, P1960, DOI 10.1016/j.pss.2011.03.018; Wilhelms D.E., 1987, 1348 US GEOL SURV, P302, DOI DOI 10.3133/PP1348; WILHELMS DE, 1976, ICARUS, V28, P551, DOI 10.1016/0019-1035(76)90128-7	31	118	123	0	51	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					59	61		10.1038/nature12280	http://dx.doi.org/10.1038/nature12280			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23823793				2022-12-28	WOS:000321285600032
J	Boeckxstaens, GE; Zaninotto, G; Richter, JE				Boeckxstaens, Guy E.; Zaninotto, Giovanni; Richter, Joel E.			Achalasia	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; PERORAL ENDOSCOPIC MYOTOMY; INTRASPHINCTERIC BOTULINUM-TOXIN; LAPAROSCOPIC HELLER MYOTOMY; ESOPHAGEAL PRESSURE TOPOGRAPHY; SQUAMOUS-CELL CARCINOMA; PNEUMATIC DILATION; IDIOPATHIC ACHALASIA; STEM-CELLS; DOR FUNDOPLICATION	Achalasia is a rare motility disorder of the oesophagus characterised by loss of enteric neurons leading to absence of peristalsis and impaired relaxation of the lower oesophageal sphincter. Although its cause remains largely unknown, ganglionitis resulting from an aberrant immune response triggered by a viral infection has been proposed to underlie the loss of oesophageal neurons, particularly in genetically susceptible individuals. The subsequent stasis of ingested food not only leads to symptoms of dysphagia, regurgitation, chest pain, and weight loss, but also results in an increased risk of oesophageal carcinoma. At present, pneumatic dilatation and Heller myotomy combined with an anti-reflux procedure are the treatments of choice and have comparable success rates. Per-oral endoscopic myotomy has recently been introduced as a new minimally invasive treatment for achalasia, but there have not yet been any randomised clinical trials comparing this option with pneumatic dilatation and Heller myotomy.	[Boeckxstaens, Guy E.] Catholic Univ Louvain, Dept Gastroenterol, Translat Res Ctr Gastrointestinal Disorders TARGI, Univ Hosp Leuven, B-3000 Louvain, Belgium; [Zaninotto, Giovanni] Univ Padua, Dept Surg & Gastroenterol Sci, UOC Gen Surg, Sts Giovanni & Paolo Hosp, Venice, Italy; [Richter, Joel E.] Univ S Florida, Joy McCann Culverhouse Ctr Esophageal & Swallowin, Div Digest Dis & Nutr, Morsani Coll Med, Tampa, FL USA	KU Leuven; University Hospital Leuven; Universite Catholique Louvain; ULSS 3 Serenissima; Ospedale SS Giovanni Paolo Venezia; University of Padua; State University System of Florida; University of South Florida	Boeckxstaens, GE (corresponding author), Catholic Univ Louvain, Dept Gastroenterol, Translat Res Ctr Gastrointestinal Disorders TARGI, Univ Hosp Leuven, Herestr 49, B-3000 Louvain, Belgium.	guy.boeckxstaens@med.kuleuven.be	Boeckxstaens, Guy/AAP-2502-2020	Zaninotto, Giovanni/0000-0003-0333-9491				Alahdab YO, 2012, NEUROGASTROENT MOTIL, V24, P27, DOI 10.1111/j.1365-2982.2011.01793.x; Annese V, 2000, GUT, V46, P597, DOI 10.1136/gut.46.5.597; Birgisson S, 1997, DIGEST DIS SCI, V42, P300, DOI 10.1023/A:1018805600276; Birgisson S, 2007, DIGEST DIS SCI, V52, P1855, DOI 10.1007/s10620-006-9286-y; Boeckxstaens G, 2012, NEUROGASTROENT MOTIL, V24, P27, DOI 10.1111/j.1365-2982.2011.01833.x; Boeckxstaens GE, 2005, NEUROGASTROENT MOTIL, V17, P13, DOI 10.1111/j.1365-2982.2005.00661.x; Boeckxstaens GE, 2008, AM J GASTROENTEROL, V103, P1610, DOI 10.1111/j.1572-0241.2008.01967.x; Boeckxstaens GE, 2011, NEW ENGL J MED, V364, P1807, DOI 10.1056/NEJMoa1010502; Boller D, 2009, SURG ENDOSC, V23, P2748, DOI 10.1007/s00464-009-0489-0; Booy JD, 2012, DIS ESOPHAGUS, V25, P209, DOI 10.1111/j.1442-2050.2011.01249.x; BORTOLOTTI M, 1981, GASTROENTEROLOGY, V80, P39; Bredenoord AJ, 2012, NEUROGASTROENT MOTIL, V24, P57, DOI 10.1111/j.1365-2982.2011.01834.x; Campos GM, 2009, ANN SURG, V249, P45, DOI 10.1097/SLA.0b013e31818e43ab; Carter JT, 2011, ARCH SURG-CHICAGO, V146, P1024, DOI 10.1001/archsurg.2011.214; Castagliuolo I, 2004, J GASTROINTEST SURG, V8, P24, DOI 10.1016/j.gassur.2003.10.004; Chen Z, 2010, J GASTROINTEST SURG, V14, P594, DOI 10.1007/s11605-010-1158-2; Chino O, 2000, ANTICANCER RES, V20, P3717; Chiu PWY, 2013, GASTROINTEST ENDOSC, V77, P29, DOI 10.1016/j.gie.2012.08.018; Clark SB, 2000, AM J SURG PATHOL, V24, P1153, DOI 10.1097/00000478-200008000-00014; Costamagna G, 2012, DIGEST LIVER DIS, V44, P827, DOI 10.1016/j.dld.2012.04.003; Costantini M, 2005, SURG ENDOSC, V19, P345, DOI 10.1007/s00464-004-8941-7; de Borst JM, 2003, EUR J GASTROEN HEPAT, V15, P825, DOI 10.1097/00042737-200307000-00016; de la Concha EG, 2000, TISSUE ANTIGENS, V56, P149, DOI 10.1034/j.1399-0039.2000.560206.x; de la Concha EG, 1998, TISSUE ANTIGENS, V52, P381; de la Serna JP, 2010, NEUROGASTROENT MOTIL, V22, pe218; de Leon AR, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01497.x; deOliveira JM, 1997, AM J ROENTGENOL, V169, P473, DOI 10.2214/ajr.169.2.9242756; Dor J, 1967, Presse Med, V75, P2563; Dunaway P M, 2001, Gastrointest Endosc Clin N Am, V11, P425; Duranceau A, 2012, DIS ESOPHAGUS, V25, P319, DOI 10.1111/j.1442-2050.2010.01157.x; Eckardt V F, 2001, Gastrointest Endosc Clin N Am, V11, P281; Eckardt VF, 1999, GASTROENTEROLOGY, V116, P1300, DOI 10.1016/S0016-5085(99)70493-2; ECKARDT VF, 1992, GASTROENTEROLOGY, V103, P1732, DOI 10.1016/0016-5085(92)91428-7; Eckardt VF, 1997, DIGEST DIS SCI, V42, P580, DOI 10.1023/A:1018855327960; Eckardt VF, 2001, GASTROINTEST ENDOSC, V11, pvi; El-Takli I, 2006, CAN J GASTROENTEROL, V20, P335, DOI 10.1155/2006/193823; Eldaif SM, 2009, ANN THORAC SURG, V87, P1558, DOI 10.1016/j.athoracsur.2009.02.078; Enestvedt BK, 2011, ALIMENT PHARM THER, V33, P33, DOI 10.1111/j.1365-2036.2010.04493.x; Facco M, 2008, AM J GASTROENTEROL, V103, P1598, DOI 10.1111/j.1572-0241.2008.01956.x; Farrukh A, 2008, DYSPHAGIA, V23, P161, DOI 10.1007/s00455-007-9116-1; Finley CJ, 2010, ANN THORAC SURG, V89, P392, DOI 10.1016/j.athoracsur.2009.10.046; Fisichella PM, 2008, WORLD J SURG, V32, P1974, DOI 10.1007/s00268-008-9656-z; GELFOND M, 1982, GASTROENTEROLOGY, V83, P963; Gennaro N, 2011, J GASTROINTEST SURG, V15, P423, DOI 10.1007/s11605-010-1392-7; Ghosh SK, 2007, AM J PHYSIOL-GASTR L, V293, pG878, DOI 10.1152/ajpgi.00252.2007; Ghoshal UC, 2004, AM J GASTROENTEROL, V99, P2304, DOI 10.1111/j.1572-0241.2004.40099.x; Ghoshal UC, 2001, DIS ESOPHAGUS, V14, P227, DOI 10.1046/j.1442-2050.2001.00189.x; Ghoshal UC, 2011, J NEUROGASTROENTEROL, V17, P9, DOI 10.5056/jnm.2011.17.1.9; Gockel HR, 2010, HUM GENET, V128, P353, DOI 10.1007/s00439-010-0874-8; Goldblum JR, 1996, GASTROENTEROLOGY, V111, P648, DOI 10.1053/gast.1996.v111.pm8780569; Guardino JM, 2004, J CLIN GASTROENTEROL, V38, P855, DOI 10.1097/00004836-200411000-00004; Hejazi RA, 2009, AM J MED SCI, V338, P69, DOI 10.1097/MAJ.0b013e31819b93e5; Heller E., 1914, MITT GRENZGEB MED CH, V27, P141; Herbella FAM, 2008, DIS ESOPHAGUS, V21, P461, DOI 10.1111/j.1442-2050.2008.00811.x; Hirota WK, 2006, GASTROINTEST ENDOSC, V63, P570, DOI 10.1016/j.gie.2006.02.004; HOWARD PJ, 1992, GUT, V33, P1011, DOI 10.1136/gut.33.8.1011; Hulselmans M, 2010, CLIN GASTROENTEROL H, V8, P30, DOI 10.1016/j.cgh.2009.09.020; Hungness ES, 2013, J GASTROINTEST SURG, V17, P228, DOI 10.1007/s11605-012-2030-3; Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080; Pinazo MJ, 2010, GASTROENT HEPAT-BARC, V33, P191, DOI 10.1016/j.gastrohep.2009.07.009; Johns Hopkins Medicine, SWALLOWING DISORDERS; JUSTVIERA JO, 1969, SURG GYNECOL OBSTETR, V128, P1081; KADAKIA SC, 1993, AM J GASTROENTEROL, V88, P34; Kahrilas P J, 1987, Am J Med, V82, P439; Kahrilas PJ, 2010, AM J GASTROENTEROL, V105, P981, DOI 10.1038/ajg.2010.43; Karanicolas PJ, 2007, SURG ENDOSC, V21, P1198, DOI 10.1007/s00464-007-9364-z; Katzka DA, 2011, ALIMENT PHARM THER, V34, P832, DOI 10.1111/j.1365-2036.2011.04816.x; Kulkarni S, 2011, AM J PHYSIOL-GASTR L, V301, pG644, DOI 10.1152/ajpgi.00123.2011; Kwiatek MA, 2010, GASTROINTEST ENDOSC, V72, P272, DOI 10.1016/j.gie.2010.01.069; Leeuwenburgh I, 2010, AM J GASTROENTEROL, V105, P2144, DOI 10.1038/ajg.2010.263; Leeuwenburgh I, 2010, DIS ESOPHAGUS, V23, P506, DOI 10.1111/j.1442-2050.2009.01040.x; Lehman MB, 2001, AM J SURG PATHOL, V25, P1413, DOI 10.1097/00000478-200111000-00009; Leyden JE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005046; Lin Z, 2012, NEUROGASTROENT MOTIL, V24, pe356, DOI 10.1111/j.1365-2982.2012.01952.x; Lopushinsky SR, 2006, JAMA-J AM MED ASSOC, V296, P2227, DOI 10.1001/jama.296.18.2227; Marlais M, 2011, ARCH DIS CHILD, V96, P192, DOI 10.1136/adc.2009.171975; MEIJSSEN MAC, 1992, GUT, V33, P155, DOI 10.1136/gut.33.2.155; Meneghelli UG, 2005, DYSPHAGIA, V20, P40, DOI 10.1007/s00455-004-0023-4; Metman EH, 1999, AM J GASTROENTEROL, V94, P1179, DOI 10.1111/j.1572-0241.1999.01062.x; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Mikaeli J, 2001, ALIMENT PHARM THER, V15, P1389, DOI 10.1046/j.1365-2036.2001.01065.x; Molena D, 2012, SEMIN THORAC CARDIOV, V24, P19, DOI 10.1053/j.semtcvs.2012.01.015; Moonen AJ, 2013, GASTROENTEROL CLIN N, V42, P45, DOI 10.1016/j.gtc.2012.11.009; Moses PL, 2003, GUT, V52, P629, DOI 10.1136/gut.52.5.629; Muehldorfer SM, 1999, ENDOSCOPY, V31, P517, DOI 10.1055/s-1999-56; NIWAMOTO H, 1995, DIGEST DIS SCI, V40, P859, DOI 10.1007/BF02064992; Nunez C, 2011, HUM IMMUNOL, V72, P749, DOI 10.1016/j.humimm.2011.05.017; O'Connor JB, 2002, DIGEST DIS SCI, V47, P1516, DOI 10.1023/A:1015811001267; Oelschlager BK, 2003, ARCH SURG-CHICAGO, V138, P490, DOI 10.1001/archsurg.138.5.490; Paladini F, 2009, NEUROGASTROENT MOTIL, V21, P597, DOI 10.1111/j.1365-2982.2009.01284.x; Pandolfino JE, 2008, GASTROENTEROLOGY, V135, P1526, DOI 10.1053/j.gastro.2008.07.022; PASRICHA PJ, 1995, NEW ENGL J MED, V332, P774, DOI 10.1056/NEJM199503233321203; PELLEGRINI C, 1992, ANN SURG, V216, P291, DOI 10.1097/00000658-199209000-00008; Perrone JM, 2004, SURG ENDOSC, V18, P1565, DOI 10.1007/s00464-004-8912-z; Portale G, 2005, J GASTROINTEST SURG, V9, P1332, DOI 10.1016/j.gassur.2005.10.001; Rawlings A, 2012, SURG ENDOSC, V26, P18, DOI 10.1007/s00464-011-1822-y; Rebecchi F, 2008, ANN SURG, V248, P1023, DOI 10.1097/SLA.0b013e318190a776; Richards WO, 2004, ANN SURG, V240, P403, DOI 10.1097/01.sla.0000136940.32255.51; Richter Joel E, 2008, Expert Rev Gastroenterol Hepatol, V2, P435, DOI 10.1586/17474124.2.3.435; Richter JE, 2011, GUT, V60, P869, DOI 10.1136/gut.2010.212423; Richter Joel E, 2010, J Neurogastroenterol Motil, V16, P232, DOI 10.5056/jnm.2010.16.3.232; Rohof WO, 2013, AM J GASTROENTEROL, V108, P49, DOI 10.1038/ajg.2012.318; Rohof WO, 2013, GASTROENTEROLOGY, V144, P718, DOI 10.1053/j.gastro.2012.12.027; Rohof WO, 2012, GASTROENTEROLOGY, V143, P328, DOI 10.1053/j.gastro.2012.04.048; Rohof WO, 2011, GASTROENTEROLOGY, V140, pS227; Rosemurgy AS, 2010, J AM COLL SURGEONS, V210, P637, DOI 10.1016/j.jamcollsurg.2010.01.035; Rossetti G, 2005, ANN SURG, V241, P614, DOI 10.1097/01.sla.0000157271.69192.96; Ruiz-De-Leon A, 2002, DIGEST DIS SCI, V47, P15, DOI 10.1023/A:1013242831900; Sadowski DC, 2010, NEUROGASTROENT MOTIL, V22, pe256, DOI 10.1111/j.1365-2982.2010.01511.x; Salvador R, 2010, J GASTROINTEST SURG, V14, P1635, DOI 10.1007/s11605-010-1318-4; Sasselli V, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-81; Savarino E, 2011, CLIN GASTROENTEROL H, V9, P1104, DOI 10.1016/j.cgh.2011.08.002; Schuchert MJ, 2008, ANN THORAC SURG, V85, P1729, DOI 10.1016/j.athoracsur.2007.11.017; Shaker A, 2012, NATURE, V485, P181, DOI 10.1038/485181a; Sharp KW, 2010, J AM COLL SURGEONS, V210, P645; Snyder CW, 2009, J GASTROINTEST SURG, V13, P2095, DOI 10.1007/s11605-009-1049-6; Storch WB, 1995, CELL MOL BIOL, V41, P1033; Storch WB, 2002, CELL MOL BIOL, V48, P247; STREITZ JM, 1995, ANN THORAC SURG, V59, P1604, DOI 10.1016/0003-4975(94)00997-L; Swanstrom LL, 2012, ANN SURG, V256, P659, DOI 10.1097/SLA.0b013e31826b5212; Torquati A, 2006, ANN SURG, V243, P587, DOI 10.1097/01.sla.0000216782.10502.47; TRACEY JP, 1994, AM J GASTROENTEROL, V89, P2014; TRAUBE M, 1989, AM J GASTROENTEROL, V84, P1259; TRIADAFILOPOULOS G, 1991, DIGEST DIS SCI, V36, P260, DOI 10.1007/BF01318193; Triadafilopoulos G, 2012, DIS ESOPHAGUS, V25, P337, DOI 10.1111/j.1442-2050.2011.01207.x; Vaezi MF, 1999, GUT, V44, P231, DOI 10.1136/gut.44.2.231; Vaezi MF, 2002, GUT, V50, P765, DOI 10.1136/gut.50.6.765; VANTRAPPEN G, 1971, GUT, V12, P268, DOI 10.1136/gut.12.4.268; Vanuytsel T, 2012, CLIN GASTROENTEROL H, V10, P142, DOI 10.1016/j.cgh.2011.10.032; Vela MF, 2006, CLIN GASTROENTEROL H, V4, P580, DOI 10.1016/S1542-3565(05)00986-9; Vela MF, 2004, AM J GASTROENTEROL, V99, P1029, DOI 10.1111/j.1572-0241.2004.30199.x; Verne GN, 1999, GASTROENTEROLOGY, V117, P26, DOI 10.1016/S0016-5085(99)70546-9; Villanacci V, 2010, J CLIN GASTROENTEROL, V44, P407, DOI 10.1097/MCG.0b013e3181bc9ebf; von Renteln D, 2012, AM J GASTROENTEROL, V107, P411, DOI 10.1038/ajg.2011.388; Wen ZH, 2004, COCHRANE DB SYST REV, V1; Willis 55Thomas, 1674, PHARMACEUTICE RATION, VII; WYCHULIS AR, 1971, J AMER MED ASSOC, V215, P1638, DOI 10.1001/jama.215.10.1638; Zaaijer JH, 1923, ANN SURG, V77, P615, DOI 10.1097/00000658-192305000-00014; Zaninotto G, 2004, ANN SURG, V239, P364, DOI 10.1097/01.sla.0000114217.52941.c5; Zaninotto G, 2002, ANN SURG, V235, P186, DOI 10.1097/00000658-200202000-00005; Zaninotto G, 2008, BRIT J SURG, V95, P1488, DOI 10.1002/bjs.6413; Zaninotto G, 2013, SHACKELFORDS SURGERY, P354; Zaninotto G, 2008, ANN SURG, V248, P986, DOI 10.1097/SLA.0b013e3181907bdd; Zendehdel K, 2011, AM J GASTROENTEROL, V106, P57, DOI 10.1038/ajg.2010.449; Zerbib F, 2006, AM J GASTROENTEROL, V101, P692, DOI 10.1111/j.1572-0241.2006.00385.x; Zhu Q, 2009, DIGEST SURG, V26, P493, DOI 10.1159/000229784	146	350	385	4	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					83	93		10.1016/S0140-6736(13)60651-0	http://dx.doi.org/10.1016/S0140-6736(13)60651-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SP	23871090	hybrid			2022-12-28	WOS:000329341200038
J	Belser, JA; Gustin, KM; Pearce, MB; Maines, TR; Zeng, H; Pappas, C; Sun, XJ; Carney, PJ; Villanueva, JM; Stevens, J; Katz, JM; Tumpey, TM				Belser, Jessica A.; Gustin, Kortney M.; Pearce, Melissa B.; Maines, Taronna R.; Zeng, Hui; Pappas, Claudia; Sun, Xiangjie; Carney, Paul J.; Villanueva, Julie M.; Stevens, James; Katz, Jacqueline M.; Tumpey, Terrence M.			Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice	NATURE			English	Article							H5N1 VIRUSES; INCREASED VIRULENCE; RECEPTOR-BINDING; HUMAN INFECTION; INTERFERON; TROPISM	On 29 March 2013, the Chinese Center for Disease Control and Prevention confirmed the first reported case of human infection with an avian influenza A (H7N9) virus(1). The recent human infections with H7N9 virus, totalling over 130 cases with 39 fatalities to date, have been characterized by severe pulmonary disease and acute respiratory distress syndrome (ARDS)(2). This is concerning because H7 viruses have typically been associated with ocular disease in humans, rather than severe respiratory disease(3). This recent outbreak underscores the need to better understand the pathogenesis and transmission of these viruses in mammals. Here we assess the ability of A/Anhui/1/2013 and A/Shanghai/1/2013 (H7N9) viruses, isolated from fatal human cases, to cause disease in mice and ferrets and to transmit to naive animals. Both H7N9 viruses replicated to higher titre in human airway epithelial cells and in the respiratory tract of ferrets compared to a seasonal H3N2 virus. Moreover, the H7N9 viruses showed greater infectivity and lethality in mice compared to genetically related H7N9 and H9N2 viruses. The H7N9 viruses were readily transmitted to naive ferrets through direct contact but, unlike the seasonal H3N2 virus, did not transmit readily by respiratory droplets. The lack of efficient respiratory droplet transmission was corroborated by low receptor-binding specificity for human-like alpha 2,6-linked sialosides. Our results indicate that H7N9 viruses have the capacity for efficient replication in mammals and human airway cells and highlight the need for continued public health surveillance of this emerging virus.	[Belser, Jessica A.; Gustin, Kortney M.; Pearce, Melissa B.; Maines, Taronna R.; Zeng, Hui; Pappas, Claudia; Sun, Xiangjie; Carney, Paul J.; Villanueva, Julie M.; Stevens, James; Katz, Jacqueline M.; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Tumpey, TM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	tft9@cdc.gov	Sun, Xiangjie/AAP-5409-2020; Stevens, James/GQH-1081-2022		National Institute of General Medical Sciences [GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the China CDC as part of the WHO Global Influenza Surveillance and Response System (GISRS) for facilitating access to viruses and A. Balish for preparation of viruses. The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agency. Glycan microarray slides were produced under contract for the CDC using a glycan library generously provided by the Consortium for Functional Glycomics, funded by National Institute of General Medical Sciences Grant GM62116.	Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belser JA, 2013, J VIROL, V87, P5746, DOI 10.1128/JVI.00154-13; Belser JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002569; Belser JA, 2009, J VIROL, V83, P7075, DOI 10.1128/JVI.00535-09; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Centers for Disease Control and Prevention, 2013, MMWR RECOMM REP, V62, P1; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; de Wit E, 2005, J VIROL, V79, P12401, DOI 10.1128/JVI.79.19.12401-12407.2005; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gerloff N. A, PLOS ONE IN PRESS; Hartley CA, 1997, ARCH VIROL, V142, P75, DOI 10.1007/s007050050060; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Van Hoeven N, 2009, J VIROL, V83, P2851, DOI 10.1128/JVI.02174-08; WHO, 2013, AV INFL A H7N9 VIR; WHO, 2013, REC COMP INFL VIR VA; Wu H, 2013, N ENGL J MED; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zeng H, 2013, J VIROL, V87, P2597, DOI 10.1128/JVI.02885-12; ZHU H, 2013, SCIENCE; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	28	248	266	4	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					556	+		10.1038/nature12391	http://dx.doi.org/10.1038/nature12391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	23842497	Green Published, Bronze			2022-12-28	WOS:000324826300060
J	McCarron, RM				McCarron, Robert M.			The DSM-5 and the Art of Medicine: Certainly Uncertain	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[McCarron, Robert M.] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	McCarron, RM (corresponding author), Univ Calif Davis, Dept Psychiat & Behav Sci, Med Ctr, 2230 Stockton Blvd, Sacramento, CA 95817 USA.	robert.mccarron@ucdmc.ucdavis.edu						American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychological Association, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596, 10.5771/0943-7444-2017-8-668]; Bouffard R, 2003, CAN J PSYCHIAT, V48, P546, DOI 10.1177/070674370304800806; KENDELL RE, 1971, ARCH GEN PSYCHIAT, V25, P123, DOI 10.1001/archpsyc.1971.01750140027006; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006	5	5	5	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2013	159	5					360	+		10.7326/0003-4819-159-7-201310010-00688	http://dx.doi.org/10.7326/0003-4819-159-7-201310010-00688			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215YA	23877282				2022-12-28	WOS:000324245900008
J	Kesselheim, AS; Cook-Deegan, RM; Winickoff, DE; Mello, MM				Kesselheim, Aaron S.; Cook-Deegan, Robert M.; Winickoff, David E.; Mello, Michelle M.			Gene Patenting The Supreme Court Finally Speaks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BREAST-CANCER; OVARIAN-CANCER; BRCA2		[Kesselheim, Aaron S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02114 USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Cook-Deegan, Robert M.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Cook-Deegan, Robert M.] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Winickoff, David E.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Duke University; Duke University; University of California System; University of California Berkeley	Kesselheim, AS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02114 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Mello, Michelle/0000-0003-2877-4270; Cook-Deegan, Robert/0000-0002-8251-4237	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003391] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 2012, HUMAN GENE PATENT RE; [Anonymous], 1995, U. S. Patent, Patent No. [6,124,104, 6124104]; [Anonymous], 1995, U.S. Patent, Patent No. [6,033,857, 6033857]; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Cook-Deegan R, 2013, ANN INTERN MED, V159, P298, DOI 10.7326/0003-4819-159-4-201308200-00668; Cook-Deegan R, 2012, SCIENCE, V338, P745, DOI 10.1126/science.1229854; Couch F, 1995, US Patent, Patent No. 5837492; Davies Kevin, 1996, BREAKTHROUGH RACE FI; Decker S., 2013, MYRIAD GENETICS SUES; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; GOLDGAR DE, 1994, J NATL CANCER I, V86, P200, DOI 10.1093/jnci/86.3.200; Graff GD, 2013, NAT BIOTECHNOL, V31, P404, DOI 10.1038/nbt.2568; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Kesselheim AS, 2012, NEW ENGL J MED, V366, P2338, DOI 10.1056/NEJMp1204164; Kesselheim AS, 2010, NEW ENGL J MED, V362, P1855, DOI 10.1056/NEJMp1004026; Kling J, 2005, EMBO REP, V6, P1012, DOI 10.1038/sj.embor.7400553; Kolata G., 2013, NEW YORK TIMES  0412, pA14; Langreth R, 2013, BLOOMBERG LAW   0614; Maxmen A, 2013, PERSONALIZED MED ENT; Merz JF, 2002, NATURE, V415, P577, DOI 10.1038/415577a; Park SS, 2013, BLOG RIGHTS     0613; Perkel JM, 2013, SCIENTIST; Rai AK, SCIENCE IN PRESS; United Nations Educational Scientific and Cultural Organization, 1997, UN DECL HUM GEN HUM; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Williams HL, 2013, J POLIT ECON, V121, P1, DOI 10.1086/669706; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Wooster R, 1996, NATURE, V379, P749, DOI 10.1038/379749a0	28	34	35	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2013	369	9					869	875		10.1056/NEJMhle1308199	http://dx.doi.org/10.1056/NEJMhle1308199			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	208KB	23841703	Green Accepted			2022-12-28	WOS:000323676100016
J	Esserman, LJ; Thompson, IM; Reid, B				Esserman, Laura J.; Thompson, Ian M., Jr.; Reid, Brian			Overdiagnosis and Overtreatment in Cancer An Opportunity for Improvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BREAST-CANCER; MORTALITY		[Esserman, Laura J.] Univ Calif San Francisco, San Francisco, CA 94115 USA; [Thompson, Ian M., Jr.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Reid, Brian] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio; Fred Hutchinson Cancer Center	Esserman, LJ (corresponding author), Univ Calif San Francisco, Mt Zion Carol Franc Buck Breast Care Ctr, 1600 Divisadero St,POB 1710, San Francisco, CA 94115 USA.	laura.esserman@ucsfmedctr.org						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Committee on a Framework for Development of a New Taxonomy of Disease; National Research Council, 2011, TOWARD PRECISION MED; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Howlader N., 2013, SEER CANCER STATISTI; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099	8	355	364	2	47	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					797	798		10.1001/jama.2013.108415	http://dx.doi.org/10.1001/jama.2013.108415			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23896967				2022-12-28	WOS:000323561400016
J	Morain, S; Greene, MF; Mello, MM				Morain, Stephanie; Greene, Michael F.; Mello, Michelle M.			A New Era in Noninvasive Prenatal Testing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Morain, Stephanie] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA; [Greene, Michael F.] Massachusetts Gen Hosp, Vincent Dept Obstet & Gynecol, Boston, MA 02114 USA; [Greene, Michael F.] Harvard Univ, Sch Med, Boston, MA USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Morain, S (corresponding author), Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA.			Morain, Stephanie/0000-0001-7278-7517; Mello, Michelle/0000-0003-2877-4270				Lindsay R, 2013, BARCL CAP 2013 GLOB; Nicolaides KH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.033; Norton ME, 2013, OBSTET GYNECOL, V121, P847, DOI 10.1097/AOG.0b013e31828642c6; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Weiss RL, 2012, AM J CLIN PATHOL, V138, P20, DOI 10.1309/AJCP6OAULC3CMFEJ	5	68	74	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					499	501		10.1056/NEJMp1304843	http://dx.doi.org/10.1056/NEJMp1304843			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	197HX	23862975				2022-12-28	WOS:000322842000003
J	Basch, E				Basch, Ethan			Toward Patient-Centered Drug Development in Oncology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Basch, Ethan] Univ N Carolina, Sch Med, Canc Outcomes Res Program, Chapel Hill, NC 27599 USA; [Basch, Ethan] Univ N Carolina, Sch Publ Hlth, Canc Outcomes Res Program, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Basch, E (corresponding author), Univ N Carolina, Sch Med, Canc Outcomes Res Program, Chapel Hill, NC 27599 USA.							Basch E, 2012, JAMA-J AM MED ASSOC, V307, P1636, DOI 10.1001/jama.2012.466; Brundage M, 2011, QUAL LIFE RES, V20, P653, DOI 10.1007/s11136-010-9793-3; Food and Drug Administration, 2009, GUID IND PAT REP OUT; Gnanasakthy A, 2012, VALUE HEALTH, V15, P437, DOI 10.1016/j.jval.2011.11.032; Harrison PL, 2012, POPUL HEALTH MANAG, V15, P325, DOI 10.1089/pop.2011.0089	5	89	89	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					397	400		10.1056/NEJMp1114649	http://dx.doi.org/10.1056/NEJMp1114649			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193GQ	23822654	Green Published			2022-12-28	WOS:000322547400002
J	Ghofrani, HA; D'Armini, AM; Grimminger, F; Hoeper, MM; Jansa, P; Kim, NH; Mayer, E; Simonneau, G; Wilkins, MR; Fritsch, A; Neuser, D; Weimann, G; Wang, C				Ghofrani, Hossein-Ardeschir; D'Armini, Andrea M.; Grimminger, Friedrich; Hoeper, Marius M.; Jansa, Pavel; Kim, Nick H.; Mayer, Eckhard; Simonneau, Gerald; Wilkins, Martin R.; Fritsch, Arno; Neuser, Dieter; Weimann, Gerrit; Wang, Chen			Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOLUBLE GUANYLATE-CYCLASE; TERM-FOLLOW-UP; ARTERIAL-HYPERTENSION; ENDARTERECTOMY; BOSENTAN; OUTCOMES; THERAPY	BACKGROUND Riociguat, a member of a new class of compounds (soluble guanylate cyclase stimulators), has been shown in previous clinical studies to be beneficial in the treatment of chronic thromboembolic pulmonary hypertension. METHODS In this phase 3, multicenter, randomized, double-blind, placebo-controlled study, we randomly assigned 261 patients with inoperable chronic thromboembolic pulmonary hypertension or persistent or recurrent pulmonary hypertension after pulmonary endarterectomy to receive placebo or riociguat. The primary end point was the change from baseline to the end of week 16 in the distance walked in 6 minutes. Secondary end points included changes from baseline in pulmonary vascular resistance, N-terminal pro-brain natriuretic peptide (NT-proBNP) level, World Health Organization (WHO) functional class, time to clinical worsening, Borg dyspnea score, quality-of-life variables, and safety. RESULTS By week 16, the 6-minute walk distance had increased by a mean of 39 m in the riociguat group, as compared with a mean decrease of 6 m in the placebo group (least-squares mean difference, 46 m; 95% confidence interval [CI], 25 to 67; P<0.001). Pulmonary vascular resistance decreased by 226 dynseccm(-5) in the riociguat group and increased by 23 dynseccm(-5) in the placebo group (least-squares mean difference, -246 dynseccm(-5); 95% CI, -303 to -190; P<0.001). Riociguat was also associated with significant improvements in the NT-proBNP level (P<0.001) and WHO functional class (P=0.003). The most common serious adverse events were right ventricular failure (in 3% of patients in each group) and syncope (in 2% of the riociguat group and in 3% of the placebo group). CONCLUSIONS Riociguat significantly improved exercise capacity and pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension. (Funded by Bayer HealthCare; CHEST-1 and CHEST-2 ClinicalTrials.gov numbers NCT00855465, and NCT00910429, respectively.)	[Ghofrani, Hossein-Ardeschir; D'Armini, Andrea M.; Grimminger, Friedrich; Hoeper, Marius M.; Jansa, Pavel; Kim, Nick H.; Mayer, Eckhard; Simonneau, Gerald; Wilkins, Martin R.; Fritsch, Arno; Neuser, Dieter; Weimann, Gerrit; Wang, Chen] Univ Hosp Giessen & Marburg, Dept Internal Med, Med Clin 2, D-35392 Giessen, Germany	University Hospital of Giessen & Marburg	Ghofrani, HA (corresponding author), Univ Hosp Giessen & Marburg, Dept Internal Med, Med Clin 2, Klinikstr 33, D-35392 Giessen, Germany.	ardeschir.ghofrani@innere.med.uni-giessen.de	Jansa, Pavel/O-2302-2017; boonstra, anco/J-5446-2014; Ghofrani, Ardeschir/AAD-5293-2020; Ghofrani, Hossein Ardeschir/AAD-2856-2022; Morsolini, Marco/K-6114-2016; Akashi, Yoshihiro J/E-5227-2011; Okumus, Gulfer/AAE-4618-2020; Akashi, Yoshihiro/J-8312-2019; Hoeper, Marius C/Z-1546-2019; Simonneau, Gerald/ABE-6614-2020; Moiseeva, Olga/A-4580-2014	Jansa, Pavel/0000-0002-3711-7064; Ghofrani, Ardeschir/0000-0002-2029-4419; Morsolini, Marco/0000-0001-5060-9357; Akashi, Yoshihiro J/0000-0001-7670-7326; Akashi, Yoshihiro/0000-0001-7670-7326; Hoeper, Marius C/0000-0001-9086-2293; Olschewski, Horst/0000-0002-2834-7466; Grimminger, Friedrich/0000-0001-8725-6276; Moiseeva, Olga/0000-0002-7817-3847; de Groote, Pascal/0000-0002-6211-0147	Bayer HealthCare; Actelion Pharmaceuticals; GlaxoSmithKline; Eli Lilly; Merck; Novartis; Pfizer; United Therapeutics	Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Actelion Pharmaceuticals; GlaxoSmithKline(GlaxoSmithKline); Eli Lilly(Eli Lilly); Merck(Merck & Company); Novartis(Novartis); Pfizer(Pfizer); United Therapeutics	Funded by Bayer HealthCare; CHEST-1 and CHEST-2 ClinicalTrials.gov numbers, NCT00855465 and NCT00910429, respectively.; Supported by Bayer HealthCare.; Dr. Ghofrani reports serving as a board member for Actelion Pharmaceuticals, Bayer, GlaxoSmithKline, Merck, Novartis, Pfizer, and Takeda Pharmaceuticals; receiving consulting fees from Actelion Pharmaceuticals, Bayer HealthCare, GlaxoSmithKline, Eli Lilly, Merck, Novartis, Pfizer, and Takeda Pharmaceuticals; receiving lecture fees from Actelion Pharmaceuticals, Bayer HealthCare, GlaxoSmithKline, Eli Lilly, Novartis, and Pfizer; and receiving grant support through his institution from Actelion Pharmaceuticals, Bayer HealthCare, Novartis, and Pfizer. Dr. D'Armini reports receiving consulting fees from Bayer HealthCare and lecture fees from Actelion Pharmaceuticals, Bayer HealthCare, and Pfizer. Dr. Grimminger reports serving as a board member for Bayer HealthCare and Pfizer; receiving consulting fees from Actelion Pharmaceuticals, Bayer HealthCare, and Pfizer; receiving lecture fees from Actelion Pharmaceuticals, Bayer HealthCare, Eli Lilly, Novartis, and Pfizer; and receiving grant support through his institution from Bayer HealthCare and Pfizer. Dr. Hoeper reports serving as a board member for and receiving consulting and lecture fees from Actelion Pharmaceuticals, Bayer HealthCare, GlaxoSmithKline, Novartis, Pfizer, and Eli Lilly; and receiving payment for the development of educational presentations from Pfizer. Dr. Jansa reports receiving consulting and lecture fees from Actelion Pharmaceuticals, Bayer HealthCare, AOP Orphan, United Therapeutics, and GlaxoSmithKline; and receiving grant support from Actelion Pharmaceuticals and United Therapeutics. Dr. Kim reports receiving consulting fees from Bayer HealthCare. Dr. Mayer reports receiving lecture fees from Actelion Pharmaceuticals, Bayer HealthCare, GlaxoSmithKline, and Pfizer. Dr. Simonneau reports serving as a board member for and receiving travel support from Actelion Pharmaceuticals, Bayer HealthCare, GlaxoSmithKline, Novartis, Eli Lilly, and Pfizer; receiving consulting and lecture fees from Actelion Pharmaceuticals, Bayer HealthCare, GlaxoSmithKline, Eli Lilly, and Pfizer; and receiving grant support through his institution from Actelion Pharmaceuticals, Bayer HealthCare, GlaxoSmithKline, Eli Lilly, and Pfizer. Dr. Wilkins reports receiving consulting and lecture fees from Pfizer and Novartis. Drs. Fritsch, Neuser, and Weimann report being employees of Bayer HealthCare. Dr. Fritsch reports holding stock in Bayer HealthCare, and Dr. Weimann reports holding five riociguat patents, through Bayer HealthCare, for indications other than chronic thromboembolic pulmonary hypertension. No other potential conflict of interest relevant to this article was reported.	Bonderman D, 2007, CIRCULATION, V115, P2153, DOI 10.1161/CIRCULATIONAHA.106.661041; Condliffe R, 2009, EUR RESPIR J, V33, P332, DOI 10.1183/09031936.00092008; Condliffe R, 2008, AM J RESP CRIT CARE, V177, P1122, DOI 10.1164/rccm.200712-1841OC; Dartevelle P, 2004, EUR RESPIR J, V23, P637, DOI 10.1183/09031936.04.00079704; Freed DH, 2011, J THORAC CARDIOV SUR, V141, P383, DOI 10.1016/j.jtcvs.2009.12.056; Galie N, 2011, EUR HEART J, V32, P926; Ghofrani HA, 2010, EUR RESPIR J, V36, P792, DOI 10.1183/09031936.00182909; GIAID A, 1995, NEW ENGL J MED, V333, P214, DOI 10.1056/NEJM199507273330403; Grimminger F, 2009, EUR RESPIR J, V33, P785, DOI 10.1183/09031936.00039808; Jais X, 2008, J AM COLL CARDIOL, V52, P2127, DOI 10.1016/j.jacc.2008.08.059; Jamieson SW, 2003, ANN THORAC SURG, V76, P1457, DOI 10.1016/S0003-4975(03)00828-2; Jenkins D, 2012, EUR RESPIR REV, V21, P32, DOI 10.1183/09059180.00009211; Kuhn KP, 2003, AM J RESP CRIT CARE, V167, P580, DOI 10.1164/rccm.200204-333OC; Lang IM, 2008, CURR OPIN CARDIOL, V23, P555, DOI 10.1097/HCO.0b013e328311f254; Lang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043433; Mayer E, 2011, J THORAC CARDIOV SUR, V141, P702, DOI 10.1016/j.jtcvs.2010.11.024; McNeil K, 2007, HEART, V93, P1152, DOI 10.1136/hrt.2004.053603; Nagaya N, 2003, CHEST, V123, P338, DOI 10.1378/chest.123.2.338; Peacock Andrew, 2006, Proc Am Thorac Soc, V3, P608, DOI 10.1513/pats.200605-114LR; Pepke-Zaba J, 2011, CIRCULATION, V124, P1973, DOI 10.1161/CIRCULATIONAHA.110.015008; Provencher S, 2006, EUR HEART J, V27, P589, DOI 10.1093/eurheartj/ehi728; RIEDEL M, 1982, CHEST, V81, P151, DOI 10.1378/chest.81.2.151; Schermuly RT, 2011, EXPERT OPIN INV DRUG, V20, P567, DOI 10.1517/13543784.2011.565048; Scholzel B, 2011, NETH HEART J, V19, P498, DOI 10.1007/s12471-011-0203-4; Scholzel BE, 2012, LUNG, V190, P161, DOI 10.1007/s00408-011-9350-z; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Suntharalingam J, 2008, CHEST, V134, P229, DOI 10.1378/chest.07-2681; Thistlethwaite PA, 2006, J THORAC CARDIOV SUR, V131, P307, DOI 10.1016/j.jtcvs.2005.07.033; Wilkens H, 2011, INT J CARDIOL, V154, pS54, DOI 10.1016/S0167-5273(11)70493-4	31	1070	1130	3	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					319	329		10.1056/NEJMoa1209657	http://dx.doi.org/10.1056/NEJMoa1209657			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188VJ	23883377	Green Published			2022-12-28	WOS:000322223900007
J	Smith, C				Smith, Caitlin			CANCER SHOWS STRENGTH THROUGH DIVERSITY	NATURE			English	Editorial Material																		Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; Bendall SC, 2012, NAT BIOTECHNOL, V30, P639, DOI 10.1038/nbt.2283; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Yin Z, 2013, NAT CELL BIOL, V15, P860, DOI 10.1038/ncb2764	4	13	15	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2013	499	7459					505	508		10.1038/499505a	http://dx.doi.org/10.1038/499505a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23887432	Bronze			2022-12-28	WOS:000322157900048
J	Gray, JAM				Gray, J. A. Muir			The Art of Medicine The shift to personalised and population medicine	LANCET			English	Editorial Material									Oxford Univ Hosp NHS Trust, Oxford OX3 9DU, England	Oxford University Hospitals NHS Foundation Trust	Gray, JAM (corresponding author), Oxford Univ Hosp NHS Trust, Oxford OX3 9DU, England.	muir.gray@medknox.net						[Anonymous], 1995, LANCET, V346, P785; British Thoracic Society and the Primary Care Respiratory Society UK, 2012, BRITISH THORACIC SOC, V4; Christensen CM, 2009, THE INNOVATORS PRESC; Goldberg D., 1983, INT J REHABIL RES, V6, P127, DOI [10.1097/00004356-198303000-00021, DOI 10.1097/00004356-198303000-00021]; Gray JAM, 2007, HOW GET BETTER VALUE; Gray M, 2009, J HEALTH SERV RES PO, V14, P129, DOI 10.1258/jhsrp.2008.008105; Mulley AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6572; NHS, 2010, THE NHS ATLAS OF VAR; Ohno T., 1988, THE TOYOTA PRODUCTIO; Porter ME, 2008, WHAT IS VALUE IN HEA; Rothwell Peter M., 2007, TREATING INDIVIDUALS; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71	12	39	40	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 20	2013	382	9888					200	201		10.1016/S0140-6736(13)61590-1	http://dx.doi.org/10.1016/S0140-6736(13)61590-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193FL	23878859				2022-12-28	WOS:000322543700016
J	Barreto, L; Khan, AR; Khanbhai, M; Brain, JL				Barreto, L.; Khan, A. R.; Khanbhai, M.; Brain, J. L.			Umbilical hernia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Barreto, L.; Khan, A. R.; Brain, J. L.] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Khanbhai, M.] NHS GP Surg, Watling Med Ctr, Burnt Oak HA8 0NR, Middx, England	Addenbrooke's Hospital; University of Cambridge	Khan, AR (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge CB2 2QQ, England.	arkhan@doctors.org.uk							0	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2013	347								f4252	10.1136/bmj.f4252	http://dx.doi.org/10.1136/bmj.f4252			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	189DN	23873946				2022-12-28	WOS:000322247400001
J	Santagata, S; Mendillo, ML; Tang, YC; Subramanian, A; Perley, CC; Roche, SP; Wong, B; Narayan, R; Kwon, H; Koeva, M; Amon, A; Golub, TR; Porco, JA; Whitesell, L; Lindquist, S				Santagata, Sandro; Mendillo, Marc L.; Tang, Yun-chi; Subramanian, Aravind; Perley, Casey C.; Roche, Stephane P.; Wong, Bang; Narayan, Rajiv; Kwon, Hyoungtae; Koeva, Martina; Amon, Angelika; Golub, Todd R.; Porco, John A., Jr.; Whitesell, Luke; Lindquist, Susan			Tight Coordination of Protein Translation and HSF1 Activation Supports the Anabolic Malignant State	SCIENCE			English	Article							HEAT-SHOCK FACTOR-1; TRANSCRIPTION FACTOR HSF1; EUKARYOTIC TRANSLATION; AMINO-ACID; IN-VITRO; CANCER; EXPRESSION; STRESS; SILVESTROL; INHIBITORS	The ribosome is centrally situated to sense metabolic states, but whether its activity, in turn, coherently rewires transcriptional responses is unknown. Here, through integrated chemical-genetic analyses, we found that a dominant transcriptional effect of blocking protein translation in cancer cells was inactivation of heat shock factor 1 (HSF1), a multifaceted transcriptional regulator of the heat-shock response and many other cellular processes essential for anabolic metabolism, cellular proliferation, and tumorigenesis. These analyses linked translational flux to the regulation of HSF1 transcriptional activity and to the modulation of energy metabolism. Targeting this link with translation initiation inhibitors such as rocaglates deprived cancer cells of their energy and chaperone armamentarium and selectively impaired the proliferation of both malignant and premalignant cells with early-stage oncogenic lesions.	[Santagata, Sandro] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA; [Santagata, Sandro] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Santagata, Sandro] Dana Farber Canc Inst, Boston, MA 02215 USA; [Santagata, Sandro; Mendillo, Marc L.; Perley, Casey C.; Kwon, Hyoungtae; Koeva, Martina; Whitesell, Luke; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Mendillo, Marc L.; Tang, Yun-chi; Perley, Casey C.; Kwon, Hyoungtae; Koeva, Martina; Amon, Angelika; Lindquist, Susan] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Tang, Yun-chi; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Tang, Yun-chi; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Subramanian, Aravind; Wong, Bang; Narayan, Rajiv; Golub, Todd R.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Roche, Stephane P.; Porco, John A., Jr.] Boston Univ, Dept Chem, Ctr Chem Methodol & Lib Dev CMLD BU, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University	Whitesell, L (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	whitesell@wi.mit.edu; lindquist_admin@wi.mit.edu	Tang, Yun-Chi/GRE-8205-2022	Amon, Angelika/0000-0001-9837-0314; tang, yun qi/0000-0001-9385-2787; Santagata, Sandro/0000-0002-7528-9668; Mendillo, Marc/0000-0001-8128-0128	Johnson & Johnson's Corporate Office of Science and Technology; Marble Fund; NIH [R01 CA175744-01, K08NS064168]; NIH Common Fund's LINCS program [5U54HG006093]; American Cancer Society New England Division-SpinOdyssey [PF-09-253-01-DMC]; Brain Science Foundation; American Brain Tumor Association; Beez Foundation; V Foundation; Jared Branfman Sunflowers for Life Fund;  [R03 MH086465-01];  [R03 DA027713-01];  [R01 GM073855]; NATIONAL CANCER INSTITUTE [R01CA175744] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027713] Funding Source: NIH RePORTER	Johnson & Johnson's Corporate Office of Science and Technology; Marble Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Common Fund's LINCS program; American Cancer Society New England Division-SpinOdyssey; Brain Science Foundation; American Brain Tumor Association; Beez Foundation; V Foundation; Jared Branfman Sunflowers for Life Fund; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank T. Volkert, J. Love, S. Gupta, and the WIBR-Genome Technology Core for sequencing support; S. Malstrom (Koch Institute for Integrative Cancer Research) for assistance with in vivo imaging; G. Bell, P. Thiru, and A. Lancaster for assistance with informatics analysis; the Connectivity Map team at the Broad Institute for generation of the LINCS data set and query tools; Joe Negri and the MLPCN team at the Broad Institute for chemical screening; and M. Duquette for assistance with animal experiments. We also thank C. Rodrigo (Boston University) for compound synthesis. We thank the Lindquist laboratory for helpful discussions and suggestions. The work was supported by the Johnson & Johnson's Corporate Office of Science and Technology focused funding program (L. W.), the Marble Fund (S. L.), and NIH R01 CA175744-01 (L. W.). The MLPCN screen was supported by R03 MH086465-01 and R03 DA027713-01 to L. W. This work was supported by the NIH Common Fund's LINCS program (5U54HG006093, "Large scale gene expression analysis of cellular states") to T. R. G. J. A. P. Jr. is supported by R01 GM073855. S. L. is an Investigator of the Howard Hughes Medical Institute. M. L. M. was supported by American Cancer Society New England Division-SpinOdyssey (PF-09-253-01-DMC). S. S. is supported by NIH (K08NS064168), the Brain Science Foundation, the American Brain Tumor Association, the Beez Foundation, the V Foundation, and the Jared Branfman Sunflowers for Life Fund. The expression profiling and ChIP-Seq data are deposited in GEO (GSE45853). The MLPCN chemical screening data are deposited in Pubchem (AID: 2118).	Alinari L, 2012, CLIN CANCER RES, V18, P4600, DOI 10.1158/1078-0432.CCR-12-0839; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; Chambers JM, 2013, ORG LETT, V15, P1406, DOI 10.1021/ol400401d; Chan JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001754; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Fang F, 2012, CANCER-AM CANCER SOC, V118, P1782, DOI 10.1002/cncr.26482; Gabai VL, 2012, MOL CELL BIOL, V32, P929, DOI 10.1128/MCB.05921-11; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hensen SMM, 2012, CELL STRESS CHAPERON, V17, P743, DOI 10.1007/s12192-012-0347-1; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jin XJ, 2011, CELL METAB, V14, P91, DOI 10.1016/j.cmet.2011.03.025; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lucas DM, 2009, BLOOD, V113, P4656, DOI 10.1182/blood-2008-09-175430; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Okabe M, 1995, LEUKEMIA RES, V19, P933, DOI 10.1016/0145-2126(95)00039-9; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Roche SP, 2010, ANGEW CHEM INT EDIT, V49, P6533, DOI 10.1002/anie.201003212; Rodrigo CM, 2012, J MED CHEM, V55, P558, DOI 10.1021/jm201263k; Roux PP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012252; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Santagata S, 2012, ACS CHEM BIOL, V7, P339, DOI 10.1021/cb200353m; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Turbyville TJ, 2006, J NAT PROD, V69, P178, DOI 10.1021/np058095b; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Whitesell L, 2012, CURR MOL MED, V12, P1108, DOI 10.2174/156652412803306657; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058	44	186	194	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143					250	+	1238303	10.1126/science.1238303	http://dx.doi.org/10.1126/science.1238303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869022	Green Submitted, Green Accepted			2022-12-28	WOS:000321959300034
J	Webster, CR; Mahaffy, PR; Flesch, GJ; Niles, PB; Jones, JH; Leshin, LA; Atreya, SK; Stern, JC; Christensen, LE; Owen, T; Franz, H; Pepin, RO; Steele, A				Webster, Chris R.; Mahaffy, Paul R.; Flesch, Gregory J.; Niles, Paul B.; Jones, John H.; Leshin, Laurie A.; Atreya, Sushil K.; Stern, Jennifer C.; Christensen, Lance E.; Owen, Tobias; Franz, Heather; Pepin, Robert O.; Steele, Andrew		MSL Sci Team	Isotope Ratios of H, C, and O in CO2 and H2O of the Martian Atmosphere	SCIENCE			English	Article							METEORITE ALH84001; CLIMATE HISTORY; SNC METEORITES; WATER CYCLE; MARS; ENVIRONMENTS; D/H; GEOCHEMISTRY; CARBONATES; EVOLUTION	Stable isotope ratios of H, C, and O are powerful indicators of a wide variety of planetary geophysical processes, and for Mars they reveal the record of loss of its atmosphere and subsequent interactions with its surface such as carbonate formation. We report in situ measurements of the isotopic ratios of D/H and O-18/O-16 in water and C-13/C-12, O-18/O-16, O-17/O-16, and (CO)-C-13-O-18/(CO)-C-12-O-16 in carbon dioxide, made in the martian atmosphere at Gale Crater from the Curiosity rover using the Sample Analysis at Mars (SAM)'s tunable laser spectrometer (TLS). Comparison between our measurements in the modern atmosphere and those of martian meteorites such as ALH 84001 implies that the martian reservoirs of CO2 and H2O were largely established similar to 4 billion years ago, but that atmospheric loss or surface interaction may be still ongoing.	[Webster, Chris R.; Flesch, Gregory J.; Christensen, Lance E.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Mahaffy, Paul R.; Stern, Jennifer C.; Franz, Heather] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Leshin, Laurie A.] Rensselaer Polytech Inst, Troy, NY 12180 USA; [Atreya, Sushil K.] Univ Michigan, Ann Arbor, MI 48105 USA; [Owen, Tobias] Univ Hawaii, Honolulu, HI 96822 USA; [Niles, Paul B.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Jones, John H.] Univ Arizona, Tucson, AZ 85721 USA; [Pepin, Robert O.] Univ Minnesota, Minneapolis, MN 55455 USA; [Steele, Andrew] Carnegie Inst Sci, Washington, DC 20015 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Rensselaer Polytechnic Institute; University of Michigan System; University of Michigan; University of Hawaii System; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Arizona; University of Minnesota System; University of Minnesota Twin Cities; Carnegie Institution for Science	Webster, CR (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	chris.r.webster@jpl.nasa.gov	Stipp, Susan L.S./B-8494-2019; Lemmon, Mark T/E-9983-2010; Blanco, Juan Jose/E-3627-2014; Glavin, Daniel P/D-6194-2012; Avalos, Juan Jose Blanco/AAB-9447-2021; Stern, Jennifer/E-3135-2012; GEFFROY, Claude/AAB-9152-2019; Webster, Chris/M-9315-2019; Muñoz, Guillermo M/L-6370-2014; Hayes, Alexander G/P-2024-2014; Gomez-Elvira, Javier/K-5829-2014; Navarro-González, Rafael/D-1748-2009; Harri, Ari-Matti/C-7142-2012; Rodriguez-Manfredi, Jose/AAG-9826-2021; De Pablo, Miguel Ángel/J-6442-2014; Gómez, Felipe/L-7315-2014; Steele, Andrew/A-3573-2013; szopa, cyril/C-6865-2015; Ramos, Miguel/K-2230-2014; Dworkin, Jason P./C-9417-2012; Martin-Torres, Javier/G-6329-2015; Balic-Zunic, Tonci/A-6362-2013; Prats, Benito/F-9467-2019; Franz, Heather B/F-3508-2012; Zorzano, María-Paz/F-2184-2015; Rodriguez-Manfredi, Jose/L-8001-2014; Baratoux, David/H-6006-2012	Stipp, Susan L.S./0000-0001-7009-643X; Lemmon, Mark T/0000-0002-4504-5136; Blanco, Juan Jose/0000-0002-8666-0696; Glavin, Daniel P/0000-0001-7779-7765; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Stern, Jennifer/0000-0002-0162-8807; GEFFROY, Claude/0000-0002-2731-9658; Muñoz, Guillermo M/0000-0001-7003-7368; Hayes, Alexander G/0000-0001-6397-2630; Gomez-Elvira, Javier/0000-0002-9068-9846; Navarro-González, Rafael/0000-0002-6078-7621; Harri, Ari-Matti/0000-0001-8541-2802; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; De Pablo, Miguel Ángel/0000-0002-4496-2741; Gómez, Felipe/0000-0001-9977-7060; Steele, Andrew/0000-0001-9643-2841; szopa, cyril/0000-0002-0090-4056; Ramos, Miguel/0000-0003-3648-6818; Dworkin, Jason P./0000-0002-3961-8997; Martin-Torres, Javier/0000-0001-6479-2236; Balic-Zunic, Tonci/0000-0003-1687-1233; Prats, Benito/0000-0003-3869-3351; Zorzano, María-Paz/0000-0002-4492-9650; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Baratoux, David/0000-0002-1785-5262				Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Borg L, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002402; CARR RH, 1985, NATURE, V314, P248, DOI 10.1038/314248a0; Criss R. E., 1999, PRINCIPLES STABLE IS; Farquar J., 2000, J GEOPHYS RES, V105; Farquhar J, 2008, REV MINERAL GEOCHEM, V68, P463, DOI 10.2138/rmg.2008.68.16; Fisher DA, 2007, ICARUS, V187, P430, DOI 10.1016/j.icarus.2006.10.032; Greenwood JP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032721; Grott M, 2011, EARTH PLANET SC LETT, V308, P391, DOI 10.1016/j.epsl.2011.06.014; Grotzinger JP, 2012, SPACE SCI REV, V170, P5, DOI 10.1007/s11214-012-9892-2; Jakosky BM, 1997, ICARUS, V130, P87, DOI 10.1006/icar.1997.5799; JAKOSKY BM, 1994, NATURE, V370, P328, DOI 10.1038/370328a0; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; KARLSSON KR, 1992, SCIENCE, V255, P1409, DOI 10.1126/science.11537889; Krasnopolsky VA, 2007, ICARUS, V192, P396, DOI 10.1016/j.icarus.2007.08.013; Lammer H, 2013, SPACE SCI REV, V174, P113, DOI 10.1007/s11214-012-9943-8; Leshin L. A., 2013, LUNAR PLANET SCI C; Leshin LA, 1996, GEOCHIM COSMOCHIM AC, V60, P2635, DOI 10.1016/0016-7037(96)00122-6; Mahaffy PR, 2013, SCIENCE, V341, P263, DOI 10.1126/science.1237966; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; MCELROY MB, 1976, SCIENCE, V194, P70, DOI 10.1126/science.194.4260.70; NIER AO, 1976, SCIENCE, V194, P1298, DOI 10.1126/science.194.4271.1298; Niles PB, 2013, SPACE SCI REV, V174, P301, DOI 10.1007/s11214-012-9940-y; Niles PB, 2010, SCIENCE, V329, P1334, DOI 10.1126/science.1192863; Niles PB, 2005, GEOCHIM COSMOCHIM AC, V69, P2931, DOI 10.1016/j.gca.2004.12.012; Novak R. E., 2005, B AM ASTRON SOC, V35, P660; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; PEPIN RO, 1994, ICARUS, V111, P289, DOI 10.1006/icar.1994.1146; ROMANEK CS, 1994, NATURE, V372, P655, DOI 10.1038/372655a0; Rothman LS, 2009, J QUANT SPECTROSC RA, V110, P533, DOI 10.1016/j.jqsrt.2009.02.013; Usui T, 2012, EARTH PLANET SC LETT, V357, P119, DOI 10.1016/j.epsl.2012.09.008; Valley JW, 1997, SCIENCE, V275, P1633, DOI 10.1126/science.275.5306.1633; Webster C. R., 2013, LUNAR PLANET SCI C; Webster CR, 2003, SCIENCE, V302, P1742, DOI 10.1126/science.1089496	35	171	176	3	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143					260	263		10.1126/science.1237961	http://dx.doi.org/10.1126/science.1237961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869013	Green Accepted			2022-12-28	WOS:000321959300038
J	Carpenter, CR				Carpenter, Christopher R.			Review: Ultrasonography reduces failed lumbar punctures and epidural catheterizations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SPINE		Washington Univ, St Louis, MO 63130 USA	Washington University (WUSTL)	Carpenter, CR (corresponding author), Washington Univ, St Louis, MO 63130 USA.		Carpenter, Christopher R./E-3720-2013	Carpenter, Christopher R./0000-0002-2603-7157				Chin KJ, 2011, ANESTHESIOLOGY, V114, P1459, DOI 10.1097/ALN.0b013e318210f9f8; Gambling DR, 2011, INT J OBSTET ANESTH, V20, P318, DOI 10.1016/j.ijoa.2010.10.001; Margarido CB, 2010, CAN J ANAESTH, V57, P120, DOI 10.1007/s12630-009-9219-2; Shah KH, 2003, ACAD EMERG MED, V10, P151, DOI 10.1111/j.1553-2712.2003.tb00033.x; Straus SE, 2006, JAMA-J AM MED ASSOC, V296, P2012, DOI 10.1001/jama.296.16.2012	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2							JC10	10.7326/0003-4819-159-2-201307160-02010	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23856696				2022-12-28	WOS:000322112000009
J	Isaacs, JT				Isaacs, John T.			Prostate Cancer Takes Nerve	SCIENCE			English	Editorial Material									Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Res Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Isaacs, JT (corresponding author), Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Res Ctr, 1650 Orleans St, Baltimore, MD 21231 USA.	isaacjo@jhmi.edu						Ayala GE, 2008, CLIN CANCER RES, V14, P7593, DOI 10.1158/1078-0432.CCR-08-1164; Barron DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013751; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Grytli HH, 2013, PROSTATE, V73, P250, DOI 10.1002/pros.22564; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166	7	11	12	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2013	341	6142					134	135		10.1126/science.1241776	http://dx.doi.org/10.1126/science.1241776			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23846894				2022-12-28	WOS:000321965300026
J	Brilakis, ES; Patel, VG; Banerjee, S				Brilakis, Emmanouil S.; Patel, Vishal G.; Banerjee, Subhash			Medical Management After Coronary Stent Implantation A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DRUG-ELUTING STENT; DUAL-ANTIPLATELET THERAPY; ELEVATION MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; TERM CLOPIDOGREL THERAPY; MAJOR NONCARDIAC SURGERY; DOUBLE-BLIND; PLATELET INHIBITION; ISCHEMIC EVENTS; ANTICOAGULANT-THERAPY	IMPORTANCE Percutaneous coronary intervention (PCI) with stents is currently the most commonly performed coronary revascularization procedure; hence, optimizing post-PCI outcomes is important for all physicians treating such patients. OBJECTIVE To review the contemporary literature on optimal medical therapy after PCI. EVIDENCE REVIEW We performed a comprehensive search of the PubMed and Cochrane Library databases for manuscripts on medical therapy after PCI, published between 2000 and February 2013. Bibliographies of the retrieved studies were searched by hand for other relevant studies. Priority was given to data from large randomized controlled trials, systematic reviews, and meta-analyses. Of the 6852 publications retrieved, 91 were included. FINDINGS Dual antiplatelet therapy with aspirin and a P2Y(12) inhibitor (eg, ticlopidine, clopidogrel, prasugrel, ticagrelor) reduces the risk of stent thrombosis and subsequent cardiovascular events post-PCI (number needed to treat, 33-53) and is the current standard of care. Aspirin should be continued indefinitely and low dose (75-100 mg daily) is preferred over higher doses. A P2Y(12) inhibitor should be administered for 12 months after PCI, unless the patient is at high risk for bleeding; however, ongoing studies are assessing the value of shorter or longer duration of P2Y(12) inhibitor administration. In patients with acute coronary syndromes, prasugrel and ticagrelor further reduce cardiovascular ischemic events compared with clopidogrel but are associated with higher bleeding risk. If possible, noncardiac surgery should be delayed until 12 months after coronary stenting. Patients receiving coronary stents who require warfarin are at high risk for bleeding if they also receive dual antiplatelet therapy. Omission of aspirin may be advantageous in such patients. Routine platelet function or genetic testing is currently not recommended to tailor antiplatelet therapy after PCI. CONCLUSIONS AND RELEVANCE Dual antiplatelet therapy remains the cornerstone of medical therapy after PCI. Continuous advances in pharmacotherapy can further enhance our capacity to improve outcomes in this high-risk patient group.	Univ Texas SW Med Ctr Dallas, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Brilakis, ES (corresponding author), Univ Texas SW Med Ctr Dallas, Div Cardiol 111A, VA North Texas Hlth Care Syst, 4500 S Lancaster Rd, Dallas, TX 75216 USA.	emmanouil.brilakis@va.gov	Brilakis, Emmanouil/B-5282-2009	Brilakis, Emmanouil/0000-0001-9416-9701	Guerbet; Gilead; Medicines Company	Guerbet; Gilead(Gilead Sciences); Medicines Company	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Brilakis reports that his spouse is an employee of Medtronic and reports receiving consulting/speaker honoraria from St Jude Medical, Terumo, Janssen, sanofi-aventis, and Bridgepoint Medical/Boston Scientific; receiving research support from Guerbet; and providing expert testimony for Thompson Coe. Dr Banerjee reports that his spouse has ownership in MDCARE Global and reports receiving research grants from Gilead and the Medicines Company, receiving consultant/speaker honoraria from Covidien and Medtronic, and owning intellectual property in HygeiaTel. No other disclosures were reported.	Airoldi F, 2007, AM J CARDIOL, V99, P916, DOI 10.1016/j.amjcard.2006.10.057; Alexander JH, 2011, NEW ENGL J MED, V365, P699, DOI 10.1056/NEJMoa1105819; Alshawabkeh LI, 2011, HELL J CARDIOL, V52, P141; Alshawabkeh LI, EUROINTERVENTION; Andrade JG, 2013, CAN J CARDIOL, V29, P204, DOI 10.1016/j.cjca.2012.06.012; Angiolillo DJ, 2007, CIRCULATION, V115, P708, DOI 10.1161/CIRCULATIONAHA.106.667741; Armstrong EJ, 2012, JACC-CARDIOVASC INTE, V5, P131, DOI 10.1016/j.jcin.2011.10.013; Bates ER, 2011, J AM COLL CARDIOL, V57, P1251, DOI 10.1016/j.jacc.2010.11.024; Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; Berger PB, 2010, JACC-CARDIOVASC INTE, V3, P920, DOI 10.1016/j.jcin.2010.03.021; Bertrand ME, 1998, CIRCULATION, V98, P1597, DOI 10.1161/01.CIR.98.16.1597; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Bhatt DL, 2002, J AM COLL CARDIOL, V39, P9, DOI 10.1016/S0735-1097(01)01713-2; Brilakis ES, 2007, J AM COLL CARDIOL, V49, P2145, DOI 10.1016/j.jacc.2007.02.046; Byrne RA, 2009, AM HEART J, V157, P620, DOI 10.1016/j.ahj.2008.12.019; Campbell CL, 2007, JAMA-J AM MED ASSOC, V297, P2018, DOI 10.1001/jama.297.18.2018; Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7; Cassese S, 2012, EUR HEART J, V33, P3078, DOI 10.1093/eurheartj/ehs318; Cattaneo M, 2010, CIRCULATION, V121, P171, DOI 10.1161/CIRCULATIONAHA.109.853069; Cheema AN, 2011, J AM COLL CARDIOL, V58, P1445, DOI 10.1016/j.jacc.2011.06.040; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Cruden NLM, 2010, CIRC-CARDIOVASC INTE, V3, P236, DOI 10.1161/CIRCINTERVENTIONS.109.934703; Cuisset T, 2006, J AM COLL CARDIOL, V48, P1339, DOI 10.1016/j.jacc.2006.06.049; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Dans AL, 2013, CIRCULATION, V127, P634, DOI 10.1161/CIRCULATIONAHA.112.115386; De Luca G, 2013, INT J CARDIOL, V167, P561, DOI 10.1016/j.ijcard.2012.01.063; Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Eriksson P, 2004, EUR HEART J, V25, P720, DOI 10.1016/j.ehj.2004.03.006; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Gandhi NK, 2011, CATHETER CARDIO INTE, V77, P972, DOI 10.1002/ccd.22744; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Goel K, 2011, CIRCULATION, V123, P2344, DOI 10.1161/CIRCULATIONAHA.110.983536; Gollapudi RR, 2004, JAMA-J AM MED ASSOC, V292, P3017, DOI 10.1001/jama.292.24.3017; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Hammill BG, 2010, CIRCULATION, V121, P63, DOI 10.1161/CIRCULATIONAHA.109.876383; Hilliard AA, 2010, JACC-CARDIOVASC INTE, V3, P172, DOI 10.1016/j.jcin.2009.11.013; Holmes DR, 2010, J AM COLL CARDIOL, V56, P321, DOI 10.1016/j.jacc.2010.05.013; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; James S, 2010, CIRCULATION, V122, P1056, DOI 10.1161/CIRCULATIONAHA.109.933796; Jeon Doo-Soo, 2010, Korean Circ J, V40, P10, DOI 10.4070/kcj.2010.40.1.10; Jneid H, 2012, J AM COLL CARDIOL, V60, P645, DOI 10.1016/j.jacc.2012.06.004; Jolly SS, 2009, EUR HEART J, V30, P900, DOI 10.1093/eurheartj/ehn417; Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Kuchulakanti PK, 2006, CIRCULATION, V113, P1108, DOI 10.1161/CIRCULATIONAHA.105.600155; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Lokhandwala JO, 2009, CIRC-CARDIOVASC INTE, V2, P348, DOI 10.1161/CIRCINTERVENTIONS.108.832964.108.832964; Mahaffey KW, 2011, CIRCULATION, V124, P544, DOI 10.1161/CIRCULATIONAHA.111.047498; Mauri L, 2010, AM HEART J, V160, pe1; Mauri L, 2010, AM HEART J, V160, P1035, DOI 10.1016/j.ahj.2010.07.038; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Montalescot G, 2006, J AM COLL CARDIOL, V48, P931, DOI 10.1016/j.jacc.2006.04.090; Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Patti G, 2005, CIRCULATION, V111, P2099, DOI 10.1161/01.CIR.0000161383.06692.D4; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Quinn MJ, 2004, J AM COLL CARDIOL, V43, P972, DOI 10.1016/j.jacc.2003.09.059; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rossini R, 2008, AM J CARDIOL, V101, P786, DOI 10.1016/j.amjcard.2007.10.045; Sachdeva A, 2012, J AM COLL CARDIOL, V60, P2357, DOI 10.1016/j.jacc.2012.09.014; Sakurai R, INT J CARDOL; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1; Silberman S, 2005, AM J CARDIOL, V95, P509, DOI 10.1016/j.amjcard.2004.10.022; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Urban P, 1998, CIRCULATION, V98, P2126, DOI 10.1161/01.CIR.98.20.2126; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Vicenzi MN, 2006, BRIT J ANAESTH, V96, P686, DOI 10.1093/bja/ael083; Von Beckerath N, 2007, EUR HEART J, V28, P1814, DOI 10.1093/eurheartj/ehl489; von Tiehl KF, 2007, J AM COLL CARDIOL, V50, P2039, DOI 10.1016/j.jacc.2007.08.016; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wallentin L, 2009, EUR HEART J, V30, P1964, DOI 10.1093/eurheartj/ehp296; Wijeysundera DN, 2012, CIRCULATION, V126, P1355, DOI 10.1161/CIRCULATIONAHA.112.102715; Wiviott SD, 2008, CIRCULATION, V118, P1626, DOI 10.1161/CIRCULATIONAHA.108.791061; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2001, NEW ENGL J MED, V345, P494	92	72	75	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					189	198		10.1001/jama.2013.7086	http://dx.doi.org/10.1001/jama.2013.7086			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23839753				2022-12-28	WOS:000321511500018
J	Talib, S; van de Poll, SWE				Talib, Shmaila; van de Poll, Sweder W. E.			Brugada syndrome diagnosed after Ramadan	LANCET			English	Editorial Material									[Talib, Shmaila; van de Poll, Sweder W. E.] St Franciscus Gasthuis, Dept Cardiol, NL-3045 PM Rotterdam, Netherlands	Franciscus Gasthuis	van de Poll, SWE (corresponding author), St Franciscus Gasthuis, Dept Cardiol, Kleiweg 500, NL-3045 PM Rotterdam, Netherlands.	s.vandepoll@sfg.nl							0	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 6	2013	382	9886					100	100		10.1016/S0140-6736(13)60810-7	http://dx.doi.org/10.1016/S0140-6736(13)60810-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177AD	23830342				2022-12-28	WOS:000321347000031
J	Kamerow, D				Kamerow, Douglas			Linking health insurance coverage to evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Woolf SH, 1996, ANNU REV PUBL HEALTH, V17, P511, DOI 10.1146/annurev.pu.17.050196.002455; Woolf SH, 2013, JAMA-J AM MED ASSOC, V309, P1899, DOI 10.1001/jama.2013.3448	2	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2013	347								f4270	10.1136/bmj.f4270	http://dx.doi.org/10.1136/bmj.f4270			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180DN	23833078				2022-12-28	WOS:000321573400004
J	Chang, JB; Ferrell, JE				Chang, Jeremy B.; Ferrell, James E., Jr.			Mitotic trigger waves and the spatial coordination of the Xenopus cell cycle	NATURE			English	Article							SURFACE CONTRACTION WAVES; NUCLEAR DIVISION; LOCALIZATION; ACTIVATION; EGGS; PROPAGATION; BISTABILITY; HYSTERESIS; OSCILLATOR; EXTRACTS	Despite the large size of the Xenopus laevis egg (approximately 1.2 mm diameter), a fertilized egg rapidly proceeds through mitosis in a spatially coordinated fashion. Mitosis is initiated by a bistable system of regulatory proteins centred on Cdk1 (refs 1, 2), raising the possibility that this spatial coordination could be achieved through trigger waves of Cdk1 activity(3). Using an extract system that performs cell cycles in vitro, here we show that mitosis does spread through Xenopus cytoplasm via trigger waves, propagating at a linear speed of approximately 60 mu m min(-1). Perturbing the feedback loops that give rise to the bistability of Cdk1 changes the speed and dynamics of the waves. Time-lapse imaging of intact eggs argues that trigger waves of Cdk1 activation are responsible for surface contraction waves, ripples in the cell cortex that precede cytokinesis(4,5). These findings indicate that Cdk1 trigger waves help ensure the spatiotemporal coordination of mitosis in large eggs. Trigger waves may be an important general mechanism for coordinating biochemical events over large distances.	[Chang, Jeremy B.; Ferrell, James E., Jr.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Ferrell, James E., Jr.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University	Chang, JB (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	jbchang@stanford.edu; james.ferrell@stanford.edu			National Institutes of Health [GM046383, GM077544]; National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077544, R01GM046383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Funabiki and M. Dasso for providing GFP-NLS protein and constructs, E. Sontag and L. Wang for discussions and calculations, T. Tsai for sharing his unpublished data on the effects of PD0166285 on Xenopus embryos, Q. Yang for helping to build the ordinary differential equation model upon which our partial differential equation model is based, G. Dey, H. Stone and B. Sullivan for discussions, S. Quake and the Quake laboratory for advice, J. Chen and the Chen laboratory for the use of their microscope and discussions, J. Pomerening for discussions and technical advice, the Stanford Cell Sciences Imaging Facility for technical assistance, and members of the Ferrell laboratory for discussions. This work was supported by grants from the National Institutes of Health (GM046383 and GM077544) and by a National Science Foundation Graduate Research Fellowship and a Lieberman Fellowship (to J.B.C.).	Bonnet J, 2008, CELL CYCLE, V7, P1991, DOI 10.4161/cc.7.13.6095; CLUTTERBUCK AJ, 1970, J GEN MICROBIOL, V60, P133, DOI 10.1099/00221287-60-1-133; FOE VE, 1983, J CELL SCI, V61, P31; Gerhart J.C., 1980, Biological Regulation and Development, V2, P133; Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003; HARA K, 1971, ROUX ARCH DEV BIOL, V167, P183, DOI 10.1007/BF00577039; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; Haskins EF, 1974, PUB WISS FILM SEKT B, V8, P1; Hausen P., 1991, EARLY DEV XENOPUS LA; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Luther R, 1906, Z ELKTROCHEM ANGEW P, V12, P596, DOI 10.1002/bbpc.19060123208; Markevich NI, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100108; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nakamura N, 2005, MOL REPROD DEV, V72, P336, DOI 10.1002/mrd.20348; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NOVAK B, 1993, J THEOR BIOL, V165, P101, DOI 10.1006/jtbi.1993.1179; Perez-Mongiovi D, 1998, J CELL SCI, V111, P385; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Rankin S, 1997, CURR BIOL, V7, P451, DOI 10.1016/S0960-9822(06)00192-8; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; SHINAGAWA A, 1989, DEV GROWTH DIFFER, V31, P249; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; TYSON JJ, 1988, PHYSICA D, V32, P327, DOI 10.1016/0167-2789(88)90062-0; Wang YL, 2001, CANCER RES, V61, P8211; Winfree, 1974, FARADAY S CHEM SOC, V9, P38; Yang Q, 2013, NAT CELL BIOL, V15, P519, DOI 10.1038/ncb2737	27	112	112	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					603	607		10.1038/nature12321	http://dx.doi.org/10.1038/nature12321			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23863935	Green Accepted			2022-12-28	WOS:000323625900040
J	Lomakin, IB; Steitz, TA				Lomakin, Ivan B.; Steitz, Thomas A.			The initiation of mammalian protein synthesis and mRNA scanning mechanism	NATURE			English	Article							EUKARYOTIC TRANSLATION INITIATION; 40S RIBOSOMAL-SUBUNIT; START CODON SELECTION; CRYSTAL-STRUCTURE; SITE SELECTION; 70S RIBOSOME; EIF1A; POSITION; COMPLEX; FIDELITY	During translation initiation in eukaryotes, the small ribosomal subunit binds messenger RNA at the 5' end and scans in the 5' to 3' direction to locate the initiation codon, form the 80S initiation complex and start protein synthesis. This simple, yet intricate, process is guided by multiple initiation factors. Here we determine the structures of three complexes of the small ribosomal subunit that represent distinct steps in mammalian translation initiation. These structures reveal the locations of eIF1, eIF1A, mRNA and initiator transfer RNA bound to the small ribosomal subunit and provide insights into the details of translation initiation specific to eukaryotes. Conformational changes associated with the captured functional states reveal the dynamics of the interactions in the P site of the ribosome. These results have functional implications for the mechanism of mRNA scanning.	[Lomakin, Ivan B.; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	ivan.lomakin@yale.edu; thomas.steitz@yale.edu		Lomakin, Ivan/0000-0001-6528-5068	National Institutes of Health (NIH) [GM022778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Steitz laboratory for useful suggestions and discussions, the staff of the Advanced Photon Source beamline 24-ID, the National Synchrotron Light Source beamlines X25 and X29, and the Richards Center facility at Yale University for support. We also thank Y. Polikanov, J. Wang and Y. Xiong for advice with crystallographic software. This work was supported by the National Institutes of Health (NIH) grant GM022778 (to T.A.S.).	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; Dong J, 2008, GENE DEV, V22, P2242, DOI 10.1101/gad.1696608; Fekete CA, 2005, EMBO J, V24, P3588, DOI 10.1038/sj.emboj.7600821; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Julian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001095; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kolitz SE, 2009, RNA, V15, P138, DOI 10.1261/rna.1318509; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lancaster L, 2000, RNA, V6, P717, DOI 10.1017/S1355838200000303; Lomakin IB, 2006, EMBO J, V25, P196, DOI 10.1038/sj.emboj.7600904; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Myasnikov AG, 2009, CURR OPIN STRUC BIOL, V19, P300, DOI 10.1016/j.sbi.2009.04.010; Noller HF, 2005, FEBS LETT, V579, P855, DOI 10.1016/j.febslet.2004.11.026; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 2001, RNA, V7, P1496, DOI 10.1017/S135583820101038X; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Rees B, 2005, ACTA CRYSTALLOGR D, V61, P1299, DOI [10.1107/S0907444905019591, 10.1107/S0904777905019591]; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; Vila-Sanjurjo A, 2003, P NATL ACAD SCI USA, V100, P8682, DOI 10.1073/pnas.1133380100; Voigts-Hoffmann F, 2012, CURR OPIN STRUC BIOL, V22, P768, DOI 10.1016/j.sbi.2012.07.010; Wegrzyn JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-232; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	50	124	128	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					307	+		10.1038/nature12355	http://dx.doi.org/10.1038/nature12355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23873042	Green Accepted			2022-12-28	WOS:000323112400026
J	Lukas, D; Clutton-Brock, TH				Lukas, D.; Clutton-Brock, T. H.			The Evolution of Social Monogamy in Mammals	SCIENCE			English	Article							PATTERNS; ORGANIZATION; REPRODUCTION; PHYLOGENIES; PRIMATES; CARE	The evolution of social monogamy has intrigued biologists for over a century. Here, we show that the ancestral condition for all mammalian groups is of solitary individuals and that social monogamy is derived almost exclusively from this social system. The evolution of social monogamy does not appear to have been associated with a high risk of male infanticide, and paternal care is a consequence rather than a cause of social monogamy. Social monogamy has evolved in nonhuman mammals where breeding females are intolerant of each other and female density is low, suggesting that it represents a mating strategy that has developed where males are unable to defend access to multiple females.	[Lukas, D.; Clutton-Brock, T. H.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Lukas, D (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	dl384@cam.ac.uk		Lukas, Dieter/0000-0002-7141-3545	Leverhulme Trust; Isaac Newton Trust; European Research Council	Leverhulme Trust(Leverhulme Trust); Isaac Newton Trust; European Research Council(European Research Council (ERC)European Commission)	We thank D. Blumstein, S. Dobson, P. Kappeler, and N. Solomon for detailed comments and critical feedback on the classification of species and B. Dantzer, E. Huchard, C. Logan, and everyone in the Large Animal Research Group in Cambridge for helpful discussions. Data are available as supplementary materials. The Leverhulme Trust, the Isaac Newton Trust, and the European Research Council provided the funding for this study.	Brotherton Peter N. M., 2003, P42; Brotherton PNM, 1997, ANIM BEHAV, V54, P1413, DOI 10.1006/anbe.1997.0551; Cant MA, 2003, J ZOOL, V259, P115, DOI 10.1017/S0952836902003011; Clutton-Brock TH, 2006, BIOL LETTERS, V2, P513, DOI 10.1098/rsbl.2006.0531; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Dobson FS, 2010, BEHAV ECOL, V21, P747, DOI 10.1093/beheco/arq048; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Gavrilets S, 2012, P NATL ACAD SCI USA, V109, P9923, DOI 10.1073/pnas.1200717109; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; Langergraber KE, 2013, BEHAV ECOL SOCIOBIOL, V67, P861, DOI 10.1007/s00265-013-1509-6; Lukas D, 2012, P ROY SOC B-BIOL SCI, V279, P2151, DOI 10.1098/rspb.2011.2468; Mealy Linda, 2000, SEX DIFFERENCES DEV; ORIANS GH, 1969, AM NAT, V103, P589, DOI 10.1086/282628; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Plavcan JM, 2012, HUM NATURE-INT BIOS, V23, P45, DOI 10.1007/s12110-012-9130-3; Porter LM, 2001, FOLIA PRIMATOL, V72, P69, DOI 10.1159/000049925; Reichard Ulrich H., 2003, P190; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Shuster S. M., 2003, MATING SYSTEMS STRAT; TABER AB, 1992, J ZOOL, V227, P417, DOI 10.1111/j.1469-7998.1992.tb04404.x; van Schaik Carel P., 2003, P59; van Schaik Carel P., 2000, P61, DOI 10.1017/CBO9780511542312.005; VANSCHAIK CP, 1990, BEHAVIOUR, V115, P30, DOI 10.1163/156853990X00284; WITTENBERGER JF, 1980, ANNU REV ECOL SYST, V11, P197, DOI 10.1146/annurev.es.11.110180.001213; WRIGHT PC, 1990, INT J PRIMATOL, V11, P89, DOI 10.1007/BF02192783	31	311	314	10	559	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					526	530		10.1126/science.1238677	http://dx.doi.org/10.1126/science.1238677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23896459	Green Accepted			2022-12-28	WOS:000322586700047
J	Okawa, T; Tsunekawa, S; Seino, Y; Hamada, Y; Oiso, Y				Okawa, Tetsuji; Tsunekawa, Shin; Seino, Yusuke; Hamada, Yoji; Oiso, Yutaka			Deceptive HbA(1c) in a patient with pure red cell aplasia	LANCET			English	Editorial Material							GLYCATED HEMOGLOBIN		[Okawa, Tetsuji; Tsunekawa, Shin; Oiso, Yutaka] Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Nagoya, Aichi 4668550, Japan; [Seino, Yusuke; Hamada, Yoji] Nagoya Univ, Grad Sch Med, Dept Metab Med, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University	Tsunekawa, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	tsune87@med.nagoya-u.ac.jp	Hamada, Yoji/I-7344-2014					Gallagher EJ, 2009, J DIABETES, V1, P9, DOI 10.1111/j.1753-0407.2009.00009.x; Lahousen T, 2004, WORLD J GASTROENTERO, V10, P2284; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nishihara E, 2011, CLIN CHIM ACTA, V412, P1689, DOI 10.1016/j.cca.2011.05.029; Schnedl WJ, 2001, DIABETES-METAB RES, V17, P94, DOI 10.1002/dmrr.186	5	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2013	382	9889					366	366		10.1016/S0140-6736(13)60815-6	http://dx.doi.org/10.1016/S0140-6736(13)60815-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FT	23890045				2022-12-28	WOS:000322544900035
J	Li, Y; Hsin, J; Zhao, LY; Cheng, YW; Shang, WN; Huang, KC; Wang, HW; Ye, S				Li, Ying; Hsin, Jen; Zhao, Lingyun; Cheng, Yiwen; Shang, Weina; Huang, Kerwyn Casey; Wang, Hong-Wei; Ye, Sheng			FtsZ Protofilaments Use a Hinge-Opening Mechanism for Constrictive Force Generation	SCIENCE			English	Article							DIVISION PROTEIN FTSZ; CELL-DIVISION; STRUCTURAL INSIGHTS; Z-RING; TUBULIN; POLYMERIZATION; CONFORMATIONS; ACTIVATION; MUTANTS	The essential bacterial protein FtsZ is a guanosine triphosphatase that self-assembles into a structure at the division site termed the "Z ring". During cytokinesis, the Z ring exerts a constrictive force on the membrane by using the chemical energy of guanosine triphosphate hydrolysis. However, the structural basis of this constriction remains unresolved. Here, we present the crystal structure of a guanosine diphosphate-bound Mycobacterium tuberculosis FtsZ protofilament, which exhibits a curved conformational state. The structure reveals a longitudinal interface that is important for function. The protofilament curvature highlights a hydrolysis-dependent conformational switch at the T3 loop that leads to longitudinal bending between subunits, which could generate sufficient force to drive cytokinesis.	[Li, Ying; Cheng, Yiwen; Shang, Weina; Ye, Sheng] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Hsin, Jen; Huang, Kerwyn Casey] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Zhao, Lingyun; Wang, Hong-Wei] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Minist Educ,Key Lab Prot Sci,Ctr Struct Biol, Beijing 100084, Peoples R China; [Ye, Sheng] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Stanford University; Tsinghua University; Zhejiang University	Ye, S (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	sye@zju.edu.cn			National Natural Science Foundation of China [31070661]; Ministry of Science and Technology [2011CB910500, 2010CB912401, 2012CB966600]; Natural Science Foundation of Zhejiang Province [R2100439]; Specialized Research Fund for the Doctoral Program of Higher Education [20110101110122]; Fundamental Research Funds for the Central Universities; Research Funds of the Tsinghua-Peking Center for Life Sciences; NIH [DP2OD006466]; Stanford University School of Medicine; NIH Ruth L. Kirschstein National Research Service Award [1F32GM100677-01A1]; National Science Foundation of China [31090360]; NSF [OCI-1053575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100677] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006466] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Funds of the Tsinghua-Peking Center for Life Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University School of Medicine; NIH Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Erickson for insightful suggestions and the pJSB100 vector; J. Lutkenhaus for the JKD7-1/pKD3 strain; M. Rajagopalan for M. tuberculosis genomic DNA; Y. Huang, Y. Jiang, H. Song, X. Feng, and J. T. Shaw for discussions and critical reviews of the manuscript; S. Huang and J. He at the Shanghai Synchrotron Radiation Facility for on-site assistance; and Y. Xu at the National Center for Protein Sciences Beijing for EM facility assistance. This work was supported in part by funds from the National Natural Science Foundation of China (grant 31070661), the Ministry of Science and Technology (grants 2011CB910500 and 2010CB912401), the Natural Science Foundation of Zhejiang Province (grant R2100439), and the Specialized Research Fund for the Doctoral Program of Higher Education (grant 20110101110122), as well as the Fundamental Research Funds for the Central Universities (to S.Y.); Research Funds of the Tsinghua-Peking Center for Life Sciences (to H.-W.W.); a NIH Director's New Innovator Award DP2OD006466 (to K. C. H.); and a Stanford University School of Medicine Dean's Postdoctoral Fellowship and an NIH Ruth L. Kirschstein National Research Service Award 1F32GM100677-01A1 (to J.H.). Y.C. is supported by the National Science Foundation of China (grant 31090360) and the Ministry of Science and Technology (grant 2012CB966600). All simulations were performed with computer time provided by the Extreme Science and Engineering Discovery Environment, which is supported by NSF grant OCI-1053575, with allocation number TG-MCB110056 (to J.H. and K. C. H.). The structure coordinates and reflection files are deposited in the Protein Data Bank (PDB) under identification (ID) number 4KWE. We declare no competing financial interests.	Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; Diaz JF, 2001, J BIOL CHEM, V276, P17307, DOI 10.1074/jbc.M010920200; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Hsin J, 2012, P NATL ACAD SCI USA, V109, P9432, DOI 10.1073/pnas.1120761109; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Huecas S, 2007, J BIOL CHEM, V282, P37515, DOI 10.1074/jbc.M706399200; Lappchen T, 2008, CHEM BIOL, V15, P189, DOI 10.1016/j.chembiol.2007.12.013; Leung AKW, 2004, J MOL BIOL, V342, P953, DOI 10.1016/j.jmb.2004.07.061; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Matsui T, 2012, ACTA CRYSTALLOGR D, V68, P1175, DOI 10.1107/S0907444912022640; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Raymond A, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-37; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Scheffers DJ, 2001, FEBS LETT, V506, P6, DOI 10.1016/S0014-5793(01)02855-1; Sossong TM, 1999, BIOCHEMISTRY-US, V38, P14843, DOI 10.1021/bi990917e; Stricker J, 2003, J BACTERIOL, V185, P4796, DOI 10.1128/JB.185.16.4796-4805.2003; Tan CM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003592	23	104	108	6	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					392	395		10.1126/science.1239248	http://dx.doi.org/10.1126/science.1239248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888039	Green Accepted			2022-12-28	WOS:000322259200048
J	Mahaffy, PR; Webster, CR; Atreya, SK; Franz, H; Wong, M; Conrad, PG; Harpold, D; Jones, JJ; Leshin, LA; Manning, H; Owen, T; Pepin, RO; Squyres, S; Trainer, M				Mahaffy, Paul R.; Webster, Christopher R.; Atreya, Sushil K.; Franz, Heather; Wong, Michael; Conrad, Pamela G.; Harpold, Dan; Jones, John J.; Leshin, Laurie A.; Manning, Heidi; Owen, Tobias; Pepin, Robert O.; Squyres, Steven; Trainer, Melissa		MSL Sci Team	Abundance and Isotopic Composition of Gases in the Martian Atmosphere from the Curiosity Rover	SCIENCE			English	Article							NOBLE-GASES; SNC METEORITES; CARBON-DIOXIDE; MARS; ORIGIN; NITROGEN; RATIOS; SHERGOTTITES; SIGNATURES; SOLAR	Volume mixing and isotope ratios secured with repeated atmospheric measurements taken with the Sample Analysis at Mars instrument suite on the Curiosity rover are: carbon dioxide (CO2), 0.960(+/-0.007); argon-40 (Ar-40), 0.0193(+/-0.0001); nitrogen (N-2), 0.0189(+/-0.0003); oxygen, 1.45(+/-0.09) x 10(-3); carbon monoxide, < 1.0 x 10(-3); and Ar-40/Ar-36, 1.9(+/-0.3) x 10(3). The Ar-40/N-2 ratio is 1.7 times greater and the Ar-40/Ar-36 ratio 1.6 times lower than values reported by the Viking Lander mass spectrometer in 1976, whereas other values are generally consistent with Viking and remote sensing observations. The Ar-40/Ar-36 ratio is consistent with martian meteoritic values, which provides additional strong support for a martian origin of these rocks. The isotopic signature delta C-13 from CO2 of similar to 45 per mil is independently measured with two instruments. This heavy isotope enrichment in carbon supports the hypothesis of substantial atmospheric loss.	[Mahaffy, Paul R.; Franz, Heather; Conrad, Pamela G.; Harpold, Dan; Trainer, Melissa] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Webster, Christopher R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Atreya, Sushil K.; Wong, Michael] Univ Michigan, Ann Arbor, MI 48109 USA; [Jones, John J.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Leshin, Laurie A.] Rensselaer Polytech Inst, Troy, NY 12180 USA; [Manning, Heidi] Concordia Coll, Moorhead, MN 56562 USA; [Owen, Tobias] Univ Hawaii, Honolulu, HI 96822 USA; [Pepin, Robert O.] Univ Minnesota, Minneapolis, MN 55455 USA; [Squyres, Steven] Cornell Univ, Ithaca, NY 14853 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Michigan System; University of Michigan; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Rensselaer Polytechnic Institute; University of Hawaii System; University of Minnesota System; University of Minnesota Twin Cities; Cornell University	Mahaffy, PR (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	paul.r.mahaffy@nasa.gov	Stipp, Susan L.S./B-8494-2019; Hayes, Alexander G/P-2024-2014; Glavin, Daniel P/D-6194-2012; Gomez-Elvira, Javier/K-5829-2014; Harri, Ari-Matti/C-7142-2012; Rodriguez-Manfredi, Jose/L-8001-2014; GEFFROY, Claude/AAB-9152-2019; Malakhov, Alexey Vladimirovich/F-7953-2017; Navarro-González, Rafael/D-1748-2009; FABRE, Cécile/B-5827-2012; Gómez, Felipe/L-7315-2014; Zorzano, María-Paz/F-2184-2015; Steele, Andrew/A-3573-2013; Teinturier, Samuel/AAS-8663-2020; Floyd, Melissa/D-4626-2012; Blanco, Juan Jose/E-3627-2014; szopa, cyril/C-6865-2015; Franz, Heather B/F-3508-2012; Dworkin, Jason P./C-9417-2012; Balic-Zunic, Tonci/A-6362-2013; Webster, Chris/M-9315-2019; Lemmon, Mark T/E-9983-2010; Rodriguez-Manfredi, Jose/AAG-9826-2021; Muñoz, Guillermo M/L-6370-2014; Muller, Jan-Peter/Q-8886-2019; De Pablo, Miguel Ángel/J-6442-2014; Martin-Torres, Javier/G-6329-2015; Ramos, Miguel/K-2230-2014; Benna, Mehdi/F-3489-2012; Prats, Benito/F-9467-2019; Trainer, Melissa G/E-1477-2012; Avalos, Juan Jose Blanco/AAB-9447-2021; Gasnault, Olivier/F-4327-2010; Vicenzi, Edward/T-9430-2017	Stipp, Susan L.S./0000-0001-7009-643X; Hayes, Alexander G/0000-0001-6397-2630; Glavin, Daniel P/0000-0001-7779-7765; Gomez-Elvira, Javier/0000-0002-9068-9846; Harri, Ari-Matti/0000-0001-8541-2802; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; GEFFROY, Claude/0000-0002-2731-9658; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Navarro-González, Rafael/0000-0002-6078-7621; FABRE, Cécile/0000-0001-8627-4050; Gómez, Felipe/0000-0001-9977-7060; Zorzano, María-Paz/0000-0002-4492-9650; Steele, Andrew/0000-0001-9643-2841; Teinturier, Samuel/0000-0003-1755-9524; Blanco, Juan Jose/0000-0002-8666-0696; szopa, cyril/0000-0002-0090-4056; Dworkin, Jason P./0000-0002-3961-8997; Balic-Zunic, Tonci/0000-0003-1687-1233; Lemmon, Mark T/0000-0002-4504-5136; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Muñoz, Guillermo M/0000-0001-7003-7368; Muller, Jan-Peter/0000-0002-5077-3736; De Pablo, Miguel Ángel/0000-0002-4496-2741; Martin-Torres, Javier/0000-0001-6479-2236; Ramos, Miguel/0000-0003-3648-6818; Prats, Benito/0000-0003-3869-3351; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Gasnault, Olivier/0000-0002-6979-9012; Wilson, Sharon/0000-0001-8872-8546; Vicenzi, Edward/0000-0003-2085-6546	UK Space Agency [ST/I003118/1] Funding Source: researchfish	UK Space Agency		Aoudjehane HC, 2012, SCIENCE, V338, P785, DOI 10.1126/science.1224514; BECKER RH, 1984, EARTH PLANET SC LETT, V69, P225, DOI 10.1016/0012-821X(84)90183-3; Billebaud F, 2009, PLANET SPACE SCI, V57, P1446, DOI 10.1016/j.pss.2009.07.004; BOGARD D, 1986, METEORITICS, V21, P337; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; Bogard DD, 2001, SPACE SCI REV, V96, P425, DOI 10.1023/A:1011974028370; Bogard DD, 1998, METEORIT PLANET SCI, V33, pA19; CARR RH, 1985, NATURE, V314, P248, DOI 10.1038/314248a0; Economou T. E., 2010, 41 LUN PLAN I SCI C; Garrison DH, 2000, METEORIT PLANET SCI, V35, pA58; Grotzinger JP, 2012, SPACE SCI REV, V170, P5, DOI 10.1007/s11214-012-9892-2; Hartogh P, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201015160; Hartogh P, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201015159; Jakosky BM, 1997, REV GEOPHYS, V35, P1, DOI 10.1029/96RG02903; JAKOSKY BM, 1994, ICARUS, V111, P271, DOI 10.1006/icar.1994.1145; Jull AJT, 1997, J GEOPHYS RES-PLANET, V102, P1663, DOI 10.1029/96JE03111; Krasnopolsky VA, 2007, ICARUS, V192, P396, DOI 10.1016/j.icarus.2007.08.013; Krasnopolsky VA, 2007, ICARUS, V190, P93, DOI 10.1016/j.icarus.2007.02.014; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; MARTI K, 1995, SCIENCE, V267, P1981, DOI 10.1126/science.7701319; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; Murty SVS, 1997, GEOCHIM COSMOCHIM AC, V61, P5417, DOI 10.1016/S0016-7037(97)00315-3; NIER AO, 1976, SCIENCE, V194, P1298, DOI 10.1126/science.194.4271.1298; Niles PB, 2010, SCIENCE, V329, P1334, DOI 10.1126/science.1192863; OTT U, 1988, GEOCHIM COSMOCHIM AC, V52, P1937, DOI 10.1016/0016-7037(88)90017-8; OTT U, 1985, METEORITICS, V20, P721; OWEN T, 1995, ICARUS, V116, P215, DOI 10.1006/icar.1995.1122; Owen T., 1977, J GEOPHYS RES, V82, P4635, DOI DOI 10.1029/JS082I028P04635; Owen T., 1994, AIP C P, V341, P123; PEPIN RO, 1985, NATURE, V317, P473, DOI 10.1038/317473a0; PEPIN RO, 1994, ICARUS, V111, P289, DOI 10.1006/icar.1994.1146; Sindoni G, 2011, PLANET SPACE SCI, V59, P149, DOI 10.1016/j.pss.2010.12.006; Smith MD, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003288; Sprague AL, 2004, SCIENCE, V306, P1364, DOI 10.1126/science.1098496; Swindle T. D., 1994, AIP C P, V341, P175; Swindle TD, 1997, J GEOPHYS RES-PLANET, V102, P1671, DOI 10.1029/96JE03110; Treiman AH, 2000, PLANET SPACE SCI, V48, P1213, DOI 10.1016/S0032-0633(00)00105-7; Webster CR, 2013, SCIENCE, V341, P260, DOI 10.1126/science.1237961; WIENS RC, 1988, GEOCHIM COSMOCHIM AC, V52, P295, DOI 10.1016/0016-7037(88)90085-3; WIENS RC, 1986, EARTH PLANET SC LETT, V77, P149, DOI 10.1016/0012-821X(86)90156-1	41	245	249	4	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143					263	266		10.1126/science.1237966	http://dx.doi.org/10.1126/science.1237966			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869014				2022-12-28	WOS:000321959300039
J	Kagan, JC				Kagan, Jonathan C.			Recognition for an Innate Explorer	CELL			English	Editorial Material									[Kagan, Jonathan C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Kagan, JC (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu			NIAID NIH HHS [AI103082, R01 AI093589, AI093589, R56 AI103082] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093589, R56AI103082] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	0	0	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					261	264		10.1016/j.cell.2013.06.047	http://dx.doi.org/10.1016/j.cell.2013.06.047			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870114	Bronze			2022-12-28	WOS:000321950700001
J	Kim, JY; Zhao, H; Martinez, J; Doggett, TA; Kolesnikov, AV; Tang, PH; Ablonczy, Z; Chan, CC; Zhou, ZQ; Green, DR; Ferguson, TA				Kim, Ji-Young; Zhao, Hui; Martinez, Jennifer; Doggett, Teresa Ann; Kolesnikov, Alexander V.; Tang, Peter H.; Ablonczy, Zsolt; Chan, Chi-Chao; Zhou, Zhenqing; Green, Douglas R.; Ferguson, Thomas A.			Noncanonical Autophagy Promotes the Visual Cycle	CELL			English	Article							RETINAL-PIGMENT EPITHELIUM; LIPID-PEROXIDATION PRODUCTS; LEBER CONGENITAL AMAUROSIS; AGE-RELATED MACULOPATHY; PHOTORECEPTOR DEGENERATION; ALPHA-V-BETA-5 INTEGRIN; MACULAR DEGENERATION; TARGETED DISRUPTION; BINDING PROTEIN; OUTER SEGMENTS	Phagocytosis and degradation of photoreceptor outer segments (POS) by retinal pigment epithelium (RPE) is fundamental to vision. Autophagy is also responsible for bulk degradation of cellular components, but its role in POS degradation is not well understood. We report that the morning burst of RPE phagocytosis coincided with the enzymatic conversion of autophagy protein LC3 to its lipidated form. LC3 associated with single-membrane phagosomes containing engulfed POS in an Atg5-dependent manner that required Beclin1, but not the autophagy preinitiation complex. The importance of this process was verified in mice with Atg5-deficient RPE cells that showed evidence of disrupted lysosomal processing. These mice also exhibited decreased photoreceptor responses to light stimuli and decreased chromophore levels that were restored with exogenous retinoid supplementation. These results establish that the interplay of phagocytosis and autophagy within the RPE is required for both POS degradation and the maintenance of retinoid levels to support vision.	[Kim, Ji-Young; Zhao, Hui; Doggett, Teresa Ann; Kolesnikov, Alexander V.; Zhou, Zhenqing; Ferguson, Thomas A.] Washington Univ, St Louis Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Martinez, Jennifer; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Tang, Peter H.; Ablonczy, Zsolt] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Chan, Chi-Chao] NEI, Immunopathol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	Saint Louis University; Washington University (WUSTL); St Jude Children's Research Hospital; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org; ferguson@vision.wustl.edu	Zhou, Zhenqing/I-7260-2016; Green, Douglas R/N-8083-2018; Kolesnikov, Alexander V/O-1840-2016; Martinez, Jennifer/C-3740-2019	Green, Douglas R/0000-0002-7332-1417; Martinez, Jennifer/0000-0002-3060-2518	National Institutes of Health [EY015570, AI40646]; Department of Ophthalmology and Visual Sciences [EY02687]; Research to Prevent Blindness (New York); BrightFocus Foundation (Clarksburg); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000222, R01EY015570, P30EY002687, R01EY019065, ZICEY000461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Ophthalmology and Visual Sciences; Research to Prevent Blindness (New York)(Research to Prevent Blindness (RPB)); BrightFocus Foundation (Clarksburg)(BrightFocus Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants EY015570 (to T.A.F.) and AI40646 (to D.R.G.) and the Department of Ophthalmology and Visual Sciences core grant (EY02687). Support was also received from Research to Prevent Blindness (New York) and the BrightFocus Foundation (Clarksburg). The authors would like to thank Wandy Beatty for performing the TEM and Jayoung Choi for assistance with the figure layouts.	BOK D, 1993, J CELL SCI, P189; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; BOSCH E, 1993, J HISTOCHEM CYTOCHEM, V41, P253, DOI 10.1177/41.2.8419462; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Davidson AE, 2011, INVEST OPHTH VIS SCI, V52, P3730, DOI 10.1167/iovs.10-6707; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Edwards RB, 2000, EXP EYE RES, V70, P235, DOI 10.1006/exer.1999.0781; EDWARDS RB, 1977, SCIENCE, V197, P1001, DOI 10.1126/science.560718; Esumi N, 2004, J BIOL CHEM, V279, P19064, DOI 10.1074/jbc.M309881200; Fan J, 2008, INVEST OPHTH VIS SCI, V49, P2384, DOI 10.1167/iovs.08-1727; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gordiyenko NV, 2010, INVEST OPHTH VIS SCI, V51, P1143, DOI 10.1167/iovs.09-4117; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Jackson GR, 2002, AGEING RES REV, V1, P381, DOI 10.1016/S1568-1637(02)00007-7; KATZ ML, 1987, MECH AGEING DEV, V39, P81, DOI 10.1016/0047-6374(87)90088-1; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kopitz J, 2004, BIOCHIMIE, V86, P825, DOI 10.1016/j.biochi.2004.09.029; Krohne TU, 2010, EXP EYE RES, V90, P465, DOI 10.1016/j.exer.2009.12.011; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Kunchithapautham K, 2007, AUTOPHAGY, V3, P65, DOI 10.4161/auto.3431; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Liou GI, 1998, J NEUROSCI, V18, P4511; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nandrot EF, 2006, AM J PHYSIOL-CELL PH, V290, pC1256, DOI 10.1152/ajpcell.00480.2005; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Nishiyama J, 2007, AUTOPHAGY, V3, P591, DOI 10.4161/auto.4964; Owsley C, 2006, INVEST OPHTH VIS SCI, V47, P1310, DOI 10.1167/iovs.05-1292; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; Rakoczy PE, 1997, BIOCHEM J, V324, P935, DOI 10.1042/bj3240935; Ramkumar HL, 2010, PROG RETIN EYE RES, V29, P169, DOI 10.1016/j.preteyeres.2010.02.002; Reme CE, 1999, INVEST OPHTH VIS SCI, V40, P2398; Ripps H, 2000, VISUAL NEUROSCI, V17, P97, DOI 10.1017/S095252380017110X; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Ruiz A, 2007, INVEST OPHTH VIS SCI, V48, P5377, DOI 10.1167/iovs.07-0673; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sanjuan MA, 2009, IMMUNOL REV, V227, P203, DOI 10.1111/j.1600-065X.2008.00732.x; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Tang PH, 2011, J NEUROSCI, V31, P18618, DOI 10.1523/JNEUROSCI.4265-11.2011; Tang PH, 2010, INVEST OPHTH VIS SCI, V51, P5958, DOI 10.1167/iovs.10-5766; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; WAHL HW, 1994, Z GERONTOL, V27, P399; Wang AL, 2009, AUTOPHAGY, V5, P1190, DOI 10.4161/auto.5.8.10087; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Zhang T, 2011, P NATL ACAD SCI USA, V108, P8879, DOI 10.1073/pnas.1017127108; Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653	63	236	240	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 18	2013	154	2					365	376		10.1016/j.cell.2013.06.012	http://dx.doi.org/10.1016/j.cell.2013.06.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870125	Green Accepted, Bronze			2022-12-28	WOS:000321950700013
J	Nussbaum, AM				Nussbaum, Abraham M.			Interpreters or Teachers?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Nussbaum, Abraham M.] Denver Hlth, Behav Hlth, Denver, CO USA; [Nussbaum, Abraham M.] Univ Chicago, Program Med & Relig, Chicago, IL 60637 USA	Denver Health Medical Center; University of Chicago	Nussbaum, AM (corresponding author), Denver Hlth, Behav Hlth, Denver, CO USA.	abraham.nussbaum@dhha.org		Nussbaum, Abraham/0000-0002-7593-0523				Breuer J., 1955, STANDARD EDITION COM, V2; Clarke DM, 2012, PSYCHOTHERAPY OF HOPE: THE LEGACY OF PERSUASION AND HEALING, P125; Farah Martha J, 2012, AJOB Neurosci, V3, P31; Frank JD, 1993, PERSUASION HEALING C; Freedman R, 2013, AM J PSYCHIAT, V170, P1, DOI 10.1176/appi.ajp.2012.12091189; Horwitz RI., 2009, BMJ-BRIT MED J, V339, P1385; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Kupfer DJ, 2013, JAMA-J AM MED ASSOC, V309, P1691, DOI 10.1001/jama.2013.2298; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Shorter Edward, 2013, EVERYONE BECAME DEPR; Stanford School of Medicine, STANF IN BEDS MED; Verghese A., 2012, WRITER MD BEST CONT, P3; Verghese A, 2008, NEW ENGL J MED, V359, P2748, DOI 10.1056/NEJMp0807461	13	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					265	266		10.1001/jama.2013.8321	http://dx.doi.org/10.1001/jama.2013.8321			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23860983				2022-12-28	WOS:000321835700011
J	Griffin, MR; Zhu, YW; Moore, MR; Whitney, CG; Grijalva, CG				Griffin, Marie R.; Zhu, Yuwei; Moore, Matthew R.; Whitney, Cynthia G.; Grijalva, Carlos G.			US Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; CHILDHOOD IMMUNIZATION; YOUNG-CHILDREN; DISEASE; IMPACT; PREVENTION; SEROTYPES; CARRIAGE; TRENDS	BACKGROUND The introduction of 7-valent pneumococcal conjugate vaccine (PCV7) into the U. S. childhood immunization schedule in 2000 has substantially reduced the incidence of vaccine-serotype invasive pneumococcal disease in young children and in unvaccinated older children and adults. By 2004, hospitalizations associated with pneumonia from any cause had also declined markedly among young children. Because of concerns about increases in disease caused by nonvaccine serotypes, we wanted to determine whether the reduction in pneumonia-related hospitalizations among young children had been sustained through 2009 and whether such hospitalizations in older age groups had also declined. METHODS We estimated annual rates of hospitalization for pneumonia from any cause using the Nationwide Inpatient Sample database. The reason for hospitalization was classified as pneumonia if pneumonia was the first listed diagnosis or if it was listed after a first diagnosis of sepsis, meningitis, or empyema. Average annual rates of pneumonia-related hospitalizations from 1997 through 1999 (before the introduction of PCV7) and from 2007 through 2009 (well after its introduction) were used to estimate annual declines in hospitalizations due to pneumonia. RESULTS The annual rate of hospitalization for pneumonia among children younger than 2 years of age declined by 551.1 per 100,000 children (95% confidence interval [CI], 445.1 to 657.1), which translates to 47,000 fewer hospitalizations annually than expected on the basis of the rates before PCV7 was introduced. The rate for adults 85 years of age or older declined by 1300.8 per 100,000 (95% CI, 984.0 to 1617.6), which translates to 73,000 fewer hospitalizations annually. For the three age groups of 18 to 39 years, 65 to 74 years, and 75 to 84 years, the annual rate of hospitalization for pneumonia declined by 8.4 per 100,000 (95% CI, 0.6 to 16.2), 85.3 per 100,000 (95% CI, 7.0 to 163.6), and 359.8 per 100,000 (95% CI, 199.6 to 520.0), respectively. Overall, we estimated an age-adjusted annual reduction of 54.8 per 100,000 (95% CI, 41.0 to 68.5), or 168,000 fewer hospitalizations for pneumonia annually. CONCLUSIONS Declines in hospitalizations for childhood pneumonia were sustained during the decade after the introduction of PCV7. Substantial reductions in hospitalizations for pneumonia among adults were also observed. (Funded by the Centers for Disease Control and Prevention.)	[Griffin, Marie R.; Grijalva, Carlos G.] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA; [Griffin, Marie R.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Zhu, Yuwei] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Griffin, Marie R.; Grijalva, Carlos G.] Vet Affairs Tennessee Valley Hlth Care Syst, Midsouth Geriatr Res Educ & Clin Ctr, Nashville, TN USA; [Moore, Matthew R.; Whitney, Cynthia G.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Centers for Disease Control & Prevention - USA	Griffin, MR (corresponding author), Village Vanderbilt, Dept Prevent Med, Suite 2600,1500 21st Ave S, Nashville, TN 37212 USA.	marie.griffin@vanderbilt.edu		Grijalva, Carlos/0000-0002-2329-7797	Centers for Disease Control and Prevention [11-IPA1110211, 12-IPA1210402]; Thrasher Research Fund [02832-9]; Glaxo-SmithKline; Pfizer	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Thrasher Research Fund; Glaxo-SmithKline(GlaxoSmithKline); Pfizer(Pfizer)	Supported in part by grants from the Centers for Disease Control and Prevention (11-IPA1110211, to Dr. Griffin, and 12-IPA1210402, to Dr. Grijalva) and the Thrasher Research Fund (02832-9, to Dr. Grijalva).; Dr. Grijalva reports receiving consulting fees from Glaxo-SmithKline and grant support through his institution from Pfizer; and Dr. Griffin, grant support through her institution from Pfizer. No other potential conflict of interest relevant to this article was reported.	Agency for Healthcare Research and Quality (US), 2009, FACTS FIG STAT HOSP; Bartlett JG, 2011, CLIN INFECT DIS, V52, pS296, DOI 10.1093/cid/cir045; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Bewick T, 2012, THORAX, V67, P540, DOI 10.1136/thoraxjnl-2011-201092; Centers for Disease Control and Prevention, SEAS INFL FLU VACC T; Cohen AL, 2010, AIDS, V24, P2253, DOI 10.1097/QAD.0b013e32833d46fd; Feikin DR, 2005, CLIN INFECT DIS, V41, P481, DOI 10.1086/432015; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Grijalva CG, 2006, PEDIATRICS, V118, P865, DOI 10.1542/peds.2006-0492; Grijalva CG, 2010, CLIN INFECT DIS, V50, P805, DOI 10.1086/650573; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Jardine A, 2010, PEDIATR INFECT DIS J, V29, P607, DOI 10.1097/INF.0b013e3181d7d09c; Kayhty H, 2006, EXPERT REV VACCINES, V5, P651, DOI 10.1586/14760584.5.5.651; Klugman K P, 2001, Lancet Infect Dis, V1, P85, DOI 10.1016/S1473-3099(01)00063-9; Koshy E, 2010, THORAX, V65, P770, DOI 10.1136/thx.2010.137802; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; Muhammad Riyadh D, 2013, Clin Infect Dis, V56, pe59, DOI 10.1093/cid/cis971; Musher DM, 2012, CLIN INFECT DIS, V55, P265, DOI 10.1093/cid/cis364; O'Brien KL, 2009, PEDIATR INFECT DIS J, V28, P463, DOI 10.1097/INF.0b013e31819b9085; Pelton SI, 2004, PEDIATR INFECT DIS J, V23, P1015, DOI 10.1097/01.inf.0000143645.58215.f0; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Poehling KA, 2004, PEDIATRICS, V114, P755, DOI 10.1542/peds.2003-0592-F; Potter R., 2009, Morbidity and Mortality Weekly Report, V58, P1059; Rosen JB, 2011, CLIN INFECT DIS, V53, P137, DOI 10.1093/cid/cir326; Shapiro ED, 2012, JAMA-J AM MED ASSOC, V307, P847, DOI 10.1001/jama.2012.194; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Wroe PC, 2012, PEDIATR INFECT DIS J, V31, P249, DOI 10.1097/INF.0b013e31824214ac; Zhou FJ, 2007, ARCH PEDIAT ADOL MED, V161, P1162, DOI 10.1001/archpedi.161.12.1162	37	372	386	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					155	163		10.1056/NEJMoa1209165	http://dx.doi.org/10.1056/NEJMoa1209165			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180BH	23841730	Green Accepted			2022-12-28	WOS:000321567300011
J	Sullivan, RJ; Lawrence, DP; Wargo, JA; Oh, KS; Gonzalez, RG; Piris, A				Sullivan, Ryan J.; Lawrence, Donald P.; Wargo, Jennifer A.; Oh, Kevin S.; Gonzalez, R. Gilberto; Piris, Adriano			Case 21-2013: A 68-Year-Old Man with Metastatic Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; BRAIN METASTASES; OPEN-LABEL; ANTITUMOR-ACTIVITY; IMPROVED SURVIVAL; MEK INHIBITION; PHASE-2 TRIAL; T-CELLS; IPILIMUMAB; VEMURAFENIB		[Sullivan, Ryan J.; Lawrence, Donald P.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Wargo, Jennifer A.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Oh, Kevin S.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Dept Neuroradiol, Boston, MA 02114 USA; [Piris, Adriano] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sullivan, Ryan J.; Lawrence, Donald P.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Wargo, Jennifer A.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Oh, Kevin S.] Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Dept Neuroradiol, Boston, MA USA; [Piris, Adriano] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Sullivan, RJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Ackerman A, 2012, J CLIN ONCOL, V30; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-107; Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davies MA, 2011, CANCER-AM CANCER SOC, V117, P1687, DOI 10.1002/cncr.25634; Falchook GS, 2012, LANCET, V379, P1893, DOI 10.1016/S0140-6736(12)60398-5; Flaherty Keith, 2010, Clin Adv Hematol Oncol, V8, P31; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Joseph RW, 2012, J IMMUNOTHER, V35, P711, DOI 10.1097/CJI.0b013e3182742c27; Khalili JS, 2012, CLIN CANCER RES, V18, P5329, DOI 10.1158/1078-0432.CCR-12-1632; KINGSLEY DPE, 1975, BRIT J RADIOL, V48, P863, DOI 10.1259/0007-1285-48-574-863; Kocher M, 2011, J CLIN ONCOL, V29, P134, DOI 10.1200/JCO.2010.30.1655; Koya RC, 2012, CANCER RES, V72, P3928, DOI 10.1158/0008-5472.CAN-11-2837; Liu CW, 2013, CLIN CANCER RES, V19, P393, DOI 10.1158/1078-0432.CCR-12-1626; Long GV, 2012, LANCET ONCOL, V13, P1087, DOI 10.1016/S1470-2045(12)70431-X; Margolin K, 2012, LANCET ONCOL, V13, P459, DOI 10.1016/S1470-2045(12)70090-6; MOLE RH, 1953, BRIT J RADIOL, V26, P234, DOI 10.1259/0007-1285-26-305-234; Patchell RA, 1998, JAMA-J AM MED ASSOC, V280, P1485, DOI 10.1001/jama.280.17.1485; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Shahabi V, 2012, CANCER IMMUNOL IMMUN, V61, P733, DOI 10.1007/s00262-012-1227-3; Shaw E, 2000, INT J RADIAT ONCOL, V47, P291, DOI 10.1016/S0360-3016(99)00507-6; Smith FO, 2007, J IMMUNOTHER, V30, P130, DOI 10.1097/01.cji.0000211334.06762.89; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vultur A, 2011, CLIN CANCER RES, V17, P1658, DOI 10.1158/1078-0432.CCR-10-0174; Weber JS, 2012, J CLIN ONCOL, V30, P2691, DOI 10.1200/JCO.2012.41.6750; Wilmott JS, 2012, CLIN CANCER RES, V18, P1386, DOI 10.1158/1078-0432.CCR-11-2479; Zhang B, 2007, J EXP MED, V204, P49, DOI 10.1084/jem.20062056	39	26	27	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					173	183		10.1056/NEJMcpc1302332	http://dx.doi.org/10.1056/NEJMcpc1302332			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180BH	23841733				2022-12-28	WOS:000321567300014
J	Bay, B; Mortensen, EL; Hvidtjorn, D; Kesmodel, US				Bay, Bjorn; Mortensen, Erik Lykke; Hvidtjorn, Dorte; Kesmodel, Ulrik Schioler			Fertility treatment and risk of childhood and adolescent mental disorders: register based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IN-VITRO FERTILIZATION; CHILDREN BORN; ASSISTED REPRODUCTION; OUTCOMES; IVF; HEALTH; ICSI	Objective To assess the mental health of children born after fertility treatment by comparing their risk of mental disorders with that of spontaneously conceived children. Design Prospective register based cohort study. Setting Nationwide register based information from Danish National Health Registers cross linked by a unique personal identification number assigned to all citizens in Denmark. Participants All children born in Denmark in 1995-2003 with follow-up in 2012 when the children were aged 8-17; 33 139 children were conceived after fertility treatment and 555 828 children were born after spontaneous conception. Main outcome measures Absolute risks and hazard ratios for overall and specific mental disorders estimated with adjustment for potential confounding variables. Estimated association between the risk of mental disorders and subtypes of procedures, hormone treatments, gamete types, and cause of infertility. Results The risk of mental disorders in children born after in vitro fertilisation or intracytoplasmic sperm injection was low, and was no higher than in spontaneously conceived children, except for a borderline significant increased risk of tic disorders (hazard ratio 1.40, 95% confidence interval 1.01 to 1.95; absolute risk 0.3%). In contrast, children born after ovulation induction with or without insemination had low but significantly increased risks of any mental disorder (1.20, 1.11 to 1.31; absolute risk 4.1%), autism spectrum disorders (1.20, 1.05 to 1.37; 1.5%), hyperkinetic disorders (1.23, 1.08 to 1.40; 1.7%), conduct, emotional, or social disorder (1.21, 1.02 to 1.45; 0.8%), and tic disorders (1.51, 1.16 to 1.96; 0.4%). There was no risk systematically related to any specific type of hormone drug treatment. Conclusions There was a small increase in the incidence of mental disorders in children born after ovulation induction/intrauterine insemination. Children born after in vitro fertilisation/intracytoplasmic sperm injection were found to have overall risk comparable with children conceived spontaneously.	[Bay, Bjorn; Kesmodel, Ulrik Schioler] Aarhus Univ, Epidemiol Sect, Sch Publ Hlth, DK-8000 Aarhus C, Denmark; [Bay, Bjorn; Kesmodel, Ulrik Schioler] Aarhus Univ Hosp, Dept Obstet & Gynaecol, Fertil Clin, DK-8200 Aarhus N, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Inst Publ Hlth, DK-1353 Copenhagen K, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Ctr Hlth Aging, DK-1353 Copenhagen K, Denmark; [Hvidtjorn, Dorte] Univ Southern Denmark, Inst Publ Hlth, DK-5000 Odense C, Denmark	Aarhus University; Aarhus University; University of Copenhagen; University of Copenhagen; University of Southern Denmark	Bay, B (corresponding author), Aarhus Univ, Epidemiol Sect, Sch Publ Hlth, Bartholins Alle 2, DK-8000 Aarhus C, Denmark.	bjornbay@me.com		Mortensen, Erik Lykke/0000-0002-6985-451X; Hvidtjorn, Dorte/0000-0003-1111-9114; Bay, Bjorn/0000-0001-9304-9695	Aarhus University; Augustinus Foundation, Denmark	Aarhus University; Augustinus Foundation, Denmark	This study was funded by a fellowship granted by Aarhus University and partially funded by the Augustinus Foundation, Denmark. The sources of funding had no role in study design, data collection, analysis, interpretation, writing the report, or in the decision to submit the article for publication.	Andersen AN, 1999, DAN MED BULL, V46, P357; [Anonymous], 2012, WORLDS NUMB IVF ICSI; Barnes J, 2004, HUM REPROD, V19, P1480, DOI 10.1093/humrep/deh239; Carson C, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4473; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; DFS, 2009, YEAR REP; EKPO G, 2011, CONTEMP OBSTET GYNEC, V56, P42; Golombok S, 2002, HUM REPROD, V17, P830, DOI 10.1093/humrep/17.3.830; Himelein MJ, 2006, OBSTET GYNECOL SURV, V61, P723, DOI 10.1097/01.ogx.0000243772.33357.84; Hvidtjorn D, 2011, J EPIDEMIOL COMMUN H, V65, P497, DOI 10.1136/jech.2009.093823; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Kallen AJB, 2011, EUR J PAEDIATR NEURO, V15, P247, DOI 10.1016/j.ejpn.2010.12.004; Kallen B, 2005, FERTIL STERIL, V84, P605, DOI 10.1016/j.fertnstert.2005.03.035; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Klemetti R, 2006, PEDIATRICS, V118, P1819, DOI 10.1542/peds.2006-0735; Klemetti R, 2010, FERTIL STERIL, V93, P1157, DOI 10.1016/j.fertnstert.2008.12.025; Knoester M, 2008, FERTIL STERIL, V90, P289, DOI 10.1016/j.fertnstert.2007.06.090; Knudsen LB, 1998, DAN MED BULL, V45, P320; Levy-Shiff R, 1998, J CLIN CHILD PSYCHOL, V27, P320, DOI 10.1207/s15374424jccp2703_8; Lidegaard O, 2005, HUM REPROD, V20, P950, DOI 10.1093/humrep/deh714; Ludwig A, 2009, FERTIL STERIL, V91, P125, DOI 10.1016/j.fertnstert.2007.11.030; Middelburg KJ, 2008, HUM REPROD UPDATE, V14, P219, DOI 10.1093/humupd/dmn005; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Pinborg A, 2013, HUM REPROD UPDATE, V19, P87, DOI 10.1093/humupd/dms044; Pinborg A, 2010, FERTIL STERIL, V94, P1320, DOI 10.1016/j.fertnstert.2009.05.091; Ponjaert-Kristoffersen I, 2004, HUM REPROD, V19, P2791, DOI 10.1093/humrep/deh511; Ponjaert-Kristoffersen I, 2005, PEDIATRICS, V115, pE283, DOI 10.1542/peds.2004-1445; StataCorp, 2011, STAT STAT SOFTW REL; State MW, 2000, J AM ACAD CHILD PSY, V39, P946, DOI 10.1097/00004583-200008000-00006; Statistics-Denmark, 2012, DOC HIGH COMPL ED, DOI Documentation on highest completed education; Tarlatzis BC, 2008, FERTIL STERIL, V89, P505, DOI 10.1016/j.fertnstert.2007.09.041; Williams KE, 2007, HUM REPROD UPDATE, V13, P607, DOI 10.1093/humupd/dmm019; Zhu JL, 2011, PAEDIATR PERINAT EP, V25, P466, DOI 10.1111/j.1365-3016.2011.01220.x	34	57	59	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2013	347								f3978	10.1136/bmj.f3978	http://dx.doi.org/10.1136/bmj.f3978			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180DN	23833075	hybrid, Green Published			2022-12-28	WOS:000321573400001
J	James, MT; Tonelli, M; Ghali, WA; Knudtson, ML; Faris, P; Manns, BJ; Pannu, N; Galbraith, PD; Hemmelgarn, BR				James, Matthew T.; Tonelli, Marcello; Ghali, William A.; Knudtson, Merril L.; Faris, Peter; Manns, Braden J.; Pannu, Neesh; Galbraith, P. Diane; Hemmelgarn, Brenda R.		Alberta Prov Project Outcome Asses; Alberta Kidney Dis Network Investi	Renal outcomes associated with invasive versus conservative management of acute coronary syndrome: propensity matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE KIDNEY INJURY; CONTRAST-INDUCED NEPHROPATHY; ACUTE MYOCARDIAL-INFARCTION; ARTERY-DISEASE; SERUM CREATININE; RISK SCORE; INTERVENTION; STRATEGY; INSUFFICIENCY; ANGIOGRAPHY	Objectives To examine the association of early invasive management of acute coronary syndrome with adverse renal outcomes and survival, and to determine whether the risks or benefits of early invasive management differ in people with pre-existing chronic kidney disease. Design Propensity score matched cohort study. Setting Acute care hospitals in Alberta, Canada, 2004-09. Participants 10 516 adults with non-ST elevation acute coronary syndrome. Interventions Participants were stratified by baseline estimated glomerular filtration rate and matched 1:1 on their propensity score for early invasive management (coronary catheterisation within two days of hospital admission). Main outcome measures Risks of acute kidney injury, kidney injury requiring dialysis, progression to end stage renal disease, and all cause mortality were compared between those who received early invasive treatment versus conservative treatment. Results Of 10 516 included participants, 4276 (40.7%) received early invasive management. After using propensity score methods to assemble a matched cohort of conservative management participants with characteristics similar to those who received early invasive management (n=6768), early invasive management was associated with an increased risk of acute kidney injury (10.3% v 8.7%, risk ratio 1.18, 95% confidence interval 1.03 to 1.36; P=0.019), but no difference in the risk of acute kidney injury requiring dialysis (0.4% v 0.3%, 1.20, 0.52 to 2.78; P=0.670). Over a median follow-up of 2.5 years, the risk of progression to end stage renal disease did not differ between the groups (0.3 v 0.4 events per 100 person years, hazard ratio 0.91, 95% confidence interval 0.55 to 1.49; P=0.712); however, early invasive management was associated with reduced long term mortality (2.4 v 3.4 events per 100 person years, 0.69, 0.58 to 0.82; P<0.001). These associations were consistent among people with pre-existing reduced estimated glomerular filtration rate and with alternate definitions for early invasive management. Conclusions Compared with conservative management, early invasive management of acute coronary syndrome is associated with a small increase in risk of acute kidney injury but not dialysis or long term progression to end stage renal disease.	[James, Matthew T.; Ghali, William A.; Knudtson, Merril L.; Manns, Braden J.; Hemmelgarn, Brenda R.] Univ Calgary, Foothills Med Ctr, Dept Med, Calgary, AB T2N 2T9, Canada; [James, Matthew T.; Ghali, William A.; Faris, Peter; Manns, Braden J.; Galbraith, P. Diane; Hemmelgarn, Brenda R.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 2T9, Canada; [Tonelli, Marcello; Pannu, Neesh] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Calgary; University of Calgary; University of Alberta	James, MT (corresponding author), Univ Calgary, Foothills Med Ctr, Dept Med, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	mjames@ucalgary.ca	Tonelli, Marcello/B-3028-2009; Faris, Peter/AAJ-3436-2020	Tonelli, Marcello/0000-0002-0846-3187; Faris, Peter/0000-0001-5208-817X	Kidney Foundation of Canada	Kidney Foundation of Canada	This study was funded by the Kidney Foundation of Canada. The study funder had no role in the study design; the collection, analysis, and interpretation of data; the writing of the report; and the decision to submit the article for publication. All authors, external and internal, had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis. All researchers acted independently of funders.	Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Austin PC, 2008, CIRC-CARDIOVASC QUAL, V1, P62, DOI 10.1161/CIRCOUTCOMES.108.790634; Bartholomew BA, 2004, AM J CARDIOL, V93, P1515, DOI 10.1016/j.amjcard.2004.03.008; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Chertow GM, 2004, J AM SOC NEPHROL, V15, P2462, DOI 10.1097/01.ASN.0000135969.33773.0B; Dangas G, 2005, AM J CARDIOL, V95, P13, DOI 10.1016/j.amjcard.2004.08.056; Finn William F, 2006, Nephrol Dial Transplant, V21, pi2, DOI 10.1093/ndt/gfl213; Fox CS, 2010, CIRCULATION, V121, P357, DOI 10.1161/CIRCULATIONAHA.109.865352; Fox KAA, 2007, HEART, V93, P177, DOI 10.1136/hrt.2005.084830; Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4; Ghali WA, 2000, CAN J CARDIOL, V16, P1225; Gruberg L, 2000, J AM COLL CARDIOL, V36, P1542, DOI 10.1016/S0735-1097(00)00917-7; Hemmelgarn BR, 2004, CIRCULATION, V110, P1890, DOI 10.1161/01.CIR.0000143629.55725.D9; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hoenig MR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004815.pub3; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Izaks GJ, 1999, JAMA-J AM MED ASSOC, V281, P1714, DOI 10.1001/jama.281.18.1714; Johnston N, 2006, AM HEART J, V152, P1052, DOI 10.1016/j.ahj.2006.07.014; Lagerqvist B, 2005, HEART, V91, P1047, DOI 10.1136/hrt.2003.031369; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2007, AM J KIDNEY DIS, V50, P1, DOI 10.1053/j.ajkd.2007.05.008; Liistro F, 2005, HEART, V91, P1284, DOI 10.1136/hrt.2004.051607; Manns BJ, 2001, CLIN INVEST MED, V24, P164; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Norris CM, 2000, J CLIN EPIDEMIOL, V53, P377, DOI 10.1016/S0895-4356(99)00181-X; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Southern DA, 2006, J CLIN EPIDEMIOL, V59, P1110, DOI 10.1016/j.jclinepi.2006.07.002; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wallentin L, 1999, LANCET, V354, P708; Weisbord SD, 2006, J AM SOC NEPHROL, V17, P2871, DOI 10.1681/ASN.2006030301; Wong JA, 2009, EUR HEART J, V30, P549, DOI 10.1093/eurheartj/ehp014	37	21	21	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2013	347								f4151	10.1136/bmj.f4151	http://dx.doi.org/10.1136/bmj.f4151			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180DN	23833076	hybrid, Green Published			2022-12-28	WOS:000321573400002
J	Lee, EJ; Pontes, MH; Groisman, EA				Lee, Eun-Jin; Pontes, Mauricio H.; Groisman, Eduardo A.			A Bacterial Virulence Protein Promotes Pathogenicity by Inhibiting the Bacterium's Own F1Fo ATP Synthase	CELL			English	Article							SALMONELLA-TYPHIMURIUM; MYCOBACTERIUM-TUBERCULOSIS; F1F0-ATP SYNTHASE; MGTC; MAGNESIUM; ENTERICA; EXPRESSION; SURVIVAL; GROWTH; LOCUS	Several intracellular pathogens, including Salmonella enterica and Mycobacterium tuberculosis, require the virulence protein MgtC to survive within macrophages and to cause a lethal infection in mice. We now report that, unlike secreted virulence factors that target the host vacuolar ATPase to withstand phagosomal acidity, the MgtC protein acts on Salmonella's own F1Fo ATP synthase. This complex couples proton translocation to ATP synthesis/hydrolysis and is required for virulence. We establish that MgtC interacts with the a subunit of the F1Fo ATP synthase, hindering ATP-driven proton translocation and NADH-driven ATP synthesis in inverted vesicles. An mgtC null mutant displays heightened ATP levels and an acidic cytoplasm, whereas mgtC overexpression decreases ATP levels. A single amino acid substitution in MgtC that prevents binding to the F1Fo ATP synthase abolishes control of ATP levels and attenuates pathogenicity. MgtC provides a singular example of a virulence protein that promotes pathogenicity by interfering with another virulence protein.	[Lee, Eun-Jin; Groisman, Eduardo A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06536 USA; [Lee, Eun-Jin; Pontes, Mauricio H.; Groisman, Eduardo A.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA; [Lee, Eun-Jin; Pontes, Mauricio H.; Groisman, Eduardo A.] Yale Microbial Divers Inst, West Haven, CT 06516 USA; [Lee, Eun-Jin] Kyung Hee Univ, Coll Life Sci, Dept Genet Engn, Yongin 446701, South Korea	Howard Hughes Medical Institute; Yale University; Yale University; Kyung Hee University	Groisman, EA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06536 USA.	eduardo.groisman@yale.edu	Pontes, Mauricio H./AAV-1024-2020	Pontes, Mauricio H./0000-0002-2618-2039	National Institutes of Health [AI49561]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Xuanlin Tu for the crosslinking experiments, Dr. John Walker and Dr. Gregory Cook for comments on the manuscript, and anonymous reviewers for valuable suggestions. This work was supported, in part, by grant AI49561 from the National Institutes of Health to E.A.G., who is an investigator of the Howard Hughes Medical Institute.	Alix E, 2008, EMBO J, V27, P546, DOI 10.1038/sj.emboj.7601983; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Alteri CJ, 2011, MOL MICROBIOL, V82, P145, DOI 10.1111/j.1365-2958.2011.07804.x; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Blanc-Potard AB, 2003, J MOL EVOL, V57, P479, DOI 10.1007/s00239-003-2496-4; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Davis R., 1980, ADV BACTERIAL GENETI; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; FOSTER JW, 1991, J BACTERIOL, V173, P5129, DOI 10.1128/jb.173.16.5129-5135.1991; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gunzel D, 2006, J BACTERIOL, V188, P5586, DOI 10.1128/JB.00296-06; Harold F. M., 1996, ESCHERICHIA COLI SAL, P283; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kumar Y, 2009, CELL HOST MICROBE, V5, P593, DOI 10.1016/j.chom.2009.05.014; Kuruma Y, 2012, BIOCHEM J, V442, P631, DOI 10.1042/BJ20111284; Lavigne JP, 2005, INFECT IMMUN, V73, P3160, DOI 10.1128/IAI.73.5.3160-3163.2005; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Lee EJ, 2012, MOL MICROBIOL, V86, P212, DOI 10.1111/j.1365-2958.2012.08188.x; Lee EJ, 2012, NATURE, V486, P271, DOI 10.1038/nature11090; Lee EJ, 2010, MOL MICROBIOL, V76, P1020, DOI 10.1111/j.1365-2958.2010.07161.x; Maloney KE, 2006, INFECT IMMUN, V74, P5477, DOI 10.1128/IAI.00798-06; Moncrief MBC, 1998, INFECT IMMUN, V66, P3802, DOI 10.1128/IAI.66.8.3802-3809.1998; Northen H, 2010, VACCINE, V28, P940, DOI 10.1016/j.vaccine.2009.10.146; Rang C, 2007, MOL MICROBIOL, V63, P605, DOI 10.1111/j.1365-2958.2006.05542.x; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Rathman M, 1996, INFECT IMMUN, V64, P2765, DOI 10.1128/IAI.64.7.2765-2773.1996; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; SNAVELY MD, 1991, J BIOL CHEM, V266, P815; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; TAO T, 1995, J BACTERIOL, V177, P2654, DOI 10.1128/jb.177.10.2654-2662.1995; Turner AK, 2003, INFECT IMMUN, V71, P3392, DOI 10.1128/IAI.71.6.3392-3401.2003; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h	40	104	106	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					146	156		10.1016/j.cell.2013.06.004	http://dx.doi.org/10.1016/j.cell.2013.06.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827679	Bronze, Green Accepted			2022-12-28	WOS:000321327900016
J	Wiener, RS; Schwartz, LM; Woloshin, S				Wiener, Renda Soylemez; Schwartz, Lisa M.; Woloshin, Steven			When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEEP-VEIN THROMBOSIS; COMPUTED-TOMOGRAPHY; EMERGENCY-DEPARTMENT; CLINICAL-OUTCOMES; MANAGEMENT; DIAGNOSIS; PREVALENCE; MORTALITY; TRENDS; OVERDIAGNOSIS		[Wiener, Renda Soylemez] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Wiener, Renda Soylemez] ENRM VA Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA; [Schwartz, Lisa M.; Woloshin, Steven] Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Schwartz, Lisa M.; Woloshin, Steven] VA Med Ctr, VA Outcomes Grp, White River Jct, VT USA	Boston University; Dartmouth College; VA Outcomes Group	Wiener, RS (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.	rwiener@bu.edu	Wiener, Renda/AAO-1557-2020	Wiener, Renda/0000-0001-7712-2135	NATIONAL CANCER INSTITUTE [K07CA138772, U19CA079689] Funding Source: NIH RePORTER; NCI NIH HHS [U19CA79689, K07 CA138772] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams DM, 2013, AM J MED, V126, P36, DOI 10.1016/j.amjmed.2012.05.028; Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; Auer RC, 2009, J AM COLL SURGEONS, V208, P871, DOI 10.1016/j.jamcollsurg.2008.12.030; Bullano Michael F, 2005, J Manag Care Pharm, V11, P663; Burge AJ, 2008, CLIN RADIOL, V63, P381, DOI 10.1016/j.crad.2007.10.004; Calder KK, 2005, ANN EMERG MED, V45, P302, DOI 10.1016/j.annemergmed.2004.10.001; Campbell IA, 2003, THORAX, V58, P470; Carrier M, 2010, J THROMB HAEMOST, V8, P1716, DOI 10.1111/j.1538-7836.2010.03938.x; DeMonaco NA, 2008, AM J MED, V121, P611, DOI 10.1016/j.amjmed.2008.02.035; Donato AA, 2010, THROMB RES, V126, pE266, DOI 10.1016/j.thromres.2010.07.001; Duff Wilson A., 2010, SEATTLE TIMES; Gage BF, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6980; Ghaye B, 2007, JBR-BTR, V90, P100; Goodman LR, 2005, RADIOLOGY, V234, P654, DOI 10.1148/radiol.2343041326; Gottlieb RH, 2005, AM J ROENTGENOL, V185, P1399, DOI 10.2214/AJR.05.0482; Hall WB, 2009, ARCH INTERN MED, V169, P1961, DOI 10.1001/archinternmed.2009.360; HANDLER JA, 1995, POSTGRAD MED, V97, P61, DOI 10.1080/00325481.1995.11945946; Heit JA, 2011, BLOOD, V118, P4992, DOI 10.1182/blood-2011-05-357343; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Lapner ST, 2013, BMJ-BRIT MED J, V346, pf757; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Minet C, 2012, CRIT CARE MED, V40, P3202, DOI 10.1097/CCM.0b013e318265e461; National Heart Lung and Blood Institute, WHAT IS PULM EMB; Park B, 2009, CHEST, V136, P983, DOI 10.1378/chest.08-2258; Parvizi J, 2007, CLIN ORTHOP RELAT R, P107, DOI 10.1097/BLO.0b013e318145af41; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; PreventDVT.org, COAL PREV DEEP VEIN; Prologo JD, 2004, AM J ROENTGENOL, V183, P1093, DOI 10.2214/ajr.183.4.1831093; Raja AS, 2012, RADIOLOGY, V262, P468, DOI 10.1148/radiol.11110951; Remy-Jardin M, 2007, RADIOLOGY, V245, P315, DOI 10.1148/radiol.2452070397; Ritchie G, 2007, THORAX, V62, P536, DOI 10.1136/thx.2006.062299; ROBIN ED, 1977, ANN INTERN MED, V87, P775, DOI 10.7326/0003-4819-87-6-775; Rohacek M, 2012, INTENS CARE MED, V38, P1345, DOI 10.1007/s00134-012-2595-z; Schultz DJ, 2004, J TRAUMA, V56, P727, DOI 10.1097/01.TA.0000119687.23542.EC; Sheh SH, 2012, AM J ROENTGENOL, V198, P1340, DOI 10.2214/AJR.11.6426; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Stein EG, 2010, AM J ROENTGENOL, V194, P392, DOI 10.2214/AJR.09.2499; Stein PD, 2012, CLIN APPL THROMB-HEM, V18, P20, DOI 10.1177/1076029611422363; Stein PD, 2003, ARCH INTERN MED, V163, P1213, DOI 10.1001/archinte.163.10.1213; Stein PD, 1997, CHEST, V111, P1246, DOI 10.1378/chest.111.5.1246; Tapson VF, 2011, ARCH INTERN MED, V171, P837, DOI 10.1001/archinternmed.2011.174; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Weiss CR, 2006, ACAD RADIOL, V13, P434, DOI 10.1016/j.acra.2006.01.002; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wiener RS, 2011, ARCH INTERN MED, V171, P831, DOI 10.1001/archinternmed.2011.178; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414	49	131	133	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2013	347								f3368	10.1136/bmj.f3368	http://dx.doi.org/10.1136/bmj.f3368			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180CL	23820021	Green Published, Bronze			2022-12-28	WOS:000321570400001
J	Rikkert, MGMO; Melis, R				Rikkert, Marcel G. M. Olde; Melis, Rene			Nonagenarians challenge predictions of cognitive decline	LANCET			English	Editorial Material							IMPAIRMENT; DEMENTIA		[Rikkert, Marcel G. M. Olde; Melis, Rene] Radboud Univ Nijmegen, Med Ctr, Dept Geriatr, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Rikkert, MGMO (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Geriatr, NL-6500 HB Nijmegen, Netherlands.	m.olde-rikkert@ger.umcn.nl	Melis, René/J-5943-2012; Rikkert, M.G.M. Olde/H-8078-2014	Melis, René/0000-0002-7863-4738; Rikkert, M.G.M. Olde/0000-0003-1397-1677				Akbarian S, 2013, JAMA NEUROL, V70, P711, DOI 10.1001/jamaneurol.2013.1459; Auyeung TW, 2008, NEUROEPIDEMIOLOGY, V31, P167, DOI 10.1159/000154929; Christensen K, 2013, LANCET; Christensen K, 2008, P NATL ACAD SCI USA, V105, P13274, DOI 10.1073/pnas.0804931105; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Flynn FR, 1999, AM PSYCHOL, V54, P520; Fries James F, 2011, J Aging Res, V2011, P261702, DOI 10.4061/2011/261702; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Hall CB, 2009, NEUROLOGY, V73, P356, DOI 10.1212/WNL.0b013e3181b04ae3; Lloyd-Sherlock P, 2012, LANCET, V379, P1295, DOI 10.1016/S0140-6736(12)60519-4; Moore Alison, 2007, Health Serv J, V117, P24; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; WHO, 2012, 10 FACTS ON AGEING A; Yaffe K, 2011, ARCH NEUROL-CHICAGO, V68, P631, DOI 10.1001/archneurol.2011.82	14	5	5	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1473	1474		10.1016/S0140-6736(13)61220-9	http://dx.doi.org/10.1016/S0140-6736(13)61220-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247MR	23849795				2022-12-28	WOS:000326622500011
J	de Wit, E; Bouwman, BAM; Zhu, Y; Klous, P; Splinter, E; Verstegen, MJAM; Krijger, PHL; Festuccia, N; Nora, EP; Welling, M; Heard, E; Geijsen, N; Poot, RA; Chambers, I; de Laat, W				de Wit, Elzo; Bouwman, Britta A. M.; Zhu, Yun; Klous, Petra; Splinter, Erik; Verstegen, Marjon J. A. M.; Krijger, Peter H. L.; Festuccia, Nicola; Nora, Elphege P.; Welling, Maaike; Heard, Edith; Geijsen, Niels; Poot, Raymond A.; Chambers, Ian; de Laat, Wouter			The pluripotent genome in three dimensions is shaped around pluripotency factors	NATURE			English	Article							CHROMOSOME CONFORMATION CAPTURE; CHROMATIN INTERACTIONS; REGULATORY LANDSCAPE; GENE-EXPRESSION; SELF-RENEWAL; DOMAINS; MAPS; DIFFERENTIATION; PROTEINS; CELLS	It is becoming increasingly clear that the shape of the genome importantly influences transcription regulation. Pluripotent stem cells such as embryonic stem cells were recently shown to organize their chromosomes into topological domains that are largely invariant between cell types(1,2). Here we combine chromatin conformation capture technologies with chromatin factor binding data to demonstrate that inactive chromatin is unusually disorganized in pluripotent stem-cell nuclei. We show that gene promoters engage in contacts between topological domains in a largely tissue-independent manner, whereas enhancers have a more tissue-restricted interaction profile. Notably, genomic clusters of pluripotency factor binding sites find each other very efficiently, in a manner that is strictly pluripotent-stem-cell-specific, dependent on the presence of Oct4 and Nanog protein and inducible after artificial recruitment of Nanog to a selected chromosomal site. We conclude that pluripotent stem cells have a unique higher-order genome structure shaped by pluripotency factors. We speculate that this interactome enhances the robustness of the pluripotent state.	[de Wit, Elzo; Bouwman, Britta A. M.; Zhu, Yun; Klous, Petra; Splinter, Erik; Verstegen, Marjon J. A. M.; Krijger, Peter H. L.; Welling, Maaike; Geijsen, Niels; de Laat, Wouter] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [de Wit, Elzo; Bouwman, Britta A. M.; Zhu, Yun; Klous, Petra; Splinter, Erik; Verstegen, Marjon J. A. M.; Krijger, Peter H. L.; Welling, Maaike; Geijsen, Niels; de Laat, Wouter] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Festuccia, Nicola; Chambers, Ian] Univ Edinburgh, Inst Stem Cell Res, Sch Biol Sci, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland; [Nora, Elphege P.; Heard, Edith] Inst Curie, CNRS, Mammalian Dev Epigenet Grp, INSERM,UMR3215,U934, F-75231 Paris, France; [Geijsen, Niels] Univ Utrecht, Sch Vet Med, NL-3584 CL Utrecht, Netherlands; [Poot, Raymond A.] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Utrecht University; Erasmus University Rotterdam; Erasmus MC	de Laat, W (corresponding author), Hubrecht Inst KNAW, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	w.delaat@hubrecht.eu	Heard, Edith/D-7197-2017; Nora, Elphège/AAW-9646-2021	Heard, Edith/0000-0001-8052-7117; Nora, Elphège/0000-0002-8347-4396; Welling, Maaike/0000-0003-3253-3410; de Laat, Wouter/0000-0002-6393-595X; Krijger, Peter/0000-0003-1702-348X; de Wit, Elzo/0000-0003-2883-1415; Chambers, Ian/0000-0003-2605-1597; Bouwman, Britta/0000-0002-9827-9497	Netherlands Institute for Regenerative Medicine (NIRM) network; Medical Research Council UK; Dutch Scientific Organization (NWO) [700.10.402, 91204082, 935170621]; InteGeR FP7 Marie Curie ITN [PITN-GA-2007-214902]; European Research Council Starting Grant [209700]; Medical Research Council [G0901533] Funding Source: researchfish; MRC [G0901533] Funding Source: UKRI	Netherlands Institute for Regenerative Medicine (NIRM) network; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dutch Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); InteGeR FP7 Marie Curie ITN; European Research Council Starting Grant(European Research Council (ERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank C. Vermeulen and S. Holwerda for counting FISH slides; G. Geeven for the analysis of sequencing data; J. Brandsma for technical assistance; P. Verschure for the LacR-GFP backbone construct; and H. Niwa for providing ZHBTc4 ES cells. We also thank the Netherlands Institute for Regenerative Medicine (NIRM) network for supporting the R. A. P. laboratory and the Medical Research Council UK for supporting the I. C. laboratory. This work was financially supported by grants from the Dutch Scientific Organization (NWO) to E.d.W. (700.10.402, 'Veni') and W.d.L. (91204082 and 935170621), InteGeR FP7 Marie Curie ITN (PITN-GA-2007-214902) and a European Research Council Starting Grant (209700, '4C') to W.d.L.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dhar SS, 2010, J NEUROCHEM, V115, P676, DOI 10.1111/j.1471-4159.2010.06956.x; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Holwerda S. J., 2013, NUCL ACIDS RES; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Karantzali E, 2011, J BIOL CHEM, V286, P1037, DOI 10.1074/jbc.M110.170050; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Krijger PHL, 2013, CURR OPIN GENET DEV, V23, P191, DOI 10.1016/j.gde.2012.12.010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Splinter E, 2011, EMBO J, V30, P4345, DOI 10.1038/emboj.2011.344; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Wilson AA, 2008, AM J RESP CELL MOL, V39, P133, DOI 10.1165/rcmb.2007-0133OC; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Xu M, 2008, J CELL BIOL, V181, P615, DOI 10.1083/jcb.200710053	40	195	196	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					227	+		10.1038/nature12420	http://dx.doi.org/10.1038/nature12420			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23883933				2022-12-28	WOS:000324244900042
J	Rudolph, CJ; Upton, AL; Stockum, A; Nieduszynski, CA; Lloyd, RG				Rudolph, Christian J.; Upton, Amy L.; Stockum, Anna; Nieduszynski, Conrad A.; Lloyd, Robert G.			Avoiding chromosome pathology when replication forks collide	NATURE			English	Article							ESCHERICHIA-COLI RECG; DNA-REPLICATION; RNA-POLYMERASE; GENOME INSTABILITY; TRANSCRIPTION; HELICASE; INITIATION; MUTATIONS; CONFLICTS; RECOMBINATION	Chromosome duplication normally initiates through the assembly of replication fork complexes at defined origins(1,2). DNA synthesis by any one fork is thought to cease when it meets another travelling in the opposite direction, at which stage the replication machinery may simply dissociate before the nascent strands are finally ligated. But what actually happens is not clear. Here we present evidence consistent with the idea that every fork collision has the potential to threaten genomic integrity. In Escherichia coli this threat is kept at bay by RecG DNA translocase(3) and by single-strand DNA exonucleases. Without RecG, replication initiates where forks meet through a replisome assembly mechanism normally associated with fork repair, replication restart and recombination(4,5), establishing new forks with the potential to sustain cell growth and division without an active origin. This potential is realized when roadblocks to fork progression are reduced or eliminated. It relies on the chromosome being circular, reinforcing the idea that replication initiation is triggered repeatedly by fork collision. The results reported raise the question of whether replication fork collisions have pathogenic potential for organisms that exploit several origins to replicate each chromosome.	[Rudolph, Christian J.; Upton, Amy L.; Stockum, Anna; Nieduszynski, Conrad A.; Lloyd, Robert G.] Univ Nottingham, Queens Med Ctr, Ctr Genet & Genom, Nottingham NG7 2UH, England; [Rudolph, Christian J.; Upton, Amy L.] Brunel Univ, Div Biosci, Sch Hlth Sci & Social Care, London UB8 3PH, England	University of Nottingham; Brunel University	Rudolph, CJ (corresponding author), Univ Nottingham, Queens Med Ctr, Ctr Genet & Genom, Nottingham NG7 2UH, England.	christian.rudolph@brunel.ac.uk	Nieduszynski, Conrad/B-2170-2010; Rudolph, Christian J./L-6525-2019	Nieduszynski, Conrad/0000-0003-2001-076X; Rudolph, Christian J./0000-0003-2493-3748	MRC [G0800970]; Leverhulme Trust; BBSRC [BB/E023754/1]; Biotechnology and Biological Sciences Research Council [BB/E023754/1] Funding Source: researchfish; Medical Research Council [G0800970] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Horiuchi and D. Sherratt for E. coli strains, A. Mahdi for help with DNA extractions, S. Malla and M. Blythe for deep sequencing, S. Demolli and D. Ivanova for control experiments, and C. Buckman and L. Harris for assistance. This work was supported by grants from the MRC (R. G. L., G0800970), the Leverhulme Trust (C.J.R.) and the BBSRC (C.A.N., BB/E023754/1).	Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Cui TL, 2007, EMBO REP, V8, P181, DOI 10.1038/sj.embor.7400880; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diffley JFX, 2011, PHILOS T R SOC B, V366, P3545, DOI 10.1098/rstb.2011.0073; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Gregg AV, 2002, MOL CELL, V9, P241, DOI 10.1016/S1097-2765(02)00455-0; Killen MW, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-33; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Mahdi AA, 2012, MOL MICROBIOL, V86, P675, DOI 10.1111/mmi.12010; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; Miller J.H., 1972, EXPT MOL GENETICS; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Muller CA, 2012, GENOME RES, V22, P1953, DOI 10.1101/gr.139477.112; Paul S, 2013, NATURE, V495, P512, DOI 10.1038/nature11989; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Reyes-Larnothe R, 2008, TRENDS MICROBIOL, V16, P238, DOI 10.1016/j.tim.2008.02.003; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; Rudolph CJ, 2010, GENETICS, V186, P473, DOI 10.1534/genetics.110.120691; Rudolph CJ, 2010, DNA REPAIR, V9, P210, DOI 10.1016/j.dnarep.2009.12.014; Rudolph CJ, 2009, MOL MICROBIOL, V74, P940, DOI 10.1111/j.1365-2958.2009.06909.x; Rybchin VN, 1999, MOL MICROBIOL, V33, P895, DOI 10.1046/j.1365-2958.1999.01533.x; Skovgaard O, 2011, GENOME RES, V21, P1388, DOI 10.1101/gr.117416.110; Steinacher R, 2012, GENE DEV, V26, P594, DOI 10.1101/gad.184663.111; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Wang XD, 2011, P NATL ACAD SCI USA, V108, pE243, DOI 10.1073/pnas.1100874108; Whitby MC, 2010, DNA REPAIR, V9, P224, DOI 10.1016/j.dnarep.2009.12.012	31	90	90	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					608	+		10.1038/nature12312	http://dx.doi.org/10.1038/nature12312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23892781	Green Accepted			2022-12-28	WOS:000323625900041
J	Parmet, WE				Parmet, Wendy E.			Holes in the Safety Net - Legal Immigrants' Access to Health Insurance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Northeastern Univ, Sch Law, Boston, MA 02115 USA	Northeastern University	Parmet, WE (corresponding author), Northeastern Univ, Sch Law, Boston, MA 02115 USA.							Goldman DP, 2005, HEALTH AFFAIR, V24, P1640, DOI 10.1377/hlthaff.24.6.1640; Passel Jeffrey S., 2009, PORTRAIT UNAUTHORIZE; PEREIRA KM, 2012, ASPE ASSISTANT SECRE; SONTAG D, 2008, NY TIMES        0803, pA1; STIMPSON JP, 2013, HLTH AFF MILLWOOD	5	13	13	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2013	369	7					596	598		10.1056/NEJMp1306637	http://dx.doi.org/10.1056/NEJMp1306637			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243YO	23883332				2022-12-28	WOS:000326354500003
J	Shulman, Z; Gitlin, AD; Targ, S; Jankovic, M; Pasqual, G; Nussenzweig, MC; Victora, GD				Shulman, Ziv; Gitlin, Alexander D.; Targ, Sasha; Jankovic, Mila; Pasqual, Giulia; Nussenzweig, Michel C.; Victora, Gabriel D.			T Follicular Helper Cell Dynamics in Germinal Centers	SCIENCE			English	Article							LYMPH-NODE; RESPONSES; SELECTION; FH	T follicular helper (T-FH) cells are a specialized subset of effector T cells that provide help to and thereby select high-affinity B cells in germinal centers (GCs). To examine the dynamic behavior of T-FH cells in GCs in mice, we used two-photon microscopy in combination with a photoactivatable fluorescent reporter. Unlike GC B cells, which are clonally restricted, T-FH cells distributed among all GCs in lymph nodes and continually emigrated into the follicle and neighboring GCs. Moreover, newly activated T-FH cells invaded preexisting GCs, where they contributed to B cell selection and plasmablast differentiation. Our data suggest that the dynamic exchange of T-FH cells between GCs ensures maximal diversification of T cell help and that their ability to enter ongoing GCs accommodates antigenic variation during the immune response.	[Shulman, Ziv; Gitlin, Alexander D.; Jankovic, Mila; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Targ, Sasha; Pasqual, Giulia; Victora, Gabriel D.] Whitehead Inst Biomed Res, Cambridge, MA 02138 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	nussen@rockefeller.edu; victora@wi.mit.edu	Nussenzweig, Michel/AAE-7292-2019; Pasqual, Giulia/AAD-8378-2022	Pasqual, Giulia/0000-0002-1476-2669; Victora, Gabriel/0000-0001-8807-348X; Gitlin, Alexander/0000-0002-9229-0919	Empire State Stem Cell Fund through New York State Department of Health [C023046]; NIH Medical Scientist Training Program [T32GM07739]; NIH [5DP5OD012146-02, AI037526-19, AI072529-06, AI100663-01]; March of Dimes Foundation Basil O'Connor Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, R37AI037526, R01AI072529, R01AI037526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012146] Funding Source: NIH RePORTER	Empire State Stem Cell Fund through New York State Department of Health; NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation Basil O'Connor Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Ploegh, K. Strijbis, and H. Sive for mice and equipment use and E. Browne for helpful discussion. The data presented are tabulated in the main paper and in the supplementary materials. Support for the Rockefeller University multiphoton microscope was granted by the Empire State Stem Cell Fund through New York State Department of Health contract C023046. Supported by NIH Medical Scientist Training Program grant T32GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program (A. D. G.), NIH grant 5DP5OD012146-02 and March of Dimes Foundation Basil O'Connor Award (G. D. V.), and NIH grants AI037526-19, AI072529-06, and AI100663-01 (M.C.N.). Z.S. is a Human Frontiers of Science fellow. G. P. is a Swiss National Science Foundation fellow. M.C.N. is an HHMI investigator.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Golby SJC, 1999, EUR J IMMUNOL, V29, P3729, DOI 10.1002/(SICI)1521-4141(199911)29:11<3729::AID-IMMU3729>3.0.CO;2-I; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; KROESE FGM, 1987, EUR J IMMUNOL, V17, P1069, DOI 10.1002/eji.1830170726; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Roers A, 2000, AM J PATHOL, V156, P1067, DOI 10.1016/S0002-9440(10)64974-7; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Zheng B, 1996, J EXP MED, V184, P1083, DOI 10.1084/jem.184.3.1083	23	227	236	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					673	677		10.1126/science.1241680	http://dx.doi.org/10.1126/science.1241680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23887872	Green Accepted, Green Submitted			2022-12-28	WOS:000322884800044
J	Szymborska, A; de Marco, A; Daigle, N; Cordes, VC; Briggs, JAG; Ellenberg, J				Szymborska, Anna; de Marco, Alex; Daigle, Nathalie; Cordes, Volker C.; Briggs, John A. G.; Ellenberg, Jan			Nuclear Pore Scaffold Structure Analyzed by Super-Resolution Microscopy and Particle Averaging	SCIENCE			English	Article							CRYOELECTRON TOMOGRAPHY; FLUORESCENCE MICROSCOPY; COMPLEX; ARCHITECTURE; RESOLUTION; MEMBRANE; NANOSCOPY; PROTEINS; MODULE; COAT	Much of life's essential molecular machinery consists of large protein assemblies that currently pose challenges for structure determination. A prominent example is the nuclear pore complex (NPC), for which the organization of its individual components remains unknown. By combining stochastic super-resolution microscopy, to directly resolve the ringlike structure of the NPC, with single particle averaging, to use information from thousands of pores, we determined the average positions of fluorescent molecular labels in the NPC with a precision well below 1 nanometer. Applying this approach systematically to the largest building block of the NPC, the Nup107-160 subcomplex, we assessed the structure of the NPC scaffold. Thus, light microscopy can be used to study the molecular organization of large protein complexes in situ in whole cells.	[Szymborska, Anna; Daigle, Nathalie; Ellenberg, Jan] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [de Marco, Alex; Briggs, John A. G.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Cordes, Volker C.] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Max Planck Society	Ellenberg, J (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jan.ellenberg@embl.de	, Alex/AAK-8000-2020; , Alex/HHC-4440-2022; Briggs, John/J-3096-2012; Ellenberg, Jan/I-4688-2014	, Alex/0000-0001-6238-5653; Ellenberg, Jan/0000-0001-5909-701X; Briggs, John/0000-0003-3990-6910; Szymborska-Mell, Anna/0000-0003-1741-4106	GSD development team of Leica Microsystems; European Molecular Biology Laboratory (EMBL) Advanced Light Microscopy Facility; EMBL Protein Expression and Purification Core; German Research Council [DFG EL 246/3-2, SPP1175]	GSD development team of Leica Microsystems; European Molecular Biology Laboratory (EMBL) Advanced Light Microscopy Facility; EMBL Protein Expression and Purification Core; German Research Council(German Research Foundation (DFG))	We gratefully acknowledge V. Doye, I. Mattaj, J. Koser, and M. Platani for the kind gifts of antibodies; the GSD development team of Leica Microsystems (especially M. Dyba, J. Folling, W. Fouquet, and G. Simonutti); the European Molecular Biology Laboratory (EMBL) Advanced Light Microscopy Facility (especially S. Terjung, B. Neumann, and J. Bulkescher) and the EMBL Protein Expression and Purification Core for support; M. Bates for advice on SR microscopy; O. Medalia for the human NPC electron density maps; M. Beck and H. Bui for help with rendering the EM density and Nup85 cDNA; S. Yoshimura for Nup160 cDNA; F. Nedelec, A. Picco, and W. Huber for help with data analysis; S. Streichan and the Ellenberg group for help with the analysis implementation (especially W. Xiang, P. Strnad, J. Roberti, S. Otsuka, and J. Hossain); and J. Ries for comments on the manuscript and Alexa Fluor 647 nanobody. This work was supported by funding from the German Research Council to J. E. (DFG EL 246/3-2 within the priority program SPP1175). The data presented here are tabulated in the main paper and the supplementary materials.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bilokapic S, 2012, P NATL ACAD SCI USA, V109, P15241, DOI 10.1073/pnas.1205151109; Bilokapic S, 2012, CURR OPIN CELL BIOL, V24, P86, DOI 10.1016/j.ceb.2011.12.011; Bock H, 2007, APPL PHYS B-LASERS O, V88, P161, DOI 10.1007/s00340-007-2729-0; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Debler EW, 2008, MOL CELL, V32, P815, DOI 10.1016/j.molcel.2008.12.001; Fernandez-Martinez J, 2012, J CELL BIOL, V196, P419, DOI 10.1083/jcb.201109008; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Kampmann M, 2011, NAT STRUCT MOL BIOL, V18, P643, DOI 10.1038/nsmb.2056; Kampmann M, 2009, NAT STRUCT MOL BIOL, V16, P782, DOI 10.1038/nsmb.1618; Loschberger A, 2012, J CELL SCI, V125, P570, DOI 10.1242/jcs.098822; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Maimon T, 2012, STRUCTURE, V20, P998, DOI 10.1016/j.str.2012.03.025; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018	27	278	285	2	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					655	658		10.1126/science.1240672	http://dx.doi.org/10.1126/science.1240672			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23845946				2022-12-28	WOS:000322884800038
J	Brodsky, JL				Brodsky, Jeffrey L.			Just a Trim, Please: Refining ER Degradation through Deubiquitination	CELL			English	Editorial Material							PROTEIN		Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK079307] Funding Source: Medline; NIGMS NIH HHS [R01 GM075061] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Ishikura S, 2010, J BIOL CHEM, V285, P23916, DOI 10.1074/jbc.M110.127936; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Nomaguchi M, 2008, MICROBES INFECT, V10, P960, DOI 10.1016/j.micinf.2008.07.006; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sanyal S, 2012, J BIOL CHEM, V287, P23594, DOI 10.1074/jbc.M112.365312; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Zhang ZR, 2013, CELL, V154, P609, DOI 10.1016/j.cell.2013.06.038	10	2	3	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					479	481		10.1016/j.cell.2013.07.008	http://dx.doi.org/10.1016/j.cell.2013.07.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23890819	Green Accepted, Bronze			2022-12-28	WOS:000322629900002
J	Bassi, C; Ho, J; Srikumar, T; Dowling, RJO; Gorrini, C; Miller, SJ; Mak, TW; Neel, BG; Raught, B; Stambolic, V				Bassi, C.; Ho, J.; Srikumar, T.; Dowling, R. J. O.; Gorrini, C.; Miller, S. J.; Mak, T. W.; Neel, B. G.; Raught, B.; Stambolic, V.			Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; TUMOR-SUPPRESSOR; PROSTATE-CANCER; MAMMALIAN-CELLS; GENE; IDENTIFICATION; RECOGNITION; PTEN/MMAC1; DELETION; DAMAGE	Loss of function of the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) tumor suppressor gene is associated with many human cancers. In the cytoplasm, PTEN antagonizes the phosphatidylinositol 3-kinase (PI3K) signaling pathway. PTEN also accumulates in the nucleus, where its function remains poorly understood. We demonstrate that SUMOylation (SUMO, small ubiquitin-like modifier) of PTEN controls its nuclear localization. In cells exposed to genotoxic stress, SUMO-PTEN was rapidly excluded from the nucleus dependent on the protein kinase ataxia telangiectasia mutated (ATM). Cells lacking nuclear PTEN were hypersensitive to DNA damage, whereas PTEN-deficient cells were susceptible to killing by a combination of genotoxic stress and a small-molecule PI3K inhibitor both in vitro and in vivo. Our findings may have implications for individualized therapy for patients with PTEN-deficient tumors.	[Bassi, C.; Srikumar, T.; Mak, T. W.; Neel, B. G.; Raught, B.; Stambolic, V.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Ho, J.; Dowling, R. J. O.; Gorrini, C.; Mak, T. W.; Neel, B. G.; Raught, B.; Stambolic, V.] Univ Hlth Network, Campbell Family Canc Res Inst, Ontario Canc Inst, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Gorrini, C.; Mak, T. W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Princess Margaret Canc Ctr, Toronto, ON M5G 2C1, Canada; [Miller, S. J.; Neel, B. G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol,Dept Med, Boston, MA 02115 USA; [Miller, S. J.; Neel, B. G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Biol Program,Dept Med, Boston, MA 02115 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Stambolic, V (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada.	vuks@uhnres.utoronto.ca	Srikumar, Tharan/Q-5642-2016; Dowling, Ryan/Q-8912-2018	Gorrini, Chiara/0000-0002-5239-6671; Dowling, Ryan/0000-0002-5381-8805; Stambolic, Vuk/0000-0001-8853-3239	Canadian Cancer Society [2011-700891]; NIH [R37 CA49152]; Ontario Ministry of Health and Long Term Care; Princess Margaret Hospital Foundation; Excellence in Radiation Research for the 21st century (EIRR21st) fellowship; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [R01CA049152, R37CA049152] Funding Source: NIH RePORTER	Canadian Cancer Society(Canadian Cancer Society (CCS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Princess Margaret Hospital Foundation; Excellence in Radiation Research for the 21st century (EIRR21st) fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Fraser for reagents, D. Durocher for advice on DNA repair assays, R. Hakem for critical reading of the manuscript, A. Wakeham for advice on xenograft experiments, and Novartis for BKM120. Supported by grants from the Canadian Cancer Society to V. S. (2011-700891) and from NIH to B.G.N. (R37 CA49152) and partially supported by a grant from the Ontario Ministry of Health and Long Term Care and the Princess Margaret Hospital Foundation. B.G.N. and T. W. M. hold Canada Research Chairs (Tier I), and B. R. holds Canada Research Chair (Tier II). C. B. was supported by the Excellence in Radiation Research for the 21st century (EIRR21st) fellowship, and R.J.O.D. was supported by a Banting Postdoctoral Fellowship from the Canadian Institutes of Health Research. C. B. and V. S. designed research; C. B., J.H., T. S., R. D., C. G., and S.J.M. performed research; C. B., T. S., B.G.N., B. R., and V. S. analyzed data; T. M., B.G.N., B. R., and V. S. supervised research; and C. B., B.G.N., and V. S. wrote the paper.	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Cairns P, 1997, CANCER RES, V57, P4997; Elliott B, 2001, MOL CELL BIOL, V21, P2671, DOI 10.1128/MCB.21.8.2671-2682.2001; Fraser M, 2012, CLIN CANCER RES, V18, P1015, DOI 10.1158/1078-0432.CCR-11-2189; Guldberg P, 1997, CANCER RES, V57, P3660; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Rasheed BKA, 1997, CANCER RES, V57, P4187; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002	21	299	311	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					395	399		10.1126/science.1236188	http://dx.doi.org/10.1126/science.1236188			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888040	Green Accepted, Green Submitted			2022-12-28	WOS:000322259200049
J	Silverman, E				Silverman, Ed			AFFORDABLE CARE ACT Everything you need to know about the Sunshine Act	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												pharmalot@gmail.com						[Anonymous], 2013, FED REG; Silverman E, 2013, PHARMALOT       0402	2	12	12	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2013	347								f4704	10.1136/bmj.f4704	http://dx.doi.org/10.1136/bmj.f4704			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BS	23894181				2022-12-28	WOS:000322532500006
J	Callard, F; Bracken, P; David, AS; Sartorius, N				Callard, Felicity; Bracken, Pat; David, Anthony S.; Sartorius, Norman			MAUDSLEY DEBATE Has psychiatric diagnosis labelled rather than enabled patients?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Callard, Felicity] Univ Durham, Durham, England; [Bracken, Pat] West Cork Mental Hlth Serv, Bantry, Cork, Ireland; [David, Anthony S.] Kings Coll London, Inst Psychiat, London, England; [Sartorius, Norman] Assoc Improvement Mental Hlth Programmes, Geneva, Switzerland	Durham University; University of London; King's College London	Callard, F (corresponding author), Univ Durham, Durham, England.	felicity.callard@durham.ac.uk; anthony.david@kcl.ac.uk	David, Anthony S/C-1315-2011; Callard, Felicity/AEP-9676-2022; Callard, Felicity J/C-8959-2009; David, Anthony/O-1750-2019	David, Anthony S/0000-0003-0967-774X; Callard, Felicity/0000-0002-5350-1963; Callard, Felicity J/0000-0002-5350-1963; David, Anthony/0000-0003-0967-774X				Bracken P, 2001, BMJ-BRIT MED J, V322, P724, DOI 10.1136/bmj.322.7288.724; Callard Felicity, 2012, MENTAL ILLNESS DISCR; Clare A., 1976, PSYCHIAT DISSENT; Davidson L, 2012, WORLD PSYCHIATRY, V11, P123, DOI 10.1016/j.wpsyc.2012.05.009; Decker HS, 2007, HIST PSYCHIATR, V18, P337, DOI 10.1177/0957154X07078976; Faulkner A, 2000, STRATEGIES LIVING RE; Gornall J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3256; Insel TR, 2005, JAMA-J AM MED ASSOC, V294, P2221, DOI 10.1001/jama.294.17.2221; Jones S, 2008, ACTA PSYCHIAT SCAND, V118, P169, DOI 10.1111/j.1600-0447.2008.01211.x; Lieberman JA, 2007, BRIT MED J, V334, P108, DOI 10.1136/bmj.39057.662373.80; Priebe S, 2013, BRIT J PSYCHIAT, V202, P319, DOI 10.1192/bjp.bp.112.116905; Rose N., 2013, NEURO NEW BRAIN SCI; Sayce L., 1999, PSYCHIAT PATIENT CIT; [No title captured]; [No title captured]; [No title captured]; [No title captured]	17	17	17	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2013	347								f4312	10.1136/bmj.f4312	http://dx.doi.org/10.1136/bmj.f4312			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193BO	23886962				2022-12-28	WOS:000322532000001
J	Doody, RS; Raman, R; Farlow, M; Iwatsubo, T; Vellas, B; Joffe, S; Kieburtz, K; He, F; Sun, XY; Thomas, RG; Aisen, PS; Siemers, E; Sethuraman, G; Mohs, R				Doody, Rachelle S.; Raman, Rema; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Bruno; Joffe, Steven; Kieburtz, Karl; He, Feng; Sun, Xiaoying; Thomas, Ronald G.; Aisen, Paul S.; Siemers, Eric; Sethuraman, Gopalan; Mohs, Richard			A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GAMMA-SECRETASE INHIBITOR; CLINICAL-TRIALS; DEMENTIA; INTERVENTION; INVENTORY; LY450139; SAFETY; SCALE	BACKGROUND Alzheimer's disease is characterized by the presence of cortical amyloid-beta (A) protein plaques, which result from the sequential action of -secretase and -secretase on amyloid precursor protein. Semagacestat is a small-molecule -secretase inhibitor that was developed as a potential treatment for Alzheimer's disease. METHODS We conducted a double-blind, placebo-controlled trial in which 1537 patients with probable Alzheimer's disease underwent randomization to receive 100 mg of semagacestat, 140 mg of semagacestat, or placebo daily. Changes in cognition from baseline to week 76 were assessed with the use of the cognitive subscale of the Alzheimer's Disease Assessment Scale for cognition (ADAS-cog), on which scores range from 0 to 70 and higher scores indicate greater cognitive impairment, and changes in functioning were assessed with the Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) scale, on which scores range from 0 to 78 and higher scores indicate better functioning. A mixed-model repeated-measures analysis was used. RESULTS The trial was terminated before completion on the basis of a recommendation by the data and safety monitoring board. At termination, there were 189 patients in the group receiving placebo, 153 patients in the group receiving 100 mg of semagacestat, and 121 patients in the group receiving 140 mg of semagacestat. The ADAS-cog scores worsened in all three groups (mean change, 6.4 points in the placebo group, 7.5 points in the group receiving 100 mg of the study drug, and 7.8 points in the group receiving 140 mg; P=0.15 and P=0.07, respectively, for the comparison with placebo). The ADCS-ADL scores also worsened in all groups (mean change at week 76, -9.0 points in the placebo group, -10.5 points in the 100-mg group, and -12.6 points in the 140-mg group; P=0.14 and P<0.001, respectively, for the comparison with placebo). Patients treated with semagacestat lost more weight and had more skin cancers and infections, treatment discontinuations due to adverse events, and serious adverse events (P<0.001 for all comparisons with placebo). Laboratory abnormalities included reduced levels of lymphocytes, T cells, immunoglobulins, albumin, total protein, and uric acid and elevated levels of eosinophils, monocytes, and cholesterol; the urine pH was also elevated. CONCLUSIONS As compared with placebo, semagacestat did not improve cognitive status, and patients receiving the higher dose had significant worsening of functional ability. Semagacestat was associated with more adverse events, including skin cancers and infections. (Funded by Eli Lilly; ClinicalTrials.gov number, NCT00594568.)	Dept Neurol, Baylor Coll Med, Alzheimers Dis & Memory Disorders Ctr, Houston, TX USA; [Doody, Rachelle S.] Baylor Coll Med, Alzheimers Dis & Memory Disorders Ct, Dept Neurol, Houston, TX USA; [Raman, Rema; Farlow, Martin; Vellas, Bruno] Univ Calif San Diego, Div Biostat & Bioinformat, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Raman, Rema; Thomas, Ronald G.; Aisen, Paul S.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Vellas, Bruno] Clin Internal Med, Clin Internal Med & Gerontol, Toulouse, France; [Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol & Neurol, Tokyo, Japan; [Joffe, Steven] Boston Childrens Hosp, Dept Hematol Oncol, Boston, MA USA	Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Tokyo; Harvard University; Boston Children's Hospital	Doody, RS (corresponding author), Alzheimers Dis & Memory Disorders Ctr, 1977 Butler Blvd,Suite E5-101, Houston, TX 77030 USA.	rdoody@bcm.edu	Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384	Eli Lilly; University of California at San Diego; NATIONAL INSTITUTE ON AGING [U19AG010483] Funding Source: NIH RePORTER	Eli Lilly(Eli Lilly); University of California at San Diego; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by Eli Lilly; ClinicalTrials. gov number, NCT00594568.); Supported by Eli Lilly and the University of California at San Diego (the latter as a fiduciary for the Alzheimer's Disease Cooperative Study), a clinical-trials consortium established by the National Institute on Aging.	Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; BERG L, 1992, ANN NEUROL, V31, P242, DOI 10.1002/ana.410310303; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Evin G, 2006, CNS DRUGS, V20, P351, DOI 10.2165/00023210-200620050-00002; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gitter BD, 2004, NEUROBIOL AGING, V25, pS571, DOI 10.1016/S0197-4580(04)81897-9; Jack C, 2001, MOL BRAIN RES, V87, P166, DOI 10.1016/S0169-328X(01)00010-9; Kind P., 1996, QUAL LIFE PHARMACOEC, V25, P3110, DOI [10.1097/00007632-200012150-00005, DOI 10.1097/00007632-200012150-00005]; May PC, 2004, NEUROBIOL AGING, V25, pS65, DOI 10.1016/S0197-4580(04)80220-3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Mohs RC, 1997, ALZ DIS ASSOC DIS, V11, pS13; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; Roher AE, 2009, ALZHEIMERS DEMENT, V5, P18, DOI 10.1016/j.jalz.2008.10.004; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Siemers E, 2005, CLIN NEUROPHARMACOL, V28, P126, DOI 10.1097/01.wnf.0000167360.27670.29; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; WALLACE JI, 1995, J AM GERIATR SOC, V43, P329, DOI 10.1111/j.1532-5415.1995.tb05803.x; Wimo A., 1998, HLTH EC DEMENTIA, DOI DOI 10.1186/S12913-017-2422-X; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200	24	767	784	2	119	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					341	350		10.1056/NEJMoa1210951	http://dx.doi.org/10.1056/NEJMoa1210951			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188VJ	23883379	Bronze			2022-12-28	WOS:000322223900009
J	Ghofrani, HA; Galie, N; Grimminger, F; Grunig, E; Humbert, M; Jing, ZC; Keogh, AM; Langleben, D; Kilama, MO; Fritsch, A; Neuser, D; Rubin, LJ				Ghofrani, Hossein-Ardeschir; Galie, Nazzareno; Grimminger, Friedrich; Gruenig, Ekkehard; Humbert, Marc; Jing, Zhi-Cheng; Keogh, Anne M.; Langleben, David; Kilama, Michael Ochan; Fritsch, Arno; Neuser, Dieter; Rubin, Lewis J.			Riociguat for the Treatment of Pulmonary Arterial Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOLUBLE GUANYLATE-CYCLASE; 6-MINUTE WALK TEST; IMPORTANT DIFFERENCE; THERAPY; TRIALS	BACKGROUND Riociguat, a soluble guanylate cyclase stimulator, has been shown in a phase 2 trial to be beneficial in the treatment of pulmonary arterial hypertension. METHODS In this phase 3, double-blind study, we randomly assigned 443 patients with symptomatic pulmonary arterial hypertension to receive placebo, riociguat in individually adjusted doses of up to 2.5 mg three times daily (2.5 mg-maximum group), or riociguat in individually adjusted doses that were capped at 1.5 mg three times daily (1.5 mg-maximum group). The 1.5 mg-maximum group was included for exploratory purposes, and the data from that group were analyzed descriptively. Patients who were receiving no other treatment for pulmonary arterial hypertension and patients who were receiving endothelin-receptor antagonists or (nonintravenous) prostanoids were eligible. The primary end point was the change from baseline to the end of week 12 in the distance walked in 6 minutes. Secondary end points included the change in pulmonary vascular resistance, N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, World Health Organization (WHO) functional class, time to clinical worsening, score on the Borg dyspnea scale, quality-of-life variables, and safety. RESULTS By week 12, the 6-minute walk distance had increased by a mean of 30 m in the 2.5 mg-maximum group and had decreased by a mean of 6 m in the placebo group (least-squares mean difference, 36 m; 95% confidence interval, 20 to 52; P<0.001). Prespecified subgroup analyses showed that riociguat improved the 6-minute walk distance both in patients who were receiving no other treatment for the disease and in those who were receiving endothelin-receptor antagonists or prostanoids. There were significant improvements in pulmonary vascular resistance (P<0.001), NT-proBNP levels (P<0.001), WHO functional class (P=0.003), time to clinical worsening (P=0.005), and Borg dyspnea score (P=0.002). The most common serious adverse event in the placebo group and the 2.5 mg-maximum group was syncope (4% and 1%, respectively). CONCLUSIONS Riociguat significantly improved exercise capacity and secondary efficacy end points in patients with pulmonary arterial hypertension. (Funded by Bayer HealthCare; PATENT-1 and PATENT-2 ClinicalTrials.gov numbers, NCT00810693 and NCT00863681, respectively.)	[Ghofrani, Hossein-Ardeschir; Grimminger, Friedrich] Univ Giessen & Marburg Lung Ctr, Giessen, Germany; [Gruenig, Ekkehard] Univ Hosp, Ctr Pulm Hypertens, Heidelberg, Germany; [Fritsch, Arno; Neuser, Dieter] Bayer HealthCare, Global Clin Dev, Wuppertal, Germany; [Galie, Nazzareno] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Kilama, Michael Ochan] Bayer HealthCare, Global Clin Dev, Milan, Italy; [Humbert, Marc] Univ Paris Sud, Serv Pneumol, Hop Bicetre, Le Kremlin Bicetre, France; [Langleben, David] Peking Union Med Coll, Lab Cardiovasc Dis, Beijing, Peoples R China; [Jing, Zhi-Cheng] Chinese Acad Med Sci, Beijing, Peoples R China; [Neuser, Dieter] McGill Univ, Jewish Gen Hosp, Ctr Pulm Vasc Dis, Montreal, PQ, Canada; [Langleben, David] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ, Canada; [Rubin, Lewis J.] Univ Calif San Diego, La Jolla, CA 92093 USA	Ruprecht Karls University Heidelberg; Bayer AG; Bayer Healthcare Pharmaceuticals; University of Bologna; Bayer AG; Bayer Healthcare Pharmaceuticals; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; McGill University; Lady Davis Institute; McGill University; University of California System; University of California San Diego	Ghofrani, HA (corresponding author), Univ Hosp Giessen, Med Clin 2, Dept Internal Med, Klinikstr 33, D-35392 Giessen, Germany.	ardeschir.ghofrani@innere.med.uni-giessen.de	Ghofrani, Hossein Ardeschir/AAD-2856-2022; Söderberg, Stefan/AAG-3881-2019; HACHULLA, ERIC/R-8488-2018; Austin, Eric Douglas/A-6070-2013; Chazova, Irina/B-8688-2017; Galie, Nazzareno/F-7004-2014; Humbert, Marc/ABD-5112-2021; Langleben, David/AAJ-9152-2020; Humbert, Marc/AAC-8459-2019; Vizza, Carmine Dario/AAC-5540-2020; Torres, Filipa/G-9742-2016; Ghofrani, Ardeschir/AAD-5293-2020; Jing, Zhi-Cheng/AAT-9081-2021	Söderberg, Stefan/0000-0001-9225-1306; HACHULLA, ERIC/0000-0001-7432-847X; Austin, Eric Douglas/0000-0002-1709-9022; Chazova, Irina/0000-0002-9822-4357; Galie, Nazzareno/0000-0003-4271-8670; Humbert, Marc/0000-0003-0703-2892; Vizza, Carmine Dario/0000-0002-3540-4983; Ghofrani, Ardeschir/0000-0002-2029-4419; Jing, Zhi-Cheng/0000-0003-0493-0929; Degano, Bruno/0000-0003-1644-7264; Hoeper, Marius/0000-0001-9086-2293; de Groote, Pascal/0000-0002-6211-0147; Grimminger, Friedrich/0000-0001-8725-6276; Sayin, Tamer/0000-0003-3716-540X; Phrommintikul, Arintaya/0000-0003-3986-1951; Frachon, Irene/0000-0001-6666-9709; Olschewski, Horst/0000-0002-2834-7466	Bayer HealthCare	Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	Funded by Bayer HealthCare; PATENT-1 and PATENT-2 ClinicalTrials.gov numbers, NCT00810693 and NCT00863681, respectively.); Supported by Bayer HealthCare.	Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Dumitrascu R, 2006, CIRCULATION, V113, P286, DOI 10.1161/CIRCULATIONAHA.105.581405; Gabler NB, 2012, CIRCULATION, V126, P349, DOI 10.1161/CIRCULATIONAHA.112.105890; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Galie N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510; Galie N, 2011, EUR HEART J, V32, P926; Galie N, 2010, CURR OPIN PULM MED, V16, pS11, DOI 10.1097/01.mcp.0000370206.61003.7e; Galie N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274; Galie N, 2009, EUR HEART J, V30, P394, DOI 10.1093/eurheartj/ehp022; Geschka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021853; Ghofrani HA, 2010, EUR RESPIR J, V36, P792, DOI 10.1183/09031936.00182909; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Gilbert C, 2009, CHEST, V135, P137, DOI 10.1378/chest.07-0275; Grimminger F, 2009, EUR RESPIR J, V33, P785, DOI 10.1183/09031936.00039808; Lang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043433; Mathai SC, 2012, AM J RESP CRIT CARE, V186, P428, DOI 10.1164/rccm.201203-0480OC; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Schermuly RT, 2008, EUR RESPIR J, V32, P881, DOI 10.1183/09031936.00114407; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Sharkovska Y, 2010, J HYPERTENS, V28, P1666, DOI 10.1097/HJH.0b013e32833b558c; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738	25	386	428	2	82	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					330	340		10.1056/NEJMoa1209655	http://dx.doi.org/10.1056/NEJMoa1209655			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188VJ	23883378	Bronze			2022-12-28	WOS:000322223900008
J	Ford, J				Ford, Jon			The NHS is facing a deepening financial crisis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jford@bma.org.uk						BBC News, 2013, BBC NEWS; BMA, ANN REPR M 2013 RED; Hawkes N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4280; Health Committee, 2013, PUBL EXP HLTH CAR SE; HM Treasury, 2010, SPEND REV 2010; HM Treasury, 2013, SPEND ROUND 2013; National Audit Office, 2012, PROGR MAK NHS EFF SA; NHS, 2009, YEAR NHS CHIEF EX AN	8	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2013	347								f4422	10.1136/bmj.f4422	http://dx.doi.org/10.1136/bmj.f4422			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184MC	23843501				2022-12-28	WOS:000321893000017
J	Petticrew, M; McKee, M; Lock, K; Green, J; Phillips, G				Petticrew, M.; McKee, M.; Lock, K.; Green, J.; Phillips, G.			In search of social equipoise	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PUBLIC-HEALTH		[Petticrew, M.; McKee, M.; Lock, K.; Green, J.; Phillips, G.] Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Petticrew, M (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England.	mark.petticrew@lshtm.ac.uk	Petticrew, Mark/AAY-6274-2021; McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Green, Judith/0000-0002-2315-5326				[Anonymous], 2000, EXPT KNOWING GENDER; Banerjee A., 2011, POOR EC RADICAL RETH; CAMPBELL DT, 1969, AM PSYCHOL, V24, P409, DOI 10.1037/h0027982; Chiong W, 2011, NEW ENGL J MED, V364, P2077, DOI 10.1056/NEJMc1102520; Edwards P, 2011, ARCH DIS CHILD, V96, P1097, DOI 10.1136/archdischild-2011-300606; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Gollust SE, 2009, AM J PUBLIC HEALTH, V99, P2160, DOI 10.2105/AJPH.2009.161414; Grundy C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4469; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Han C JJ, 2012, 35 LLAKES; Haynes L., 2012, TEST LEARN ADAPT DEV; Herring R, 2008, DRUG-EDUC PREV POLIC, V15, P251, DOI 10.1080/09687630801920641; Local Government Operational Research Unit, 1973, ID CHRON SICK DIS RE; MCPHERSON K, 1982, NEW ENGL J MED, V307, P1310, DOI 10.1056/NEJM198211183072104; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Petticrew M, EVIDENCE PO IN PRESS; Petticrew M, 2013, EVID POLICY, V9, P87, DOI 10.1332/174426413X663742; Shemilt I, 2004, CHILD CARE HLTH DEV, V30, P413, DOI 10.1111/j.1365-2214.2004.00453.x; Taber CS, 2006, AM J POLIT SCI, V50, P755, DOI 10.1111/j.1540-5907.2006.00214.x; Thomson H, 2006, J EPIDEMIOL COMMUN H, V60, P108, DOI 10.1136/jech.2005.038885; Thomson H, 2004, BMJ-BRIT MED J, V328, P282, DOI 10.1136/bmj.328.7434.282; Vize R., 2013, GUARDIAN; WENNBERG J, 1982, SCI AM, V246, P120, DOI 10.1038/scientificamerican0482-120	23	15	15	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2013	347								f4016	10.1136/bmj.f4016	http://dx.doi.org/10.1136/bmj.f4016			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180DG	23828896	Green Submitted			2022-12-28	WOS:000321572600001
J	Longo, G; Berti, I; Burks, AW; Krauss, B; Barbi, E				Longo, Giorgio; Berti, Irene; Burks, A. Wesley; Krauss, Baruch; Barbi, Egidio			IgE-mediated food allergy in children	LANCET			English	Review							ORAL TOLERANCE INDUCTION; COWS MILK ALLERGY; TREE NUT ALLERGY; NATURAL-HISTORY; PEANUT ALLERGY; POSITION PAPER; EGG ALLERGY; IMMEDIATE HYPERSENSITIVITY; CLINICAL PREDICTORS; ELIMINATION DIETS	Food allergy is a serious health issue affecting roughly 4% of children, with a substantial effect on quality of life. Prognosis is good for the most frequent allergens with almost all children outgrowing their allergy. However, the long-term implications for disease burden are substantial for children with persistent allergies (eg, peanuts, tree nuts, fish, and shellfish) and for those with high concentrations of milk, egg, and wheat IgE. Antigen avoidance has been the time-honoured approach both for prevention and treatment. However, findings from studies done in the past 5 years show that early contact with food can induce tolerance and desensitisation to foods. We review the epidemiology, natural history, and management of food allergy, and discuss the areas of controversy and future directions in research and clinical practice.	[Longo, Giorgio; Berti, Irene; Barbi, Egidio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy; [Burks, A. Wesley] North Carolina Childrens Hosp, Chapel Hill, NC USA; [Krauss, Baruch] Boston Childrens Hosp, Boston, MA USA	IRCCS Burlo Garofolo; Harvard University; Boston Children's Hospital	Barbi, E (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy.	ebarbi@libero.it	Barbi, Egidio/K-4016-2018; Krauss, Baruch/U-6182-2019	Barbi, Egidio/0000-0002-6343-846X; Berti, Irene/0000-0001-6063-2737	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	GL, IB, EB, and BK have no conflicts of interest to declare. WB is a minority stockholder for Allertein (USA), MastCell, Inc. (USA), and is a consulatant for Merck and Co (USA). He has received grants for research projects from the National Institutes of Health. He is on the Medical Board of Directors of Food Allergy and Anaphylaxis Network (USA), Board Member of the American Academy of Allergy, Asthma and Immunology (USA), Dermatological Allergy Committee Member of the American College of Allergy, Asthma and Immunology (USA), Study Section Member of NIH Hypersensitivity, Autoimmune, and Immune-mediated Diseases Study (USA), and is on the Reviewer Board of the Journal of Allergy and Clinical Immunology (USA).	Agostoni C, 2007, PEDIAT ALLERG IMM-UK, V18, P599, DOI 10.1111/j.1399-3038.2007.00566.x; Alvaro M, 2012, EUR J PEDIATR, V171, P1389, DOI 10.1007/s00431-012-1739-z; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Baker SS, 2000, PEDIATRICS, V106, P346; Barbi E, 2004, ALLERGY, V59, P668, DOI 10.1111/j.1398-9995.2004.00398.x; Barbi E, 2012, EUR ANN ALLERGY CLIN, V44, P18; Barbi E, 2012, ALLERGOL IMMUNOPATH, V40, P41, DOI 10.1016/j.aller.2011.05.004; BOCK SA, 1989, J ALLERGY CLIN IMMUN, V83, P900, DOI 10.1016/0091-6749(89)90103-6; Boyano-Martinez T, 2002, J ALLERGY CLIN IMMUN, V110, P304, DOI 10.1067/mai.2002.126081; Buchanan AD, 2007, J ALLERGY CLIN IMMUN, V119, P199, DOI 10.1016/j.jaci.2006.09.016; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; Burks AW, 2012, J ALLERGY CLIN IMMUN, V129, P906, DOI 10.1016/j.jaci.2012.02.001; Burks AW, 2009, J ALLERGY CLIN IMMUN, V123, P424, DOI 10.1016/j.jaci.2008.12.015; Calvani M, 2011, J ALLERGY CLIN IMMUN, V128, P250, DOI 10.1016/j.jaci.2011.03.037; Celik-Bilgili S, 2005, CLIN EXP ALLERGY, V35, P268, DOI 10.1111/j.1365-2222.2005.02150.x; Chapman JA, 2006, ANN ALLERG ASTHMA IM, V96, pS1, DOI 10.1016/S1081-1206(10)60926-X; CHOO KJ, 2010, COCHRANE DB SYST REV, V3; Christie L, 2002, J AM DIET ASSOC, V102, P1648, DOI 10.1016/S0002-8223(02)90351-2; Cohen A, 2007, PEDIAT ALLERG IMM-UK, V18, P217, DOI 10.1111/j.1399-3038.2006.00506.x; Colver AF, 2005, ACTA PAEDIATR, V94, P689, DOI 10.1080/08035250510031566; Darsow U, 2010, J EUR ACAD DERMATOL, V24, P317, DOI 10.1111/j.1468-3083.2009.03415.x; DAVID TJ, 1984, ARCH DIS CHILD, V59, P983, DOI 10.1136/adc.59.10.983; Devenney I, 2006, ACTA PAEDIATR, V95, P1133, DOI 10.1080/08035250500516672; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Fiocchi A, 2010, PEDIAT ALLERG IMM-UK, V21, P1, DOI [10.1111/j.1399-3038.2010.01068.x, 10.1097/WOX.0b013e3181defeb9]; Fisher HR, 2011, ARCH DIS CHILD, V96, P259, DOI 10.1136/adc.2009.172460; Fleischer DM, 2011, J PEDIATR-US, V158, P578, DOI 10.1016/j.jpeds.2010.09.027; Flinterman AE, 2006, ALLERGY, V61, P370, DOI 10.1111/j.1398-9995.2006.01018.x; Foucard T, 2004, ACTA PAEDIATR, V93, P730, DOI 10.1080/08035250410027544; Fuentes-Aparicio V, 2013, ALLERGOL IMMUNOPATH, V41, P143, DOI 10.1016/j.aller.2012.02.007; Garcia C, 2007, ALLERGOL IMMUNOPATH, V35, P15, DOI 10.1157/13099090; Garcia-Ara C, 2001, J ALLERGY CLIN IMMUN, V107, P185, DOI 10.1067/mai.2001.111592; Greenhawt M, 2010, ALLERGY ASTHMA PROC, V31, P392, DOI 10.2500/aap.2010.31.3393; Grundy J, 2002, J ALLERGY CLIN IMMUN, V110, P784, DOI 10.1067/mai.2002.128802; Gupta R, 2007, THORAX, V62, P91, DOI 10.1136/thx.2004.038844; Hill DJ, 2008, CLIN EXP ALLERGY, V38, P161, DOI 10.1111/j.1365-2222.2007.02861.x; Ho MHK, 2008, J ALLERGY CLIN IMMUN, V121, P731, DOI 10.1016/j.jaci.2007.11.024; Host A, 1994, Pediatr Allergy Immunol, V5, P1; Jones SM, 2009, J ALLERGY CLIN IMMUN, V124, P292, DOI 10.1016/j.jaci.2009.05.022; Kagan RS, 2003, J ALLERGY CLIN IMMUN, V112, P1223, DOI 10.1016/j.jaci.2003.09.026; Katz Y, 2011, J ALLERGY CLIN IMMUN, V127, P289, DOI 10.1016/j.jaci.2010.08.053; Katz Y, 2010, J ALLERGY CLIN IMMUN, V126, P77, DOI 10.1016/j.jaci.2010.04.020; Keet CA, 2012, J ALLERGY CLIN IMMUN, V129, P448, DOI 10.1016/j.jaci.2011.10.023; Keet CA, 2009, ANN ALLERG ASTHMA IM, V102, P410, DOI 10.1016/S1081-1206(10)60513-3; Kim JS, 2011, J ALLERGY CLIN IMMUN, V128, P125, DOI 10.1016/j.jaci.2011.04.036; Kim JS, 2010, CURR OPIN ALLERGY CL, V10, P252, DOI 10.1097/ACI.0b013e328337bd3a; Klinnert MD, 2008, CURR ALLERGY ASTHM R, V8, P195, DOI 10.1007/s11882-008-0033-7; Kotaniemi-Syrjanen A, 2010, PEDIAT ALLERG IMM-UK, V21, pE421, DOI 10.1111/j.1399-3038.2009.00946.x; Kramer MS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000133.pub2; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Lack G, 2008, J ALLERGY CLIN IMMUN, V121, P1331, DOI 10.1016/j.jaci.2008.04.032; Lack G, 2012, J ALLERGY CLIN IMMUN, V129, P1187, DOI 10.1016/j.jaci.2012.02.036; LARRAMENDI CH, 1992, ALLERGY, V47, P490, DOI 10.1111/j.1398-9995.1992.tb00670.x; Leonard SA, 2012, J ALLERGY CLIN IMMUN, V130, P473, DOI 10.1016/j.jaci.2012.06.006; Lin RY, 2005, ANN ALLERG ASTHMA IM, V95, P159, DOI 10.1016/S1081-1206(10)61206-9; Longo G, 2012, EUR ANN ALLERGY CLIN, V44, P54; Longo G, 2008, J ALLERGY CLIN IMMUN, V121, P343, DOI 10.1016/j.jaci.2007.10.029; Macdougall CF, 2002, ARCH DIS CHILD, V86, P236, DOI 10.1136/adc.86.4.236; Martorell A, 2011, CLIN EXP ALLERGY, V41, P1297, DOI 10.1111/j.1365-2222.2011.03749.x; Meglio P, 2004, ALLERGY, V59, P980, DOI 10.1111/j.1398-9995.2004.00542.x; Mehr S, 2007, PEDIAT ALLERG IMM-UK, V18, P448, DOI 10.1111/j.1399-3038.2007.00529.x; Muraro A, 2007, ALLERGY, V62, P857, DOI 10.1111/j.1398-9995.2007.01421.x; Nadeau KC, 2012, IMMUNOL ALLERGY CLIN, V32, P111, DOI 10.1016/j.iac.2011.11.004; Niggemann B, 1999, CLIN EXP ALLERGY, V29, P91, DOI 10.1046/j.1365-2222.1999.00454.x; Nowak-Wegrzyn A, 2011, J ALLERGY CLIN IMMUN, V127, P558, DOI 10.1016/j.jaci.2010.12.1098; Nowak-Wegrzyn A, 2009, J ALLERGY CLIN IMMUN, V123, pS365, DOI 10.1016/j.jaci.2009.03.042; Nwaru BI, 2010, PEDIATRICS, V125, P50, DOI 10.1542/peds.2009-0813; Osborn DA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003664.pub3; Osborne NJ, 2011, J ALLERGY CLIN IMMUN, V127, P668, DOI 10.1016/j.jaci.2011.01.039; Osterballe M, 2005, PEDIAT ALLERG IMM-UK, V16, P567, DOI 10.1111/j.1399-3038.2005.00251.x; Osterballe M, 2003, J ALLERGY CLIN IMMUN, V112, P196, DOI 10.1067/mai.2003.1603; Patriarca G, 2003, ALIMENT PHARM THER, V17, P459, DOI 10.1046/j.1365-2036.2003.01468.x; Patriarca G, 1998, HEPATO-GASTROENTEROL, V45, P52; Perry TT, 2004, J ALLERGY CLIN IMMUN, V114, P144, DOI 10.1016/j.jaci.2004.04.009; Pesonen M, 2006, CLIN EXP ALLERGY, V36, P1011, DOI 10.1111/j.1365-2222.2006.02526.x; Poole JA, 2006, PEDIATRICS, V117, P2175, DOI 10.1542/peds.2005-1803; Poulos LM, 2007, J ALLERGY CLIN IMMUN, V120, P878, DOI 10.1016/j.jaci.2007.07.040; Prescott S, 2011, PEDIAT ALLERG IMM-UK, V22, P155, DOI 10.1111/j.1399-3038.2011.01145.x; Prescott SL, 2008, PEDIAT ALLERG IMM-UK, V19, P375, DOI 10.1111/j.1399-3038.2008.00718.x; Prescott SL, 2010, CURR OPIN ALLERGY CL, V10, P258, DOI 10.1097/ACI.0b013e328339ab25; Pumphrey RSH, 2003, J ALLERGY CLIN IMMUN, V112, P451, DOI 10.1067/mai.2003.1614; Romano A, 2001, INT ARCH ALLERGY IMM, V125, P264, DOI 10.1159/000053825; Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026; Rouf K, 2012, CLIN CHILD PSYCHOL P, V17, P49, DOI 10.1177/1359104511415636; Saarinen KM, 2000, CLIN EXP ALLERGY, V30, P400, DOI 10.1046/j.1365-2222.2000.00732.x; SALOGA J, 1994, AM J RESP CRIT CARE, V149, P65, DOI 10.1164/ajrccm.149.1.8111600; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Savage JH, 2007, J ALLERGY CLIN IMMUN, V120, P1413, DOI 10.1016/j.jaci.2007.09.040; Savage JH, 2010, J ALLERGY CLIN IMMUN, V125, P683, DOI 10.1016/j.jaci.2009.12.994; Sears MR, 2002, LANCET, V360, P901, DOI 10.1016/S0140-6736(02)11025-7; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; Sicherer SH, 2003, J ALLERGY CLIN IMMUN, V112, P1203, DOI 10.1016/S0091-6749(03)02026-8; Skripak JM, 2008, PEDIAT ALLERG IMM-UK, V19, P368, DOI 10.1111/j.1399-3038.2008.00723.x; Skripak JM, 2007, J ALLERGY CLIN IMMUN, V120, P1172, DOI 10.1016/j.jaci.2007.08.023; Skripak JM, 2008, J ALLERGY CLIN IMMUN, V122, P1154, DOI 10.1016/j.jaci.2008.09.030; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Staden U, 2007, ALLERGY, V62, P1261, DOI 10.1111/j.1398-9995.2007.01501.x; Strid J, 2004, EUR J IMMUNOL, V34, P2100, DOI 10.1002/eji.200425196; Tang MLK, 2008, PAEDIAT CHILD HLTH, V18, P309; Thyagarajan A, 2010, J ALLERGY CLIN IMMUN, V126, P31, DOI 10.1016/j.jaci.2010.05.012; TIAINEN JM, 1995, EUR J CLIN NUTR, V49, P605; Tole JW, 2007, IMMUNOL ALLERGY CLIN, V27, P309, DOI 10.1016/j.iac.2007.03.011; Tsabouri S, 2012, PEDIAT ALLERG IMM-UK, V23, P608, DOI 10.1111/j.1399-3038.2012.01275.x; van Reijsen FC, 1998, J ALLERGY CLIN IMMUN, V101, P207, DOI 10.1016/S0091-6749(98)70410-5; Vander Leek TK, 2000, J PEDIATR-US, V137, P749, DOI 10.1067/mpd.2000.109376; Venter C, 2008, ALLERGY, V63, P354, DOI 10.1111/j.1398-9995.2007.01570.x; von Hertzen LC, 2009, ALLERGY, V64, P678, DOI 10.1111/j.1398-9995.2009.02024.x; Wassenberg J, 2012, PEDIAT ALLERG IMM-UK, V23, P412, DOI 10.1111/j.1399-3038.2012.01310.x; Wasserman RL, 2011, J ALLERGY CLIN IMMUN, V127, P290, DOI 10.1016/j.jaci.2010.08.052; Werfel T, 2007, ALLERGY, V62, P723, DOI 10.1111/j.1398-9995.2007.01429.x; Werfel Thomas, 2009, J Dtsch Dermatol Ges, V7, P265, DOI 10.1111/j.1610-0387.2008.06901.x; Zutavern A, 2008, PEDIATRICS, V121, pE44, DOI 10.1542/peds.2006-3553	116	127	133	1	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1656	1664		10.1016/S0140-6736(13)60309-8	http://dx.doi.org/10.1016/S0140-6736(13)60309-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254CN	23845860				2022-12-28	WOS:000327140700025
J	Sander, JW				Sander, Josemir W.			Comorbidity and premature mortality in epilepsy	LANCET			English	Editorial Material							PSYCHIATRIC COMORBIDITY; SOMATIC COMORBIDITY; PEOPLE; POPULATION; RISK		[Sander, Josemir W.] UCL Inst Neurol, Dept Clin & Expt Epilepsy, NIHR Univ Coll London Hosp Biomed Res Ctr, London WC1N 3BG, England; [Sander, Josemir W.] Epilepsy Soc, Chalfont St Peter, PA USA; [Sander, Josemir W.] Stichting Epilepsie Instellingen Nederland, Heemstede, Netherlands	University College London Hospitals NHS Foundation Trust; University of London; University College London	Sander, JW (corresponding author), UCL Inst Neurol, Dept Clin & Expt Epilepsy, NIHR Univ Coll London Hosp Biomed Res Ctr, London WC1N 3BG, England.	l.sander@ucl.ac.uk	Sander, Josemir W/C-1576-2008	Sander, Josemir W/0000-0001-6041-9661				Bell GS, 2009, EPILEPSIA, V50, P1933, DOI 10.1111/j.1528-1167.2009.02106.x; Bell GS, 2004, J NEUROL NEUROSUR PS, V75, P1756, DOI 10.1136/jnnp.2003.029918; Fazel S, 2013, LANCET; Gaitatzis A, 2004, BRAIN, V127, P2427, DOI 10.1093/brain/awh267; Gaitatzis A, 2004, ACTA NEUROL SCAND, V110, P207, DOI 10.1111/j.1600-0404.2004.00324.x; Gaitatzis A, 2012, EPILEPSIA, V53, P1282, DOI 10.1111/j.1528-1167.2012.03528.x; Hermann BP, 2000, EPILEPSIA, V41, pS31, DOI 10.1111/j.1528-1157.2000.tb01522.x; Hesdorffer DC, 2012, ANN NEUROL, V72, P184, DOI 10.1002/ana.23601; Neligan A, 2011, BRAIN, V134, P388, DOI 10.1093/brain/awq378; Smith D, 1999, QJM-INT J MED, V92, P15, DOI 10.1093/qjmed/92.1.15; Tellez-Zenteno JF, 2005, EPILEPSIA, V46, P1955, DOI 10.1111/j.1528-1167.2005.00344.x; Tellez-Zenteno JF, 2007, EPILEPSIA, V48, P2336	12	9	10	1	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1618	1619		10.1016/S0140-6736(13)61136-8	http://dx.doi.org/10.1016/S0140-6736(13)61136-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254CN	23883700				2022-12-28	WOS:000327140700009
J	Goldhirsch, A; Gelber, RD; Piccart-Gebhart, MJ; de Azambuja, E; Procter, M; Suter, TM; Jackisch, C; Cameron, D; Weber, HA; Heinzmann, D; Dal Lago, L; McFadden, E; Dowsett, M; Untch, M; Gianni, L; Bell, R; Kohne, CH; Vindevoghel, A; Andersson, M; Brunt, AM; Otero-Reyes, D; Song, S; Smith, I; Leyland-Jones, B; Baselga, J				Goldhirsch, Aron; Gelber, Richard D.; Piccart-Gebhart, Martine J.; de Azambuja, Evandro; Procter, Marion; Suter, Thomas M.; Jackisch, Christian; Cameron, David; Weber, Harald A.; Heinzmann, Dominik; Dal Lago, Lissandra; McFadden, Eleanor; Dowsett, Mitch; Untch, Michael; Gianni, Luca; Bell, Richard; Koehne, Claus-Henning; Vindevoghel, Anita; Andersson, Michael; Brunt, A. Murray; Otero-Reyes, Douglas; Song, Santai; Smith, Ian; Leyland-Jones, Brian; Baselga, Jose		Herceptin Adjuvant HERA Trial	2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial	LANCET			English	Article							FOLLOW-UP; CHEMOTHERAPY; THERAPY	Background Trastuzumab has established efficacy against breast cancer with overexpression or amplification of the HER2 oncogene. The standard of care is 1 year of adjuvant trastuzumab, but the optimum duration of treatment is unknown. We compared 2 years of treatment with trastuzumab with 1 year of treatment, and updated the comparison of 1 year of trastuzumab versus observation at a median follow-up of 8 years, for patients enrolled in the HERceptin Adjuvant (HERA) trial. Methods The HERA trial is an international, multicentre, randomised, open-label, phase 3 trial comparing treatment with trastuzumab for 1 and 2 years with observation after standard neoadjuvant chemotherapy, adjuvant chemotherapy, or both in 5102 patients with HER2-positive early breast cancer. The primary endpoint was disease-free survival. The comparison of 2 years versus 1 year of trastuzumab treatment involved a landmark analysis of 3105 patients who were disease-free 12 months after randomisation to one of the trastuzumab groups, and was planned after observing at least 725 disease-free survival events. The updated intention-to-treat comparison of 1 year trastuzumab treatment versus observation alone in 3399 patients at a median follow-up of 8 years (range 0-10) is also reported. This study is registered with ClinicalTrials.gov, number NCT00045032. Findings We recorded 367 events of disease-free survival in 1552 patients in the 1 year group and 367 events in 1553 patients in the 2 year group (hazard ratio [HR] 0.99, 95% CI 0.85-1.14, p=0.86). Grade 3-4 adverse events and decreases in left ventricular ejection fraction during treatment were reported more frequently in the 2 year treatment group than in the 1 year group (342 [20.4%] vs 275 [16.3%] grade 3-4 adverse events, and 120 [7.2%] vs 69 [4.1%] decreases in left ventricular ejection fraction, respectively). HRs for a comparison of 1 year of trastuzumab treatment versus observation were 0.76 (95% CI 0.67-0.86, p<0.0001) for disease-free survival and 0.76 (0.65-0.88, p=0.0005) for overall survival, despite crossover of 884 (52%) patients from the observation group to trastuzumab therapy. Interpretation 2 years of adjuvant trastuzumab is not more effective than is 1 year of treatment for patients with HER2-positive early breast cancer. 1 year of treatment provides a significant disease-free and overall survival benefit compared with observation and remains the standard of care.	[Goldhirsch, Aron] European Inst Oncol, Dept Med, I-20141 Milan, Italy; [Gelber, Richard D.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Gelber, Richard D.; Procter, Marion; McFadden, Eleanor] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium; [Suter, Thomas M.] Univ Hosp Bern, Inselspital, Swiss Cardiovasc Ctr, Bern, Switzerland; [Cameron, David] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Cameron, David] Univ Edinburgh, Dept Oncol, Edinburgh, Midlothian, Scotland; [Weber, Harald A.; Heinzmann, Dominik] F Hoffmann La Roche, Basel, Switzerland; [Dowsett, Mitch] Royal Marsden Natl Hlth Serv Trust, Acad Dept Biochem, London, England; [Untch, Michael] Helios Klinikum Berlin Buch, Dept Gynecol & Obstet & Multidisciplinary, Breast Canc Ctr, Berlin, Germany; [Gianni, Luca] Osped San Raffaele, Dept Med Oncol, Milan, Italy; [Bell, Richard] Geelong Hosp, Andrew Love Canc Ctr, Geelong, Vic, Australia; [Koehne, Claus-Henning] Klinikum Oldenburg, Klin Onkol Hamatol, Oldenburg, Germany; [Vindevoghel, Anita] Clin & Maternit St Elisabet, Namur, Belgium; [Andersson, Michael] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark; [Brunt, A. Murray] Univ Hosp North Staffordshire, Ctr Canc, Stoke On Trent, Staffs, England; [Brunt, A. Murray] Keele Univ, Stoke On Trent, Staffs, England; [Otero-Reyes, Douglas] Ctr Int Med Adv, Dept Oncol, San Jose, Costa Rica; [Song, Santai] 307 Hosp PLA, Ctr Canc, Beijing, Peoples R China; Royal Marsden Hosp, Breast Unit, London SW3 6JJ, England; [Smith, Ian] Inst Canc Res, London SW3 6JB, England; [Leyland-Jones, Brian] Sanford Breast Canc Res, Sioux Falls, SD USA; [Baselga, Jose] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	IRCCS European Institute of Oncology (IEO); Harvard University; Dana-Farber Cancer Institute; Institut Jules Bordet; Universite Libre de Bruxelles; University of Bern; University Hospital of Bern; University of Edinburgh; University of Edinburgh; Roche Holding; Royal Marsden NHS Foundation Trust; Helios Kliniken; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Geelong Hospital; Klinikum Oldenburg; Rigshospitalet; University of Copenhagen; Keele University; Fifth Medical Center of Chinese PLA General Hospital; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Memorial Sloan Kettering Cancer Center	Goldhirsch, A (corresponding author), European Inst Oncol, Dept Med, Via Ripamonti 435, I-20141 Milan, Italy.	aaron.goldhirsch@ieo.it	Kwong, Ava/D-8005-2013	Kwong, Ava/0000-0002-6968-9489; de Azambuja, Evandro/0000-0001-9501-4509; GIANNI, LUCA/0000-0002-2372-9625; Brunt, Adrian Murray/0000-0002-4797-5097	F Hoffmann-La Roche (Roche); National Institute for Health Research [NF-SI-0512-10122] Funding Source: researchfish	F Hoffmann-La Roche (Roche)(Hoffmann-La RocheRoche Holding); National Institute for Health Research(National Institute for Health Research (NIHR))	F Hoffmann-La Roche (Roche).	Bedard PL, 2008, CLIN BREAST CANCER, V8, pS157, DOI 10.3816/CBC.2008.s.012; Bowles EJA, 2012, JNCI-J NATL CANCER I, V104, P1293, DOI 10.1093/jnci/djs317; Cancer Research UK, TRIAL COMP 6 MONTHS; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Joensuu H, 2009, J CLIN ONCOL, V27, P5685, DOI 10.1200/JCO.2008.21.4577; Kalbfleisch JD, 2002, STAT ANAL FAILURE TI, P247; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pivot X, 2013, LANCET ONCOL, V14, P741, DOI 10.1016/S1470-2045(13)70225-0; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Procter M, 2010, J CLIN ONCOL, V28, P3422, DOI 10.1200/JCO.2009.26.0463; Romond EH, 2012, J CLIN ONCOL, V30, P3792, DOI 10.1200/JCO.2011.40.0010; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Suter TM, 2007, J CLIN ONCOL, V25, P3859, DOI 10.1200/JCO.2006.09.1611	16	359	385	3	64	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2013	382	9897					1021	1028		10.1016/S0140-6736(13)61094-6	http://dx.doi.org/10.1016/S0140-6736(13)61094-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222PB	23871490				2022-12-28	WOS:000324742200022
J	Sommers, BD				Sommers, Benjamin D.			Stuck between Health and Immigration Reform - Care for Undocumented Immigrants	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Sommers, BD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							Buettgens M., 2011, WHO WILL BE UNINSURE; Passel Jeffrey S., 2009, PORTRAIT UNAUTHORIZE; Rodriguez MA, 2009, J GEN INTERN MED, V24, P508, DOI 10.1007/s11606-009-1098-2; Sommers BD, 2012, HEALTH AFFAIR, V31, P2831; Tavernise Sabrina, 2013, NY TIMES, pA1	5	59	59	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2013	369	7					593	595		10.1056/NEJMp1306636	http://dx.doi.org/10.1056/NEJMp1306636			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243YO	23883331	Green Published			2022-12-28	WOS:000326354500002
J	Murray, CJL; Abraham, J; Ali, MK; Alvarado, M; Atkinson, C; Baddour, LM; Bartels, DH; Benjamin, EJ; Bhalla, K; Birbeck, G; Bolliger, I; Burstein, R; Carnahan, E; Chen, HL; Chou, D; Chugh, SS; Cohen, A; Colson, KE; Cooper, LT; Couser, W; Criqui, MH; Dabhadkar, KC; Dahodwala, N; Danaei, G; Dellavalle, RP; Des Jarlais, DC; Dicker, D; Ding, EL; Dorsey, R; Duber, H; Ebel, BE; Engell, RE; Ezzati, M; Felson, DT; Finucane, MM; Flaxman, S; Flaxman, AD; Fleming, T; Forouzanfar, MH; Freedman, G; Freeman, MK; Gabriel, SE; Gakidou, E; Gillum, RF; Gonzalez-Medina, D; Gosselin, R; Grant, B; Gutierrez, HR; Hagan, H; Havmoeller, R; Hoffman, H; Jacobsen, KH; James, SL; Jasrasaria, R; Jayaraman, S; Johns, N; Kassebaum, N; Khatibzadeh, S; Knowlton, LM; Lan, Q; Leasher, JL; Lim, S; Lin, JK; Lipshultz, SE; London, S; Lozano, R; Lu, Y; MacIntyre, MF; Mallinger, L; McDermott, MM; Meltzer, M; Mensah, GA; Michaud, C; Miller, TR; Mock, C; Moffitt, TE; Mokdad, AA; Mokdad, AH; Moran, AE; Mozaffarian, D; Murphy, T; Naghavi, M; Narayan, KMV; Nelson, RG; Olives, C; Omer, SB; Ortblad, K; Ostro, B; Pelizzari, PM; Phillips, D; Pope, CA; Raju, M; Ranganathan, D; Razavi, H; Ritz, B; Rivara, FP; Roberts, T; Sacco, RL; Salomon, JA; Sampson, U; Sanman, E; Sapkota, A; Schwebel, DC; Shahraz, S; Shibuya, K; Shivakoti, R; Silberberg, D; Singh, GM; Singh, D; Singh, JA; Sleet, DA; Steenland, K; Tavakkoli, M; Taylor, JA; Thurston, GD; Towbin, JA; Vavilala, MS; Vos, T; Wagner, GR; Weinstock, MA; Weisskopf, MG; Wilkinson, JD; Wulf, S; Zabetian, A; Lopez, AD				Murray, Christopher J. L.; Abraham, Jerry; Ali, Mohammed K.; Alvarado, Miriam; Atkinson, Charles; Baddour, Larry M.; Bartels, David H.; Benjamin, Emelia J.; Bhalla, Kavi; Birbeck, Gretchen; Bolliger, Ian; Burstein, Roy; Carnahan, Emily; Chen, Honglei; Chou, David; Chugh, Sumeet S.; Cohen, Aaron; Colson, K. Ellicott; Cooper, Leslie T.; Couser, William; Criqui, Michael H.; Dabhadkar, Kaustubh C.; Dahodwala, Nabila; Danaei, Goodarz; Dellavalle, Robert P.; Des Jarlais, Don C.; Dicker, Daniel; Ding, Eric L.; Dorsey, Ray; Duber, Herbert; Ebel, Beth E.; Engell, Rebecca E.; Ezzati, Majid; Felson, David T.; Finucane, Mariel M.; Flaxman, Seth; Flaxman, Abraham D.; Fleming, Thomas; Forouzanfar, Mohammad H.; Freedman, Greg; Freeman, Michael K.; Gabriel, Sherine E.; Gakidou, Emmanuela; Gillum, Richard F.; Gonzalez-Medina, Diego; Gosselin, Richard; Grant, Bridget; Gutierrez, Hialy R.; Hagan, Holly; Havmoeller, Rasmus; Hoffman, Howard; Jacobsen, Kathryn H.; James, Spencer L.; Jasrasaria, Rashmi; Jayaraman, Sudha; Johns, Nicole; Kassebaum, Nicholas; Khatibzadeh, Shahab; Knowlton, Lisa Marie; Lan, Qing; Leasher, Janet L.; Lim, Stephen; Lin, John Kent; Lipshultz, Steven E.; London, Stephanie; Lozano, Rafael; Lu, Yuan; MacIntyre, Michael F.; Mallinger, Leslie; McDermott, Mary M.; Meltzer, Michele; Mensah, George A.; Michaud, Catherine; Miller, Ted R.; Mock, Charles; Moffitt, Terrie E.; Mokdad, Ali A.; Mokdad, Ali H.; Moran, Andrew E.; Mozaffarian, Dariush; Murphy, Tasha; Naghavi, Mohsen; Narayan, K. M. Venkat; Nelson, Robert G.; Olives, Casey; Omer, Saad B.; Ortblad, Katrina; Ostro, Bart; Pelizzari, Pamela M.; Phillips, David; Pope, C. Arden, III; Raju, Murugesan; Ranganathan, Dharani; Razavi, Homie; Ritz, Beate; Rivara, Frederick P.; Roberts, Thomas; Sacco, Ralph L.; Salomon, Joshua A.; Sampson, Uchechukwu; Sanman, Ella; Sapkota, Amir; Schwebel, David C.; Shahraz, Saeid; Shibuya, Kenji; Shivakoti, Rupak; Silberberg, Donald; Singh, Gitanjali M.; Singh, David; Singh, Jasvinder A.; Sleet, David A.; Steenland, Kyle; Tavakkoli, Mohammad; Taylor, Jennifer A.; Thurston, George D.; Towbin, Jeffrey A.; Vavilala, Monica S.; Vos, Theo; Wagner, Gregory R.; Weinstock, Martin A.; Weisskopf, Marc G.; Wilkinson, James D.; Wulf, Sarah; Zabetian, Azadeh; Lopez, Alan D.		Us Burden Dis Collaborators	The State of US Health, 1990-2010 Burden of Diseases, Injuries, and Risk Factors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; PUBLIC-HEALTH; CARDIOVASCULAR-DISEASE; BUILT ENVIRONMENT; PHYSICAL-ACTIVITY; UNITED-STATES; 187 COUNTRIES; LIFE-STYLE	IMPORTANCE Understanding the major health problems in the United States and how they are changing over time is critical for informing national health policy. OBJECTIVES To measure the burden of diseases, injuries, and leading risk factors in the United States from 1990 to 2010 and to compare these measurements with those of the 34 countries in the Organisation for Economic Co-operation and Development (OECD) countries. DESIGN We used the systematic analysis of descriptive epidemiology of 291 diseases and injuries, 1160 sequelae of these diseases and injuries, and 67 risk factors or clusters of risk factors from 1990 to 2010 for 187 countries developed for the Global Burden of Disease 2010 Study to describe the health status of the United States and to compare US health outcomes with those of 34 OECD countries. Years of life lost due to premature mortality (YLLs) were computed by multiplying the number of deaths at each age by a reference life expectancy at that age. Years lived with disability (YLDs) were calculated by multiplying prevalence (based on systematic reviews) by the disability weight (based on population-based surveys) for each sequela; disability in this study refers to any short- or long-term loss of health. Disability-adjusted life-years (DALYs) were estimated as the sum of YLDs and YLLs. Deaths and DALYs related to risk factors were based on systematic reviews and meta-analyses of exposure data and relative risks for risk-outcome pairs. Healthy life expectancy (HALE) was used to summarize overall population health, accounting for both length of life and levels of ill health experienced at different ages. RESULTS US life expectancy for both sexes combined increased from 75.2 years in 1990 to 78.2 years in 2010; during the same period, HALE increased from 65.8 years to 68.1 years. The diseases and injuries with the largest number of YLLs in 2010 were ischemic heart disease, lung cancer, stroke, chronic obstructive pulmonary disease, and road injury. Age-standardized YLL rates increased for Alzheimer disease, drug use disorders, chronic kidney disease, kidney cancer, and falls. The diseases with the largest number of YLDs in 2010 were low back pain, major depressive disorder, other musculoskeletal disorders, neck pain, and anxiety disorders. As the US population has aged, YLDs have comprised a larger share of DALYs than have YLLs. The leading risk factors related to DALYs were dietary risks, tobacco smoking, high body mass index, high blood pressure, high fasting plasma glucose, physical inactivity, and alcohol use. Among 34 OECD countries between 1990 and 2010, the US rank for the age-standardized death rate changed from 18th to 27th, for the age-standardized YLL rate from 23rd to 28th, for the age-standardized YLD rate from 5th to 6th, for life expectancy at birth from 20th to 27th, and for HALE from 14th to 26th. CONCLUSIONS AND RELEVANCE From 1990 to 2010, the United States made substantial progress in improving health. Life expectancy at birth and HALE increased, all-cause death rates at all ages decreased, and age-specific rates of years lived with disability remained stable. However, morbidity and chronic disability now account for nearly half of the US health burden, and improvements in population health in the United States have not kept pace with advances in population health in other wealthy nations.	[Murray, Christopher J. L.; Alvarado, Miriam; Atkinson, Charles; Bolliger, Ian; Burstein, Roy; Carnahan, Emily; Chou, David; Colson, K. Ellicott; Dicker, Daniel; Duber, Herbert; Engell, Rebecca E.; Flaxman, Abraham D.; Gakidou, Emmanuela; Gonzalez-Medina, Diego; James, Spencer L.; Jasrasaria, Rashmi; Johns, Nicole; Lim, Stephen; MacIntyre, Michael F.; Mallinger, Leslie; Mokdad, Ali A.; Mokdad, Ali H.; Murphy, Tasha; Naghavi, Mohsen; Ortblad, Katrina; Phillips, David; Ranganathan, Dharani; Roberts, Thomas; Sanman, Ella; Vos, Theo; Wulf, Sarah] Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Couser, William; Ebel, Beth E.; Kassebaum, Nicholas; Mock, Charles; Olives, Casey; Rivara, Frederick P.; Vavilala, Monica S.] Univ Washington, Seattle, WA 98195 USA; [Abraham, Jerry] Univ Texas San Antonio, Sch Med, San Antonio, TX USA; [Omer, Saad B.; Steenland, Kyle] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Ali, Mohammed K.; Dabhadkar, Kaustubh C.; Narayan, K. M. Venkat; Zabetian, Azadeh] Emory Univ, Atlanta, GA 30322 USA; [Baddour, Larry M.; Gabriel, Sherine E.] Mayo Clin, Rochester, MN USA; [Danaei, Goodarz; Ding, Eric L.; Finucane, Mariel M.; Khatibzadeh, Shahab; Knowlton, Lisa Marie; Lin, John Kent; Lu, Yuan; Singh, Gitanjali M.; Tavakkoli, Mohammad; Weisskopf, Marc G.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Bartels, David H.; Jayaraman, Sudha; Mozaffarian, Dariush] Harvard Univ, Sch Med, Boston, MA USA; [Bhalla, Kavi] Harvard Univ, Boston, MA 02115 USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Felson, David T.] Boston Univ, Boston, MA 02215 USA; [Birbeck, Gretchen] Michigan State Univ, E Lansing, MI USA; [Chen, Honglei; London, Stephanie] NIEHS, Res Triangle Pk, NC 27709 USA; [Lan, Qing] NCI, Occupat & Environm Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Grant, Bridget; Hoffman, Howard; Mensah, George A.] NIH, Bethesda, MD 20892 USA; [Nelson, Robert G.] Natl Inst Diabet & Digest & Kidney Dis, Bethesda, MD USA; [Wagner, Gregory R.] NIOSH, Baltimore, MD USA; [Chugh, Sumeet S.; Havmoeller, Rasmus] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Havmoeller, Rasmus] Karolinska Inst, Stockholm, Sweden; [Cohen, Aaron] Hlth Effects Inst, Boston, MA USA; [Cooper, Leslie T.] Loyola Univ, Sch Med, Chicago, IL 60611 USA; [Criqui, Michael H.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Dahodwala, Nabila; Silberberg, Donald] Univ Penn, Philadelphia, PA 19104 USA; [Dellavalle, Robert P.] Denver VA Med Ctr, Denver, CO USA; [Des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Dorsey, Ray; Shivakoti, Rupak] Johns Hopkins Univ, Baltimore, MD USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostatist, MRC HPA Ctr Environm & Hlth, London, England; [Flaxman, Seth] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Gillum, Richard F.] Howard Univ, Coll Med, Washington, DC USA; [Gosselin, Richard] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Gutierrez, Hialy R.] Mailman Sch Publ Hlth, New York, NY USA; [Moran, Andrew E.] Columbia Univ, New York, NY USA; [Hagan, Holly; Thurston, George D.] NYU, New York, NY USA; [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA; [Leasher, Janet L.] Nova SE Univ, Ft Lauderdale, FL 33314 USA; [Lipshultz, Steven E.; Sacco, Ralph L.; Wilkinson, James D.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Lopez, Alan D.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Lozano, Rafael] Inst Nacl Salud Publ, Ctr Invest Sistemas Salud, Cuernavaca, Morelos, Mexico; [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; [Meltzer, Michele] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Michaud, Catherine] China Med Board, Boston, MA USA; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Moffitt, Terrie E.] Duke Univ, Durham, NC USA; [Mozaffarian, Dariush] Brigham & Womens Hosp, Boston, MA 02115 USA; [Ostro, Bart] Calif Environm Protect Agcy, Sacramento, CA USA; [Pelizzari, Pamela M.] Ctr Medicare & Medicaid Serv, Baltimore, MD USA; [Pope, C. Arden, III] Brigham Young Univ, Provo, UT 84602 USA; [Raju, Murugesan] Univ Missouri, Mason Eye Inst, Columbia, MO 65211 USA; [Razavi, Homie] Ctr Dis Anal, Louisville, CO USA; [Ritz, Beate] Univ Calif Los Angeles, Los Angeles, CA USA; [Sampson, Uchechukwu] Vanderbilt Univ, Nashville, TN 37235 USA; [Sapkota, Amir] Univ Maryland, Sch Publ Hlth, College Pk, MD 20742 USA; [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA; [Shahraz, Saeid] Brandeis Univ, Waltham, MA USA; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Singh, David] Queens Med Ctr, Honolulu, HI USA; [Sleet, David A.] Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Taylor, Jennifer A.] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Towbin, Jeffrey A.] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Weinstock, Martin A.] Brown Univ, Providence, RI 02912 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Texas System; University of Texas at San Antonio (UTSA); Emory University; Rollins School Public Health; Emory University; Mayo Clinic; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Boston University; Boston University; Michigan State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Cedars Sinai Medical Center; Karolinska Institutet; Health Effects Institute (HEI); Loyola University Chicago; University of California System; University of California San Diego; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Harvard University; Beth Israel Deaconess Medical Center; Johns Hopkins University; Imperial College London; Carnegie Mellon University; Howard University; University of California System; University of California San Francisco; Columbia University; New York University; George Mason University; Nova Southeastern University; University of Miami; University of Melbourne; Instituto Nacional de Salud Publica; Northwestern University; Feinberg School of Medicine; Jefferson University; Pacific Institute for Research & Evaluation (PIRE); Duke University; Harvard University; Brigham & Women's Hospital; California Environmental Protection Agency; Centers for Medicare & Medicaid Services; Brigham Young University; University of Missouri System; University of Missouri Columbia; University of California System; University of California Los Angeles; Vanderbilt University; University System of Maryland; University of Maryland College Park; University of Alabama System; University of Alabama Birmingham; Brandeis University; University of Tokyo; The Queen's Medical Center; Centers for Disease Control & Prevention - USA; Drexel University; Cincinnati Children's Hospital Medical Center; Brown University	Murray, CJL (corresponding author), Inst Hlth Metr & Evaluat, 2301 5th Ave,Ste 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Jayaraman, Sudha/AAH-3059-2019; Ritz, Beate R/E-3043-2015; Sapkota, Amir/A-5968-2011; Pope, C. Arden/ABD-5522-2021; Singh, Jasvinder/R-6172-2019; Lopez, Alan/AAA-2734-2022; Ali, Mohammed K/N-9833-2013; Jacobsen, Kathryn H./B-5857-2008; Moffitt, Terrie E/D-5295-2011; Lozano, Rafael/T-5352-2018; Mozaffarian, Dariush/ABC-2822-2020; Salomon, Joshua/S-1929-2019; Towbin, Jeffrey A./J-5595-2019; Narayan, K.M. Venkat/J-9819-2012; Danaei, Goodarz/B-6085-2008; Thurston, George/ABB-1359-2021; Lopez, Alan D/F-1487-2010; Sacco, Ralph/Y-9278-2019; Salomon, Joshua A/D-3898-2009; Ding, Eric L./K-1118-2019; Schwebel, David/GXH-9944-2022; Wagner, Gregory R/B-1014-2009; Dellavalle, Robert/L-2020-2013; Bolliger, Ian W/C-4207-2016; Ortblad, Katrina/ABF-9070-2020; Lu, Yuan/D-4941-2015; Shivakoti, Rupak/HIU-0448-2022; Leasher, Janet/B-8889-2016; Benjamin, Emelia/E-7103-2011	Jayaraman, Sudha/0000-0003-1094-5836; Singh, Jasvinder/0000-0003-3485-0006; Jacobsen, Kathryn H./0000-0002-4198-6246; Moffitt, Terrie E/0000-0002-8589-6760; Lozano, Rafael/0000-0002-7356-8823; Salomon, Joshua/0000-0003-3929-5515; Towbin, Jeffrey A./0000-0002-6585-714X; Narayan, K.M. Venkat/0000-0001-8621-5405; Lopez, Alan D/0000-0001-5818-6512; Salomon, Joshua A/0000-0003-3929-5515; Ding, Eric L./0000-0002-5881-8097; Dellavalle, Robert/0000-0001-8132-088X; Bolliger, Ian W/0000-0001-8055-297X; Ortblad, Katrina/0000-0002-5675-8836; Lu, Yuan/0000-0001-5264-2169; Mock, Charles/0000-0002-0564-568X; Johns, Nicole/0000-0003-4513-4582; Pelizzari, Pamela/0000-0002-6992-9462; Mensah, George/0000-0002-0387-5326; Lin, John/0000-0003-2490-4453; Felson, David/0000-0002-2668-2447; Shivakoti, Rupak/0000-0002-2773-9310; Shibuya, Kenji/0000-0003-2528-7530; Sleet, David/0000-0002-6165-3289; Leasher, Janet/0000-0002-8779-5162; Ranganathan, Dharani/0000-0001-6506-2825; Benjamin, Emelia/0000-0003-4076-2336	National Institutes of Health, the National Institute of Environmental Health Sciences; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986, ZIAES043012] Funding Source: NIH RePORTER	National Institutes of Health, the National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study is supported in part by the Intramural Program of the National Institutes of Health, the National Institute of Environmental Health Sciences, and in part by the Bill and Melinda Gates Foundation.	ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; Agency for Healthcare Research and Quality, 2011, US MEDICAL EXPENDITU; Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Amos A, 2012, TOB CONTROL, V21, P236, DOI 10.1136/tobaccocontrol-2011-050280; Anderson GF, 2002, MULTINATIONAL COMPAR; Izquierdo FA, 2011, ACCIDENT ANAL PREV, V43, P911, DOI 10.1016/j.aap.2010.11.014; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Ball K, 2010, OBESITY EPIDEMIOLOGY, V2, P10518; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; BUTSON ARC, 1950, LANCET, V258, P993; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Canadian Institute for Health Information, 2011, NATIONAL AMBULATORY; Chen JT, 2013, AM J EPIDEMIOL, V177, P870, DOI 10.1093/aje/kwt041; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Collins F., 2011, FY 2012 BUDGET SUBMI; Connor J, 1999, J EPIDEMIOL COMMUN H, V53, P725, DOI 10.1136/jech.53.11.725; Cullen KW, 2013, HEALTH EDUC RES, V28, P704, DOI 10.1093/her/cyt059; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Dowd JB, 2011, INT J EPIDEMIOL, V40, P183, DOI 10.1093/ije/dyq189; Dwyer-Lindgren L, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-7; El-Serag HB, 2000, ARCH INTERN MED, V160, P3227, DOI 10.1001/archinte.160.21.3227; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Fisher ES, 2006, NEW ENGL J MED, V355, P1845, DOI 10.1056/NEJMp068221; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Healthcare Cost and Utilization Project, 2013, SID RELATED REPORTS; Jackson RJ, 2003, AM J PUBLIC HEALTH, V93, P1382, DOI 10.2105/AJPH.93.9.1382; Kindig DA, 2013, HEALTH AFFAIR, V32, P451, DOI 10.1377/hlthaff.2011.0892; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kramer MS, 2002, PAEDIATR PERINAT EP, V16, P16, DOI 10.1046/j.1365-3016.2002.00390.x; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Michaud CM, 2001, JAMA-J AM MED ASSOC, V285, P535, DOI 10.1001/jama.285.5.535; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2055, DOI 10.1016/S0140-6736(12)62134-5; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, ON THE COMPARABLE QU; National Center for Health Statistics, 1992, NATIONAL HOSPITAL AM; National Center for Health Statistics, NATIONAL HEALTH AND; National Center for Health Statistics, 1993, NATIONAL AMBULATORY; National Center for Injury Prevention and Control, INJURY PREVENTION AN; National Comorbidity Survey, NCS AND NCRS DATA; OECD, OECD HEALTH DATA 201; Olives C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060308; Peto R, 2010, NEW ENGL J MED, V362, P855, DOI 10.1056/NEJMc1000079; Redelmeier DA, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001463; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Sharma LL, 2010, AM J PUBLIC HEALTH, V100, P240, DOI 10.2105/AJPH.2009.160960; Steiner TJ, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-1; Tomz Michael, CLARIFY SOFTWARE FOR; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wallinga D, 2010, HEALTH AFFAIR, V29, P405, DOI 10.1377/hlthaff.2010.0102; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Whitelegg J., 2006, VISION ZERO ADOPTING; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willett WC, 2013, JAMA-J AM MED ASSOC, V309, P1681, DOI 10.1001/jama.2013.3075; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025; Woolf SH, 2013, US HEALTH IN INTERNA; World Cancer Research Fund American Institute for Cancer R, 2007, FOOD NUTRITION PHYSI; World Health Organization, GLOBAL HEALTH EXPEND; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	81	1611	1640	14	89	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2013	310	6					591	608		10.1001/jama.2013.13805	http://dx.doi.org/10.1001/jama.2013.13805			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	200HI	23842577	Green Submitted, Green Accepted			2022-12-28	WOS:000323058400015
J	Arie, S				Arie, Sophie			PUBLICATION ETHICS Unintended consequences of sanctions against Iran	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sophiearie@fmail.co.uk						Elsevier, 2013, TRAD SANCT IR AFF PU; US Government, 2013, IR T SANCT REG	2	8	8	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2013	347								f4650	10.1136/bmj.f4650	http://dx.doi.org/10.1136/bmj.f4650			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192YR	23881946				2022-12-28	WOS:000322524400012
J	Mahler, DL; Ingram, T; Revell, LJ; Losos, JB				Mahler, D. Luke; Ingram, Travis; Revell, Liam J.; Losos, Jonathan B.			Exceptional Convergence on the Macroevolutionary Landscape in Island Lizard Radiations	SCIENCE			English	Article							ADAPTIVE RADIATION; ECOLOGICAL OPPORTUNITY; STABILIZING SELECTION; EVOLUTION; MODELS; DIVERSIFICATION; DETERMINISM; CONTINGENCY; SPECIATION; DIVERSITY	G. G. Simpson, one of the chief architects of evolutionary biology's modern synthesis, proposed that diversification occurs on a macroevolutionary adaptive landscape, but landscape models are seldom used to study adaptive divergence in large radiations. We show that for Caribbean Anolis lizards, diversification on similar Simpsonian landscapes leads to striking convergence of entire faunas on four islands. Parallel radiations unfolding at large temporal scales shed light on the process of adaptive diversification, indicating that the adaptive landscape may give rise to predictable evolutionary patterns in nature, that adaptive peaks may be stable over macroevolutionary time, and that available geographic area influences the ability of lineages to discover new adaptive peaks.	[Mahler, D. Luke] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Ingram, Travis; Losos, Jonathan B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Revell, Liam J.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	University of California System; University of California Davis; Harvard University; University of Massachusetts System; University of Massachusetts Boston	Mahler, DL (corresponding author), Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA.	lmahler@ucdavis.edu	Revell, Liam J/AAF-1151-2019; Ingram, Travis/HCI-1116-2022	Revell, Liam J/0000-0003-0767-4713; Ingram, Travis/0000-0003-0709-5260	National Evolutionary Synthesis Center; NSF	National Evolutionary Synthesis Center; NSF(National Science Foundation (NSF))	We thank G. Bradburd, C. Davis, L. Harmon, and F. Jenkins for discussion and advice; the National Evolutionary Synthesis Center and NSF for financial support; and three anonymous reviewers for insightful feedback. Data are archived in Dryad (http://datadryad.org, doi: 10.5061/dryad.9g182).	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; CODY ML, 1978, ANNU REV ECOL SYST, V9, P265, DOI 10.1146/annurev.es.09.110178.001405; Conte GL, 2012, P ROY SOC B-BIOL SCI, V279, P5039, DOI 10.1098/rspb.2012.2146; Estes S, 2007, AM NAT, V169, P227, DOI 10.1086/510633; Frederich B, 2013, AM NAT, V181, P94, DOI 10.1086/668599; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Givnish T.J., 1999, BIOL BIODIVERSITY, P67; Gould S. J., 1989, WONDERFUL LIFE BURGE; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Hansen TF, 2012, ADAPTIVE LANDSCAPE IN EVOLUTIONARY BIOLOGY, P205; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; Ingram T, 2013, METHODS ECOL EVOL, V4, P416, DOI 10.1111/2041-210X.12034; Kassen R, 2009, ANN NY ACAD SCI, V1168, P3, DOI 10.1111/j.1749-6632.2009.04574.x; Kisel Y, 2010, AM NAT, V175, P316, DOI 10.1086/650369; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; Pinto G, 2008, P ROY SOC B-BIOL SCI, V275, P2749, DOI 10.1098/rspb.2008.0686; Rabosky DL, 2010, P NATL ACAD SCI USA, V107, P22178, DOI 10.1073/pnas.1007606107; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Stayton CT, 2008, J THEOR BIOL, V252, P1, DOI 10.1016/j.jtbi.2008.01.008; Stiassny MLJ, 1999, SCI AM, V280, P64, DOI 10.1038/scientificamerican0299-64; Svensson EI, 2012, ADAPTIVE LANDSCAPE IN EVOLUTIONARY BIOLOGY, P1; Thomas GH, 2012, METHODS ECOL EVOL, V3, P145, DOI 10.1111/j.2041-210X.2011.00132.x; Uyeda JC, 2011, P NATL ACAD SCI USA, V108, P15908, DOI 10.1073/pnas.1014503108; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144; Williams E.E., 1983, P326; Young KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004740	32	287	289	2	238	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143					292	295		10.1126/science.1232392	http://dx.doi.org/10.1126/science.1232392			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869019				2022-12-28	WOS:000321959300048
J	Laxman, S; Sutter, BM; Wu, X; Kumar, S; Guo, XF; Trudgian, DC; Mirzaei, H; Tu, BP				Laxman, Sunil; Sutter, Benjamin M.; Wu, Xi; Kumar, Sujai; Guo, Xiaofeng; Trudgian, David C.; Mirzaei, Hamid; Tu, Benjamin P.			Sulfur Amino Acids Regulate Translational Capacity and Metabolic Homeostasis through Modulation of tRNA Thiolation	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; ELONGATOR COMPLEX; THIO-MODIFICATION; MODIFIER URM1; CELL-GROWTH; YEAST; PATHWAY; SYSTEM; CYCLE; MECHANISM	Protein translation is an energetically demanding process that must be regulated in response to changes in nutrient availability. Herein, we report that intracellular methionine and cysteine availability directly controls the thiolation status of wobble-uridine (U-34) nucleotides present on lysine, glutamine, or glutamate tRNAs to regulate cellular translational capacity and metabolic homeostasis. tRNA thiolation is important for growth under nutritionally challenging environments and required for efficient translation of genes enriched in lysine, glutamine, and glutamate codons, which are enriched in proteins important for translation and growth-specific processes. tRNA thiolation is downregulated during sulfur starvation in order to decrease sulfur consumption and growth, and its absence leads to a compensatory increase in enzymes involved in methionine, cysteine, and lysine biosynthesis. Thus, tRNA thiolation enables cells to modulate translational capacity according to the availability of sulfur amino acids, establishing a functional significance for this conserved tRNA nucleotide modification in cell growth control.	[Laxman, Sunil; Sutter, Benjamin M.; Wu, Xi; Guo, Xiaofeng; Trudgian, David C.; Mirzaei, Hamid; Tu, Benjamin P.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kumar, Sujai] Univ Edinburgh, Ashworth Labs, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Edinburgh	Tu, BP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	benjamin.tu@utsouthwestern.edu	Kumar, Sujai/D-1768-2011; Laxman, Sunil/F-9886-2018; Trudgian, David/D-4785-2012	Kumar, Sujai/0000-0001-5902-6641; Laxman, Sunil/0000-0002-0861-5080; Trudgian, David/0000-0002-7084-6787	UTSW Endowed Scholars Program; Welch Foundation [I-1797]; NIGMS [R01GM094314]; Burroughs Wellcome Fund; David and Lucile Packard Foundation; Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094314] Funding Source: NIH RePORTER	UTSW Endowed Scholars Program; Welch Foundation(The Welch Foundation); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Uttam Tambar for suggestions during the synthesis of APM; Randal Halfmann, Paul Dutchak, and members of the Tu Lab for extensive discussions and critical input. This work was supported by the UTSW Endowed Scholars Program, the Welch Foundation (I-1797), award R01GM094314 from NIGMS, the Burroughs Wellcome Fund, the David and Lucile Packard Foundation, and the Damon Runyon Cancer Research Foundation. B.P.T. is a consultant and shareholder of Peloton Therapeutics.	Abdullah U, 2009, EUKARYOT CELL, V8, P1362, DOI 10.1128/EC.00015-09; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Blagosklonny MV, 2009, AGING-US, V1, P357, DOI 10.18632/aging.100040; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Charneski CA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001508; Chen CC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002258; Chen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020783; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fichtner L, 2003, MOL MICROBIOL, V49, P1297, DOI 10.1046/j.1365-2958.2003.03632.x; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kalhor HR, 2003, MOL CELL BIOL, V23, P9283, DOI 10.1128/MCB.23.24.9283-9292.2003; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Murray DB, 2003, EXP CELL RES, V287, P10, DOI 10.1016/S0014-4827(03)00068-5; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Nakai Y, 2008, J BIOL CHEM, V283, P27469, DOI 10.1074/jbc.M804043200; NAU F, 1976, BIOCHIMIE, V58, P629, DOI 10.1016/S0300-9084(76)80387-2; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Phelps SS, 2004, J MOL BIOL, V338, P439, DOI 10.1016/j.jmb.2004.02.070; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Sutter BM, 2013, CELL, V154, P403, DOI 10.1016/j.cell.2013.06.041; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Van der Veen AG, 2011, P NATL ACAD SCI USA, V108, P1763, DOI 10.1073/pnas.1014402108; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; Wu X, 2011, MOL BIOL CELL, V22, P4124, DOI 10.1091/mbc.E11-06-0525; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	44	143	145	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					416	429		10.1016/j.cell.2013.06.043	http://dx.doi.org/10.1016/j.cell.2013.06.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870129	Green Accepted, Bronze			2022-12-28	WOS:000321950700017
J	Lyons, DB; Allen, WE; Goh, T; Tsai, L; Barnea, G; Lomvardas, S				Lyons, David B.; Allen, William E.; Goh, Tracie; Tsai, Lulu; Barnea, Gilad; Lomvardas, Stavros			An Epigenetic Trap Stabilizes Singular Olfactory Receptor Expression	CELL			English	Article							ODORANT RECEPTORS; GENE-EXPRESSION; SENSORY NEURONS; MOUSE; LSD1; CRE; MAP; DEMETHYLATION; FEEDBACK; MICE	The molecular mechanisms regulating olfactory receptor (OR) expression in the mammalian nose are not yet understood. Here, we identify the transient expression of histone demethylase LSD1 and the OR-dependent expression of adenylyl cyclase 3 (Adcy3) as requirements for initiation and stabilization of OR expression. As a transcriptional coactivator, LSD1 is necessary for desilencing and initiating OR transcription, but as a transcriptional corepressor, it is incompatible with maintenance of OR expression, and its downregulation is imperative for stable OR choice. Adcy3, a sensor of OR expression and a transmitter of an OR-elicited feedback, mediates the downregulation of LSD1 and promotes the differentiation of olfactory sensory neurons (OSNs). This novel, three-node signaling cascade locks the epigenetic state of the chosen OR, stabilizes its singular expression, and prevents the transcriptional activation of additional OR alleles for the life of the neuron.	[Lyons, David B.; Lomvardas, Stavros] Univ Calif San Francisco, Tetrad Program, San Francisco, CA 94158 USA; [Goh, Tracie; Lomvardas, Stavros] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Allen, William E.; Tsai, Lulu; Barnea, Gilad] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Brown University	Lomvardas, S (corresponding author), Univ Calif San Francisco, Tetrad Program, San Francisco, CA 94158 USA.	stavros.lomvardas@ucsf.edu		Lyons, David/0000-0002-5721-4080; Korsak, Lulu/0000-0001-7662-3448; Lomvardas, Stavros/0000-0002-7668-3026	Roadmap for Epigenomics grant [5R01DA030320-02]; EUREKA grant [5R01MH091661-02]; Mcknight Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601, T32GM007810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030320] Funding Source: NIH RePORTER	Roadmap for Epigenomics grant; EUREKA grant; Mcknight Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Excellent technical support was provided by Zoe Evans. We would like to thank Dr. Geoff Rosenfeld for the LSD1 conditional KO mice and Dr. Nicholas Ryba for the G gamma 8 tTA transgenic mice. We would also like to thank Drs. Shah and Ngai, as well as members of the Lomvardas lab, for critical reading of the manuscript. This project was funded by the Roadmap for Epigenomics grant #5R01DA030320-02 and a EUREKA grant #5R01MH091661-02, as well as the Mcknight Foundation.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Anand R, 2007, J BIOL CHEM, V282, P35425, DOI 10.1074/jbc.R700027200; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chesler AT, 2007, P NATL ACAD SCI USA, V104, P1039, DOI 10.1073/pnas.0609215104; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Clowney EJ, 2011, GENOME RES, V21, P1249, DOI 10.1101/gr.120162.110; Dal Col JA, 2007, DEVELOPMENT, V134, P2481, DOI 10.1242/dev.006346; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Hou HF, 2010, CURR OPIN STRUC BIOL, V20, P739, DOI 10.1016/j.sbi.2010.09.006; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Iwema CL, 2003, J COMP NEUROL, V459, P209, DOI 10.1002/cne.10583; Johnston RJ, 2011, CELL, V145, P956, DOI 10.1016/j.cell.2011.05.003; Klungland A, 2007, DNA REPAIR, V6, P481, DOI 10.1016/j.dnarep.2006.10.012; Krolewski RC, 2013, J COMP NEUROL, V521, P833, DOI 10.1002/cne.23204; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; McIntyre JC, 2008, CHEM SENSES, V33, P825, DOI 10.1093/chemse/bjn061; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Michaloski JS, 2006, GENOME RES, V16, P1091, DOI 10.1101/gr.5185406; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Nickell MD, 2012, J COMP NEUROL, V520, P2608, DOI 10.1002/cne.23052; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; RYBA NJP, 1995, J BIOL CHEM, V270, P6757, DOI 10.1074/jbc.270.12.6757; Santoro SW, 2012, ELIFE, V1, DOI 10.7554/eLife.00070; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; Tian HK, 2008, MOL CELL NEUROSCI, V38, P484, DOI 10.1016/j.mcn.2008.04.006; Vasiliauskas D, 2011, NATURE, V479, P108, DOI 10.1038/nature10451; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zou DJ, 2007, J NEUROSCI, V27, P6675, DOI 10.1523/JNEUROSCI.0699-07.2007	57	103	105	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 18	2013	154	2					325	336		10.1016/j.cell.2013.06.039	http://dx.doi.org/10.1016/j.cell.2013.06.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870122	Green Accepted, Bronze			2022-12-28	WOS:000321950700010
J	Chung, WM; Buseman, CM; Joyner, SN; Hughes, SM; Fomby, TB; Luby, JP; Haley, RW				Chung, Wendy M.; Buseman, Christen M.; Joyner, Sibeso N.; Hughes, Sonya M.; Fomby, Thomas B.; Luby, James P.; Haley, Robert W.			The 2012 West Nile Encephalitis Epidemic in Dallas, Texas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADULT MOSQUITO MANAGEMENT; HUMAN-HEALTH-RISK; UNITED-STATES; VIRUS-INFECTION; SACRAMENTO COUNTY; DISEASE; CALIFORNIA; INSECTICIDE; EXPOSURE; COLORADO	IMPORTANCE After progressive declines over recent years, in 2012 West Nile virus epidemics resurged nationwide, with the greatest number of cases centered in Dallas County, Texas. OBJECTIVE To analyze the epidemiologic, meteorologic, and geospatial features of the 2012 Dallas West Nile virus epidemic to guide future prevention efforts. DESIGN, SETTING, AND PATIENTS Public health surveillance of Dallas County, an area of 2257 km(2) and population of 2.4 million. Surveillance data included numbers of residents diagnosed with West Nile virus infection between May 30, 2012, and December 3, 2012; mosquito trap results; weather data; and syndromic surveillance from area emergency departments. MAIN OUTCOMES AND MEASURES Incidence and age-adjusted incidence rates of West Nile neuroinvasive disease (WNND), daily prevalence of emergency department visits for asthma and skin rash, and Culex quinquefasciatus species-specific vector index (an estimate of the average number of West Nile virus-infected mosquitoes per trap-night). RESULTS The investigation identified 173 cases of WNND, 225 of West Nile fever, 17 West Nile virus-positive blood donors, and 19 deaths in 2012. The incidence rate for WNND was 7.30 per 100 000 residents in 2012, compared with 2.91 per 100 000 in 2006, the largest previous Dallas County outbreak. An unusually rapid and early escalation of large numbers of human cases closely followed increasing infection trends in mosquitoes. The Cx quinquefasciatus species-specific vector index predicted the onset of symptoms among WNND cases 1 to 2 weeks later (count regression beta = 2.97 [95% CI, 2.34 to 3.60]; P < .001). Although initially widely distributed, WNND cases soon clustered in neighborhoods with high housing density in the north central area of the county, reflecting higher vector indices and following geospatial patterns of West Nile virus in prior years. During the 11 years since West Nile virus was first identified in Dallas, the log-transformed annual prevalence of WNND was inversely associated with the number of days with low temperatures below 28 degrees F (-2.2 degrees C) in December through February (beta = -0.29 [95% CI, -0.36 to -0.21]; P < .001). Aerial insecticide spraying was not associated with increases in emergency department visits for respiratory symptoms (beta = -4.03 [95% CI, -13.76 to 5.70]; P = .42) or skin rash (beta = -1.00 [95% CI, -6.92 to 4.92]; P = .74). CONCLUSIONS AND RELEVANCE Large West Nile virus epidemics in Dallas County begin early after unusually warm winters, revisit similar geographical distributions, and are strongly predicted by the mosquito vector index. Consideration of weather patterns and historical geographical hot spots and acting on the vector index may help prevent West Nile virus-associated illness.	[Chung, Wendy M.; Buseman, Christen M.; Joyner, Sibeso N.; Hughes, Sonya M.] Dallas Cty Hlth & Human Serv, Program Epidemiol, Dallas, TX USA; [Luby, James P.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Infect Dis, Dallas, TX 75390 USA; [Haley, Robert W.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Epidemiol, Dallas, TX 75390 USA; [Fomby, Thomas B.] So Methodist Univ, Dept Econ, Richard B Johnson Ctr Econ Studies, Dallas, TX 75275 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Southern Methodist University	Haley, RW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Epidemiol, 5325 Harry Hines Blvd, Dallas, TX 75390 USA.	robert.haley@utsouthwestern.edu	Luby, James/AAS-7788-2021; Haley, Robert/P-9026-2014	Haley, Robert/0000-0001-8849-9579				Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; [Anonymous], 2013, LOCAL CLIMATOLOGICAL; Barber LM, 2010, EMERG INFECT DIS, V16, P480, DOI 10.3201/eid1603.090667; Biggerstaff B. J., 2009, POOLEDINFRATE VERSIO; Bolling BG, 2009, J MED ENTOMOL, V46, P1519, DOI 10.1603/033.046.0641; Brown HE, 2008, EMERG INFECT DIS, V14, P1539, DOI 10.3201/eid1410.071396; Carney RM, 2008, EMERG INFECT DIS, V14, P747, DOI 10.3201/eid1405.071347; Chuang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046882; Chuang TW, 2012, J MED ENTOMOL, V49, P851, DOI 10.1603/ME11150; Clayton J.S., 2002, ASP APPL BIOL, V66, P1; Division of Notifiable Diseases and Healthcare Information, 2012, 2012 NATIONALLY NOTI; Division of Vector-borne Diseases Centers for Disease Control and Prevention (CDC), 2013, WEST NILE VIRUS IN T; Elnaiem DEA, 2008, J MED ENTOMOL, V45, P751, DOI 10.1603/0022-2585(2008)45[751:IOASOP]2.0.CO;2; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gomez A, 2008, EMERG INFECT DIS, V14, P962, DOI 10.3201/eid1406.070352; Gujral IB, 2007, EMERG INFECT DIS, V13, P419, DOI 10.3201/eid1303.060941; Haley RW, 2012, JAMA-J AM MED ASSOC, V308, P1325, DOI 10.1001/2012.jama.11930; Hamer GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023767; Huhn GD, 2005, AM J TROP MED HYG, V72, P768, DOI 10.4269/ajtmh.2005.72.768; Jones RC, 2011, J AM MOSQUITO CONTR, V27, P315, DOI 10.2987/10-6098.1; Karpati AM, 2004, ENVIRON HEALTH PERSP, V112, P1183, DOI 10.1289/ehp.6946; Kwan JL, 2012, EMERG INFECT DIS, V18, P1298, DOI 10.3201/eid1808.111558; Landesman WJ, 2007, VECTOR-BORNE ZOONOT, V7, P337, DOI 10.1089/vbz.2006.0590; Luby J P, 1979, Epidemiol Rev, V1, P55; LUBY JP, 1972, AM J EPIDEMIOL, V96, P107, DOI 10.1093/oxfordjournals.aje.a121436; Macedo PA, 2007, J TOXICOL ENV HEAL A, V70, P1758, DOI 10.1080/15287390701459049; Macedo PA, 2010, J AM MOSQUITO CONTR, V26, P57, DOI 10.2987/09-5961.1; MacKinlay AC, 1997, J ECON LIT, V35, P13; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; Mount GA, 1996, J AM MOSQUITO CONTR, V12, P601; Nasci RS, 2005, PRESENTED AT 71ST AN; Paz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056398; Petersen LR, 2012, NEW ENGL J MED, V367, P1281, DOI 10.1056/NEJMp1210537; Peterson RKD, 2006, ENVIRON HEALTH PERSP, V114, P366, DOI 10.1289/ehp.8667; Preftakes CJ, 2011, INT J ENV RES PUB HE, V8, P2142, DOI 10.3390/ijerph8062142; Reisen WK, 2008, EMERG INFECT DIS, V14, P1747, DOI 10.3201/eid1411.080719; Rochlin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023280; Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19; Turner Kathryn, 2011, Morbidity and Mortality Weekly Report, V60, P1421; U.S. Census Bureau, 2010, AMERICAN FACTFINDER; Walsh MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030620; Winters AM, 2010, AM J TROP MED HYG, V82, P945, DOI 10.4269/ajtmh.2010.09-0648; Zohrabian A, 2004, EMERG INFECT DIS, V10, P1736, DOI 10.3201/eid1010.030925	43	62	64	0	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					297	307		10.1001/jama.2013.8267	http://dx.doi.org/10.1001/jama.2013.8267			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23860988	Bronze			2022-12-28	WOS:000321835700017
J	March, L				March, Lyn			Surgery and physical therapy did not differ for function in meniscal tears with knee osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Sydney, Royal N Shore Hosp, Dept Rheumatol, St Leonards, NSW 2065, Australia	Royal North Shore Hospital; University of Sydney	March, L (corresponding author), Univ Sydney, Royal N Shore Hosp, Dept Rheumatol, St Leonards, NSW 2065, Australia.							Hare KB, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-71; Sihvonen R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002510	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2							JC13	10.7326/0003-4819-159-2-201307160-02013	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23856699				2022-12-28	WOS:000322112000012
J	Murphy, MF; Waters, JH; Wood, EM; Yazer, MH				Murphy, Michael F.; Waters, Jonathan H.; Wood, Erica M.; Yazer, Mark H.			Transfusing blood safely and appropriately	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DECISION-SUPPORT-SYSTEMS; TRANEXAMIC ACID; SAMPLE COLLECTION; PATIENT OUTCOMES; PERFORMANCE; MANAGEMENT; IMPLEMENTATION; REQUIREMENTS; TECHNOLOGY; PROGRAM		[Murphy, Michael F.] John Radcliffe Hosp, NHS Blood & Transplant, Oxford OX3 9BQ, England; [Murphy, Michael F.] Oxford Univ Hosp, Oxford Biomed Res Ctr, NIHR, Oxford, England; [Murphy, Michael F.] Univ Oxford, Oxford OX1 2JD, England; [Waters, Jonathan H.] Univ Pittsburgh, Med Ctr, Dept Anesthesiol & Bioengn, Pittsburgh, PA USA; [Wood, Erica M.] Monash Univ, Dept Epidemiol & Prevent Med, Transfus Res Unit, Melbourne, Vic 3004, Australia; [Wood, Erica M.] Monash Med Ctr, Dept Clin Haematol, Melbourne, Vic, Australia; [Yazer, Mark H.] Univ Pittsburgh, Inst Transfus Med, Pittsburgh, PA USA; [Yazer, Mark H.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	University of Oxford; University of Oxford; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Monash University; Monash University; Institute for Transfusion Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Murphy, MF (corresponding author), John Radcliffe Hosp, NHS Blood & Transplant, Oxford OX3 9BQ, England.	mike.murphy@nhsbt.nhs.uk	Wood, Erica M/I-1956-2014	Wood, Erica M/0000-0001-7527-2340				Afshari A, 2011, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD007871.PUB2; Askeland RW, 2008, TRANSFUSION, V48, P1308, DOI 10.1111/j.1537-2995.2008.01668.x; British Committee for Standards in Haematology, 2012, BRIT J HAEMATOL, V159, P143; British Committee for Standards in Haematology, 2012, BRIT J HAEMATOL, V160, P35; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Chan J. C. W., 2004, Hong Kong Medical Journal, V10, P166; Cochrane Library Special Collection, 2012, AV UNN TRANSF; Department of Health, 2007, 2007001 HSC DEP HLTH; Dzik WH, 2003, VOX SANG, V85, P40, DOI 10.1046/j.1423-0410.2003.00313.x; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Goodell PP, 2010, AM J CLIN PATHOL, V134, P202, DOI 10.1309/AJCP9OFJN7FLTXDB; Goodnough LT, 2013, LANCET, V381, P1845, DOI 10.1016/S0140-6736(13)60650-9; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Harm SK, TRANSFUSION IN PRESS; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Jacobs MR, 2011, TRANSFUSION, V51, P2573, DOI 10.1111/j.1537-2995.2011.03308.x; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Keeling D, 2011, BRIT J HAEMATOL, V154, P311, DOI 10.1111/j.1365-2141.2011.08753.x; Ker K, 2012, BRIT MED J, V344, pe3504; Little T, 2011, SURVEY IT SYSTEMS HO; Murphy MF, 2008, TRANSFUSION MED, V18, P204, DOI 10.1111/j.1365-3148.2008.00850.x; Murphy MF, 2011, VOX SANG, V100, P46, DOI 10.1111/j.1423-0410.2010.01366.x; Murphy MF, 2004, TRANSFUSION MED, V14, P113, DOI 10.1111/j.0958-7578.2004.0488.x; Murphy MF, 2007, TRANSFUSION, V47, P771, DOI 10.1111/j.1537-2995.2007.01189.x; Murphy MF, 2012, TRANSFUSION, V52, P2502, DOI 10.1111/j.1537-2995.2011.03509.x; Murphy MF, 2009, TRANSFUSION, V49, P829, DOI 10.1111/j.1537-2995.2009.02120.x; National Blood Authority Australia, PAT BLOOD MAN GUID; NHS Blood and Transplant, NAT COMP AUD BLOOD T; Oxford University Hospitals, 2013, EL BLOOD TRANSF IMPR; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Radkay Lisa, 2012, Immunohematology, V28, P39; Retter A, 2013, BRIT J HAEMATOL, V160, P445, DOI 10.1111/bjh.12143; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Rothschild JM, 2007, TRANSFUSION, V47, P228, DOI 10.1111/j.1537-2995.2007.01093.x; Serious Hazards of Transfusion (SHOT) scheme, 2011, ANN SHOT REP 2011; Staves J, 2008, TRANSFUSION, V48, P415, DOI 10.1111/j.1537-2995.2007.01545.x; Turner CL, 2003, TRANSFUSION, V43, P1200, DOI 10.1046/j.1537-2995.2003.00428.x; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Waters JH, 2012, TRANSFUSION; Waters JH, 2011, TRANSFUSION, V51, P2126, DOI 10.1111/j.1537-2995.2011.03111.x; Wong J, 2010, J BONE JOINT SURG AM, V92A, P2503, DOI 10.2106/JBJS.I.01518; Yazer MH, 2012, TRANSFUSION, V52, P1640, DOI 10.1111/j.1537-2995.2011.03451.x; Yazer MH, 2013, TRANSFUSION	45	17	19	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 16	2013	347								f4303	10.1136/bmj.f4303	http://dx.doi.org/10.1136/bmj.f4303			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	189DE	23861410				2022-12-28	WOS:000322246500004
J	Argus, JP; Bensinger, SJ				Argus, Joseph P.; Bensinger, Steven J.			Fueling Function Over Expansion in T Cells	SCIENCE			English	Editorial Material							METABOLISM; ACTIVATION; FATE		[Argus, Joseph P.; Bensinger, Steven J.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med, Los Angeles, CA 90095 USA; [Argus, Joseph P.; Bensinger, Steven J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Bensinger, Steven J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Bensinger, Steven J.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Argus, JP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med, Los Angeles, CA 90095 USA.	sbensinger@mednet.ucla.edu						Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698	9	4	4	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2013	341	6141					37	38		10.1126/science.1242100	http://dx.doi.org/10.1126/science.1242100			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828930				2022-12-28	WOS:000321291700036
J	Sheikh, N; Sharma, S				Sheikh, Nabeel; Sharma, Sanjay			A young athlete with bradycardia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							2ND-DEGREE ATRIOVENTRICULAR-BLOCK; HEART-RATE		[Sheikh, Nabeel; Sharma, Sanjay] St George Hosp, London SW17 0QT, England	St Georges University London	Sheikh, N (corresponding author), St George Hosp, London SW17 0QT, England.	nabeelsheikh99@yahoo.com		Sharma, Sanjay/0000-0002-3630-6138				Baggish AL, 2011, CIRCULATION, V123, P2723, DOI 10.1161/CIRCULATIONAHA.110.981571; Barold S Serge, 2012, Herzschrittmacherther Elektrophysiol, V23, P296, DOI 10.1007/s00399-012-0240-8; Barold SS, 2011, BRIT J SPORT MED, V45, P687, DOI 10.1136/bjsm.2008.047365; Barold SS, 2001, AM J CARDIOL, V88, P1018, DOI 10.1016/S0002-9149(01)01980-4; Barold SS, 2001, MAYO CLIN PROC, V76, P44, DOI 10.4065/76.1.44; Coote JH, 2010, EXP PHYSIOL, V95, P431, DOI 10.1113/expphysiol.2009.047548; Corrado D, 2010, EUR HEART J, V31, P243, DOI 10.1093/eurheartj/ehp473; Opthof T., 2000, CARDIOVASC RES, V45, P492; Perez Riera Andres Ricardo, 2008, Cardiol J, V15, P408; Rowell L., 1986, HUMAN CIRCULATION RE; Uberoi A, 2011, CIRCULATION, V124, P746, DOI 10.1161/CIRCULATIONAHA.110.013078; Uusitalo AIT, 1998, INT J SPORTS MED, V19, P532, DOI 10.1055/s-2007-971956; Yamamoto K, 2001, MED SCI SPORT EXER, V33, P1496, DOI 10.1097/00005768-200109000-00012	13	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2013	347								f4258	10.1136/bmj.f4258	http://dx.doi.org/10.1136/bmj.f4258			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180DG	23828898				2022-12-28	WOS:000321572600004
J	Hawkes, N				Hawkes, Nigel			Doctors may have lost the chance to make a difference	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Dyer C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f4017	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2013	347								f4200	10.1136/bmj.f4200	http://dx.doi.org/10.1136/bmj.f4200			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180CZ	23823997				2022-12-28	WOS:000321571800003
J	Gostin, LO				Gostin, Lawrence O.			Who Owns Human Genes? Is DNA Patentable?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Jolie A., 2013, NY TIMES, V162, pA25; Pollack A, 2013, NY TIMES, pA16	2	4	4	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					791	792		10.1001/jama.2013.177833	http://dx.doi.org/10.1001/jama.2013.177833			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23877839				2022-12-28	WOS:000323561400013
J	Moriates, C; Shah, NT; Arora, VM				Moriates, Christopher; Shah, Neel T.; Arora, Vineet M.			First, Do No (Financial) Harm	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Moriates, Christopher] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Shah, Neel T.] Harvard Univ, Sch Med, Boston, MA USA; [Arora, Vineet M.] Univ Chicago, Chicago, IL 60637 USA	University of California System; University of California San Francisco; Harvard University; Harvard Medical School; University of Chicago	Moriates, C (corresponding author), Univ Calif San Francisco, 505 Parnassus Ave,M1287, San Francisco, CA 94143 USA.	cmoriates@medicine.ucsf.edu		Moriates, Christopher/0000-0002-3153-2558; Arora, Vineet/0000-0002-4745-7599				Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Centers for Medicare & Medicaid Services, 2011, ARE YOU A HOSPITAL I; Gill L, 2011, CONSUMER REPORTS; Graham JD, 2010, J HOSP MED, V5, P295, DOI 10.1002/jhm.655; Pronovost PJ, 2008, J CRIT CARE, V23, P207, DOI 10.1016/j.jcrc.2007.09.002; Schoen C, 2008, HEALTH AFFAIR, V27, pW298, DOI 10.1377/hlthaff.27.4.w298	7	49	49	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2013	310	6					577	578		10.1001/jama.2013.7516	http://dx.doi.org/10.1001/jama.2013.7516			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200HI	23835949				2022-12-28	WOS:000323058400008
J	Atanur, SS; Diaz, AG; Maratou, K; Sarkis, A; Rotival, M; Game, L; Tschannen, MR; Kaisaki, PJ; Otto, GW; Ma, MCJ; Keane, TM; Hummel, O; Saar, K; Chen, W; Guryev, V; Gopalakrishnan, K; Garrett, MR; Joe, B; Citterio, L; Bianchi, G; McBride, M; Dominiczak, A; Adams, DJ; Serikawa, T; Flicek, P; Cuppen, E; Hubner, N; Petretto, E; Gauguier, D; Kwitek, A; Jacob, H; Aitman, TJ				Atanur, Santosh S.; Diaz, Ana Garcia; Maratou, Klio; Sarkis, Allison; Rotival, Maxime; Game, Laurence; Tschannen, Michael R.; Kaisaki, Pamela J.; Otto, Georg W.; Ma, Man Chun John; Keane, Thomas M.; Hummel, Oliver; Saar, Kathrin; Chen, Wei; Guryev, Victor; Gopalakrishnan, Kathirvel; Garrett, Michael R.; Joe, Bina; Citterio, Lorena; Bianchi, Giuseppe; McBride, Martin; Dominiczak, Anna; Adams, David J.; Serikawa, Tadao; Flicek, Paul; Cuppen, Edwin; Hubner, Norbert; Petretto, Enrico; Gauguier, Dominique; Kwitek, Anne; Jacob, Howard; Aitman, Timothy J.			Genome Sequencing Reveals Loci under Artificial Selection that Underlie Disease Phenotypes in the Laboratory Rat	CELL			English	Article							OXIDATIVE STRESS; CARDIAC-HYPERTROPHY; GENETIC-ANALYSIS; ANGIOTENSIN-II; HYPERTENSION; GENERATION; PRESSURE; MUTATION; MECHANISMS; PHYSIOLOGY	Large numbers of inbred laboratory rat strains have been developed for a range of complex disease phenotypes. To gain insights into the evolutionary pressures underlying selection for these phenotypes, we sequenced the genomes of 27 rat strains, including 11 models of hypertension, diabetes, and insulin resistance, along with their respective control strains. Altogether, we identified more than 13 million single-nucleotide variants, indels, and structural variants across these rat strains. Analysis of strain-specific selective sweeps and gene clusters implicated genes and pathways involved in cation transport, angiotensin production, and regulators of oxidative stress in the development of cardiovascular disease phenotypes in rats. Many of the rat loci that we identified overlap with previously mapped loci for related traits in humans, indicating the presence of shared pathways underlying these phenotypes in rats and humans. These data represent a step change in resources available for evolutionary analysis of complex traits in disease models.	[Atanur, Santosh S.; Diaz, Ana Garcia; Maratou, Klio; Aitman, Timothy J.] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Physiol Genom & Med Grp, London W12 0NN, England; [Atanur, Santosh S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0NN, England; [Rotival, Maxime; Petretto, Enrico] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Integrat Genom & Med Grp, London W12 0NN, England; [Game, Laurence] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Genom Core Lab, London W12 0NN, England; [Sarkis, Allison; Tschannen, Michael R.; Jacob, Howard] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Kaisaki, Pamela J.; Otto, Georg W.; Gauguier, Dominique] Univ Oxford, Welcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Ma, Man Chun John; Kwitek, Anne] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Keane, Thomas M.; Adams, David J.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Hummel, Oliver; Saar, Kathrin; Chen, Wei; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Guryev, Victor; Cuppen, Edwin] Hubrecht Inst KNAW, NL-3584 Utrecht, Netherlands; [Guryev, Victor; Cuppen, Edwin] Univ Med Ctr Utrecht, NL-3584 Utrecht, Netherlands; [Guryev, Victor] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, NL-9700 AD Groningen, Netherlands; [Gopalakrishnan, Kathirvel; Joe, Bina] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Ctr Hypertens & Personalized Med, Toledo, OH 43606 USA; [Garrett, Michael R.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Citterio, Lorena; Bianchi, Giuseppe] Univ Vita Salute San Raffaele, Chair Nephrol, San Raffaele Sci Inst, OU Nephrol, I-20132 Milan, Italy; [McBride, Martin; Dominiczak, Anna] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Serikawa, Tadao] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto 6068501, Japan; [Flicek, Paul] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Hubner, Norbert] DZHK German Ctr Cardiovasc Res, D-13092 Berlin, Germany; [Gauguier, Dominique] INSERM, Cordeliers Res Ctr, UMR S872, F-75006 Paris, France	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Medical College of Wisconsin; University of Oxford; Wellcome Centre for Human Genetics; University of Iowa; Wellcome Trust Sanger Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Groningen; University System of Ohio; University of Toledo; University of Mississippi; University of Mississippi Medical Center; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Glasgow; Kyoto University; European Molecular Biology Laboratory (EMBL); German Centre for Cardiovascular Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Aitman, TJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Physiol Genom & Med Grp, London W12 0NN, England.	t.aitman@csc.mrc.ac.uk	Chen, Wei/C-1273-2011; Dominiczak, Anna F/P-9390-2017; Cuppen, Edwin/F-5696-2011; Citterio, Lorena/AAC-1589-2019; Gauguier, Dominique/G-2190-2016; Cuppen, Edwin/H-2389-2016	Dominiczak, Anna F/0000-0003-4913-3608; Cuppen, Edwin/0000-0002-0400-9542; Citterio, Lorena/0000-0001-6455-2291; Gauguier, Dominique/0000-0001-6156-9530; Cuppen, Edwin/0000-0002-0400-9542; Bianchi, Giuseppe/0000-0002-8365-3618; Saar, Kathrin/0000-0002-4483-1557; Otto, Georg W/0000-0002-3929-948X; Aitman, Timothy/0000-0002-7875-4502; Adams, David/0000-0001-9490-0306; Rotival, Maxime/0000-0003-2519-8044; Keane, Thomas/0000-0001-7532-6898; Flicek, Paul/0000-0002-3897-7955; Maratou, Klio/0000-0001-6061-2322; Faber, Allison/0000-0003-0657-8746; Guryev, Victor/0000-0002-5810-6022; Garcia Diaz, Ana Isabel/0000-0001-6941-6272; Ma, John/0000-0002-2000-8144; Kwitek, Anne/0000-0003-1024-4116	Medical Research Council; British Heart Foundation Center of Research Excellence [RE/08/002]; EU-funded Euratrans project [HEALTH-F4-2010-241504]; National BioResource Project-Rat; TOP grant from the Netherlands Research Council (NWO-CW) [700.58.303]; NIH [5R01HL069321]; Euratrans; BMPF-funded German Center for Cardiovascular Research; Wellcome Trust Senior Fellowship in Basic Biomedical Science [057733]; Wellcome Trust Core Award Grant [075491/Z/04]; Institute of Cardiometabolism and Nutrition [ICAN, ANR10- IAHU-05]; NIH/NHLBI [HL094446]; Robert M. Hearin Foundation; EMBL; EU-funded Euratrans project; MRC [MC_U120061454, G0800024, MC_U120097112] Funding Source: UKRI; Cancer Research UK [13031] Funding Source: researchfish; Medical Research Council [MC_U120097112, MC_U120061454, G0800024] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069321, R01HL094446, R01HL089895, R01HL020176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK089417] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation Center of Research Excellence; EU-funded Euratrans project; National BioResource Project-Rat; TOP grant from the Netherlands Research Council (NWO-CW); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Euratrans; BMPF-funded German Center for Cardiovascular Research; Wellcome Trust Senior Fellowship in Basic Biomedical Science(Wellcome Trust); Wellcome Trust Core Award Grant(Wellcome Trust); Institute of Cardiometabolism and Nutrition; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert M. Hearin Foundation; EMBL; EU-funded Euratrans project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	T.J.A. acknowledges funding from the Medical Research Council, British Heart Foundation Center of Research Excellence (RE/08/002), and the EU-funded Euratrans project (HEALTH-F4-2010-241504). We thank the National BioResource Project-Rat (http://www.anim.med.kyoto-u.ac.jp/NBR/) for providing DNA from rat strain LE/Stm and Jean Sassard for provision of rats for DNA sequencing of LH, LN, and LL rats. E.C. is supported by a TOP grant (700.58.303) from the Netherlands Research Council (NWO-CW). H.J. acknowledges funding from NIH grant 5R01HL069321. N.H. acknowledges funding from Euratrans and the BMPF-funded German Center for Cardiovascular Research. D.G. acknowledges support from a Wellcome Trust Senior Fellowship in Basic Biomedical Science (057733), a Wellcome Trust Core Award Grant (075491/Z/04), and support from the Institute of Cardiometabolism and Nutrition (ICAN, ANR10- IAHU-05). M.R.G. is supported by NIH/NHLBI HL094446 and Robert M. Hearin Foundation. P.F. acknowledges funding from EMBL and from the EU-funded Euratrans project. We thank Allen Cowley for helpful discussions on the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BIANCHI G, 1986, J HYPERTENS, V4, pS33; Bianchi G, 2005, HYPERTENSION, V45, P331, DOI 10.1161/01.HYP.0000156497.39375.37; BIANCHI G, 1990, J HYPERTENS, V8, pS213; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cusi D, 1997, LANCET, V349, P1353, DOI 10.1016/S0140-6736(97)01029-5; Dalberg U, 2007, INT IMMUNOL, V19, P447, DOI 10.1093/intimm/dxm009; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; DEKEIJZER MH, 1988, RENAL PHYSIOL BIOCH, V11, P103; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferrandi M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001815; Gamliel-Lazarovich A, 2012, ATHEROSCLEROSIS, V222, P92, DOI 10.1016/j.atherosclerosis.2012.01.047; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; JACKSON R, 1983, METABOLISM, V32, P83, DOI 10.1016/S0026-0495(83)80017-1; Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006; Jong D. W., 1984, HDB HYPERTENSION, V4; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; KREISBERG JI, 1978, AM J PATHOL, V92, P637; Kriz W, 1998, NEPHROL DIAL TRANSPL, V13, P2781, DOI 10.1093/ndt/13.11.2781; KURTZ TW, 1989, HYPERTENSION, V13, P188, DOI 10.1161/01.HYP.13.2.188; Kushiro T, 2005, CLIN EXP HYPERTENS, V27, P9, DOI 10.1081/CEH-200044244; Kwasnicka-Crawford DA, 2005, GENOMICS, V86, P182, DOI 10.1016/j.ygeno.2005.04.002; Lezin ES, 1999, HYPERTENSION, V34, P187, DOI 10.1161/01.HYP.34.2.187; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li M, 2004, J CLIN INVEST, V114, P112, DOI 10.1172/JCI200420805; Li YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030214; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lindsey J. R., 1979, The laboratory rat. Volume I. Biology and diseases., P1; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Mattson DL, 2007, AM J PHYSIOL-RENAL, V293, pF1905, DOI 10.1152/ajprenal.00012.2007; McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Precourt LP, 2011, ATHEROSCLEROSIS, V214, P20, DOI 10.1016/j.atherosclerosis.2010.08.076; Rapp JP, 2000, PHYSIOL REV, V80, P135, DOI 10.1152/physrev.2000.80.1.135; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Sato T, 2005, BIOINFORMATICS, V21, P3482, DOI 10.1093/bioinformatics/bti564; Simonis M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r31; Sober S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006034; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; Swei A, 1997, HYPERTENSION, V30, P1628, DOI 10.1161/01.HYP.30.6.1628; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; TAJIMA F, 1989, GENETICS, V123, P585; Tillier ERM, 2009, GENOME RES, V19, P1861, DOI 10.1101/gr.092452.109; Uehara Y, 2013, CURR PHARM DESIGN, V19, P3054; van Rodijnen WF, 2002, HYPERTENSION, V39, P111, DOI 10.1161/hy1201.096817; Vaziri ND, 2006, NAT CLIN PRACT NEPHR, V2, P582, DOI 10.1038/ncpneph0283; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF1103, DOI 10.1152/ajprenal.00374.2007; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Wu YR, 2013, J RENIN-ANGIO-ALDO S, V14, P263, DOI 10.1177/1470320312448949; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620	65	127	127	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					691	703		10.1016/j.cell.2013.06.040	http://dx.doi.org/10.1016/j.cell.2013.06.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23890820	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000322629900020
J	Kim, Y; Zhu, J; Yeom, B; Di Prima, M; Su, XL; Kim, JG; Yoo, SJ; Uher, C; Kotov, NA				Kim, Yoonseob; Zhu, Jian; Yeom, Bongjun; Di Prima, Matthew; Su, Xianli; Kim, Jin-Gyu; Yoo, Seung Jo; Uher, Ctirad; Kotov, Nicholas A.			Stretchable nanoparticle conductors with self-organized conductive pathways	NATURE			English	Article							CARBON NANOTUBES; ELASTIC CONDUCTORS; FILMS; TRANSPARENT; ELECTRONICS; COMPOSITES; SENSORS; ROUTE	Research in stretchable conductors is fuelled by diverse technological needs. Flexible electronics, neuroprosthetic and cardiostimulating implants, soft robotics and other curvilinear systems require materials with high conductivity over a tensile strain of 100 per cent (refs 1-3). Furthermore, implantable devices or stretchable displays(4) need materials with conductivities a thousand times higher while retaining a strain of 100 per cent. However, the molecular mechanisms that operate during material deformation and stiffening make stretchability and conductivity fundamentally difficult properties to combine. The macroscale stretching of solids elongates chemical bonds, leading to the reduced overlap and delocalization of electronic orbitals(5). This conductivity-stretchability dilemma can be exemplified by liquid metals, in which conduction pathways are retained on large deformation but weak interatomic bonds lead to compromised strength. The best-known stretchable conductors use polymer matrices containing percolated networks of high-aspect-ratio nanometre-scale tubes or nanowires to address this dilemma to some extent(6-11). Further improvements have been achieved by using fillers (the conductive component) with increased aspect ratio, of all-metallic composition(12), or with specific alignment (the way the fillers are arranged in the matrix)(13,14). However, the synthesis and separation of high-aspect-ratio fillers is challenging, stiffness increases with the volume content of metallic filler, and anisotropy increases with alignment(15). Pre-strained substrates(16,17), buckled microwires(18) and three-dimensional microfluidic polymer networks(19) have also been explored. Here we demonstrate stretchable conductors of polyurethane containing spherical nanoparticles deposited by either layer-by-layer assembly or vacuum-assisted flocculation. High conductivity and stretchability were observed in both composites despite the minimal aspect ratio of the nanoparticles. These materials also demonstrate the electronic tunability of mechanical properties, which arise from the dynamic self-organization of the nanoparticles under stress. A modified percolation theory incorporating the self-assembly behaviour of nanoparticles gave an excellent match with the experimental data.	[Kim, Yoonseob; Zhu, Jian; Yeom, Bongjun; Di Prima, Matthew; Kotov, Nicholas A.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Su, Xianli; Uher, Ctirad] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Kim, Jin-Gyu; Yoo, Seung Jo] Korea Basic Sci Inst KBSI, Div Electron Microscop Res, Taejon 305806, South Korea	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Korea Basic Science Institute (KBSI)	Kotov, NA (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	kotov@umich.edu	Su, Xianli/A-9685-2012; Zhu, Jian/H-6443-2015; Kotov, Nicholas/AAZ-4204-2021; Zhu, Jian/D-4122-2012	Zhu, Jian/0000-0002-7004-0257; Kotov, Nicholas/0000-0002-6864-5804; Yeom, Bongjun/0000-0001-8914-0947; Di Prima, Matthew/0000-0003-1623-1324; Su, Xianli/0000-0003-4428-6461; Kim, Yoonseob/0000-0002-6892-8281	STX foundation, Seoul, Korea; Center for Solar and Thermal Energy Conversion, an Energy Frontier Research Center (EFRC); US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0000957]; Center for Photonic and Multiscale Nanomaterials (C-PHOM) as a part of the National Science Foundation Materials Research Science and Engineering Center [DMR 1120923]; AFOSR [FA9550-08-1-0382]; Game Changer programme; NSF [DMR-0320740, DMR-9871177]; Directorate For Engineering [0938019] Funding Source: National Science Foundation	STX foundation, Seoul, Korea; Center for Solar and Thermal Energy Conversion, an Energy Frontier Research Center (EFRC); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Center for Photonic and Multiscale Nanomaterials (C-PHOM) as a part of the National Science Foundation Materials Research Science and Engineering Center; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Game Changer programme; NSF(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank the STX foundation, Seoul, Korea, for partial funding of this research by providing a stipend to Y.K. The LBL/VAF preparation and low-temperature-conductivity studies were in part supported by the Center for Solar and Thermal Energy Conversion, an Energy Frontier Research Center (EFRC) funded by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under award number DE-SC0000957. The in-depth study of the self-assembly processes was funded by the Center for Photonic and Multiscale Nanomaterials (C-PHOM) as a part of the National Science Foundation Materials Research Science and Engineering Center programme DMR 1120923. We are also grateful to AFOSR, project FA9550-08-1-0382 and Game Changer programme for funding used for M.D.P.'s salary. The DARPA MATLOG project made possible the measurements of damping coefficients. We thank the University of Michigan's Electron Microscopy and Analysis Laboratory (EMAL) for its assistance with electron microscopy, and for NSF grants (numbers DMR-0320740 and DMR-9871177), for funding the FEI Nova Nanolab Dualbeam Focused Ion Beam Workstation and Scanning Electron Microscope and the JEOL 2010F analytical electron microscope used in this work. We also thank EMAL and the College of Engineering for assistance with the Bruker NanoStar Small-Angle X-ray Scattering System. We also thank E. Arruda, J. Shaw and S. Daly for the use of mechanical facilities. We are grateful to Y. S. Huh for help with the high-voltage electron microscopy image.	Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Chun KY, 2010, NAT NANOTECHNOL, V5, P853, DOI 10.1038/NNANO.2010.232; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Dirix Y, 1999, ADV MATER, V11, P223, DOI 10.1002/(SICI)1521-4095(199903)11:3<223::AID-ADMA223>3.0.CO;2-J; Fan ZY, 2009, ADV MATER, V21, P3730, DOI 10.1002/adma.200900860; Fuhrer MS, 2000, SCIENCE, V288, P494, DOI 10.1126/science.288.5465.494; Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760; Hu LB, 2010, NANO LETT, V10, P708, DOI 10.1021/nl903949m; Jin HJ, 2011, SCIENCE, V332, P1179, DOI 10.1126/science.1202190; Kim DH, 2008, P NATL ACAD SCI USA, V105, P18675, DOI 10.1073/pnas.0807476105; Lee P, 2012, ADV MATER, V24, P3326, DOI 10.1002/adma.201200359; Li J, 2007, ADV FUNCT MATER, V17, P3207, DOI 10.1002/adfm.200700065; Lipomi DJ, 2011, NAT NANOTECHNOL, V6, P788, DOI [10.1038/nnano.2011.184, 10.1038/NNANO.2011.184]; Liu K, 2011, ADV FUNCT MATER, V21, P2721, DOI 10.1002/adfm.201100306; Mamedov AA, 2002, NAT MATER, V1, P190, DOI 10.1038/nmat747; Mittal V., 2013, ADV STRUCTURED MAT, P258; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; Park J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1929; Perez-Juste J, 2005, ADV FUNCT MATER, V15, P1065, DOI 10.1002/adfm.200400591; Podsiadlo P, 2009, ACS NANO, V3, P1564, DOI 10.1021/nn900239w; Reuter T, 2002, NANO LETT, V2, P709, DOI 10.1021/nl025608f; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Schlicke H, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/30/305303; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Sekitani T, 2009, NAT MATER, V8, P494, DOI [10.1038/NMAT2459, 10.1038/nmat2459]; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Torquato S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.266601; Xu F, 2012, ADV FUNCT MATER, V22, P1279, DOI 10.1002/adfm.201102032; Yu CJ, 2009, ADV MATER, V21, P4793, DOI 10.1002/adma.200901775; Zhang YY, 2010, ADV MATER, V22, P3027, DOI 10.1002/adma.200904426	30	603	619	46	1474	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					59	U77		10.1038/nature12401	http://dx.doi.org/10.1038/nature12401			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23863931				2022-12-28	WOS:000322514800027
J	Duarte, MJ; Klemm, J; Klemm, SO; Mayrhofer, KJJ; Stratmann, M; Borodin, S; Romero, AH; Madinehei, M; Crespo, D; Serrano, J; Gerstl, SSA; Choi, PP; Raabe, D; Renner, FU				Duarte, M. J.; Klemm, J.; Klemm, S. O.; Mayrhofer, K. J. J.; Stratmann, M.; Borodin, S.; Romero, A. H.; Madinehei, M.; Crespo, D.; Serrano, J.; Gerstl, S. S. A.; Choi, P. P.; Raabe, D.; Renner, F. U., II			Element-Resolved Corrosion Analysis of Stainless-Type Glass-Forming Steels	SCIENCE			English	Article							BULK METALLIC GLASSES; FE-CR; PASSIVITY BREAKDOWN; PITTING CORROSION; AMORPHOUS-ALLOYS; ICP-MS; PASSIVATION; BEHAVIOR; MO; DISSOLUTION	Ultrathin passive films effectively prevent the chemical attack of stainless steel grades in corrosive environments; their stability depends on the interplay between structure and chemistry of the constituents iron, chromium, and molybdenum (Fe-Cr-Mo). Carbon (C), and eventually boron (B), are also important constituents of steels, although in small quantities. In particular, nanoscale inhomogeneities along the surface can have an impact on material failure but are still poorly understood. Addressing a stainless-type glass-forming Fe50Cr15Mo14C15B6 alloy and using a combination of complementary high-resolution analytical techniques, we relate near-atomistic insights into increasingly inhomogeneous nanostructures with time-and element-resolved dissolution behavior. The progressive elemental partitioning on the nanoscale determines the degree of passivation. A detrimental transition from Cr-controlled passivity to Mo-controlled breakdown is dissected atom by atom, demonstrating the importance of nanoscale knowledge for understanding corrosion.	[Duarte, M. J.; Klemm, J.; Klemm, S. O.; Mayrhofer, K. J. J.; Stratmann, M.; Borodin, S.; Renner, F. U., II] Max Planck Inst Eisenforsch GmbH, Dept Interface Chem & Surface Engn, D-40237 Dusseldorf, Germany; [Duarte, M. J.; Romero, A. H.] Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados, Dept Mat, Queretaro 76230, Mexico; [Duarte, M. J.; Madinehei, M.; Crespo, D.] Univ Politecn Cataluna, Dept Fis Aplicada, Castelldefels 08860, Spain; [Duarte, M. J.; Gerstl, S. S. A.; Choi, P. P.; Raabe, D.] Max Planck Inst Eisenforsch GmbH, Dept Microstruct Phys & Alloy Design, D-40237 Dusseldorf, Germany; [Romero, A. H.] Max Planck Inst Mikrostrukturphys, D-06120 Halle, Germany; [Serrano, J.] Univ Politecn Cataluna, ICREA, Castelldefels 08860, Spain	Max Planck Society; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universitat Politecnica de Catalunya; Max Planck Society; Max Planck Society; ICREA; Universitat Politecnica de Catalunya	Duarte, MJ (corresponding author), Max Planck Inst Eisenforsch GmbH, Dept Interface Chem & Surface Engn, D-40237 Dusseldorf, Germany.	j.duarte@mpie.de; frank.renner@uhasselt.be	Choi, Pyuck-Pa/B-9012-2016; Serrano, Jorge/AAT-7290-2021; Mayrhofer, Karl/D-4166-2009; Raabe, Dierk/A-6470-2009; Renner, Frank U/G-1655-2014; Crespo, Daniel/M-1535-2013; Romero, Aldo/AAD-2526-2020; Serrano, Jorge/GVT-0742-2022; romero, aldo/B-2344-2016	Choi, Pyuck-Pa/0000-0001-9920-0755; Mayrhofer, Karl/0000-0002-4248-0431; Raabe, Dierk/0000-0003-0194-6124; Renner, Frank U/0000-0003-0425-393X; Crespo, Daniel/0000-0003-1743-2400; Duarte Correa, Maria Jazmin/0000-0001-7951-7640; Madinehei, Milad/0000-0002-9525-2520; romero, aldo/0000-0001-5968-0571; Serrano, Jorge/0000-0002-5870-1462	Micinn [MAT2010-14907]; Generalitat de Catalunya [2009SGR01225, 2009SGR01251]; Conacyt, Mexico [152153]; Marie-Curie Intra-European Fellowship; DAAD [PPP 0811941]; ICREA Funding Source: Custom	Micinn(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); Conacyt, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Marie-Curie Intra-European Fellowship(European Commission); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); ICREA(ICREA)	We acknowledge A. Kostka for providing TEM, STEM, and EDX measurements and helpful discussions. For assistance in SAEM, we thank P. Keil. A. Mingers is acknowledged for ICP-MS measurements. M.J.D., J.S., and D. C. acknowledge financial support from Micinn MAT2010-14907, Generalitat de Catalunya 2009SGR01225 and 2009SGR01251. M.J.D. and A. H. R. acknowledge support from Conacyt, Mexico, through projects PPROALMEX-DAAD-Conacyt and 152153. A. H. R. was supported by the Marie-Curie Intra-European Fellowship. F. U. R. acknowledges support by DAAD PPP 0811941.	ARCHER MD, 1987, ELECTROCHIM ACTA, V32, P13, DOI 10.1016/0013-4686(87)87002-0; Betova I, 2002, CORROS SCI, V44, P2675, DOI 10.1016/S0010-938X(02)00073-2; Byrne CJ, 2008, SCIENCE, V321, P502, DOI 10.1126/science.1158864; CASTLE JE, 1990, J ELECTROCHEM SOC, V137, P2031, DOI 10.1149/1.2086860; FUJIMOTO S, 1993, CORROS SCI, V35, P51, DOI 10.1016/0010-938X(93)90132-Z; GREER AL, 1995, SCIENCE, V267, P1947, DOI 10.1126/science.267.5206.1947; Ha HM, 2009, J ELECTROCHEM SOC, V156, pC246, DOI 10.1149/1.3148325; Hashimoto K, 2002, CORROSION, V58, P715, DOI 10.5006/1.3277653; Hashimoto K, 2011, APPL SURF SCI, V257, P8141, DOI 10.1016/j.apsusc.2010.12.142; HAUPT S, 1995, CORROS SCI, V37, P43, DOI 10.1016/0010-938X(94)00104-E; Heusler KE, 1997, CORROS SCI, V39, P1177, DOI 10.1016/S0010-938X(97)00016-4; Homazava N, 2008, SPECTROCHIM ACTA B, V63, P777, DOI 10.1016/j.sab.2008.04.015; Hono K, 2000, MATER CHARACT, V44, P203, DOI 10.1016/S1044-5803(99)00047-9; Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6; Kelly TF, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2709758; Kiminami CS, 2010, J NON-CRYST SOLIDS, V356, P2651, DOI 10.1016/j.jnoncrysol.2010.04.051; Klemm SO, 2011, ELECTROCHEM COMMUN, V13, P1533, DOI 10.1016/j.elecom.2011.10.017; Klemm SO, 2011, ELECTROCHIM ACTA, V56, P4315, DOI 10.1016/j.electacta.2011.01.052; Marcus P, 2008, CORROS SCI, V50, P2698, DOI 10.1016/j.corsci.2008.06.047; Maurice V, 1998, J ELECTROCHEM SOC, V145, P909, DOI 10.1149/1.1838366; Meng Q, 2003, NATURE, V424, P389, DOI 10.1038/424389b; NEWMAN RC, 1985, CORROS SCI, V25, P331, DOI 10.1016/0010-938X(85)90111-8; Ogle K, 2010, ELECTROCHIM ACTA, V55, P913, DOI 10.1016/j.electacta.2009.08.028; OKAMOTO G, 1973, CORROS SCI, V13, P471, DOI 10.1016/0010-938X(73)90031-0; Pang S, 2002, MATER TRANS, V43, P2137, DOI 10.2320/matertrans.43.2137; Pardo A, 2007, ACTA MATER, V55, P2239, DOI 10.1016/j.actamat.2006.11.021; Ponnambalam V, 2004, J MATER RES, V19, P1320, DOI [10.1557/JMR.2004.0176, 10.1557/jmr.2004.0176]; Punckt C, 2004, SCIENCE, V305, P1133, DOI 10.1126/science.1101358; Ryan MP, 2002, NATURE, V415, P770, DOI 10.1038/415770a; Schroers J, 2010, ADV MATER, V22, P1566, DOI 10.1002/adma.200902776; Scully JR, 2007, J MATER RES, V22, P302, DOI 10.1557/JMR.2007.0051; WILLIAMS DE, 1991, NATURE, V350, P216, DOI 10.1038/350216a0	32	115	118	6	344	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					372	376		10.1126/science.1230081	http://dx.doi.org/10.1126/science.1230081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888035	Green Submitted			2022-12-28	WOS:000322259200043
J	Suzuki, J; Denning, DP; Imanishi, E; Horvitz, HR; Nagata, S				Suzuki, Jun; Denning, Daniel P.; Imanishi, Eiichi; Horvitz, H. Robert; Nagata, Shigekazu			Xk-Related Protein 8 and CED-8 Promote Phosphatidylserine Exposure in Apoptotic Cells	SCIENCE			English	Article							PHOSPHOLIPID SCRAMBLASE; CALCIUM; IDENTIFICATION; APPEARANCE; ENGULFMENT; CLEARANCE	A classic feature of apoptotic cells is the cell-surface exposure of phosphatidylserine (PtdSer) as an "eat me" signal for engulfment. We show that the Xk-family protein Xkr8 mediates PtdSer exposure in response to apoptotic stimuli. Mouse Xkr8(-/-) cells or human cancer cells in which Xkr8 expression was repressed by hypermethylation failed to expose PtdSer during apoptosis and were inefficiently engulfed by phagocytes. Xkr8 was activated directly by caspases and required a caspase-3 cleavage site for its function. CED-8, the only Caenorhabditis elegans Xk-family homolog, also promoted apoptotic PtdSer exposure and cell-corpse engulfment. Thus, Xk-family proteins have evolutionarily conserved roles in promoting the phagocytosis of dying cells by altering the phospholipid distribution in the plasma membrane.	[Suzuki, Jun; Imanishi, Eiichi; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; [Denning, Daniel P.; Horvitz, H. Robert] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Denning, Daniel P.; Horvitz, H. Robert] MIT, Dept Biol, Cambridge, MA 02139 USA; [Nagata, Shigekazu] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Japan Society for the Promotion of Science (JSPS); JSPS; Damon Runyon Cancer Research Foundation; Charles A. King Trust; Grants-in-Aid for Scientific Research [22000013] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Damon Runyon Cancer Research Foundation; Charles A. King Trust; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank W. Hiraoka, M. Umeda, and M. Fujii for the PLB-985 cell line, the RO09-0198 peptide, and secretarial assistance, respectively. This work was supported in part by Grants-in-Aid for Specially Promoted Research from the Japan Society for the Promotion of Science (JSPS) to S.N., a Grant-in-Aid for Young Scientists (B) from JSPS to J.S., and postdoctoral fellowships from the Damon Runyon Cancer Research Foundation and the Charles A. King Trust to D. P. D. H. R. H. is the David H. Koch Professor of Biology at the Massachusetts Institute of Technology and is a Howard Hughes Medical Institute Investigator.	Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Calenda G, 2006, GENE, V370, P6, DOI 10.1016/j.gene.2005.10.037; Denning DP, 2012, NATURE, V488, P226, DOI 10.1038/nature11240; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P504, DOI 10.1006/bbrc.1999.1820; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Franks AL, 2012, ANTICANCER RES, V32, P1119; Hampton MB, 1996, FEBS LETT, V399, P277, DOI 10.1016/S0014-5793(96)01341-5; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Mapes J, 2012, CURR BIOL, V22, P1267, DOI 10.1016/j.cub.2012.05.052; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Schoenwaelder SM, 2009, BLOOD, V114, P663, DOI 10.1182/blood-2009-01-200345; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Venegas V, 2007, MOL BIOL CELL, V18, P3180, DOI 10.1091/mbc.E07-02-0138; Williamson P, 2001, BIOCHEMISTRY-US, V40, P8065, DOI 10.1021/bi001929z; Wu YC, 2000, GENE DEV, V14, P536; Zhang Y, 2012, CURR BIOL, V22, P1276, DOI 10.1016/j.cub.2012.06.004	24	340	349	6	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144					403	406		10.1126/science.1236758	http://dx.doi.org/10.1126/science.1236758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23845944	Green Published			2022-12-28	WOS:000322259200051
J	Giovannoni, S; Temperton, B; Zhao, YL				Giovannoni, Stephen; Temperton, Ben; Zhao, Yanlin			SAR11 viruses and defensive host strains reply	NATURE			English	Letter							BACTERIA		[Giovannoni, Stephen; Temperton, Ben; Zhao, Yanlin] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA	Oregon State University	Giovannoni, S (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu	Temperton, Ben/AAE-2785-2021	Temperton, Ben/0000-0002-3667-8302				Grote J, 2012, MBIO, V3, DOI 10.1128/mBio.00252-12; Lennon JT, 2007, ISME J, V1, P300, DOI 10.1038/ismej.2007.37; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Sowell SM, 2008, APPL ENVIRON MICROB, V74, P4091, DOI 10.1128/AEM.00599-08; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Sun J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023973; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Tripp HJ, 2009, ENVIRON MICROBIOL, V11, P230, DOI 10.1111/j.1462-2920.2008.01758.x; Vage S, 2013, NATURE, V499, pE3, DOI 10.1038/nature12387; Vergin KL, 2013, ISME J, V7, P1322, DOI 10.1038/ismej.2013.32; Zhao YL, 2013, NATURE, V494, P357, DOI 10.1038/nature11921	11	22	22	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					E4	E5		10.1038/nature12388	http://dx.doi.org/10.1038/nature12388			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23887435				2022-12-28	WOS:000322157900002
J	Moser, DE; Chamberlain, KR; Tait, KT; Schmitt, AK; Darling, JR; Barker, IR; Hyde, BC				Moser, D. E.; Chamberlain, K. R.; Tait, K. T.; Schmitt, A. K.; Darling, J. R.; Barker, I. R.; Hyde, B. C.			Solving the Martian meteorite age conundrum using micro-baddeleyite and launch-generated zircon	NATURE			English	Article							PB ISOTOPIC SYSTEMATICS; U-PB; EARLY DIFFERENTIATION; MAGMA OCEAN; MARS; CRYSTALLIZATION; EVOLUTION; SHERGOTTY	Invaluable records of planetary dynamics and evolution can be recovered from the geochemical systematics of single meteorites(1). However, the interpreted ages of the ejected igneous crust of Mars differ by up to four billion years(1-6), a conundrum(7) due in part to the difficulty of using geochemistry alone to distinguish between the ages of formation and the ages of the impact events that launched debris towards Earth. Here we solve the conundrum by combining in situ electron-beam nanostructural analyses and U-Pb (uranium-lead) isotopic measurements of the resistant micromineral baddeleyite (ZrO2) and host igneous minerals in the highly shock-metamorphosed shergottite Northwest Africa 5298 (ref. 8), which is a basaltic Martian meteorite. We establish that the micro-baddeleyite grains pre-date the launch event because they are shocked, cogenetic with host igneous minerals, and preserve primary igneous growth zoning. The grains least affected by shock disturbance, and which are rich in radiogenic Pb, date the basalt crystallization near the Martian surface to 187 +/- 33 million years before present. Primitive, non-radiogenic Pb isotope compositions of the host minerals, common to most shergottites(1-4), do not help us to date the meteorite, instead indicating a magma source region that was fractionated more than four billion years ago(9-12) to form a persistent reservoir so far unique to Mars(1,9). Local impact melting during ejection from Mars less than 22 +/- 2 million years ago caused the growth of unshocked, launch-generated zircon and the partial disturbance of baddeleyite dates. We can thus confirm the presence of ancient, non-convecting mantle beneath young volcanic Mars, place an upper bound on the interplanetary travel time of the ejected Martian crust, and validate a new approach to the geochronology of the inner Solar System.	[Moser, D. E.; Darling, J. R.; Barker, I. R.] Univ Western Ontario, Dept Earth Sci, London, ON N6A 5B7, Canada; [Chamberlain, K. R.] Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; [Tait, K. T.; Hyde, B. C.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Schmitt, A. K.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	Western University (University of Western Ontario); University of Wyoming; Royal Ontario Museum; University of California System; University of California Los Angeles	Moser, DE (corresponding author), Univ Western Ontario, Dept Earth Sci, 1151 Richmond St, London, ON N6A 5B7, Canada.	desmond.moser@uwo.ca	Darling, James R/A-6910-2010	Darling, James R/0000-0003-2763-6634; Barker, Ivan/0000-0001-9525-6946; Schmitt, Axel/0000-0002-9029-4211	NSERC; Wyoming NASA; NSF EAR/IF; Government of Canada; University of Western Ontario's Center for Planetary Science and Exploration	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wyoming NASA; NSF EAR/IF(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Government of Canada(CGIAR); University of Western Ontario's Center for Planetary Science and Exploration	We acknowledge the generosity of NWA 5298 donor D. Gregory. This project was supported by NSERC Discovery Grants to D. E. M. and K.T.T., a Wyoming NASA Space grant to K. R. C., an NSF EAR/IF grant to the UCLA SIMS laboratory, and postdoctoral funding to J.R.D. from the Government of Canada and the University of Western Ontario's Center for Planetary Science and Exploration. We thank S. Swapp and N. Swoboda-Colberg for assistance locating and imaging SIMS targets, and I. Craig (University of Western Ontario) for graphics art support. We also thank L. Nyquist and A. Brandon for reviews of the manuscript.	BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; Borg L, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002402; Borg LE, 2005, GEOCHIM COSMOCHIM AC, V69, P5819, DOI 10.1016/j.gca.2005.08.007; Bouvier A, 2008, EARTH PLANET SC LETT, V266, P105, DOI 10.1016/j.epsl.2007.11.006; Brandon AD, 2000, GEOCHIM COSMOCHIM AC, V64, P4083, DOI 10.1016/S0016-7037(00)00482-8; Brandon AD, 2012, GEOCHIM COSMOCHIM AC, V76, P206, DOI 10.1016/j.gca.2011.09.047; Chamberlain KR, 2010, PRECAMBRIAN RES, V183, P379, DOI 10.1016/j.precamres.2010.05.004; CHEN JH, 1986, GEOCHIM COSMOCHIM AC, V50, P955, DOI 10.1016/0016-7037(86)90376-5; Debaille V, 2007, NATURE, V450, P525, DOI 10.1038/nature06317; El Goresy A, 2013, GEOCHIM COSMOCHIM AC, V101, P233, DOI 10.1016/j.gca.2012.10.002; Foley CN, 2005, GEOCHIM COSMOCHIM AC, V69, P4557, DOI 10.1016/j.gca.2005.05.009; Gaffney AM, 2007, GEOCHIM COSMOCHIM AC, V71, P5016, DOI 10.1016/j.gca.2007.08.009; Head JN, 2002, SCIENCE, V298, P1752, DOI 10.1126/science.1077483; Heaman LM, 2009, CHEM GEOL, V261, P42, DOI 10.1016/j.chemgeo.2008.10.021; Hui HJ, 2011, METEORIT PLANET SCI, V46, P1313, DOI 10.1111/j.1945-5100.2011.01231.x; JAGOUTZ E, 1991, SPACE SCI REV, V56, P13, DOI 10.1007/BF00178386; Johnson CL, 2005, EARTH PLANET SC LETT, V230, P241, DOI 10.1016/j.epsl.2004.10.038; Krogh T. E., 1996, GEOPHYS MONOGR SER, V95, P343, DOI DOI 10.1029/GM095; Lapen TJ, 2010, SCIENCE, V328, P347, DOI 10.1126/science.1185395; Moser DE, 2011, CAN J EARTH SCI, V48, P117, DOI 10.1139/E11-011; Nemchin A, 2009, NAT GEOSCI, V2, P133, DOI 10.1038/NGEO417; Neukum G, 2010, EARTH PLANET SC LETT, V294, P204, DOI 10.1016/j.epsl.2009.09.006; Niihara T, 2012, EARTH PLANET SC LETT, V341, P195, DOI 10.1016/j.epsl.2012.06.002; Niihara T, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2011JE003802; Nimmo F, 2008, NATURE, V453, P1220, DOI 10.1038/nature07025; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; Peterson N. D., 2007, LUNAR PLANET SCI C, VXXXVIII; Sano Y, 2000, METEORIT PLANET SCI, V35, P341, DOI 10.1111/j.1945-5100.2000.tb01779.x; Schmitt AK, 2010, CHEM GEOL, V269, P386, DOI 10.1016/j.chemgeo.2009.10.013; Tornabene LL, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002600	30	76	77	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					454	+		10.1038/nature12341	http://dx.doi.org/10.1038/nature12341			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23887429				2022-12-28	WOS:000322157900035
J	Groves, T				Groves, Trish			OPEN DATA What does oseltamivir do, and how will we know?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tgroves@bmj.com	Groves, Trish/A-9119-2009	Groves, Trish/0000-0001-7915-6419				Krumholz HM, 2013, BMJ-BRIT MED J, V346, pf547	1	4	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2013	347								f4687	10.1136/bmj.f4687	http://dx.doi.org/10.1136/bmj.f4687			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BM	23884974				2022-12-28	WOS:000322531800013
J	Guerra, JR; Alderuccio, JP; Sandhu, J; Chaudhari, S				Guerra, Jose Rodolfo; Alderuccio, Juan Pablo; Sandhu, Jagbir; Chaudhari, Shobhana			Granulomatous tattoo reaction in a young man	LANCET			English	Editorial Material							SARCOIDOSIS		[Guerra, Jose Rodolfo; Alderuccio, Juan Pablo; Chaudhari, Shobhana] New York Med Coll, Metropolitan Hosp Ctr, Dept Med, New York, NY 10029 USA; [Sandhu, Jagbir] New York Med Coll, Metropolitan Hosp Ctr, Dept Pathol, New York, NY 10029 USA	Metropolitan Hospital Center; New York Medical College; Metropolitan Hospital Center; New York Medical College	Guerra, JR (corresponding author), New York Med Coll, Metropolitan Hosp Ctr, Dept Med, 1901 1st Ave, New York, NY 10029 USA.	jose.guerraorellana@nychhc.org						Anolik Robert, 2010, Dermatol Online J, V16, P19; Antonovich DD, 2005, ARCH DERMATOL, V141, P869, DOI 10.1001/archderm.141.7.869; Baumgartner M, 2010, J DTSCH DERMATOL GES, V8, P900, DOI 10.1111/j.1610-0387.2010.07391.x; Grunewald J, 2007, AM J RESP CRIT CARE, V175, P40, DOI 10.1164/rccm.200608-1197OC; Lodha S, 2009, CHEST, V136, P583, DOI 10.1378/chest.08-1527	5	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 20	2013	382	9888					284	284		10.1016/S0140-6736(13)60853-3	http://dx.doi.org/10.1016/S0140-6736(13)60853-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FL	23870530				2022-12-28	WOS:000322543700038
J	Sebag, JA; Zhang, C; Hinkle, PM; Bradshaw, AM; Cone, RD				Sebag, Julien A.; Zhang, Chao; Hinkle, Patricia M.; Bradshaw, Amanda M.; Cone, Roger D.			Developmental Control of the Melanocortin-4 Receptor by MRAP2 Proteins in Zebrafish	SCIENCE			English	Article							ACCESSORY PROTEIN; FRAMESHIFT MUTATION; OBESITY; TRAFFICKING; MC4R; MC2	The melanocortin-4 receptor (MC4R) is essential for control of energy homeostasis in vertebrates. MC4R interacts with melanocortin receptor accessory protein 2 (MRAP2) in vitro, but its functions in vivo are unknown. We found that MRAP2a, a larval form, stimulates growth of zebrafish by specifically blocking the action of MC4R. In cell culture, this protein binds MC4R and reduces the ability of the receptor to bind its ligand, alpha-melanocyte-stimulating hormone (alpha-MSH). A paralog, MRAP2b, expressed later in development, also binds MC4R but increases ligand sensitivity. Thus, MRAP2 proteins allow for developmental control of MC4R activity, with MRAP2a blocking its function and stimulating growth during larval development, whereas MRAP2b enhances responsiveness to alpha-MSH once the zebrafish begins feeding, thus increasing the capacity for regulated feeding and growth.	[Sebag, Julien A.; Zhang, Chao; Bradshaw, Amanda M.; Cone, Roger D.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Hinkle, Patricia M.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	Vanderbilt University; University of Rochester	Cone, RD (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	roger.cone@vanderbilt.edu	sebag, julien/AAU-2142-2020	sebag, julien/0000-0002-8366-312X	NIH [DK075721, DK070332, DK19974, F23DK091055]; United States-Israel Binational Agricultural Research and Development Fund (BARD) [IS-4489-12]; Vanderbilt Diabetes Research and Training Center [DK020593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, R01DK070332, R01DK075721, P30DK020593, R56DK075721, R01DK019974, T32DK007563, F32DK091055] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development Fund (BARD)(US-Israel Binational Science Foundation); Vanderbilt Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by NIH grants DK075721 and DK070332 (R. D. C.), DK19974 (P. M. H.), and F23DK091055 (J.A.S.); United States-Israel Binational Agricultural Research and Development Fund (BARD) research grant IS-4489-12 (R. D. C. and C.Z.); and Vanderbilt Diabetes Research and Training Center grant DK020593 (R. D. C.). All data and methods are publicly available in the supplementary materials.	Asai M, 2013, SCIENCE, V341, P275, DOI 10.1126/science.1233000; Chan LF, 2009, P NATL ACAD SCI USA, V106, P6146, DOI 10.1073/pnas.0809918106; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Hinkle PM, 2011, EUR J PHARMACOL, V660, P94, DOI 10.1016/j.ejphar.2010.10.113; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Agulleiro MJ, 2010, MOL CELL ENDOCRINOL, V320, P145, DOI 10.1016/j.mce.2010.01.032; Lampert KP, 2010, CURR BIOL, V20, P1729, DOI 10.1016/j.cub.2010.08.029; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Roy S, 2007, MOL ENDOCRINOL, V21, P1656, DOI 10.1210/me.2007-0041; Sebag JA, 2007, P NATL ACAD SCI USA, V104, P20244, DOI 10.1073/pnas.0708916105; Sebag JA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000593; Sebag JA, 2009, J BIOL CHEM, V284, P22641, DOI 10.1074/jbc.M109.022400; Sebag JA, 2009, J BIOL CHEM, V284, P610, DOI 10.1074/jbc.M804413200; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Zhang C, 2012, CELL METAB, V15, P256, DOI 10.1016/j.cmet.2011.12.014	16	110	115	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					278	281		10.1126/science.1232995	http://dx.doi.org/10.1126/science.1232995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869017	Green Accepted			2022-12-28	WOS:000321959300044
J	Millay, DP; O'Rourke, JR; Sutherland, LB; Bezprozvannaya, S; Shelton, JM; Bassel-Duby, R; Olson, EN				Millay, Douglas P.; O'Rourke, Jason R.; Sutherland, Lillian B.; Bezprozvannaya, Svetlana; Shelton, John M.; Bassel-Duby, Rhonda; Olson, Eric N.			Myomaker is a membrane activator of myoblast fusion and muscle formation	NATURE			English	Article							CELL-CELL FUSION; PROTEIN; MOUSE; EXPRESSION; MYOGENESIS; MICE; RAC1; GENE	Fusion of myoblasts is essential for the formation of multi-nucleated muscle fibres. However, the identity of muscle-specific proteins that directly govern this fusion process in mammals has remained elusive. Here we identify a muscle-specific membrane protein, named myomaker, that controls myoblast fusion. Myomaker is expressed on the cell surface of myoblasts during fusion and is downregulated thereafter. Overexpression of myomaker in myoblasts markedly enhances fusion, and genetic disruption of myomaker in mice causes perinatal death due to an absence of multi-nucleated muscle fibres. Remarkably, forced expression of myomaker in fibroblasts promotes fusion with myoblasts, demonstrating the direct participation of this protein in the fusion process. Pharmacological perturbation of the actin cytoskeleton abolishes the activity of myomaker, consistent with previous studies implicating actin dynamics in myoblast fusion. These findings reveal a long-sought myogenic fusion protein that controls mammalian myoblast fusion and provide new insights into the molecular underpinnings of muscle formation.	[Millay, Douglas P.; O'Rourke, Jason R.; Sutherland, Lillian B.; Bezprozvannaya, Svetlana; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Shelton, John M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu			National Institutes of Health National Research Service Award Fellowship [F32AR05948403]; National Institutes of Health [HL-077439, HL-111665, HL093039, U01-HL-100401]; Robert A. Welch Foundation [1-0025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077439, R01HL093039, U01HL100401, R01HL111665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR059484] Funding Source: NIH RePORTER	National Institutes of Health National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Cabrera for graphics, the Transgenic Technology Center at University of Texas Southwestern Medical Center for embryonic stem cell injections, J. A. Richardson for histology and the University of Texas Southwestern Live Cell Imaging Facility (K. Luby-Phelps and A. Budge) for microscopy and live cell-imaging assistance. We thank D. Rosenbaum, W. Snell, S. Schmid, J. Seemann and members of the Olson laboratory for scientific discussions. D. P. M. was financed by a National Institutes of Health National Research Service Award Fellowship (F32AR05948403). This work was supported by grants from the National Institutes of Health (HL-077439, HL-111665, HL093039 and U01-HL-100401) and the Robert A. Welch Foundation (grant 1-0025) (to E.N.O.).	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; Charrasse S, 2007, MOL BIOL CELL, V18, P1734, DOI 10.1091/mbc.E06-08-0766; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen EH, 2001, DEV CELL, V1, P705, DOI 10.1016/S1534-5807(01)00084-3; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Corcoran JA, 2004, J VIROL, V78, P4342, DOI 10.1128/JVI.78.8.4342-4351.2004; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Gruenbaum-Cohen Y, 2012, P NATL ACAD SCI USA, V109, P11211, DOI 10.1073/pnas.1116065109; Hargrave M, 2000, METH MOL B, V123, P279; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Kang JS, 2010, CURR OPIN CLIN NUTR, V13, P243, DOI 10.1097/MCO.0b013e328336ea98; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Nowak SJ, 2009, J CELL SCI, V122, P3282, DOI 10.1242/jcs.047597; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Pei JM, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-37; Powell GT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001216; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Shelton JM, 2000, J LIPID RES, V41, P532; Shilagardi K, 2013, SCIENCE, V340, P359, DOI 10.1126/science.1234781; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Vasyutina E, 2009, P NATL ACAD SCI USA, V106, P8935, DOI 10.1073/pnas.0902501106; Wilson NF, 1998, TRENDS CELL BIOL, V8, P93, DOI 10.1016/S0962-8924(98)01234-3; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0	32	295	307	1	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					301	+		10.1038/nature12343	http://dx.doi.org/10.1038/nature12343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23868259	Green Accepted			2022-12-28	WOS:000321910700028
J	Song, JM; Gao, X; Galan, JE				Song, Jeongmin; Gao, Xiang; Galan, Jorge E.			Structure and function of the Salmonella Typhi chimaeric A(2)B(5) typhoid toxin	NATURE			English	Article							CYTOLETHAL DISTENDING TOXIN; PERTUSSIS TOXIN; TYPHIMURIUM; MICROARRAY; DELIVERY; GENES; EXPRESSION; DEFICIENT; EXOTOXIN; STRATEGY	Salmonella enterica serovar Typhi (S. Typhi) differs from most other salmonellae in that it causes a life-threatening systemic infection known as typhoid fever(1). The molecular bases for its unique clinical presentation are unknown(2). Here we find that the systemic administration of typhoid toxin, a unique virulence factor of S. Typhi, reproduces many of the acute symptoms of typhoid fever in an animal model. We identify specific carbohydrate moieties on specific surface glycoproteins that serve as receptors for typhoid toxin, which explains its broad cell target specificity. We present the atomic structure of typhoid toxin, which shows an unprecedented A(2)B(5) organization with two covalently linked A subunits non-covalently associated to a pentameric B subunit. The structure provides insight into the toxin's receptor-binding specificity and delivery mechanisms and reveals how the activities of two powerful toxins have been co-opted into a single, unique toxin that can induce many of the symptoms characteristic of typhoid fever. These findings may lead to the development of potentially life-saving therapeutics against typhoid fever.	[Song, Jeongmin; Gao, Xiang; Galan, Jorge E.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	jorge.galan@yale.edu		Song, Jeongmin/0000-0002-6777-3505; gao, xiang/0000-0001-6397-5639	PHS Grant [GM098791]; Northeast Biodefense Center [U54-AI057158]; NIAID [AI079022]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R01AI079022, R01AI114618, R56AI079022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM098791] Funding Source: NIH RePORTER	PHS Grant; Northeast Biodefense Center; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Galan laboratory for careful review of this manuscript. We thank E. Folta-Stogniew for help with conducting the surface plasmon resonance and light-scattering size-exclusion chromatography assays. We also thank M. Lara-Tejero and X. Liu for mass spectrometry analysis, J. M. Kim for help with glycan array analysis software, and K.-W. Kim for help in animal inoculations. We thank W. Meng for providing help with X-ray diffraction data collection, J. Wang and C. Yan for suggestions and providing help with structure refinement, and X. Gong and M. Ke for help and suggestions with molecular docking. The glycan array analysis was carried out at the Consortium for Functional Glycomics Protein-Glycan Interaction Core, at Emory University, which is supported by PHS Grant GM098791. J. S. was supported in part by a grant from the Northeast Biodefense Center U54-AI057158 and this work was supported by NIAID Grant AI079022 to J.E.G.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Butler T, 2011, CLIN MICROBIOL INFEC, V17, P959, DOI 10.1111/j.1469-0691.2011.03552.x; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Charles R. C., 2010, CLIN VACCINE IMMUNOL; Connor BA, 2005, LANCET INFECT DIS, V5, P623, DOI 10.1016/S1473-3099(05)70239-5; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GALAN JE, 1991, INFECT IMMUN, V59, P2901; Haghjoo E, 2004, P NATL ACAD SCI USA, V101, P4614, DOI 10.1073/pnas.0400932101; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; KUMAR R, 1990, P NATL ACAD SCI USA, V87, P9948, DOI 10.1073/pnas.87.24.9948; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2002, TRENDS MICROBIOL, V10, P147, DOI 10.1016/S0966-842X(02)02316-8; Liang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01043; Liu XY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002562; Locht C, 2011, FEBS J, V278, P4668, DOI 10.1111/j.1742-4658.2011.08237.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MERRITT EA, 1995, CURR OPIN STRUC BIOL, V5, P165, DOI 10.1016/0959-440X(95)80071-9; Millen SH, 2010, BIOCHEMISTRY-US, V49, P5954, DOI 10.1021/bi100474z; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Saitoh M, 2005, MICROBIOL-SGM, V151, P3089, DOI 10.1099/mic.0.27933-0; Song XZ, 2011, NAT METHODS, V8, P85, DOI 10.1038/NMETH.1540; Spano S, 2008, CURR OPIN MICROBIOL, V11, P15, DOI 10.1016/j.mib.2007.12.002; Spano S, 2008, CELL HOST MICROBE, V3, P30, DOI 10.1016/j.chom.2007.11.001; Spano S, 2011, P NATL ACAD SCI USA, V108, P18418, DOI 10.1073/pnas.1111959108; STANLEY P, 1975, P NATL ACAD SCI USA, V72, P3323, DOI 10.1073/pnas.72.9.3323; STEIN PE, 1994, NAT STRUCT BIOL, V1, P591, DOI 10.1038/nsb0994-591; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Yu CY, 2007, MOL BIOL CELL, V18, P1710, DOI 10.1091/mbc.E06-07-0629; Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537	40	143	148	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2013	499	7458					350	U129		10.1038/nature12377	http://dx.doi.org/10.1038/nature12377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23842500	Green Accepted			2022-12-28	WOS:000321910700039
J	White, JK; Gerdin, AK; Karp, NA; Ryder, E; Buljan, M; Bussell, JN; Salisbury, J; Clare, S; Ingham, NJ; Podrini, C; Houghton, R; Estabel, J; Bottomley, JR; Melvin, DG; Sunter, D; Adams, NC; Tannahill, D; Logan, DW; MacArthur, DG; Flint, J; Mahajan, VB; Tsang, SH; Smyth, I; Watt, FM; Skarnes, WC; Dougan, G; Adams, DJ; Ramirez-Solis, R; Bradley, A; Steel, KP				White, Jacqueline K.; Gerdin, Anna-Karin; Karp, Natasha A.; Ryder, Ed; Buljan, Marija; Bussell, James N.; Salisbury, Jennifer; Clare, Simon; Ingham, Neil J.; Podrini, Christine; Houghton, Richard; Estabel, Jeanne; Bottomley, Joanna R.; Melvin, David G.; Sunter, David; Adams, Niels C.; Tannahill, David; Logan, Darren W.; MacArthur, Daniel G.; Flint, Jonathan; Mahajan, Vinit B.; Tsang, Stephen H.; Smyth, Ian; Watt, Fiona M.; Skarnes, William C.; Dougan, Gordon; Adams, David J.; Ramirez-Solis, Ramiro; Bradley, Allan; Steel, Karen P.		Sanger Inst Mouse Genetics Project	Genome-wide Generation and Systematic Phenotyping of Knockout Mice Reveals New Roles for Many Genes	CELL			English	Article							DUPLICATE GENES; INTELLECTUAL DISABILITY; TRANSMEMBRANE PROTEINS; DEFICIENCY CAUSES; MOUSE; RESOURCE; EXPRESSION; MUTATIONS; GENETICS; ROBUSTNESS	Mutations in whole organisms are powerful ways of interrogating gene function in a realistic context. We describe a program, the Sanger Institute Mouse Genetics Project, that provides a step toward the aim of knocking out all genes and screening each line for a broad range of traits. We found that hitherto unpublished genes were as likely to reveal phenotypes as known genes, suggesting that novel genes represent a rich resource for investigating the molecular basis of disease. We found many unexpected phenotypes detected only because we screened for them, emphasizing the value of screening all mutants for a wide range of traits. Haploinsufficiency and pleiotropy were both surprisingly common. Forty-two percent of genes were essential for viability, and these were less likely to have a paralog and more likely to contribute to a protein complex than other genes. Phenotypic data and more than 900 mutants are openly available for further analysis.	[White, Jacqueline K.; Gerdin, Anna-Karin; Karp, Natasha A.; Ryder, Ed; Buljan, Marija; Bussell, James N.; Salisbury, Jennifer; Clare, Simon; Ingham, Neil J.; Podrini, Christine; Houghton, Richard; Estabel, Jeanne; Bottomley, Joanna R.; Melvin, David G.; Sunter, David; Adams, Niels C.; Tannahill, David; Logan, Darren W.; MacArthur, Daniel G.; Skarnes, William C.; Dougan, Gordon; Adams, David J.; Ramirez-Solis, Ramiro; Bradley, Allan; Steel, Karen P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Flint, Jonathan] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Mahajan, Vinit B.] Univ Iowa, Omics Lab, Iowa City, IA 52242 USA; [Tsang, Stephen H.] Columbia Univ, Harkness Eye Inst, New York, NY 10032 USA; [Smyth, Ian] Monash Univ, Melbourne, Vic 3800, Australia; [Watt, Fiona M.; Sanger Inst Mouse Genetics Project] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Steel, Karen P.] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 1UL, England	Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; University of Iowa; Columbia University; Monash University; University of Cambridge; University of London; King's College London	Steel, KP (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	karen.steel@kcl.ac.uk	Yalcin, Binnaz/ABB-7735-2020; Watt, Fiona/AHB-0226-2022; Yalcin, Binnaz/P-5482-2016; Carragher, Damian/E-6673-2016; Ismail, Ozama/AFQ-9517-2022; Ryder, Edward/AAK-1243-2021; Podrini, Christine/K-8621-2016; Liakath-Ali, Kif/AAB-7672-2020	Yalcin, Binnaz/0000-0002-1924-6807; Watt, Fiona/0000-0001-9151-5154; Yalcin, Binnaz/0000-0002-1924-6807; Carragher, Damian/0000-0003-4341-4943; Ryder, Edward/0000-0002-1799-9899; Podrini, Christine/0000-0002-5391-3378; Karp, Natasha/0000-0002-8404-2907; Bradley, Allan/0000-0002-2349-8839; Mahajan, Vinit/0000-0003-1886-1741; Ismail, Ozama/0000-0002-0871-3924; Ingham, Neil Jon/0000-0002-0916-7347; Oakley, Darren/0000-0001-8075-3368; Agu, Chukwuma/0000-0002-8368-4457; MacArthur, Daniel/0000-0002-5771-2290; Smyth, Ian/0000-0002-1727-7829; Flint, Jonathan/0000-0002-9427-4429; Ramirez-Solis, Ramiro/0000-0003-4182-173X; Logan, Darren/0000-0003-1545-5510; Richardson, David/0000-0003-0247-9118; Dumeau, Charles-Etienne/0000-0002-6916-7277; Adams, David/0000-0001-9490-0306; Tannahill, David/0000-0002-3811-6864; Liakath-Ali, Kif/0000-0001-9047-7424	Wellcome Trust [098051, RG45277 PCAG/116]; Medical Research Council; European Commission (EUMODIC) [LSHG-CT-2006-037188]; NIH [EY08213, 5K08EY020530-02]; Research to Prevent Blindness; Australian Research Council [DP1092723]; Cancer Research UK; MRC [MC_qA137918, G0300212] Funding Source: UKRI; Cancer Research UK [12401, 13031] Funding Source: researchfish; Medical Research Council [MC_qA137918, G0300212] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY008213, K08EY020530, R01EY018213] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission (EUMODIC)(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Australian Research Council(Australian Research Council); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Alex Bateman, Lars Barquist, Steve O'Rahilly, Keith Burling, Seth Grant, Pentao Liu, and Lorraine Everett for advice and the EUMODIC consortium for discussions. This work was supported by the Wellcome Trust (grant Nos. 098051 to Wellcome Trust Sanger Institute and RG45277 PCAG/116 to F.M.W.), Medical Research Council (to K.P.S. and F.M.W.), European Commission (EUMODIC contract No. LSHG-CT-2006-037188), NIH (EY08213 to S.H.T. and 5K08EY020530-02 to V.B.M.), Research to Prevent Blindness (to S.H.T. and V.B.M.), Australian Research Council (DP1092723 to I.S.), and Cancer Research UK (to D.J.A.). J.K.W. and K.P.S. conceived and devised the single phenotyping pipeline and principles of analysis and presentation of the data; R.R.S., J.K.W., R.H., J.R.B., and E.R. managed mouse production and genotyping; J.N.B. and J.S. managed mouse breeding; A.K.G., C.P., J.E., D.S., N.I., and J.K.W. managed mouse phenotyping and analyzed data; the Sanger Institute Mouse Genetics Project team contributed to all aspects of the work; S.C. and G.D. led the infectious challenge screen; V.B.M. and S.H.T. led the eye histopathology screen; I.S. and F.M.W. led the skin screen; J.F. led the brain histopathology screen; D.J.A. led the micronucleus screen; J.N.B. and J.R.B. managed mouse distribution; J.K.W., A.K.G., M.B., and K.P.S. compiled Tables S1, S2, S5, and S6; N.A.K., D.M., D.S., and M.B. carried out annotation and statistical analysis; N.C.A., D.G.M., and W.C.S. led development of informatics support; D.W.L. wrote Wiki pages for the mutants; J.K.W., D.J.A., R.R.S., and K.P.S. led the project; and K.P.S., A.B., and J.K.W. wrote the paper with contributions from all authors.	Abou Jamra R, 2011, AM J HUM GENET, V88, P788, DOI 10.1016/j.ajhg.2011.04.019; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Andrews TD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120061; Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Bearer EL, 2000, ANN HUM GENET, V64, P189, DOI 10.1046/j.1469-1809.2000.6430189.x; Brown SDM, 2012, DIS MODEL MECH, V5, P289, DOI 10.1242/dmm.009878; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Conant GC, 2004, P ROY SOC B-BIOL SCI, V271, P89, DOI 10.1098/rspb.2003.2560; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Fischer H, 2011, J INVEST DERMATOL, V131, P1208, DOI 10.1038/jid.2011.13; Fisher CL, 2010, BLOOD, V115, P38, DOI 10.1182/blood-2009-07-230698; Flint J, 2012, NAT REV GENET, V13, P807, DOI 10.1038/nrg3335; Forzati F, 2012, J CLIN INVEST, V122, P612, DOI 10.1172/JCI58620; Friesema ECH, 2006, MOL ENDOCRINOL, V20, P2761, DOI 10.1210/me.2005-0256; Fuchs H, 2012, MAMM GENOME, V23, P611, DOI 10.1007/s00335-012-9415-1; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hawkins TE, 1999, MOL CELL BIOL, V19, P8028; Jimenez-Sanchez G, 2001, NATURE, V409, P853, DOI 10.1038/35057050; Kim YK, 2007, GENE EXPR PATTERNS, V7, P143, DOI 10.1016/j.modgep.2006.06.006; Laughlin MR, 2012, MAMM GENOME, V23, P623, DOI 10.1007/s00335-012-9425-z; Liang H, 2007, TRENDS GENET, V23, P375, DOI 10.1016/j.tig.2007.04.005; Liao BY, 2007, TRENDS GENET, V23, P378, DOI 10.1016/j.tig.2007.05.006; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; Miller LD, 2001, MOL CELL BIOL, V21, P6626, DOI 10.1128/MCB.21.19.6626-6639.2001; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Moreno-De-Luca A, 2011, J MED GENET, V48, P141, DOI 10.1136/jmg.2010.082263; Nijnik A, 2012, J IMMUNOL, V189, P102, DOI 10.4049/jimmunol.1200282; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Prosser HM, 2011, NAT BIOTECHNOL, V29, P843, DOI 10.1038/nbt.1929; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Schmalzigaug R, 2009, NEUROSCI LETT, V451, P156, DOI 10.1016/j.neulet.2008.12.034; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wakana S, 2009, EXP ANIM TOKYO, V58, P443, DOI 10.1538/expanim.58.443	41	337	350	1	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					452	464		10.1016/j.cell.2013.06.022	http://dx.doi.org/10.1016/j.cell.2013.06.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870131	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000321950700020
J	Rajkumar, R; Kesselheim, AS				Rajkumar, Rahul; Kesselheim, Aaron S.			Balancing Access and Innovation India's Supreme Court Rules on Imatinib	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rajkumar, Rahul] US Dept HHS, Ctr Medicare Serv, Baltimore, MD USA; [Rajkumar, Rahul] US Dept HHS, Ctr Medicaid Serv, Baltimore, MD USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA 02120 USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER; AHRQ HHS [K08HS18465-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Amin T, 2009, HEALTH AFFAIR, V28, pW948, DOI 10.1377/hlthaff.28.5.w948; Bhagwati J, 2002, FINANCIAL TIMES; Initiative for Medicines Access and Knowledge, 2013, ROADM HIV DRUG PIP I; Kapczynski A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049470; Madison J, 1914, HARPERS MAGAZINE, P490; Pricewaterhouse Coopers, GLOB PHARM LOOKS IND, P5; World Intellectual Property Organization, INT PROP SOM BAS DEF	7	2	2	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					263	264		10.1001/jama.2013.7336	http://dx.doi.org/10.1001/jama.2013.7336			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23824051				2022-12-28	WOS:000321835700010
J	Smolin, JA; Smith, G; Vargo, A				Smolin, John A.; Smith, Graeme; Vargo, Alexander			Oversimplifying quantum factoring	NATURE			English	Article							EXPERIMENTAL REALIZATION; ALGORITHM; QUBIT; COMPUTATION	Shor's quantum factoring algorithm exponentially outperforms known classical methods. Previous experimental implementations have used simplifications dependent on knowing the factors in advance. However, as we show here, all composite numbers admit simplification of the algorithm to a circuit equivalent to flipping coins. The difficulty of a particular experiment therefore depends on the level of simplification chosen, not the size of the number factored. Valid implementations should not make use of the answer sought.	[Smolin, John A.; Smith, Graeme; Vargo, Alexander] IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Smolin, JA (corresponding author), IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA.	smolin@alum.mit.edu			IARPA [W911NF-10-1-0324]; DARPA QUEST [HR0011-09-C-0047]	IARPA; DARPA QUEST(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	We acknowledge support from IARPA (contract no. W911NF-10-1-0324) and from the DARPA QUEST programme (contract no. HR0011-09-C-0047). All statements of fact, opinion or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of the US Government.	Aliferis P, 2008, QUANTUM INF COMPUT, V8, P181; Griffiths RB, 1996, PHYS REV LETT, V76, P3228, DOI 10.1103/PhysRevLett.76.3228; Heath TL., 1956, EUCLID 13 BOOKS ELEM; Lanyon BP, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.250505; LENSTRA AK, 1990, PROCEEDINGS OF THE TWENTY SECOND ANNUAL ACM SYMPOSIUM ON THEORY OF COMPUTING, P564, DOI 10.1145/100216.100295; Lu CY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.250504; Lucero E, 2012, NAT PHYS, V8, P719, DOI [10.1038/nphys2385, 10.1038/NPHYS2385]; Martin-Lopez E, 2012, NAT PHOTONICS, V6, P773, DOI [10.1038/NPHOTON.2012.259, 10.1038/nphoton.2012.259]; Mosca M, 1999, LECT NOTES COMPUT SC, V1509, P174; Parker S, 2000, PHYS REV LETT, V85, P3049, DOI 10.1103/PhysRevLett.85.3049; Politi A, 2009, SCIENCE, V325, P1221, DOI 10.1126/science.1173731; Shor P. W., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P124, DOI 10.1109/SFCS.1994.365700; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a; Zalka C., 2006, SHORS ALGORITHM FEWE; Zhou Z., 2013, FACTORING 51 85 8 QU; Zi S., 2004, FLEETING FOOTSTEPS T; ZUREK WH, 1981, PHYS REV D, V24, P1516, DOI 10.1103/PhysRevD.24.1516	18	26	36	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					163	165		10.1038/nature12290	http://dx.doi.org/10.1038/nature12290			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23846653	Green Submitted			2022-12-28	WOS:000321557600052
J	Zheng, Y; Zhang, CJ; Croucher, DR; Soliman, MA; St-Denis, N; Pasculescu, A; Taylor, L; Tate, SA; Hardy, WR; Colwill, K; Dai, AY; Bagshaw, R; Dennis, JW; Gingras, AC; Daly, RJ; Pawson, T				Zheng, Yong; Zhang, Cunjie; Croucher, David R.; Soliman, Mohamed A.; St-Denis, Nicole; Pasculescu, Adrian; Taylor, Lorne; Tate, Stephen A.; Hardy, W. Rod; Colwill, Karen; Dai, Anna Yue; Bagshaw, Rick; Dennis, James W.; Gingras, Anne-Claude; Daly, Roger J.; Pawson, Tony			Temporal regulation of EGF signalling networks by the scaffold protein Shc1	NATURE			English	Article							TYROSINE PHOSPHATASE-PEST; ADAPTER PROTEIN; BINDING PROTEIN; BREAST-CANCER; PHOSPHORYLATION; INVOLVEMENT; ACTIVATION; DIVERSITY; GTPASE; ROLES	Cell-surface receptors frequently use scaffold proteins to recruit cytoplasmic targets, but the rationale for this is uncertain. Activated receptor tyrosine kinases, for example, engage scaffolds such as Shc1 that contain phosphotyrosine (pTyr)-binding (PTB) domains. Using quantitative mass spectrometry, here we show that mammalian Shc1 responds to epidermal growth factor (EGF) stimulation through multiple waves of distinct phosphorylation events and protein interactions. After stimulation, Shc1 rapidly binds a group of proteins that activate pro-mitogenic or survival pathways dependent on recruitment of the Grb2 adaptor to Shc1 pTyr sites. Akt-mediated feedback phosphorylation of Shc1 Ser 29 then recruits the Ptpn12 tyrosine phosphatase. This is followed by a sub-network of proteins involved in cytoskeletal reorganization, trafficking and signal termination that binds Shc1 with delayed kinetics, largely through the SgK269 pseudokinase/adaptor protein. Ptpn12 acts as a switch to convert Shc1 from pTyr/Grb2-based signalling to SgK269-mediated pathways that regulate cell invasion and morphogenesis. The Shc1 scaffold therefore directs the temporal flow of signalling information after EGF stimulation.	[Zheng, Yong; Zhang, Cunjie; Soliman, Mohamed A.; St-Denis, Nicole; Pasculescu, Adrian; Taylor, Lorne; Colwill, Karen; Dai, Anna Yue; Bagshaw, Rick; Dennis, James W.; Gingras, Anne-Claude; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Croucher, David R.] Natl Univ Ireland Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland; [Soliman, Mohamed A.; Dennis, James W.; Gingras, Anne-Claude; Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Soliman, Mohamed A.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Tate, Stephen A.] AB SCIEX, Concord, ON L4K 4V8, Canada; [Hardy, W. Rod] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Daly, Roger J.] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Daly, Roger J.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW 2010, Australia	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University College Dublin; University of Toronto; Egyptian Knowledge Bank (EKB); Cairo University; University of Massachusetts System; University of Massachusetts Worcester; Monash University; Garvan Institute of Medical Research	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	pawson@lunenfeld.ca	Colwill, Karen/K-5101-2012; Bagshaw, Rick/B-7739-2009; Dennis, James/E-7268-2013; Pawson, Tony J/E-4578-2013; Gingras, Anne-Claude/ABA-8341-2020; Gingras, Anne-Claude/E-9982-2010	Colwill, Karen/0000-0002-8979-1659; Bagshaw, Rick/0000-0001-5013-4291; Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Daly, Roger/0000-0002-5739-8027; tate, stephen/0000-0001-5508-0819; Croucher, David/0000-0003-4965-8674	Genome Canada through the Ontario Genomics Institute; Ontario Research Fund from the Ontario Ministry of Research and Innovation; Terry Fox Foundation; Canadian Institutes of Health Research [MOP-13466-6849]; Canada Foundation for Innovation; Vanier Canada Graduate Studentship; CIHR; National Health and Medical Research Council of Australia; Cancer Council New South Wales (NSW); Cancer Institute NSW	Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Research Fund from the Ontario Ministry of Research and Innovation; Terry Fox Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Vanier Canada Graduate Studentship; CIHR(Canadian Institutes of Health Research (CIHR)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council New South Wales (NSW)(Cancer Council New South Wales); Cancer Institute NSW	We thank J. Moffat for shRNA lentiviruses and K. Shokat for PI3Kp110 isoform-specific inhibitors. We thank C. Jorgensen, R. Williams, I. Louria-Hayon, R. Tian, and E. Petsalaki for critical input, A. James, V. Nguyen, and B. Larsen for technical assistance and M. M. Stacey, C. Chen and J. Jin for comments on the manuscript. Supported by Genome Canada through the Ontario Genomics Institute, the Ontario Research Fund from the Ontario Ministry of Research and Innovation, a Terry Fox Foundation team grant, the Canadian Institutes of Health Research (MOP-13466-6849), and the Canada Foundation for Innovation. M. A. S. is supported by a Vanier Canada Graduate Studentship and R. B. is supported by a CIHR postdoctoral fellowship. Support for R. J. D. was from the National Health and Medical Research Council of Australia and Cancer Council New South Wales (NSW), and for D. R. C. from Cancer Institute NSW.	Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Bisson N, 2011, NAT BIOTECHNOL, V29, P653, DOI 10.1038/nbt.1905; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Charest A, 1996, J BIOL CHEM, V271, P8424, DOI 10.1074/jbc.271.14.8424; Chen D, 1996, J BIOL CHEM, V271, P6328, DOI 10.1074/jbc.271.11.6328; Croucher DR, 2013, CANCER RES, V73, P1969, DOI 10.1158/0008-5472.CAN-12-1472; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Debily MA, 2004, HUM MOL GENET, V13, P323, DOI 10.1093/hmg/ddh024; Faisal A, 2002, J BIOL CHEM, V277, P30144, DOI 10.1074/jbc.M203229200; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hardy WR, 2007, SCIENCE, V317, P251, DOI 10.1126/science.1140114; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kondo A, 2000, MOL BIOL CELL, V11, P1315, DOI 10.1091/mbc.11.4.1315; Kuroiwa M, 2011, J CELL SCI, V124, P1726, DOI 10.1242/jcs.080291; Lai KMV, 2000, GENE DEV, V14, P1132; Lange V, 2008, MOL CELL PROTEOMICS, V7, P1489, DOI 10.1074/mcp.M800032-MCP200; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muller T, 2010, ONCOGENE, V29, P2393, DOI 10.1038/onc.2010.6; Okabayashi Y, 1996, J BIOL CHEM, V271, P5265; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; R Development Core Team, 2010, LANG ENV STAT COMP; Rittling SR, 1996, EXP CELL RES, V229, P7, DOI 10.1006/excr.1996.0337; Sarkar D, 2008, USE R, P1; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schmandt R, 1999, ONCOGENE, V18, P1867, DOI 10.1038/sj.onc.1202507; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Tanaka H, 2006, J BIOL CHEM, V281, P10355, DOI 10.1074/jbc.M511314200; Tashiro K, 2009, J BIOL CHEM, V284, P20206, DOI 10.1074/jbc.M109.021139; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Unwin RD, 2009, NAT PROTOC, V4, P870, DOI 10.1038/nprot.2009.57; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Vanderlaan RD, 2011, CIRC RES, V108, P184, DOI 10.1161/CIRCRESAHA.110.233924; Wang YC, 2010, P NATL ACAD SCI USA, V107, P10920, DOI 10.1073/pnas.0914776107	41	193	202	4	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					166	+		10.1038/nature12308	http://dx.doi.org/10.1038/nature12308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23846654	Green Accepted			2022-12-28	WOS:000321557600053
J	Jha, S				Jha, Saurabh			From Imaging Gatekeeper to Service Provider - A Transatlantic Journey	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hosp Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Jha, S (corresponding author), Hosp Univ Penn, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA.								0	16	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					5	7		10.1056/NEJMp1305679	http://dx.doi.org/10.1056/NEJMp1305679			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175WE	23822775				2022-12-28	WOS:000321263500004
J	Chaffer, CL; Marjanovic, ND; Lee, T; Bell, G; Kleer, CG; Reinhardt, F; D'Alessio, AC; Young, RA; Weinberg, RA				Chaffer, Christine L.; Marjanovic, Nemanja D.; Lee, Tony; Bell, George; Kleer, Celina G.; Reinhardt, Ferenc; D'Alessio, Ana C.; Young, Richard A.; Weinberg, Robert A.			Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HISTONE METHYLTRANSFERASE ACTIVITY; STEM-CELLS; PROTEIN; STATE; COMPLEX; RISE	The recent discovery that normal and neoplastic epithelial cells re-enter the stem cell state raised the intriguing possibility that the aggressiveness of carcinomas derives not from their existing content of cancer stem cells (CSCs) but from their proclivity to generate new CSCs from non-CSC populations. Here, we demonstrate that non-CSCs of human basal breast cancers are plastic cell populations that readily switch from a non-CSC to CSC state. The observed cell plasticity is dependent on ZEB1, a key regulator of the epithelial-mesenchymal transition. We find that plastic non-CSCs maintain the ZEB1 promoter in a bivalent chromatin configuration, enabling them to respond readily to microenvironmental signals, such as TGF beta. In response, the ZEB1 promoter converts from a bivalent to active chromatin configuration, ZEB1 transcription increases, and non-CSCs subsequently enter the CSC state. Our findings support a dynamic model in which interconversions between low and high tumorigenic states occur frequently, thereby increasing tumorigenic and malignant potential.	[Chaffer, Christine L.; Marjanovic, Nemanja D.; Lee, Tony; Bell, George; Reinhardt, Ferenc; D'Alessio, Ana C.; Young, Richard A.; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kleer, Celina G.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Young, Richard A.; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Weinberg, Robert A.] Ludwig MIT Ctr Mol Oncol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT)	Chaffer, CL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	chaffer@wi.mit.edu; weinberg@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	Advanced Medical Research Foundation (A.M.R.F.); Breast Cancer Research Foundation; NIH [HG002668, CA146445]; NATIONAL CANCER INSTITUTE [R01CA146445, R01CA125577, P30CA014051, U01CA154224] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	Advanced Medical Research Foundation (A.M.R.F.); Breast Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was largely supported by the Advanced Medical Research Foundation (A.M.R.F.), with additional support from the Breast Cancer Research Foundation (R.A.W.), and NIH grants HG002668 (R.A.Y.) and CA146445 (R.A.Y. and T.I.L.). R.A.W. is an American Cancer Society Research Professor and a Daniel K. Ludwig Foundation Cancer Research Professor. The authors thank the core Flow Cytometry Facilities at Whitehead Institute for Biomedical Research and The Koch Institute of MIT and Elinor Ng-Eaton for technical support, as well as Paul Bernath for critical review of the manuscript. R.A.Y is a founder of Syros Pharmaceuticals.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maruyama R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001369; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998	29	598	618	5	105	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					61	74		10.1016/j.cell.2013.06.005	http://dx.doi.org/10.1016/j.cell.2013.06.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827675	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000321327900010
J	Fullgrabe, J; Lynch-Day, MA; Heldring, N; Li, WB; Struijk, RB; Ma, Q; Hermanson, O; Rosenfeld, MG; Klionsky, DJ; Joseph, B				Fullgrabe, Jens; Lynch-Day, Melinda A.; Heldring, Nina; Li, Wenbo; Struijk, Robert B.; Ma, Qi; Hermanson, Ola; Rosenfeld, Michael G.; Klionsky, Daniel J.; Joseph, Bertrand			The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy	NATURE			English	Article							H4K16 ACETYLATION; IN-VIVO; GENOME; PROTEIN; ACTIVATION; DROSOPHILA; PATHWAY; DISEASE; GENES; DEATH	Autophagy is an evolutionarily conserved catabolic process involved in several physiological and pathological processes(1,2). Although primarily cytoprotective, autophagy can also contribute to cell death; it is thus important to understand what distinguishes the life or death decision in autophagic cells(3). Here we report that induction of autophagy is coupled to reduction of histone H4 lysine 16 acetylation (H4K16ac) through downregulation of the histone acetyltransferase hMOF (also called KAT8 or MYST1), and demonstrate that this histone modification regulates the outcome of autophagy. At a genome-wide level, we find that H4K16 deacetylation is associated predominantly with the downregulation of autophagy-related genes. Antagonizing H4K16ac downregulation upon autophagy induction results in the promotion of cell death. Our findings establish that alteration in a specific histone post-translational modification during autophagy affects the transcriptional regulation of autophagy-related genes and initiates a regulatory feedback loop, which serves as a key determinant of survival versus death responses upon autophagy induction.	[Fullgrabe, Jens; Struijk, Robert B.; Joseph, Bertrand] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, S-17176 Stockholm, Sweden; [Lynch-Day, Melinda A.; Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Lynch-Day, Melinda A.; Klionsky, Daniel J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Lynch-Day, Melinda A.; Klionsky, Daniel J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Heldring, Nina; Hermanson, Ola] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Li, Wenbo; Ma, Qi; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; [Ma, Qi] Univ Calif San Diego, Grad Program Bioinformat & Syst Biol, La Jolla, CA 92093 USA	Karolinska Institutet; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Karolinska Institutet; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Joseph, B (corresponding author), Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, S-17176 Stockholm, Sweden.	bertrand.joseph@ki.se	Ma, Qi/C-9716-2015; li, wenbo/GZM-8930-2022; , Ola/AAF-5126-2021	Hermanson, Ola/0000-0001-9320-7921; Struijk, Robin/0000-0002-8581-864X; Joseph, Bertrand/0000-0001-5655-9979; Fullgrabe, Jens/0000-0003-0047-4719; Ma, Qi/0000-0002-8705-4460	Karolinska Institutet Foundations; Rackham Predoctoral Fellowship; US Department of Defense [BC110381]; National Institutes of Health [GM53396]; National Institutes of Health/National Cancer Institute; Department of Defense; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	Karolinska Institutet Foundations(Karolinska Institutet); Rackham Predoctoral Fellowship; US Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Mc Inerney, M. Malewicz, S. Orrenius and T. Panaretakis for discussion, and L. Guarente, V. Kaminskyy, M. Komatsu, G. Mc Inerney, M. Panas, R. G. Roeder and L. Xiaoling for reagents and cell lines. J.F. is supported by a fellowship from the Karolinska Institutet Foundations, M.A.L.-D. is partly supported by a Rackham Predoctoral Fellowship and W.L. is supported by breast cancer research Postdoctoral Fellowship Award (BC110381) from the US Department of Defense. This work was supported by a National Institutes of Health grant GM53396 (to D.J.K.) and National Institutes of Health/National Cancer Institute and Department of Defense grants (to M.G.R.), the Swedish Cancer Society, the Swedish Childhood Cancer Foundation (to B.J. and O.H.) and the Swedish Research Council (to B.J.). M.G.R. is an investigator of the Howard Hughes Medical Institute.	Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Cao Y, 2008, J CELL BIOL, V182, P703, DOI 10.1083/jcb.200801035; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Fullgrabe J, 2010, CELL DEATH DIFFER, V17, P1238, DOI 10.1038/cdd.2010.58; Hajji N, 2010, ONCOGENE, V29, P2192, DOI 10.1038/onc.2009.505; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Katoh H, 2011, MOL CELL, V44, P770, DOI 10.1016/j.molcel.2011.10.012; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin SY, 2012, SCIENCE, V336, P477, DOI 10.1126/science.1217032; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morselli E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.8; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yi C, 2012, SCIENCE, V336, P474, DOI 10.1126/science.1216990; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057	36	207	213	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					468	+		10.1038/nature12313	http://dx.doi.org/10.1038/nature12313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23863932	Green Accepted			2022-12-28	WOS:000323316100037
J	Kapczynski, A				Kapczynski, Amy			Engineered in India Patent Law 2.0	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Law, New Haven, CT 06520 USA	Yale University	Kapczynski, A (corresponding author), Yale Univ, Sch Law, New Haven, CT 06520 USA.							Hemphill CS, 2012, J HEALTH ECON, V31, P327, DOI 10.1016/j.jhealeco.2012.01.004; Hemphill CS, 2011, J EMPIR LEGAL STUD, V8, P613, DOI 10.1111/j.1740-1461.2011.01235.x; Kapczynski A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049470	3	22	22	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					497	499		10.1056/NEJMp1304400	http://dx.doi.org/10.1056/NEJMp1304400			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	197HX	23862973				2022-12-28	WOS:000322842000002
J	Salathe, M; Freifeld, CC; Mekaru, SR; Tomasulo, AF; Brownstein, JS				Salathe, Marcel; Freifeld, Clark C.; Mekaru, Sumiko R.; Tomasulo, Anna F.; Brownstein, John S.			Influenza A (H7N9) and the Importance of Digital Epidemiology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE DETECTION		[Salathe, Marcel] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Freifeld, Clark C.; Mekaru, Sumiko R.; Tomasulo, Anna F.; Brownstein, John S.] Boston Childrens Hosp, Informat Program, Boston, MA USA; [Freifeld, Clark C.] Boston Univ, Coll Engn, Dept Biomed Engn, Boston, MA 02215 USA; [Mekaru, Sumiko R.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Brownstein, John S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Boston Children's Hospital; Boston University; Boston University; Harvard University; Harvard Medical School	Salathe, M (corresponding author), Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.			Salathe, Marcel/0000-0002-5079-7797; Mekaru, Sumiko/0000-0002-9782-3833	NLM NIH HHS [R01 LM010812] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [R01LM010812] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Chan EH, 2010, P NATL ACAD SCI USA, V107, P21701, DOI 10.1073/pnas.1006219107; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Xu C, MONITORING AVIAN INF	5	101	104	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					401	404		10.1056/NEJMp1307752	http://dx.doi.org/10.1056/NEJMp1307752			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193GQ	23822655	Green Accepted			2022-12-28	WOS:000322547400004
J	Alvarado, JC; Dewan, Y; Elsayed, HF; Gogichaishvili, T; Gupta, S; Hunt, BJ; Iribhogbe, P; Izurieta, M; Khamis, H; Komolafe, EO; Mantilla, JHM; Miranda, J; Uribe, CHM; Olaomi, O; Olldashi, F; Perel, P; Ramana, PV; Ravi, RR; Roberts, I; Shakur, H				Caballero Alvarado, Jose; Dewan, Yashbir; Elsayed, Hesham Fathy; Gogichaishvili, Tamar; Gupta, Sanjay; Hunt, B. J.; Iribhogbe, Pius; Izurieta, Mario; Khamis, Hussein; Komolafe, Edward O.; Mejia Mantilla, Jorge H.; Miranda, Jaime; Morales Uribe, Carlos H.; Olaomi, Oluwole; Olldashi, Fatos; Perel, Pablo; Ramana, P. V.; Ravi, R. R.; Roberts, Ian; Shakur, Haleema			IMPROVING TRAUMA CARE WORLDWIDE Tranexamic acid in trauma: we need stronger global health policy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY		[Caballero Alvarado, Jose] Hosp Reg Docente Trujillo, Trujillo, Peru; [Dewan, Yashbir] MIND Max Inst Neurosci Dehradun, Dehra Dun, India; [Elsayed, Hesham Fathy] Suez Canal Univ Hosp, Ismailia, Egypt; [Gupta, Sanjay] Fortis Hosp Delhi, Delhi, India; [Hunt, B. J.] Guys & St Thomas NHS Fdn Trust, London, England; [Iribhogbe, Pius] Univ Benin, Teaching Hosp, Benin, Nigeria; [Izurieta, Mario] Hosp Alcivar, Alcivar, Ecuador; [Komolafe, Edward O.] Obafemi Awolowo Univ, Teaching Hosp, Ife, Nigeria; [Mejia Mantilla, Jorge H.] Fdn Valle del Lili, Cali, Colombia; [Miranda, Jaime] Univ Peruana Cayetano Heredia, Lima, Peru; [Olaomi, Oluwole] Natl Hosp Abuja, Abuja, Nigeria; [Perel, Pablo; Roberts, Ian; Shakur, Haleema] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Ravi, R. R.] Med Trust Hosp Kochi, Kochi, Kerala, India	Egyptian Knowledge Bank (EKB); Suez Canal University; Guy's & St Thomas' NHS Foundation Trust; University of Benin; Obafemi Awolowo University; Universidad Peruana Cayetano Heredia; University of London; London School of Hygiene & Tropical Medicine	Roberts, I (corresponding author), Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.	ian.roberts@lshtm.ac.uk	Dewan, Yashbir/C-6503-2013	Dewan, Yashbir/0000-0002-7154-1301; /0000-0002-2342-301X; Miranda, J. Jaime/0000-0002-4738-5468; Caballero-Alvarado, Jose/0000-0001-8297-6901; komolafe, edward/0000-0003-1261-3501; RAMANA, P V/0000-0003-4654-0590; Shakur-Still, Haleema/0000-0002-6511-109X				[Anonymous], 2011, INJURED SOLDIERS AFG; Guerriero C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018987; Guerriero Carla, 2010, Cost Eff Resour Alloc, V8, P1, DOI 10.1186/1478-7547-8-1; Jayaraman S, 2010, TRANSFUSION, V50, P433, DOI 10.1111/j.1537-2995.2009.002402.x; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Road Safety Fund, UN DEC ACT ROAD SAF; Roberts I, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5839; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Sefeane TI, 2011, SA orthop. j., V10, P30; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sidibe M, 2012, LANCET, V380, P2058, DOI 10.1016/S0140-6736(12)62088-1	13	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2013	347								f4593	10.1136/bmj.f4593	http://dx.doi.org/10.1136/bmj.f4593			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192YR	23881931	Green Accepted			2022-12-28	WOS:000322524400006
J	Gutierrez, MP; Lee, LP				Gutierrez, Maria Paz; Lee, Luke P.			Multiscale Design and Integration of Sustainable Building Functions	SCIENCE			English	Editorial Material									[Gutierrez, Maria Paz] Univ Calif Berkeley, Dept Architecture, Berkeley, CA 94270 USA; [Lee, Luke P.] Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Dept Bioengn, Berkeley, CA 94270 USA; [Lee, Luke P.] Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Dept Elect Engn, Berkeley, CA 94270 USA; [Lee, Luke P.] Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Dept Comp Sci, Berkeley, CA 94270 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gutierrez, MP (corresponding author), Univ Calif Berkeley, Dept Architecture, Berkeley, CA 94270 USA.	mpazgut@berkeley.edu; lplee@berkeley.edu	Lee, Luke/AAN-6695-2021	Gutierrez, Maria Paz/0000-0001-6288-6327	Directorate For Engineering [1038279] Funding Source: National Science Foundation	Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Ashby MF, 2009, NANOMATERIALS, NANOTECHNOLOGIES AND DESIGN: AN INTRODUCTION FOR ENGINEERS AND ARCHITECTS, P1; Butti K, 1980, GOLDEN THREAD 2500 Y; DAVIES MG, 1986, INT J ENERG RES, V10, P305, DOI 10.1002/er.4440100403; Fernandez JE, 2007, SCIENCE, V315, P1807, DOI 10.1126/science.1137542; Frechette RE, 2008, CTBUH P COUNC TALL B, P7; Gershenfeld N, 2010, SCIENCE, V327, P1086, DOI 10.1126/science.1174082; Hernandez P, 2010, ENERG BUILDINGS, V42, P815, DOI 10.1016/j.enbuild.2009.12.001; Holdren JP, 2008, SCIENCE, V319, P424, DOI 10.1126/science.1153386; Malkawi Ali, 2004, ADV BUILDING SIMULAT, P1; Rosenzweig C, 2010, NATURE, V467, P909, DOI 10.1038/467909a; Sartori I, 2012, ENERG BUILDINGS, V48, P220, DOI 10.1016/j.enbuild.2012.01.032; Sobek W., 2009, TECHNOLOGY GUIDE PRI, P432; U.S. Department of Energy, ZER EN BUILD	13	21	22	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					247	248		10.1126/science.1237278	http://dx.doi.org/10.1126/science.1237278			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	185HV	23869011				2022-12-28	WOS:000321959300032
J	Hermans, TM; Frauenrath, H; Stellacci, F				Hermans, Thomas M.; Frauenrath, Holger; Stellacci, Francesco			Droplets Out of Equilibrium	SCIENCE			English	Editorial Material									[Hermans, Thomas M.] Univ Strasbourg, Inst Sci & Ingn Supramol, F-67083 Strasbourg, France; [Frauenrath, Holger; Stellacci, Francesco] Ecole Polytech Fed Lausanne, Inst Mat, CH-1015 Lausanne, Switzerland	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hermans, TM (corresponding author), Univ Strasbourg, Inst Sci & Ingn Supramol, F-67083 Strasbourg, France.	francesco.stellacci@epfl.ch	Stellacci, Francesco/B-1990-2008; Frauenrath, Holger/I-2734-2012; Hermans, Thomas/D-5629-2012	Stellacci, Francesco/0000-0003-4635-6080; Hermans, Thomas/0000-0003-1121-1754				BAKER D, 1994, BIOCHEMISTRY-US, V33, P7505, DOI 10.1021/bi00190a002; Brunsveld L, 2001, CHEM REV, V101, P4071, DOI 10.1021/cr990125q; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Grzybowski BA, 2009, SOFT MATTER, V5, P1110, DOI 10.1039/b819321p; Lehn J.-M., 1995, SUPRAMOLECULAR CHEM; Muthukumar M, 1997, SCIENCE, V277, P1225, DOI 10.1126/science.277.5330.1225; Nicolis G, 1977, SELF ORG NONEQUILIBR; Nicolis G., 1989, EXPLORING COMPLEXITY; Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384; Timonen JVI, 2013, SCIENCE, V341, P253, DOI 10.1126/science.1233775; Tretiakov KV, 2009, SOFT MATTER, V5, P1279, DOI 10.1039/b811254a; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821	12	17	17	0	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					243	244		10.1126/science.1241793	http://dx.doi.org/10.1126/science.1241793			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869009				2022-12-28	WOS:000321959300029
J	Philippe, N; Legendre, M; Doutre, G; Coute, Y; Poirot, O; Lescot, M; Arslan, D; Seltzer, V; Bertaux, L; Bruley, C; Garin, J; Claverie, JM; Abergel, C				Philippe, Nadege; Legendre, Matthieu; Doutre, Gabriel; Coute, Yohann; Poirot, Olivier; Lescot, Magali; Arslan, Defne; Seltzer, Virginie; Bertaux, Lionel; Bruley, Christophe; Garin, Jerome; Claverie, Jean-Michel; Abergel, Chantal			Pandoraviruses: Amoeba Viruses with Genomes Up to 2.5 Mb Reaching That of Parasitic Eukaryotes	SCIENCE			English	Article							GIANT VIRUS; MIMIVIRUS; ACANTHAMOEBA; SEQUENCE; HIGHLIGHTS; REASONS; GENES	Ten years ago, the discovery of Mimivirus, a virus infecting Acanthamoeba, initiated a reappraisal of the upper limits of the viral world, both in terms of particle size (>0.7 micrometers) and genome complexity (>1000 genes), dimensions typical of parasitic bacteria. The diversity of these giant viruses (the Megaviridae) was assessed by sampling a variety of aquatic environments and their associated sediments worldwide. We report the isolation of two giant viruses, one off the coast of central Chile, the other from a freshwater pond near Melbourne (Australia), without morphological or genomic resemblance to any previously defined virus families. Their micrometer-sized ovoid particles contain DNA genomes of at least 2.5 and 1.9 megabases, respectively. These viruses are the first members of the proposed "Pandoravirus" genus, a term reflecting their lack of similarity with previously described microorganisms and the surprises expected from their future study.	[Philippe, Nadege; Legendre, Matthieu; Doutre, Gabriel; Poirot, Olivier; Lescot, Magali; Arslan, Defne; Seltzer, Virginie; Bertaux, Lionel; Claverie, Jean-Michel; Abergel, Chantal] Aix Marseille Univ, Struct & Genom Informat Lab, CNRS, UMR 7256, F-13288 Marseille 9, France; [Philippe, Nadege] Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, SE-75124 Uppsala, Sweden; [Coute, Yohann; Bruley, Christophe; Garin, Jerome] Univ Grenoble 1, CEA, IRTSV, INSERM,U1038, F-38054 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Uppsala University; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Claverie, JM (corresponding author), Aix Marseille Univ, Struct & Genom Informat Lab, CNRS, UMR 7256, 163 Ave Luminy,Case 934, F-13288 Marseille 9, France.	jean-michel.claverie@univ-amu.fr; chantal.abergel@igs.cnrs-mrs.fr	Couté, Yohann/G-2695-2015; Claverie, Jean-Michel/AAG-4889-2019; Claverie, Jean Michel/Z-2183-2019	Couté, Yohann/0000-0003-3896-6196; Claverie, Jean-Michel/0000-0003-1424-0315; Olivier, Poirot/0000-0003-3570-7893; Lescot, Magali/0000-0001-8189-0823; Philippe, Nadege/0000-0001-9154-0341; Bertaux, Lionel/0000-0002-2343-0252; Legendre, Matthieu/0000-0002-8413-2910; Abergel, Chantal/0000-0003-1875-4049; Bruley, Christophe/0000-0003-2155-1234	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Centre de l'Energie Atomique; Agence National pour la Recherche [ANR-BLAN08-0089, ANR-09-GENM-032-001, ANR-10-INBS-08-01]; ASSEMBLE grant [227799]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre de l'Energie Atomique; Agence National pour la Recherche(French National Research Agency (ANR)); ASSEMBLE grant	We thank S. Faugeron and R. Finke from the Estacion de Investigaciones Marinas in Chile for help during the sampling expedition. We also thank J. Hajdu for invaluable support and J.-P. Chauvin and A. Aouane for expert assistance on the Institut de Biologie du Developpement de Marseille Luminy imagery facility, as well as A. Bernadac and A. Kosta from the Institut de Microbiologie de la Mediterranee. We thank E. Fabre and V. Schmidt for technical assistance, and P. Bonin and R. Claverie for helpful discussions. This work was supported by Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Centre de l'Energie Atomique, and Agence National pour la Recherche (ANR-BLAN08-0089, ANR-09-GENM-032-001, and ANR-10-INBS-08-01). The sampling expedition was sponsored by the ASSEMBLE grant 227799. The genome sequences of P. salinus and P. dulcis have been deposited in GenBank (accession numbers KC977471 and KC977470, respectively). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the data set identifier PXD000213 and DOI 10.6019/PXD000213.	Abergel C, 2007, J VIROL, V81, P12406, DOI 10.1128/JVI.01107-07; Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Byrne D, 2009, GENOME RES, V19, P1233, DOI 10.1101/gr.091561.109; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Clarke M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r11; Claverie JM, 2009, CURR TOP MICROBIOL, V328, P89; Claverie JM, 2013, ADV VIRUS RES, V85, P25, DOI 10.1016/B978-0-12-408116-1.00002-1; Claverie JM, 2010, TRENDS GENET, V26, P431, DOI 10.1016/j.tig.2010.07.003; Claverie JM, 2009, ANNU REV GENET, V43, P49, DOI 10.1146/annurev-genet-102108-134255; Claverie JM, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2108-c3; Colson Philippe, 2011, Genome Biol Evol, V3, P737, DOI 10.1093/gbe/evr048; Corradi N, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1082; Desnues C, 2012, P NATL ACAD SCI USA, V109, P18078, DOI 10.1073/pnas.1208835109; Dolan A, 1998, J VIROL, V72, P2010, DOI 10.1128/JVI.72.3.2010-2021.1998; Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107; Hoffmann R, 1998, ENDOCYTOBIOSIS CELL, V12, P185; Hyun JK, 2007, J VIROL, V81, P11075, DOI 10.1128/JVI.00594-07; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Jeudy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003122; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; La Scola B, 2003, SCIENCE, V299, P2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Legendre M, 2010, GENOME RES, V20, P664, DOI 10.1101/gr.102582.109; Liu Hua, 2006, Korean Journal of Parasitology, V44, P117, DOI 10.3347/kjp.2006.44.2.117; LWOFF A, 1957, J GEN MICROBIOL, V17, P239, DOI 10.1099/00221287-17-2-239; Moreira D, 2009, NAT REV MICROBIOL, V7, P306, DOI 10.1038/nrmicro2108; Munson DA, 2006, J EUKARYOT MICROBIOL, V53, pS12, DOI 10.1111/j.1550-7408.2006.00157.x; Ogata H, 2011, ISME J, V5, P1143, DOI 10.1038/ismej.2010.210; Piacente F, 2012, J BIOL CHEM, V287, P3009, DOI 10.1074/jbc.M111.314559; Pombert JF, 2012, P NATL ACAD SCI USA, V109, P12638, DOI 10.1073/pnas.1205020109; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Samson RY, 2009, TRENDS MICROBIOL, V17, P507, DOI 10.1016/j.tim.2009.08.003; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Scheid P, 2010, PARASITOL RES, V106, P1371, DOI 10.1007/s00436-010-1811-4; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Suhre K, 2005, P NATL ACAD SCI USA, V102, P14689, DOI 10.1073/pnas.0506465102; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092; Yoosuf N, 2012, GENOME BIOL EVOL, V4, P1324, DOI 10.1093/gbe/evs109; Zauberman N, 2008, PLOS BIOL, V6, P1104, DOI 10.1371/journal.pbio.0060114	45	360	370	6	244	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143					281	286		10.1126/science.1239181	http://dx.doi.org/10.1126/science.1239181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869018	Green Published			2022-12-28	WOS:000321959300045
J	Akl, EA; Guyatt, G				Akl, Elie A.; Guyatt, Gordon			Review: Routine venous thromboembolism prophylaxis in hospitalized frail older patients has uncertain benefit	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Akl, Elie A.] Amer Univ Beirut, Beirut, Lebanon; [Guyatt, Gordon] McMaster Univ, Hamilton, ON, Canada	American University of Beirut; McMaster University	Akl, EA (corresponding author), Amer Univ Beirut, Beirut, Lebanon.		Akl, Elie/K-5269-2019; Akl, Elie A/R-2079-2016	Akl, Elie A/0000-0002-3444-8618				Kahn SR, 2012, CHEST, V141, pe195S; Qaseem A, 2011, ANN INTERN MED, V155, P625, DOI 10.7326/0003-4819-155-9-201111010-00011	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2							JC9	10.7326/0003-4819-159-2-201307160-02009	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23856707				2022-12-28	WOS:000322112000008
J	Fokou, M; Teyang, A				Fokou, Marcus; Teyang, Abel			Simultaneous Gangrene of Both Left Extremities	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fokou, Marcus; Teyang, Abel] Yaounde Gen Hosp, Yaounde, Cameroon		Fokou, M (corresponding author), Yaounde Gen Hosp, Yaounde, Cameroon.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					172	172		10.1056/NEJMicm1206131	http://dx.doi.org/10.1056/NEJMicm1206131			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180BH	23841732				2022-12-28	WOS:000321567300013
J	Jiang, LB; Mu, JB; Zhang, QF; Ni, T; Srinivasan, P; Rayavara, K; Yang, WJ; Turner, L; Lavstsen, T; Theander, TG; Peng, WQ; Wei, GY; Jing, QQ; Wakabayashi, Y; Bansal, A; Luo, Y; Ribeiro, JMC; Scherf, A; Aravind, L; Zhu, J; Zhao, KJ; Miller, LH				Jiang, Lubin; Mu, Jianbing; Zhang, Qingfeng; Ni, Ting; Srinivasan, Prakash; Rayavara, Kempaiah; Yang, Wenjing; Turner, Louise; Lavstsen, Thomas; Theander, Thor G.; Peng, Weiqun; Wei, Guiying; Jing, Qingqing; Wakabayashi, Yoshiyuki; Bansal, Abhisheka; Luo, Yan; Ribeiro, Jose M. C.; Scherf, Artur; Aravind, L.; Zhu, Jun; Zhao, Keji; Miller, Louis H.			PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum	NATURE			English	Article							ANTIGENIC VARIATION; LYSINE 36; TRANSCRIPTION; ERYTHROCYTES; PARASITES; TARGETS; PROTEIN	The variant antigen Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), which is expressed on the surface of P. falciparum-infected red blood cells, is a critical virulence factor for malaria(1). Each parasite has 60 antigenically distinct var genes that each code for a different PfEMP1 protein. During infection the clonal parasite population expresses only one gene at a time before switching to the expression of a new variant antigen as an immune-evasion mechanism to avoid the host antibody response(2,3). The mechanism by which 59 of the 60 var genes are silenced remains largely unknown(4-7). Here we show that knocking out the P. falciparum variant-silencing SET gene (here termed PfSETvs), which encodes an orthologue of Drosophila melanogaster ASH1 and controls histone H3 lysine 36 trimethylation (H3K36me3) on var genes, results in the transcription of virtually all var genes in the single parasite nuclei and their expression as proteins on the surface of individual infected red blood cells. PfSETvs-dependent H3K36me3 is present along the entire gene body, including the transcription start site, to silence var genes. With low occupancy of PfSETvs at both the transcription start site of var genes and the intronic promoter, expression of var genes coincides with transcription of their corresponding antisense long noncoding RNA. These results uncover a previously unknown role of PfSETvs-dependent H3K36me3 in silencing var genes in P. falciparum that might provide a general mechanism by which orthologues of PfSETvs repress gene expression in other eukaryotes. PfSETvs knockout parasites expressing all PfEMP1 proteins may also be applied to the development of a malaria vaccine.	[Jiang, Lubin; Jing, Qingqing] Chinese Acad Sci, Inst Pasteur Shanghai, Unit Human Parasite Mol & Cell Biol, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [Jiang, Lubin; Jing, Qingqing] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Mu, Jianbing; Srinivasan, Prakash; Rayavara, Kempaiah; Bansal, Abhisheka; Ribeiro, Jose M. C.; Miller, Louis H.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Zhang, Qingfeng; Wei, Guiying] Tongji Univ, Sch Med, Inst Infect Dis & Vaccine Dev, Shanghai 200092, Peoples R China; [Zhang, Qingfeng; Scherf, Artur] Inst Pasteur, Dept Parasitol & Mycol, Unite Biol Interact Hote Parasite, F-75015 Paris, France; [Zhang, Qingfeng; Scherf, Artur] CNRS, URA 2581, F-75015 Paris, France; [Ni, Ting] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Ni, Ting] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Yang, Wenjing; Wakabayashi, Yoshiyuki; Luo, Yan; Zhu, Jun] NHLBI, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA; [Turner, Louise; Lavstsen, Thomas; Theander, Thor G.] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Ctr Med Parasitol, DK-1014 Copenhagen, Denmark; [Turner, Louise; Lavstsen, Thomas; Theander, Thor G.] Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-1014 Copenhagen, Denmark; [Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tongji University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Fudan University; Fudan University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Copenhagen; Rigshospitalet; University of Copenhagen; George Washington University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Jiang, LB (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Unit Human Parasite Mol & Cell Biol, Key Lab Mol Virol & Immunol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	lbjiang@ips.ac.cn; lmiller@niaid.nih.gov	Ribeiro, Jose/J-7011-2015; Bansal, Abhisheka/ABC-7871-2020; /AAI-2516-2019; Theander, Thor/F-6714-2015; Scherf, Artur/A-9674-2014	Bansal, Abhisheka/0000-0002-2959-8494; Theander, Thor/0000-0002-3509-7514; Scherf, Artur/0000-0003-2411-3328; Turner, Louise/0000-0003-4494-2289; Peng, Weiqun/0000-0001-5521-9091; Aravind, L/0000-0003-0771-253X; Ribeiro, Jose/0000-0002-9107-0818; Lavstsen, Thomas/0000-0002-3044-4249; ZHANG, Qingfeng/0000-0002-8759-9102	Intramural Research Program of the National Institute of Allergy and Infectious Disease; National Heart, Lung, and Blood Institute, National Institutes of Health; National Natural Science Foundation of China [81271863]; Key Research Program of the Chinese Academy of Sciences [KSZD-EW-Z-003-1-2]; ERC [250320]; Lundbeck Foundation [R108-2012-10328, R140-2013-13448] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZICHL006058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000241, ZIAAI000810] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); ERC(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. K. Pierce at the National Institute of Allergy and Infectious Diseases, National Institutes of Health, for critical suggestions on the manuscript and A. F. Cowman for providing the pHTK transfection plasmid. We also thank V. Nair and E. Fisher at the NIH Research Technology Branch for assistance with electron microscopy. This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Disease and the National Heart, Lung, and Blood Institute, National Institutes of Health, and also by the National Natural Science Foundation of China (81271863) and the Key Research Program of the Chinese Academy of Sciences (KSZD-EW-Z-003-1-2). A. S. was supported by an ERC grant PlasmoEscape (250320). All authors have reviewed and agreed with the content of the manuscript.	Aravind L, 2011, PROG MOL BIOL TRANSL, V101, P105, DOI 10.1016/B978-0-12-387685-0.00004-4; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Chantalat S, 2011, GENOME RES, V21, P1426, DOI 10.1101/gr.118091.110; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; Cui LW, 2008, INT J PARASITOL, V38, P1083, DOI 10.1016/j.ijpara.2008.01.002; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Epp C, 2009, RNA, V15, P116, DOI 10.1261/rna.1080109; Jiang HY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r33; Jiang LB, 2010, P NATL ACAD SCI USA, V107, P2224, DOI 10.1073/pnas.0913396107; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kim T, 2012, CELL, V150, P1158, DOI 10.1016/j.cell.2012.08.016; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; NEWBOLD CI, 1992, EXP PARASITOL, V75, P281, DOI 10.1016/0014-4894(92)90213-T; Rechtsteiner A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001091; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Soubes SC, 1997, EXP PARASITOL, V86, P79, DOI 10.1006/expr.1997.4153; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Tanaka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028171; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Werven FJ, 2012, CELL, V150, P1170, DOI 10.1016/j.cell.2012.06.049; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Volz JC, 2012, CELL HOST MICROBE, V11, P7, DOI 10.1016/j.chom.2011.11.011; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; WELLEMS TE, 1988, REV BRAS GENET, V11, P813	36	162	175	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					223	+		10.1038/nature12361	http://dx.doi.org/10.1038/nature12361			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23823717	Green Accepted, Bronze			2022-12-28	WOS:000321557600065
J	Doll, J; Zeitler, E; Becker, R				Doll, Jacob; Zeitler, Emily; Becker, Richard			Generic Clopidogrel - Time to Substitute?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Doll, Jacob; Zeitler, Emily; Becker, Richard] Duke Univ, Med Ctr, Durham, NC USA	Duke University	Doll, J (corresponding author), Duke Univ, Med Ctr, Durham, NC USA.								0	8	8	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					145	146		10.1001/jama.2013.7155	http://dx.doi.org/10.1001/jama.2013.7155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23839745				2022-12-28	WOS:000321511500034
J	Thornton, D; Stappers, B; Bailes, M; Barsdell, B; Bates, S; Bhat, NDR; Burgay, M; Burke-Spolaor, S; Champion, DJ; Coster, P; D'Amico, N; Jameson, A; Johnston, S; Keith, M; Kramer, M; Levin, L; Milia, S; Ng, C; Possenti, A; van Straten, W				Thornton, D.; Stappers, B.; Bailes, M.; Barsdell, B.; Bates, S.; Bhat, N. D. R.; Burgay, M.; Burke-Spolaor, S.; Champion, D. J.; Coster, P.; D'Amico, N.; Jameson, A.; Johnston, S.; Keith, M.; Kramer, M.; Levin, L.; Milia, S.; Ng, C.; Possenti, A.; van Straten, W.			A Population of Fast Radio Bursts at Cosmological Distances	SCIENCE			English	Article							MULTIBEAM PULSAR SURVEY; GAMMA-RAY BURSTS; REIONIZATION HISTORY; DISCOVERY; SEARCH; FLARE	Searches for transient astrophysical sources often reveal unexpected classes of objects that are useful physical laboratories. In a recent survey for pulsars and fast transients, we have uncovered four millisecond-duration radio transients all more than 40 degrees from the Galactic plane. The bursts' properties indicate that they are of celestial rather than terrestrial origin. Host galaxy and intergalactic medium models suggest that they have cosmological redshifts of 0.5 to 1 and distances of up to 3 gigaparsecs. No temporally coincident x- or gamma-ray signature was identified in association with the bursts. Characterization of the source population and identification of host galaxies offers an opportunity to determine the baryonic content of the universe.	[Thornton, D.; Stappers, B.; Kramer, M.] Univ Manchester, Sch Phys & Astron, Jodrell Bank, Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Thornton, D.; Coster, P.; Johnston, S.; Keith, M.] Commonwealth Sci & Ind Res Org CSIRO Astron & Spa, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; [Bailes, M.; Barsdell, B.; Bhat, N. D. R.; Coster, P.; Jameson, A.; van Straten, W.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Bailes, M.; Barsdell, B.; Bhat, N. D. R.; Jameson, A.; van Straten, W.] Australian Res Council Ctr Excellence All Sky Ast, Hawthorn, Vic 3122, Australia; [Bates, S.; Levin, L.] W Virginia Univ, Ctr Astrophys, Morgantown, WV 26506 USA; [Bhat, N. D. R.] Curtin Univ, Fac Sci & Engn, Dept Imaging & Appl Phys, Int Ctr Radio Astron Res, Perth, WA 6845, Australia; [Burgay, M.; D'Amico, N.; Milia, S.; Possenti, A.] Osservatorio Astron Cagliari, Ist Nazl Astrofis, I-09012 Capoterra, CA, Italy; [Burke-Spolaor, S.] CALTECH, Jet Prop Lab, Pasadena, CA 91104 USA; [Champion, D. J.; Kramer, M.; Ng, C.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [D'Amico, N.] Univ Cagliari, Dipartimento Fis, I-09042 Monserrato, CA, Italy	University of Manchester; Jodrell Bank Centre for Astrophysics; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Swinburne University of Technology; West Virginia University; Curtin University; Istituto Nazionale Astrofisica (INAF); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society; University of Cagliari	Thornton, D (corresponding author), Univ Manchester, Sch Phys & Astron, Jodrell Bank, Ctr Astrophys, Manchester M13 9PL, Lancs, England.	thornton@jb.man.ac.uk	Keith, Michael/AAH-2606-2019; Johnston, Simon/AAW-8490-2020	Keith, Michael/0000-0001-5567-5492; Johnston, Simon/0000-0002-7122-4963; Spolaor, Sarah/0000-0003-4052-7838; Kramer, Michael/0000-0002-4175-2271; Bailes, Matthew/0000-0003-3294-3081; van Straten, Willem/0000-0003-2519-7375; Burgay, Marta/0000-0002-8265-4344; Ng, Cherry/0000-0002-3616-5160; Champion, David/0000-0003-1361-7723; Levin Preston, Lina/0000-0002-2034-2986; Bhat, Ramesh/0000-0002-8383-5059; Milia, Sabrina/0000-0002-1110-5882	NASA; Commonwealth of Australia; CAASTRO [CE110001020]; Science and Technology Facilities Council; CSIRO Astronomy and Space Science; Curtin Research Fellowship [CRF12228]; Science and Technology Facilities Council [ST/G002487/1, ST/J001562/1, ST/F002874/1] Funding Source: researchfish; STFC [ST/J001562/1, ST/F002874/1, ST/G002487/1] Funding Source: UKRI	NASA(National Aeronautics & Space Administration (NASA)); Commonwealth of Australia(Australian Government); CAASTRO; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); CSIRO Astronomy and Space Science; Curtin Research Fellowship; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This research has made use of the NASA/IPAC (Infrared Processing and Analysis Center) Extragalactic Database (NED), which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA. This research has made use of data obtained from the High Energy Astrophysics Science Archive Research Center, provided by NASA's Goddard Space Flight Center. Part of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. The Parkes radio telescope is part of the Australia Telescope National Facility, which is funded by the Commonwealth of Australia for operation as a National Facility managed by CSIRO. Part of this research was conducted because of the support of CAASTRO through project number CE110001020. D. T. gratefully acknowledges the support of the Science and Technology Facilities Council and CSIRO Astronomy and Space Science in his Ph.D. studentship. N.D.R.B. is supported by a Curtin Research Fellowship (CRF12228).	Bagchi M, 2012, MON NOT R ASTRON SOC, V425, P2501, DOI 10.1111/j.1365-2966.2012.21708.x; Bannister KW, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/38; Bhat NDR, 2004, ASTROPHYS J, V605, P759, DOI 10.1086/382680; Burke-Spolaor S, 2011, MON NOT R ASTRON SOC, V416, P2465, DOI 10.1111/j.1365-2966.2011.18521.x; Burke-Spolaor S, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/18; Cordes J. M., 2009, SKA MEMO SER, V97, P1; Deneva JS, 2009, ASTROPHYS J LETT, V702, pL177, DOI 10.1088/0004-637X/702/2/L177; Diehl R, 2006, NATURE, V439, P45, DOI 10.1038/nature04364; Egorov AE, 2009, ASTRON LETT+, V35, P241, DOI 10.1134/S1063773709040033; Frail DA, 2001, ASTROPHYS J, V562, pL55, DOI 10.1086/338119; Hansen BMS, 2001, MON NOT R ASTRON SOC, V322, P695, DOI 10.1046/j.1365-8711.2001.04103.x; Hurley K, 2005, NATURE, V434, P1098, DOI 10.1038/nature03519; Inoue S, 2004, MON NOT R ASTRON SOC, V348, P999, DOI 10.1111/j.1365-2966.2004.07359.x; Ioka K, 2003, ASTROPHYS J, V598, pL79, DOI 10.1086/380598; ISLIKER H, 1994, ASTRON ASTROPHYS SUP, V104, P145; Keane EF, 2012, MON NOT R ASTRON SOC, V425, pL71, DOI 10.1111/j.1745-3933.2012.01306.x; Keith MJ, 2010, MON NOT R ASTRON SOC, V409, P619, DOI 10.1111/j.1365-2966.2010.17325.x; Lorimer DR, 2007, SCIENCE, V318, P777, DOI 10.1126/science.1147532; Madgwick DS, 2002, MON NOT R ASTRON SOC, V333, P133, DOI 10.1046/j.1365-8711.2002.05393.x; Manchester RN, 2001, MON NOT R ASTRON SOC, V328, P17, DOI 10.1046/j.1365-8711.2001.04751.x; Ofek EO, 2007, ASTROPHYS J, V659, P339, DOI 10.1086/511147; REES MJ, 1977, NATURE, V266, P333, DOI 10.1038/266333a0; ROEDER RC, 1969, ASTROPHYS J, V155, P1047, DOI 10.1086/149933; Rubio-Herrera E, 2013, MON NOT R ASTRON SOC, V428, P2857, DOI 10.1093/mnras/sts205; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; WILLIAMSON IP, 1972, MON NOT R ASTRON SOC, V157, P55, DOI 10.1093/mnras/157.1.55	26	697	703	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2013	341	6141					53	56		10.1126/science.1236789	http://dx.doi.org/10.1126/science.1236789			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828936	Green Submitted			2022-12-28	WOS:000321291700044
J	Murch, KW; Weber, SJ; Beck, KM; Ginossar, E; Siddiqi, I				Murch, K. W.; Weber, S. J.; Beck, K. M.; Ginossar, E.; Siddiqi, I.			Reduction of the radiative decay of atomic coherence in squeezed vacuum	NATURE			English	Article							QUANTUM-NOISE; LIGHT; CAVITY; EXCITATION; AMPLIFICATION; RESONANCE; STATES; LIMIT	Quantum fluctuations of the electromagnetic vacuum are responsible for physical effects such as the Casimir force and the radiative decay of atoms, and set fundamental limits on the sensitivity of measurements. Entanglement between photons can produce correlations that result in a reduction of these fluctuations below the ordinary vacuum level, allowing measurements that surpass the standard quantum limit in sensitivity(1-5). The effects of such 'squeezed states' of light on matter were first considered in a prediction(6) of the radiative decay rates of atoms in squeezed vacuum. Despite efforts to demonstrate such effects in experiments with natural atoms(7-9), a direct quantitative observation of this prediction has remained elusive. Here we report a twofold reduction of the transverse radiative decay rate of a superconducting artificial atom coupled to continuum squeezed vacuum. The artificial atom is effectively a two-level system formed by the strong interaction between a superconducting circuit and a microwave-frequency cavity. A Josephson parametric amplifier is used to generate quadrature-squeezed electromagnetic vacuum. The observed twofold reduction in the decay rate of the atom allows the transverse coherence time, T-2, to exceed the ordinary vacuum decay limit, 2T(1). We demonstrate that the measured radiative decay dynamics can be used to reconstruct the Wigner distribution of the itinerant squeezed state. Our results confirm a canonical prediction(6) of quantum optics and should enable new studies of the quantum light-matter interaction.	[Murch, K. W.; Weber, S. J.; Siddiqi, I.] Univ Calif Berkeley, Dept Phys, Quantum Nanoelect Lab, Berkeley, CA 94720 USA; [Beck, K. M.] MIT, Dept Phys, MIT Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA; [Beck, K. M.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Ginossar, E.] Univ Surrey, Adv Technol Inst, Guildford GU2 7XH, Surrey, England; [Ginossar, E.] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England	University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Surrey; University of Surrey	Murch, KW (corresponding author), Univ Calif Berkeley, Dept Phys, Quantum Nanoelect Lab, Berkeley, CA 94720 USA.	katerm@berkeley.edu	Siddiqi, Irfan/E-5548-2015	Beck, Kristin/0000-0003-2486-4164	Office of Naval Research [N00014-13-1-0150]; Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office [W911NF-11-1-0029]; EPSRC [EP/I026231/1]; US NSF GRFP [0645960]; IGERT [0801525]; Engineering and Physical Sciences Research Council [EP/I026231/1] Funding Source: researchfish	Office of Naval Research(Office of Naval Research); Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); US NSF GRFP; IGERT(National Science Foundation (NSF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank C. Macklin, N. Roch and Lev S. Bishop for discussions. This research was supported in part (K. W. M., S.J.W. and I. S.) by the Office of Naval Research (N00014-13-1-0150) and the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office (W911NF-11-1-0029). All statements of fact, opinion or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of IARPA, the ODNI or the US government. E. G. acknowledges support from EPSRC (EP/I026231/1). K. M. B. acknowledges support from US NSF GRFP (0645960) and IGERT (0801525).	Bergeal N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.123902; Bergeal N, 2010, NATURE, V465, P64, DOI 10.1038/nature09035; Brooks DWC, 2012, NATURE, V488, P476, DOI 10.1038/nature11325; CARMICHAEL HJ, 1987, PHYS REV LETT, V58, P2539, DOI 10.1103/PhysRevLett.58.2539; Castellanos-Beltran MA, 2008, NAT PHYS, V4, P929, DOI 10.1038/nphys1090; Dayan B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.023005; Eichler C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.113601; Flurin E, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.183901; GARDINER CW, 1986, PHYS REV LETT, V56, P1917, DOI 10.1103/PhysRevLett.56.1917; GEORGIADES NP, 1995, PHYS REV LETT, V75, P3426, DOI 10.1103/PhysRevLett.75.3426; Ginossar E, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.075333; Goda K, 2008, NAT PHYS, V4, P472, DOI 10.1038/nphys920; Hald J, 1999, PHYS REV LETT, V83, P1319, DOI 10.1103/PhysRevLett.83.1319; Hatridge M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.134501; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Kamal A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.184301; Kirchmair G, 2013, NATURE, V495, P205, DOI 10.1038/nature11902; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Mallet F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.220502; Ourjoumtsev A, 2011, NATURE, V474, P623, DOI 10.1038/nature10170; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; PARKINS AS, 1993, PHYS REV A, V48, P758, DOI 10.1103/PhysRevA.48.758; POLZIK ES, 1992, PHYS REV LETT, V68, P3020, DOI 10.1103/PhysRevLett.68.3020; Reed MD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.173601; Roch N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.147701; Schoelkopf RJ, 2008, NATURE, V451, P664, DOI 10.1038/451664a; SLUSHER RE, 1985, PHYS REV LETT, V55, P2409, DOI 10.1103/PhysRevLett.55.2409; Treps N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.203601; Turchette QA, 1998, PHYS REV A, V58, P4056, DOI 10.1103/PhysRevA.58.4056; XIAO M, 1987, PHYS REV LETT, V59, P278, DOI 10.1103/PhysRevLett.59.278	32	97	97	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2013	499	7456					62	65		10.1038/nature12264	http://dx.doi.org/10.1038/nature12264			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23823794	Green Submitted			2022-12-28	WOS:000321285600033
J	Mehrotra, A				Mehrotra, Ateev			The Convenience Revolution for Treatment of Low-Acuity Conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RETAIL CLINICS; VISITS; CARE; OFFICE		Univ Pittsburgh, Sch Med, RAND Hlth, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; RAND Corporation	Mehrotra, A (corresponding author), Univ Pittsburgh, Sch Med, RAND Hlth, 4570 5th Ave,Ste 600, Pittsburgh, PA 15213 USA.	mehrotra@rand.org	Mehrotra, Ateev/AAO-8454-2021	Mehrotra, Ateev/0000-0003-2223-1582	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097759] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI097759, R21 AI097759-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Christensen C.M., 2000, HARVARD BUSINESS REV; Courneya PT, 2013, HEALTH AFFAIR, V32, P385, DOI 10.1377/hlthaff.2012.1157; Mehrotra A, 2008, HEALTH AFFAIR, V27, P1272, DOI 10.1377/hlthaff.27.5.1272; Mehrotra A, 2013, JAMA INTERN MED, V173, P72, DOI 10.1001/2013.jamainternmed.305; Mehrotra A, 2012, HEALTH AFFAIR, V31, P2123, DOI 10.1377/hlthaff.2011.1128; Mehrotra A, 2009, ANN INTERN MED, V151, P321, DOI 10.7326/0003-4819-151-5-200909010-00006; Pitts SR, 2010, HEALTH AFFAIR, V29, P1620, DOI 10.1377/hlthaff.2009.1026; Rohrer James E, 2012, Qual Manag Health Care, V21, P44, DOI 10.1097/QMH.0b013e3182418157	8	46	46	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					35	36		10.1001/jama.2013.6825	http://dx.doi.org/10.1001/jama.2013.6825			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175SK	23821082	Green Accepted			2022-12-28	WOS:000321253000016
J	Rahman, SS				Rahman, Suraiya Simi			Pay It Forward	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROFESSIONALISM		Los Angeles Cty USC Med Ctr, Los Angeles, CA USA		Rahman, SS (corresponding author), Los Angeles Cty USC Med Ctr, Los Angeles, CA USA.	simirahm@usc.edu						Mueller Paul S., 2009, Keio Journal of Medicine, V58, P133; Smith LG, 2005, AM J MED, V118, P439, DOI 10.1016/j.amjmed.2005.01.021	2	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					37	38		10.1001/jama.2013.5163	http://dx.doi.org/10.1001/jama.2013.5163			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175SK	23821083				2022-12-28	WOS:000321253000017
J	Ramirez, S; Liu, X; Lin, PA; Suh, J; Pignatelli, M; Redondo, RL; Ryan, TJ; Tonegawa, S				Ramirez, Steve; Liu, Xu; Lin, Pei-Ann; Suh, Junghyup; Pignatelli, Michele; Redondo, Roger L.; Ryan, Tomas J.; Tonegawa, Susumu			Creating a False Memory in the Hippocampus	SCIENCE			English	Article							LONG-TERM POTENTIATION; FEAR MEMORY; ASSOCIATIVE MEMORY; PATTERN SEPARATION; DENTATE GYRUS; AMYGDALA; RECALL; BRAIN	Memories can be unreliable. We created a false memory in mice by optogenetically manipulating memory engram-bearing cells in the hippocampus. Dentate gyrus (DG) or CA1 neurons activated by exposure to a particular context were labeled with channelrhodopsin-2. These neurons were later optically reactivated during fear conditioning in a different context. The DG experimental group showed increased freezing in the original context, in which a foot shock was never delivered. The recall of this false memory was context-specific, activated similar downstream regions engaged during natural fear memory recall, and was also capable of driving an active fear response. Our data demonstrate that it is possible to generate an internally represented and behaviorally expressed fear memory via artificial means.	[Ramirez, Steve; Liu, Xu; Lin, Pei-Ann; Suh, Junghyup; Pignatelli, Michele; Redondo, Roger L.; Ryan, Tomas J.; Tonegawa, Susumu] MIT, Dept Biol, Picower Inst Learning & Memory, RIKEN Massachusetts Inst Technol MIT Ctr Neural C, Cambridge, MA 02139 USA; [Ramirez, Steve; Liu, Xu; Lin, Pei-Ann; Suh, Junghyup; Pignatelli, Michele; Redondo, Roger L.; Ryan, Tomas J.; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Liu, Xu; Redondo, Roger L.; Ryan, Tomas J.; Tonegawa, Susumu] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Tonegawa, S (corresponding author), MIT, Dept Biol, Picower Inst Learning & Memory, RIKEN Massachusetts Inst Technol MIT Ctr Neural C, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu	Suh, Junghyup/AAO-8265-2020	Pignatelli, Michele/0000-0002-4918-2066; Lin, Pei-Ann/0000-0003-4727-4407; Ryan, Tomas/0000-0003-0121-8514	RIKEN Brain Science Institute	RIKEN Brain Science Institute	We thank S. Huang, M. Serock, A. Mockett, J. Zhou, and D. S. Roy for help with the experiments; J. Z. Young and K. L. Mulroy for comments and discussions on the manuscript; and all the members of the Tonegawa lab for their support. This work was supported by the RIKEN Brain Science Institute.	Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; Brandon SE, 2000, BEHAV BRAIN RES, V110, P67, DOI 10.1016/S0166-4328(99)00185-0; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; DOYERE V, 1992, HIPPOCAMPUS, V2, P39, DOI 10.1002/hipo.450020106; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Loftus E, 2003, NAT REV NEUROSCI, V4, P231, DOI 10.1038/nrn1054; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; McTighe SM, 2010, SCIENCE, V330, P1408, DOI 10.1126/science.1194780; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pavlov I.P., 1927, CONDITIONED REFLEXES; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2013, NAT NEUROSCI, V16, P119, DOI 10.1038/nn.3294; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935	30	480	497	16	472	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					387	391		10.1126/science.1239073	http://dx.doi.org/10.1126/science.1239073			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888038	Green Submitted			2022-12-28	WOS:000322259200047
J	Vage, S; Storesund, JE; Thingstad, TF				Vage, Selina; Storesund, Julia E.; Thingstad, T. Frede			SAR11 viruses and defensive host strains	NATURE			English	Letter									[Vage, Selina; Storesund, Julia E.; Thingstad, T. Frede] Univ Bergen, Dept Biol, N-5020 Bergen, Norway	University of Bergen	Vage, S (corresponding author), Univ Bergen, Dept Biol, N-5020 Bergen, Norway.	Selina.Vage@bio.uib.no	Våge, Selina/ABE-3106-2020; Thingstad, Tron Frede/B-2254-2008	Thingstad, Tron Frede/0000-0002-5593-819X; Storesund, Julia E./0000-0003-4618-2324				Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; Grote J, 2012, MBIO, V3, DOI 10.1128/mBio.00252-12; Kirchman DL, 2013, NATURE, V494, P320, DOI 10.1038/nature11951; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Teira E, 2009, ENV MICROBIOL REP, V1, P545, DOI 10.1111/j.1758-2229.2009.00079.x; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Vage S, 2013, ENVIRON MICROBIOL, V15, P1842, DOI 10.1111/1462-2920.12077; Zhao YL, 2013, NATURE, V494, P357, DOI 10.1038/nature11921	10	28	28	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					E3	E4		10.1038/nature12387	http://dx.doi.org/10.1038/nature12387			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23887434				2022-12-28	WOS:000322157900001
J	Costello, MJ; May, RM; Stork, NE				Costello, Mark J.; May, Robert M.; Stork, Nigel E.			Response to Comments on "Can We Name Earth's Species Before They Go Extinct?"	SCIENCE			English	Editorial Material							RATES; BIODIVERSITY; DISCOVERY; DIVERSITY; MAGNITUDE; RICHNESS; SCALES		[Costello, Mark J.] Univ Auckland, Inst Marine Sci, Leigh Marine Lab, Warkworth, New Zealand; [May, Robert M.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Stork, Nigel E.] Griffith Univ, Sch Environm, Environm Futures Ctr, Brisbane, Qld 4111, Australia	University of Auckland; University of Oxford; Griffith University	Costello, MJ (corresponding author), Univ Auckland, Inst Marine Sci, Leigh Marine Lab, POB 349, Warkworth, New Zealand.	m.costello@auckland.ac.nz	Costello, Mark/C-9267-2013	Costello, Mark/0000-0003-2362-0328; Stork, Nigel/0000-0001-7812-2452				Appeltans W, 2012, WORLD REGISTER MARIN; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Bebber DP, 2010, P NATL ACAD SCI USA, V107, P22169, DOI 10.1073/pnas.1011841108; BISBY FA, 2011, SPECIES 2000 ITIS CA; Costello MJ, 2013, SYST BIOL, V62, P616, DOI 10.1093/sysbio/syt024; Costello MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051629; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Costello MJ, 2012, SYST BIOL, V61, P871, DOI 10.1093/sysbio/syr080; Costello MJ, 2011, GLOBAL ECOL BIOGEOGR, V20, P319, DOI 10.1111/j.1466-8238.2010.00603.x; De Clerck O, 2013, J PHYCOL, V49, P215, DOI 10.1111/jpy.12020; Eschmeyer WN, 2010, ZOOTAXA, P19; FENCHEL T, 1993, OIKOS, V68, P375, DOI 10.2307/3544855; Finlay BJ, 2004, PROTIST, V155, P237, DOI 10.1078/143446104774199619; Finlay BJ, 2001, PROTIST, V152, P355, DOI 10.1078/1434-4610-00073; Finlay BJ, 2006, P ROY SOC B-BIOL SCI, V273, P1935, DOI 10.1098/rspb.2006.3525; Fontaine B, 2012, CURR BIOL, V22, pR943, DOI 10.1016/j.cub.2012.10.029; GASTON KJ, 1991, CONSERV BIOL, V5, P283, DOI 10.1111/j.1523-1739.1991.tb00140.x; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108; Laurance WF, 2013, SCIENCE, V339, P1275, DOI 10.1126/science.339.6125.1275-a; Lohrmann V., TAXONOMISCHE FORSCHU; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; Mora C., 2013, SCIENCE, V340, P237; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Reuters T., IND ORG NAM; SMITH FDM, 1993, NATURE, V364, P494, DOI 10.1038/364494b0; STORK NE, 1993, BIODIVERS CONSERV, V2, P215, DOI 10.1007/BF00056669; Stork NE, 2007, NATURE, V448, P657, DOI 10.1038/448657a; Stork NE, 2010, BIODIVERS CONSERV, V19, P357, DOI 10.1007/s10531-009-9761-9; Tancoigne E., 2013, CLADISTICS, V2013, P1; Tancoigne E, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-5; Wheeler Q. D., 2011 STATE OBSERVED	33	18	20	2	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143								10.1126/science.1237381	http://dx.doi.org/10.1126/science.1237381			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	185HV	23869006				2022-12-28	WOS:000321959300024
J	Clarke, LE; Barres, BA				Clarke, Laura E.; Barres, Ben A.			Glia Keep Synapse Distribution under Wraps	CELL			English	Editorial Material							ELEGANS; MAINTENANCE		[Clarke, Laura E.; Barres, Ben A.] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA	Stanford University	Clarke, LE (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	lclarke2@stanford.edu			NATIONAL INSTITUTE ON AGING [R01AG048814] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG048814] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aurelio O, 2002, SCIENCE, V295, P686, DOI 10.1126/science.1066642; Benard C, 2009, CURR TOP DEV BIOL, V87, P175, DOI 10.1016/S0070-2153(09)01206-X; Bulow HE, 2004, NEURON, V42, P367, DOI 10.1016/S0896-6273(04)00246-6; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; POMEROY SL, 1988, J CELL BIOL, V107, P1167, DOI 10.1083/jcb.107.3.1167; Procko C, 2011, DEVELOPMENT, V138, P1371, DOI 10.1242/dev.058305; Sasakura H, 2005, EMBO J, V24, P1477, DOI 10.1038/sj.emboj.7600621; Shao ZY, 2013, CELL, V154, P337, DOI 10.1016/j.cell.2013.06.028; Woo WM, 2008, DEVELOPMENT, V135, P2747, DOI 10.1242/dev.015289	10	12	12	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					267	268		10.1016/j.cell.2013.06.045	http://dx.doi.org/10.1016/j.cell.2013.06.045			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870116	Bronze, Green Accepted			2022-12-28	WOS:000321950700003
J	Terasaki, M; Shemesh, T; Kasthuri, N; Klemm, RW; Schalek, R; Hayworth, KJ; Hand, AR; Yankova, M; Huber, G; Lichtman, JW; Rapoport, TA; Kozlov, MM				Terasaki, Mark; Shemesh, Tom; Kasthuri, Narayanan; Klemm, Robin W.; Schalek, Richard; Hayworth, Kenneth J.; Hand, Arthur R.; Yankova, Maya; Huber, Greg; Lichtman, Jeff W.; Rapoport, Tom A.; Kozlov, Michael M.			Stacked Endoplasmic Reticulum Sheets Are Connected by Helicoidal Membrane Motifs	CELL			English	Article							GRAIN-BOUNDARY MORPHOLOGY; TRANSLOCON COMPLEXES; ELECTRON-MICROSCOPY; RIBOSOME RECEPTOR; HOMOTYPIC FUSION; ER; CELLS; MICROTUBULES; PROTEINS; BINDING	The endoplasmic reticulum (ER) often forms stacked membrane sheets, an arrangement that is likely required to accommodate a maximum of membrane-bound polysomes for secretory protein synthesis. How sheets are stacked is unknown. Here, we used improved staining and automated ultrathin sectioning electron microscopy methods to analyze stacked ER sheets in neuronal cells and secretory salivary gland cells of mice. Our results show that stacked ER sheets form a continuous membrane system in which the sheets are connected by twisted membrane surfaces with helical edges of left- or right-handedness. The three-dimensional structure of tightly stacked ER sheets resembles a parking garage, in which the different levels are connected by helicoidal ramps. A theoretical model explains the experimental observations and indicates that the structure corresponds to a minimum of elastic energy of sheet edges and surfaces. The structure allows the dense packing of ER sheets in the restricted space of a cell.	[Terasaki, Mark; Huber, Greg] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06030 USA; [Yankova, Maya] Univ Connecticut, Ctr Hlth, Cent Electron Microscopy Facil, Farmington, CT 06030 USA; [Shemesh, Tom] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; [Kasthuri, Narayanan; Schalek, Richard; Hayworth, Kenneth J.; Lichtman, Jeff W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Klemm, Robin W.; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Klemm, Robin W.; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Hand, Arthur R.] Univ Connecticut, Sch Dent Med, Dept Craniofacial Sci, Farmington, CT 06032 USA; [Hand, Arthur R.] Univ Connecticut, Sch Dent Med, Dept Cell Biol, Farmington, CT 06032 USA; [Huber, Greg] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Kozlov, Michael M.] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	University of Connecticut; University of Connecticut; Columbia University; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Connecticut; University of Connecticut; University of California System; University of California Santa Barbara; Tel Aviv University; Sackler Faculty of Medicine	Terasaki, M (corresponding author), Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06030 USA.	terasaki@uchc.edu; tom_rapoport@hms.harvard.edu	Shemesh, Tom/J-5060-2013; Klemm, Robin/ABA-2252-2020; Klemm, Robin/C-5463-2014	Klemm, Robin/0000-0003-2313-8240; Klemm, Robin/0000-0003-2313-8240	Israel Science Foundation (ISF); Marie Curie network "Virus Entry"; National Science Foundation [NSF PHY11-25915]; Richard Berlin Center for Cell Analysis and Modeling; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016411] Funding Source: NIH RePORTER	Israel Science Foundation (ISF)(Israel Science Foundation); Marie Curie network "Virus Entry"; National Science Foundation(National Science Foundation (NSF)); Richard Berlin Center for Cell Analysis and Modeling; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank Shigeki Watanabe for providing his unpublished freeze substitution protocol and Yoko Shibata, Rindy Jaffe, and Adrian Salic for critical reading of the manuscript. We thank Sid Tamm for pointing out the parking garage analogy. M.M.K. is supported by the Israel Science Foundation (ISF) and the Marie Curie network "Virus Entry" and holds the Joseph Klafter Chair in Biophysics. T.A.R. is a Howard Hughes Medical Institute Investigator. G.H. acknowledges support from the National Science Foundation under grant NSF PHY11-25915 and from the Richard Berlin Center for Cell Analysis and Modeling.	Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Becker F, 1999, J CELL BIOL, V146, P273, DOI 10.1083/jcb.146.2.273; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; CATALAN E., 1842, J MATH PURE APPL, V7, P203; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; do Carmo M.P., 1986, MATH MODELS COLLECTI, P44; Fawcett D.W., 1981, CELL; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Gido SP, 1997, MACROMOLECULES, V30, P3739, DOI 10.1021/ma9603037; GIDO SP, 1993, MACROMOLECULES, V26, P4506, DOI 10.1021/ma00069a016; HAND AR, 1972, AM J ANAT, V135, P71, DOI 10.1002/aja.1001350107; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [10.1017/s1431927606066268, DOI 10.1017/S1431927606066268]; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2011, CELL, V147, P1226, DOI 10.1016/j.cell.2011.11.022; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Kamien RD, 1997, J PHYS II, V7, P157, DOI 10.1051/jp2:1997119; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Nikonov AV, 2007, J CELL SCI, V120, P2248, DOI 10.1242/jcs.008979; Nikonov AV, 2002, J CELL BIOL, V158, P497, DOI 10.1083/jcb.200201116; Ogawa-Goto K, 2007, MOL BIOL CELL, V18, P3741, DOI 10.1091/mbc.E06-12-1125; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; PALADE GE, 1956, J BIOPHYS BIOCHEM CY, V2, P171, DOI 10.1083/jcb.2.2.171; PALADE GE, 1956, J BIOPHYS BIOCHEM CY, V2, P671, DOI 10.1083/jcb.2.6.671; PORTER KR, 1953, ANAT REC, V117, P685, DOI 10.1002/ar.1091170403; Puhka M, 2012, MOL BIOL CELL, V23, P2424, DOI 10.1091/mbc.E10-12-0950; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; Senda T, 1998, ANAT REC, V251, P339; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Tapia JC, 2012, NAT PROTOC, V7, P193, DOI 10.1038/nprot.2011.439; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047	39	143	144	2	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					285	296		10.1016/j.cell.2013.06.031	http://dx.doi.org/10.1016/j.cell.2013.06.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870120	Bronze, Green Accepted			2022-12-28	WOS:000321950700007
J	Ferner, R				Ferner, Robin			Hallucination	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				Abouesh A, 2002, J CLIN PSYCHOPHARM, V22, P71, DOI 10.1097/00004714-200202000-00012; ALLEN JR, 1985, NEW ENGL J MED, V313, P642; ARASKIEWICZ A, 1994, MED HYPOTHESES, V42, P261, DOI 10.1016/0306-9877(94)90128-7; BATCHELOR RCL, 1951, LANCET, V261, P195; Bouso JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042421; Grob CS, 1996, J NERV MENT DIS, V184, P86, DOI 10.1097/00005053-199602000-00004; Keeley PW, 2000, BRIT MED J, V321, P1608, DOI 10.1136/bmj.321.7276.1608; Landais A, 2014, REV MED INTERNE, V35, P199, DOI 10.1016/j.revmed.2013.02.027; McKenna D.J., 1998, HEFFTER REV PSYCHEDE, V1, P65; Sacks OW, 2012, HALLUCINATIONS: RESEARCH AND PRACTICE, P133, DOI 10.1007/978-1-4614-0959-5_11	10	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2013	347								f4570	10.1136/bmj.f4570	http://dx.doi.org/10.1136/bmj.f4570			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	189DG	23873925				2022-12-28	WOS:000322246700012
J	Basch, E; Torda, P; Adams, K				Basch, Ethan; Torda, Phyllis; Adams, Karen			Standards for Patient-Reported Outcome-Based Performance Measures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Basch, Ethan] Univ N Carolina, Sch Med, Chapel Hill, NC 27514 USA; [Basch, Ethan] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC 27514 USA; [Torda, Phyllis] Natl Comm Qual Assurance, Washington, DC USA; [Adams, Karen] Natl Qual Forum, Washington, DC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Basch, E (corresponding author), Univ N Carolina, Sch Med, Canc Outcomes Res Program, 170 Manning Dr, Chapel Hill, NC 27514 USA.	ebasch@med.unc.edu						Brundage M, 2013, QUAL LIFE RES, V22, P1161, DOI 10.1007/s11136-012-0252-1; Devlin N., 2010, GETTING MOST OUT PRO; Gnanasakthy A, 2012, VALUE HEALTH, V15, P437, DOI 10.1016/j.jval.2011.11.032; Gotay CC, 2008, J CLIN ONCOL, V26, P1355, DOI 10.1200/JCO.2007.13.3439; Harrison PL, 2012, POPUL HEALTH MANAG, V15, P325, DOI 10.1089/pop.2011.0089; Jones Nathaniel 3rd, 2004, Health Qual Life Outcomes, V2, P33, DOI 10.1186/1477-7525-2-33; Minnesota Community Measurement, MINN HLTH SCOR OV; National Quality Forum, 2013, PAT REP OUTC PROS PE; US Department of Health and Human Services . Food and Drug Administration, 2009, GUID IND PAT REP OUT	9	89	89	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					139	140		10.1001/jama.2013.6855	http://dx.doi.org/10.1001/jama.2013.6855			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23839744				2022-12-28	WOS:000321511500007
J	Strand, KM; Heimstad, R; Iversen, AC; Austgulen, R; Lydersen, S; Andersen, GL; Irgens, LM; Vik, T				Strand, Kristin Melheim; Heimstad, Runa; Iversen, Ann-Charlotte; Austgulen, Rigmor; Lydersen, Stian; Andersen, Guro L.; Irgens, Lorentz M.; Vik, Torstein			Mediators of the association between pre-eclampsia and cerebral palsy: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WHITE-MATTER DAMAGE; RISK-FACTORS; CHILDREN BORN; GESTATIONAL-AGE; BIRTH; COMPLICATIONS; NORWAY; INFANT	Objective To test the hypothesis that pre-eclampsia is a risk factor for cerebral palsy mediated through preterm birth and being born small for gestational age. Design Population based cohort study. Setting Clinical data from the Norwegian Cerebral Palsy Registry were linked with perinatal data prospectively recorded by the Medical Birth Registry of Norway. Participants All singleton babies who survived the neonatal period during 1996-2006 (849 children with cerebral palsy and 616 658 control children). Main outcome measures Cerebral palsy and cerebral palsy subtypes. Results Children exposed to pre-eclampsia had an excess risk of cerebral palsy (unadjusted odds ratio 2.5, 95% confidence interval 2.0 to 3.2) compared with unexposed children. Among children born at term (>= 37 weeks), exposure to pre-eclampsia was not associated with an excess risk of cerebral palsy in babies not born small for gestational age (1.2, 0.7 to 2.0), whereas children exposed to pre-eclampsia and born small for gestational age had a significantly increased risk of cerebral palsy (3.2, 1.5 to 6.7). Non-small for gestational age babies born very preterm (<32 weeks) and exposed to pre-eclampsia had a reduced risk of cerebral palsy compared with unexposed children born at the same gestational age (0.5, 0.3 to 0.8), although the risk was not statistically significantly reduced among children exposed to pre-eclampsia and born small for gestational age (0.7, 0.4 to 1.3). Exposure to pre-eclampsia was not associated with a specific cerebral palsy subtype. Conclusions Exposure to pre-eclampsia was associated with an increased risk of cerebral palsy, and this association was mediated through the children being born preterm or small for gestational age, or both. Among children born at term, pre-eclampsia was a risk factor for cerebral palsy only when the children were small for gestational age.	[Strand, Kristin Melheim; Iversen, Ann-Charlotte; Austgulen, Rigmor] Norwegian Univ Sci & Technol NTNU, MTFS, Dept Canc Res & Mol Med, N-7491 Trondheim, Norway; [Heimstad, Runa] St Olavs Univ Hosp, Dept Obstet & Gynecol, Trondheim, Norway; [Lydersen, Stian] NTNU, Reg Ctr Child & Adolescent Mental Hlth, Trondheim, Norway; [Andersen, Guro L.] Vestfold Hosp, Habilitat Ctr, Norwegian Cerebral Palsy Registry, Tonsberg, Norway; [Irgens, Lorentz M.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Med Birth Registry Norway, Locus Registry Based Epidemiol, N-5020 Bergen, Norway; [Vik, Torstein] NTNU, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Bergen; Norwegian University of Science & Technology (NTNU)	Strand, KM (corresponding author), Norwegian Univ Sci & Technol NTNU, MTFS, Dept Canc Res & Mol Med, POB 8905, N-7491 Trondheim, Norway.	krist@stud.ntnu.no	Iversen, Ann-Charlotte/C-6920-2011	Iversen, Ann-Charlotte/0000-0001-7726-7684				ACOG Committee on Practice Bulletins--Obstetrics, 2002, Obstet Gynecol, V99, P159; Andersen GL, 2008, EUR J PAEDIATR NEURO, V12, P4, DOI 10.1016/j.ejpn.2007.05.001; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Dammann O, 2002, MENT RETARD DEV D R, V8, P46, DOI 10.1002/mrdd.10005; GAFFNEY G, 1994, BRIT MED J, V308, P743, DOI 10.1136/bmj.308.6931.743; Gardosi J, 2009, AM J OBSTET GYNECOL, V201, p25e1; Greenwood C, 2005, ARCH DIS CHILD-FETAL, V90, P141, DOI 10.1136/adc.2004.052860; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Jarvis S, 2003, LANCET, V362, P1106, DOI 10.1016/S0140-6736(03)14466-2; Kulak W, 2010, ADV MED SCI-POLAND, V55, P216, DOI 10.2478/v10039-010-0030-7; Lee J, 2005, JAMA-J AM MED ASSOC, V293, P723, DOI 10.1001/jama.293.6.723; Mann JR, 2011, PAEDIATR PERINAT EP, V25, P100, DOI 10.1111/j.1365-3016.2010.01157.x; McElrath TF, 2009, AM J EPIDEMIOL, V170, P819, DOI 10.1093/aje/kwp206; MURPHY DJ, 1995, LANCET, V346, P1449, DOI 10.1016/S0140-6736(95)92471-X; Nelson KB, 2007, STROKE, V38, P742, DOI 10.1161/01.STR.0000247921.97794.5e; NELSON KB, 1984, JAMA-J AM MED ASSOC, V251, P1843, DOI 10.1001/jama.251.14.1843; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Oian P, 1998, VEILEDER FODSELSHJEL, P94; PALMER L, 1995, PAEDIATR PERINAT EP, V9, P171, DOI 10.1111/j.1365-3016.1995.tb00132.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Spinillo A, 1998, EUR J OBSTET GYN R B, V77, P151, DOI 10.1016/S0301-2115(97)00246-7; Stoknes M, 2012, EUR J PAEDIATR NEURO, V16, P56, DOI 10.1016/j.ejpn.2011.10.004; Thomsen LCV, 2013, ACTA OBSTET GYNECOL, DOI 10.111/aogs.12159; Thorngren-Jerneck K, 2006, OBSTET GYNECOL, V108, P1499, DOI 10.1097/01.AOG.0000247174.27979.6b; VanderWeele TJ, 2011, PAEDIATR PERINAT EP, V25, P111, DOI 10.1111/j.1365-3016.2010.01175.x; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; WEINBERG CR, 1993, AM J EPIDEMIOL, V137, P1; Wilson-Costello D, 2001, Semin Pediatr Neurol, V8, P120, DOI 10.1053/spen.2001.25228; Wu CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.060	30	34	35	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2013	347								f4089	10.1136/bmj.f4089	http://dx.doi.org/10.1136/bmj.f4089			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184LT	23838554	hybrid, Green Published			2022-12-28	WOS:000321892000003
J	Lindson-Hawley, N; Aveyard, P; Hughes, JR				Lindson-Hawley, Nicola; Aveyard, Paul; Hughes, John R.			Gradual Reduction vs Abrupt Cessation as a Smoking Cessation Strategy in Smokers Who Want to Quit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lindson-Hawley, Nicola] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Aveyard, Paul] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Hughes, John R.] Univ Vermont, Dept Psychiat Psychol & Family Med, Burlington, VT 05405 USA	University of Birmingham; University of Oxford; University of Vermont	Lindson-Hawley, N (corresponding author), Univ Birmingham, Birmingham B15 2TT, W Midlands, England.	n.l.lindson@bham.ac.uk	Hughes, John/H-9687-2013	Hughes, John/0000-0002-0092-9309; Aveyard, Paul/0000-0002-1802-4217; Lindson, Nicola/0000-0003-2539-9268	British Heart Foundation [PG/08/047/25082] Funding Source: Medline; Department of Health [09/110/01] Funding Source: Medline; National Institute for Health Research [09/110/01] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Cheong Y, 2007, NICOTINE TOB RES, V9, P801, DOI 10.1080/14622200701484961; CINCIRIPINI PM, 1995, J CONSULT CLIN PSYCH, V63, P388, DOI 10.1037/0022-006X.63.3.388; Ferguson J, 2005, ADDICTION, V100, P59, DOI 10.1111/j.1360-0443.2005.01028.x; Fiore MC, TREATING TOBACCO USE; Hughes JR, 2007, ADDICTION, V102, P1326, DOI 10.1111/j.1360-0443.2007.01948.x; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Lindson-Hawley N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008033.pub3; Treatobacco.net, NATIONAL TREATMENT G	8	10	10	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					91	92		10.1001/jama.2013.6473	http://dx.doi.org/10.1001/jama.2013.6473			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175SK	23821093				2022-12-28	WOS:000321253000027
J	Atkinson, MA; Eisenbarth, GS; Michels, AW				Atkinson, Mark A.; Eisenbarth, George S.; Michels, Aaron W.			Type 1 diabetes	LANCET			English	Article							STEM-CELL TRANSPLANTATION; INSULIN-PUMP THERAPY; DOUBLE-BLIND; C-PEPTIDE; COMPLICATIONS-TRIAL/EPIDEMIOLOGY; CARDIOVASCULAR-DISEASE; NOCTURNAL HYPOGLYCEMIA; GENETIC SUSCEPTIBILITY; ISLET TRANSPLANTATION; ARTIFICIAL PANCREAS	Over the past decade, knowledge of the pathogenesis and natural history of type 1 diabetes has grown substantially, particularly with regard to disease prediction and heterogeneity, pancreatic pathology, and epidemiology. Technological improvements in insulin pumps and continuous glucose monitors help patients with type 1 diabetes manage the challenge of lifelong insulin administration. Agents that show promise for averting debilitating disease-associated complications have also been identifi ed. However, despite broad organisational, intellectual, and fi scal investments, no means for preventing or curing type 1 diabetes exists, and, globally, the quality of diabetes management remains uneven. This Seminar discusses current progress in epidemiology, pathology, diagnosis, and treatment of type 1 diabetes, and prospects for an improved future for individuals with this disease.	[Atkinson, Mark A.] Univ Florida, Dept Pathol, Gainesville, FL 32610 USA; [Atkinson, Mark A.] Univ Florida, Dept Pediat, Gainesville, FL 32610 USA; [Eisenbarth, George S.; Michels, Aaron W.] Barbara Davis Ctr Childhood Diabet, Aurora, CO USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Atkinson, MA (corresponding author), Univ Florida, Dept Pathol, Coll Med, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	atkinson@ufl.edu		Michels, Aaron/0000-0003-3766-5244	National Institutes of Health; Juvenile Diabetes Research Foundation; American Diabetes Association; Brehm Coalition for Type 1 Diabetes research; Children's Diabetes Foundation; Helmsley Trust; Jeffrey Keene Family Professorship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK095995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); Brehm Coalition for Type 1 Diabetes research; Children's Diabetes Foundation; Helmsley Trust; Jeffrey Keene Family Professorship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partly supported by grants from the National Institutes of Health, the Juvenile Diabetes Research Foundation, the American Diabetes Association, the Brehm Coalition for Type 1 Diabetes research, the Children's Diabetes Foundation, the Helmsley Trust, and the Jeffrey Keene Family Professorship.	Ahmet A, 2011, J PEDIATR-US, V159, P297, DOI 10.1016/j.jpeds.2011.01.064; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Atkinson MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002757; Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; Atkinson MA, 2011, DIABETES, V60, P361, DOI 10.2337/db10-1506; Bach JF, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007799; Bach JF, 2011, SEMIN IMMUNOL, V23, P174, DOI 10.1016/j.smim.2011.07.009; Bach JF, 2011, LANCET, V378, P459, DOI 10.1016/S0140-6736(11)60980-X; Beck RW, 2010, DIABETES CARE, V33, P1004, DOI 10.2337/dc09-2081; Beran D, 2005, DIABETES CARE, V28, P2136, DOI 10.2337/diacare.28.9.2136; Beran D, 2012, LANCET, V380, P1648, DOI 10.1016/S0140-6736(12)61950-3; Bergenstal RM, 2011, DIABETES CARE, V34, P2403, DOI 10.2337/dc11-1248; Bergenstal RM, 2010, NEW ENGL J MED, V363, P311, DOI 10.1056/NEJMoa1002853; Berhan Y, 2011, DIABETES, V60, P577, DOI 10.2337/db10-0813; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bingley PJ, 2010, J CLIN ENDOCR METAB, V95, P25, DOI 10.1210/jc.2009-1365; Blanton D, 2011, DIABETES, V60, P2566, DOI 10.2337/db11-0576; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Boerner BP, 2011, ANN NY ACAD SCI, V1243, P103, DOI 10.1111/j.1749-6632.2011.06340.x; Bonifacio E, 2010, ENDOCRIN METAB CLIN, V39, P513, DOI 10.1016/j.ecl.2010.05.007; Breton M, 2012, DIABETES, V61, P2230, DOI 10.2337/db11-1445; Buckingham B, 2010, DIABETES CARE, V33, P1013, DOI 10.2337/dc09-2303; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Buzzetti R, 2011, DIABETES, V60, P3067, DOI 10.2337/db10-0560; Campbell-Thompson M, 2012, JAMA-J AM MED ASSOC, V308, P2337, DOI 10.1001/jama.2012.15008; Campbell-Thompson M, 2012, DIABETES-METAB RES, V28, P608, DOI 10.1002/dmrr.2316; Chaturvedi N, 2008, LANCET, V372, P1394, DOI 10.1016/S0140-6736(08)61412-9; Cobelli C, 2011, DIABETES, V60, P2672, DOI 10.2337/db11-0654; Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; Couri CEB, 2009, JAMA-J AM MED ASSOC, V301, P1573, DOI 10.1001/jama.2009.470; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Dabelea D, 2009, LANCET, V373, P1999, DOI 10.1016/S0140-6736(09)60874-6; Dall TM, 2009, POPUL HEALTH MANAG, V12, P103, DOI 10.1089/pop.2009.12203; de Boer IH, 2011, ARCH INTERN MED, V171, P412, DOI 10.1001/archinternmed.2011.16; Diabetes Prevention Trial Type Stu, 2005, DIABETES CARE, V28, P1068; Eckel RH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004219; Ehehalt S, 2012, PEDIATR DIABETES, V13, P15, DOI 10.1111/j.1399-5448.2011.00799.x; Ehehalt S, 2010, DIABETES CARE, V33, P338, DOI 10.2337/dc09-1503; Eisenbarth GS, 2007, J CLIN ENDOCR METAB, V92, P2403, DOI 10.1210/jc.2007-0339; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Ferrannini E, 2010, DIABETES, V59, P679, DOI 10.2337/db09-1378; Fonseca VA, 2009, DIABETES CARE, V32, P1, DOI [10.2337/dc09-9033, 10.2337/dc09-S301]; FOULIS AK, 1984, DIABETOLOGIA, V26, P456; FOULIS AK, 1986, DIABETOLOGIA, V29, P267, DOI 10.1007/BF00452061; Gaglia JL, 2011, J CLIN INVEST, V121, P442, DOI 10.1172/JCI44339; Gale EAM, 2005, DIABETOLOGIA, V48, P2195, DOI 10.1007/s00125-005-1954-5; Gale EAM, 2005, DIABETOLOGIA, V48, P1435, DOI 10.1007/s00125-005-1833-0; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Gale EAM, 2006, LANCET, V368, P1626, DOI 10.1016/S0140-6736(06)69672-4; Garg S, 2012, DIABETES TECHNOL THE, V14, P205, DOI 10.1089/dia.2011.0292; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gianani R, 2010, DIABETOLOGIA, V53, P690, DOI 10.1007/s00125-009-1642-y; Gibly RF, 2011, DIABETOLOGIA, V54, P2494, DOI 10.1007/s00125-011-2243-0; Gillespie KM, 2004, LANCET, V364, P1699, DOI 10.1016/S0140-6736(04)17357-1; Gottumukkala Raju V S R K, 2012, Sci Transl Med, V4, p138ra80, DOI 10.1126/scitranslmed.3003551; Greenbaum C, 2011, DIABETES, V60, P693, DOI 10.2337/db10-1810; Greenbaum CJ, 2012, DIABETES, V61, P2066, DOI 10.2337/db11-1538; Gregg BE, 2012, J CLIN ENDOCR METAB, V97, P3197, DOI 10.1210/jc.2012-1206; Groop PH, 2009, DIABETES, V58, P1651, DOI 10.2337/db08-1543; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; Hattersley A, 2009, PEDIATR DIABETES, V10, P33, DOI 10.1111/j.1399-5448.2009.00571.x; Heller S, 2012, LANCET, V379, P1489, DOI 10.1016/S0140-6736(12)60204-9; Herold KC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002981; Hirsch IB, 2012, DIABETES TECHNOL THE, V14, P201, DOI 10.1089/dia.2012.0036; Hirsch IB, 2009, J CLIN ENDOCR METAB, V94, P2232, DOI 10.1210/jc.2008-2625; Howson JMM, 2011, DIABETES, V60, P2645, DOI 10.2337/db11-0364; In't Veld P, 2011, ISLETS, V3, P131, DOI 10.4161/isl.3.4.15728; Kahn HS, 2009, DIABETES CARE, V32, P2010, DOI 10.2337/dc09-0891; Keenan Hillary A, 2010, Diabetes, V59, P2846, DOI 10.2337/db10-0676; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; Kielgast U, 2011, DIABETES, V60, P1599, DOI 10.2337/db10-1790; Knip M, 2011, HORM RES PAEDIAT, V76, P57, DOI 10.1159/000329169; Knip M, 2010, NEW ENGL J MED, V363, P1900, DOI 10.1056/NEJMoa1004809; Knip M, 2010, AM J CLIN NUTR, V91, p1506S, DOI 10.3945/ajcn.2010.28701C; Kukko M, 2005, J CLIN ENDOCR METAB, V90, P2712, DOI 10.1210/jc.2004-1371; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Leslie RDG, 2008, DIABETES-METAB RES, V24, P511, DOI 10.1002/dmrr.877; Leslie RD, 2010, DIABETES, V59, P330, DOI 10.2337/db09-1620; Ludvigsson J, 2012, NEW ENGL J MED, V366, P433, DOI 10.1056/NEJMoa1107096; Maahs DM, 2010, ENDOCRIN METAB CLIN, V39, P481, DOI 10.1016/j.ecl.2010.05.011; MACLAREN N, 1992, NEW ENGL J MED, V327, P348, DOI 10.1056/NEJM199207303270509; MASER RE, 1991, ARTERIOSCLER THROMB, V11, P958, DOI 10.1161/01.ATV.11.4.958; Melendez-Ramirez LY, 2010, ENDOCRIN METAB CLIN, V39, P625, DOI 10.1016/j.ecl.2010.05.009; Michels AW, 2011, SEMIN IMMUNOL, V23, P214, DOI 10.1016/j.smim.2011.07.003; Mollsten A, 2010, DIABETES, V59, P1803, DOI 10.2337/db09-1744; Moltchanova EV, 2009, DIABETIC MED, V26, P673, DOI 10.1111/j.1464-5491.2009.02743.x; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; Naik RG, 2009, J CLIN ENDOCR METAB, V94, P4635, DOI 10.1210/jc.2009-1120; Nanto-Salonen K, 2008, LANCET, V372, P1746, DOI 10.1016/S0140-6736(08)61309-4; Nathan DM, 2009, ARCH INTERN MED, V169, P1307, DOI 10.1001/archinternmed.2009.193; Nathan DM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1707, DOI 10.1001/archopht.126.12.1707; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Noble JA, 2010, DIABETES, V59, P2972, DOI 10.2337/db10-0699; Oral EA, 2012, PEDIATR DIABETES, V13, P68, DOI 10.1111/j.1399-5448.2011.00797.x; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Orchard TJ, 2006, DIABETES CARE, V29, P2528, DOI 10.2337/dc06-1161; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Ostman J, 2008, J INTERN MED, V263, P386, DOI 10.1111/j.1365-2796.2007.01896.x; Parikka V, 2012, DIABETOLOGIA, V55, P1926, DOI 10.1007/s00125-012-2523-3; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Pezzolesi MG, 2009, DIABETES, V58, P1403, DOI 10.2337/db08-1514; Pflueger M, 2011, DIABETES, V60, P2740, DOI 10.2337/db10-1652; Pickup John C, 2011, BMJ, V343, pd3805, DOI 10.1136/bmj.d3805; Pickup JC, 2012, NEW ENGL J MED, V366, P1616, DOI 10.1056/NEJMct1113948; Podar T, 2001, DIABETOLOGIA, V44, pB17, DOI 10.1007/PL00002947; Polychronakos C, 2011, NAT REV GENET, V12, P781, DOI 10.1038/nrg3069; Pop-Busui R, 2009, CIRCULATION, V119, P2886, DOI 10.1161/CIRCULATIONAHA.108.837369; Pozzilli P, 2012, NAT REV ENDOCRINOL, V8, P78, DOI 10.1038/nrendo.2011.228; Puett Robin C, 2012, Health Place, V18, P911, DOI 10.1016/j.healthplace.2012.02.007; Rewers M, 2008, ANN NY ACAD SCI, V1150, P1, DOI 10.1196/annals.1447.062; Roep BO, 2011, CURR OPIN IMMUNOL, V23, P746, DOI 10.1016/j.coi.2011.10.001; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Ryan Gina, 2009, Drug Des Devel Ther, V2, P203; Schloot NC, 2007, DIABETES-METAB RES, V23, P276, DOI 10.1002/dmrr.707; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sherry N, 2011, LANCET, V378, P487, DOI 10.1016/S0140-6736(11)60931-8; Skyler JS, 2008, ANN NY ACAD SCI, V1150, P190, DOI 10.1196/annals.1447.055; Soderstrom U, 2012, ACTA PAEDIATR, V101, P73, DOI 10.1111/j.1651-2227.2011.02410.x; Soltesz G, 2007, PEDIATR DIABETES, V8, P6, DOI 10.1111/j.1399-5448.2007.00280.x; Sosenko JM, 2012, DIABETES CARE, V35, P1552, DOI 10.2337/dc12-0011; Sosenko JM, 2010, DIABETES, V59, P2386, DOI 10.2337/db10-0534; Sosenko JM, 2010, DIABETES CARE, V33, P620, DOI 10.2337/dc09-1770; Staeva TP, 2013, DIABETES, V62, P9, DOI 10.2337/db12-0562; Steck AK, 2011, DIABETES CARE, V34, P1397, DOI 10.2337/dc10-2088; Steck AK, 2011, DIABETES, V60, P1045, DOI 10.2337/db10-1419; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; Stene LC, 2012, CLIN EXP IMMUNOL, V168, P12, DOI 10.1111/j.1365-2249.2011.04555.x; Svoren BM, 2009, J PEDIATR-US, V154, P132, DOI 10.1016/j.jpeds.2008.07.015; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Tao B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011501; Thunander M, 2008, DIABETES RES CLIN PR, V82, P247, DOI 10.1016/j.diabres.2008.07.022; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Tuomi T, 2005, DIABETES, V54, pS40, DOI 10.2337/diabetes.54.suppl_2.S40; Usher-Smith JA, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4092; Vaarala O, 2012, ARCH PEDIAT ADOL MED, V166, P608, DOI 10.1001/archpediatrics.2011.1559; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568; Waden J, 2009, DIABETES, V58, P2649, DOI 10.2337/db09-0693; Walter M, 2009, DIABETES CARE, V32, P2036, DOI 10.2337/dc09-0449; Wherrett DK, 2011, LANCET, V378, P319, DOI 10.1016/S0140-6736(11)60895-7; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wiggin TD, 2009, DIABETES, V58, P1634, DOI 10.2337/db08-1771; Wilkin TJ, 2009, INT J OBESITY, V33, P716, DOI 10.1038/ijo.2009.97; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Winkler C, 2012, GENES IMMUN, V13, P549, DOI 10.1038/gene.2012.36; Winkler C, 2011, DIABETES, V60, P685, DOI 10.2337/db10-1269; Yeh HC, 2012, ANN INTERN MED, V157, P336, DOI 10.7326/0003-4819-157-5-201209040-00508; Yeung WCG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d35; Ziegler AG, 2012, DIABETOLOGIA, V55, P1937, DOI 10.1007/s00125-012-2472-x; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018	155	1284	1334	26	408	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					69	82		10.1016/S0140-6736(13)60591-7	http://dx.doi.org/10.1016/S0140-6736(13)60591-7			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SP	23890997	Green Accepted			2022-12-28	WOS:000329341200037
J	Said-Criado, I; Gil-Aguado, A				Said-Criado, Ismael; Gil-Aguado, Antonio			Nodular lymphoid hyperplasia in common variable immunodeficiency	LANCET			English	Editorial Material									[Said-Criado, Ismael] Hosp Univ Ramon & Cajal, Madrid 28034, Spain; [Gil-Aguado, Antonio] Hosp Univ La Paz, Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz	Said-Criado, I (corresponding author), Hosp Univ Ramon & Cajal, Serv Med Interna, Carretera Colmenar Viejo,Km 9,100, Madrid 28034, Spain.	ismael.said@gmail.com							0	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					E2	E2		10.1016/S0140-6736(13)60256-1	http://dx.doi.org/10.1016/S0140-6736(13)60256-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SP	23870815				2022-12-28	WOS:000329341200002
J	Huntingford, C; Jones, PD; Livina, VN; Lenton, TM; Cox, PM				Huntingford, Chris; Jones, Philip D.; Livina, Valerie N.; Lenton, Timothy M.; Cox, Peter M.			No increase in global temperature variability despite changing regional patterns	NATURE			English	Article							EXTREME EVENTS; CLIMATE; ERA-40; CMIP5; ICE	Evidence from Greenland ice cores shows that year-to-year temperature variability was probably higher in some past cold periods(1), but there is considerable interest in determining whether global warming is increasing climate variability at present(2-6). This interest is motivated by an understanding that increased variability and resulting extreme weather conditions may be more difficult for society to adapt to than altered mean conditions(3). So far, however, in spite of suggestions of increased variability(2), there is considerable uncertainty as to whether it is occurring(7). Here we show that although fluctuations in annual temperature have indeed shown substantial geographical variation over the past few decades(2), the time-evolving standard deviation of globally averaged temperature anomalies has been stable. A feature of the changes has been a tendency for many regions of low variability to experience increases, which might contribute to the perception of increased climate volatility. The normalization of temperature anomalies(2) creates the impression of larger relative overall increases, but our use of absolute values, which we argue is a more appropriate approach, reveals little change. Regionally, greater year-to-year changes recently occurred in much of North America and Europe. Many climate models predict that total variability will ultimately decrease under high greenhouse gas concentrations, possibly associated with reductions in sea-ice cover. Our findings contradict the view that a warming world will automatically be one of more overall climatic variation.	[Huntingford, Chris] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [Jones, Philip D.] Univ E Anglia, Fac Sci, Sch Environm Sci, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England; [Jones, Philip D.] King Abdulaziz Univ, Dept Meteorol, Ctr Excellence Climate Change Res, Jeddah 21589, Saudi Arabia; [Livina, Valerie N.] Univ E Anglia, Fac Sci, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Livina, Valerie N.] Natl Phys Lab, Teddington TW11 0LW, Middx, England; [Lenton, Timothy M.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4PS, Devon, England; [Cox, Peter M.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England	UK Centre for Ecology & Hydrology (UKCEH); University of East Anglia; King Abdulaziz University; University of East Anglia; National Physical Laboratory - UK; University of Exeter; University of Exeter	Huntingford, C (corresponding author), Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England.	chg@ceh.ac.uk	Huntingford, Christopher/A-4307-2008; Jones, Philip Douglas/C-8718-2009; Cox, Peter Michae;/B-3299-2012; Livina, Valerie N/C-7636-2011; Lenton, Tim M/X-1893-2018	Huntingford, Christopher/0000-0002-5941-7770; Jones, Philip Douglas/0000-0001-5032-5493; Cox, Peter Michae;/0000-0002-0679-2219; Livina, Valerie N/0000-0003-3759-9013; Lenton, Tim M/0000-0002-6725-7498	US DOE [DE-SC0005689]; NERC [NE/F005474/1]; Natural Environment Research Council [ceh010023, NE/F005474/1] Funding Source: researchfish	US DOE(United States Department of Energy (DOE)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We gratefully acknowledge the Newton Institute for Mathematical Sciences programme Mathematical and Statistical Approaches to Climate Modelling and Prediction. C. H. also acknowledges the CEH National Capability Budget. P.D.J. has been supported by the US DOE (grant DE-SC0005689). V.N.L. and T. M. L. were supported by NERC (grant NE/F005474/1).	Bender FAM, 2012, CLIM DYNAM, V38, P2037, DOI 10.1007/s00382-011-1065-6; Budikova D, 2009, GLOBAL PLANET CHANGE, V68, P149, DOI 10.1016/j.gloplacha.2009.04.001; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Dethloff K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025245; Field C.B., 2012, MANAGING RISKS EXTRE; Francis JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051000; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hartmann B, 2005, J CLIMATE, V18, P4824, DOI 10.1175/JCLI3532.1; Johanson CM, 2009, J CLIMATE, V22, P2713, DOI 10.1175/2008JCLI2620.1; Jones CD, 2011, GEOSCI MODEL DEV, V4, P543, DOI 10.5194/gmd-4-543-2011; Jones PD, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017139; KATZ RW, 1992, CLIMATIC CHANGE, V21, P289, DOI 10.1007/BF00139728; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; Lu J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036076; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Rahmstorf S, 2011, P NATL ACAD SCI USA, V108, P17905, DOI 10.1073/pnas.1101766108; Raisanen J, 2002, J CLIMATE, V15, P2395, DOI 10.1175/1520-0442(2002)015<2395:CICIIT>2.0.CO;2; Rhines A, 2013, P NATL ACAD SCI USA, V110, pE546, DOI 10.1073/pnas.1218748110; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Simmons AJ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012442; Simmons AJ, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD005306; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; TRENBERTH KE, 1990, B AM METEOROL SOC, V71, P988, DOI 10.1175/1520-0477(1990)071<0988:ROICCI>2.0.CO;2; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Zhou YP, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015197	31	162	163	5	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					327	+		10.1038/nature12310	http://dx.doi.org/10.1038/nature12310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23883935				2022-12-28	WOS:000323112400031
J	Zhang, JW; Ferre-D'Amare, AR				Zhang, Jinwei; Ferre-D'Amare, Adrian R.			Co-crystal structure of a T-box riboswitch stem I domain in complex with its cognate tRNA	NATURE			English	Article							AMINOACYL-TRANSFER-RNA; RIBOSOMAL-RNA; BACILLUS-SUBTILIS; RIBONUCLEASE-P; ANTITERMINATION; MOTIF; RECOGNITION; SYNTHETASE; TRNA(GLY); FEATURES	In Gram-positive bacteria, T-box riboswitches regulate the expression of aminoacyl-tRNA synthetases and other proteins in response to fluctuating transfer RNA aminoacylation levels under various nutritional states(1). T-boxes reside in the 5'-untranslated regions of the messenger RNAs they regulate, and consist of two conserved domains. Stem I contains the specifier trinucleotide that base pairs with the anticodon of cognate tRNA. 3' to stem I is the antiterminator domain, which base pairs with the tRNA acceptor end and evaluates its aminoacylation state(2). Despite high phylogenetic conservation and widespread occurrence in pathogens, the structural basis of tRNA recognition(3,4) by this riboswitch remains ill defined. Here we demonstrate that the similar to 100-nucleotide T-box stem I is necessary and sufficient for specific, high-affinity (dissociation constant (K-d) similar to 150 nM) tRNA binding, and report the structure of Oceanobacillus iheyensis glyQ stem I in complex with its cognate tRNA at 3.2 angstrom resolution. Stem I recognizes the overall architecture of tRNA in addition to its anticodon, something accomplished by large ribonucleoproteins such as the ribosome, or proteins such as aminoacyl-tRNA synthetases(5), but is unprecedented for a compact mRNA domain. The C-shaped stem I cradles the L-shaped tRNA, forming an extended (1,604 angstrom(2)) intermolecular interface. In addition to the specifier-anticodon interaction, two interdigitated T-loops near the apex of stem I stack on the tRNA elbow in a manner analogous to those of the J11/12-J12/11 motif(6) of RNase P and the L1 stalk(7) of the ribosomal E-site. Because these ribonucleoproteins and T-boxes are unrelated, this strategy to recognize a universal tRNA feature probably evolved convergently. Mutually induced fit of stem I and the tRNA exploiting the intrinsic flexibility of tRNA and its conserved post-transcriptional modifications results in high shape complementarity, which in addition to providing specificity and affinity, globally organizes the T-box to orchestrate tRNA-dependent transcription regulation.	[Zhang, Jinwei; Ferre-D'Amare, Adrian R.] NHLBI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Ferre-D'Amare, AR (corresponding author), NHLBI, 50 South Dr,MSC 8012, Bethesda, MD 20892 USA.	adrian.ferre@nih.gov	Zhang, Jinwei/AAU-9195-2020	Zhang, Jinwei/0000-0002-2114-173X	National Institute for General Medical Sciences, National Institutes of Health (NIH); US Department of Energy; intramural program of the National Heart, Lung, and Blood Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006102] Funding Source: NIH RePORTER	National Institute for General Medical Sciences, National Institutes of Health (NIH); US Department of Energy(United States Department of Energy (DOE)); intramural program of the National Heart, Lung, and Blood Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the staff at beamlines 24-ID-C and 24-ID-E of APS and 5.0.1 and 5.0.2 of the ALS for crystallographic data collection support, G. Piszczek for ITC support, R. Levine and D.-Y. Lee for help with mass spectrometry, K. Perry and K. R. Rajashankar for assistance with initial crystallographic phasing, and N. Baird, T. Hamma, C. Jones, M. Lau, J. Posakony, A. Roll-Mecak, O. Uhlenbeck and K. Warner for discussions. This work is partly based on research conducted at the APS on the Northeastern Collaborative Access Team (NE-CAT) beamlines, and at the ALS on the Berkeley Center for Structural Biology beamlines, which are both supported by the National Institute for General Medical Sciences, National Institutes of Health (NIH). Use of ALS and APS was supported by the US Department of Energy. This work was supported in part by the intramural program of the National Heart, Lung, and Blood Institute, NIH.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baird NJ, 2013, RNA, V19, P167, DOI 10.1261/rna.036269.112; Baird NJ, 2012, RNA, V18, P759, DOI 10.1261/rna.031518.111; Baird NJ, 2010, RNA, V16, P598, DOI 10.1261/rna.1852310; Byrne RT, 2010, NUCLEIC ACIDS RES, V38, P4154, DOI 10.1093/nar/gkq133; Chan C. W., 2013, WILEY INTERDISC 0623; Chang AT, 2012, BIOCHEMISTRY-US, V51, P3662, DOI 10.1021/bi201900j; Correll CC, 1997, CELL, V91, P705, DOI 10.1016/S0092-8674(00)80457-2; Dalluge JJ, 1996, NUCLEIC ACIDS RES, V24, P1073, DOI 10.1093/nar/24.6.1073; DeLano W.L, PYMOL MOL GRAPHICS S; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Edwards TE, 2007, CURR OPIN STRUC BIOL, V17, P273, DOI 10.1016/j.sbi.2007.05.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Green NJ, 2010, FEBS LETT, V584, P318, DOI 10.1016/j.febslet.2009.11.056; Grigg JC, 2013, P NATL ACAD SCI USA, V110, P7240, DOI 10.1073/pnas.1222214110; GRUNDY FJ, 1993, CELL, V74, P475, DOI 10.1016/0092-8674(93)80049-K; Gutierrez-Preciado A, 2009, MICROBIOL MOL BIOL R, V73, P36, DOI 10.1128/MMBR.00026-08; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Krasilnikov AS, 2003, NATURE, V421, P760, DOI 10.1038/nature01386; Kulshina N, 2010, RNA, V16, P186, DOI 10.1261/rna.1847310; Lehmann J, 2013, NUCLEIC ACIDS RES, V41, P5494, DOI 10.1093/nar/gkt219; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Leontis NB, 1998, RNA, V4, P1134, DOI 10.1017/S1355838298980566; Lescoute A, 2005, NUCLEIC ACIDS RES, V33, P2395, DOI 10.1093/nar/gki535; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nikulin A, 2003, NAT STRUCT BIOL, V10, P104, DOI 10.1038/nsb886; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perona JJ, 2012, BIOCHEMISTRY-US, V51, P8705, DOI 10.1021/bi301180x; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Vitreschak AG, 2008, RNA, V14, P717, DOI 10.1261/rna.819308; Wang JC, 2011, J MOL BIOL, V408, P99, DOI 10.1016/j.jmb.2011.02.014; Winkler WC, 2001, RNA, V7, P1165, DOI 10.1017/S1355838201002370; Winkler WC, 2002, THESIS OHIO STATE U; Xiao H, 2008, CHEM BIOL, V15, P1125, DOI 10.1016/j.chembiol.2008.09.004; Xiao H, 2008, NATURE, V454, P358, DOI 10.1038/nature07033; Yousef MR, 2005, J MOL BIOL, V349, P273, DOI 10.1016/j.jmb.2005.03.061; Yousef MR, 2003, RNA, V9, P1148, DOI 10.1261/rna.5540203	52	101	104	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2013	500	7462					363	+		10.1038/nature12440	http://dx.doi.org/10.1038/nature12440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23892783	Green Accepted			2022-12-28	WOS:000323112400039
J	Zhang, ZR; Bonifacino, JS; Hegde, RS				Zhang, Zai-Rong; Bonifacino, Juan S.; Hegde, Ramanujan S.			Deubiquitinases Sharpen Substrate Discrimination during Membrane Protein Degradation from the ER	CELL			English	Article							VPU PROTEIN; IN-VITRO; TRANSMEMBRANE DOMAIN; CYTOPLASMIC DOMAIN; QUALITY-CONTROL; CD4; MECHANISM; COMPLEX; UBIQUITINATION; TAIL	Newly synthesized membrane proteins are queried by ubiquitin ligase complexes and triaged between degradative and nondegradative fates. The mechanisms that convert modest differences in substrateligase interactions into decisive outcomes of ubiquitination are not well understood. Here, we reconstitute membrane protein recognition and ubiquitination in liposomes using purified components from a viral-mediated degradation pathway. We find that substrate-ligase interactions in the membrane directly influence processivity of ubiquitin attachment to modulate polyubiquitination. Unexpectedly, differential processivity alone could not explain the differential fates in cultured cells of degraded and nondegraded clients. Both computational and experimental analyses identified continuous deubiquitination as a prerequisite for maximal substrate discrimination. Deubiquitinases reduce polyubiquitin dwell times preferentially on clients that dissociate more rapidly from the ligase. This explains how small differences in substrate-ligase interaction can be amplified into larger differences in net degradation. These results provide a conceptual framework for substrate discrimination during membrane protein quality control.	[Zhang, Zai-Rong; Bonifacino, Juan S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Hegde, Ramanujan S.] MRC Lab Mol Biol, Cambridge CB2 0QH, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); MRC Laboratory Molecular Biology	Zhang, ZR (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, Nanobiol Inst, Orange, CT 06477 USA.	zairong.zhang@gmail.com; rhegde@mrc-lmb.cam.ac.uk	Zhang, Zairong/G-1030-2013	Bonifacino, Juan S./0000-0002-5673-6370; ZHANG, ZAIRONG/0000-0001-9768-0548; Hegde, Ramanujan/0000-0001-8338-852X	NIH; Medical Research Council of the UK; MRC [MC_UP_A022_1007] Funding Source: UKRI; Medical Research Council [MC_UP_A022_1007] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607, ZIAHD008909] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank R. Deshaies, B. Schulman, X. Yang, H. Ploegh, and V. Denic for reagents, M. Mariappan, J. Magada n, M.M. Babu, S. Shao, and M. RodrigoBrenni for discussions, and A. Sharma for technical support. This research was supported by the Intramural Research Program of the NIH, Intramural AIDS Targeted Antiviral Program of the NIH, and the Medical Research Council of the UK. Z.-R.Z. designed most of the experiments, performed all of the experiments, analyzed data, and helped draft the paper; R.S.H. conceived and guided the project, designed some of the experiments, analyzed data, and wrote the paper with input from Z.-R.Z.; J.S.B. provided advice, support, and comments on the paper.	Blount JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036542; BOUR S, 1995, J VIROL, V69, P1510, DOI 10.1128/JVI.69.3.1510-1520.1995; CHEN MY, 1993, J VIROL, V67, P3877, DOI 10.1128/JVI.67.7.3877-3884.1993; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Furman MH, 2002, J BIOL CHEM, V277, P3258, DOI 10.1074/jbc.M109765200; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hassiepen U, 2007, ANAL BIOCHEM, V371, P201, DOI 10.1016/j.ab.2007.07.034; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Ishikura S, 2010, J BIOL CHEM, V285, P23916, DOI 10.1074/jbc.M110.127936; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; Li T, 2005, METHOD ENZYMOL, V398, P125, DOI 10.1016/S0076-6879(05)98012-9; Magadan JG, 2012, J VIROL, V86, P757, DOI 10.1128/JVI.05933-11; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Melikova MS, 2006, CELL BIOL INT, V30, P31, DOI 10.1016/j.cellbi.2005.09.003; Meusser B, 2004, MOL CELL, V14, P247, DOI 10.1016/S1097-2765(04)00212-6; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nomaguchi M, 2008, MICROBES INFECT, V10, P960, DOI 10.1016/j.micinf.2008.07.006; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; SCHUBERT U, 1994, J VIROL, V68, P2260, DOI 10.1128/JVI.68.4.2260-2271.1994; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Sharma A, 2010, METHODS MOL BIOL, V619, P339, DOI 10.1007/978-1-60327-412-8_20; Singh SK, 2012, FEBS J, V279, P3705, DOI 10.1111/j.1742-4658.2012.08732.x; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tian XF, 2011, ASSAY DRUG DEV TECHN, V9, P165, DOI 10.1089/adt.2010.0317; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025	50	51	51	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					609	622		10.1016/j.cell.2013.06.038	http://dx.doi.org/10.1016/j.cell.2013.06.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23890821	Green Published, hybrid			2022-12-28	WOS:000322629900014
J	Wang, Z; Chinoy, ZS; Ambre, SG; Peng, WJ; McBride, R; de Vries, RP; Glushka, J; Paulson, JC; Boons, GJ				Wang, Zhen; Chinoy, Zoeisha S.; Ambre, Shailesh G.; Peng, Wenjie; McBride, Ryan; de Vries, Robert P.; Glushka, John; Paulson, James C.; Boons, Geert-Jan			A General Strategy for the Chemoenzymatic Synthesis of Asymmetrically Branched N-Glycans	SCIENCE			English	Article							RECEPTOR SPECIFICITY; INFLUENZA-VIRUSES; GLYCOSYLATION; OLIGOSACCHARIDE; GLYCOMICS; BINDING; HEMAGGLUTININ; TRANSMISSION; MICROARRAYS; ACTIVATION	A systematic, efficient means of producing diverse libraries of asymmetrically branched N-glycans is needed to investigate the specificities and biology of glycan-binding proteins. To that end, we describe a core pentasaccharide that at potential branching positions is modified by orthogonal protecting groups to allow selective attachment of specific saccharide moieties by chemical glycosylation. The appendages were selected so that the antenna of the resulting deprotected compounds could be selectively extended by glycosyltransferases to give libraries of asymmetrical multi-antennary glycans. The power of the methodology was demonstrated by the preparation of a series of complex oligosaccharides that were printed as microarrays and screened for binding to lectins and influenza-virus hemagglutinins, which showed that recognition is modulated by presentation of minimal epitopes in the context of complex N-glycans.	[Wang, Zhen; Chinoy, Zoeisha S.; Ambre, Shailesh G.; Glushka, John; Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Chinoy, Zoeisha S.; Ambre, Shailesh G.; Boons, Geert-Jan] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Peng, Wenjie; McBride, Ryan; de Vries, Robert P.; Paulson, James C.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Peng, Wenjie; McBride, Ryan; de Vries, Robert P.; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Scripps Research Institute; Scripps Research Institute	Boons, GJ (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	gjboons@ccrc.uga.edu	Paulson, James/AAG-3565-2019; McBride, Ryan/E-6812-2011; Boons, Geert-Jan P H/J-3211-2016; Chinoy, Zoeisha S/K-3974-2015; de Vries, Robert/K-7212-2013	Boons, Geert-Jan P H/0000-0003-3111-5954; de Vries, Robert/0000-0002-1586-4464; Peng, Wenjie/0000-0001-5093-7115; Chinoy, Zoeisha/0000-0003-4654-5711	NIH from the National Center for Research Resources [P41RR005351]; National Institute of General Medical Sciences [P41GM103390, R01GM090269]; Institute of Allergy and Infectious Disease [AI058113]; Centers for Disease Control; Netherlands Organization for Scientific Research (NWO); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090269, P41GM103390] Funding Source: NIH RePORTER	NIH from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grant P41RR005351 from the National Center for Research Resources (G.J.-B. and J.G.), National Institute of General Medical Sciences grants P41GM103390 (G.J.B. and J.G.) and R01GM090269 (G.J.-B.), Institute of Allergy and Infectious Disease grant AI058113 (J.C.P.), and a contract from the Centers for Disease Control (J.C.P.). R.P.d.V. is a recipient of a Rubicon grant from the Netherlands Organization for Scientific Research (NWO). We thank A. Crie and M. Wolfert for assistance in preparation of the manuscript, K. Moremen (University of Georgia) for providing ST6Gal-1 and ST3Gal-IV, and P. Wu (Albert Einstein College of Medicine) and W. Wakarchuk (Ryerson University) for providing the plasmids for alpha 1,3FucT and beta 1,3GlcNAcT, respectively. G.J.-B. conceived the idea, Z.W. performed the chemical synthesis, S. G. A. assisted with chemical synthesis, Z.S.C. performed the enzymatic transformations, and W. P. and Z.W. assisted with the enzymatic transformation. Z.S.C. and J.G. performed the analysis of the complex glycans. W. P. performed the attachment of the reactive linker to the glycans, R. M. performed the microarray screening, R.P.d.V. prepared the influenza HA, and J.C.P. supervised and analyzed the microarray studies. G.J.-B. and J.C.P. wrote the paper. The data for this report are archived as supplementary materials on Science Online. A patent application related to the described chemoenzymatic approach has been filed by the University of Georgia Research Foundation and lists G.J.-B and Z.W. as inventors. The authors declare no competing financial interests.	Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Blixt O, 2006, METHOD ENZYMOL, V415, P137, DOI 10.1016/S0076-6879(06)15009-0; Bohorov O, 2006, GLYCOBIOLOGY, V16, p21C, DOI 10.1093/glycob/cwl044; Boltje TJ, 2009, NAT CHEM, V1, P611, DOI [10.1038/NCHEM.399, 10.1038/nchem.399]; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Gabius HJ, 2011, TRENDS BIOCHEM SCI, V36, P298, DOI 10.1016/j.tibs.2011.01.005; Hanashima S, 2005, ANGEW CHEM INT EDIT, V44, P4218, DOI 10.1002/anie.200500777; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Itakura Y, 2007, J BIOCHEM, V142, P459, DOI 10.1093/jb/mvm153; Jonke S, 2006, CHEM-EUR J, V12, P1274, DOI 10.1002/chem.200500707; Laurent N, 2008, CHEM COMMUN, P4400, DOI 10.1039/b806983m; Lepenies B, 2010, CURR OPIN CHEM BIOL, V14, P404, DOI 10.1016/j.cbpa.2010.02.016; Marino K, 2010, NAT CHEM BIOL, V6, P713, DOI [10.1038/nchembio.437, 10.1038/NCHEMBIO.437]; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; North SJ, 2009, CURR OPIN STRUC BIOL, V19, P498, DOI 10.1016/j.sbi.2009.05.005; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Palcic MM, 2011, CURR OPIN CHEM BIOL, V15, P226, DOI 10.1016/j.cbpa.2010.11.022; Pearce MB, 2012, P NATL ACAD SCI USA, V109, P3944, DOI 10.1073/pnas.1119945109; Ranzinger R, 2009, GLYCOBIOLOGY, V19, P1563, DOI 10.1093/glycob/cwp137; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Sauerzapfe B, 2009, GLYCOCONJUGATE J, V26, P141, DOI 10.1007/s10719-008-9172-2; Schmaltz RM, 2011, CHEM REV, V111, P4259, DOI 10.1021/cr200113w; SCHMIDT RR, 1994, ADV CARBOHYD CHEM BI, V50, P21, DOI 10.1016/S0065-2318(08)60150-X; Serna S, 2010, CHEM-EUR J, V16, P13163, DOI 10.1002/chem.201001295; SPIK G, 1985, FEBS LETT, V183, P65, DOI 10.1016/0014-5793(85)80955-8; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sun B, 2008, CHEM-EUR J, V14, P7072, DOI 10.1002/chem.200800757; Unverzagt C, 1996, ANGEW CHEM INT EDIT, V35, P2350, DOI 10.1002/anie.199623501; Unverzagt C, 2009, CHEM-EUR J, V15, P12292, DOI 10.1002/chem.200901908; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Walczak MA, 2012, J AM CHEM SOC, V134, P16430, DOI 10.1021/ja307628w; Walther T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003223; Wang W, 2009, P NATL ACAD SCI USA, V106, P16096, DOI 10.1073/pnas.0908248106; Yu B, 2001, TETRAHEDRON LETT, V42, P2405, DOI 10.1016/S0040-4039(01)00157-5; Zhu XM, 2009, ANGEW CHEM INT EDIT, V48, P1900, DOI 10.1002/anie.200802036	38	243	267	0	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					379	383		10.1126/science.1236231	http://dx.doi.org/10.1126/science.1236231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888036	Green Accepted			2022-12-28	WOS:000322259200045
J	Kaltenbrunner, M; Sekitani, T; Reeder, J; Yokota, T; Kuribara, K; Tokuhara, T; Drack, M; Schwodiauer, R; Graz, I; Bauer-Gogonea, S; Bauer, S; Someya, T				Kaltenbrunner, Martin; Sekitani, Tsuyoshi; Reeder, Jonathan; Yokota, Tomoyuki; Kuribara, Kazunori; Tokuhara, Takeyoshi; Drack, Michael; Schwoediauer, Reinhard; Graz, Ingrid; Bauer-Gogonea, Simona; Bauer, Siegfried; Someya, Takao			An ultra-lightweight design for imperceptible plastic electronics	NATURE			English	Article							FIELD-EFFECT TRANSISTORS; ORGANIC TRANSISTORS; THIN-FILM; N-CHANNEL; SILICON; PERFORMANCE; CIRCUITS; SEMICONDUCTORS; MECHANICS; PRESSURE	Electronic devices have advanced from their heavy, bulky origins to become smart, mobile appliances. Nevertheless, they remain rigid, which precludes their intimate integration into everyday life. Flexible, textile and stretchable electronics are emerging research areas and may yield mainstream technologies(1-3). Rollable and unbreakable backplanes with amorphous silicon field-effect transistors on steel substrates only 3 mu m thick have been demonstrated(4). On polymer substrates, bending radii of 0.1 mm have been achieved inflexible electronic devices(5-7). Concurrently, the need for compliant electronics that can not only be flexed but also conform to three-dimensional shapes has emerged(3). Approaches include the transfer of ultrathin polyimide layers encapsulating silicon CMOS circuits onto pre-stretched elastomers(8), the use of conductive elastomers integrated with organic field-effect transistors (OFETs) on polyimide islands(9), and fabrication of OFETs and gold interconnects on elastic substrates(10) to realize pressure, temperature and optical sensors(11-14). Here we present a platform that makes electronics both virtually unbreakable(4) and imperceptible. Fabricated directly on ultrathin (1 mu m) polymer foils, our electronic circuits are light (3 g m(-2)) and ultraflexible and conform to their ambient, dynamic environment. Organic transistors with an ultra-dense oxide gate dielectric a few nanometres thick formed at room temperature enable sophisticated large-area electronic foils with unprecedented mechanical and environmental stability: they withstand repeated bending to radii of 5 mu m and less, can be crumpled like paper, accommodate stretching up to 230% on prestrained elastomers, and can be operated at high temperatures and in aqueous environments. Because manufacturing costs of organic electronics are potentially low, imperceptible electronic foils may be as common in the future as plastic wrap is today. Applications include matrix-addressed tactile sensor foils for health care and monitoring, thin-film heaters, temperature and infrared sensors, displays(15), and organic solar cells(16).	[Kaltenbrunner, Martin; Sekitani, Tsuyoshi; Reeder, Jonathan; Yokota, Tomoyuki; Kuribara, Kazunori; Tokuhara, Takeyoshi; Someya, Takao] Univ Tokyo, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan; [Kaltenbrunner, Martin; Sekitani, Tsuyoshi; Someya, Takao] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Bunkyo Ku, Tokyo 1130032, Japan; [Kaltenbrunner, Martin; Drack, Michael; Schwoediauer, Reinhard; Graz, Ingrid; Bauer-Gogonea, Simona; Bauer, Siegfried] Johannes Kepler Univ Linz, A-4040 Linz, Austria	University of Tokyo; Japan Science & Technology Agency (JST); Johannes Kepler University Linz	Someya, T (corresponding author), Univ Tokyo, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	martin@ntech.t.u-tokyo.ac.jp; someya@ee.t.u-tokyo.ac.jp	Bauer, Siegfried/A-2354-2009; Graz, Ingrid/A-7994-2011; Reeder, Jonathan/T-5358-2018; Kuribara, Kazunori/M-2674-2018; Kaltenbrunner, Martin/G-8743-2012; Graz, Ingrid/AFP-2308-2022; Sekitani, Tsuyoshi/G-4599-2018; Someya, Takao/H-3052-2015	Bauer, Siegfried/0000-0002-7770-9435; Graz, Ingrid/0000-0001-7205-4161; Reeder, Jonathan/0000-0002-7624-7355; Kuribara, Kazunori/0000-0003-2746-1467; Kaltenbrunner, Martin/0000-0002-7247-9183; Graz, Ingrid/0000-0001-7205-4161; Someya, Takao/0000-0003-3051-1138; Bauer-Gogonea, Simona/0000-0002-6538-3992	JST Someya Bio-Harmonized ERATO; ERC; Wilhelm Macke Foundation; mobility programme of the Johannes Kepler University Linz (KIP)	JST Someya Bio-Harmonized ERATO; ERC(European Research Council (ERC)European Commission); Wilhelm Macke Foundation; mobility programme of the Johannes Kepler University Linz (KIP)	We thank I. Abfalter for discussions. This work was supported by the JST Someya Bio-Harmonized ERATO grant and the ERC Advanced Investigators Grant 'Soft-Map' of S. Bauer. M. K. acknowledges financial support from the Wilhelm Macke Foundation and the mobility programme of the Johannes Kepler University Linz (KIP).	Baeg KJ, 2011, J POLYM SCI POL PHYS, V49, P62, DOI 10.1002/polb.22148; BAUER S, 1990, J APPL PHYS, V68, P6361, DOI 10.1063/1.346882; Cherenack K, 2012, J APPL PHYS, V112, DOI 10.1063/1.4742728; de Almeida LAL, 2004, APPL PHYS LETT, V85, P3605, DOI 10.1063/1.1808890; Facchetti A, 2005, ADV MATER, V17, P1705, DOI 10.1002/adma.200500517; Garditz C, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2711708; Geib S, 2013, ADV FUNCT MATER, V23, P3866, DOI 10.1002/adfm.201203600; Gonzalez M., 2010, 11 INT C THERM MECH, P1; Graz IM, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3570661; Jung BJ, 2010, ADV FUNCT MATER, V20, P2930, DOI 10.1002/adfm.201000655; Kaltenbrunner M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1772; Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; Kim DH, 2008, SCIENCE, V320, P507, DOI 10.1126/science.1154367; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Klauk H, 2007, NATURE, V445, P745, DOI 10.1038/nature05533; Lipomi DJ, 2011, NAT NANOTECHNOL, V6, P788, DOI [10.1038/nnano.2011.184, 10.1038/NNANO.2011.184]; LOHRENGEL MM, 1993, MAT SCI ENG R, V11, P243, DOI 10.1016/0927-796X(93)90005-N; Ma EY, 1999, APPL PHYS LETT, V74, P2661, DOI 10.1063/1.123930; Mardare AI, 2012, PHYS STATUS SOLIDI A, V209, P813, DOI 10.1002/pssa.201100785; Oh DW, 2011, ADV MATER, V23, P5028, DOI 10.1002/adma.201102994; Oh JH, 2010, ADV FUNCT MATER, V20, P2148, DOI 10.1002/adfm.201000425; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Sekitani T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2115075; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Sekitani T, 2010, NAT MATER, V9, P1015, DOI 10.1038/NMAT2896; Shahrjerdi D, 2013, NANO LETT, V13, P315, DOI 10.1021/nl304310x; Sokolov AN, 2012, ACCOUNTS CHEM RES, V45, P361, DOI 10.1021/ar2001233; Someya T, 2005, P NATL ACAD SCI USA, V102, P12321, DOI 10.1073/pnas.0502392102; Suo Z, 1999, APPL PHYS LETT, V74, P1177, DOI 10.1063/1.123478; Tu KN, 2003, J APPL PHYS, V94, P5451, DOI 10.1063/1.1611263; Usta H, 2008, J AM CHEM SOC, V130, P8580, DOI 10.1021/ja802266u; Wagner S, 2012, MRS BULL, V37, P207, DOI 10.1557/mrs.2012.37; Wang B, 2013, INFRARED PHYS TECHN, V57, P8, DOI 10.1016/j.infrared.2012.10.006; White M. S., NATURE PHOT IN PRESS; Wong W. S., 2010, FLEXIBLE ELECT MAT A; Yamamoto T, 2007, J AM CHEM SOC, V129, P2224, DOI 10.1021/ja068429z; Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727; Zang J., 2013, NAT MATER, V12, P1; Zhang XH, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3077025; Zschieschang U, 2012, J MATER CHEM, V22, P4273, DOI 10.1039/c1jm14917b	40	1791	1835	114	2453	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					458	+		10.1038/nature12314	http://dx.doi.org/10.1038/nature12314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23887430				2022-12-28	WOS:000322157900036
J	Palmer, TM; Nordestgaard, BG; Benn, M; Tybjaerg-Hansen, A; Smith, GD; Lawlor, DA; Timpson, NJ				Palmer, Tom M.; Nordestgaard, Borge G.; Benn, Marianne; Tybjaerg-Hansen, Anne; Smith, George Davey; Lawlor, Debbie A.; Timpson, Nicholas J.			Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SERUM URATE; TRANSPORTER SLC2A9; GENERAL-POPULATION; ALL-CAUSE; RISK; MORTALITY	Objectives To assess the associations between both uric acid levels and hyperuricaemia, with ischaemic heart disease and blood pressure, and to explore the potentially confounding role of body mass index. Design Mendelian randomisation analysis, using variation at specific genes (SLC2A9 (rs7442295) as an instrument for uric acid; and FTO (rs9939609), MC4R (rs17782313), and TMEM18 (rs6548238) for body mass index). Setting Two large, prospective cohort studies in Denmark. Participants We measured levels of uric acid and related covariables in 58 072 participants from the Copenhagen General Population Study and 10 602 from the Copenhagen City Heart Study, comprising 4890 and 2282 cases of ischaemic heart disease, respectively. Main outcome Blood pressure and prospectively assessed ischaemic heart disease. Results Estimates confirmed known observational associations between plasma uric acid and hyperuricaemia with risk of ischaemic heart disease and diastolic and systolic blood pressure. However, when using genotypic instruments for uric acid and hyperuricaemia, we saw no evidence for causal associations between uric acid, ischaemic heart disease, and blood pressure. We used genetic instruments to investigate body mass index as a potentially confounding factor in observational associations, and saw a causal effect on uric acid levels. Every four unit increase of body mass index saw a rise in uric acid of 0.03 mmol/L (95% confidence interval 0.02 to 0.04), and an increase in risk of hyperuricaemia of 7.5% (3.9% to 11.1%). Conclusion By contrast with observational findings, there is no strong evidence for causal associations between uric acid and ischaemic heart disease or blood pressure. However, evidence supports a causal effect between body mass index and uric acid level and hyperuricaemia. This finding strongly suggests body mass index as a confounder in observational associations, and suggests a role for elevated body mass index or obesity in the development of uric acid related conditions.	[Palmer, Tom M.] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Warwick, England; [Smith, George Davey; Lawlor, Debbie A.; Timpson, Nicholas J.] Univ Bristol, Med Res Council Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Nordestgaard, Borge G.; Benn, Marianne; Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Nordestgaard, Borge G.; Benn, Marianne; Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Nordestgaard, Borge G.; Benn, Marianne; Tybjaerg-Hansen, Anne] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark	University of Warwick; University of Bristol; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Timpson, NJ (corresponding author), Univ Bristol, Med Res Council Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England.	n.j.timpson@bristol.ac.uk	Nordestgaard, Borge Gronne/ABF-1310-2020; Davey Smith, George/A-7407-2013; Timpson, Nicholas John/O-7548-2015; Fox, Laura J/C-6249-2016; Benn, Marianne/O-4164-2019; Attrill, Lauren/V-1688-2018	Davey Smith, George/0000-0002-1407-8314; Timpson, Nicholas John/0000-0002-7141-9189; Benn, Marianne/0000-0002-1701-595X; Palmer, Tom/0000-0003-4655-4511; s, hema/0000-0002-3440-9475; Nordestgaard, Borge/0000-0002-1954-7220; Lawlor, Debbie A/0000-0002-6793-2262	UK Medical Research Council [G0601625]; Danish Heart Foundation; Danish Medical Research Council; Copenhagen County Foundation; Herlev Hospital, Copenhagen University Hospital; MRC [MC_UU_12013/1, MC_UU_12013/3, MC_UU_12013/5, G0601625] Funding Source: UKRI; Medical Research Council [MC_UU_12013/1, MC_UU_12013/3, MC_UU_12013/5, G0601625] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Heart Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Copenhagen County Foundation; Herlev Hospital, Copenhagen University Hospital; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	NJT, DAL, and GDS work in the UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol. TMP also received support from a UK Medical Research Council grant (G0601625). The Copenhagen General Population Study and Copenhagen City Heart Study are supported by the Danish Heart Foundation, Danish Medical Research Council, Copenhagen County Foundation, and Herlev Hospital, Copenhagen University Hospital. All researchers operate independently of the funding bodies noted in this disclosure.	Alderman M, 2004, CURR MED RES OPIN, V20, P369, DOI 10.1185/030079904125002982; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ANGRIST JD, 1995, J AM STAT ASSOC, V90, P431, DOI 10.2307/2291054; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Brandstatter A, 2008, DIABETES CARE, V31, P1662, DOI 10.2337/dc08-0349; Burgess S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7325; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Deveci OS, 2010, INT J CLIN PRACT, V64, P900, DOI 10.1111/j.1742-1241.2009.02263.x; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Ishizaka N, 2010, J RHEUMATOL, V37, P410, DOI 10.3899/jrheum.090736; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Liese AD, 1999, EPIDEMIOLOGY, V10, P391, DOI 10.1097/00001648-199907000-00009; Lyngdoh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039321; McKeigue PM, 2010, INT J EPIDEMIOL, V39, P907, DOI 10.1093/ije/dyp397; Meisinger C, 2008, ARTERIOSCL THROM VAS, V28, P1186, DOI 10.1161/ATVBAHA.107.160184; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212; Parsa A, 2012, KIDNEY INT, V81, P502, DOI 10.1038/ki.2011.414; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Sethi AA, 2001, HYPERTENSION, V37, P875, DOI 10.1161/01.HYP.37.3.875; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stark K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007729; Strasak A, 2008, CLIN CHEM, V54, P273, DOI 10.1373/clinchem.2007.094425; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Thomas DC, 2007, ANN EPIDEMIOL, V17, P511, DOI 10.1016/j.annepidem.2006.12.005; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; Timpson NJ, 2009, HYPERTENSION, V54, P84, DOI 10.1161/HYPERTENSIONAHA.109.130005; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Williams G. C, 1996, EVOLUTION HEALING NE; Wright AF, 2010, KIDNEY INT, V78, P446, DOI 10.1038/ki.2010.206; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI 10.1161/CIRCGENETICS.109.934455; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	45	177	178	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 18	2013	347								f4262	10.1136/bmj.f4262	http://dx.doi.org/10.1136/bmj.f4262			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	189DI	23869090	Green Published, hybrid			2022-12-28	WOS:000322246900010
J	Subramanian, R; Ti, SC; Tan, L; Darst, SA; Kapoor, TM				Subramanian, Radhika; Ti, Shih-Chieh; Tan, Lei; Darst, Seth A.; Kapoor, Tarun M.			Marking and Measuring Single Microtubules by PRC1 and Kinesin-4	CELL			English	Article							SPINDLE MIDZONE FORMATION; MONOPOLAR CYTOKINESIS; CROSS-LINKING; CELL-CYCLE; PROTEIN; BINDING; KIF4; LENGTH; POLARIZATION; INSIGHTS	Error-free cell division depends on the assembly of the spindle midzone, a specialized array of overlapping microtubules that emerges between segregating chromosomes during anaphase. The molecular mechanisms by which a subset of dynamic microtubules from the metaphase spindle are selected and organized into a stable midzone array are poorly understood. Here, we show using in vitro reconstitution assays that PRC1 and kinesin-4, two microtubule-associated proteins required for midzone assembly, can tag microtubule plus ends. Remarkably, the size of these tags is proportional to filament length. We determine the crystal structure of the PRC1 homodimer and map the protein-protein interactions needed for tagging microtubule ends. Importantly, length-dependent microtubule plus-end-tagging by PRC1 is also observed in dividing cells. Our findings suggest how biochemically similar microtubules can be differentially marked, based on length, for selective regulation during the formation of specialized arrays, such as those required for cytokinesis.	[Subramanian, Radhika; Ti, Shih-Chieh; Tan, Lei; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA; [Darst, Seth A.] Rockefeller Univ, Lab Mol Biophys, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10065 USA.	kapoor@rockefeller.edu		Ti, Shih-Chieh/0000-0002-0517-0899	NIH [GM065933]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022321, S10RR023748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065933] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Sarah Wacker (while at the Rockefeller University) for assistance with purification of full-length kinesin-4 and Deena Oren (Rockefeller University Structural Biology Resource Center [SBRC]) for technical support. T.M.K. is a Scholar of the Leukemia and Lymphoma Society and is grateful to the NIH (GM065933) for support. We also acknowledge the SBRC (NIH 1S10RR022321-01) and the Keck Facility (Yale University) (NIH 1S10RR023748-01) for instrument use.	Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Duellberg C, 2013, TRENDS CELL BIOL, V23, P54, DOI 10.1016/j.tcb.2012.10.003; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Golji J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000389; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Hill RB, 2000, ACCOUNTS CHEM RES, V33, P745, DOI 10.1021/ar970004h; Ho CMK, 2011, PLANT CELL, V23, P2909, DOI 10.1105/tpc.110.078204; Hu CK, 2008, J CELL BIOL, V181, P195, DOI 10.1083/jcb.200711105; Hu CK, 2011, CURR BIOL, V21, P815, DOI 10.1016/j.cub.2011.04.019; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; SEKINE Y, 1994, J CELL BIOL, V127, P187, DOI 10.1083/jcb.127.1.187; Shannon KB, 2005, MOL BIOL CELL, V16, P4423, DOI 10.1091/mbc.E04-11-0974; Shrestha S, 2012, MOL BIOL CELL, V23, P1196, DOI 10.1091/mbc.E11-12-1008; Subramanian R, 2012, DEV CELL, V23, P874, DOI 10.1016/j.devcel.2012.10.011; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	23	98	99	1	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					377	390		10.1016/j.cell.2013.06.021	http://dx.doi.org/10.1016/j.cell.2013.06.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870126	Bronze, Green Accepted			2022-12-28	WOS:000321950700014
J	Sutter, BM; Wu, X; Laxman, S; Tu, BP				Sutter, Benjamin M.; Wu, Xi; Laxman, Sunil; Tu, Benjamin P.			Methionine Inhibits Autophagy and Promotes Growth by Inducing the SAM-Responsive Methylation of PP2A	CELL			English	Article							PHOSPHOPROTEIN PHOSPHATASE 2A; TRANSFER-RNA SYNTHETASE; SULFUR AMINO-ACIDS; SACCHAROMYCES-CEREVISIAE; BOVINE BRAIN; CARBOXYL METHYLATION; CATALYTIC SUBUNIT; PROTEIN PHOSPHATASE-2A; REGULATE AUTOPHAGY; YEAST PROTEOME	Autophagy is a process of cellular self-digestion induced by various forms of starvation. Although nitrogen deficit is a common trigger, some yeast cells induce autophagy upon switch from a rich to minimal media without nitrogen starvation. We show that the amino acid methionine is sufficient to inhibit such non-nitrogen-starvation (NNS)-induced autophagy. Methionine boosts synthesis of the methyl donor, S-adenosylmethionine (SAM). SAM inhibits autophagy and promotes growth through the action of the methyltransferase Ppm1p, which modifies the catalytic subunit of PP2A in tune with SAM levels. Methylated PP2A promotes dephosphorylation of Npr2p, a component of a conserved complex that regulates NNS autophagy and other growth-related processes. Thus, methionine and SAM levels represent a critical gauge of amino acid availability that is sensed via the methylation of PP2A to reciprocally regulate cell growth and autophagy.	[Sutter, Benjamin M.; Wu, Xi; Laxman, Sunil; Tu, Benjamin P.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Tu, BP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	benjamin.tu@utsouthwestern.edu	Laxman, Sunil/F-9886-2018	Laxman, Sunil/0000-0002-0861-5080	Chilton Foundation; Med into Grad Initiative; HHMI; NIGMS [R01GM094314]; UTSW Endowed Scholars Program; Welch Foundation [I-1797]; Burroughs Wellcome Fund; David and Lucile Packard Foundation; Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094314] Funding Source: NIH RePORTER	Chilton Foundation; Med into Grad Initiative; HHMI(Howard Hughes Medical Institute); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UTSW Endowed Scholars Program; Welch Foundation(The Welch Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Tu lab for helpful discussions. X.W. was supported by a fellowship from the Chilton Foundation and a Med into Grad Initiative sponsored by HHMI. This research was supported by award R01GM094314 from NIGMS, the UTSW Endowed Scholars Program, the Welch Foundation (I-1797), the Burroughs Wellcome Fund, the David and Lucile Packard Foundation, and the Damon Runyon Cancer Research Foundation. B.P.T. is a consultant and shareholder of Peloton Therapeutics.	Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Dokudovskaya S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006478; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hickman MJ, 2011, MOL BIOL CELL, V22, P4192, DOI 10.1091/mbc.E11-05-0467; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Ji L, 2002, CANCER RES, V62, P2715; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kaiser P, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-16; Kalhor HR, 2001, ARCH BIOCHEM BIOPHYS, V395, P239, DOI 10.1006/abbi.2001.2558; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; KODAKI T, 1987, J BIOL CHEM, V262, P15428; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laxman S, 2013, CELL, V154, P416, DOI 10.1016/j.cell.2013.06.043; LEE J, 1993, J BIOL CHEM, V268, P19192; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Ma XQ, 2011, CHEM BIOL, V18, P1474, DOI 10.1016/j.chembiol.2011.08.009; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Neklesa TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000515; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; Patton EE, 2000, EMBO J, V19, P1613, DOI 10.1093/emboj/19.7.1613; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Singhal T, 2008, MOL IMAGING BIOL, V10, P1, DOI 10.1007/s11307-007-0115-2; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; UNGER MW, 1976, P NATL ACAD SCI USA, V73, P1664, DOI 10.1073/pnas.73.5.1664; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Wu X, 2011, MOL BIOL CELL, V22, P4124, DOI 10.1091/mbc.E11-06-0525; XIE HY, 1994, BIOCHEM BIOPH RES CO, V203, P1710, DOI 10.1006/bbrc.1994.2383; XIE HY, 1993, J BIOL CHEM, V268, P13364; XIE HY, 1994, J BIOL CHEM, V269, P1981	45	145	148	1	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 18	2013	154	2					403	415		10.1016/j.cell.2013.06.041	http://dx.doi.org/10.1016/j.cell.2013.06.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870128	Bronze, Green Accepted			2022-12-28	WOS:000321950700016
J	Jarvis, JN; Coltart, CEM; Pule, M; Chiodini, PL; Doherty, T				Jarvis, Joseph N.; Coltart, Cordelia E. M.; Pule, Martin; Chiodini, Peter L.; Doherty, Tom			Artemisinin therapy and severe delayed haemolysis	LANCET			English	Editorial Material							INTRAVENOUS ARTESUNATE; SEVERE MALARIA		[Jarvis, Joseph N.; Coltart, Cordelia E. M.; Chiodini, Peter L.; Doherty, Tom] Hosp Trop Dis, London WC1E 6JB, England; [Jarvis, Joseph N.; Chiodini, Peter L.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Pule, Martin] Univ Coll London Hosp, Dept Clin Haematol, London, England	University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; University College London	Jarvis, JN (corresponding author), Hosp Trop Dis, Mortimer Market,Capper St, London WC1E 6JB, England.	joejarvis@doctors.net.uk		Chiodini, Peter/0000-0003-0317-7090; Jarvis, Joseph/0000-0003-1459-5554; Pule, Martin/0000-0002-8347-9867	National Institute for Health Research [CL-2012-20-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Caramello P, 2012, J ANTIMICROB CHEMOTH, V67, P2053, DOI 10.1093/jac/dks139; Kreeftmeijer-Vegter AR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-102; Rolling T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-169; Zoller T, 2011, EMERG INFECT DIS, V17, P771, DOI 10.3201/eid1705.101229	4	18	18	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 13	2013	382	9887					180	180		10.1016/S0140-6736(13)60812-0	http://dx.doi.org/10.1016/S0140-6736(13)60812-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187JY	23849926				2022-12-28	WOS:000322115300033
J	Tucker, ME				Tucker, Miriam E.			How should clinical trial data be shared?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												miriametucker@aol.com						Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; European Medicines Agency, 2013, EUROPEAN MEDICINES A; GlaxoSmithKline, 2013, GSK GIVES UPDATE ON; Institute of Medicine of the National Academies, 2012, SHARING CLINICAL RES; Lehman Richard, 2012, BMJ-BRIT MED J, V344, P8158; National Cancer Institute, PEDATRIC ONCOLOGY BR; Rodgers MA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3981; Tucker ME, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3769; US Food and Drug Administration, 2012, FDA TRANSPARENCY INI; Yale School of Medicine, 2013, YODA PROJECT; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	11	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 12	2013	347								f4465	10.1136/bmj.f4465	http://dx.doi.org/10.1136/bmj.f4465			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184MT	23851723				2022-12-28	WOS:000321895300005
J	Payne, D				Payne, David			Can they hack it? Yes they can	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dpayne@bmj.com						Bower C, 2013, BMJ WEB DEVELOPMENT; Hilton J, FSO FOCUSSING STUDEN; Krause T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4891; Weir A, HBPM DIAGNOSIS APP	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2013	347								f4437	10.1136/bmj.f4437	http://dx.doi.org/10.1136/bmj.f4437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184LT	23838619	Bronze			2022-12-28	WOS:000321892000009
J	Ozkan, E; Carrillo, RA; Eastman, CL; Weiszmann, R; Waghray, D; Johnson, KG; Zinn, K; Celniker, SE; Garcia, KC				Oezkan, Engin; Carrillo, Robert A.; Eastman, Catharine L.; Weiszmann, Richard; Waghray, Deepa; Johnson, Karl G.; Zinn, Kai; Celniker, Susan E.; Garcia, K. Christopher			An Extracellular Interactome of Immunoglobulin and LRR Proteins Reveals Receptor-Ligand Networks	CELL			English	Article							RICH REPEAT PROTEINS; DROSOPHILA-MELANOGASTER; SECRETED PROTEIN; AXON GUIDANCE; GENE; SUPERFAMILY; IDENTIFICATION; RESOURCE; PATHWAY; SLIT	Extracellular domains of cell surface receptors and ligands mediate cell-cell communication, adhesion, and initiation of signaling events, but most existing protein-protein "interactome'' data sets lack information for extracellular interactions. We probed interactions between receptor extracellular domains, focusing on a set of 202 proteins composed of the Drosophila melanogaster immunoglobulin superfamily (IgSF), fibronectin type III (FnIII), and leucinerich repeat (LRR) families, which are known to be important in neuronal and developmental functions. Out of 20,503 candidate protein pairs tested, we observed 106 interactions, 83 of which were previously unknown. We "deorphanized'' the 20 member subfamily of defective-in-proboscis-response IgSF proteins, showing that they selectively interact with an 11 member subfamily of previously uncharacterized IgSF proteins. Both subfamilies interact with a single common "orphan'' LRR protein. We also observed interactions between Hedgehog and EGFR pathway components. Several of these interactions could be visualized in live-dissected embryos, demonstrating that this approach can identify physiologically relevant receptor-ligand pairs.	[Oezkan, Engin; Eastman, Catharine L.; Waghray, Deepa; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Oezkan, Engin; Eastman, Catharine L.; Waghray, Deepa; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Carrillo, Robert A.; Zinn, Kai] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Weiszmann, Richard; Celniker, Susan E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Dept Genome Dynam, Berkeley, CA 94720 USA; [Johnson, Karl G.] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Johnson, Karl G.] Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; California Institute of Technology; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Claremont Colleges; Pomona College; Claremont Colleges; Pomona College	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Carrillo, Robert/0000-0002-2067-9861; Johnson, Karl/0000-0003-3931-5985; Ozkan, Engin/0000-0002-0263-6729	NSF [0841551]; NIH RO1 [NS62821, NS28182]; NHGRI [P41HG3487]; Department of Energy [DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG003487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028182, R01NS028182, R01NS062821] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Natalia Goriatcheva for technical help; Kevin J. Mitchell and Karsten Hokamp for sharing their list of Drosophila melanogaster LRR proteins; Claudia Y. Janda for technical discussions on interaction assays; Stephen R. Quake, Liqun Luo, Xiaomeng M. Yu, Weizhe Hong, and Marena Tynan La Fontaine for discussions; Nick V. Grishin for discussions on bioinformatics; and Demet Arac, and Michael E. Birnbaum for critical reading of the manuscript. Work at Pomona, Caltech, and LBNL was supported by NSF grant 0841551 to K.G.J., by NIH RO1 grants NS62821 and NS28182 to K.Z., and by NHGRI grant P41HG3487 to S.E.C. through the Department of Energy under contract DE-AC02-05CH11231, respectively. K.C.G. is an Investigator of the Howard Hughes Medical Institute.	Aberle H, 2009, FLY, V3, P270, DOI 10.4161/fly.9790; Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Amin A, 1999, DEVELOPMENT, V126, P2623; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Crozatier M, 2002, DEVELOPMENT, V129, P4261; da Cunha JPC, 2009, P NATL ACAD SCI USA, V106, P16752, DOI 10.1073/pnas.0907939106; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; Diehn M, 2006, PLOS GENET, V2, P39, DOI 10.1371/journal.pgen.0020011; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Donaldson T, 2004, GENETICS, V167, P687, DOI 10.1534/genetics.103.019588; Fambrough D, 1996, CELL, V87, P1049, DOI 10.1016/S0092-8674(00)81799-7; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Holler N, 2000, J IMMUNOL METHODS, V237, P159, DOI 10.1016/S0022-1759(99)00239-2; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee Hyung-Kook Peter, 2009, J Vis Exp, DOI 10.3791/1647; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Murali T, 2011, NUCLEIC ACIDS RES, V39, pD736, DOI 10.1093/nar/gkq1092; Nakamura M, 2002, J NEUROSCI, V22, P3463; Palsson-McDermott EM, 2007, BIOCHEM SOC T, V35, P1437, DOI 10.1042/BST0351437; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Pipes GCT, 2001, DEVELOPMENT, V128, P4545; Ramani SR, 2012, ANAL BIOCHEM, V420, P127, DOI 10.1016/j.ab.2011.09.017; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Siebert M, 2009, GENE DEV, V23, P1052, DOI 10.1101/gad.520509; Sink H, 2001, CELL, V105, P57, DOI 10.1016/S0092-8674(01)00296-3; Sollner C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r99; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Stapleton M., 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0080, DOI 10.1186/GB-2002-3-12-RESEARCH0080]; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Vogel C, 2003, DEVELOPMENT, V130, P6317, DOI 10.1242/dev.00848; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Voulgaraki D, 2005, IMMUNOLOGY, V115, P337, DOI 10.1111/j.1365-2567.2005.02161.x; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Wright GJ, 2010, BIOCHEM SOC T, V38, P919, DOI 10.1042/BST0380919; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461; Zinn K, 2009, GENE DEV, V23, P1042, DOI 10.1101/gad.1803009	54	134	135	2	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					228	239		10.1016/j.cell.2013.06.006	http://dx.doi.org/10.1016/j.cell.2013.06.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827685	Green Accepted, Bronze			2022-12-28	WOS:000321327900022
J	Diamant, M; Morsink, LM				Diamant, Michaela; Morsink, Linde M.			SGLT2 inhibitors for diabetes: turning symptoms into therapy	LANCET			English	Editorial Material							GLUCOSE; HYPERGLYCEMIA; MELLITUS; KIDNEY		[Diamant, Michaela; Morsink, Linde M.] Vrije Univ Amsterdam Med Ctr, Ctr Diabet, NL-1018 HZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Diamant, M (corresponding author), Vrije Univ Amsterdam Med Ctr, Ctr Diabet, NL-1018 HZ Amsterdam, Netherlands.	m.diamant@vumc.nl		Morsink, Linde M./0000-0001-5408-5298				Barnett D.M., 2005, JOSLINS DIABETES MEL, P1; Bergman H, 1938, AM J PHYSIOL, V124, P279, DOI 10.1152/ajplegacy.1938.124.2.279; Burki TK, 2012, LANCET, V379, P507, DOI 10.1016/S0140-6736(12)60216-5; Cefalu WT, 2013, LANCET; European Medicines Agency, 2012, FORG; FARBER SJ, 1951, J CLIN INVEST, V30, P125, DOI 10.1172/JCI102424; Gerich JE, 2010, DIABETIC MED, V27, P136, DOI 10.1111/j.1464-5491.2009.02894.x; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Meyer C, 1998, J CLIN INVEST, V102, P619, DOI 10.1172/JCI2415; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Santer R, 2003, J AM SOC NEPHROL, V14, P2873, DOI 10.1097/01.ASN.0000092790.89332.D2; U.S. Food and Drug Administration, 2013, FDA APPR INV TREAT T; US Food and Drug Administration, 2013, CAN ADJ TREATM DIET	13	11	18	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 14	2013	382	9896					917	918		10.1016/S0140-6736(13)60902-2	http://dx.doi.org/10.1016/S0140-6736(13)60902-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VD	23850056				2022-12-28	WOS:000324238000005
J	Brucker, RM; Bordenstein, SR				Brucker, Robert M.; Bordenstein, Seth R.			The Hologenomic Basis of Speciation: Gut Bacteria Cause Hybrid Lethality in the Genus Nasonia	SCIENCE			English	Article							INCOMPATIBILITIES	Although the gut microbiome influences numerous aspects of organismal fitness, its role in animal evolution and the origin of new species is largely unknown. Here we present evidence that beneficial bacterial communities in the guts of closely related species of the genus Nasonia form species-specific phylosymbiotic assemblages that cause lethality in interspecific hybrids. Bacterial constituents and abundance are irregular in hybrids relative to parental controls, and antibiotic curing of the gut bacteria significantly rescues hybrid survival. Moreover, feeding bacteria to germ-free hybrids reinstates lethality and recapitulates the expression of innate immune genes observed in conventionally reared hybrids. We conclude that in this animal complex, the gut microbiome and host genome represent a coadapted "hologenome" that breaks down during hybridization, promoting hybrid lethality and assisting speciation.	[Brucker, Robert M.; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Bordenstein, Seth R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Brucker, RM (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA.	bruckerm@gmail.com; s.bordenstein@vanderbilt.edu			NSF [DEB 1046149]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Sequences are available at the Dryad Digital Repository, doi:10.5061/dryad.3c190. We thank S. Bordenstein and A. Williams for technical assistance during the development of the in vitro cultivation method; L. Funkhouser, D. Sutherland, and C. Wogsland for their assistance in genotyping Nasonia hybrids; R. Pauly for bioinformatic assistance; and B. Jovanovic, L. Funkhouser, K. Jernigan, and N. Renner for providing feedback on an earlier version of the manuscript. We apologize in advance to colleagues whose papers we could not cite due to space restrictions. This research was made possible by NSF award DEB 1046149 to S.R.B.	Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; BREEUWER JAJ, 1995, EVOLUTION, V49, P705, DOI 10.1111/j.1558-5646.1995.tb02307.x; Brucker RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051269; Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011; Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x; Koevoets T, 2012, HEREDITY, V108, P302, DOI 10.1038/hdy.2011.75; Koevoets T, 2012, J EVOLUTION BIOL, V25, P304, DOI 10.1111/j.1420-9101.2011.02424.x; Mayr E., 1963, ANIMAL SPECIES EVOLU; Niehuis O, 2008, GENETICS, V178, P413, DOI 10.1534/genetics.107.080523; Orr HA, 1996, GENETICS, V144, P1331; Werren J. H., 2009, COLD SPRING HARBOR P, V2009, DOI [10.1101/pdb.emo134, DOI 10.1101/PDB.EM0134]; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	13	254	260	11	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					667	669		10.1126/science.1240659	http://dx.doi.org/10.1126/science.1240659			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23868918				2022-12-28	WOS:000322884800042
J	Hou, PP; Li, YQ; Zhang, X; Liu, C; Guan, JY; Li, HG; Zhao, T; Ye, JQ; Yang, WF; Liu, K; Ge, J; Xu, J; Zhang, Q; Zhao, Y; Deng, HK				Hou, Pingping; Li, Yanqin; Zhang, Xu; Liu, Chun; Guan, Jingyang; Li, Honggang; Zhao, Ting; Ye, Junqing; Yang, Weifeng; Liu, Kang; Ge, Jian; Xu, Jun; Zhang, Qiang; Zhao, Yang; Deng, Hongkui			Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds	SCIENCE			English	Article							S-ADENOSYLHOMOCYSTEINE HYDROLASE; REGENERATIVE MEDICINE; STATE	Pluripotent stem cells can be induced from somatic cells, providing an unlimited cell resource, with potential for studying disease and use in regenerative medicine. However, genetic manipulation and technically challenging strategies such as nuclear transfer used in reprogramming limit their clinical applications. Here, we show that pluripotent stem cells can be generated from mouse somatic cells at a frequency up to 0.2% using a combination of seven small-molecule compounds. The chemically induced pluripotent stem cells resemble embryonic stem cells in terms of their gene expression profiles, epigenetic status, and potential for differentiation and germline transmission. By using small molecules, exogenous "master genes" are dispensable for cell fate reprogramming. This chemical reprogramming strategy has potential use in generating functional desirable cell types for clinical applications.	[Hou, Pingping; Li, Yanqin; Zhang, Xu; Liu, Chun; Guan, Jingyang; Li, Honggang; Zhao, Ting; Ye, Junqing; Liu, Kang; Ge, Jian; Xu, Jun; Zhang, Qiang; Zhao, Yang; Deng, Hongkui] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Hou, Pingping; Li, Yanqin; Zhang, Xu; Liu, Chun; Guan, Jingyang; Li, Honggang; Zhao, Ting; Ye, Junqing; Liu, Kang; Ge, Jian; Xu, Jun; Zhang, Qiang; Zhao, Yang; Deng, Hongkui] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Zhang, Xu; Liu, Chun; Ye, Junqing; Ge, Jian; Zhang, Qiang; Deng, Hongkui] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Shenzhen 518055, Peoples R China; [Yang, Weifeng] Beijing Vitalstar Biotechnol Co Ltd, Beijing 100012, Peoples R China	Peking University; Peking University; Peking University; University Town of Shenzhen	Zhao, Y (corresponding author), Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China.	yangzhao@pku.edu.cn; hongkui_deng@pku.edu.cn	Zhang, Xu/G-7395-2011; LIU, CHUN/N-6909-2014; kang, liu/ABB-8964-2020	Zhang, Xu/0000-0002-9817-4492; Guan, Jingyang/0000-0002-1638-3339; Ge, Jian/0000-0001-5745-6605; Liu, Chun/0000-0002-8242-3896	National 973 Basic Research Program of China [2012CB966401, 2010CB945204]; Key New Drug Creation and Manufacturing Program [2011ZX09102-010-03]; National Natural Science Foundation of China [90919031]; Ministry of Science and Technology [2011AA020107, 2011DFA30730, 2013DFG30680]; Beijing Science and Technology Plan [Z121100005212001]; Ministry of Education of China (111 project); Peking-Tsinghua Center for Life Sciences	National 973 Basic Research Program of China(National Basic Research Program of China); Key New Drug Creation and Manufacturing Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Beijing Science and Technology Plan; Ministry of Education of China (111 project); Peking-Tsinghua Center for Life Sciences	We thank X. Zhang, J. Wang, C. Han, Z. Hou, J. Liu, and L. Ai for technical assistance. This work was supported by grants from the National 973 Basic Research Program of China (2012CB966401 and 2010CB945204), the Key New Drug Creation and Manufacturing Program (2011ZX09102-010-03), the National Natural Science Foundation of China (90919031), the Ministry of Science and Technology (2011AA020107, 2011DFA30730 and 2013DFG30680), the Beijing Science and Technology Plan (Z121100005212001), the Ministry of Education of China (111 project), and a Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences. Microarray and RNA-seq data are deposited in the Gene Expression Omnibus (GEO) database (accession no. GSE48243). The authors have filed a patent for the small-molecule combinations used in the chemical reprogramming reported in this paper.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chiang PK, 1998, PHARMACOL THERAPEUT, V77, P115, DOI 10.1016/S0163-7258(97)00089-2; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gordon RK, 2003, EUR J BIOCHEM, V270, P3507, DOI 10.1046/j.1432-1033.2003.03726.x; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li W, 2012, P NATL ACAD SCI USA, V109, P20853, DOI 10.1073/pnas.1219181110; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Neff AW, 2011, DEV DYNAM, V240, P979, DOI 10.1002/dvdy.22554; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhu SY, 2011, ANNU REV BIOMED ENG, V13, P73, DOI 10.1146/annurev-bioeng-071910-124715	26	895	1026	33	675	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					651	654		10.1126/science.1239278	http://dx.doi.org/10.1126/science.1239278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23868920				2022-12-28	WOS:000322884800037
J	Brodsky, EE; Lajoie, LJ				Brodsky, Emily E.; Lajoie, Lia J.			Anthropogenic Seismicity Rates and Operational Parameters at the Salton Sea Geothermal Field	SCIENCE			English	Article							EARTHQUAKE; CALIFORNIA; SYSTEMS	Geothermal power is a growing energy source; however, efforts to increase production are tempered by concern over induced earthquakes. Although increased seismicity commonly accompanies geothermal production, induced earthquake rate cannot currently be forecast on the basis of fluid injection volumes or any other operational parameters. We show that at the Salton Sea Geothermal Field, the total volume of fluid extracted or injected tracks the long-term evolution of seismicity. After correcting for the aftershock rate, the net fluid volume (extracted-injected) provides the best correlation with seismicity in recent years. We model the background earthquake rate with a linear combination of injection and net production rates that allows us to track the secular development of the field as the number of earthquakes per fluid volume injected decreases over time.	[Brodsky, Emily E.; Lajoie, Lia J.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95060 USA	University of California System; University of California Santa Cruz	Brodsky, EE (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95060 USA.	brodsky@es.ucsc.edu	Brodsky, Emily/B-9139-2014	Brodsky, Emily/0000-0002-6855-6860	Southern California Earthquake Center (SCEC); NSF [EAR-0106924]; U.S. Geological Survey [02HQAG0008]	Southern California Earthquake Center (SCEC); NSF(National Science Foundation (NSF)); U.S. Geological Survey(United States Geological Survey)	This work was funded in part by the Southern California Earthquake Center (SCEC contribution 1752). SCEC is funded by NSF Cooperative Agreement EAR-0106924 and U.S. Geological Survey Cooperative Agreement 02HQAG0008. Geothermal operation data are archived and distributed by the California Department of Conservation (www.conservation.ca.gov/dog/geothermal/manual/Pages/production.aspx) and seismic data are from the Southern California Seismic Network (www.data.scec.org/eq-catalogs). Comments from T. Lay, A. Shuler, P. Fulton, and M. Clapham improved the manuscript, and P. Fulton's assistance with figures is greatly appreciated.	Bachmann CE, 2011, GEOPHYS J INT, V186, P793, DOI 10.1111/j.1365-246X.2011.05068.x; Brodsky EE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047253; California Department of Conservation, GEOSTEAM QUER GEOTH; Chen X., 2011, J GEOPHYS RES, V118, P1193; Chu RS, 2013, B SEISMOL SOC AM, V103, P1141, DOI 10.1785/0120120324; Evans KF, 2012, GEOTHERMICS, V41, P30, DOI 10.1016/j.geothermics.2011.08.002; Frohlich C, 2011, B SEISMOL SOC AM, V101, P327, DOI 10.1785/0120100131; Hainzl S, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003247; Hauksson E, 2012, B SEISMOL SOC AM, V102, P2239, DOI 10.1785/0120120010; Keranen KM, 2013, GEOLOGY, V41, P699, DOI 10.1130/G34045.1; KING GCP, 1994, B SEISMOL SOC AM, V84, P935; Lei XL, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005604; Llenos AL, 2009, EARTH PLANET SC LETT, V281, P59, DOI 10.1016/j.epsl.2009.02.011; Lohman RB, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004596; Majer EL, 2007, GEOTHERMICS, V36, P185, DOI 10.1016/j.geothermics.2007.03.003; McGarr A., 2002, INT HDB EARTHQUAKE E, P77; Mossop A, 1999, J GEOPHYS RES-SOL EA, V104, P29113, DOI 10.1029/1999JB900284; MUFFLER LJP, 1969, GEOL SOC AM BULL, V80, P157; NICHOLSON C, 1992, PURE APPL GEOPHYS, V139, P561, DOI 10.1007/BF00879951; Nicol A, 2011, ENRGY PROCED, V4, P3699, DOI 10.1016/j.egypro.2011.02.302; OGATA Y, 1992, J GEOPHYS RES-SOL EA, V97, P19845, DOI 10.1029/92JB00708; RALEIGH CB, 1976, SCIENCE, V191, P1230, DOI 10.1126/science.191.4233.1230; Shapiro Serge A., 2010, Leading Edge, V29, P304, DOI 10.1190/1.3353727; The California Energy Commission, GEOTH EN CAL; van der Elst NJ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006681; Woessner J, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007846; YOUNKER LW, 1982, J VOLCANOL GEOTH RES, V12, P221, DOI 10.1016/0377-0273(82)90028-2	27	99	101	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					543	546		10.1126/science.1239213	http://dx.doi.org/10.1126/science.1239213			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23845943				2022-12-28	WOS:000322586700052
J	Kiessling, LL; Kraft, MB				Kiessling, Laura L.; Kraft, Matthew B.			A Path to Complex Carbohydrates	SCIENCE			English	Editorial Material							GLYCOSYLTRANSFERASES		[Kiessling, Laura L.; Kraft, Matthew B.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Kiessling, Laura L.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kiessling, LL (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	kiessling@chem.wisc.edu		Kiessling, Laura/0000-0001-6829-1500	NIAID NIH HHS [R01 AI055258, R01 AI063596] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063596, R01AI055258] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chokhawala HA, 2008, ACS CHEM BIOL, V3, P567, DOI 10.1021/cb800127n; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; Hsu CH, 2011, ANGEW CHEM INT EDIT, V50, P11872, DOI 10.1002/anie.201100125; Kiessling LL, 2010, ANNU REV BIOCHEM, V79, P619, DOI 10.1146/annurev.biochem.77.070606.100917; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lepenies B, 2010, CURR OPIN CHEM BIOL, V14, P404, DOI 10.1016/j.cbpa.2010.02.016; National Research Council (US) Committee on Assessing the Importance and Impact of Glycomics and Glycosciences, 2012, TRANSF GLYC ROADM FU; PAULSON JC, 1977, J BIOL CHEM, V252, P2363; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; University of Georgia Complex Carbohydrates Research Center, REP GLYC EXPR CONSTR; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Walczak MA, 2013, J AM CHEM SOC, V135, P4700, DOI 10.1021/ja401385v; Wang Z, 2013, SCIENCE, V341, P379, DOI 10.1126/science.1236231; Werz DB, 2007, ACS CHEM BIOL, V2, P685, DOI 10.1021/cb700178s	15	6	6	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					357	358		10.1126/science.1241788	http://dx.doi.org/10.1126/science.1241788			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888030				2022-12-28	WOS:000322259200036
J	Brewer, C				Brewer, Colin			NOTHING'S SACRED How to learn scepticism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												brewerismo@gmail.com						Feynman RP, 1992, SURELY YOURE JOKING	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2013	347								f4626	10.1136/bmj.f4626	http://dx.doi.org/10.1136/bmj.f4626			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BM	23884972				2022-12-28	WOS:000322531800011
J	Xie, W; Ren, B				Xie, Wei; Ren, Bing			Enhancing Pluripotency and Lineage Specification	SCIENCE			English	Editorial Material							EMBRYONIC STEM-CELLS; HUMAN ES; GENOME; DIFFERENTIATION; DYNAMICS; GENES		[Xie, Wei; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Xie, Wei] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Peking Tsinghua Ctr Life Sci, Beijing 100084, Peoples R China	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Tsinghua University	Xie, W (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	xiewei121@gmail.com; biren@ucsd.edu	Xie, Wei/J-1380-2017	Xie, Wei/0000-0003-2126-3849	NHLBI NIH HHS [5U01HL107442] Funding Source: Medline; NIEHS NIH HHS [U01 ES017166, U01ES017166] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Hawkins RD, 2011, CELL RES, V21, P1393, DOI 10.1038/cr.2011.146; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	17	30	33	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143					245	247		10.1126/science.1236254	http://dx.doi.org/10.1126/science.1236254			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869010				2022-12-28	WOS:000321959300031
J	Boland, B				Boland, Billy			Rather than emulate Ofsted's culture of fear, the UK care regulator must engage clinicians to improve standards	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Hertfordshire Partnership NHS Fdn Trust, St Albans AL3 5TL, England		Boland, B (corresponding author), Hertfordshire Partnership NHS Fdn Trust, St Albans AL3 5TL, England.	billy.boland@hpft.nhs.uk						[Anonymous], 2012, BBC NEWS; Boland B, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2716; Care Quality Commission, 2012, ANN REP ACC; Francis R., 2013, REPORT MID STAFFORDS; General Medical Council, 2013, GOOD MED PRACTICE; NHS Information Centre, 2012, AB VULN AD ENGL 2010; O'Dowd A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4359; Office for Standards in Education Children's Services and Skills, 2012, OFST RES ACC 2011 20	8	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 18	2013	347								f4611	10.1136/bmj.f4611	http://dx.doi.org/10.1136/bmj.f4611			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	189DI	23869092				2022-12-28	WOS:000322246900002
J	Neumann, PJ				Neumann, Peter J.			Communicating and Promoting Comparative-Effectiveness Research Findings	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA USA	Tufts Medical Center	Neumann, PJ (corresponding author), Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA USA.							Griffin JP, 2012, HEALTH AFFAIR, V31, P2188, DOI 10.1377/hlthaff.2012.0958; Kesselheim AS, 2012, HEALTH AFFAIR, V31, P2200, DOI 10.1377/hlthaff.2012.0787; Neumann PJ, 2012, VALUE HEALTH, V15, P948, DOI 10.1016/j.jval.2012.05.002; Neumann PJ, 2011, PHARMACOECONOMICS, V29, P687, DOI 10.2165/11590510-000000000-00000; Perfetto EM, 2012, HEALTH AFFAIR, V31, P2213, DOI 10.1377/hlthaff.2012.0745	5	11	11	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	2013	369	3					209	211		10.1056/NEJMp1300312	http://dx.doi.org/10.1056/NEJMp1300312			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	185DQ	23863049				2022-12-28	WOS:000321945800005
J	Cipriani, A; Higgins, JPT; Geddes, JR; Salanti, G				Cipriani, Andrea; Higgins, Julian P. T.; Geddes, John R.; Salanti, Georgia			Conceptual and Technical Challenges in Network Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Article							MULTIPLE-TREATMENTS; INCONSISTENCY; CONSISTENCY; GUIDELINES; TRIALS; BIAS	The increase in treatment options creates an urgent need for comparative effectiveness research. Randomized, controlled trials comparing several treatments are usually not feasible, so other methodological approaches are needed. Meta-analyses provide summary estimates of treatment effects by combining data from many studies. However, an important drawback is that standard meta-analyses can compare only 2 interventions at a time. A new meta-analytic technique, called network meta-analysis (or multiple treatments meta-analysis or mixed-treatment comparison), allows assessment of the relative effectiveness of several interventions, synthesizing evidence across a network of randomized trials. Despite the growing prevalence and influence of network meta-analysis in many fields of medicine, several issues need to be addressed when constructing one to avoid conclusions that are inaccurate, invalid, or not clearly justified. This article explores the scope and limitations of network meta-analysis and offers advice on dealing with heterogeneity, inconsistency, and potential sources of bias in the available evidence to increase awareness among physicians about some of the challenges in interpretation.	Univ Verona, I-37134 Verona, Italy; Univ Oxford, Oxford, England; Univ Bristol, Bristol, Avon, England; Univ York, York YO10 5DD, N Yorkshire, England; Univ Ioannina, Sch Med, GR-45110 Ioannina, Greece	University of Verona; University of Oxford; University of Bristol; University of York - UK; University of Ioannina	Cipriani, A (corresponding author), Univ Verona, Dept Publ Hlth & Community Med, Policlin GB Rossi, Piazzale LA Scuro 10, I-37134 Verona, Italy.	andrea.cipriani@psych.ox.ac.uk	Bannuru, Raveendhara/G-2601-2011; Higgins, Julian PT/H-4008-2011; Geddes, John/B-8240-2011; Cipriani, Andrea/P-6944-2015	Bannuru, Raveendhara/0000-0002-8069-5783; Higgins, Julian PT/0000-0002-8323-2514; Geddes, John/0000-0002-5281-5960; Cipriani, Andrea/0000-0001-5179-8321; Salanti, Georgia/0000-0002-3830-8508	European Research Council [260559 IMMA]; MRC [MC_U105285807] Funding Source: UKRI; Medical Research Council [MC_U105285807] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10150] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Grant Support: By the European Research Council (grant 260559 IMMA; Dr. Salanti).	Baker Stuart G, 2002, BMC Med Res Methodol, V2, P13, DOI 10.1186/1471-2288-2-13; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Chaimani A, 2012, RES SYNTH METHODS, V3, P161, DOI 10.1002/jrsm.57; Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Cooper NJ, 2009, STAT MED, V28, P1861, DOI 10.1002/sim.3594; Deeks JJ, 2002, STAT MED, V21, P1575, DOI 10.1002/sim.1188; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2010, J R STAT SOC A STAT, V173, P613, DOI 10.1111/j.1467-985X.2010.00639.x; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2010, J CLIN EPIDEMIOL, V63, P587, DOI 10.1016/j.jclinepi.2010.01.005; Donegan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011054; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Friedrich JO, 2011, J CLIN EPIDEMIOL, V64, P556, DOI 10.1016/j.jclinepi.2010.09.016; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Hawkins N, 2009, VALUE HEALTH, V12, P996, DOI 10.1111/j.1524-4733.2009.00541.x; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Horton J, 2010, J CLIN EPIDEMIOL, V63, P289, DOI 10.1016/j.jclinepi.2009.04.007; Ioannidis JPA, 2006, LANCET, V368, P1470, DOI 10.1016/S0140-6736(06)69615-3; Jansen JP, 2012, J CLIN EPIDEMIOL, V65, P798, DOI 10.1016/j.jclinepi.2012.01.002; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Li TJ, 2012, ANN INTERN MED, V156, P367, DOI 10.7326/0003-4819-156-5-201203060-00009; Li TJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-79; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Lunn DJ, 2002, J PHARMACOKINET PHAR, V29, P271, DOI 10.1023/A:1020206907668; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Mills EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016237; Mitka M, 2010, JAMA-J AM MED ASSOC, V304, P2230, DOI 10.1001/jama.2010.1663; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Salanti G, 2010, STAT MED, V29, P2369, DOI 10.1002/sim.4001; Salanti G, 2009, J CLIN EPIDEMIOL, V62, P857, DOI 10.1016/j.jclinepi.2008.10.001; Song F, 2008, J CLIN EPIDEMIOL, V61, P455, DOI 10.1016/j.jclinepi.2007.06.006; Song FJ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-138; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Van der Wees P, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-3; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; Wells GA, 2009, INDIRECT EVIDENCE IN; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045	47	576	585	0	53	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2					130	W54		10.7326/0003-4819-159-2-201307160-00008	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23856683				2022-12-28	WOS:000322112000019
J	Hirabayashi, T; Takeuchi, D; Tamura, K; Miyashita, Y				Hirabayashi, Toshiyuki; Takeuchi, Daigo; Tamura, Keita; Miyashita, Yasushi			Microcircuits for Hierarchical Elaboration of Object Coding Across Primate Temporal Areas	SCIENCE			English	Article							FUNCTIONAL CONNECTIVITY; VISUAL-CORTEX; MEMORY; MONKEY; INFORMATION; SIGNAL; RETRIEVAL; DYNAMICS; CORTICES; NEURONS	In primates, neuronal representations of objects are processed hierarchically in occipitotemporal cortices. A "novel" feature of objects is thought to emerge and become prevalent at a cortical area because of processing in this area. We tested the possibility that a feature representation prevalent in a given area emerges in the microcircuit of a hierarchically prior area as a small number of prototypes and then becomes prevalent in the subsequent area. We recorded multiple single units in each of hierarchically sequential areas TE and 36 of macaque temporal cortex and found the predicted convergent microcircuit for object-object association in area TE. Associative codes were then built up over time in the microcircuit of area 36. These results suggest a computational principle underlying sequentially elaborated object representations.	[Hirabayashi, Toshiyuki; Takeuchi, Daigo; Tamura, Keita; Miyashita, Yasushi] Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan; [Miyashita, Yasushi] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama 3320012, Japan; [Miyashita, Yasushi] Natl Inst Nat Sci, Dept Brain Sci, Ctr Novel Sci Initiat, Minato Ku, Tokyo 1050001, Japan	University of Tokyo; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; Novel Science Initiatives (CNSI)	Miyashita, Y (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	Miyashita, Yasushi/B-7171-2019; Tamura, Keita/I-2931-2012	Miyashita, Yasushi/0000-0003-3496-8637; Tamura, Keita/0000-0003-2697-1510	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)/JSPS KAKENHI [19002010, 24220008]; CREST, Japan Science and Technology Agency; Takeda Science Foundation; MEXT [18700378]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank G. Rangarajan for kindly providing the script to conduct the nonparametric Granger causality analysis, H. Kasahara and T. Watanabe for experimental assistance, and M. Takeda and K. W. Koyano for helpful discussions. This work was supported in part by Ministry of Education, Culture, Sports, Science, and Technology (MEXT)/JSPS KAKENHI grant nos. 19002010 and 24220008 to Y.M.; by CREST, Japan Science and Technology Agency to Y.M.; by a grant from Takeda Science Foundation to Y.M.; and a Grant-in-Aid for Young Scientists (B) from MEXT to T. H. (18700378).	Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hirabayashi T, 2005, J NEUROSCI, V25, P10299, DOI 10.1523/JNEUROSCI.3036-05.2005; Hirabayashi T, 2013, NEURON, V77, P192, DOI 10.1016/j.neuron.2012.10.031; Hirabayashi T, 2010, J NEUROSCI, V30, P10407, DOI 10.1523/JNEUROSCI.0135-10.2010; Kourtzi Z, 2011, ANNU REV NEUROSCI, V34, P45, DOI 10.1146/annurev-neuro-060909-153218; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Menz MD, 2004, J NEUROPHYSIOL, V91, P1794, DOI 10.1152/jn.00574.2003; Menz MD, 2003, NAT NEUROSCI, V6, P59, DOI 10.1038/nn986; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Naya Y, 2003, J NEUROSCI, V23, P2861; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; Priebe NJ, 2012, NEURON, V75, P194, DOI 10.1016/j.neuron.2012.06.011; Reid RC, 1996, CURR OPIN NEUROBIOL, V6, P475, DOI 10.1016/S0959-4388(96)80052-3; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Saleem KS, 1996, J NEUROSCI, V16, P4757; Sherman SM, 2011, J NEUROPHYSIOL, V106, P1068, DOI 10.1152/jn.00429.2011; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Takeuchi D, 2011, SCIENCE, V331, P1443, DOI 10.1126/science.1199967; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Tsui JMG, 2010, J NEUROPHYSIOL, V103, P3123, DOI 10.1152/jn.00654.2009	28	30	31	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2013	341	6142					191	195		10.1126/science.1236927	http://dx.doi.org/10.1126/science.1236927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23846902				2022-12-28	WOS:000321965300047
J	Lo-Coco, F; Avvisati, G; Vignetti, M; Thiede, C; Orlando, SM; Iacobelli, S; Ferrara, F; Fazi, P; Cicconi, L; Di Bona, E; Specchia, G; Sica, S; Divona, M; Levis, A; Fiedler, W; Cerqui, E; Breccia, M; Fioritoni, G; Salih, HR; Cazzola, M; Melillo, L; Carella, AM; Brandts, CH; Morra, E; von Lilienfeld-Toal, M; Hertenstein, B; Wattad, M; Lubbert, M; Hanel, M; Schmitz, N; Link, H; Kropp, MG; Rambaldi, A; La Nasa, G; Luppi, M; Ciceri, F; Finizio, O; Venditti, A; Fabbiano, F; Dohner, K; Sauer, M; Ganser, A; Amadori, S; Mandelli, F; Dohner, H; Ehninger, G; Schlenk, RF; Platzbecker, U				Lo-Coco, F.; Avvisati, G.; Vignetti, M.; Thiede, C.; Orlando, S. M.; Iacobelli, S.; Ferrara, F.; Fazi, P.; Cicconi, L.; Di Bona, E.; Specchia, G.; Sica, S.; Divona, M.; Levis, A.; Fiedler, W.; Cerqui, E.; Breccia, M.; Fioritoni, G.; Salih, H. R.; Cazzola, M.; Melillo, L.; Carella, A. M.; Brandts, C. H.; Morra, E.; von Lilienfeld-Toal, M.; Hertenstein, B.; Wattad, M.; Luebbert, M.; Haenel, M.; Schmitz, N.; Link, H.; Kropp, M. G.; Rambaldi, A.; La Nasa, G.; Luppi, M.; Ciceri, F.; Finizio, O.; Venditti, A.; Fabbiano, F.; Doehner, K.; Sauer, M.; Ganser, A.; Amadori, S.; Mandelli, F.; Doehner, H.; Ehninger, G.; Schlenk, R. F.; Platzbecker, U.		Grp Italiano Malattie Ematologiche; German-Austrian Acute Myeloid; Study Alliance Leukemia	Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYMERASE-CHAIN-REACTION; MINIMAL-RESIDUAL-DISEASE; FUSION GENE TRANSCRIPTS; FRONT-LINE THERAPY; CONSOLIDATION THERAPY; CHEMOTHERAPY; ANTHRACYCLINE; RELAPSE; TRIAL; RISK	BACKGROUND All-trans retinoic acid (ATRA) with chemotherapy is the standard of care for acute promyelocytic leukemia (APL), resulting in cure rates exceeding 80%. Pilot studies of treatment with arsenic trioxide with or without ATRA have shown high efficacy and reduced hematologic toxicity. METHODS We conducted a phase 3, multicenter trial comparing ATRA plus chemotherapy with ATRA plus arsenic trioxide in patients with APL classified as low-to-intermediate risk (white-cell count, <= 10x10(9) per liter). Patients were randomly assigned to receive either ATRA plus arsenic trioxide for induction and consolidation therapy or standard ATRA-idarubicin induction therapy followed by three cycles of consolidation therapy with ATRA plus chemotherapy and maintenance therapy with low-dose chemotherapy and ATRA. The study was designed as a noninferiority trial to show that the difference between the rates of event-free survival at 2 years in the two groups was not greater than 5%. RESULTS Complete remission was achieved in all 77 patients in the ATRA-arsenic trioxide group who could be evaluated (100%) and in 75 of 79 patients in the ATRA-chemotherapy group (95%) (P = 0.12). The median follow-up was 34.4 months. Two-year event-free survival rates were 97% in the ATRA-arsenic trioxide group and 86% in the ATRA-chemotherapy group (95% confidence interval for the difference, 2 to 22 percentage points; P<0.001 for noninferiority and P = 0.02 for superiority of ATRA-arsenic trioxide). Overall survival was also better with ATRA-arsenic trioxide (P = 0.02). As compared with ATRA-chemotherapy, ATRA-arsenic trioxide was associated with less hematologic toxicity and fewer infections but with more hepatic toxicity. CONCLUSIONS ATRA plus arsenic trioxide is at least not inferior and may be superior to ATRA plus chemotherapy in the treatment of patients with low-to-intermediate-risk APL.	[Lo-Coco, F.; Cicconi, L.; Venditti, A.; Amadori, S.] Univ Roma Tor Vergata, Dipartimento Biomed Prevenzione, Rome, Italy; [Iacobelli, S.] Univ Roma Tor Vergata, Ctr Biostat Bioinformat, Rome, Italy; [Lo-Coco, F.] Santa Lucia Fdn, Rome, Italy; [Avvisati, G.] Univ Campus Biomed, Dipartimento Ematol, Rome, Italy; [Vignetti, M.; Fazi, P.; Mandelli, F.] GIMEMA Data Ctr, Orlando, FL USA; [Mandelli, F.] Hlth Outcomes Res Unit, Rome, Italy; [Cazzola, M.] Dipartimento Ematol & Trapianto Cellule Staminali, Naples, Italy; [Di Bona, E.] Osped S Bortolo, Unita Operat Ematol, Dipartimento Terapie Cellulari Ematol, Vicenza, Italy; [Specchia, G.] Univ Bari, Dipartimento Ematol, Bari, Italy; [Sica, S.] Univ Cattolica Sacro Cuore, Ist Ematol, Rome, Italy; [Divona, M.] Policlinico Univ Tor Vergata, Rome, Italy; [Cerqui, E.] Spedali Civil Brescia, Dipartimento Ematol, I-25125 Brescia, Italy; [Breccia, M.] Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari Ematol, Rome, Italy; [Fioritoni, G.] Osped Civile, Dipartimento Ematol, Pescara, Italy; [Cazzola, M.] Univ Pavia, Dipartimento Ematol Oncol, IRCCS, I-27100 Pavia, Italy; [Melillo, L.] Osped Casa Sollievo Sofferenza, Div Ematol Trapianto Cellule Staminali, San Giovanni Rotondo, Italy; [Carella, A. M.] AOU San Martino IST, IRCCS, UOC Ematologia 1, Genoa, Italy; [Morra, E.] Ospedale Niguarda Ca Granda, Dipartimento Ematol, Milan, Italy; [Kropp, M. G.] Azienda Ospedaliera Pugliese Ciaccio, Catanzaro, Italy; [Rambaldi, A.] USC Ematol Azienda Ospedaliera Papa Giovanni XXII, Bergamo, Italy; [La Nasa, G.] Univ Cagliari, Osped R Binaghi, Ctr Trapianti Midollo Osseo, Dipartimento Sci Med, Cagliari, Italy; [Luppi, M.] Univ Modena & Reggio Emilia, Dept Med & Surg Sci, Modena, Italy; [Ciceri, F.] Ist Sci San Raffaele, Dipartimento Ematol Trapianto Midollo, Milan, Italy; [Finizio, O.] Osped Cardarelli, Div Ematol TERE, Naples, Italy; [Fabbiano, F.] Ospedali Riuniti Villa Sofia Cervello, Div Ematol Unita Trapianti Midollo Osseo, Palermo, Italy; [Sauer, M.; Ehninger, G.; Platzbecker, U.] Universitatsklin Carl Gustav Carus, Dresden, Germany; [Fiedler, W.] Univ Med Ctr Hamburg Eppendorf, Hubertus Wald Univ Canc Ctr, Dept Hematol & Oncol, Hamburg, Germany; [Salih, H. R.] Univ Tubingen, Abteilug Hamatol Onkol Rheumatol Immunol & Pulmol, Tubingen, Germany; [Brandts, C. H.] Goethe Univ Frankfurt, Dept Med Hematol Oncol, D-60054 Frankfurt, Germany; [von Lilienfeld-Toal, M.] Univ Hosp Bonn, Dept Internal Med 3, Bonn, Germany; [Hertenstein, B.] Klinikum Bremen Mitte, Med Klin 1, Bremen, Germany; [Wattad, M.] Kliniken Essen Sud, Essen, Germany; [Luebbert, M.] Univ Hosp Freiburg, Dept Internal Med 1, Freiburg, Germany; [Haenel, M.] Klinikum Chemnitz, Chemnitz, Germany; [Schmitz, N.] Asklepios Klin St Georg Hamburg, Abt Hamatol Onkol & Stammzelltransplantat, Hamburg, Germany; [Link, H.] Kaiserslautern, Westpfalzklinikum, Dept Med 1, Kaiserslautern, Germany; [Doehner, K.; Doehner, H.; Schlenk, R. F.] Univ Ulm, D-89069 Ulm, Germany; [Ganser, A.] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany	University of Rome Tor Vergata; University of Rome Tor Vergata; IRCCS Santa Lucia; University Campus Bio-Medico - Rome Italy; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; Universita degli Studi di Bari Aldo Moro; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Hospital Spedali Civili Brescia; Sapienza University Rome; University of Pavia; IRCCS Casa Sollievo Della Sofferenza; University of Genoa; IRCCS AOU San Martino IST; Ospedale Niguarda Ca' Granda; ASST Papa Giovanni XXIII; University of Cagliari; Universita di Modena e Reggio Emilia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Antonio Cardarelli Hospital; Technische Universitat Dresden; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Goethe University Frankfurt; University of Bonn; Klinikum Bremen-Mitte; University of Freiburg; Chemnitz Clinic; Asklepios Klinik St. Georg; Ulm University; Hannover Medical School	Lo-Coco, F (corresponding author), Univ Roma Tor Vergata, Dipartimento Biomed Prevenzione, Rome, Italy.		Schlenk, Richard/AAG-3218-2019; Breccia, Massimo/G-6026-2018; Rambaldi, Alessandro/M-6172-2019; Venditti, Adriano/E-4139-2015; Thiede, Christian/AAS-7595-2020; Cazzola, Mario/AAQ-8854-2021; Luppi, Mario/J-3668-2016; Döhner, Hartmut/C-8933-2016; Haenel, Mathias Hänel/AAF-2220-2021; Vignetti, Marco/HHS-9990-2022; sica, simona/AAC-3679-2020; Link, Hartmut/AAP-8537-2020; Rambaldi, Alessandro/P-2603-2018; Specchia, Giorgina/K-3084-2016	Breccia, Massimo/0000-0003-1163-6162; Rambaldi, Alessandro/0000-0002-3739-7502; Venditti, Adriano/0000-0002-0245-0553; Thiede, Christian/0000-0003-1241-2048; Cazzola, Mario/0000-0001-6984-8817; Luppi, Mario/0000-0002-0373-1154; Döhner, Hartmut/0000-0003-2116-5536; Rambaldi, Alessandro/0000-0002-3739-7502; fazi, paola/0000-0002-4211-9240; Amadori, Sergio/0000-0002-2356-8681; sica, simona/0000-0003-2426-3465; La Nasa, Giorgio/0000-0002-8247-583X; Avvisati, Giuseppe/0000-0002-5027-5868; Melillo, Lorella/0000-0003-0455-2251; LO COCO, FRANCESCO/0000-0002-9499-8005; Brandts, Christian H./0000-0003-1732-2535; Specchia, Giorgina/0000-0002-2479-9529; Vignetti, Marco/0000-0003-1278-604X; Fiedler, Walter/0000-0003-0275-8803; Salih, Helmut/0000-0002-6719-1847	Associazione Italiana contro le Leucemie; Associazione Italiana per la Ricerca sul Cancro [IG 5916]; German Ministry of Education and Research [01KG0903]	Associazione Italiana contro le Leucemie; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Supported by grants from Associazione Italiana contro le Leucemie and Associazione Italiana per la Ricerca sul Cancro (IG 5916, to Dr. Lo-Coco) and the German Ministry of Education and Research (01KG0903, to Dr. Platzbecker).	Ades L, 2008, BLOOD, V111, P1078, DOI 10.1182/blood-2007-07-099978; Ades L, 2010, BLOOD, V115, P1690, DOI 10.1182/blood-2009-07-233387; Asou N, 2007, BLOOD, V110, P59, DOI 10.1182/blood-2006-08-043992; Avvisati G, 2011, BLOOD, V117, P4716, DOI 10.1182/blood-2010-08-302950; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Breccia M, 2012, EXPERT OPIN PHARMACO, V13, P1031, DOI 10.1517/14656566.2012.677436; Burnett AK, 2013, LEUKEMIA, V27, P843, DOI 10.1038/leu.2012.360; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Diverio D, 1998, BLOOD, V92, P784; Estey E, 2006, BLOOD, V107, P3469, DOI 10.1182/blood-2005-10-4006; Falini B, 1997, BLOOD, V90, P4046, DOI 10.1182/blood.V90.10.4046; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Ghavamzadeh A, 2011, J CLIN ONCOL, V29, P2753, DOI 10.1200/JCO.2010.32.2107; Grimwade D, 2000, BLOOD, V96, P1297; Grimwade D, 2010, CANCER TREAT RES, V145, P219, DOI 10.1007/978-0-387-69259-3_13; Grimwade D, 2009, J CLIN ONCOL, V27, P3650, DOI 10.1200/JCO.2008.20.1533; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; Iland HJ, 2012, BLOOD, V120, P1570, DOI 10.1182/blood-2012-02-410746; Lallemand-Breitenbach V, 1999, J EXP MED, V189, P1043, DOI 10.1084/jem.189.7.1043; Lengfelder E, 2009, LEUKEMIA, V23, P2248, DOI 10.1038/leu.2009.183; Lo-Coco F, 2010, BLOOD, V116, P3171, DOI 10.1182/blood-2010-03-276196; Mathews V, 2006, BLOOD, V107, P2627, DOI 10.1182/blood-2005-08-3532; Montesinos P, 2009, BLOOD, V113, P775, DOI 10.1182/blood-2008-07-168617; Powell BL, 2010, BLOOD, V116, P3751, DOI 10.1182/blood-2010-02-269621; Ravandi F, 2009, J CLIN ONCOL, V27, P504, DOI 10.1200/JCO.2008.18.6130; SAGIE A, 1992, AM J CARDIOL, V70, P797, DOI 10.1016/0002-9149(92)90562-D; Sanz MA, 2000, BLOOD, V96, P1247; Sanz MA, 2010, BLOOD, V115, P5137, DOI 10.1182/blood-2010-01-266007; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Shao WL, 1998, J NATL CANCER I, V90, P124, DOI 10.1093/jnci/90.2.124; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Soignet SL, 2001, J CLIN ONCOL, V19, P3852, DOI 10.1200/JCO.2001.19.18.3852; Tallman MS, 2002, BLOOD, V100, P4298, DOI 10.1182/blood-2002-02-0632; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Tsimberidou AM, 2006, LEUKEMIA LYMPHOMA, V47, P1062, DOI 10.1080/10428190500463932; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; ZHANG P, 1996, CHIN J HEMATOL, V17, P58; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	40	938	980	7	120	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					111	121		10.1056/NEJMoa1300874	http://dx.doi.org/10.1056/NEJMoa1300874			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180BH	23841729	Bronze, Green Submitted			2022-12-28	WOS:000321567300007
J	Carville, S; Harker, M; Henderson, R; Gray, H				Carville, Serena; Harker, Martin; Henderson, Robert; Gray, Huon		Guideline Dev Grp	Acute management of myocardial infarction with ST-segment elevation: summary of NICE guidance PRACTICE	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DECLINE		[Carville, Serena; Harker, Martin] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Henderson, Robert] Nottingham Univ Hosp NHS Trust, Trent Cardiac Ctr, Nottingham NG5 1PB, England; [Gray, Huon] Univ Hosp Southampton NHS Fdn Trust, Wessex Cardiac Unit, Southampton SO16 6YD, Hants, England	Royal College of Physicians; Nottingham University Hospital NHS Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust	Gray, H (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Wessex Cardiac Unit, Southampton SO16 6YD, Hants, England.	huon@cardiology.co.uk		Harker, Martin/0000-0001-6154-3517				Department of Health, 2008, TREATM HEART ATT NAT; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Myocardial Ischaemia National Audit Project [MINAP], 2010, NHS CAR PAT HEART AT; National Institute for Health and Care Excellence, 2010, CHEST PAIN REC ONS A; National Institute for Health and Care Excellence, 2013, AC MAN MYOC INF ST S, V167; National Institute for Health and Clinical Excellence, 2007, POSTM INF SEC PREV P, V48; Smolina K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8059; Townsend N, 2012, COR HEART DIS STAT 2; Wailoo A, 2010, HEART, V96, P668, DOI 10.1136/hrt.2009.167130	10	10	11	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2013	347								f4006	10.1136/bmj.f4006	http://dx.doi.org/10.1136/bmj.f4006			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184MC	23843545				2022-12-28	WOS:000321893000003
J	Iacobucci, G				Iacobucci, Gareth			GPs put the squeeze on access to hospital care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Department of Health, 2012, CREAT CHANG INN HLTH; Moberly T., 2012, GP              1119; National Institute for Health and Clinical Excellence, 2013, FERT ASS TREATM PEOP; O'Dowd, 2013, BMJ-BRIT MED J, V346, pf346; Royal College of Surgeons of England, 2013, RESH SURG SERV PRINC	5	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2013	347								f4432	10.1136/bmj.f4432	http://dx.doi.org/10.1136/bmj.f4432			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184MC	23843502				2022-12-28	WOS:000321893000019
J	Bateman, IJ; Harwood, AR; Mace, GM; Watson, RT; Abson, DJ; Andrews, B; Binner, A; Crowe, A; Day, BH; Dugdale, S; Fezzi, C; Foden, J; Hadley, D; Haines-Young, R; Hulme, M; Kontoleon, A; Lovett, AA; Munday, P; Pascual, U; Paterson, J; Perino, G; Sen, A; Siriwardena, G; van Soest, D; Termansen, M				Bateman, Ian J.; Harwood, Amii R.; Mace, Georgina M.; Watson, Robert T.; Abson, David J.; Andrews, Barnaby; Binner, Amy; Crowe, Andrew; Day, Brett H.; Dugdale, Steve; Fezzi, Carlo; Foden, Jo; Hadley, David; Haines-Young, Roy; Hulme, Mark; Kontoleon, Andreas; Lovett, Andrew A.; Munday, Paul; Pascual, Unai; Paterson, James; Perino, Grischa; Sen, Antara; Siriwardena, Gavin; van Soest, Daan; Termansen, Mette			Bringing Ecosystem Services into Economic Decision-Making: Land Use in the United Kingdom	SCIENCE			English	Article							TRADEOFFS; POLICY	Landscapes generate a wide range of valuable ecosystem services, yet land-use decisions often ignore the value of these services. Using the example of the United Kingdom, we show the significance of land-use change not only for agricultural production but also for emissions and sequestration of greenhouse gases, open-access recreational visits, urban green space, and wild-species diversity. We use spatially explicit models in conjunction with valuation methods to estimate comparable economic values for these services, taking account of climate change impacts. We show that, although decisions that focus solely on agriculture reduce overall ecosystem service values, highly significant value increases can be obtained from targeted planning by incorporating all potential services and their values and that this approach also conserves wild-species diversity.	[Bateman, Ian J.; Harwood, Amii R.; Andrews, Barnaby; Binner, Amy; Day, Brett H.; Dugdale, Steve; Fezzi, Carlo; Hadley, David; Lovett, Andrew A.; Munday, Paul; Perino, Grischa; Sen, Antara] Univ E Anglia, Sch Environm Sci, CSERGE, Norwich NR4 7TJ, Norfolk, England; [Mace, Georgina M.] UCL, Dept Genet Ecol & Environm, London WC1E 6BT, England; [Watson, Robert T.] Univ E Anglia, Dept Environm Sci, Tyndall Ctr, Norwich NR4 7TJ, Norfolk, England; [Watson, Robert T.] Monash Univ, Monash Sustainabil Inst, Melbourne, Vic 3004, Australia; [Abson, David J.] Univ Luneburg, FuturES Res Ctr, D-21335 Luneburg, Germany; [Abson, David J.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Crowe, Andrew] HM Govt, Food & Environm Res Agcy, Dept Environm Food & Rural Affairs, London SW1P 3JR, England; [Foden, Jo] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft NR33 0HT, Suffolk, England; [Hadley, David] Univ New England, UNE Business Sch, Armidale, NSW 2351, Australia; [Haines-Young, Roy] Univ Nottingham, Sch Geog, CEM, Nottingham NG7 2RD, England; [Hulme, Mark; Siriwardena, Gavin] British Trust Ornithol, Thetford IP24 2PU, Norfolk, England; [Kontoleon, Andreas; Pascual, Unai] Univ Cambridge, Dept Land Econ, Cambridge CB3 9EP, England; [Pascual, Unai] Basque Fdn Sci, Basque Ctr Climate Change, Bilbao 48011, Bizkaia, Spain; [Pascual, Unai] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Bizkaia, Spain; [Paterson, James] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland; [Perino, Grischa] Univ Hamburg, Sch Business Econ & Social Sci, D-20354 Hamburg, Germany; [van Soest, Daan] Vrije Univ Amsterdam, Dept Spatial Econ, NL-1081 HV Amsterdam, Netherlands; [van Soest, Daan] Vrije Univ Amsterdam, Inst Environm Studies IVM, NL-1081 HV Amsterdam, Netherlands; [van Soest, Daan] Tilburg Univ, Dept Econ, NL-5037 Tilburg, Netherlands; [Termansen, Mette] Aarhus Univ, Dept Environm Sci, DK-8000 Aarhus, Denmark	University of East Anglia; University of London; University College London; University of East Anglia; Monash University; Leuphana University Luneburg; University of Leeds; Food & Environment Research Agency; Centre for Environment Fisheries & Aquaculture Science; University of New England; University of Nottingham; British Trust for Ornithology; University of Cambridge; Basque Centre for Climate Change (BC3); Basque Foundation for Science; Basque Foundation for Science; University of Edinburgh; University of Hamburg; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Tilburg University; Aarhus University	Bateman, IJ (corresponding author), Univ E Anglia, Sch Environm Sci, CSERGE, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	i.bateman@uea.ac.uk	Lovett, Andrew A/C-9942-2011; Harwood, Amii R/H-8032-2013; Lovett, Andrew/Q-6723-2019; Pascual, Unai/O-7946-2019; Mace, Georgina M/I-3072-2016; van Soest, Daan P/C-5544-2013; Foden, Jo/Q-7452-2018; PASCUAL, UNAI/B-4766-2012; Crowe, Andrew/AAF-9669-2020; Hadley, David/C-5924-2008; Azkarate, Ainhoa/K-9087-2013; Hulme, Mark/AAT-2651-2020; Abson, David/AAE-9027-2019	Harwood, Amii R/0000-0002-2808-4109; Lovett, Andrew/0000-0003-0554-9273; Pascual, Unai/0000-0002-5696-236X; Mace, Georgina M/0000-0001-8965-5211; van Soest, Daan P/0000-0002-3100-1810; PASCUAL, UNAI/0000-0002-5696-236X; Crowe, Andrew/0000-0003-3521-7501; Hadley, David/0000-0001-8634-2586; Azkarate, Ainhoa/0000-0003-0471-3094; Hulme, Mark/0000-0002-7211-3464; Paterson, James/0000-0003-3264-8242; Bateman, Ian/0000-0002-2791-6137; Binner, Amy/0000-0003-3235-0585; Abson, David/0000-0003-3755-785X; Fezzi, Carlo/0000-0002-4860-9128; Day, Brett/0000-0001-7519-5672; Perino, Grischa/0000-0001-6519-1029; Termansen, Mette/0000-0003-4875-2810	UK-NEA; UK Defra; Social and Environmental Economic Research (SEER) project (ESRC) [RES-060-25-0063]; ESRC [ES/G035989/1] Funding Source: UKRI; Economic and Social Research Council [ES/G035989/1] Funding Source: researchfish	UK-NEA; UK Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Social and Environmental Economic Research (SEER) project (ESRC); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by The UK-NEA and its Follow-On program [which are together supported by the UK Defra; the devolved administrations of Scotland, Wales, and Northern Ireland; the Natural Environment Research Council (NERC) and the Economic and Social Research Council (ESRC)]; and the Social and Environmental Economic Research (SEER) project (ESRC Funder Ref: RES-060-25-0063). I.J.B. led the project with support from all authors; the analysis was designed by I.J.B., A. R. H., G. M. M., and R. W.; C. F., I.J.B., U. P., D. H., P. M., A. R. H., and A. S. undertook the farm land-use analysis; D.J.A., U. P., M. T., C. F., and I.J.B. undertook the GHG analysis; A. S., A. R. H., I.J.B., A. C., J.F., and P. M. undertook the recreation analysis; G. P., B. A., A. K., and I.J.B. undertook the urban green space analysis; M. H., G. S., S. D., and A. A. L. undertook the biodiversity analysis; R. H.-Y. and J.P. undertook the scenario-building exercise; A. R. H. undertook the synthesis and targeting analysis with I.J.B., G. M. M., A. B., B. H. D., and D. v. S.; I.J.B., A. R. H., and G. M. M. wrote the paper with contributions from all authors. We are grateful to P. Dasgupta and K.-G. Maler for research advice. We declare no conflict of interest. Data are included in the supplementary materials available on Science Online.	[Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2013, ENCY BIODIVERSITY; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Bateman I.J., 2003, APPL ENV EC GIS APPR, DOI [10.1017/CBO9780511493461, DOI 10.1017/CBO9780511493461]; Bateman IJ, 2011, ENVIRON RESOUR ECON, V48, P177, DOI 10.1007/s10640-010-9418-x; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Casweb, 2001, UK DAT SERV CENS SUP; Defra, 2013, CAP PAYM; Department for Environment Food and Rural Affairs, 2010, JUN AGR CENS; Department for Environment Food and Rural Affairs (Defra) (United Kingdom); Department of Agriculture and Rural Development (Northern Ireland); The Department for Rural Affairs and Heritage Welsh Assembly Government; Rural and Environment Research and Analysis Directorate The Scottish Government, 2011, AGR UK 2011; Department of Energy and Climate Change, 2009, GUID EST CARB VAL 20; Ferraro PJ, 2008, ECOL ECON, V65, P810, DOI 10.1016/j.ecolecon.2007.07.029; Fezzi C, 2008, AGR ECON-BLACKWELL, V39, P197, DOI 10.1111/j.1574-0862.2008.00323.x; Fezzi C, 2011, AM J AGR ECON, V93, P1168, DOI 10.1093/ajae/aar037; Fezzi C, 2010, AGR ECON-BLACKWELL, V41, P123, DOI 10.1111/j.1574-0862.2009.00430.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109; Jenkins GJ, 2009, UK CLIMATE PROJECTIO; Kinzig AP, 2011, SCIENCE, V334, P603, DOI 10.1126/science.1210297; Lal R, 2004, ENVIRON INT, V30, P981, DOI 10.1016/j.envint.2004.03.005; Lawton J.H., 2010, MAKING SPACE NATURE; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Mosier AR, 1998, CLIMATIC CHANGE, V40, P39, DOI 10.1023/A:1005338731269; Moxey A., 2012, AGR WATER QUALITY MO; Naidoo R, 2006, PLOS BIOL, V4, P2153, DOI 10.1371/journal.pbio.0040360; National Ecosystem Assessment (NEA), 2011, UK NAT EC ASS TECHN; Natural England, 2010, NECR050; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Ordnance Survey, 2010, LAND FORM PANORAMA D; Polasky S, 2011, ENVIRON RESOUR ECON, V48, P219, DOI 10.1007/s10640-010-9407-0; Risely K., 2011, 624 BTO; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith P, 2007, AGR ECOSYST ENVIRON, V118, P6, DOI 10.1016/j.agee.2006.06.006; U.K. Agriculture, 2013, EC TRENDS; Van Liedekerke M., 2005, ESDBV2 RASTER ARCH	40	656	705	72	1115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2013	341	6141					45	50		10.1126/science.1234379	http://dx.doi.org/10.1126/science.1234379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828934				2022-12-28	WOS:000321291700042
J	Garnett, T; Appleby, MC; Balmford, A; Bateman, IJ; Benton, TG; Bloomer, P; Burlingame, B; Dawkins, M; Dolan, L; Fraser, D; Herrero, M; Hoffmann, I; Smith, P; Thornton, PK; Toulmin, C; Vermeulen, SJ; Godfray, HCJ				Garnett, T.; Appleby, M. C.; Balmford, A.; Bateman, I. J.; Benton, T. G.; Bloomer, P.; Burlingame, B.; Dawkins, M.; Dolan, L.; Fraser, D.; Herrero, M.; Hoffmann, I.; Smith, P.; Thornton, P. K.; Toulmin, C.; Vermeulen, S. J.; Godfray, H. C. J.			Sustainable Intensification in Agriculture: Premises and Policies	SCIENCE			English	Editorial Material									[Garnett, T.; Dawkins, M.; Dolan, L.; Godfray, H. C. J.] Univ Oxford, Oxford OX1 3QY, England; [Appleby, M. C.] World Soc Protect Anim, London WC1 X8HB, England; [Balmford, A.] Univ Cambridge, Cambridge CB2 3EJ, England; [Bateman, I. J.] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Benton, T. G.] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England; [Bloomer, P.] Oxfam, Oxford OX4 2JY, England; [Burlingame, B.; Hoffmann, I.] Food & Agr Org United Nations, I-00153 Rome, Italy; [Fraser, D.] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada; [Herrero, M.] Commonwealth Sci & Ind Res Org, Brisbane, Qld, Australia; [Smith, P.] Univ Aberdeen, Aberdeen AB24 3UU, Scotland; [Thornton, P. K.; Vermeulen, S. J.] CGIAR, DK-1958 Frederiksberg, Denmark; [Toulmin, C.] Int Inst Environm & Dev, London WC1X 8NH, England	University of Oxford; University of Cambridge; University of East Anglia; University of Leeds; Food & Agriculture Organization of the United Nations (FAO); University of British Columbia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Aberdeen; CGIAR	Godfray, HCJ (corresponding author), Univ Oxford, S Parks Rd, Oxford OX1 3QY, England.	charles.godfray@zoo.ox.ac.uk	Smith, Pete/G-1041-2010; Thornton, Philip/AAB-8806-2020; Benton, Tim G/C-6493-2009; Burlingame, Barbara A/H-6754-2017; Herrero, Mario/A-6678-2015	Smith, Pete/0000-0002-3784-1124; Thornton, Philip/0000-0002-1854-0182; Benton, Tim G/0000-0002-7448-1973; Burlingame, Barbara A/0000-0002-9286-5751; Herrero, Mario/0000-0002-7741-5090; Dolan, Liam/0000-0003-1206-7096; Balmford, Andrew/0000-0002-0144-3589; Bateman, Ian/0000-0002-2791-6137	Biotechnology and Biological Sciences Research Council [BB/K001388/1] Funding Source: researchfish; Economic and Social Research Council [ES/G035989/1] Funding Source: researchfish; BBSRC [BB/K001388/1] Funding Source: UKRI; ESRC [ES/G035989/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], 2009, MILL DEV GOALS REP; Dawkins M. S., 2011, WHY ANIMALS MATTER; Diamond Collins E., 2012, WOLF SHEEPS CLOTHING; FAO (Food Agric. Organ. U. N.), 2011, SAV GROW POL GUID SU; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food and Agriculture Organization of the United Nations, 2008, INTR BAS CONC FOOD S; Fraser D., 2008, UNDERSTANDING ANIMAL; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; *GOV OFF SCI, 2011, FORESIGHT FUTURE FOO; IAASTD, 2009, AGR CROSSR SYNTH REP; Parry M, 2009, CLIMATE CHANGE: OBSERVED IMPACTS ON PLANET EARTH, pXIII, DOI 10.1016/B978-0-444-53301-2.00027-0; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Royal Society, 2009, REAP BEN SCI SUST IN; Sen A, 1981, POVERTY FAMINES; Stern Nicholas, 2007, EC CLIMATE CHANGE; Thompson P, 2010, ETHICS INTENSIFICATI; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108	17	940	969	40	783	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					33	34		10.1126/science.1234485	http://dx.doi.org/10.1126/science.1234485			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176GL	23828927	Green Submitted			2022-12-28	WOS:000321291700033
J	Jeskowiak, A; Goerge, T				Jeskowiak, Antonia; Goerge, Tobias			Cutaneous Necrosis Associated with Cold Agglutinins	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jeskowiak, Antonia; Goerge, Tobias] Univ Hosp Muenster, Munster, Germany	University of Munster	Jeskowiak, A (corresponding author), Univ Hosp Muenster, Munster, Germany.	tobias.goerge@ukmuenster.de							0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					E1	E1		10.1056/NEJMicm1212538	http://dx.doi.org/10.1056/NEJMicm1212538			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175WE	23822796				2022-12-28	WOS:000321263500001
J	Rosenbaum, S; Sommers, BD				Rosenbaum, Sara; Sommers, Benjamin D.			Using Medicaid to Buy Private Health Insurance - The Great New Experiment?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenbaum, Sara] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Hlth Policy, Washington, DC 20052 USA; [Sommers, Benjamin D.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	George Washington University; Harvard University; Harvard T.H. Chan School of Public Health	Rosenbaum, S (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Hlth Policy, Washington, DC 20052 USA.							[Anonymous], 2013, EACH STAT STANDS ACA; Elmendorf D. W., 2012, ESTIMATES INSURANCE; Pear Robert, 2013, NY TIMES, pA14; Sommers BD, 2013, NEW ENGL J MED, V368, P496, DOI 10.1056/NEJMp1215785; Sommers BD, 2011, HEALTH AFFAIR, V30, P228, DOI 10.1377/hlthaff.2010.1000	5	19	19	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					7	9		10.1056/NEJMp1304170	http://dx.doi.org/10.1056/NEJMp1304170			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175WE	23822776	Green Published			2022-12-28	WOS:000321263500005
J	Cotney, J; Leng, J; Yin, J; Reilly, SK; DeMare, LE; Emera, D; Ayoub, AE; Rakic, P; Noonan, JP				Cotney, Justin; Leng, Jing; Yin, Jun; Reilly, Steven K.; DeMare, Laura E.; Emera, Deena; Ayoub, Albert E.; Rakic, Pasko; Noonan, James P.			The Evolution of Lineage-Specific Regulatory Activities in the Human Embryonic Limb	CELL			English	Article							GENOME-WIDE ASSOCIATION; TRANSPOSABLE ELEMENTS; GENE-EXPRESSION; ENHANCER; MAP; SEQUENCES; DEFINES; HEIGHT; MOUSE; STATE	The evolution of human anatomical features likely involved changes in gene regulation during development. However, the nature and extent of human-specific developmental regulatory functions remain unknown. We obtained a genome-wide view of cis-regulatory evolution in human embryonic tissues by comparing the histone modification H3K27ac, which provides a quantitative readout of promoter and enhancer activity, during human, rhesus, and mouse limb development. Based on increased H3K27ac, we find that 13% of promoters and 11% of enhancers have gained activity on the human lineage since the human-rhesus divergence. These gains largely arose by modification of ancestral regulatory activities in the limb or potential co-option from other tissues and are likely to have heterogeneous genetic causes. Most enhancers that exhibit gain of activity in humans originated in mammals. Gains at promoters and enhancers in the human limb are associated with increased gene expression, suggesting they include molecular drivers of human morphological evolution.	[Cotney, Justin; Yin, Jun; Reilly, Steven K.; DeMare, Laura E.; Emera, Deena; Noonan, James P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Ayoub, Albert E.; Rakic, Pasko] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Ayoub, Albert E.; Rakic, Pasko; Noonan, James P.] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06520 USA; [Leng, Jing; Noonan, James P.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06511 USA	Yale University; Yale University; Yale University; Yale University	Noonan, JP (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA.	james.noonan@yale.edu	Noonan, James/ABF-1320-2021; Cotney, Justin L/ABE-8500-2021; Yin, Jun/A-7502-2010	Cotney, Justin L/0000-0001-8230-2157; Yin, Jun/0000-0003-4543-1229; Reilly, Steven/0000-0003-3140-1483	National Institutes of Health [GM094780, DA023999, NS014841]; Edward J. Mallinckrodt Jr. Foundation; Rudolph Andersen Fellowship; Howard Hughes Medical Research Scholars Fellowship; NSF Graduate Research Fellowship; MRC [G0700089, MC_PC_15004] Funding Source: UKRI; Medical Research Council [G0700089, MC_PC_15004] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward J. Mallinckrodt Jr. Foundation; Rudolph Andersen Fellowship; Howard Hughes Medical Research Scholars Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants GM094780 (to J.P.N.), DA023999 (to P.R.), and NS014841 (to P.R.); a career award from the Edward J. Mallinckrodt Jr. Foundation (to J.P.N.); a Rudolph Andersen Fellowship (to J.C.); a Howard Hughes Medical Research Scholars Fellowship (to L.E.D.); and an NSF Graduate Research Fellowship (to S.K.R.). The human embryonic and fetal material was provided by the Joint MRC (G0700089)/Wellcome Trust (GR082557) Human Developmental Biology Resource. We thank Marianne Horn and Steve R. Wilson for technical assistance and veterinary expertise. We also thank Shrikant Mane, John Overton, Sheila Umlauf, and Alex Lopez at the Yale Center for Genome Analysis for generating sequencing data and Nicholas Carriero and Robert Bjornson at the Yale University Biomedical Performance Computing Center for computer resource support.	Aiello L., 2002, INTRO HUMAN EVOLUTIO; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Cormier TA, 2001, MAMM GENOME, V12, P796, DOI 10.1007/s00335-001-1006-5; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dominguez MH, 2013, CEREB CORTEX, V23, P2632, DOI 10.1093/cercor/bhs252; Duboc V, 2011, DEV DYNAM, V240, P1017, DOI 10.1002/dvdy.22582; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Goke J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002304; Green P, 2013, SCIENCE, V340, DOI 10.1126/science.1233195; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lorenzo P, 1998, J BIOL CHEM, V273, P23463, DOI 10.1074/jbc.273.36.23463; Marzke MW, 2000, J ANAT, V197, P121, DOI 10.1046/j.1469-7580.2000.19710121.x; Masuya H, 1997, DEV BIOL, V182, P42, DOI 10.1006/dbio.1996.8457; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schoenwolf GC., 2009, LARSENS HUMAN EMBRYO; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shibata Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002789; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Taher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028358; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wakabayashi T, 2010, BIOCHEM BIOPH RES CO, V391, P1116, DOI 10.1016/j.bbrc.2009.12.034; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhao JH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-96	47	131	134	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					185	196		10.1016/j.cell.2013.05.056	http://dx.doi.org/10.1016/j.cell.2013.05.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827682	Bronze, Green Accepted			2022-12-28	WOS:000321327900019
J	Fineberg, HV				Fineberg, Harvey V.			The Paradox of Disease Prevention Celebrated in Principle, Resisted in Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VACCINE; EXEMPTIONS; EXPERIENCE	Prevention of disease is often difficult to put into practice. Among the obstacles: the success of prevention is invisible, lacks drama, often requires persistent behavior change, and may be long delayed; statistical lives have little emotional effect, and benefits often do not accrue to the payer; avoidable harm is accepted as normal, preventive advice may be inconsistent, and bias against errors of commission may deter action; prevention is expected to produce a net financial return, whereas treatment is expected only to be worth its cost; and commercial interests as well as personal, religious, or cultural beliefs may conflict with disease prevention. Six strategies can help overcome these obstacles: (1) Pay for preventive services. (2) Make prevention financially rewarding for individuals and families. (3) Involve employers to promote health in the workplace and provide incentives to employees to maintain healthy practices. (4) Reengineer products and systems to make prevention simpler, lower in cost, and less dependent on individual action. (5) Use policy to reinforce choices that favor prevention. (6) Use multiple media channels to educate, elicit health-promoting behavior, and strengthen healthy habits. Prevention of disease will succeed over time insofar as it can be embedded in a culture of health.	Inst Med, Washington, DC 20001 USA		Fineberg, HV (corresponding author), Inst Med, 500 5th St NW, Washington, DC 20001 USA.	fineberg@nas.edu						[Anonymous], 2010, PERT WHOOP COUGH CAL; [Anonymous], ZOMB NOV; [Anonymous], VIS ZER APPR TRAFF S; Burd SA, 2009, WALL ST J       0612; CHURCH MA, 1979, LANCET, V2, P188; Feikin DR, 2000, JAMA-J AM MED ASSOC, V284, P3145, DOI 10.1001/jama.284.24.3145; Franklin B, 1895, AUTOBIOGRAPHY BENJAM; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Henke RM, 2011, HEALTH AFFAIR, V30, P490, DOI 10.1377/hlthaff.2010.0806; Li W, SUMMARY VITAL STAT 2; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; May T, 2003, VACCINE, V21, P1048, DOI 10.1016/S0264-410X(02)00627-8; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Pace LE, 2013, CANCER-AM CANCER SOC, V119, P2518, DOI 10.1002/cncr.28105; Poland GA, 2001, VACCINE, V19, P2440, DOI 10.1016/S0264-410X(00)00469-2; Sato H, 1999, CLIN INFECT DIS, V28, pS124, DOI 10.1086/515063; Saul S., 2007, NY TIMES; Schwartz T, 1981, MEDIA 2 GOD; Shakespeare William, HAMLET; Sharfstein J, JAMA FORUM PUBLIC HL; Trinkaus E, 2011, P NATL ACAD SCI USA, V108, P1267, DOI 10.1073/pnas.1018700108; U.S. Preventive Services Task Force, 2011, SCREEN BREAST CANC	23	65	69	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					85	90		10.1001/jama.2013.7518	http://dx.doi.org/10.1001/jama.2013.7518			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175SK	23821092				2022-12-28	WOS:000321253000026
J	Margolis, KL; Asche, SE; Bergdall, AR; Dehmer, SP; Groen, SE; Kadrmas, HM; Kerby, TJ; Klotzle, KJ; Maciosek, MV; Michels, RD; O'Connor, PJ; Pritchard, RA; Sekenski, JL; Sperl-Hillen, JM; Trower, NK				Margolis, Karen L.; Asche, Stephen E.; Bergdall, Anna R.; Dehmer, Steven P.; Groen, Sarah E.; Kadrmas, Holly M.; Kerby, Tessa J.; Klotzle, Krissa J.; Maciosek, Michael V.; Michels, Ryan D.; O'Connor, Patrick J.; Pritchard, Rachel A.; Sekenski, Jaime L.; Sperl-Hillen, JoAnn M.; Trower, Nicole K.			Effect of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Control A Cluster Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SELF-MANAGEMENT; HYPERTENSION CONTROL; PRIMARY-CARE; INTERVENTIONS; IMPROVE; METAANALYSIS; MEDICATION; ADHERENCE; DISEASE; NURSE	IMPORTANCE Only about half of patients with high blood pressure (BP) in the United States have their BP controlled. Practical, robust, and sustainable models are needed to improve BP control in patients with uncontrolled hypertension. OBJECTIVES To determine whether an intervention combining home BP telemonitoring with pharmacist case management improves BP control compared with usual care and to determine whether BP control is maintained after the intervention is stopped. DESIGN, SETTING, AND PATIENTS A cluster randomized clinical trial of 450 adults with uncontrolled BP recruited from 14 692 patients with electronic medical records across 16 primary care clinics in an integrated health system in Minneapolis-St Paul, Minnesota, with 12 months of intervention and 6 months of postintervention follow-up. INTERVENTIONS Eight clinics were randomized to provide usual care to patients (n = 222) and 8 clinics were randomized to provide a telemonitoring intervention (n = 228). Intervention patients received home BP telemonitors and transmitted BP data to pharmacists who adjusted antihypertensive therapy accordingly. MAIN OUTCOMES AND MEASURES Control of systolic BP to less than 140 mm Hg and diastolic BP to less than 90 mm Hg (<130/80mmHg in patients with diabetes or chronic kidney disease) at 6 and 12 months. Secondary outcomes were change in BP, patient satisfaction, and BP control at 18 months (6 months after intervention stopped). RESULTS At baseline, enrollees were 45% women, 82% white, mean(SD)age, 61.1(12.0)years; mean systolic BP, 148 mm Hg; diastolic BP, 85 mm Hg. The proportion of patients with BP control at both 6 and 12 months was significantly greater in the telemonitoring group than in the usual care group. [GRAPHICS] Compared with the usual care group, systolic BP decreased more from baseline among patients in the telemonitoring intervention group at 6 months (-10.7 mm Hg [95% CI, -14.3 to -7.3 mm Hg]; P<.001), at 12 months (-9.7 mm Hg [95% CI, -13.4 to -6.0 mm Hg]; P<.001), and at 18 months (-6.6 mm Hg [95% CI, -10.7 to -2.5 mm Hg]; P=.004). CONCLUSIONS AND RELEVANCE Home BP telemonitoring and pharmacist case management achieved better BP control compared with usual care during 12 months of intervention that persisted during 6 months of postintervention follow-up.	[Margolis, Karen L.; Asche, Stephen E.; Bergdall, Anna R.; Dehmer, Steven P.; Maciosek, Michael V.; O'Connor, Patrick J.; Pritchard, Rachel A.; Sekenski, Jaime L.; Sperl-Hillen, JoAnn M.; Trower, Nicole K.] HealthPartners, Inst Educ & Res, Minneapolis, MN 55440 USA; [Kerby, Tessa J.] HealthPartners, Hlth Improvement, Minneapolis, MN 55440 USA; [Groen, Sarah E.; Kadrmas, Holly M.; Klotzle, Krissa J.; Michels, Ryan D.] HealthPartners, Clin Pharm, Minneapolis, MN 55440 USA		Margolis, KL (corresponding author), HealthPartners, Inst Educ & Res, POB 1524,MS 21111R, Minneapolis, MN 55440 USA.	karen.l.margolis@healthpartners.com	O'Connor, Patrick/HII-2987-2022	Sperl-Hillen, JoAnn/0000-0002-9840-9255; Maciosek, Michael/0000-0002-8164-8858; O'Connor, Patrick/0000-0002-2324-6228; Margolis, Karen/0000-0003-1862-7402	National Heart, Lung, and Blood Institute [R01HL090965]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090965] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by grant R01HL090965 from the National Heart, Lung, and Blood Institute.	Agarwal R, 2011, HYPERTENSION, V57, P29, DOI 10.1161/HYPERTENSIONAHA.110.160911; Agency for Healthcare Research and Quality, 2007, PREPARING A QUESTION; Artinian NT, 2007, NURS RES, V56, P312, DOI 10.1097/01.NNR.0000289501.45284.6e; Artinian NT, 2001, HEART LUNG, V30, P191, DOI 10.1067/mhl.2001.112684; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bosworth HB, 2011, ARCH INTERN MED, V171, P1173, DOI 10.1001/archinternmed.2011.276; Bosworth HB, 2009, ANN INTERN MED, V151, P687, DOI 10.7326/0003-4819-151-10-200911170-00148; Bray EP, 2010, ANN MED, V42, P371, DOI 10.3109/07853890.2010.489567; Cappuccio FP, 2004, BMJ-BRIT MED J, V329, P145, DOI 10.1136/bmj.38121.684410.AE; Carter BL, 2012, J CLIN HYPERTENS, V14, P51, DOI 10.1111/j.1751-7176.2011.00542.x; Carter BL, 2009, ARCH INTERN MED, V169, P1996, DOI 10.1001/archinternmed.2009.358; Carter BL, 2009, ARCH INTERN MED, V169, P1748, DOI 10.1001/archinternmed.2009.316; Centers for Medicare & Medicaid Services, 2010, MEDICARE PART D MEDI; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Clark CE, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3995; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; Fahey T, 2005, BRIT J GEN PRACT, V55, P875; Friedman RH, 1996, AM J HYPERTENS, V9, P285, DOI 10.1016/0895-7061(95)00353-3; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; Guide to Community Preventive Services, CARDIOVASCULAR DISEA; Hsiao C, 2010, NATIONAL AMBULATORY; Kerby TJ, 2012, J CLIN HYPERTENS, V14, P668, DOI 10.1111/j.1751-7176.2012.00685.x; Magid DJ, 2013, CIRC-CARDIOVASC QUAL, V6, P157, DOI 10.1161/CIRCOUTCOMES.112.968172; Mancia G, 2006, HYPERTENSION, V47, P846, DOI 10.1161/01.HYP.0000215363.69793.bb; Margolis KL, 2012, CONTEMP CLIN TRIALS, V33, P794, DOI 10.1016/j.cct.2012.03.014; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; Mengden T, 1998, AM J HYPERTENS, V11, P1413, DOI 10.1016/S0895-7061(98)00241-6; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Pickering T, 1996, AM J HYPERTENS, V9, P1, DOI 10.1016/0895-7061(95)00341-X; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rogers MAM, 2001, ANN INTERN MED, V134, P1024, DOI 10.7326/0003-4819-134-11-200106050-00008; Schroeder K, 2004, ARCH INTERN MED, V164, P722, DOI 10.1001/archinte.164.7.722; Staessen JA, 2004, JAMA-J AM MED ASSOC, V291, P955, DOI 10.1001/jama.291.8.955; Tsai AC, 2005, AM J MANAG CARE, V11, P478; Uhlig K., 2012, AGE HEALTHCAR RES QU; Walsh JME, 2006, MED CARE, V44, P646, DOI 10.1097/01.mlr.0000220260.30768.32; Wang V, 2012, AM HEART J, V163, P980, DOI 10.1016/j.ahj.2012.03.016; Ware JE, 2002, HOW TO SCORE VERSION; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925; Welch LK, 2011, AM J MANAG CARE, V17, P473; Wentzlaff DM, 2011, J CLIN HYPERTENS, V13, P431, DOI 10.1111/j.1751-7176.2011.00435.x	43	349	364	5	59	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					46	56		10.1001/jama.2013.6549	http://dx.doi.org/10.1001/jama.2013.6549			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175SK	23821088	Bronze, Green Accepted			2022-12-28	WOS:000321253000022
J	Boyd, MA; Donovan, B				Boyd, Mark A.; Donovan, Basil			Antiretroviral therapy: dolutegravir sets SAIL(ING)	LANCET			English	Editorial Material							CO-FORMULATED ELVITEGRAVIR; HIV-1 INFECTION; DOUBLE-BLIND; INITIAL TREATMENT; CONTROLLED-TRIAL; RALTEGRAVIR; EMTRICITABINE; COBICISTAT; TENOFOVIR; EFAVIRENZ		[Boyd, Mark A.; Donovan, Basil] Univ New S Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW 2052, Australia	University of New South Wales Sydney; Kirby Institute	Boyd, MA (corresponding author), Univ New S Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW 2052, Australia.	mboyd@kirby.unsw.edu.au	Donovan, Basil J/K-1246-2012	Donovan, Basil J/0000-0001-8851-4126; Boyd, Mark/0000-0002-6848-3307				Cahn P, 2013, LANCET; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Madruga JV, 2007, LANCET, V370, P29, DOI 10.1016/S0140-6736(07)61047-2; Nichols G, 2012, J INT AIDS SOC S4, V15, P18112; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Underwood MR, 2012, JAIDS-J ACQ IMM DEF, V61, P297, DOI 10.1097/QAI.0b013e31826bfd02; Walmsley S, 2012, 52 INT C ANT CHEM SE	10	4	5	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 24	2013	382	9893					664	666		10.1016/S0140-6736(13)61456-7	http://dx.doi.org/10.1016/S0140-6736(13)61456-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206SI	23830358				2022-12-28	WOS:000323542400006
J	Ladin, K; Hanto, DW				Ladin, Keren; Hanto, Douglas W.			Rationing Lung Transplants - Procedural Fairness in Allocation and Appeals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ladin, Keren] Tufts Univ, Dept Occupat Therapy, Medford, MA 02155 USA; [Ladin, Keren] Tufts Univ, Lab Res Eth Aging & Community Hlth REACH Lab, Medford, MA 02155 USA; [Ladin, Keren] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Hanto, Douglas W.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63130 USA; [Hanto, Douglas W.] Washington Univ, Sch Med, Dept Continuing Med Educ, St Louis, MO 63130 USA	Tufts University; Tufts University; Massachusetts Department of Public Health; Tufts University; Washington University (WUSTL); Washington University (WUSTL)	Ladin, K (corresponding author), Tufts Univ, Dept Occupat Therapy, Medford, MA 02155 USA.		Hanto, Douglas/AAZ-5390-2021	Hanto, Douglas/0000-0003-4088-3568; Ladin, Keren/0000-0002-4310-8260				Adler Frederick R, 2009, Proc Am Thorac Soc, V6, P619, DOI 10.1513/pats.2009008-088TL; [Anonymous], 2012, OPTN SRTR ANN DAT RE; Colvin-Adams M, 2012, AM J TRANSPLANT, V12, P3213, DOI 10.1111/j.1600-6143.2012.04258.x; Daniels N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1850; Marasco SF, 2012, ANN THORAC SURG, V93, P1836, DOI 10.1016/j.athoracsur.2012.03.051	5	24	24	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2013	369	7					599	601		10.1056/NEJMp1307792	http://dx.doi.org/10.1056/NEJMp1307792			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243YO	23883330	Green Published			2022-12-28	WOS:000326354500005
J	Mashaghi, A; Kramer, G; Bechtluft, P; Zachmann-Brand, B; Driessen, AJM; Bukau, B; Tans, SJ				Mashaghi, Alireza; Kramer, Guenter; Bechtluft, Philipp; Zachmann-Brand, Beate; Driessen, Arnold J. M.; Bukau, Bernd; Tans, Sander J.			Reshaping of the conformational search of a protein by the chaperone trigger factor	NATURE			English	Article							SINGLE-MOLECULE; RIBOSOME; SPECTROSCOPY; DOMAIN	Protein folding is often described as a search process, in which polypeptides explore different conformations to find their native structure. Molecular chaperones are known to improve folding yields by suppressing aggregation between polypeptides before this conformational search starts(1,2), as well as by rescuing misfolds after it ends(1,3). Although chaperones have long been speculated to also affect the conformational search itself-by reshaping the underlying folding landscape along the folding trajectory(4,5)-direct experimental evidence has been scarce so far. In Escherichia coli, the general chaperone trigger factor(6-8) (TF) could play such a role. TF has been shown to interact with nascent chains at the ribosome(9,10), with polypeptides released from the ribosome into the cytosol(11), and with fully folded proteins before their assembly into larger complexes(12). To investigate the effect of TF from E. coli on the conformational search of polypeptides to their native state, we investigated individual maltose binding protein (MBP) molecules using optical tweezers. Here we show that TF binds folded structures smaller than one domain, which are then stable for seconds and ultimately convert to the native state. Moreover, TF stimulates native folding in constructs of repeated MBP domains. The results indicate that TF promotes correct folding by protecting partially folded states from distant interactions that produce stable misfolded states. As TF interacts with most newly synthesized proteins in E. coli, we expect these findings to be of general importance in understanding protein folding pathways.	[Mashaghi, Alireza; Bechtluft, Philipp; Tans, Sander J.] FOM Inst AMOLF, NL-1098 XG Amsterdam, Netherlands; [Kramer, Guenter; Zachmann-Brand, Beate; Bukau, Bernd] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Allianz, D-69120 Heidelberg, Germany; [Driessen, Arnold J. M.] Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, NL-9749 AG Groningen, Netherlands; [Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, NL-9749 AG Groningen, Netherlands	AMOLF; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Groningen; University of Groningen	Tans, SJ (corresponding author), FOM Inst AMOLF, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands.	tans@amolf.nl	Tans, Sander/AAS-2901-2020; Mashaghi, Alireza/Q-8218-2017; Institute, Zernike/W-7033-2019; Driessen, Arnold J.M./D-1876-2012	Mashaghi, Alireza/0000-0002-2157-1211; Bukau, Bernd/0000-0003-0521-7199; Kramer, Gunter/0000-0001-7552-8393; Driessen, Arnold J.M./0000-0001-9258-9104	Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO); Deutsche Forschungsgemeinschaft [SFB 638, FOR967]	Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Work in the laboratory of S.J.T. is part of the research programme of the Stichting voor Fundamenteel Onderzoek der Materie (FOM), which is financially supported by the Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO). Work in the laboratory of B.B. and G.K. is supported by grants from the Deutsche Forschungsgemeinschaft (SFB 638, FOR967). We are grateful to M. Meyer for his support in performing and analysing FTIR experiments. We thank T. Shimizu, L. Guilbride, M. Dogterom and members of the Tans group for critical reading of the manuscript.	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592; Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; Bertz M, 2008, J MOL BIOL, V378, P447, DOI 10.1016/j.jmb.2008.02.025; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; Cao Y, 2007, P NATL ACAD SCI USA, V104, P15677, DOI 10.1073/pnas.0705367104; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Jaenicke R, 1999, PROG BIOPHYS MOL BIO, V71, P155, DOI 10.1016/S0079-6107(98)00032-7; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Lakshmipathy SK, 2010, J BIOL CHEM, V285, P27911, DOI 10.1074/jbc.M110.134163; Maier R, 2001, J MOL BIOL, V314, P1181, DOI 10.1006/jmbi.2000.5192; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Martinez-Hackert E, 2009, CELL, V138, P923, DOI 10.1016/j.cell.2009.07.044; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Park S, 2007, BIOPHYS J, V93, P4108, DOI 10.1529/biophysj.107.108100; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Thomas PD, 1996, P NATL ACAD SCI USA, V93, P11628, DOI 10.1073/pnas.93.21.11628; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z	30	91	93	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					98	U125		10.1038/nature12293	http://dx.doi.org/10.1038/nature12293			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23831649				2022-12-28	WOS:000322514800036
J	Zhang, QY; Shi, JZ; Deng, GH; Guo, J; Zeng, XY; He, XJ; Kong, HH; Gu, CY; Li, XY; Liu, JX; Wang, GJ; Chen, Y; Liu, LL; Liang, LB; Li, YY; Fan, J; Wang, JL; Li, WH; Guan, LZ; Li, QM; Yang, HL; Chen, PC; Jiang, L; Guan, YT; Xin, XG; Jiang, YP; Tian, GB; Wang, XR; Qiao, CL; Li, CJ; Bu, ZG; Chen, HL				Zhang, Qianyi; Shi, Jianzhong; Deng, Guohua; Guo, Jing; Zeng, Xianying; He, Xijun; Kong, Huihui; Gu, Chunyang; Li, Xuyong; Liu, Jinxiong; Wang, Guojun; Chen, Yan; Liu, Liling; Liang, Libin; Li, Yuanyuan; Fan, Jun; Wang, Jinliang; Li, Wenhui; Guan, Lizheng; Li, Qimeng; Yang, Huanliang; Chen, Pucheng; Jiang, Li; Guan, Yuntao; Xin, Xiaoguang; Jiang, Yongping; Tian, Guobin; Wang, Xiurong; Qiao, Chuanling; Li, Chengjun; Bu, Zhigao; Chen, Hualan			H7N9 Influenza Viruses Are Transmissible in Ferrets by Respiratory Droplet	SCIENCE			English	Article							SINGLE AMINO-ACID; A VIRUS; RECEPTOR SPECIFICITY; MOLECULAR-BASIS; MOUSE MODEL; GUINEA-PIG; HOST-RANGE; HEMAGGLUTININ; POULTRY; HUMANS	A newly emerged H7N9 virus has caused 132 human infections with 37 deaths in China since 18 February 2013. Control measures in H7N9 virus-positive live poultry markets have reduced the number of infections; however, the character of the virus, including its pandemic potential, remains largely unknown. We systematically analyzed H7N9 viruses isolated from birds and humans. The viruses were genetically closely related and bound to human airway receptors; some also maintained the ability to bind to avian airway receptors. The viruses isolated from birds were nonpathogenic in chickens, ducks, and mice; however, the viruses isolated from humans caused up to 30% body weight loss in mice. Most importantly, one virus isolated from humans was highly transmissible in ferrets by respiratory droplet. Our findings indicate nothing to reduce the concern that these viruses can transmit between humans.	[Zhang, Qianyi; Shi, Jianzhong; Deng, Guohua; Guo, Jing; Zeng, Xianying; He, Xijun; Kong, Huihui; Gu, Chunyang; Li, Xuyong; Liu, Jinxiong; Wang, Guojun; Chen, Yan; Liu, Liling; Liang, Libin; Li, Yuanyuan; Fan, Jun; Wang, Jinliang; Li, Wenhui; Guan, Lizheng; Li, Qimeng; Yang, Huanliang; Chen, Pucheng; Jiang, Li; Guan, Yuntao; Xin, Xiaoguang; Jiang, Yongping; Tian, Guobin; Wang, Xiurong; Qiao, Chuanling; Li, Chengjun; Bu, Zhigao; Chen, Hualan] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China; [Zhang, Qianyi; Gu, Chunyang; Wang, Guojun; Li, Qimeng; Chen, Hualan] Gansu Agr Univ, Coll Vet Med, Lanzhou 730030, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Gansu Agricultural University	Chen, HL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China.	chenhualan@caas.cn	Li, Chengjun/GWM-7661-2022; He, Xijun/GQO-9594-2022; xuyong, li/CAG-6328-2022; li, Yuanyuan/AAX-3953-2020; Yang, Huanliang/GRX-5540-2022	li, Yuanyuan/0000-0001-8467-9759; 	Ministry of Agriculture [CARS-42-G08]; Ministry of Science and Technology [KJYJ-2013-01-01, 2012ZX10004214]	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	We thank S. Watson for editing the manuscript, Y. Shu from the China Centers for Disease Control and Prevention for providing the H7N9 viruses isolated from humans, and the Consortium for Functional Glycomics (Scripps Research Institute, Department of Molecular Biology, La Jolla, CA) for providing the glycans. This work was supported by the Ministry of Agriculture (CARS-42-G08) and by the Ministry of Science and Technology (KJYJ-2013-01-01 and 2012ZX10004214). Virus sequence data from this study were deposited in GenBank with the accession numbers CY146905 to CY147200 and in Global Initiative on Sharing Avian Influenza Data with the accession numbers EPI440678 to 440701 and EIP457614 to 457885.	[Anonymous], 2011, MANUAL DIAGNOSTIC TE; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Li Q., 2013, NEW ENGL J MED, DOI [DOI 10.1056/NEJMOA1304617, 23614499]; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Seibert CW, 2010, J VIROL, V84, P11219, DOI 10.1128/JVI.01424-10; Shi JZ, 2013, CHINESE SCI BULL, V58, P1857, DOI 10.1007/s11434-013-5873-4; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; World Health Organization, 2013, NUMB CONF HUM CAS AV; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455; Zhang Y, 2012, J VIROL, V86, P9666, DOI 10.1128/JVI.00958-12	25	315	369	4	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144					410	414		10.1126/science.1240532	http://dx.doi.org/10.1126/science.1240532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23868922				2022-12-28	WOS:000322259200053
J	Morriss, R; Kapur, N; Byng, R				Morriss, Richard; Kapur, Nav; Byng, Richard			PRACTICE POINTER Assessing risk of suicide or self harm in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Morriss, Richard] Univ Nottingham, Inst Mental Hlth, Nottingham NG7 2TU, England; [Kapur, Nav] Univ Manchester, Manchester, Lancs, England; [Byng, Richard] Univ Plymouth, Peninsula Sch Med, Plymouth PL4 8AA, Devon, England	University of Nottingham; University of Manchester; University of Plymouth	Morriss, R (corresponding author), Univ Nottingham, Inst Mental Hlth, Univ Nottingham Innovat Pk, Nottingham NG7 2TU, England.	richard.morriss@nottingham.ac.uk		Morriss, Richard/0000-0003-2910-4121; Kapur, Nav/0000-0002-3100-3234; Byng, Richard/0000-0001-7411-9467				Academy of Medical Royal Colleges, 2012, FDN PROGR CURR; Bergen H, 2012, LANCET, V380, P1568, DOI 10.1016/S0140-6736(12)61141-6; Galfalvy HC, 2008, ACTA PSYCHIAT SCAND, V117, P244, DOI 10.1111/j.1600-0447.2008.01162.x; GASK L, 2006, PSYCHIATRY, V5, P266; Gvion Y, 2011, ARCH SUICIDE RES, V15, P93, DOI 10.1080/13811118.2011.565265; Hawton K, 2003, PSYCHOL MED, V33, P987, DOI 10.1017/S0033291703007943; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Milner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051333; Morriss R, 1999, J AFFECT DISORDERS, V52, P77, DOI 10.1016/S0165-0327(98)00080-9; National Institute for Health and Clinical Excellence, 2012, SELF HARM LONG TERM, VCG133; South West Public Health Observatory, 2011, SUIC SELF HARM S W S; Whitley E, 1999, BRIT MED J, V319, P1034, DOI 10.1136/bmj.319.7216.1034; Windfuhr K, 2011, BRIT MED BULL, V100, P101, DOI 10.1093/bmb/ldr042	13	16	16	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2013	347								f4572	10.1136/bmj.f4572	http://dx.doi.org/10.1136/bmj.f4572			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193BO	23886963				2022-12-28	WOS:000322532000002
J	Gandin, V; Topisirovic, I				Gandin, Valentina; Topisirovic, Ivan			Trans-HSF1 Express	SCIENCE			English	Editorial Material							HEAT-SHOCK; TRANSLATION; ELONGATION		[Gandin, Valentina] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3A 1A3, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada	Lady Davis Institute; McGill University; McGill University	Gandin, V (corresponding author), McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3A 1A3, Canada.	ivan.topisirovic@mcgill.ca	Topisirovic, Ivan/A-9426-2008	Topisirovic, Ivan/0000-0002-5510-9762; Gandin, Valentina/0000-0003-2627-1303				Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Malina A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012377; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Pavitt GD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012278; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Santagata S, 2013, SCIENCE, V341, P250, DOI 10.1126/science.1238303; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Svitkin YV, 2001, RNA, V7, P1743	12	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143					242	243		10.1126/science.1242359	http://dx.doi.org/10.1126/science.1242359			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869008				2022-12-28	WOS:000321959300028
J	Haiser, HJ; Gootenberg, DB; Chatman, K; Sirasani, G; Balskus, EP; Turnbaugh, PJ				Haiser, Henry J.; Gootenberg, David B.; Chatman, Kelly; Sirasani, Gopal; Balskus, Emily P.; Turnbaugh, Peter J.			Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta	SCIENCE			English	Article							DIGOXIN; FLORA	Despite numerous examples of the effects of the human gastrointestinal microbiome on drug efficacy and toxicity, there is often an incomplete understanding of the underlying mechanisms. Here, we dissect the inactivation of the cardiac drug digoxin by the gut Actinobacterium Eggerthella lenta. Transcriptional profiling, comparative genomics, and culture-based assays revealed a cytochrome-encoding operon up-regulated by digoxin, inhibited by arginine, absent in nonmetabolizing E. lenta strains, and predictive of digoxin inactivation by the human gut microbiome. Pharmacokinetic studies using gnotobiotic mice revealed that dietary protein reduces the in vivo microbial metabolism of digoxin, with significant changes to drug concentration in the serum and urine. These results emphasize the importance of viewing pharmacology from the perspective of both our human and microbial genomes.	[Haiser, Henry J.; Gootenberg, David B.; Chatman, Kelly; Turnbaugh, Peter J.] Harvard Univ, Ctr Syst Biol, FAS, Cambridge, MA 02138 USA; [Sirasani, Gopal; Balskus, Emily P.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Turnbaugh, PJ (corresponding author), Harvard Univ, Ctr Syst Biol, FAS, Cambridge, MA 02138 USA.	pturnbaugh@fas.harvard.edu	Haiser, Henry/AAN-5187-2020	Gootenberg, David/0000-0001-5416-106X; Turnbaugh, Peter/0000-0002-0888-2875	NIH [P50 GM068763]; Harvard Digestive Diseases Center [2P30DK034854-26]; Canadian Institutes of Health Research [MFE-112991]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	B. Budnik and S. Trauger for liquid chromatography-mass spectrometry (LC-MS) analyses; V. Yeliseyev, A. Liou, and R. Carmody for mouse studies; C. Reardon and C. Daly for sequencing support; C. Maurice, L. David, R. Dutton, B. Wolfe, J. Button, M. Elliot, Y. Falanga, R. Losick, A. Murray, and B. Stern for helpful discussions. Mouse experiments were done with the generous support of the Harvard Digestive Diseases Center and the University of North Carolina gnotobiotic cores. This work was supported by grants from the NIH (P50 GM068763) and the Harvard Digestive Diseases Center (2P30DK034854-26). H. J. H. is supported by the Canadian Institutes of Health Research (MFE-112991). RNA-Seq data are deposited in the Gene Expression Omnibus (GEO) database (accession GSE43919).	DOBKIN JF, 1983, SCIENCE, V220, P325; Farr CD, 2002, BIOCHEMISTRY-US, V41, P1137, DOI 10.1021/bi011511g; Goodman L.S., 2011, GOODMAN GILMANS PHAR, V13th ed.; Haiser HJ, 2012, SCIENCE, V336, P1253, DOI 10.1126/science.1224396; LINDENBAUM J, 1981, NEW ENGL J MED, V305, P789, DOI 10.1056/NEJM198110013051403; MATHAN VI, 1989, GUT, V30, P971, DOI 10.1136/gut.30.7.971; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Saunders E, 2009, STAND GENOMIC SCI, V1, P174, DOI 10.4056/sigs.33592; SPERRY JF, 1976, J BACTERIOL, V127, P780, DOI 10.1128/JB.127.2.780-784.1976; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175	11	370	391	0	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					295	298		10.1126/science.1235872	http://dx.doi.org/10.1126/science.1235872			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869020	Green Accepted, Green Submitted			2022-12-28	WOS:000321959300049
J	Wang, ZC; Becker, H				Wang, Zaicong; Becker, Harry			Ratios of S, Se and Te in the silicate Earth require a volatile-rich late veneer	NATURE			English	Article							HIGHLY SIDEROPHILE ELEMENTS; OROGENIC PERIDOTITES; TERRESTRIAL PLANETS; MANTLE; TELLURIUM; ACCRETION; XENOLITHS; SYSTEMATICS; SELENIUM; TEMPERATURES	The excess of highly siderophile (iron-loving) elements (HSEs) and the chondritic ratios of most HSEs in the bulk silicate Earth (BSE) may reflect the accretion of a chondritic 'late veneer' of about 0.5 per cent of Earth's mass after core formation(1,2). The amount of volatiles contained in the late veneer is a key constraint on the budget and the origin of the volatiles in Earth. At high pressures and temperatures, the moderately volatile chalcogen elements sulphur (S), selenium (Se) and tellurium (Te) are moderately to highly siderophile; thus, if depleted by core formation their mantle abundances should reflect the volatile composition of the late veneer(3,4). Here we report ratios and abundances of S, Se and Te in the mantle determined from new isotope dilution data for post-Archaean mantle peridotites. The mean S/Se and Se/Te ratios of mantle lherzolites overlap with CI (Ivuna-type) carbonaceous chondrite values(5,6). The Se/Te ratios of ordinary and enstatite chondrites are significantly different. The chalcogen/HSE ratio of the BSE is similar to that of CM (Mighei-type) carbonaceous chondrites, consistent with the view that the HSE signature of the BSE reflects a predominance of slightly volatile-depleted, carbonaceous-chondrite-like material, possibly with a minor proportion of non-chondritic material(7). Depending on the estimates for the abundances of water and carbon in the BSE8, the late veneer may have supplied 20 to 100 per cent of the budget of hydrogen and carbon in the BSE.	[Wang, Zaicong; Becker, Harry] Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany	Free University of Berlin	Wang, ZC (corresponding author), Free Univ Berlin, Inst Geol Wissensch, Malteserstr 74-100, D-12249 Berlin, Germany.	zaicongwang@gmail.com; hbecker@zedat.fu-berlin.de	Wang, Zaicong/D-3434-2014	Wang, Zaicong/0000-0002-3584-1673	Freie Universitat Berlin; China Scholarship Council fellowship	Freie Universitat Berlin; China Scholarship Council fellowship(China Scholarship Council)	Some peridotite and meteorite samples were provided by S. Gao, J.-P. Lorand, G. MacPherson and M. Wadhwa. We thank F. Wombacher and C. Funk for discussions and M. Feth, K. Hammerschmidt and M. Weynell for technical assistance. This work was supported by funds from Freie Universitat Berlin and a China Scholarship Council fellowship to Z.W.	Abe Y., 2000, ORIGIN EARTH MOON, P413; Albarede F, 2009, NATURE, V461, P1227, DOI 10.1038/nature08477; Alexander CMO, 2012, SCIENCE, V337, P721, DOI 10.1126/science.1223474; Becker H, 2006, GEOCHIM COSMOCHIM AC, V70, P4528, DOI 10.1016/j.gca.2006.06.004; Bodinier JL, 2003, TREATISE GEOCHEMISTR, V2, P103, DOI DOI 10.1016/B978-0-08-095975-7.00204-7; Bottke WF, 2010, SCIENCE, V330, P1527, DOI 10.1126/science.1196874; DREIBUS G, 1995, METEORITICS, V30, P439, DOI 10.1111/j.1945-5100.1995.tb01150.x; Fehr MA, 2004, INT J MASS SPECTROM, V232, P83, DOI 10.1016/j.ijms.2003.11.006; Fischer-Godde M, 2012, GEOCHIM COSMOCHIM AC, V77, P135, DOI 10.1016/j.gca.2011.11.014; Fischer-Godde M, 2011, CHEM GEOL, V280, P365, DOI 10.1016/j.chemgeo.2010.11.024; HERTOGEN J, 1980, GEOCHIM COSMOCHIM AC, V44, P2125, DOI 10.1016/0016-7037(80)90209-4; Jenner FE, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC004009; Konig S, 2012, GEOCHIM COSMOCHIM AC, V86, P354, DOI 10.1016/j.gca.2012.03.014; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Lorand JP, 2010, CHEM GEOL, V278, P120, DOI 10.1016/j.chemgeo.2010.09.007; Lyubetskaya T, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004223; Mann U, 2012, GEOCHIM COSMOCHIM AC, V84, P593, DOI 10.1016/j.gca.2012.01.026; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Meisel T, 2001, GEOCHIM COSMOCHIM AC, V65, P1311, DOI 10.1016/S0016-7037(00)00566-4; MORGAN JW, 1986, J GEOPHYS RES-SOLID, V91, P2375, DOI 10.1029/JB091iB12p12375; Palme H., 2003, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; Rose-Weston L, 2009, GEOCHIM COSMOCHIM AC, V73, P4598, DOI 10.1016/j.gca.2009.04.028; Rubie DC, 2011, EARTH PLANET SC LETT, V301, P31, DOI 10.1016/j.epsl.2010.11.030; Schonbachler M, 2010, SCIENCE, V328, P884, DOI 10.1126/science.1186239; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001; Walker RJ, 2002, GEOCHIM COSMOCHIM AC, V66, P4187, DOI 10.1016/S0016-7037(02)01003-7; Wang ZC, 2013, GEOCHIM COSMOCHIM AC, V108, P21, DOI 10.1016/j.gca.2013.01.021; Wood BJ, 2006, NATURE, V441, P825, DOI 10.1038/nature04763; Wood BJ, 2010, NATURE, V465, P767, DOI 10.1038/nature09072; Yi W, 2000, J GEOPHYS RES-SOL EA, V105, P18927, DOI 10.1029/2000JB900152	31	162	165	10	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					328	+		10.1038/nature12285	http://dx.doi.org/10.1038/nature12285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23868263				2022-12-28	WOS:000321910700034
J	Darnovsky, M				Darnovsky, Marcy			A slippery slope to human germline modification	NATURE			English	Editorial Material									Ctr Genet & Soc, Berkeley, CA USA		Darnovsky, M (corresponding author), Ctr Genet & Soc, Berkeley, CA USA.	darnovsky@geneticsandsociety.org						Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391	1	23	23	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2013	499	7457					127	127		10.1038/499127a	http://dx.doi.org/10.1038/499127a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	179YA	23846625	Bronze			2022-12-28	WOS:000321557600006
J	Cole, TB				Cole, Thomas B.			Sunflower Willie Cole	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					126	130		10.1001/jama.2013.5198	http://dx.doi.org/10.1001/jama.2013.5198			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23839731				2022-12-28	WOS:000321511500001
J	Leitner, A; Aebersold, R				Leitner, Alexander; Aebersold, Ruedi			SnapShot: Mass Spectrometry for Protein and Proteome Analyses	CELL			English	Editorial Material							BIOLOGY		[Leitner, Alexander; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8006 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Leitner, A (corresponding author), ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland.		Leitner, Alexander/U-1601-2019	Leitner, Alexander/0000-0003-4126-0725				Altelaar AFM, 2013, NAT REV GENET, V14, P35, DOI 10.1038/nrg3356; Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Dunham WH, 2012, PROTEOMICS, V12, P1576, DOI 10.1002/pmic.201100523; Elschenbroich S, 2010, EXPERT REV PROTEOMIC, V7, P141, DOI 10.1586/EPR.09.97; Franck J, 2009, MOL CELL PROTEOMICS, V8, P2023, DOI 10.1074/mcp.R800016-MCP200; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Ornatsky O, 2010, J IMMUNOL METHODS, V361, P1, DOI 10.1016/j.jim.2010.07.002; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Walzthoeni T, 2013, CURR OPIN STRUC BIOL, V23, P252, DOI 10.1016/j.sbi.2013.02.008; Zhang YY, 2013, CHEM REV, V113, P2343, DOI 10.1021/cr3003533	11	14	14	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					252	253	252.e1	10.1016/j.cell.2013.06.025	http://dx.doi.org/10.1016/j.cell.2013.06.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827686	Bronze			2022-12-28	WOS:000321327900024
J	Joensuu, H				Joensuu, Heikki			Duration of adjuvant trastuzumab: shorter beats longer	LANCET			English	Editorial Material							BREAST-CANCER; CHEMOTHERAPY; TAMOXIFEN		[Joensuu, Heikki] Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00029 Helsinki, Finland; [Joensuu, Heikki] Univ Helsinki, FIN-00029 Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Joensuu, H (corresponding author), Univ Helsinki, Cent Hosp, Dept Oncol, Haartmaninkatu 4, FIN-00029 Helsinki, Finland.	heikki.joensuu@hus.fi		Joensuu, Heikki/0000-0003-0281-2507	Cancer Foundation Finland sr [120084, 110071, 130093] Funding Source: researchfish	Cancer Foundation Finland sr		Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Goldhirsch A, 2013, LANCET; Inoue K, 2010, BREAST CANCER RES TR, V119, P127, DOI 10.1007/s10549-009-0498-7; Jin H, 2012, J CLIN ONCOL, V30, P718, DOI 10.1200/JCO.2010.34.4010; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Perez EA, 2011, J CLIN ONCOL, V29, P4491, DOI 10.1200/JCO.2011.36.7045; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pivot X, 2013, LANCET ONCOL, V14, P741, DOI 10.1016/S1470-2045(13)70225-0; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2	13	5	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2013	382	9897					1010	1011		10.1016/S0140-6736(13)61448-8	http://dx.doi.org/10.1016/S0140-6736(13)61448-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222PB	23871493				2022-12-28	WOS:000324742200009
J	Cefalu, WT; Leiter, LA; Yoon, KH; Arias, P; Niskanen, L; Xie, J; Balis, DA; Canovatchel, W; Meininger, G				Cefalu, William T.; Leiter, Lawrence A.; Yoon, Kun-Ho; Arias, Pablo; Niskanen, Leo; Xie, John; Balis, Dainius A.; Canovatchel, William; Meininger, Gary			Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial	LANCET			English	Article							COTRANSPORTER 2 INHIBITOR; GLYCEMIC CONTROL; ADD-ON; MONOTHERAPY; DAPAGLIFLOZIN; MELLITUS; WEIGHT; GLIPIZIDE	Background Sodium-glucose cotransporter 2 (SGLT2) inhibitors improve glycaemia in patients with type 2 diabetes by enhancing urinary glucose excretion. We compared the efficacy and safety of canagliflozin, an SGLT2 inhibitor, with glimepiride in patients with type 2 diabetes inadequately controlled with metformin. Methods We undertook this 52 week, randomised, double-blind, active-controlled, phase 3 non-inferiority trial at 157 centres in 19 countries between Aug 28, 2009, and Dec 21, 2011. Patients aged 18-80 years with type 2 diabetes and glycated haemoglobin A(1c) (HbA(1c)) of 7.0-9.5% on stable metformin were randomly assigned (1:1:1) by computer-generated random sequence via an interactive voice or web response system to receive canagliflozin 100 mg or 300 mg, or glimepiride (up-titrated to 6 mg or 8 mg per day) orally once daily. Patients, study investigators, and local sponsor personnel were masked to treatment. The primary endpoint was change in HbA(1c) from baseline to week 52, with a non-inferiority margin of 0.3% for the comparison of each canagliflozin dose with glimepiride. If non-inferiority was shown, we assessed superiority on the basis of an upper bound of the 95% CI for the difference of each canagliflozin dose versus glimepiride of less than 0.0%. Analysis was done in a modified intention-to-treat population, including all randomised patients who received at least one dose of study drug. This study is registered with ClinicalTrials.gov, number NCT00968812. Findings 1450 of 1452 randomised patients received at least one dose of glimepiride (n=482), canagliflozin 100 mg (n=483), or canagliflozin 300 mg (n=485). For lowering of HbA(1c) at 52 weeks, canagliflozin 100 mg was non-inferior to glimepiride (least-squares mean difference -0.01% [95% CI -0.11 to 0.09]), and canagliflozin 300 mg was superior to glimepiride (-0.12% [-0.22 to -0.02]). 39 (8%) patients had serious adverse events in the glimepiride group versus 24 (5%) in the canagliflozin 100 mg group and 26 (5%) in the 300 mg group. In the canagliflozin 100 mg and 300 mg groups versus the glimepiride group, we recorded a greater number of genital mycotic infections (women: 26 [11%] and 34 [14%] vs five [2%]; men: 17 [7%] and 20 [8%] vs three [1%]), urinary tract infections (31 [6%] for both canagliflozin doses vs 22 [5%]), and osmotic diuresis-related events (pollakiuria: 12 [3%] for both doses vs one [<1%]; polyuria: four [<1%] for both doses vs two [<1%]). Interpretation Canagliflozin provides greater HbA(1c) reduction than does glimepiride, and is well tolerated in patients with type 2 diabetes receiving metformin. These findings support the use of canagliflozin as a viable treatment option for patients who do not achieve sufficient glycaemic control with metformin therapy.	[Cefalu, William T.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Cefalu, William T.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, New Orleans, LA USA; [Leiter, Lawrence A.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Yoon, Kun-Ho] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea; [Arias, Pablo] Univ Nacl Rosario, Sch Med, RA-2000 Rosario, Santa Fe, Argentina; [Arias, Pablo] Litoral Univ, Sch Med, Santa Fe, Argentina; [Niskanen, Leo] Univ Eastern Finland, Kuopio, Finland; [Xie, John; Balis, Dainius A.; Canovatchel, William; Meininger, Gary] Janssen Res & Dev LLC, Raritan, NJ USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Catholic University of Korea; Seoul St. Mary's Hospital; National University of Rosario; University of Eastern Finland; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Cefalu, WT (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	william.cefalu@pbrc.edu	Leiter, Lawrence/AAG-4059-2020		Janssen Research & Development, LLC.	Janssen Research & Development, LLC.	Janssen Research & Development, LLC.	Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Bolinder J, 2012, J CLIN ENDOCR METAB, V97, P1020, DOI 10.1210/jc.2011-2260; Brown JB, 2010, DIABETES CARE, V33, P501, DOI 10.2337/dc09-1749; Charpentier G, 2001, DIABETIC MED, V18, P828, DOI 10.1046/j.1464-5491.2001.00582.x; Clar C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001007; Cook MN, 2007, DIABETIC MED, V24, P350, DOI 10.1111/j.1464-5491.2007.02078.x; Devineni D, 2012, DIABETES OBES METAB, V14, P539, DOI 10.1111/j.1463-1326.2012.01558.x; Devineni D, 2013, J CLIN PHARMACOL, V53, P601, DOI 10.1002/jcph.88; FLETCHER SW, 1993, ANN INTERN MED, V119, P764, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00026; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Jendle J, 2009, DIABETES OBES METAB, V11, P1163, DOI 10.1111/j.1463-1326.2009.01158.x; Liang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030555; Matthews DR, 2010, DIABETES OBES METAB, V12, P780, DOI 10.1111/j.1463-1326.2010.01233.x; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; Nauck MA, 2011, DIABETES CARE, V34, P2015, DOI 10.2337/dc11-0606; Neumiller JJ, 2010, DRUGS, V70, P377, DOI 10.2165/11318680-000000000-00000; Nicolle LE, 2012, CURR MED RES OPIN, V28, P1167, DOI 10.1185/03007995.2012.689956; Nomura S, 2010, J MED CHEM, V53, P6355, DOI 10.1021/jm100332n; Nyirjesy P, 2012, CURR MED RES OPIN, V28, P1173, DOI 10.1185/03007995.2012.697053; Rosenstock J, 2012, DIABETES CARE, V35, P1232, DOI 10.2337/dc11-1926; Rothenberg P, 2010, 46 ANN M EUR ASS STU; Schernthaner G, 2013, DIABETES CARE, V36, P2508, DOI 10.2337/dc12-2491; Sha S, 2011, DIABETES OBES METAB, V13, P669, DOI 10.1111/j.1463-1326.2011.01406.x; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Stenlof K, 2013, DIABETES OBES METAB, V15, P372, DOI 10.1111/dom.12054; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WEIDMANN P, 1992, EUR HEART J, V13, P61, DOI 10.1093/eurheartj/13.suppl_G.61; Wilding J, 2012, DIABETOLOGIA, V55, pS315	30	523	549	2	95	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2013	382	9896					941	950		10.1016/S0140-6736(13)60683-2	http://dx.doi.org/10.1016/S0140-6736(13)60683-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VD	23850055				2022-12-28	WOS:000324238000027
J	Bauch, CT; Oraby, T				Bauch, Chris T.; Oraby, Tamer			Assessing the pandemic potential of MERS-CoV	LANCET			English	Editorial Material							SARS; CORONAVIRUS		[Bauch, Chris T.] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada; [Bauch, Chris T.; Oraby, Tamer] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada	University of Waterloo; University of Guelph	Bauch, CT (corresponding author), Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada.	cbauch@uwaterloo.ca						[Anonymous], 2013, MIDDL E RESP SYNDR C; Bauch CT, 2005, EPIDEMIOLOGY, V16, P791, DOI 10.1097/01.ede.0000181633.80269.4c; Blumberg S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002993; Breban R, 2013, LANCET; Cauchemez S, 2013, Euro Surveill, V18; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Drosten C, 2013, LANCET INFECT DIS; Galvani AP, 2005, NATURE, V438, P293, DOI 10.1038/438293a; Holmes KV, 2005, SCIENCE, V309, P1822, DOI 10.1126/science.1118817; Khan K, 2010, J TRAVEL MED, V17, P75, DOI 10.1111/j.1708-8305.2010.00397.x; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102	13	49	52	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2013	382	9893					662	664		10.1016/S0140-6736(13)61504-4	http://dx.doi.org/10.1016/S0140-6736(13)61504-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206SI	23831143	Green Published, Bronze			2022-12-28	WOS:000323542400005
J	Kong, XQ; Deng, HX; Yan, FY; Kim, J; Swisher, JA; Smit, B; Yaghi, OM; Reimer, JA				Kong, Xueqian; Deng, Hexiang; Yan, Fangyong; Kim, Jihan; Swisher, Joseph A.; Smit, Berend; Yaghi, Omar M.; Reimer, Jeffrey A.			Mapping of Functional Groups in Metal-Organic Frameworks	SCIENCE			English	Article							ECHO DOUBLE-RESONANCE; NMR-SPECTROSCOPY; REDOR NMR	We determined the heterogeneous mesoscale spatial apportionment of functional groups in a series of multivariate metal-organic frameworks (MTV-MOF-5) containing BDC (1,4-benzenedicarboxylate) linkers with different functional groups-B (BDC-NH2), E (BDC-NO2), F [(BDC-(CH3)(2)], H [BDC-(OC3H5)(2)], and I [BDC-(OC7H7)(2)]-using solid-state nuclear magnetic resonance measurements combined with molecular simulations. Our analysis reveals that these methods discern between random (EF), alternating (EI and EHI), and various cluster (BF) forms of functional group apportionments. This combined synthetic, characterization, and computational approach predicts the adsorptive properties of crystalline MTV-MOF systems. This methodology, developed in the context of ordered frameworks, is a first step in resolving the more general problem of spatial disorder in other ordered materials, including mesoporous materials, functionalized polymers, and defect distributions within crystalline solids.	[Kong, Xueqian; Yan, Fangyong; Swisher, Joseph A.; Smit, Berend; Reimer, Jeffrey A.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Kong, Xueqian; Reimer, Jeffrey A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Environm Energy Technol Div, Berkeley, CA 94720 USA; [Deng, Hexiang; Smit, Berend; Yaghi, Omar M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Deng, Hexiang; Yan, Fangyong; Kim, Jihan; Swisher, Joseph A.; Smit, Berend; Yaghi, Omar M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Yaghi, Omar M.] NanoCentury KAIST Inst, Taejon 305701, South Korea; [Yaghi, Omar M.] World Class Univ, Grad Sch Energy Environm Water & Sustainabil, Taejon 305701, South Korea	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Korea Advanced Institute of Science & Technology (KAIST)	Yaghi, OM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	yaghi@berkeley.edu; reimer@berkeley.edu	Kim, Jihan/AAE-6280-2021; EFRC, CGS/I-6680-2012; Deng, Hexiang/N-5616-2017; Stangl, Kristin/D-1502-2015; Kim, Jihan/H-8002-2013; Yaghi, Omar M/C-6749-2013; Smit, Berend/B-7580-2009; Kong, Xueqian/P-3152-2018	Deng, Hexiang/0000-0002-9398-7996; Smit, Berend/0000-0003-4653-8562; Kong, Xueqian/0000-0002-1901-9073; Yaghi, Omar/0000-0002-5611-3325	Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001015]; BASF SE (Ludwigshafen, Germany)	Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); BASF SE (Ludwigshafen, Germany)	This research was supported through the Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-SC0001015, and the synthesis effort (H.D.) was partially supported by BASF SE (Ludwigshafen, Germany). For all computations, we used the resources of the National Energy Research Scientific Computing Center (NERSC). We thank W. Morris, C. Stevens, and H. Furukawa for their invaluable assistance.	Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Cegelski L, 2010, J AM CHEM SOC, V132, P16052, DOI 10.1021/ja104827k; Deng HX, 2010, SCIENCE, V327, P846, DOI 10.1126/science.1181761; Frenkel D., 2000, UNDERSTANDING MOL SI; GULLION T, 1989, J MAGN RESON, V81, P196, DOI 10.1016/0022-2364(89)90280-1; Hemminger J., 2012, QUANTA CONTINUUM OPP; Jaroniec CP, 2000, J MAGN RESON, V146, P132, DOI 10.1006/jmre.2000.2128; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Loos S, 2012, ACTA CRYSTALLOGR E, V68, P02501, DOI 10.1107/S1600536812031431; Louie EA, 2006, J MAGN RESON, V178, P11, DOI 10.1016/j.jmr.2005.06.018; MUELLER KT, 1995, J MAGN RESON SER A, V113, P81, DOI 10.1006/jmra.1995.1059	12	341	349	51	1181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2013	341	6148					882	885		10.1126/science.1238339	http://dx.doi.org/10.1126/science.1238339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23887875	Green Published, Green Submitted			2022-12-28	WOS:000323370600041
J	Cargnello, M; Doan-Nguyen, VVT; Gordon, TR; Diaz, RE; Stach, EA; Gorte, RJ; Fornasiero, P; Murray, CB				Cargnello, Matteo; Doan-Nguyen, Vicky V. T.; Gordon, Thomas R.; Diaz, Rosa E.; Stach, Eric A.; Gorte, Raymond J.; Fornasiero, Paolo; Murray, Christopher B.			Control of Metal Nanocrystal Size Reveals Metal-Support Interface Role for Ceria Catalysts	SCIENCE			English	Article							CO OXIDATION-KINETICS; GAS SHIFT CATALYSIS; NANOPARTICLES; RH; PRESSURE; AU; PD	Interactions between ceria (CeO2) and supported metals greatly enhance rates for a number of important reactions. However, direct relationships between structure and function in these catalysts have been difficult to extract because the samples studied either were heterogeneous or were model systems dissimilar to working catalysts. We report rate measurements on samples in which the length of the ceria-metal interface was tailored by the use of monodisperse nickel, palladium, and platinum nanocrystals. We found that carbon monoxide oxidation in ceria-based catalysts is greatly enhanced at the ceria-metal interface sites for a range of group VIII metal catalysts, clarifying the pivotal role played by the support.	[Cargnello, Matteo; Fornasiero, Paolo] Univ Trieste, Dept Chem & Pharmaceut Sci, ICCOM CNR, Consortium INSTM, I-34127 Trieste, Italy; [Cargnello, Matteo; Doan-Nguyen, Vicky V. T.; Murray, Christopher B.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Gordon, Thomas R.; Murray, Christopher B.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Diaz, Rosa E.; Stach, Eric A.] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [Gorte, Raymond J.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA	Consiglio Nazionale delle Ricerche (CNR); Isituto di Chimica dei Composti Organometallici (ICCOM-CNR); University of Trieste; University of Pennsylvania; University of Pennsylvania; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Pennsylvania	Fornasiero, P (corresponding author), Univ Trieste, Dept Chem & Pharmaceut Sci, ICCOM CNR, Consortium INSTM, I-34127 Trieste, Italy.	pfornasiero@units.it; cbmurray@sas.upenn.edu	Fornasiero, Paolo/J-5758-2019; Stach, Eric A/D-8545-2011; Gordon, Thomas R/H-2924-2012; Fornasiero, Paolo/B-7279-2011; Doan-Nguyen, Vicky/AAY-6277-2020; Stach, Eric Andrew/M-6455-2019	Fornasiero, Paolo/0000-0003-1082-9157; Stach, Eric A/0000-0002-3366-2153; Fornasiero, Paolo/0000-0003-1082-9157; Doan-Nguyen, Vicky/0000-0003-4204-3271; Stach, Eric Andrew/0000-0002-3366-2153; Cargnello, Matteo/0000-0002-7344-9031	University of Trieste through FRA project; COST Action [CM1104]; U.S. Department of Energy's Advanced Research Projects Agency, Energy (ARPA-E) [DE-AR0000123]; NSF through the Nano/Bio Interface Center at the University of Pennsylvania [DMR08-32802]; Air Force Office of Scientific Research Multidisciplinary University Initiative [FA9550-08-1-0309]; Richard Perry University; U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-98CH10886]	University of Trieste through FRA project; COST Action(European Cooperation in Science and Technology (COST)); U.S. Department of Energy's Advanced Research Projects Agency, Energy (ARPA-E); NSF through the Nano/Bio Interface Center at the University of Pennsylvania; Air Force Office of Scientific Research Multidisciplinary University Initiative; Richard Perry University; U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank M. Graziani, T. Montini (University of Trieste), B. Diroll, and K. Bakhmutsky (University of Pennsylvania) for discussions and help. Supported by University of Trieste through FRA project and COST Action CM1104 (M. C. and P. F.); the U.S. Department of Energy's Advanced Research Projects Agency, Energy (ARPA-E) grant DE-AR0000123 (V.V.T.D.-N.); NSF through the Nano/Bio Interface Center at the University of Pennsylvania, grant DMR08-32802 (T. R. G.); Air Force Office of Scientific Research Multidisciplinary University Initiative grant FA9550-08-1-0309 (R.J.G.); and a Richard Perry University Professorship (C. B. M.). Aberration-corrected EM (R. E. D. and E. A. S.) was carried out at the Center for Functional Nanomaterials, Brookhaven National Laboratory, which is supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under contract DE-AC02-98CH10886. M. C. conceived the idea for the study. M. C. and V.V.T.D.-N. synthesized the metal NCs. M. C. prepared the catalysts and collected the catalytic data. R. E. D. performed TEM, STEM, and ETEM characterization with help from V.V.T.D.-N. and T. R. G. E. A. S. coordinated all TEM studies. T. R. G. prepared the physical model of the NCs. R.J.G., P. F., and C. B. M. supervised the project. M. C. wrote the draft and all authors commented on the data and the manuscript.	Allian AD, 2011, J AM CHEM SOC, V133, P4498, DOI 10.1021/ja110073u; Bunluesin T, 1998, APPL CATAL B-ENVIRON, V15, P107, DOI 10.1016/S0926-3373(97)00040-4; BUNLUESIN T, 1995, J CATAL, V157, P222, DOI 10.1006/jcat.1995.1282; Bunluesin T, 1996, CATAL LETT, V41, P1, DOI 10.1007/BF00811703; Carlsson A, 2006, J PHYS CHEM B, V110, P5286, DOI 10.1021/jp0569537; CHE M, 1989, ADV CATAL, V36, P55, DOI 10.1016/S0360-0564(08)60017-6; Dong AG, 2010, NATURE, V466, P474, DOI 10.1038/nature09188; Freund HJ, 2011, ANGEW CHEM INT EDIT, V50, P10064, DOI 10.1002/anie.201101378; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Gonzalez JC, 2009, ANGEW CHEM INT EDIT, V48, P5313, DOI 10.1002/anie.200901308; Herzing AA, 2008, SCIENCE, V321, P1331, DOI 10.1126/science.1159639; Janssens TVW, 2007, TOP CATAL, V44, P15, DOI 10.1007/s11244-007-0335-3; Kim SW, 2003, NANO LETT, V3, P1289, DOI 10.1021/nl0343405; KOROS RM, 1967, CHEM ENG SCI, V22, P470, DOI 10.1016/0009-2509(67)80134-9; OH SH, 1988, J CATAL, V112, P543, DOI 10.1016/0021-9517(88)90169-8; Oosterbeek H, 2007, PHYS CHEM CHEM PHYS, V9, P3570, DOI 10.1039/b703003g; Qiao BT, 2011, NAT CHEM, V3, P634, DOI [10.1038/nchem.1095, 10.1038/NCHEM.1095]; Shekhar M, 2012, J AM CHEM SOC, V134, P4700, DOI 10.1021/ja210083d; Somorjai GA, 2007, PHYS CHEM CHEM PHYS, V9, P3500, DOI 10.1039/b618805b; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Trovarelli A, 1996, CATAL REV, V38, P439, DOI 10.1080/01614949608006464; Vayssilov GN, 2011, NAT MATER, V10, P310, DOI [10.1038/nmat2976, 10.1038/NMAT2976]; Williams WD, 2010, J AM CHEM SOC, V132, P14018, DOI 10.1021/ja1064262; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566; ZAFIRIS GS, 1993, J CATAL, V143, P86, DOI 10.1006/jcat.1993.1255; ZAFIRIS GS, 1993, J CATAL, V139, P561, DOI 10.1006/jcat.1993.1049	26	935	950	101	1982	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					771	773		10.1126/science.1240148	http://dx.doi.org/10.1126/science.1240148			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23868919				2022-12-28	WOS:000323122200043
J	Singh, R; Ong-Abdullah, M; Low, ETL; Manaf, MAA; Rosli, R; Nookiah, R; Ooi, LCL; Ooi, SE; Chan, KL; Halim, MA; Azizi, N; Nagappan, J; Bacher, B; Lakey, N; Smith, SW; He, D; Hogan, M; Budiman, MA; Lee, EK; DeSalle, R; Kudrna, D; Goicoechea, JL; Wing, RA; Wilson, RK; Fulton, RS; Ordway, JM; Martienssen, RA; Sambanthamurthi, R				Singh, Rajinder; Ong-Abdullah, Meilina; Low, Eng-Ti Leslie; Manaf, Mohamad Arif Abdul; Rosli, Rozana; Nookiah, Rajanaidu; Ooi, Leslie Cheng-Li; Ooi, Siew-Eng; Chan, Kuang-Lim; Halim, Mohd Amin; Azizi, Norazah; Nagappan, Jayanthi; Bacher, Blaire; Lakey, Nathan; Smith, Steven W.; He, Dong; Hogan, Michael; Budiman, Muhammad A.; Lee, Ernest K.; DeSalle, Rob; Kudrna, David; Goicoechea, Jose Luis; Wing, Rod A.; Wilson, Richard K.; Fulton, Robert S.; Ordway, Jared M.; Martienssen, Robert A.; Sambanthamurthi, Ravigadevi			Oil palm genome sequence reveals divergence of interfertile species in Old and New Worlds	NATURE			English	Article							LINKAGE MAPS; MESOCARP; IDENTIFICATION; CONSTRUCTION; ANNOTATION; MATURATION; GENERATION; SOFTWARE; INSIGHTS; PROTEIN	Oil palm is the most productive oil-bearing crop. Although it is planted on only 5% of the total world vegetable oil acreage, palm oil accounts for 33% of vegetable oil and 45% of edible oil worldwide, but increased cultivation competes with dwindling rainforest reserves. We report the 1.8-gigabase (Gb) genome sequence of the African oil palm Elaeis guineensis, the predominant source of worldwide oil production. A total of 1.535 Gb of assembled sequence and transcriptome data from 30 tissue types were used to predict at least 34,802 genes, including oil biosynthesis genes and homologues of WRINKLED1 (WRI1), and other transcriptional regulators(1), which are highly expressed in the kernel. We also report the draft sequence of the South American oil palm Elaeis oleifera, which has the same number of chromosomes (2n=32) and produces fertile interspecific hybrids with E. guineensis(2) but seems to have diverged in the New World. Segmental duplications of chromosome arms define the palaeotetraploid origin of palm trees. The oil palm sequence enables the discovery of genes for important traits as well as somaclonal epigenetic alterations that restrict the use of clones in commercial plantings(3), and should therefore help to achieve sustainability for biofuels and edible oils, reducing the rainforest footprint of this tropical plantation crop.	[Singh, Rajinder; Ong-Abdullah, Meilina; Low, Eng-Ti Leslie; Manaf, Mohamad Arif Abdul; Rosli, Rozana; Nookiah, Rajanaidu; Ooi, Leslie Cheng-Li; Ooi, Siew-Eng; Chan, Kuang-Lim; Halim, Mohd Amin; Azizi, Norazah; Nagappan, Jayanthi; Sambanthamurthi, Ravigadevi] Persiaran Inst, Malaysian Palm Oil Board, Kajang 43000, Selangor, Malaysia; [Bacher, Blaire; Lakey, Nathan; Smith, Steven W.; He, Dong; Hogan, Michael; Budiman, Muhammad A.; Ordway, Jared M.] Orion Genom, St Louis, MO 63108 USA; [Lee, Ernest K.; DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Kudrna, David; Goicoechea, Jose Luis; Wing, Rod A.] Univ Arizona, Arizona Genom Inst, Tucson, AZ 85705 USA; [Wilson, Richard K.; Fulton, Robert S.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Cold Spring Harbor, NY 11724 USA	Malaysian Palm Oil Board; American Museum of Natural History (AMNH); University of Arizona; Washington University (WUSTL); Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu; raviga@mpob.gov.my	Wing, Rod A/Z-2885-2019; Singh, Rajinder/P-9179-2015; Low, Eng Ti Leslie/AHD-7011-2022; Wilson, Richard K./AAF-4139-2019	Wing, Rod A/0000-0001-6633-6226; Singh, Rajinder/0000-0001-9933-4884; Low, Eng Ti Leslie/0000-0003-3414-8401; Wilson, Richard K./0000-0002-1992-1358; Sambanthamurthi, Ravi/0000-0003-3023-9306; Ong-Abdullah, Meilina/0000-0003-4825-5021; Ooi, Leslie/0000-0002-6996-2801; Chan, Kuang-Lim/0000-0002-8419-0432; Lee, Ernest/0000-0002-0974-7763; Ooi, Siew-Eng/0000-0002-6621-5456; Azizi, Norazah/0000-0001-5023-9763	Malaysian Palm Oil Board; NSF [0421604]; Division Of Integrative Organismal Systems [0922738] Funding Source: National Science Foundation	Malaysian Palm Oil Board; NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We acknowledge the contributions of N. Ahmad, M. Marjuni and N. Abdullah for sampling of oil palm materials. We thank MoGene, GeneWorks, Beijing Genome Institute, Tufts University Core Facility and Macrogen for sequencing services. We thank D. Stevenson for discussions. We appreciate the constant support of Y. M. Choo, and the Ministry of Plantation Industries and Commodities, Malaysia. The project was endorsed by the Cabinet Committee on the Competitiveness of the Palm Oil Industry (CCPO) and funded by the Malaysian Palm Oil Board. E. K. L., R. D. and R. A. M. are supported by a grant from NSF 0421604 (Genomics of Comparative Seed Plant Evolution).	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAFOR ME, 1986, J SCI FOOD AGR, V37, P825, DOI 10.1002/jsfa.2740370902; Bedell JA, 2005, PLOS BIOL, V3, P103, DOI 10.1371/journal.pbio.0030013; Bourgis F, 2011, P NATL ACAD SCI USA, V108, P12527, DOI 10.1073/pnas.1106502108; Castilho A, 2000, ANN BOT-LONDON, V85, P837, DOI 10.1006/anbo.2000.1145; Chiu JC, 2006, BIOINFORMATICS, V22, P699, DOI 10.1093/bioinformatics/btk040; Cochard B, 2005, OCL OILS FAT CROP LI, V12, P141, DOI 10.1051/ocl.2005.0141; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corley R. H. V., 2003, OIL PALM, V4th, P1; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dransfield J., 2008, GENERA PALMARUM EVOL; Du JC, 2010, PLANT J, V63, P584, DOI 10.1111/j.1365-313X.2010.04263.x; HARDON J J, 1969, Euphytica, V18, P372, DOI 10.1007/BF00397784; HARTLEY C, 1988, OIL PALM, P47; Ho CL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-381; Jaligot E, 2011, ANN BOT-LONDON, V108, P1453, DOI 10.1093/aob/mcq266; Jansen J, 2005, GENETICS, V170, P2013, DOI 10.1534/genetics.105.041822; Jouannic S, 2005, FEBS LETT, V579, P2709, DOI 10.1016/j.febslet.2005.03.093; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lee EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002411; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Low ETL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-62; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mayes S, 1997, GENOME, V40, P116, DOI 10.1139/g97-016; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Purseglove J. W, 1972, TROPICAL CROPS MONOC, P416; RICHARDS EJ, 1992, NUCLEIC ACIDS RES, V20, P4039, DOI 10.1093/nar/20.15.4039; Riggins CW, 2012, MOL PHYLOGENET EVOL, V64, P471, DOI 10.1016/j.ympev.2012.05.003; Sambanthamurthi R, 2000, PROG LIPID RES, V39, P507, DOI 10.1016/S0163-7827(00)00015-1; Shaarani SM, 2010, INT J AGRIC BIOL, V12, P101; Singh R, 2008, ASIA PAC J MOL BIOL, V16, P53; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tranbarger TJ, 2011, PLANT PHYSIOL, V156, P564, DOI 10.1104/pp.111.175141; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; ZEVEN A C, 1965, Journal of the Nigerian Institute for Oil Palm Research, V4, P218	42	336	360	5	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					335	+		10.1038/nature12309	http://dx.doi.org/10.1038/nature12309			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23883927	hybrid, Green Accepted			2022-12-28	WOS:000323112400033
J	Barve, A; Wagner, A				Barve, Aditya; Wagner, Andreas			A latent capacity for evolutionary innovation through exaptation in metabolic systems	NATURE			English	Article							ESCHERICHIA-COLI; GENOTYPE NETWORKS; EVOLVABILITY; RECRUITMENT; ROBUSTNESS; DATABASE; LIGAND; GENES; KEGG; RNA	Some evolutionary innovations may originate non-adaptively as exaptations, or pre-adaptations, which are by-products of other adaptive traits(1-5). Examples include feathers, which originated before they were used in flight(2), and lens crystallins, which are light-refracting proteins that originated as enzymes(6). The question of how often adaptive traits have non-adaptive origins has profound implications for evolutionary biology, but is difficult to address systematically. Here we consider this issue in metabolism, one of the most ancient biological systems that is central to all life. We analyse a metabolic trait of great adaptive importance: the ability of a metabolic reaction network to synthesize all biomass from a single source of carbon and energy. We use novel computational methods to sample randomly many metabolic networks that can sustain life on any given carbon source but contain an otherwise random set of known biochemical reactions. We show that when we require such networks to be viable on one particular carbon source, they are typically also viable on multiple other carbon sources that were not targets of selection. For example, viability on glucose may entail viability on up to 44 other sole carbon sources. Any one adaptation in these metabolic systems typically entails multiple potential exaptations. Metabolic systems thus contain a latent potential for evolutionary innovations with non-adaptive origins. Our observations suggest that many more metabolic traits may have non-adaptive origins than is appreciated at present. They also challenge our ability to distinguish adaptive from non-adaptive traits.	[Barve, Aditya; Wagner, Andreas] Univ Zurich, Inst Evolutionary Biol & Environm Sci, CH-8057 Zurich, Switzerland; [Barve, Aditya; Wagner, Andreas] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Wagner, Andreas] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Zurich; Swiss Institute of Bioinformatics; The Santa Fe Institute	Wagner, A (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Sci, Bldg Y27,Winterthurerstr 190, CH-8057 Zurich, Switzerland.	andreas.wagner@ieu.uzh.ch			Swiss National Science Foundation [315230-129708]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank K. Raman, N. Sabath, J. L. Payne and J. Rodrigues for discussions. A.W. acknowledges financial support through Swiss National Science Foundation grant 315230-129708.	Aguilar C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-385; Amitai G, 2007, HFSP J, V1, P67, DOI [10.2976/1.2739115/10.2976/1, 10.2976/1.2739115]; Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Barve A, 2012, P NATL ACAD SCI USA, V109, pE1121, DOI 10.1073/pnas.1113065109; Binder K, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-642-03163-2; Cowperthwaite MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000110; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Ferrada E, 2012, BIOPHYS J, V102, P1916, DOI 10.1016/j.bpj.2012.01.047; Goto S, 2002, NUCLEIC ACIDS RES, V30, P402, DOI 10.1093/nar/30.1.402; Goto S, 2000, NUCLEIC ACIDS RES, V28, P380, DOI 10.1093/nar/28.1.380; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; Kim JH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.88; Koskiniemi S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002787; LIPMAN DJ, 1991, P ROY SOC B-BIOL SCI, V245, P7, DOI 10.1098/rspb.1991.0081; Ma HW, 2003, BIOINFORMATICS, V19, P1423, DOI 10.1093/bioinformatics/btg177; Martin OC, 2008, BIOPHYS J, V94, P2927, DOI 10.1529/biophysj.107.114348; Meijnen JP, 2008, APPL ENVIRON MICROB, V74, P5031, DOI 10.1128/AEM.00924-08; Moore E.F., 1959, P INT S SWITCH THEOR, V1959, P285; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; Neidhardt F., 1987, ESCHERICHIA COLI SAL, V1, P13; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Pievani T, 2011, J ANTHROPOL SCI, V89, P9, DOI 10.4436/jass.89015; Poulsen TS, 1999, J BACTERIOL, V181, P7126, DOI 10.1128/JB.181.22.7126-7130.1999; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Rodrigues JFM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-39; Rodrigues JFM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000613; Samal A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-30; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Tomarev SI, 1996, EUR J BIOCHEM, V235, P449, DOI 10.1111/j.1432-1033.1996.00449.x; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262	40	96	96	1	67	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					203	+		10.1038/nature12301	http://dx.doi.org/10.1038/nature12301			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23851393	Green Accepted			2022-12-28	WOS:000322825500034
J	Hendrickson, WA				Hendrickson, Wayne A.			Jerome Karle (1918-2013) OBITUARY	NATURE			English	Biographical-Item									Columbia Univ, New York, NY 10027 USA	Columbia University	Hendrickson, WA (corresponding author), Columbia Univ, New York, NY 10027 USA.	wayne@xtl.cumc.columbia.edu						KARLE J, PUBLICATION LIST	1	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2013	499	7459					410	410		10.1038/499410a	http://dx.doi.org/10.1038/499410a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23887424	Bronze			2022-12-28	WOS:000322157900022
J	Hollenstein, K; Kean, J; Bortolato, A; Cheng, RKY; Dore, AS; Jazayeri, A; Cooke, RM; Weir, M; Marshall, FH				Hollenstein, Kaspar; Kean, James; Bortolato, Andrea; Cheng, Robert K. Y.; Dore, Andrew S.; Jazayeri, Ali; Cooke, Robert M.; Weir, Malcolm; Marshall, Fiona H.			Structure of class B GPCR corticotropin-releasing factor receptor 1	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; MOLECULAR RECOGNITION; PARATHYROID-HORMONE; PEPTIDE RECEPTOR; AGONIST; BINDING; THERMOSTABILIZATION; REFINEMENT; ACTIVATION	Structural analysis of class B G-protein-coupled receptors (GPCRs), cell-surface proteins that respond to peptide hormones, has been restricted to the amino-terminal extracellular domain, thus providing little understanding of the membrane-spanning signal transduction domain. The corticotropin-releasing factor receptor type 1 is a class B receptor which mediates the response to stress and has been considered a drug target for depression and anxiety. Here we report the crystal structure of the transmembrane domain of the human corticotropin-releasing factor receptor type 1 incomplex with the small-molecule antagonist CP-376395. The structure provides detailed insight into the architecture of class B receptors. Atomic details of the interactions of the receptor with the non-peptide ligand that binds deep within the receptor are described. This structure provides a model for all class B GPCRs and may aid in the design of new small-molecule drugs for diseases of brain and metabolism.	[Hollenstein, Kaspar; Kean, James; Bortolato, Andrea; Cheng, Robert K. Y.; Dore, Andrew S.; Jazayeri, Ali; Cooke, Robert M.; Weir, Malcolm; Marshall, Fiona H.] Heptares Therapeut Ltd, Welwyn Garden City AL7 3AX, Herts, England	Heptares Therapeutics Ltd.	Marshall, FH (corresponding author), Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England.	fiona.marshall@heptares.com	Marshall, Fiona/AAZ-9626-2020	Hollenstein, Kaspar/0000-0001-7606-4105; Marshall, Fiona/0000-0002-8681-005X				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berg C, 2003, NAT REV DRUG DISCOV, V2, P257, DOI 10.1038/nrd1068; Bhavsar S, 2013, CURR DIABETES REV, V9, P161; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YL, 2008, J MED CHEM, V51, P1385, DOI 10.1021/jm070579c; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chugunov AO, 2010, MOL PHARMACOL, V78, P394, DOI 10.1124/mol.110.063578; Congreve M, 2011, ADV PHARMACOL, V62, P1, DOI 10.1016/B978-0-12-385952-5.00011-7; Conner AC, 2005, MOL PHARMACOL, V67, P20, DOI 10.1124/mol.67.1.20; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ganguli SC, 1998, J PHARMACOL EXP THER, V286, P593; Gardella TJ, 1996, J BIOL CHEM, V271, P12820, DOI 10.1074/jbc.271.22.12820; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Haddadian EJ, 2011, BIOPHYS J, V101, P899, DOI 10.1016/j.bpj.2011.06.063; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Heller RS, 1996, BIOCHEM BIOPH RES CO, V223, P624, DOI 10.1006/bbrc.1996.0945; Hemley CF, 2007, CURR DRUG TARGETS, V8, P105, DOI 10.2174/138945007779315542; Hjorth SA, 1998, MOL ENDOCRINOL, V12, P78, DOI 10.1210/mend.12.1.0045; Hoare SRJ, 2008, MOL PHARMACOL, V73, P1371, DOI 10.1124/mol.107.042978; Hoare SRJ, 2006, BIOCHEM PHARMACOL, V72, P244, DOI 10.1016/j.bcp.2006.04.007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019682; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Mann RJ, 2010, PEPTIDES, V31, P2289, DOI 10.1016/j.peptides.2010.09.015; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Piserchio A, 2000, BIOCHEMISTRY-US, V39, P8153, DOI 10.1021/bi000196f; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vohra S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0846; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Zorrilla EP, 2010, DRUG DISCOV TODAY, V15, P371, DOI 10.1016/j.drudis.2010.02.011	55	336	346	1	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					438	+		10.1038/nature12357	http://dx.doi.org/10.1038/nature12357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23863939				2022-12-28	WOS:000322157900032
J	Morden, NE; Schwartz, LM; Fisher, ES; Woloshin, S				Morden, Nancy E.; Schwartz, Lisa M.; Fisher, Elliott S.; Woloshin, Steven			Accountable Prescribing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								<p id="p002">To avoid rewarding poor prescribing, we should move beyond numerically driven quality measures to measures that match treatment goals to the best evidence and encourage use of the safest, most effective, and lowest-cost drugs or nondrug treatments. <p id="p003">Physicians spend a lot of time treating numbers blood pressure, cholesterol levels, glycated hemoglobin levels. Professional guidelines, pharmaceutical marketing, and public health campaigns teach physicians and patients that better numbers mean success. Unfortunately, better numbers don't reliably translate into what really matters: patients who feel better and live longer. Often the health benefit gained by reaching a goal depends on how it is reached. When physicians strive for numerical goals without prioritizing the possible treatment strategies, patients may get less effective, less safe, or even unnecessary medications. <p id="p004">Many quality measures reinforce a focus on numerical goals. For example, performance-measure ...	[Morden, Nancy E.; Schwartz, Lisa M.; Fisher, Elliott S.; Woloshin, Steven] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Morden, Nancy E.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Morden, Nancy E.; Schwartz, Lisa M.; Fisher, Elliott S.; Woloshin, Steven] Geisel Sch Med, Dept Community & Family Med, Hanover, NH USA; [Schwartz, Lisa M.; Woloshin, Steven] Affairs Outcomes Grp, White River Jct, VT USA	Dartmouth College; Dartmouth College; Dartmouth College	Morden, NE (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA.				NIA NIH HHS [K23 AG035030, P01 AG019783] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K23AG035030, P01AG019783] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2007, ACT PIOGL HYDR TABL; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Fisher ES, 2011, NEW ENGL J MED, V365, P2445, DOI 10.1056/NEJMp1112442	3	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					299	302		10.1056/NEJMp1301805	http://dx.doi.org/10.1056/NEJMp1301805			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	188VJ	23883375	Green Accepted, Bronze			2022-12-28	WOS:000322223900003
J							Drug Therapeutics Bulletin	FROM DRUG AND THERAPEUTICS BULLETIN An introduction to patient decision aids	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Drug & Therapeut Bulletin Editorial Off, London WC1H 9JR, England		Drug & Therapeut Bulletin Editorial Off, London WC1H 9JR, England.			Gupta, Vivek/0000-0002-0202-7843				Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Chewning B, 2012, PATIENT EDUC COUNS, V86, P9, DOI 10.1016/j.pec.2011.02.004; Coulter A., 2011, MAKING SHARED DECISI; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; International Patient Decision Aids Standards Collaboration, 2005, CRIT JUDG QUAL PAT D; Legare F, 2008, PATIENT EDUC COUNS, V73, P526, DOI 10.1016/j.pec.2008.07.018; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Say R, 2006, PATIENT EDUC COUNS, V60, P102, DOI 10.1016/j.pec.2005.02.003; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181	10	48	49	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2013	347								f4147	10.1136/bmj.f4147	http://dx.doi.org/10.1136/bmj.f4147			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	192YR	23881944				2022-12-28	WOS:000322524400001
J	Baggett, TP; Tobey, ML; Rigotti, NA				Baggett, Travis P.; Tobey, Matthew L.; Rigotti, Nancy A.			Tobacco Use among Homeless People - Addressing the Neglected Addiction	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SMOKING		[Baggett, Travis P.; Rigotti, Nancy A.] Massachusetts Gen Hosp, Div Gen Med, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA; [Tobey, Matthew L.] Massachusetts Gen Hosp, Global Primary Care Program, Boston, MA 02114 USA; [Baggett, Travis P.; Rigotti, Nancy A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Baggett, Travis P.] Boston Hlth Care Homeless Program, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Baggett, TP (corresponding author), Massachusetts Gen Hosp, Div Gen Med, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA.							Apollonio DE, 2005, TOB CONTROL, V14, P409, DOI 10.1136/tc.2005.011890; Arnsten JH, 2004, ADDICT BEHAV, V29, P1155, DOI 10.1016/j.addbeh.2004.03.010; Baggett TP, 2012, J HEALTH CARE POOR U, V23, P1650, DOI 10.1353/hpu.2012.0162; Baggett TP, 2010, AM J PREV MED, V39, P164, DOI 10.1016/j.amepre.2010.03.024; Hwang SW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4036	5	71	71	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	2013	369	3					201	204		10.1056/NEJMp1301935	http://dx.doi.org/10.1056/NEJMp1301935			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	185DQ	23863048				2022-12-28	WOS:000321945800002
J	Gangireddy, VGR; Coleman, T				Gangireddy, Venu Gopala Reddy; Coleman, Teresa			Congenital Melanocytic Nevus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gangireddy, Venu Gopala Reddy; Coleman, Teresa] Georgia Regents Univ, Augusta, GA USA	University System of Georgia; Augusta University	Gangireddy, VGR (corresponding author), Georgia Regents Univ, Augusta, GA USA.	venureddy82@gmail.com	Gangireddy, Venu Gopala Reddy/I-1460-2019	Gangireddy, Venu Gopala Reddy/0000-0001-6656-216X					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	2013	369	3					264	264		10.1056/NEJMicm1204915	http://dx.doi.org/10.1056/NEJMicm1204915			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DQ	23863053				2022-12-28	WOS:000321945800012
J	Galagan, JE; Minch, K; Peterson, M; Lyubetskaya, A; Azizi, E; Sweet, L; Gomes, A; Rustad, T; Dolganov, G; Glotova, I; Abeel, T; Mahwinney, C; Kennedy, AD; Allard, R; Brabant, W; Krueger, A; Jaini, S; Honda, B; Yu, WH; Hickey, MJ; Zucker, J; Garay, C; Weiner, B; Sisk, P; Stolte, C; Winkler, JK; Van de Peer, Y; Iazzetti, P; Camacho, D; Dreyfuss, J; Liu, Y; Dorhoi, A; Mollenkopf, HJ; Drogaris, P; Lamontagne, J; Zhou, YY; Piquenot, J; Park, ST; Raman, S; Kaufmann, SHE; Mohney, RP; Chelsky, D; Moody, DB; Sherman, DR; Schoolnik, GK				Galagan, James E.; Minch, Kyle; Peterson, Matthew; Lyubetskaya, Anna; Azizi, Elham; Sweet, Linsday; Gomes, Antonio; Rustad, Tige; Dolganov, Gregory; Glotova, Irina; Abeel, Thomas; Mahwinney, Chris; Kennedy, Adam D.; Allard, Rene; Brabant, William; Krueger, Andrew; Jaini, Suma; Honda, Brent; Yu, Wen-Han; Hickey, Mark J.; Zucker, Jeremy; Garay, Christopher; Weiner, Brian; Sisk, Peter; Stolte, Christian; Winkler, Jessica K.; Van de Peer, Yves; Iazzetti, Paul; Camacho, Diogo; Dreyfuss, Jonathan; Liu, Yang; Dorhoi, Anca; Mollenkopf, Hans-Joachim; Drogaris, Paul; Lamontagne, Julie; Zhou, Yiyong; Piquenot, Julie; Park, Sang Tae; Raman, Sahadevan; Kaufmann, Stefan H. E.; Mohney, Robert P.; Chelsky, Daniel; Moody, D. Branch; Sherman, David R.; Schoolnik, Gary K.			The Mycobacterium tuberculosis regulatory network and hypoxia	NATURE			English	Article							CONTROLLING GENE-EXPRESSION; FREE MYCOLIC ACIDS; DEVR DOSR REGULON; VIRULENCE; CHOLESTEROL; INSIGHTS; PROTEIN; PHOP; BIOSYNTHESIS; MACROPHAGES	We have taken the first steps towards a complete reconstruction of the Mycobacterium tuberculosis regulatory network based on ChIP-Seq and combined this reconstruction with system-wide profiling of messenger RNAs, proteins, metabolites and lipids during hypoxia and re-aeration. Adaptations to hypoxia are thought to have a prominent role in M. tuberculosis pathogenesis. Using ChIP-Seq combined with expression data from the induction of the same factors, we have reconstructed a draft regulatory network based on 50 transcription factors. This network model revealed a direct interconnection between the hypoxic response, lipid catabolism, lipid anabolism and the production of cell wall lipids. As a validation of this model, in response to oxygen availability we observe substantial alterations in lipid content and changes in gene expression and metabolites in corresponding metabolic pathways. The regulatory network reveals transcription factors underlying these changes, allows us to computationally predict expression changes, and indicates that Rv0081 is a regulatory hub.	[Galagan, James E.; Peterson, Matthew; Mahwinney, Chris; Krueger, Andrew; Jaini, Suma; Honda, Brent; Yu, Wen-Han; Garay, Christopher; Iazzetti, Paul; Camacho, Diogo; Dreyfuss, Jonathan] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Galagan, James E.; Park, Sang Tae; Raman, Sahadevan] Boston Univ, Dept Microbiol, Boston, MA 02215 USA; [Galagan, James E.; Lyubetskaya, Anna; Azizi, Elham; Gomes, Antonio; Glotova, Irina] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Galagan, James E.; Abeel, Thomas; Zucker, Jeremy; Weiner, Brian; Sisk, Peter; Stolte, Christian] Eli & Edythe L Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Minch, Kyle; Rustad, Tige; Brabant, William; Hickey, Mark J.; Winkler, Jessica K.; Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Sweet, Linsday; Moody, D. Branch] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Sweet, Linsday; Moody, D. Branch] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Dolganov, Gregory; Liu, Yang; Schoolnik, Gary K.] Stanford Med Sch, Dept Med, Stanford, CA 94305 USA; [Dolganov, Gregory; Liu, Yang; Schoolnik, Gary K.] Stanford Med Sch, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Abeel, Thomas; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Kennedy, Adam D.; Mohney, Robert P.] Metabolon Inc, Durham, NC 27713 USA; [Allard, Rene; Drogaris, Paul; Lamontagne, Julie; Zhou, Yiyong; Piquenot, Julie; Chelsky, Daniel] Capr Prote Inc, Montreal, PQ H4S 2C8, Canada; [Dorhoi, Anca; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany; [Mollenkopf, Hans-Joachim] Max Planck Inst Infect Biol, Microarray Core Facil, D-10117 Berlin, Germany; [Sherman, David R.] Univ Washington, Dept Global Hlth, Interdisciplinary Program Pathobiol, Seattle, WA 98195 USA; [Schoolnik, Gary K.] Stanford Med Sch, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA	Boston University; Boston University; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Center for Infectious Disease Research; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Stanford University; Stanford University; Ghent University; Metabolon; Max Planck Society; Max Planck Society; University of Washington; University of Washington Seattle; Stanford University	Galagan, JE (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	jgalag@bu.edu	Lyubetskaya, Anna/A-6290-2017; Van de Peer, Yves/AAE-7666-2019; Zucker, Jeremy/M-3643-2016; Mollenkopf, Hans-Joachim/AAH-2500-2019; Van de Peer, Yves/D-4388-2009; Kaufmann, Stefan HE/I-5454-2014	Van de Peer, Yves/0000-0003-4327-3730; Zucker, Jeremy/0000-0002-7276-9009; Van de Peer, Yves/0000-0003-4327-3730; Raman, Sahadevan/0000-0001-5309-8169; Dreyfuss, Jonathan/0000-0001-7242-3991; Galagan, James/0000-0003-0542-3291; Gomes, Antonio LC/0000-0003-3790-3724; Mollenkopf, Hans-Joachim/0000-0003-1167-4783; Abeel, Thomas/0000-0002-7205-7431; Azizi, Elham/0000-0001-5059-6971; Camacho, Diogo/0000-0002-1971-3524; Stolte, Christian/0000-0002-8228-4195; Lyubetskaya, Anna/0000-0003-2485-3924; Yu, Wen-Han/0000-0002-1671-9744; Garay, Christopher/0000-0002-2682-5508; Kaufmann, Stefan HE/0000-0001-9866-8268	National Institute of Allergy and Infectious Diseases National Institute of Health, Department of Health and Human Services [HHSN272200800059C, U19 AI 076217, R01 AI 071155]; Paul G. Allen Family Foundation; National Science Foundation Pre-doctoral Fellowship Program; Burroughs Wellcome Fund Award for Translational Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071155, U19AI076217, T32AI007509] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases National Institute of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Paul G. Allen Family Foundation; National Science Foundation Pre-doctoral Fellowship Program(National Science Foundation (NSF)); Burroughs Wellcome Fund Award for Translational Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases National Institute of Health, Department of Health and Human Services, under contract no. HHSN272200800059C and U19 AI 076217, R01 AI 071155, the Paul G. Allen Family Foundation (to DRS), the National Science Foundation Pre-doctoral Fellowship Program (to K. M.), and the Burroughs Wellcome Fund Award for Translational Research. We acknowledge D. C. Young for lipidomics mass spectrometry services and advice. We would also like to thank L. Carvalho for his advice on the statistical analysis of the gene expression modelling. We are grateful for the administrative assistance of S. Shiviah and S. Tucker and for the support and advice of V. Di Francesco, K. Lacourciere, P. Dudley and M. Polanski.	Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; Arnvig KB, 2012, RNA BIOL, V9, P427, DOI 10.4161/rna.20105; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Cho BK, 2012, NAT CHEM BIOL, V8, P65, DOI 10.1038/nchembio.710; Colangeli R, 2009, P NATL ACAD SCI USA, V106, P4414, DOI 10.1073/pnas.0810126106; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Ehrt S, 2006, FUTURE MICROBIOL, V1, P177, DOI 10.2217/17460913.1.2.177; Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Galagan J, 2013, CURR TOP MICROBIOL, V363, P43, DOI 10.1007/82_2012_257; Gao CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036255; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Gautam US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016500; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P5154, DOI 10.1073/pnas.0913551107; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Klotzsche M, 2009, NUCLEIC ACIDS RES, V37, P1778, DOI 10.1093/nar/gkp015; Low KL, 2009, J BACTERIOL, V191, P5037, DOI 10.1128/JB.00530-09; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miner MD, 2009, INDIAN J EXP BIOL, V47, P407; Nazarova EV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P636, DOI 10.1134/S0006297911060034; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Ojha AK, 2010, J BIOL CHEM, V285, P17380, DOI 10.1074/jbc.M110.112813; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rousseau C, 2004, CELL MICROBIOL, V6, P277, DOI 10.1046/j.1462-5822.2004.00368.x; Russell DG, 2002, J CELL BIOL, V158, P421, DOI 10.1083/jcb.200205034; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Ryndak M, 2008, TRENDS MICROBIOL, V16, P528, DOI 10.1016/j.tim.2008.08.006; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Vasudeva-Rao HM, 2008, INFECT IMMUN, V76, P2478, DOI 10.1128/IAI.01443-07; Yang XX, 2009, BIOCHEMISTRY-US, V48, P3819, DOI 10.1021/bi9005418	46	297	299	4	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					178	183		10.1038/nature12337	http://dx.doi.org/10.1038/nature12337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23823726	Green Accepted			2022-12-28	WOS:000321557600055
J	Quaynor, SD; Stradtman, EW; Kim, HG; Shen, YP; Chorich, LP; Schreihofer, DA; Layman, LC				Quaynor, Samuel D.; Stradtman, Earl W., Jr.; Kim, Hyung-Goo; Shen, Yiping; Chorich, Lynn P.; Schreihofer, Derek A.; Layman, Lawrence C.			Delayed Puberty and Estrogen Resistance in a Woman with Estrogen Receptor alpha Variant	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE; CLONING; BETA; MUTATION; FEMALE; MOUSE; CDNA; MICE	Although androgen resistance has been characterized in men with a normal chromosome complement and mutations in the androgen-receptor gene, a mutation in the gene encoding estrogen receptor a (ESR1) was previously described only in one man and not, to our knowledge, in a woman. We now describe an 18-year-old woman without breast development and with markedly elevated serum levels of estrogens and bilateral multicystic ovaries. She was found to have a homozygous loss-of-function ESR1 mutation in a completely conserved residue that interferes with estrogen signaling. Her clinical presentation was similar to that in the mouse orthologue knockout. This case shows that disruption of ESR1 causes profound estrogen resistance in women. (Funded by the National Institutes of Health.)	[Quaynor, Samuel D.; Kim, Hyung-Goo; Chorich, Lynn P.; Layman, Lawrence C.] Georgia Regents Univ, Sect Reprod Endocrinol Infertil & Genet, Dept Obstet & Gynecol, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Quaynor, Samuel D.; Kim, Hyung-Goo; Chorich, Lynn P.; Layman, Lawrence C.] Georgia Regents Univ, Neurosci Program, Med Coll Georgia, Augusta, GA 30912 USA; [Shen, Yiping] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Shen, Yiping] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Shanghai 200030, Peoples R China; [Schreihofer, Derek A.] Univ N Texas, Dept Pharmacol & Neurosci, Hlth Sci Ctr Ft Worth, Ft Worth, TX USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Harvard University; Harvard Medical School; Shanghai Jiao Tong University; University of North Texas System; University of North Texas Health Science Center	Layman, LC (corresponding author), Georgia Regents Univ, Sect Reprod Endocrinol Infertil & Genet, Dept Obstet & Gynecol, 1120 15th St, Augusta, GA 30912 USA.	lalayman@gru.edu			National Institutes of Health [HD33004]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD033004] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD033004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by a grant from the National Institutes of Health (HD33004, to Dr. Layman).	BROWN TR, 1988, P NATL ACAD SCI USA, V85, P8151, DOI 10.1073/pnas.85.21.8151; CHAREST NJ, 1991, MOL ENDOCRINOL, V5, P573, DOI 10.1210/mend-5-4-573; Christian CA, 2008, ENDOCRINOLOGY, V149, P5328, DOI 10.1210/en.2008-0520; Durbin Kaci L, 2011, J Pediatr Adolesc Gynecol, V24, pe93, DOI 10.1016/j.jpag.2010.08.003; GREEN S, 1986, J STEROID BIOCHEM, V24, P77, DOI 10.1016/0022-4731(86)90035-X; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; ITO Y, 1993, P NATL ACAD SCI USA, V90, P11673, DOI 10.1073/pnas.90.24.11673; Katsuki A, 2001, DIABETES CARE, V24, P362, DOI 10.2337/diacare.24.2.362; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; KING WJ, 1984, NATURE, V307, P745, DOI 10.1038/307745a0; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Layman LC, 1997, NEW ENGL J MED, V337, P607, DOI 10.1056/NEJM199708283370905; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; PATTERSON MN, 1994, NUCLEIC ACIDS RES, V22, P3560; Schreihofer DA, 2005, MOL CELL ENDOCRINOL, V231, P13, DOI 10.1016/j.mce.2004.12.006; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Smith EP, 2008, J CLIN ENDOCR METAB, V93, P3088, DOI 10.1210/jc.2007-2397; Sund KL, 2013, GENET MED, V15, P70, DOI 10.1038/gim.2012.94; TOFT D, 1966, P NATL ACAD SCI USA, V55, P1574, DOI 10.1073/pnas.55.6.1574; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; WALTER P, 1985, P NATL ACAD SCI USA, V82, P7889, DOI 10.1073/pnas.82.23.7889	25	83	86	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					164	171		10.1056/NEJMoa1303611	http://dx.doi.org/10.1056/NEJMoa1303611			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180BH	23841731	Green Accepted			2022-12-28	WOS:000321567300012
J	Bosland, MC; Kato, I; Zeleniuch-Jacquotte, A; Schmoll, J; Rueter, EE; Melamed, J; Kong, MX; Macias, V; Kajdacsy-Balla, A; Lumey, LH; Xie, H; Gao, WH; Walden, P; Lepor, H; Taneja, SS; Randolph, C; Schlicht, MJ; Meserve-Watanabe, H; Deaton, RJ; Davies, JA				Bosland, Maarten C.; Kato, Ikuko; Zeleniuch-Jacquotte, Anne; Schmoll, Joanne; Rueter, Erika Enk; Melamed, Jonathan; Kong, Max Xiangtian; Macias, Virgilia; Kajdacsy-Balla, Andre; Lumey, L. H.; Xie, Hui; Gao, Weihua; Walden, Paul; Lepor, Herbert; Taneja, Samir S.; Randolph, Carla; Schlicht, Michael J.; Meserve-Watanabe, Hiroko; Deaton, Ryan J.; Davies, Joanne A.			Effect of Soy Protein Isolate Supplementation on Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHASE-II TRIAL; HPLC ANALYSIS; ANTIGEN; MEN; ISOFLAVONES; CONSUMPTION; PHYTOESTROGENS; TISSUE; RISK; CHEMOPREVENTION	IMPORTANCE Soy consumption has been suggested to reduce risk or recurrence of prostate cancer, but this has not been tested in a randomized trial with prostate cancer as the end point. OBJECTIVE To determine whether daily consumption of a soy protein isolate supplement for 2 years reduces the rate of biochemical recurrence of prostate cancer after radical prostatectomy or delays such recurrence. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind trial conducted from July 1997 to May 2010 at 7 US centers comparing daily consumption of a soy protein supplement vs placebo in 177 men at high risk of recurrence after radical prostatectomy for prostate cancer. Supplement intervention was started within 4 months after surgery and continued for up to 2 years, with prostate-specific antigen (PSA) measurements made at 2-month intervals in the first year and every 3 months thereafter. INTERVENTION Participants were randomized to receive a daily serving of a beverage powder containing 20 g of protein in the form of either soy protein isolate (n=87) or, as placebo, calcium caseinate (n=90). MAIN OUTCOMES AND MEASURES Biochemical recurrence rate of prostate cancer (defined as development of a PSA level of >= 0.07 ng/mL) over the first 2 years following randomization and time to recurrence. RESULTS The trial was stopped early for lack of treatment effects at a planned interim analysis with 81 evaluable participants in the intervention group and 78 in the placebo group. Overall, 28.3% of participants developed biochemical recurrence within 2 years of entering the trial (close to the a priori predicted recurrence rate of 30%). Among these, 22 (27.2%) occurred in the intervention group and 23 (29.5%) in the placebo group. The resulting hazard ratio for active treatment was 0.96 (95% CI, 0.53-1.72; log-rank P = .89). Adherence was greater than 90% and there were no apparent adverse events related to supplementation. CONCLUSION AND RELEVANCE Daily consumption of a beverage powder supplement containing soy protein isolate for 2 years following radical prostatectomy did not reduce biochemical recurrence of prostate cancer in men at high risk of PSA failure.	[Bosland, Maarten C.; Rueter, Erika Enk; Macias, Virgilia; Kajdacsy-Balla, Andre; Schlicht, Michael J.; Deaton, Ryan J.] Univ Illinois, Dept Pathol, Coll Med, Chicago, IL 60612 USA; [Xie, Hui; Gao, Weihua] Univ Illinois, Sch Publ Hlth, Dept Epidemiol & Biostat, Chicago, IL 60612 USA; [Kato, Ikuko] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Kato, Ikuko] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Bosland, Maarten C.; Schmoll, Joanne; Randolph, Carla; Meserve-Watanabe, Hiroko; Davies, Joanne A.] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Melamed, Jonathan; Kong, Max Xiangtian] NYU, Sch Med, Dept Pathol, New York, NY USA; [Zeleniuch-Jacquotte, Anne] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Bosland, Maarten C.; Walden, Paul; Lepor, Herbert; Taneja, Samir S.] NYU, Sch Med, Dept Urol, New York, NY 10003 USA; [Lumey, L. H.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Wayne State University; Wayne State University; New York University; New York University; New York University; New York University; Columbia University	Bosland, MC (corresponding author), Univ Illinois, Dept Pathol, 840 S Wood St,Room 130 CSN,MC 847, Chicago, IL 60612 USA.	boslandm@uic.edu	Gao, Wei/GXH-0380-2022; Melamed, Jonathan/AAV-3769-2020	Melamed, Jonathan/0000-0003-2844-7990; , hui/0000-0003-3328-7135; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303	National Institute of Health [U01 CA072290, R01 CA166195, P50 CA16087, UL1 TR000050]; NATIONAL CANCER INSTITUTE [U01CA072290, P30CA016087, R01CA116195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000050] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by National Institute of Health grants U01 CA072290 and R01 CA166195 as well as National Institute of Health grants P50 CA16087 and UL1 TR000050, with minor support from the Prevent Cancer Foundation and the United Soybean Board. Solae LLC provided the intervention materials.	Adams KF, 2004, CANCER EPIDEM BIOMAR, V13, P644; [Anonymous], 2006, DIETARY REFERENCE IN; Arcangeli CG, 1997, J UROLOGY, V158, P2182, DOI 10.1016/S0022-5347(01)68191-6; BARNES S, 1995, J CELL BIOCHEM, P181; BEGG CB, 1980, BIOMETRICS, V36, P81, DOI 10.2307/2530497; Bektic Jasmin, 2005, Clin Prostate Cancer, V4, P124, DOI 10.3816/CGC.2005.n.021; Franke AA, 1998, P SOC EXP BIOL MED, V217, P263, DOI 10.3181/00379727-217-44231; FRANKE AA, 1995, P SOC EXP BIOL MED, V208, P18, DOI 10.3181/00379727-208-43826; Gamache PH, 1998, P SOC EXP BIOL MED, V217, P274; Greenlee H, 2004, J ALTERN COMPLEM MED, V10, P660, DOI 10.1089/acm.2004.10.660; Hamilton-Reeves JM, 2008, NUTR CANCER, V60, P7, DOI 10.1080/01635580701586770; Harper CE, 2009, PROSTATE, V69, P1668, DOI 10.1002/pros.21017; Hussain M, 2003, NUTR CANCER, V47, P111, DOI 10.1207/s15327914nc4702_1; Hwang YW, 2009, NUTR CANCER, V61, P598, DOI 10.1080/01635580902825639; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jenkins DJA, 2003, J UROLOGY, V169, P507, DOI 10.1016/S0022-5347(05)63944-4; Kumar NB, 2004, PROSTATE, V59, P141, DOI 10.1002/pros.10362; Kwan W, 2010, NUTR CANCER, V62, P198, DOI 10.1080/01635580903305318; Lazarevic B, 2011, NUTR CANCER, V63, P889, DOI 10.1080/01635581.2011.582221; Maskarinec G, 2006, EUR J CLIN NUTR, V60, P1423, DOI 10.1038/sj.ejcn.1602473; McCormick DL, 2007, NUTR CANCER, V57, P184, DOI 10.1080/01635580701277478; Melamed J, 2004, CLIN CANCER RES, V10, P4614, DOI 10.1158/1078-0432.CCR-04-0240; NOMURA AMY, 1991, EPIDEMIOL REV, V13, P200, DOI 10.1093/oxfordjournals.epirev.a036069; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Ozten-Kandas Nur, 2011, J Carcinog, V10, P27, DOI 10.4103/1477-3163.90438; Pendleton JM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-132; Ploussard G, 2011, EUR UROL, V60, P291, DOI 10.1016/j.eururo.2011.05.006; Pollard M, 2000, IN VIVO, V14, P389; PRESTIGIACOMO AF, 1994, J UROLOGY, V152, P1515, DOI 10.1016/S0022-5347(17)32459-X; SAKR WA, 1993, J UROLOGY, V150, P379, DOI 10.1016/S0022-5347(17)35487-3; Shah O, 2001, J UROLOGY, V165, P1943, DOI 10.1016/S0022-5347(05)66247-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spentzos D, 2003, CLIN CANCER RES, V9, P3282; STEELE VE, 1995, J NUTR, V125, pS713, DOI 10.1093/jn/125.3_Suppl.713S; Steiner C, 2008, BR J NUTR S1, V99E, pS78; Urban D, 2001, J UROLOGY, V165, P294, DOI 10.1097/00005392-200101000-00082; Uzzo RG, 2004, BJU INT, V93, P955, DOI 10.1111/j.1464-410X.2004.04759.x; Van Veldhuizen PJ, 2006, ONCOL REP, V16, P1221; Wang Jun, 2007, J Carcinog, V6, P3, DOI 10.1186/1477-3163-6-3; Westerlund A, 2011, ANN ONCOL, V22, P967, DOI 10.1093/annonc/mdq456; White RWD, 2010, NUTR CANCER, V62, P1036, DOI 10.1080/01635581.2010.492085; White RWD, 2004, UROLOGY, V63, P259, DOI 10.1016/j.urology.2003.09.061; Williams AE, 2003, NUTR CANCER, V47, P118, DOI 10.1207/s15327914nc4702_2; WYNDER EL, 1994, NUTR CANCER, V22, P1, DOI 10.1080/01635589409514327; Yan L, 2009, AM J CLIN NUTR, V89, P1155, DOI 10.3945/ajcn.2008.27029; Yossepowitch O, 2002, J UROLOGY, V168, P2011, DOI 10.1016/S0022-5347(05)64284-X	46	37	37	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					170	178		10.1001/jama.2013.7842	http://dx.doi.org/10.1001/jama.2013.7842			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23839751	Green Accepted			2022-12-28	WOS:000321511500016
J	Murray, RL; Leonardi-Bee, J; Marsh, J; Jayes, L; Li, J; Parrott, S; Britton, J				Murray, R. L.; Leonardi-Bee, J.; Marsh, J.; Jayes, L.; Li, J.; Parrott, S.; Britton, J.			Systematic identification and treatment of smokers by hospital based cessation practitioners in a secondary care setting: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NICOTINE-REPLACEMENT THERAPY; SMOKING-CESSATION; INTERVENTIONS; OPPORTUNITIES	Objectives To investigate the effectiveness of the systematic default provision of smoking cessation support to all adult smokers admitted to hospital, relative to usual care. Design Open, cluster randomised controlled trial. Setting Acute medical wards in one large teaching hospital in the United Kingdom. Participants 264 patients randomised to intervention and 229 to usual care; primary outcome data were available at four weeks for 260 and 224 patients, respectively. All adult smokers and recent ex-smokers able to give informed consent were eligible for entry into the study. Interventions The intervention comprised systematic smoking ascertainment and default provision of behavioural support and cessation pharmacotherapy for the duration of the hospital stay for all smokers and recent ex-smokers, with follow-up and referral to community services after discharge. Usual care comprised cessation support delivered at the initiative and discretion of clinical staff. All staff and patients were aware of group assignment. Main outcome measures Smoking cessation at four weeks, validated by measuring exhaled carbon monoxide. Secondary outcomes were uptake of inpatient behavioural support, use of cessation pharmacotherapy, referral to and uptake of community support after discharge, and validated smoking cessation at six months. Participants lost to follow-up were assumed to have reverted to smoking. Results All patients in the intervention group received at least brief advice to quit smoking, compared to 106 (46%) patients in the usual care group. Cessation at four weeks was achieved by 38% (n=98) of intervention patients and 17% (n=37) of usual care patients (adjusted odds ratio 2.10 (95% confidence interval 0.96 to 4.61), P=0.06, number of patients needed to treat 8). Uptake of inpatient behavioural support, use of pharmacotherapy, and referral to and uptake of community support after discharge were all substantially and statistically significantly higher in the intervention group than in the usual care group. Cessation at six months was achieved by 19% (n=47) of intervention and 9% (n=19) of usual care patients, although this difference was not significant (adjusted odds ratio 1.53 (95% confidence interval 0.60 to 3.91); P=0.37). Conclusions Substantial improvements in smoking cessation among smokers admitted to hospital can be achieved by systematic ascertainment and delivery of cessation support in secondary care.	[Murray, R. L.; Leonardi-Bee, J.; Marsh, J.; Jayes, L.; Britton, J.] Univ Nottingham, City Hosp Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England; [Murray, R. L.; Leonardi-Bee, J.; Marsh, J.; Jayes, L.; Britton, J.] Univ Nottingham, City Hosp Nottingham, UK Ctr Tobacco & Alcohol Studies, Nottingham NG5 1PB, England; [Li, J.; Parrott, S.] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Li, J.; Parrott, S.] Univ York, UK Ctr Tobacco & Alcohol Studies, York YO10 5DD, N Yorkshire, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; University of York - UK; University of York - UK	Murray, RL (corresponding author), Univ Nottingham, City Hosp Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England.	rachael.murray@nottingham.ac.uk	Li, Jinshuo/C-6827-2019; Murray, Rachael/L-4922-2019	Li, Jinshuo/0000-0003-1496-7450; Murray, Rachael/0000-0001-5477-2557; Parrott, Steven James/0000-0002-0165-1150; Leonardi-Bee, Jo/0000-0003-0893-6068	National Institute for Health Research [RP-PG-0608-10020]; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1, MR/K023195/1B] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This paper presents independent research funded by the National Institute for Health Research under its Programme Grants for Applied Research programme (RP-PG-0608-10020). The views expressed in this presentation are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health.	British Heart Foundation, 2010, STOP SMOK QUIT HLTH; Department of Health, 2011, NHS STOP SMOK SERV S; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Fiore MC, 1996, TREATING TOBACCO USE; Freund M, 2008, NICOTINE TOB RES, V10, P757, DOI 10.1080/14622200802027131; Goldstein MG, 1999, AM J PREV MED, V17, P317; Hajek P, 2002, BMJ-BRIT MED J, V324, P87, DOI 10.1136/bmj.324.7329.87; Hawkshaw BA, 2005, MED J AUSTRALIA, V182, P43, DOI 10.5694/j.1326-5377.2005.tb06557.x; Lewis KE, 2009, NICOTINE TOB RES, V11, P756, DOI 10.1093/ntr/ntp061; Liu SK, 2010, J CANCER EDUC, V25, P297, DOI 10.1007/s13187-010-0135-5; May FC, 2008, EUR J CARDIOV PREV R, V15, P646, DOI 10.1097/HJR.0b013e3283101075; Molyneux A, 2003, THORAX, V58, P484, DOI 10.1136/thorax.58.6.484; Murray R, 2012, CLIN MED, V12, P59, DOI 10.7861/clinmedicine.12-1-59; National Centre for Smoking Cessation and Training, 2012, STREAML SEC CAR SYST; National Health Service, 2013, SMOKEFREE; National Institute for Health and Clinical Excellence, 2006, BRIEF INT REF SMOK C; Parrott S, 1998, THORAX, V53, pAS1; Raw M, 1998, THORAX, V53, pS1, DOI 10.1136/thx.53.2008.S1; Reid RD, 2010, NICOTINE TOB RES, V12, P11, DOI 10.1093/ntr/ntp165; Rigotti NA, 1999, AM J PREV MED, V17, P255, DOI 10.1016/S0749-3797(99)00095-1; Rigotti NA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001837.pub3; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Thy T, 2007, CLIN RESPIR J, V1, P30, DOI 10.1111/j.1752-699X.2007.00005.x; U.S. Department of Health and Human Services, 2008, TREATING TOBACCO USE; Vaughn Thomas E, 2002, J Ambul Care Manage, V25, P17; Vega S, 2010, NEW ZEAL MED J, V123, P35; Warner DO, 2004, ANESTH ANALG, V99, P1766, DOI 10.1213/01.ANE.0000136773.40216.87; Warner KE, 2008, SALUD PUBLICA MEXICO, V50, pS283, DOI 10.1590/S0036-36342008000900004; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x	29	25	25	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2013	347								f4004	10.1136/bmj.f4004	http://dx.doi.org/10.1136/bmj.f4004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184LN	23836616	hybrid, Green Published			2022-12-28	WOS:000321891300001
J	Poduri, A; Evrony, GD; Cai, XY; Walsh, CA				Poduri, Annapurna; Evrony, Gilad D.; Cai, Xuyu; Walsh, Christopher A.			Somatic Mutation, Genomic Variation, and Neurological Disease	SCIENCE			English	Review							DE-NOVO MUTATIONS; PALLIDOLUYSIAN ATROPHY DRPLA; TUBEROUS SCLEROSIS COMPLEX; AUTISM SPECTRUM DISORDERS; TRIPLET REPEAT EXPANSIONS; SINGLE-CELL ANALYSIS; L1 RETROTRANSPOSITION; RETT-SYNDROME; HUMAN BRAIN; CAG REPEAT	Genetic mutations causing human disease are conventionally thought to be inherited through the germ line from one's parents and present in all somatic (body) cells, except for most cancer mutations, which arise somatically. Increasingly, somatic mutations are being identified in diseases other than cancer, including neurodevelopmental diseases. Somatic mutations can arise during the course of prenatal brain development and cause neurological disease-even when present at low levels of mosaicism, for example-resulting in brain malformations associated with epilepsy and intellectual disability. Novel, highly sensitive technologies will allow more accurate evaluation of somatic mutations in neurodevelopmental disorders and during normal brain development.	[Poduri, Annapurna] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Poduri, Annapurna; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Evrony, Gilad D.; Cai, Xuyu; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Evrony, Gilad D.; Cai, Xuyu; Walsh, Christopher A.] Boston Childrens Hosp, Dept Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Evrony, Gilad D.; Cai, Xuyu; Walsh, Christopher A.] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu		Walsh, Christopher/0000-0002-0156-2238; Evrony, Gilad/0000-0001-7621-2630	National Institute of Neurological Disorders and Stroke (NINDS) [K23NS069784]; NIH Medical Science Training Program [T32GM007753]; Louis Lange III Scholarship in Translational Research; NIH National Institute of General Medical Sciences [T32GM007726-35]; Simons Foundation; Manton Center for Orphan Disease Research; NINDS [R01 NS079277, RO1 NS032457, R01 NS035129]; National Institute of Mental Health [RO1 MH083565, 1RC2MH089952]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007226, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089952, R01MH083565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129, R37NS035129, R01NS032457, R01NS079277, K23NS069784] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Medical Science Training Program; Louis Lange III Scholarship in Translational Research; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Simons Foundation; Manton Center for Orphan Disease Research; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	A.P. is supported by the National Institute of Neurological Disorders and Stroke (NINDS) (K23NS069784). G.D.E. is supported in part by NIH Medical Science Training Program grant T32GM007753 and by the Louis Lange III Scholarship in Translational Research. X.C. was supported in part by NIH National Institute of General Medical Sciences grant T32GM007726-35. C.A.W. is supported by the Simons Foundation, the Manton Center for Orphan Disease Research, and grants from NINDS (R01 NS079277, RO1 NS032457, and R01 NS035129) and the National Institute of Mental Health (RO1 MH083565 and 1RC2MH089952). C.A.W. is an Investigator of the Howard Hughes Medical Institute.	Aldred MA, 2000, HUM MUTAT, V16, P183, DOI 10.1002/1098-1004(200009)16:3<183::AID-HUMU1>3.0.CO;2-L; Alzualde A, 2010, AM J MED GENET B, V153B, P1283, DOI 10.1002/ajmg.b.31099; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Bahi-Buisson N, 2013, BRAIN, V136, P223, DOI 10.1093/brain/aws323; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Beck JA, 2004, HUM MOL GENET, V13, P1219, DOI 10.1093/hmg/ddh134; Cartwright MS, 2005, NEUROLOGY, V64, P1634, DOI 10.1212/01.WNL.0000154465.87255.78; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Crowe CA, 1997, AM J MED GENET, V71, P406, DOI 10.1002/(SICI)1096-8628(19970905)71:4<406::AID-AJMG7>3.3.CO;2-G; Daber R, 2011, AM J MED GENET A, V155A, P2489, DOI 10.1002/ajmg.a.34172; Erickson RP, 2010, MUTAT RES-REV MUTAT, V705, P96, DOI 10.1016/j.mrrev.2010.04.002; Erickson RP, 2003, MUTAT RES-REV MUTAT, V543, P125, DOI 10.1016/S1383-5742(03)00010-3; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Franco SJ, 2013, NEURON, V77, P19, DOI 10.1016/j.neuron.2012.12.022; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Garcia-Linares C, 2011, HUM MUTAT, V32, P78, DOI 10.1002/humu.21387; Genmaro E, 2006, BIOCHEM BIOPH RES CO, V341, P489, DOI 10.1016/j.bbrc.2005.12.209; Gerard-Blanluet M, 2002, AM J MED GENET, V111, P295, DOI 10.1002/ajmg.10481; Gleeson JG, 2000, AM J HUM GENET, V67, P574, DOI 10.1086/303043; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; GRIFFITHS PD, 1994, NEUROPEDIATRICS, V25, P140, DOI 10.1055/s-2008-1073012; Han S, 2004, CANCER RES, V64, P812, DOI 10.1158/0008-5472.CAN-03-3277; Hashida H, 2001, J NEUROL SCI, V190, P87, DOI 10.1016/S0022-510X(01)00596-2; Hellenbroich Y, 2001, ACTA NEUROL SCAND, V103, P188, DOI 10.1034/j.1600-0404.2001.103003188.x; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Hua Y, 2003, CEREB CORTEX, V13, P693, DOI 10.1093/cercor/13.6.693; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; Ito Y, 1998, NEUROCHEM RES, V23, P25, DOI 10.1023/A:1022441101801; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Kahlem P, 2000, NEUROSCI LETT, V286, P203, DOI 10.1016/S0304-3940(00)01029-6; Kennedy SR, 2012, MECH AGEING DEV, V133, P118, DOI 10.1016/j.mad.2011.10.009; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; KLECZKOWSKA A, 1990, J MED GENET, V27, P505, DOI 10.1136/jmg.27.8.505; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kurek KC, 2012, AM J HUM GENET, V90, P1108, DOI 10.1016/j.ajhg.2012.05.006; Laus AC, 2012, AM J MED GENET A, V158A, P821, DOI 10.1002/ajmg.a.32988; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lindhurst MJ, 2012, NAT GENET, V44, P928, DOI 10.1038/ng.2332; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Magavi S, 2012, J NEUROSCI, V32, P4762, DOI 10.1523/JNEUROSCI.3560-11.2012; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Mollersen L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001242; Montermini L, 1997, NEUROLOGY, V49, P606, DOI 10.1212/WNL.49.2.606; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; NELLIST M, 1993, CELL, V75, P1305; Niida Y, 2001, AM J HUM GENET, V69, P493, DOI 10.1086/321972; O'Huallachain M, 2012, P NATL ACAD SCI USA, V109, P18018, DOI 10.1073/pnas.1213736109; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; PANGALOS C, 1994, AM J HUM GENET, V54, P473; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Patel C, 2009, AM J MED GENET A, V149A, P1795, DOI 10.1002/ajmg.a.32959; Pieras JI, 2011, BRAIN DEV-JPN, V33, P608, DOI 10.1016/j.braindev.2010.09.012; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Qin W, 2010, BRAIN PATHOL, V20, P1096, DOI 10.1111/j.1750-3639.2010.00416.x; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Reid CB, 1997, DEVELOPMENT, V124, P2441; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; SCHRANDERSTUMPEL CTRM, 1994, AM J MED GENET, V50, P377, DOI 10.1002/ajmg.1320500416; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Sicca F, 2003, NEUROLOGY, V61, P1042, DOI 10.1212/WNL.61.8.1042; Smahi A, 2000, NATURE, V405, P466; Topcu M, 2002, EUR J HUM GENET, V10, P77, DOI 10.1038/sj.ejhg.5200745; UENO S, 1995, HUM MOL GENET, V4, P663, DOI 10.1093/hmg/4.4.663; Vadlamudi L, 2010, NEW ENGL J MED, V363, P1335, DOI 10.1056/NEJMoa0910752; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Ware ML, 1999, CEREB CORTEX, V9, P636, DOI 10.1093/cercor/9.6.636; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025	85	364	370	4	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2013	341	6141					43	+	1237758	10.1126/science.1237758	http://dx.doi.org/10.1126/science.1237758			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828942	Green Accepted			2022-12-28	WOS:000321291700040
J	Boyle, J				Boyle, John			Biology must develop its own big-data systems	NATURE			English	Editorial Material												john.boyle@kymab.com		Boyle, John/0000-0002-5378-5361					0	12	16	1	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2013	499	7456					7	7		10.1038/499007a	http://dx.doi.org/10.1038/499007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176ED	23823760	Bronze			2022-12-28	WOS:000321285600004
J	Gerber, C				Gerber, Christoph			Heinrich Rohrer (1933-2013) Co-inventor of the scanning tunnelling microscope. OBITUARY	NATURE			English	Biographical-Item									[Gerber, Christoph] Univ Basel, Swiss Nanosci Inst, CH-4003 Basel, Switzerland	University of Basel	Gerber, C (corresponding author), Univ Basel, Swiss Nanosci Inst, CH-4003 Basel, Switzerland.	christoph.gerber@unibas.ch		Gerber, Christoph/0000-0001-7035-3838					0	0	0	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2013	499	7456					30	30		10.1038/499030a	http://dx.doi.org/10.1038/499030a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23823788	Bronze			2022-12-28	WOS:000321285600020
J	Du, XF; Wang, J; Zhu, HP; Rinaldo, L; Lamar, KM; Palmenberg, AC; Hansel, C; Gomez, CM				Du, Xiaofei; Wang, Jun; Zhu, Haipeng; Rinaldo, Lorenzo; Lamar, Kay-Marie; Palmenberg, Ann C.; Hansel, Christian; Gomez, Christopher M.			Second Cistron in CACNA1A Gene Encodes a Transcription Factor Mediating Cerebellar Development and SCA6	CELL			English	Article							ALTERED SYNAPTIC-TRANSMISSION; CA2+ CHANNEL; CALCIUM-CHANNEL; CLIMBING FIBER; MICE LACKING; ATAXIA; RECEPTOR; DYSFUNCTION; ELIMINATION; MUTATION	The CACNA1A gene, encoding the voltage-gated calcium channel subunit alpha 1A, is involved in pre- and postsynaptic Ca2+ signaling, gene expression, and several genetic neurological disorders. We found that CACNA1A coordinates gene expression using a bicistronic mRNA bearing a cryptic internal ribosomal entry site (IRES). The first cistron encodes the well-characterized alpha 1A subunit. The second expresses a transcription factor, alpha 1ACT, which coordinates expression of a program of genes involved in neural and Purkinje cell development. alpha 1ACT also contains the polyglutamine (polyQ) tract that, when expanded, causes spinocerebellar ataxia type 6 (SCA6). When expressed as an independent polypeptide, alpha 1ACT-bearing an expanded polyQ tract-lacks transcription factor function and neurite outgrowth properties, causes cell death in culture, and leads to ataxia and cerebellar atrophy in transgenic mice. Suppression of CACNA1A IRES function in SCA6 may be a potential therapeutic strategy.	[Du, Xiaofei; Wang, Jun; Zhu, Haipeng; Lamar, Kay-Marie; Gomez, Christopher M.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Rinaldo, Lorenzo; Hansel, Christian] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Palmenberg, Ann C.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA	University of Chicago; University of Chicago; University of Wisconsin System; University of Wisconsin Madison	Gomez, CM (corresponding author), Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	cgomez@neurology.bsd.uchicago.edu		Lamar, Kay-Marie/0000-0001-9572-8384	National Ataxia Foundation (NAF); National Organization of Rare Diseases (NORD); National Institute of Neurological Disorders and Stroke [NS-062771]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033202, R01NS062771] Funding Source: NIH RePORTER	National Ataxia Foundation (NAF); National Organization of Rare Diseases (NORD); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Professors Sangram S. Sisodia, Brian Popko, and Bert L. Semler for helpful comments on the manuscript, Dr. Raymond Roos for helpful discussions, Dr. Xiaorong Zhu for protein purification technical assistance, Dr. Jeremy Marks and Dr. Janice Wang for rat granule cell cultures and transfection, Dr. Yuanxin Hu for assembling the vectors for PC-alpha 1ACT<INF>WT</INF> and PC-alpha 1ACT<INF>SCA6</INF> mice and performing pilot immunoblot and immunohistochemical studies, Devon Collins and Kareisha Robinson for technical support in mouse breeding, genotyping, and DigiGait testing, and Tom Hampton for DigiGait assistance on data analysis. We also thank Professor Anne Willis for providing pRF vector, Dr. Suneil Malik for providing pGL3GRN vector, and Dr. Haiteng Deng for performing LC-MS/MS. We thank the Floyd family for supporting SCA6 research. This work was also supported by funding from the National Ataxia Foundation (NAF), the National Organization of Rare Diseases (NORD), and the National Institute of Neurological Disorders and Stroke (NS-062771) (to C.H.).	[Anonymous], NEURON, V41, P687; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Berthet C, 2002, GENES CELLS, V7, P29, DOI 10.1046/j.1356-9597.2001.00497.x; Cain SM, 2011, BIOFACTORS, V37, P197, DOI 10.1002/biof.158; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cimato TR, 1997, J CELL BIOL, V138, P1089, DOI 10.1083/jcb.138.5.1089; Coldwell MJ, 2001, ONCOGENE, V20, P4095, DOI 10.1038/sj.onc.1204547; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Du XF, 2009, J CLIN ENDOCR METAB, V94, P2594, DOI 10.1210/jc.2009-0139; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Hashimoto K, 2005, NEUROSCI RES, V53, P221, DOI 10.1016/j.neures.2005.07.007; Hashimoto K, 2011, P NATL ACAD SCI USA, V108, P9987, DOI 10.1073/pnas.1101488108; Ishiguro T, 2010, ACTA NEUROPATHOL, V119, P447, DOI 10.1007/s00401-009-0630-0; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kordasiewicz HB, 2006, HUM MOL GENET, V15, P1587, DOI 10.1093/hmg/ddl080; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Kubodera T, 2003, NEUROSCI LETT, V341, P74, DOI 10.1016/S0304-3940(03)00156-3; Kurnellas MP, 2007, ANN NY ACAD SCI, V1099, P287, DOI 10.1196/annals.1387.025; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Liu SL, 2008, J PHYSIOL-LONDON, V586, P4501, DOI 10.1113/jphysiol.2008.156232; Marqueze-Pouey B, 2008, TRAFFIC, V9, P1088, DOI 10.1111/j.1600-0854.2008.00743.x; Matsukawa H, 2003, J NEUROSCI, V23, P7677; Matsushita K, 2002, J NEUROSCI, V22, P4388, DOI 10.1523/JNEUROSCI.22-11-04388.2002; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Palmenberg AC, 1997, SEMIN VIROL, V8, P231, DOI 10.1006/smvy.1997.0126; Rajakulendran S, 2012, NAT REV NEUROL, V8, P86, DOI 10.1038/nrneurol.2011.228; ROUAULT JP, 1993, GENE, V129, P303, DOI 10.1016/0378-1119(93)90284-A; Saegusa H, 2007, MOL CELL NEUROSCI, V34, P261, DOI 10.1016/j.mcn.2006.11.006; Scott VES, 1998, J NEUROSCI, V18, P641; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Spriggs KA, 2009, NUCLEIC ACIDS RES, V37, P5881, DOI 10.1093/nar/gkp623; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; Ul-Hussain M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-52; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Watanabe M, 2011, EUR J NEUROSCI, V34, P1697, DOI 10.1111/j.1460-9568.2011.07894.x; Watase K, 2008, P NATL ACAD SCI USA, V105, P11987, DOI 10.1073/pnas.0804350105; Wilkins MR, 1999, METH MOL B, V112, P531; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Zacharias DA, 1999, BBA-GEN SUBJECTS, V1428, P397, DOI 10.1016/S0304-4165(99)00058-6; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	107	110	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					118	133		10.1016/j.cell.2013.05.059	http://dx.doi.org/10.1016/j.cell.2013.05.059			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827678	Green Accepted, Bronze			2022-12-28	WOS:000321327900014
J	Ledwidge, M; Gallagher, J; Conlon, C; Tallon, E; O'Connell, E; Dawkins, I; Watson, C; O'Hanlon, R; Bermingham, M; Patle, A; Badabhagni, MR; Murtagh, G; Voon, V; Tilson, L; Barry, M; McDonald, L; Maurer, B; McDonald, K				Ledwidge, Mark; Gallagher, Joseph; Conlon, Carmel; Tallon, Elaine; O'Connell, Eoin; Dawkins, Ian; Watson, Chris; O'Hanlon, Rory; Bermingham, Margaret; Patle, Anil; Badabhagni, Mallikarjuna R.; Murtagh, Gillian; Voon, Victor; Tilson, Leslie; Barry, Michael; McDonald, Laura; Maurer, Brian; McDonald, Kenneth			Natriuretic Peptide-Based Screening and Collaborative Care for Heart Failure The STOP-HF Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR EVENTS; EUROPEAN COUNTRIES; RISK; PREVENTION; HYPERTENSION; DYSFUNCTION; REDUCTION; LOSARTAN; VALIDITY; DISEASE	IMPORTANCE Prevention strategies for heart failure are needed. OBJECTIVE To determine the efficacy of a screening program using brain-type natriuretic peptide (BNP) and collaborative care in an at-risk population in reducing newly diagnosed heart failure and prevalence of significant left ventricular (LV) systolic and/or diastolic dysfunction. DESIGN, SETTING, AND PARTICIPANTS The St Vincent's Screening to Prevent Heart Failure Study, a parallel-group randomized trial involving 1374 participants with cardiovascular risk factors (mean age, 64.8 [SD, 10.2] years) recruited from 39 primary care practices in Ireland between January 2005 and December 2009 and followed up until December 2011 (mean follow-up, 4.2 [SD, 1.2] years). INTERVENTION Patients were randomly assigned to receive usual primary care (control condition; n=677) or screening with BNP testing (n=697). Intervention-group participants with BNP levels of 50 pg/mL or higher underwent echocardiography and collaborative care between their primary care physician and specialist cardiovascular service. MAIN OUTCOMES AND MEASURES The primary end point was prevalence of asymptomatic LV dysfunction with or without newly diagnosed heart failure. Secondary end points included emergency hospitalization for arrhythmia, transient ischemic attack, stroke, myocardial infarction, peripheral or pulmonary thrombosis/embolus, or heart failure. RESULTS A total of 263 patients (41.6%) in the intervention group had at least 1 BNP reading of 50 pg/mL or higher. The intervention group underwent more cardiovascular investigations (control, 496 per 1000 patient-years vs intervention, 850 per 1000 patient-years; incidence rate ratio, 1.71; 95% CI, 1.61-1.83; P<.001) and received more renin-angiotensin-aldosterone system-based therapy at follow-up (control, 49.6%; intervention, 56.5%; P=.01). The primary end point of LV dysfunction with or without heart failure was met in 59 (8.7%) of 677 in the control group and 37 (5.3%) of 697 in the intervention group (odds ratio [OR], 0.55; 95% CI, 0.37-0.82; P=.003). Asymptomatic LV dysfunction was found in 45 (6.6%) of 677 control-group patients and 30 (4.3%) of 697 intervention-group patients (OR, 0.57; 95% CI, 0.37-0.88; P=.01). Heart failure occurred in 14 (2.1%) of 677 control-group patients and 7 (1.0%) of 697 intervention-group patients (OR, 0.48; 95% CI, 0.20-1.20; P=.12). The incidence rates of emergency hospitalization for major cardiovascular events were 40.4 per 1000 patient-years in the control group vs 22.3 per 1000 patient-years in the intervention group (incidence rate ratio, 0.60; 95% CI, 0.45-0.81; P=.002). CONCLUSION AND RELEVANCE Among patients at risk of heart failure, BNP-based screening and collaborative care reduced the combined rates of LV systolic dysfunction, diastolic dysfunction, and heart failure.	[Ledwidge, Mark; Gallagher, Joseph; Conlon, Carmel; Tallon, Elaine; O'Connell, Eoin; Dawkins, Ian; Watson, Chris; O'Hanlon, Rory; Bermingham, Margaret; Patle, Anil; Badabhagni, Mallikarjuna R.; Murtagh, Gillian; Voon, Victor; McDonald, Laura; Maurer, Brian; McDonald, Kenneth] St Michaels Hosp, St Vincents Healthcare Grp, Chron Cardiovasc Dis Management Unit, Dublin, Ireland; [Ledwidge, Mark; Gallagher, Joseph; Tallon, Elaine; O'Connell, Eoin; Watson, Chris; O'Hanlon, Rory; Bermingham, Margaret; Voon, Victor] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Tilson, Leslie; Barry, Michael] St James Hosp, Natl Ctr Pharmacoecon, Dublin, Ireland	University College Dublin; Trinity College Dublin	McDonald, K (corresponding author), St Vincents Healthcare Grp, Chron Cardiovasc Dis Management Unit, Dublin 4, Ireland.	kenneth.mcdonald@ucd.ie	Voon, Valerie/O-7038-2017	Voon, Valerie/0000-0001-6790-1776; Ledwidge, Mark/0000-0001-7391-2949; Barry, Michael/0000-0002-6232-3003; , The Heartbeat Trust/0000-0002-4020-6754; Conlon Heaney, Carmel M/0000-0002-0931-6891; Voon, Victor/0000-0002-9923-2279; McDonald, Kenneth/0000-0001-8011-3301; Gallagher, Joseph/0000-0002-5564-2890	Heartbeat Trust; Health Services Executive; Health Research Board of the Irish Government; European Commission [261409]; Pfizer; A. Menarini; Alere; Roche; Takeda; Takeda, Abbott; Covidien; Servier	Heartbeat Trust; Health Services Executive; Health Research Board of the Irish Government; European Commission(European CommissionEuropean Commission Joint Research Centre); Pfizer(Pfizer); A. Menarini(Menarini Group); Alere; Roche(Roche Holding); Takeda(Takeda Pharmaceutical Company Ltd); Takeda, Abbott; Covidien; Servier(Servier)	The STOP-HF study was funded by the Heartbeat Trust, an independent charity focused on heart failure prevention; the Health Services Executive and the Health Research Board of the Irish Government; and the European Commission Framework Programme 7 Health Project 261409 Metabolic Road to Diastolic Heart Failure (MEDIA) project. The Heartbeat Trust has received unrestricted educational and research grants from Pfizer, A. Menarini, Alere, Roche, Takeda, Abbott, Covidien, and Servier.	Alfie J, 2011, REV RECENT CLIN TRIA, V6, P134, DOI 10.2174/157488711795177912; Bangalore S, 2008, J AM COLL CARDIOL, V52, P1062, DOI 10.1016/j.jacc.2008.05.057; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Fox KM, 2003, LANCET, V362, P782; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hobbs FDR, 2002, FAM PRACT, V19, P596, DOI 10.1093/fampra/19.6.596; Huffman MD, 2012, CIRCULATION, V125, P2595, DOI 10.1161/CIRCULATIONAHA.111.070722; Karuppiah S, 2006, IRISH J MED SCI, V175, P5, DOI 10.1007/BF03167960; Kjekshus J, 1997, J Card Fail, V3, P249, DOI 10.1016/S1071-9164(97)90022-1; Kotseva K, 2009, EUR J CARDIOV PREV R, V16, P121, DOI 10.1097/HJR.0b013e3283294b1d; Maeda K, 1998, AM HEART J, V135, P825, DOI 10.1016/S0002-8703(98)70041-9; McGrady M, 2013, EUR J HEART FAIL, V15, P573, DOI 10.1093/eurjhf/hft001; Mitka M, 2001, JAMA-J AM MED ASSOC, V285, P1828, DOI 10.1001/jama.285.14.1828; Onodera M, 2012, INT HEART J, V53, P176, DOI 10.1536/ihj.53.176; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; Phelan D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049259; Rathi S, 2012, MED CLIN N AM, V96, P881, DOI 10.1016/j.mcna.2012.07.011; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Sabatine MS, 2004, J AM COLL CARDIOL, V44, P1988, DOI 10.1016/j.jacc.2004.07.057; Tarnow L, 2006, DIABETOLOGIA, V49, P2256, DOI 10.1007/s00125-006-0359-4; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Wachtell K, 2002, CIRCULATION, V105, P1071, DOI 10.1161/hc0902.104599; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635; YOSHIMURA M, 1993, CIRCULATION, V87, P464, DOI 10.1161/01.CIR.87.2.464	26	343	351	3	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					66	74		10.1001/jama.2013.7588	http://dx.doi.org/10.1001/jama.2013.7588			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175SK	23821090	Bronze			2022-12-28	WOS:000321253000024
J	Haroon, MF; Hu, SH; Shi, Y; Imelfort, M; Keller, J; Hugenholtz, P; Yuan, ZG; Tyson, GW				Haroon, Mohamed F.; Hu, Shihu; Shi, Ying; Imelfort, Michael; Keller, Jurg; Hugenholtz, Philip; Yuan, Zhiguo; Tyson, Gene W.			Anaerobic oxidation of methane coupled to nitrate reduction in a novel archaeal lineage	NATURE			English	Article							IN-SITU HYBRIDIZATION; COENZYME-M REDUCTASE; OXIDIZING ARCHAEA; BACTERIA; COMMUNITY; MICROORGANISMS; NITRITE; GENOME; METATRANSCRIPTOMICS; METHANOGENESIS	Anaerobic oxidation of methane (AOM) is critical for controlling the flux of methane from anoxic environments. AOM coupled to iron(1), manganese(1) and sulphate(2) reduction have been demonstrated in consortia containing anaerobic methanotrophic (ANME) archaea. More recently it has been shown that the bacterium Candidatus 'Methylomirabilis oxyfera' can couple AOM to nitrite reduction through an intra-aerobic methane oxidation pathway(3). Bioreactors capable of AOM coupled to denitrification have resulted in the enrichment of 'M. oxyfera' and a novel ANME lineage, ANME-2d(4,5). However, as 'M. oxyfera' can independently couple AOM to denitrification, the role of ANME-2d in the process is unresolved. Here, a bioreactor fed with nitrate, ammonium and methane was dominated by a single ANME-2d population performing nitrate-driven AOM. Metagenomic, single-cell genomic and metatranscriptomic analyses combined with bioreactor performance and C-13- and N-15-labelling experiments show that ANME-2d is capable of independent AOM through reverse methanogenesis using nitrate as the terminal electron acceptor. Comparative analyses reveal that the genes for nitrate reduction were transferred laterally from a bacterial donor, suggesting selection for this novel process within ANME-2d. Nitrite produced by ANME-2d is reduced to dinitrogen gas through a syntrophic relationship with an anaerobic ammonium-oxidizing bacterium, effectively outcompeting 'M. oxyfera' in the system. We propose the name Candidatus 'Methanoperedens nitror-educens' for the ANME-2d population and the family Candidatus 'Methanoperedenaceae' for the ANME-2d lineage. We predict that 'M. nitroreducens' and other members of the 'Methanoperedenaceae' have an important role in linking the global carbon and nitrogen cycles in anoxic environments.	[Haroon, Mohamed F.; Imelfort, Michael; Hugenholtz, Philip; Tyson, Gene W.] Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogen, Brisbane, Qld 4072, Australia; [Hu, Shihu; Shi, Ying; Imelfort, Michael; Keller, Jurg; Yuan, Zhiguo; Tyson, Gene W.] Univ Queensland, Adv Water Management Ctr, Fac Engn Architecture & Informat Technol, Brisbane, Qld 4072, Australia; [Hugenholtz, Philip] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland; University of Queensland	Tyson, GW (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogen, Brisbane, Qld 4072, Australia.	z.yuan@awmc.uq.edu.au; g.tyson@uq.edu.au	Hu, Shihu/L-6085-2019; Hugenholtz, Philip/AAD-9138-2019; Tyson, Gene W/C-6558-2013; Yuan, Zhiguo/AAO-1328-2021; Yuan, Zhiguo/C-4980-2013	Hugenholtz, Philip/0000-0001-5386-7925; Tyson, Gene W/0000-0001-8559-9427; Yuan, Zhiguo/0000-0002-7566-1482; Keller, Jurg/0000-0001-6796-0936; Hu, Shihu/0000-0002-1858-8872	Australian Research Council (ARC) [DP0666762, DP0987204]; Australian Centre for Ecogenomics; ARC Queen Elizabeth II Fellowship [DP1093175]; ARC Discovery Outstanding Researcher Award [DP120103498]; China Scholarship Council	Australian Research Council (ARC)(Australian Research Council); Australian Centre for Ecogenomics; ARC Queen Elizabeth II Fellowship(Australian Research Council); ARC Discovery Outstanding Researcher Award(Australian Research Council); China Scholarship Council(China Scholarship Council)	We thank the ACE sequencing team; M. Butler, F. May and S. Low for their help with the 454 pyrosequencing, Illumina and Ion Torrent sequencing and the DOE Joint Genome Institute for single-cell sequencing. We also thank P. Lu for assistance with bioreactor operation, R. Zeng and P. Lant for their contribution to the development of initial bioreactors, B. Keller, J. Li, Y. Rui and Y. Wang for chemical and isotopic analyses, and D. Willner for assistance with genomic analysis. We are grateful to J. Euzeby for etymological advice. This work is supported by the Australian Research Council (ARC) through projects DP0666762 and DP0987204 and strategic funds from the Australian Centre for Ecogenomics. G. W. T. is supported by an ARC Queen Elizabeth II Fellowship (DP1093175). P. H. is supported by an ARC Discovery Outstanding Researcher Award (DP120103498). Y. S. is supported by the China Scholarship Council.	Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; BROOKS PD, 1989, SOIL SCI SOC AM J, V53, P1707, DOI 10.2136/sssaj1989.03615995005300060016x; Cabello P, 2004, MICROBIOL-SGM, V150, P3527, DOI 10.1099/mic.0.27303-0; Caldwell SL, 2008, ENVIRON SCI TECHNOL, V42, P6791, DOI 10.1021/es800120b; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Dekas AE, 2009, SCIENCE, V326, P422, DOI 10.1126/science.1178223; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; Hallam SJ, 2003, APPL ENVIRON MICROB, V69, P5483, DOI 10.1128/AEM.69.9.5483-5491.2003; Heller C, 2008, GEOMICROBIOL J, V25, P149, DOI 10.1080/01490450802006884; Hu SH, 2011, ENV MICROBIOL REP, V3, P315, DOI 10.1111/j.1758-2229.2010.00227.x; Hu SH, 2009, ENV MICROBIOL REP, V1, P377, DOI 10.1111/j.1758-2229.2009.00083.x; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kuenen JG, 2008, NAT REV MICROBIOL, V6, P320, DOI 10.1038/nrmicro1857; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luesken FA, 2011, APPL ENVIRON MICROB, V77, P6802, DOI 10.1128/AEM.05539-11; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Nauhaus K, 2005, ENVIRON MICROBIOL, V7, P98, DOI 10.1111/j.1462-2920.2004.00669.x; Orcutt B, 2008, ENVIRON MICROBIOL, V10, P1108, DOI 10.1111/j.1462-2920.2007.01526.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Scheller S, 2010, NATURE, V465, P606, DOI 10.1038/nature09015; Schmid M, 2001, ENVIRON MICROBIOL, V3, P450, DOI 10.1046/j.1462-2920.2001.00211.x; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; SMITH MR, 1983, J BACTERIOL, V156, P516, DOI 10.1128/JB.156.2.516-523.1983; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Stokke R, 2012, ENVIRON MICROBIOL, V14, P1333, DOI 10.1111/j.1462-2920.2012.02716.x; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Trotsenko YA, 2008, ADV APPL MICROBIOL, V63, P183, DOI 10.1016/S0065-2164(07)00005-6; Wu M, 2012, BIOINFORMATICS, V28, P1033, DOI 10.1093/bioinformatics/bts079; Yilmaz S, 2010, ISME J, V4, P1352, DOI 10.1038/ismej.2010.73	47	730	792	72	1227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					567	+		10.1038/nature12375	http://dx.doi.org/10.1038/nature12375			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23892779				2022-12-28	WOS:000323625900032
J	Biffi, A; Montini, E; Lorioli, L; Cesani, M; Fumagalli, F; Plati, T; Baldoli, C; Martino, S; Calabria, A; Canale, S; Benedicenti, F; Vallanti, G; Biasco, L; Leo, S; Kabbara, N; Zanetti, G; Rizzo, WB; Mehta, NAL; Cicalese, MP; Casiraghi, M; Boelens, JJ; Del Carro, U; Dow, DJ; Schmidt, M; Assanelli, A; Neduva, V; Di Serio, C; Stupka, E; Gardner, J; von Kalle, C; Bordignon, C; Ciceri, F; Rovelli, A; Roncarolo, MG; Aiuti, A; Sessa, M; Naldini, L				Biffi, Alessandra; Montini, Eugenio; Lorioli, Laura; Cesani, Martina; Fumagalli, Francesca; Plati, Tiziana; Baldoli, Cristina; Martino, Sabata; Calabria, Andrea; Canale, Sabrina; Benedicenti, Fabrizio; Vallanti, Giuliana; Biasco, Luca; Leo, Simone; Kabbara, Nabil; Zanetti, Gianluigi; Rizzo, William B.; Mehta, Nalini A. L.; Cicalese, Maria Pia; Casiraghi, Miriam; Boelens, Jaap J.; Del Carro, Ubaldo; Dow, David J.; Schmidt, Manfred; Assanelli, Andrea; Neduva, Victor; Di Serio, Clelia; Stupka, Elia; Gardner, Jason; von Kalle, Christof; Bordignon, Claudio; Ciceri, Fabio; Rovelli, Attilio; Roncarolo, Maria Grazia; Aiuti, Alessandro; Sessa, Maria; Naldini, Luigi			Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy	SCIENCE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; CHRONIC GRANULOMATOUS-DISEASE; CENTRAL-NERVOUS-SYSTEM; GROSS MOTOR FUNCTION; MOUSE MODEL; INTEGRATION SITES; TRANSPLANTATION; VECTOR; SCID-X1; MICROGLIA	Metachromatic leukodystrophy (MLD) is an inherited lysosomal storage disease caused by arylsulfatase A (ARSA) deficiency. Patients with MLD exhibit progressive motor and cognitive impairment and die within a few years of symptom onset. We used a lentiviral vector to transfer a functional ARSA gene into hematopoietic stem cells (HSCs) from three presymptomatic patients who showed genetic, biochemical, and neurophysiological evidence of late infantile MLD. After reinfusion of the gene-corrected HSCs, the patients showed extensive and stable ARSA gene replacement, which led to high enzyme expression throughout hematopoietic lineages and in cerebrospinal fluid. Analyses of vector integrations revealed no evidence of aberrant clonal behavior. The disease did not manifest or progress in the three patients 7 to 21 months beyond the predicted age of symptom onset. These findings indicate that extensive genetic engineering of human hematopoiesis can be achieved with lentiviral vectors and that this approach may offer therapeutic benefit for MLD patients.	[Biffi, Alessandra; Montini, Eugenio; Lorioli, Laura; Cesani, Martina; Plati, Tiziana; Calabria, Andrea; Benedicenti, Fabrizio; Biasco, Luca; Roncarolo, Maria Grazia; Aiuti, Alessandro; Naldini, Luigi] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy TIGET, I-20132 Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Biffi, A (corresponding author), Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy TIGET, I-20132 Milan, Italy.	biffi.alessandra@hsr.it; naldini.luigi@hsr.it	Del Carro, Ubaldo/AAO-3457-2020; Martino, Sabata/F-2309-2014; Plati, Tiziana/AAN-2195-2020; Calabria, Andrea/AAA-3349-2019; Biffi, Alessandra/AAA-8890-2019; Di Serio, Clelia/AAO-5494-2020; Sessa, Maria/AAC-1943-2022; Montini, Eugenio/L-1152-2016; AIUTI, ALESSANDRO/K-3918-2016; Fumagalli, Francesca/J-8697-2018; Baldoli, Cristina/AAF-2005-2020	Del Carro, Ubaldo/0000-0003-3301-5412; Martino, Sabata/0000-0002-3942-237X; Plati, Tiziana/0000-0003-0131-109X; Calabria, Andrea/0000-0003-3515-3384; Sessa, Maria/0000-0002-9589-0290; Montini, Eugenio/0000-0003-1771-6067; AIUTI, ALESSANDRO/0000-0002-5398-1717; Fumagalli, Francesca/0000-0001-7476-4087; Della Rosa, Pasquale Anthony/0000-0002-3137-1731; DI SERIO, Mariaclelia Stefania/0000-0001-6385-6058; Baldoli, Cristina/0000-0003-2697-5132; RONCAROLO, Maria Grazia/0000-0002-2193-9186; Boelens, Jaap Jan/0000-0003-2232-6952; Leo, Simone/0000-0001-8271-5429; Stupka, Elia/0000-0003-3154-4011; NALDINI, Luigi/0000-0002-7835-527X	Fondazione Telethon (TIGET) [B2, F3, D2, D1]; European Union (EU) [F2-2010-241622, GA 222878 PERSIST]; European Leukodystrophy Foundation [ELA 2007-00515]; Italian Ministry of Health [Progetto Giovani Ricercatori GR-2008-57, Progetto Giovani Ricercatori GR-2007-684057]; European Research Council (ERC) [249845]; Italian Ministry of Health; Association for International Cancer Research [AICR 09-0784]; Italian Higher Institute of Health; Worldwide Cancer Research [09-0784] Funding Source: researchfish	Fondazione Telethon (TIGET)(Fondazione Telethon); European Union (EU)(CGIAREuropean Commission); European Leukodystrophy Foundation; Italian Ministry of Health(Ministry of Health, Italy); European Research Council (ERC)(European Research Council (ERC)European Commission); Italian Ministry of Health(Ministry of Health, Italy); Association for International Cancer Research; Italian Higher Institute of Health; Worldwide Cancer Research	This work was supported by Fondazione Telethon (TIGET grant B2 and F3), the European Union (EU) Seventh Framework Program (FP7)-HEALTH F2-2010-241622 [Therapeutic Challenge in Leukodystrophies (LEUKOTREAT)], the European Leukodystrophy Foundation (ELA 2007-00515), and Italian Ministry of Health (Progetto Giovani Ricercatori GR-2008-57) to A.B.; Fondazione Telethon (TIGET grant D2), the EU FP7-HEALTH (GA 222878 PERSIST), the European Research Council (ERC) (Advanced Grant 249845 TARGETINGGENETHERAPY), and the Italian Ministry of Health to L.N.; Fondazione Telethon (TIGET grant D1 and core grant), Association for International Cancer Research (AICR 09-0784), and Italian Ministry of Health (Progetto Giovani Ricercatori GR-2007-684057) to E.M.; and the Italian Higher Institute of Health (Italia-USA Collaborative Program on Rare Diseases) to M.S. We thank the medical and nursing staff of the TIGET Pediatric Clinical Research Unit, Pediatric Immunohematology and Bone Marrow Transplant Unit; R. Miniero, R. Fiori, P. Silvani, and L. Sacchi for critical help with patient management; L. Callegaro, S. Di Nunzio, M. Bonopane, G. Tomaselli, and the TIGET clinical trial office for trial management; P. Massariello and other MolMed staff for help with patient cell manipulation; I. Spiga for ARSA gene mutation analysis; S. Gerevini for initial brain MRI studies; P. Aubourg for patient referral and, together with N. Cartier, for sharing the original ALD HSC-GT IS data set; D. Redaelli and S. Acquati for molecular and biochemical studies; F. Morena for biochemical studies; A. Capotondo for studies on the MLD mouse model; M. Marini and D. Cesana for technical help on LAM-PCR amplification and bioinformatics; M. Gabaldo for support with project management; G. Royal, L. King, and F. Govani for help with 454-pyrosequencing and sequence data management; and J. Appleby for advice and support. We are especially indebted to F. Pasinelli for unremitting support of this project and to the patients who joined the trial and their families for their commitment and endurance. We dedicate this work to the memory of all MLD patients and their families who accompanied us in the long path from preclinical studies to clinical testing. C.B. is Chief Executive Officer and Chairman of the Scientific Advisory Board of MolMed S.p.A., a biotechnology company focused on research, development, and clinical validation of new cancer therapies. L.N. is an inventor of several patents on lentiviral vector technology that are owned by the Salk Institute and Cell Genesis and are licensed to Lentigen. L.N. is entitled to receive royalties from one of these patents (U.S. Patent No. 6,013,516 with the Salk Institute).	Abel U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000570; Aicardi J, 1998, DIS NERVOUS SYSTEM C; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Araya K, 2009, MOL GENET METAB, V98, P255, DOI 10.1016/j.ymgme.2009.05.006; Biffi A, 2008, CLIN GENET, V74, P349, DOI 10.1111/j.1399-0004.2008.01058.x; Biffi A, 2008, BONE MARROW TRANSPL, V42, pS2, DOI 10.1038/bmt.2008.275; Biffi A, 2004, J CLIN INVEST, V113, P1118, DOI 10.1172/JCI200419205; Biffi A, 2006, J CLIN INVEST, V116, P3070, DOI 10.1172/JCI28873; Biffi A, 2011, HUM MOL GENET, V20, pR42, DOI 10.1093/hmg/ddr142; Biffi A, 2011, BLOOD, V117, P5332, DOI 10.1182/blood-2010-09-306761; Boelens JJ, 2010, PEDIATR CLIN N AM, V57, P123, DOI 10.1016/j.pcl.2009.11.004; Boelens JJ, 2006, J INHERIT METAB DIS, V29, P413, DOI 10.1007/s10545-005-0258-8; Capotondo A, 2007, HUM GENE THER, V18, P821, DOI 10.1089/hum.2007.048; Capotondo A, 2012, P NATL ACAD SCI USA, V109, P15018, DOI 10.1073/pnas.1205858109; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2007, J CLIN INVEST, V117, P1456, DOI 10.1172/JCI30953; Childs GV, 2000, METH MOL B, V123, P131; Gentner B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001522; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Groeschel S, 2011, J INHERIT METAB DIS, V34, P1095, DOI 10.1007/s10545-011-9361-1; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Kehrer C, 2011, DEV MED CHILD NEUROL, V53, P156, DOI 10.1111/j.1469-8749.2010.03821.x; Koul R L, 1994, Indian Pediatr, V31, P694; KRIVIT W, 1995, CELL TRANSPLANT, V4, P385, DOI 10.1016/0963-6897(95)00021-O; Martino S, 2005, J BIOTECHNOL, V117, P243, DOI 10.1016/j.jbiotec.2005.01.018; Mattioli C, 2007, PEDIATR ANESTH, V17, P64, DOI 10.1111/j.1460-9592.2006.02002.x; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Rovelli AM, 2005, BONE MARROW TRANSPL, V35, pS23, DOI 10.1038/sj.bmt.1704839; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; SATOH T, 1988, ACTA PATHOL JAPON, V38, P1041; Scaramuzza S, 2013, MOL THER, V21, P175, DOI 10.1038/mt.2012.23; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Visigalli I, 2010, BLOOD, V116, P5130, DOI 10.1182/blood-2010-04-278234; Voigt RG, 2003, CLIN PEDIATR, V42, P427, DOI 10.1177/000992280304200507; Wang GP, 2010, BLOOD, V115, P4356, DOI 10.1182/blood-2009-12-257352; YATZIV S, 1981, CLIN GENET, V19, P222; Zychlinski D, 2008, MOL THER, V16, P718, DOI 10.1038/mt.2008.5	47	832	870	2	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2013	341	6148					864	U58		10.1126/science.1233158	http://dx.doi.org/10.1126/science.1233158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23845948	Green Published			2022-12-28	WOS:000323370600034
J	Boseley, S				Boseley, Sarah			Profile Peter Lamptey: uniting science, policy, and implementation	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 27	2013	382	9889					301	301		10.1016/S0140-6736(13)61625-6	http://dx.doi.org/10.1016/S0140-6736(13)61625-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FT	23890035				2022-12-28	WOS:000322544900013
J	Chesler, PM; Liu, H; Adams, A				Chesler, Paul M.; Liu, Hong; Adams, Allan			Holographic Vortex Liquids and Superfluid Turbulence	SCIENCE			English	Article							QUANTUM TURBULENCE; MUTUAL FRICTION; HEAT CURRENT; HELIUM-II; DECAY	Superfluid turbulence is a fascinating phenomenon for which a satisfactory theoretical framework is lacking. Holographic duality provides a systematic approach to studying such quantum turbulence by mapping the dynamics of a strongly interacting quantum liquid into the dynamics of classical gravity. We use this gravitational description to numerically construct turbulent flows in a holographic superfluid in two spatial dimensions. We find that the superfluid kinetic energy spectrum obeys the Kolmogorov -5/3 scaling law, with energy injected at long wavelengths undergoing a direct cascade to short wavelengths where dissipation by vortex annihilation and vortex drag becomes efficient. This dissipation has a simple gravitational interpretation as energy flux across a black hole event horizon.	[Chesler, Paul M.; Liu, Hong; Adams, Allan] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Chesler, PM (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	pchesler@mit.edu; hong_liu@mit.edu; awa@mit.edu		Chesler, Paul/0000-0001-6327-8462	Pappalardo Fellowship in Physics at MIT; Simons Fellowship; U.S. Department of Energy Office of Nuclear Physics [DE-FG02-94ER40818]	Pappalardo Fellowship in Physics at MIT; Simons Fellowship; U.S. Department of Energy Office of Nuclear Physics(United States Department of Energy (DOE))	We thank L. Lehner, J. McGreevy, D. Pesin, and L. Yaffe for helpful conversations, and S. Hartnoll for pointing out an error in a previous version of this paper. A. A. thanks the Stanford Institute for Theoretical Physics for hospitality during early stages of this work and the Aspen Center for Physics during its completion. Supported by a Pappalardo Fellowship in Physics at MIT (P. M. C.), a Simons Fellowship (H. L.), and U.S. Department of Energy Office of Nuclear Physics grant DE-FG02-94ER40818.	Adams A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/115009; Araki T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.145301; Feynman R. P., 1955, PROG LOW TEMP PHYS, V1, P17; Gubser SS, 1998, PHYS LETT B, V428, P105, DOI 10.1016/S0370-2693(98)00377-3; Gubser SS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.141601; Hartnoll SA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.031601; Hartnoll SA, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/22/224002; Henn EAL, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.045301; Herzog CP, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/34/343001; Horng TL, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.023618; Keranen V, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.126012; Kobayashi M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.065302; Maldacena J., 1999, International Journal of Theoretical Physics, V38, P1113, DOI 10.1023/A:1026654312961; Maurer J, 1998, EUROPHYS LETT, V43, P29, DOI 10.1209/epl/i1998-00314-9; McGreevy J, 2010, ADV HIGH ENERGY PHYS, V2010, DOI 10.1155/2010/723105; Montull M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.091601; Nore C, 1997, PHYS REV LETT, V78, P3896, DOI 10.1103/PhysRevLett.78.3896; Numasato R, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.063630; Numasato R, 2010, J LOW TEMP PHYS, V158, P415, DOI 10.1007/s10909-009-9965-0; Paoletti MS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.154501; Paoletti MS, 2011, ANNU REV CONDEN MA P, V2, P213, DOI 10.1146/annurev-conmatphys-062910-140533; Parker NG, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.145301; Reeves MT, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.104501; Seman JA, 2011, J PHYS CONF SER, V264, DOI 10.1088/1742-6596/264/1/012004; SMITH MR, 1993, PHYS REV LETT, V71, P2583, DOI 10.1103/PhysRevLett.71.2583; Stalp SR, 1999, PHYS REV LETT, V82, P4831, DOI 10.1103/PhysRevLett.82.4831; SVISTUNOV BV, 1995, PHYS REV B, V52, P3647, DOI 10.1103/PhysRevB.52.3647; Tsubota M, 2013, PHYS REP, V522, P191, DOI 10.1016/j.physrep.2012.09.007; Vinen WF, 2002, J LOW TEMP PHYS, V128, P167, DOI 10.1023/A:1019695418590; VINEN WF, 1957, PROC R SOC LON SER-A, V240, P128, DOI 10.1098/rspa.1957.0072; VINEN WF, 1957, PROC R SOC LON SER-A, V240, P114, DOI 10.1098/rspa.1957.0071; VINEN WF, 1957, P ROY SOC LOND A MAT, V242, P489; White AC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.075301; Witten E., 1998, ADV THEOR MATH PHYS, V2, P253, DOI [10.4310/ATMP.1998.v2.n2.a2, DOI 10.4310/ATMP.1998.V2.N2.A2]	36	88	88	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					368	372		10.1126/science.1233529	http://dx.doi.org/10.1126/science.1233529			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888034	Green Submitted			2022-12-28	WOS:000322259200042
J	Yang, WT; Wang, JG; Moore, DC; Liang, HP; Dooner, M; Wu, Q; Terek, R; Chen, Q; Ehrlich, MG; Quesenberry, PJ; Neel, BG				Yang, Wentian; Wang, Jianguo; Moore, Douglas C.; Liang, Haipei; Dooner, Mark; Wu, Qian; Terek, Richard; Chen, Qian; Ehrlich, Michael G.; Quesenberry, Peter J.; Neel, Benjamin G.			Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling	NATURE			English	Article							OSSIFICATION GROOVE; RANVIER; CHONDROGENESIS; OSTEOGENESIS; RECEPTOR; PATHWAY; GROWTH; MUTANT; CELLS; MODEL	The tyrosine phosphatase SHP2, encoded by PTPN11, is required for the survival, proliferation and differentiation of various cell types(1,2). Germline activating mutations in PTPN11 cause Noonan syndrome, whereas somatic PTPN11 mutations cause childhood myeloproliferative disease and contribute to some solid tumours. Recently, heterozygous inactivating mutations in PTPN11 were found in metachondromatosis, a rare inherited disorder featuring multiple exostoses, enchondromas, joint destruction and bony deformities(3,4). The detailed pathogenesis of this disorder has remained unclear. Here we use a conditional knockout (floxed) Ptpn11 allele (Ptpn11(fl)) and Cre recombinase transgenic mice to delete Ptpn11 specifically in monocytes, macrophages and osteoclasts (lysozyme M-Cre; LysMCre) or in cathepsin K (Ctsk)-expressing cells, previously thought to be osteoclasts. LysMCre; Ptpn11(fl/fl) mice had mild osteopetrosis. Notably, however, CtskCre; Ptpn11(fl/fl) mice developed features very similar to metachondromatosis. Lineage tracing revealed a novel population of CtskCre-expressing cells in the perichondrial groove of Ranvier that display markers and functional properties consistent with mesenchymal progenitors. Chondroid neoplasms arise from these cells and show decreased extracellular signal-regulated kinase (ERK) pathway activation, increased Indian hedgehog (Ihh) and parathyroid hormone-related protein (Pthrp, also known as Pthlh) expression and excessive proliferation. Shp2-deficient chondroprogenitors had decreased fibroblast growth factor-evoked ERK activation and enhanced Ihh and Pthrp expression, whereas fibroblast growth factor receptor (FGFR) or mitogen-activated protein kinase kinase (MEK) inhibitor treatment of chondroid cells increased Ihh and Pthrp expression. Importantly, smoothened inhibitor treatment ameliorated metachondromatosis features in CtskCre; Ptpn11(fl/fl) mice. Thus, in contrast to its pro-oncogenic role in haematopoietic and epithelial cells, Ptpn11 is a tumour suppressor in cartilage, acting through a FGFR/MEK/ERK-dependent pathway in a novel progenitor cell population to prevent excessive Ihh production.	[Yang, Wentian; Wang, Jianguo; Moore, Douglas C.; Liang, Haipei; Terek, Richard; Chen, Qian; Ehrlich, Michael G.] Brown Univ, Alpert Med Sch, Dept Orthopaed, Providence, RI 02903 USA; [Yang, Wentian; Wang, Jianguo; Moore, Douglas C.; Liang, Haipei; Terek, Richard; Chen, Qian; Ehrlich, Michael G.] Rhode Isl Hosp, Providence, RI 02903 USA; [Dooner, Mark; Quesenberry, Peter J.] Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Dooner, Mark; Quesenberry, Peter J.] Rhode Isl Hosp, COBRE Ctr Stem Cell Biol, Providence, RI 02903 USA; [Dooner, Mark; Quesenberry, Peter J.] Brown Univ, Alpert Med Sch, Providence, RI 02903 USA; [Wu, Qian] Univ Connecticut, Ctr Hlth, Dept Pathol & Lab Med, Farmington, CT 06030 USA; [Neel, Benjamin G.] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Neel, Benjamin G.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; University of Connecticut; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Yang, WT (corresponding author), Brown Univ, Alpert Med Sch, Dept Orthopaed, Providence, RI 02903 USA.	wyang@lifespan.org	Chen, Qian/C-4354-2011	Chen, Qian/0000-0003-4406-5618; Dooner, Mark/0000-0003-0653-6562; terek, richard/0000-0002-6322-6790	National Institute for General Medicine Sciences (NIGMS) [8P20GM103468]; NIH [R21AR57156, R37CA49152]; Rhode Island Hospital Orthopaedic Foundation; Pediatric Orthopaedic Society of North America; Orthopaedic Research and Education Foundation; Ontario Ministry of Health and Long Term Care; Princess Margaret Cancer Foundation; NATIONAL CANCER INSTITUTE [R37CA049152] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR025179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103468, P20GM104937] Funding Source: NIH RePORTER	National Institute for General Medicine Sciences (NIGMS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island Hospital Orthopaedic Foundation; Pediatric Orthopaedic Society of North America; Orthopaedic Research and Education Foundation; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Princess Margaret Cancer Foundation(University of Toronto); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kato for Ctsk-Cre mice, A. Craft for review of the manuscript, X. Wang and P. Monfils for help with histology and J. Cao for helping with mu-CT analysis. This publication was made possible by the National Institutes of Health (NIH) and the National Institute for General Medicine Sciences (NIGMS) grant no. 8P20GM103468. This work was also funded by NIH R21AR57156 (to W.Y.) and R37CA49152 (to B.G.N.), the Rhode Island Hospital Orthopaedic Foundation and a grant from the Pediatric Orthopaedic Society of North America and the Orthopaedic Research and Education Foundation (to W.Y.). B.G.N. is a Canada Research Chair, Tier 1, and is also supported in part by the Ontario Ministry of Health and Long Term Care and the Princess Margaret Cancer Foundation.	Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Bovee JVMG, 2010, NAT REV CANCER, V10, P481, DOI 10.1038/nrc2869; Bowen ME, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002050; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dodds RA, 1998, J BONE MINER RES, V13, P673, DOI 10.1359/jbmr.1998.13.4.673; Fenichel I, 2006, INT ORTHOP, V30, P353, DOI 10.1007/s00264-006-0082-2; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hidaka K, 2001, INT J BIOCHEM CELL B, V33, P1094, DOI 10.1016/S1357-2725(01)00067-X; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Karlsson C, 2009, J ANAT, V215, P355, DOI 10.1111/j.1469-7580.2009.01115.x; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Langenskiold A, 1998, J PEDIATR ORTHOPED, V18, P173, DOI 10.1097/00004694-199803000-00008; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Neel B. G., 2009, HDB CELL SIGNALING, P771; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Pannier S, 2008, BEST PRACT RES CL RH, V22, P45, DOI 10.1016/j.berh.2007.12.004; Pansuriya TC, 2010, INT J CLIN EXP PATHO, V3, P557; Pretzel D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3320; Robinson D, 1999, CLIN ORTHOP RELAT R, pS163; RODRIGUEZ JI, 1985, CALCIFIED TISSUE INT, V37, P677, DOI 10.1007/BF02554930; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; SHAPIRO F, 1977, J BONE JOINT SURG AM, V59, P703, DOI 10.2106/00004623-197759060-00001; Sobreira NLM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000991; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tartaglia M, 2011, BEST PRACT RES CL EN, V25, P161, DOI 10.1016/j.beem.2010.09.002; Tiet TD, 2006, AM J PATHOL, V168, P321, DOI 10.2353/ajpath.2006.050001; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002	33	152	163	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					491	+		10.1038/nature12396	http://dx.doi.org/10.1038/nature12396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23863940	Green Accepted			2022-12-28	WOS:000322157900043
J	Campion, J; Bhugra, D; Bailey, S; Marmot, M				Campion, Jonathan; Bhugra, Dinesh; Bailey, Sue; Marmot, Michael			Inequality and mental disorders: opportunities for action	LANCET			English	Editorial Material									[Campion, Jonathan] UCL, UCL Inst Hlth Equ, Fac Brain Sci, London WC1E 7HB, England; [Marmot, Michael] UCL, Dept Epidemiol & Publ Hlth, London WC1E 7HB, England; [Campion, Jonathan] Univ Coll London Partners, Dept Populat Mental Hlth, London, England; [Campion, Jonathan] South London & Maudsley NHS Fdn Trust, London, England; [Campion, Jonathan; Bhugra, Dinesh] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London, England; [Bailey, Sue] Royal Coll Psychiatrists, London SW1X 8PG, England; [Bailey, Sue] Univ Cent Lancashire, Sch Social Work, Preston PR1 2HE, Lancs, England; [Bailey, Sue] Greater Manchester West NHS Mental Hlth Trust, Manchester, Lancs, England	University of London; University College London; University of London; University College London; University of London; University College London; South London & Maudsley NHS Trust; University of London; King's College London; University of Central Lancashire	Campion, J (corresponding author), UCL, UCL Inst Hlth Equ, Fac Brain Sci, London WC1E 7HB, England.	jonathan_campion@yahoo.co.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	ESRC [ES/F02679X/1] Funding Source: UKRI; MRC [G0601647, G1000616, G0701830, G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish; Medical Research Council [G0902037, G0100222, G8802774, G1000616, G0701830, G0601647, G19/35] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Allen M, 2013, WORKING HLTH EQUITY; [Anonymous], GUIDANCE COMMISSIONI; [Anonymous], 2011 12 NAT SURV INV; [Anonymous], MENT HLTH ATL; Brugha T, 2009, ADULT PSYCHIAT MORBI; Campion J, 2012, EUR PSYCHIAT, V27, P68, DOI 10.1016/j.eurpsy.2011.10.004; Green H., 2005, J RES SPEC EDUC NEED; HM Government and Department of Health, 2011, NO HLTH MENT HLTH CR; McManus S., 2010, CIGARETTE SMOKING ME; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Pickett KE, 2010, BRIT J PSYCHIAT, V197, P426, DOI 10.1192/bjp.bp.109.072066; Royal College of Psychiatrists, 2018, WHOL PERS CAR RHET R; United Nations, 1966, INT COV EC SOC CULT; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; World Health Organization, 2008, The global burden of disease: 2004 update	15	33	33	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 20	2013	382	9888					183	184		10.1016/S0140-6736(13)61411-7	http://dx.doi.org/10.1016/S0140-6736(13)61411-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193FL	23870520				2022-12-28	WOS:000322543700005
J	Watts, G				Watts, Geoff			Profile Ruslan Medzhitov: creative and conceptual immunologist	LANCET			English	Biographical-Item																			0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 20	2013	382	9888					199	199		10.1016/S0140-6736(13)61589-5	http://dx.doi.org/10.1016/S0140-6736(13)61589-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FL	23870523				2022-12-28	WOS:000322543700015
J	Porcello, D; Hsi, S				Porcello, Darrell; Hsi, Sherry			Crowdsourcing and Curating Online Education Resources	SCIENCE			English	Editorial Material									[Porcello, Darrell; Hsi, Sherry] Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Porcello, D (corresponding author), Univ Calif Berkeley, Lawrence Hall Sci, Berkeley, CA 94720 USA.	porcello@berkeley.edu						[Anonymous], 2011, 2010 SPEAK UP REP; Project Tomorrow, 2012, 2011 SPEAK UP REP; Wikimedia Foundation, 2011 2012 ANN REP; Zia L. L., 2000, D LIB, V6	4	39	39	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					240	241		10.1126/science.1234722	http://dx.doi.org/10.1126/science.1234722			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	185HV	23869007				2022-12-28	WOS:000321959300027
J	Kiyomitsu, T; Cheeseman, IM				Kiyomitsu, Tomomi; Cheeseman, Iain M.			Cortical Dynein and Asymmetric Membrane Elongation Coordinately Position the Spindle in Anaphase	CELL			English	Article							CELL-DIVISION; MITOTIC SPINDLE; CYTOPLASMIC DYNEIN; CONTRACTILE RING; CLEAVAGE FURROW; ACTIN CORTEX; AURORA-B; CYTOKINESIS; PROTEIN; ANILLIN	Mitotic spindle position defines the cell-cleavage site during cytokinesis. However, the mechanisms that control spindle positioning to generate equal-sized daughter cells remain poorly understood. Here, we demonstrate that two mechanisms act coordinately to center the spindle during anaphase in symmetrically dividing human cells. First, the spindle is positioned directly by the microtubule-based motor dynein, which we demonstrate is targeted to the cell cortex by two distinct pathways: a G alpha i/LGN/NuMA-dependent pathway and a 4.1G/R and NuMA-dependent, anaphase-specific pathway. Second, we find that asymmetric plasma membrane elongation occurs in response to spindle mispositioning to alter the cellular boundaries relative to the spindle. Asymmetric membrane elongation is promoted by chromosome-derived Ran-GTP signals that locally reduce Anillin at the growing cell cortex. In asymmetrically elongating cells, dynein-dependent spindle anchoring at the stationary cell cortex ensures proper spindle positioning. Our results reveal the anaphase-specific spindle centering systems that achieve equal-sized cell division.	[Kiyomitsu, Tomomi; Cheeseman, Iain M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kiyomitsu, Tomomi; Cheeseman, Iain M.] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Kiyomitsu, T (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	tomomi.kiyomitsu@gmail.com; icheese@wi.mit.edu		Cheeseman, Iain/0000-0002-3829-5612	Leukemia & Lymphoma Society; Human Frontiers Science Foundation; NIH/National Institute of General Medical Sciences [GM088313]; American Cancer Society [121776]; Human Frontiers Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088313] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Human Frontiers Science Foundation; NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Defne Yarar, Adam Martin, Jonathan Coravos, and members of the Cheeseman laboratory for discussions and critical readings of the manuscript. We also thank Duane Compton for providing reagents. This work was supported by a Scholar award to I.M.C. from the Leukemia & Lymphoma Society, an award from the Human Frontiers Science Foundation, a grant from the NIH/National Institute of General Medical Sciences (GM088313), and a Research Scholar Grant (121776) from the American Cancer Society. I.M.C. is a Thomas D. and Virginia W. Cabot Career Development Professor of Biology. T.K. is supported by a long-term fellowship from the Human Frontiers Science Program.	Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Burgess DR, 2005, TRENDS CELL BIOL, V15, P156, DOI 10.1016/j.tcb.2005.01.006; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Collins ES, 2012, MOL BIOL CELL, V23, P3380, DOI 10.1091/mbc.E12-02-0109; COMPTON DA, 1995, J CELL SCI, V108, P621; Connell M, 2011, MOL BIOL CELL, V22, P4220, DOI 10.1091/mbc.E11-02-0173; D'Avino PP, 2009, J CELL SCI, V122, P1071, DOI 10.1242/jcs.034785; Diakowski W, 2006, FOLIA HISTOCHEM CYTO, V44, P231; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kotadia S, 2012, J CELL BIOL, V199, P745, DOI 10.1083/jcb.201208041; Kotak S, 2012, J CELL BIOL, V199, P97, DOI 10.1083/jcb.201203166; Mattagajasingh SN, 1999, J CELL BIOL, V145, P29, DOI 10.1083/jcb.145.1.29; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Niiya F, 2005, J BIOL CHEM, V280, P36502, DOI 10.1074/jbc.M508007200; NISHITANI H, 1991, EMBO J, V10, P1555, DOI 10.1002/j.1460-2075.1991.tb07675.x; Ou GS, 2010, SCIENCE, V330, P677, DOI 10.1126/science.1196112; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Salbreux G, 2012, TRENDS CELL BIOL, V22, P536, DOI 10.1016/j.tcb.2012.07.001; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Sedzinski J, 2011, NATURE, V476, P462, DOI 10.1038/nature10286; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Silverman-Gavrila RV, 2008, MOL BIOL CELL, V19, P3735, DOI 10.1091/mbc.E08-01-0049; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Xiao ZN, 2012, BIOCHEM BIOPH RES CO, V420, P888, DOI 10.1016/j.bbrc.2012.03.095; Ye KQ, 1999, J NEUROSCI, V19, P10747, DOI 10.1523/JNEUROSCI.19-24-10747.1999	38	171	178	0	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					391	402		10.1016/j.cell.2013.06.010	http://dx.doi.org/10.1016/j.cell.2013.06.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870127	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000321950700015
J	Mouchiroud, L; Houtkooper, RH; Moullan, N; Katsyuba, E; Ryu, D; Canto, C; Mottis, A; Jo, YS; Viswanathan, M; Schoonjans, K; Guarente, L; Auwerx, J				Mouchiroud, Laurent; Houtkooper, Riekelt H.; Moullan, Norman; Katsyuba, Elena; Ryu, Dongryeol; Canto, Carles; Mottis, Adrienne; Jo, Young-Suk; Viswanathan, Mohan; Schoonjans, Kristina; Guarente, Leonard; Auwerx, Johan			The NAD(+)/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling	CELL			English	Article							DIET-INDUCED OBESITY; EXTENDS LIFE-SPAN; HIGH-FAT DIET; CAENORHABDITIS-ELEGANS; POLY(ADP-RIBOSE) POLYMERASE-1; TRANSCRIPTION FACTORS; CALORIE RESTRICTION; ENERGY-EXPENDITURE; OXIDATIVE STRESS; C. ELEGANS	NAD(+) is an important cofactor regulating metabolic homeostasis and a rate-limiting substrate for sirtuin deacylases. We show that NAD(+) levels are reduced in aged mice and Caenorhabditis elegans and that decreasing NAD(+) levels results in a further reduction in worm lifespan. Conversely, genetic or pharmacological restoration of NAD(+) prevents age-associated metabolic decline and promotes longevity in worms. These effects are dependent upon the protein deacetylase sir-2.1 and involve the induction of mitonuclear protein imbalance as well as activation of stress signaling via the mitochondrial unfolded protein response (UPRmt) and the nuclear translocation and activation of FOXO transcription factor DAF-16. Our data suggest that augmenting mitochondrial stress signaling through the modulation of NAD(+) levels may be a target to improve mitochondrial function and prevent or treat age-associated decline.	[Mouchiroud, Laurent; Houtkooper, Riekelt H.; Moullan, Norman; Katsyuba, Elena; Ryu, Dongryeol; Canto, Carles; Mottis, Adrienne; Jo, Young-Suk; Schoonjans, Kristina; Auwerx, Johan] Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Houtkooper, Riekelt H.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Viswanathan, Mohan; Guarente, Leonard] MIT, Dept Biol, Paul F Glenn Lab, Cambridge, MA 02139 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Amsterdam; Academic Medical Center Amsterdam; Massachusetts Institute of Technology (MIT)	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland.	admin.auwerx@epfl.ch	Houtkooper, Riekelt H/E-1602-2011; Auwerx, Johan/ABE-9307-2021; Ryu, Dongryeol/AAQ-3642-2020; Houtkooper, Riekelt/P-5001-2019	Houtkooper, Riekelt H/0000-0001-9961-0842; Ryu, Dongryeol/0000-0001-5905-6760; Schoonjans, Kristina/0000-0003-1247-4265; Auwerx, Johan/0000-0002-5065-5393; Canto, Carles/0000-0002-5167-7922	Fondation pour la Recherche Medicale; ZonMw [91613050]; AMC; Ecole Polytechnique Federale de Lausanne; EU [ERC-2008-AdG-23138]; NIH [R01HL106511-01A, R01AG043930]; Velux Stiftung; Swiss National Science Foundation [31003A-124713, 31003A-125487, CSRII3-136201]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015339, R01AG043930] Funding Source: NIH RePORTER	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ZonMw(Netherlands Organization for Health Research and Development); AMC; Ecole Polytechnique Federale de Lausanne; EU(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Velux Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Pierre Gonczy for sharing reagents and equipment, the Caenorhabditis Genetics Center for providing worm strains, and the Auwerx team for discussions. L.M. is supported by the "Fondation pour la Recherche Medicale" and R.H.H. by a VENI grant from ZonMw (number 91613050) and an AMC postdoctoral fellowship. J.A. is the Nestle Chair in Energy Metabolism. This work is supported by grants from the Ecole Polytechnique Federale de Lausanne, EU Ideas program (ERC-2008-AdG-23138), NIH (R01HL106511-01A and R01AG043930), Velux Stiftung, and Swiss National Science Foundation (31003A-124713, 31003A-125487, and CSRII3-136201).	Alam H, 2010, CELL METAB, V12, P30, DOI 10.1016/j.cmet.2010.05.004; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Erener S, 2012, FASEB J, V26, P2631, DOI 10.1096/fj.11-200212; Ferraris DV, 2010, J MED CHEM, V53, P4561, DOI 10.1021/jm100012m; Gagnon SN, 2002, BIOCHEM J, V368, P263, DOI 10.1042/BJ20020669; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hashimoto T, 2010, BIOGERONTOLOGY, V11, P31, DOI 10.1007/s10522-009-9225-3; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Houtkooper RH, 2012, J CELL BIOL, V199, P205, DOI 10.1083/jcb.201207019; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Houtkooper RH, 2010, CELL, V142, P9, DOI 10.1016/j.cell.2010.06.029; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Mangerich A, 2010, MECH AGEING DEV, V131, P389, DOI 10.1016/j.mad.2010.05.005; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Mouchiroud L, 2011, AGING CELL, V10, P39, DOI 10.1111/j.1474-9726.2010.00640.x; Penning TD, 2009, J MED CHEM, V52, P514, DOI 10.1021/jm801171j; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	49	739	767	10	194	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					430	441		10.1016/j.cell.2013.06.016	http://dx.doi.org/10.1016/j.cell.2013.06.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870130	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000321950700018
J	He, GZ; Zhang, L; Mol, APJ; Lu, YL; Liu, JG				He, Guizhen; Zhang, Lei; Mol, Arthur P. J.; Lu, Yonglong; Liu, Jianguo			Revising China's Environmental Law	SCIENCE			English	Editorial Material									[He, Guizhen; Lu, Yonglong] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing 100085, Peoples R China; [Zhang, Lei; Mol, Arthur P. J.] Wageningen Univ, NL-6706 KN Wageningen, Netherlands; [Zhang, Lei; Mol, Arthur P. J.] Renmin Univ China, Beijing 100086, Peoples R China; [Liu, Jianguo] Michigan State Univ, E Lansing, MI 48823 USA	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Wageningen University & Research; Renmin University of China; Michigan State University	Lu, YL (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing 100085, Peoples R China.	yllu@rcees.ac.cn	jingjing, yuan/N-1658-2013; mol, arthur PJ/H-2093-2012; Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087; mol, arthur/0000-0002-4446-2595				[Anonymous], 2012, 18 CPC NAT C 14 NOV; Chang J. W., 2008, US CHINA LAW REV, V5, P1; He GZ, 2012, ENVIRON DEV, V3, P25, DOI 10.1016/j.envdev.2012.05.005; He GZ, 2012, ENVIRON SCI TECHNOL, V46, P7442, DOI 10.1021/es302429e; He GZ, 2009, ENVIRON MANAGE, V44, P579, DOI 10.1007/s00267-009-9341-5; Liu JG, 2010, SCIENCE, V328, P50, DOI 10.1126/science.1186234; McElwee Charles R., 2011, ENV LAW CHINA MITIGA; Mol APJ, 2006, ENVIRON POLIT, V15, P149, DOI 10.1080/09644010600562765; Organisation for Economic Cooperation and Development, 2006, ENV COMPL ENF CHIN A; Ortolano, 2000, ENV REGULATION CHINA; Wang C. F., 2006, J ENVIRON LAW, V8, P159; Wang J., 2011, ENV PROTECT, V11, P34; Wang T., 2012, SO WEEKLY GUANG 0914; World Bank, 2009, STRENGTH CHIN ENV PR; Wu J, 2011, ENVIRON IMPACT ASSES, V31, P77, DOI 10.1016/j.eiar.2010.04.010	15	45	48	6	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					133	133		10.1126/science.1235000	http://dx.doi.org/10.1126/science.1235000			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	185KA	23846893	Green Submitted			2022-12-28	WOS:000321965300025
J	Fain, K; Daubresse, M; Alexander, GC				Fain, Kevin; Daubresse, Matthew; Alexander, G. Caleb			The Food and Drug Administration Amendments Act and Postmarketing Commitments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Fain, Kevin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Daubresse, Matthew; Alexander, G. Caleb] Johns Hopkins Univ, Ctr Drug Safety & Effectiveness, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Alexander, GC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St,W6035, Baltimore, MD 21205 USA.	galexand@jhsph.edu	Fain, Kevin/H-6573-2019	Fain, Kevin/0000-0001-7839-7149	AHRQ HHS [R01 HS0189960] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Department of Health and Human Services Office of Inspector General, 2006, FDAS MON POSTM STUD; Institute of Medicine, FUT DRUG SAF PROM PR; Schultz WB, 2007, NEW ENGL J MED, V357, P2217, DOI 10.1056/NEJMp078212; US Food and Drug Administration, POSTM REQ COMM ANN R; US Food and Drug Administration (FDA), POSTM REQ COMM STAT	5	49	49	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					202	204		10.1001/jama.2013.7900	http://dx.doi.org/10.1001/jama.2013.7900			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23839755				2022-12-28	WOS:000321511500020
J	Becker, AE; Kleinman, A				Becker, Anne E.; Kleinman, Arthur			GLOBAL HEALTH Mental Health and the Global Agenda	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MIDDLE-INCOME COUNTRIES; SYSTEMATIC ANALYSIS; PRIORITY ACTIONS; DISEASE; PSYCHIATRY; DEPRESSION; DISORDERS; OUTCOMES; THERAPY; INTERVENTION	WHEN THE WORLD HEALTH ORGANIZATION (WHO) EUROPEAN MINISterial Conference on Mental Health endorsed the statement "No health without mental health" in 2005,(1) it spoke to the intrinsic - and indispensable - role of mental health care in health care writ large. Yet mental health has long been treated in ways that reflect the opposite of that sentiment. This historical divide - in practice and in policy - between physical health and mental health has in turn perpetuated large gaps in resources across economic, social, and scientific domains. The upshot is a global tragedy: a legacy of the neglect and marginalization of mental health.(2) The scale of the global impact of mental illness is substantial, with mental illness constituting an estimated 7.4% of the world's measurable burden of disease.(3) The lack of access to mental health services of good quality is profound in populations with limited resources, for whom numerous social hazards exacerbate vulnerability to poor health. The human toll of mental disorders is further compounded by collateral adverse effects on health and social well-being, including exposure to stigma and human rights abuses, forestallment of educational and social opportunities, and entry into a pernicious cycle of social disenfranchisement and poverty.(4,5) Advances in efforts to alleviate the human and social costs of mental disorders have been both too slow and too few.	[Becker, Anne E.; Kleinman, Arthur] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Becker, Anne E.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Kleinman, Arthur] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University	Kleinman, A (corresponding author), Harvard Univ, Dept Anthropol, William James Hall,33 Kirkland St, Cambridge, MA 02138 USA.	kleinman@wjh.harvard.edu		Becker, Anne/0000-0001-9129-6510	John Wiley and Sons	John Wiley and Sons	Dr. Becker reports receiving payments for editorial work from John Wiley and Sons, for editorial work, travel, and meeting participation from the Academy for Eating Disorders, and for travel and meeting participation from MA Healthcare, the Succeed Foundation, the American Psychiatric Association, and the National Eating Disorders Association. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2009, MENT HLTH SYST SEL L; [Anonymous], 2012, WHO MHGAP NEWSLETTER; [Anonymous], 2009, SCAL UP NURC MED ED; [Anonymous], 2011, MENT HLTH ATL; [Anonymous], 2005, EUR J EDUC PSYCHOL; Bass J, 2006, BRIT J PSYCHIAT, V188, P567, DOI 10.1192/bjp.188.6.567; Bass JK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001159; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Behforouz HL, 2004, CLIN INFECT DIS, V38, pS429, DOI 10.1086/421408; Bloom DE, 2011, GLOBAL EC BURDEN NON; Bruckner TA, 2011, B WORLD HEALTH ORGAN, V89, P184, DOI 10.2471/BLT.10.082784; Celletti F, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001108; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Cohen A., 2001, EFFECTIVENESS MENTAL; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Desjarlais R., 1995, WORLD MENTAL HLTH; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Fricchione GL, 2012, HARVARD REV PSYCHIAT, V20, P47, DOI 10.3109/10673229.2012.655211; Horton R, 2003, LANCET, V361, P712, DOI 10.1016/S0140-6736(03)12665-7; Humayun Q, 2011, LANCET, V378, P565, DOI 10.1016/S0140-6736(11)61282-8; Ivers LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019276; Jenkins R, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-17; Kakuma R, 2011, LANCET, V378, P1654, DOI 10.1016/S0140-6736(11)61093-3; Kiima D, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-19; Lee PT, 2010, LANCET, V376, P516, DOI 10.1016/S0140-6736(10)61254-8; Lewin SA, 2005, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD004015.PUB2; Lund C, 2011, LANCET, V378, P1502, DOI 10.1016/S0140-6736(11)60754-X; Muijen M, 2006, WORLD PSYCHIATRY, V5, P113; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Olugbile Olufemi, 2008, Int Psychiatry, V5, P32; Patel V, 2009, PSYCHOL MED, V39, P1759, DOI 10.1017/S0033291709005224; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Patel V, 2007, BRIT J PSYCHIAT, V190, P77, DOI 10.1192/bjp.bp.106.025692; Patel V, 2011, BRIT J PSYCHIAT, V199, P459, DOI 10.1192/bjp.bp.111.092155; Patel Vikram, 2003, World Psychiatry, V2, P163; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000160; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Petersen I, 2012, COMMUNITY MENT HLT J, V48, P336, DOI 10.1007/s10597-011-9429-2; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Raviola G, 2011, LANCET, V378, P1613, DOI 10.1016/S0140-6736(11)60941-0; Razzouk D, 2010, HEALTH POLICY, V94, P211, DOI 10.1016/j.healthpol.2009.09.009; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Saraceno B, 2009, EUR ARCH PSY CLIN N, V259, P109, DOI 10.1007/s00406-009-0059-4; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Thara Rangawsamy, 2008, Int J Ment Health Syst, V2, P11, DOI 10.1186/1752-4458-2-11; Thornicroft G, 2012, HARVARD REV PSYCHIAT, V20, P13, DOI 10.3109/10673229.2012.649117; Tomlinson M, 2009, B WORLD HEALTH ORGAN, V87, P438, DOI 10.2471/BLT.08.054353; Tyrer P, 2005, BRIT J PSYCHIAT, V186, P1, DOI 10.1192/bjp.186.1.1; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WHO, 2001, WORLD HLTH REPORT 20; WHO, 2002, MENT HLTH GLOB ACT P; World Health Organization, 2010, WHO MHGAP INT GUID M; World Health Organization, 2007, GLOB FUND STRAT APPR; World Health Organization (WHO), 2010, MENT HLTH DEV TARG P; *WORLD HLTH ASS, 2012, 65 WORLD HLTH ASS GE	57	200	205	3	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					66	73		10.1056/NEJMra1110827	http://dx.doi.org/10.1056/NEJMra1110827			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175WE	23822778	Green Published, Bronze			2022-12-28	WOS:000321263500011
J	Ferguson, DJ; Maclennan, J; Bastow, ID; Pyle, DM; Jones, SM; Keir, D; Blundy, JD; Plank, T; Yirgu, G				Ferguson, D. J.; Maclennan, J.; Bastow, I. D.; Pyle, D. M.; Jones, S. M.; Keir, D.; Blundy, J. D.; Plank, T.; Yirgu, G.			Melting during late-stage rifting in Afar is hot and deep	NATURE			English	Article							CONTINENTAL MARGINS; SEDIMENTARY BASINS; FLOOD BASALTS; MANTLE; EXTENSION; LITHOSPHERE; TRANSITION; GENERATION; EARTH; SEGMENTATION	Investigations of a variety of continental rifts and margins worldwide have revealed that a considerable volume of melt can intrude into the crust during continental breakup(1-8), modifying its composition and thermal structure. However, it is unclear whether the cause of voluminous melt production at volcanic rifts is primarily increased mantle temperature or plate thinning(1,2,8-12). Also disputed is the extent to which plate stretching or thinning is uniform or varies with depth with the entire continental lithospheric mantle potentially being removed before plate rupture(13-16). Here we show that the extensive magmatism during rifting along the southern Red Sea rift in Afar, a unique region of sub-aerial transition from continental to oceanic rifting, is driven by deep melting of hotter-than-normal asthenosphere. Petrogenetic modelling shows that melts are predominantly generated at depths greater than 80 kilometres, implying the existence of a thick upper thermo-mechanical boundary layer in a rift system approaching the point of plate rupture. Numerical modelling of rift development shows that when breakup occurs at the slow extension rates observed in Afar, the survival of a thick plate is an inevitable consequence of conductive cooling of the lithosphere, even when the underlying asthenosphere is hot. Sustained magmatic activity during rifting in Afar thus requires persistently high mantle temperatures, which would allow melting at high pressure beneath the thick plate. If extensive plate thinning does occur during breakup it must do so abruptly at a late stage, immediately before the formation of the new ocean basin(16).	[Ferguson, D. J.; Plank, T.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Maclennan, J.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Bastow, I. D.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Pyle, D. M.] Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England; [Jones, S. M.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England; [Keir, D.] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England; [Blundy, J. D.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Yirgu, G.] Univ Addis Ababa, Dept Earth Sci, Addis Ababa, Ethiopia	Columbia University; University of Cambridge; Imperial College London; University of Oxford; University of Birmingham; NERC National Oceanography Centre; University of Southampton; University of Bristol; Addis Ababa University	Ferguson, DJ (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	davef@ldeo.columbia.edu	Ferguson, David/C-9136-2013; Plank, Terry/D-9542-2012; Pyle, David M/C-5707-2009; Maclennan, John/E-6549-2010; Bastow, Ian/AAL-2933-2020; Jones, Stephen M/O-5276-2017; Bastow, Ian D/I-3783-2013; Keir, Derek/AAB-6110-2020; Maclennan, John/R-1962-2019	Pyle, David M/0000-0002-2663-9940; Maclennan, John/0000-0001-6857-9600; Bastow, Ian/0000-0003-1468-9278; Jones, Stephen M/0000-0002-8480-3518; Bastow, Ian D/0000-0003-1468-9278; Keir, Derek/0000-0001-8787-8446; Maclennan, John/0000-0001-6857-9600; Plank, Terry/0000-0002-1665-0484; Ferguson, David/0000-0003-0612-6512	NERC; LDEO; NERC [NE/E005284/1, NE/E007414/1, NE/E006469/1] Funding Source: UKRI; Natural Environment Research Council [NE/E006469/1, NE/E007414/1, NE/E005284/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); LDEO; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We acknowledge help and support by members of the NERC Afar Rift Consortium. This project was supported by a NERC consortium grant. D.J.F. acknowledges support from a LDEO postdoctoral fellowship.	Armitage JJ, 2010, NATURE, V465, P913, DOI 10.1038/nature09063; Asimow PD, 2004, J PETROL, V45, P2349, DOI 10.1093/petrology/egh043; Bastow ID, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003036; Bastow ID, 2011, NAT GEOSCI, V4, P248, DOI [10.1038/NGEO1095, 10.1038/ngeo1095]; Boutilier RR, 1999, J GEOPHYS RES-SOL EA, V104, P7389, DOI 10.1029/1998JB900076; BOWN JW, 1995, J GEOPHYS RES-SOL EA, V100, P18011, DOI 10.1029/94JB01478; Canil D, 2002, EARTH PLANET SC LETT, V195, P75, DOI 10.1016/S0012-821X(01)00582-9; Dick HJB, 2003, NATURE, V426, P405, DOI 10.1038/nature02128; Eagles G, 2002, EARTH PLANET SC LETT, V203, P607, DOI 10.1016/S0012-821X(02)00916-0; Esedo R, 2012, GEOSPHERE, V8, P1078, DOI 10.1130/GES00748.1; Ferguson DJ, 2010, EARTH PLANET SC LETT, V292, P409, DOI 10.1016/j.epsl.2010.02.010; Field L, 2012, B VOLCANOL, V74, P2251, DOI 10.1007/s00445-012-0660-7; Gibson SA, 2010, EARTH PLANET SC LETT, V300, P275, DOI 10.1016/j.epsl.2010.10.002; Hammond JOS, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003738; Hayward NJ, 1996, TECTONICS, V15, P244, DOI 10.1029/95TC02292; Herzberg C, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001390; Huismans R, 2011, NATURE, V473, P74, DOI 10.1038/nature09988; JARVIS GT, 1980, EARTH PLANET SC LETT, V48, P42, DOI 10.1016/0012-821X(80)90168-5; Keranen K, 2004, GEOLOGY, V32, P949, DOI 10.1130/G20737.1; Kojitani H, 1997, EARTH PLANET SC LETT, V153, P209, DOI 10.1016/S0012-821X(97)00186-6; KRESS VC, 1991, CONTRIB MINERAL PETR, V108, P82, DOI 10.1007/BF00307328; Le Roux V, 2010, GEOCHIM COSMOCHIM AC, V74, P2779, DOI 10.1016/j.gca.2010.02.004; Lee CTA, 2009, EARTH PLANET SC LETT, V279, P20, DOI 10.1016/j.epsl.2008.12.020; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; MCKENZIE D, 1978, EARTH PLANET SC LETT, V40, P25, DOI 10.1016/0012-821X(78)90071-7; MCKENZIE D, 1991, J PETROL, V32, P1021, DOI 10.1093/petrology/32.5.1021; Nielsen TK, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000662; Pik R, 1999, GEOCHIM COSMOCHIM AC, V63, P2263, DOI 10.1016/S0016-7037(99)00141-6; Robinson JAC, 1998, EARTH PLANET SC LETT, V164, P277, DOI 10.1016/S0012-821X(98)00213-1; Rooney TO, 2012, GEOLOGY, V40, P27, DOI 10.1130/G32382.1; Rychert CA, 2012, NAT GEOSCI, V5, P406, DOI [10.1038/NGEO1455, 10.1038/ngeo1455]; Shillington DJ, 2009, GEOLOGY, V37, P7, DOI 10.1130/G25302A.1; Thybo H, 2009, NATURE, V457, P873, DOI 10.1038/nature07688; White N, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000173; WHITE R, 1989, J GEOPHYS RES-SOLID, V94, P7685, DOI 10.1029/JB094iB06p07685; White RS, 2008, NATURE, V452, P460, DOI 10.1038/nature06687; WHITE RS, 1992, J GEOPHYS RES-SOL EA, V97, P19683, DOI 10.1029/92JB01749; Wolfenden E, 2005, GEOL SOC AM BULL, V117, P846, DOI 10.1130/B25516.1; Wright TJ, 2006, NATURE, V442, P291, DOI 10.1038/nature04978; [No title captured], DOI DOI 10.1038/39853	42	74	75	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2013	499	7456					70	+		10.1038/nature12292	http://dx.doi.org/10.1038/nature12292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23823795	Green Published			2022-12-28	WOS:000321285600035
J	Aoto, J; Martinelli, DC; Malenka, RC; Tabuchi, K; Sudhof, TC				Aoto, Jason; Martinelli, David C.; Malenka, Robert C.; Tabuchi, Katsuhiko; Suedhof, Thomas C.			Presynaptic Neurexin-3 Alternative Splicing trans-Synaptically Controls Postsynaptic AMPA Receptor Trafficking	CELL			English	Article							SYNAPSE FORMATION; CA2+ CHANNELS; NEUROLIGINS; ALPHA; PROTEINS; SUBICULUM; NEURONS; DEPENDENCE; DIVERSITY; MECHANISM	Neurexins are essential presynaptic cell adhesion molecules that are linked to schizophrenia and autism and are subject to extensive alternative splicing. Here, we used a genetic approach to test the physiological significance of neurexin alternative splicing. We generated knockin mice in which alternatively spliced sequence #4 (SS4) of neuexin-3 is constitutively included but can be selectively excised by cre-recombination. SS4 of neurexin-3 was chosen because it is highly regulated and controls neurexin binding to neuroligins, LRRTMs, and other ligands. Unexpectedly, constitutive inclusion of SS4 in presynaptic neurexin-3 decreased postsynaptic AMPA, but not NMDA receptor levels, and enhanced postsynaptic AMPA receptor endocytosis. Moreover, constitutive inclusion of SS4 in presynaptic neurexin-3 abrogated postsynaptic AMPA receptor recruitment during NMDA receptor-dependent LTP. These phenotypes were fully rescued by constitutive excision of SS4 in neurexin-3. Thus, alternative splicing of presynaptic neurexin-3 controls postsynaptic AMPA receptor trafficking, revealing an unanticipated alternative splicing mechanism for trans-synaptic regulation of synaptic strength and long-term plasticity.	[Aoto, Jason; Martinelli, David C.; Tabuchi, Katsuhiko; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Aoto, Jason; Martinelli, David C.; Tabuchi, Katsuhiko; Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Malenka, Robert C.] Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat, Stanford, CA 94305 USA; [Tabuchi, Katsuhiko] Shinshu Univ, Sch Med, Dept Neurophysiol, Matsumoto, Nagano 3908621, Japan	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Shinshu University	Sudhof, TC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 265 Campus Dr, Stanford, CA 94305 USA.	tcs1@stanford.edu	Aoto, Jason/AAR-3604-2021	Aoto, Jason/0000-0003-0568-634X; Martinelli, David/0000-0002-8318-3986	NIMH [R37 MH052804]; NINDS [NS077906]; Simons Foundation [177850]; American Heart Association [11POST7360078]; NIDA [F32 DA031654]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH052804, P50MH086403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA031654, R01DA030379] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Simons Foundation; American Heart Association(American Heart Association); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank Wei Xu, Wade Morishita, Lu Chen, and Csaba Foldy for advice. This paper was supported by grants from the NIMH (R37 MH052804), the NINDS (NS077906), and the Simons Foundation (177850) to T.C.S. and by fellowship awards from the American Heart Association (11POST7360078 to J.A.) and NIDA (F32 DA031654 to D.C.M.).	Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Chen YC, 2012, J NEUROSCI, V32, P16018, DOI 10.1523/JNEUROSCI.1685-12.2012; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; de la Prida LM, 2003, HIPPOCAMPUS, V13, P728, DOI 10.1002/hipo.10123; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Etherton MR, 2011, EMBO J, V30, P2908, DOI 10.1038/emboj.2011.182; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Hishimoto A, 2007, HUM MOL GENET, V16, P2880, DOI 10.1093/hmg/ddm247; Hu ZT, 2012, SCIENCE, V337, P980, DOI 10.1126/science.1224896; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Lachman HM, 2007, HUM MOL GENET, V16, P1327, DOI 10.1093/hmg/ddm081; Lee K, 2013, P NATL ACAD SCI USA, V110, P336, DOI 10.1073/pnas.1219987110; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; O'Mara S, 2005, J ANAT, V207, P271, DOI 10.1111/j.1469-7580.2005.00446.x; Reichelt AC, 2012, NEUROPHARMACOLOGY, V62, P1519, DOI 10.1016/j.neuropharm.2011.01.024; Resnick M, 2008, NEUROSCI LETT, V439, P235, DOI 10.1016/j.neulet.2008.05.034; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Rozic G, 2013, J MOL NEUROSCI, V50, P221, DOI 10.1007/s12031-012-9919-x; Schnell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048045; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Shapiro-Reznik M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037894; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Soler-Llavina GJ, 2013, NEURON, V79, P439, DOI 10.1016/j.neuron.2013.06.007; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Sugita S, 1999, NEURON, V22, P489, DOI 10.1016/S0896-6273(00)80704-7; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; TAUBE JS, 1993, EXP BRAIN RES, V96, P304; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Vaags AK, 2012, AM J HUM GENET, V90, P133, DOI 10.1016/j.ajhg.2011.11.025; Wozny C, 2008, J PHYSIOL-LONDON, V586, P2725, DOI 10.1113/jphysiol.2007.149203; Xu W, 2012, NEURON, V73, P990, DOI 10.1016/j.neuron.2011.12.036	52	183	187	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					75	88		10.1016/j.cell.2013.05.060	http://dx.doi.org/10.1016/j.cell.2013.05.060			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827676	Green Accepted, Bronze			2022-12-28	WOS:000321327900011
J	Collis, E; Al-Qurainy, R				Collis, Emily; Al-Qurainy, R.			Care of the dying patient in the community	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SPOTLIGHT PALLIATIVE CARE; PEOPLE DIE; LIFE CARE; DEATH; HOME; PLACE; CANCER; END; INTERVENTION; PREFERENCES		[Collis, Emily; Al-Qurainy, R.] Cent London Community Healthcare Trust, Pembridge Palliat Care Ctr, St Charles Ctr Hlth & Wellbeing, London W10 6DZ, England		Collis, E (corresponding author), Cent London Community Healthcare Trust, Pembridge Palliat Care Ctr, St Charles Ctr Hlth & Wellbeing, London W10 6DZ, England.	emily.collis@clch.nhs.uk	Hill-Cawthorne, Grant A/B-8039-2009; Westby, Maggie/O-8794-2014	Hill-Cawthorne, Grant A/0000-0002-3828-5473; Westby, Maggie/0000-0003-4273-3942				Abel J, 2013, BMJ SUPPORT PALLIAT, V3, P168, DOI 10.1136/bmjspcare-2012-000327; Arthur A, 2011, BEREAVEMENT CARE SER; Bomba P, 2012, BMJ SUPPORT PALLIAT, V2, P184; Boyd K, 2010, BR J GEN PRACT, V60, pe449; Boyd K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4863; Brumley Richard D, 2003, J Palliat Med, V6, P715, DOI 10.1089/109662103322515220; Calanzani N., 2013, CURRENT FUTURE NEEDS; Candy B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007544.pub2; Dale J, 2009, QUAL SAF HEALTH CARE, V18, P174, DOI 10.1136/qshc.2007.024836; Department of Health, 2013, HLTH SOC CAR ACT 201; Department of Health, 2012, 1 NAT VOICES SURV BE; Department of Health, 2008, END LIF CAR STRAT PR; Gao W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001410; General Medical Council, 2010, TREATM CAR END LIF G; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; GOMES B, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD007760.PUB2; Gomes B, 2012, BMJ SUPPORT PALLIAT, V2, P6; Gomes B., 2011, LOCAL PREFERENCES PL; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Gomez-Batiste X, 2012, BMJ SUPPORT PALLIAT; Gott M, 2004, PALLIATIVE MED, V18, P460, DOI 10.1191/0269216304pm889oa; Grande GE, 2004, J PALLIATIVE CARE, V20, P69, DOI 10.1177/082585970402000202; Grant L, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4859; Grbich Carol, 2005, Palliat Support Care, V3, P5; Gruneir A, 2007, MED CARE RES REV, V64, P351, DOI 10.1177/1077558707301810; Harding R, 2013, PSYCHOONCOLOGY, DOI 10.1002/pon.3283; Harrison N, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X641465; Hasselaar J, 2012, BMJ-BRIT MED J, V2, P4; Houttekier D, 2010, J AM GERIATR SOC, V58, P751, DOI 10.1111/j.1532-5415.2010.02771.x; Hughes PM, 2010, PALLIATIVE MED, V24, P68, DOI 10.1177/0269216309346591; Hughes-Hallett T, 2011, FUNDING RIGHT CARE S; Jones J, 1999, BMJ-BRIT MED J, V319, P1547, DOI 10.1136/bmj.319.7224.1547; Jordhoy MS, 2000, LANCET, V356, P888, DOI 10.1016/S0140-6736(00)02678-7; Lyons P., 2011, BMJ SUPPORT PALLIAT, V1, P81, DOI [DOI 10.1136/BMJSPCARE-2011-000053.54, 10.1136/bmjspcare-2011-000053.54]; Millington-Sanders C, 2013, EPACCS NATL CONTEXT; Mitchell GK, 2002, PALLIATIVE MED, V16, P457, DOI 10.1191/0269216302pm573oa; National Audit Office, 2008, END LIFE CARE; National Center forHealth Statistics, 2011, HLTH US 2010 SPEC FE; National Institute for Clinical Excellence, 2004, IMPR SUPP PALL CAR A; Petkova H., 2012, UNDERSTANDING PLACE; Pritchard RS, 1998, J AM GERIATR SOC, V46, P1242, DOI 10.1111/j.1532-5415.1998.tb04540.x; Royal College of General Practitioners, 2013, RCGP COMM GUID END L; Royal College of Physicians and British Society of Gastroenterology, 2010, OR FEED DIFF DIL GUI; Shepperd S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009231; Shepperd S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007491; Sleeman KE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2174; Thomas K, 2007, PALLIATIVE MED, V21, P49, DOI 10.1177/0269216306072501; Thoonsen B, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X654597; Tibaldi V, 2004, ARCH GERONTOL GERIAT, P431; Travis SS, 2002, GERONTOLOGIST, V42, P342, DOI 10.1093/geront/42.3.342	52	13	13	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2013	347								f4085	10.1136/bmj.f4085	http://dx.doi.org/10.1136/bmj.f4085			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180CZ	23823993				2022-12-28	WOS:000321571800001
J	Guo, JL; Covell, DJ; Daniels, JP; Iba, M; Stieber, A; Zhang, B; Riddle, DM; Kwong, LK; Xu, Y; Trojanowski, JQ; Lee, VMY				Guo, Jing L.; Covell, Dustin J.; Daniels, Joshua P.; Iba, Michiyo; Stieber, Anna; Zhang, Bin; Riddle, Dawn M.; Kwong, Linda K.; Xu, Yan; Trojanowski, John Q.; Lee, Virginia M. Y.			Distinct alpha-Synuclein Strains Differentially Promote Tau Inclusions in Neurons	CELL			English	Article							SPORADIC PARKINSONS-DISEASE; LEWY BODIES; IN-VITRO; ALZHEIMERS-DISEASE; FIBRIL FORMATION; BRAIN PATHOLOGY; AMYLOID FIBRILS; SYNTHETIC TAU; MOUSE MODEL; DEMENTIA	Many neurodegenerative diseases are characterized by the accumulation of insoluble protein aggregates, including neurofibrillary tangles comprised of tau in Alzheimer's disease and Lewy bodies composed of alpha-synuclein in Parkinson's disease. Moreover, different pathological proteins frequently codeposit in disease brains. To test whether aggregated alpha-synuclein can directly cross-seed tau fibrillization, we administered preformed alpha-synuclein fibrils assembled from recombinant protein to primary neurons and transgenic mice. Remarkably, we discovered two distinct strains of synthetic alpha-synuclein fibrils that demonstrated striking differences in the efficiency of cross-seeding tau aggregation, both in neuron cultures and in vivo. Proteinase K digestion revealed conformational differences between the two synthetic alpha-synuclein strains and also between sarkosyl-insoluble alpha-synuclein extracted from two subgroups of Parkinson's disease brains. We speculate that distinct strains of pathological alpha-synuclein likely exist in neurodegenerative disease brains and may underlie the tremendous heterogeneity of synucleinopathies.	[Lee, Virginia M. Y.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Inst Aging, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Inst Aging, Philadelphia, PA 19104 USA.	vmylee@upenn.edu			NIH/NIA [AG17586, NS53488]; Marian S. Ware Alzheimer Program; Dr. Arthur Peck Fund; Jeff and Anne Keefer Fund; Parkinson Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017586] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Marian S. Ware Alzheimer Program; Dr. Arthur Peck Fund; Jeff and Anne Keefer Fund; Parkinson Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank Patrick O'Brien and Insung Song for recombinant protein purification, Ashley Chen for mouse husbandry and technical assistance, Drs. Charlotte Chung and Hien Tran for providing extra neurons whenever needed, John Robinson for providing frozen brain tissues, Dr. David J. Irwin for helpful discussion, Drs. Kurt Brunden and Kelvin C. Luk for critical reading of the manuscript, and all the other members of the Center for Neurodegenerative Disease Research for their help and support. Patrick O'Brien is also thanked for providing the first preparation of strain B 1-120-Myc fibrils to make this study possible. The N-terminal sequencing analysis was provided by Nancy A. Williams from the Keck Biotechnology Resource Laboratory (Yale University). mAbs MC1 and TG3 are generous gifts from Dr. Peter Davies (Albert Einstein College of Medicine). The authors are also grateful to Drs. Zhong-yuan Kan and Walter Englander for training and use of the Aviv model 202 spectrophotometer and Robert Culik and Dr. Feng Gai for their assistance in acquiring FTIR spectra. This study was supported by NIH/NIA grant AG17586, NS53488, the Marian S. Ware Alzheimer Program, the Dr. Arthur Peck Fund, The Jeff and Anne Keefer Fund, and the Parkinson Council.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Baba M, 1998, AM J PATHOL, V152, P879; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Furukawa Y, 2011, J BIOL CHEM, V286, P27236, DOI 10.1074/jbc.M111.248963; Galpern WR, 2006, ANN NEUROL, V59, P449, DOI 10.1002/ana.20819; Gearing M, 1999, ARCH NEUROL-CHICAGO, V56, P203, DOI 10.1001/archneur.56.2.203; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Gomez-Tortosa E, 2000, ANN NY ACAD SCI, V920, P9; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Guo JL, 2013, FEBS LETT, V587, P717, DOI 10.1016/j.febslet.2013.01.051; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Halliday G, 2008, ACTA NEUROPATHOL, V115, P409, DOI 10.1007/s00401-008-0344-8; Halliday GM, 2011, ACTA NEUROPATHOL, V122, P187, DOI 10.1007/s00401-011-0852-9; Huang CY, 2002, P NATL ACAD SCI USA, V99, P2788, DOI 10.1073/pnas.052700099; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; KOSAKA K, 1988, CLIN NEUROPATHOL, V7, P299; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tsuboi Y, 2005, PARKINSONISM RELAT D, V11, pS47, DOI 10.1016/j.parkreldis.2004.10.014; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WITMAN GB, 1976, P NATL ACAD SCI USA, V73, P4070, DOI 10.1073/pnas.73.11.4070; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	54	466	474	4	100	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					103	117		10.1016/j.cell.2013.05.057	http://dx.doi.org/10.1016/j.cell.2013.05.057			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827677	Green Accepted, Bronze			2022-12-28	WOS:000321327900013
J	Leahy, DJ				Leahy, Daniel J.			Piecing Together the Extracellular Puzzle	CELL			English	Editorial Material							PROTEIN INTERACTIONS		Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 725 North Wolfe St, Baltimore, MD 21205 USA.	dleahy@jhmi.edu						Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Mangelberger D, 2012, FRONT BIOSCI-LANDMRK, V17, P90, DOI 10.2741/3917; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Ozkan E, 2013, CELL, V154, P228, DOI 10.1016/j.cell.2013.06.006; Siebert M, 2009, GENE DEV, V23, P1052, DOI 10.1101/gad.520509; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461	7	2	2	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					23	25		10.1016/j.cell.2013.06.014	http://dx.doi.org/10.1016/j.cell.2013.06.014			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827672	Bronze			2022-12-28	WOS:000321327900007
J	Stephenson, J; Crane, SF; Levy, C; Maslin, M				Stephenson, Judith; Crane, Susan F.; Levy, Caren; Maslin, Mark			Population, development, and climate change: links and effects on human health	LANCET			English	Review							CARBON-DIOXIDE; PUBLIC-HEALTH; GROWTH; TRANSITION; FERTILITY; DYNAMICS; WORLD; CAIRO; CARE	Global health, population growth, economic development, environmental degradation, and climate change are the main challenges we face in the 21st century. However, because the academics, non-governmental organisations, and policy makers in these specialties work within separate communities, our understanding of the associations between them is restricted. We organised an international symposium in May, 2011 in London, UK, for academics and technical experts from population, developmental, and environmental science to encourage debate and collaboration between these disciplines. The conference provided the impetus for this Review, which describes, in historical context, key events and fundamental intercommunity debates from the perspectives of population, development, and climate change communities. We consider the interconnections between population, development, and climate change and their effects on health, including new analysis of longstanding debates, and identify opportunities for effective collaboration on shared goals.	[Stephenson, Judith] UCL, UCL Inst Womens Hlth, London WC1E 6BT, England; [Crane, Susan F.] UCL, UCL Inst Global Hlth, London WC1E 6BT, England; [Levy, Caren] UCL, UCL Dev Planning Unit, London WC1E 6BT, England; [Maslin, Mark] UCL, Dept Geog, London WC1E 6BT, England; [Maslin, Mark] UCL, Inst Environm, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Stephenson, J (corresponding author), UCL, UCL Inst Womens Hlth, Mortimer St, London WC1E 6BT, England.	judith.stephenson@ucl.ac.uk		Maslin, Mark/0000-0001-9957-3463	Leverhulme	Leverhulme	This Review arose out of discussions held during a Leverhulme-funded UCL symposium Population Footprints in May, 2011. We thank Ndola Prata (Bixby Center for Population, Health and Sustainability, University of California, Berkeley, CA, USA) for her contribution to an earlier draft.	Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Allen A., 2005, URBAN DEV DEBATES NE, P1; [Anonymous], 1978, ALM AT C PRIM HLTH C; [Anonymous], 2005, CONDITIONS AGR GROWT; [Anonymous], 2011, WORLD POP PROSP 2010; [Anonymous], 2010, MILL DEV GOALS REP; Becker G. S., 1960, DEMOGR ECON CHANGE; Bloom D.E., 2004, 10817 NAT BUR EC RES; Bloom DE, 1998, WORLD BANK ECON REV, V12, P419, DOI 10.1093/wber/12.3.419; Campbell M, 2007, SCIENCE, V315, P1501, DOI 10.1126/science.1140057; Canning D, 2012, LANCET, V380, P165, DOI 10.1016/S0140-6736(12)60827-7; Carr B, 2012, LANCET, V380, P80, DOI 10.1016/S0140-6736(12)60905-2; Chapman DS, 2010, EOS T AM GEOPHYS UN, V91, P325, DOI DOI 10.1029/2010E0370001; CLELAND J, 1987, POP STUD-J DEMOG, V41, P5, DOI 10.1080/0032472031000142516; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Cleland J, 2009, BEST PRACT RES CL OB, V23, P165, DOI 10.1016/j.bpobgyn.2008.11.002; Coale A.J., 1958, POPULATION GROWTH EC; Collumbien M., 2004, COMP QUANTIFICATION, P1255; Corfee-Morlot J, 2007, PHILOS T R SOC A, V365, P2741, DOI 10.1098/rsta.2007.2084; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Cueto M, 2004, AM J PUBLIC HEALTH, V94, P1864, DOI 10.2105/AJPH.94.11.1864; Das Gupta M, 2011, 5719 WORLD BANK; DASGUPTA P, 1992, AMBIO, V21, P95; Dasgupta P, 1995, J ECON LIT, V33, P1879; Debpuur C, 2002, STUD FAMILY PLANN, V33, P141, DOI 10.1111/j.1728-4465.2002.00141.x; Demeny P, 2003, POPUL DEV REV, V29, P1, DOI 10.1111/j.1728-4457.2003.00001.x; Dyson T, 2010, POPULATION DEV DEMOG; Dyson T, 2005, POPUL ENVIRON, V27, P117, DOI 10.1007/s11111-006-0017-2; Ehrlich PR, 1968, POPULATION BOMB; Folbre N., 1988, HOME DIVIDED WOMEN I; Friel S, 2011, ANNU REV PUBL HEALTH, V32, P225, DOI 10.1146/annurev-publhealth-031210-101220; Furedi F, 1997, POPULATION DEV CRITI; GALLOWAY PR, 1986, POPUL DEV REV, V12, P1, DOI 10.2307/1973349; Gillespie DG, 2004, INT FAM PLAN PERSPEC, V30, P34, DOI 10.1363/3003404; Greer G, 2009, LANCET, V374, P674, DOI 10.1016/S0140-6736(09)61543-9; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Harris N., 2002, THINKING UNTHINKABLE; Hartman B, 1987, REPROD RIGHTS WRONGS; Harvey D., 1996, JUSTICE NATURE GEOGR, V468; Heath J., 1996, ENVIRON DEV ECON, V1, P65, DOI DOI 10.1017/S1355770X00000383; Higgins M, 1997, POPUL DEV REV, V23, P261, DOI 10.2307/2137546; Kabeer N., 1996, 7 UNRISD; KEELING CD, 1960, TELLUS, V12, P200, DOI 10.1111/j.2153-3490.1960.tb01300.x; KEELING CD, 1970, P AM PHILOS SOC, V114, P10; Kelley AC, 2001, POPULATION MATTERS D; Lee R, 2003, J ECON PERSPECT, V17, P167, DOI 10.1257/089533003772034943; Lee R, 2010, EUR J POPUL, V26, P159, DOI 10.1007/s10680-009-9186-x; Maddison A., 2003, DEV CTR STUDIES WORL; Malakoff D, 2011, SCIENCE, V333, P544, DOI 10.1126/science.333.6042.544; Maslin M, 2013, GEOGR J, V179, P264, DOI 10.1111/j.1475-4959.2012.00494.x; MASON A, 1988, POPUL DEV REV, V14, P113, DOI 10.2307/1972502; Mathai M., B WHO; MAULDIN WP, 1974, STUD FAMILY PLANN, V5, P357, DOI 10.2307/1965198; Mazur L, 2010, CONSCIENCE, V31, P13; MCINTOSH CA, 1995, POPUL DEV REV, V21, P223, DOI 10.2307/2137493; McMichael AJ, 2011, ANNU REV PUBL HEALTH, V32, P179, DOI 10.1146/annurev-publhealth-031210-101203; McMichael AJ, 2009, LANCET, V374, P2123, DOI 10.1016/S0140-6736(09)62031-6; Montgomery MR, 2008, SCIENCE, V319, P761, DOI 10.1126/science.1153012; Nakicenovic N., 2000, INTERGOVERNMENTAL PA, P599; National Academy of Sciences, 1971, RAP POP GROWTH CONS; Notestein F., 1945, FOOD WORLD, P36; O'Neill BC, 2012, LANCET, V380, P157, DOI 10.1016/S0140-6736(12)60958-1; O'Neill BC, 2010, P NATL ACAD SCI USA, V107, P17521, DOI 10.1073/pnas.1004581107; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Redclift M, 2005, SUSTAIN DEV, V13, P212, DOI 10.1002/sd.281; REVELLE R, 1957, TELLUS, V9, P18, DOI 10.1111/j.2153-3490.1957.tb01849.x; Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8; SHEVASUNT S, 1978, STUD FAMILY PLANN, V9, P212, DOI 10.2307/1965866; Shi AQ, 2003, ECOL ECON, V44, P29, DOI 10.1016/S0921-8009(02)00223-9; SIMMONS R, 1988, STUD FAMILY PLANN, V19, P29, DOI 10.2307/1966737; Simon J L, 1981, Res Popul Econ, V3, P239; Singh S, 2009, ADDING IT COSTS BENE; Smith K, 2011, NAT CLIM CHANGE, V1, P331; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Speidel JJ, 2009, PHILOS T R SOC B, V364, P3049, DOI 10.1098/rstb.2009.0162; Stephenson J, 2010, J PUBLIC HEALTH-UK, V32, P150, DOI 10.1093/pubmed/fdq038; The Royal Commission on Environmental Pollution, 2011, 29 ROYAL COMM ENV PO; The Royal Society, 2012, PEOPL PLAN; TIFFEN M, 1994, WORLD DEV, V22, P997, DOI 10.1016/0305-750X(94)90144-9; *UN, 1995, INT C POP DEV CAIR 5; UN Economic and Social Council, 2009, FLOW RES ASS IMPL PR; United Nations, 1953, UN POP STUD, V17; United Nations Department of Economic and Social Affairs, 2004, P UN EXP M WORLD POP; United Nations Division for Sustainable Development, 1992, UN C ENV DEV RIO JAN; United Nations Human Settlements Programme (UN-HABITAT), 2005, GLOB URB OBS URB IND; United Nations Population Fund (UNFPA), 2007, STAT WORLD POP UNL P; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; WALSH JA, 1979, NEW ENGL J MED, V301, P967, DOI 10.1056/NEJM197911013011804	89	21	24	1	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1665	1673		10.1016/S0140-6736(13)61460-9	http://dx.doi.org/10.1016/S0140-6736(13)61460-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254CN	23849794				2022-12-28	WOS:000327140700026
J	Jamal, SA; Vandermeer, B; Raggi, P; Mendelssohn, DC; Chatterley, T; Dorgan, M; Lok, CE; Fitchett, D; Tsuyuki, RT				Jamal, Sophie A.; Vandermeer, Ben; Raggi, Paolo; Mendelssohn, David C.; Chatterley, Trish; Dorgan, Marlene; Lok, Charmaine E.; Fitchett, David; Tsuyuki, Ross T.			Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis	LANCET			English	Article							CORONARY-ARTERY CALCIFICATION; HEMODIALYSIS-PATIENTS; AORTIC CALCIFICATION; RENAL-DISEASE; SEVELAMER; CARBONATE; PROGRESSION; IMPACT; PHOSPHORUS; METABOLISM	Background Phosphate binders (calcium-based and calcium-free) are recommended to lower serum phosphate and prevent hyperphosphataemia in patients with chronic kidney disease, but their effects on mortality and cardiovascular outcomes are unknown. We aimed to update our meta-analysis on the effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease. Methods We did a systematic review of articles published in any language after Aug 1, 2008, up until Oct 22, 2012, by searching Medline, Embase, International Pharmaceutical Abstracts, Cochrane Central Register of Controlled Trials, and Cumulative Index to Nursing and Allied Health Literature. We included all randomised and non-randomised trials that compared outcomes between patients with chronic kidney disease taking calcium-based phosphate binders with those taking non-calcium-based binders. Eligible studies, determined by consensus with predefined criteria, were reviewed, and data were extracted onto a standard form. We combined data from randomised trials to assess the primary outcome of all-cause mortality using the DerSimonian and Laird random effects model. Findings Our search identified 847 reports, of which eight new studies (five randomised trials) met our inclusion criteria and were added to the ten (nine randomised trials) included in our previous meta-analysis. Analysis of the 11 randomised trials (4622 patients) that reported an outcome of mortality showed that patients assigned to non-calcium-based binders had a 22% reduction in all-cause mortality compared with those assigned to calcium-based phosphate binders (risk ratio 0.78, 95% CI 0.61-0.98). Interpretation Non-calcium-based phosphate binders are associated with a decreased risk of all-cause mortality compared with calcium-based phosphate binders in patients with chronic kidney disease. Further studies are needed to identify causes of mortality and to assess whether mortality differs by type of non-calcium-based phosphate binder.	[Jamal, Sophie A.] Univ Toronto, Womens Coll Hosp, Div Endocrinol & Metab, Toronto, ON, Canada; [Jamal, Sophie A.] Univ Toronto, St Michaels Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Lok, Charmaine E.] Univ Toronto, St Michaels Hosp, Div Nephrol, Toronto, ON, Canada; [Fitchett, David] Univ Toronto, St Michaels Hosp, Div Cardiol, Toronto, ON, Canada; [Mendelssohn, David C.] Univ Toronto, Toronto, ON, Canada; [Vandermeer, Ben] Univ Alberta, Alberta Res Ctr Hlth Evidence, Dept Pediat, Edmonton, AB, Canada; [Raggi, Paolo] Univ Alberta, Walter C Mackenzie Hlth Sci Ctr, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Chatterley, Trish; Dorgan, Marlene] Univ Alberta, Walter C Mackenzie Hlth Sci Ctr, John W Scott Hlth Sci Lib, Edmonton, AB, Canada; [Tsuyuki, Ross T.] Univ Alberta, Div Cardiol, Edmonton, AB, Canada; [Mendelssohn, David C.] Humber River Reg Hosp, Dept Nephrol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Womens College Hospital; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Jamal, SA (corresponding author), Womens Coll Hosp, Res Inst, Toronto, ON M5G 1N8, Canada.	sophie.jamal@utoronto.ca	Tsuyuki, Ross T/E-2462-2016	Tsuyuki, Ross T/0000-0002-3724-598X; Lok, Charmaine/0000-0001-5365-0064	Genzyme	Genzyme(Sanofi-AventisGenzyme Corporation)	PR has received honoraria for speaking engagements for Sanofi. DCM is on advisory boards for Genzyme and Amgen, and has received a speaking honorarium from Amgen. CEL is a consultant for Gore, Roche, and Takeda. RTT has received consulting fees from Genzyme. All other authors declare that they have no conflicts of interest.	Barreto DV, 2008, NEPHRON CLIN PRACT, V110, pC273, DOI 10.1159/000170783; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Block GA, 2005, KIDNEY INT, V68, P1815, DOI 10.1111/j.1523-1755.2005.00600.x; Block GA, 2012, J AM SOC NEPHROL, V23, P1407, DOI 10.1681/ASN.2012030223; Borzecki AM, 2007, J CLIN PHARM THER, V32, P617, DOI 10.1111/j.1365-2710.2007.00871.x; Braun J, 2004, CLIN NEPHROL, V62, P104; Chertow GM, 2003, AM J NEPHROL, V23, P307, DOI 10.1159/000072822; Chertow GM, 2002, KIDNEY INT, V62, P245, DOI 10.1046/j.1523-1755.2002.00434.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Iorio B, 2012, CLIN J AM SOC NEPHRO, V7, P487, DOI 10.2215/CJN.03820411; Di Iorio B, 2011, KIDNEY BLOOD PRESS R, V34, P180, DOI 10.1159/000325656; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Jamal SA, 2009, NEPHROL DIAL TRANSPL, V24, P3168, DOI 10.1093/ndt/gfp350; Jean G, 2011, HEMODIAL INT, V15, P485, DOI 10.1111/j.1542-4758.2011.00575.x; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kakuta T, 2011, AM J KIDNEY DIS, V57, P422, DOI 10.1053/j.ajkd.2010.10.055; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Molony DA, 2011, ADV CHRONIC KIDNEY D, V18, P120, DOI 10.1053/j.ackd.2011.02.004; Panichi V, 2010, J NEPHROL, V23, P556; Qunibi W, 2008, AM J KIDNEY DIS, V51, P952, DOI 10.1053/j.ajkd.2008.02.298; Russo D, 2007, KIDNEY INT, V72, P1255, DOI 10.1038/sj.ki.5002518; Sadek T, 2003, NEPHROL DIAL TRANSPL, V18, P582, DOI 10.1093/ndt/18.3.582; Shantouf R, 2010, CLIN NEPHROL, V74, P12; Suki WN, 2008, J RENAL NUTR, V18, P91, DOI 10.1053/j.jrn.2007.10.019; Takei T, 2008, NEPHRON CLIN PRACT, V108, pC278, DOI 10.1159/000127361; Toussaint ND, 2011, NEPHROLOGY, V16, P290, DOI 10.1111/j.1440-1797.2010.01412.x; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; WILSON R, 2009, AM SCHOLAR, V78, P2	33	294	308	2	77	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2013	382	9900					1268	1277		10.1016/S0140-6736(13)60897-1	http://dx.doi.org/10.1016/S0140-6736(13)60897-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235XP	23870817				2022-12-28	WOS:000325756400030
J	Benowitz, NL; Goniewicz, ML				Benowitz, Neal L.; Goniewicz, Maciej L.			The Regulatory Challenge of Electronic Cigarettes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NICOTINE		[Benowitz, Neal L.] Univ Calif San Francisco, Div Clin Pharmacol & Expt Therapeut, Dept Med, San Francisco, CA 94143 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Therapeut Sci, San Francisco Gen Hosp, Med Serv,Med Ctr, San Francisco, CA 94143 USA; [Goniewicz, Maciej L.] Roswell Pk Canc Inst, Dept Hlth Behav, Div Canc Prevent & Populat Sci, Buffalo, NY 14263 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Roswell Park Cancer Institute	Benowitz, NL (corresponding author), Univ Calif San Francisco, Div Clin Pharmacol & Expt Therapeut, POB 1220, San Francisco, CA 94143 USA.	nbenowitz@medsfgh.ucsf.edu	Goniewicz, Maciej L/D-8986-2012; Goniewicz, Maciej Lukasz/Z-1604-2019	Goniewicz, Maciej Lukasz/0000-0001-6748-3068				Adkison SE, 2013, AM J PREV MED, V44, P207, DOI 10.1016/j.amepre.2012.10.018; Benowitz NL, 2008, CLIN PHARMACOL THER, V83, P531, DOI 10.1038/clpt.2008.3; Caponnetto P, 2013, Monaldi Arch Chest Dis, V79, P12; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Goniewicz M. L., 2013, TOB CONTROL, DOI [10.1136/tobaccocontrol-2012-050859, DOI 10.1136/TOBACCOCONTR0L-2012-050859]; Noel JK, 2011, TOB CONTROL, V20, P81, DOI 10.1136/tc.2010.038562; Pearson JL, 2012, AM J PUBLIC HEALTH, V102, P1758, DOI 10.2105/AJPH.2011.300526; Polosa R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-786; US Food and Drug Aaministration, REG E CIG OTH TOB PR	9	135	136	0	106	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					685	686		10.1001/jama.2013.109501	http://dx.doi.org/10.1001/jama.2013.109501			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	202XP	23856948	Green Submitted			2022-12-28	WOS:000323254500012
J	Velaphi, S; Perlman, J				Velaphi, Sithembiso; Perlman, Jeffrey			Wiping versus suction to clear neonatal airways at birth	LANCET			English	Editorial Material							EMERGENCY CARDIOVASCULAR CARE; RANDOMIZED CONTROLLED-TRIAL; VAGINALLY BORN INFANTS; ORONASOPHARYNGEAL SUCTION; CARDIOPULMONARY-RESUSCITATION; NO SUCTION; TERM; GUIDELINES; TRAUMA		[Velaphi, Sithembiso] Univ Witwatersrand, Chris Hani Baragwanath Hosp, Fac Hlth Sci, Dept Paediat,Metab Unit, ZA-2013 Johannesburg, South Africa; [Perlman, Jeffrey] Weill Cornell Med Coll, Div Neonatol, New York, NY USA	University of Witwatersrand; Cornell University	Velaphi, S (corresponding author), Univ Witwatersrand, Chris Hani Baragwanath Hosp, Fac Hlth Sci, Dept Paediat,Metab Unit, PO Bertsham, ZA-2013 Johannesburg, South Africa.	Sithembiso.Velaphi@wits.ac.za						Alur P, 2012, RESUSCITATION, V83, P746, DOI 10.1016/j.resuscitation.2011.11.023; Carrasco M, 1997, J PEDIATR-US, V130, P832, DOI 10.1016/S0022-3476(97)80031-5; ESTOL PC, 1992, J PERINAT MED, V20, P297, DOI 10.1515/jpme.1992.20.4.297; Gungor S, 2006, GYNECOL OBSTET INVES, V61, P9, DOI 10.1159/000087604; Gungor S, 2005, AUST NZ J OBSTET GYN, V45, P453, DOI 10.1111/j.1479-828X.2005.00452.x; Kattwinkel J, 2006, TXB NEONATAL RESUSCI; Kattwinkel J, 2010, CIRCULATION, V122, pS909, DOI 10.1161/CIRCULATIONAHA.110.971119; Kelleher J, 2013, LANCET; KUZENSKI BM, 1978, NURS RES, V27, P260, DOI 10.1097/00006199-197827040-00015; THAMBIRAN AK, 1966, BRIT J ANAESTH, V38, P459, DOI 10.1093/bja/38.6.459; Waltman PA, 2004, J MIDWIFERY WOM HEAL, V49, P32, DOI 10.1016/j.jmwh.2003.10.003; World Health Organization,, 2012, GUID BAS NEWB RES; Wyllie J, 2010, RESUSCITATION, V81, pE260, DOI 10.1016/j.resuscitation.2010.08.029	13	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 27	2013	382	9889					290	291		10.1016/S0140-6736(13)61052-1	http://dx.doi.org/10.1016/S0140-6736(13)61052-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FT	23856022				2022-12-28	WOS:000322544900006
J	Saterberg, T; Sellman, S; Ebenman, B				Saterberg, Torbjorn; Sellman, Stefan; Ebenman, Bo			High frequency of functional extinctions in ecological networks	NATURE			English	Article							TROPHIC CASCADES; FOOD; INCREASES; VIABILITY; SHIFTS	Intensified exploitation of natural populations and habitats has led to increased mortality rates and decreased abundances of many species(1,2). There is a growing concern that this might cause critical abundance thresholds of species to be crossed(1,3-5), with extinction cascades and state shifts in ecosystems as a consequence(4,6,7). When increased mortality rate and decreased abundance of a given species lead to extinction of other species, this species can be characterized as functionally extinct even though it still exists. Although such functional extinctions have been observed in some ecosystems(3,4,8), their frequency is largely unknown. Here we use a new modelling approach to explore the frequency and pattern of functional extinctions in ecological networks. Specifically, we analytically derive critical abundance thresholds of species by increasing their mortality rates until an extinction occurs in the network. Applying this approach on natural and theoretical food webs, we show that the species most likely to go extinct first is not the one whose mortality rate is increased but instead another species. Indeed, up to 80% of all first extinctions are of another species, suggesting that a species' ecological functionality is often lost before its own existence is threatened. Furthermore, we find that large-bodied species at the top of the food chains can only be exposed to small increases in mortality rate and small decreases in abundance before going functionally extinct compared to small-bodied species lower in the food chains. These results illustrate the potential importance of functional extinctions in ecological networks and lend strong support to arguments advocating a more community-oriented approach in conservation biology, with target levels for populations based on ecological functionality rather than on mere persistence(8-11).	[Saterberg, Torbjorn; Sellman, Stefan; Ebenman, Bo] Linkoping Univ, Dept Phys Chem & Biol, Div Theoret Biol, SE-58183 Linkoping, Sweden	Linkoping University	Ebenman, B (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Div Theoret Biol, SE-58183 Linkoping, Sweden.	boebe@ifm.liu.se		Saterberg, Torbjorn/0000-0002-5881-7983; Sellman, Stefan/0000-0002-5595-8780	Linkoping University	Linkoping University	We thank N. Virgo, A. Clark, R. Law, O. Petchey, P. Munger, D. Gilljam, A. Curtsdotter and U. Wennergren for comments and discussion. D. Gilljam and A. Curtsdotter also provided computer code for part of the analysis. This project was supported by a Faculty grant from Linkoping University to B.E.	Anderson SH, 2011, SCIENCE, V331, P1068, DOI 10.1126/science.1199092; [Anonymous], 2001, IUCN RED LIST CAT CR; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Berg S, 2011, OIKOS, V120, P510, DOI 10.1111/j.1600-0706.2010.18864.x; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borrvall C, 2000, ECOL LETT, V3, P131, DOI 10.1046/j.1461-0248.2000.00130.x; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Chesson P, 2008, NATURE, V456, P235, DOI 10.1038/nature07248; Colwell RK, 2012, ANNU REV ECOL EVOL S, V43, P183, DOI 10.1146/annurev-ecolsys-110411-160304; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Ebenman B, 2005, TRENDS ECOL EVOL, V20, P568, DOI 10.1016/j.tree.2005.06.011; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Estes JA, 2010, CONSERV BIOL, V24, P852, DOI 10.1111/j.1523-1739.2009.01428.x; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Ives AR, 2004, NATURE, V429, P174, DOI 10.1038/nature02515; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Lewis HM, 2007, J THEOR BIOL, V247, P64, DOI 10.1016/j.jtbi.2007.02.006; McConkey KR, 2006, ECOLOGY, V87, P271, DOI 10.1890/05-0386; Montoya JM, 2009, ECOLOGY, V90, P2426, DOI 10.1890/08-0657.1; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Sabo JL, 2008, BIOL CONSERV, V141, P276, DOI 10.1016/j.biocon.2007.10.002; Sahasrabudhe S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1163; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Soule ME, 2005, BIOSCIENCE, V55, P168, DOI 10.1641/0006-3568(2005)055[0168:SISCPM]2.0.CO;2; Soule ME, 2003, CONSERV BIOL, V17, P1238, DOI 10.1046/j.1523-1739.2003.01599.x; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Terborgh J., 2010, TROPHIC CASCADES PRE	32	131	139	3	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					468	+		10.1038/nature12277	http://dx.doi.org/10.1038/nature12277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23831648				2022-12-28	WOS:000322157900038
J	Siu, FY; He, M; de Graaf, C; Han, GW; Yang, DH; Zhang, ZY; Zhou, CH; Xu, QP; Wacker, D; Joseph, JS; Liu, W; Lau, J; Cherezov, V; Katritch, V; Wang, MW; Stevens, RC				Siu, Fai Yiu; He, Min; de Graaf, Chris; Han, Gye Won; Yang, Dehua; Zhang, Zhiyun; Zhou, Caihong; Xu, Qingping; Wacker, Daniel; Joseph, Jeremiah S.; Liu, Wei; Lau, Jesper; Cherezov, Vadim; Katritch, Vsevolod; Wang, Ming-Wei; Stevens, Raymond C.			Structure of the human glucagon class B G-protein-coupled receptor	NATURE			English	Article							2ND TRANSMEMBRANE HELIX; LIGAND-BINDING; PEPTIDE-1 RECEPTOR; CRYSTALLIZING MEMBRANE; EXTRACELLULAR LOOP; PHOTOLABILE PROBES; OPIOID RECEPTOR; MOLECULAR-BASIS; VPAC1 RECEPTOR; AMINO-TERMINUS	Binding of the glucagon peptide to the glucagon receptor (GCGR) triggers the release of glucose from the liver during fasting; thus GCGR plays an important role in glucose homeostasis. Here we report the crystal structure of the seven transmembrane helical domain of human GCGR at 3.4 angstrom resolution, complemented by extensive site-specific mutagenesis, and a hybrid model of glucagon bound to GCGR to understand the molecular recognition of the receptor for its native ligand. Beyond the shared seven transmembrane fold, the GCGR transmembrane domain deviates from class A G-protein-coupled receptors witha large ligand-binding pocket and the first transmembrane helix having a 'stalk' region that extends three alpha-helical turns above the plane of the membrane. The stalk positions the extracellular domain (similar to 12 kilodaltons) relative to the membrane to form the glucagon-binding site that captures the peptide and facilitates the insertion of glucagon's amino terminus into the seven transmembrane domain.	[Siu, Fai Yiu; Han, Gye Won; Wacker, Daniel; Joseph, Jeremiah S.; Liu, Wei; Cherezov, Vadim; Katritch, Vsevolod; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [He, Min; Yang, Dehua; Zhang, Zhiyun; Zhou, Caihong; Wang, Ming-Wei] Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; [He, Min; Yang, Dehua; Zhang, Zhiyun; Zhou, Caihong; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [de Graaf, Chris] Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst AIMMS, Fac Sci, Div Med Chem, NL-1081 HV Amsterdam, Netherlands; [Xu, Qingping] SLAC Natl Accelerator Lab, Joint Ctr Struct Genom, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Lau, Jesper] Novo Nordisk, Prot & Peptide Chem, DK-2760 Malov, Denmark	Scripps Research Institute; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Vrije Universiteit Amsterdam; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Novo Nordisk	Wang, MW (corresponding author), Natl Ctr Drug Screening, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.	wangmw@mail.shcnc.ac.cn; stevens@scripps.edu	Katritch, Vsevolod/Y-2721-2019; Han, Gye Won/GLQ-8724-2022; Cherezov, Vadim/L-9812-2013; Yang, Dehua/M-5789-2019; Yang, Dehua/S-6156-2017; Han, Gye Won/GLQ-8673-2022; Lau, Jesper/G-3834-2011; Han, Gye Won/GLT-1531-2022; Stevens, Raymond/K-7272-2015; Katritch, Vsevolod/Q-8357-2016; de Graaf, Chris/J-8549-2017	Han, Gye Won/0000-0003-4107-835X; Cherezov, Vadim/0000-0002-5265-3914; Stevens, Raymond/0000-0002-4522-8725; Katritch, Vsevolod/0000-0003-3883-4505; de Graaf, Chris/0000-0002-1226-2150	NIH Road map [P50GM073197, U54 GM094618, U54 GM094586]; Ministry of Health [2012ZX09304-011, 2013ZX09507002]; Shanghai Science and Technology Development Fund [11DZ2292200]; Novo Nordisk-Chinese Academy of Sciences Research Fund [NNCAS-2011-7]; Thousand Talents Program in China; NIH [F32 DK088392]; Netherlands Organization for Scientific Research (NWO) through a VENI [700.59.408]; COST Action [CM1207]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK088392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586, P50GM073197, U54GM094618] Funding Source: NIH RePORTER	NIH Road map(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health; Shanghai Science and Technology Development Fund; Novo Nordisk-Chinese Academy of Sciences Research Fund; Thousand Talents Program in China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research (NWO) through a VENI(Netherlands Organization for Scientific Research (NWO)); COST Action(European Cooperation in Science and Technology (COST)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Road map grant P50GM073197 for technology development (V. C. and R. C. S.), and PSI: Biology grant U54 GM094618 for biological studies and structure production (target GPCR-49) (V. K., V. C. and R. C. S.); PSI: Biology grant U54 GM094586 for structure QC; The Ministry of Health grants 2012ZX09304-011 and 2013ZX09507002 (M.-W.W.), Shanghai Science and Technology Development Fund 11DZ2292200 (M.-W.W.); Novo Nordisk-Chinese Academy of Sciences Research Fund NNCAS-2011-7 (M.-W.W.); Thousand Talents Program in China (R. C. S. and M.-W. W.); NIH Postdoctoral Training Grant (NRSA) F32 DK088392 (F.Y.S.); The Netherlands Organization for Scientific Research (NWO) through a VENI grant (Grant 700.59.408 to C.d.G.); COST Action CM1207, GLISTEN (C.d.G). We also thank V. Hruby and M. Cai for advice with the glucagon binding assay and general discussions; J. Velasquez for help with molecular biology; T. Trinh and M. Chu for help with baculovirus expression; K. Kadyshevskaya for assistance with figure preparation; X. Q. Cai, J. Wang, Y. Feng, A. T. Dai, Y. Zhou, J. J. Deng, Y. B. Dai and J. W. Zhao for technical assistance in mutation studies; A. Walker for assistance with manuscript preparation; and J. Smith and R. Fischetti for assistance in development and use of the minibeam and beamtime at GM/CA-CAT beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and National Institute of General Medical Sciences grant Y1-GM-1104.	Ahn JM, 2001, J MED CHEM, V44, P1372, DOI 10.1021/jm000453e; [Anonymous], 2009, BUSTER V 2 8 0; [Anonymous], 2012, ICM MAN V 3 0; Arnautova YA, 2011, PROTEINS, V79, P477, DOI 10.1002/prot.22896; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BHAT TN, 1988, J APPL CRYSTALLOGR, V21, P279, DOI 10.1107/S0021889887012755; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cascieri MA, 1999, J BIOL CHEM, V274, P8694, DOI 10.1074/jbc.274.13.8694; Ceraudo E, 2012, FASEB J, V26, P2060, DOI 10.1096/fj.11-196444; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Cho YM, 2012, PHARMACOL THERAPEUT, V135, P247, DOI 10.1016/j.pharmthera.2012.05.009; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; de Graaf C, 2011, CHEMMEDCHEM, V6, P2159, DOI 10.1002/cmdc.201100317; Di Paolo E, 1999, RECEPTOR CHANNEL, V6, P309; Di Paolo E, 1999, PEPTIDES, V20, P1187, DOI 10.1016/S0196-9781(99)00122-9; Di Paolo E, 1998, FEBS LETT, V424, P207, DOI 10.1016/S0014-5793(98)00175-6; Dong MQ, 2012, FASEB J, V26, P5092, DOI 10.1096/fj.12-212399; Dong M, 2011, J BIOL CHEM, V286, P23888, DOI 10.1074/jbc.M111.245969; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Ganguli SC, 1998, J PHARMACOL EXP THER, V286, P593; Gensure RC, 2003, MOL ENDOCRINOL, V17, P2647, DOI 10.1210/me.2003-0275; Hanson MA, 2007, PROTEIN EXPRES PURIF, V56, P85, DOI 10.1016/j.pep.2007.06.003; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Inooka H, 2001, NAT STRUCT BIOL, V8, P161, DOI 10.1038/84159; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; Miller LA, 2007, ART AM, V95, P35; Misquitta Y, 2003, BIOPHYS J, V85, P3084, DOI 10.1016/S0006-3495(03)74727-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neumann JM, 2008, TRENDS BIOCHEM SCI, V33, P314, DOI 10.1016/j.tibs.2008.05.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Perret J, 2002, BIOCHEM J, V362, P389, DOI 10.1042/0264-6021:3620389; Prevost M, 2010, J BIOL CHEM, V285, P30951, DOI 10.1074/jbc.M110.102814; Roberts DJ, 2011, PEPTIDES, V32, P1593, DOI 10.1016/j.peptides.2011.06.009; Runge S, 2003, J BIOL CHEM, V278, P28005, DOI 10.1074/jbc.M301085200; Schwarzenbacher R, 2008, ACTA CRYSTALLOGR D, V64, P133, DOI 10.1107/S0907444907050111; Solano RM, 2001, J BIOL CHEM, V276, P1084, DOI 10.1074/jbc.M007686200; Tan YV, 2004, J BIOL CHEM, V279, P38889, DOI 10.1074/jbc.M404460200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger Thomas C., 2012, Journal of Structural and Functional Genomics, V13, P81, DOI 10.1007/s10969-012-9129-3; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tseng CC, 1997, BIOCHEM BIOPH RES CO, V232, P96, DOI 10.1006/bbrc.1997.6231; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Unson CG, 2002, BIOCHEMISTRY-US, V41, P11795, DOI 10.1021/bi025711j; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Xu F, 2011, CRYST GROWTH DES, V11, P1193, DOI 10.1021/cg101385e; Yaqub T, 2010, MOL PHARMACOL, V77, P547, DOI 10.1124/mol.109.060111	61	300	310	5	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					444	+		10.1038/nature12393	http://dx.doi.org/10.1038/nature12393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23863937	Green Accepted			2022-12-28	WOS:000322157900033
J	Bretheau, L; Girit, CO; Pothier, H; Esteve, D; Urbina, C				Bretheau, L.; Girit, C. Oe; Pothier, H.; Esteve, D.; Urbina, C.			Exciting Andreev pairs in a superconducting atomic contact	NATURE			English	Article							JOSEPHSON CURRENT; SPECTROSCOPY; SUPERCURRENT; RESONATOR; JUNCTIONS; CHANNEL; STATES; QUBIT	The Josephson effect describes the flow of supercurrent in a weak link-such as a tunnel junction, nanowire or molecule-between two superconductors(1). It is the basis for a variety of circuits and devices, with applications ranging from medicine(2) to quantum information(3). Experiments using Josephson circuits that behave like artificial atoms(4) are now revolutionizing the way we probe and exploit the laws of quantum physics(5,6). Microscopically, the supercurrent is carried by Andreev pair states, which are localized at the weak link. These states come in doublets and have energies inside the superconducting gap(7-10). Existing Josephson circuits are based on properties of just the ground state of each doublet, and so far the excited states have not been directly detected. Here we establish their existence through spectroscopic measurements of superconducting atomic contacts. The spectra, which depend on the atomic configuration and on the phase difference between the superconductors, are in complete agreement with theory. Andreev doublets could be exploited to encode information in novel types of superconducting qubits(11-13).	[Bretheau, L.; Girit, C. Oe; Pothier, H.; Esteve, D.; Urbina, C.] CEA Saclay, IRAMIS, Serv Phys Etat Condense, Quantron Grp,CNRS,URA 2464, F-91191 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Urbina, C (corresponding author), CEA Saclay, IRAMIS, Serv Phys Etat Condense, Quantron Grp,CNRS,URA 2464, F-91191 Gif Sur Yvette, France.	cristian.urbina@cea.fr	Pothier, Hugues/D-1151-2014; Bretheau, Landry/Q-5468-2018; Girit, Çağlar/D-4845-2014; Girit, Çağlar/AFT-1507-2022; Urbina, Cristian/M-6412-2015	Pothier, Hugues/0000-0002-0601-6885; Bretheau, Landry/0000-0001-5628-934X; Girit, Çağlar/0000-0001-8953-9261; Girit, Çağlar/0000-0001-8953-9261; Urbina, Cristian/0000-0001-9145-8081	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA grant [PIIF-GA-2011-298415]; ANR contract DOCFLUC; ANR contract MASH; C'Nano	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA grant; ANR contract DOCFLUC(French National Research Agency (ANR)); ANR contract MASH(French National Research Agency (ANR)); C'Nano	We acknowledge technical assistance from P. Senat and P.-F. Orfila, theoretical input from M. Houzet, help in the experiments from L. Tosi, and discussions with V. Shumeiko, A. Levy-Yeyati and within the Quantronics group. This work was supported by ANR contracts DOCFLUC and MASH, and by C'Nano. The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no. PIIF-GA-2011-298415.	BAGWELL PF, 1992, PHYS REV B, V46, P12573, DOI 10.1103/PhysRevB.46.12573; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BEENAKKER CWJ, 1991, PHYS REV LETT, V66, P3056, DOI 10.1103/PhysRevLett.66.3056; Billangeon PM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.126802; Chtchelkatchev NM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.226806; Deacon RS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.076805; Della Rocca ML, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.127005; EDSTAM J, 1994, APPL PHYS LETT, V64, P2733, DOI 10.1063/1.111458; Fuechsle M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.127001; FURUSAKI A, 1991, SOLID STATE COMMUN, V78, P299, DOI 10.1016/0038-1098(91)90201-6; Hofheinz M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.217005; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; HOLST T, 1994, PHYS REV LETT, V73, P3455, DOI 10.1103/PhysRevLett.73.3455; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; KULIK IO, 1970, SOV PHYS JETP-USSR, V30, P944; Leppakangas J, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.054504; Lucero E, 2012, NAT PHYS, V8, P719, DOI [10.1038/nphys2385, 10.1038/NPHYS2385]; Morpurgo AF, 2000, J LOW TEMP PHYS, V118, P637, DOI 10.1023/A:1004639327733; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Padurariu C, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/57006; Pillet JD, 2010, NAT PHYS, V6, P965, DOI 10.1038/NPHYS1811; Romero G, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.180506; Scheer E, 1997, PHYS REV LETT, V78, P3535, DOI 10.1103/PhysRevLett.78.3535; Skoldberg J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087002; vanRuitenbeek JM, 1996, REV SCI INSTRUM, V67, P108, DOI 10.1063/1.1146558; Wendin G, 2007, LOW TEMP PHYS+, V33, P724, DOI 10.1063/1.2780165; Zazunov A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.087003; Zgirski M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.257003	30	115	117	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2013	499	7458					312	315		10.1038/nature12315	http://dx.doi.org/10.1038/nature12315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23868261	Green Submitted			2022-12-28	WOS:000321910700030
J	Shao, ZY; Watanabe, S; Christensen, R; Jorgensen, EM; Colon-Ramos, DA				Shao, Zhiyong; Watanabe, Shigeki; Christensen, Ryan; Jorgensen, Erik M.; Colon-Ramos, Daniel A.			Synapse Location during Growth Depends on Glia Location	CELL			English	Article							CELL-ADHESION MOLECULE; CAENORHABDITIS-ELEGANS EPIDERMIS; NERVOUS-SYSTEM; FUNCTIONAL-CHARACTERIZATION; FGF RECEPTOR; MAINTENANCE; TRANSPORTER; MECHANISMS; PROTEIN; FAMILY	Synaptic contacts are largely established during embryogenesis and are then maintained during growth. To identify molecules involved in this process, we conducted a forward genetic screen in C. elegans and identified cima-1. In cima-1 mutants, synaptic contacts are correctly established during embryogenesis, but ectopic synapses emerge during postdevelopmental growth. cima-1 encodes a solute carrier in the SLC17 family of transporters that includes sialin, a protein that when mutated in humans results in neurological disorders. cima-1 does not function in neurons but rather functions in the nearby epidermal cells to correctly position glia during postlarval growth. Our findings indicate that CIMA-1 antagonizes the FGF receptor (FGFR), and does so most likely by inhibiting FGFR's role in epidermal-glia adhesion rather than signaling. Our data suggest that epidermal-glia crosstalk, in this case mediated by a transporter and the FGF receptor, is vital to preserve embryonically derived circuit architecture during postdevelopmental growth.	[Shao, Zhiyong; Christensen, Ryan; Colon-Ramos, Daniel A.] Yale Univ, Sch Med, Dept Cell Biol, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06536 USA; [Watanabe, Shigeki; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Dept Biol, Salt Lake City, UT 84112 USA	Yale University; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Colon-Ramos, DA (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, Program Cellular Neurosci Neurodegenerat & Repair, POB 9812, New Haven, CT 06536 USA.			Watanabe, Shigeki/0000-0001-7580-8141	Klingenstein Foundation; Alfred P. Sloan Foundation; March of Dimes Research Grant;  [R00 NS057931];  [R01 NS076558];  [NIH R01 NS034307];  [NSF 0920069]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034307, R00NS057931, R01NS076558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Klingenstein Foundation(Klingenstein Philanthropies); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); March of Dimes Research Grant(March of Dimes); ; ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some illustrations were created by Z.F. Altun and D.H. Hall from WormAtlas. The EM in Fig 5A, Fig S1C and S1D were prepared by J. White, E. Southgate, N. Thomson and S. Brenner at the LMB/MRC labs in Cambridge, England (White et al., 1986). The adult image in the graphical abstract was created by Dr. Maria Gallegos of Cal State University. We thank Dr. H. Bulow, Dr. M. Stern, Dr. S. Shaham, Dr. T. Kinnunen, Dr. J. Fares, Dr. K. Shen, and CGC for strains and reagents. We also thank A. Perez and A. Roque for technical assistance, Dr. X. Song for helping with the protein blots, and D. Hall, S. Margolis, P. De Camilli, S. Strittmatter, M. Hammarlund, and members of the Colon-Ramos lab for helpful discussions and sharing of advice. This work was funded by the following grants to D.C.-R. (R00 NS057931, R01 NS076558, a fellowship from the Klingenstein Foundation and the Alfred P. Sloan Foundation and a March of Dimes Research Grant) and to E.M.J (NIH R01 NS034307, NSF 0920069). E.M.J. is an Investigator of the Howard Hughes Medical Institute. Z.S. and D.A.C-R. designed experiments. S.W. and E.M.J. performed the fEM experiments. R.C. performed wild type EM reconstruction and AIY Zone 1 length quantification. Z.S. performed all other experiments. Z.S. and D.A.C-R. analyzed and interpreted the data. Z.S., S.W., E.M.J., and D.A.C.-R. wrote the paper.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Allan S, 2006, CEREBROVASC DIS, V21, P137, DOI 10.1159/000090447; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Aurelio O, 2002, SCIENCE, V295, P686, DOI 10.1126/science.1066642; Banerjee S, 2007, ANNU REV NEUROSCI, V30, P235, DOI 10.1146/annurev.neuro.30.051606.094345; Benard C, 2009, CURR TOP DEV BIOL, V87, P175, DOI 10.1016/S0070-2153(09)01206-X; Benard CY, 2006, DEVELOPMENT, V133, P3329, DOI 10.1242/dev.02507; Benard CY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002819; Borland CZ, 2001, BIOESSAYS, V23, P1120, DOI 10.1002/bies.10007; BRENNER S, 1974, GENETICS, V77, P71; Brink DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037876; Bulow HE, 2004, NEURON, V42, P367, DOI 10.1016/S0896-6273(04)00246-6; Chelur DS, 2007, P NATL ACAD SCI USA, V104, P2283, DOI 10.1073/pnas.0610877104; Chisholm Andrew D, 2005, WormBook, P1; Chisholm AD, 2012, WIRES DEV BIOL, V1, P861, DOI 10.1002/wdev.79; Chisholm AD, 2012, WIRES DEV BIOL, V1, P879, DOI 10.1002/wdev.77; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; COX GN, 1985, MOL CELL BIOL, V5, P363, DOI 10.1128/MCB.5.2.363; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fuentes-Medel Y, 2012, CURR BIOL, V22, P1831, DOI 10.1016/j.cub.2012.07.063; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Goodman SJ, 2003, DEVELOPMENT, V130, P3757, DOI 10.1242/dev.00604; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Huang P, 2004, DEVELOPMENT, V131, P2595, DOI 10.1242/dev.01135; Johnson RP, 2012, GENETICS, V190, P1365, DOI 10.1534/genetics.111.136184; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kim JH, 2006, J BIOCHEM MOL BIOL, V39, P339; Knight CG, 2002, EVOL DEV, V4, P16, DOI 10.1046/j.1525-142x.2002.01058.x; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; LIU ZC, 1991, NATURE, V350, P162, DOI 10.1038/350162a0; McMiller TL, 2005, GENE, V356, P1, DOI 10.1016/j.gene.2005.05.003; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miyaji T, 2011, J NEUROCHEM, V119, P1, DOI 10.1111/j.1471-4159.2011.07388.x; Miyaji T, 2010, BIOL PHARM BULL, V33, P1783, DOI 10.1248/bpb.33.1783; Morin P, 2004, EMBO J, V23, P4560, DOI 10.1038/sj.emboj.7600464; Myall NJ, 2007, MOL GENET METAB, V92, P371, DOI 10.1016/j.ymgme.2007.08.121; Nonet ML, 1997, J NEUROSCI, V17, P8061; Page AP, 2007, WORMBOOK, DOI [10.1895/wormbook.1.138.1, DOI 10.1895/W0RMB00K.1.138.1]; Pfrieger FW, 2010, BRAIN RES REV, V63, P39, DOI 10.1016/j.brainresrev.2009.11.002; Pocock R, 2008, MOL CELL NEUROSCI, V37, P56, DOI 10.1016/j.mcn.2007.08.014; Polanska UM, 2009, J BIOL CHEM, V284, P33030, DOI 10.1074/jbc.M109.058925; Qin LZ, 2012, P NATL ACAD SCI USA, V109, P13434, DOI 10.1073/pnas.1116633109; Reimer RJ, 2013, MOL ASPECTS MED, V34, P350, DOI 10.1016/j.mam.2012.05.004; Sasakura H, 2005, EMBO J, V24, P1477, DOI 10.1038/sj.emboj.7600621; Shaham S, 2006, CURR OPIN NEUROBIOL, V16, P522, DOI 10.1016/j.conb.2006.08.001; Shi L, 2012, TRENDS NEUROSCI, V35, P441, DOI 10.1016/j.tins.2012.04.005; Sreedharan S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-17; Stavoe AKH, 2012, J CELL BIOL, V197, P75, DOI 10.1083/jcb.201110127; Stevens B, 2008, NEUROSIGNALS, V16, P278, DOI 10.1159/000123038; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sundaram Meera V, 2006, WormBook, P1; Tam SJ, 2010, ANNU REV NEUROSCI, V33, P379, DOI 10.1146/annurev-neuro-060909-152829; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Watanabe S, 2012, METHOD CELL BIOL, V111, P283, DOI 10.1016/B978-0-12-416026-2.00015-7; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Woo WM, 2008, DEVELOPMENT, V135, P2747, DOI 10.1242/dev.015289; Wreden CC, 2005, J BIOL CHEM, V280, P1408, DOI 10.1074/jbc.M411295200; Yoshimura S, 2008, DEVELOPMENT, V135, P2263, DOI 10.1242/dev.019547	63	47	55	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 18	2013	154	2					337	350		10.1016/j.cell.2013.06.028	http://dx.doi.org/10.1016/j.cell.2013.06.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870123	Bronze, Green Accepted			2022-12-28	WOS:000321950700011
J	Baillie, JK; Digard, P				Baillie, J. Kenneth; Digard, Paul			Influenza - Time to Target the Host?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Baillie, J. Kenneth; Digard, Paul] Univ Edinburgh, Roslin Inst, Easter Bush, England; [Baillie, J. Kenneth] Royal Infirm, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Royal Infirmary of Edinburgh	Baillie, JK (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush, England.		Baillie, Kenneth/AEK-6650-2022; Baillie, John Kenneth/F-3124-2011; Digard, Paul/B-7717-2008	Baillie, Kenneth/0000-0001-5258-793X; Baillie, John Kenneth/0000-0001-5258-793X; Digard, Paul/0000-0002-0872-9440	Medical Research Council [G0700815] Funding Source: Medline; BBSRC [BBS/E/D/20241864] Funding Source: UKRI; MRC [G0700815] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Horby P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033180; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Porter CJH, 2007, NAT REV DRUG DISCOV, V6, P231, DOI 10.1038/nrd2197; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294	5	41	46	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					191	193		10.1056/NEJMcibr1304414	http://dx.doi.org/10.1056/NEJMcibr1304414			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180BH	23841736	Green Published			2022-12-28	WOS:000321567300019
J	Holme, R; de Viron, O				Holme, R.; de Viron, O.			Characterization and implications of intradecadal variations in length of day	NATURE			English	Article							ELECTRICAL-CONDUCTIVITY; MAGNETIC JERK; MANTLE; ROTATION; EARTH; FIELD	Variations in Earth's rotation (defined in terms of length of day) arise from external tidal torques, or from an exchange of angular momentum between the solid Earth and its fluid components(1). On short timescales (annual or shorter) the non-tidal component is dominated by the atmosphere, with small contributions from the ocean and hydrological system. On decadal timescales, the dominant contribution is from angular momentum exchange between the solid mantle and fluid outer core. Intradecadal periods have been less clear and have been characterized by signals with a wide range of periods and varying amplitudes, including a peak at about 6 years (refs 2-4). Here, by working in the time domain rather than the frequency domain, we show a clear partition of the non-atmospheric component into only three components: a decadally varying trend, a 5.9-year period oscillation, and jumps at times contemporaneous with geomagnetic jerks. The nature of the jumps in length of day leads to a fundamental change in what class of phenomena may give rise to the jerks, and provides a strong constraint on electrical conductivity of the lower mantle, which can in turn constrain its structure and composition.	[Holme, R.] Univ Liverpool, Sch Environm Sci, Liverpool L69 3GP, Merseyside, England; [de Viron, O.] Univ Paris Diderot, Sorbonne Paris Cit, Inst Phys Globe, UMR7154, F-75013 Paris, France	University of Liverpool; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite	Holme, R (corresponding author), Univ Liverpool, Sch Environm Sci, Liverpool L69 3GP, Merseyside, England.	holme@liv.ac.uk	de Viron, Olivier/N-6647-2014	de Viron, Olivier/0000-0003-3112-9686	Centre National d'Etudes Spatiales (CNES) through the TOSCA (Terre, Ocean, Surfaces Continentales, Atmosphere) programme; French Institut Universitaire de France; National Oceanographic Partnership Program	Centre National d'Etudes Spatiales (CNES) through the TOSCA (Terre, Ocean, Surfaces Continentales, Atmosphere) programme; French Institut Universitaire de France; National Oceanographic Partnership Program	O.d.V. was supported by Centre National d'Etudes Spatiales (CNES) through the TOSCA (Terre, Ocean, Surfaces Continentales, Atmosphere) programme, and by the French Institut Universitaire de France. The oceanographic model used is a contribution of the Consortium for Estimating the Circulation and Climate of the Ocean (ECCO) funded by the National Oceanographic Partnership Program.	Alexandrescu M, 1996, J GEOPHYS RES-SOL EA, V101, P21975, DOI 10.1029/96JB01648; BACKUS GE, 1983, GEOPHYS J ROY ASTR S, V74, P713; BENTON ER, 1983, GEOPHYS J ROY ASTR S, V75, P77, DOI 10.1111/j.1365-246X.1983.tb01914.x; Bloxham J, 2002, NATURE, V420, P65, DOI 10.1038/nature01134; BLOXHAM J, 1986, GEOPHYS J INT, V87, P669, DOI 10.1111/j.1365-246X.1986.tb06643.x; BUFFETT BA, 1992, J GEOPHYS RES-SOL EA, V97, P19581, DOI 10.1029/92JB00977; del Rio RA, 2003, J GEODYN, V36, P423, DOI 10.1016/S0264-3707(03)00060-7; del Rio RA, 2000, ANN GEOPHYS-ATM HYDR, V18, P347, DOI 10.1007/s005850050894; Gillet N, 2010, NATURE, V465, P74, DOI 10.1038/nature09010; Gorshkov VL, 2010, SOLAR SYST RES+, V44, P487, DOI 10.1134/S003809461006002X; Gross R. S, 2007, TREATISE GEOPHYS, V3, P107; Gross RS, 2006, SURV GEOPHYS, V27, P615, DOI 10.1007/s10712-006-9008-1; Hernlund JW, 2005, NATURE, V434, P882, DOI 10.1038/nature03472; Holme R, 2005, GEOPHYS J INT, V160, P435, DOI 10.1111/j.1365-246X.2004.02510.x; Holme R, 1998, GEODYNAMICS, V28, P139; Holme R, 2009, NATURE, V459, P652, DOI 10.1038/459652a; Liao DC, 1999, J GEODESY, V73, P466, DOI 10.1007/PL00004002; Mandea M, 2010, SPACE SCI REV, V155, P147, DOI 10.1007/s11214-010-9663-x; Mound JE, 2006, EARTH PLANET SC LETT, V243, P383, DOI 10.1016/j.epsl.2006.01.043; Olsen N, 1999, GEOPHYS J INT, V138, P179, DOI 10.1046/j.1365-246x.1999.00854.x; Olsen N, 2008, NAT GEOSCI, V1, P390, DOI 10.1038/ngeo203; Ono S, 2006, EARTH PLANET SC LETT, V246, P326, DOI 10.1016/j.epsl.2006.04.017; Pinheiro K, 2008, GEOPHYS J INT, V173, P781, DOI 10.1111/j.1365-246X.2008.03762.x; Pinheiro KJ, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003706; Velimsky J, 2010, PHYS EARTH PLANET IN, V180, P111, DOI 10.1016/j.pepi.2010.02.007; VONDRAK J, 1977, STUD GEOPHYS GEOD, V21, P107, DOI 10.1007/BF01634821; Wardinski I, 2008, EARTH PLANET SC LETT, V267, P468, DOI 10.1016/j.epsl.2007.12.008	27	96	98	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					202	+		10.1038/nature12282	http://dx.doi.org/10.1038/nature12282			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23846659				2022-12-28	WOS:000321557600060
J	Hsu, CW; Zhen, B; Lee, J; Chua, SL; Johnson, SG; Joannopoulos, JD; Soljacic, M				Hsu, Chia Wei; Zhen, Bo; Lee, Jeongwon; Chua, Song-Liang; Johnson, Steven G.; Joannopoulos, John D.; Soljacic, Marin			Observation of trapped light within the radiation continuum	NATURE			English	Article							BOUND-STATES; WAVES	The ability to confine light is important both scientifically and technologically. Many light confinement methods exist, but they all achieve confinement with materials or systems that forbid outgoing waves. These systems can be implemented by metallic mirrors, by photonic band-gap materials(1), by highly disordered media (Anderson localization(2)) and, for a subset of outgoing waves, by translational symmetry (total internal reflection1) or by rotational or reflection symmetry(3,4). Exceptions to these examples exist only in theoretical proposals(5-8). Here we predict and show experimentally that light can be perfectly confined in a patterned dielectric slab, even though outgoing waves are allowed in the surrounding medium. Technically, this is an observation of an 'embedded eigenvalue' 9-namely, a bound state in a continuum of radiation modes-that is not due to symmetry incompatibility(5-8,10-16). Such a bound state can exist stably in a general class of geometries in which all of its radiation amplitudes vanish simultaneously as a result of destructive interference. This method to trap electromagnetic waves is also applicable to electronic(12) and mechanical waves(14,15).	[Hsu, Chia Wei; Zhen, Bo; Lee, Jeongwon; Chua, Song-Liang; Johnson, Steven G.; Joannopoulos, John D.; Soljacic, Marin] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Hsu, Chia Wei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Johnson, Steven G.] MIT, Dept Math, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Hsu, CW (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	cwhsu@mit.edu	Soljacic, Marin/AAA-4868-2019; Joannopoulos, John D/E-6401-2013; Hsu, Chia Wei (Wade)/G-5486-2011	Hsu, Chia Wei (Wade)/0000-0002-9609-7155; Johnson, Steven/0000-0001-7327-4967	Army Research Office through the Institute for Soldier Nanotechnologies [W911NF-07-D0004]; S3TEC, an Energy Frontier Research Center; US Department of Energy [DE-SC0001299]; Materials Research Science and Engineering Centers of the National Science Foundation [DMR-0819762]	Army Research Office through the Institute for Soldier Nanotechnologies; S3TEC, an Energy Frontier Research Center; US Department of Energy(United States Department of Energy (DOE)); Materials Research Science and Engineering Centers of the National Science Foundation	We thank L. Lu, O. Shapira and Y. Shen for discussions. This work was partly supported by the Army Research Office through the Institute for Soldier Nanotechnologies under contract no. W911NF-07-D0004. B.Z., J.L. (fabrication) and M. S. were partly supported by S3TEC, an Energy Frontier Research Center funded by the US Department of Energy under grant no. DE-SC0001299. S.-L. C. and J.L. were also partly supported by the Materials Research Science and Engineering Centers of the National Science Foundation under grant no. DMR-0819762.	Fan SH, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.235112; FRIEDRICH H, 1985, PHYS REV A, V32, P3231, DOI 10.1103/PhysRevA.32.3231; Hislop P. D., 1996, INTRODUCTION TO SPEC; Hsu CW, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.40; Joannopoulos JD, 2008, PHOTONIC CRYSTALS: MOLDING THE FLOW OF LIGHT, 2ND EDITION, P1; Johnson SG, 2001, OPT EXPRESS, V8, P173, DOI 10.1364/OE.8.000173; Kruger H, 2012, J MATH ANAL APPL, V395, P776, DOI 10.1016/j.jmaa.2012.05.075; Lee J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.067401; Linton CM, 2007, WAVE MOTION, V45, P16, DOI 10.1016/j.wavemoti.2007.04.009; Liu V, 2012, COMPUT PHYS COMMUN, V183, P2233, DOI 10.1016/j.cpc.2012.04.026; Marinica DC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.183902; Molina MI, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.070401; Plotnik Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.183901; Porter R, 2005, WAVE MOTION, V43, P29, DOI 10.1016/j.wavemoti.2005.05.005; STILLINGER FH, 1975, PHYS REV A, V11, P446, DOI 10.1103/PhysRevA.11.446; Taflove A., 2005, COMPUTATIONAL ELECTR; von Neumann J, 1929, PHYS Z, V30, P467; Watts MR, 2002, OPT LETT, V27, P1785, DOI 10.1364/OL.27.001785; Zhang JM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.116405	20	687	698	63	351	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					188	191		10.1038/nature12289	http://dx.doi.org/10.1038/nature12289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23846657	Green Submitted			2022-12-28	WOS:000321557600057
J	Mayr, G; Manegold, A				Mayr, Gerald; Manegold, Albrecht			Can ovarian follicles fossilize?	NATURE			English	Letter							THEROPOD DINOSAUR; CHINA; PRESERVATION; EVOLUTION		[Mayr, Gerald; Manegold, Albrecht] Forschungsinst Senckenberg, Sekt Ornithol, D-60325 Frankfurt, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN)	Mayr, G (corresponding author), Forschungsinst Senckenberg, Sekt Ornithol, Senckenberganlage 25, D-60325 Frankfurt, Germany.	albrecht.manegold@senckenberg.de						Benton MJ, 2008, P GEOLOGIST ASSOC, V119, P209, DOI 10.1016/S0016-7878(08)80302-1; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Cleland TP, 2011, NATURWISSENSCHAFTEN, V98, P203, DOI 10.1007/s00114-010-0760-1; Dal Sasso C, 1998, NATURE, V392, P383; Fisher PE, 2000, SCIENCE, V288, P503, DOI 10.1126/science.288.5465.503; Griffiths Peter, 1994, Revue de Paleobiologie Volume Special, V7, P85; Lerosey-Aubril R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032934; Reisdorf Achim G., 2012, Palaeobiodiversity Palaeoenvironments, V92, P119, DOI 10.1007/s12549-011-0068-y; Sasanami T, 2003, J STEROID BIOCHEM, V84, P109, DOI 10.1016/S0960-0760(03)00008-6; Sato T, 2005, SCIENCE, V308, P375, DOI 10.1126/science.1110578; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Zelenitsky Darla K., 2006, Journal of the Paleontological Society of Korea, V22, P209; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740; Zheng SL, 2004, REV PALAEOBOT PALYNO, V131, P91, DOI 10.1016/j.revpalbo.2004.03.002; Zheng XT, 2013, NATURE, V495, P507, DOI 10.1038/nature11985	15	14	15	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2013	499	7457					E1	E1		10.1038/nature12367	http://dx.doi.org/10.1038/nature12367			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23846661				2022-12-28	WOS:000321557600001
J	Steinacher, M; Joos, F; Stocker, TF				Steinacher, Marco; Joos, Fortunat; Stocker, Thomas F.			Allowable carbon emissions lowered by multiple climate targets	NATURE			English	Article							OCEAN ACIDIFICATION; MITIGATION; CALCIFICATION; 21ST-CENTURY; SENSITIVITY; RISK	Climate targets are designed to inform policies that would limit the magnitude and impacts of climate change caused by anthropogenic emissions of greenhouse gases and other substances. The target that is currently recognized by most world governments(1) places a limit of two degrees Celsius on the global mean warming since preindustrial times. This would require large sustained reductions in carbon dioxide emissions during the twenty-first century and beyond(2-4). Such a global temperature target, however, is not sufficient to control many other quantities, such as transient sea level rise(5), ocean acidification(6,7) and net primary production on land(8,9). Here, using an Earth system model of intermediate complexity (EMIC) in an observation-informed Bayesian approach, we show that allowable carbon emissions are substantially reduced when multiple climate targets are set. We take into account uncertainties in physical and carbon cycle model parameters, radiative efficiencies(10), climate sensitivity(11) and carbon cycle feedbacks(12,13) along with a large set of observational constraints. Within this framework, we explore a broad range of economically feasible greenhouse gas scenarios from the integrated assessment community(14-17) to determine the likelihood of meeting a combination of specific global and regional targets under various assumptions. For any given likelihood of meeting a set of such targets, the allowable cumulative emissions are greatly reduced from those inferred from the temperature target alone. Therefore, temperature targets alone are unable to comprehensively limit the risks from anthropogenic emissions.	[Steinacher, Marco; Joos, Fortunat; Stocker, Thomas F.] Univ Bern, CH-3012 Bern, Switzerland; [Steinacher, Marco; Joos, Fortunat; Stocker, Thomas F.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland	University of Bern; University of Bern	Steinacher, M (corresponding author), Univ Bern, CH-3012 Bern, Switzerland.	steinacher@climate.unibe.ch	Stocker, Thomas/B-1273-2013; Joos, Fortunat/B-4118-2018; Steinacher, Marco/J-1527-2012	Joos, Fortunat/0000-0002-9483-6030; Steinacher, Marco/0000-0002-4795-1749	Swiss National Science Foundation; European Commission [EPOCA 211384, 264879]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank T. Kaminski for providing the Global Atmospheric Tracer Model (TM2) transport matrices, J. M. Lyman, H. Keith, and S. Gerber for providing observational data sets, R. Spahni, R. Roth, S. Ritz, B. Stocker and K. Strassmann for discussions and help with the model code, and K. Bieri for the IT support. We are grateful to the modelling teams participating in the EMF-21, International Institute for Applied Systems Analysis (IIASA) GGI, and AME projects for providing scenario data, and to the EMIC AR5 and coupled model intercomparison (CMIP5) projects for providing model forcing data sets. This project was funded by the Swiss National Science Foundation and the European Project on Ocean Acidification (EPOCA 211384) and the European Project CARBOCHANGE (264879) which both received funding from the European Commission's Seventh Framework Programme (FP7/20072013).	Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; Boden T., 2012, GLOBAL CO2 EMISSIONS; Calvin K, 2012, ENERG ECON, V34, pS251, DOI 10.1016/j.eneco.2012.09.003; Chan NCS, 2013, GLOBAL CHANGE BIOL, V19, P282, DOI 10.1111/gcb.12011; Church JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048794; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; FORSTER P, 2007, PHYS SCI BASIS, P129; Frieler K, 2013, NAT CLIM CHANGE, V3, P165, DOI 10.1038/NCLIMATE1674; Fung IY, 2005, P NATL ACAD SCI USA, V102, P11201, DOI 10.1073/pnas.0504949102; Grubler A, 2007, TECHNOL FORECAST SOC, V74, P873, DOI 10.1016/j.techfore.2006.07.009; Harrould-Kolieb ER, 2012, CLIM POLICY, V12, P378, DOI 10.1080/14693062.2012.620788; Hickler T, 2008, GLOBAL CHANGE BIOL, V14, P1531, DOI 10.1111/j.1365-2486.2008.01598.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Isaaks E. H., 1989, APPL GEOSTATISTICS, P278; Johnson MD, 2012, J EXP MAR BIOL ECOL, V434, P94, DOI 10.1016/j.jembe.2012.08.005; Joos F, 2001, GLOBAL BIOGEOCHEM CY, V15, P891, DOI 10.1029/2000GB001375; Joos F., 2011, OCEAN ACIDIFICATION, P319; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Knox J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034032; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Meehl GA, 2012, NAT CLIM CHANGE, V2, P576, DOI 10.1038/NCLIMATE1529; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Muller SA, 2006, J CLIMATE, V19, P5479, DOI 10.1175/JCLI3911.1; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parekh P, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001531; Powlson DS, 2011, FOOD POLICY, V36, pS72, DOI 10.1016/j.foodpol.2010.11.025; Ritz SP, 2011, QUATERNARY SCI REV, V30, P3728, DOI 10.1016/j.quascirev.2011.09.021; Ritz SP, 2011, J CLIMATE, V24, P349, DOI 10.1175/2010JCLI3351.1; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Rougier J, 2007, CLIMATIC CHANGE, V81, P247, DOI 10.1007/s10584-006-9156-9; Running SW, 2012, SCIENCE, V337, P1458, DOI 10.1126/science.1227620; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Spahni R., 2012, CLIM PAST DISCUSS, V8, P5633, DOI [10.5194/cpd-8-5633-2012, DOI 10.5194/CPD-8-5633-2012]; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Strassmann KM, 2008, TELLUS B, V60, P583, DOI 10.1111/j.1600-0889.2008.00340.x; Tomassini L, 2010, CLIMATIC CHANGE, V103, P399, DOI 10.1007/s10584-009-9763-3; United Nations, 2011, C PART 16 SESS CANC; Weyant JR, 2006, ENERG J, P1; Yamamoto-Kawai M, 2009, SCIENCE, V326, P1098, DOI 10.1126/science.1174190; Yara Y, 2012, BIOGEOSCIENCES, V9, P4955, DOI 10.5194/bg-9-4955-2012; Zickfeld K, 2009, P NATL ACAD SCI USA, V106, P16129, DOI 10.1073/pnas.0805800106	49	69	69	5	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					197	+		10.1038/nature12269	http://dx.doi.org/10.1038/nature12269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23823728				2022-12-28	WOS:000321557600059
J	Ko, DT; Tu, JV; Austin, PC; Wijeysundera, HC; Samadashvili, Z; Guo, H; Cantor, WJ; Hannan, EL				Ko, Dennis T.; Tu, Jack V.; Austin, Peter C.; Wijeysundera, Harindra C.; Samadashvili, Zaza; Guo, Helen; Cantor, Warren J.; Hannan, Edward L.			Prevalence and Extent of Obstructive Coronary Artery Disease Among Patients Undergoing Elective Coronary Catheterization in New York State and Ontario	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BYPASS GRAFT-SURGERY; CENTER THINK-TANK; AMERICAN-COLLEGE; UNITED-STATES; CARDIAC-CATHETERIZATION; MYOCARDIAL-INFARCTION; HEART-ASSOCIATION; ACHIEVING QUALITY; POPULATION RATES; TEMPORAL TRENDS	IMPORTANCE Prior studies have shown that physicians in New York State (New York) perform twice as many cardiac catheterizations per capita as those in Ontario for stable patients. However, the role of patient selection in these findings and their implications for detection of obstructive coronary artery disease (CAD) are largely unknown. OBJECTIVE To evaluate the extent of obstructive CAD and to compare the probability of detecting obstructive CAD for patients undergoing cardiac catheterization. DESIGN, SETTING, AND PATIENTS An observational study was conducted involving patients without a history of cardiac disease who underwent elective cardiac catheterization between October 1, 2008, and September 30, 2011. Obstructive CAD was defined as diameter stenosis of 50% or more in the left main coronary artery or stenosis of 70% or more in a major epicardial vessel. MAIN OUTCOMES AND MEASURES Observed rates and predicted probabilities of obstructive CAD. Predicted probabilities were estimated using logistic regression models. RESULTS A total of 18 114 patients from New York and 54 933 from Ontario were included. The observed rate of obstructive CAD was significantly lower in New York at 30.4% (95% CI, 29.7%-31.0%) than in Ontario at 44.8% (95% CI, 44.4%-45.3%; P < .001). The percentage of patients with left main or 3-vessel CAD was also significantly lower in New York than in Ontario (7.0% [95% CI, 6.6%-7.3%] vs 13.0% [95% CI, 12.8%-13.3%]; P < .001). In New York, a substantially higher percentage of patients with low predicted probability of obstructive CAD underwent cardiac catheterization; for example, only 19.3% (95% CI, 18.7%-19.9%) of patients undergoing cardiac catheterization in New York had a greater than 50% predicted probability of having obstructive CAD than those in Ontario at 41% (95% CI, 40.6%-41.4%; P < .001). At 30 days, crude mortality for patients undergoing cardiac catheterization was slightly higher in New York at 0.65% (90 of 13 824; 95% CI, 0.51%-0.78%) than in Ontario at 0.38% (153 of 40 794; 95% CI, 0.32%-0.43%; P < .001). CONCLUSIONS AND RELEVANCE In Ontario compared with New York State, patients undergoing elective cardiac catheterization were significantly more likely to have obstructive CAD. This appears to be related to a higher percentage of patients in New York with low predicted probability of CAD undergoing cardiac catheterization.	[Ko, Dennis T.; Tu, Jack V.; Austin, Peter C.; Wijeysundera, Harindra C.; Guo, Helen] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; [Ko, Dennis T.; Tu, Jack V.; Wijeysundera, Harindra C.] Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Toronto, ON M4N 3M5, Canada; [Ko, Dennis T.; Tu, Jack V.; Wijeysundera, Harindra C.; Cantor, Warren J.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Cantor, Warren J.] Southlake Reg Hlth Ctr, Newmarket, ON, Canada; [Samadashvili, Zaza; Hannan, Edward L.] SUNY Albany, Albany, NY 12222 USA	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Southlake Regional Health Centre; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Ko, DT (corresponding author), Inst Clin Evaluat Sci, G106-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	dennis.ko@ices.on.ca	Wijeysundera, Harindra/AAA-6058-2020	Austin, Peter/0000-0003-3337-233X; Ko, Dennis/0000-0001-6840-8051; Wijeysundera, Harindra/0000-0001-8464-1080	Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-term Care (MOHLTC); MOHLTC; Canadian Institutes of Health Research (CIHR) [102487]; Canada Research Chair in Health Services Research; Heart and Stroke Foundation of Ontario	Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); MOHLTC(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Health Services Research(Canada Research Chairs); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-term Care (MOHLTC). The authors acknowledge that the clinical registry data used in this publication are from the Cardiac Care Network of Ontario and its member hospitals. The Cardiac Care Network of Ontario serves as a system support to the MOHLTC, Local Health Integration Networks, and service providers and is dedicated to improving the quality, efficiency, access and equity in the delivery of the continuum of adult cardiovascular services in Ontario, Canada. The Cardiac Care Network of Ontario is funded by the MOHLTC. The analysis of this study was supported by a Canadian Institutes of Health Research (CIHR) operating grant MOP (102487). Dr Ko is supported by a CIHR New Investigator Award. Dr Tu is supported by a Canada Research Chair in Health Services Research and a Career Investigator Award from the Heart and Stroke Foundation of Ontario. Dr Austin is supported by a Career Investigator Award from the Heart and Stroke Foundation of Ontario.	Alter DA, 2006, CIRCULATION, V113, P380, DOI 10.1161/CIRCULATIONAHA.105.560466; Batchelor WB, 1999, J AM COLL CARDIOL, V34, P12, DOI 10.1016/S0735-1097(99)00174-6; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Douglas PS, 2006, J AM COLL CARDIOL, V48, P2141, DOI 10.1016/j.jacc.2006.06.076; Douglas PS, 2009, JACC-CARDIOVASC IMAG, V2, P231, DOI 10.1016/j.jcmg.2008.11.012; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; Graham MM, 2005, CAN MED ASSOC J, V173, P35, DOI 10.1503/cmaj.1041444; Hannan EL, 2012, CIRCULATION, V125, P1870, DOI 10.1161/CIRCULATIONAHA.111.071811; Hannan EL, 2010, CIRCULATION, V121, P267, DOI 10.1161/CIRCULATIONAHA.109.887539; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Ko DT, 2007, CIRCULATION, V115, P196, DOI 10.1161/CIRCULATIONAHA.106.657601; Ko DT, 2010, CIRCULATION, V121, P2635, DOI 10.1161/CIRCULATIONAHA.109.926881; Ko DT, 2005, ARCH INTERN MED, V165, P2486, DOI 10.1001/archinte.165.21.2486; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; Natarajan MK, 2005, CAN MED ASSOC J, V173, P49, DOI 10.1503/cmaj.050432; Patel MR, 2012, J AM COLL CARDIOL, V59, P1995, DOI [10.1016/j.jacc.2012.03.003, 10.1002/ccd.24467]; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Steyerberg E., 2009, CLIN PREDICTION MODE; Tu JV, 2007, NEW ENGL J MED, V357, P1393, DOI 10.1056/NEJMoa071076; Tu JV, 2008, CIRCULATION, V118, P2588, DOI 10.1161/CIRCULATIONAHA.107.729806; Tu JV, 1997, NEW ENGL J MED, V336, P1500, DOI 10.1056/NEJM199705223362106; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	23	53	57	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					163	169		10.1001/jama.2013.7834	http://dx.doi.org/10.1001/jama.2013.7834			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23839750	Bronze			2022-12-28	WOS:000321511500015
J	Van Damme, P; Leuridan, E; Hendrickx, G; Vorsters, A; Theeten, H; Leino, T; Salminen, M; Kuusi, M				Van Damme, Pierre; Leuridan, Elke; Hendrickx, Greet; Vorsters, Alex; Theeten, Heidi; Leino, Tuija; Salminen, Mika; Kuusi, Markku			Should Europe have a universal hepatitis B vaccination programme?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VIRUS INFECTION; SEX WORKERS; TRANSMISSION; NETHERLANDS; RISK; IMMUNIZATION; EPIDEMIOLOGY; PREVALENCE; STRATEGIES; MIGRATION		[Van Damme, Pierre; Leuridan, Elke; Hendrickx, Greet; Vorsters, Alex; Theeten, Heidi] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, B-2020 Antwerp, Belgium; [Leino, Tuija] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Salminen, Mika; Kuusi, Markku] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland	University of Antwerp; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Van Damme, P (corresponding author), Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, B-2020 Antwerp, Belgium.	pierre.vandamme@ua.ac.be; markku.kuusi@thl.fi	vorsters, alex/A-9605-2012; Salminen, Mika/D-8784-2013; van damme, pierre/I-4846-2013	vorsters, alex/0000-0002-0265-058X; Salminen, Mika/0000-0003-3020-0866; Leuridan, Elke/0000-0001-7482-799X; van damme, pierre/0000-0002-8642-1249	GlaxoSmithKline Biologicals; Sanofi Pasteur; Merck	GlaxoSmithKline Biologicals(GlaxoSmithKline); Sanofi Pasteur; Merck(Merck & Company)	The authors have read and understood the BMJ Group policy on declaration of interests and declare the following interests: PvD is head of the Vaccine and Infectious Disease Institute at the University of Antwerp, which is a WHO collaborating centre for the prevention and control of infectious diseases; chair of the European Technical Advisory Group of Experts on immunisation at WHO EURO; and executive secretary of the Viral Hepatitis Prevention Board, which is supported by unrestricted grants from the vaccine industry (GlaxoSmithKline Biologicals, Sanofi Pasteur, and Merck). PvD acts as chief and principal investigator for vaccine trials, for which the university obtains research grants from vaccine manufacturers.	Aweis D, 2001, Commun Dis Public Health, V4, P247; Baars JE, 2011, EUR J PUBLIC HEALTH, V21, P333, DOI 10.1093/eurpub/ckq117; Baars JE, 2009, WOMEN HEALTH ISS, V19, P61, DOI 10.1016/j.whi.2008.09.002; Beeching NJ, 2004, BRIT MED J, V329, P1059, DOI 10.1136/bmj.329.7474.1059; Beutels P, 2001, HEALTH ECON, V10, P751, DOI 10.1002/hec.625; Boccalini S, 2013, HUM VACC IMMUNOTHER, V9, P1; Cai W, 2011, PEDIATR INFECT DIS J, V30, P19, DOI 10.1097/INF.0b013e3181ef22d5; Chu JJ, 2012, EUR J PUBLIC HLTH; Day CA, 2010, DRUG ALCOHOL DEPEN, V108, P134, DOI 10.1016/j.drugalcdep.2009.11.013; Edmunds W J, 1998, Commun Dis Public Health, V1, P221; Fisker N, 2004, J CLIN VIROL, V31, P46, DOI 10.1016/j.jcv.2004.05.004; Gjorup IE, 2003, J INFECTION, V47, P231, DOI 10.1016/S0163-4453(03)00070-7; Hahne S, 2004, J CLIN VIROL, V29, P211, DOI 10.1016/j.jcv.2003.09.016; Heininger U, 2010, PEDIATR INFECT DIS J, V29, P248, DOI 10.1097/INF.0b013e3181bd7f89; Kretzschmar M, 2002, EPIDEMIOL INFECT, V128, P229, DOI 10.1017/S0950268801006562; Kretzschmar M, 2009, VACCINE, V27, P1254, DOI 10.1016/j.vaccine.2008.12.009; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lindh M, 2000, INFECTION, V28, P161, DOI 10.1007/s150100050071; MAHONEY FJ, 1995, PEDIATRICS, V96, P1113; Marschall T, 2008, EUR J GASTROEN HEPAT, V20, P1214, DOI 10.1097/MEG.0b013e32830e289e; Nardone A, 2009, EPIDEMIOL INFECT, V137, P961, DOI 10.1017/S0950268808001672; Organization WH, 2009, WEEKLY EPIDEMIOLOGIC, V84, P405; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Rantala M, 2008, EUROSURVEILLANCE, V13, P1; Rimseliene G, 2009, EUR SCI C APPL INF D; Romano L, 2011, DIGEST LIVER DIS, V43, pS2, DOI 10.1016/S1590-8658(10)60685-8; Salleras L, 2007, VACCINE, V25, P8726, DOI 10.1016/j.vaccine.2007.10.027; Tilson L, 2008, EUR J PUBLIC HEALTH, V18, P275, DOI 10.1093/eurpub/ckm123; Van Damme P., 2013, VACCINES-BASEL, P205; van Houdt R, 2009, VACCINE, V27, P3530, DOI 10.1016/j.vaccine.2009.03.072; World Health Organization, 2012, PREV CONTR VIR HEP I; World Health Organization, 2010, 63 WORLD HLTH ASS VI; Wouters K, 2007, VACCINE, V25, P1893, DOI 10.1016/j.vaccine.2006.09.073	33	13	13	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2013	347								f4057	10.1136/bmj.f4057	http://dx.doi.org/10.1136/bmj.f4057			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	184MC	23843546	Green Submitted			2022-12-28	WOS:000321893000004
J	Castellani, J				Castellani, John			Are clinical trial data shared sufficiently today? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Pharmaceutical Research Manufacturers of America, 2011, PRINC COND CLIN TRIA	2	17	18	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2013	347								f1881	10.1136/bmj.f1881	http://dx.doi.org/10.1136/bmj.f1881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184LT	23838461	Bronze			2022-12-28	WOS:000321892000002
J	Weimerskirch, H				Weimerskirch, Henri			Seabirds-Individuals in Colonies	SCIENCE			English	Editorial Material							INFORMATION; BIRDS		CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS)	Weimerskirch, H (corresponding author), CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France.	henriw@cebc.cnrs.fr	Weimerskirch, Henri/F-5562-2013; Weimerskirch, Henri/K-7306-2019	Weimerskirch, Henri/0000-0002-0457-586X				ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; CAIRNS DK, 1989, AM NAT, V134, P141, DOI 10.1086/284970; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; RICHNER H, 1995, ADV STUD BEHAV, V24, P1, DOI 10.1016/S0065-3454(08)60391-5; Rutz C, 2012, CURR BIOL, V22, pR669, DOI 10.1016/j.cub.2012.06.037; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Weimerskirch H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009928; Wittenberger J.F., 1985, Avian Biology, V8, P1	11	4	4	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					35	36		10.1126/science.1240316	http://dx.doi.org/10.1126/science.1240316			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828928				2022-12-28	WOS:000321291700034
J	Casey, JD; Solomon, DH; Gaziano, TA; Miller, AL; Loscalzo, J				Casey, Jonathan D.; Solomon, Daniel H.; Gaziano, Thomas A.; Miller, Amy Leigh; Loscalzo, Joseph			A Patient with Migrating Polyarthralgias	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE RHEUMATIC-FEVER; UNITED-STATES; DISEASE		Brigham & Womens Hosp, Dept Med, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Miller, AL (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02120 USA.	almiller@partners.org	Loscalzo, Joseph/ABD-8980-2021	Casey, Jonathan/0000-0002-0977-290X				Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; CILLIERS AM, 2003, COCHRANE DB SYST REV, V2; Denny LW, 1950, JAMA-J AM MED ASSOC, V143, P151; Gerber MA, 2009, CIRCULATION, V119, P1541, DOI 10.1161/CIRCULATIONAHA.109.191959; Lee GM, 2006, CLIN INFECT DIS, V42, P448, DOI 10.1086/499817; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; Robertson Katharine A, 2005, BMC Cardiovasc Disord, V5, P11, DOI 10.1186/1471-2261-5-11; Seckeler Michael D, 2011, Clin Epidemiol, V3, P67, DOI 10.2147/CLEP.S12977; Shulman ST, 2006, CLIN INFECT DIS, V42, P441, DOI 10.1086/499812; Skoularigis J, 1994, CIRCULATION, V90, pII; VEASY LG, 1987, NEW ENGL J MED, V316, P421, DOI 10.1056/NEJM198702193160801	11	1	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					75	80		10.1056/NEJMcps1208808	http://dx.doi.org/10.1056/NEJMcps1208808			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175WE	23822780				2022-12-28	WOS:000321263500013
J	Mandal, AK; Gothwal, VK				Mandal, Anil K.; Gothwal, Vijaya K.			Sudden Unilateral Corneal Clouding in an Infant	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mandal, Anil K.; Gothwal, Vijaya K.] LV Prasad Eye Inst, Hyderabad, Andhra Pradesh, India	L. V. Prasad Eye Institute	Mandal, AK (corresponding author), LV Prasad Eye Inst, Hyderabad, Andhra Pradesh, India.	mandal@lvpei.org	Mandal, Anil/AAY-4809-2020; Gothwal, Vijaya/AAY-4526-2020						0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					74	74		10.1056/NEJMicm1213817	http://dx.doi.org/10.1056/NEJMicm1213817			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175WE	23822779				2022-12-28	WOS:000321263500012
J	Tam, VC; Quehenberger, O; Oshansky, CM; Suen, R; Armando, AM; Treuting, PM; Thomas, PG; Dennis, EA; Aderem, A				Tam, Vincent C.; Quehenberger, Oswald; Oshansky, Christine M.; Suen, Rosa; Armando, Aaron M.; Treuting, Piper M.; Thomas, Paul G.; Dennis, Edward A.; Aderem, Alan			Lipidomic Profiling of Influenza Infection Identifies Mediators that Induce and Resolve Inflammation	CELL			English	Article							HUMAN PLASMA; VIRUS; ACID; LUNG; RECEPTOR; LEUKOTOXIN; RESOLUTION; ROLES; NEUTROPHILS; ACTIVATION	Bioactive lipid mediators play a crucial role in the induction and resolution of inflammation. To elucidate their involvement during influenza infection, liquid chromatography/mass spectrometry lipidomic profiling of 141 lipid species was performed on a mouse influenza model using two viruses of significantly different pathogenicity. Infection by the low-pathogenicity strain X31/H3N2 induced a proinflammatory response followed by a distinct antiinflammatory response; infection by the high-pathogenicity strain PR8/H1N1 resulted in overlapping pro-and anti-inflammatory states. Integration of the large-scale lipid measurements with targeted gene expression data demonstrated that 5-lipoxygenase metabolites correlated with the pathogenic phase of the infection, whereas 12/15-lipoxygenase metabolites were associated with the resolution phase. Hydroxylated linoleic acid, specifically the ratio of 13- to 9-hydroxyoctadecadienoic acid, was identified as a potential biomarker for immune status during an active infection. Importantly, some of the findings from the animal model were recapitulated in studies of human nasopharyngeal lavages obtained during the 2009-2011 influenza seasons.	[Tam, Vincent C.; Suen, Rosa; Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Quehenberger, Oswald] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Armando, Aaron M.; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Quehenberger, Oswald; Armando, Aaron M.; Dennis, Edward A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Oshansky, Christine M.; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Treuting, Piper M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; St Jude Children's Research Hospital; University of Washington; University of Washington Seattle	Aderem, A (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	alan.aderem@seattlebiomed.org	Treuting, Piper M./AAB-2721-2019; Thomas, Paul G./H-1063-2018; Dennis, Edward A./M-5554-2019	Treuting, Piper M./0000-0002-1812-1519; Thomas, Paul G./0000-0001-7955-0256; Dennis, Edward A./0000-0003-3738-3140; Tam, Vincent/0000-0003-0898-2531	National Institute of Allergy and Infectious Diseases [HHSN272200800058C]; American Lebanese Syrian Associated Charities (ALSAC); NIH/NIAID Center of Excellence for Influenza Research and Surveillance [HHSN266200700005C]; NIGMS [U54 GM069338]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NIH/NIAID Center of Excellence for Influenza Research and Surveillance(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Alan Diercks and Peter Askovich for helpful advice and critical reading of the manuscript. This work was supported by National Institute of Allergy and Infectious Diseases Contract no. HHSN272200800058C, "A Systems Biology Approach to Infectious Disease Research'', the American Lebanese Syrian Associated Charities (ALSAC), the NIH/NIAID Center of Excellence for Influenza Research and Surveillance (HHSN266200700005C), and NIGMS U54 GM069338 (to E.A.D.).	ALLAN W, 1990, J IMMUNOL, V144, P3980; Altmann R, 2007, BIOCHEM PHARMACOL, V74, P612, DOI 10.1016/j.bcp.2007.05.027; Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Belvisi MG, 2009, BRIT J PHARMACOL, V158, P994, DOI 10.1111/j.1476-5381.2009.00373.x; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Drake DR, 2008, J LIPID RES, V49, P4, DOI 10.1194/jlr.R700016-JLR200; Dumlao DS, 2011, BBA-MOL CELL BIOL L, V1811, P724, DOI 10.1016/j.bbalip.2011.06.005; FRANCIS T, 1945, J INFECT DIS, V76, P70, DOI 10.1093/infdis/76.1.70; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Hattori T, 2008, J INVEST DERMATOL, V128, P1123, DOI 10.1038/sj.jid.5701172; ISHIZAKI T, 1995, AM J PHYSIOL-LUNG C, V269, pL65, DOI 10.1152/ajplung.1995.269.1.L65; Ishizaki T, 1999, PULM PHARMACOL THER, V12, P145, DOI 10.1006/pupt.1999.0179; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jankov RP, 2002, J PHARMACOL EXP THER, V301, P435, DOI 10.1124/jpet.301.2.435; Ji RR, 2011, TRENDS NEUROSCI, V34, P599, DOI 10.1016/j.tins.2011.08.005; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kiss L, 2000, AM J RESP CRIT CARE, V161, P1917, DOI 10.1164/ajrccm.161.6.9906058; Kronke G, 2009, J IMMUNOL, V183, P3383, DOI 10.4049/jimmunol.0900327; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Levy BD, 2007, J IMMUNOL, V178, P496, DOI 10.4049/jimmunol.178.1.496; Morgan LT, 2010, BIOCHEM J, V431, P141, DOI 10.1042/BJ20100415; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; O'Flaherty JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045480; Obinata H, 2009, PROSTAG OTH LIPID M, V89, P66, DOI 10.1016/j.prostaglandins.2008.11.002; Quehenberger O, 2011, NEW ENGL J MED, V365, P1812, DOI 10.1056/NEJMra1104901; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; SERHAN CN, 1995, BIOCHEMISTRY-US, V34, P14609, DOI 10.1021/bi00044a041; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Sisemore MF, 2001, ARCH BIOCHEM BIOPHYS, V392, P32, DOI 10.1006/abbi.2001.2434; Spiteller P, 1997, CHEM PHYS LIPIDS, V89, P131, DOI 10.1016/S0009-3084(97)00070-4; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Thomson SJ, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/605101; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Totani Y, 2000, EUR RESPIR J, V15, P75, DOI 10.1183/09031936.00.15107500; Wray JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007421	43	164	172	1	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					213	227		10.1016/j.cell.2013.05.052	http://dx.doi.org/10.1016/j.cell.2013.05.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827684	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000321327900021
J	Sheridan, E; Wright, J; Small, N; Corry, PC; Oddie, S; Whibley, C; Petherick, ES; Malik, T; Pawson, N; McKinney, PA; Parslow, RC				Sheridan, Eamonn; Wright, John; Small, Neil; Corry, Peter C.; Oddie, Sam; Whibley, Catherine; Petherick, Emily S.; Malik, Teena; Pawson, Nicole; McKinney, Patricia A.; Parslow, Roger C.			Risk factors for congenital anomaly in a multiethnic birth cohort: an analysis of the Born in Bradford study	LANCET			English	Article							PARENTAL CONSANGUINITY; RECESSIVE DISEASE; PREGNANCY; DEFECTS; MALFORMATIONS; CONSEQUENCES; POPULATION; JERUSALEM; MORTALITY; CHILDREN	Background Congenital anomalies are a leading cause of infant death and disability and their incidence varies between ethnic groups in the UK. Rates of infant death are highest in children of Pakistani origin, and congenital anomalies are the most common cause of death in children younger than 12 in this ethnic group. We investigated the incidence of congenital anomalies in a large multiethnic birth cohort to identify the causes of the excess of congenital anomalies in this community. Methods We obtained questionnaire data from the mothers of children with one or more anomalies from the Born in Bradford study, a prospective birth cohort study of 13 776 babies and their families in which recruitment was undertaken between 2007 and 2011. Details of anomalies were prospectively reported to the study and we cross checked these details against medical records. We linked data for anomalies to maternal questionnaire and clinical data gathered as part of the Born in Bradford study. We calculated univariate and multivariate risk ratios (RRs) with 95% CIs for various maternal risk factors. Findings Of 11 396 babies for whom questionnaire data were available, 386 (3%) had a congenital anomaly. Rates for congenital anomaly were 305.74 per 10 000 livebirths, compared with a national rate of 165.90 per 10 000. The risk was greater for mothers of Pakistani origin than for those of white British origin (univariate RR 1.96, 95% CI 1.56-2.46). Overall, 2013 (18%) babies were the off spring of first-cousin unions. These babies were mainly of Pakistani origin-1922 (37%) of 5127 babies of Pakistani origin had parents in fi rst-cousin unions. Consanguinity was associated with a doubling of risk for congenital anomaly (multivariate RR 2.19, 95% CI 1.67-2.85); we noted no association with increasing deprivation. 31% of all anomalies in children of Pakistani origin could be attributed to consanguinity. We noted a similar increase in risk for mothers of white British origin older than 34 years (multivariate RR 1.83, 95% CI 1.14-3.00). Maternal education to degree level was protective (0.53, 95% CI 0.38-0.75), irrespective of ethnic origin. Interpretation Consanguinity is a major risk factor for congenital anomaly. The risk remains even after adjustment for deprivation, and accounts for almost a third of anomalies in babies of Pakistani origin. High levels of educational attainment are associated with reduced risk in all ethnic groups. Our findings will be valuable in health promotion and public health, and to those commissioning antenatal, paediatric, and clinical genetic services. Sensitive advice about the risks should be provided to communities at increased risk, and to couples in consanguineous unions, to assist in reproductive decision making.	[Sheridan, Eamonn; Wright, John; Corry, Peter C.; Oddie, Sam; Petherick, Emily S.; Pawson, Nicole] Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford BD9 6RJ, W Yorkshire, England; [Sheridan, Eamonn] St James Univ Hosp, Dept Genet, Leeds LS9 7TF, W Yorkshire, England; [Small, Neil] Univ Bradford, Sch Hlth Studies, Bradford BD7 1DP, W Yorkshire, England; [Whibley, Catherine; McKinney, Patricia A.; Parslow, Roger C.] Univ Leeds, Leeds Inst Genet Therapeut & Hlth, Paediat Epidemiol Grp, Div Epidemiol & Biostat, Leeds, W Yorkshire, England; [Malik, Teena] Chapel Allerton Hosp, Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England	Bradford Royal Infirmary; Saint James's University Hospital; University of Bradford; University of Leeds; Chapel Allerton Hospital	Sheridan, E (corresponding author), St James Univ Hosp, Leeds Inst Biomed & Clin Sci, Genet Sect, Wellcome Trust Brenner Bldg,Beckett St, Leeds LS9 7TF, W Yorkshire, England.	medesh@leeds.ac.uk	Petherick, Emily s/J-9755-2012; Parslow, Roger/AAV-1477-2020; Wright, John/H-1624-2012	Petherick, Emily s/0000-0001-6778-8128; Wright, John/0000-0001-9572-7293; Parslow, Roger/0000-0002-3945-5294	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care programme	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care programme	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care programme.	AHMAD WIU, 1994, J PUBLIC HEALTH MED, V16, P423, DOI 10.1093/oxfordjournals.pubmed.a043023; Bennett Robin L, 2002, J Genet Couns, V11, P97, DOI 10.1023/A:1014593404915; Bittles A. H., 2008, PEDIAT CHILD HLTH, V18, P244, DOI [10.1016/j.paed.2008.02.008, DOI 10.1016/j.paed.2008.02.008]; British Isles Network of Congenital Anomaly Registers, CONG AN STAT 2009 EN; Bromiker R, 2004, CLIN GENET, V66, P63, DOI 10.1111/j.0009-9163.2004.00264.x; Bundey Sarah, 1993, European Journal of Human Genetics, V1, P206; Corrigan N, 2009, BIRTH DEFECTS RES A, V85, P523, DOI 10.1002/bdra.20567; Corry P C, 2002, Community Genet, V5, P201, DOI 10.1159/000066337; Department for Communities and Local Government, 2011, ENGL IND DEPR 2010; Department of Health, 2007, STAT PUBL HLTH ANN R; Devereux G, 2004, ARCH DIS CHILD, V89, P8; EUROCAT, 2005, EUROCAT GUID 1 3 REF; Evans J., 2010, GESTATION SPECIFIC I; Garner S., 2011, POVERTY ETHNICITY PL; Gibb F, RISE MARRIAGES COUSI; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Hamamy H, 2011, GENET MED, V13, P841, DOI 10.1097/GIM.0b013e318217477f; Harlap S, 2008, HUM HERED, V66, P180, DOI 10.1159/000133837; Hollowell J, 2011, SEMIN PERINATOL, V35, P240, DOI 10.1053/j.semperi.2011.02.021; Kelly T, 2011, BRADFORD IS VERY INB; Kurinczuk JJ, 2010, 4 NAT PER EP UN; Macintosh MCM, 2006, BRIT MED J, V333, P177, DOI 10.1136/bmj.38856.692986.AE; Martinez-Frias ML, 2004, BIRTH DEFECTS RES A, V70, P194, DOI 10.1002/bdra.20017; NHS Bradford, 2006, BRADF DISTR INF MORT; Overall ADJ, 2009, HUM HERED, V67, P140, DOI 10.1159/000179561; Qureshi N, 2011, J ROY COLL PHYS EDIN, V41, P194, DOI 10.4997/JRCPE.2011.301; Schwarz K, 2002, EYE, V16, P530, DOI 10.1038/sj.eye.6700059; Stoltenberg C, 1997, AM J EPIDEMIOL, V145, P439; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875; World Health Organization, 2006, GLOB DAT BOD MASS IN; World Health Organization, 2006, DEF DIAGN DIAB MELL; Wright J, 2013, INT J EPIDEMIOL, V42, P978, DOI 10.1093/ije/dys112; Zlotogora J, 2010, AM J MED GENET A, V152A, P2023, DOI 10.1002/ajmg.a.33537; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	35	136	139	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1350	1359		10.1016/S0140-6736(13)61132-0	http://dx.doi.org/10.1016/S0140-6736(13)61132-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	23830354				2022-12-28	WOS:000325975700025
J	Forastiere, F; Agabiti, N				Forastiere, Francesco; Agabiti, Nera			Assessing the link between air pollution and heart failure	LANCET			English	Editorial Material							LONG-TERM EXPOSURE; UPDATE		[Forastiere, Francesco; Agabiti, Nera] Lazio Reg Hlth Serv, Dept Epidemiol, I-00198 Rome, Italy		Forastiere, F (corresponding author), Lazio Reg Hlth Serv, Dept Epidemiol, Via Santa Costanza 53, I-00198 Rome, Italy.	f.forastiere@deplazio.it	Agabiti, Nera/K-1053-2016; Forastiere, Francesco/J-9067-2016	Agabiti, Nera/0000-0003-3385-1197; Forastiere, Francesco/0000-0002-9162-5684				Atkinson RW, 2013, EPIDEMIOLOGY, V24, P44, DOI 10.1097/EDE.0b013e318276ccb8; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brunekreef B, 2012, EUR RESPIR J, V39, P525, DOI 10.1183/09031936.00001112; Colais P, 2012, EPIDEMIOLOGY, V23, P473, DOI 10.1097/EDE.0b013e31824d5a85; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Gullestad L, 2012, CARDIOLOGY, V122, P23, DOI 10.1159/000338166; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Mureddu GF, 2012, EUR J HEART FAIL, V14, P718, DOI 10.1093/eurjhf/hfs052; Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9; Shah ASV, 2013, LANCET; Van Hee VC, 2011, EPIDEMIOLOGY, V22, P773, DOI 10.1097/EDE.0b013e31823061a9; Wold LE, 2012, CIRC-HEART FAIL, V5, P452, DOI 10.1161/CIRCHEARTFAILURE.112.966580	12	16	16	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2013	382	9897					1008	1010		10.1016/S0140-6736(13)61167-8	http://dx.doi.org/10.1016/S0140-6736(13)61167-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222PB	23849323				2022-12-28	WOS:000324742200008
J	Gjelstad, S; Hoye, S; Straand, J; Brekke, M; Dalen, I; Lindbaek, M				Gjelstad, Svein; Hoye, Sigurd; Straand, Jorund; Brekke, Mette; Dalen, Ingvild; Lindbaek, Morten			Improving antibiotic prescribing in acute respiratory tract infections: cluster randomised trial from Norwegian general practice (prescription peer academic detailing (Rx-PAD) study)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; EDUCATIONAL INTERVENTION; SORE THROAT; RESISTANCE; PRACTITIONERS; CONSUMPTION; MACROLIDE; PATTERNS; EUROPE	Objective To assess the effects of a multifaceted educational intervention in Norwegian general practice aiming to reduce antibiotic prescription rates for acute respiratory tract infections and to reduce the use of broad spectrum antibiotics. Design Cluster randomised controlled study. Setting Existing continuing medical education groups were recruited and randomised to intervention or control. Participants 79 groups, comprising 382 general practitioners, completed the interventions and data extractions. Interventions The intervention groups had two visits by peer academic detailers, the first presenting the national clinical guidelines for antibiotic use and recent research evidence on acute respiratory tract infections, the second based on feedback reports on each general practitioner's antibiotic prescribing profile from the preceding year. Regional one day seminars were arranged as a supplement. The control arm received a different intervention targeting prescribing practice for older patients. Main outcome measures Prescription rates and proportion of non-penicillin V antibiotics prescribed at the group level before and after the intervention, compared with corresponding data from the controls. Results In an adjusted, multilevel model, the effect of the intervention on the 39 intervention groups (183 general practitioners) was a reduction (odds ratio 0.72, 95% confidence interval 0.61 to 0.84) in prescribing of antibiotics for acute respiratory tract infections compared with the controls (40 continuing medical education groups with 199 general practitioners). A corresponding reduction was seen in the odds (0.64, 0.49 to 0.82) for prescribing a non-penicillin V antibiotic when an antibiotic was issued. Prescriptions per 1000 listed patients increased from 80.3 to 84.6 in the intervention arm and from 80.9 to 89.0 in the control arm, but this reflects a greater incidence of infections (particularly pneumonia) that needed treating in the intervention arm. Conclusions The intervention led to improved antibiotic prescribing for respiratory tract infections in a representative sample of Norwegian general practitioners, and the courses were feasible to the general practitioners.	[Gjelstad, Svein; Hoye, Sigurd; Straand, Jorund; Brekke, Mette; Dalen, Ingvild; Lindbaek, Morten] Univ Oslo, Inst Hlth & Soc, Dept Gen Practice Family Med, N-0318 Oslo, Norway; [Gjelstad, Svein; Hoye, Sigurd; Lindbaek, Morten] Univ Oslo, Inst Hlth & Soc, Antibiot Ctr Primary Care, N-0318 Oslo, Norway	University of Oslo; University of Oslo	Gjelstad, S (corresponding author), Univ Oslo, Inst Hlth & Soc, Dept Gen Practice Family Med, POB 1130, N-0318 Oslo, Norway.	svein.gjelstad@medisin.uio.no			Norwegian Ministry of Health; Norwegian Medical Association; Research Council of Norway	Norwegian Ministry of Health; Norwegian Medical Association; Research Council of Norway(Research Council of Norway)	The study was carried out with grants from the Norwegian Ministry of Health, the Norwegian Medical Association, and the Research Council of Norway.	Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; [Anonymous], 2000, GUID ANT TREATM GEN; Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; Arroll B, 2005, RESP MED, V99, P255, DOI 10.1016/j.rmed.2004.11.004; Butler CC, 2012, BMJ-BRIT MED J, V344, DOI [10.1136/bmj.d8173, 10.1136/bmj.e682]; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Flottorp S, 2002, BMJ-BRIT MED J, V325, P367, DOI 10.1136/bmj.325.7360.367; Fretheim A, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-5; Frich JC, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-12; Gjelstad S, 2011, J ANTIMICROB CHEMOTH, V66, P2425, DOI 10.1093/jac/dkr295; Gjelstad S, 2009, SCAND J PRIM HEALTH, V27, P208, DOI 10.3109/02813430903438718; Gjelstad S, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-75; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hoye S, BR J GEN PR IN PRESS; Knights S., 1985, REFLECTION TURNING E, P85; LECLERCQ R, 1991, ANTIMICROB AGENTS CH, V35, P1267, DOI 10.1128/AAC.35.7.1267; Lindbaek M, 2002, BRIT J GEN PRACT, V52, P491; Munck AP, 1999, SCAND J PRIM HEALTH, V17, P185; Pinheiro JC, 2006, J COMPUT GRAPH STAT, V15, P58, DOI 10.1198/106186006X96962; Sanders S, 1999, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000219.PUB2; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Smith SM, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD000245.PUB2]; Spurling GKP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004417.pub3; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719; Straand J, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-72; Welschen I, 2004, BRIT MED J, V329, P431, DOI 10.1136/bmj.38182.591238.EB; *WONCA INT CLASS C, 1998, ICPC 2 INT CLASS PRI; Zwart S, 2000, BRIT MED J, V320, P150, DOI 10.1136/bmj.320.7228.150	28	74	74	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2013	347								f4403	10.1136/bmj.f4403	http://dx.doi.org/10.1136/bmj.f4403			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BS	23894178	Green Published, hybrid			2022-12-28	WOS:000322532500002
J	Shah, ASV; Newby, DE; Mills, NL				Shah, Anoop S. V.; Newby, David E.; Mills, Nicholas L.			RATIONAL TESTING High sensitivity cardiac troponin in patients with chest pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MYOCARDIAL-INFARCTION; EARLY-DIAGNOSIS; I ASSAY; T ASSAY		[Shah, Anoop S. V.; Newby, David E.; Mills, Nicholas L.] Univ Edinburgh, British Heart Fdn, Univ Ctr Cardiovasc Sci, Edinburgh EH16 4SU, Midlothian, Scotland	University of Edinburgh	Mills, NL (corresponding author), Univ Edinburgh, British Heart Fdn, Univ Ctr Cardiovasc Sci, Edinburgh EH16 4SU, Midlothian, Scotland.	nick.mills@ed.ac.uk	Newby, David Ernest/AAB-1364-2019	Shah, Anoop/0000-0002-2825-3419; Mills, Nicholas/0000-0003-0533-7991	British Heart Foundation [FS/10/024/28266, SP/12/10/29922] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Apple FS, 2012, CLIN CHEM, V58, P1574, DOI 10.1373/clinchem.2012.192716; Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; Cooper A, 2010, BRIT MED J, V340, pc1118; Fesmire FM, 1998, ANN EMERG MED, V31, P3, DOI 10.1016/S0196-0644(98)70274-4; Keller T, 2011, JAMA-J AM MED ASSOC, V306, P2684, DOI 10.1001/jama.2011.1896; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Mills NL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1533; Mills NL, 2011, JAMA-J AM MED ASSOC, V305, P1210, DOI 10.1001/jama.2011.338; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Thygesen K, 2012, EUR HEART J, V33, P2252, DOI 10.1093/eurheartj/ehs154; Twerenbold R, 2012, EUR HEART J, V33, P579, DOI 10.1093/eurheartj/ehr492	14	23	23	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2013	347								f4222	10.1136/bmj.f4222	http://dx.doi.org/10.1136/bmj.f4222			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192XV	23878152				2022-12-28	WOS:000322522200002
J	Song, SJ; Poliseno, L; Song, MS; Ala, U; Webster, K; Ng, C; Beringer, G; Brikbak, NJ; Yuan, X; Cantley, LC; Richardson, AL; Pandolfi, PP				Song, Su Jung; Poliseno, Laura; Song, Min Sup; Ala, Ugo; Webster, Kaitlyn; Ng, Christopher; Beringer, Gary; Brikbak, Nicolai J.; Yuan, Xin; Cantley, Lewis C.; Richardson, Andrea L.; Pandolfi, Pier Paolo			MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling	CELL			English	Article							ESTROGEN-RECEPTOR-ALPHA; MESENCHYMAL TRANSITION; 5-HYDROXYMETHYLCYTOSINE CONTENT; EPITHELIAL PHENOTYPE; DOWN-REGULATION; MIR-200 FAMILY; MESSENGER-RNA; HUMAN GENES; TGF-BETA; CELLS	Tumor cells metastasize to distant organs through genetic and epigenetic alterations, including changes in microRNA (miR) expression. Here we find miR-22 triggers epithelial-mesenchymal transition (EMT), enhances invasiveness and promotes metastasis in mouse xenografts. In a conditional mammary gland-specific transgenic (TG) mouse model, we show that miR-22 enhances mammary gland side-branching, expands the stem cell compartment, and promotes tumor development. Critically, miR-22 promotes aggressive metastatic disease in MMTV-miR-22 TG mice, as well as compound MMTV-neu or -PyVT-miR-22 TG mice. We demonstrate that miR-22 exerts its metastatic potential by silencing antimetastatic miR-200 through direct targeting of the TET (Ten eleven translocation) family of methylcytosine dioxygenases, thereby inhibiting demethylation of the mir-200 promoter. Finally, we show that miR-22 overexpression correlates with poor clinical outcomes and silencing of the TET-miR-200 axis in patients. Taken together, our findings implicate miR-22 as a crucial epigenetic modifier and promoter of EMT and breast cancer stemness toward metastasis.	[Song, Su Jung; Poliseno, Laura; Song, Min Sup; Ala, Ugo; Webster, Kaitlyn; Ng, Christopher; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Genet Program,Div Genet,Dept Med & Pathol, Boston, MA 02115 USA; [Ng, Christopher; Cantley, Lewis C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct,Dept Med, Boston, MA 02115 USA; [Yuan, Xin] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Hematol Oncol Div,Dept Med, Boston, MA 02115 USA; [Beringer, Gary; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Brikbak, Nicolai J.; Richardson, Andrea L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Genet Program,Div Genet,Dept Med & Pathol, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu	Cantley, Lewis C/D-1800-2014; Ala, Ugo/K-2029-2016; Poliseno, Laura/B-5711-2012	Cantley, Lewis C/0000-0002-1298-7653; Ala, Ugo/0000-0001-5408-6397; Pandolfi, Pier Paolo/0000-0002-5352-5295; Webster, Kaitlyn/0000-0001-9902-0500; Poliseno, Laura/0000-0001-6557-955X; Ng, Christopher/0000-0001-8815-7958; Birkbak, Nicolai/0000-0003-1613-9587	NIH [CA 082328-14]; NATIONAL CANCER INSTITUTE [R01CA082328] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to all members of the Pandolfi lab and in particular to Keisuke Ito and Leonardo Salmena for advice and discussion. We thank Thomas Garvey for critical editing of the manuscript as well as Yvonne Tay, Luo Man-Lee, April Greene-Colozzi, and Soon Jung Kim for experimental and technical support. This work was supported by NIH grant CA 082328-14 awarded to P.P.P.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Haffner MC, 2011, ONCOTARGET, V2, P627; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Ito K, 2009, CURR OPIN GENET DEV, V19, P51, DOI 10.1016/j.gde.2009.01.004; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jackson-Fisher AJ, 2004, P NATL ACAD SCI USA, V101, P17138, DOI 10.1073/pnas.0407057101; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; Ling B, 2012, J CANCER RES CLIN, V138, P1355, DOI 10.1007/s00432-012-1194-2; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MCCARTHY JB, 1985, CANCER METAST REV, V4, P125, DOI 10.1007/BF00050692; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shorning BY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016209; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Song SJ, 2013, CELL STEM CELL, V13, P87, DOI 10.1016/j.stem.2013.06.003; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Vuoristo M, 2007, MELANOMA RES, V17, P215, DOI 10.1097/CMR.0b013e328270b935; Wang T, 2012, INT J BIOCHEM CELL B, V44, P366, DOI 10.1016/j.biocel.2011.11.012; Withana NP, 2012, CANCER RES, V72, P1199, DOI 10.1158/0008-5472.CAN-11-2759; Xiong JH, 2010, FEBS J, V277, P1684, DOI 10.1111/j.1742-4658.2010.07594.x; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Yoshimoto N, 2011, BREAST CANCER RES TR, V130, P331, DOI 10.1007/s10549-011-1672-2	60	345	358	1	92	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					311	324		10.1016/j.cell.2013.06.026	http://dx.doi.org/10.1016/j.cell.2013.06.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23830207	Bronze, Green Accepted			2022-12-28	WOS:000321950700009
J	Lapi, F; Azoulay, L; Niazi, T; Yin, H; Benayoun, S; Suissa, S				Lapi, Francesco; Azoulay, Laurent; Niazi, Tamim; Yin, Hui; Benayoun, Serge; Suissa, Samy			Androgen Deprivation Therapy and Risk of Acute Kidney Injury in Patients With Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRACTICE RESEARCH DATABASE; ACUTE-RENAL-FAILURE; SERUM TESTOSTERONE; HORMONE AGONIST; MORTALITY; VALIDITY; TIME; CESSATION; DISEASE; OBESITY	IMPORTANCE The use of androgen deprivation therapy (ADT) in the treatment of advanced prostate cancer has been shown to delay the clinical progression of the disease. However, the testosterone suppression associated with this therapy may lead to a hypogonadal condition that can have detrimental effects on renal function, thus raising the hypothesis that ADT-induced hypogonadism could potentially lead to acute kidney injury (AKI). OBJECTIVE To determine whether the use of ADT is associated with an increased risk of AKI in patients newly diagnosed with prostate cancer. DESIGN AND SETTING A nested case-control analysis using medical information extracted from the UK Clinical Practice Research Datalink linked to the Hospital Episodes Statistics database. PARTICIPANTS Men newly diagnosed with nonmetastatic prostate cancer between January 1, 1997, and December 31, 2008, were selected and followed up until December 31, 2009. Cases were patients with incident AKI during follow-up who were randomly matched with up to 20 controls on age, calendar year of prostate cancer diagnosis, and duration of follow-up. MAIN OUTCOMES AND MEASURES Conditional logistic regression was used to estimate odds ratios (ORs) with 95% CIs of AKI associated with the use of ADT. ADT was categorized into 1 of 6 mutually exclusive groups: gonadotropin-releasing hormone agonists, oral antiandrogens, combined androgen blockade, bilateral orchiectomy, estrogens, and combination of the above. RESULTS A total of 10 250 patients met the study inclusion criteria. During a mean follow-up of 4.1 (SD, 2.9) years, 232 incident cases of AKI were identified (rate, 5.5/1000 person-years). Overall, current use of any ADT was associated with an increased risk of AKI when compared with never use (OR, 2.48 [95% CI, 1.61-3.82]), generating a rate difference of 4.43/1000 persons per year (95% CI, 1.54-7.33). This association was mainly driven by a combined androgen blockade consisting of gonadotropin-releasing hormone agonists with oral antiandrogens (OR, 4.50 [95% CI, 2.61-7.78]), estrogens (OR, 4.00 [95% CI, 1.06-15.03]), other combination therapies (OR, 4.04 [95% CI, 1.88-8.69]), and gonadotropin-releasing hormone agonists (OR, 1.93 [95% CI, 1.20-3.10]). CONCLUSIONS AND RELEVANCE In a cohort of patients with newly diagnosed nonmetastatic prostate cancer, the use of ADT was significantly associated with an increased risk of AKI. These findings require replication in other well-designed studies as well as further investigation of their clinical importance.	[Lapi, Francesco; Azoulay, Laurent; Yin, Hui; Suissa, Samy] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Lapi, Francesco; Suissa, Samy] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Lapi, Francesco] Univ Florence, Dept Preclin & Clin Pharmacol, Florence, Italy; [Azoulay, Laurent] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Niazi, Tamim] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Dept Oncol,Div Radiat Oncol, Montreal, PQ H3T 1E2, Canada; [Benayoun, Serge] Hop Maison Neuve Rosemont, Dept Surg, Serv Urol, Montreal, PQ H1T 2M4, Canada	Lady Davis Institute; McGill University; McGill University; University of Florence; McGill University; McGill University; Universite de Montreal	Suissa, S (corresponding author), McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, 3755 Cote St Catherine, Montreal, PQ H3T 1E2, Canada.	samy.suissa@mcgill.ca	Azoulay, Laurent/Z-4421-2019	Azoulay, Laurent/0000-0001-5162-3556	Canadian Institutes of Health Research; Fonds de recherche en sante du Quebec; Prostate Cancer Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Prostate Cancer Canada	Dr Lapi was the recipient of a Canadian Institutes of Health Research Postdoctoral Research Award. Dr Azoulay is the recipient of a Chercheur-Boursier Award from the Fonds de recherche en sante du Quebec. Dr Suissa is the recipient of the James McGill Chair. The data in this study were acquired with a grant from Prostate Cancer Canada.	Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Altiparmak MR, 2002, MED ONCOL, V19, P117, DOI 10.1385/MO:19:2:117; Azoulay L, 2011, EUR UROL, V60, P1244, DOI 10.1016/j.eururo.2011.08.041; Basaria S, 2008, J ANDROL, V29, P534, DOI 10.2164/jandrol.108.005454; Billings FT, 2012, J AM SOC NEPHROL, V23, P1221, DOI 10.1681/ASN.2011090940; Billings FT, 2011, FREE RADICAL BIO MED, V50, P1480, DOI 10.1016/j.freeradbiomed.2011.02.011; Bong GW, 2008, UROLOGY, V71, P1177, DOI 10.1016/j.urology.2007.09.066; Braga-Basaria M, 2006, INT J IMPOT RES, V18, P494, DOI 10.1038/sj.ijir.3901471; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; Cooperberg MR, 2009, JNCI-J NATL CANCER I, V101, P878, DOI 10.1093/jnci/djp122; Cooperberg MR, 2003, J NATL CANCER I, V95, P981, DOI 10.1093/jnci/95.13.981; Essebag V, 2003, AM HEART J, V146, P581, DOI 10.1016/S0002-8703(03)00512-X; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hsiao PG, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.05.003; Hutchens MP, 2012, AM J PHYSIOL-RENAL, V303, pF377, DOI 10.1152/ajprenal.00354.2011; Kaku H, 2006, PROSTATE, V66, P439, DOI 10.1002/pros.20341; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Khatri M, J STROKE CEREBROVASC; Loboz KK, 2005, BRIT J CLIN PHARMACO, V59, P239, DOI 10.1111/j.0306-5251.2004.2188.x; Manabe Y, 2009, NEUROL INT, V1, P1, DOI 10.4081/ni.2009.e1; Molinari C, 2002, J PHYSIOL-LONDON, V543, P365, DOI 10.1113/jphysiol.2002.022756; PAUL AB, 1994, BRIT J UROL, V74, P642, DOI 10.1111/j.1464-410X.1994.tb09198.x; Perlmutter Mark A, 2007, Rev Urol, V9 Suppl 1, pS3; Quality and Outcomes Framework, 2009, QUAL OUTC FRAM; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Shahinian VB, 2005, CANCER-AM CANCER SOC, V103, P1615, DOI 10.1002/cncr.20955; Suissa S, 2007, NAT CLIN PRACT RHEUM, V3, P725, DOI 10.1038/ncprheum0652; Suissa S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P811; Vlasschaert MEO, 2011, AM J KIDNEY DIS, V57, P29, DOI 10.1053/j.ajkd.2010.08.031; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; Ympa YP, 2005, AM J MED, V118, P827, DOI 10.1016/j.amjmed.2005.01.069	35	74	75	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					289	296		10.1001/jama.2013.8638	http://dx.doi.org/10.1001/jama.2013.8638			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23860987	Bronze			2022-12-28	WOS:000321835700016
J	Reece, EA; Brown, AG; Sharfstein, JM				Reece, E. Albert; Brown, Anthony G.; Sharfstein, Joshua M.			New Incentive-Based Programs Maryland's Health Disparities Initiatives	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Reece, E. Albert] Univ Maryland, Sch Med, Off Dean, Baltimore, MD 21201 USA; [Brown, Anthony G.] Off Lieutenant Governor, Annapolis, MD USA; [Sharfstein, Joshua M.] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; Maryland Department of Health & Mental Hygiene	Reece, EA (corresponding author), Univ Maryland, Sch Med, Off Dean, 655 W Baltimore St,Room 14-029, Baltimore, MD 21201 USA.	deanmed@som.umaryland.edu						Agency for Healthcare Research and Quality (AHRQ), 2011, 2010 NATIONAL HEALTH, V11-0005; [Anonymous], LT GOV BROWN ANNOUNC; Centers for Disease Control and Prevention, 2011, CDC HEALTH DISPARITI; Department of Housing and Urban Development, 2005, SPOTLIGHT ON RESULTS; Dobbie W, 2009, NATIONAL BUREAU OF E; Health Disparities Work group Maryland Health Care Quality and Cost Council, 2012, HEALTH DISPARITIES W; Maryland Health Services Cost Review Commission, COMPLICATIONS MARYLA	7	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					259	260		10.1001/jama.2013.7236	http://dx.doi.org/10.1001/jama.2013.7236			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23860982				2022-12-28	WOS:000321835700008
J	Vazquez, S; Rondina, MT				Vazquez, Sara; Rondina, Matthew T.			Apixaban reduced stroke or systemic embolism in AF more than warfarin regardless of type or duration of AF	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Vazquez, Sara; Rondina, Matthew T.] Univ Utah, Univ Healthcare Thrombosis Serv, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Vazquez, S (corresponding author), Univ Utah, Univ Healthcare Thrombosis Serv, Salt Lake City, UT 84112 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL092161] Funding Source: NIH RePORTER; NHLBI NIH HHS [K23 HL092161] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ageno W, 2013, J THROMB HAEMOST, V11, P151, DOI [10.1111/jth.12234, 10.1111/jth.12038]; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2							JC8	10.7326/0003-4819-159-2-201307160-02008	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23856706				2022-12-28	WOS:000322112000007
J	Bentley, WE; Payne, GF				Bentley, William E.; Payne, Gregory F.			Nature's Other Self-Assemblers	SCIENCE			English	Editorial Material									[Bentley, William E.] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Bentley, WE (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 5115 Plant Sci Bldg, College Pk, MD 20742 USA.	gpayne@umd.edu						Bothma JP, 2008, ADV MATER, V20, P3539, DOI 10.1002/adma.200703141; d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786; Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581; Dreyer DR, 2012, LANGMUIR, V28, P6428, DOI 10.1021/la204831b; Ejima H, 2013, SCIENCE, V341, P154, DOI 10.1126/science.1237265; Kim E, 2013, ACS CHEM BIOL, V8, P716, DOI 10.1021/cb300605s; Kozlovskaya V, 2010, SOFT MATTER, V6, P3596, DOI 10.1039/b927369g; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; MCGINNESS J, 1974, SCIENCE, V183, P853, DOI 10.1126/science.183.4127.853; Page SE, 2012, ENVIRON SCI TECHNOL, V46, P1590, DOI 10.1021/es203836f; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Sedo J, 2013, ADV MATER, V25, P653, DOI 10.1002/adma.201202343; Simon JD, 2010, ACCOUNTS CHEM RES, V43, P1452, DOI 10.1021/ar100079y; Squadrito GL, 2001, FREE RADICAL BIO MED, V31, P1132, DOI 10.1016/S0891-5849(01)00703-1; WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038	15	47	48	2	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2013	341	6142					136	137		10.1126/science.1241562	http://dx.doi.org/10.1126/science.1241562			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23846896				2022-12-28	WOS:000321965300028
J							Drug Therapeutics Bulletin	Management of infantile colic	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SPINAL MANIPULATION; BLIND; ACUPUNCTURE; CHILDREN; MASSAGE; FORMULA; TRIAL; CARE		Drug & Therapeut Bulletin Editorial Off, London WC1H 9JR, England		Drug & Therapeut Bulletin Editorial Off, London WC1H 9JR, England.							Alcantara J, 2011, EXPLORE-NY, V7, P168, DOI [10.1016/j.explore.2011.02.00, 10.1016/j.explore.2011.02.002]; Arikan D, 2008, J CLIN NURS, V17, P1754, DOI 10.1111/j.1365-2702.2007.02093.x; Bolte RG, 1992, EMERGEN MED, P1810; Catherine NLA, 2008, J DEV BEHAV PEDIATR, V29, P508, DOI 10.1097/DBP.0b013e31818d0c0c; Cetinkaya B, 2012, INT J NURS PRACT, V18, P164, DOI 10.1111/j.1440-172X.2012.02015.x; Cohen-Silver J, 2009, CLIN PEDIATR, V48, P14, DOI 10.1177/0009922808323116; Critch JN, 2011, PAED CHILD HEALT-CAN, V16, P47, DOI 10.1093/pch/16.1.47; Dupont C, 2010, EUR J CLIN NUTR, V64, P765, DOI 10.1038/ejcn.2010.81; Ernst E, 2009, INT J CLIN PRACT, V63, P1351, DOI 10.1111/j.1742-1241.2009.02133.x; Ferrance Randy J, 2010, Chiropr Osteopat, V18, P14, DOI 10.1186/1746-1340-18-14; Hall B, 2012, J PAEDIATR CHILD H, V48, P128, DOI 10.1111/j.1440-1754.2011.02061.x; Iacovou M, 2012, MATERN CHILD HLTH J, V16, P1319, DOI 10.1007/s10995-011-0842-5; JONES W, 2012, PHARM J, V289, P128; Kaley F, 2011, INFANT MENT HEALTH J, V32, P526, DOI 10.1002/imhj.20308; Landgren K, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-93; Landgren K, 2010, ACUPUNCT MED, V28, P174, DOI 10.1136/aim.2010.002394; Lucassen PLBJ, 1998, BMJ-BRIT MED J, V316, P1563, DOI 10.1136/bmj.316.7144.1563; Map of Medicine, 2011, INF COL; National Collaborating Centre for Primary Care (UK), 2006, POSTN CAR ROUT POSTN; Newnham CA, 2009, INFANT BEHAV DEV, V32, P17, DOI 10.1016/j.infbeh.2008.09.004; NHS Evidence Clinical Knowledge Summaries, 2011, INF COL; Perry R, 2011, PEDIATRICS, V127, P720, DOI 10.1542/peds.2010-2098; Posadzki P, 2012, FOCUS ALTERN COMPLEM, V17, P22; Posadzki P, 2011, NEW ZEAL MED J, V124, P55; Reinthal M, 2008, ACUPUNCT MED, V26, P171, DOI 10.1136/aim.26.3.171; Roberts DM, 2004, AM FAM PHYSICIAN, V70, P735; Salisbury AL, 2012, INFANT MENT HEALTH J, V33, P110, DOI 10.1002/imhj.20340; Savino F, 2010, CURR OPIN PEDIATR, V22, P791, DOI 10.1097/MOP.0b013e32833fac24; Savino F, 2010, PEDIATRICS, V126, pE526, DOI 10.1542/peds.2010-0433; Scientific Advice Committee on Nutrition, 2003, SOYA BAS INF FORM; van Sleuwen BE, 2007, PEDIATRICS, V120, pe1097, DOI 10.1542/peds.2006-2083; Wade S, 2001, BMJ-BRIT MED J, V323, P437, DOI 10.1136/bmj.323.7310.437; WESSEL MA, 1954, PEDIATRICS, V14, P421	33	15	17	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2013	347								f4102	10.1136/bmj.f4102	http://dx.doi.org/10.1136/bmj.f4102			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184MC	23843563				2022-12-28	WOS:000321893000005
J	Man, XY; Zheng, M				Man, Xiao-Yong; Zheng, Min			Generalized Cutaneous Papules and Nodules in an Asian Man	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ROSAI-DORFMAN-DISEASE; MASSIVE LYMPHADENOPATHY; SINUS HISTIOCYTOSIS; ENTITY		[Man, Xiao-Yong; Zheng, Min] Zhejiang Univ, Sch Med, Dept Dermatol, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China	Zhejiang University	Zheng, M (corresponding author), Zhejiang Univ, Sch Med, Dept Dermatol, Affiliated Hosp 2, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	minz@zju.edu.cn						[Anonymous], RASAI DORFMAN DISEAS; Burn T, 2010, ROOKS TEXTBOOK OF DE; Chan CC, 2006, ARCH DERMATOL, V142, P428, DOI 10.1001/archderm.142.4.428; FOUCAR E, 1990, SEMIN DIAGN PATHOL, V7, P19; Lu CI, 2004, J AM ACAD DERMATOL, V51, P931, DOI 10.1016/j.jaad.2004.04.030; Overholtzer M, 2008, NAT REV MOL CELL BIO, V9, P796, DOI 10.1038/nrm2504; PAULLI M, 1992, HUM PATHOL, V23, P647, DOI 10.1016/0046-8177(92)90320-3; ROSAI J, 1969, ARCH PATHOL, V87, P63; Satter EK, 2003, BRIT J DERMATOL, V149, P672, DOI 10.1046/j.1365-2133.2003.05499.x	9	2	2	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					199	200		10.1001/jama.2013.8058	http://dx.doi.org/10.1001/jama.2013.8058			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23839754				2022-12-28	WOS:000321511500019
J	Cahn, P; Pozniak, AL; Mingrone, H; Shuldyakov, A; Brites, C; Andrade-Villanueva, JF; Richmond, G; Buendia, CB; Fourie, J; Ramgopal, M; Hagins, D; Felizarta, F; Madruga, J; Reuter, T; Newman, T; Small, CB; Lombaard, J; Grinsztejn, B; Dorey, D; Underwood, M; Griffith, S; Min, S				Cahn, Pedro; Pozniak, Anton L.; Mingrone, Horacio; Shuldyakov, Andrey; Brites, Carlos; Andrade-Villanueva, Jaime F.; Richmond, Gary; Beltran Buendia, Carlos; Fourie, Jan; Ramgopal, Moti; Hagins, Debbie; Felizarta, Franco; Madruga, Jose; Reuter, Tania; Newman, Tamara; Small, Catherine B.; Lombaard, John; Grinsztejn, Beatriz; Dorey, David; Underwood, Mark; Griffith, Sandy; Min, Sherene		Extended SAILING Study Team	Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study	LANCET			English	Article							CO-FORMULATED ELVITEGRAVIR; INITIAL TREATMENT; CROSS-RESISTANCE; PHASE-II; INFECTION; TRIAL; PHARMACOKINETICS; EMTRICITABINE; COBICISTAT; EFAVIRENZ	Background Dolutegravir (GSK1349572), a once-daily HIV integrase inhibitor, has shown potent antiviral response and a favourable safety profile. We evaluated safety, efficacy, and emergent resistance in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV-1 with at least two-class drug resistance. Methods ING111762 (SAILING) is a 48 week, phase 3, randomised, double-blind, active-controlled, non-inferiority study that began in October, 2010. Eligible patients had two consecutive plasma HIV-1 RNA assessments of 400 copies per mL or higher (unless >1000 copies per mL at screening), resistance to two or more classes of antiretroviral drugs, and had one to two fully active drugs for background therapy. Participants were randomly assigned (1: 1) to once-daily dolutegravir 50 mg or twice-daily raltegravir 400 mg, with investigator-selected background therapy. Matching placebo was given, and study sites were masked to treatment assignment. The primary endpoint was the proportion of patients with plasma HIV-1 RNA less than 50 copies per mL at week 48, evaluated in all participants randomly assigned to treatment groups who received at least one dose of study drug, excluding participants at one site with violations of good clinical practice. Non-inferiority was prespecified with a 12% margin; if non-inferiority was established, then superiority would be tested per a prespecified sequential testing procedure. A key prespecified secondary endpoint was the proportion of patients with treatment-emergent integrase-inhibitor resistance. The trial is registered at ClinicalTrials.gov, NCT01231516. Findings Analysis included 715 patients (354 dolutegravir; 361 raltegravir). At week 48, 251 (71%) patients on dolutegravir had HIV-1 RNA less than 50 copies per mL versus 230 (64%) patients on raltegravir (adjusted difference 7.4%, 95% CI 0.7 to 14.2); superiority of dolutegravir versus raltegravir was then concluded (p=0.03). Significantly fewer patients had virological failure with treatment-emergent integrase-inhibitor resistance on dolutegravir (four vs 17 patients; adjusted difference -3.7%, 95% CI -6.1 to -1.2; p=0.003). Adverse event frequencies were similar across groups; the most commonly reported events for dolutegravir versus raltegravir were diarrhoea (71 [20%] vs 64 [18%] patients), upper respiratory tract infection (38 [11%] vs 29 [8%]), and headache (33 [9%] vs 31 [9%]). Safety events leading to discontinuation were infrequent in both groups (nine [3%] dolutegravir, 14 [4%] raltegravir). Interpretation Once-daily dolutegravir, in combination with up to two other antiretroviral drugs, is well tolerated with greater virological effect compared with twice-daily raltegravir in this treatment-experienced patient group.	[Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Pozniak, Anton L.] Chelsea & Westminster Hosp NHS Fdn Trust, London, England; [Mingrone, Horacio] Fdn IDEAA, Buenos Aires, DF, Argentina; [Shuldyakov, Andrey] Saratov Reg Ctr Prophylact AIDS, Saratov, Russia; [Brites, Carlos] Univ Fed Bahia, Complexo Hosp Prof Edgard Santos, Salvador, BA, Brazil; [Andrade-Villanueva, Jaime F.] Univ Guadalajara, Fray Antonio Alcalde CUCS, Hosp Civil Guadalajara, Guadalajara 44430, Jalisco, Mexico; [Richmond, Gary] Broward Hlth Med Ctr, Ft Lauderdale, FL USA; [Beltran Buendia, Carlos] Hosp Barros Luco, Santiago, Chile; [Fourie, Jan] Fourie Med Ctr, Dundee, South Africa; [Ramgopal, Moti] Midway Immunol & Res Ctr, Ft Pierce, FL USA; [Hagins, Debbie] Chatham CARE Ctr, Savannah, GA USA; [Madruga, Jose] Ctr Referencia & Treinamento DST AIDS, Sao Paulo, Brazil; [Reuter, Tania] Univ Fed Espirito Santo, Vitoria, Brazil; [Newman, Tamara] Inst Infectol Emilio Ribas, Sao Paulo, Brazil; [Small, Catherine B.] New York Med Coll, Valhalla, NY 10595 USA; [Lombaard, John] JOSHA Res, Bloemfontein, South Africa; [Grinsztejn, Beatriz] Inst Pesquisa Clin Evandro Chagas Fiocruz, Rio De Janeiro, Brazil; [Dorey, David] GlaxoSmithKline, Mississauga, ON, Canada; [Underwood, Mark; Griffith, Sandy; Min, Sherene] GlaxoSmithKline, Res Triangle Pk, NC USA	Imperial College London; Universidade Federal da Bahia; Universidad de Guadalajara; Universidad de Chile; Universidade Federal do Espirito Santo; New York Medical College; Fundacao Oswaldo Cruz; GlaxoSmithKline; GlaxoSmithKline	Cahn, P (corresponding author), Fdn Huesped, C1202ABB, Buenos Aires, DF, Argentina.	pcahn@huesped.org.ar	Streinu-Cercel, Adrian/M-5835-2017; Brites, Carlos/D-1353-2013; Shuldyakov, Andrey/U-5598-2017; Rugina, Sorin/U-5168-2019; Andrade-Villanueva, Jaime Federico/GPK-6845-2022	Streinu-Cercel, Adrian/0000-0001-6382-5067; Brites, Carlos/0000-0002-4673-6991; Shuldyakov, Andrey/0000-0002-3009-9262; Griffith, Sandy/0000-0002-3430-5131; Moutschen, Michel/0000-0002-6405-1785; Kozal, Michael/0000-0002-3100-8254; Ribera, Esteban/0000-0002-3752-8808; Andrade-Villanueva, Jaime Federico/0000-0003-1948-655X; REUTER, TANIA/0000-0003-2176-5603; Meier, Jeffery/0000-0001-9491-1697; Underwood, Mark/0000-0002-6803-2346	ViiV Healthcare	ViiV Healthcare	ViiV Healthcare.	Committee for Medicinal Products for Human Use (CHMP), 2007, GUID CLIN D IN PRESS; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; Eron JJ, 2011, LANCET INFECT DIS, V11, P907, DOI 10.1016/S1473-3099(11)70196-7; Garrido C, 2012, ANTIMICROB AGENTS CH, V56, P2873, DOI 10.1128/AAC.06170-11; German P, 2010, JAIDS-J ACQ IMM DEF, V55, P323, DOI 10.1097/QAI.0b013e3181eb376b; Hazuda DJ, 2007, ANTIVIR THER, V12, pS10; Hightower KE, 2011, ANTIMICROB AGENTS CH, V55, P4552, DOI 10.1128/AAC.00157-11; KASTRUP J, 1985, BRIT J UROL, V57, P265, DOI 10.1111/j.1464-410X.1985.tb06340.x; Koteff J, 2013, BRIT J CLIN PHARMACO, V75, P990, DOI 10.1111/j.1365-2125.2012.04440.x; Lennox JL, 2010, JAIDS-J ACQ IMM DEF, V55, P39, DOI 10.1097/QAI.0b013e3181da1287; Lepist E, 2011, 51 INT C ANT AG CHEM; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Margot NA, 2012, ANTIVIR RES, V93, P288, DOI 10.1016/j.antiviral.2011.12.008; McColl DJ, 2007, ANTIVIR THER, V12, pS11; Mesplede T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-22; Min S, 2010, ANTIMICROB AGENTS CH, V54, P254, DOI 10.1128/AAC.00842-09; Molina JM, 2012, LANCET INFECT DIS, V12, P27, DOI 10.1016/S1473-3099(11)70249-3; Nichols G, 2012, 11 INT C DRUG THER H; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9; Smith F, 2011, DRUG INF J, V45, P291, DOI 10.1177/009286151104500309; Song I, 2012, REV ANTIVIR THER INF, V3, P9; Song I, 2011, ANTIMICROB AGENTS CH, V55, P3517, DOI 10.1128/AAC.00073-11; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; [US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER)], 2001, ICH GUID IND E 10 CH; Walmsley S, 2012, 52 INT C ANT AG CHEM; [No title captured]	28	390	399	1	65	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 24	2013	382	9893					700	708		10.1016/S0140-6736(13)61221-0	http://dx.doi.org/10.1016/S0140-6736(13)61221-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206SI	23830355				2022-12-28	WOS:000323542400028
J	de Bakker, MAG; Fowler, DA; den Oude, K; Dondorp, EM; Navas, MCG; Horbanczuk, JO; Sire, JY; Szczerbinska, D; Richardson, MK				de Bakker, Merijn A. G.; Fowler, Donald A.; den Oude, Kelly; Dondorp, Esther M.; Navas, M. Carmen Garrido; Horbanczuk, Jaroslaw O.; Sire, Jean-Yves; Szczerbinska, Danuta; Richardson, Michael K.			Digit loss in archosaur evolution and the interplay between selection and constraints	NATURE			English	Article							SONIC HEDGEHOG; DROMAIUS-NOVAEHOLLANDIAE; DEVELOPMENTAL BASIS; LIMB BUD; BIRDS; REDUCTION; PATTERN; LOCOMOTION; GENES; SIZE	Evolution involves interplay between natural selection and developmental constraints(1-3). This is seen, for example, when digits are lost from the limbs during evolution(1,3,4). Extant archosaurs (crocodiles and birds) show several instances of digit loss(3,5,6) under different selective regimes, and show limbs with one, two, three, four or the ancestral number of five digits. The 'lost' digits sometimes persist for millions of years as developmental vestiges(7-10). Here we examine digit loss in the Nile crocodile and five birds, using markers of three successive stages of digit development. In two independent lineages under different selection, wing digit I and all its markers disappear. In contrast, hindlimb digit V persists in all species sampled, both as cartilage, and as Sox9-expressing precartilage domains, 250 million years after the adult digit disappeared. There is therefore a mismatch between evolution of the embryonic and adult phenotypes. All limbs, regardless of digit number, showed similar expression of sonic hedgehog (Shh). Even in the one-fingered emu wing, expression of posterior genes Hoxd11 and Hoxd12 was conserved, whereas expression of anterior genes Gli3 and Alx4 was not. We suggest that the persistence of digit V in the embryo may reflect constraints, particularly the conserved posterior gene networks associated with the zone of polarizing activity (ZPA(11)). The more rapid and complete disappearance of digit I may reflect its ZPA-independent specification, and hence, weaker developmental constraints. Interacting with these constraints are selection pressures for limb functions such as flying and perching. This model may help to explain the diverse patterns of digit loss in tetrapods. Our study may also help to understand how selection on adults leads to changes in development.	[de Bakker, Merijn A. G.; Fowler, Donald A.; den Oude, Kelly; Dondorp, Esther M.; Navas, M. Carmen Garrido; Richardson, Michael K.] Leiden Univ, Inst Biol, Dept Integrat Zool, Sylvius Lab, NL-2333 BE Leiden, Netherlands; [Horbanczuk, Jaroslaw O.] Polish Acad Sci, Inst Genet & Anim Breeding, PL-05552 Jastrzebiec, Poland; [Sire, Jean-Yves] Univ Paris 06, UMR 7138, F-75005 Paris, France; [Szczerbinska, Danuta] Western Pomeranian Univ Technol, Dept Poultry & Ornamental Bird Breeding, PL-71466 Szczecin, Poland	Leiden University; Leiden University - Excl LUMC; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; West Pomeranian University of Technology	Richardson, MK (corresponding author), Leiden Univ, Inst Biol, Dept Integrat Zool, Sylvius Lab, Sylviusweg 72, NL-2333 BE Leiden, Netherlands.	m.k.richardson@biology.leidenuniv.nl	Navas, M. Carmen Garrido/A-9173-2019; Garrido Navas, M. Carmen/N-1004-2017; Horbanczuk, Jaroslaw/ABD-8389-2021; Szczerbińska, Danuta/J-5734-2016	Navas, M. Carmen Garrido/0000-0002-3965-0663; Garrido Navas, M. Carmen/0000-0002-3965-0663; Horbanczuk, Jaroslaw Olav/0000-0002-7561-0941; de Bakker, Merijn/0000-0002-2061-7986				Abourachid A, 2000, IBIS, V142, P538, DOI 10.1111/j.1474-919X.2000.tb04455.x; ALBERCH P, 1983, J EMBRYOL EXP MORPH, V76, P177; ALBERCH P, 1985, EVOLUTION, V39, P8, DOI 10.1111/j.1558-5646.1985.tb04076.x; Crumly CR, 2004, J EXP ZOOL PART B, V302B, P134, DOI 10.1002/jez.b.20010; Feduccia A, 2002, NATURWISSENSCHAFTEN, V89, P391, DOI 10.1007/s00114-002-0350-y; Gillis JA, 2009, P NATL ACAD SCI USA, V106, P5720, DOI 10.1073/pnas.0810959106; Haddrath O, 2012, P ROY SOC B-BIOL SCI, V279, P4617, DOI 10.1098/rspb.2012.1630; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harfe BD, 2011, DEV DYNAM, V240, P915, DOI 10.1002/dvdy.22597; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Kundrat M, 2009, J EXP ZOOL PART B, V312B, P30, DOI 10.1002/jez.b.21240; Larsson HCE, 2002, J EXP ZOOL, V294, P146, DOI 10.1002/jez.10153; Lorda-Diez CI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024546; Maxwell EE, 2007, J MORPHOL, V268, P423, DOI 10.1002/jmor.10527; Middleton KM, 2001, J MORPHOL, V250, P51, DOI 10.1002/jmor.1058; Muller G. B., 1990, J MORPHOL, V203, P151; Nagai H, 2011, DEV DYNAM, V240, P162, DOI 10.1002/dvdy.22520; Pagan SM, 1996, DEV BIOL, V180, P35, DOI 10.1006/dbio.1996.0282; Richardson M, 2012, CLONE BONE SYNERGY M, P328; Richardson MK, 2003, J EXP ZOOL PART B, V296B, P8, DOI 10.1002/jez.b.00013; Richardson MK, 1999, BIOESSAYS, V21, P604, DOI 10.1002/(SICI)1521-1878(199907)21:7<604::AID-BIES9>3.0.CO;2-U; Schaller NU, 2011, J EXP BIOL, V214, P1123, DOI 10.1242/jeb.043596; Scherz PJ, 2007, DEV BIOL, V308, P343, DOI 10.1016/j.ydbio.2007.05.030; Sears KE, 2011, EVOL DEV, V13, P533, DOI 10.1111/j.1525-142X.2011.00509.x; Shapiro MD, 2003, J EXP ZOOL PART B, V297B, P48, DOI 10.1002/jez.b.00019; Shapiro Michael D., 2007, P225; Sheth R, 2012, SCIENCE, V338, P1476, DOI 10.1126/science.1226804; VANDENBERG C, 1995, J EXP BIOL, V198, P1655; Welten MCM, 2005, EVOL DEV, V7, P18, DOI 10.1111/j.1525-142X.2005.05003.x; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	30	59	60	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2013	500	7463					445	+		10.1038/nature12336	http://dx.doi.org/10.1038/nature12336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23831646				2022-12-28	WOS:000323316100032
J	Cisse, II; Izeddin, I; Causse, SZ; Boudarene, L; Senecal, A; Muresan, L; Dugast-Darzacq, C; Hajj, B; Dahan, M; Darzacq, X				Cisse, Ibrahim I.; Izeddin, Ignacio; Causse, Sebastien Z.; Boudarene, Lydia; Senecal, Adrien; Muresan, Leila; Dugast-Darzacq, Claire; Hajj, Bassam; Dahan, Maxime; Darzacq, Xavier			Real-Time Dynamics of RNA Polymerase II Clustering in Live Human Cells	SCIENCE			English	Article							IN-VIVO; LIVING CELLS; GENE-EXPRESSION; P-TEFB; TRANSCRIPTION; ORGANIZATION; PROTEIN; REPLICATION; ELONGATION; MECHANISMS	Transcription is reported to be spatially compartmentalized in nuclear transcription factories with clusters of RNA polymerase II (Pol II). However, little is known about when these foci assemble or their relative stability. We developed a quantitative single-cell approach to characterize protein spatiotemporal organization, with single-molecule sensitivity in live eukaryotic cells. We observed that Pol II clusters form transiently, with an average lifetime of 5.1 (+/- 0.4) seconds, which refutes the notion that they are statically assembled substructures. Stimuli affecting transcription yielded orders-of-magnitude changes in the dynamics of Pol II clusters, which implies that clustering is regulated and plays a role in the cell's ability to effect rapid response to external signals. Our results suggest that transient crowding of enzymes may aid in rate-limiting steps of gene regulation.	[Cisse, Ibrahim I.; Izeddin, Ignacio; Causse, Sebastien Z.; Boudarene, Lydia; Senecal, Adrien; Dugast-Darzacq, Claire; Darzacq, Xavier] Ecole Normale Super, Inst Biol, IBENS, CNRS,UMR8197, F-75005 Paris, France; [Cisse, Ibrahim I.; Izeddin, Ignacio; Boudarene, Lydia; Dahan, Maxime] Ecole Normale Super, Inst Biol, Dept Phys, Lab Kastler Brossel,CNRS,UMR8552, F-75230 Paris 05, France; [Cisse, Ibrahim I.; Hajj, Bassam; Dahan, Maxime; Darzacq, Xavier] Transcript Imaging Consortium, Ashburn, VA 20147 USA; [Muresan, Leila] Ecole Normale Super, Inst Biol, IBENS, DYOGEN,CNRS,UMR8197, F-75005 Paris, France; [Dugast-Darzacq, Claire] Univ Paris Diderot, Paris Cite Sorbonne, F-75013 Paris, France; [Senecal, Adrien; Dahan, Maxime] Univ Paris 06, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Dahan, M (corresponding author), Ecole Normale Super, Inst Biol, Dept Phys, Lab Kastler Brossel,CNRS,UMR8552, 46 Rue Ulm, F-75230 Paris 05, France.	maxime.dahan@curie.fr; darzacq@ens.fr	Dahan, Maxime/F-1740-2010; Izeddin, Ignacio/H-2628-2013; Causse, Sebastien Zwe/AAZ-7365-2021; Muresan, Leila/AGK-4203-2022	Izeddin, Ignacio/0000-0002-8476-3915; Muresan, Leila/0000-0002-7602-0249; Darzacq, Xavier/0000-0003-2537-8395; Dugast-Darzacq, Claire/0000-0001-8602-3534; BOUDARENE, LYDIA/0000-0002-6204-4936; HAJJ, Bassam/0000-0002-5097-6832; Causse, Sebastien/0000-0003-3246-3491; Dahan, Maxime/0000-0002-4943-2491	European Molecular Biology Organization; Foundation Pierre Gilles de Gennes (FPGG); Netherlands Organization for Scientific Research; FPGG; La Ligue nationale contre le cancer; Centre de Genetique Moleculaire [UPR 3404]; Agence Nationale de la Recherche Pol2Kinetics; DYNAFT; Nikon France	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Foundation Pierre Gilles de Gennes (FPGG); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); FPGG; La Ligue nationale contre le cancer(Ligue nationale contre le cancer); Centre de Genetique Moleculaire; Agence Nationale de la Recherche Pol2Kinetics(French National Research Agency (ANR)); DYNAFT; Nikon France	We acknowledge J. T. Lis, I. Golding, R. Phillips, O. Bensaude, and E. Bertrand for valuable discussions. We thank members of the Darzacq, Dahan, and Howard Hughes Medical Institute-Janelia Farm Transcription Imaging Consortium groups for suggestions. I. I. C. was supported by fellowships from the European Molecular Biology Organization and the Foundation Pierre Gilles de Gennes (FPGG). I. I. acknowledges the Netherlands Organization for Scientific Research and FPGG for financial support. A. S. was supported by La Ligue nationale contre le cancer. L. M. acknowledges support from Centre de Genetique Moleculaire UPR 3404. This work was supported by grants Agence Nationale de la Recherche Pol2Kinetics to X. D. and DYNAFT to X. D. and M. D.; X. D. and M. D. acknowledge the support of Nikon France.	Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; HERRERA RE, 1989, NATURE, V340, P68, DOI 10.1038/340068a0; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; MACKMAN N, 1990, P NATL ACAD SCI USA, V87, P2254, DOI 10.1073/pnas.87.6.2254; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sugaya K, 2000, J CELL SCI, V113, P2679; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025	22	278	283	0	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					664	667		10.1126/science.1239053	http://dx.doi.org/10.1126/science.1239053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23828889				2022-12-28	WOS:000322884800041
J	Artaud, F; Dugravot, A; Sabia, S; Singh-Manoux, A; Tzourio, C; Elbaz, A				Artaud, Fanny; Dugravot, Aline; Sabia, Severine; Singh-Manoux, Archana; Tzourio, Christophe; Elbaz, Alexis			Unhealthy behaviours and disability in older adults: Three-City Dijon cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTHY LIFE-STYLE; INCIDENT MOBILITY LIMITATION; MEDITERRANEAN DIET; PHYSICAL-ACTIVITY; DISABLEMENT PROCESS; FUNCTIONAL DECLINE; COMBINED IMPACT; WOMENS HEALTH; RISK-FACTORS; MORTALITY	Objectives To examine the individual and combined associations of unhealthy behaviours (low/intermediate physical activity, consuming fruit and vegetables less than once a day, current smoking/short term ex-smoking, never/former/heavy alcohol drinking), assessed at start of follow-up, with hazard of disability among older French adults and to assess the role of potential mediators, assessed repeatedly, of these associations. Design Population based cohort study. Setting Dijon centre of Three-City study. Participants 3982 (2410 (60.5%) women) French community dwellers aged 65 or over included during 1999-2001; participants were disability-free at baseline when health behaviours were assessed. Main outcome measure Hierarchical indicator of disability (no, light, moderate, severe) combining data from three disability scales (mobility, instrumental activities of daily living, basic activities of daily living) assessed five times between 2001 and 2012. Results During the 12 year follow-up, 1236 participants (861 (69.7%) women) developed moderate or severe disability. Interval censored survival analyses (adjusted for age, sex, marital status, and education) showed low/intermediate physical activity (hazard ratio 1.72, 95% confidence interval 1.48 to 2.00), consuming fruit and vegetables less than once a day (1.24, 1.10 to 1.41), and current smoking/short term ex-smoking (1.26, 1.05 to 1.50) to be independently associated with an increased hazard of disability, whereas no robust association with alcohol consumption was found. The hazard of disability increased progressively with the number of unhealthy behaviours independently associated with disability (P<0.001); participants with three unhealthy behaviours had a 2.53 (1.86 to 3.43)-fold increased hazard of disability compared with those with none. Reverse causation bias was verified by excluding participants who developed disability in the first four years of follow-up; these analyses on 890 disability events yielded results similar to those in the main analysis. 30.5% of the association between the unhealthy behaviours score and disability was explained by body mass index, cognitive function, depressive symptoms, trauma, chronic conditions, and cardiovascular disease and its risk factors; the main contributors were chronic conditions and, to a lesser extent, depressive symptoms, trauma, and body mass index. Conclusions An unhealthy lifestyle is associated with greater hazard of incident disability, and the hazard increases progressively with the number of unhealthy behaviours. Chronic conditions, depressive symptoms, trauma, and body mass index partially explained this association.	[Artaud, Fanny; Dugravot, Aline; Singh-Manoux, Archana; Elbaz, Alexis] INSERM, Ctr Res Epidemiol & Populat Hlth CESP, U1018, F-94807 Villejuif, France; [Artaud, Fanny; Dugravot, Aline; Singh-Manoux, Archana; Elbaz, Alexis] Univ Versailles St Quentin, UMRS 1018, F-78035 Versailles, France; [Sabia, Severine; Singh-Manoux, Archana; Elbaz, Alexis] UCL, Dept Epidemiol & Publ Hlth, London, England; [Singh-Manoux, Archana] Hop Ste Perine, AP HP, Ctr Gerontol, Paris, France; [Tzourio, Christophe] INSERM, U708, Bordeaux, France; [Tzourio, Christophe] Univ Bordeaux 2, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Sainte-Perine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Elbaz, A (corresponding author), INSERM, Ctr Res Epidemiol & Populat Hlth CESP, U1018, F-94807 Villejuif, France.	alexis.elbaz@inserm.fr	Elbaz, Alexis/F-8952-2017; Tzourio, christophe/L-6344-2019; Sabia, Séverine/G-2966-2017; Tzourio, christophe/B-4015-2009; Singh-Manoux, Archana/F-6804-2013	Elbaz, Alexis/0000-0001-9724-5490; Tzourio, christophe/0000-0002-6517-2984; Sabia, Séverine/0000-0003-3109-9720; Tzourio, christophe/0000-0002-6517-2984; Singh-Manoux, Archana/0000-0002-1244-5037; Dugravot, Aline/0000-0002-4546-0970; ARTAUD, Fanny/0000-0003-1899-8502	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; Conseils Regionaux of Bourgogne; Fondation de France; Ministry of Research-INSERM Program; "Cohortes et collections de donnees biologiques"; Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Conseil General de la Cote d'or; Fondation Plan Alzheimer; Institut national de prevention et d'education pour la sante (INPES) [063/11-DAS]; Ministere de l'Enseignement Superieur et de la Recherche, Paris, France; EHESP (Ecole des Hautes Etudes en Sante Publique), Rennes, France	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); Conseils Regionaux of Bourgogne(Region Bourgogne-Franche-Comte); Fondation de France(Fondation de France); Ministry of Research-INSERM Program; "Cohortes et collections de donnees biologiques"; Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Conseil General de la Cote d'or(Region Bourgogne-Franche-Comte); Fondation Plan Alzheimer; Institut national de prevention et d'education pour la sante (INPES); Ministere de l'Enseignement Superieur et de la Recherche, Paris, France; EHESP (Ecole des Hautes Etudes en Sante Publique), Rennes, France	The 3C study is conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Victor Segalen-Bordeaux II University, and the Sanofi-Synthelabo Company. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Conseils Regionaux of Bourgogne, Fondation de France, Ministry of Research-INSERM Program, "Cohortes et collections de donnees biologiques," Mutuelle Generale de l'Education Nationale, Institut de la Longevite, Conseil General de la Cote d'or, and Fondation Plan Alzheimer. This research was also funded by Institut national de prevention et d'education pour la sante (INPES, No 063/11-DAS). FA is the recipient of a doctoral grant from the Ministere de l'Enseignement Superieur et de la Recherche, Paris, France, and the EHESP (Ecole des Hautes Etudes en Sante Publique), Rennes, France. The sponsors had no role in study design, data collection, data analysis, data interpretation, the writing of the report, or the decision to submit the paper for publication.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Andrews G, 1999, MANAGEMENT MENTAL DI; Barberger-Gateau P, 2000, DISABIL REHABIL, V22, P308, DOI 10.1080/096382800296665; Barberger-Gateau P, 2002, DEMENT GERIATR COGN, V13, P60, DOI 10.1159/000048635; Blachier M, 2012, ANN NEUROL, V71, P661, DOI 10.1002/ana.22656; Buck B, 2012, CLUSTERING UNHEALTHY; Chakravarty EF, 2012, AM J MED, V125, P190, DOI 10.1016/j.amjmed.2011.08.006; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Chiuve SE, 2011, JAMA-J AM MED ASSOC, V306, P62, DOI 10.1001/jama.2011.907; CRIQUI MH, 1979, AM J EPIDEMIOL, V109, P394, DOI 10.1093/oxfordjournals.aje.a112695; Donald IP, 2010, AGE AGEING, V39, P337, DOI 10.1093/ageing/afq015; Duee M, 2006, DONNEES SOC SOCIETEF, V7, P613; Feart C, 2011, EUR J EPIDEMIOL, V26, P747, DOI 10.1007/s10654-011-9611-4; Ford ES, 2009, ARCH INTERN MED, V169, P1355, DOI 10.1001/archinternmed.2009.237; Fried LP, 2001, J CLIN EPIDEMIOL, V54, P889, DOI 10.1016/S0895-4356(01)00357-2; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; GLYNN RJ, 1985, AM J PUBLIC HEALTH, V75, P1413, DOI 10.2105/AJPH.75.12.1413; Hamer M, 2011, J AM GERIATR SOC, V59, P370, DOI 10.1111/j.1532-5415.2011.03258.x; Harrington J, 2010, EUR J PUBLIC HEALTH, V20, P91, DOI 10.1093/eurpub/ckp102; Hewitt M, 2003, J GERONTOL A-BIOL, V58, P82; Houston DK, 2005, AM J CLIN NUTR, V81, P515; Joly P, 2002, BIOSTATISTICS, V3, P433, DOI 10.1093/biostatistics/3.3.433; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Koster A, 2008, J AM GERIATR SOC, V56, P636, DOI 10.1111/j.1532-5415.2007.01632.x; Koster A, 2007, OBESITY, V15, P3122, DOI 10.1038/oby.2007.372; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; LACROIX AZ, 1993, AM J EPIDEMIOL, V137, P858, DOI 10.1093/oxfordjournals.aje.a116747; Landi F, 2007, AGING CLIN EXP RES, V19, P410; Larrieu S, 2004, INT J OBESITY, V28, P1555, DOI 10.1038/sj.ijo.0802755; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Liao WC, 2011, J AM GERIATR SOC, V59, P200, DOI 10.1111/j.1532-5415.2010.03272.x; Ling SM, 2006, ARTHRIT RHEUM-ARTHR, V55, P256, DOI 10.1002/art.21858; Loef M, 2012, PREV MED, V55, P163, DOI 10.1016/j.ypmed.2012.06.017; Maraldi C, 2009, J AM GERIATR SOC, V57, P1767, DOI 10.1111/j.1532-5415.2009.02479.x; Morimoto LM, 2003, AM J EPIDEMIOL, V158, P259, DOI 10.1093/aje/kwg147; Peres K, 2005, AGING CLIN EXP RES, V17, P229; Peres K, 2005, DISABIL REHABIL, V27, P263, DOI 10.1080/09638280400006515; Poortinga W, 2007, PREV MED, V44, P124, DOI 10.1016/j.ypmed.2006.10.006; Pronk NP, 2004, AM J PREV MED, V27, P25, DOI 10.1016/j.amepre.2004.04.022; ROSOW I, 1966, J GERONTOL, V21, P556, DOI 10.1093/geronj/21.4.556; Rosso AL, 2013, J AM GERIATR SOC, V61, P371, DOI 10.1111/jgs.12147; Sabia S, 2012, CAN MED ASSOC J, V184, P1985, DOI 10.1503/cmaj.121080; Sabia S, 2009, AM J EPIDEMIOL, V170, P428, DOI 10.1093/aje/kwp161; Tsubota-Utsugi M, 2011, J AM GERIATR SOC, V59, P1993, DOI 10.1111/j.1532-5415.2011.03633.x; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; van den Brandt PA, 2011, AM J CLIN NUTR, V94, P913, DOI 10.3945/ajcn.110.008250; Vercambre MN, 2009, BRIT J NUTR, V102, P419, DOI 10.1017/S0007114508201959; Vita AJ, 1998, NEW ENGL J MED, V338, P1035, DOI 10.1056/NEJM199804093381506; Wang L, 2002, J AM GERIATR SOC, V50, P1525, DOI 10.1046/j.1532-5415.2002.50408.x; Wong E, 2012, ANN EPIDEMIOL, V22, P710, DOI 10.1016/j.annepidem.2012.07.009; Young Y, 2010, J AM MED DIR ASSOC, V11, P645, DOI 10.1016/j.jamda.2009.12.084	55	82	86	0	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2013	347								f4240	10.1136/bmj.f4240	http://dx.doi.org/10.1136/bmj.f4240			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	192YR	23881930	Green Published, hybrid			2022-12-28	WOS:000322524400002
J	Burschka, J; Pellet, N; Moon, SJ; Humphry-Baker, R; Gao, P; Nazeeruddin, MK; Gratzel, M				Burschka, Julian; Pellet, Norman; Moon, Soo-Jin; Humphry-Baker, Robin; Gao, Peng; Nazeeruddin, Mohammad K.; Graetzel, Michael			Sequential deposition as a route to high-performance perovskite-sensitized solar cells	NATURE			English	Article							EFFICIENT; INTERCALATION; EXCHANGE; RAMAN	Following pioneering work(1), solution-processable organic-inorganic hybrid perovskites-such as CH3NH3PbX3 (X = Cl, Br, I)-have attracted attention as light-harvesting materials for mesoscopic solar cells(2-15). So far, the perovskite pigment has been deposited in a single step onto mesoporous metal oxide films using a mixture of PbX2 and CH3NH3X in a common solvent. However, the uncontrolled precipitation of the perovskite produces large morphological variations, resulting in a wide spread of photovoltaic performance in the resulting devices, which hampers the prospects for practical applications. Here we describe a sequential deposition method for the formation of the perovskite pigment within the porous metal oxide film. PbI2 is first introduced from solution into a nanoporous titanium dioxide film and subsequently transformed into the perovskite by exposing it to a solution of CH3NH3I. We find that the conversion occurs within the nanoporous host as soon as the two components come into contact, permitting much better control over the perovskite morphology than is possible with the previously employed route. Using this technique for the fabrication of solid-state mesoscopic solar cells greatly increases the reproducibility of their performance and allows us to achieve a power conversion efficiency of approximately 15 per cent (measured under standard AM1.5G test conditions on solar zenith angle, solar light intensity and cell temperature). This two-step method should provide new opportunities for the fabrication of solution-processed photovoltaic cells with unprecedented power conversion efficiencies and high stability equal to or even greater than those of today's best thin-film photovoltaic devices.	[Burschka, Julian; Pellet, Norman; Moon, Soo-Jin; Humphry-Baker, Robin; Gao, Peng; Nazeeruddin, Mohammad K.; Graetzel, Michael] Swiss Fed Inst Technol, Dept Chem & Chem Engn, Lab Photon & Interfaces, CH-1015 Lausanne, Switzerland; [Pellet, Norman] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Max Planck Society	Gratzel, M (corresponding author), Swiss Fed Inst Technol, Dept Chem & Chem Engn, Lab Photon & Interfaces, Stn 6, CH-1015 Lausanne, Switzerland.	michael.graetzel@epfl.ch	Nazeeruddin, Mohammad K/B-1323-2008; 添, 王/ABI-8105-2020; Gao, Peng/F-3114-2012; Gao, Peng/F-3114-2012	Nazeeruddin, Mohammad K/0000-0001-5955-4786; Gao, Peng/0000-0002-4963-2282; Gao, Peng/0000-0002-6016-3229	Aisin Cosmos R&D Co., Ltd, Japan; European Community [ENERGY.2012.10.2.1]; NANOMATCELL [308997]; Global Research Laboratory Program, Korea; Center for Advanced Molecular Photovoltaics of King Abdullah University of Science and Technology [KUS-C1-015-21]; Solvay S.A.; Ministry of Education, Science and Technology through the National Research Foundation of Korea [R31-2008-000-10035-0]; Max Planck Society; King Abdulaziz University, Jeddah; Nanyang Technolocal University, Singapore; European Research Council [ARG 247404]	Aisin Cosmos R&D Co., Ltd, Japan; European Community(European Commission); NANOMATCELL; Global Research Laboratory Program, Korea; Center for Advanced Molecular Photovoltaics of King Abdullah University of Science and Technology; Solvay S.A.(Solvay SA); Ministry of Education, Science and Technology through the National Research Foundation of Korea; Max Planck Society(Max Planck SocietyFoundation CELLEX); King Abdulaziz University, Jeddah; Nanyang Technolocal University, Singapore; European Research Council(European Research Council (ERC)European Commission)	We thank M. Marszalek for recording SEM images, M. Tschumi for help with the stability measurements and K. Schenk for the XRD characterization. We acknowledge financial support from Aisin Cosmos R&D Co., Ltd, Japan; the European Community's Seventh Framework Programme (FP7/2007-2013) ENERGY.2012.10.2.1; NANOMATCELL, grant agreement no. 308997; the Global Research Laboratory Program, Korea; the Center for Advanced Molecular Photovoltaics (award no. KUS-C1-015-21) of King Abdullah University of Science and Technology; and Solvay S.A. M.K.N. thanks the World Class University programmes (Photovoltaic Materials, Department of Material Chemistry, Korea University), funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea (R31-2008-000-10035-0). M. G. thanks the Max Planck Society for a Max Planck Fellowship at the MPI for Solid State Research in Stuttgart, Germany; the King Abdulaziz University, Jeddah and the Nanyang Technolocal University, Singapore for Adjunct Professor appointments; and the European Research Council for an Advanced Research Grant (ARG 247404) funded under the "Mesolight" project.	Baikie T, 2013, J MATER CHEM A, V1, P5628, DOI 10.1039/c3ta10518k; Ball JM, 2013, ENERG ENVIRON SCI, V6, P1739, DOI 10.1039/c3ee40810h; Beberwyck BJ, 2012, J AM CHEM SOC, V134, P19977, DOI 10.1021/ja309416c; Beckmann PA, 2010, CRYST RES TECHNOL, V45, P455, DOI 10.1002/crat.201000066; Bi DQ, 2013, J PHYS CHEM LETT, V4, P1532, DOI 10.1021/jz400638x; Burschka J, 2011, J AM CHEM SOC, V133, P18042, DOI 10.1021/ja207367t; Cai B, 2013, ENERG ENVIRON SCI, V6, P1480, DOI 10.1039/c3ee40343b; Crossland EJW, 2013, NATURE, V495, P215, DOI 10.1038/nature11936; Edri E, 2013, J PHYS CHEM LETT, V4, P897, DOI 10.1021/jz400348q; Etgar L, 2012, J AM CHEM SOC, V134, P17396, DOI 10.1021/ja307789s; Gurina GI, 2004, J SOLID STATE CHEM, V177, P909, DOI 10.1016/j.jssc.2003.09.028; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI [10.1038/NPHOTON.2013.80, 10.1038/nphoton.2013.80]; Im JH, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-353; Im JH, 2011, NANOSCALE, V3, P4088, DOI 10.1039/c1nr10867k; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Li HB, 2011, NANO LETT, V11, P4964, DOI 10.1021/nl202927a; Liang KN, 1998, CHEM MATER, V10, P403, DOI 10.1021/cm970568f; Luther JM, 2009, J AM CHEM SOC, V131, P16851, DOI 10.1021/ja906503w; Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Preda N, 2006, J PHYS-CONDENS MAT, V18, P8899, DOI 10.1088/0953-8984/18/39/020; Qiu JH, 2013, NANOSCALE, V5, P3245, DOI 10.1039/c3nr00218g; WARREN RF, 1993, J PHYS-CONDENS MAT, V5, P6407, DOI 10.1088/0953-8984/5/35/006	25	7572	7756	257	10389	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2013	499	7458					316	+		10.1038/nature12340	http://dx.doi.org/10.1038/nature12340			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23842493				2022-12-28	WOS:000321910700031
J	Kovalchik, SA; Tammemagi, M; Berg, CD; Caporaso, NE; Riley, TL; Korch, M; Silvestri, GA; Chaturvedi, AK; Katki, HA				Kovalchik, Stephanie A.; Tammemagi, Martin; Berg, Christine D.; Caporaso, Neil E.; Riley, Tom L.; Korch, Mary; Silvestri, Gerard A.; Chaturvedi, Anil K.; Katki, Hormuzd A.			Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREDICTION; MODEL; BENEFITS; VALIDATION; SELECTION; CRITERIA; PROSTATE	Background In the National Lung Screening Trial (NLST), screening with low-dose computed tomography (CT) resulted in a 20% reduction in lung-cancer mortality among participants between the ages of 55 and 74 years with a minimum of 30 pack-years of smoking and no more than 15 years since quitting. It is not known whether the benefits and potential harms of such screening vary according to lung-cancer risk. Methods We assessed the variation in efficacy, the number of false positive results, and the number of lung-cancer deaths prevented among 26,604 participants in the NLST who underwent low-dose CT screening, as compared with the 26,554 participants who underwent chest radiography, according to the quintile of 5-year risk of lung-cancer death (ranging from 0.15 to 0.55% in the lowest-risk group [quintile 1] to more than 2.00% in the highest-risk group [quintile 5]). Results The number of lung-cancer deaths per 10,000 person-years that were prevented in the CT-screening group, as compared with the radiography group, increased according to risk quintile (0.2 in quintile 1, 3.5 in quintile 2, 5.1 in quintile 3, 11.0 in quintile 4, and 12.0 in quintile 5; P=0.01 for trend). Across risk quintiles, there were significant decreasing trends in the number of participants with false positive results per screening-prevented lung-cancer death (1648 in quintile 1, 181 in quintile 2, 147 in quintile 3, 64 in quintile 4, and 65 in quintile 5). The 60% of participants at highest risk for lung-cancer death (quintiles 3 through 5) accounted for 88% of the screening-prevented lung-cancer deaths and for 64% of participants with false positive results. The 20% of participants at lowest risk (quintile 1) accounted for only 1% of prevented lung-cancer deaths. Conclusions Screening with low-dose CT prevented the greatest number of deaths from lung cancer among participants who were at highest risk and prevented very few deaths among those at lowest risk. These findings provide empirical support for risk-based targeting of smokers for such screening. (Funded by the National Cancer Institute.)	[Kovalchik, Stephanie A.; Caporaso, Neil E.; Chaturvedi, Anil K.; Katki, Hormuzd A.] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA; [Berg, Christine D.] NCI, Canc Prevent Div, NIH, Rockville, MD USA; [Riley, Tom L.; Korch, Mary] Informat Management Serv Inc, Rockville, MD USA; [Tammemagi, Martin] Brock Univ, Dept Community Hlth Sci, St Catharines, ON L2S 3A1, Canada; [Silvestri, Gerard A.] Med Univ S Carolina, Div Pulm & Crit Care Med, Charleston, SC 29425 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Brock University; Medical University of South Carolina	Kovalchik, SA (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, 9609 Med Ctr Dr,Rm 7E-606 MSC 9780, Bethesda, MD 20892 USA.	kovalchiksa@mail.nih.gov; katkih@mail.nih.gov	Katki, Hormuzd A/B-4003-2015; Berg, Christine/K-1047-2014; Chaturvedi, Anil/J-2024-2015	Chaturvedi, Anil/0000-0003-2696-8899; Tammemagi, Martin/0000-0002-4989-5058	Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Department of Health and Human Services; NCI; Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, NCI; Early Detection Research Group and Biometry Research Group, Division of Cancer Prevention, NCI [N01-CN-25514, N01-CN-25522, N01-CN-25515, N01-CN-25512, N01-CN-25513, N01-CN-25516, N01-CN-25511, N01-CN-25524, N01-CN-25518, N01-CN-75022, N01-CN-25476, N02-CN-63300]; NATIONAL CANCER INSTITUTE [U01CA080098, U01CA079778, N01CA075022, ZIACP010181, N01CA025524, N01CA025512, N01CA025522, N01CA025514, N01CA025515, N01CA025511, N01CA025516, N01CA025518, N01CA025513] Funding Source: NIH RePORTER	Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Department of Health and Human Services; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Treatment & Diagnosis); Early Detection Research Group and Biometry Research Group, Division of Cancer Prevention, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health, Department of Health and Human Services. The PLCO trial was supported by the NCI. The American College of Radiology Imaging Network component of the NLST was supported by grants (U01-CA-80098 and U01-CA-79778) under a cooperative agreement with the Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, NCI. The Lung Screening Study sites of the NLST were funded through contracts with the Early Detection Research Group and Biometry Research Group, Division of Cancer Prevention, NCI (N01-CN-25514, to University of Colorado-Denver; N01-CN-25522, to Georgetown University; N01-CN-25515, to Pacific Health Research and Education Institute; N01-CN-25512, to Henry Ford Health System; N01-CN-25513, to University of Minnesota; N01-CN-25516, to Washington University in St. Louis; N01-CN-25511, to University of Pittsburgh; N01-CN-25524, to University of Utah; N01-CN-25518, to Marshfield Clinic Research Foundation; N01-CN-75022, to University of Alabama at Birmingham; N01-CN-25476, to Westat; N02-CN-63300, to Information Management Services).	Aberle DR, 2011, J NATL CANCER I, V103, P1560, DOI 10.1093/jnci/djr347; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Bach PB, 2012, ANN INTERN MED, V157, P571, DOI 10.7326/0003-4819-157-8-201210160-00524; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Barnes PM, 2011, EARLY RELEASE SELECT; BENICHOU J, 1990, BIOMETRICS, V46, P813, DOI 10.2307/2532098; Boiselle PM, 2013, JAMA-J AM MED ASSOC, V309, P1163, DOI 10.1001/jama.2012.216988; Cassidy A, 2008, BRIT J CANCER, V98, P270, DOI 10.1038/sj.bjc.6604158; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227; Couraud S, 2013, ANN ONCOL, V24, P586, DOI 10.1093/annonc/mds476; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Heuvers ME, 2012, NEW ENGL J MED, V366, P192, DOI 10.1056/NEJMc1111935; Jaklitsch MT, 2012, J THORAC CARDIOV SUR, V144, P33, DOI 10.1016/j.jtcvs.2012.05.060; Jett JR, 2011, ANN INTERN MED, V155, P540, DOI 10.7326/0003-4819-155-8-201110180-00367; Maisonneuve P, 2011, CANCER PREV RES, V4, P1778, DOI 10.1158/1940-6207.CAPR-11-0026; O'Connor GT, 2012, JAMA-J AM MED ASSOC, V307, P2434, DOI 10.1001/jama.2012.6096; Oken MM, 2005, JNCI-J NATL CANCER I, V97, P1832, DOI 10.1093/jnci/dji430; Pinsky PF, 2012, J MED SCREEN, V19, P154, DOI 10.1258/jms.2012.012010; R Development Core Team, 2012, R LANG ENV STAT COMP; Raji OY, 2012, ANN INTERN MED, V157, P242, DOI 10.7326/0003-4819-157-4-201208210-00004; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Silvestri GA, 2011, ANN INTERN MED, V155, P537, DOI 10.7326/0003-4819-155-8-201110180-00364; Sox HC, 2011, NEW ENGL J MED, V365, P455, DOI 10.1056/NEJMe1103776; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Tammemagi CM, 2011, JNCI-J NATL CANCER I, V103, P1058, DOI 10.1093/jnci/djr173; Taylor JMG, 2008, CLIN CANCER RES, V14, P5977, DOI 10.1158/1078-0432.CCR-07-4534; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172; Wood DE, 2012, J NATL COMPR CANC NE, V10, P240, DOI 10.6004/jnccn.2012.0022; Young RP, 2012, JAMA-J AM MED ASSOC, V308, P1320, DOI 10.1001/2012.jama.11892	33	411	425	0	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 18	2013	369	3					245	254		10.1056/NEJMoa1301851	http://dx.doi.org/10.1056/NEJMoa1301851			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DQ	23863051	Green Accepted			2022-12-28	WOS:000321945800010
J	Sansregret, L; Petronczki, M				Sansregret, Laurent; Petronczki, Mark			Born Equal: Dual Safeguards for Daughter Cell Size Symmetry	CELL			English	Editorial Material							MITOTIC SPINDLE; DIVISION; POSITION; DYNEIN		[Sansregret, Laurent; Petronczki, Mark] Canc Res UK London Res Inst, Clare Hall Labs, Cell Div, S Mimms EN6 3LD, Herts, England; [Sansregret, Laurent; Petronczki, Mark] Canc Res UK London Res Inst, Clare Hall Labs, Aneuploidy Lab, S Mimms EN6 3LD, Herts, England	Cancer Research UK; Cancer Research UK	Sansregret, L (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Cell Div, Blanche Lane, S Mimms EN6 3LD, Herts, England.	laurent.sansregret@cancer.org.uk; mark.petronczki@cancer.org.uk		Petronczki, Mark/0000-0003-0139-5692				Collins ES, 2012, MOL BIOL CELL, V23, P3380, DOI 10.1091/mbc.E12-02-0109; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Kiyomitsu T, 2013, CELL, V154, P391, DOI 10.1016/j.cell.2013.06.010; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Kotak S, 2012, J CELL BIOL, V199, P97, DOI 10.1083/jcb.201203166; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Sedzinski J, 2011, NATURE, V476, P462, DOI 10.1038/nature10286; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10	10	1	1	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					269	271		10.1016/j.cell.2013.06.035	http://dx.doi.org/10.1016/j.cell.2013.06.035			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870117	Bronze			2022-12-28	WOS:000321950700004
J	Ellsworth, WL				Ellsworth, William L.			Injection-Induced Earthquakes	SCIENCE			English	Review							DENVER EARTHQUAKES; FLUID-INJECTION; RESERVOIRS; HAZARD; OIL	Earthquakes in unusual locations have become an important topic of discussion in both North America and Europe, owing to the concern that industrial activity could cause damaging earthquakes. It has long been understood that earthquakes can be induced by impoundment of reservoirs, surface and underground mining, withdrawal of fluids and gas from the subsurface, and injection of fluids into underground formations. Injection-induced earthquakes have, in particular, become a focus of discussion as the application of hydraulic fracturing to tight shale formations is enabling the production of oil and gas from previously unproductive formations. Earthquakes can be induced as part of the process to stimulate the production from tight shale formations, or by disposal of wastewater associated with stimulation and production. Here, I review recent seismic activity that may be associated with industrial activity, with a focus on the disposal of wastewater by injection in deep wells; assess the scientific understanding of induced earthquakes; and discuss the key scientific challenges to be met for assessing this hazard.	US Geol Survey, Earthquake Sci Ctr, Menlo Pk, CA 94025 USA	United States Department of the Interior; United States Geological Survey	Ellsworth, WL (corresponding author), US Geol Survey, Earthquake Sci Ctr, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	ellsworth@usgs.gov						Ake J, 2005, B SEISMOL SOC AM, V95, P664, DOI 10.1785/0120040072; [Anonymous], 2012, INVESTIGATION OF OBS; [Anonymous], 2012, TECHNICAL REPORT CEN; Avouac JP, 2012, NAT GEOSCI, V5, P763, DOI 10.1038/ngeo1609; Bakun WH, 2005, NATURE, V437, P969, DOI 10.1038/nature04067; Barton C, 2009, AAPG BULL, V93, P1551, DOI 10.1306/06180909030; Brodsky EE, 2013, SCIENCE, V341, P543, DOI 10.1126/science.1239213; Brown W. A., 2013, SEISMOL RES LETT, V84, P374; Committee on Induced Seismicity Potential in Energy Technologies, 2012, INDUCED SEISMICITY P; DAVIS SD, 1989, B SEISMOL SOC AM, V79, P1477; Deichmann N, 2009, SEISMOL RES LETT, V80, P784, DOI 10.1785/gssrl.80.5.784; Deng K, 2010, B SEISMOL SOC AM, V100, P2805, DOI 10.1785/0120090222; Evans KF, 2012, GEOTHERMICS, V41, P30, DOI 10.1016/j.geothermics.2011.08.002; Frohlich C, 2012, P NATL ACAD SCI USA, V109, P13934, DOI 10.1073/pnas.1207728109; Frohlich C, 2011, B SEISMOL SOC AM, V101, P327, DOI 10.1785/0120100131; Ge SM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040349; Gonzalez PJ, 2012, NAT GEOSCI, V5, P821, DOI [10.1038/ngeo1610, 10.1038/NGEO1610]; Green C.A., 2012, PREESE HALL SHALE GA; Gupta HK, 2002, EARTH-SCI REV, V58, P279, DOI 10.1016/S0012-8252(02)00063-6; HARLOW DH, 1993, B SEISMOL SOC AM, V83, P1143; HEALY JH, 1968, SCIENCE, V161, P1301, DOI 10.1126/science.161.3848.1301; HERRMANN RB, 1981, B SEISMOL SOC AM, V71, P731; Holland AA, 2013, B SEISMOL SOC AM, V103, P1784, DOI 10.1785/0120120109; Horton S, 2012, SEISMOL RES LETT, V83, P250, DOI 10.1785/gssrl.83.2.250; HSIEH PA, 1981, J GEOPHYS RES, V86, P903, DOI 10.1029/JB086iB02p00903; HUBBERT MK, 1959, GEOL SOC AM BULL, V70, P115; janska E., 2012, LEAD EDGE, V31, P1462, DOI [DOI 10.1190/TLE31121462.1, 10.1190/tle31121462.1]; Keller G. R., 2013, OKLAHOMA GEOLOGICAL; Keranen KM, 2013, GEOLOGY, V41, P699, DOI 10.1130/G34045.1; Kim WY, 2013, J GEOPHYS RES-SOL EA, V118, P3506, DOI 10.1002/jgrb.50247; McGarr A., 2002, INTERNATIONAL HANDBO, V8; McGuire R. K., 2004, EARTHQUAKE ENGINEERI; Nicholson C., 1990, U S GEOL SURV BULL, V1951; PENNINGTON WD, 1986, B SEISMOL SOC AM, V76, P939; Petersen M. D., 2008, U S GEOL SURV OPEN F; RALEIGH CB, 1976, SCIENCE, V191, P1230, DOI 10.1126/science.191.4233.1230; Rubinstein J. L., 2013, SEISMOL RES LETT, V84, P374; SIMPSON DW, 1988, B SEISMOL SOC AM, V78, P2025; Tagliabue J., 2013, NEW YORK TIMES, pA6; Townend J, 2000, GEOLOGY, V28, P399, DOI 10.1130/0091-7613(2000)28<399:HFKTCS>2.0.CO;2; van der Elst NJ, 2013, SCIENCE, V341, P164, DOI 10.1126/science.1238948; van Eck T, 2006, ENG GEOL, V87, P105, DOI 10.1016/j.enggeo.2006.06.005; Vernon F.L., 2012, GEOL SOC AM ABSTR, V44, P511; Zoback MD, 2012, EARTH MAGAZINE, P38	44	1357	1396	45	838	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2013	341	6142					142	+	1225942	10.1126/science.1225942	http://dx.doi.org/10.1126/science.1225942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23846903	Green Submitted			2022-12-28	WOS:000321965300032
J	Matlock, DD; Groeneveld, PW; Sidney, S; Shetterly, S; Goodrich, G; Glenn, K; Xu, S; Yang, L; Farmer, SA; Reynolds, K; Cassidy-Bushrow, AE; Lieu, T; Boudreau, DM; Greenlee, RT; Tom, J; Vupputuri, S; Adams, KF; Smith, DH; Gunter, MJ; Go, AS; Magid, DJ				Matlock, Daniel D.; Groeneveld, Peter W.; Sidney, Steve; Shetterly, Susan; Goodrich, Glenn; Glenn, Karen; Xu, Stan; Yang, Lin; Farmer, Steven A.; Reynolds, Kristi; Cassidy-Bushrow, Andrea E.; Lieu, Tracy; Boudreau, Denise M.; Greenlee, Robert T.; Tom, Jeffrey; Vupputuri, Suma; Adams, Kenneth F.; Smith, David H.; Gunter, Margaret J.; Go, Alan S.; Magid, David J.			Geographic Variation in Cardiovascular Procedure Use Among Medicare Fee-for-Service vs Medicare Advantage Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REGIONAL-VARIATION; HEALTH-CARE; QUALITY; PERCEPTIONS; OUTCOMES; POLICY; RISK	IMPORTANCE Little is known about how different financial incentives between Medicare Advantage and Medicare fee-for-service (FFS) reimbursement structures influence use of cardiovascular procedures. OBJECTIVE To compare regional cardiovascular procedure rates between Medicare Advantage and Medicare FFS beneficiaries. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional study of Medicare beneficiaries older than 65 years between 2003-2007 comparing rates of coronary angiography, percutaneous coronary intervention (PCI), and coronary artery bypass graft (CABG) surgery across 32 hospital referral regions in 12 states. MAIN OUTCOMES AND MEASURES Rates of coronary angiography, PCI, and CABG surgery. RESULTS We evaluated a total of 878 339 Medicare Advantage patients and 5 013 650 Medicare FFS patients. Compared with Medicare FFS patients, Medicare Advantage patients had lower age-, sex-, race-, and income-adjusted procedure rates per 1000 person-years for angiography (16.5 [95% CI, 14.8-18.2] vs 25.9 [95% CI, 24.0-27.9]; P < .001) and PCI (6.8 [95% CI, 6.0-7.6] vs 9.8 [95% CI, 9.0-10.6]; P < .001) but similar rates for CABG surgery (3.1 [95% CI, 2.8-3.5] vs 3.4 [95% CI, 3.1-3.7]; P = .33). There were no significant differences between Medicare Advantage and Medicare FFS patients in the rates per 1000 person-years of urgent angiography (3.9 [95% CI, 3.6-4.2] vs 4.3 [95% CI, 4.0-4.6]; P = .24) or PCI (2.4 [95% CI, 2.2-2.7] vs 2.7 [95% CI, 2.5-2.9]; P = .16). Procedure rates varied widely across hospital referral regions among Medicare Advantage and Medicare FFS patients. For angiography, the rates per 1000 person-years ranged from 9.8 to 40.6 for Medicare Advantage beneficiaries and from 15.7 to 44.3 for Medicare FFS beneficiaries. For PCI, the rates ranged from 3.5 to 16.8 for Medicare Advantage and from 4.7 to 16.1 for Medicare FFS. The rates for CABG surgery ranged from 1.5 to 6.1 for Medicare Advantage and from 2.5 to 6.0 for Medicare FFS. Across regions, we found no statistically significant correlation between Medicare Advantage and Medicare FFS beneficiary utilization for angiography (Spearman r = 0.19, P = .29) and modest correlations for PCI (Spearman r = 0.33, P = .06) and CABG surgery (Spearman r = 0.35, P = .05). Among Medicare Advantage beneficiaries, adjustment for additional cardiac risk factors had little influence on procedure rates. CONCLUSIONS AND RELEVANCE Although Medicare beneficiaries enrolled in capitated Medicare Advantage programs had lower angiography and PCI procedure rates than those enrolled in Medicare FFS, the degree of geographic variation in procedure rates was substantial among Medicare Advantage beneficiaries and was similar in magnitude to that observed among Medicare FFS beneficiaries.	[Matlock, Daniel D.] Univ Colorado, Sch Med, Aurora, CO USA; [Matlock, Daniel D.; Shetterly, Susan; Xu, Stan; Magid, David J.] Colorado Cardiovasc Outcomes Res Grp, Denver, CO USA; [Matlock, Daniel D.; Shetterly, Susan; Goodrich, Glenn; Glenn, Karen; Xu, Stan; Magid, David J.] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA; [Groeneveld, Peter W.; Yang, Lin] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Groeneveld, Peter W.] Philadelphia VA Med Ctr, Philadelphia, PA USA; [Sidney, Steve; Go, Alan S.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Farmer, Steven A.] Northwestern Univ, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Farmer, Steven A.] Northwestern Univ, Kellogg Sch Management, Chicago, IL 60611 USA; [Reynolds, Kristi] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Cassidy-Bushrow, Andrea E.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Lieu, Tracy] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA USA; [Lieu, Tracy] Harvard Univ, Sch Med, Boston, MA USA; [Boudreau, Denise M.] Grp Hlth Res Inst, Seattle, WA USA; [Greenlee, Robert T.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Tom, Jeffrey] Kaiser Permanente Ctr Hlth Res, Honolulu, HI USA; [Vupputuri, Suma] Kaiser Permanente Ctr Hlth Res Southeast, Atlanta, GA USA; [Adams, Kenneth F.] HealthPartners Res Fdn, Minneapolis, MN USA; [Smith, David H.] Kaiser Permanente Northwest Ctr Hlth Res, Portland, OR USA; [Gunter, Margaret J.] Lovelace Clin Fdn, Albuquerque, NM USA; [Go, Alan S.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Go, Alan S.] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; [Go, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Go, Alan S.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Palo Alto, CA 94304 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Kaiser Permanente; Northwestern University; Northwestern University; Kaiser Permanente; Henry Ford Health System; Henry Ford Hospital; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Kaiser Permanente; Kaiser Permanente; HealthPartners Institute for Education & Research; Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Matlock, DD (corresponding author), Univ Colorado Denver, Sch Med, Div Gen Internal Med, Acad Off 1, 12631 E 17th Ave,Campus Box B-180, Aurora, CO 80045 USA.	daniel.matlock@ucdenver.edu	Go, Alan S./AAE-7745-2019; Reynolds, Kristi/AAN-1434-2021	Reynolds, Kristi/0000-0001-7619-1649; Groeneveld, Peter/0000-0002-7374-4292; Matlock, Dan/0000-0001-9597-9642; Cassidy-Bushrow, Andrea/0000-0001-8272-4448	National Institute on Aging [1K23AG040696]; National Heart, Lung, and Blood Institute; Cardiovascular Research Network [U19 HL91179-01, 1RC2HL101666-01, 1R01HL086919]; Agency for Healthcare Research and Quality [1R01HS018403]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018403] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U19HL091179, R01HL086919, RC2HL101666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG040696] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cardiovascular Research Network; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Matlock was supported by a career development award from the National Institute on Aging (1K23AG040696). The study was supported by the National Heart, Lung, and Blood Institute and the Cardiovascular Research Network (U19 HL91179-01, 1RC2HL101666-01, and 1R01HL086919). Medicare data for the project were obtained under Agency for Healthcare Research and Quality grant 1R01HS018403.	Anderson HV, 2010, CIRC-CARDIOVASC QUAL, V3, P6, DOI 10.1161/CIRCOUTCOMES.109.927103; Anthony DL, 2009, HEALTH AFFAIR, V28, P864, DOI 10.1377/hlthaff.28.3.864; Bach PB, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp0909947; Baker LC, 2008, HEALTH AFFAIR, V27, pW123, DOI 10.1377/hlthaff.27.2.w123; Barnato AE, 2007, J PALLIAT MED, V10, P1093, DOI 10.1089/jpm.2006.0258; Cooper AL, 2012, NEW ENGL J MED, V366, P150, DOI 10.1056/NEJMsa1104273; Dartmouth Institute for Health Policy and Clinical Practice, DARTM ATL HLTH CAR; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2003, PERSPECT BIOL MED, V46, P69, DOI 10.1353/pbm.2003.0004; Fowler FJ, 2008, JAMA-J AM MED ASSOC, V299, P2406, DOI 10.1001/jama.299.20.2406; Go AS, 2008, CIRC-CARDIOVASC QUAL, V1, P138, DOI 10.1161/CIRCOUTCOMES.108.801654; Gordis L., 2004, EPIDEMIOLOGY; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Institute of Medicine, 1990, CLIN PRACTICE GUIDEL; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Ko DT, 2008, J AM COLL CARDIOL, V51, P716, DOI 10.1016/j.jacc.2007.10.039; Lin CY, 2009, MED CARE, V47, P524, DOI 10.1097/MLR.0b013e31819261bd; Lucas FL, 2010, CIRC-CARDIOVASC QUAL, V3, P253, DOI 10.1161/CIRCOUTCOMES.108.840009; Magid David J, 2008, Expert Rev Cardiovasc Ther, V6, P1043, DOI 10.1586/14779072.6.8.1043; Matlock DD, 2012, ARCH INTERN MED, V172, P634, DOI 10.1001/archinternmed.2012.394; Matlock DD, 2011, CIRC-CARDIOVASC QUAL, V4, P114, DOI 10.1161/CIRCOUTCOMES.110.958264; McGuire TG, 2011, MILBANK Q, V89, P289, DOI 10.1111/j.1468-0009.2011.00629.x; Stiefel Matt, 2008, Perm J, V12, P4; Sutherland JM, 2009, NEW ENGL J MED, V361, P1227, DOI 10.1056/NEJMp0907172; Wennberg D, 1997, J Health Serv Res Policy, V2, P75; Wennberg D.E, 1999, DARTMOUTH ATLAS CARD; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zarabozo C, 2009, HEALTH AFFAIR, V28, pW55, DOI 10.1377/hlthaff.28.1.w55	30	63	63	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					155	162		10.1001/jama.2013.7837	http://dx.doi.org/10.1001/jama.2013.7837			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23839749	Green Accepted, Bronze			2022-12-28	WOS:000321511500014
J	McDermott, MM; Liu, K; Guralnik, JM; Criqui, MH; Spring, B; Tian, L; Domanchuk, K; Ferrucci, L; Lloyd-Jones, D; Kibbe, M; Tao, HM; Zhao, LH; Liao, YH; Rejeski, WJ				McDermott, Mary M.; Liu, Kiang; Guralnik, Jack M.; Criqui, Michael H.; Spring, Bonnie; Tian, Lu; Domanchuk, Kathryn; Ferrucci, Luigi; Lloyd-Jones, Donald; Kibbe, Melina; Tao, Huimin; Zhao, Lihui; Liao, Yihua; Rejeski, W. Jack			Home-Based Walking Exercise Intervention in Peripheral Artery Disease A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FUNCTIONAL PERFORMANCE PREDICTS; LOWER-EXTREMITY FUNCTION; ANKLE BRACHIAL INDEX; PHYSICAL-ACTIVITY; TREADMILL WALKING; MOBILITY LOSS; DAILY-LIFE; LEG; ASSOCIATION; MORTALITY	IMPORTANCE Clinical practice guidelines state there is insufficient evidence to support advising patients with peripheral artery disease (PAD) to participate in a home-based walking exercise program. OBJECTIVE To determine whether a home-based walking exercise program that uses a group-mediated cognitive behavioral intervention, incorporating both group support and self-regulatory skills, can improve functional performance compared with a health education control group in patients with PAD with and without intermittent claudication. DESIGN, SETTING, AND PATIENTS Randomized controlled clinical trial of 194 patients with PAD, including 72.2% without classic symptoms of intermittent claudication, performed in Chicago, Illinois between July 22, 2008, and December 14, 2012. INTERVENTIONS Participants were randomized to 1 of 2 parallel groups: a home-based group-mediated cognitive behavioral walking intervention or an attention control condition. MAIN OUTCOMES AND MEASURES The primary outcomewas 6-month change in 6-minute walk performance. Secondary outcomes included 6-month change in treadmill walking, physical activity, the Walking Impairment Questionnaire (WIQ), and Physical and Mental Health Composite Scores from the 12-item Short-Form Health Survey. RESULTS Participants randomized to the intervention group significantly increased their 6-minute walk distance ([reported in meters] 357.4 to 399.8 vs 353.3 to 342.2 for those in the control group; mean difference, 53.5 [95% CI, 33.2 to 73.8]; P<.001), maximal treadmill walking time (intervention, 7.91 to 9.44 minutes vs control, 7.56 to 8.09; mean difference, 1.01 minutes [95% CI, 0.07 to 1.95]; P=.04), accelerometer-measured physical activity over 7 days (intervention, 778.0 to 866.1 vs control, 671.6 to 645.0; mean difference, 114.7 activity units [95% CI, 12.82 to 216.5]; P=.03), WIQ distance score (intervention, 35.3 to 47.4 vs control, 33.3 to 34.4; mean difference, 11.1 [95% CI, 3.9 to 18.1]; P=.003), and WIQ speed score (intervention, 36.1 to 47.7 vs control, 35.3-36.6; mean difference, 10.4 [95% CI, 3.4 to 17.4]; P=.004). CONCLUSION AND RELEVANCE A home-based walking exercise program significantly improved walking endurance, physical activity, and patient-perceived walking endurance and speed in PAD participants with and without classic claudication symptoms. These findings have implications for the large number of patients with PAD who are unable or unwilling to participate in supervised exercise programs.	[McDermott, Mary M.; Liu, Kiang; Domanchuk, Kathryn] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [McDermott, Mary M.; Liu, Kiang; Spring, Bonnie; Lloyd-Jones, Donald; Tao, Huimin; Zhao, Lihui; Liao, Yihua] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Guralnik, Jack M.] Univ Maryland, Dept Epidemiol, Baltimore, MD 21201 USA; [Criqui, Michael H.] Univ Calif San Diego, San Diego, CA 92103 USA; [Tian, Lu] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ferrucci, Luigi] NIA, Div Intramural Res, Baltimore, MD 21224 USA; [Kibbe, Melina] Northwestern Univ, Dept Surg, Chicago, IL 60611 USA; [Rejeski, W. Jack] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27109 USA; [Rejeski, W. Jack] Wake Forest Univ, Dept Geriatr Med, Winston Salem, NC 27109 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Diego; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Northwestern University; Wake Forest University; Wake Forest University	McDermott, MM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, 750 N Lake Shore Dr,10th Floor, Chicago, IL 60611 USA.	mdm608@northwestern.edu		Lloyd-Jones, Donald/0000-0003-0847-6110; tian, lu/0000-0002-5893-0169; Spring, Bonnie/0000-0003-0692-9868	National Heart, Lung, and Blood Institute [R01-HL088589, R01-HL107510]; Intramural Research Program, National Institutes on Aging (NIA), National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107510, R01HL088589] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program, National Institutes on Aging (NIA), National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by R01-HL088589 and R01-HL107510 from the National Heart, Lung, and Blood Institute. Supported in part by the Intramural Research Program, National Institutes on Aging (NIA), National Institutes of Health. No other funding was used to carry out the study or complete the manuscript.	Amirhamzeh MMR, 1997, EUR J VASC ENDOVASC, V13, P301, DOI 10.1016/S1078-5884(97)80102-5; Bandura A, 1998, PSYCHOL HEALTH, V13, P623, DOI 10.1080/08870449808407422; Baumeister RF, 1994, LOSING CONTROL WHY P, DOI 10.5860/choice.32-6508; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cartwright D. E., 1953, GROUP DYNAMICS RES T; Collins TC, 2011, DIABETES CARE, V34, P2174, DOI 10.2337/dc10-2399; Criqui M H, 1996, Vasc Med, V1, P65; Fakhry F, 2012, J VASC SURG, V56, P1132, DOI 10.1016/j.jvs.2012.04.046; Gardner AW, 2011, CIRCULATION, V123, P491, DOI 10.1161/CIRCULATIONAHA.110.963066; GARDNER AW, 1991, MED SCI SPORT EXER, V23, P402; Garg PK, 2009, CIRCULATION, V119, P251, DOI 10.1161/CIRCULATIONAHA.108.791491; GREIG C, 1993, J AM GERIATR SOC, V41, P15, DOI 10.1111/j.1532-5415.1993.tb05941.x; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Heun R, 1998, INT J GERIATR PSYCH, V13, P368, DOI 10.1002/(SICI)1099-1166(199806)13:6<368::AID-GPS775>3.3.CO;2-0; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hirsch AT, 2001, VASC MED, V6, P87, DOI 10.1191/135886301701568756; McDermott MM, 2008, J VASC SURG, V48, P1231, DOI 10.1016/j.jvs.2008.06.050; McDermott MM, 2008, J AM COLL CARDIOL, V51, P1482, DOI 10.1016/j.jacc.2007.12.034; McDermott MM, 2007, J AM COLL CARDIOL, V50, P974, DOI 10.1016/j.jacc.2007.05.030; McDermott MM, 2012, CONTEMP CLIN TRIALS, V33, P1311, DOI 10.1016/j.cct.2012.08.001; McDermott MM, 2011, J AM COLL CARDIOL, V57, P962, DOI 10.1016/j.jacc.2010.09.053; McDermott MM, 2009, JAMA-J AM MED ASSOC, V301, P165, DOI 10.1001/jama.2008.962; McDermott MM, 2002, J GEN INTERN MED, V17, P895, DOI 10.1046/j.1525-1497.2002.20307.x; McDermott MM, 2002, ANN INTERN MED, V136, P873, DOI 10.7326/0003-4819-136-12-200206180-00008; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; McDermott MM, 2001, J AM GERIATR SOC, V49, P747, DOI 10.1046/j.1532-5415.2001.49151.x; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Menard JR, 2004, J VASC SURG, V39, P1186, DOI 10.1016/j.jvs.2004.01.034; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Regensteiner JG, 1997, ANGIOLOGY, V48, P291, DOI 10.1177/000331979704800402; Regensteiner JG, 1990, J VASC MED BIOL, V2, P142; Regensteiner Judith G., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P233, DOI 10.2174/1568006043336195; Richardson M T, 1995, J Cardiopulm Rehabil, V15, P107, DOI 10.1097/00008483-199503000-00003; Rooke TW, 2011, CIRCULATION, V124, P2020, DOI 10.1161/CIR.0b013e31822e80c3; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Savage P, 2001, J Cardiopulm Rehabil, V21, P152, DOI 10.1097/00008483-200105000-00006; Shadman R, 2004, J AM COLL CARDIOL, V44, P618, DOI 10.1016/j.jacc.2004.04.044; Stevens JW, 2012, BRIT J SURG, V99, P1630, DOI 10.1002/bjs.8895; SWERTS PMJ, 1990, PHYS THER, V70, P439, DOI 10.1093/ptj/70.7.439; TASC Working Group, 2000, EUR J VASC ENDOVASC, V19, pS1; Tian L, 2012, BIOSTATISTICS, V13, P256, DOI 10.1093/biostatistics/kxr050; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Watson L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000990.pub2	44	183	186	4	56	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					57	65		10.1001/jama.2013.7231	http://dx.doi.org/10.1001/jama.2013.7231			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175SK	23821089	Green Accepted, Bronze			2022-12-28	WOS:000321253000023
J	Fazel, S; Wolf, A; Langstrom, N; Newton, CR; Lichtenstein, P				Fazel, Seena; Wolf, Achim; Langstrom, Niklas; Newton, Charles R.; Lichtenstein, Paul			Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study	LANCET			English	Article							SUDDEN UNEXPECTED DEATH; BIPOLAR DISORDER; SUICIDE; CLASSIFICATION; SCHIZOPHRENIA; TERMINOLOGY; DIAGNOSES; VALIDITY; ILLNESS; RISK	Background Epilepsy is associated with high rates of premature mortality, but the contribution of psychiatric comorbidity is uncertain. We assessed the prevalence and risks of premature mortality from external causes such as suicide, accidents, and assaults in people with epilepsy with and without psychiatric comorbidity. Methods We studied all individuals born in Sweden between 1954 and 2009 with inpatient and outpatient diagnoses of epilepsy (n=69 995) for risks and causes of premature mortality. Patients were compared with age-matched and sex-matched general population controls (n=660 869) and unaffected siblings (n=81 396). Sensitivity analyses were done to investigate whether these odds differed by sex, age, seizure types, comorbid psychiatric diagnosis, and different time periods after epilepsy diagnosis. Findings 6155 (8.8%) people with epilepsy died during follow-up, at a median age of 34.5 (IQR 21.0-44.0) years with substantially elevated odds of premature mortality (adjusted odds ratio [aOR] of 11.1 [95% CI 10.6-11.6] compared with general population controls, and 11.4 [10.4-12.5] compared with unaffected siblings). Of those deaths, 15.8% (n=972) were from external causes, with high odds for non-vehicle accidents (aOR 5.5, 95 % CI 4.7-6.5) and suicide (3.7, 3.3-4.2). Of those who died from external causes, 75.2% had comorbid psychiatric disorders, with strong associations in individuals with co-occurring depression (13.0, 10.3-16.6) and substance misuse (22.4, 18.3-27.3), compared with patients with no epilepsy and no psychiatric comorbidity. Interpretation Reducing premature mortality from external causes of death should be a priority in epilepsy management. Psychiatric comorbidity plays an important part in the premature mortality seen in epilepsy. The ability of health services and public health measures to prevent such deaths requires review.	[Fazel, Seena; Wolf, Achim; Newton, Charles R.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Langstrom, Niklas; Lichtenstein, Paul] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of Oxford; Karolinska Institutet	Fazel, S (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Warneford Lane, Oxford OX3 7JX, England.	seena.fazel@psych.ox.ac.uk	Newton, Charles/V-7872-2019; Fazel, Seena/B-5307-2008; Langstrom, Niklas/C-5615-2009; Newton, Charles RJC/B-7578-2014	Newton, Charles/0000-0002-6999-5507; Fazel, Seena/0000-0002-5383-5365; Langstrom, Niklas/0000-0002-2686-6799; Newton, Charles RJC/0000-0002-6999-5507; lichtenstein, paul/0000-0003-3037-5287	Wellcome Trust; Swedish Prison and Probation Service; Swedish Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Prison and Probation Service; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Wellcome Trust, the Swedish Prison and Probation Service, and the Swedish Research Council.	Bell GS, 2009, EPILEPSIA, V50, P1933, DOI 10.1111/j.1528-1167.2009.02106.x; Bell GS, 2009, CURR OPIN NEUROL, V22, P174, DOI 10.1097/WCO.0b013e328328f8c3; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Christensen J, 2007, LANCET NEUROL, V6, P693, DOI 10.1016/S1474-4422(07)70175-8; Christensen J, 2012, EPILEPSIA, V53, P14, DOI 10.1111/j.1528-1167.2012.03553.x; COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; Department of Health, 2012, PREV SUIC ENGL CROSS; Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906; Eurostat, DEATH DUE SUIC SEX S; Faingold CL, 2011, EPILEPSY BEHAV, V22, P186, DOI 10.1016/j.yebeh.2011.06.015; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Fazel S, 2010, ARCH GEN PSYCHIAT, V67, P931, DOI 10.1001/archgenpsychiatry.2010.97; Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675; Gaitatzis A, 2004, ACTA NEUROL SCAND, V110, P207, DOI 10.1111/j.1600-0404.2004.00324.x; Hjern A, 2002, LANCET, V360, P443, DOI 10.1016/S0140-6736(02)09674-5; JIANG GX, 1995, ACTA NEUROL SCAND, V91, P109; Klein-Geltink JE, 2007, J CLIN EPIDEMIOL, V60, P766, DOI 10.1016/j.jclinepi.2006.11.008; Kondziella D, 2009, ACTA NEUROL SCAND, V119, P75, DOI 10.1111/j.1600-0404.2008.01088.x; Kwon C, 2011, NEUROLOGY, V76, P801, DOI 10.1212/WNL.0b013e31820e7b3b; Lhatoo SD, 2005, EPILEPSIA, V46, P36, DOI 10.1111/j.1528-1167.2005.00406.x; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Board of Health and Welfare, 2009, CAUS DEATH REG; National Board of Health and Welfare, 1993, EXP REP EP PREV MAN; Neeleman J, 1997, PSYCHOL MED, V27, P467, DOI 10.1017/S0033291796004631; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Nilsson L, 1997, EPILEPSIA, V38, P1062, DOI 10.1111/j.1528-1157.1997.tb01194.x; Rai D, 2012, EPILEPSIA, V53, P1095, DOI 10.1111/j.1528-1167.2012.03500.x; Rockett IRH, 1999, SUICIDE LIFE-THREAT, V29, P141; Runeson B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3222; Sander JW, 2004, J NEUROL NEUROSUR PS, V75, P349, DOI 10.1136/jnnp.2003.029223; Sellgren C, 2011, ACTA PSYCHIAT SCAND, V124, P447, DOI 10.1111/j.1600-0447.2011.01747.x; Shorvon S, 2011, LANCET, V378, P2028, DOI 10.1016/S0140-6736(11)60176-1; Statistics Sweden, 2005, FLERG 2004 BESKR INN; Swedish National Board of Health and Welfare, PAT REG; Tellez-Zenteno JF, 2005, EPILEPSY RES, V65, P101, DOI 10.1016/j.eplepsyres.2005.05.004; Tellez-Zenteno JF, 2007, EPILEPSIA, V48, P2336; US Department of Health and Human Services (HHS) Office of the Surgeon General and National Action Alliance for Suicide Prevention, 2012, NAT STRAT SUIC PREV; van den Broek M, 2004, EPILEPSIA, V45, P667, DOI 10.1111/j.0013-9580.2004.33903.x; WHO, 2000, PREV SUIC RES PRIM H	42	213	218	0	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1646	1654		10.1016/S0140-6736(13)60899-5	http://dx.doi.org/10.1016/S0140-6736(13)60899-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254CN	23883699	Green Published			2022-12-28	WOS:000327140700023
J	Lister, R; Mukamel, EA; Nery, JR; Urich, M; Puddifoot, CA; Johnson, ND; Lucero, J; Huang, Y; Dwork, AJ; Schultz, MD; Yu, M; Tonti-Filippini, J; Heyn, H; Hu, SJ; Wu, JC; Rao, A; Esteller, M; He, C; Haghighi, FG; Sejnowski, TJ; Behrens, MM; Ecker, JR				Lister, Ryan; Mukamel, Eran A.; Nery, Joseph R.; Urich, Mark; Puddifoot, Clare A.; Johnson, Nicholas D.; Lucero, Jacinta; Huang, Yun; Dwork, Andrew J.; Schultz, Matthew D.; Yu, Miao; Tonti-Filippini, Julian; Heyn, Holger; Hu, Shijun; Wu, Joseph C.; Rao, Anjana; Esteller, Manel; He, Chuan; Haghighi, Fatemeh G.; Sejnowski, Terrence J.; Behrens, M. Margarita; Ecker, Joseph R.			Global Epigenomic Reconfiguration During Mammalian Brain Development	SCIENCE			English	Article							HUMAN PREFRONTAL CORTEX; HUMAN CEREBRAL-CORTEX; EMBRYONIC STEM-CELLS; DNA METHYLATION; ACCESSIBLE CHROMATIN; DEOXYRIBONUCLEIC-ACID; TRANSCRIPTION FACTOR; SYNAPTIC PLASTICITY; MEMORY FORMATION; NERVOUS-SYSTEM	DNA methylation is implicated in mammalian brain development and plasticity underlying learning and memory. We report the genome-wide composition, patterning, cell specificity, and dynamics of DNA methylation at single-base resolution in human and mouse frontal cortex throughout their lifespan. Widespread methylome reconfiguration occurs during fetal to young adult development, coincident with synaptogenesis. During this period, highly conserved non-CG methylation (mCH) accumulates in neurons, but not glia, to become the dominant form of methylation in the human neuronal genome. Moreover, we found an mCH signature that identifies genes escaping X-chromosome inactivation. Last, whole-genome single-base resolution 5-hydroxymethylcytosine (hmC) maps revealed that hmC marks fetal brain cell genomes at putative regulatory regions that are CG-demethylated and activated in the adult brain and that CG demethylation at these hmC-poised loci depends on Tet2 activity.	[Lister, Ryan; Nery, Joseph R.; Urich, Mark; Schultz, Matthew D.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Lister, Ryan; Tonti-Filippini, Julian] Univ Western Australia, Sch Chem & Biochem, Plant Energy Biol Australian Res Council Ctr Exce, Perth, WA 6009, Australia; [Lister, Ryan; Tonti-Filippini, Julian] Univ Western Australia, Sch Chem & Biochem, Computat Syst Biol Western Australia CoE, Perth, WA 6009, Australia; [Mukamel, Eran A.; Puddifoot, Clare A.; Johnson, Nicholas D.; Lucero, Jacinta; Sejnowski, Terrence J.; Behrens, M. Margarita] Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; [Huang, Yun; Rao, Anjana] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Huang, Yun; Rao, Anjana] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Dwork, Andrew J.; Haghighi, Fatemeh G.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Dwork, Andrew J.; Haghighi, Fatemeh G.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Dwork, Andrew J.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Schultz, Matthew D.] Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; [Yu, Miao; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Yu, Miao; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Heyn, Holger; Esteller, Manel] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Canc Epigenet Grp, Barcelona 08907, Spain; [Hu, Shijun; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Div Cardiol, Stanford, CA 94305 USA; [Esteller, Manel] ICREA, Barcelona, Catalonia, Spain; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.; Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; University of Western Australia; University of Western Australia; Salk Institute; La Jolla Institute for Immunology; Columbia University; New York State Psychiatry Institute; Columbia University; University of California System; University of California San Diego; University of Chicago; University of Chicago; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Stanford University; ICREA; University of California System; University of California San Diego; Howard Hughes Medical Institute; Salk Institute	Lister, R (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ryan.lister@uwa.edu.au; mbehrens@salk.edu; ecker@salk.edu	Ecker, Joseph R/B-9144-2008; Hu, Shijun/I-5818-2012; Lister, Ryan/B-5168-2012; Sejnowski, Terrence/AAV-5558-2021; Behrens, M. Margarita/K-2576-2014; Nery, Joseph/AAE-8422-2019; Esteller, Manel/L-5956-2014; Tonti-Filippini, Julian S/L-8020-2018; Wu, Joseph/H-1067-2013	Ecker, Joseph R/0000-0001-5799-5895; Lister, Ryan/0000-0001-6637-7239; Nery, Joseph/0000-0003-0153-5659; Esteller, Manel/0000-0003-4490-6093; Tonti-Filippini, Julian S/0000-0003-3464-0770; Heyn, Holger/0000-0002-3276-1889; Johnson, Nicholas/0000-0003-3229-6849; Wu, Joseph/0000-0002-6068-8041; Huang, Yun/0000-0001-5950-9168; Mukamel, Eran/0000-0003-3203-9535; Hu, Shijun/0000-0002-0068-8429	European Commission [LSHM-CT-2004-503039]; National Institutes of Mental Health [MH094670]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GMBF3034]; NIH [HG006827, AI44432, HD065812, CA151535]; California Institute of Regenerative Medicine [RM-01729]; Leukemia and Lymphoma Society [TRP 6187-12]; Australian Research Council; Government of Western Australia; Center for Theoretical Biological Physics, University of California San Diego; NIH (National Institute of Neurological Diseases and Stroke) [K99NS080911]; NSF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065812] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA151535] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094670, R01MH094774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS080911] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Australian Research Council(Australian Research Council); Government of Western Australia; Center for Theoretical Biological Physics, University of California San Diego; NIH (National Institute of Neurological Diseases and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ICREA(ICREA)	We thank W. F. Loomis for critical reading of this manuscript; J. Chambers for technical assistance with animal breeding; D. Chambers for technical assistance with cell sorting; M. Lutz and T. Berggren for provision of the HUES6 cells; F. Yue, G. Hon, and B. Ren for providing mapped mouse ChIP-Seq data and assistance with TAB-Seq; and A. Nimmerjahn for providing the S100b-eGFP mice. Human brain tissue was obtained from the National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, Maryland, the IDIBELL Biobank, which is part of the BrainNet Europe Bank funded by the European Commission (LSHM-CT-2004-503039). We thank the Stamatoyannopoulos laboratory (University of Washington) and the Mouse ENCODE Consortium for generating and providing access to the DNaseI hypersensitivity data sets (35). This work was supported by a National Institutes of Mental Health grant to M. M. B. and J. R. E. (MH094670); the Howard Hughes Medical Institute to T. J. S. and J. R. E.; the Gordon and Betty Moore Foundation (GMBF3034) to J. R. E.; NIH grant HG006827 to C. H.; NIH RO1 grants AI44432, HD065812, and CA151535; grant RM-01729 from the California Institute of Regenerative Medicine; and Translational Research grant TRP 6187-12 from the Leukemia and Lymphoma Society (to A. R.). R. L. was supported by an Australian Research Council Future Fellowship. Support was also provided by the Government of Western Australia through funding for the Western Australia CoE for Computational Systems Biology. E. A. M. was supported by the Center for Theoretical Biological Physics, University of California San Diego, and NIH (National Institute of Neurological Diseases and Stroke grant K99NS080911). W. A. P. was supported by a predoctoral graduate research fellowship from the NSF. Analyzed data sets can be accessed at http://neomorph.salk.edu/brain_methylomes. Sequence data can be downloaded from National Center for Biotechnology Information GEO (GSE47966). Tet2 mutant mice are available under a material transfer agreement from the La Jolla Institute for Allergy and Immunology. Correspondence and requests for materials should be addressed to R. L. (ryan.lister@uwa.edu.au), M. M. B. (mbehrens@salk.edu), and J.R.E. (ecker@salk.edu).	Akhtar MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034863; Auerbach RK, 2009, P NATL ACAD SCI USA, V106, P14926, DOI 10.1073/pnas.0905443106; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chugani HT, 1998, PREV MED, V27, P184, DOI 10.1006/pmed.1998.0274; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Huang Y, 2012, NAT PROTOC, V7, P1897, DOI 10.1038/nprot.2012.103; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Levitt P, 2003, J PEDIATR-US, V143, pS35, DOI 10.1067/S0022-3476(03)00400-1; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; PENN NW, 1972, BIOCHEM J, V126, P781, DOI 10.1042/bj1260781; PENN NW, 1976, BIOCHEM J, V155, P709, DOI 10.1042/bj1550709; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Sharp AJ, 2011, GENOME RES, V21, P1592, DOI 10.1101/gr.112680.110; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Suderman M, 2012, P NATL ACAD SCI USA, V109, P17266, DOI 10.1073/pnas.1121260109; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Uhlhaas PJ, 2011, SCHIZOPHRENIA BULL, V37, P514, DOI 10.1093/schbul/sbr034; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389; Zovkic IB, 2013, LEARN MEMORY, V20, P61, DOI 10.1101/lm.026575.112	61	1188	1207	3	237	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2013	341	6146					629	+	1237905	10.1126/science.1237905	http://dx.doi.org/10.1126/science.1237905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23828890	Green Accepted, Green Submitted			2022-12-28	WOS:000322884800030
J	Sikes, JM; Newmark, PA				Sikes, James M.; Newmark, Phillip A.			Restoration of anterior regeneration in a planarian with limited regenerative ability	NATURE			English	Article							POLARITY; HEAD; SYSTEM; WOUNDS	Variability of regenerative potential among animals has long perplexed biologists(1). On the basis of their exceptional regenerative abilities, planarians have become important models for understanding the molecular basis of regeneration(2). However, planarian species with limited regenerative abilities are also found(3,4). Despite the importance of understanding the differences between closely related, regenerating and non-regenerating organisms, few studies have focused on the evolutionary loss of regeneration(5), and the molecular mechanisms leading to such regenerative loss remain obscure. Here we examine Procotyla fluviatilis, a planarian with restricted ability to replace missing tissues(6), using next-generation sequencing to define the gene expression programs active in regeneration-permissive and regeneration-deficient tissues. We found that Wnt signalling is aberrantly activated in regeneration-deficient tissues. Notably, downregulation of canonical Wnt signalling in regeneration-deficient regions restores regenerative abilities: blastemas form and new heads regenerate in tissues that normally never regenerate. This work reveals that manipulating a single signalling pathway can reverse the evolutionary loss of regenerative potential.	[Sikes, James M.; Newmark, Phillip A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA; [Sikes, James M.; Newmark, Phillip A.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sikes, JM (corresponding author), Univ San Francisco, Dept Biol, San Francisco, CA 94117 USA.	jsikes@usfca.edu		Newmark, Phillip/0000-0003-0793-022X	National Institute of General Medicine Sciences [F32GM097921]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097921] Funding Source: NIH RePORTER	National Institute of General Medicine Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Newmark laboratory members for comments, A. Vieira for technical assistance, A. Hernandez and the W.M. Keck Center for Comparative and Functional Genomics for sequencing assistance, and the National Forest Service, Illinois Department of Natural Resources, USA, and Montgomery County (Maryland) Department of Parks, USA, for field collection permits. We also thank A. Boney, J. Brubacher, T. Chong, M. Issigonis, H. Iyer and B. Lambrus for assistance in field collections. This work was supported by National Institute of General Medicine Sciences fellowship F32GM097921 (J.M.S.). P.A.N. is an investigator of the Howard Hughes Medical Institute.	Bely AE, 2010, INTEGR COMP BIOL, V50, P515, DOI 10.1093/icb/icq118; Bely AE, 2010, TRENDS ECOL EVOL, V25, P161, DOI 10.1016/j.tree.2009.08.005; Calow P., 1978, LIFE CYCLES EVOLUTIO; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Chong T, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-69; Collins JJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000509; Fedecka-Bruner B., 1967, Bull biol Fr Belg, V101, P255; Forsthoefel DJ, 2011, DEV BIOL, V356, P445, DOI 10.1016/j.ydbio.2011.05.669; GRASSO M, 1978, Bollettino di Zoologia, V45, P365; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Gurley KA, 2010, DEV BIOL, V347, P24, DOI 10.1016/j.ydbio.2010.08.007; Kenk R., 1972, BIOTA FRESHWATER ECO; Lillie FR, 1901, AM J PHYSIOL, V6, P129, DOI 10.1152/ajplegacy.1901.6.2.129; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Morgan TH, 1904, BIOL BULL-US, V6, P159, DOI 10.2307/1535722; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Pellettieri J, 2010, DEV BIOL, V338, P76, DOI 10.1016/j.ydbio.2009.09.015; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2011, SCIENCE, V332, P852, DOI 10.1126/science.1202143; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; ROMERO R, 1988, FORTSCHR ZOOL, V36, P283; Rouhana L, 2012, DEVELOPMENT, V139, P1083, DOI 10.1242/dev.076182; STEPH.F, 1961, J EMBRYOL EXP MORPH, V9, P642; Tasaki J, 2011, DEVELOPMENT, V138, P2417, DOI 10.1242/dev.060764; Wenemoser D, 2012, GENE DEV, V26, P988, DOI 10.1101/gad.187377.112; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; Yazawa S, 2009, P NATL ACAD SCI USA, V106, P22329, DOI 10.1073/pnas.0907464106	31	90	94	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					77	U98		10.1038/nature12403	http://dx.doi.org/10.1038/nature12403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23883929	Green Accepted			2022-12-28	WOS:000322514800031
J	Leslie, NR; Brunton, VG				Leslie, Nicholas R.; Brunton, Valerie G.			Where Is PTEN?	SCIENCE			English	Editorial Material							NUCLEAR PTEN; CANCER; PHOSPHATASE; FIBROBLASTS; MUTATIONS		[Leslie, Nicholas R.] Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland; [Brunton, Valerie G.] Univ Edinburgh, Edinburgh Canc Res UK Ctr, Inst Genet & Mol Med, Edinburgh EH4 2XR, Midlothian, Scotland	Heriot Watt University; University of Edinburgh	Leslie, NR (corresponding author), Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland.	n.r.leslie@hw.ac.uk		LESLIE, Nicholas/0000-0001-5131-0541	Medical Research Council [G0801865] Funding Source: Medline; MRC [G0801865] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Campbell I, 2009, CANCER RES, V69, P6765, DOI 10.1158/0008-5472.CAN-08-4253; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vanhaesebroeck B, 2011, CURR TOP MICROBIOL, V347, P1, DOI 10.1007/82_2010_65	14	11	11	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144					355	356		10.1126/science.1242541	http://dx.doi.org/10.1126/science.1242541			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888029				2022-12-28	WOS:000322259200035
J	Kalantar-Zadeh, K; Uppot, RN; Lewandrowski, KB				Kalantar-Zadeh, Kamyar; Uppot, Raul N.; Lewandrowski, Kent B.			Case 23-2013: A 54-Year-Old Woman with Abdominal Pain, Vomiting, and Confusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LACTIC-ACIDOSIS; RENAL-FAILURE; PANCREATITIS; INTOXICATION; DIALYSIS		[Kalantar-Zadeh, Kamyar] Univ Calif Irvine, Dept Med, Orange, CA 92717 USA; [Uppot, Raul N.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Lewandrowski, Kent B.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Uppot, Raul N.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA USA; [Lewandrowski, Kent B.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA	University of California System; University of California Irvine; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kalantar-Zadeh, K (corresponding author), Univ Calif Irvine, Dept Med, Orange, CA 92717 USA.		Kalantar-Zadeh, Kamyar/Q-4734-2018; Uppot, Raul/AAF-1859-2019	Kalantar-Zadeh, Kamyar/0000-0002-8666-0725; 				ADROGUE HJ, 1989, NEW ENGL J MED, V320, P1312, DOI 10.1056/NEJM198905183202004; CASPAR CB, 1991, AM J MED, V91, P197, DOI 10.1016/0002-9343(91)90015-P; Chu J, 2012, UPTODATE; Fainsinger R L, 1992, J Palliat Care, V8, P52; Fimognari FL, 2006, DIABETES CARE, V29, P1183, DOI 10.2337/dc06-0338; Friesecke S, 2010, CRIT CARE, V14, DOI 10.1186/cc9376; Kalantar-Zadeh K, 2004, SEMIN DIALYSIS, V17, P455, DOI 10.1111/j.0894-0959.2004.17606.x; Kalantar-Zadeh K, 2012, DIABETES CARE, V35, P1625, DOI 10.2337/dc12-0483; Kovesdy CP, 2010, SEMIN DIALYSIS, V23, P148, DOI 10.1111/j.1525-139X.2010.00701.x; Kraut JA, 2007, CLIN J AM SOC NEPHRO, V2, P162, DOI 10.2215/CJN.03020906; KURTZ I, 1979, CAN MED ASSOC J, V121, P157; Kussmaul Adolf, 1964, JAMA-J AM MED ASSOC, V189, P58; Mallick S, 2004, POSTGRAD MED J, V80, P239, DOI 10.1136/pgmj.2003.011957; MG Cogan, 1991, FLUID ELECTROLYTES P, P203; Nguyen HL, 2011, HEMODIAL INT, V15, pS68, DOI 10.1111/j.1542-4758.2011.00605.x; Protti A, 2010, CRIT CARE, V14, DOI 10.1186/cc8885; Rifkin DE, 2012, J AM SOC NEPHROL, V23, P979, DOI 10.1681/ASN.2011121185; TULLIS JL, 1948, AM J MED SCI, V215, P424, DOI 10.1097/00000441-194804000-00009; Vecchio S, 2011, CRIT CARE, V15, DOI 10.1186/cc9404	19	30	30	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					374	382		10.1056/NEJMcpc1208154	http://dx.doi.org/10.1056/NEJMcpc1208154			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188VJ	23841704				2022-12-28	WOS:000322223900013
J	Ma, L; Roman-Campos, D; Austin, ED; Eyries, M; Sampson, KS; Soubrier, F; Germain, M; Tregouet, DA; Borczuk, A; Rosenzweig, EB; Girerd, B; Montani, D; Humbert, M; Loyd, JE; Kass, RS; Chung, WK				Ma, Lijiang; Roman-Campos, Danilo; Austin, Eric D.; Eyries, Melanie; Sampson, Kevin S.; Soubrier, Florent; Germain, Marine; Tregouet, David-Alexandre; Borczuk, Alain; Rosenzweig, Erika Berman; Girerd, Barbara; Montani, David; Humbert, Marc; Loyd, James E.; Kass, Robert S.; Chung, Wendy K.			A Novel Channelopathy in Pulmonary Arterial Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; MORPHOGENETIC PROTEIN-RECEPTOR; DOMAIN POTASSIUM CHANNELS; SMOOTH-MUSCLE-CELLS; K+ CHANNEL; TASK-1; GENE; EXPRESSION; MUTATIONS; ENDOGLIN	BACKGROUND Pulmonary arterial hypertension is a devastating disease with high mortality. Familial cases of pulmonary arterial hypertension are usually characterized by autosomal dominant transmission with reduced penetrance, and some familial cases have unknown genetic causes. METHODS We studied a family in which multiple members had pulmonary arterial hypertension without identifiable mutations in any of the genes known to be associated with the disease, including BMPR2, ALK1, ENG, SMAD9, and CAV1. Three family members were studied with whole-exome sequencing. Additional patients with familial or idiopathic pulmonary arterial hypertension were screened for the mutations in the gene that was identified on whole-exome sequencing. All variants were expressed in COS-7 cells, and channel function was studied by means of patch-clamp analysis. RESULTS We identified a novel heterozygous missense variant c.608 GA (G203D) in KCNK3 (the gene encoding potassium channel subfamily K, member 3) as a disease-causing candidate gene in the family. Five additional heterozygous missense variants in KCNK3 were independently identified in 92 unrelated patients with familial pulmonary arterial hypertension and 230 patients with idiopathic pulmonary arterial hypertension. We used in silico bioinformatic tools to predict that all six novel variants would be damaging. Electrophysiological studies of the channel indicated that all these missense mutations resulted in loss of function, and the reduction in the potassium-channel current was remedied by the application of the phospholipase inhibitor ONO-RS-082. CONCLUSIONS Our study identified the association of a novel gene, KCNK3, with familial and idiopathic pulmonary arterial hypertension. Mutations in this gene produced reduced potassium-channel current, which was successfully remedied by pharmacologic manipulation. (Funded by the National Institutes of Health.)	[Ma, Lijiang; Eyries, Melanie; Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Sampson, Kevin S.; Rosenzweig, Erika Berman; Loyd, James E.] Columbia Univ, Med Ctr, Dept Pharmacol, Columbia, NY USA; [Soubrier, Florent] Columbia Univ, Med Ctr, Dept Pathol, Columbia, NY USA; [Austin, Eric D.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN USA; [Humbert, Marc] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Germain, Marine] ICAN, AP HP, Paris, France; [Tregouet, David-Alexandre] UPMC, INSERM, Paris, France; [Germain, Marine; Tregouet, David-Alexandre] UPMC UMRS 937, INSERM, ICAN, Paris, France; [Montani, David; Loyd, James E.] INSERM, APHP, Dept Hosp, DHU TORINO, Le Kremlin Bicetre, France; [Girerd, Barbara; Montani, David; Humbert, Marc] LERMIT, Le Kremlin Bicetre, France	Columbia University; Columbia University; Columbia University; Vanderbilt University; Vanderbilt University; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ma, L (corresponding author), Columbia Univ, Med Ctr, Dept Pediat, 1150 St Nicholas Ave, New York, NY 10032 USA.	wkc15@columbia.edu	Borczuk, Alain/AAI-8226-2021; Trégouët, David-Alexandre/P-9210-2019; EYRIES, melanie/ABF-1034-2020; Rosenzweig, Erika/AAC-3680-2019; BORCZUK, alain/AHA-5172-2022; David, Montani/I-6885-2019; Campos, Danilo Roman/I-2655-2012; Olschewski, Horst/L-3547-2019; Humbert, Marc/AAC-8459-2019; Tregouet, David-Alexandre/E-3961-2016; Humbert, Marc/ABD-5112-2021; Borczuk, Alain/AFU-5278-2022	Borczuk, Alain/0000-0001-6807-8064; Trégouët, David-Alexandre/0000-0001-9084-7800; David, Montani/0000-0002-9358-6922; Campos, Danilo Roman/0000-0002-2690-912X; Olschewski, Horst/0000-0002-2834-7466; Humbert, Marc/0000-0003-0703-2892; Borczuk, Alain/0000-0001-6807-8064; Loyd, James/0000-0002-5042-7390; Germain, Marine/0000-0002-8489-8916; Rosenzweig, Erika B./0000-0003-4849-214X	National Institutes of Health [R01 HL060056, P01 HL072058, K23 HL098743, R01 HL 56810]; Vanderbilt Clinical and Translational Science Awards grant from the National Center for Research Resources [UL1 RR024975]; National Heart, Lung, and Blood Institute (NHLBI) [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924]; NHLBI [RC2 HL-102925, RC2 HL-102926]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108800, R01HL056810, R01HL111259, R01HL060056, RC2HL102924, K23HL098743, RC2HL102923, RC2HL103010, R01HL048164, RC2HL102925, P01HL072058, RC2HL102926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Clinical and Translational Science Awards grant from the National Center for Research Resources; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Institutes of Health.; Supported by grants (R01 HL060056, P01 HL072058, K23 HL098743, and R01 HL 56810) from the National Institutes of Health and a Vanderbilt Clinical and Translational Science Awards grant (UL1 RR024975) from the National Center for Research Resources. Funding for the Grand Opportunity Exome Sequencing Project (GO-ESP) was provided by grants (RC2 HL-103010, RC2 HL-102923, and RC2 HL-102924) from the National Heart, Lung, and Blood Institute (NHLBI). Exome sequencing was performed through grants (RC2 HL-102925 and RC2 HL-102926) from the NHLBI.	Abdalla SA, 2000, HUM MOL GENET, V9, P1227, DOI 10.1093/hmg/9.8.1227; [Anonymous], 2001, Method of treating a condition associated with phosphorylation of TASK-1: patent, Patent No. 8097650; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Gardener MJ, 2004, BRIT J PHARMACOL, V142, P192, DOI 10.1038/sj.bjp.0705691; Girerd B, 2010, AM J RESP CRIT CARE, V181, P851, DOI 10.1164/rccm.200908-1284OC; Gurney AM, 2003, CIRC RES, V93, P957, DOI 10.1161/01.RES.0000099883.68414.61; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Hartness ME, 2001, J BIOL CHEM, V276, P26499, DOI 10.1074/jbc.M010357200; HIGENBOTTAM T, 1984, LANCET, V1, P1046; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Machado RD, 2009, J AM COLL CARDIOL, V54, pS32, DOI 10.1016/j.jacc.2009.04.015; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Morecroft I, 2009, BRIT J PHARMACOL, V157, P1241, DOI 10.1111/j.1476-5381.2009.00283.x; Nasim MT, 2011, HUM MUTAT, V32, P1385, DOI 10.1002/humu.21605; Olschewski A, 2006, CIRC RES, V98, P1072, DOI 10.1161/01.RES.0000219677.12988.e9; Osipenko ON, 1997, BRIT J PHARMACOL, V120, P1461, DOI 10.1038/sj.bjp.0701075; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Remillard CV, 2007, AM J PHYSIOL-CELL PH, V292, pC1837, DOI 10.1152/ajpcell.00405.2006; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Seyler C, 2012, BRIT J PHARMACOL, V165, P1467, DOI 10.1111/j.1476-5381.2011.01626.x; Shintani M, 2009, J MED GENET, V46, P331, DOI 10.1136/jmg.2008.062703; Streit AK, 2011, J BIOL CHEM, V286, P13977, DOI 10.1074/jbc.M111.227884; Tang B, 2009, AM J RESP CELL MOL, V41, P476, DOI 10.1165/rcmb.2008-0412OC; Trapp S, 2008, J NEUROSCI, V28, P8844, DOI 10.1523/JNEUROSCI.1810-08.2008; Yu SP, 2000, P NATL ACAD SCI USA, V97, P9360, DOI 10.1073/pnas.97.17.9360; Yuan XJ, 1998, LANCET, V351, P726, DOI 10.1016/S0140-6736(05)78495-6; Yuill KH, 2007, PFLUG ARCH EUR J PHY, V455, P333, DOI 10.1007/s00424-007-0282-7; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	36	320	333	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					351	361		10.1056/NEJMoa1211097	http://dx.doi.org/10.1056/NEJMoa1211097			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188VJ	23883380	Green Accepted			2022-12-28	WOS:000322223900010
J	Tiley, C				Tiley, Christopher			We should harness the power of our colleagues' fresh ideas	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									River St Surg, St Austell PL26 6UE, England		Tiley, C (corresponding author), River St Surg, St Austell PL26 6UE, England.	christopher.tiley@mevagissey.cornwall.nhs.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2013	347								f4538	10.1136/bmj.f4538	http://dx.doi.org/10.1136/bmj.f4538			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	189DG	23863986				2022-12-28	WOS:000322246700009
J	Adrian, C				Adrian, Chris			The art of medicine The bad chaplain	LANCET			English	Editorial Material									Columbia Univ Coll Phys & Surg, Program Narrat Med, New York, NY 10032 USA	Columbia University	Adrian, C (corresponding author), Columbia Univ Coll Phys & Surg, Program Narrat Med, 630 W 168th St, New York, NY 10032 USA.	cadrian@mail.harvard.edu							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 13	2013	382	9887					120	121		10.1016/S0140-6736(13)61552-4	http://dx.doi.org/10.1016/S0140-6736(13)61552-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	187JY	23858552				2022-12-28	WOS:000322115300013
J	Garman, D; Cohen, A; Jones, B; Goldston, D				Garman, David; Cohen, Armond; Jones, Benjamin; Goldston, David			What would you cut?	NATURE			English	Editorial Material									[Garman, David] Decker Garman Sullivan, Alexandria, VA USA; Clean Air Task Force, Boston, MA USA; [Jones, Benjamin] Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA	Northwestern University	Garman, D (corresponding author), Decker Garman Sullivan, Alexandria, VA USA.								0	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2013	499	7457					147	148						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	179YA	23846645				2022-12-28	WOS:000321557600016
J	Lencastre, A; Tosti, A				Lencastre, Andre; Tosti, Antonella			A Receding Hairline	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lencastre, Andre] Hosp Santo Antonio Capuchos, Lisbon, Portugal; [Tosti, Antonella] Univ Miami Hosp, Miami, FL USA	University of Miami	Lencastre, A (corresponding author), Hosp Santo Antonio Capuchos, Lisbon, Portugal.			tosti, antonella/0000-0001-5516-4043					0	3	3	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					E2	E2		10.1056/NEJMicm1206227	http://dx.doi.org/10.1056/NEJMicm1206227			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180BH	23841744				2022-12-28	WOS:000321567300001
J	Luo, JH; Rossouw, J; Margolis, KL				Luo, Juhua; Rossouw, Jacques; Margolis, Karen L.			Smoking Cessation, Weight Change, and Coronary Heart Disease Among Postmenopausal Women With and Without Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CARDIOVASCULAR-DISEASE		[Luo, Juhua] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN 47405 USA; [Rossouw, Jacques] NHLBI, Bethesda, MD 20892 USA; [Margolis, Karen L.] HealthPartners Inst Educ & Res, Minneapolis, MN USA	Indiana University System; Indiana University Bloomington; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Luo, JH (corresponding author), Indiana Univ, Sch Publ Hlth, 1025 E 7th St, Bloomington, IN 47405 USA.	juhluo@indiana.edu		Margolis, Karen/0000-0003-1862-7402; luo, juhua/0000-0002-8901-4462	NIDDK NIH HHS [R21 DK074646] Funding Source: Medline; WHI NIH HHS [N01WH42132, N01WH32109, N01WH32105, N01WH42112, N01WH32112, N01WH42117, N01WH42126, N01WH32115, N01WH32101, N01WH32113, N01WH32122, N01WH32111, N01WH42131, N01WH32100, N01WH42114, N01WH32108, N01WH42119, N01WH42121, N01WH32119, N01WH42116, N01WH42107, N01WH32102, N01WH42130, N01WH42113, N01WH42118, N01WH32118, N01WH42108, N01WH42129, N01WH42120, N01WH42124, N01WH22110, N01WH32106, N01WH42125, N01WH42122, N01WH42111, N01WH42115, N01WH42109, N01WH44221, N01WH24152, N01WH42110, N01WH42123] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074646] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032101, N01WH042120, N01WH042111, N01WH042113, N01WH042132, N01WH042115, N01WH042109, N01WH032105, N01WH042130, N01WH042116, N01WH022110, N01WH032119, N01WH032111, N01WH042121, N01WH042112, N01WH032102, N01WH032122, N01WH032112, N01WH042126, N01WH042131, N01WH032100, N01WH032118, N01WH032108, N01WH032113, N01WH042118, N01WH042122, N01WH042108, N01WH042125, N01WH042123, N01WH032109, N01WH032106, N01WH042110, N01WH042119, N01WH042107, N01WH042117, N01WH042129, N01WH042124, N01WH042114, N01WH032115] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); WHI NIH HHS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Clair C, 2013, JAMA-J AM MED ASSOC, V309, P1014, DOI 10.1001/jama.2013.1644; Jackson JM, 2013, J CLIN EPIDEMIOL, V66, P349, DOI 10.1016/j.jclinepi.2012.01.013; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Luo JH, 2012, ARCH INTERN MED, V172, P438, DOI 10.1001/archinternmed.2012.24	6	29	31	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					94	96		10.1001/jama.2013.6871	http://dx.doi.org/10.1001/jama.2013.6871			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175SK	23821094	Green Accepted, Bronze			2022-12-28	WOS:000321253000028
J	Lyus, R; Robson, S; Parsons, J; Fisher, J; Cameron, M				Lyus, Richard; Robson, Stephen; Parsons, John; Fisher, Jane; Cameron, Martin			Second trimester abortion for fetal abnormality	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MIDTRIMESTER DILATION; PREGNANCY; EVACUATION; TERMINATION; INDUCTION; LABOR; PROVISION; CHOICE		[Lyus, Richard; Parsons, John] British Pregnancy Advisory Serv, Richmond TW1 2AR, Surrey, England; [Robson, Stephen] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Fisher, Jane] Antenatal Results & Choices, London, England; [Cameron, Martin] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England	Newcastle University - UK; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Lyus, R (corresponding author), British Pregnancy Advisory Serv, Richmond TW1 2AR, Surrey, England.	Richard.lyus@bpas.org						Borgatta L, 2011, CONTRACEPTION, V84, P4, DOI 10.1016/j.contraception.2011.02.005; Bryant AG, 2011, OBSTET GYNECOL, V117, P788, DOI 10.1097/AOG.0b013e31820c3d26; Chasen ST, 2005, AM J OBSTET GYNECOL, V193, P1161, DOI 10.1016/j.ajog.2005.05.078; Cowett AA, 2006, AM J OBSTET GYNECOL, V194, P768, DOI 10.1016/j.ajog.2005.09.003; Department of Health, 2011, AB STAT ENGL WAL; Grimes DA, 2004, BJOG-INT J OBSTET GY, V111, P148, DOI 10.1046/j.1471-0528.2003.00034.x; Grimes DA, 2008, REPROD HEALTH MATTER, V16, P183, DOI 10.1016/S0968-8080(08)31378-0; Grossman D, 2008, REPROD HEALTH MATTER, V16, P173, DOI 10.1016/S0968-8080(08)31379-2; Grossman D, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-224; Harris LH, 2008, REPROD HEALTH MATTER, V16, P74, DOI 10.1016/S0968-8080(08)31396-2; Jackson JE, 2007, INT J GYNECOL OBSTET, V96, P12, DOI 10.1016/j.ijgo.2006.08.011; Kalish RB, 2002, AM J OBSTET GYNECOL, V187, P882, DOI 10.1067/mob.2002.127139; Kelly T, 2010, BJOG-INT J OBSTET GY, V117, P1512, DOI 10.1111/j.1471-0528.2010.02712.x; Kerns J, 2012, INT J GYNECOL OBSTET, V116, P244, DOI 10.1016/j.ijgo.2011.10.016; Kerns JL, 2012, AM J PERINAT, V29, P709, DOI 10.1055/s-0032-1314893; Korenromp MJ, 2007, AM J OBSTET GYNECOL, V196, P149; Mentula MJ, 2011, HUM REPROD, V26, P927, DOI 10.1093/humrep/der016; RCOG, 2010, TERM PREGN FET ABN E; Royal College of Obstetricians and Gynaecologists, 2011, CAR WOM REQ IND AB R; SHULMAN LP, 1990, OBSTET GYNECOL, V75, P1037; Thomas J, 2003, INT J GYNECOL OBSTET, V83, P327, DOI 10.1016/S0020-7292(03)00305-9; Vogt C, 2012, ULTRASOUND OBST GYN, V39, P666, DOI 10.1002/uog.10106; Whitley KA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.028	23	9	9	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2013	347								f4165	10.1136/bmj.f4165	http://dx.doi.org/10.1136/bmj.f4165			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180CZ	23823994				2022-12-28	WOS:000321571800002
J	Sandin, S; Nygren, KG; Iliadou, A; Hultman, CM; Reichenberg, A				Sandin, Sven; Nygren, Karl-Gosta; Iliadou, Anastasia; Hultman, Christina M.; Reichenberg, Abraham			Autism and Mental Retardation Among Offspring Born After In Vitro Fertilization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDREN BORN; ASSISTED CONCEPTION; SPECTRUM DISORDERS; NEUROLOGICAL SEQUELAE; COGNITIVE-DEVELOPMENT; SINGLETONS BORN; FOLLOW-UP; RISK; ICSI; INJECTION	IMPORTANCE Between 1978 and 2010, approximately 5 million infants were born after in vitro fertilization (IVF) treatments. Yet limited information on neurodevelopment after IVF exists, especially after the first year of life. OBJECTIVE To examine the association between use of any IVF and different IVF procedures and the risk of autistic disorder and mental retardation in the offspring. DESIGN, SETTING, AND PARTICIPANTS A population-based, prospective cohort study using Swedish national health registers. Offspring born between 1982 and 2007 were followed up for a clinical diagnosis of autistic disorder or mental retardation until December 31, 2009. The exposure of interest was IVF, categorized according to whether intracytoplasmic sperm injection (ICSI) for male infertility was used and whether embryos were fresh or frozen. For ICSI, whether sperm were ejaculated or surgically extracted was also considered. MAIN OUTCOMES AND MEASURES Relative risks (RRs) for autistic disorder and mental retardation and rates per 100 000 person-years, comparing spontaneously conceived offspring with those born after an IVF procedure and comparing 5 IVF procedures used in Sweden vs IVF without ICSI with fresh embryo transfer, the most common treatment. We also analyzed the subgroup restricted to singletons. RESULTS Of the more than 2.5 million infants born, 30 959 (1.2%) were conceived by IVF and were followed up for a mean 10 (SD, 6) years. Overall, 103 of 6959 children (1.5%) with autistic disorder and 180 of 15 830 (1.1%) with mental retardation were conceived by IVF. The RR for autistic disorder after any procedure compared with spontaneous conception was 1.14 (95% CI, 0.94-1.39; 19.0 vs 15.6 per 100 000 person-years). The RR for mental retardation was 1.18 (95% CI, 1.01-1.36; 46.3 vs 39.8 per 100 000 person-years). For both outcomes, there was no statistically significant association when restricting analysis to singletons. Compared with IVF without ICSI with fresh embryo transfer, there were statistically significantly increased risks of autistic disorder following ICSI using surgically extracted sperm and fresh embryos (RR, 4.60 [95% CI, 2.14-9.88]; 135.7 vs 29.3 per 100 000 person-years); for mental retardation following ICSI using surgically extracted sperm and fresh embryos (RR, 2.35 [95% CI, 1.01-5.45]; 144.1 vs 60.8 per 100 000 person-years); and following ICSI using ejaculated sperm and fresh embryos (RR, 1.47 [95% CI, 1.03-2.09]; 90.6 vs 60.8 per 100 000 person-years). When restricting the analysis to singletons, the risks of autistic disorder associated with ICSI using surgically extracted sperm were not statistically significant, but the risks associated with ICSI using frozen embryos were significant for mental retardation (with frozen embryos, RR, 2.36 [95% CI, 1.04-5.36], 118.4 vs 50.6 per 100 000 person-years]; with fresh embryos, RR, 1.60 [95% CI, 1.00-2.57], 80.0 vs 50.6 per 100 000 person-years). CONCLUSIONS AND RELEVANCE Compared with spontaneous conception, IVF treatment overall was not associated with autistic disorder but was associated with a small but statistically significantly increased risk of mental retardation. For specific procedures, IVF with ICSI for paternal infertility was associated with a small increase in the RR for autistic disorder and mental retardation compared with IVF without ICSI. The prevalence of these disorders was low, and the increase in absolute risk associated with IVF was small. JAMA. 2013;310(1):75-84.	[Sandin, Sven; Reichenberg, Abraham] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London SE5 8AF, England; [Sandin, Sven; Nygren, Karl-Gosta; Iliadou, Anastasia; Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Reichenberg, Abraham] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Reichenberg, Abraham] Mt Sinai Sch Med, Dept Prevent Med, New York, NY USA	University of London; King's College London; Karolinska Institutet; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Sandin, S (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychosis Studies, De Crespigny Pk, London SE5 8AF, England.	sven.sandin@kcl.ac.uk	Sandin, Sven/L-5357-2015; Sandin, Sven/ABE-2959-2021; Reichenberg, Abraham/GQB-1227-2022	Sandin, Sven/0000-0001-6994-4884; Sandin, Sven/0000-0001-6994-4884; 	Autism Speaks; Swedish Research Council; EU [259 679]	Autism Speaks; Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission)	This study was funded by Autism Speaks and the Swedish Research Council. Dr Iliadou was supported by grant 259 679 from the EU-FP7 HEALTH.	Allen C, 2005, BJOG-INT J OBSTET GY, V112, P1589, DOI 10.1111/j.1471-0528.2005.00784.x; [Anonymous], 2012, HUM FERTIL, V15, P62, DOI 10.3109/14647273.2012.663571; Axelsson O, 2003, ACTA OBSTET GYN SCAN, V82, P491, DOI 10.1034/j.1600-0412.2003.00172.x; Benedetti A, 2004, STAT MED, V23, P3781, DOI 10.1002/sim.2073; Bonduelle M, 1998, LANCET, V351, P1553, DOI 10.1016/S0140-6736(98)24021-9; Carson C, 2010, HUM REPROD, V25, P244, DOI 10.1093/humrep/dep344; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Dada R, 2012, J ASSIST REPROD GEN, V29, P213, DOI 10.1007/s10815-012-9715-0; De Rycke M, 2002, HUM REPROD, V17, P2487, DOI 10.1093/humrep/17.10.2487; Ekbom A, 2011, METHODS MOL BIOL, V675, P215, DOI 10.1007/978-1-59745-423-0_10; Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906; Eroglu A, 2012, SEMIN REPROD MED, V30, P92, DOI 10.1055/s-0032-1307417; FITZMAURICE GM, 2004, APPL LONGITUDINAL AN, P291; FUNDERBURK SJ, 1983, J AUTISM DEV DISORD, V13, P325, DOI 10.1007/BF01531570; Grether JK, 2009, AM J EPIDEMIOL, V170, P1118, DOI 10.1093/aje/kwp247; Hastie T., 2009, UNSUPERVISED LEARNIN; Hollander E, 2010, TXB AUTISM SPECTRUM; HOLM S, 1979, SCAND J STAT, V6, P65; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Hvidtjorn D, 2011, J EPIDEMIOL COMMUN H, V65, P497, DOI 10.1136/jech.2009.093823; Hvidtjorn D, 2009, ARCH PEDIAT ADOL MED, V163, P72, DOI 10.1001/archpediatrics.2008.507; Knoester M, 2008, FERTIL STERIL, V90, P289, DOI 10.1016/j.fertnstert.2007.06.090; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Leslie GI, 2003, HUM REPROD, V18, P2067, DOI 10.1093/humrep/deg408; Leunens L, 2008, HUM REPROD, V23, P105, DOI 10.1093/humrep/dem257; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lyall K, 2012, PAEDIATR PERINAT EP, V26, P361, DOI 10.1111/j.1365-3016.2012.01294.x; Maimburg RD, 2007, HUM REPROD, V22, P1841, DOI 10.1093/humrep/dem082; Mann MRW, 1999, HUM MOL GENET, V8, P1867, DOI 10.1093/hmg/8.10.1867; Mash EJ, 2002, CHILD PSYCHOPATHOLOG; Middelburg KJ, 2008, HUM REPROD UPDATE, V14, P219, DOI 10.1093/humupd/dmn005; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Paoloni-Giacobino Ariane, 2004, Reprod Health, V1, P6, DOI 10.1186/1742-4755-1-6; Pinborg A, 2004, BMJ-BRIT MED J, V329, P311, DOI 10.1136/bmj.38156.715694.3A; Ponjaert-Kristoffersen I, 2005, PEDIATRICS, V115, pE283, DOI 10.1542/peds.2004-1445; Practice Comm Amer Soc Reprod Med, 2004, FERTIL STERIL, V82, pS151, DOI 10.1016/j.fertnstert.2004.05.037; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Sandin S, 2012, J AM ACAD CHILD ADOL, V51, pe1; Sandin S, 2012, J AM ACAD CHILD PSY, V51, P477, DOI 10.1016/j.jaac.2012.02.018; Sazonova A, 2011, HUM REPROD, V26, P2878, DOI 10.1093/humrep/der241; Schanen NC, 2006, HUM MOL GENET, V15, pR138, DOI 10.1093/hmg/ddl213; Sellgren C, 2011, ACTA PSYCHIAT SCAND, V124, P447, DOI 10.1111/j.1600-0447.2011.01747.x; Stromberg B, 2002, LANCET, V359, P461, DOI 10.1016/S0140-6736(02)07674-2; Whitehead J., 1980, Applied Statistics, V29, P268, DOI 10.2307/2346901; Zachor DA, 2011, RES DEV DISABIL, V32, P2950, DOI 10.1016/j.ridd.2011.05.007	45	127	143	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					75	84		10.1001/jama.2013.7222	http://dx.doi.org/10.1001/jama.2013.7222			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175SK	23821091	Bronze			2022-12-28	WOS:000321253000025
J	Ulitsky, I; Bartel, DP				Ulitsky, Igor; Bartel, David P.			lincRNAs: Genomics, Evolution, and Mechanisms	CELL			English	Review							LONG NONCODING RNA; PROTEIN-CODING GENE; X-CHROMOSOME INACTIVATION; XIST GENE; COMPUTATIONAL IDENTIFICATION; TRANSCRIPTIONAL NOISE; ACTIVE CHROMATIN; WIDE ANALYSIS; REVEALS; EXPRESSION	Long intervening noncoding RNAs (lincRNAs) are transcribed from thousands of loci in mammalian genomes and might play widespread roles in gene regulation and other cellular processes. This Review outlines the emerging understanding of lincRNAs in vertebrate animals, with emphases on how they are being identified and current conclusions and questions regarding their genomics, evolution and mechanisms of action.	[Ulitsky, Igor; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ulitsky, Igor; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Ulitsky, Igor; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu	Ulitsky, Igor/HCH-7453-2022	Ulitsky, Igor/0000-0003-0555-6561	NIH [GM067031]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Shkumatava, M. Cabili, B. Kleaveland, L. Boyer, and other colleagues for stimulating discussions and for helpful comments on this manuscript. Our work on lincRNAs is supported by NIH grant GM067031. D.B. is an Investigator of the Howard Hughes Medical Institute.	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anguera MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002248; Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beletskii A, 2001, P NATL ACAD SCI USA, V98, P9215, DOI 10.1073/pnas.161173098; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bieberstein NI, 2012, CELL REP, V2, P62, DOI 10.1016/j.celrep.2012.05.019; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Broadbent KM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r56; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; Brockdorff N, 2013, RNA, V19, P429, DOI 10.1261/rna.037598.112; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Brown JA, 2012, P NATL ACAD SCI USA, V109, P19202, DOI 10.1073/pnas.1217338109; Brunner AL, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r75; Bussotti G, 2011, NUCLEIC ACIDS RES, V39, P6886, DOI 10.1093/nar/gkr335; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Caparros ML, 2002, CYTOGENET GENOME RES, V99, P99, DOI 10.1159/000071580; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; COCCIA EM, 1992, MOL CELL BIOL, V12, P3514, DOI 10.1128/MCB.12.8.3514; Conrad NK, 2006, MOL CELL, V24, P943, DOI 10.1016/j.molcel.2006.10.029; Crowe ML, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-16; de Almeida SF, 2011, NAT STRUCT MOL BIOL, V18, P977, DOI 10.1038/nsmb.2123; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Elisaphenko EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002521; Feuerhahn S, 2010, FEBS LETT, V584, P3812, DOI 10.1016/j.febslet.2010.07.032; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gorodkin J, 2010, TRENDS BIOTECHNOL, V28, P9, DOI 10.1016/j.tibtech.2009.09.006; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; HACKETT PB, 1986, J MOL BIOL, V190, P45, DOI 10.1016/0022-2836(86)90074-4; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; He S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-102; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ishii N, 2006, J HUM GENET, V51, P1087, DOI 10.1007/s10038-006-0070-9; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Khachane AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-435; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kloc M, 2005, DEVELOPMENT, V132, P3445, DOI 10.1242/dev.01919; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kowalczyk MS, 2012, NATURE, V482, P310, DOI 10.1038/482310a; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu JF, 2006, PLOS GENET, V2, P529, DOI 10.1371/journal.pgen.0020029; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Liu XF, 2012, EMBO J, V31, P4415, DOI 10.1038/emboj.2012.292; Maenner S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000276; Managadze D, 2011, GENOME BIOL EVOL, V3, P1390, DOI 10.1093/gbe/evr116; Marques AC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r102; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Menschaert G, 2013, MOL CELL PROTEOMICS, V12, P1780, DOI 10.1074/mcp.M113.027540; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2012, NAT BIOTECHNOL, V30, P99, DOI 10.1038/nbt.2024; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Mitton-Fry RM, 2010, SCIENCE, V330, P1244, DOI 10.1126/science.1195858; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Murthy UMS, 2010, FEBS LETT, V584, P1531, DOI 10.1016/j.febslet.2010.03.003; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Nam JW, 2012, GENOME RES, V22, P2529, DOI 10.1101/gr.140475.112; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Novikova IV, 2012, NUCLEIC ACIDS RES, V40, P5034, DOI 10.1093/nar/gks071; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rapicavoli NA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-49; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Sarma Kavitha, 2010, Proc Natl Acad Sci U S A, V107, P22196, DOI 10.1073/pnas.1009785107; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schorderet P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002071; Schultes EA, 2005, NAT STRUCT MOL BIOL, V12, P1130, DOI 10.1038/nsmb1014; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sone M, 2007, J CELL SCI, V120, P2498, DOI 10.1242/jcs.009357; Souquere S, 2010, MOL BIOL CELL, V21, P4020, DOI 10.1091/mbc.E10-08-0690; Stadler PF, 2010, LECT N BIOINFORMAT, V6268, P1, DOI 10.1007/978-3-642-15060-9_1; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Sun R, 1996, P NATL ACAD SCI USA, V93, P11883, DOI 10.1073/pnas.93.21.11883; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tan MH, 2013, GENOME RES, V23, P201, DOI 10.1101/gr.141424.112; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tsuiji H, 2011, GENES CELLS, V16, P479, DOI 10.1111/j.1365-2443.2011.01502.x; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Tycowski KT, 2012, CELL REP, V2, P26, DOI 10.1016/j.celrep.2012.05.020; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang J, 2004, NATURE, V431, DOI 10.1038/nature03016; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Washietl S, 2011, RNA, V17, P578, DOI 10.1261/rna.2536111; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112; WOESE CR, 1980, NUCLEIC ACIDS RES, V8, P2275, DOI 10.1093/nar/8.10.2275; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Xie C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002942; Yao HJ, 2010, GENE DEV, V24, P2543, DOI 10.1101/gad.1967810; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yin QF, 2012, MOL CELL, V48, P219, DOI 10.1016/j.molcel.2012.07.033; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zhu LC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-47; Ziats MN, 2013, J MOL NEUROSCI, V49, P589, DOI 10.1007/s12031-012-9880-8	182	1857	1951	13	415	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					26	46		10.1016/j.cell.2013.06.020	http://dx.doi.org/10.1016/j.cell.2013.06.020			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827673	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000321327900008
J	Cappa, C; Moneti, F; Wardlaw, T; Bissell, S				Cappa, Claudia; Moneti, Francesca; Wardlaw, Tessa; Bissell, Susan			Elimination of female genital mutilation/cutting	LANCET			English	Editorial Material									[Cappa, Claudia; Wardlaw, Tessa] UNICEF, Stat & Monitoring Sect, New York, NY 10017 USA; [Moneti, Francesca; Bissell, Susan] UNICEF, Child Protect Sect, New York, NY 10017 USA	UNICEF; UNICEF	Cappa, C (corresponding author), UNICEF, Stat & Monitoring Sect, New York, NY 10017 USA.	ccappa@unicef.org						Bicchieri C, 2011, SOCIAL NORMS; Hosken F, 1994, WOMENS INT NETWORK N; Mackie G, 2009, SOCIAL DYNAMICS ABAN; UN General Assembly, 2013, INT GLOB EFF EL FEM; UNICEF, 2013, FEM GEN MUT CUTT STA	5	4	4	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 28	2013	382	9898					1080	1081		10.1016/S0140-6736(13)61532-9	http://dx.doi.org/10.1016/S0140-6736(13)61532-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	228SG	23886657				2022-12-28	WOS:000325208100009
J	Shah, ASV; Langrish, JP; Nair, H; McAllister, DA; Hunter, AL; Donaldson, K; Newby, DE; Mills, NL				Shah, Anoop S. V.; Langrish, Jeremy P.; Nair, Harish; McAllister, David A.; Hunter, Amanda L.; Donaldson, Ken; Newby, David E.; Mills, Nicholas L.			Global association of air pollution and heart failure: a systematic review and meta-analysis	LANCET			English	Review							EMERGENCY-DEPARTMENT VISITS; LONG-TERM EXPOSURE; DIESEL-EXHAUST INHALATION; DAILY HOSPITAL ADMISSIONS; FINE PARTICULATE MATTER; CASE-CROSSOVER ANALYSIS; CARDIOVASCULAR-DISEASE; CARBON-MONOXIDE; DAILY MORTALITY; TIME-SERIES	Background Acute exposure to air pollution has been linked to myocardial infarction, but its effect on heart failure is uncertain. We did a systematic review and meta-analysis to assess the association between air pollution and acute decompensated heart failure including hospitalisation and heart failure mortality. Methods Five databases were searched for studies investigating the association between daily increases in gaseous (carbon monoxide, sulphur dioxide, nitrogen dioxide, ozone) and particulate (diameter <2.5 mu m [PM2.5] or <10 mu m [PM10]) air pollutants, and heart failure hospitalisations or heart failure mortality. We used a random-effects model to derive overall risk estimates per pollutant. Findings Of 1146 identified articles, 195 were reviewed in-depth with 35 satisfying inclusion criteria. Heart failure hospitalisation or death was associated with increases in carbon monoxide (3.52% per 1 part per million; 95% CI 2.52-4.54), sulphur dioxide (2.36% per 10 parts per billion; 1.35-3.38), and nitrogen dioxide (1.70% per 10 parts per billion; 1.25-2.16), but not ozone (0.46% per 10 parts per billion; -0.10 to 1.02) concentrations. Increases in particulate matter con centration were associated with heart failure hospitalisation or death (PM2.5 2.12% per 10 mu g/m(3), 95% CI 1.42-2.82; PM10 1.63% per 10 mu g/m(3), 95% CI 1.20-2.07). Strongest associations were seen on the day of exposure, with more persistent effects for PM2.5. In the USA, we estimate that a mean reduction in PM2.5 of 3.9 mu g/m(3) would prevent 7978 heart failure hospitalisations and save a third of a billion US dollars a year. Interpretation Air pollution has a close temporal association with heart failure hospitalisation and heart failure mortality. Although more studies from developing nations are required, air pollution is a pervasive public health issue with major cardiovascular and health economic consequences, and it should remain a key target for global health policy.	[Shah, Anoop S. V.; Langrish, Jeremy P.; Hunter, Amanda L.; Donaldson, Ken; Newby, David E.; Mills, Nicholas L.] Univ Edinburgh, BHF Univ Ctr Cardiovasc Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Nair, Harish; McAllister, David A.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Nair, Harish] Publ Hlth Fdn India, New Delhi, India	University of Edinburgh; University of Edinburgh; Public Health Foundation of India	Mills, NL (corresponding author), Univ Edinburgh, BHF Univ Ctr Cardiovasc Sci, Chancellors Bldg, Edinburgh EH16 4SB, Midlothian, Scotland.	nick.mills@ed.ac.uk	Newby, David Ernest/AAB-1364-2019; Nair, Harish/E-7431-2010	Nair, Harish/0000-0002-9432-9100; Shah, Anoop/0000-0002-2825-3419; McAllister, David/0000-0003-3550-1764; Mills, Nicholas/0000-0003-0533-7991	British Heart Foundation; MRC [G0901697] Funding Source: UKRI; British Heart Foundation [RG/10/9/28286, PG/11/27/28842, FS/10/024/28266] Funding Source: researchfish; Medical Research Council [G0901697] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	British Heart Foundation.	ALLRED EN, 1989, NEW ENGL J MED, V321, P1426, DOI 10.1056/NEJM198911233212102; American Thoracic Society, 2012, ATS TEST EPA FIELD H; Barnett AG, 2006, ENVIRON HEALTH PERSP, V114, P1018, DOI 10.1289/ehp.8674; Bateson TF, 2004, EPIDEMIOLOGY, V15, P143, DOI 10.1097/01.ede.0000112210.68754.fa; Bell ML, 2009, CIRCULATION, V120, P949, DOI 10.1161/CIRCULATIONAHA.109.851113; Belleudi V, 2010, EPIDEMIOLOGY, V21, P414, DOI 10.1097/EDE.0b013e3181d5c021; Berry C, 2001, EUR J HEART FAIL, V3, P283, DOI 10.1016/S1388-9842(01)00123-4; Briggs D, 2003, BRIT MED BULL, V68, P1, DOI 10.1093/bmb/ldg019; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Burnett RT, 1999, ARCH ENVIRON HEALTH, V54, P130, DOI 10.1080/00039899909602248; Burnett RT, 1997, EPIDEMIOLOGY, V8, P162, DOI 10.1097/00001648-199703000-00007; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Colais P, 2012, EPIDEMIOLOGY, V23, P473, DOI 10.1097/EDE.0b013e31824d5a85; Colais P, 2009, EPIDEMIOL PREV, V33, P77; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Dominici F, 2002, AM J EPIDEMIOL, V156, P193, DOI 10.1093/aje/kwf062; Dominici F, 2010, EPIDEMIOLOGY, V21, P187, DOI 10.1097/EDE.0b013e3181cc86e8; Dunlay SM, 2009, J AM COLL CARDIOL, V54, P1695, DOI 10.1016/j.jacc.2009.08.019; Dunlay SM, 2009, AM J MED, V122, P1023, DOI 10.1016/j.amjmed.2009.04.022; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evans J, 2013, ENVIRON RES, V120, P33, DOI 10.1016/j.envres.2012.08.005; FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243; Forastiere F, 2008, EPIDEMIOLOGY, V19, P571, DOI 10.1097/EDE.0b013e3181761f8a; Fung KY, 2003, INT J EPIDEMIOL, V32, P1064, DOI 10.1093/ije/dyg246; Global Health Observatory Data Repository, 2008, GLOB HLTH OBS DAT RE; Goldberg MS, 2003, ENVIRON RES, V91, P8, DOI 10.1016/S0013-9351(02)00022-1; Gomez AM, 2001, CIRCULATION, V104, P688, DOI 10.1161/hc3201.092285; Guttikunda SK, 2013, ATMOS ENVIRON, V67, P101, DOI 10.1016/j.atmosenv.2012.10.040; Haley VB, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-42; Health Effects Institute, 2003, REV AN TIM SER STUD; Healthcare Cost and Utilization Project, 2008, HCUP FACTS FIG STAT; Hoek G, 2001, EPIDEMIOLOGY, V12, P355, DOI 10.1097/00001648-200105000-00017; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Koken PJM, 2003, ENVIRON HEALTH PERSP, V111, P1312, DOI 10.1289/ehp.5957; Kwon HJ, 2001, EPIDEMIOLOGY, V12, P413, DOI 10.1097/00001648-200107000-00011; Langrish JP, 2012, ENVIRON HEALTH PERSP, V120, P367, DOI 10.1289/ehp.1103898; Langrish JP, 2010, INHAL TOXICOL, V22, P192, DOI 10.3109/08958370903144105; Lee IM, 2007, INHAL TOXICOL, V19, P899, DOI 10.1080/08958370701479406; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Linn WS, 2000, ENVIRON HEALTH PERSP, V108, P427, DOI 10.2307/3454383; Lippmann M, 2000, Res Rep Health Eff Inst, P5; Lucking AJ, 2008, EUR HEART J, V29, P3043, DOI 10.1093/eurheartj/ehn464; Lumley T, 1999, BIAS CASE CROSSOVER; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Martins LC, 2006, REV SAUDE PUBL, V40, P677, DOI 10.1590/S0034-89102006000500018; McGowan JA, 2002, AUST NZ J PUBL HEAL, V26, P23, DOI 10.1111/j.1467-842X.2002.tb00266.x; Metzger KB, 2004, EPIDEMIOLOGY, V15, P46, DOI 10.1097/01.EDE.0000101748.28283.97; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Mills NL, 2011, EUR HEART J, V32, P2660, DOI 10.1093/eurheartj/ehr195; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Molina MJ, 2004, J AIR WASTE MANAGE, V54, P644, DOI 10.1080/10473289.2004.10470936; Morris RD, 1998, ENVIRON HEALTH PERSP, V106, P649; MORRIS RD, 1995, AM J PUBLIC HEALTH, V85, P1361, DOI 10.2105/AJPH.85.10.1361; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9; NIEDERMAIER ON, 1993, CIRCULATION, V88, P562, DOI 10.1161/01.CIR.88.2.562; Peel JL, 2007, AM J EPIDEMIOL, V165, P625, DOI 10.1093/aje/kwk051; Peters A, 2000, EPIDEMIOLOGY, V11, P11, DOI 10.1097/00001648-200001000-00005; Peters A, 2001, CIRCULATION, V103, P2810; Pieters N, 2012, HEART, V98, P1127, DOI 10.1136/heartjnl-2011-301505; Poloniecki JD, 1997, OCCUP ENVIRON MED, V54, P535, DOI 10.1136/oem.54.8.535; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Rich DQ, 2008, ENVIRON HEALTH PERSP, V116, P1167, DOI 10.1289/ehp.11230; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; SCHWARTZ J, 1995, AM J EPIDEMIOL, V142, P23, DOI 10.1093/oxfordjournals.aje.a117541; Stieb DM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-25; Stieb DM, 2000, J EXPO ANAL ENV EPID, V10, P461, DOI 10.1038/sj.jea.7500112; Tsai DH, 2012, HYPERTENSION, V60, P1061, DOI 10.1161/HYPERTENSIONAHA.112.195370; Ueda K, 2009, CIRC J, V73, P1248, DOI 10.1253/circj.CJ-08-1149; Wellenius GA, 2006, AM J CARDIOL, V97, P404, DOI 10.1016/j.amjcard.2005.08.061; Wellenius GA, 2005, AM J EPIDEMIOL, V161, P1030, DOI 10.1093/aje/kwi135; Wellenius GA, 2012, ARCH INTERN MED, V172, P229, DOI 10.1001/archinternmed.2011.732; Wold LE, 2012, CIRC-HEART FAIL, V5, P452, DOI 10.1161/CIRCHEARTFAILURE.112.966580; Wong CA, 1999, J EPIDEMIOL COMMUN H, V53, P580, DOI 10.1136/jech.53.9.580; Wong TW, 1999, OCCUP ENVIRON MED, V56, P679, DOI 10.1136/oem.56.10.679; Yang CY, 2008, J TOXICOL ENV HEAL A, V71, P1085, DOI 10.1080/15287390802114428; Ye F, 2001, ENVIRON HEALTH PERSP, V109, P355, DOI 10.2307/3454894; Zanobetti A, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-58; Zevin S, 2001, J AM COLL CARDIOL, V38, P1633, DOI 10.1016/S0735-1097(01)01616-3	86	713	754	19	379	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2013	382	9897					1039	1048		10.1016/S0140-6736(13)60898-3	http://dx.doi.org/10.1016/S0140-6736(13)60898-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222PB	23849322	Green Published, Green Accepted			2022-12-28	WOS:000324742200024
J	Yagi, K; Yunes, N				Yagi, Kent; Yunes, Nicolas			I-Love-Q: Unexpected Universal Relations for Neutron Stars and Quark Stars	SCIENCE			English	Article							EQUATION-OF-STATE; MULTIPOLE MOMENTS; DENSE MATTER; SPACE	Neutron stars and quark stars are not only characterized by their mass and radius but also by how fast they spin, through their moment of inertia, and how much they can be deformed, through their Love number and quadrupole moment. These depend sensitively on the star's internal structure and thus on unknown nuclear physics. We find universal relations between the moment of inertia, the Love number, and the quadrupole moment that are independent of the neutron and quark star's internal structure. These can be used to learn about neutron star deformability through observations of the moment of inertia, break degeneracies in gravitational wave detection to measure spin in binary inspirals, distinguish neutron stars from quark stars, and test general relativity in a nuclear structure-independent fashion.	[Yagi, Kent; Yunes, Nicolas] Montana State Univ, Dept Phys, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Yagi, K (corresponding author), Montana State Univ, Dept Phys, Bozeman, MT 59717 USA.	kyagi@physics.montana.edu	Yunes, Nicolas/AAG-3146-2019	Yunes, Nicolas/0000-0001-6147-1736	NSF [PHY-1114374]; NASA [NNX11AI49G]	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	We thank E. O'Connor and B. Lackey for providing tabulated EoSs, as well as E. Berti, L. Blanchet, V. Cardoso, T. Hinderer, K. Hotokezaka, M. Kramer, L. Lindblom, F. Nakano, F. Ozel, P. Pani, E. Poisson, S. Ransom, L. Rezzolla, M. Shibata, T. Tanaka, and four anonymous reviewers for their comments. We also thank the Yukawa Institute for Theoretical Physics at Kyoto University, where this work was initiated during the Long-Term Workshop YITP-T-12-03 on "Gravity and Cosmology 2012." N.Y. acknowledges support from NSF grant PHY-1114374, as well as support provided by NASA grant NNX11AI49G.	Akmal A, 1998, PHYS REV C, V58, P1804, DOI 10.1103/PhysRevC.58.1804; Alexander S, 2009, PHYS REP, V480, P1, DOI 10.1016/j.physrep.2009.07.002; Ali-Haimoud Y, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.124033; Burgay M, 2003, NATURE, V426, P531, DOI 10.1038/nature02124; Damour T., 1983, P 2 M GROSSM M GEN R; Damour T, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.123007; Douchin F, 2001, ASTRON ASTROPHYS, V380, P151, DOI 10.1051/0004-6361:20011402; Flanagan EE, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.021502; GEROCH R, 1970, J MATH PHYS, V11, P2580, DOI 10.1063/1.1665427; HANSEN RO, 1974, J MATH PHYS, V15, P46, DOI 10.1063/1.1666501; HARTLE JB, 1967, ASTROPHYS J, V150, P1005, DOI 10.1086/149400; HAWKING SW, 1972, COMMUN MATH PHYS, V25, P152, DOI 10.1007/BF01877517; Hinderer T, 2008, ASTROPHYS J, V677, P1216, DOI 10.1086/533487; Hinderer T, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.123016; Kramer M, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/7/073001; Lattimer JM, 2007, PHYS REP, V442, P109, DOI 10.1016/j.physrep.2007.02.003; Lattimer JM, 2005, ASTROPHYS J, V629, P979, DOI 10.1086/431543; LATTIMER JM, 1991, NUCL PHYS A, V535, P331, DOI 10.1016/0375-9474(91)90452-C; Lattimer JM, 2001, ASTROPHYS J, V550, P426, DOI 10.1086/319702; Ozel F, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/1/016901; PANDHARIPANDE VR, 1975, NUCL PHYS A, VA237, P507, DOI 10.1016/0375-9474(75)90415-7; Poisson E, 1998, PHYS REV D, V57, P5287, DOI 10.1103/PhysRevD.57.5287; Postnikov S, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.024016; PRAKASH M, 1995, PHYS REV D, V52, P661, DOI 10.1103/PhysRevD.52.661; Shen H, 1998, NUCL PHYS A, V637, P435, DOI 10.1016/S0375-9474(98)00236-X; Stairs Ingrid H, 2003, Living Rev Relativ, V6, P5, DOI 10.12942/lrr-2003-5; Will CM, 2006, LIVING REV RELATIV, V9, DOI 10.12942/lrr-2006-3	29	249	250	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					365	368		10.1126/science.1236462	http://dx.doi.org/10.1126/science.1236462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888033	Green Submitted			2022-12-28	WOS:000322259200041
J	Baugh, CW; Schuur, JD				Baugh, Christopher W.; Schuur, Jeremiah D.			Observation Care - High-Value Care or a Cost-Shifting Loophole?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								<p id="p002">Protocolized observation care in dedicated hospital units can result in higher-value care for some conditions, but by treating observation billing for inpatient care the same as for observation-unit care, current policy promotes cost shifting without rewarding higher value. <p id="p003">A 2012 New York Times article told the story of Miriam Nyman, an 83-year-old Rhode Island woman who was hospitalized after a fall in 2009.(1) Mrs. Nyman broke her neck and spent 4 nights in the hospital, so she was shocked to learn that the entire hospitalization was classified as an outpatient visit and billed as an observation stay. That meant that her subsequent stay in a skilled nursing facility was not covered by Medicare, and she was left with more than $35,000 in out-of-pocket expenses. Similar cases reported elsewhere in the United States highlight a critical and overlooked Medicare ...	[Baugh, Christopher W.; Schuur, Jeremiah D.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Baugh, CW (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.		Baugh, Christopher William/AAJ-3688-2021	Baugh, Christopher William/0000-0002-2360-1891				American Hospital's Association, 2013, EXPL IMP RAC PROGR H; Baugh CW, 2012, HEALTH AFFAIR, V31, P2314, DOI 10.1377/hlthaff.2011.0926; Feng ZL, 2012, HEALTH AFFAIR, V31, P1251, DOI 10.1377/hlthaff.2012.0129; Medicare Payment Advisory Commission, 2012, EXPL IMP RAC PROGR H; Span P., 2012, NEW YORK TIMES  0622	5	52	52	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					302	305		10.1056/NEJMp1304493	http://dx.doi.org/10.1056/NEJMp1304493			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	188VJ	23883376				2022-12-28	WOS:000322223900004
J	Yefsah, T; Sommer, AT; Ku, MJH; Cheuk, LW; Ji, WJ; Bakr, WS; Zwierlein, MW				Yefsah, Tarik; Sommer, Ariel T.; Ku, Mark J. H.; Cheuk, Lawrence W.; Ji, Wenjie; Bakr, Waseem S.; Zwierlein, Martin W.			Heavy solitons in a fermionic superfluid	NATURE			English	Article							DARK SOLITONS; CONDENSATE; DEPLETION; DYNAMICS; STATES; WAVES	Solitons-solitary waves that maintain their shape as they propagate-occur as water waves in narrow canals, as light pulses in optical fibres and as quantum mechanical matter waves in superfluids and superconductors. Their highly nonlinear and localized nature makes them very sensitive probes of the medium in which they propagate. Here we create long-lived solitons in a strongly interacting superfluid of fermionic atoms and directly observe their motion. As the interactions are tuned from the regime of Bose-Einstein condensation of tightly bound molecules towards the Bardeen-Cooper-Schrieffer limit of long-range Cooper pairs, the solitons' effective mass increases markedly, to more than 200 times their bare mass, signalling strong quantum fluctuations. This mass enhancement is more than 50 times larger than the theoretically predicted value. Our work provides a benchmark for theories of non-equilibrium dynamics of strongly interacting fermions.	[Yefsah, Tarik; Sommer, Ariel T.; Ku, Mark J. H.; Cheuk, Lawrence W.; Ji, Wenjie; Bakr, Waseem S.; Zwierlein, Martin W.] MIT, Dept Phys, Elect Res Lab, MIT Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Zwierlein, MW (corresponding author), MIT, Dept Phys, Elect Res Lab, MIT Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA.	zwierlein@mit.edu	Yefsah, Tarik/AAA-1429-2019	Yefsah, Tarik/0000-0002-6024-5611; /0000-0003-1391-0428; Sommer, Ariel/0000-0003-3390-4455; Cheuk, Lawrence/0000-0002-8329-8812; /0000-0001-8120-8548; Ku, Mark Jen-Hao/0000-0003-3144-3069	NSF; ARO MURI on Atomtronics; AFOSR PECASE; ONR; Army Research Office; DARPA OLE programme; David and Lucile Packard Foundation; Direct For Mathematical & Physical Scien [0969311] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); ARO MURI on Atomtronics; AFOSR PECASE; ONR(Office of Naval Research); Army Research Office; DARPA OLE programme; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank L. Pitaevskii, S. Stringari, F. Dalfovo, W. Zwerger and D. Huse for discussions. This work was supported by the NSF, the ARO MURI on Atomtronics, AFOSR PECASE, ONR, a grant from the Army Research Office with funding from the DARPA OLE programme, and the David and Lucile Packard Foundation.	Adams A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/115009; Anderson BP, 2001, PHYS REV LETT, V86, P2926, DOI 10.1103/PhysRevLett.86.2926; Antezza M, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.043610; Becker C, 2008, NAT PHYS, V4, P496, DOI 10.1038/nphys962; Bertaina G, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.150402; Bulgac A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.150401; Bulgac A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.215301; Burger S, 1999, PHYS REV LETT, V83, P5198, DOI 10.1103/PhysRevLett.83.5198; Busch T, 2000, PHYS REV LETT, V84, P2298, DOI 10.1103/PhysRevLett.84.2298; Busch T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.010401; CAROLI C, 1964, PHYS LETT, V9, P307, DOI 10.1016/0031-9163(64)90375-0; Denschlag J, 2000, SCIENCE, V287, P97, DOI 10.1126/science.287.5450.97; Dutton Z, 2001, SCIENCE, V293, P663, DOI 10.1126/science.1062527; Dziarmaga J, 2005, LASER PHYS, V15, P674; Dziarmaga J, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.043620; Dziarmaga J, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.043615; Engels P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.160405; Feder DL, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.053606; Fedichev PO, 1999, PHYS REV A, V60, P3220, DOI 10.1103/PhysRevA.60.3220; Frantzeskakis DJ, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/21/213001; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; Goldstone J., 1981, Physical Review Letters, V47, P986, DOI 10.1103/PhysRevLett.47.986; HEEGER AJ, 1988, REV MOD PHYS, V60, P781, DOI 10.1103/RevModPhys.60.781; JACKIW R, 1976, PHYS REV D, V13, P3398, DOI 10.1103/PhysRevD.13.3398; Karpiuk T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.205302; Keranen V, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.121901; Keranen V, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.126011; Ketterle W, 2008, RIV NUOVO CIMENTO, V31, P247, DOI 10.1393/ncr/i2008-10033-1; Konotop VV, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.240403; Ku MJH, 2012, SCIENCE, V335, P563, DOI 10.1126/science.1214987; Law CK, 2002, J PHYS B-AT MOL OPT, V35, P3583, DOI 10.1088/0953-4075/35/16/316; Liao RY, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.041604; Lutchyn RM, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.033609; Martin AD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.194102; Middelkamp S, 2011, PHYS LETT A, V375, P642, DOI 10.1016/j.physleta.2010.11.025; Mishmash RV, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.140403; Monceau P, 2012, ADV PHYS, V61, P325, DOI 10.1080/00018732.2012.719674; Muryshev AE, 1999, PHYS REV A, V60, pR2665, DOI 10.1103/PhysRevA.60.R2665; Radzihovsky L, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.023611; Schirotzek A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.140403; Scott RG, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023044; Scott RG, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.185301; Spuntarelli A, 2010, PHYS REP, V488, P111, DOI 10.1016/j.physrep.2009.12.005; Spuntarelli A, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/035010; Walczak PB, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.013611; Weller A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.130401; Yoshida N, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.063601; Zurek WH, 1996, PHYS REP, V276, P177, DOI 10.1016/S0370-1573(96)00009-9; Zwerger W., 2011, LECT NOTES PHYS, V836; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858	50	131	132	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					426	430		10.1038/nature12338	http://dx.doi.org/10.1038/nature12338			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23863930	Green Submitted			2022-12-28	WOS:000322157900030
J	Chinthapalli, K				Chinthapalli, Krishna			PALLIATIVE CARE The birth and death of the Liverpool care pathway	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				Doughty, 2012, DAILY MAIL; Economist Intelligence Unit, 2010, QUAL DEATH RANK END; Hawkes N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4568; Koestler-Grack RA, 2009, M CURIE SCI; Neuberger J., 2013, MORE CARE LESS PATHW	5	7	7	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2013	347								f4669	10.1136/bmj.f4669	http://dx.doi.org/10.1136/bmj.f4669			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BM	23884973				2022-12-28	WOS:000322531800012
J	Svansoe, VL				Svansoe, Vibeke Lyngklip			PATIENT SAFETY Patient safety without the blame game	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Berlingske, Copenhagen, Denmark		Svansoe, VL (corresponding author), Berlingske, Copenhagen, Denmark.	vs@berlingske.dk						Danish Patient Safety Database, ARSB 2012; Danish Patient Safety Database, 2013, MED UDST; Danish Patient Safety Database, 2011, ARSB 2011; DSI Institut for Sundhedsv&aelig;sen, 2001, UT HAEND DANSK SYG; National Agency of Patients' Rights and Complaints, 2011, CARD; National Institute of Municipal and Regional Analysis and Research, 2013, FORSKN KVAL PAT DANM; Norwegian Knowledge Centre for the Health Services, 2012, REP LEARN CENTR 2012; Vibjerg T., 2013, MORGENAVISEN JYLLAND	8	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2013	347								f4615	10.1136/bmj.f4615	http://dx.doi.org/10.1136/bmj.f4615			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BM	23884971				2022-12-28	WOS:000322531800010
J	Gunanathan, C; Milstein, D				Gunanathan, Chidambaram; Milstein, David			Applications of Acceptorless Dehydrogenation and Related Transformations in Chemical Synthesis	SCIENCE			English	Review							METAL-LIGAND COOPERATION; THERMOCHEMICAL ALKANE DEHYDROGENATION; CATALYZED N-ALKYLATION; SECONDARY ALCOHOLS; AROMATIZATION-DEAROMATIZATION; SELECTIVE SYNTHESIS; HYDROGEN-PRODUCTION; BORROWING HYDROGEN; HYDRIDE TRANSFER; TERTIARY-AMINES	Conventional oxidations of organic compounds formally transfer hydrogen atoms from the substrate to an acceptor molecule such as oxygen, a metal oxide, or a sacrificial olefin. In acceptorless dehydrogenation (AD) reactions, catalytic scission of C-H, N-H, and/or O-H bonds liberates hydrogen gas with no need for a stoichiometric oxidant, thereby providing efficient, nonpolluting activation of substrates. In addition, the hydrogen gas is valuable in itself as a high-energy, clean fuel. Here, we review AD reactions selectively catalyzed by transition metal complexes, as well as related transformations that rely on intermediates derived from reversible dehydrogenation. We delineate the methodologies evolving from this recent concept and highlight the effect of these reactions on chemical synthesis.	[Gunanathan, Chidambaram] NISER, Sch Chem Sci, Bhubaneswar 751005, Orissa, India; [Milstein, David] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel	National Institute of Science Education & Research (NISER); Weizmann Institute of Science	Milstein, D (corresponding author), Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel.	david.milstein@weizmann.ac.il	Milstein, David/E-9092-2012; Chidambaram, Gunanathan/I-3528-2012	Milstein, David/0000-0002-2320-0262; 	European Research Council (ERC) [246837]; Kimmel Center for Molecular Design	European Research Council (ERC)(European Research Council (ERC)); Kimmel Center for Molecular Design	Supported by the European Research Council (ERC) under the FP7 framework (no. 246837) and by the Kimmel Center for Molecular Design. C. G. thanks the Department of Science and Technology and NISER, and he is a Ramanujan Fellow. D. M. is the Israel Matz Professorial Chair of Organic Chemistry.	AOKI T, 1993, ORGANOMETALLICS, V12, P294, DOI 10.1021/om00026a013; Bahn S, 2011, CHEMCATCHEM, V3, P1853, DOI 10.1002/cctc.201100255; Balaraman E, 2013, NAT CHEM, V5, P122, DOI [10.1038/NCHEM.1536, 10.1038/nchem.1536]; Balaraman E, 2011, ANGEW CHEM INT EDIT, V50, P11702, DOI 10.1002/anie.201106612; Balaraman E, 2011, NAT CHEM, V3, P609, DOI [10.1038/NCHEM.1089, 10.1038/nchem.1089]; Balaraman E, 2010, J AM CHEM SOC, V132, P16756, DOI 10.1021/ja1080019; BAUDRY D, 1983, J CHEM SOC CHEM COMM, P788, DOI 10.1039/c39830000788; Berliner MA, 2011, ORG PROCESS RES DEV, V15, P1052, DOI 10.1021/op200174k; BLUM Y, 1985, J ORGANOMET CHEM, V282, pC7, DOI 10.1016/0022-328X(85)87154-0; Bower JF, 2011, TOP ORGANOMETAL CHEM, V34, P107, DOI 10.1007/978-3-642-15334-1_5; BURK MJ, 1984, ORGANOMETALLICS, V3, P816, DOI 10.1021/om00083a034; Cami-Kobeci G, 2004, CHEM COMMUN, P1072, DOI 10.1039/b402020k; Cantillo D, 2011, EUR J INORG CHEM, P3008, DOI 10.1002/ejic.201100443; CHARMAN HB, 1970, J CHEM SOC B, P584, DOI 10.1039/j29700000584; Chen C, 2011, J ORG CHEM, V76, P10005, DOI 10.1021/jo201756z; Choi J, 2011, CHEM REV, V111, P1761, DOI 10.1021/cr1003503; CRABTREE RH, 1979, J AM CHEM SOC, V101, P7738, DOI 10.1021/ja00520a030; Dobereiner GE, 2010, CHEM REV, V110, P681, DOI 10.1021/cr900202j; DOBSON A, 1975, J ORGANOMET CHEM, V87, pC52, DOI 10.1016/S0022-328X(00)88159-0; Eary CT, 2006, TETRAHEDRON LETT, V47, P6899, DOI 10.1016/j.tetlet.2006.07.033; Edwards MG, 2002, ANGEW CHEM INT EDIT, V41, P4740, DOI 10.1002/anie.200290034; Esteruelas MA, 2011, ORGANOMETALLICS, V30, P2468, DOI 10.1021/om200290u; Fujita K, 2005, ORG LETT, V7, P4017, DOI 10.1021/ol051517o; Fujita K, 2003, TETRAHEDRON LETT, V44, P2687, DOI 10.1016/S0040-4039(03)00371-X; Fujita K, 2007, ORG LETT, V9, P109, DOI 10.1021/ol062806v; Fujita K, 2011, ORG LETT, V13, P2278, DOI 10.1021/ol2005424; Gargir M, 2012, ORGANOMETALLICS, V31, P6207, DOI 10.1021/om300516j; Gnanaprakasam B, 2012, J POLYM SCI POL CHEM, V50, P1755, DOI 10.1002/pola.25943; Gnanaprakasam B, 2011, ANGEW CHEM INT EDIT, V50, P12240, DOI 10.1002/anie.201105876; Gnanaprakasam B, 2011, J AM CHEM SOC, V133, P1682, DOI 10.1021/ja109944n; Gnanaprakasam B, 2010, ADV SYNTH CATAL, V352, P3169, DOI 10.1002/adsc.201000663; Gnanaprakasam B, 2010, ANGEW CHEM INT EDIT, V49, P1468, DOI 10.1002/anie.200907018; Goldman AS, 2006, SCIENCE, V312, P257, DOI 10.1126/science.1123787; GRIGG R, 1981, TETRAHEDRON LETT, V22, P4107, DOI 10.1016/S0040-4039(01)82078-5; GRIGG R, 1981, J CHEM SOC CHEM COMM, P611, DOI 10.1039/c39810000611; Guerbet M.C.R, 1899, ACAD SCI PARIS, V128, P1002; Guillena G, 2010, CHEM REV, V110, P1611, DOI 10.1021/cr9002159; Gunanathan C, 2008, ANGEW CHEM INT EDIT, V47, P8661, DOI 10.1002/anie.200803229; Gunanathan C, 2007, SCIENCE, V317, P790, DOI 10.1126/science.1145295; Gunanathan C, 2011, TOP ORGANOMETAL CHEM, V37, P55, DOI 10.1007/3418_2011_6; Gunanathan C, 2011, ACCOUNTS CHEM RES, V44, P588, DOI 10.1021/ar2000265; Gunanathan C, 2010, J AM CHEM SOC, V132, P14763, DOI 10.1021/ja107770y; Gunanathan C, 2009, J AM CHEM SOC, V131, P3146, DOI 10.1021/ja808893g; Hamid MHSA, 2009, J AM CHEM SOC, V131, P1766, DOI 10.1021/ja807323a; Hamid MHSA, 2007, ADV SYNTH CATAL, V349, P1555, DOI 10.1002/adsc.200600638; He LP, 2012, ORGANOMETALLICS, V31, P5208, DOI 10.1021/om300422v; Hunsicker DM, 2012, MACROMOL RAPID COMM, V33, P232, DOI 10.1002/marc.201100653; Imm S, 2011, ANGEW CHEM INT EDIT, V50, P7599, DOI 10.1002/anie.201103199; Jensen T, 2009, J ORG CHEM, V74, P3990, DOI 10.1021/jo900341w; Kawahara R, 2012, J AM CHEM SOC, V134, P3643, DOI 10.1021/ja210857z; Kohl SW, 2009, SCIENCE, V324, P74, DOI 10.1126/science.1168600; Kossoy E, 2012, ADV SYNTH CATAL, V354, P497, DOI 10.1002/adsc.201100672; Leung JC, 2012, J AM CHEM SOC, V134, P15700, DOI 10.1021/ja3075049; Li HX, 2012, EUR J INORG CHEM, P5011, DOI 10.1002/ejic.201200473; Li HX, 2011, ORGANOMETALLICS, V30, P5233, DOI 10.1021/om200620n; Ligthart GBWL, 2003, TETRAHEDRON LETT, V44, P1507, DOI 10.1016/S0040-4039(02)02842-3; Liu FC, 1999, CHEM COMMUN, P655, DOI 10.1039/a900631a; Maenaka Y, 2012, J AM CHEM SOC, V134, P9417, DOI 10.1021/ja302788c; Maggi A, 2012, ORGANOMETALLICS, V31, P451, DOI 10.1021/om201095m; Marr AC, 2012, CATAL SCI TECHNOL, V2, P279, DOI 10.1039/c1cy00338k; Martinez R, 2006, TETRAHEDRON, V62, P8982, DOI 10.1016/j.tet.2006.07.012; Miao L, 2009, ORG LETT, V11, P1579, DOI 10.1021/ol9002288; Michlik S, 2013, NAT CHEM, V5, P140, DOI [10.1038/NCHEM.1547, 10.1038/nchem.1547]; Montag M, 2012, J AM CHEM SOC, V134, P10325, DOI 10.1021/ja303121v; MORTON D, 1987, J CHEM SOC CHEM COMM, P248, DOI 10.1039/c39870000248; MURAHASHI S, 1982, TETRAHEDRON LETT, V23, P229, DOI 10.1016/S0040-4039(00)86792-1; MURAHASHI SI, 1981, TETRAHEDRON LETT, V22, P5327, DOI 10.1016/S0040-4039(01)92493-1; MURAHASHI SI, 1987, J ORG CHEM, V52, P4319, DOI 10.1021/jo00228a032; Musa S, 2011, ANGEW CHEM INT EDIT, V50, P3533, DOI 10.1002/anie.201007367; MUZART J, 1992, CHEM REV, V92, P113, DOI 10.1021/cr00009a005; Nielsen M, 2012, ANGEW CHEM INT EDIT, V51, P5711, DOI 10.1002/anie.201200625; Nielsen M, 2011, ANGEW CHEM INT EDIT, V50, P9593, DOI 10.1002/anie.201104722; Nordstrom LU, 2008, J AM CHEM SOC, V130, P17672, DOI 10.1021/ja808129p; Obora Y, 2011, SYNLETT, P30, DOI 10.1055/s-0030-1259094; Oppenauer RV, 1937, RECL TRAV CHIM PAY-B, V56, P137; Pattabiraman VR, 2011, NATURE, V480, P471, DOI 10.1038/nature10702; Pingen D, 2010, ANGEW CHEM INT EDIT, V49, P8130, DOI 10.1002/anie.201002583; Punniyamurthy T, 2005, CHEM REV, V105, P2329, DOI 10.1021/cr050523v; Que L, 2008, NATURE, V455, P333, DOI 10.1038/nature07371; Schley ND, 2011, ORGANOMETALLICS, V30, P4174, DOI 10.1021/om2004755; Sheldon RA, 2002, ACCOUNTS CHEM RES, V35, P774, DOI 10.1021/ar010075n; Slatford PA, 2006, TETRAHEDRON LETT, V47, P6787, DOI 10.1016/j.tetlet.2006.07.069; Spasyuk D, 2012, ORGANOMETALLICS, V31, P5239, DOI 10.1021/om300670r; Spasyuk D, 2012, ANGEW CHEM INT EDIT, V51, P2772, DOI 10.1002/anie.201108956; Srimani D, 2013, ANGEW CHEM INT EDIT, V52, P4012, DOI 10.1002/anie.201300574; Srimani D, 2012, ADV SYNTH CATAL, V354, P2403, DOI 10.1002/adsc.201200438; Tojo G, 2007, BASIC REACT ORG SYNT, P1; TSUJI Y, 1985, J ORG CHEM, V50, P1365, DOI 10.1021/jo00209a004; Walther G, 2011, CHEMSUSCHEM, V4, P1052, DOI 10.1002/cssc.201100187; Watson AJA, 2010, SCIENCE, V329, P635, DOI 10.1126/science.1191843; Whitney S, 2007, ORG LETT, V9, P3299, DOI 10.1021/ol071274v; Xu WW, 1997, CHEM COMMUN, P2273, DOI 10.1039/a705105k; Yamaguchi R, 2008, ORG LETT, V10, P181, DOI 10.1021/ol702522k; Zbieg JR, 2012, SCIENCE, V336, P324, DOI 10.1126/science.1219274; Zeng GX, 2011, INORG CHEM, V50, P10572, DOI 10.1021/ic200205e; Zeng HX, 2011, J AM CHEM SOC, V133, P1159, DOI 10.1021/ja106958s; Zhang J, 2006, ANGEW CHEM INT EDIT, V45, P1113, DOI 10.1002/anie.200503771; Zhang J, 2005, J AM CHEM SOC, V127, P10840, DOI 10.1021/ja052862b; Zhang J, 2004, ORGANOMETALLICS, V23, P4026, DOI 10.1021/om049716j; Zhang J, 2011, ORGANOMETALLICS, V30, P5716, DOI 10.1021/om200595m; Zhang M, 2013, ANGEW CHEM INT EDIT, V52, P597, DOI 10.1002/anie.201206082	101	1026	1043	41	934	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143					249	+	1229712	10.1126/science.1229712	http://dx.doi.org/10.1126/science.1229712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869021				2022-12-28	WOS:000321959300033
J	Bianco, P				Bianco, Paolo			Don't market stem-cell products ahead of proof	NATURE			English	Editorial Material									Sapienza Univ Rome, Rome, Italy	Sapienza University Rome	Bianco, P (corresponding author), Sapienza Univ Rome, Rome, Italy.	paolo.bianco@uniroma1.it						[Anonymous], 2013, NATURE, V499, P125	1	23	23	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					255	255		10.1038/499255a	http://dx.doi.org/10.1038/499255a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23868224	Bronze			2022-12-28	WOS:000321910700004
J	Clevers, H				Clevers, Hans			The Intestinal Crypt, A Prototype Stem Cell Compartment	CELL			English	Review							MOUSE SMALL INTESTINE; WNT/BETA-CATENIN; BETA-CATENIN; PANETH CELLS; PROGENITOR CELLS; SECRETORY PROGENITOR; JUVENILE POLYPOSIS; COLORECTAL-CANCER; SELF-RENEWAL; IN-VITRO		[Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr, NL-3584 CX Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu						Andreu P, 2008, DEV BIOL, V324, P288, DOI 10.1016/j.ydbio.2008.09.027; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Bjerknes M, 2012, DEV BIOL, V362, P194, DOI 10.1016/j.ydbio.2011.12.009; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Clevers H, 2013, CELL, V152, P1198, DOI 10.1016/j.cell.2013.02.030; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; de Lau W, 2012, MOL CELL BIOL, V32, P3639, DOI 10.1128/MCB.00434-12; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Escobar M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1260; Estivariz CF, 1998, JPEN-PARENTER ENTER, V22, P259, DOI 10.1177/0148607198022005259; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; FRIEDMAN NB, 1945, J EXP MED, V81, P553, DOI 10.1084/jem.81.6.553; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; LEBLOND CP, 1958, ANAT REC, V132, P247, DOI 10.1002/ar.1091320303; LEBLOND CP, 1948, ANAT REC, V100, P357, DOI 10.1002/ar.1091000306; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lieberkuhn J.N., 1745, THESIS; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Lopez-Diaz L, 2007, DEV BIOL, V309, P298, DOI 10.1016/j.ydbio.2007.07.015; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; May CL, 2010, MOL CELL ENDOCRINOL, V323, P70, DOI 10.1016/j.mce.2009.12.009; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Paneth J., 1887, ARCH MIKROSK ANAT, V31, P113, DOI [10.1007/BF02955706, DOI 10.1007/BF02955706]; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; QUASTLER H, 1959, EXP CELL RES, V17, P420, DOI 10.1016/0014-4827(59)90063-1; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038965; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; Stamataki D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024484; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; STEVENS CE, 1947, ANAT REC, V97, P373; Stringari C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00568; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Ueo T, 2012, DEVELOPMENT, V139, P1071, DOI 10.1242/dev.069070; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; VanDussen KL, 2010, DEV BIOL, V346, P215, DOI 10.1016/j.ydbio.2010.07.026; Vidrich A, 2009, AM J PHYSIOL-GASTR L, V297, pG168, DOI 10.1152/ajpgi.90589.2008; WALKER BE, 1958, EXP CELL RES, V14, P510, DOI 10.1016/0014-4827(58)90158-7; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	122	713	740	9	168	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 18	2013	154	2					274	284		10.1016/j.cell.2013.07.004	http://dx.doi.org/10.1016/j.cell.2013.07.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870119	Bronze			2022-12-28	WOS:000321950700006
J	Garcia-Reitboeck, P; Al-Memar, A				Garcia-Reitboeck, Pablo; Al-Memar, Ali			Reversible Cerebral Vasoconstriction after Preeclampsia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Garcia-Reitboeck, Pablo; Al-Memar, Ali] St George Hosp, London, England	St Georges University London	Garcia-Reitboeck, P (corresponding author), St George Hosp, London, England.	pgarciareitboeck@gmail.com		Garcia Reitboeck, Pablo/0000-0003-3315-4877					0	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	2013	369	3					E4	E4		10.1056/NEJMicm1204506	http://dx.doi.org/10.1056/NEJMicm1204506			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DQ	23863073				2022-12-28	WOS:000321945800001
J	Reining, A; Nozinovic, S; Schlepckow, K; Buhr, F; Furtig, B; Schwalbe, H				Reining, Anke; Nozinovic, Senada; Schlepckow, Kai; Buhr, Florian; Fuertig, Boris; Schwalbe, Harald			Three-state mechanism couples ligand and temperature sensing in riboswitches	NATURE			English	Article							BASE-PAIR RESOLUTION; ADENINE RIBOSWITCH; ESCHERICHIA-COLI; GENE-EXPRESSION; MESSENGER-RNAS; MELTING CURVES; NMR; BINDING; SPECTROSCOPY; TRANSCRIPTION	Riboswitches are cis-acting gene-regulatory RNA elements that can function at the level of transcription, translation and RNA cleavage(1-3). The commonly accepted molecular mechanism for riboswitch function proposes a ligand-dependent conformational switch between two mutually exclusive states(4). According to this mechanism, ligand binding to an aptamer domain induces an allosteric conformational switch of an expression platform, leading to activation or repression of ligand-related gene expression(5). However, many riboswitch properties cannot be explained by a pure two-state mechanism. Here we show that the regulation mechanism of the adenine-sensing riboswitch, encoded by the add gene on chromosome II of the human Gram-negative pathogenic bacterium Vibrio vulnificus(6), is notably different from a two-state switch mechanism in that it involves three distinct stable conformations. We characterized the temperature and Mg2+ dependence of the population ratios of the three conformations and the kinetics of their interconversion at nucleotide resolution. The observed temperature dependence of a pre-equilibrium involving two structurally distinct ligand-free conformations of the add riboswitch conferred efficient regulation over a physiologically relevant temperature range. Such robust switching is a key requirement for gene regulation in bacteria that have to adapt to environments with varying temperatures. The translational adenine-sensing riboswitch represents the first example, to our knowledge, of a temperature-compensated regulatory RNA element.	[Reining, Anke; Nozinovic, Senada; Schlepckow, Kai; Buhr, Florian; Fuertig, Boris; Schwalbe, Harald] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Schwalbe, H (corresponding author), Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Ctr Biomol Magnet Resonance, Max von Laue Str 7, D-60438 Frankfurt, Germany.	fuertig@nmr.uni-frankfurt.de; schwalbe@nmr.uni-frankfurt.de	Schwalbe, Harald J/F-9023-2010; Schwalbe, Harald/AAB-3143-2020	Schwalbe, Harald J/0000-0001-5693-7909; Schwalbe, Harald/0000-0001-5693-7909; Furtig, Boris/0000-0001-6443-7656	German funding agency (DFG) in Collaborative Research Center 902	German funding agency (DFG) in Collaborative Research Center 902	We thank E. Stirnal, H. Keller and C. Richter for technical support. We thank F. Narberhaus, J. Wohnert, J. Wachtveitl, J. Soppa, E. Schleiff, A. Heckel, M. Hengesbach and C. Griesinger for stimulating discussions. This work was funded by the German funding agency (DFG) in Collaborative Research Center 902.	Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Birikh KR, 1997, EUR J BIOCHEM, V245, P1, DOI 10.1111/j.1432-1033.1997.t01-3-00001.x; Buck J, 2007, P NATL ACAD SCI USA, V104, P15699, DOI 10.1073/pnas.0703182104; Dixon N, 2010, P NATL ACAD SCI USA, V107, P2830, DOI 10.1073/pnas.0911209107; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fasman GD, 1975, HDB BIOCH MOL BIOL, VI, P65; Garst AD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003533; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Kortmann J, 2012, NAT REV MICROBIOL, V10, P255, DOI 10.1038/nrmicro2730; Lee MK, 2010, P NATL ACAD SCI USA, V107, P9192, DOI 10.1073/pnas.1001195107; Lemay JF, 2007, RNA, V13, P339, DOI 10.1261/rna.142007; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Li YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025286, 10.1371/journal.pone.0018954]; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Mok KH, 2003, J AM CHEM SOC, V125, P12484, DOI 10.1021/ja036357v; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Neupane K, 2011, NUCLEIC ACIDS RES, V39, P7677, DOI 10.1093/nar/gkr305; Noeske J, 2005, P NATL ACAD SCI USA, V102, P1372, DOI 10.1073/pnas.0406347102; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Rinnenthal J, 2010, NUCLEIC ACIDS RES, V38, P3834, DOI 10.1093/nar/gkq124; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Stoddard CD, 2013, J MOL BIOL, V425, P1596, DOI 10.1016/j.jmb.2013.02.023; Stoldt M, 1999, EMBO J, V18, P6508, DOI 10.1093/emboj/18.22.6508; Wacker A, 2012, RNA BIOL, V9, P672, DOI 10.4161/rna.20106; Wang JB, 2009, J MOL BIOL, V393, P717, DOI 10.1016/j.jmb.2009.08.001; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Wilson RC, 2011, J MOL BIOL, V405, P926, DOI 10.1016/j.jmb.2010.10.056; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2003, CHEMBIOCHEM, V4, P1024, DOI 10.1002/cbic.200300685; Xu Q, 2003, P NATL ACAD SCI USA, V100, P1286, DOI 10.1073/pnas.0337479100	36	142	145	3	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					355	U135		10.1038/nature12378	http://dx.doi.org/10.1038/nature12378			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23842498				2022-12-28	WOS:000321910700040
J	Seabrook, GR				Seabrook, Gary R.			Does Rigorous Quality Process Reporting Guarantee Superior-Quality Health Care?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SURGICAL-SITE INFECTIONS; RISK	IMPORTANCE Timing of prophylactic antibiotic administration for surgical procedures is a nationally mandated and publicly reported quality metric sponsored by the Centers for Medicare and Medicaid Services Surgical Care Improvement Project. Numerous studies have failed to demonstrate that adherence to the Surgical Care Improvement Project prophylactic antibiotic timely administration measure is associated with decreased surgical site infection (SSI). OBJECTIVE To determine whether prophylactic antibiotic timing is associated with SSI occurrence. DESIGN Retrospective cohort study using national Veterans Affairs patient-level data on prophylactic antibiotic timing for orthopedic, colorectal, vascular, and gynecologic procedures from 2005 through 2009. SETTING National Veterans Affairs Surgical Care Improvement Project data from 112 Veterans Affairs hospitals and matched Veterans Affairs Surgical Quality Improvement Program data. PATIENTS Patients undergoing hip or knee arthroplasty, colorectal surgical procedures, arterial vascular surgical procedures, and hysterectomy. INTERVENTION Timing of prophylactic antibiotic administration with respect to surgical incision time. MAIN OUTCOMES AND MEASURES Data for prophylactic antibiotic agent, prophylactic antibiotic timing with respect to surgical incision, and patient and procedure risk variables were assessed for their relationship with the occurrence of a composite superficial or deep incisional SSI within 30 days after the procedure. Nonlinear generalized additive models were used to examine the association between antibiotic timing and SSI. RESULTS Of the 32 459 operations, prophylactic antibiotics were administered at a median of 28 minutes (interquartile range, 17-39minutes) prior to surgical incision, and 1497 cases (4.6%) developed an SSI. Compared with procedures with antibiotic administration within 60 minutes prior to incision, higher SSI rates were observed for timing more than 60 minutes prior to incision (unadjusted odds ratio [OR] = 1.34; 95% CI, 1.08-1.66) but not after incision (unadjusted OR = 1.26; 95% CI, 0.92-1.72). In unadjusted generalized additive models, we observed a significant nonlinear relationship between prophylactic antibiotic timing and SSI when considering timing as a continuous variable (P = .01). In generalized additive models adjusted for patient, procedure, and antibiotic variables, no significant association between prophylactic antibiotic timing and SSI was observed. Vancomycin hydrochloride was associated with higher SSI occurrence for orthopedic procedures (adjusted OR = 1.75; 95% CI, 1.16-2.65). Cefazolin sodium and quinolone in combination with an anaerobic agent were associated with fewer SSI events (cefazolin: adjusted OR = 0.49; 95% CI, 0.34-0.71; quinolone: adjusted OR = 0.55; 95% CI, 0.35-0.87) for colorectal procedures. CONCLUSIONS AND RELEVANCE The SSI risk varies by patient and procedure factors as well as antibiotic properties but is not significantly associated with prophylactic antibiotic timing. While adherence to the timely prophylactic antibiotic measure is not bad care, there is little evidence to suggest that it is better care.	Med Coll Wisconsin, Div Vasc Surg, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Seabrook, GR (corresponding author), Med Coll Wisconsin, Div Vasc Surg, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	gseabroo@mcw.edu						[Anonymous], FED REG; Centers for Medicare & Medicaid Services, 2011, FED REGISTER, V76, P74538; Darouiche RO, 2010, NEW ENGL J MED, V362, P18, DOI 10.1056/NEJMoa0810988; Edmiston CE, 2008, J AM COLL SURGEONS, V207, P233, DOI 10.1016/j.jamcollsurg.2007.12.054; Edmiston CE, 2013, SURGERY, V154, P89, DOI 10.1016/j.surg.2013.03.008; Edmiston CE, 2011, SURG INFECT, V12, P169, DOI 10.1089/sur.2011.036; Hawn MT, 2011, ANN SURG, V254, P494, DOI 10.1097/SLA.0b013e31822c6929; Hawn MT, JAMA SURG, DOI 10.100/jamasurg.2013.134; Lyu H, 2013, JAMA SURG, V148, P362, DOI 10.1001/2013.jamasurg.270; Nicholas LH, 2010, ARCH SURG-CHICAGO, V145, P999, DOI 10.1001/archsurg.2010.191	10	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					316	317		10.1001/jama.2013.7131	http://dx.doi.org/10.1001/jama.2013.7131			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23860990				2022-12-28	WOS:000321835700019
J	Batail, P				Batail, Patrick			Tuning Molecular Solids	SCIENCE			English	Editorial Material							ORGANIC FRAMEWORK		Univ Angers, Moltech Lab, CNRS UMR 6200, F-49045 Angers 01, France	Centre National de la Recherche Scientifique (CNRS); Universite d'Angers	Batail, P (corresponding author), Univ Angers, Moltech Lab, CNRS UMR 6200, F-49045 Angers 01, France.	patrick.batail@univ-angers.fr						Bennett MV, 2001, J AM CHEM SOC, V123, P8022, DOI 10.1021/ja0110473; Besara T, 2011, P NATL ACAD SCI USA, V108, P6828, DOI 10.1073/pnas.1102079108; Burdett J.K., 1995, CHEM BONDING SOLIDS; Cheetham AK, 2006, CHEM COMMUN, P4780, DOI 10.1039/b610264f; Fu DW, 2013, SCIENCE, V339, P425, DOI [10.1126/science.1230473, 10.1126/science.1229675]; Heuze K, 1999, CHEM-EUR J, V5, P2971, DOI 10.1002/(SICI)1521-3765(19991001)5:10<2971::AID-CHEM2971>3.0.CO;2-S; HUMMELEN JC, 1995, J ORG CHEM, V60, P532, DOI 10.1021/jo00108a012; O'Keeffe M, 2000, J SOLID STATE CHEM, V152, P3, DOI 10.1006/jssc.2000.8723; Rosseinsky MJ, 1998, CHEM MATER, V10, P2665, DOI 10.1021/cm980226p; Roy X, 2013, SCIENCE, V341, P157, DOI 10.1126/science.1236259; Yu J. G. G., 1995, SCIENCE, V270, P1789	11	5	5	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					135	136		10.1126/science.1240813	http://dx.doi.org/10.1126/science.1240813			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23846895				2022-12-28	WOS:000321965300027
J	Chaigne-Delalande, B; Li, FY; O'Connor, GM; Lukacs, MJ; Jiang, P; Zheng, LX; Shatzer, A; Biancalana, M; Pittaluga, S; Matthews, HF; Jancel, TJ; Bleesing, JJ; Marsh, RA; Kuijpers, TW; Nichols, KE; Lucas, CL; Nagpal, S; Mehmet, H; Su, HC; Cohen, JI; Uzel, G; Lenardo, MJ				Chaigne-Delalande, Benjamin; Li, Feng-Yen; O'Connor, Geraldine M.; Lukacs, Marshall J.; Jiang, Ping; Zheng, Lixin; Shatzer, Amber; Biancalana, Matthew; Pittaluga, Stefania; Matthews, Helen F.; Jancel, Timothy J.; Bleesing, Jack J.; Marsh, Rebecca A.; Kuijpers, Taco W.; Nichols, Kim E.; Lucas, Carrie L.; Nagpal, Sunil; Mehmet, Huseyin; Su, Helen C.; Cohen, Jeffrey I.; Uzel, Gulbu; Lenardo, Michael J.			Mg2+ Regulates Cytotoxic Functions of NK and CD8 T Cells in Chronic EBV Infection Through NKG2D	SCIENCE			English	Article							KILLER-CELLS; MAGNESIUM; MAGT1; ACTIVATION; COSTIMULATION; SURVEILLANCE; METABOLISM; GROWTH; TRPM7	The magnesium transporter 1 (MAGT1) is a critical regulator of basal intracellular free magnesium (Mg2+) concentrations. Individuals with genetic deficiencies in MAGT1 have high levels of Epstein-Barr virus (EBV) and a predisposition to lymphoma. We show that decreased intracellular free Mg2+ causes defective expression of the natural killer activating receptor NKG2D in natural killer (NK) and CD8(+) T cells and impairs cytolytic responses against EBV. Notably, magnesium supplementation in MAGT1-deficient patients restores intracellular free Mg2+ and NKG2D while concurrently reducing EBV-infected cells in vivo, demonstrating a link between NKG2D cytolytic activity and EBV antiviral immunity in humans. Moreover, these findings reveal a specific molecular function of free basal intracellular Mg2+ in eukaryotic cells.	[Chaigne-Delalande, Benjamin; Li, Feng-Yen; Lukacs, Marshall J.; Jiang, Ping; Zheng, Lixin; Biancalana, Matthew; Matthews, Helen F.; Lucas, Carrie L.; Lenardo, Michael J.] NIAID, Mol Dev Immune Syst Sect, Lymphocyte Mol Genet Unit, Immunol Lab,NIH, Bethesda, MD 20892 USA; [Li, Feng-Yen] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [O'Connor, Geraldine M.; Cohen, Jeffrey I.] Frederick Natl Lab Canc Res, Canc & Inflammat Program, Expt Immunol Lab, Frederick, MD 21702 USA; [Shatzer, Amber] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Pittaluga, Stefania] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Jancel, Timothy J.] NIH, Ctr Clin, Dept Pharm, Bethesda, MD 20892 USA; [Bleesing, Jack J.; Marsh, Rebecca A.] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA; [Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Nichols, Kim E.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Nagpal, Sunil; Mehmet, Huseyin] Merck Res Labs, Resp & Immunol Div, Boston, MA USA; [Su, Helen C.] NIAID, Immunol Dis Unit, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Uzel, Gulbu] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Cincinnati Children's Hospital Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Merck & Company; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lenardo, MJ (corresponding author), NIAID, Mol Dev Immune Syst Sect, Lymphocyte Mol Genet Unit, Immunol Lab,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	lenardo@nih.gov	Timothy Jancel, PharmD/K-5570-2019; Su, Helen C/H-9541-2015; Nichols, Kim/E-9353-2016; Nichols, Kim/AAP-8592-2020	Timothy Jancel, PharmD/0000-0002-2022-0970; Su, Helen C/0000-0002-5582-9110; Nichols, Kim/0000-0002-5581-6555; Nichols, Kim/0000-0002-5581-6555; O'Connor, Geraldine/0000-0002-7440-162X; Biancalana, Matthew/0000-0002-1078-1838; Lucas, Carrie/0000-0002-5754-0820	Division of Intramural Research, National Institute of Allergy and Infectious Diseases; National Cancer Institute, NIH; Medical Scientist Training Program at the University of California-San Francisco; NIH; Pharmacology Research Associate Training (PRAT) program; National Institute of General Medical Sciences, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000769, ZIAAI000913, ZIAAI000717, ZIAAI000565, ZIAAI001059, ZIAAI000566, ZIAAI000718, ZIAAI001187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL006002] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Scientist Training Program at the University of California-San Francisco; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacology Research Associate Training (PRAT) program; National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CLINICAL CENTER	This research was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases and the National Cancer Institute, NIH. We thank H. Malech, A. Snow, J. Niemela, G. Fahle, and T. Dimaggio for assistance in various aspects of the research and patient evaluation and S. Holland for clinical insights and support. We also thank R. Germain, P. Schwartzberg, R. Siegel, T. Waldmann, K. Schafer-Weaver, C. Kanellopoulou, S. Muljo, D. McVicar, J. Milner, R. Baker, and S. Holland for critically reading the manuscript. We thank E. Long and S. Rajagopalan for sharing antibodies and cell lines and helpful assistance with NK experiments; we also thank K. Dowdell, R. Orentas, and B. Lafont for sharing reagents and D. Douek, D. Price, and M. Quigley for assistance with tetramer staining. We are grateful to Merck Research Laboratories for generous support in kind of reagents and materials, and to P. R. Vagelos and R. Vessey for fostering the collaboration. F.-Y.L. was supported by the Medical Scientist Training Program at the University of California-San Francisco and the NIH M.D./Ph.D. Partnership program, and thanks K. Shannon and J. Toutolmin for support and encouragement. We also acknowledge support by the Pharmacology Research Associate Training (PRAT) program (to C. L. L.), National Institute of General Medical Sciences, NIH. The data presented in this paper are tabulated in the main paper and in the supplementary materials.	Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Deason-Towne F, 2011, FEBS LETT, V585, P2275, DOI 10.1016/j.febslet.2011.05.052; Filipovich AH, 2010, BLOOD, V116, P3398, DOI 10.1182/blood-2010-03-275909; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; GRUBBS RD, 1987, MAGNESIUM, V6, P113; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hayakawa Y, 2006, SEMIN IMMUNOL, V18, P176, DOI 10.1016/j.smim.2006.03.005; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Li FY, 2011, MAGNESIUM RES, V24, pS109, DOI 10.1684/mrh.2011.0286; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Nakajima H, 2000, EUR J IMMUNOL, V30, P3309, DOI 10.1002/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3; Obeidy P, 2009, INT J BIOCHEM CELL B, V41, P2364, DOI 10.1016/j.biocel.2009.07.005; Ogasawara K, 2005, J CLIN IMMUNOL, V25, P534, DOI 10.1007/s10875-005-8786-4; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Palendira U, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001187; Pappworth IY, 2007, J VIROL, V81, P474, DOI 10.1128/JVI.01777-06; Park YP, 2011, BLOOD, V118, P3019, DOI 10.1182/blood-2011-04-346825; Pievani A, 2011, BLOOD, V118, P3301, DOI 10.1182/blood-2011-02-336321; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; Reiners KS, 2013, MOL THER, V21, P895, DOI 10.1038/mt.2013.14; Rettinger E, 2012, CYTOTHERAPY, V14, P91, DOI 10.3109/14653249.2011.613931; Rezaei N, 2011, J ALLERGY CLIN IMMUN, V127, P1329, DOI 10.1016/j.jaci.2011.02.047; Rezaei N, 2011, BRIT J HAEMATOL, V152, P13, DOI 10.1111/j.1365-2141.2010.08442.x; RUBIN H, 1975, P NATL ACAD SCI USA, V72, P3551, DOI 10.1073/pnas.72.9.3551; Schweigel M, 2008, MAGNESIUM RES, V21, P118; Sharifi R, 2004, BLOOD, V103, P3821, DOI 10.1182/blood-2003-09-3359; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Slavuljica I, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00085; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Wang R, 2012, P NATL ACAD SCI USA, V109, pE3578, DOI 10.1073/pnas.1214088109; Wolf FI, 2010, CELL CYCLE, V9, P3399, DOI 10.4161/cc.9.17.13072; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106; Zingoni A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00408	37	198	206	6	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2013	341	6142					186	191		10.1126/science.1240094	http://dx.doi.org/10.1126/science.1240094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23846901	Green Accepted			2022-12-28	WOS:000321965300046
J	Garcia-Sastre, A				Garcia-Sastre, Adolfo			Lessons from Lipids in the Fight against Influenza	CELL			English	Editorial Material									[Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Garcia-Sastre, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	adolfo.garcia-sastre@mssm.edu						Korth MJ, 2013, SEMIN IMMUNOL, V25, P228, DOI 10.1016/j.smim.2012.11.001; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Shaw ML, 2011, REV MED VIROL, V21, P358, DOI 10.1002/rmv.703	3	10	10	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					22	23		10.1016/j.cell.2013.06.024	http://dx.doi.org/10.1016/j.cell.2013.06.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827671	Bronze			2022-12-28	WOS:000321327900006
J	Gnann, JW; Whitley, RJ				Gnann, JW; Whitley, RJ			Herpes zoster	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RELIEVES POSTHERPETIC NEURALGIA; HUMAN-IMMUNODEFICIENCY-VIRUS; PLACEBO-CONTROLLED TRIAL; CONTROLLED CLINICAL-TRIAL; VARICELLA-ZOSTER; ORAL ACYCLOVIR; RANDOMIZED TRIAL; NATURAL-HISTORY; DOUBLE-BLIND; PAIN		Univ Alabama Birmingham, Div Infect Dis, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; Vet Affairs Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Gnann, JW (corresponding author), Univ Alabama Birmingham, Div Infect Dis, Dept Med, 845 S 19th St,BBRB 220, Birmingham, AL 35294 USA.				Intramural NIH HHS [Z01 AI000430-23] Funding Source: Medline; NCRR NIH HHS [RR-032] Funding Source: Medline; NIAID NIH HHS [N01-AI-15113, N01-AI-62554, N01-AI-12667] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alper BS, 2000, J FAM PRACTICE, V49, P255; BERNSTEIN JE, 1989, J AM ACAD DERMATOL, V21, P265, DOI 10.1016/S0190-9622(89)70171-7; BEUTNER KR, 1995, ANTIMICROB AGENTS CH, V39, P1546, DOI 10.1128/AAC.39.7.1546; Bowsher D, 1997, J PAIN SYMPTOM MANAG, V13, P327, DOI 10.1016/S0885-3924(97)00077-8; BUCHBINDER SP, 1992, J INFECT DIS, V166, P1153, DOI 10.1093/infdis/166.5.1153; Choo PW, 1997, ARCH INTERN MED, V157, P1217, DOI 10.1001/archinte.157.11.1217; CHOO PW, 1995, J INFECT DIS, V172, P706, DOI 10.1093/infdis/172.3.706; COBO LM, 1986, OPHTHALMOLOGY, V93, P763; COBO M, 1987, CURR EYE RES, V6, P195, DOI 10.3109/02713688709020090; Cohen JI, 1999, ANN INTERN MED, V130, P922, DOI 10.7326/0003-4819-130-11-199906010-00017; Colin J, 2000, OPHTHALMOLOGY, V107, P1507, DOI 10.1016/S0161-6420(00)00222-0; Dahl H, 1997, J CLIN MICROBIOL, V35, P347, DOI 10.1128/JCM.35.2.347-349.1997; Decroix J, 2000, J EUR ACAD DERMATOL, V14, P23, DOI 10.1046/j.1468-3083.2000.00020.x; DEMORAGAS JM, 1957, ARCH DERMATOL, V75, P193, DOI 10.1001/archderm.1957.01550140037006; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; Dworkin RH, 1996, PAIN, V67, P241, DOI 10.1016/0304-3959(96)03122-3; Dworkin RH, 2000, CLIN J PAIN, V16, pS90, DOI 10.1097/00002508-200006001-00016; Galer BS, 1999, PAIN, V80, P533, DOI 10.1016/S0304-3959(98)00244-9; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; GLESBY MJ, 1995, CLIN INFECT DIS, V21, P370, DOI 10.1093/clinids/21.2.370; Gnann JW, 1998, ANTIMICROB AGENTS CH, V42, P1139, DOI 10.1128/AAC.42.5.1139; GNANN JW, 1991, J HOSP INFECT, V18, P317, DOI 10.1016/0195-6701(91)90038-A; Harrison RA, 1999, J PAIN SYMPTOM MANAG, V17, P410, DOI 10.1016/S0885-3924(99)00013-5; HUFF JC, 1988, AM J MED, V85, P84; Jackson JL, 1997, ARCH INTERN MED, V157, P909, DOI 10.1001/archinte.157.8.909; Kanazi GE, 2000, DRUGS, V59, P1113, DOI 10.2165/00003495-200059050-00007; KISHOREKUMAR R, 1990, CLIN PHARMACOL THER, V47, P305, DOI 10.1038/clpt.1990.33; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; Kotani N, 2000, NEW ENGL J MED, V343, P1514, DOI 10.1056/NEJM200011233432102; Levin MJ, 1998, J INFECT DIS, V178, pS109, DOI 10.1086/514264; Liesegang TJ, 1999, MAYO CLIN PROC, V74, P983; MAX MB, 1988, NEUROLOGY, V38, P1427, DOI 10.1212/WNL.38.9.1427; MCKENDRICK MW, 1986, BRIT MED J, V293, P1529, DOI 10.1136/bmj.293.6561.1529; MCKENDRICK MW, 1989, BRIT MED J, V298, P431, DOI 10.1136/bmj.298.6671.431; MORTON P, 1989, NEW ZEAL MED J, V102, P93; Ormerod LD, 1998, CLIN INFECT DIS, V26, P34, DOI 10.1086/516285; Oxman MN, 1995, NEUROLOGY, V45, pS41, DOI 10.1212/WNL.45.12_Suppl_8.S41; RAGOZZINO MW, 1982, NEW ENGL J MED, V307, P393, DOI 10.1056/NEJM198208123070701; RAGOZZINO MW, 1982, MEDICINE, V61, P310, DOI 10.1097/00005792-198209000-00003; Rowbotham M, 1998, JAMA-J AM MED ASSOC, V280, P1837, DOI 10.1001/jama.280.21.1837; SAFRIN S, 1991, ANN INTERN MED, V115, P19, DOI 10.7326/0003-4819-115-1-19; THANH HX, 1992, OPHTHALMOLOGY, V99, P1062; TYRING S, 1995, ANN INTERN MED, V123, P89, DOI 10.7326/0003-4819-123-2-199507150-00002; Tyring S, 2001, BRIT J OPHTHALMOL, V85, P576, DOI 10.1136/bjo.85.5.576; Tyring SK, 2000, ARCH FAM MED, V9, P863, DOI 10.1001/archfami.9.9.863; Volmink J, 1996, FAM PRACT, V13, P84, DOI 10.1093/fampra/13.1.84; Watson CPN, 1998, NEUROLOGY, V50, P1837; Whitley RJ, 1999, J INFECT DIS, V179, P9, DOI 10.1086/314562; Whitley RJ, 1996, ANN INTERN MED, V125, P376, DOI 10.7326/0003-4819-125-5-199609010-00004; Wood MJ, 1998, J INFECT DIS, V178, pS81, DOI 10.1086/514271; WOOD MJ, 1994, NEW ENGL J MED, V330, P896, DOI 10.1056/NEJM199403313301304; Wood MJ, 1996, CLIN INFECT DIS, V22, P341, DOI 10.1093/clinids/22.2.341; Wu CL, 2000, PAIN, V87, P121, DOI 10.1016/S0304-3959(00)00230-X	53	812	850	5	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2002	347	5					340	346		10.1056/NEJMcp013211	http://dx.doi.org/10.1056/NEJMcp013211			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	587WC	12151472				2022-12-28	WOS:000177665900008
